PT	AU	BA	BE	GP	AF	BF	CA	TI	SO	SE	BS	LA	DT	CT	CY	CL	SP	HO	DE	ID	AB	C1	RP	EM	RI	OI	FU	FX	CR	NR	TC	Z9	PU	PI	PA	SN	EI	BN	J9	JI	PD	PY	VL	IS	PN	SU	SI	MA	BP	EP	AR	DI	D2	PG	WC	SC	GA	UT	PM
J	Adamczewska, AM; Morris, S				Adamczewska, AM; Morris, S			Locomotion, respiratory physiology, and energetics of amphibious and terrestrial crabs	PHYSIOLOGICAL AND BIOCHEMICAL ZOOLOGY			English	Article; Proceedings Paper	5th International Congress of Comparative Physiology and Biochemistry (ICCPB '99)	AUG 23-28, 1999	UNIV CALGARY, CALGARY, CANADA		UNIV CALGARY		FRESH-WATER CRAB; ACID-BASE STATUS; HEMOLYMPH OXYGEN-TRANSPORT; CARDISOMA-HIRTIPES DANA; ISLAND BLUE-CRAB; CRAYFISH AUSTROPOTAMOBIUS-PALLIPES; CRUSTACEAN HYPERGLYCEMIC HORMONE; POTAMONAUTES-WARRENI CALMAN; YABBY CHERAX-DESTRUCTOR; HEMIGRAPSUS-NUDUS DANA	The transition from breathing air to breathing water requires physiological and morphological adaptations. The study of crustaceans in transitional habitats provides important information as to the nature of these adaptations. This article addresses the physiology of air breathing in amphibious and terrestrial crabs and their relative locomotor abilities. Potamonautes warreni is an apparently amphibious freshwater crab from southern Africa, Cardisoma hirtipes is an air-breathing gecarcinid crab with some dependency on freshwater, and Gecarcoidea natalis is an obligate air-breathing gecarcinid endemic to Christmas Island in the Indian Ocean. All three species have well-developed lungs but retain gills and show seasonally different activity patterns that, in the gercarcinids, especially G. natalis, include long-distance breeding migrations. The three species were better at breathing air than water, but P. warreni was the best at breathing water. Cardisoma hirtipes is essentially an obligate air breather and appears to experience facultative hypometabolism during immersion. Cardisoma hirtipes has a haemocyanin with a high affinity for O-2 that facilitates loading from air but makes 30% of the Hc bound O-2 inaccessible. The gecarcinids but not P. warreni show increased diffusion limitation for O-2 over the lung during exercise. Gecarcoidea natalis outperforms C. hirtipes by virtue of a unique haemolymph shunt from the lung into the gills. Paradoxically, it is modifications of the gills for aerial O-2 uptake in G. natalis that allow for relatively greater haemolymph oxygenation. Despite showing decreased arterial-venous Delta Po-2, P. warreni increased the arterial-venous Delta [O-2] with no recourse to anaerobiosis during 5 min exercise. In the short term, P. warreni is more adept at walking than C. hirtipes. The breeding migrations of C. hirtipes and G. natalis were completely aerobic, but G. natalis walk farther and probably faster. Seasonal changes in underlying metabolism of G. natalis are strongly implied, including variations in hyperglycaemic hormone, variable basal metabolic rates, and a diel alkalosis present only in migrating crabs. The persistent dependence on water for reproduction is a determining factor in the biology of air-breathing crabs. The annual migrations include costs other than locomotion, for example, burrow construction and intermale competition. Estimates of costs that consider walking alone will underestimate the metabolic and stored fuel requirements for successful reproduction.	Univ Tokyo, Ocean Res Inst, InterRidge Off, Nakano Ku, Tokyo 1648639, Japan; Univ Bristol, Sch Biol Sci, Morlab, Bristol BS8 1UG, Avon, England	Adamczewska, AM (reprint author), Univ Tokyo, Ocean Res Inst, InterRidge Off, Nakano Ku, 1-15-1 Minamidai, Tokyo 1648639, Japan.						Adamczewska AM, 1998, J EXP BIOL, V201, P3233; Adamczewska AM, 1997, J CRUSTACEAN BIOL, V17, P596, DOI 10.2307/1549363; ADAMCZEWSKA AM, 1994, J EXP BIOL, V188, P257; ADAMCZEWSKA AM, 2001, IN PRESS BIOL B; ADAMCZEWSKA AM, 1994, J EXP BIOL, V188, P235; Adamczewska AM, 1998, J EXP BIOL, V201, P3221; Adamczewska AM, 2000, J EXP ZOOL, V286, P552, DOI 10.1002/(SICI)1097-010X(20000501)286:6<552::AID-JEZ2>3.0.CO;2-J; Adamczewska AM, 1996, PHYSIOL ZOOL, V69, P67; TAYLOR EW, 1978, J COMP PHYSIOL, V127, P315; FARRELLY CA, 1992, ZOOMORPHOLOGY, V112, P39, DOI 10.1007/BF01632993; HENRY RP, 1994, AM ZOOL, V34, P205; DIAZ H, 1977, BIOL BULL, V153, P485, DOI 10.2307/1540602; CAMERON JN, 1985, J EXP BIOL, V114, P197; LUSCHEN W, 1993, COMP BIOCHEM PHYS C, V105, P291, DOI 10.1016/0742-8413(93)90210-C; TAYLOR HH, 1979, J ZOOL, V189, P359; BURNETT LE, 1988, AM ZOOL, V28, P125; LALLIER F, 1989, RESP PHYSIOL, V77, P323, DOI 10.1016/0034-5687(89)90120-5; GREENAWAY P, 1989, J EXP BIOL, V143, P333; FARRELLY CA, 1993, J MORPHOL, V215, P245, DOI 10.1002/jmor.1052150306; INNES AJ, 1986, COMP BIOCHEM PHYS A, V85, P621, DOI 10.1016/0300-9629(86)90271-9; Webster SG, 1996, J EXP BIOL, V199, P1579; GREENAWAY P, 1983, J EXP BIOL, V103, P237; WOOD CM, 1985, J EXP BIOL, V114, P151; MCMAHON BR, 1990, PHYSIOL ZOOL, V63, P35; BURNETT LE, 1987, PHYSIOL ZOOL, V60, P27; Thorpe KE, 1995, ANIM BEHAV, V50, P1657; WOOD CM, 1981, J EXP ZOOL, V218, P23, DOI 10.1002/jez.1402180104; Morris S, 2000, J EXP BIOL, V203, P389; FARRELLY CA, 1994, J EXP BIOL, V187, P113; PILLAY KK, 1973, MAR BIOL, V18, P167, DOI 10.1007/BF00367985; REGNAULT M, 1981, J COMP PHYSIOL, V141, P549; CHARMANTIER G, 1992, J CRUSTACEAN BIOL, V12, P620, DOI 10.2307/1548843; BISHOP J. A., 1963, AUSTRALIAN JOUR MAR AND FRESHWATER RES, V14, P218; Bliss D. E., 1978, B AM MUS NAT HIST, V160, P111; BOOTH CE, 1984, RESP PHYSL, V58, P395; Burggren W.W., 1988, P1, DOI 10.1017/CBO9780511753428.002; BURGGREN WW, 1981, J EXP ZOOL, V218, P53, DOI 10.1002/jez.1402180107; CAMERON JN, 1981, J EXP ZOOL, V218, P65, DOI 10.1002/jez.1402180108; Chang E.S., 1983, P263; Chung JS, 1996, EUR J BIOCHEM, V240, P358, DOI 10.1111/j.1432-1033.1996.0358h.x; COLCOTT TG, 1988, BIOL LAND CRABS, P55; de Wilde P. A. W. J., 1973, STUD FAUNA CURACAO, V44, P1; DEFURT PL, 1988, COMP BIOCHEM PHYS A, V89, P97, DOI 10.1016/0300-9629(88)91145-0; DEJOURS P., 1981, PRINCIPLES COMP RESP; DelaCruz J, 1997, J EXP ZOOL, V279, P537, DOI 10.1002/(SICI)1097-010X(19971215)279:6<537::AID-JEZ1>3.0.CO;2-O; DelaCruz J, 1997, PHYSIOL ZOOL, V70, P100; DeWachter B, 1996, J EXP BIOL, V199, P627; ENGLAND WR, 1983, PHYSIOL ZOOL, V56, P614; GHERARDI F, 1989, BIOL BEHAV, V14, P28; GHERARDI F, 1988, ETHOLOGY, V77, P300; GIBSON-HILL C. A., 1947, BULL RAFFLES MUS, V18, P43; GIFFORD CA, 1962, BIOL BULL, V97, P207; Gray HS, 1995, CHRISTMAS ISLAND NAT; GREEN PT, 1993, ROLE RED LAND CRABS; Green PT, 1997, J TROP ECOL, V13, P17; GREENAWAY P, 1994, J CRUSTACEAN BIOL, V14, P438, DOI 10.2307/1548991; Greenaway P, 1996, PHYSIOL ZOOL, V69, P785; GREENAWAY P, 1992, AUST J MAR FRESH RES, V43, P1573; GREENAWAY P, 1983, J EXP BIOL, V103, P225; GREENAWAY P, 1990, PHYSIOL ZOOL, V63, P117; GREENAWAY P, 1988, J EXP BIOL, V140, P493; GREENAWAY P, 1984, AUST J ZOOL, V32, P1, DOI 10.1071/ZO9840001; Hartnoll R.G., 1988, P6, DOI 10.1017/CBO9780511753428.003; HAWKINS AJS, 1982, J EXP MAR BIOL ECOL, V60, P103, DOI 10.1016/0022-0981(82)90153-8; HAWKINS AJS, 1998, COMP BIOCH PHYSL A, V73, P347; HENRY RP, 1994, J EXP BIOL, V186, P215; HENRY RP, 1991, J EXP ZOOL, V259, P294, DOI 10.1002/jez.1402590304; HERREID CF, 1979, RESPIR PHYSL, V36, P109; HERREIDII CF, 1983, COMP BIOCHEM PHYS A, V74, P117, DOI 10.1016/0300-9629(83)90721-1; Hicks J., 1990, CHRISTMAS CRABS; HICKS JW, 1985, AUST J ZOOL, V33, P127, DOI 10.1071/ZO9850127; INNES AJ, 1987, COMP BIOCHEM PHYS A, V87, P1, DOI 10.1016/0300-9629(87)90415-4; INNES AJ, 1986, J EXP MAR BIOL ECOL, V100, P127, DOI 10.1016/0022-0981(86)90159-0; ISHII K, 1989, RESP PHYSIOL, V78, P73, DOI 10.1016/0034-5687(89)90143-6; KLAASSEN F, 1975, Forma et Functio, V8, P101; KUCHARSKI LCR, 1991, COMP BIOCHEM PHYS A, V99, P215, DOI 10.1016/0300-9629(91)90261-A; LAKE PS, 1991, OIKOS, V62, P25, DOI 10.2307/3545442; LALLIER F, 1987, COMP BIOCHEM PHYS A, V86, P255, DOI 10.1016/0300-9629(87)90327-6; McMahon B.R., 1981, P299; McMahon B.R., 1988, P249, DOI 10.1017/CBO9780511753428.009; MCMAHON BR, 1979, J EXP BIOL, V80, P271; MICHELI F, 1990, FRESHWATER BIOL, V23, P491, DOI 10.1111/j.1365-2427.1990.tb00290.x; Morris S, 1996, J EXP MAR BIOL ECOL, V206, P149, DOI 10.1016/S0022-0981(96)02658-5; Morris S, 1998, J COMP PHYSIOL B, V168, P389, DOI 10.1007/s003600050158; MORRIS S, 1994, AM ZOOL, V34, P216; Morris S, 1996, PHYSIOL ZOOL, V69, P806; MORRIS S, 1991, J EXP BIOL, V161, P315; MORRIS S, 1998, ECOPHYSIOLOGICAL SIG; MORRIS S, 1986, J EXP BIOL, V121, P315; MORRIS S, 1991, Memoirs of the Queensland Museum, V31, P241; MORRIS S, 1990, J COMP PHYSIOL B, V160, P217, DOI 10.1007/BF00300957; MORRIS S, 1996, J CRUSTACEAN BIOL, V16, P252; NISHIDA S, 1995, MAR BIOL, V123, P837, DOI 10.1007/BF00349128; OMAHONEY PM, 1984, COMP BIOCHEM PHYS A, V79, P275, DOI 10.1016/0300-9629(84)90429-8; Piiper J., 1982, COMPANION ANIMAL PHY, P49; SHAH GM, 1978, COMP BIOCHEM PHYS A, V60, P335, DOI 10.1016/0300-9629(78)90258-X; SMATRESK NJ, 1979, J EXP ZOOL, V210, P205, DOI 10.1002/jez.1402100202; SMULLEN RP, 1994, INVERTEBR REPROD DEV, V26, P23, DOI 10.1080/07924259.1994.9672397; TAYLOR AC, 1982, COMP BIOCHEM PHYS A, V72, P683, DOI 10.1016/0300-9629(82)90148-7; TAYLOR AC, 1981, J EXP BIOL, V93, P197; TAYLOR EW, 1981, J EXP BIOL, V92, P109; TAYLOR EW, 1988, BIOL J LINN SOC, V34, P229, DOI 10.1111/j.1095-8312.1988.tb01961.x; Taylor H.H., 1992, P203; TAYLOR HH, 1984, J EXP BIOL, V111, P103; van Aardt W.J., 1990, Southern African Journal of Aquatic Sciences, V16, P16; VANAARDT WJ, 1993, COMP BIOCHEM PHYS A, V106, P31, DOI 10.1016/0300-9629(93)90034-2; VANAARDT WJ, 1990, S AFR J ZOOL, V25, P11; VARLEY DG, 1994, J EXP BIOL, V190, P179; WEINSTEIN RB, 1994, PHYSIOL ZOOL, V67, P873; WEINSTEIN RB, 1995, J EXP BIOL, V198, P989; WEINSTEIN RB, 1992, AM J PHYSIOL, V262, pR852; WILKENS JL, 1989, J COMP PHYSIOL B, V159, P29, DOI 10.1007/BF00692680; WOLCOTT DL, 1992, AM ZOOL, V32, P370; Wolcott T.G., 1985, Contributions in Marine Science, V27, P257; WOLCOTT TG, 1991, PHYSIOL ZOOL, V64, P344; WOLCOTT TG, 1985, J EXP MAR BIOL ECOL, V91, P93, DOI 10.1016/0022-0981(85)90223-0; WOOD CM, 1981, J EXP ZOOL, V218, P7, DOI 10.1002/jez.1402180103; WOOD CM, 1986, J EXP BIOL, V126, P271; Zoond A, 1931, J EXP BIOL, V8, P250	119	10	10	UNIV CHICAGO PRESS	CHICAGO	1427 E 60TH ST, CHICAGO, IL 60637-2954 USA	1522-2152			PHYSIOL BIOCHEM ZOOL	Physiol. Biochem. Zool.	NOV-DEC	2000	73	6					706	725		10.1086/318099		20	Physiology; Zoology	Physiology; Zoology	388GT	WOS:000166172300007		
J	Kikusui, T; Takeuchi, Y; Mori, Y				Kikusui, T; Takeuchi, Y; Mori, Y			Involvement of corticotropin-releasing factor in the retrieval process of fear-conditioned ultrasonic vocalization in rats	PHYSIOLOGY & BEHAVIOR			English	Article						contextual memory retrieval; CP-154,526; CRF; ultrasonic vocalization	MORRIS WATER MAZE; FACTOR CRF; RECEPTOR ANTAGONIST; RATTUS-NORVEGICUS; AGGRESSIVE ENCOUNTERS; HORMONE-SECRETION; PREWEANLING RATS; MEMORY RETENTION; TRANSGENIC MICE; LOCUS-COERULEUS	The role of the corticotropin-releasing factor (CRF) system in the fear-conditioned ultrasonic vocalizations (USVs) induced by foot shocks in rats was investigated. In the acquisition phase of fear conditioning, the intracerebroventricular administration of CRF receptor antagonist alpha -hCRF attenuated USV responses related to context memory. Even after experiencing eight consecutive days of foot-shock challenges, the alpha -hCRF group emitted similar number of USVs as the control group if they were not given the drug. After the conditioning phase, the groups treated with alpha -hCRF or CRF receptor 1 (CRFR1) antagonist CP-154,526 emitted fewer conditioned USVs than the control group, although there was no difference in the USVs after the shock, which reflected physical stress. These results suggest that the central CRF systems, especially those mediated via CRFR1, are involved in the retrieval process, but not the acquisition or retention processes, of fear-related memory. (C) 2000 Elsevier Science Inc. All rights reserved.	Univ Tokyo, Lab Vet Ethol, Tokyo, Japan	Kikusui, T (reprint author), 1-1-1 Yayoi,Bunkyo Ku, Tokyo 1138657, Japan.	akikus@mail.ecc.u-tokyo.ac.jp					ALLIN JT, 1972, ANIM BEHAV, V20, P175, DOI 10.1016/S0003-3472(72)80189-1; MCNAMARA RK, 1993, BRAIN RES REV, V18, P33, DOI 10.1016/0165-0173(93)90006-L; INSEL TR, 1986, PHARMACOL BIOCHEM BE, V24, P1263, DOI 10.1016/0091-3057(86)90182-6; SWIERGIEL AH, 1993, BRAIN RES, V623, P229, DOI 10.1016/0006-8993(93)91432-R; LIANG KC, 1988, PSYCHOPHARMACOLOGY, V96, P232; TORNATZKY W, 1994, PSYCHOPHARMACOLOGY, V116, P346, DOI 10.1007/BF02245339; CHEN RP, 1993, P NATL ACAD SCI USA, V90, P8967, DOI 10.1073/pnas.90.19.8967; MCNAMARA RK, 1991, PHARMACOL BIOCHEM BE, V38, P651, DOI 10.1016/0091-3057(91)90028-Z; SALES GD, 1972, ANIM BEHAV, V20, P88, DOI 10.1016/S0003-3472(72)80177-5; Chen YL, 1997, J MED CHEM, V40, P1749, DOI 10.1021/jm960861b; Heinrichs SC, 1997, REGUL PEPTIDES, V71, P15, DOI 10.1016/S0167-0115(97)01005-7; Heinrichs SC, 1996, NEUROSCIENCE, V74, P303, DOI 10.1016/0306-4522(96)00140-6; BLUMBERG MS, 1990, BEHAV NEUROSCI, V104, P808, DOI 10.1037//0735-7044.104.5.808; DEVRY J, 1993, EUR J PHARMACOL, V249, P331, DOI 10.1016/0014-2999(93)90530-U; Smagin GN, 1996, NEUROSCI LETT, V220, P167, DOI 10.1016/S0304-3940(96)13254-7; VALE W, 1981, SCIENCE, V213, P1394, DOI 10.1126/science.6267699; STENZELPOORE MP, 1994, J NEUROSCI, V14, P2579; KALTWASSER MT, 1991, BEHAV BRAIN RES, V43, P133; Schulz DW, 1996, P NATL ACAD SCI USA, V93, P10477, DOI 10.1073/pnas.93.19.10477; CHANG CP, 1993, NEURON, V11, P1187, DOI 10.1016/0896-6273(93)90230-O; Radulovic J, 1999, J NEUROSCI, V19, P5016; Lundkvist J, 1996, EUR J PHARMACOL, V309, P195, DOI 10.1016/0014-2999(96)00337-8; KOOB GF, 1985, FED PROC, V44, P259; AROLFO MP, 1991, BEHAV NEURAL BIOL, V55, P131, DOI 10.1016/0163-1047(91)80133-Y; BLUMBERG MS, 1991, NEUROSCI BIOBEHAV R, V15, P383, DOI 10.1016/S0149-7634(05)80031-4; BRIONI JD, 1992, PHARMACOL BIOCHEM BE, V41, P1, DOI 10.1016/0091-3057(92)90050-P; BURESOVA O, 1986, BEHAV NEUROSCI, V100, P476; BUTLER PD, 1990, J NEUROSCI, V10, P176; DUNN AJ, 1990, BRAIN RES REV, V15, P71, DOI 10.1016/0165-0173(90)90012-D; [Anonymous], 1990, ANN NY ACAD SCI; FEKETE M, 1985, NEUROPEPTIDES, V6, P283, DOI 10.1016/0143-4179(85)90001-0; GARDNER CR, 1985, J PHARMACOL METHOD, V14, P181, DOI 10.1016/0160-5402(85)90031-2; HANEY M, 1993, J COMP PSYCHOL, V107, P373, DOI 10.1037//0735-7036.107.4.373; HARVEY AT, 1995, DEV BRAIN RES, V87, P125; Heinrichs SC, 1997, PEPTIDES, V18, P711, DOI 10.1016/S0196-9781(97)00120-4; INSEL TR, 1989, PHARMACOL BIOCHEM BE, V32, P197, DOI 10.1016/0091-3057(89)90233-5; KALTWASSER MT, 1990, PHYSIOL BEHAV, V48, P13, DOI 10.1016/0031-9384(90)90253-Z; Karolyi IJ, 1999, P NATL ACAD SCI USA, V96, P11595, DOI 10.1073/pnas.96.20.11595; Kumar KB, 1996, J NEURAL TRANSM, V103, P1117, DOI 10.1007/BF01291796; LEE EHY, 1989, BEHAV NEURAL BIOL, V52, P285, DOI 10.1016/S0163-1047(89)90412-3; MICZEK KA, 1991, ADV PHAR SC, P409; MOSS DE, 1981, PHARMACOL BIOCHEM BE, V14, P321, DOI 10.1016/0091-3057(81)90397-X; Naito H, 1998, EXP ANIM TOKYO, V47, P89, DOI 10.1538/expanim.47.89; NOIROT E, 1972, DEV PSYCHOBIOL, V5, P371, DOI 10.1002/dev.420050410; OWENS MJ, 1991, PHARMACOL REV, V43, P425; RIVIER C, 1982, SCIENCE, V218, P377, DOI 10.1126/science.6289439; RIVIER CL, 1986, ANNU REV PHYSIOL, V48, P475; ROMNEY DM, 1984, PSYCHOPHARMACOL BULL, V20, P313; TAKAHASHI LK, 1992, PHYSIOL BEHAV, V52, P493, DOI 10.1016/0031-9384(92)90336-Z; TAKAHASHI LK, 1991, DEV PSYCHOBIOL, V24, P341, DOI 10.1002/dev.420240504; THOMAS DA, 1983, J COMP PSYCHOL, V97, P201, DOI 10.1037/0735-7036.97.3.201; VANDERPOEL AM, 1989, PSYCHOPHARMACOLOGY, V97, P147; VANDERPOEL AM, 1991, BEHAVIOUR, V119, P127, DOI 10.1163/156853991X00409; VIVIAN JA, 1993, PSYCHOPHARMACOLOGY, V112, P66, DOI 10.1007/BF02247364; VIVIAN JA, 1994, PSYCHOPHARMACOLOGY, V114, P101, DOI 10.1007/BF02245450; Wu HC, 1997, NEUROSCIENCE, V78, P147, DOI 10.1016/S0306-4522(96)00533-7; ZANOTTI A, 1994, PSYCHOPHARMACOLOGY, V115, P73, DOI 10.1007/BF02244754	57	32	32	PERGAMON-ELSEVIER SCIENCE LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND	0031-9384			PHYSIOL BEHAV	Physiol. Behav.	NOV 1	2000	71	3-4					323	328		10.1016/S0031-9384(00)00352-8		6	Psychology, Biological; Behavioral Sciences	Psychology; Behavioral Sciences	385GD	WOS:000165994500012		
J	Koyama, S; Kamimura, S				Koyama, S; Kamimura, S			Influence of social dominance and female odor on the sperm activity of male mice	PHYSIOLOGY & BEHAVIOR			English	Article						social dominance; female odor; sperm activity; mice	PLASMA TESTOSTERONE LEVELS; MALE LABORATORY MICE; MUS-MUSCULUS; HOUSE MOUSE; STRESS; BEHAVIOR; MOTILITY; RANK; CORTICOSTERONE; EPIDIDYMIS	In mammals, sperm activity is known to be varied largely according to individuals though physiological reasons have not been clarified yet. In our previous study [Koyama S, Kamimura S. Lowered sperm motility in mice of subordinate social status. Physiol Behav 1999;65:665-669.], we showed that sperm motility was higher in the dominant mice than the subordinate mice, by which it was suggested that social factors could affect sperm activity in mammals. In the present study, we investigated how the observed influence of social dominance would be modified by the existence of females. From 5 to 15 weeks of age, male mice were pair housed and were kept under three different housing conditions: (1) with females; (2) with bedding soiled by females; and (3) control group. The social dominance of the paired males was determined by resident-intruder tests that were carried out from 8 to 15 weeks of age. At the end of 15 weeks of age, sperm activity, weights of organs, level of serum testosterone and corticosterone were determined. It was revealed that sperm density was higher and weight of preputial glands was heavier in dominants than in subordinates when they were kept with females or female bedding, In the subordinates, however, there were no differences among the three housing conditions; that is, there were no female effects on the subordinates. On the other hand, sperm motility was high in the dominants of control group, low in the subordinates, and lower in the dominants that were kept with females. The dominants of the males that were kept with females showed high aggressiveness, and there were negative correlationships to be seen between aggressiveness and sperm motility. It was suggested that: (1) Female odor promotes spermatogenesis of the dominants, but it does not promote that of the subordinates. (2) Sperm motility is more affected by social dominance than by female odor. (3) Excessive aggressiveness has negative influence on sperm motility. (C) 2000 Elsevier Science Inc. All rights reserved.	Univ Tokyo, Grad Sch Arts & Sci, Dept Life Sci, Div Biol,Meguro Ku, Tokyo 1538902, Japan	Koyama, S (reprint author), Univ Tokyo, Grad Sch Arts & Sci, Dept Life Sci, Div Biol,Meguro Ku, 3-8-1 Komaba, Tokyo 1538902, Japan.						AMANN RP, 1993, REPROD FERT DEVELOP, V5, P361, DOI 10.1071/RD9930361; von Holst D, 1999, NATURWISSENSCHAFTEN, V86, P388, DOI 10.1007/s001140050638; BERRY RJ, 1992, BIOL REV, V67, P519, DOI 10.1111/j.1469-185X.1992.tb01192.x; Cavaggioni A, 1999, ARCH ITAL BIOL, V137, P193; Barnard CJ, 1997, PHYSIOL BEHAV, V62, P857, DOI 10.1016/S0031-9384(97)00249-7; MACHIDA T, 1981, HORM BEHAV, V15, P238, DOI 10.1016/0018-506X(81)90013-1; BLANCHARD DC, 1993, BEHAV BRAIN RES, V58, P113, DOI 10.1016/0166-4328(93)90096-9; HOSKINS DD, 1978, FED PROC, V37, P2534; ELLIS L, 1995, ETHOL SOCIOBIOL, V16, P257, DOI 10.1016/0162-3095(95)00050-U; BRONSON FH, 1973, PHYSIOL BEHAV, V10, P947, DOI 10.1016/0031-9384(73)90065-6; Koyama S, 1999, PHYSIOL BEHAV, V65, P665; BRONSON FH, 1973, BEHAV BIOL, V9, P625, DOI 10.1016/S0091-6773(73)80056-2; BATTY J, 1978, ANIM BEHAV, V26, P349, DOI 10.1016/0003-3472(78)90053-2; Brown R.E., 1979, Advances in the Study of Behavior, V10, P103, DOI 10.1016/S0065-3454(08)60094-7; Brown RE., 1985, SOCIAL ODOURS MAMMAL, P245; EBERHART JA, 1980, HORM BEHAV, V14, P247, DOI 10.1016/0018-506X(80)90033-1; GRAY S, 1995, ANIM BEHAV, V49, P821; HILAKIVI LA, 1989, AGGRESSIVE BEHAV, V15, P273; MICZEK KA, 1991, NEUROBIOLOGY STRESS, P323; MUGFORD RA, 1973, J COMP PHYSIOL PSYCH, V84, P289, DOI 10.1037/h0035320; ROSE RM, 1971, NATURE, V231, P366, DOI 10.1038/231366a0; SAPOLSKY RM, 1989, AM J PRIMATOL, V18, P1, DOI 10.1002/ajp.1350180102; SHARPE RM, 1994, PHYSL REPROD, P81; SI YM, 1993, MOL REPROD DEV, V36, P89, DOI 10.1002/mrd.1080360113; Smith FV, 1996, ANIM BEHAV, V52, P141, DOI 10.1006/anbe.1996.0160; SRIVASTAVA RK, 1993, P SOC EXP BIOL MED, V204, P231; TAYLOR GT, 1987, PHYSIOL BEHAV, V39, P429, DOI 10.1016/0031-9384(87)90368-4; TURNEY TH, 1984, PHYSIOL BEHAV, V33, P559, DOI 10.1016/0031-9384(84)90371-8; Vandenbergh John G., 1994, P343; Wingfield John C., 1994, P303; ZAYAN R, 1991, BEHAV PROCESS, V25, P81, DOI 10.1016/0376-6357(91)90011-N	31	32	34	PERGAMON-ELSEVIER SCIENCE LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND	0031-9384			PHYSIOL BEHAV	Physiol. Behav.	NOV 1	2000	71	3-4					415	422		10.1016/S0031-9384(00)00361-9		8	Psychology, Biological; Behavioral Sciences	Psychology; Behavioral Sciences	385GD	WOS:000165994500023		
J	Furumoto, T; Hata, S; Izui, K				Furumoto, T; Hata, S; Izui, K			Isolation and characterization of cDNAs for differentially accumulated transcripts between mesophyll cells and bundle sheath strands of maize leaves	PLANT AND CELL PHYSIOLOGY			English	Article						cDNA cloning; C4 photosynthesis; differential screening; in situ hybridization; Zea mays	CHLOROPLAST MESSENGER-RNA; PLASTOME-ENCODED GENES; PHOTOSYSTEM-II; C-4 PLANTS; PHOSPHOENOLPYRUVATE CARBOXYKINASE; EXPRESSION; PROTEIN; ENZYME; STRESS; LEAF	To characterize novel genes functioning specifically in mesophyll cells (MCs) or bundle sheath cells (BSCs) of C4 plants, differential screening of a maize cDNA library was conducted using P-32-labeled single-strand cDNAs prepared from;MCs and bundle sheath strands (BSS) as probes. Ten genes encoding thylakoid membrane proteins in chloroplasts were identified as MC-abundant genes. These included genes for chlorophyll a/b, binding proteins, plastocyanin, PsaD, PsbT, PsbR, PsbO, PsaK, PsaG, PsaN and ferredoxin, Seven genes identified as BSS-abundant genes encoded PEP carboxykinase, salt-inducible SalT homolog, heavy metal-inducible metallothionein-like protein, ABA- and drought-inducible glycine-rich protein, and three proteins of unknown function tone of which was named Bss1), In situ hybridization analyses for several selected genes revealed that mRNAs for the metallothionein-like protein and Bssl were accumulated specifically in BSCs, and that mRNA for the SalT homolog was accumulated in vascular cells around phloem cells. Results suggest that the functional differentiation of MC chloroplasts accompany preferential expression of these small proteins in photosystem complexes and that BSCs are the major site of stress responses.	Kyoto Univ, Div Appl Biosci, Grad Sch Agr, Sakyo Ku, Kyoto 6068502, Japan; Kyoto Univ, Lab Plant Physiol, Grad Sch Biostudies, Sakyo Ku, Kyoto 6068502, Japan; Univ Tokyo, Grad Sch Sci, Dept Biol Sci, Bunkyo Ku, Tokyo 1130033, Japan	Izui, K (reprint author), Kyoto Univ, Div Appl Biosci, Grad Sch Agr, Sakyo Ku, Kyoto 6068502, Japan.						Brutnell TP, 1999, PLANT CELL, V11, P849; Furumoto T, 1999, PLANT MOL BIOL, V41, P301, DOI 10.1023/A:1006317120460; CLAES B, 1990, PLANT CELL, V2, P19, DOI 10.1105/tpc.2.1.19; KANAI R, 1973, PLANT PHYSIOL, V51, P1133, DOI 10.1104/pp.51.6.1133; Wingler A, 1999, PLANT PHYSIOL, V120, P539, DOI 10.1104/pp.120.2.539; Sugita M, 1996, PLANT MOL BIOL, V32, P315, DOI 10.1007/BF00039388; Walker RP, 1997, AUST J PLANT PHYSIOL, V24, P459; Chitnis PR, 1996, PLANT PHYSIOL, V111, P661, DOI 10.1104/pp.111.3.661; Hankamer B, 1997, ANNU REV PLANT PHYS, V48, P641, DOI 10.1146/annurev.arplant.48.1.641; BERTHOLD DA, 1995, J BIOL CHEM, V270, P29293; Burgener M, 1998, PLANT PHYSIOL, V116, P1315, DOI 10.1104/pp.116.4.1315; DIDIERJEAN L, 1992, PLANT MOL BIOL, V18, P847, DOI 10.1007/BF00020034; FRAMOND AJ, 1991, FEBS LETT, V290, P103; Furumoto T, 1996, FEBS LETT, V396, P147, DOI 10.1016/0014-5793(96)01090-3; GASSER CS, 1989, PLANT CELL, V1, P15; GOMEZ J, 1988, NATURE, V334, P262, DOI 10.1038/334262a0; ISUEM ND, 1993, PLANT PHYSIOL, V102, P1353; Kanai REG, 1999, C4 PLANT BIOL, P49, DOI 10.1016/B978-012614440-6/50004-5; KIMATA Y, 1989, PLANT PHYSIOL, V89, P1193, DOI 10.1104/pp.89.4.1193; KOUCHI H, 1993, MOL GEN GENET, V238, P106; KUBICKI A, 1994, PLANT MOL BIOL, V25, P669, DOI 10.1007/BF00029605; Kudla J, 1996, EMBO J, V15, P7137; Leegood R.C., 1999, C4 PLANT BIOL, P89, DOI 10.1016/B978-012614440-6/50005-7; Lisitsky I, 1996, P NATL ACAD SCI USA, V93, P13398, DOI 10.1073/pnas.93.23.13398; Matsumura T, 1999, PLANT PHYSIOL, V119, P481, DOI 10.1104/pp.119.2.481; MEIERHOFF K, 1993, PLANTA, V191, P23; Nelson Timothy, 1994, P541; OSWALD A, 1990, EUR J BIOCHEM, V190, P185, DOI 10.1111/j.1432-1033.1990.tb15563.x; Pfundel E, 1996, PLANT PHYSIOL, V112, P1055; Sambrook J., 1989, MOL CLONING LAB MANU; SCHUSTER G, 1985, J BIOL CHEM, V260, P1866; Sheen J, 1999, ANNU REV PLANT PHYS, V50, P187, DOI 10.1146/annurev.arplant.50.1.187; SHEEN JY, 1995, METHOD CELL BIOL, V49, P105; SHEEN JY, 1987, PLANT MOL BIOL, V9, P217, DOI 10.1007/BF00166458; SHEEN JY, 1986, P NATL ACAD SCI USA, V83, P7811, DOI 10.1073/pnas.83.20.7811; Sugiyama T, 1998, STRESS RESPONSES OF PHOTOSYNTHETIC ORGANISMS, P167; Wyrich R, 1998, PLANT MOL BIOL, V37, P319, DOI 10.1023/A:1005900118292	37	30	32	JAPANESE SOC PLANT PHYSIOLOGISTS	KYOTO	SHIMOTACHIURI OGAWA HIGASHI KAMIKYOKU, KYOTO, 602, JAPAN	0032-0781			PLANT CELL PHYSIOL	Plant Cell Physiol.	NOV	2000	41	11					1200	1209		10.1093/pcp/pcd047		10	Plant Sciences; Cell Biology	Plant Sciences; Cell Biology	376UB	WOS:000165474200004		
J	Nakashima, J; Takabe, K; Fujita, M; Fukuda, H				Nakashima, J; Takabe, K; Fujita, M; Fukuda, H			Autolysis during in vitro tracheary element differentiation: Formation and location of the perforation	PLANT AND CELL PHYSIOLOGY			English	Article						perforation; programmed cell death; tracheary element differentiation; Zinnia elegans	ZINNIA-ELEGANS; MESOPHYLL; CELLS	Tracheary elements differentiated from isolated Zinnia mesophyll cells were observed at various times of culture under a scanning electron microscope. Perforation occurred on the primary wall at one of the longitudinal ends in single tracheary elements. In double tracheary elements, which both of two cells derived from a single cell differentiated into, the pore opened on the primary walls both at the junction of the two tracheary elements and at a longitudinal end of one of the two tracheary elements. These results suggest not only that a single tracheary element has its own program to form a perforation at one end without being affected by neighboring cells, but also that isolated cells indeed hold some traces of polarity and cell-cell communication.	Univ Tokyo, Dept Biol Sci, Grad Sch Sci, Tokyo 1130033, Japan; Kyoto Univ, Dept Forest Sci, Grad Sch Agr, Kyoto 6068502, Japan	Nakashima, J (reprint author), Univ Tokyo, Dept Biol Sci, Grad Sch Sci, Tokyo 1130033, Japan.						FUKUDA H, 1980, PLANT PHYSIOL, V65, P57, DOI 10.1104/pp.65.1.57; FRANKLIN GL, 1945, NATURE, V155, P51, DOI 10.1038/155051a0; Shinohara N, 2000, P NATL ACAD SCI USA, V97, P2585, DOI 10.1073/pnas.050582197; Fukuda H, 1997, PLANT CELL, V9, P1147, DOI 10.1105/tpc.9.7.1147; Groover A, 1997, PROTOPLASMA, V196, P197, DOI 10.1007/BF01279568; BURGESS J, 1984, MICRON MICROSC ACTA, V15, P153, DOI 10.1016/0739-6260(84)90046-7; BURGESS J, 1984, PLANTA, V160, P481, DOI 10.1007/BF00411135; Buvat R, 1989, ONTOGENY CELL DIFFER; Carlquist S, 1999, AM J BOT, V86, P457, DOI 10.2307/2656805; Esau K, 1965, VASCULAR DIFFERENTIA; ESAU K, 1978, ANN BOT-LONDON, V42, P665; Meylan BA, 1981, XYLEM CELL DEV, P96; OBRIEN TP, 1981, XYLEM CELL DEV, P4; Schneider EL, 2000, AM J BOT, V87, P176, DOI 10.2307/2656903; SUGIYAMA M, 1986, PLANT CELL PHYSIOL, V27, P601	15	33	34	JAPANESE SOC PLANT PHYSIOLOGISTS	KYOTO	SHIMOTACHIURI OGAWA HIGASHI KAMIKYOKU, KYOTO, 602, JAPAN	0032-0781			PLANT CELL PHYSIOL	Plant Cell Physiol.	NOV	2000	41	11					1267	1271		10.1093/pcp/pcd055		5	Plant Sciences; Cell Biology	Plant Sciences; Cell Biology	376UB	WOS:000165474200012		
J	Sugihara, K; Hanagata, N; Dubinsky, Z; Baba, S; Karube, I				Sugihara, K; Hanagata, N; Dubinsky, Z; Baba, S; Karube, I			Molecular characterization of cDNA encoding oxygen evolving enhancer protein 1 increased by salt treatment in the mangrove Bruguiera gymnorrhiza	PLANT AND CELL PHYSIOLOGY			English	Article						Bruguiera gymnorrhiza; molecular cloning; oxygen evolving enhancer protein 1; salt tolerance; two-dimensional gel electrophoresis	PHOTOSYSTEM-II; POLYPEPTIDES; CHLOROPLASTS; EXPRESSION; EVOLUTION; MEMBRANE; DROUGHT; COMPLEX; STRESS; 33-KDA	Young plants of the common Okinawa mangrove species Bruguiera gymnorrhiza were transferred from freshwater to a medium with seawater salt level (500 mM NaCl), Two-dimensional gel electrophoresis revealed in the leaf extract of the plant a 33 kDa protein with pi 5.2, whose quantity increased as a result of NaCI treatment, The N-terminal amino acids sequence of this protein had a significant homology with mature region of oxygen evolving enhancer protein 1 (OEE1) precursor. The cloning of OEE1 precursor cDNA fragment was carried out by means of reverse transcription-PCR (RT-PCR) using degenerated primers, Both 3'- and 5'-regions were isolated by rapid amplification of cDNA ends (RACE) method. The deduced amino acid sequence consisted of 322 amino acids and was 87% identical to that of Nictiana tabacum. In B.gymnorrhiza, the predicted amino acid sequence of the mature protein starts at the residue number 85 of the open reading frame. The first 84-amino acid residues correspond to a typical transit sequence for the signal directing OEE1 to its appropriate compartment of chloroplast. The expression of OEE1,was analyzed together with other OEE subunits and DI protein of photosystem II. The transcript levels of all the three OEEs were enhanced by NaCI treatment, but the significant increase of D1 protein was not observed.	Univ Tokyo, Adv Sci & Technol Res Ctr, Meguro Ku, Tokyo 1538904, Japan; Bar Ilan Univ, Fac Life Sci, IL-52900 Ramat Gan, Israel; Univ Ryukyus, Coll Agr, Okinawa 9030129, Japan	Hanagata, N (reprint author), Univ Tokyo, Adv Sci & Technol Res Ctr, Meguro Ku, 4-6-1 Komaba, Tokyo 1538904, Japan.						REVIRON MP, 1992, PLANT PHYSIOL, V100, P1486, DOI 10.1104/pp.100.3.1486; SINGH NK, 1987, PLANT PHYSIOL, V85, P529, DOI 10.1104/pp.85.2.529; CLAES B, 1990, PLANT CELL, V2, P19, DOI 10.1105/tpc.2.1.19; HURKMAN WJ, 1986, PLANT PHYSIOL, V81, P802, DOI 10.1104/pp.81.3.802; HURKMAN WJ, 1991, PLANT PHYSIOL, V97, P366, DOI 10.1104/pp.97.1.366; DEVITRY C, 1989, J CELL BIOL, V109, P991, DOI 10.1083/jcb.109.3.991; DURE L, 1981, BIOCHEMISTRY-US, V20, P4162, DOI 10.1021/bi00517a033; FROHMAN MA, 1988, P NATL ACAD SCI USA, V85, P8998, DOI 10.1073/pnas.85.23.8998; KATO S, 1986, NIHON KAISUI GAKKAIS, V40, P9; KAVELAKI K, 1991, PHOTOSYNTH RES, V29, P149, DOI 10.1007/BF00036218; KAWAMITSU Y, 1995, SCI REV COLL AGR U R, V42, P9; KING GJ, 1988, PLANT MOL BIOL, V10, P401, DOI 10.1007/BF00014946; MIYAO M, 1984, FEBS LETT, V168, P118, DOI 10.1016/0014-5793(84)80218-5; MIZOBUCHI A, 1989, BIOCHIM BIOPHYS ACTA, V977, P26, DOI 10.1016/S0005-2728(89)80005-2; MUROTA K, 1994, PLANT CELL PHYSIOL, V35, P107; Muthuchelian K, 1996, BIOL PLANTARUM, V38, P245, DOI 10.1007/BF02873853; POPP M, 1984, Z PFLANZENPHYSIOL, V113, P411; ROBINSON C, 1994, PLANT MOL BIOL, V26, P15, DOI 10.1007/BF00039516; SCHOLAND.PF, 1968, PHYSIOL PLANTARUM, V21, P251, DOI 10.1111/j.1399-3054.1968.tb07248.x; Seidler A, 1996, EUR J BIOCHEM, V242, P485, DOI 10.1111/j.1432-1033.1996.0485r.x; TAKEMURA T, 2000, IN PRESS AQUA BOT; TOMLINSON PB, 1994, BOT MANGROVES, P419; Tsukamoto Takamasa, 1998, Environment Control in Biology, V36, P27	23	73	89	JAPANESE SOC PLANT PHYSIOLOGISTS	KYOTO	SHIMOTACHIURI OGAWA HIGASHI KAMIKYOKU, KYOTO, 602, JAPAN	0032-0781			PLANT CELL PHYSIOL	Plant Cell Physiol.	NOV	2000	41	11					1279	1285		10.1093/pcp/pcd061		7	Plant Sciences; Cell Biology	Plant Sciences; Cell Biology	376UB	WOS:000165474200014		
J	Itoh, JI; Kitano, H; Matsuoka, M; Nagato, Y				Itoh, JI; Kitano, H; Matsuoka, M; Nagato, Y			SHOOT ORGANIZATION genes regulate shoot apical meristem organization and the pattern of leaf primordium initiation in rice	PLANT CELL			English	Article							FLORAL ORGAN NUMBER; MUTANT NARROW SHEATH; MAIZE HOMEOBOX GENE; ARABIDOPSIS-THALIANA; VEGETATIVE SHOOT; PERIANTHIA GENE; ROUGH SHEATH2; CELL FATE; EXPRESSION; MUTATIONS	The mechanism regulating the pattern of leaf initiation was analyzed by using shoot organization (sho) mutants derived from three loci (SHO1, SHO2, and SHO3). In the early vegetative phase, sho mutants show an increased rate of leaf production with random phyllotaxy. The resulting leaves are malformed, threadlike, or short and narrow. Their shoot apical meristems are relatively low and wide, that is, flat shaped, although their shape and size are highly variable among plants of the same genotype. Statistical analysis reveals that the shape of the shoot meristem rather than its size is closely correlated with the variations of plastochron and phyllotaxy. Rapid and random leaf production in sho mutants is correlated with the frequent and disorganized cell divisions in the shoot meristem and with a reduction of expression domain of a rice homeobox gene, OSH1. These changes in the organization and behavior of the shoot apical meristems suggest that sho mutants have fewer indeterminate cells and more determinate cells than wild type, with many cells acting as leaf founder cells. Thus, the SHO genes have an important role in maintaining the proper organization of the shoot apical meristem, which is essential for the normal initiation pattern of leaf primordia.	Univ Tokyo, Grad Sch Agr & Life Sci, Tokyo 1138657, Japan; Nagoya Univ, Grad Sch Bioagr Sci, Nagoya, Aichi 4648601, Japan; Nagoya Univ, Biosci Ctr, Nagoya, Aichi 4648601, Japan; Natl Inst Genet, Mishima, Shizuoka 4118540, Japan	Nagato, Y (reprint author), Univ Tokyo, Grad Sch Agr & Life Sci, Tokyo 1138657, Japan.						Moussian B, 1998, EMBO J, V17, P1799, DOI 10.1093/emboj/17.6.1799; CLARK SE, 1993, DEVELOPMENT, V119, P397; Jackson D, 1999, DEVELOPMENT, V126, P315; SMITH LG, 1992, DEVELOPMENT, V116, P21; Timmermans MCP, 1998, DEVELOPMENT, V125, P2813; Chuang CF, 1999, GENE DEV, V13, P334, DOI 10.1101/gad.13.3.334; Mayer KFX, 1998, CELL, V95, P805, DOI 10.1016/S0092-8674(00)81703-1; Satoh N, 1999, DEVELOPMENT, V126, P3629; Souer E, 1996, CELL, V85, P159, DOI 10.1016/S0092-8674(00)81093-4; Laux T, 1996, DEVELOPMENT, V122, P87; Green PB, 1996, ANN BOT-LONDON, V77, P515, DOI 10.1006/anbo.1996.0062; Running MP, 1996, DEVELOPMENT, V122, P1261; Itoh JI, 1998, PLANT CELL, V10, P1511; Clark SE, 1997, CELL, V89, P575, DOI 10.1016/S0092-8674(00)80239-1; BARTON MK, 1993, DEVELOPMENT, V119, P823; LEYSER HMO, 1992, DEVELOPMENT, V116, P397; JACKSON D, 1994, DEVELOPMENT, V120, P405; Kerstetter RA, 1997, DEVELOPMENT, V124, P3045; Clark SE, 1996, DEVELOPMENT, V122, P1567; Tsiantis M, 1999, SCIENCE, V284, P154, DOI 10.1126/science.284.5411.154; Kerstetter RA, 1997, PLANT CELL, V9, P1001, DOI 10.1105/tpc.9.7.1001; Meyerowitz EM, 1997, CELL, V88, P299, DOI 10.1016/S0092-8674(00)81868-1; Long JA, 1996, NATURE, V379, P66, DOI 10.1038/379066a0; Fleming AJ, 1997, SCIENCE, V276, P1415, DOI 10.1126/science.276.5317.1415; Lynn K, 1999, DEVELOPMENT, V126, P469; HONG SK, 1995, DEV GENET, V16, P298, DOI 10.1002/dvg.1020160403; Timmermans MCP, 1999, SCIENCE, V284, P151, DOI 10.1126/science.284.5411.151; SELKER JML, 1992, DEV BIOL, V153, P29, DOI 10.1016/0012-1606(92)90089-Y; Scanlon MJ, 1996, DEVELOPMENT, V122, P1683; CHAUDHURY AM, 1993, PLANT J, V4, P907, DOI 10.1046/j.1365-313X.1993.04060907.x; Bowman J, 1994, ARABIDOPSIS ATLAS MO; CALLOS JD, 1994, PLANT J, V6, P835, DOI 10.1046/j.1365-313X.1994.6060835.x; CALLOS JD, 1994, PLANT J, V6, P1, DOI 10.1046/j.1365-313X.1994.6010001.x; Clark SE, 1997, PLANT CELL, V9, P1067, DOI 10.1105/tpc.9.7.1067; Fleming AJ, 1999, PLANTA, V208, P166, DOI 10.1007/s004250050546; GREEN PB, 1994, J EXP BOT, V45, P1775; Hara Noboru, 1997, Phytomorphology, V47, P437; HERR JM, 1982, STAIN TECHNOL, V57, P161; KOUCHI H, 1993, MOL GEN GENET, V238, P106; MATSUOKA M, 1993, PLANT CELL, V5, P1039, DOI 10.1105/tpc.5.9.1039; MEDFORD JI, 1992, PLANT CELL, V4, P1029; MURASHIGE T, 1962, PHYSIOL PLANTARUM, V15, P473, DOI 10.1111/j.1399-3054.1962.tb08052.x; Nagasawa N, 1996, PLANTA, V198, P627; Sato Y, 1996, P NATL ACAD SCI USA, V93, P8117, DOI 10.1073/pnas.93.15.8117; Scanlon MJ, 1997, DEV BIOL, V182, P52, DOI 10.1006/dbio.1996.8452; SCHNEEBERGER R, 1998, DEVELOPMENT, V12, P787; SINHA NR, 1993, GENE DEV, V7, P2857; SNOW M, 1931, PHILOS T ROY SOC LON, V25, P301; Steeves T. A., 1989, PATTERNS PLANT DEV; TAMURA Y, 1992, PLANT SCI, V82, P91, DOI 10.1016/0168-9452(92)90011-A; Veit B, 1998, NATURE, V393, P166, DOI 10.1038/30239; Wardlaw C. W., 1949, GROWTH S, V13, P93	52	60	64	AMER SOC PLANT PHYSIOLOGISTS	ROCKVILLE	15501 MONONA DRIVE, ROCKVILLE, MD 20855 USA	1040-4651			PLANT CELL	Plant Cell	NOV	2000	12	11					2161	2174		10.1105/tpc.12.11.2161		14	Biochemistry & Molecular Biology; Plant Sciences; Cell Biology	Biochemistry & Molecular Biology; Plant Sciences; Cell Biology	384AM	WOS:000165916900011		
J	Sivaguru, M; Fujiwara, T; Samaj, J; Baluska, F; Yang, ZM; Osawa, H; Maeda, T; Mori, T; Volkmann, D; Matsumoto, H				Sivaguru, M; Fujiwara, T; Samaj, J; Baluska, F; Yang, ZM; Osawa, H; Maeda, T; Mori, T; Volkmann, D; Matsumoto, H			Aluminum-induced 1 -> 3-beta-D-glucan inhibits cell-to-cell trafficking of molecules through plasmodesmata. A new mechanism of aluminum toxicity in plants	PLANT PHYSIOLOGY			English	Article							INOSITOL TRISPHOSPHATE; SETCREASEA-PURPUREA; MOVEMENT PROTEIN; TRANSITION ZONE; VIRAL MOVEMENT; STAMINAL HAIRS; DISTAL PART; ROOT APEX; TRANSPORT; CALCIUM	Symplastic intercellular transport in plants is achieved by plasmodesmata (PD). These cytoplasmic channels are well known to interconnect plant cells to facilitate intercellular movement of water, nutrients, and signaling molecules including hormones. However, it is not known whether Al may affect this cell-to-cell transport process, which is a critical feature for roots as organs of nutrient/water uptake. We have microinjected the dye lucifer yellow carbohydrazide into peripheral root cells of an Al-sensitive wheat (Triticum aestivum cv Scout 66) either before or after Al treatment and followed the cell-to-cell dye-coupling through PD. Here we show that the Al-induced root growth inhibition is closely associated with the Al-induced blockage of cell-to-cell dye coupling. Immunofluorescence combined with immune-electron microscopic techniques using monoclonal antibodies against 1-->3-beta -D-glucan (callose) revealed circumstantial evidence that Al-induced callose deposition at PD may responsible for this blockage of symplastic transport. Use of 2-deoxy-D-glucose, a callose synthesis inhibitor, allowed us to demonstrate that a reduction in callose particles correlated well with the improved dye-coupling and reduced root growth inhibition. While assessing the tissue specificity of this Al effect, comparable responses were obtained From the dye-coupling pattern in tobacco (Nicotiana tabacum) mesophyll cells. Analyses of the Al-induced expression of PD-associated proteins, such as calreticulin and unconventional myosin VIII, showed enhanced fluorescence and co-localizations with callose deposits. These results suggest that Al-signal mediated localized alterations to calcium homeostasis may drive callose formation and PD closure. Our data demonstrate that extracellular Al-induced callose deposition at PD could effectively block symplastic transport and communication in higher plants.	Okayama Univ, Res Inst Bioresources, Kurashiki, Okayama 7100046, Japan; Univ Tokyo, Dept Appl Biol Chem, Grad Sch Agr & Life Sci, Tokyo 1138657, Japan; Japan Sci & Technol Corp, Precursory Res Embryon Sci & Technol, JST, Chiba 2631123, Japan; Slovak Acad Sci, Inst Plant Genet & Biotechnol, Dept Agron, Nitra 95007, Slovakia; Univ Bonn, Dept Plant Cell Biol, D-53115 Bonn, Germany; BioOriented Technol Res Advancement Inst, Omiya, Saitama 3318537, Japan; Changchun Univ Agr & Anim Sci, Changchun 130062, Peoples R China	Matsumoto, H (reprint author), Okayama Univ, Res Inst Bioresources, Kurashiki, Okayama 7100046, Japan.		FUJIWARA, Toru/A-4119-2011				Rashotte AM, 2000, PLANT PHYSIOL, V122, P481, DOI 10.1104/pp.122.2.481; MEIKLE PJ, 1991, PLANTA, V185, P1, DOI 10.1007/BF00194507; Silva IR, 2000, PLANT PHYSIOL, V123, P543, DOI 10.1104/pp.123.2.543; Lazarowitz SG, 1999, PLANT CELL, V11, P535; Kollmeier M, 2000, PLANT PHYSIOL, V122, P945, DOI 10.1104/pp.122.3.945; Larsen PB, 1997, PLANT PHYSIOL, V114, P1207; Muller A, 1998, EMBO J, V17, P6903, DOI 10.1093/emboj/17.23.6903; Estelle M, 1998, PLANT CELL, V10, P1775; Kragler F, 1998, ANN BOT-LONDON, V81, P1, DOI 10.1006/anbo.1997.0522; KOCHIAN LV, 1995, ANNU REV PLANT PHYS, V46, P237, DOI 10.1146/annurev.arplant.46.1.237; Iglesias VA, 2000, PLANT J, V21, P157, DOI 10.1046/j.1365-313x.2000.00658.x; Sivaguru M, 1998, PLANT PHYSIOL, V116, P155, DOI 10.1104/pp.116.1.155; Blancaflor EB, 1998, PLANT PHYSIOL, V118, P159, DOI 10.1104/pp.118.1.159; LUCAS WJ, 1995, CURR OPIN CELL BIOL, V7, P673, DOI 10.1016/0955-0674(95)80109-X; Jones DL, 1998, PLANT PHYSIOL, V116, P81, DOI 10.1104/pp.116.1.81; Oparka KJ, 1999, CELL, V97, P743, DOI 10.1016/S0092-8674(00)80786-2; Boevink P, 1998, PLANT J, V15, P441, DOI 10.1046/j.1365-313X.1998.00208.x; Zhang WH, 1999, AUST J PLANT PHYSIOL, V26, P401; HORST WJ, 1995, Z PFLANZ BODENKUNDE, V158, P419, DOI 10.1002/jpln.19951580503; Sivaguru M, 1999, PLANT PHYSIOL, V119, P1073, DOI 10.1104/pp.119.3.1073; LUCAS WJ, 1993, NEW PHYTOL, V125, P435, DOI 10.1111/j.1469-8137.1993.tb03897.x; DING B, 1992, PROTOPLASMA, V169, P28, DOI 10.1007/BF01343367; Matsumoto H, 2000, INT REV CYTOL, V200, P1, DOI 10.1016/S0074-7696(00)00001-2; SANDERSON MJ, 1995, CIBA F SYMP, V188, P175; Radford JE, 1998, PROTOPLASMA, V201, P30, DOI 10.1007/BF01280708; Baluska F, 1999, PLANT J, V19, P481, DOI 10.1046/j.1365-313X.1999.00530.x; BALROW PW, 2000, ANNU REV PLANT PHYS, V51, P289; Baluska F, 2000, PLANT BIOLOGY, V2, P253, DOI 10.1055/s-2000-3705; BARONEPEL O, 1988, J CELL BIOL, V106, P715, DOI 10.1083/jcb.106.3.715; Blackman LM, 1999, EUR J CELL BIOL, V78, P297; Blackman LM, 1998, PLANT J, V14, P733, DOI 10.1046/j.1365-313x.1998.00161.x; Clark SE, 1996, TRENDS PLANT SCI, V1, P406, DOI 10.1016/1360-1385(96)89230-2; CLELAND RE, 1994, PROTOPLASMA, V178, P81, DOI 10.1007/BF01404123; Ding B, 1996, PLANT J, V10, P157, DOI 10.1046/j.1365-313X.1996.10010157.x; DUCKETT CM, 1994, DEVELOPMENT, V120, P3247; Epel BL, 1996, GENE, V173, P75, DOI 10.1016/0378-1119(95)00678-8; EPEL BL, 1991, PHYSIOL PLANTARUM, V83, P149, DOI 10.1034/j.1399-3054.1991.830122.x; EPEL BL, 1994, PLANT MOL BIOL, V26, P1343, DOI 10.1007/BF00016479; FUJIWARA T, 1993, PLANT CELL, V5, P1783; GHARYAL PK, 1989, J BIOL CHEM, V264, P12119; Gisel A, 1999, DEVELOPMENT, V126, P1879; GRUHN P, 1995, PLANT NUTR MANAGEMEN, P1; Holdaway-Clarke TL, 2000, PLANTA, V210, P329, DOI 10.1007/PL00008141; Jones DL, 1998, PLANTA, V206, P378, DOI 10.1007/s004250050413; Kauss H., 1996, MEMBRANES SPECIALIZE, P77; Krause KH, 1997, CELL, V88, P439, DOI 10.1016/S0092-8674(00)81884-X; Lee JY, 2000, PLANTA, V210, P177, DOI 10.1007/PL00008124; Lomax Terri L., 1995, P509; LUCAS WJ, 1994, ANNU REV PHYTOPATHOL, V32, P387; Lucas WJ, 1999, J EXP BOT, V50, P979, DOI 10.1093/jexbot/50.suppl_1.979; MERRY L, 1996, J BIOL CHEM, V271, P9332; Mezitt LA, 1996, PLANT MOL BIOL, V32, P251, DOI 10.1007/BF00039385; Miller D, 1997, PLANT CELL, V9, P2105; Moffat AS, 1999, SCIENCE, V285, P369, DOI 10.1126/science.285.5426.369; OPARKA KJ, 1992, PLANT J, V2, P741, DOI 10.1111/j.1365-313X.1992.tb00143.x; Overall RL, 1996, TRENDS PLANT SCI, V1, P307, DOI 10.1016/S1360-1385(96)88177-0; Radford JE, 1998, PLANT J, V14, P743, DOI 10.1046/j.1365-313x.1998.00162.x; Reichelt S, 1999, PLANT J, V19, P555, DOI 10.1046/j.1365-313X.1999.00553.x; Rengel Z, 1996, NEW PHYTOL, V134, P389, DOI 10.1111/j.1469-8137.1996.tb04356.x; ROBARDS AW, 1990, ANNU REV PLANT PHYS, V41, P369, DOI 10.1146/annurev.pp.41.060190.002101; RODRIGUEZGALVEZ E, 1995, PLANTA, V197, P535; SEJU K, 1998, J PLANT BIOL, V41, P269; Sivaguru M, 1999, PHYSIOL PLANTARUM, V107, P110, DOI 10.1034/j.1399-3054.1999.100115.x; TAYLOR GJ, 1995, PLANT SOIL, V171, P89, DOI 10.1007/BF00009570; TUCKER EB, 1990, PLANTA, V182, P34, DOI 10.1007/BF00239980; Tucker EB, 1996, PLANT PHYSIOL, V111, P459; TUCKER EB, 1988, PLANTA, V174, P358, DOI 10.1007/BF00959521; VANBEL AJE, 1995, BOT ACTA, V108, P174; WHITE RG, 1994, PROTOPLASMA, V180, P169, DOI 10.1007/BF01507853; WOLF S, 1989, SCIENCE, V246, P377, DOI 10.1126/science.246.4928.377; Wyatt Sarah E., 1993, Trends in Cell Biology, V3, P413, DOI 10.1016/0962-8924(93)90022-S; XHU T, 1998, PROTOPLASMA, V203, P35; Yahalom A, 1998, J PLANT PHYSIOL, V153, P354; ZAMBRYSKI P, 1995, SCIENCE, V270, P1943, DOI 10.1126/science.270.5244.1943; ZHANG GC, 1994, J PLANT PHYSIOL, V144, P229	75	152	157	AMER SOC PLANT PHYSIOLOGISTS	ROCKVILLE	15501 MONONA DRIVE, ROCKVILLE, MD 20855 USA	0032-0889			PLANT PHYSIOL	Plant Physiol.	NOV	2000	124	3					991	1005		10.1104/pp.124.3.991		15	Plant Sciences	Plant Sciences	374VV	WOS:000165365800009		
J	Fujiki, Y; Ito, M; Nishida, I; Watanabe, A				Fujiki, Y; Ito, M; Nishida, I; Watanabe, A			Multiple signaling pathways in gene expression during sugar starvation. Pharmacological analysis of din gene expression in suspension-cultured cells of Arabidopsis	PLANT PHYSIOLOGY			English	Article							SENESCENCE-ASSOCIATED GENE; ALPHA-AMYLASE GENE; MAIZE ROOT-TIPS; CARBON CATABOLITE REPRESSION; HIGHER-PLANTS; GLUCOSE STARVATION; OKADAIC ACID; RICE; SUCROSE; DEHYDROGENASE	We have identified many dark-inducible (din) genes that are expressed in Arabidopsis leaves kept in the dark. Ln the present study we addressed the question of how plant cells sense the depletion of sugars, and how sugar starvation triggers din gene expression in suspension-cultured cells of Arabidopsis. Depletion of sucrose in the medium triggered marked accumulation of din transcripts. Suppression of din gene expression by 2-deoxy-Glc, and a non-suppressive effect exerted by 8-O-methyl-Glc, suggested that sugar-repressible expression of din genes is mediated through the phosphorylation of hexose by hexokinase, as exemplified in the repression of photosynthetic genes by sugars. We have further shown that the signaling triggered by sugar starvation involves protein phosphorylation and dephosphorylation events, and have provided the first evidence that multiple I,pathways of protein dephosphorylation exist in sugar starvation-induced gene expression. An inhibitor of serine/threonine protein kinase, K-252a, inhibited din gene expression in sugar-depleted cells. Okadaic acid, which may preferentially inhibit type 2A protein phosphatases over type 1, enhanced the transcript levels of all clin genes, except din6 and din10, under sugar starvation. Conversely, a more potent inhibitor of type 1 and 2A protein phosphatases, calyculin A, increased transcripts from din2 and din9, but decreased those from other din genes, in sugar-depleted cells. On the other hand, calyculin A, but not okadaic acid, completely inhibited the gene expression of chlorophyll a/b-binding protein under sugar starvation. These results indicate that multiple signaling pathways, mediated by different types of protein phosphatases, regulate gt ne expression during sugar starvation.	Univ Tokyo, Grad Sch Sci, Dept Sci Biol, Bunkyo Ku, Tokyo 1130033, Japan	Fujiki, Y (reprint author), Univ Tokyo, Grad Sch Sci, Dept Sci Biol, Bunkyo Ku, Tokyo 1130033, Japan.		Nishida, Ikuo/E-3339-2010; Fujiki, Yuki/F-1580-2011; Ito, Masaki/G-4252-2013	Nishida, Ikuo/0000-0002-9649-349X; 			Halford NG, 1998, PLANT MOL BIOL, V37, P735, DOI 10.1023/A:1006024231305; JOURNET EP, 1986, J BIOL CHEM, V261, P3193; Lalonde S, 1999, PLANT CELL, V11, P707; Koch KE, 1996, ANNU REV PLANT PHYS, V47, P509, DOI 10.1146/annurev.arplant.47.1.509; Christie JM, 1996, PLANT CELL, V8, P1555; YU SM, 1991, J BIOL CHEM, V266, P21131; Pego JV, 2000, J EXP BOT, V51, P407, DOI 10.1093/jexbot/51.suppl_1.407; BROUQUISSE R, 1992, PLANTA, V188, P384, DOI 10.1007/BF00192806; Arguello-Astorga G, 1998, ANNU REV PLANT PHYS, V49, P525, DOI 10.1146/annurev.arplant.49.1.525; HENSEL LL, 1993, PLANT CELL, V5, P553, DOI 10.1105/tpc.5.5.553; JANG JC, 1994, PLANT CELL, V6, P1665; Koch KE, 2000, J EXP BOT, V51, P417, DOI 10.1093/jexbot/51.suppl_1.417; AZUMI Y, 1991, PLANT PHYSIOL, V95, P577, DOI 10.1104/pp.95.2.577; AXELOS M, 1992, PLANT PHYSIOL BIOCH, V30, P123; DIEUAIDE M, 1992, PLANT PHYSIOL, V99, P595, DOI 10.1104/pp.99.2.595; Sheu JJ, 1996, J BIOL CHEM, V271, P26998; Jang JC, 1997, PLANT CELL, V9, P5, DOI 10.1105/tpc.9.1.5; Gancedo JM, 1998, MICROBIOL MOL BIOL R, V62, P334; Oh SA, 1996, PLANT MOL BIOL, V30, P739, DOI 10.1007/BF00019008; Moriyasu Y, 1996, PLANT PHYSIOL, V111, P1233; Yu SM, 1999, PLANT PHYSIOL, V121, P687, DOI 10.1104/pp.121.3.687; Brouquisse R, 1998, PLANT PHYSIOL, V117, P1281, DOI 10.1104/pp.117.4.1281; TERZAGHI WB, 1995, ANNU REV PLANT PHYS, V46, P445, DOI 10.1146/annurev.arplant.46.1.445; CHEVALIER C, 1995, PLANT MOL BIOL, V28, P473, DOI 10.1007/BF00020395; COHEN P, 1990, TRENDS BIOCHEM SCI, V15, P98, DOI 10.1016/0968-0004(90)90192-E; Davies KM, 1996, PLANT PHYSIOL, V111, P877, DOI 10.1104/pp.111.3.877; Fujiki Y, 2000, J BIOL CHEM, V275, P6007, DOI 10.1074/jbc.275.8.6007; FUJIKI Y, 1997, PLANT PHYSIOL, V114, pS95; GRAHAM IA, 1994, PLANT CELL, V6, P761, DOI 10.1105/tpc.6.5.761; Halford NG, 1999, TRENDS PLANT SCI, V4, P117, DOI 10.1016/S1360-1385(99)01377-1; Ikeda Y, 1999, PLANT PHYSIOL, V121, P813, DOI 10.1104/pp.121.3.813; JAMES F, 1993, PLANT PHYSIOL BIOCH, V31, P845; Kurotani K, 1999, PLANT CELL PHYSIOL, V40, P423; Luan S, 1998, TRENDS PLANT SCI, V3, P271, DOI 10.1016/S1360-1385(98)01258-8; LUE MY, 1994, BIOCHEM BIOPH RES CO, V205, P807, DOI 10.1006/bbrc.1994.2737; Moore BD, 1999, TRENDS PLANT SCI, V4, P250, DOI 10.1016/S1360-1385(99)01433-8; Nakabayashi K, 1999, PLANT CELL PHYSIOL, V40, P504; Nozawa A, 1999, PLANT CELL PHYSIOL, V40, P942; Prata RTN, 1997, PLANT PHYSIOL, V114, P307; SHEEN J, 1993, EMBO J, V12, P3497; Shimada Y, 1998, PLANT CELL PHYSIOL, V39, P139; Smeekens S, 1997, PLANT PHYSIOL, V115, P7; TAKEDA S, 1994, PLANT PHYSIOL, V106, P567; Umemura T, 1998, PLANTA, V204, P420, DOI 10.1007/s004250050275	44	52	60	AMER SOC PLANT PHYSIOLOGISTS	ROCKVILLE	15501 MONONA DRIVE, ROCKVILLE, MD 20855 USA	0032-0889			PLANT PHYSIOL	Plant Physiol.	NOV	2000	124	3					1139	1147		10.1104/pp.124.3.1139		9	Plant Sciences	Plant Sciences	374VV	WOS:000165365800023		
J	Morifuji, T				Morifuji, T			A twisted invariant for finitely presentable groups	PROCEEDINGS OF THE JAPAN ACADEMY SERIES A-MATHEMATICAL SCIENCES			English	Article						twisted invariant; finitely presentable group; Alexander polynomial		Following Wada's construction [4] on the twisted Alexander polynomial, we introduce a new twisted invariant for finitely presentable groups.	Univ Tokyo, Grad Sch Math Sci, Meguro Ku, Tokyo 1538914, Japan							WADA M, 1994, TOPOLOGY, V33, P241, DOI 10.1016/0040-9383(94)90013-2; FOX RH, 1953, ANN MATH, V57, P547, DOI 10.2307/1969736; Masley J.M., 1976, J REINE ANGEW MATH, V286, P248; Tietze H, 1908, MONATSHEFTE MATH PHY, V19, P1, DOI 10.1007/BF01736688	4	4	4	JAPAN ACAD	TOKYO	7-32, UENO PARK, TAITO-KU, TOKYO, 110-0007, JAPAN	0386-2194			P JPN ACAD A-MATH	Proc. Jpn. Acad. Ser. A-Math. Sci.	NOV	2000	76	9					143	145				3	Mathematics	Mathematics	384WQ	WOS:000165969800005		
J	Kobayashi, K				Kobayashi, K			Horizontally-moving subducted slab may generate enigmatic features of the Palau and Yap Trench-Arcs	PROCEEDINGS OF THE JAPAN ACADEMY SERIES B-PHYSICAL AND BIOLOGICAL SCIENCES			English	Article						moving slab; proximity of arc/trench; Palau Trench; Yap Trench; Philippine-Sea plate	SEA PLATE MOTION; HEAT-FLOW; PACIFIC; ISLANDS; ROCKS	The Philippine-Sea plate in the northwestern Pacific Ocean is moving horizontally toward N55 degreesW at rates of 40 to 90 mm/yr (greater southward) relative to underlying asthenosphere. The Palau and Yap Trenches situated at its southeastern margin are moving together with the Philippine-Sea plate. Resistance of viscous asthenosphere against vertically subducted rigid slabs is estimated based upon a simple viscous flow model. It has been shown that appreciably large uplifting pressure is generated in the frontal zone of the vertical slab, while tectonic erosion in the trench bottom proceeds both under the influence of the viscous flow. This model may reasonably explain enigmatic features of the Palau and Yap Trench-Arc systems revealed by detailed topographic mapping and submersible investigation such as (1) large water depths (Exceeding 8000 m) in spite of their extremely small plate convergence rates, (2) exposure of serpentinized peridotite. gabbro and basalt despite a large amount of slope failure deposits containing a huge reefal limestone block, (3) abnormally close proximity crf islands to the trench axis, (1) deficiency of barrier reefs on their trench-facing! side in spite of the easterly to northeasterly prevailing wind.	Univ Tokyo, Tokyo, Japan	Kobayashi, K (reprint author), 4-11-12 Ikenohata,Taito Ku, Tokyo 1100008, Japan.						SENO T, 1993, J GEOPHYS RES-SOL EA, V98, P17941, DOI 10.1029/93JB00782; MORGAN WJ, 1968, J GEOPHYS RES, V73, P1959, DOI 10.1029/JB073i006p01959; MINSTER JB, 1978, J GEOPHYS RES, V83, P5331, DOI 10.1029/JB083iB11p05331; EASTON WH, 1980, QUATERNARY RES, V14, P199, DOI 10.1016/0033-5894(80)90048-4; FUJIOKA K, 1989, J GEOGR, V98, P66; FUJITA M, 1998, REP HYDROGR RES, V34, P13; FUJIWARA T, 1996, JAMSTEC J DEEP SEA R, V12, P307; Fujiwara T, 2000, MAR GEOPHYS RES, V21, P69, DOI 10.1023/A:1004781927661; HALUNEN AJ, 1973, J GEOPHYS RES, V78, P5195, DOI 10.1029/JB078i023p05195; HASTON R, 1988, GEOLOGY, V16, P654, DOI 10.1130/0091-7613(1988)016<0654:PRFPWC>2.3.CO;2; HAWKINS J, 1977, EARTH PLANET SC LETT, V37, P216, DOI 10.1016/0012-821X(77)90166-2; IDA Y, 1978, J PHYS EARTH S, V26, pS64; KATO S, 1986, TECHNICAL B HYDROGRA, V4, P8; Kitazato Hiroshi, 1996, JAMSTEC Journal of Deep Sea Research, V12, P315; Kobayashi K, 1997, P JPN ACAD B-PHYS, V73, P89, DOI 10.2183/pjab.73.89; KOBAYASHI K, 1985, KH841, P1; Kotake Y., 1998, J SEISMOL SOC JPN, V51, P171; MATSUZAKA S, 1991, GEOPHYS RES LETT, V18, P1417, DOI 10.1029/91GL01799; Meijer A., 1983, GEOPHYS MONOGR SER, V27, P349; NAGIHARA S, 1989, TECTONOPHYSICS, V163, P93, DOI 10.1016/0040-1951(89)90120-0; NUGENT LE, 1948, GEOL SOC AM BULL, V59, P977, DOI 10.1130/0016-7606(1948)59[977:EPIIM]2.0.CO;2; NUNN PD, 1994, OCEANIC ISLANDS, P1; Sandwell DT, 1997, J GEOPHYS RES-SOL EA, V102, P10039, DOI 10.1029/96JB03223; SATO T, 1997, TECTONOPHYSICS, V271, P285, DOI 10.1016/S0040-1951(96)00251-X; SHIRAKI K, 1971, EARTH PLANET SC LETT, V13, P167, DOI 10.1016/0012-821X(71)90120-8; TAYAMA R, 1952, REPT HYDROGR RES, V11, P292; TOMODA Y, 1986, KH861, P1; TURCOTTE DL, 1982, GEODYNAMICS APPL CON, P231	28	2	2	JAPAN ACAD	TOKYO	7-32, UENO PARK, TAITO-KU, TOKYO, 110-0007, JAPAN	0386-2208			P JPN ACAD B-PHYS	Proc. Jpn. Acad. Ser. B-Phys. Biol. Sci.	NOV	2000	76	9					133	138		10.2183/pjab.76.133		6	Multidisciplinary Sciences	Science & Technology - Other Topics	384WR	WOS:000165970000001		
J	Sakakibara, M				Sakakibara, M			Remarks on a deformation quantization the canonical Nambu bracket	PROGRESS OF THEORETICAL PHYSICS			English	Article							MECHANICS	We give a deformation quantization of the canonical Nambu bracket which satisfies the skew-symmetry and the fundamental identity with "loop variables". We show that the Nambu bracket is reduced to the Poisson bracket.	Univ Tokyo, Dept Phys, Tokyo 1130033, Japan	Sakakibara, M (reprint author), Univ Tokyo, Dept Phys, Tokyo 1130033, Japan.						NAMBU Y, 1973, PHYS REV D, V7, P2405, DOI 10.1103/PhysRevD.7.2405; DITO G, 1997, COMMUN MATH PHYS, V163, P1; Kontsevich M., QALG9709040; SAHOO D, 1994, MOD PHYS LETT A, V9, P2727, DOI 10.1142/S0217732394002574; TAKHTAJAN L, 1994, COMMUN MATH PHYS, V160, P295, DOI 10.1007/BF02103278; XIONG CS, HEPTH0003292	6	8	8	PROGRESS THEORETICAL PHYSICS PUBLICATION OFFICE	KYOTO	C/O KYOTO UNIV, YUKAWA HALL, KYOTO, 606-8502, JAPAN	0033-068X			PROG THEOR PHYS	Prog. Theor. Phys.	NOV	2000	104	5					1067	1071		10.1143/PTP.104.1067		5	Physics, Multidisciplinary	Physics	381LP	WOS:000165764600012		
J	Momose, A; Takeda, T; Itai, Y				Momose, A; Takeda, T; Itai, Y			Blood vessels: Depiction at phase-contrast X-ray imaging without contrast agents in the mouse and rat - Feasibility study	RADIOLOGY			English	Article						blood vessels; radiography, phase contrast; synchrotron	COMPUTED-TOMOGRAPHY; INTERFEROMETER	The ability of phase-contrast x-ray imaging to depict blood vessels with; out contrast agents was tested by observing livers of a mouse and a rat with synchrotron x rays, Livers were excised by tying arteries and veins to prevent blood from flowing out of the liver. An x-ray interferometer was used to obtain x-ray phase contrast. With the technique of phase-shifting x-ray interferometry, the image mapping x-ray phase shift caused by a liver was measured. The x-ray phase shift caused by blood was substantially different from that caused by other soft tissues; consequently, trees of blood vessels were revealed on the image. Vessels with diameter smaller than 0.1 mm were recognized. This result allows new possibilities for investigation of the vascular system.	Adv Res Lab, Hitachi, Ibaraki, Japan; Univ Tsukuba, Inst Clin Med, Tsukuba, Ibaraki 305, Japan	Momose, A (reprint author), Univ Tokyo, Fac Engn, Dept Appl Phys, Bunkyo Ku, Hongo 7-3-1, Tokyo 1138656, Japan.						Wilkins SW, 1996, NATURE, V384, P335, DOI 10.1038/384335a0; Momose A, 1996, NAT MED, V2, P473, DOI 10.1038/nm0496-473; BONSE U, 1965, APPL PHYS LETT, V6, P155, DOI 10.1063/1.1754212; MOMOSE A, 1995, NUCL INSTRUM METH A, V352, P622, DOI 10.1016/0168-9002(95)90017-9; Snigirev A, 1995, REV SCI INSTRUM, V66, P5486, DOI 10.1063/1.1146073; DAVIS TJ, 1995, NATURE, V373, P595, DOI 10.1038/373595a0; MOMOSE A, 1995, MED PHYS, V22, P375, DOI 10.1118/1.597472; Beckmann F, 1997, J COMPUT ASSIST TOMO, V21, P539, DOI 10.1097/00004728-199707000-00006; Momose A, 1996, P SOC PHOTO-OPT INS, V2708, P674, DOI 10.1117/12.237831; Momose A., 1998, MED APPL SYNCHROTRON, P54; MOMOSE A, 1995, ACAD RADIOL, V2, P883, DOI 10.1016/S1076-6332(05)80067-4; MOMOSE A, 1998, XRAY MICROSCOPY SPEC, P207; SUZUKI Y, 1989, REV SCI INSTRUM, V60, P2299, DOI 10.1063/1.1140798; Yoneyama A, 1999, REV SCI INSTRUM, V70, P4582, DOI 10.1063/1.1150116	14	67	77	RADIOLOGICAL SOC NORTH AMER	EASTON	20TH AND NORTHAMPTON STS, EASTON, PA 18042 USA	0033-8419			RADIOLOGY	Radiology	NOV	2000	217	2					593	596				4	Radiology, Nuclear Medicine & Medical Imaging	Radiology, Nuclear Medicine & Medical Imaging	367JW	WOS:000090058800042		
J	Yamane, K; Ihn, H; Asano, Y; Yazawa, N; Kubo, M; Kikuchi, K; Soma, Y; Tamaki, K				Yamane, K; Ihn, H; Asano, Y; Yazawa, N; Kubo, M; Kikuchi, K; Soma, Y; Tamaki, K			Clinical and laboratory features of scleroderma patients with pulmonary hypertension	RHEUMATOLOGY			English	Article						pulmonary hypertension; scleroderma; Doppler echocardiography	PROGRESSIVE SYSTEMIC-SCLEROSIS; ARTERIAL-HYPERTENSION; PREVALENCE	Objective. Pulmonary hypertension (PH) is a frequent cause of death in patients with systemic sclerosis (SSc). In this study, we examined the occurrence of PH and investigated the clinical and laboratory features of SSc patients with PH. Methods. A cross-sectional study of 125 Japanese patients with SSc was conducted using Doppler echocardiography, other multiple cardiopulmonary tests, and laboratory examination. Results. PH (systolic pressure >40 mmHg) was diagnosed in 20 patients (16%) by Doppler echocardiography. In the six patients who had secondary pulmonary hypertension (SPH), PH was due to severe pulmonary fibrosis; 14 patients had isolated pulmonary hypertension (IPH). An elevated erythrocyte sedimentation rate (ESR) and increased immunoglobulin G (IgG) were found in a significantly greater proportion of the patients with PK than in those without PH. The incidence of pitting scars/ulcers was significantly greater in the patients with SPH than in those without PH. Conclusion. Elevated ESR and increased IgG were common features of scleroderma patients with PH, and scleroderma patients with SPH were inclined to have pitting scars/ulcers.	Univ Tokyo, Fac Med, Dept Dermatol, Bunkyo Ku, Tokyo 1138655, Japan	Ihn, H (reprint author), Univ Tokyo, Fac Med, Dept Dermatol, Bunkyo Ku, 7-3-1 Hongo, Tokyo 1138655, Japan.						LEROY EC, 1988, J RHEUMATOL, V15, P202; Kharitonov SA, 1997, THORAX, V52, P1051; UNGERER RG, 1983, AM J MED, V75, P65, DOI 10.1016/0002-9343(83)91169-5; RODNAN GP, 1979, ARTHRITIS RHEUM, V22, P130, DOI 10.1002/art.1780220205; STUPI AM, 1986, ARTHRITIS RHEUM, V29, P515, DOI 10.1002/art.1780290409; STEEN VD, 1988, ARTHRITIS RHEUM, V31, P196, DOI 10.1002/art.1780310207; Battle RW, 1996, CHEST, V110, P1515, DOI 10.1378/chest.110.6.1515; Ihn H, 1998, BRIT J RHEUMATOL, V37, P1188; Koh ET, 1996, BRIT J RHEUMATOL, V35, P989; LEROY EC, 1992, ANN RHEUM DIS, V51, P3412; Murata I, 1997, CHEST, V111, P36, DOI 10.1378/chest.111.1.36; Negi VS, 1998, J RHEUMATOL, V25, P462; STEEN VD, 1985, ARTHRITIS RHEUM, V28, P759, DOI 10.1002/art.1780280706; Subcommittee for Scleroderma Criteria of the American Rheumatism Association Diagnostic and Therapeutic Criteria Committee, 1980, ARTHRITIS RHEUM, V23, P581	14	46	48	OXFORD UNIV PRESS	OXFORD	GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND	1462-0324			RHEUMATOLOGY	RHEUMATOLOGY	NOV	2000	39	11					1269	1271		10.1093/rheumatology/39.11.1269		3	Rheumatology	Rheumatology	377NW	WOS:000165520500015		
J	Sorimachi, H				Sorimachi, H			Structure and function of calpain and its homologues	SEIKAGAKU			Japanese	Review							GIRDLE MUSCULAR-DYSTROPHY; MUSCLE-SPECIFIC CALPAIN; ACTIVATED NEUTRAL PROTEASE; CALCIUM-DEPENDENT PROTEASE; CHICKEN SKELETAL-MUSCLE; SEX DETERMINATION GENE; SMALL OPTIC LOBES; MU-CALPAIN; SCHISTOSOMA-MANSONI; MOLECULAR-CLONING		Univ Tokyo, Lab Biol Funct, Dept Appl Biol Chem, Grad Sch Agr & Life Sci,Bunkyo Ku, Tokyo 1138657, Japan			Sorimachi, Hiroyuki/C-6448-2009	Sorimachi, Hiroyuki/0000-0001-9509-6727			Anderson LVB, 1998, AM J PATHOL, V153, P1169, DOI 10.1016/S0002-9440(10)65661-1; ANDRESEN K, 1991, J BIOL CHEM, V266, P15085; Sorimachi H, 1995, J BIOL CHEM, V270, P31158; Scoles DR, 1998, NAT GENET, V18, P354, DOI 10.1038/ng0498-354; Blanchard H, 1997, NAT STRUCT BIOL, V4, P532, DOI 10.1038/nsb0797-532; Kamei M, 2000, GENOMICS, V64, P82, DOI 10.1006/geno.1999.6098; Gregorio CC, 1999, CURR OPIN CELL BIOL, V11, P18, DOI 10.1016/S0955-0674(99)80003-9; Kinbara K, 1998, BIOCHEM J, V335, P589; Arthur JSC, 2000, MOL CELL BIOL, V20, P4474, DOI 10.1128/MCB.20.12.4474-4481.2000; Kimura Y, 1998, NAT MED, V4, P915, DOI 10.1038/nm0898-915; Rizo J, 1998, J BIOL CHEM, V273, P15879, DOI 10.1074/jbc.273.26.15879; SUZUKI K, 1995, BIOL CHEM H-S, V376, P523; Strobl S, 2000, P NATL ACAD SCI USA, V97, P588, DOI 10.1073/pnas.97.2.588; Tokuda M, 1998, INFECT IMMUN, V66, P5232; Ono Y, 1998, BIOCHEM BIOPH RES CO, V245, P289, DOI 10.1006/bbrc.1998.8085; Lee MS, 2000, NATURE, V405, P360, DOI 10.1038/35012636; RICHARD I, 1995, CELL, V81, P27, DOI 10.1016/0092-8674(95)90368-2; MEYER WL, 1964, BIOCHEMISTRY-US, V3, P1033, DOI 10.1021/bi00896a004; Futai E, 1999, MOL GEN GENET, V260, P559; BOURGEAU G, 1992, INFECT IMMUN, V60, P3186; Konno T, 1997, BBA-PROTEIN STRUCT M, V1342, P73, DOI 10.1016/S0167-4838(97)00092-7; Satoh M, 1999, BIOCHEM BIOPH RES CO, V262, P411, DOI 10.1006/bbrc.1999.1221; Kamei M, 1998, GENOMICS, V51, P197, DOI 10.1006/geno.1998.5395; Ozawa E, 1998, MUSCLE NERVE, V21, P421, DOI 10.1002/(SICI)1097-4598(199804)21:4<421::AID-MUS1>3.0.CO;2-B; Markgraf CG, 1998, STROKE, V29, P152; DAVLETOV BA, 1993, J BIOL CHEM, V268, P26386; GUROFF G, 1964, J BIOL CHEM, V239, P149; DELANEY SJ, 1991, P NATL ACAD SCI USA, V88, P7214, DOI 10.1073/pnas.88.16.7214; Yap KL, 1999, PROTEINS, V37, P499, DOI 10.1002/(SICI)1097-0134(19991115)37:3<499::AID-PROT17>3.0.CO;2-Y; Wang KKW, 2000, TRENDS NEUROSCI, V23, P20, DOI 10.1016/S0166-2236(99)01479-4; Richard I, 1999, AM J HUM GENET, V64, P1524, DOI 10.1086/302426; Yang W, 2000, VACCINE, V19, P103, DOI 10.1016/S0264-410X(00)00165-1; Kusakawa G, 2000, J BIOL CHEM, V275, P17166, DOI 10.1074/jbc.M907757199; Patrick GN, 1999, NATURE, V402, P615; Bushby KMD, 1999, BRAIN, V122, P1403, DOI 10.1093/brain/122.8.1403; Franz T, 1999, MAMM GENOME, V10, P318, DOI 10.1007/s003359900995; BERTI PJ, 1995, J MOL BIOL, V246, P273, DOI 10.1006/jmbi.1994.0083; Chou FL, 1999, NEUROLOGY, V52, P1015; Barnes TM, 1996, EMBO J, V15, P4477; Baghdiguian S, 1999, NAT MED, V5, P503; Hosfield CM, 1999, EMBO J, V18, P6880, DOI 10.1093/emboj/18.24.6880; Shinozaki K, 1998, INT J MOL MED, V1, P797; Lin GD, 1997, NAT STRUCT BIOL, V4, P539, DOI 10.1038/nsb0797-539; Mayans O, 1998, NATURE, V395, P863; Tidball JG, 2000, INT J BIOCHEM CELL B, V32, P1, DOI 10.1016/S1357-2725(99)00095-3; Wolfe MS, 1999, NATURE, V398, P513, DOI 10.1038/19077; Brookmeyer R, 1998, AM J PUBLIC HEALTH, V88, P1337, DOI 10.2105/AJPH.88.9.1337; Cox GF, 1997, CURR OPIN CARDIOL, V12, P329; Stracher A, 1999, ANN NY ACAD SCI, V884, P52, DOI 10.1111/j.1749-6632.1999.tb08635.x; Horikawa Y, 2000, NAT GENET, V26, P163; AZANZA JL, 1979, BIOCHEM J, V183, P339; Beckmann JS, 1996, AM J HUM GENET, V59, P1400; Beckmann JS, 1999, BRIT MED BULL, V55, P340, DOI 10.1258/0007142991902411; Bushby KMD, 1999, HUM MOL GENET, V8, P1875, DOI 10.1093/hmg/8.10.1875; Carafoli E, 1998, BIOCHEM BIOPH RES CO, V247, P193, DOI 10.1006/bbrc.1998.8378; Chakrabarti AK, 1996, J NEUROSCI RES, V44, P374; CONG JY, 1989, J BIOL CHEM, V264, P10096; CRAWFORD C, 1993, BIOCHEM J, V296, P135; Croall DE, 1996, BBA-PROTEIN STRUCT M, V1298, P276, DOI 10.1016/S0167-4838(96)00138-0; CROALL DE, 1994, BIOCHEMISTRY-US, V33, P13223, DOI 10.1021/bi00249a008; CROALL DE, 1983, J BIOL CHEM, V258, P5660; Dear N, 1997, GENOMICS, V45, P175, DOI 10.1006/geno.1997.4870; ECK MJ, 1988, J BIOL CHEM, V263, P12816; ELCE JS, 1984, BIOCHEM J, V220, P507; Elce JS, 1997, BIOCHEM J, V326, P31; EMORI Y, 1986, FEBS LETT, V194, P249, DOI 10.1016/0014-5793(86)80094-1; Futai E, 1999, J BIOSCI BIOENG, V88, P438, DOI 10.1016/S1389-1723(99)80223-0; Gregorio CC, 1998, J CELL BIOL, V143, P1013, DOI 10.1083/jcb.143.4.1013; Hackel M, 2000, BBA-PROTEIN STRUCT M, V1479, P155, DOI 10.1016/S0167-4838(00)00051-0; Haravuori H, 1998, AM J HUM GENET, V62, P620, DOI 10.1086/301752; HATHAWAY DR, 1982, J BIOL CHEM, V257, P9072; Herasse M, 1999, MOL CELL BIOL, V19, P4047; HOFFMAN EP, 1987, CELL, V51, P919, DOI 10.1016/0092-8674(87)90579-4; ISHIURA S, 1979, J BIOCHEM-TOKYO, V86, P579; ISHIURA S, 1978, J BIOCHEM-TOKYO, V84, P225; Jankovic D, 1996, J IMMUNOL, V157, P806; Johnson GVW, 1997, BIOESSAYS, V19, P1011, DOI 10.1002/bies.950191111; Kakkar R, 1998, ARCH BIOCHEM BIOPHYS, V358, P320, DOI 10.1006/abbi.1998.0858; KARCZ SR, 1991, MOL BIOCHEM PARASIT, V49, P333, DOI 10.1016/0166-6851(91)90078-K; Kawasaki H, 1996, MOL MEMBR BIOL, V13, P217; Kinbara K, 1998, BIOCHEM PHARMACOL, V56, P415; Koga H, 1998, ONCOGENE, V17, P801, DOI 10.1038/sj.onc.1202010; Kosower NS, 2000, METH MOL B, V144, P181; Kretsinger RH, 1997, NAT STRUCT BIOL, V4, P514, DOI 10.1038/nsb0797-514; Lee HJ, 1998, BIOL CHEM, V379, P175, DOI 10.1515/bchm.1998.379.2.175; Lim LE, 1998, CURR OPIN NEUROL, V11, P443, DOI 10.1097/00019052-199810000-00006; Ma H, 2000, CURR EYE RES, V20, P183, DOI 10.1076/0271-3683(200003)20:3;1-9;FT183; MA H, 1993, J BIOCHEM-TOKYO, V113, P591; Maki M, 1997, BIOCHEM J, V328, P718; Maki M, 2000, METH MOL B, V144, P85; Maruyama K, 2000, INT J MOL MED, V5, P269; MELLGREN RL, 1993, J BIOL CHEM, V268, P653; Melloni E, 1998, J BIOL CHEM, V273, P12827, DOI 10.1074/jbc.273.21.12827; MELLONI E, 1984, BIOCHEM INT, V8, P477; MELLONI E, 1982, BIOCHEM BIOPH RES CO, V107, P1053, DOI 10.1016/0006-291X(82)90628-3; Melloni E, 2000, J BIOL CHEM, V275, P82, DOI 10.1074/jbc.275.1.82; Melloni E, 2000, BIOCHEM BIOPH RES CO, V272, P472, DOI 10.1006/bbrc.2000.2796; MENARD R, 1998, HDB PROTEOLYTIC ENZY, P546; Minami N, 1999, J NEUROL SCI, V171, P31, DOI 10.1016/S0022-510X(99)00245-2; Moreira ES, 2000, NAT GENET, V24, P163; Mugita N, 1997, BIOCHEM BIOPH RES CO, V239, P845, DOI 10.1006/bbrc.1997.7571; Negrete-Urtasun S, 1999, MOL MICROBIOL, V33, P994, DOI 10.1046/j.1365-2958.1999.01540.x; Noguchi M, 1997, P NATL ACAD SCI USA, V94, P11534, DOI 10.1073/pnas.94.21.11534; OHNO S, 1984, NATURE, V312, P566, DOI 10.1038/312566a0; Ono Y, 1999, TRENDS CARDIOVAS MED, V9, P114, DOI 10.1016/S1050-1738(99)00018-3; Ono Y, 1999, CALPAIN PHARM TOXICO, P1; Ono Y, 1998, J BIOL CHEM, V273, P17073, DOI 10.1074/jbc.273.27.17073; Ozawa E, 1999, MOL CELL BIOCHEM, V190, P143, DOI 10.1023/A:1006974613418; PONTREMOLI S, 1984, P NATL ACAD SCI-BIOL, V81, P53, DOI 10.1073/pnas.81.1.53; Pratt VM, 1997, AM J HUM GENET, V61, P231; Prigge JT, 1998, POULTRY SCI, V77, P1411; SAIDO TC, 1992, J BIOCHEM-TOKYO, V111, P81; SAIDO TC, 1992, J BIOL CHEM, V267, P24585; SAITO KI, 1993, P NATL ACAD SCI USA, V90, P2628, DOI 10.1073/pnas.90.7.2628; Scoles DR, 2000, HUM MOL GENET, V9, P1567, DOI 10.1093/hmg/9.11.1567; SIDDIQUI AA, 1993, BIOCHIM BIOPHYS ACTA, V1181, P37, DOI 10.1016/0925-4439(93)90087-H; Sokol SB, 2000, GENE DEV, V14, P901; Sorimachi H, 1997, J MOL BIOL, V270, P688, DOI 10.1006/jmbi.1997.1145; SORIMACHI H, 1989, J BIOL CHEM, V264, P20106; Sorimachi H, 1997, BIOCHEM J, V328, P721; Sorimachi H, 2000, METH MOL B, V144, P75; SORIMACHI H, 1993, J BIOL CHEM, V268, P19476; SORIMACHI H, 1993, J BIOL CHEM, V268, P10593; SORIMACHI H, 2000, NEUROSCI NEWS, V3, P20; StemmerRachamimov AO, 1997, AM J PATHOL, V151, P1649; SUGITA H, 1980, J BIOCHEM-TOKYO, V87, P339; SUZUKI K, 1981, J BIOCHEM-TOKYO, V90, P275; Suzuki K, 1998, FEBS LETT, V433, P1, DOI 10.1016/S0014-5793(98)00856-4; Tagawa K, 2000, HUM MOL GENET, V9, P1393, DOI 10.1093/hmg/9.9.1393; Thompson VF, 2000, BIOCHEM BIOPH RES CO, V267, P495, DOI 10.1006/bbrc.1999.2001; Tkachuk V A, 2000, Membr Cell Biol, V13, P263; Tompa P, 1996, J BIOL CHEM, V271, P33161; Tsuchiya Y, 1997, CURR OPIN NEUROL, V10, P421, DOI 10.1097/00019052-199710000-00011; TSUJI S, 1981, J BIOCHEM-TOKYO, V90, P1405; WANG KKW, 1989, BIOCHEM J, V262, P693; Xu HM, 1998, J NEUROSCI RES, V51, P403, DOI 10.1002/(SICI)1097-4547(19980201)51:3<403::AID-JNR13>3.0.CO;2-7; Yokota M, 1999, BRAIN RES, V819, P8, DOI 10.1016/S0006-8993(98)01334-1; YOSHIMURA N, 1983, J BIOL CHEM, V258, P8883; YOSHIZAWA T, 1995, BIOCHEM BIOPH RES CO, V208, P376, DOI 10.1006/bbrc.1995.1348; Zhang W, 1996, Biochem Biophys Res Commun, V227, P891	140	4	4	JAPANESE BIOCHEMICAL SOC	TOKYO	ISHIKAWA BLDG-3F, 25-16 HONGO-5-CHOME, BUNKYO-KU, TOKYO, 113, JAPAN	0037-1017			SEIKAGAKU	Seikagaku	NOV	2000	72	11					1297	1315				19	Biochemistry & Molecular Biology	Biochemistry & Molecular Biology	378VX	WOS:000165606800002		
J	Watanabe, Y				Watanabe, Y			RNA-dependent RNA polymerase detected in plants	SEIKAGAKU			Japanese	Article							TOBACCO MOSAIC-VIRUS; NUCLEOTIDE-SEQUENCE; RESISTANCE; REPLICASE; PROTEIN; PROTOPLASTS; INFECTION; REQUIRES; STRAIN; DNA		Univ Tokyo, Grad Sch Arts & Sci, Dept Life Sci, Meguro Ku, Tokyo 1538902, Japan							Beclin C, 1998, VIROLOGY, V252, P313, DOI 10.1006/viro.1998.9457; Brigneti G, 1998, EMBO J, V17, P6739, DOI 10.1093/emboj/17.22.6739; Elmayan T, 1998, PLANT CELL, V10, P1747; Cogoni C, 1999, NATURE, V399, P166; Mourrain P, 2000, CELL, V101, P533, DOI 10.1016/S0092-8674(00)80863-6; Voinnet O, 1998, CELL, V95, P177, DOI 10.1016/S0092-8674(00)81749-3; Hamilton AJ, 1999, SCIENCE, V286, P950, DOI 10.1126/science.286.5441.950; Ratcliff FG, 1999, PLANT CELL, V11, P1207; ANDERSON JM, 1992, P NATL ACAD SCI USA, V89, P8759, DOI 10.1073/pnas.89.18.8759; Palauqui JC, 1997, EMBO J, V16, P4738, DOI 10.1093/emboj/16.15.4738; Ratcliff F, 1997, SCIENCE, V276, P1558, DOI 10.1126/science.276.5318.1558; Schiebel W, 1998, PLANT CELL, V10, P2087, DOI 10.1105/tpc.10.12.2087; Dalmay T, 2000, CELL, V101, P543, DOI 10.1016/S0092-8674(00)80864-8; BLUMENTHAL T, 1979, ANNU REV BIOCHEM, V48, P525, DOI 10.1146/annurev.bi.48.070179.002521; Kasschau KD, 1998, CELL, V95, P461, DOI 10.1016/S0092-8674(00)81614-1; Bass BL, 2000, CELL, V101, P235, DOI 10.1016/S0092-8674(02)71133-1; Covey SN, 1997, NATURE, V385, P781, DOI 10.1038/385781a0; Zamore PD, 2000, CELL, V101, P25, DOI 10.1016/S0092-8674(00)80620-0; CARR JP, 1992, MOL PLANT MICROBE IN, V5, P397, DOI 10.1094/MPMI-5-397; DEHAAN P, 1992, BIO-TECHNOL, V10, P1133; Franze de Fernandez MT, 1968, NATURE, V219, P588; Franze de Fernandez MT, 1972, J BIOL CHEM, V247, P824; HARUNA I, 1965, P NATL ACAD SCI USA, V54, P1189, DOI 10.1073/pnas.54.4.1189; HARUNA I, 1965, P NATL ACAD SCI USA, V54, P579, DOI 10.1073/pnas.54.2.579; HELLWALD KH, 1994, J GEN VIROL, V75, P2121, DOI 10.1099/0022-1317-75-8-2121; ISHII S, 1991, VERTEBRATE ENDOCRI B, V4, P33; ISHIKAWA M, 1993, J VIROL, V67, P5328; ISHIKAWA M, 1986, NUCLEIC ACIDS RES, V14, P8291, DOI 10.1093/nar/14.21.8291; NISHIGUCHI M, 1985, NUCLEIC ACIDS RES, V13, P5585, DOI 10.1093/nar/13.15.5585; Osman TAM, 1997, J VIROL, V71, P6075; Powell-Abel P, 1986, SCIENCE, V232, P738; TAKANAMI Y, 1982, BIOCHEMISTRY-US, V21, P3161, DOI 10.1021/bi00256a020; Watanabe T, 1999, J VIROL, V73, P2633; WATANABE Y, 1987, J MOL BIOL, V194, P699, DOI 10.1016/0022-2836(87)90247-6; WATANABE Y, 1986, VIROLOGY, V149, P64, DOI 10.1016/0042-6822(86)90087-5; WATANABE Y, 1987, VIROLOGY, V161, P527, DOI 10.1016/0042-6822(87)90147-4; Yamanaka T, 2000, P NATL ACAD SCI USA, V97, P10107, DOI 10.1073/pnas.170295097	37	0	0	JAPANESE BIOCHEMICAL SOC	TOKYO	ISHIKAWA BLDG-3F, 25-16 HONGO-5-CHOME, BUNKYO-KU, TOKYO, 113, JAPAN	0037-1017			SEIKAGAKU	Seikagaku	NOV	2000	72	11					1317	1324				8	Biochemistry & Molecular Biology	Biochemistry & Molecular Biology	378VX	WOS:000165606800003		
J	Hashimoto, K; Hirasawa, T; Arai, M; Tamura, M				Hashimoto, K; Hirasawa, T; Arai, M; Tamura, M			Study on ignition quality improvement of LPG (part 1) evaluation of ignition quality of LPG with cetane number improving agents	SEKIYU GAKKAISHI-JOURNAL OF THE JAPAN PETROLEUM INSTITUTE			Japanese	Article						liquified petroleum gas; autoignition; cetane number; additive; diesel fuel; constant volume bomb		The objective of this study is to improve the ignition quality of LPG in order to utilize LPG as diesel fuel. First, the relationship between the cetane numbers and ignition delay periods of primary standard fuels (mixtures of n-cetane and heptamethylnonane) and diesel fuels was investigated by measuring the ignition delay periods using a constant volume combustion chamber. A good relationship between the cetane numbers and ignition delay periods under the conditions of combustion chamber temperature of 550 degreesC and pressure of 4 MPa. Consequently, a cetane number estimation function could be established. Next, the constant volume combustion chamber was modified to evaluate the ignition delay period of LPG with cetane number improving agents and these cetane numbers were estimated. The estimated cetane numbers of LPG with cetane number improving agents agreed with those calculated using the results of the diesel engine study. The estimated cetane numbers of LPG with 15 wt% cetane number improving agents were greater than 45 suggesting that LPG can be used as diesel fuel.	Univ Tokyo, Grad Sch Frontier Sci, Inst Environm Studies, Bunkyo Ku, Tokyo 1130033, Japan; Univ Tokyo, Sch Engn, Dept Chem Syst Engn, Bunkyo Ku, Tokyo 1138656, Japan	Hashimoto, K (reprint author), Univ Tokyo, Grad Sch Frontier Sci, Inst Environm Studies, Bunkyo Ku, 7-3-1 Hongo, Tokyo 1130033, Japan.						Aligrot C, 1997, 970638 SAE; Freedman B, 1990, 900343 SAE; Goto S., 1999, 1999013602 SAE; GOTO S, 1992, JIDOSHA GIJUTSUKAI K, V921, P229; GOTO S, 1993, JIDOSHA GIJUTSU, V47, P63; HASHIMOTO K, 1995, NIPPON ENERUGI GAKKA, V74, P200; HASHIMOTO K, 1996, SEKIYU GAKKAISHI, V39, P166; HIKINO K, 1989, JIDOSHA GIJUTSUKAI K, V892, P253; HURN RW, 1952, SAE QUART T, V6, P25; IKEGAMI M, 1986, NIHON KIKAI GAKKAI R, V52, P2761; RUSSELL TJ, 1989, GASOLINE DIESEL FUEL, P71; Ryan T. W., 1987, 870586 SAE; Ryan T. W., 1985, 852103 SAE; Ryan T. W., 1988, 881626 SAE; Siebers D., 1985, 852102 SAE; WOLFER HH, 1950, 358 T ROYAL AIRCR ES	16	5	5	JAPAN PETROLEUM INST	TOKYO	COSMO HIRAKAWA-CHO BLDG, 3-14, 1-CHOME HIRAKAWA-CHO, CHIYODA-KU, TOKYO, 102, JAPAN	0582-4664			SEKIYU GAKKAISHI	Sekiyu Gakkaishi	NOV	2000	43	6					386	391				6	Energy & Fuels; Engineering, Petroleum	Energy & Fuels; Engineering	386CR	WOS:000166043000002		
J	Chang, J; Tsubaki, N; Fujimoto, K; Yoshimoto, M				Chang, J; Tsubaki, N; Fujimoto, K; Yoshimoto, M			Enhancing effect of local heating by an inside filament on hydrothermal cracking of hydrocarbon catalyzed by Ni/Al2O3	SEKIYU GAKKAISHI-JOURNAL OF THE JAPAN PETROLEUM INSTITUTE			English	Letter						hydrothermal process; hydrocarbon; heavy oil; initiation; filament	MODEL-COMPOUND; HEAVY OIL	During the hydrothermal cracking of hydrocarbon and heavy oil catalyzed by Ni/Al2O3, the conversions of hydrocarbon and heavy oil were remarkably enhanced by heating with a small inside filament. The experiment facts suggested that the heating with inside filament might realize higher temperature zone at local space in the reactor, which was responsible for an increase of the concentration of free radicals, and enhanced the conversion of hydrocarbons even at lower temperature.	Univ Tokyo, Sch Engn, Dept Appl Chem, Bunkyo Ku, Tokyo 1138656, Japan; Petr Energy Ctr Japan, Takatsu Ku, Kawasaki, Kanagawa 2130012, Japan	Tsubaki, N (reprint author), Univ Tokyo, Sch Engn, Dept Appl Chem, Bunkyo Ku, Hongo 7-3-1, Tokyo 1138656, Japan.						AIMOTO K, 1991, ENERG FUEL, V5, P739, DOI 10.1021/ef00029a020; BEATON WI, 1991, CATAL REV, V33, P281, DOI 10.1080/01614949108020302; Fujimoto K, 2000, SEKIYU GAKKAISHI, V43, P25; CHANG J, 1999, ACS PREPR DIV FUEL C, V44, P801; Chang J, 1999, ENERG FUEL, V13, P1107, DOI 10.1021/ef990041k; SAVAGE PE, 1987, IND ENG CHEM RES, V26, P488, DOI 10.1021/ie00063a015	6	0	0	JAPAN PETROLEUM INST	TOKYO	COSMO HIRAKAWA-CHO BLDG, 3-14, 1-CHOME HIRAKAWA-CHO, CHIYODA-KU, TOKYO, 102, JAPAN	0582-4664			SEKIYU GAKKAISHI	Sekiyu Gakkaishi	NOV	2000	43	6					414	415				2	Energy & Fuels; Engineering, Petroleum	Energy & Fuels; Engineering	386CR	WOS:000166043000007		
J	Yamaguchi, S; Nakamura, K; Higuchi, T; Shin, S; Iguchi, Y				Yamaguchi, S; Nakamura, K; Higuchi, T; Shin, S; Iguchi, Y			Basicity and hydroxyl capacity of proton-conducting perovskites	SOLID STATE IONICS			English	Article; Proceedings Paper	12th International Conference on Solid State Ionics	JUN 06-12, 1999	HALKIDIKI, GREECE	Minist Cultural Affairs, Minist Educ, Minist Macedonia & Thrace, Gen Secretariat Res & Technol, Univ Patras, Res Comm, Aristotle Univ Thessaloniki, Univ Thessaly, Patras Sci Pk, Chem Process Engn Res Inst, Natl Bank Greece, Commercial Bank Greece, Agr Bank Greece, Athenian Brewry SA, Patras Plant, LPC Hellas, Leader Books SA, GlaxoWellcome, George P Vasilopoulos SA, Hlthcon Ltd, Energizer, ONR, Elefctrochem Soc, High Temperature Mat Div		proton; perovskite; basicity; capacity; solubility; activity; thermodynamics	BACEO3	In order to understand the large solubility of protons in perovskite proton conductors, a new approach employing the hydroxyl capacity, termed C-OH' = [OHO']. [V-O"](-1) . p(H2O)(-1/2), is proposed and examined for 5 mol% YbO1.5-doped BaCeO3. Prior to the solubility experiments, the phase relation in an isothermal section of the phase diagram for BaO-CeO2-YbO1.5 was determined and activity measurements for BaO were carried out. The values of C-OH' were evaluated by measuring the solubility of water using the thermogravimetric method under a controlled BaO activity by employing the reaction BaO(in BuCeO3) + CO2(g) = BaCO3. C-OH' did not exhibit a strong dependency on the BaO activity, indicating that the basicity of BaCeO3, defncd as the activity of O2- ions, is almost constant across the homogeneity region. It has been estimated that the A-site vacancy in ABO(3) mainly contributes to the steep change in BaO activity. (C) 2000 Elsevier Science B.V. All rights reserved.	Nagoya Inst Technol, Dept Mat Sci & Engn, Showa Ku, Nagoya, Aichi 4668555, Japan; Sci Univ Tokyo, Fac Sci, Shinjuku Ku, Tokyo 1620825, Japan; Univ Tokyo, Inst Solid State Phys, Tanashi, Tokyo 1888501, Japan	Yamaguchi, S (reprint author), Nagoya Inst Technol, Dept Mat Sci & Engn, Showa Ku, Nagoya, Aichi 4668555, Japan.		Higuchi, Tohru/C-6544-2012				GOPALAN S, 1993, J ELECTROCHEM SOC, V140, P1060, DOI 10.1149/1.2056197; BANYA S, 1991, CHEM PROPERTIES MOLT, P174; LEVITSKII VA, 1986, INORG MATER, V21, P186; Makovec D, 1997, J AM CERAM SOC, V80, P3145; NORBY T, 1997, CURR OPIN SOLID ST M, V2, P693; SCHOLTEN MJ, 1993, SOLID STATE IONICS, V61, P183; Wagner C., 1975, Metallurgical Transactions B (Process Metallurgy), V6B, DOI 10.1007/BF02913825; Yamaguchi S., UNPUB	8	29	29	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	0167-2738			SOLID STATE IONICS	Solid State Ion.	NOV	2000	136				SI		191	195		10.1016/S0167-2738(00)00305-2		5	Chemistry, Physical; Physics, Condensed Matter	Chemistry; Physics	385GZ	WOS:000165996600027		
J	Higuchi, T; Tsukamoto, T; Sata, N; Ishigame, M; Kobayashi, K; Yamaguchi, S; Ishiwata, Y; Yokoya, T; Fujisawa, M; Shin, S				Higuchi, T; Tsukamoto, T; Sata, N; Ishigame, M; Kobayashi, K; Yamaguchi, S; Ishiwata, Y; Yokoya, T; Fujisawa, M; Shin, S			Hole-state and defect structure of proton conductor SrTiO3 observed by high-resolution X-ray absorption spectroscopy	SOLID STATE IONICS			English	Article; Proceedings Paper	12th International Conference on Solid State Ionics	JUN 06-12, 1999	HALKIDIKI, GREECE	Minist Cultural Affairs, Minist Educ, Minist Macedonia & Thrace, Gen Secretariat Res & Technol, Univ Patras, Res Comm, Aristotle Univ Thessaloniki, Univ Thessaly, Patras Sci Pk, Chem Process Engn Res Inst, Natl Bank Greece, Commercial Bank Greece, Agr Bank Greece, Athenian Brewry SA, Patras Plant, LPC Hellas, Leader Books SA, GlaxoWellcome, George P Vasilopoulos SA, Hlthcon Ltd, Energizer, ONR, Elefctrochem Soc, High Temperature Mat Div		protonic conductor; SrTiO3; XAS; hole-state; proton level; acceptor level	P-TYPE SRTIO3; PHOTOEMISSION	The hole-state and defect structure of proton conductor SrTi1-xScxO3 have been studied by high-resolution X-ray absorption spectroscopy. The proton-induced level is observed in proton-doped SrTi1-xScxO3. The energy separation between the top of the valence band and the bottom of the acceptor or proton level is considered to be the activation energy determined by electronic or proton conductivity. (C) 2000 Elsevier Science B.V. All rights reserved.	Sci Univ Tokyo, Fac Sci, Shinjuku Ku, Tokyo 1628501, Japan; Tohoku Univ, Sci Measurements Res Inst, Sendai, Miyagi 9808577, Japan; Natl Inst Mat & Chem Res, Tsukuba, Ibaraki 3058565, Japan; Nagoya Inst Technol, Dept Mat Sci & Engn, Nagoya, Aichi 4668555, Japan; Univ Tokyo, Inst Solid State Phys, Tanashi, Tokyo 1888501, Japan	Higuchi, T (reprint author), Sci Univ Tokyo, Dept Appl Phys, 1-3 Kagurazaka, Tokyo 1620825, Japan.		Higuchi, Tohru/C-6544-2012; KOBAYASHI, Kiyoshi/H-2921-2011; YOKOYA, Takayoshi/B-1478-2011	KOBAYASHI, Kiyoshi/0000-0001-9644-1879; 			ABBATE M, 1991, PHYS REV B, V44, P5419, DOI 10.1103/PhysRevB.44.5419; Higuchi T, 1998, PHYS REV B, V57, P6978, DOI 10.1103/PhysRevB.57.6978; SHIN S, 1990, SOLID STATE IONICS, V40-1, P910, DOI 10.1016/0167-2738(90)90151-G; Sata N, 1996, SOLID STATE IONICS, V86-8, P629, DOI 10.1016/0167-2738(96)00226-3; Fujisawa M, 1996, REV SCI INSTRUM, V67, P345, DOI 10.1063/1.1146621; Higuchi T, 1998, SOLID STATE IONICS, V108, P349, DOI 10.1016/S0167-2738(98)00062-9; HIRAMOTO K, UNPUB; IWAHARA H, 1981, J SOLID STATE IONICS, V3, P359	8	11	11	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	0167-2738			SOLID STATE IONICS	Solid State Ion.	NOV	2000	136				SI		261	264		10.1016/S0167-2738(00)00319-2		4	Chemistry, Physical; Physics, Condensed Matter	Chemistry; Physics	385GZ	WOS:000165996600037		
J	Yamaguchi, S; Kobayashi, K; Higuchi, T; Shin, S; Iguchi, Y				Yamaguchi, S; Kobayashi, K; Higuchi, T; Shin, S; Iguchi, Y			Electronic transport properties and electronic structure of InO1.5-doped CaZrO3	SOLID STATE IONICS			English	Article; Proceedings Paper	12th International Conference on Solid State Ionics	JUN 06-12, 1999	HALKIDIKI, GREECE	Minist Cultural Affairs, Minist Educ, Minist Macedonia & Thrace, Gen Secretariat Res & Technol, Univ Patras, Res Comm, Aristotle Univ Thessaloniki, Univ Thessaly, Patras Sci Pk, Chem Process Engn Res Inst, Natl Bank Greece, Commercial Bank Greece, Agr Bank Greece, Athenian Brewry SA, Patras Plant, LPC Hellas, Leader Books SA, GlaxoWellcome, George P Vasilopoulos SA, Hlthcon Ltd, Energizer, ONR, Elefctrochem Soc, High Temperature Mat Div		conductivity; thermoelectric power; Seebeck coefficient; mixed conductor; proton conductor; mobility; XAS	CALCIUM ZIRCONATE; TEMPERATURE	Simultaneous measurements of total conductivity and thermoelectric power have been made on 1 mol% InO1.5-doped CaZrO3 (CaZr0.99In0.01O0.995) in order to evaluate defect chemical parameters and both electronic and ionic transport properties. The concentrations of holes, protons, and oxygen vacancies and their mobility, in addition to the heat of transport of oxide ions and protons, have been estimated using defect chemical and irreversible thermochemical analyses. The present results show that the dissolution reaction of protons saturates below 1173 K and the concentration of holes decreases by the dissolution of protons, indicating the presence of direct substitution of protons with holes. Ols X-ray absorption spectroscopy has been employed to observe the electronic structure near the band gap, showing the presence of holes at the top of the valence band and the splitting of the hole state when protons dissolve. The decrease in the hole concentration observed under reducing conditions is consistent with the defect chemical analysis. (C) 2000 Elsevier Science B.V. All rights reserved.	Nagoya Inst Technol, Dept Mat Sci & Engn, Showa Ku, Nagoya, Aichi 4668555, Japan; Natl Inst Mat & Chem Res, Tsukuba, Ibaraki 3058565, Japan; Sci Univ Tokyo, Fac Sci, Tokyo 1620825, Japan; Univ Tokyo, Inst Solid State Phys, Tanashi, Tokyo 1888501, Japan	Yamaguchi, S (reprint author), Nagoya Inst Technol, Dept Mat Sci & Engn, Showa Ku, Nagoya, Aichi 4668555, Japan.		Higuchi, Tohru/C-6544-2012; KOBAYASHI, Kiyoshi/H-2921-2011	KOBAYASHI, Kiyoshi/0000-0001-9644-1879			Amezawa K, 1996, DENKI KAGAKU, V64, P688; KURITA N, 1995, J ELECTROCHEM SOC, V142, P1552, DOI 10.1149/1.2048611; Yamaguchi S, 1998, SOLID STATE IONICS, V113, P393, DOI 10.1016/S0167-2738(98)00303-8; Kobayashi K, 1998, SOLID STATE IONICS, V108, P355, DOI 10.1016/S0167-2738(98)00063-0; Sata N, 1996, SOLID STATE IONICS, V86-8, P629, DOI 10.1016/0167-2738(96)00226-3; Heyne L., 1971, P BRIT CERAMIC SOC, V19, P229; Higuchi T, 2000, SOLID STATE IONICS, V136, P261, DOI 10.1016/S0167-2738(00)00319-2; Higuchi Takeshi, UNPUB; IWAHARA H, 1981, J SOLID STATE IONICS, V3, P359; Morita Y, 1997, DENKI KAGAKU, V65, P663; NORBY T, 1977, CURR OPIN SOLID ST M, V2, P693; SHEWMON PG, 1989, DIFFUSION SOLIDS, P223; Wagner C., 1972, PROGR SOLID STATE CH, V7, P1, DOI 10.1016/0079-6786(72)90003-9; Yamaguchi S., UNPUB; YOO HI, 1992, J PHYS CHEM SOLIDS, V53, P973, DOI 10.1016/0022-3697(92)90126-X	15	43	43	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	0167-2738			SOLID STATE IONICS	Solid State Ion.	NOV	2000	136				SI		305	311		10.1016/S0167-2738(00)00408-2		7	Chemistry, Physical; Physics, Condensed Matter	Chemistry; Physics	385GZ	WOS:000165996600044		
J	Hibino, M; Han, WC; Kudo, T				Hibino, M; Han, WC; Kudo, T			Electrochemical lithium intercalation into a hexagonal WO3 framework and its structural change	SOLID STATE IONICS			English	Article; Proceedings Paper	12th International Conference on Solid State Ionics	JUN 06-12, 1999	HALKIDIKI, GREECE	Minist Cultural Affairs, Minist Educ, Minist Macedonia & Thrace, Gen Secretariat Res & Technol, Univ Patras, Res Comm, Aristotle Univ Thessaloniki, Univ Thessaly, Patras Sci Pk, Chem Process Engn Res Inst, Natl Bank Greece, Commercial Bank Greece, Agr Bank Greece, Athenian Brewry SA, Patras Plant, LPC Hellas, Leader Books SA, GlaxoWellcome, George P Vasilopoulos SA, Hlthcon Ltd, Energizer, ONR, Elefctrochem Soc, High Temperature Mat Div		tungsten trioxide; lithium intercalation; DV-X alpha	TUNGSTEN TRIOXIDE; CHEMISTRY; INSERTION; HYDROGEN; OXIDES; FORM	Hexagonal tungsten trioxide (h-WO3) (ideally P6/mmm) has three kinds of lithium intercalation sites which are the hexagonal-window (1a), hexagonal-cavity (1b) and trigonal-cavity (2d). Calculation by the DV-X alpha method using a LixW36O138(60-x)- cluster showed that inserted lithium ions were more stable at the trigonal-cavity site than at the other sites. When lithium intercalation in h-WO3 was performed electrochemically, OCV (open circuit voltage) traces exhibited large hysteresis between insertion and the extraction process. On the basis of DV-X alpha calculation results and changes in lattice parameters, we concluded that lithium ions started occupying hexagonal-window and/or hexagonal-cavity sites before the trigonal-cavity site was completely filled in the insertion process, and that lithium ions at the trigonal-cavity site were extracted after the hexagonal-window and hexagonal-cavity sites were almost empty during the extraction process. (C) 2000 Elsevier Science B.V. All rights reserved.	Univ Tokyo, Inst Ind Sci, Minato Ku, Tokyo, Japan	Hibino, M (reprint author), Univ Tokyo, Inst Ind Sci, Minato Ku, 7-22-1 Roppongi, Tokyo, Japan.						ADACHI H, 1978, J PHYS SOC JPN, V45, P875; OI J, 1992, J SOLID STATE CHEM, V96, P13, DOI 10.1016/S0022-4596(05)80292-0; CHENG KH, 1981, SOLID STATE IONICS, V5, P355, DOI 10.1016/0167-2738(81)90266-6; GERAND B, 1979, J SOLID STATE CHEM, V29, P429, DOI 10.1016/0022-4596(79)90199-3; Kumagai N, 1996, SOLID STATE IONICS, V86-8, P1443, DOI 10.1016/0167-2738(96)00327-X; Zheng T, 1996, J ELECTROCHEM SOC, V143, P2137, DOI 10.1149/1.1836972; FIGLARZ M, 1989, PROG SOLID STATE CH, V19, P1, DOI 10.1016/0079-6786(89)90005-8; GERAND B, 1981, J SOLID STATE CHEM, V38, P312, DOI 10.1016/0022-4596(81)90062-1; GERAND B, 1978, 9 INT C EL MICR TOR, V1, P260; Han WC, 1998, B CHEM SOC JPN, V71, P933, DOI 10.1246/bcsj.71.933; KUDO T, 1990, SOLID STATE IONICS, V40-1, P567, DOI 10.1016/0167-2738(90)90072-Y; SCHLASCHE B, 1982, REV CHIM MINER, V19, P534; SLADE RCT, 1989, SOLID STATE IONICS, V32-3, P154, DOI 10.1016/0167-2738(89)90216-6	13	31	31	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	0167-2738			SOLID STATE IONICS	Solid State Ion.	NOV	2000	135	1-4			SI		61	69		10.1016/S0167-2738(00)00332-5		9	Chemistry, Physical; Physics, Condensed Matter	Chemistry; Physics	382ZG	WOS:000165856800008		
J	Abiko, H; Hibino, M; Kudo, T				Abiko, H; Hibino, M; Kudo, T			Anomaly in the potential-composition profile of a LiMn2O4 spinel at low temperature	SOLID STATE IONICS			English	Article; Proceedings Paper	12th International Conference on Solid State Ionics	JUN 06-12, 1999	HALKIDIKI, GREECE	Minist Cultural Affairs, Minist Educ, Minist Macedonia & Thrace, Gen Secretariat Res & Technol, Univ Patras, Res Comm, Aristotle Univ Thessaloniki, Univ Thessaly, Patras Sci Pk, Chem Process Engn Res Inst, Natl Bank Greece, Commercial Bank Greece, Agr Bank Greece, Athenian Brewry SA, Patras Plant, LPC Hellas, Leader Books SA, GlaxoWellcome, George P Vasilopoulos SA, Hlthcon Ltd, Energizer, ONR, Elefctrochem Soc, High Temperature Mat Div		lithium ion battery; LiMn2O4; Jahn-Teller distortion; potential-composition profile	LITHIUM; TRANSITION; BATTERIES	The potential-composition (phi -x) curve of a stoichiometric LiMn2O4 spinel shows an anomaly that a new voltage step appears at x=0.7 (in LixMn2O4) at low temperature (T less than or equal to 278 K). To investigate the relation between this anomaly and structural transition due to the Jahn-Teller distortion, we recorded the phi -x profiles at 298 and 273 K with several nonstoichiometric specimens, Li-excess Li1+yMn2-yO4 as well as Li-deficient compounds apparently expressed by Li1-yMn2O4, because it is sensitive to stoichiometry whether the compound undergoes the transition or not. It was found that Li-deficient compounds (y' = 0.03-0.05) showed a similar anomalous step, though no first-order transition was observed in the relevant temperature range by the DSC technique. The same thing was also found for a Li-excess sample with y = 0.01. These facts indicate that the origin of the anomaly is not directly related to the Jahn-Teller distortion. (C) 2000 Elsevier Science B.V. All rights reserved.	Univ Tokyo, Inst Ind Sci, Minato Ku, Tokyo 1068558, Japan	Kudo, T (reprint author), Univ Tokyo, Inst Ind Sci, Minato Ku, 7-22-1,Roppongi, Tokyo 1068558, Japan.						Abiko H, 1998, ELECTROCHEM SOLID ST, V1, P114; Ammundsen B, 1997, J PHYS CHEM B, V101, P8156, DOI 10.1021/jp971413y; YAMADA A, 1995, J ELECTROCHEM SOC, V142, P2149, DOI 10.1149/1.2044266; Oikawa K, 1998, SOLID STATE IONICS, V109, P35, DOI 10.1016/S0167-2738(98)00073-3; Gao Y, 1996, PHYS REV B, V54, P3878, DOI 10.1103/PhysRevB.54.3878; Guan J, 1998, SOLID STATE IONICS, V110, P21, DOI 10.1016/S0167-2738(98)00096-4; Guohua L., 1996, J ELECTROCHEM SOC, V143, P178, DOI 10.1149/1.1836405; GYOMARD D, 1994, SOLID STATE IONICS, V69, P222; Hosoya M, 1997, J ELECTROCHEM SOC, V144, pL52, DOI 10.1149/1.1837550; Kanamura K, 1996, J MATER CHEM, V6, P33, DOI 10.1039/jm9960600033; Kudo T, 1998, ELECTROCHIM ACTA, V43, P781, DOI 10.1016/S0013-4686(97)00205-3; NAGASHIMA K, 1964, JPN ANALYST, V13, P261; Rousse G, 1999, ELECTROCHEM SOLID ST, V2, P6, DOI 10.1149/1.1390716; SCHRODER H, 1954, METALL, V8, P542; YAMADA A, 1995, MATER RES BULL, V30, P715, DOI 10.1016/0025-5408(95)00048-8	15	8	8	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	0167-2738			SOLID STATE IONICS	Solid State Ion.	NOV	2000	135	1-4			SI		115	120		10.1016/S0167-2738(00)00289-7		6	Chemistry, Physical; Physics, Condensed Matter	Chemistry; Physics	382ZG	WOS:000165856800015		
J	Endo, A; Fukunaga, H; Wen, C; Yamada, K				Endo, A; Fukunaga, H; Wen, C; Yamada, K			Cathodic reaction mechanism of dense La0.6Sr0.4CoO3 and La0.81Sr0.09MnO3 electrodes for solid oxide fuel cells	SOLID STATE IONICS			English	Article; Proceedings Paper	12th International Conference on Solid State Ionics	JUN 06-12, 1999	HALKIDIKI, GREECE	Minist Cultural Affairs, Minist Educ, Minist Macedonia & Thrace, Gen Secretariat Res & Technol, Univ Patras, Res Comm, Aristotle Univ Thessaloniki, Univ Thessaly, Patras Sci Pk, Chem Process Engn Res Inst, Natl Bank Greece, Commercial Bank Greece, Agr Bank Greece, Athenian Brewry SA, Patras Plant, LPC Hellas, Leader Books SA, GlaxoWellcome, George P Vasilopoulos SA, Hlthcon Ltd, Energizer, ONR, Elefctrochem Soc, High Temperature Mat Div		cathodic reaction mechanism; dense electrode; solid oxide fuel cell; LSC; LSM		Dense La0.6Sr0.4CoO3 (LSC) and La0.81Sr0.09MnO3 (LSM) were prepared by laser ablation on samaria-doped ceria (SDC) and yttria-stabilized zirconia (YSZ) substrates, respectively. The interfacial conductivity of the dense LSM electrodes was independent of the oxygen partial pressure and inversely proportional to the thickness of the LSM film. On the other hand, the interfacial conductivity of the dense LSC electrode was proportional to the square root of the oxygen partial pressure, which indicates the sensitivity of the surface reaction to the overpotential. To determine the origin of the overpotential, we constructed a surface-reaction model. Good agreement was found between our model and experimental results. (C) 2000 Elsevier Science B.V. All rights reserved.	Univ Tokyo, Sch Engn, Dept Chem Syst Engn, Bunkyo Ku, Tokyo 1138656, Japan; Natl Inst Mat & Chem Res, Dept Chem Syst, Tsukuba, Ibaraki 3058565, Japan	Yamada, K (reprint author), Univ Tokyo, Sch Engn, Dept Chem Syst Engn, Bunkyo Ku, 7-3-1 Hongo, Tokyo 1138656, Japan.						MINH NQ, 1993, J AM CERAM SOC, V76, P563, DOI 10.1111/j.1151-2916.1993.tb03645.x; Fukunaga H, 1996, SOLID STATE IONICS, V86-8, P1179, DOI 10.1016/0167-2738(96)00284-6; Steele BCH, 1996, SOLID STATE IONICS, V86-8, P1223, DOI 10.1016/0167-2738(96)00291-3; Endo A, 1996, SOLID STATE IONICS, V86-8, P1191, DOI 10.1016/0167-2738(96)00286-X; Boukamp B.A., 1988, EQUIVALENT CIRCUIT U; Endo A, 1998, J ELECTROCHEM SOC, V145, pL35, DOI 10.1149/1.1838332; ISHIHARA T, 1993, 2 S SOL OX FUEL CELL, P77; Morgensen M., 1996, SOLID STATE IONICS, V86-88, P1151; Svensson AM, 1996, SOLID STATE IONICS, V86-8, P1211, DOI 10.1016/0167-2738(96)00289-5; YASUDA I, 1996, SOLID STATE IONICS, V86, P1223	10	81	81	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	0167-2738			SOLID STATE IONICS	Solid State Ion.	NOV	2000	135	1-4			SI		353	358		10.1016/S0167-2738(00)00466-5		6	Chemistry, Physical; Physics, Condensed Matter	Chemistry; Physics	382ZG	WOS:000165856800048		
J	Kobayashi, K; Yamaguchi, S; Higuchi, T; Shin, S; Iguchi, Y				Kobayashi, K; Yamaguchi, S; Higuchi, T; Shin, S; Iguchi, Y			Electronic transport properties and electronic structure of TiO(2)-doped YSZ	SOLID STATE IONICS			English	Article; Proceedings Paper	12th International Conference on Solid State Ionics	JUN 06-12, 1999	HALKIDIKI, GREECE	Minist Cultural Affairs, Minist Educ, Minist Macedonia & Thrace, Gen Secretariat Res & Technol, Univ Patras, Res Comm, Aristotle Univ Thessaloniki, Univ Thessaly, Patras Sci Pk, Chem Process Engn Res Inst, Natl Bank Greece, Commercial Bank Greece, Agr Bank Greece, Athenian Brewry SA, Patras Plant, LPC Hellas, Leader Books SA, GlaxoWellcome, George P Vasilopoulos SA, Hlthcon Ltd, Energizer, ONR, Elefctrochem Soc, High Temperature Mat Div		TiO(2)-doped yttria-stabilized zirconia; mixed conductor; electronic conductivity; Dc-polarization; XAS	YTTRIA-STABILIZED ZIRCONIA; CONDUCTIVITY MEASUREMENTS; ELECTRICAL-CONDUCTIVITY; SOLID ELECTROLYTES; CERAMICS; CRYSTALS; TITANIA; OXIDES; PHASE; TIO2	Electronic conductivity of yttria-stabilized zirconia (YSZ doped with 2 mol% of TiO(2) was measured by the depolarization technique using the Hebb-Wagner's asymmetric cell. The X-ray absorption spectroscopy (XAS) was also employed for 2, 5 and 10 mol% of TiO(2)-doped YSZ in order to investigate the electronic structure near the band gap. The partial conductivity of conduction electrons equilibrated at unit oxygen partial pressure (sigma (n)) increased with increasing TiO(2) concentration and the apparent activation energy of sigma (n) decreased by the TiO(2) doping, In contrast, the partial conductivity of holes and the apparent activation energy were almost independent of TiO(2) concentration. These results suggest the band-gap narrowing by TiO(2) doping, which is consistent with the results of the X-ray absorption spectroscopy measurements, where unoccupied t2g states of Ti3d below the conduction band grew with the increase of the TiO(2) concentration. The change in the electronic conductivity with TiO(2) concentration was discussed based on the percolation theory. (C) 2000 Elsevier Science B.V. All rights reserved.	Nagoya Inst Technol, Dept Mat Sci & Engn, Showa Ku, Nagoya, Aichi 4668555, Japan; Tokyo Univ Sci, Fac Sci, Shinjuku Ku, Tokyo 1620825, Japan; Univ Tokyo, Inst Solid State Phys, Tanashi, Tokyo 1888501, Japan	Kobayashi, K (reprint author), Natl Inst Mat & Chem Res, Higashi 1-1, Tsukuba, Ibaraki 3058565, Japan.	kiyoshi@nimc.go.jp	Higuchi, Tohru/C-6544-2012; KOBAYASHI, Kiyoshi/H-2921-2011	KOBAYASHI, Kiyoshi/0000-0001-9644-1879			Swider KE, 1996, J ELECTROCHEM SOC, V143, P3706, DOI 10.1149/1.1837276; Kobayashi K, 1997, SOLID STATE IONICS, V93, P193, DOI 10.1016/S0167-2738(96)00534-6; NAITO H, 1992, SOLID STATE IONICS, V53, P436, DOI 10.1016/0167-2738(92)90412-I; KROGER FA, 1956, SOLID STATE PHYS, V3, P307; LIOU SS, 1989, APPL PHYS A-MATER, V49, P25; BLUMENTH.RN, 1966, J PHYS CHEM SOLIDS, V27, P643, DOI 10.1016/0022-3697(66)90215-0; BORIS AV, 1990, SOLID STATE IONICS, V40-1, P269, DOI 10.1016/0167-2738(90)90338-R; BREDIKHIN S, 1994, PHYS REV B, V50, P2444, DOI 10.1103/PhysRevB.50.2444; BURKE LD, 1971, Z PHYS CHEM NEUE FOL, V74, P146; KLEITZ M, 1981, ADV CERAM, V3, P349; KOBAYASHI K, 1998, KR J CERAM, V4, P114; Kobayashi K, 1998, J CERAM SOC JPN, V106, P860, DOI 10.2109/jcersj.106.860; Kobayashi K, 1998, J CERAM SOC JPN, V106, P1073, DOI 10.2109/jcersj.106.1073; KOPP A, 1992, SOLID STATE IONICS, V53, P853, DOI 10.1016/0167-2738(92)90265-Q; KOPP A, 1993, P INT C ZIRC LANC, V5, P567; LINDEGAARD T, 1993, P 14 RIS INT S MAT S, P311; MIZUSAKI J, 1980, REV CHIM MINER, V17, P356; Nicoloso N, 1997, ELEC SOC S, V95, P106; VOHRER U, 1991, SENSOR ACTUAT B-CHEM, V4, P411, DOI 10.1016/0925-4005(91)80144-9; VOHRER U, 1993, SOLID STATE IONICS, V59, P141, DOI 10.1016/0167-2738(93)90240-4; Wagner C., 1956, P 7 INT COM EL THERM, P361; WEPPNER W, 1976, Z NATURFORSCH A, V31, P1336	22	19	19	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	0167-2738			SOLID STATE IONICS	Solid State Ion.	NOV	2000	135	1-4			SI		643	651		10.1016/S0167-2738(00)00426-4		9	Chemistry, Physical; Physics, Condensed Matter	Chemistry; Physics	382ZG	WOS:000165856800090		
J	Sakurai, T				Sakurai, T			Case study 1: Bigger interconnects may bring big gains in chip performance	SOLID STATE TECHNOLOGY			English	News Item									Univ Tokyo, Tokyo, Japan	Sakurai, T (reprint author), Univ Tokyo, Tokyo, Japan.							0	0	0	PENNWELL PUBL CO SOLID STATE TECHNOLOGY OFFICE	NASHUA	TEN TARA BLVD 5TH FLOOR, NASHUA, NH 03062-2801 USA	0038-111X			SOLID STATE TECHNOL	Solid State Technol.	NOV	2000	43	11					56	56				1	Engineering, Electrical & Electronic; Physics, Applied; Physics, Condensed Matter	Engineering; Physics	373AX	WOS:000165267200013		
J	Matsushima, K				Matsushima, K			Chemokines - Introduction	SPRINGER SEMINARS IN IMMUNOPATHOLOGY			English	Editorial Material							NEUTROPHIL CHEMOTACTIC FACTOR; HUMAN INTERLEUKIN-8 RECEPTOR; MICE; LYMPHOPOIESIS; MYELOPOIESIS; PURIFICATION; ANTIBODIES; MIGRATION; COFACTOR; CLONING		Univ Tokyo, Sch Med, Dept Mol Prevent Med, Bunkyo Ku, Tokyo 1130033, Japan	Matsushima, K (reprint author), Univ Tokyo, Sch Med, Dept Mol Prevent Med, Bunkyo Ku, 7-3-1 Hongo, Tokyo 1130033, Japan.						AKAHOSHI T, 1988, J EXP MED, V167, P924, DOI 10.1084/jem.167.3.924; Feng Y, 1996, SCIENCE, V272, P872, DOI 10.1126/science.272.5263.872; Nagasawa T, 1996, NATURE, V382, P635, DOI 10.1038/382635a0; HOLMES WE, 1991, SCIENCE, V253, P1278, DOI 10.1126/science.1840701; MATSUSHIMA K, 1989, J EXP MED, V169, P1485, DOI 10.1084/jem.169.4.1485; Alkhatib G, 1996, SCIENCE, V272, P1955, DOI 10.1126/science.272.5270.1955; Boring L, 1998, NATURE, V394, P894, DOI 10.1038/29788; MURPHY PM, 1991, SCIENCE, V253, P1280, DOI 10.1126/science.1891716; CHEN XS, 1994, NATURE, V372, P179, DOI 10.1038/372179a0; Sonoda Y, 1998, J IMMUNOL, V160, P6159; Wada T, 1996, FASEB J, V10, P1418; Ma Q, 1998, P NATL ACAD SCI USA, V95, P9448, DOI 10.1073/pnas.95.16.9448; YOSHIMURA T, 1987, P NATL ACAD SCI USA, V84, P9233, DOI 10.1073/pnas.84.24.9233; CACALANO G, 1994, SCIENCE, V265, P682, DOI 10.1126/science.8036519; SEKIDO N, 1993, NATURE, V365, P654, DOI 10.1038/365654a0; Broxmeyer HE, 1999, J EXP MED, V189, P1987, DOI 10.1084/jem.189.12.1987; Furukawa Y, 1999, CIRC RES, V84, P306; Hopken UE, 1996, NATURE, V383, P86, DOI 10.1038/383086a0; Hopken UE, 1997, J EXP MED, V186, P749, DOI 10.1084/jem.186.5.749; Kimura H, 1998, LAB INVEST, V78, P571; Laterveer L, 1996, EXP HEMATOL, V24, P1387; STRIETER RM, 1995, J BIOL CHEM, V270, P27348; Su SB, 1997, BLOOD, V90, P605; YOSHIMURA T, 1987, J IMMUNOL, V139, P788	24	3	3	SPRINGER-VERLAG	NEW YORK	175 FIFTH AVE, NEW YORK, NY 10010 USA	0344-4325			SPRINGER SEMIN IMMUN	Springer Semin. Immunopathol.	NOV	2000	22	4					321	328		10.1007/s002810000049		8	Immunology; Pathology	Immunology; Pathology	383PV	WOS:000165892100001		
J	Yoneyama, H; Kawasaki, S; Matsushima, K				Yoneyama, H; Kawasaki, S; Matsushima, K			Regulation of Th1 and Th2 immune responses by chemokines	SPRINGER SEMINARS IN IMMUNOPATHOLOGY			English	Article							ACTIVATED T-CELLS; DENDRITIC CELLS; IN-VIVO; RECEPTOR EXPRESSION; HELPER-CELLS; SELECTIVE EXPRESSION; T-HELPER-2 CELLS; UP-REGULATION; CUTTING EDGE; CC-CHEMOKINE		Univ Tokyo, Sch Med, Dept Mol Prevent Med, Bunkyo Ku, Tokyo 1130033, Japan; Univ Tokyo, CREST, Bunkyo Ku, Tokyo 1130033, Japan	Yoneyama, H (reprint author), Univ Tokyo, Sch Med, Dept Mol Prevent Med, Bunkyo Ku, 7-3-1 Hongo, Tokyo 1130033, Japan.						Adema GJ, 1997, NATURE, V387, P713, DOI 10.1038/42716; Annunziato F, 1999, J LEUKOCYTE BIOL, V65, P691; Kalinski P, 1999, IMMUNOL TODAY, V20, P561, DOI 10.1016/S0167-5699(99)01547-9; Randolph DA, 1999, J CLIN INVEST, V104, P1021, DOI 10.1172/JCI7631; Charbonnier AS, 1999, J EXP MED, V190, P1755, DOI 10.1084/jem.190.12.1755; Vestergaard C, 1999, J CLIN INVEST, V104, P1097, DOI 10.1172/JCI7613; Ansel KM, 1999, J EXP MED, V190, P1123, DOI 10.1084/jem.190.8.1123; Gu L, 2000, NATURE, V404, P407, DOI 10.1038/35006097; D'Ambrosio D, 1998, J IMMUNOL, V161, P5111; Yang D, 1999, SCIENCE, V286, P525, DOI 10.1126/science.286.5439.525; Cyster JG, 1999, SCIENCE, V286, P2098, DOI 10.1126/science.286.5447.2098; Stumbles PA, 1998, J EXP MED, V188, P2019, DOI 10.1084/jem.188.11.2019; Shields PL, 1999, J IMMUNOL, V163, P6236; Sallusto F, 1998, IMMUNOL TODAY, V19, P568, DOI 10.1016/S0167-5699(98)01346-2; Campbell JJ, 1998, SCIENCE, V279, P381, DOI 10.1126/science.279.5349.381; Sallusto F, 1999, EUR J IMMUNOL, V29, P2037, DOI 10.1002/(SICI)1521-4141(199906)29:06<2037::AID-IMMU2037>3.0.CO;2-V; Zabel BA, 1999, J EXP MED, V190, P1241, DOI 10.1084/jem.190.9.1241; ESTAQUIER J, 1995, J EXP MED, V182, P1759, DOI 10.1084/jem.182.6.1759; Gunn MD, 1999, J EXP MED, V189, P451, DOI 10.1084/jem.189.3.451; Qin SX, 1998, J CLIN INVEST, V101, P746, DOI 10.1172/JCI1422; Sallusto F, 1997, SCIENCE, V277, P2005, DOI 10.1126/science.277.5334.2005; Tang HL, 1999, SCIENCE, V284, P819, DOI 10.1126/science.284.5415.819; O'Garra A, 1998, IMMUNITY, V8, P275, DOI 10.1016/S1074-7613(00)80533-6; Schaniel C, 1998, J EXP MED, V188, P451, DOI 10.1084/jem.188.3.451; Campbell JJ, 1999, NATURE, V400, P776, DOI 10.1038/23495; Loetscher P, 1998, NATURE, V391, P344, DOI 10.1038/34814; Butcher EC, 1996, SCIENCE, V272, P60, DOI 10.1126/science.272.5258.60; Banchereau J, 1998, NATURE, V392, P245, DOI 10.1038/32588; Sorensen TL, 1999, J CLIN INVEST, V103, P807, DOI 10.1172/JCI5150; Sallusto F, 1999, NATURE, V401, P708, DOI 10.1038/44385; Mackay CR, 1999, NATURE, V401, P659, DOI 10.1038/44309; Siveke JT, 1998, J IMMUNOL, V160, P550; Lloyd CM, 2000, J EXP MED, V191, P265, DOI 10.1084/jem.191.2.265; Zlotnik A, 2000, IMMUNITY, V12, P121, DOI 10.1016/S1074-7613(00)80165-X; Sallusto F, 1998, J EXP MED, V187, P875, DOI 10.1084/jem.187.6.875; Murai M, 1999, J CLIN INVEST, V104, P49, DOI 10.1172/JCI6642; Garside P, 1998, SCIENCE, V281, P96, DOI 10.1126/science.281.5373.96; Bonecchi R, 1998, J EXP MED, V187, P129, DOI 10.1084/jem.187.1.129; VELLA AT, 1992, J IMMUNOL, V148, P2283; Ngo VN, 1998, J EXP MED, V188, P181, DOI 10.1084/jem.188.1.181; Iwasaki A, 2000, J EXP MED, V191, P1381, DOI 10.1084/jem.191.8.1381; Maldonado-Lopez R, 1999, J EXP MED, V189, P587, DOI 10.1084/jem.189.3.587; Iwasaki A, 1999, J EXP MED, V190, P229, DOI 10.1084/jem.190.2.229; AYALA A, 1994, ARCH SURG-CHICAGO, V129, P1172; Bell EB, 1998, IMMUNOL TODAY, V19, P60, DOI 10.1016/S0167-5699(97)01211-5; BLASCHKE V, 1995, CELL TISSUE RES, V282, P377, DOI 10.1007/s004410050489; BRADLEY LM, 1991, J EXP MED, V174, P547, DOI 10.1084/jem.174.3.547; D'Ambrosio D, 2000, IMMUNOL TODAY, V21, P183, DOI 10.1016/S0167-5699(00)01590-5; DIENOSJEAN MC, 1999, J LEUKOCYTE BIOL, V66, P252; FOSTER R, 1999, CELL, V99, P23; Gonzalo JA, 1999, J IMMUNOL, V163, P403; IMAL T, 1998, INT IMMUNOL, V11, P81; Ludewig B, 1998, J EXP MED, V188, P1493, DOI 10.1084/jem.188.8.1493; Luettig B, 1999, J IMMUNOL, V163, P4300; Luther SA, 1997, J EXP MED, V185, P551, DOI 10.1084/jem.185.3.551; Meeusen ENT, 1996, IMMUNOL TODAY, V17, P421, DOI 10.1016/0167-5699(96)10055-4; Melchers F, 1999, CELL, V99, P351, DOI 10.1016/S0092-8674(00)81521-4; OSULLIVAN ST, 1995, ANN SURG, V222, P482; O'Garra A, 2000, NATURE, V404, P719, DOI 10.1038/35008191; PABST R, 1992, IMMUNOL TODAY, V13, P119, DOI 10.1016/0167-5699(92)90106-H; Randolph DA, 1999, SCIENCE, V286, P2159, DOI 10.1126/science.286.5447.2159; Reiner SL, 1999, IMMUNITY, V11, P1, DOI 10.1016/S1074-7613(00)80076-X; Schuhbauer DMS, 2000, EUR J IMMUNOL, V30, P1255; Shreedhar V, 1999, IMMUNITY, V11, P625, DOI 10.1016/S1074-7613(00)80137-5; Suzuki N, 1999, INT IMMUNOL, V11, P553, DOI 10.1093/intimm/11.4.553; SWELL WA, 1996, IMMUNOL CELL BIOL, V74, P274; Tanaka Y, 1999, EUR J IMMUNOL, V29, P633, DOI 10.1002/(SICI)1521-4141(199902)29:02<633::AID-IMMU633>3.0.CO;2-I; Tietz W, 1997, EUR J IMMUNOL, V27, P2225, DOI 10.1002/eji.1830270916; Westermann J, 1999, IMMUNOL TODAY, V20, P302, DOI 10.1016/S0167-5699(99)01474-7; Westermann J, 1996, IMMUNOL TODAY, V17, P278, DOI 10.1016/0167-5699(96)80545-7; XUADAMO J, 1992, INT IMMUNOL, V4, P423; Yoneyama H, 1998, J CLIN INVEST, V102, P1933, DOI 10.1172/JCI4619	72	9	9	SPRINGER-VERLAG	NEW YORK	175 FIFTH AVE, NEW YORK, NY 10010 USA	0344-4325			SPRINGER SEMIN IMMUN	Springer Semin. Immunopathol.	NOV	2000	22	4					329	344		10.1007/s002810000050		16	Immunology; Pathology	Immunology; Pathology	383PV	WOS:000165892100002		
J	Yasuda, Y; Takamiya, M; Hiramoto, T				Yasuda, Y; Takamiya, M; Hiramoto, T			Threshold voltage fluctuations induced by statistical 'position' and 'number' impurity fluctuations in bulk MOSFETs	SUPERLATTICES AND MICROSTRUCTURES			English	Article; Proceedings Paper	5th Silicon Nanoelectronics Workshop	JUN 11-12, 2000	HONOLULU, HAWAII	Inst Elect & Electr Engineers		threshold voltage fluctuations; bulk MOSFET; FD SOI MOSFET; depletion layer width	DOPANT	Threshold voltage (V-th) fluctuations due to the statistical impurity fluctuations in bulk MOSFETs are successfully separated into the impurity 'number' fluctuations and impurity 'position' distribution, and the mechanism of V-th fluctuations in bulk MOSFETs is investigated by comparing bulk MOSFETs with fully depleted (FD) SOI MOSFET by means of 2D simulation. It is found that the bulk MOSFET has smaller V-th fluctuations due to self-compensation mechanism of impurity 'number' fluctuations, while the self-compensation of impurity 'position' distribution is negligible. (C) 2000 Academic Press.	Univ Tokyo, Inst Ind Sci, Tokyo, Japan; Chuo Univ, Fac Sci & Engn, Chuo, Japan; Univ Tokyo, VLSI Design & Educ Ctr, Tokyo, Japan	Yasuda, Y (reprint author), Univ Tokyo, Inst Ind Sci, Tokyo, Japan.						Asenov A, 1998, IEEE T ELECTRON DEV, V45, P2505, DOI 10.1109/16.735728; Stolk PA, 1998, IEEE T ELECTRON DEV, V45, P1960, DOI 10.1109/16.711362; MIZUNO T, 1993, S VLSI, P41; TANG X, 1999, IEEE INT SOI C, P42; Vasileska D., 1998, P 1998 6 INT WORKSH, P259; Wong H.-S., 1993, IEDM, P705; YASUDA Y, 1999, SI NAN WORKSH, P89; Yasuda Y, 2000, IEEE T ELECTRON DEV, V47, P1838, DOI 10.1109/16.870557	8	2	2	ACADEMIC PRESS LTD	LONDON	24-28 OVAL RD, LONDON NW1 7DX, ENGLAND	0749-6036			SUPERLATTICE MICROST	Superlattices Microstruct.	NOV-DEC	2000	28	5-6					357	361		10.1006/spmi.2000.0934		5	Physics, Condensed Matter	Physics	384AT	WOS:000165917400006		
J	Shi, Y; Yuan, XL; Wu, J; Bu, HM; Yang, HG; Han, P; Zheng, YD; Hiramoto, T				Shi, Y; Yuan, XL; Wu, J; Bu, HM; Yang, HG; Han, P; Zheng, YD; Hiramoto, T			Dynamics of tunneling into charge-tunable Si quantum dots	SUPERLATTICES AND MICROSTRUCTURES			English	Article; Proceedings Paper	5th Silicon Nanoelectronics Workshop	JUN 11-12, 2000	HONOLULU, HAWAII	Inst Elect & Electr Engineers		quantum dots; direct tunneling; Coulomb charging effect; admittance	GROUND-STATE ENERGIES; SILICON; ELECTRON; STORAGE; MEMORY; OXIDATION; COULOMB	Using frequency-dependent admittance spectroscopy, the dynamics characteristics of tunneling into charge-tunable silicon quantum dots (Si-QDs) with a SiO2/Si-QDs/SiO2/Si-substrate structure are investigated. Two resonance peaks, both for capacitance and conductance in the inversion region, are observed at room temperature, being attributed to the direct tunneling between the conductance band of Si-substrate and the lowest two electronic state levels of the Si-QD. Moreover, the Coulomb charging energy of the dots is extracted from the experimental results. (C) 2000 Academic Press.	Nanjing Univ, Dept Phys, Nanjing 210093, Peoples R China; Nanjing Univ, Natl Lab Solid State Microstruct, Nanjing 210093, Peoples R China; Univ Tokyo, Inst Ind Sci, Tokyo 1068558, Japan	Shi, Y (reprint author), Nanjing Univ, Dept Phys, Nanjing 210093, Peoples R China.		Bu, Huiming/A-3337-2011				LIU HI, 1994, APPL PHYS LETT, V64, P1383, DOI 10.1063/1.111914; LANNOO M, 1995, PHYS REV LETT, V74, P3415, DOI 10.1103/PhysRevLett.74.3415; Bodefeld MC, 1999, APPL PHYS LETT, V74, P1839, DOI 10.1063/1.123686; BRYANT GW, 1987, PHYS REV LETT, V59, P1140, DOI 10.1103/PhysRevLett.59.1140; Likharev KK, 1999, P IEEE, V87, P606, DOI 10.1109/5.752518; DREXLER H, 1994, PHYS REV LETT, V73, P2252, DOI 10.1103/PhysRevLett.73.2252; ASHOORI RC, 1993, PHYS REV LETT, V71, P613, DOI 10.1103/PhysRevLett.71.613; BABIC D, 1992, PHYS REV B, V45, P14150, DOI 10.1103/PhysRevB.45.14150; Ferreyra JM, 1999, PHYS REV B, V60, P10672, DOI 10.1103/PhysRevB.60.10672; Liu JL, 1996, APPL PHYS LETT, V69, P1761, DOI 10.1063/1.117477; Luyken RJ, 1999, APPL PHYS LETT, V74, P2486, DOI 10.1063/1.123015; METZNER C, 1999, SUPERLATTICE MICROST, V25, P538; Nicollian E.H., 1982, MOS METAL OXIDE SEMI; Shi Y, 1998, J APPL PHYS, V84, P2358, DOI 10.1063/1.368346; Warburton RJ, 1998, PHYS REV B, V58, P16221, DOI 10.1103/PhysRevB.58.16221; Welser JJ, 1997, IEEE ELECTR DEVICE L, V18, P278, DOI 10.1109/55.585357; Wong HSP, 1999, P IEEE, V87, P537, DOI 10.1109/5.752515; Yano K, 1999, P IEEE, V87, P633, DOI 10.1109/5.752519	18	3	3	ACADEMIC PRESS LTD	LONDON	24-28 OVAL RD, LONDON NW1 7DX, ENGLAND	0749-6036			SUPERLATTICE MICROST	Superlattices Microstruct.	NOV-DEC	2000	28	5-6					387	392		10.1006/spmi.2000.0938		6	Physics, Condensed Matter	Physics	384AT	WOS:000165917400010		
J	Ito, T; Izaki, T; Terashima, K				Ito, T; Izaki, T; Terashima, K			Development of plasma chip	SURFACE & COATINGS TECHNOLOGY			English	Article; Proceedings Paper	27th International Conference on Metallurgical Coatings and Thin Films	APR 10-14, 2000	SAN DIEGO, CALIFORNIA	Amer Vacuum Soc, Adv Surface Engn Div		plasma chip; microscale plasma; coplanar film electrodes; Langmuir probe measurement	PROBE	A prototype plasma chip has been developed with microscale plasmas generated using coplanar film electrodes (CFE). A plasma chip on which plasma-processing apparatuses are integrated has some advantages for plasma processing compared to conventional ones. For instance, it is highly favorable due to its higher processing speed. The high processing speed results from a combination of high speeds of individual process due to the use of high density microscale plasma and the possibility of parallel processing with integrated apparatuses. The high density of the microscale plasma (gas, H-2; pressure, 1 atm; applied voltage, 450 V; electrodes gap, 10 mum; plasma current, 10(-5) A) has been confirmed experimentally by optical emission spectroscopy and Langmuir probe measurement. This density was above 10(15) cm(-3), much higher than that for macroscale plasma. (C) 2000 Elsevier Science B.V. All rights reserved.	Univ Tokyo, Grad Sch Frontier Sci, Dept Adv Mat Sci, Bunkyo Ku, Tokyo 1138656, Japan	Ito, T (reprint author), Univ Tokyo, Grad Sch Frontier Sci, Dept Adv Mat Sci, Bunkyo Ku, 7-3-1 Hongo, Tokyo 1138656, Japan.						VASILE MJ, 1991, REV SCI INSTRUM, V62, P2167, DOI 10.1063/1.1142334; CHANG JS, 1976, PHYS FLUIDS, V19, P25, DOI 10.1063/1.861324; Colton R. J., 1998, PROCEDURES SCANNING; Griem H. R., 1974, SPECTRAL LINE BROADE; ITO T, 1999, P 14 INT S PLASM CHE, P967; ITO T, 2000, IN PRESS THIN SOLID; KAMITSUMA M, 1982, PHYS FLUIDS, V25, P1169, DOI 10.1063/1.863885; KAWASAKI H, 2000, IN PRESS THIN SOLID; Mott-Smth HM, 1926, PHYS REV, V28, P0727, DOI 10.1103/PhysRev.28.727; Terashima K, 1996, THIN SOLID FILMS, V281, P634, DOI 10.1016/0040-6090(96)08707-X; ZAKHAROVA VM, 1960, SOV PHYS-TECH PHYS, V5, P411	11	19	19	ELSEVIER SCIENCE SA	LAUSANNE	PO BOX 564, 1001 LAUSANNE, SWITZERLAND	0257-8972			SURF COAT TECH	Surf. Coat. Technol.	NOV	2000	133						497	500		10.1016/S0257-8972(00)00982-8		4	Materials Science, Coatings & Films; Physics, Applied	Materials Science; Physics	383MX	WOS:000165887500077		
J	Sakamoto, Y; Nagai, M; Tanaka, N; Nobori, M; Tsukamoto, T; Nokubi, M; Suzuki, Y; Makuuchi, M				Sakamoto, Y; Nagai, M; Tanaka, N; Nobori, M; Tsukamoto, T; Nokubi, M; Suzuki, Y; Makuuchi, M			Anatomical segmentectomy of the head of the pancreas along the embryological fusion plane: A feasible procedure?	SURGERY			English	Article							UNCINATE PROCESS; RESECTION; DUODENUM; DIVISUM; DUCTS	Background. Less extensive resection of the head of the pancreas has been the procedure of choice recently for low-grade malignant neoplasms. The anatomical detail of the head of the pancreas is currently insufficient for segmental resection along the embryological fusion plane. Methods. The anatomy of the head of the pancreas was analyzed in 31 consecutive autopsy specimens. An anterior (n=10) or posterior (n=10) segmentectomy of the head of each pancreas was performed along the macroscopically found fusion plane. The pancreatic arteries, the portal vein, the bile duct, and the pancreatic duct were visualized by injecting 3 silicon dyes of different colors. Another 11 specimens were examined by pancreatography before and after anterior (n=5) or posterior (n=6) segmentectomy. Eight of these 11 specimens were stained immunohistochemically to reveal the distribution of pancreatic polypeptide cells after segmentectomy. Results. The cleavage between the anterior and posterior segments was discovered at the anterior inferior edge or at the posterior superior edge of the head of the pancreas. Anterior segmentectomy was accomplished while preserving the anterior and posterior pancreaticoduodenal arcades and the lower bile duct in the posterior segment. Posterior segmentectomy involved the removal of the lower bile duct and the posterior pancreaticoduodenal arcades. Pancreatography after segmentectomy showed the division of the ducts of Wirsung and Santorini with the peripheral branches. The immunohistochemical boundary of pancreatic polypeptide cells coincided with the surgical plane. These results showed the anterior and posterior segments were originated from the embryologically dorsal and ventral primordia, respectively. Conclusions. The current anterior or posterior segmentectomy of the head of the pancreas corresponded to the resection of the embryologically dorsal or ventral primordium, respectively. Anterior segmentectomy of the head of the pancreas might be a clinically applicable procedure; however, posterior segmentectomy involving the resection of the lower bile duct may be impractical.	Univ Tokyo, Grad Sch Med, Dept Surg, Hepatobiliary Pancreat Surg Div,Bunkyo Ku, Tokyo 1138655, Japan; Asahi Gen Hosp, Dept Surg & Pathol, Chiba, Japan	Sakamoto, Y (reprint author), Univ Tokyo, Grad Sch Med, Dept Surg, Hepatobiliary Pancreat Surg Div,Bunkyo Ku, 7-3-1 Hongo, Tokyo 1138655, Japan.		幕内, 雅敏/A-2140-2012				Abe H, 1998, INT J PANCREATOL, V23, P77; ADDA G, 1984, ANAT CLIN, V5, P275, DOI 10.1007/BF01798752; Talamini MA, 1998, ANN SURG, V227, P896, DOI 10.1097/00000658-199806000-00013; SKANDALAKIS LJ, 1993, SURG CLIN N AM, V73, P661; ATRI M, 1994, RADIOLOGY, V190, P441; BERMAN LG, 1960, SURG GYNECOL OBSTET, V110, P391; Bittner R, 1985, SURGERY, V97, P467; BLAIR AJ, 1984, ANN SURG, V200, P590, DOI 10.1097/00000658-198411000-00006; Borghi F, 1998, ARCH SURG-CHICAGO, V133, P297, DOI 10.1001/archsurg.133.3.297; COOPERMAN M, 1982, AM J SURG, V143, P107, DOI 10.1016/0002-9610(82)90138-6; Furukawa H, 1999, ARCH SURG-CHICAGO, V134, P1086, DOI 10.1001/archsurg.134.10.1086; HAYAKAWA T, 1989, INT J PANCREATOL, V5, P317; HSU SM, 1981, J HISTOCHEM CYTOCHEM, V29, P577; IMAIZUMI T, 1990, J BIL PANC, V11, P621; Kamisawa T, 1998, AM J GASTROENTEROL, V93, P2135; KAMIYA J, 1994, J BIL PANC, V15, P1233; KIMURA W, 1995, ANN SURG, V221, P359, DOI 10.1097/00000658-199504000-00005; Kozu T, 1995, Gastrointest Endosc Clin N Am, V5, P1; MALAISSELAGAE F, 1979, DIABETOLOGIA, V17, P361, DOI 10.1007/BF01236270; Nakagohri T, 1996, SURG TODAY, V26, P640; Ryu M, 1996, SURG TODAY, V26, P476; SUDA K, 1983, AM J GASTROENTEROL, V79, P335; SUDA K, 1981, ACTA PATHOL JAPON, V31, P583; Tadokoro H, 1997, PANCREAS, V14, P407, DOI 10.1097/00006676-199705000-00012; Takada T, 1993, J HEP BIL PANCR SURG, V1, P36, DOI 10.1007/BF01235933; TAKADA T, 1993, HEPATO-GASTROENTEROL, V40, P356; Takahashi S, 1999, SURGERY, V125, P178, DOI 10.1067/msy.2099.93619; WATANABE G, 1998, GEKA, V60, P1158; WATANABE G, 1991, TAN TO SUI, V12, P1369; Woodburne RT, 1988, ESSENTIALS HUMAN ANA, P450; YEO CJ, 1993, ARCH SURG-CHICAGO, V128, P1143	31	27	27	MOSBY, INC	ST LOUIS	11830 WESTLINE INDUSTRIAL DR, ST LOUIS, MO 63146-3318 USA	0039-6060			SURGERY	Surgery	NOV	2000	128	5					822	831		10.1067/msy.2000.109611		10	Surgery	Surgery	370DJ	WOS:000165107700009		
J	Fujiwara, A; Kan, T; Fukuyama, T				Fujiwara, A; Kan, T; Fukuyama, T			Total synthesis of lipogrammistin-A: Efficient macrocyclization with 2-nitrobenzenesulfonamide	SYNLETT			English	Article						lipogrammistin-A; 2-nitrobenzenesulfonamide; nosyl group (Ns); macrocyclization; alkylation; Mitsunobu reaction	LIPOPHILIC ICHTHYOTOXIN; SECONDARY-AMINES; SOAPFISH	Total synthesis of lipogrammistin-A (1) was accomplished using a 2-nitrobenzenesulfonyl (Ns) group for both protection and activation of amines. The beta -amino ester derivative 16 was synthesized from carboxylic acid 12 in six steps by way of reduction to the aldehyde and the subsequent Wittig olefination. N-Alkylation of the Ns group under Mitsunobu conditions followed by amide formation provided 20. Intramolecular alkylation of the Ns group in 20 gave the 18-membered ring 21 as the exclusive product. After removal of the Ns group, selective acylation of the two of the three amino groups with (S)-2-methylbutyric acid furnished the desired compound 1.	Univ Tokyo, CREST, JST,Grad Sch Pharmaceut Sci, Bunkyo Ku, Tokyo 1130033, Japan	Fukuyama, T (reprint author), Univ Tokyo, CREST, JST,Grad Sch Pharmaceut Sci, Bunkyo Ku, 7-3-1 Hongo, Tokyo 1130033, Japan.						Fukuyama T, 1997, TETRAHEDRON LETT, V38, P5831, DOI 10.1016/S0040-4039(97)01334-8; FUKUYAMA T, 1995, TETRAHEDRON LETT, V36, P6373, DOI 10.1016/0040-4039(95)01316-A; FUKUYAMA T, 1990, J AM CHEM SOC, V112, P7050, DOI 10.1021/ja00175a043; Fukuyama T, 1999, SYNLETT, P1301; Guggisberg A., 1983, ALKALOIDS, P85; Hidai Y, 1999, TETRAHEDRON LETT, V40, P4711, DOI 10.1016/S0040-4039(99)00851-5; HOLFE G, 1978, ANGEW CHEM INT EDIT, V17, P569; Kuroki Y, 1998, B CHEM SOC JPN, V71, P1221, DOI 10.1246/bcsj.71.1221; MESEGUER JD, 1980, SYNTHESIS-STUTTGART, P547; MITSUNOBU O, 1992, ORG REACTIONS, V42, P335; OHNO M, 1981, J AM CHEM SOC, V103, P2405, DOI 10.1021/ja00399a043; Onuki H, 1998, J ORG CHEM, V63, P3925, DOI 10.1021/jo9722461; ONUKI H, 1993, TETRAHEDRON LETT, V34, P5609, DOI 10.1016/S0040-4039(00)73894-9; SAKAITANI M, 1988, TETRAHEDRON LETT, V29, P2983, DOI 10.1016/0040-4039(88)85064-0	14	39	39	GEORG THIEME VERLAG KG	STUTTGART	RUDIGERSTR 14, D-70469 STUTTGART, GERMANY	0936-5214			SYNLETT	Synlett	NOV	2000		11					1667	1669				3	Chemistry, Organic	Chemistry	375HT	WOS:000165394000038		
J	Watanabe, H; Itoh, D; Kitahara, T				Watanabe, H; Itoh, D; Kitahara, T			Synthesis of (4S,6S)-4-hydroxy-1,7-dioxaspiro[5.5]undecane, a component of the olive fruit fly pheromone, by employing a novel asymmetric oxy-Michael addition	SYNTHESIS-STUTTGART			English	Article						pheromone; olive fruit fly; Bactrocera oleae; oxy-Michael addition; asymmetric reaction; Wittig reactions; stereoselective synthesis; protecting groups	SAKURAI ISMS REACTION; DACUS-OLEAE; SEX-PHEROMONE; ACETALS; SPIROKETALS; CLEAVAGE; 1,7-DIOXASPIRO<5.5>UNDECANE; ENANTIOMERS; EFFICIENT; KETALS	The pheromone component 3 of the olive fruit fly was synthesized in an optically pure form. The key step of the synthesis is a novel asymmetric oxy-Michael addition, which was recently developed by our group.	Univ Tokyo, Dept Appl Biol Chem, Bunkyo Ku, Tokyo 1138657, Japan	Watanabe, H (reprint author), Univ Tokyo, Dept Appl Biol Chem, Bunkyo Ku, 1-1-1 Yayoi, Tokyo 1138657, Japan.						SZAREK WA, 1986, TETRAHEDRON LETT, V27, P3827, DOI 10.1016/S0040-4039(00)83890-3; Marko IE, 1999, ANGEW CHEM INT EDIT, V38, P3207, DOI 10.1002/(SICI)1521-3773(19991102)38:21<3207::AID-ANIE3207>3.0.CO;2-I; DALE JA, 1973, J AM CHEM SOC, V95, P512, DOI 10.1021/ja00783a034; LEBLANC Y, 1986, J ORG CHEM, V51, P789, DOI 10.1021/jo00356a004; EVANS DA, 1993, J ORG CHEM, V58, P2446, DOI 10.1021/jo00061a018; MARKO IE, 1992, J ORG CHEM, V57, P2211, DOI 10.1021/jo00034a003; LIPSHUTZ BH, 1985, TETRAHEDRON LETT, V26, P705, DOI 10.1016/S0040-4039(00)89114-5; BAKER R, 1980, J CHEM SOC CHEM COMM, P52, DOI 10.1039/c39800000052; BAKER R, 1982, J CHEM SOC CHEM COMM, P601, DOI 10.1039/c39820000601; BERRANGER T, 1995, J ORG CHEM, V60, P1720, DOI 10.1021/jo00111a033; CUBERO II, 1992, J CHEM ECOL, V18, P115; Evans DA, 1997, ANGEW CHEM INT EDIT, V36, P2738, DOI 10.1002/anie.199727381; HANIOTAKIS G, 1986, J CHEM ECOL, V12, P1559, DOI 10.1007/BF01012372; HERSCOVICI J, 1980, J CHEM SOC CHEM COMM, P561, DOI 10.1039/c39800000561; KHANDEKAR G, 1993, J CHEM SOC PERK T 1, P1507, DOI 10.1039/p19930001507; KIM KS, 1986, J ORG CHEM, V51, P404, DOI 10.1021/jo00353a027; LAWSON EN, 1993, J ORG CHEM, V58, P2501, DOI 10.1021/jo00061a025; LIEB F, 1978, Patent No. 2711010; MARKO IE, 1992, TETRAHEDRON LETT, V33, P1799, DOI 10.1016/S0040-4039(00)91736-2; MORI K, 1992, TOTAL SYNTHESIS NATU, P462; MORI K, 1984, TETRAHEDRON LETT, V25, P3875, DOI 10.1016/S0040-4039(01)91192-X; MORI K, 1985, TETRAHEDRON, V41, P3663, DOI 10.1016/S0040-4020(01)91385-7; OTERA J, 1986, TETRAHEDRON LETT, V27, P5743, DOI 10.1016/S0040-4039(00)85315-0; TEWSON TJ, 1978, J ORG CHEM, V43, P1090, DOI 10.1021/jo00400a014; WATANABE H, UNPUB CHIRALITY	25	4	4	GEORG THIEME VERLAG KG	STUTTGART	RUDIGERSTR 14, D-70469 STUTTGART, GERMANY	0039-7881			SYNTHESIS-STUTTGART	Synthesis	NOV	2000		13					1925	1929				5	Chemistry, Organic	Chemistry	375HY	WOS:000165394500019		
J	Molnar, K; Ogawa, K				Molnar, K; Ogawa, K			A survey on coccidian infection of Lake Biwa fishes in Japan, with the description of four new species of Goussia Labbe, 1896 (Apicomplexa)	SYSTEMATIC PARASITOLOGY			English	Article							INTESTINE	Thirty-two specimens of 11 freshwater fish species from Lake Biwa, Japan were surveyed for coccidian infections. Four fish species proved to be infected with apicomplexans belonging to the genus Goussia. Altogether, seven Goussia species were found. Oocysts of four species inhabiting the intestinal epithelium were shed at the sporulated stage. Two other intestinal species left the fish unsporulated. A few relatively large and aged oocysts of a further species were found in the renal tubules. The sporulated intestinal species were described as Goussia biwaensis n. sp., G. grygieri n. sp., G. nipponica n. sp. and G. wakabayashii n. sp.	Hungarian Acad Sci, Vet Med Res Inst, H-1581 Budapest, Hungary; Univ Tokyo, Grad Sch Agr & Life Sci, Dept Aquat Biosci, Bunkyo Ku, Tokyo 1138657, Japan	Molnar, K (reprint author), Hungarian Acad Sci, Vet Med Res Inst, POB 18, H-1581 Budapest, Hungary.						Duszynski DW, 1997, J PARASITOL, V83, P333, DOI 10.2307/3284470; DYKOVA I, 1981, J FISH DIS, V4, P487, DOI 10.1111/j.1365-2761.1981.tb01161.x; MOLNAR K, 1989, DIS AQUAT ORGAN, V7, P89; LUKES J, 1990, DIS AQUAT ORGAN, V8, P85, DOI 10.3354/dao008085; AWAKURA T, 1983, SCI REPORTS HOKKAIDO, V38, P33; BANDONI SM, 1988, J PARASITOL, V74, P519, DOI 10.2307/3282166; Baska F, 1997, DIS AQUAT ORGAN, V29, P49, DOI 10.3354/dao029049; Chen C., 1973, ILLUSTRATED GUIDE FI; Chen C.L., 1956, ACTA HYDROBIOL SINIC, V1, P19; CHEN CL, 1956, ACTA HYDROBIOL, V2, P279; Davies A. J., 1993, ADV PARASIT, V32, P294; Dogiel V. A., 1948, IZVESTIYA VSESOYUZNO, V27, P17; Dogiel V. A., 1959, Ceskoslovenska Parasitologie, V6, P15; Fujita T., 1934, Proceedings 5th Pan-Pacific Sci Congr, V5, P4135; KENT ML, 1988, J PROTOZOOL, V35, P287, DOI 10.1111/j.1550-7408.1988.tb04345.x; Levine N.D, 1988, PROTOZOAN PHYLUM API, VI; LI LX, 1995, T RES FISH DIS, V2, P102; Lom J., 1992, DEV AQUACULTURE FISH, V26; MOLNAR K, 1977, Parasitologia Hungarica, V10, P41; MOLNAR K, 1996, DIS AQUAT ORGAN, V27, P137; MOLNAR K, 1986, ACTA VET HUNG, V34, P169; MORI S, 1990, Memoirs of the Faculty of Science Kyoto University Series of Biology, V14, P13; OVERSTREET RM, 1984, J PROTOZOOL, V31, P332, DOI 10.1111/j.1550-7408.1984.tb02972.x; PATERSON WB, 1982, CAN J ZOOL, V60, P764, DOI 10.1139/z82-106; Shulman S. S., 1962, KEY PARASITES FRESHW, P7; SU X-Q, 1987, Acta Zootaxonomica Sinica, V12, P10; Tokumori H., 1985, Fish Pathology, V20, P505	27	5	5	KLUWER ACADEMIC PUBL	DORDRECHT	SPUIBOULEVARD 50, PO BOX 17, 3300 AA DORDRECHT, NETHERLANDS	0165-5752			SYST PARASITOL	Syst. Parasitol.	NOV	2000	47	3					215	222		10.1023/A:1006413021773		8	Parasitology	Parasitology	362UZ	WOS:000089797800007		
J	Nakajima, A; Abe, K; Hashimoto, K; Watanabe, T				Nakajima, A; Abe, K; Hashimoto, K; Watanabe, T			Preparation of hard super-hydrophobic films with visible light transmission.	THIN SOLID FILMS			English	Article						super-hydrophobic; sol-gel method; hardness; phase separation; surface roughness; wetting; surface morphology; surface structure	SOL-GEL METHOD; SILICA FILMS; REPELLENT	Hard super-hydrophobic thin films were prepared combining a phase separation of tetraethyl orthosilicate (TEOS) induced by the addition of an acrylic polymer, and subsequent fluoroalkylsilane (FAS) coating. The microstructure of the films was crater-like, and the structural dimension depended on the degree of the phase separation. The dominant mechanism of the hydrophobicity of the film was changed from Wenzel's mode to Cassie's mode with increasing surface roughness. The film obtained by proper composition possessed high transmittance in the visible wavelength range and its hardness was almost at the same level as normal silica-based hard coatings. (C) 2000 Elsevier Science S.A. All rights reserved.	Univ Tokyo, Adv Sci & Technol Res Inst, Meguro Ku, Tokyo 1538904, Japan; Tokyo Denki Univ, Fac Engn, Dept Mat Sci & Engn, Chiyoda Ku, Tokyo 1138656, Japan	Hashimoto, K (reprint author), Univ Tokyo, Adv Sci & Technol Res Inst, Meguro Ku, 4-6-1 Komaba, Tokyo 1538904, Japan.		Hashimoto, Kazuhito/C-5011-2012; Nakajima, Akira/B-9310-2015	Hashimoto, Kazuhito/0000-0002-8384-8749; Nakajima, Akira/0000-0003-0056-9283			CASSIE ABD, 1948, DISCUSS FARADAY SOC, V3, P11, DOI 10.1039/df9480300011; Hozumi A, 1997, THIN SOLID FILMS, V303, P222, DOI 10.1016/S0040-6090(97)00076-X; Yamauchi G, 1996, COLLOID SURFACE A, V116, P125, DOI 10.1016/0927-7757(96)03653-9; Tadanaga K, 1997, J AM CERAM SOC, V80, P3213; Onda T, 1996, LANGMUIR, V12, P2125, DOI 10.1021/la950418o; Nakajima A, 1999, ADV MATER, V11, P1365, DOI 10.1002/(SICI)1521-4095(199911)11:16<1365::AID-ADMA1365>3.0.CO;2-F; Kajihara K, 1998, J AM CERAM SOC, V81, P2670; WENZEL RN, 1949, J PHYS COLLOID CHEM, V53, P1466, DOI 10.1021/j150474a015; NAKANISHI K, 1992, J NON-CRYST SOLIDS, V147, P291, DOI 10.1016/S0022-3093(05)80632-5; MORRA M, 1989, LANGMUIR, V5, P872, DOI 10.1021/la00087a050; Johnson Jr R. E., 1964, ADV CHEM SER, V43, P112, DOI 10.1021/ba-1964-0043.ch007; Johnson R. E., 1963, ADV CHEM SER, V43, P136; Kunigi Y., 1993, J ELECTROANAL CHEM, V353, P209; Makita K, 1997, J CERAM SOC JPN, V105, P1012, DOI 10.2109/jcersj.105.1012; OGAWA K, 1993, JPN J APPL PHYS 2, V32, pL614, DOI 10.1143/JJAP.32.L614; Onda K., 1997, TSUKUBA RES CONSORTI, V4, P56; SHOUJI M, 1998, J CHEM SOC JPN, V12, P837; Washo B. D., 1982, ORG COAT APPL POLYM, V47, P69	18	228	252	ELSEVIER SCIENCE SA	LAUSANNE	PO BOX 564, 1001 LAUSANNE, SWITZERLAND	0040-6090			THIN SOLID FILMS	Thin Solid Films	NOV 1	2000	376	1-2					140	143		10.1016/S0040-6090(00)01417-6		4	Materials Science, Multidisciplinary; Materials Science, Coatings & Films; Physics, Applied; Physics, Condensed Matter	Materials Science; Physics	371YT	WOS:000165207400019		
J	Hohjoh, H; Terada, N; Kawashima, M; Honda, Y; Tokunaga, K				Hohjoh, H; Terada, N; Kawashima, M; Honda, Y; Tokunaga, K			Significant association of the tumor necrosis factor receptor 2 (TNFR2) gene with human narcolepsy	TISSUE ANTIGENS			English	Article						association study; narcolepsy; tumor necrosis factor receptor 2; single-nucleotide polymorphism	POLYMORPHISM; JAPANESE	We report on the association study of the tumor necrosis factor receptor 2 (TNFR2) gene with human narcolepsy. A single-nucleotide polymorphism in TNFR2. which is involved in an amino acid substitution [methionine(M)/arginine(R)] at position 196. was investigated in 149 Japanese narcoleptic patients and 204 healthy individuals as controls. Results reveal that the frequency of the TNFR2-196R allele significantly increased in the patients as compared with that in the controls (P=0.029). suggesting that TNFR2 is likely associated with the susceptibility; to narcolepsy. In addition, the analyses of the relationship of TNFR2 and TNF alpha with the susceptibility to narcolepsy indicate the possibility that an additive effect on the susceptibility to the disorder lies between TNFR2-196R and TNF-alpha -857T) alleles.	Univ Tokyo, Grad Sch Med, Dept Human Genet, Bunkyo Ku, Tokyo 1130033, Japan; Serwa Hosp, Neuropsychiat Res Inst, Tokyo, Japan	Hohjoh, H (reprint author), Univ Tokyo, Grad Sch Med, Dept Human Genet, Bunkyo Ku, 7-3-1 Hongo, Tokyo 1130033, Japan.						JUJI T, 1984, TISSUE ANTIGENS, V24, P316, DOI 10.1111/j.1399-0039.1984.tb02144.x; Sakurai T, 1998, CELL, V92, P573, DOI 10.1016/S0092-8674(00)80949-6; Komata T, 1999, TISSUE ANTIGENS, V53, P527, DOI 10.1034/j.1399-0039.1999.530602.x; Lin L, 1999, CELL, V98, P365, DOI 10.1016/S0092-8674(00)81965-0; Mignot E, 1997, SLEEP, V20, P1012; BANNAI M, 1994, EUR J IMMUNOGENET, V21, P1, DOI 10.1111/j.1744-313X.1994.tb00170.x; Benzing T, 1999, NAT MED, V5, P913; Bidwell J, 1999, GENES IMMUN, V1, P3, DOI 10.1038/sj.gene.6363645; Hohjoh H, 1999, TISSUE ANTIGENS, V54, P138, DOI 10.1034/j.1399-0039.1999.540204.x; HONDA Y, 1997, SLEEP SLEEP DISORDER, P341; Kawai S, 1996, EUR J IMMUNOGENET, V23, P471, DOI 10.1111/j.1744-313X.1996.tb00137.x; KEMPER O, 1991, HUM GENET, V87, P623; LANGDON N, 1984, LANCET, V2, P1178; Matsushita M, 1999, TISSUE ANTIGENS, V54, P478, DOI 10.1034/j.1399-0039.1999.540505.x; TSUCHIYA N, 2000, IN PRESS GENE IMMUN	15	35	36	MUNKSGAARD INT PUBL LTD	COPENHAGEN	35 NORRE SOGADE, PO BOX 2148, DK-1016 COPENHAGEN, DENMARK	0001-2815			TISSUE ANTIGENS	Tissue Antigens	NOV	2000	56	5					446	448		10.1034/j.1399-0039.2000.560508.x		3	Cell Biology; Immunology; Pathology	Cell Biology; Immunology; Pathology	379RN	WOS:000165656400008		
J	Wakabayashi, T; Takada, K; Somei, J; Kita, Y				Wakabayashi, T; Takada, K; Somei, J; Kita, Y			The role of an e-mail list system for communication among medical professionals, transplant candidates, recipients, and their families in Japan	TRANSPLANTATION PROCEEDINGS			English	Article; Proceedings Paper	6th Congress of the Asian-Society-of-Transplantation	SEP 20-24, 1999	SUNTEC CITY, SINGAPORE	Soc Transplantat Singapore, Asian Soc Transplantat, Transplantat Soc, Novartis Pte Ltd, Janssen-Cilag, Fujisawa, Roche Singapore Pte Ltd, Fresenius Ag, Baxter Hlthcare Far E Pte Ltd, Transmed Pte Ltd			QUALITY-OF-LIFE; OVERSEAS		Transplant Recipients Int Org, Japan Chapter, Tokyo, Japan	Kita, Y (reprint author), Univ Tokyo, Grad Sch Med, Dept Surg, Bunkyo Ku, 7-3-1 Hongo, Tokyo 1138656, Japan.						AOKI S, 1992, TRANSPLANT P, V24, P2064; Aranami Y, 1998, TRANSPLANT P, V30, P3635, DOI 10.1016/S0041-1345(98)01169-5; Aranami Y, 1999, INT CONGR SER, V1174, P131; Kita Y, 1998, TRANSPLANT P, V30, P3621, DOI 10.1016/S0041-1345(98)01162-2; Kita Y, 1996, TRANSPLANT P, V28, P2406; Kita Y, 1996, TRANSPLANT P, V28, P1934; OHKUBO M, 1995, TRANSPLANT P, V27, P1452	7	0	0	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0041-1345			TRANSPL P	Transplant. Proc.	NOV	2000	32	7					1613	1614		10.1016/S0041-1345(00)01450-0		2	Immunology; Surgery; Transplantation	Immunology; Surgery; Transplantation	385JV	WOS:000166001400077		
J	Tomikawa, S; Ando, Y; Nomura, Y; Bech, Y				Tomikawa, S; Ando, Y; Nomura, Y; Bech, Y			Leukocytopheresis therapy for chronic renal allograft rejection	TRANSPLANTATION PROCEEDINGS			English	Article; Proceedings Paper	6th Congress of the Asian-Society-of-Transplantation	SEP 20-24, 1999	SUNTEC CITY, SINGAPORE	Soc Transplantat Singapore, Asian Soc Transplantat, Transplantat Soc, Novartis Pte Ltd, Janssen-Cilag, Fujisawa, Roche Singapore Pte Ltd, Fresenius Ag, Baxter Healthcare Far E Pte Ltd, Transmed Pte Ltd					Univ Tokyo, Dept Surg, Inst Med Sci, Minato Ku, Tokyo 1080071, Japan	Tomikawa, S (reprint author), Univ Tokyo, Dept Surg, Inst Med Sci, Minato Ku, 4-6-1 Shirokanedai, Tokyo 1080071, Japan.						FUJITA S, 1990, JPN J CLIN IMMUNOL, V13, P268; HOSTETTER TH, 1994, KIDNEY INT, V46, P266, DOI 10.1038/ki.1994.269; Nomura Y, 1998, TRANSPLANT P, V30, P3580, DOI 10.1016/S0041-1345(98)01144-0; SAWADA K, 1995, J GASTROENTEROL, V30, P322, DOI 10.1007/BF02347507	4	4	4	ELSEVIER SCIENCE INC	NEW YORK	655 AVENUE OF THE AMERICAS, NEW YORK, NY 10010 USA	0041-1345			TRANSPLANT P	Transplant. Proc.	NOV	2000	32	7					1761	1764		10.1016/S0041-1345(00)01386-5		4	Immunology; Surgery; Transplantation	Immunology; Surgery; Transplantation	385JV	WOS:000166001400141		
J	Han, YS; Ueda, M; Tanabe, S; Nakatani, T; Kishimoto, T; Nagai, R				Han, YS; Ueda, M; Tanabe, S; Nakatani, T; Kishimoto, T; Nagai, R			Phenotypic modulation of neointimal smooth muscle cells during the evolution of transplant renal arteriosclerosis determined via myosin heavy chain expression	TRANSPLANTATION PROCEEDINGS			English	Article; Proceedings Paper	6th Congress of the Asian-Society-of-Transplantation	SEP 20-24, 1999	SUNTEC CITY, SINGAPORE	Soc Transplantat Singapore, Asian Soc Transplantat, Transplantat Soc, Novartis Pte Ltd, Janssen-Cilag, Fujisawa, Roche Singapore Pte Ltd, Fresenius Ag, Baxter Healthcare Far E Pte Ltd, Transmed Pte Ltd			VASCULAR DEVELOPMENT; ARTERIOPATHY; ANGIOPLASTY; ALLOGRAFTS; ISOFORMS		Osaka City Univ, Sch Med, Dept Pathol, Abeno Ku, Osaka 545, Japan; Osaka City Univ, Sch Med, Dept Urol, Abeno Ku, Osaka 545, Japan; Univ Tokyo, Dept Cardiol, Tokyo, Japan	Ueda, M (reprint author), Osaka City Univ, Sch Med, Dept Pathol, Abeno Ku, 1-4-3 Asahimachi, Osaka 545, Japan.						Aikawa M, 1997, CIRCULATION, V96, P82; AIKAWA M, 1993, CIRC RES, V73, P1000; KOCHER O, 1991, LAB INVEST, V65, P459; DEMETRIS AJ, 1989, TRANSPLANT P, V21, P3667; HAN YS, 1994, TRANSPLANT P, V26, P931; KUROO M, 1991, J BIOL CHEM, V266, P3768; KUROO M, 1989, J BIOL CHEM, V264, P18272; NAGAI R, 1988, P NATL ACAD SCI USA, V85, P1047, DOI 10.1073/pnas.85.4.1047; Takagi M, 1997, ARTERIOSCL THROM VAS, V17, P3611; Tanabe S, 1996, Transpl Int, V9 Suppl 1, pS45, DOI 10.1111/j.1432-2277.1996.tb01673.x; Tanabe S, 1997, TRANSPLANT P, V29, P1517, DOI 10.1016/S0041-1345(96)00657-4	11	0	0	ELSEVIER SCIENCE INC	NEW YORK	655 AVENUE OF THE AMERICAS, NEW YORK, NY 10010 USA	0041-1345			TRANSPLANT P	Transplant. Proc.	NOV	2000	32	7					1786	1788		10.1016/S0041-1345(00)01373-7		3	Immunology; Surgery; Transplantation	Immunology; Surgery; Transplantation	385JV	WOS:000166001400154		
J	Uchida, H; Morioka, H; Ogawa, N; Tomikawa, S; Beck, Y; Nomura, Y; Aqndoh, Y; Meigata, K; Ohtsubo, O				Uchida, H; Morioka, H; Ogawa, N; Tomikawa, S; Beck, Y; Nomura, Y; Aqndoh, Y; Meigata, K; Ohtsubo, O			Biliary tract complications in renal allograft recipients: Two case reports	TRANSPLANTATION PROCEEDINGS			English	Article; Proceedings Paper	6th Congress of the Asian-Society-of-Transplantation	SEP 20-24, 1999	SUNTEC CITY, SINGAPORE	Soc Transplantat Singapore, Asian Soc Transplantat, Transplantat Soc, Novartis Pte Ltd, Janssen-Cilag, Fujisawa, Roche Singapore Pte Ltd, Fresenius Ag, Baxter Healthcare Far E Pte Ltd, Transmed Pte Ltd			CHOLECYSTECTOMY; TRANSPLANTATION; CHOLECYSTITIS		Kitatama Hosp, Dept Surg, Chofu, Tokyo 1820021, Japan; Univ Tokyo, Inst Med Sci, Dept Surg, Tokyo, Japan; Univ Tokyo, Inst Med Sci, Dept Organ Transplantat, Tokyo, Japan	Uchida, H (reprint author), Kitatama Hosp, Dept Surg, 4-1-1 Chofugaoka, Chofu, Tokyo 1820021, Japan.						Floege J, 1996, NEPHRON, V72, P9; Feltis BA, 1998, CLIN TRANSPLANT, V12, P278; GRAHAM SM, 1995, AM J SURG, V169, P44, DOI 10.1016/S0002-9610(99)80108-1; Greenstein SM, 1997, TRANSPLANTATION, V63, P1030, DOI 10.1097/00007890-199704150-00023; LORBER MI, 1987, TRANSPLANTATION, V43, P35, DOI 10.1097/00007890-198701000-00009; Melvin WS, 1998, AM J SURG, V175, P317, DOI 10.1016/S0002-9610(98)00009-9; UCHIDA H, 1991, Journal of Toxicological Sciences, V16, P181; UCHIDA H, 1985, ISHOKU, V20, P174	8	4	4	ELSEVIER SCIENCE INC	NEW YORK	655 AVENUE OF THE AMERICAS, NEW YORK, NY 10010 USA	0041-1345			TRANSPLANT P	Transplant. Proc.	NOV	2000	32	7					1898	1900		10.1016/S0041-1345(00)01483-4		3	Immunology; Surgery; Transplantation	Immunology; Surgery; Transplantation	385JV	WOS:000166001400208		
J	Watanabe, Y; Yoshimura, R; Wada, S; Chargui, J; Suzuki, J; Kimura, K; Isobe, M; Kishimoto, T				Watanabe, Y; Yoshimura, R; Wada, S; Chargui, J; Suzuki, J; Kimura, K; Isobe, M; Kishimoto, T			Study of the relationship between nonmuscle myosin heavy chain B (SMemb) and acute rejection of rat renal transplantation models	TRANSPLANTATION PROCEEDINGS			English	Article; Proceedings Paper	6th Congress of the Asian-Society-of-Transplantation	SEP 20-24, 1999	SUNTEC CITY, SINGAPORE	Soc Transplantat Singapore, Asian Soc Transplantat, Transplantat Soc, Novartis Pte Ltd, Janssen-Cilag, Fujisawa, Roche Singapore Pte Ltd, Fresenius Ag, Baxter Healthcare Far E Pte Ltd, Transmed Pte Ltd			SMOOTH-MUSCLE; VASCULAR DEVELOPMENT; CDNA CLONING; EXPRESSION; ISOFORMS; ALLOGRAFTS; IMPACT		Osaka City Univ, Sch Med, Dept Urol, Abeno Ku, Osaka 5458585, Japan; Shinshu Univ, Sch Med, Dept Internal Med 1, Matsumoto, Nagano 390, Japan; Univ Tokyo, Fac Med, Dept Internal Med 2, Tokyo 113, Japan	Watanabe, Y (reprint author), Osaka City Univ, Sch Med, Dept Urol, Abeno Ku, 1-5-7 Asahimachi, Osaka 5458585, Japan.						MATAS AJ, 1994, TRANSPLANTATION, V57, P857, DOI 10.1097/00007890-199403270-00015; AIKAWA M, 1993, CIRC RES, V73, P1000; Ebihara I, 1998, NEPHRON, V79, P317, DOI 10.1159/000045056; FISHER B, 1965, SURGERY, V58, P904; GIORNO R, 1984, DIAGN CLIN IMMUNOL, V2, P161; Hiroi J, 1996, KIDNEY INT, V49, P1231, DOI 10.1038/ki.1996.177; KIMURA K, 1996, KIDNEY INT S55, V49, pS169; KUROO M, 1991, J BIOL CHEM, V266, P3768; KUROO M, 1989, J BIOL CHEM, V264, P18272; Mise N, 1998, NEPHRON, V78, P284, DOI 10.1159/000044937; NAGAI R, 1989, J BIOL CHEM, V264, P9734; NAGAI R, 1988, P NATL ACAD SCI USA, V85, P1047, DOI 10.1073/pnas.85.4.1047; NAKAMURA T, 1995, CLIN SCI, V89, P45; Suzuki JI, 1996, CIRCULATION, V94, P1118; YILMAZ S, 1993, TRANSPLANTATION, V56, P1153, DOI 10.1097/00007890-199311000-00020	15	0	0	ELSEVIER SCIENCE INC	NEW YORK	655 AVENUE OF THE AMERICAS, NEW YORK, NY 10010 USA	0041-1345			TRANSPLANT P	Transplant. Proc.	NOV	2000	32	7					1997	1998		10.1016/S0041-1345(00)01528-1		2	Immunology; Surgery; Transplantation	Immunology; Surgery; Transplantation	385JV	WOS:000166001400253		
J	Ando, Y; Beck, Y; Nakayama, S; Asami, A; Nomura, Y; Tomikawa, S; Takiguchi, M				Ando, Y; Beck, Y; Nakayama, S; Asami, A; Nomura, Y; Tomikawa, S; Takiguchi, M			Induction of long-term heart graft survival by intrathymic injection of HLA class I peptide: A study with HLA class I transgenic mice model	TRANSPLANTATION PROCEEDINGS			English	Article; Proceedings Paper	6th Congress of the Asian-Society-of-Transplantation	SEP 20-24, 1999	SUNTEC CITY, SINGAPORE	Soc Transplantat Singapore, Asian Soc Transplantat, Transplantat Soc, Novartis Pte Ltd, Janssen-Cilag, Fujisawa, Roche Singapore Pte Ltd, Fresenius Ag, Baxter Healthcare Far E Pte Ltd, Transmed Pte Ltd					Univ Tokyo, Inst Med Sci, Dept Surg, Tokyo, Japan; Kumamoto Univ, Grad Sch Med Sci, Ctr AIDS Res, Div Viral Immunol, Kumamoto, Japan	Ando, Y (reprint author), Princess Alexandra Hosp, Queensland Liver Transplant Serv, Woolloongabba, Qld 4102, Australia.		Kumamoto University, CAIDS/G-8446-2013				CORRY RJ, 1973, TRANSPLANTATION, V16, P343, DOI 10.1097/00007890-197310000-00010; BILLINGHAM RE, 1951, J EXP BIOL, V28, P385; KARAKI S, 1993, IMMUNOGENETICS, V37, P139; OOBA T, 1989, IMMUNOGENETICS, V30, P76, DOI 10.1007/BF02421534; Schonbach C, 1996, VIROLOGY, V226, P102, DOI 10.1006/viro.1996.0632; SEBZDA E, 1994, SCIENCE, V263, P1615, DOI 10.1126/science.8128249	6	1	1	ELSEVIER SCIENCE INC	NEW YORK	655 AVENUE OF THE AMERICAS, NEW YORK, NY 10010 USA	0041-1345			TRANSPLANT P	Transplant. Proc.	NOV	2000	32	7					2049	2050		10.1016/S0041-1345(00)01553-0		2	Immunology; Surgery; Transplantation	Immunology; Surgery; Transplantation	385JV	WOS:000166001400278		
J	Imai, T; Inoue, S; Kuzuhara, K; Hosoya, Y; Honda, M; Takasaki, E; Yoshida, KI; Manaka, K; Nishimura, Y; Bekku, Y; Tomikawa, S; Nagao, T; Uchida, H				Imai, T; Inoue, S; Kuzuhara, K; Hosoya, Y; Honda, M; Takasaki, E; Yoshida, KI; Manaka, K; Nishimura, Y; Bekku, Y; Tomikawa, S; Nagao, T; Uchida, H			Immunosuppressive effect of bactobolamine on in vitro lymphocyte alloactivation: Synergism with cyclosporine	TRANSPLANTATION PROCEEDINGS			English	Article; Proceedings Paper	6th Congress of the Asian-Society-of-Transplantation	SEP 20-24, 1999	SUNTEC CITY, SINGAPORE	Soc Transplantat Singapore, Asian Soc Transplantat, Transplantat Soc, Novartis Pte Ltd, Janssen-Cilag, Fujisawa, Roche Singapore Pte Ltd, Fresenius Ag, Baxter Healthcare Far E Pte Ltd, Transmed Pte Ltd			AGENT		Toranomon Gen Hosp, Kidney Ctr, Takatsu Ku, Kanagawa 2318587, Japan; Dokkyo Univ, Sch Med, Dept Urol, Mibu, Tochigi, Japan; Dokkyo Univ, Sch Med, Res Ctr Tissue Culture, Mibu, Tochigi, Japan; Univ Tokyo, Inst Med Sci, Dept Surg & Organ Transplantat, Tokyo, Japan; Tokyo Med & Dent Univ, Dept Surg, Tokyo, Japan; Kitatama Hosp, Dept Surg, Tokyo, Japan	Imai, T (reprint author), Toranomon Gen Hosp, Kidney Ctr, Takatsu Ku, 1-3-1 Kajigaya, Kanagawa 2318587, Japan.		Manaka, Ken-ichi/C-3081-2008				BEKKU Y, 1992, TRANSPLANT P, V24, P1368; IMAI T, 1992, TRANSPLANT P, V24, P1424; Kikuchi K, 1996, TRANSPLANT P, V28, P1392; Tomikawa S, 1996, TRANSPLANT P, V28, P1049; Tomikawa S, 1997, TRANSPLANT P, V29, P1276, DOI 10.1016/S0041-1345(96)00510-6; Watanabe K, 1996, TRANSPLANT P, V28, P1366; ZEEVI A, 1987, TRANSPLANT P, V19, P40	7	0	0	ELSEVIER SCIENCE INC	NEW YORK	655 AVENUE OF THE AMERICAS, NEW YORK, NY 10010 USA	0041-1345			TRANSPLANT P	Transplant. Proc.	NOV	2000	32	7					2060	2062		10.1016/S0041-1345(00)01558-X		3	Immunology; Surgery; Transplantation	Immunology; Surgery; Transplantation	385JV	WOS:000166001400283		
J	Guo, L; Harihara, Y; Hirata, M; Kita, Y; Sano, K; Kusaka, K; Hisatomi, S; Miura, Y; Makuuchi, M				Guo, L; Harihara, Y; Hirata, M; Kita, Y; Sano, K; Kusaka, K; Hisatomi, S; Miura, Y; Makuuchi, M			Role of natural killer cells in allograft rejection	TRANSPLANTATION PROCEEDINGS			English	Article; Proceedings Paper	6th Congress of the Asian-Society-of-Transplantation	SEP 20-24, 1999	SUNTEC CITY, SINGAPORE	Soc Transplantat Singapore, Asian Soc Transplantat, Transplantat Soc, Novartis Pte Ltd, Janssen-Cilag, Fujisawa, Roche Singapore Pte Ltd, Fresenius Ag, Baxter Healthcare Far E Pte Ltd, Transmed Pte Ltd			RESISTANCE; INFECTION		Univ Tokyo, Liver Transplant Team, Bunkyo Ku, Tokyo 113, Japan	Guo, L (reprint author), Univ Tokyo, Liver Transplant Team, Bunkyo Ku, 7-3-1 Hongo, Tokyo 113, Japan.		幕内, 雅敏/A-2140-2012				ONO K, 1969, J THORAC CARDIOV SUR, V57, P225; SCALZO AA, 1992, J IMMUNOL, V149, P581; BANCROFT GJ, 1993, CURR OPIN IMMUNOL, V5, P503, DOI 10.1016/0952-7915(93)90030-V; BERKE G, 1994, ANNU REV IMMUNOL, V12, P735, DOI 10.1146/annurev.immunol.12.1.735; BUKOWSKI JF, 1984, J VIROL, V52, P119; HUMPHREYS T, 1994, IMMUNOL TODAY, V15, P316, DOI 10.1016/0167-5699(94)90079-5; LOCKSLEY RM, 1993, P NATL ACAD SCI USA, V90, P5879, DOI 10.1073/pnas.90.13.5879	7	1	1	ELSEVIER SCIENCE INC	NEW YORK	655 AVENUE OF THE AMERICAS, NEW YORK, NY 10010 USA	0041-1345			TRANSPLANT P	Transplant. Proc.	NOV	2000	32	7					2089	2090		10.1016/S0041-1345(00)01581-5		2	Immunology; Surgery; Transplantation	Immunology; Surgery; Transplantation	385JV	WOS:000166001400297		
J	Harihara, Y; Makuuchi, M; Kawasaki, S; Hashikura, Y; Kawarasaki, H; Takayama, T; Kubota, K; Ito, M; Mizuta, K; Yoshino, H; Hirata, M; Kita, Y; Sano, K; Hisatomi, S; Kusaka, K; Hashizume, K				Harihara, Y; Makuuchi, M; Kawasaki, S; Hashikura, Y; Kawarasaki, H; Takayama, T; Kubota, K; Ito, M; Mizuta, K; Yoshino, H; Hirata, M; Kita, Y; Sano, K; Hisatomi, S; Kusaka, K; Hashizume, K			Influence of HLA compatibility on living-related liver transplantation	TRANSPLANTATION PROCEEDINGS			English	Article; Proceedings Paper	6th Congress of the Asian-Society-of-Transplantation	SEP 20-24, 1999	SUNTEC CITY, SINGAPORE	Soc Transplantat Singapore, Asian Soc Transplantat, Transplantat Soc, Novartis Pte Ltd, Janssen-Cilag, Fujisawa, Roche Singapore Pte Ltd, Fresenius Ag, Baxter Healthcare Far E Pte Ltd, Transmed Pte Ltd			SURVIVAL		Univ Tokyo, Liver Transplant Team, Bunkyo Ku, Tokyo 113, Japan	Harihara, Y (reprint author), Univ Tokyo, Liver Transplant Team, Bunkyo Ku, 7-3-1 Hongo, Tokyo 113, Japan.		幕内, 雅敏/A-2140-2012				DONALDSON P, 1993, HEPATOLOGY, V17, P1008, DOI 10.1016/0270-9139(93)90115-4; Meyer C, 1997, TRANSPLANT P, V29, P2332, DOI 10.1016/S0041-1345(97)00389-8; NIKAEIN A, 1994, TRANSPLANTATION, V58, P786, DOI 10.1097/00007890-199410150-00006; YAGIHASHI A, 1992, TRANSPLANT P, V24, P2432	4	3	3	ELSEVIER SCIENCE INC	NEW YORK	655 AVENUE OF THE AMERICAS, NEW YORK, NY 10010 USA	0041-1345			TRANSPLANT P	Transplant. Proc.	NOV	2000	32	7					2107	2107		10.1016/S0041-1345(00)01590-6		1	Immunology; Surgery; Transplantation	Immunology; Surgery; Transplantation	385JV	WOS:000166001400306		
J	Hirata, M; Harihara, Y; Kita, Y; Hisatomi, S; Miura, Y; Yoshino, H; Mizuta, K; Ito, M; Sano, K; Kusaka, K; Kawarasaki, H; Kubota, K; Takayama, T; Hashizume, K; Makuuchi, M				Hirata, M; Harihara, Y; Kita, Y; Hisatomi, S; Miura, Y; Yoshino, H; Mizuta, K; Ito, M; Sano, K; Kusaka, K; Kawarasaki, H; Kubota, K; Takayama, T; Hashizume, K; Makuuchi, M			Impact of HLA matching in living-related liver transplantation	TRANSPLANTATION PROCEEDINGS			English	Article; Proceedings Paper	6th Congress of the Asian-Society-of-Transplantation	SEP 20-24, 1999	SUNTEC CITY, SINGAPORE	Soc Transplantat Singapore, Asian Soc Transplantat, Transplantat Soc, Novartis Pte Ltd, Janssen-Cilag, Fujisawa, Roche Singapore Pte Ltd, Fresenius Ag, Baxter Healthcare Far E Pte Ltd, Transmed Pte Ltd			REJECTION		Univ Tokyo, Fac Med, Liver Transplantat Team, Tokyo 113, Japan	Hirata, M (reprint author), Univ Tokyo, Grad Sch, Dept Surg, Bunkyo Ku, 7-3-1 Hongo, Tokyo 1138655, Japan.		幕内, 雅敏/A-2140-2012				Cecka J M, 1986, Clin Transpl, P141; MOORE SB, 1987, TRANSPLANT P, V19, P2390; NIKAEIN A, 1994, TRANSPLANTATION, V58, P786, DOI 10.1097/00007890-199410150-00006; SAIDMAN SL, 1990, TRANSPLANTATION, V49, P107, DOI 10.1097/00007890-199001000-00024; TAKEMOTO S, 1993, TRANSPLANTATION, V55, P1005, DOI 10.1097/00007890-199305000-00010	5	3	3	ELSEVIER SCIENCE INC	NEW YORK	655 AVENUE OF THE AMERICAS, NEW YORK, NY 10010 USA	0041-1345			TRANSPLANT P	Transplant. Proc.	NOV	2000	32	7					2108	2109		10.1016/S0041-1345(00)01591-8		2	Immunology; Surgery; Transplantation	Immunology; Surgery; Transplantation	385JV	WOS:000166001400307		
J	Fukunishi, I; Kita, Y; Wakabayashi, T; Fukuhara, S; Harihara, Y; Takayama, T; Kubota, K; Kawarasaki, H; Makuuchi, M				Fukunishi, I; Kita, Y; Wakabayashi, T; Fukuhara, S; Harihara, Y; Takayama, T; Kubota, K; Kawarasaki, H; Makuuchi, M			Health status survey of adult patients undergoing living-related liver transplantation	TRANSPLANTATION PROCEEDINGS			English	Article; Proceedings Paper	6th Congress of the Asian-Society-of-Transplantation	SEP 20-24, 1999	SUNTEC CITY, SINGAPORE	Soc Transplantat Singapore, Asian Soc Transplantat, Transplantat Soc, Novartis Pte Ltd, Janssen-Cilag, Fujisawa, Roche Singapore Pte Ltd, Fresenius Ag, Baxter Healthcare Far E Pte Ltd, Transmed Pte Ltd					Tokyo Inst Psychiat, Setagaya Ku, Tokyo 1568585, Japan; Univ Tokyo, Liver Transplant Team, Grad Sch Med, Tokyo, Japan; Transplant Recipients Int Org, Japan Chapter, Tokyo, Japan	Fukunishi, I (reprint author), Tokyo Inst Psychiat, Setagaya Ku, 2-1-8 Kamikitazawa, Tokyo 1568585, Japan.		幕内, 雅敏/A-2140-2012				Fukuhara S, 1998, J CLIN EPIDEMIOL, V51, P1037, DOI 10.1016/S0895-4356(98)00095-X; Fukunishi I, 1997, PSYCHIAT CLIN NEUROS, V51, P301, DOI 10.1111/j.1440-1819.1997.tb03202.x; FUKUNISHI I, 1998, PSYCHIAT TIMES, V15, P48; LEVIN NW, 1993, AM J KIDNEY DIS, V22, P3; WARE JE, 1992, MED CARE, V30, P73	5	4	4	ELSEVIER SCIENCE INC	NEW YORK	655 AVENUE OF THE AMERICAS, NEW YORK, NY 10010 USA	0041-1345			TRANSPLANT P	Transplant. Proc.	NOV	2000	32	7					2149	2151		10.1016/S0041-1345(00)01611-0		3	Immunology; Surgery; Transplantation	Immunology; Surgery; Transplantation	385JV	WOS:000166001400326		
J	Harihara, Y; Makuuchi, M; Kawarasaki, H; Takayama, T; Kubota, K; Ito, M; Mizuta, K; Yoshino, H; Hirata, M; Kita, Y; Sano, K; Hisatomi, S; Kusaka, K; Miura, Y; Taniai, N; Asato, H; Nakatsuka, T; Hashizume, K				Harihara, Y; Makuuchi, M; Kawarasaki, H; Takayama, T; Kubota, K; Ito, M; Mizuta, K; Yoshino, H; Hirata, M; Kita, Y; Sano, K; Hisatomi, S; Kusaka, K; Miura, Y; Taniai, N; Asato, H; Nakatsuka, T; Hashizume, K			Living-related liver transplantation in adults compared with children	TRANSPLANTATION PROCEEDINGS			English	Article; Proceedings Paper	6th Congress of the Asian-Society-of-Transplantation	SEP 20-24, 1999	SUNTEC CITY, SINGAPORE	Soc Transplantat Singapore, Asian Soc Transplantat, Transplantat Soc, Novartis Pte Ltd, Janssen-Cilag, Fujisawa, Roche Singapore Pte Ltd, Fresenius Ag, Baxter Healthcare Far E Pte Ltd, Transmed Pte Ltd					Univ Tokyo, Liver Transplant Team, Bunkyo Ku, Tokyo 113, Japan	Harihara, Y (reprint author), Univ Tokyo, Liver Transplant Team, Bunkyo Ku, 7-3-1 Hongo, Tokyo 113, Japan.		幕内, 雅敏/A-2140-2012				Lo CM, 1997, ANN SURG, V226, P261, DOI 10.1097/00000658-199709000-00005; HASHIKURA Y, 1994, LANCET, V343, P1233, DOI 10.1016/S0140-6736(94)92450-3; URATA K, 1995, HEPATOLOGY, V21, P1317, DOI 10.1016/0270-9139(95)90053-5; Harihara Y, 1998, TRANSPLANT P, V30, P129, DOI 10.1016/S0041-1345(97)01209-8; KAWASAKI S, 1992, LANCET, V339, P580, DOI 10.1016/0140-6736(92)90867-3	5	1	1	ELSEVIER SCIENCE INC	NEW YORK	655 AVENUE OF THE AMERICAS, NEW YORK, NY 10010 USA	0041-1345			TRANSPLANT P	Transplant. Proc.	NOV	2000	32	7					2160	2161		10.1016/S0041-1345(00)01615-8		2	Immunology; Surgery; Transplantation	Immunology; Surgery; Transplantation	385JV	WOS:000166001400330		
J	Harihara, Y; Sano, K; Makuuchi, M; Kawarasaki, H; Takayama, T; Kubota, K; Ito, M; Mizuta, K; Yoshino, H; Hirata, M; Kita, Y; Hisatomi, S; Kusaka, K; Miura, Y; Hashizume, K				Harihara, Y; Sano, K; Makuuchi, M; Kawarasaki, H; Takayama, T; Kubota, K; Ito, M; Mizuta, K; Yoshino, H; Hirata, M; Kita, Y; Hisatomi, S; Kusaka, K; Miura, Y; Hashizume, K			Influence of donor age on the graft function after living-related liver transplantation	TRANSPLANTATION PROCEEDINGS			English	Article; Proceedings Paper	6th Congress of the Asian-Society-of-Transplantation	SEP 20-24, 1999	SUNTEC CITY, SINGAPORE	Soc Transplantat Singapore, Asian Soc Transplantat, Transplantat Soc, Novartis Pte Ltd, Janssen-Cilag, Fujisawa, Roche Singapore Pte Ltd, Fresenius Ag, Baxter Healthcare Far E Pte Ltd, Transmed Pte Ltd					Univ Tokyo, Liver Transplant Team, Bunkyo Ku, Tokyo 113, Japan	Harihara, Y (reprint author), Univ Tokyo, Liver Transplant Team, Bunkyo Ku, 7-3-1 Hongo, Tokyo 113, Japan.		幕内, 雅敏/A-2140-2012				CARLIS LD, 1999, TRANSPLANT P, V31, P397; Gayowski T, 1998, TRANSPLANTATION, V65, P499, DOI 10.1097/00007890-199802270-00008; Harihara Y, 1998, TRANSPLANT P, V30, P129, DOI 10.1016/S0041-1345(97)01209-8; MORIMOTO T, 1995, CLIN TRANSPLANT, V9, P60	4	0	0	ELSEVIER SCIENCE INC	NEW YORK	655 AVENUE OF THE AMERICAS, NEW YORK, NY 10010 USA	0041-1345			TRANSPLANT P	Transplant. Proc.	NOV	2000	32	7					2164	2165		10.1016/S0041-1345(00)01617-1		2	Immunology; Surgery; Transplantation	Immunology; Surgery; Transplantation	385JV	WOS:000166001400332		
J	Harihara, Y; Sano, K; Makuuchi, M; Kawarasaki, H; Takayama, T; Kubota, K; Ito, M; Mizuta, K; Yoshino, H; Hirata, M; Kita, Y; Hisatomi, S; Kusaka, K; Miura, Y; Hashizume, K				Harihara, Y; Sano, K; Makuuchi, M; Kawarasaki, H; Takayama, T; Kubota, K; Ito, M; Mizuta, K; Yoshino, H; Hirata, M; Kita, Y; Hisatomi, S; Kusaka, K; Miura, Y; Hashizume, K			Correlation between graft size and necessary tacrolimus dose after living-related liver transplantation	TRANSPLANTATION PROCEEDINGS			English	Article; Proceedings Paper	6th Congress of the Asian-Society-of-Transplantation	SEP 20-24, 1999	SUNTEC CITY, SINGAPORE	Soc Transplantat Singapore, Asian Soc Transplantat, Transplantat Soc, Novartis Pte Ltd, Janssen-Cilag, Fujisawa, Roche Singapore Pte Ltd, Fresenius Ag, Baxter Healthcare Far E Pte Ltd, Transmed Pte Ltd					Univ Tokyo, Liver Transplant Team, Bunkyo Ku, Tokyo 113, Japan	Harihara, Y (reprint author), Univ Tokyo, Liver Transplant Team, Bunkyo Ku, 7-3-1 Hongo, Tokyo 113, Japan.		幕内, 雅敏/A-2140-2012				EIDELMAN BH, 1991, TRANSPLANT P, V23, P3175; *EUR FK506 MULT LI, 1994, LANCET, V344, P423; Harihara Y, 1998, TRANSPLANT P, V30, P129, DOI 10.1016/S0041-1345(97)01209-8; Inomata Y, 1996, TRANSPLANTATION, V61, P247, DOI 10.1097/00007890-199601270-00015; Watkins PB, 1996, THER DRUG MONIT, V18, P368, DOI 10.1097/00007691-199608000-00009	5	5	5	ELSEVIER SCIENCE INC	NEW YORK	655 AVENUE OF THE AMERICAS, NEW YORK, NY 10010 USA	0041-1345			TRANSPLANT P	Transplant. Proc.	NOV	2000	32	7					2166	2167		10.1016/S0041-1345(00)01618-3		2	Immunology; Surgery; Transplantation	Immunology; Surgery; Transplantation	385JV	WOS:000166001400333		
J	Taniai, N; Harihara, Y; Kita, Y; Akune, T; Tanaka, K; Hirata, M; Sano, K; Kusaka, K; Kubota, K; Takayama, T; Kawarasaki, H; Makuuchi, M; Yoshida, H; Akimaru, K; Tajiri, T; Onda, M				Taniai, N; Harihara, Y; Kita, Y; Akune, T; Tanaka, K; Hirata, M; Sano, K; Kusaka, K; Kubota, K; Takayama, T; Kawarasaki, H; Makuuchi, M; Yoshida, H; Akimaru, K; Tajiri, T; Onda, M			Pretransplant evaluation of bone mineral density in adult patients with end-stage cholestatic liver disease	TRANSPLANTATION PROCEEDINGS			English	Article; Proceedings Paper	6th Congress of the Asian-Society-of-Transplantation	SEP 20-24, 1999	SUNTEC CITY, SINGAPORE	Soc Transplantat Singapore, Asian Soc Transplantat, Transplantat Soc, Novartis Pte Ltd, Janssen-Cilag, Fujisawa, Roche Singapore Pte Ltd, Fresenius Ag, Baxter Healthcare Far E Pte Ltd, Transmed Pte Ltd			TRANSPLANTATION		Nippon Med Sch, Dept Surg 1, Bunkyo Ku, Tokyo 1138603, Japan; Univ Tokyo, Liver Transplant Team, Tokyo, Japan; Univ Tokyo, Grad Sch Med, Tokyo, Japan	Taniai, N (reprint author), Nippon Med Sch, Dept Surg 1, Bunkyo Ku, 1-1-5 Sendagi, Tokyo 1138603, Japan.		幕内, 雅敏/A-2140-2012				MOVSOWITZ C, 1988, ENDOCRINOLOGY, V123, P2571; CVETKOVIC M, 1994, TRANSPLANTATION, V57, P1231, DOI 10.1097/00007890-199404270-00016; LUKERT BP, 1990, ANN INTERN MED, V112, P352; EASTELL R, 1991, HEPATOLOGY, V14, P296, DOI 10.1016/0270-9139(91)91418-Z; HAAGSMA EB, 1988, J HEPATOL, V6, P94, DOI 10.1016/S0168-8278(88)80467-7; HULLEY SB, 1971, J CLIN INVEST, V50, P2506, DOI 10.1172/JCI106751; Losowsky MS, 1996, GUT, V39, P505, DOI 10.1136/gut.39.4.505; PORAYKO MK, 1991, TRANSPLANT P, V23, P1462	8	0	0	ELSEVIER SCIENCE INC	NEW YORK	655 AVENUE OF THE AMERICAS, NEW YORK, NY 10010 USA	0041-1345			TRANSPLANT P	Transplant. Proc.	NOV	2000	32	7					2187	2188		10.1016/S0041-1345(00)01628-6		2	Immunology; Surgery; Transplantation	Immunology; Surgery; Transplantation	385JV	WOS:000166001400343		
J	Kita, Y; Harihara, Y; Hirata, M; Kusaka, K; Sano, K; Mori, M; Ito, M; Yoshino, H; Nakao, A; Takizawa, H; Hirai, H; Kubota, K; Takayama, T; Kawarasaki, H; Maekawa, K; Makuuchi, M				Kita, Y; Harihara, Y; Hirata, M; Kusaka, K; Sano, K; Mori, M; Ito, M; Yoshino, H; Nakao, A; Takizawa, H; Hirai, H; Kubota, K; Takayama, T; Kawarasaki, H; Maekawa, K; Makuuchi, M			Adult-to-adult living-related liver transplantation for hepatitis B-related cirrhosis in Japan: Two case reports	TRANSPLANTATION PROCEEDINGS			English	Article; Proceedings Paper	6th Congress of the Asian-Society-of-Transplantation	SEP 20-24, 1999	SUNTEC CITY, SINGAPORE	Soc Transplantat Singapore, Asian Soc Transplantat, Transplantat Soc, Novartis Pte Ltd, Janssen-Cilag, Fujisawa, Roche Singapore Pte Ltd, Fresenius Ag, Baxter Healthcare Far E Pte Ltd, Transmed Pte Ltd			INTRAHEPATIC PORTOSYSTEMIC SHUNT; LAMIVUDINE; VEIN		Univ Tokyo, Grad Sch Med, Dept Surg, Liver Transplant Team,Bunkyo Ku, Tokyo 1138655, Japan	Kita, Y (reprint author), Univ Tokyo, Grad Sch Med, Dept Surg, Liver Transplant Team,Bunkyo Ku, 7-3-1 Hongo, Tokyo 1138655, Japan.		幕内, 雅敏/A-2140-2012				Somberg KA, 1997, TRANSPLANTATION, V63, P1074, DOI 10.1097/00007890-199704270-00005; DEMETRIS AJ, 1990, AM J PATHOL, V137, P667; Sawyer RG, 1998, ANN SURG, V227, P841, DOI 10.1097/00000658-199806000-00007; Clavien PA, 1998, ANN SURG, V227, P440, DOI 10.1097/00000658-199803000-00017; URATA K, 1995, HEPATOLOGY, V21, P1317, DOI 10.1016/0270-9139(95)90053-5; Markowitz JS, 1998, HEPATOLOGY, V28, P585, DOI 10.1002/hep.510280241; WEINER RS, 1986, ANN INTERN MED, V104, P168; Kawasaki S, 1998, ANN SURG, V227, P269, DOI 10.1097/00000658-199802000-00017; AFESSA B, 1993, MAYO CLIN PROC, V68, P427; Farney AC, 1998, TRANSPLANTATION, V65, P572, DOI 10.1097/00007890-199802270-00020; HIRATA M, 1989, TRANSPLANT P, V31, P2904; Lafayette RA, 1997, CLIN NEPHROL, V48, P159; Perrillo R, 1999, HEPATOLOGY, V29, P1581, DOI 10.1002/hep.510290507	13	0	0	ELSEVIER SCIENCE INC	NEW YORK	655 AVENUE OF THE AMERICAS, NEW YORK, NY 10010 USA	0041-1345			TRANSPLANT P	Transplant. Proc.	NOV	2000	32	7					2189	2192		10.1016/S0041-1345(00)01629-8		4	Immunology; Surgery; Transplantation	Immunology; Surgery; Transplantation	385JV	WOS:000166001400344		
J	Kita, Y; Harihara, Y; Hirata, M; Kusaka, K; Sano, K; Ito, M; Yoshino, H; Kubota, K; Nakao, A; Kawarasaki, H; Takayama, T; Maekawa, K; Makuuchi, M				Kita, Y; Harihara, Y; Hirata, M; Kusaka, K; Sano, K; Ito, M; Yoshino, H; Kubota, K; Nakao, A; Kawarasaki, H; Takayama, T; Maekawa, K; Makuuchi, M			Factors influencing persistent hyperbilirubinemia following adult-to-adult living-related liver transplantation	TRANSPLANTATION PROCEEDINGS			English	Article; Proceedings Paper	6th Congress of the Asian-Society-of-Transplantation	SEP 20-24, 1999	SUNTEC CITY, SINGAPORE	Soc Transplantat Singapore, Asian Soc Transplantat, Transplantat Soc, Novartis Pte Ltd, Janssen-Cilag, Fujisawa, Roche Singapore Pte Ltd, Fresenius Ag, Baxter Healthcare Far E Pte Ltd, Transmed Pte Ltd			DONORS		Univ Tokyo, Grad Sch Med, Dept Surg, Liver Transplant Team,Bunkyo Ku, Tokyo 1138655, Japan	Kita, Y (reprint author), Univ Tokyo, Grad Sch Med, Dept Surg, Liver Transplant Team,Bunkyo Ku, 7-3-1 Hongo, Tokyo 1138655, Japan.		幕内, 雅敏/A-2140-2012				Emond JC, 1996, ANN SURG, V224, P544, DOI 10.1097/00000658-199610000-00012; Kiuchi T, 1999, TRANSPLANTATION, V67, P321, DOI 10.1097/00007890-199901270-00024; URATA K, 1995, HEPATOLOGY, V21, P1317, DOI 10.1016/0270-9139(95)90053-5; Kawasaki S, 1998, ANN SURG, V227, P269, DOI 10.1097/00000658-199802000-00017; WILLIAMS JW, 1986, AM J SURG, V151, P65, DOI 10.1016/0002-9610(86)90013-9	5	6	8	ELSEVIER SCIENCE INC	NEW YORK	655 AVENUE OF THE AMERICAS, NEW YORK, NY 10010 USA	0041-1345			TRANSPLANT P	Transplant. Proc.	NOV	2000	32	7					2193	2194		10.1016/S0041-1345(00)01630-4		2	Immunology; Surgery; Transplantation	Immunology; Surgery; Transplantation	385JV	WOS:000166001400345		
J	Hirata, M; Harihara, Y; Hisatomi, S; Miura, Y; Yoshino, H; Mizuta, K; Ito, M; Sano, K; Taniai, N; Kusaka, K; Kita, Y; Kawarasaki, H; Kubota, K; Takayama, T; Hashizume, K; Makuuchi, M				Hirata, M; Harihara, Y; Hisatomi, S; Miura, Y; Yoshino, H; Mizuta, K; Ito, M; Sano, K; Taniai, N; Kusaka, K; Kita, Y; Kawarasaki, H; Kubota, K; Takayama, T; Hashizume, K; Makuuchi, M			Living-related liver transplantation for patients with primary biliary cirrhosis	TRANSPLANTATION PROCEEDINGS			English	Article; Proceedings Paper	6th Congress of the Asian-Society-of-Transplantation	SEP 20-24, 1999	SUNTEC CITY, SINGAPORE	Soc Transplantat Singapore, Asian Soc Transplantat, Transplantat Soc, Novartis Pte Ltd, Janssen-Cilag, Fujisawa, Roche Singapore Pte Ltd, Fresenius Ag, Baxter Healthcare Far E Pte Ltd, Transmed Pte Ltd					Univ Tokyo, Fac Med, Liver Transplantat Team, Tokyo 113, Japan	Hirata, M (reprint author), Univ Tokyo, Fac Med, Dept Surg 2, Bunkyo Ku, 7-3-1 Hongo, Tokyo 113, Japan.		幕内, 雅敏/A-2140-2012				DICKSON ER, 1989, HEPATOLOGY, V10, P1, DOI 10.1002/hep.1840100102; MURTAUGH PA, 1994, HEPATOLOGY, V20, P126, DOI 10.1016/0270-9139(94)90144-9; URATA K, 1995, HEPATOLOGY, V21, P1317, DOI 10.1016/0270-9139(95)90053-5; Kim WR, 1998, HEPATOLOGY, V28, P33, DOI 10.1002/hep.510280106; WATER JV, 1996, HEPATOLOGY, V24, P1079	5	1	1	ELSEVIER SCIENCE INC	NEW YORK	655 AVENUE OF THE AMERICAS, NEW YORK, NY 10010 USA	0041-1345			TRANSPLANT P	Transplant. Proc.	NOV	2000	32	7					2208	2209		10.1016/S0041-1345(00)01637-7		2	Immunology; Surgery; Transplantation	Immunology; Surgery; Transplantation	385JV	WOS:000166001400352		
J	Taniai, N; Harihara, Y; Kita, Y; Hirata, M; Sano, K; Kusaka, K; Kubota, K; Takayama, T; Kawarasaki, H; Makuuchi, M; Yoshida, H; Akimaru, K; Tajiri, T; Onda, M				Taniai, N; Harihara, Y; Kita, Y; Hirata, M; Sano, K; Kusaka, K; Kubota, K; Takayama, T; Kawarasaki, H; Makuuchi, M; Yoshida, H; Akimaru, K; Tajiri, T; Onda, M			Persistent pleural and peritoneal fluid discharge after adult-to-adult living-related liver transplantation	TRANSPLANTATION PROCEEDINGS			English	Article; Proceedings Paper	6th Congress of the Asian-Society-of-Transplantation	SEP 20-24, 1999	SUNTEC CITY, SINGAPORE	Soc Transplantat Singapore, Asian Soc Transplantat, Transplantat Soc, Novartis Pte Ltd, Janssen-Cilag, Fujisawa, Roche Singapore Pte Ltd, Fresenius Ag, Baxter Healthcare Far E Pte Ltd, Transmed Pte Ltd			ASCITES		Nippon Med Sch, Dept Surg 1, Bunkyo Ku, Tokyo 1138603, Japan; Univ Tokyo, Grad Sch Med, Liver Transplant Team, Tokyo, Japan	Taniai, N (reprint author), Nippon Med Sch, Dept Surg 1, Bunkyo Ku, 1-1-5 Sendagi, Tokyo 1138603, Japan.		幕内, 雅敏/A-2140-2012				Adetiloye VA, 1998, PEDIATR RADIOL, V28, P539, DOI 10.1007/s002470050406; URATA K, 1995, HEPATOLOGY, V21, P1317, DOI 10.1016/0270-9139(95)90053-5; Kawasaki S, 1998, ANN SURG, V227, P269, DOI 10.1097/00000658-199802000-00017; GANE E, 1995, GASTROENTEROLOGY, V109, P1631, DOI 10.1016/0016-5085(95)90653-3; NOBLEJAMIESON G, 1991, ARCH DIS CHILD, V66, P988	5	1	1	ELSEVIER SCIENCE INC	NEW YORK	655 AVENUE OF THE AMERICAS, NEW YORK, NY 10010 USA	0041-1345			TRANSPLANT P	Transplant. Proc.	NOV	2000	32	7					2213	2214		10.1016/S0041-1345(00)01639-0		2	Immunology; Surgery; Transplantation	Immunology; Surgery; Transplantation	385JV	WOS:000166001400354		
J	Taniai, N; Harihara, Y; Kita, Y; Hirata, M; Sano, K; Kubota, K; Takayama, T; Kawarasaki, H; Makuuchi, M; Yoshida, H; Akimaru, K; Tajiri, T; Onda, M				Taniai, N; Harihara, Y; Kita, Y; Hirata, M; Sano, K; Kubota, K; Takayama, T; Kawarasaki, H; Makuuchi, M; Yoshida, H; Akimaru, K; Tajiri, T; Onda, M			Rupture of newly developed esophageal varices after adult-to-adult living-related liver transplantation	TRANSPLANTATION PROCEEDINGS			English	Article; Proceedings Paper	6th Congress of the Asian-Society-of-Transplantation	SEP 20-24, 1999	SUNTEC CITY, SINGAPORE	Soc Transplantat Singapore, Asian Soc Transplantat, Transplantat Soc, Novartis Pte Ltd, Janssen-Cilag, Fujisawa, Roche Singapore Pte Ltd, Fresenius Ag, Baxter Healthcare Far E Pte Ltd, Transmed Pte Ltd			RESECTION		Nippon Med Sch, Dept Surg 1, Bunkyo Ku, Tokyo 1138603, Japan; Univ Tokyo, Grad Sch Med, Liver Transplant Team, Tokyo, Japan	Taniai, N (reprint author), Nippon Med Sch, Dept Surg 1, Bunkyo Ku, 1-1-5 Sendagi, Tokyo 1138603, Japan.		幕内, 雅敏/A-2140-2012				Miyagawa S, 1998, TRANSPLANTATION, V66, P661, DOI 10.1097/00007890-199809150-00021; URATA K, 1995, HEPATOLOGY, V21, P1317, DOI 10.1016/0270-9139(95)90053-5; HADENGUE A, 1993, HEPATOLOGY, V17, P175, DOI 10.1016/0270-9139(93)90072-U; Kawasaki S, 1998, ANN SURG, V227, P269, DOI 10.1097/00000658-199802000-00017; KANEMATSU T, 1985, ARCH SURG-CHICAGO, V120, P1303; PAULSEN AW, 1992, HEPATOLOGY, V16, P100, DOI 10.1002/hep.1840160118	6	3	3	ELSEVIER SCIENCE INC	NEW YORK	655 AVENUE OF THE AMERICAS, NEW YORK, NY 10010 USA	0041-1345			TRANSPLANT P	Transplant. Proc.	NOV	2000	32	7					2264	2265		10.1016/S0041-1345(00)01658-4		2	Immunology; Surgery; Transplantation	Immunology; Surgery; Transplantation	385JV	WOS:000166001400376		
J	Hirata, M; Harihara, Y; Hisatomi, S; Miura, Y; Yoshino, H; Mizuta, K; Ito, M; Sano, K; Taniai, N; Kusaka, K; Kita, Y; Kawarasaki, H; Kubota, K; Takayama, T; Makuuchi, M				Hirata, M; Harihara, Y; Hisatomi, S; Miura, Y; Yoshino, H; Mizuta, K; Ito, M; Sano, K; Taniai, N; Kusaka, K; Kita, Y; Kawarasaki, H; Kubota, K; Takayama, T; Makuuchi, M			A case of esophageal variceal rupture following acute portal vein thrombosis three days after living-related liver transplantation	TRANSPLANTATION PROCEEDINGS			English	Article; Proceedings Paper	6th Congress of the Asian-Society-of-Transplantation	SEP 20-24, 1999	SUNTEC CITY, SINGAPORE	Soc Transplantat Singapore, Asian Soc Transplantat, Transplantat Soc, Novartis Pte Ltd, Janssen-Cilag, Fujisawa, Roche Singapore Pte Ltd, Fresenius Ag, Baxter Healthcare Far E Pte Ltd, Transmed Pte Ltd			COMPLICATIONS		Univ Tokyo, Grad Sch Med, Dept Surg, Bunkyo Ku, Tokyo 1138655, Japan	Hirata, M (reprint author), Univ Tokyo, Grad Sch Med, Dept Surg, Bunkyo Ku, 7-3-1 Hongo, Tokyo 1138655, Japan.		幕内, 雅敏/A-2140-2012				LERUT J, 1987, ANN SURG, V205, P404, DOI 10.1097/00000658-198704000-00011; Cherukuri R, 1998, TRANSPLANTATION, V65, P1124, DOI 10.1097/00007890-199804270-00018; WOZNEY P, 1986, AM J ROENTGENOL, V147, P657; Funaki B, 1997, AM J ROENTGENOL, V169, P551	4	9	10	ELSEVIER SCIENCE INC	NEW YORK	655 AVENUE OF THE AMERICAS, NEW YORK, NY 10010 USA	0041-1345			TRANSPLANT P	Transplant. Proc.	NOV	2000	32	7					2266	2268		10.1016/S0041-1345(00)01659-6		3	Immunology; Surgery; Transplantation	Immunology; Surgery; Transplantation	385JV	WOS:000166001400377		
J	Kuwabara, T; Warashina, M; Taira, K				Kuwabara, T; Warashina, M; Taira, K			Allosterically controllable maxizymes cleave mRNA with high efficiency and specificity	TRENDS IN BIOTECHNOLOGY			English	Review							CHRONIC MYELOGENOUS LEUKEMIA; CHRONIC MYELOCYTIC-LEUKEMIA; RIBOZYME-MEDIATED CLEAVAGE; RNA-HAMMERHEAD RIBOZYMES; METAL-ION MECHANISM; TAT MESSENGER-RNA; PHILADELPHIA-CHROMOSOME; MARROW TRANSPLANTATION; SEQUENCE REQUIREMENTS; THERAPEUTIC AGENTS	Ribozymes are small and versatile nucleic acids that. can cleave RNA molecules at specific sites. However, because of the limited number of cleavable sequences on the target mRNA, in some cases conventional ribozymes do not have precise cleavage specificity. To overcome this problem, an allosteric version (a maxizyme) was developed that displayed activity and specificity in vivo. More than five custom-designed maxizymes have demonstrated sensor functions, which indicates that the technology might be broadly applicable in molecular biology and possibly in the clinic.	MITI, Agcy Ind Sci & Technol, Natl Inst Adv Interdisciplinary Res, Tsukuba Sci City 3058562, Japan; Univ Tokyo, Grad Sch Engn, Dept Chem & Biotechnol, Tokyo 1138656, Japan	Kuwabara, T (reprint author), MITI, Agcy Ind Sci & Technol, Natl Inst Adv Interdisciplinary Res, 1-1-4 Higashi, Tsukuba Sci City 3058562, Japan.						Amontov SV, 1996, J AM CHEM SOC, V118, P1624, DOI 10.1021/ja9517734; HEISTERKAMP N, 1983, NATURE, V306, P239, DOI 10.1038/306239a0; Bertrand E, 1997, RNA, V3, P75; Zhou DM, 1998, CHEM REV, V98, P991, DOI 10.1021/cr9604292; MCGLAVE P, 1993, BLOOD, V81, P543; Birikh KR, 1997, EUR J BIOCHEM, V245, P1, DOI 10.1111/j.1432-1033.1997.t01-3-00001.x; ROWLEY JD, 1973, NATURE, V243, P290, DOI 10.1038/243290a0; GROFFEN J, 1984, CELL, V36, P93, DOI 10.1016/0092-8674(84)90077-1; DALEY GQ, 1990, SCIENCE, V247, P824, DOI 10.1126/science.2406902; KONOPKA JB, 1984, CELL, V37, P1035, DOI 10.1016/0092-8674(84)90438-0; Kuwabara T, 1997, NUCLEIC ACIDS RES, V25, P3074, DOI 10.1093/nar/25.15.3074; PYLE AM, 1993, SCIENCE, V261, P709, DOI 10.1126/science.7688142; BARTRAM CR, 1983, NATURE, V306, P277, DOI 10.1038/306277a0; PICCIRILLI JA, 1993, NATURE, V361, P85, DOI 10.1038/361085a0; Murray JB, 1998, CHEM BIOL, V5, P587, DOI 10.1016/S1074-5521(98)90116-8; STEITZ TA, 1993, P NATL ACAD SCI USA, V90, P6498, DOI 10.1073/pnas.90.14.6498; Good PD, 1997, GENE THER, V4, P45, DOI 10.1038/sj.gt.3300354; Weinstein LB, 1997, NATURE, V388, P805; YARUS M, 1993, FASEB J, V7, P31; MCCALL MJ, 1992, P NATL ACAD SCI USA, V89, P5710, DOI 10.1073/pnas.89.13.5710; SHIMAYAMA T, 1995, BIOCHEMISTRY-US, V34, P3649, DOI 10.1021/bi00011a020; BRATTY J, 1993, BIOCHIM BIOPHYS ACTA, V1216, P345, DOI 10.1016/0167-4781(93)90001-T; DAHM SC, 1993, BIOCHEMISTRY-US, V32, P13040, DOI 10.1021/bi00211a013; DEISSEROTH AB, 1994, BLOOD, V83, P3068; Du ZM, 1998, HUM GENE THER, V9, P1551, DOI 10.1089/hum.1998.9.11-1551; ECKSTEIN F, 1996, CATALYTIC RNA, V10; ERICKSON RP, 1992, GENE REGULATION BIOL; FU DJ, 1994, J AM CHEM SOC, V116, P4591, DOI 10.1021/ja00090a007; GISHIZKY ML, 1992, SCIENCE, V256, P836, DOI 10.1126/science.1375394; Hamada M, 1999, FEBS LETT, V461, P77, DOI 10.1016/S0014-5793(99)01367-8; HENDRY P, 1992, NUCLEIC ACIDS RES, V20, P5737, DOI 10.1093/nar/20.21.5737; KOIZUMI M, 1988, FEBS LETT, V228, P228, DOI 10.1016/0014-5793(88)80004-8; Kore AR, 1998, NUCLEIC ACIDS RES, V26, P4116, DOI 10.1093/nar/26.18.4116; Koseki S, 1999, J VIROL, V73, P1868; Kuwabara T, 1998, NAT BIOTECHNOL, V16, P961; Kuwabara T, 1999, P NATL ACAD SCI USA, V96, P1886, DOI 10.1073/pnas.96.5.1886; Kuwabara T, 1998, MOL CELL, V2, P617, DOI 10.1016/S1097-2765(00)80160-4; Kuwabara T, 1996, NUCLEIC ACIDS RES, V24, P2302, DOI 10.1093/nar/24.12.2302; LONG DM, 1994, P NATL ACAD SCI USA, V91, P6977, DOI 10.1073/pnas.91.15.6977; Lott WB, 1998, P NATL ACAD SCI USA, V95, P542, DOI 10.1073/pnas.95.2.542; Marshall KA, 1999, NAT STRUCT BIOL, V6, P992; MURRAY JAH, 1992, ANTISENSE RNA DNA; Nakayama A, 1999, FEBS LETT, V448, P67, DOI 10.1016/S0014-5793(99)00325-7; PERRIMAN R, 1992, GENE, V113, P157, DOI 10.1016/0378-1119(92)90391-2; ROSSI JJ, 1990, TRENDS BIOTECHNOL, V8, P179, DOI 10.1016/0167-7799(90)90169-X; ROSSI JJ, 1995, TRENDS BIOTECHNOL, V13, P301, DOI 10.1016/S0167-7799(00)88969-6; RUFFNER DE, 1990, BIOCHEMISTRY-US, V29, P10695, DOI 10.1021/bi00499a018; SARVER N, 1990, SCIENCE, V247, P1222, DOI 10.1126/science.2107573; SAWATA S, 1995, J AM CHEM SOC, V117, P2357, DOI 10.1021/ja00113a028; SAWATA S, 1993, NUCLEIC ACIDS RES, V21, P5656, DOI 10.1093/nar/21.24.5656; SHELDON CC, 1989, NUCLEIC ACIDS RES, V17, P5679, DOI 10.1093/nar/17.14.5679; SHIMAYAMA T, 1993, NUCLEIC ACIDS RES, V21, P2605, DOI 10.1093/nar/21.11.2605; SHTIVELMAN E, 1986, CELL, V47, P277, DOI 10.1016/0092-8674(86)90450-2; SNYDER DS, 1990, HEMATOL ONCOL CLIN N, V4, P535; Soukup GA, 1999, TRENDS BIOTECHNOL, V17, P469, DOI 10.1016/S0167-7799(99)01383-9; SULLENGER BA, 1993, SCIENCE, V262, P1566, DOI 10.1126/science.8248806; Tanabe T, 2000, NATURE, V406, P473; Tanabe T, 2000, BIOMACROMOLECULES, V1, P108, DOI 10.1021/bm990009x; TAYLOR NR, 1992, NUCLEIC ACIDS RES, V20, P4559, DOI 10.1093/nar/20.17.4559; TURNER PC, 1997, RIBOZYME PROTOCOLS, V74; TUSCHL T, 1993, P NATL ACAD SCI USA, V90, P6991, DOI 10.1073/pnas.90.15.6991; UCHIMARU T, 1993, FASEB J, V7, P137; UEBAYASI M, 1994, J ORG CHEM, V59, P7414, DOI 10.1021/jo00103a038; Warashina M, 1997, J ORG CHEM, V62, P9138, DOI 10.1021/jo9712411; Yoshinari K, 2000, NUCLEIC ACIDS RES, V28, P1730, DOI 10.1093/nar/28.8.1730; Zhou DM, 1997, P NATL ACAD SCI USA, V94, P14343, DOI 10.1073/pnas.94.26.14343; Zhou DM, 1996, J AM CHEM SOC, V118, P5862, DOI 10.1021/ja9606790; Zhou JM, 2000, J INORG BIOCHEM, V78, P261, DOI 10.1016/S0162-0134(00)00005-2; ZOUMADAKIS M, 1995, NUCLEIC ACIDS RES, V23, P1192, DOI 10.1093/nar/23.7.1192	69	30	32	ELSEVIER SCIENCE LONDON	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0167-7799			TRENDS BIOTECHNOL	Trends Biotechnol.	NOV	2000	18	11					462	468		10.1016/S0167-7799(00)01498-0		7	Biotechnology & Applied Microbiology	Biotechnology & Applied Microbiology	373BE	WOS:000165267900006		
J	Sagehashi, M; Sakoda, A; Suzuki, M				Sagehashi, M; Sakoda, A; Suzuki, M			A predictive model of long-term stability after biomanipulation of shallow lakes	WATER RESEARCH			English	Article						lake mathematical model; set membership estimation; biomanipulation; long-term stability; mesocosm	NITROGEN-LIMITED GROWTH; MARINE PHYTOPLANKTON; THALASSIOSIRA-GRAVIDA; SKELETONEMA-COSTATUM; AMMONIUM LIMITATION; CHAETOCEROS-DEBILIS; NUTRIENT; MICROALGAE; CARBON; LIGHT	The eutrophication of lakes causes serious problems, such as water-bloom consisting of the harmful blue-green algae. To prevent an unusual degree of growth of phytoplankton, various restoration methods have been tried. "Biomanipulation": which uses zooplankton to prey on the phytoplankton, is a promising method because it can, In principle, create a desirable ecosystem. However, there are many equivocal points in the long-term stability of a newly developed ecosystem after biomanipulations. The fate prediction of a water ecosystem using a lake mathematical model is thus essential for implementing biomanipulations. There remain, however, many uncertain points in the dynamic parameters of the lake models, especially the parameters concerned with zooplankton and fish. In this study, we established a lake mathematical model based on the carbon, nitrogen and phosphorus flows among the biotic and abiotic substances in a water ecosystem. In this model, two types of phytoplankton (non blue-green algae and blue-green algae), three types of zooplankton (rotatoria. cladocera and copepoda), planktivorous fish (crucian carp), detritus and dissolved matters were considered. The dynamic parameters were estimated with a set membership estimation algorithm using random scanning based on mesocosm experiments, which can provide more rigid data than actual lake observations can. The model calculations showed good agreement with the observation data for both the non-filamentous blue-green algae dominant case and the filamentous blue-green algae dominant case. Using this model, we calculated the long-term stability of the effects of biomanipulations in a hypothetical lake. The calculation results clarified the blue-green algal species specificity in the longterm effects of biomanipulations. In the non-filamentous blue-green algal dominant case, the Long-term stable suppression of algal growth was predicted under a certain threshold fish biomass, while in the filamentous blue-green algal dominant case, the suppression was not sustainable even in a no-fish-coexisting series. Model simulation is very important to the design of biomanipulations, and the model proposed in this study is suitable for this purpose. (C) 2000 Elsevier Science Ltd. All rights reserved.	Univ Tokyo, Inst Ind Sci, Minato Ku, Tokyo 1068558, Japan; UN Univ, Shibuya Ku, Tokyo 1508925, Japan	Sagehashi, M (reprint author), Univ Tokyo, Inst Ind Sci, Minato Ku, 22-1 Roppongi 7 Chome, Tokyo 1068558, Japan.						GEIDER RJ, 1987, NEW PHYTOL, V106, P1, DOI 10.1111/j.1469-8137.1987.tb04788.x; JORGENSEN SE, 1986, ECOL MODEL, V32, P165, DOI 10.1016/0304-3800(86)90024-4; BATES SS, 1976, LIMNOL OCEANOGR, V21, P212; DROOP MR, 1973, J PHYCOL, V9, P264; ARNOLD DE, 1971, LIMNOL OCEANOGR, V16, P906; CAPERON J, 1972, DEEP-SEA RES, V19, P619, DOI 10.1016/0011-7471(72)90090-3; CONWAY HL, 1977, MAR BIOL, V43, P33, DOI 10.1007/BF00392569; HARRISON PJ, 1977, MAR BIOL, V43, P19, DOI 10.1007/BF00392568; BENNDORF J, 1987, SCHWEIZ Z HYDROL, V49, P237, DOI 10.1007/BF02538505; BERMAN T, 1974, MAR BIOL, V28, P305, DOI 10.1007/BF00388498; Boyle TP, 1997, ECOL APPL, V7, P1099; BROQVIST S, 1971, MATH MODELL EKKOSYST; CAPERON J, 1972, DEEP-SEA RES, V19, P601, DOI 10.1016/0011-7471(72)90089-7; CRYER M, 1986, LIMNOL OCEANOGR, V31, P1022; FAAFENG BA, 1990, VERH INT VER LIMNOL, V24, P597; GEIDER RJ, 1997, MARINE ECOLOGY PROGR; CARPENTER E J, 1971, Ecology (Washington D C), V52, P183, DOI 10.2307/1934753; HOSPER SH, 1999, J JAPAN SOC WATER EN, V22, P18; *HYDR ENG CTR, 1975, WAT QUAL RIV RES SYS; JANSE JH, 1992, HYDROBIOLOGIA, V233, P199; JANSE J H, 1990, Hydrobiological Bulletin, V24, P69, DOI 10.1007/BF02256750; Jayaweera M, 1996, ECOL MODEL, V85, P113, DOI 10.1016/0304-3800(94)00153-7; JORGENSEN S E, 1976, Ecological Modelling, V2, P147, DOI 10.1016/0304-3800(76)90030-2; JORGENSEN S E, 1976, Ecological Modelling, V2, P303, DOI 10.1016/0304-3800(76)90013-2; KASPRZAK P, 1993, ARCH HYDROBIOL, V128, P149; KEESMAN K, 1990, WATER RESOUR RES, V26, P2643; KONG DS, 1994, P C LIMN STUD KAS WA, P39; KOSCHEL R, 1993, VERH INT VER LIMNOL, V25, P647; LEHMAN JT, 1976, LIMNOL OCEANOGR, V21, P724; MACKERETH FJ, 1953, J EXP BOT, V4, P296, DOI 10.1093/jxb/4.3.296; MATSUOKA Y, 1986, ECOL MODEL, V31, P201, DOI 10.1016/0304-3800(86)90064-5; NYHOLM N, 1978, ECOL MODEL, V4, P279, DOI 10.1016/0304-3800(78)90011-X; OCONNOR DJ, 1976, SYSTEMS APPROACH WAT, P299; OH HM, 1991, J APPL PHYCOL, V3, P211, DOI 10.1007/BF00003579; RICHEY JE, 1977, ECOSYSTEM MODELLING, P267; SCAVIA D, 1976, Ecological Modelling, V2, P33, DOI 10.1016/0304-3800(76)90005-3; SCHEFFER M, 1989, Hydrobiological Bulletin, V23, P73, DOI 10.1007/BF02286429; SCHEFFER M, 1991, OIKOS, V62, P271, DOI 10.2307/3545491; Shapiro J., 1975, Proceedings of a Symposium on Water Quality and Management through Biological Control, Gainesville, 1975., P85; SHAPIRO J, 1990, HYDROBIOLOGIA, V200, P13, DOI 10.1007/BF02530325; Shapiro J., 1980, Developments in Hydrobiology, V2, P105; STONE L, 1993, LIMNOL OCEANOGR, V38, P1680; SUZUKI M, 1993, LIMNOL OCEANOGR, V38, P1680; SUZUKI M, IN PRESS ECOLOGICAL; TALBOT P, 1991, WATER RES, V25, P465, DOI 10.1016/0043-1354(91)90083-3; TATRAI I, 1986, FRESHWATER BIOL, V16, P417, DOI 10.1111/j.1365-2427.1986.tb00982.x; *TETR TECH INC, 1977, EC CONST; TETT P, 1975, LIMNOL OCEANOGR, V20, P587; Wetzel R. G., 1975, LIMNOLOGY	49	25	31	PERGAMON-ELSEVIER SCIENCE LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND	0043-1354			WATER RES	Water Res.	NOV	2000	34	16					4014	4028		10.1016/S0043-1354(00)00165-2		15	Engineering, Environmental; Environmental Sciences; Water Resources	Engineering; Environmental Sciences & Ecology; Water Resources	362YR	WOS:000089806300013		
J	Ohashi, K; Sasaki, M; Sasagawa, H; Nakamura, J; Natori, S; Kubo, T				Ohashi, K; Sasaki, M; Sasagawa, H; Nakamura, J; Natori, S; Kubo, T			Functional flexibility of the honey bee hypopharyngeal gland in a dequeened colony	ZOOLOGICAL SCIENCE			English	Article							APIS-MELLIFERA L; DEPENDENT ROLE CHANGE; ALPHA-GLUCOSIDASE; EXPRESSION; DIVISION; LABOR; GENE	The role of the worker honey bee Apis mellifera L. changes depending on age after eclosion (age polyethism): young workers (nurse bees) take care of their brood by synthesizing and secreting brood food (royal jelly), while older workers (foragers) forage for nectar and process it into honey. Previously, we showed that the major proteins synthesized in the hypopharyngeal gland of the worker change from brood food proteins to alpha -glucosidase at the single secretory cell level in parallel with this age polyethism [Kubo et al., J. Biochem. 119, 291-295 (1996); Ohashi et al., Eur. J. Biochem. 249, 797-802 (1997)]. Here, we examined whether the function of the hypopharyngeal gland has flexibility depending on the colony conditions, by creating a dequeened colony in which the older workers were compelled to feed the drone larvae. it was found that most of the older workers in the dequeened colony synthesized brood food proteins as did nurse bees. Furthermore, the percentage of workers that synthesized brood food proteins was maintained at 80-90% of the total workers for at least two months, as in a normal colony. These results indicate that the function of the hypopharyngeal gland cells of the worker has flexibility and can, if necessary, be maintained as that of the nurse bee, depending on the condition of the colony.	Univ Tokyo, Grad Sch Pharmaceut Sci, Bunkyo Ku, Tokyo 1130033, Japan; Tamagawa Univ, Fac Agr, Tokyo 1948610, Japan; Natl Inst Sericultural & Entomol Sci, Japan Sci & Technol Corp, PRESTO, Tsukuba, Ibaraki 3058634, Japan	Kubo, T (reprint author), Univ Tokyo, Grad Sch Pharmaceut Sci, Bunkyo Ku, Tokyo 1130033, Japan.						Ohashi K, 1999, EUR J BIOCHEM, V265, P127, DOI 10.1046/j.1432-1327.1999.00696.x; Huang ZY, 1996, BEHAV ECOL SOCIOBIOL, V39, P147, DOI 10.1007/s002650050276; LINDAUER M, 1952, Z VERGL PHYSIOL, V34, P299, DOI 10.1007/BF00298048; Kubo T, 1996, J BIOCHEM-TOKYO, V119, P291; WINSTON ML, 1985, CAN J ZOOL, V63, P777; Huang ZY, 1998, J COMP PHYSIOL A, V183, P143, DOI 10.1007/s003590050242; WHITE JW, 1963, BIOCHIM BIOPHYS ACTA, V73, P57; Ohashi K, 1996, BIOCHEM BIOPH RES CO, V221, P380, DOI 10.1006/bbrc.1996.0604; RUTZ W, 1976, J INSECT PHYSIOL, V22, P1485, DOI 10.1016/0022-1910(76)90214-6; KNECHT D, 1990, APIDOLOGIE, V21, P457, DOI 10.1051/apido:19900507; Ohashi K, 1997, EUR J BIOCHEM, V249, P797, DOI 10.1111/j.1432-1033.1997.t01-1-00797.x; DAYER F C, 1991, DIVERSITY GENUS APIS, P2133; FAIRBANK.G, 1971, BIOCHEMISTRY-US, V10, P2606, DOI 10.1021/bi00789a030; FERGUSSON LA, 1988, CAN J ZOOL, V66, P1997; SAKAGAMI S F, 1968, Researches on Population Ecology (Tokyo), V10, P127, DOI 10.1007/BF02510869; FUKUDA H, 1983, RES POPUL ECOL, V25, P249, DOI 10.1007/BF02515602; HALBERSTADT K, 1980, INSECT SOC, V27, P61, DOI 10.1007/BF02224521; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; MILOJEVIC BD, 1940, BEE WORLD, V21, P41; ROBINSON GE, 1989, SCIENCE, V246, P109, DOI 10.1126/science.246.4926.109; ROSCH G. A., 1930, ZEITSCHR WISSENSCH BIOL ABT C ZEITSCHR VERGLEICH PHYSIOL, V12, P1, DOI 10.1007/BF00339476; SAKAGAMI SHOICHI F., 1953, JAPANESE JOUR ZOOL, V11, P117; SAKAGAMI S. F., 1958, BEHAVIOUR, V13, P280, DOI 10.1163/156853957X00056; SASAGAWA H, 1989, APPL ENTOMOL ZOOL, V24, P66; SIMPSON J, 1968, Journal of Apicultural Research, V7, P29; WINTON MI, 1987, BIOL HONEY BEE	26	21	22	ZOOLOGICAL SOC JAPAN	TOKYO	TOSHIN-BUILDING, HONGO 2-27-2, BUNKYO-KU, TOKYO, 113, JAPAN	0289-0003			ZOOL SCI	Zool. Sci.	NOV	2000	17	8					1089	1094		10.2108/zsj.17.1089		6	Zoology	Zoology	389PJ	WOS:000166246700009		
J	Kojima, S; Segawa, R; Fujiwara, Y; Hashimoto, J; Ohta, S				Kojima, S; Segawa, R; Fujiwara, Y; Hashimoto, J; Ohta, S			Genetic differentiation of populations of a hydrothermal vent-endemic gastropod, Ifremeria nautilei, between the North Fiji Basin and the Manus Basin revealed by nucleotide sequences of mitochondrial DNA	ZOOLOGICAL SCIENCE			English	Article							PAPUA-NEW-GUINEA; COMMUNITIES; SYMBIOSIS; RATES; FAUNA	The genetic differentiation of populations of a hydrothermal vent-endemic gastropod, Ifremeria nautilei, between two back-are basins in the south Western Pacific, namely the Manus Basin and the North Fiji Basin, was analyzed on the basis of nucleotide sequences of the mitochondrial gene for cytochrome oxidase I. The two populations of I. nautilei had no common haplotypes and appeared, therefore, to be isolated from one another. All haplotypes obtained from the North Fiji Basin formed a monophyletic group supported by a high bootstrap probability and the genetic diversity of the population in the North Fiji Basin was much smaller than that of the population in the Manus Basin. The population in the North Fiji Basin might have been founded by relatively recent migrants from the Man us Basin. The present results suggest that the larval dispersal ability of I. nautilei might be lower than that of an undescribed species in the closely related genus Alviniconcha.	Univ Tokyo, Ocean Res Inst, Tokyo 1648639, Japan; Tokyo Metropolitan Univ, Fac Sci, Dept Biol, Tokyo 1920364, Japan; Japan Marine Sci & Technol Ctr, Kanagawa 2370061, Japan	Kojima, S (reprint author), Univ Tokyo, Ocean Res Inst, 1-15-1 Minamidai, Tokyo 1648639, Japan.	kojima@ori.u-tokyo.ac.jp					Raymond M, 1995, EVOLUTION, V49, P1280, DOI 10.2307/2410454; Tunnicliffe V, 1996, NATURE, V379, P531, DOI 10.1038/379531a0; WAREN A, 1993, ZOOL SCR, V22, P1, DOI 10.1111/j.1463-6409.1993.tb00342.x; Knowlton N, 1998, P ROY SOC B-BIOL SCI, V265, P2257; HESSLER RR, 1991, DEEP-SEA RES, V38, P185, DOI 10.1016/0198-0149(91)90079-U; Tunnicliffe V, 1998, ADV MAR BIOL, V34, P353, DOI 10.1016/S0065-2881(08)60213-8; STEIN JL, 1988, BIOL BULL, V174, P373, DOI 10.2307/1541963; Auzende JM, 1997, CR ACAD SCI II A, V325, P585, DOI 10.1016/S1251-8050(97)89459-1; Beck L.A., 1991, Annalen des Naturhistorischen Museums in Wien Serie B Botanik und Zoologie, V92, P277; Both R., 1986, EOS, V67, P489; BOUCHET P, 1991, C R ACAD SCI PARIS 3, V612, P495; BUTT J, 1994, J GEOPHYS RES-OCEANS, V99, P12503, DOI 10.1029/94JC00399; Craig H., 1987, EOS T AM GEOPHYS UN, V68, P1531; DESBRUYERES D, 1994, MAR GEOL, V116, P227, DOI 10.1016/0025-3227(94)90178-3; Dixon D.R., 1995, Geological Society Special Publication, V87, P343, DOI 10.1144/GSL.SP.1995.087.01.26; ENDOW K, 1989, NIHON BISEIBUTSU SEI, V3, P73; Hasegawa Takashi, 1996, Benthos Research, V51, P33; Herzig P., 1994, EOS, V75, P513, DOI 10.1029/94EO02009; HOFFMANN RJ, 1992, GENETICS, V131, P397; *KAIYO 87 SHIPB PA, 1988, MER, V26, P36; KIMURA M, 1980, J MOL EVOL, V16, P111, DOI 10.1007/BF01731581; KOJIMA S, 1998, JAMSTEC J DEEP SEA R, V14, P501; KOJIMA S, 1997, MAR BIOL, V127, P505; KOMM B, 1982, COMP BIOCHEM PHYS B, V73, P923, DOI 10.1016/0305-0491(82)90338-8; Kumar S., 1993, MEGA MOL EVOLUTIONAR; Nei M., 1987, MOL EVOLUTIONARY GEN; Ohta Suguru, 1997, JAMSTEC Journal of Deep Sea Research, V13, P233; OKUTANI T, 1988, Venus the Japanese Journal of Malacology, V47, P1; ROFF DA, 1989, MOL BIOL EVOL, V6, P539; Saitou N, 1987, MOL BIOL EVOL, V10, P471; SCHNEIDER S, 1996, ARLQUIN SOFTWARE PAC; Shimayama T, 1990, NUCL ACIDS S SER, V22, P77; TAJIMA F, 1983, GENETICS, V105, P437; The Nautilau Group, 1990, EOS T AM GEOPHYS UN, V71, P678; Tufar W., 1990, MITT OSTERR GEOL GES, V82, P183; Windoffer R, 1997, BIOL BULL-US, V193, P381, DOI 10.2307/1542940	36	17	18	ZOOLOGICAL SOC JAPAN	TOKYO	TOSHIN-BUILDING, HONGO 2-27-2, BUNKYO-KU, TOKYO, 113-0033, JAPAN	0289-0003			ZOOL SCI	Zool. Sci.	NOV	2000	17	8					1167	1174		10.2108/zsj.17.1167		8	Zoology	Zoology	389PJ	WOS:000166246700019		
J	Hirabayashi, T; Shimizu, T				Hirabayashi, T; Shimizu, T			Localization and regulation of cytosolic phospholipase A(2)	BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR AND CELL BIOLOGY OF LIPIDS			English	Review						Ca2+; C2 domain; phosphorylation; isoprenylation; phosphatidylinositol 4,5-bisphosphate; vimentin	ARACHIDONOYL-HYDROLYZING PHOSPHOLIPASE-A2; PROTEIN-KINASE-C; MACROPHAGE CELL-LINE; PRODUCT-CONTAINING VESICLES; PLATELET-ACTIVATING-FACTOR; LEUKOTRIENE C-4 SYNTHASE; TUMOR-NECROSIS-FACTOR; LIPID-BINDING DOMAIN; MOLECULAR-CLONING; NUCLEAR-ENVELOPE	Liberation of arachidonic acid by cytosolic phospholipase A(2) (cPLA(2)) upon cell activation is often the initial and rate-limiting step in leukotriene and prostaglandin biosynthesis. This review discusses the essential features of cPLA(2) isoforms and addresses intriguing insights into the catalytic and regulatory mechanisms. Gene expression, posttranslational modification and subcellular localization can regulate these isoforms. Translocation of cPLA(2)alpha from the cytosol to the perinuclear region in response to calcium transients is critical for the immediate arachidonic acid release. Therefore, particular emphasis is placed on the mechanism of the translocation and the role of the proteins and lipids implicated in this process. The regional distribution and cellular localization of cPLA(2) may help to better understand its function as an arachidonic acid supplier to downstream enzymes and as a regulator of specific cellular processes. (C) 2000 Elsevier Science B.V. All rights reserved.	Univ Tokyo, Fac Med, Dept Biochem & Mol Biol, Bunkyo Ku, Tokyo 1130033, Japan; CREST, Japan Sci & Technol Corp, Tokyo, Japan	Hirabayashi, T (reprint author), Univ Tokyo, Fac Med, Dept Biochem & Mol Biol, Bunkyo Ku, Hongo 7-3-1, Tokyo 1130033, Japan.						LIN LL, 1993, CELL, V72, P269, DOI 10.1016/0092-8674(93)90666-E; Ito K, 1998, J BIOL CHEM, V273, P1684, DOI 10.1074/jbc.273.3.1684; Jakobsson PJ, 1999, P NATL ACAD SCI USA, V96, P7220, DOI 10.1073/pnas.96.13.7220; Ishii S, 2000, PROG LIPID RES, V39, P41, DOI 10.1016/S0163-7827(99)00016-8; Fujishima H, 1999, P NATL ACAD SCI USA, V96, P4803, DOI 10.1073/pnas.96.9.4803; Stephenson D, 1999, GLIA, V27, P110, DOI 10.1002/(SICI)1098-1136(199908)27:2<110::AID-GLIA2>3.0.CO;2-C; KRAMER RM, 1993, J BIOL CHEM, V268, P26796; Dana R, 1998, J BIOL CHEM, V273, P441, DOI 10.1074/jbc.273.1.441; DECARVALHO MGS, 1995, J BIOL CHEM, V270, P20439; Schievella AR, 1995, J BIOL CHEM, V270, P30749; Bonventre JV, 1997, NATURE, V390, P622, DOI 10.1038/37635; FORMAN BM, 1995, CELL, V83, P803, DOI 10.1016/0092-8674(95)90193-0; Kramer RM, 1996, J BIOL CHEM, V271, P27723; Spencer AG, 1998, J BIOL CHEM, V273, P9886, DOI 10.1074/jbc.273.16.9886; Kramer RM, 1997, FEBS LETT, V410, P49, DOI 10.1016/S0014-5793(97)00322-0; MOSKOWITZ MA, 1984, SCIENCE, V224, P886, DOI 10.1126/science.6719118; Wu T, 1997, J BIOL CHEM, V272, P17145, DOI 10.1074/jbc.272.27.17145; Perisic O, 1998, J BIOL CHEM, V273, P1596, DOI 10.1074/jbc.273.3.1596; PETERSGOLDEN M, 1993, BIOCHEM BIOPH RES CO, V196, P147, DOI 10.1006/bbrc.1993.2227; Clemens JA, 1996, STROKE, V27, P527; KLIEWER SA, 1995, CELL, V83, P813, DOI 10.1016/0092-8674(95)90194-9; KRAMER RM, 1995, J BIOL CHEM, V270, P27395; ABRAMOVITZ M, 1993, EUR J BIOCHEM, V215, P105, DOI 10.1111/j.1432-1033.1993.tb18012.x; Dennis EA, 1997, TRENDS BIOCHEM SCI, V22, P1, DOI 10.1016/S0968-0004(96)20031-3; IRVINE RF, 1982, BIOCHEM J, V204, P3; Devchand PR, 1996, NATURE, V384, P39, DOI 10.1038/384039a0; LIN LL, 1992, J BIOL CHEM, V267, P23451; SHIMIZU T, 1990, J NEUROCHEM, V55, P1, DOI 10.1111/j.1471-4159.1990.tb08813.x; Nagase T, 2000, NAT IMMUNOL, V1, P42; Pickard RT, 1996, J BIOL CHEM, V271, P19225; WELSCH DJ, 1994, P NATL ACAD SCI USA, V91, P9745, DOI 10.1073/pnas.91.21.9745; HARA S, 1994, J BIOL CHEM, V269, P19897; KRAMER RM, 1991, J BIOL CHEM, V266, P5268; CLARK JD, 1990, P NATL ACAD SCI USA, V87, P7708, DOI 10.1073/pnas.87.19.7708; Lautens LL, 1998, BRAIN RES, V809, P18, DOI 10.1016/S0006-8993(98)00806-3; Murakami M, 1997, CRIT REV IMMUNOL, V17, P225; STEPHENSON DT, 1994, BRAIN RES, V637, P97, DOI 10.1016/0006-8993(94)91221-1; MILLER B, 1992, NATURE, V355, P722, DOI 10.1038/355722a0; Byrum RS, 1997, J EXP MED, V185, P1065, DOI 10.1084/jem.185.6.1065; Leslie CC, 1997, J BIOL CHEM, V272, P16709, DOI 10.1074/jbc.272.27.16709; Bittova L, 1999, J BIOL CHEM, V274, P9665, DOI 10.1074/jbc.274.14.9665; ANTOINE C, 1992, BIOCHIM BIOPHYS ACTA, V1128, P139, DOI 10.1016/0005-2760(92)90299-B; Dessen A, 1999, CELL, V97, P349, DOI 10.1016/S0092-8674(00)80744-8; DIXON RAF, 1990, NATURE, V343, P282, DOI 10.1038/343282a0; Balsinde J, 1997, J BIOL CHEM, V272, P16069, DOI 10.1074/jbc.272.26.16069; VENABLE ME, 1993, J LIPID RES, V34, P691; Narumiya S, 1999, PHYSIOL REV, V79, P1193; Lim H, 1999, GENE DEV, V13, P1561, DOI 10.1101/gad.13.12.1561; Chan BS, 1998, J BIOL CHEM, V273, P6689, DOI 10.1074/jbc.273.12.6689; Nalefski EA, 1996, PROTEIN SCI, V5, P2375; Uozumi N, 1997, NATURE, V390, P618; Underwood KW, 1998, J BIOL CHEM, V273, P21926, DOI 10.1074/jbc.273.34.21926; Ball A, 1999, P NATL ACAD SCI USA, V96, P6637, DOI 10.1073/pnas.96.12.6637; BAZAN NG, 1970, BIOCHIM BIOPHYS ACTA, V218, P1, DOI 10.1016/0005-2760(70)90086-X; Borsch-Haubold AG, 1998, J BIOL CHEM, V273, P4449, DOI 10.1074/jbc.273.8.4449; Bottomley MJ, 1998, BBA-MOL CELL BIOL L, V1436, P165, DOI 10.1016/S0005-2760(98)00141-6; Buckland AG, 1997, BIOCHEM SOC T, V25, pS599; Burke JR, 1997, BBA-PROTEIN STRUCT M, V1341, P223, DOI 10.1016/S0167-4838(97)00085-X; CHANNON JY, 1990, J BIOL CHEM, V265, P5409; CLARK JD, 1991, CELL, V65, P1043, DOI 10.1016/0092-8674(91)90556-E; CLARK JD, 1995, J LIPID MEDIAT CELL, V12, P83, DOI 10.1016/0929-7855(95)00012-F; Davletov B, 1998, J BIOL CHEM, V273, P19093, DOI 10.1074/jbc.273.30.19093; deCarvalho MGS, 1996, J BIOL CHEM, V271, P6987; DIEZ E, 1990, J BIOL CHEM, V265, P14654; DIEZ E, 1994, BIOCHEM J, V301, P721; DIEZ E, 1992, J BIOL CHEM, V267, P18342; Flati V, 1996, EMBO J, V15, P1566; FUJIMORI Y, 1993, EUR J BIOCHEM, V218, P629, DOI 10.1111/j.1432-1033.1993.tb18416.x; Fukuda T, 1999, AM J PHYSIOL-LUNG C, V277, pL533; GAUDET RJ, 1980, J NEUROCHEM, V35, P653, DOI 10.1111/j.1471-4159.1980.tb03704.x; GHOMASHCHI F, 1992, BIOCHEMISTRY-US, V31, P3814, DOI 10.1021/bi00130a012; Gijon MA, 1999, J CELL BIOL, V145, P1219, DOI 10.1083/jcb.145.6.1219; Gilbert JJ, 1996, J IMMUNOL, V156, P2054; GLOVER S, 1995, J BIOL CHEM, V270, P15359; GRONICH JH, 1990, BIOCHEM J, V271, P37; GRONICH JH, 1988, J BIOL CHEM, V263, P16645; HANAHAN DJ, 1986, ANNU REV BIOCHEM, V55, P483, DOI 10.1146/annurev.biochem.55.1.483; HANEL AM, 1993, BIOCHEMISTRY-US, V32, P5949, DOI 10.1021/bi00074a005; HANEL AM, 1995, BIOCHEMISTRY-US, V34, P7807, DOI 10.1021/bi00024a004; HARDER T, 1993, J CELL SCI, V104, P1109; HAYAKAWA M, 1993, J BIOL CHEM, V268, P11290; Hirabayashi T, 1999, J BIOL CHEM, V274, P5163, DOI 10.1074/jbc.274.8.5163; Hixon MS, 1998, BIOCHEMISTRY-US, V37, P8516, DOI 10.1021/bi980416d; Huang Z, 1996, BIOCHEMISTRY-US, V35, P3712, DOI 10.1021/bi952541k; Hwang SC, 1996, J BIOL CHEM, V271, P18342; KARGMAN S, 1992, J CELL BIOL, V119, P1701, DOI 10.1083/jcb.119.6.1701; KAST R, 1993, J BIOL CHEM, V268, P16795; Kishimoto K, 1999, NEUROSCIENCE, V92, P1061, DOI 10.1016/S0306-4522(99)00051-2; Klapisz E, 1999, EUR J BIOCHEM, V265, P957, DOI 10.1046/j.1432-1327.1999.00797.x; Kol S, 1997, ENDOCRINOLOGY, V138, P322, DOI 10.1210/en.138.1.322; LAM BK, 1994, P NATL ACAD SCI USA, V91, P7663, DOI 10.1073/pnas.91.16.7663; LESLIE CC, 1991, J BIOL CHEM, V266, P11366; LESLIE CC, 1990, BIOCHIM BIOPHYS ACTA, V1045, P261, DOI 10.1016/0005-2760(90)90129-L; LESLIE CC, 1988, BIOCHIM BIOPHYS ACTA, V963, P476, DOI 10.1016/0005-2760(88)90316-5; LIN LL, 1992, P NATL ACAD SCI USA, V89, P6147, DOI 10.1073/pnas.89.13.6147; MACDONALD JIS, 1989, J BIOL CHEM, V264, P17718; MALAVIYA R, 1993, J BIOL CHEM, V268, P4939; Mangat H, 1997, J CLIN INVEST, V100, P1941, DOI 10.1172/JCI119725; MCPHAIL LC, 1984, SCIENCE, V224, P622, DOI 10.1126/science.6231726; MIYASHITA A, 1995, NUCLEIC ACIDS RES, V23, P293, DOI 10.1093/nar/23.2.293; MORITA I, 1995, J BIOL CHEM, V270, P10902; Mosior M, 1998, J BIOL CHEM, V273, P2184, DOI 10.1074/jbc.273.4.2184; MURAKAMI M, 1995, J BIOL CHEM, V270, P3239; Nakatani Y, 2000, J BIOL CHEM, V275, P1161, DOI 10.1074/jbc.275.2.1161; NALEFSKI EA, 1994, J BIOL CHEM, V269, P18239; Nalefski EA, 1998, J BIOL CHEM, V273, P1365, DOI 10.1074/jbc.273.3.1365; NEMENOFF RA, 1993, J BIOL CHEM, V268, P1960; OHASHI K, 1992, J BIOL CHEM, V267, P789; OWADA Y, 1994, MOL BRAIN RES, V25, P364, DOI 10.1016/0169-328X(94)90174-0; PENROSE JF, 1995, AM J RESP CRIT CARE, V152, P283; Perisic O, 1999, J BIOL CHEM, V274, P14979, DOI 10.1074/jbc.274.21.14979; PetersGolden M, 1996, BIOCHEM J, V318, P797; PETERSGOLDEN M, 1993, AM J PHYSIOL, V264, pL438; Pickard RT, 1999, J BIOL CHEM, V274, P8823, DOI 10.1074/jbc.274.13.8823; Qiu ZH, 1998, J BIOL CHEM, V273, P8203, DOI 10.1074/jbc.273.14.8203; QIU ZH, 1994, J BIOL CHEM, V269, P19480; REYNOLDS LJ, 1993, BIOCHIM BIOPHYS ACTA, V1167, P272, DOI 10.1016/0005-2760(93)90229-3; ROLLINS TE, 1980, J BIOL CHEM, V255, P4872; ROUZER CA, 1986, P NATL ACAD SCI USA, V83, P857, DOI 10.1073/pnas.83.4.857; SAMUELSSON B, 1987, SCIENCE, V237, P1171, DOI 10.1126/science.2820055; Schalkwijk CG, 1996, BIOCHEM J, V313, P91; SHARP JD, 1993, J LIPID MEDIATOR, V8, P183; SHARP JD, 1994, J BIOL CHEM, V269, P23250; SHARP JD, 1991, J BIOL CHEM, V266, P14850; SHIMIZU T, 1986, P NATL ACAD SCI USA, V83, P4175, DOI 10.1073/pnas.83.12.4175; Shuttleworth TJ, 1996, J BIOL CHEM, V271, P21720; Sierra-Honigmann M. Rocio, 1996, Laboratory Investigation, V74, P684; Song CZ, 1999, J BIOL CHEM, V274, P17063, DOI 10.1074/jbc.274.24.17063; TAKAYAMA K, 1991, FEBS LETT, V282, P326, DOI 10.1016/0014-5793(91)80506-X; TAY A, 1994, BIOCHEM J, V304, P417; TAY A, 1994, BBA-GENE STRUCT EXPR, V1217, P345, DOI 10.1016/0167-4781(94)90299-2; Tischfield JA, 1997, J BIOL CHEM, V272, P17247, DOI 10.1074/jbc.272.28.17247; TRIMBLE LA, 1993, BIOCHEMISTRY-US, V32, P12560, DOI 10.1021/bi00210a002; UEDA N, 1986, J BIOL CHEM, V261, P7982; WIJKANDER J, 1991, EUR J BIOCHEM, V202, P873, DOI 10.1111/j.1432-1033.1991.tb16445.x; WIJKANDER J, 1992, FEBS LETT, V311, P299, DOI 10.1016/0014-5793(92)81124-5; WIJKANDER J, 1992, BIOCHEM BIOPH RES CO, V184, P118, DOI 10.1016/0006-291X(92)91166-N; WINITZ S, 1994, J BIOL CHEM, V269, P1889; WOODS JW, 1993, J EXP MED, V178, P1935, DOI 10.1084/jem.178.6.1935; WU T, 1994, NUCLEIC ACIDS RES, V22, P5093, DOI 10.1093/nar/22.23.5093; WU T, 1994, J CLIN INVEST, V93, P571, DOI 10.1172/JCI117009; Wu T, 1996, BBA-MOL CELL RES, V1310, P175; Xu GY, 1998, J MOL BIOL, V280, P485, DOI 10.1006/jmbi.1998.1874; XU XX, 1994, J BIOL CHEM, V269, P31693; Yao XL, 1999, J BIOL CHEM, V274, P17202, DOI 10.1074/jbc.274.24.17202; Yokomizo T, 2000, AM J RESP CRIT CARE, V161, pS51; YOSHIDA S, 1980, J NEUROSURG, V53, P323, DOI 10.3171/jns.1980.53.3.0323; Yu WG, 1998, AM J PATHOL, V152, P759; 2000, BIOCH J, V1488	149	146	156	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	1388-1981			BBA-MOL CELL BIOL L	BBA-Mol. Cell. Biol. Lipids	OCT 31	2000	1488	1-2					124	138		10.1016/S1388-1981(00)00115-3		15	Biochemistry & Molecular Biology; Biophysics; Cell Biology	Biochemistry & Molecular Biology; Biophysics; Cell Biology	377XL	WOS:000165551500012		
J	Kammori, M; Takubo, K; Nakamura, KI; Furugouri, E; Endo, H; Kanauchi, H; Mimura, Y; Kaminishi, M				Kammori, M; Takubo, K; Nakamura, KI; Furugouri, E; Endo, H; Kanauchi, H; Mimura, Y; Kaminishi, M			Telomerase activity and telomere length in benign and malignant human thyroid tissues	CANCER LETTERS			English	Article						human thyroid tumor; telomerase activity; telomere length	TUMORS; PROTEIN; YEAST; CARCINOMA; CANCER; CELLS; TRF2; RNA; CHROMOSOMES; EXPRESSION	Several studies have demonstrated that telomerase is activated and telomere length is altered in various types of tumors. In this study, we investigated telomerase activities and telomere length in 21 thyroid tumors. Telomerase activity was detected in 11 of 12 thyroid cancers and three of nine follicular adenomas. The mean telomere lengths in the cancers tissue and follicular adenomas were lower than in the respective background tissues, the differences being significant (P = 0.0055 and P < 0.006), respectively. Our findings suggest that change in telomerase activity and telomere length may be important for development of thyroid tumors. (C) 2000 Published by Elsevier Science Ireland Ltd. All rights reserved.	Univ Tokyo, Dept Surg, Endocrine & Metab Unit, Bunkyo Ku, Tokyo 1128688, Japan; Tokyo Metropolitan Inst Gerontol, Dept Clin Pathol, Bunkyo Ku, Tokyo 1128688, Japan; Univ Tokyo, Dept Pathol, Bunkyo Ku, Tokyo 1128688, Japan	Kammori, M (reprint author), Univ Tokyo, Dept Surg, Endocrine & Metab Unit, Bunkyo Ku, 3-28-6 Mejirodai, Tokyo 1128688, Japan.						Greider CW, 1996, ANNU REV BIOCHEM, V65, P337, DOI 10.1146/annurev.bi.65.070196.002005; MOYZIS RK, 1988, P NATL ACAD SCI USA, V85, P6622, DOI 10.1073/pnas.85.18.6622; HARLEY CB, 1990, NATURE, V345, P458, DOI 10.1038/345458a0; CHONG L, 1995, SCIENCE, V270, P1663, DOI 10.1126/science.270.5242.1663; Broccoli D, 1997, NAT GENET, V17, P231, DOI 10.1038/ng1097-231; MAZZAFERRI EL, 1993, NEW ENGL J MED, V328, P553; Marcand S, 1997, SCIENCE, V275, P986, DOI 10.1126/science.275.5302.986; LaBranche H, 1998, NAT GENET, V19, P199, DOI 10.1038/575; HEDINGER C, 1989, CANCER, V63, P908, DOI 10.1002/1097-0142(19890301)63:5<908::AID-CNCR2820630520>3.0.CO;2-I; RIDGWAY EC, 1992, J CLIN ENDOCR METAB, V74, P231, DOI 10.1210/jc.74.2.231; YAMASHITA S, 1986, J CLIN ENDOCR METAB, V63, P1170; LEVY MZ, 1992, J MOL BIOL, V225, P951, DOI 10.1016/0022-2836(92)90096-3; van Steensel B, 1998, CELL, V92, P401, DOI 10.1016/S0092-8674(00)80932-0; Karlseder J, 1999, SCIENCE, V283, P1321, DOI 10.1126/science.283.5406.1321; Winokur ST, 1994, CHROMOSOME RES, V2, P225, DOI 10.1007/BF01553323; Cooper JP, 1997, NATURE, V385, P744, DOI 10.1038/385744a0; Tsujimoto H, 1997, P NATL ACAD SCI USA, V94, P3140, DOI 10.1073/pnas.94.7.3140; Blasco MA, 1997, CELL, V91, P25, DOI 10.1016/S0092-8674(01)80006-4; VAZIRI H, 1993, AM J HUM GENET, V52, P661; HARLEY CB, 1994, COLD SPRING HARB SYM, V59, P307; Bartuski AJ, 1997, GENOMICS, V43, P321, DOI 10.1006/geno.1997.4827; BRABANT G, 1991, MOL CELL ENDOCRINOL, V82, pR7, DOI 10.1016/0303-7207(91)90018-N; Bryan TM, 1998, EXP CELL RES, V239, P370, DOI 10.1006/excr.1997.3907; Bryan TM, 1998, P NATL ACAD SCI USA, V95, P8479, DOI 10.1073/pnas.95.15.8479; Camargo AA, 1997, GENOMICS, V42, P467, DOI 10.1006/geno.1997.4758; CHEN H, 1995, ANN SURG, V222, P101, DOI 10.1097/00000658-199507000-00016; Cheng AJ, 1998, BRIT J CANCER, V77, P2177, DOI 10.1038/bjc.1998.363; COUNTER CM, 1994, P NATL ACAD SCI USA, V91, P2900, DOI 10.1073/pnas.91.8.2900; DEGROOT LJ, 1995, ENDOCRINOLOGY, P834; DEMICCO DD, 1984, CANCER, V53, P1995, DOI 10.1002/1097-0142(19840501)53:9<1995::AID-CNCR2820530932>3.0.CO;2-S; GHALI VS, 1992, HUM PATHOL, V23, P21, DOI 10.1016/0046-8177(92)90005-N; Haugen BR, 1997, THYROID, V7, P337, DOI 10.1089/thy.1997.7.337; Hiyama E, 1998, Nihon Rinsho, V56, P1139; Jones CJ, 1998, EXP CELL RES, V240, P333, DOI 10.1006/excr.1998.3944; KIM NW, 1994, SCIENCE, V266, P2011, DOI 10.1126/science.7605428; Ouellette MM, 1999, BIOCHEM BIOPH RES CO, V254, P795, DOI 10.1006/bbrc.1998.0114; PRICE CM, 1994, J EUKARYOT MICROBIOL, V41, P267, DOI 10.1111/j.1550-7408.1994.tb01507.x; ROMANO MI, 1993, HORM RES, V39, P161, DOI 10.1159/000182718; SHAMPAY J, 1989, NUCLEIC ACIDS RES, V17, P3247, DOI 10.1093/nar/17.8.3247; SHEIBANI K, 1986, AM J SURG PATHOL, V10, P227, DOI 10.1097/00000478-198604000-00001; Takubo K, 1997, J SURG ONCOL, V66, P88, DOI 10.1002/(SICI)1096-9098(199710)66:2<88::AID-JSO3>3.0.CO;2-H; Umbricht CB, 1997, CANCER RES, V57, P2144	42	41	46	ELSEVIER SCI IRELAND LTD	CLARE	CUSTOMER RELATIONS MANAGER, BAY 15, SHANNON INDUSTRIAL ESTATE CO, CLARE, IRELAND	0304-3835			CANCER LETT	Cancer Lett.	OCT 31	2000	159	2					175	181		10.1016/S0304-3835(00)00547-4		7	Oncology	Oncology	396XQ	WOS:000166663600009		
J	Toyo-Oka, T; Kawada, T; Nakazawa, M; Sakamoto, A; Urabe, M; Wang, Y; Shin, WS; Sato, H; Monahan, J; Ozawa, K				Toyo-Oka, T; Kawada, T; Nakazawa, M; Sakamoto, A; Urabe, M; Wang, Y; Shin, WS; Sato, H; Monahan, J; Ozawa, K			Dilated cardiomyopathy (DCM) is rescued by recombinant adeno-associated virus (rAAV)-mediated somatic gene therapy	CIRCULATION			English	Meeting Abstract									Univ Tokyo, Tokyo, Japan; Niigata Univ, Hosp Med, Div Pharma, Niigata, Japan; Niigata Univ, Niigata, Japan; NCVRC, Biotech Div, Osaka, Japan; Jichi Med Sch, Tochigi, Japan; Univ Tokyo, Tokyo, Japan; Avigen Inc, Alameda, CA USA								0	0	0	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	530 WALNUT ST, PHILADELPHIA, PA 19106-3621 USA	0009-7322			CIRCULATION	Circulation	OCT 31	2000	102	18		S		42	11	11				1	Cardiac & Cardiovascular Systems; Peripheral Vascular Disease	Cardiovascular System & Cardiology	367QE	WOS:000090072300043		
J	Sata, M; Takahashi, A; Ako, J; Maejima, Y; Nakajima, H; Adachi, F; Hirata, Y; Ouchi, Y; Walsh, K				Sata, M; Takahashi, A; Ako, J; Maejima, Y; Nakajima, H; Adachi, F; Hirata, Y; Ouchi, Y; Walsh, K			Tranilast inhibits neointimal hyperplasia via a p21WAF1-dependent pathway	CIRCULATION			English	Meeting Abstract									Univ Tokyo, Tokyo, Japan; St Elizabeths Med Ctr, Boston, MA USA								0	0	0	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	530 WALNUT ST, PHILADELPHIA, PA 19106-3621 USA	0009-7322			CIRCULATION	Circulation	OCT 31	2000	102	18		S		225	49	49				1	Cardiac & Cardiovascular Systems; Peripheral Vascular Disease	Cardiovascular System & Cardiology	367QE	WOS:000090072300225		
J	Sata, M; Maejima, Y; Nakajima, H; Adachi, F; Aoyagi, T; Sugiura, S; Fukino, K; Hirata, Y				Sata, M; Maejima, Y; Nakajima, H; Adachi, F; Aoyagi, T; Sugiura, S; Fukino, K; Hirata, Y			Acute and chronic smooth muscle cell apoptosis after angioplasty occurs independently of the Fas pathway	CIRCULATION			English	Meeting Abstract									Univ Tokyo, Tokyo, Japan; Univ Tokyo, Grad Sch Med, Tokyo, Japan								0	0	0	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	530 WALNUT ST, PHILADELPHIA, PA 19106-3621 USA	0009-7322			CIRCULATION	Circulation	OCT 31	2000	102	18		S		277	59	59				1	Cardiac & Cardiovascular Systems; Peripheral Vascular Disease	Cardiovascular System & Cardiology	367QE	WOS:000090072300277		
J	Asakawa, M; Takano, H; Nagai, T; Saito, T; Masuda, Y; Uozumi, H; Komuro, I				Asakawa, M; Takano, H; Nagai, T; Saito, T; Masuda, Y; Uozumi, H; Komuro, I			Stimulation of PPAR gamma inhibits cardiac hypertrophy in vitro and in vivo.	CIRCULATION			English	Meeting Abstract									Chiba Univ, Chiba, Japan; Univ Tokyo, Grad Sch Med, Tokyo, Japan								0	0	0	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	530 WALNUT ST, PHILADELPHIA, PA 19106-3621 USA	0009-7322			CIRCULATION	Circulation	OCT 31	2000	102	18		S		342	72	72				1	Cardiac & Cardiovascular Systems; Peripheral Vascular Disease	Cardiovascular System & Cardiology	367QE	WOS:000090072300341		
J	Takimoto, E; Wakimoto, K; Toko, H; Hosoda, T; Hiroi, Y				Takimoto, E; Wakimoto, K; Toko, H; Hosoda, T; Hiroi, Y			Na+/Ca+ exchanger knockout mice showed enhanced cardiac function and hypertrophic response to pressure overload	CIRCULATION			English	Meeting Abstract									Univ Tokyo, Grad Sch Med, Tokyo, Japan; Tanabe Seiyaku Co Ltd, Osaka, Japan								0	0	0	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	530 WALNUT ST, PHILADELPHIA, PA 19106-3621 USA	0009-7322			CIRCULATION	Circulation	OCT 31	2000	102	18		S		456	96	97				2	Cardiac & Cardiovascular Systems; Peripheral Vascular Disease	Cardiovascular System & Cardiology	367QE	WOS:000090072300455		
J	Monzen, K; Hiroi, Y; Oka, T; Hosoda, T; Shiojima, I; Hayashi, D; Komuro, I				Monzen, K; Hiroi, Y; Oka, T; Hosoda, T; Shiojima, I; Hayashi, D; Komuro, I			Smads, TAK1 and their common target ATF-2 play a critical role in cardiomyocyte differentiation	CIRCULATION			English	Meeting Abstract									Univ Tokyo, Grad Sch Med, Tokyo, Japan								0	0	0	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	530 WALNUT ST, PHILADELPHIA, PA 19106-3621 USA	0009-7322			CIRCULATION	Circulation	OCT 31	2000	102	18		S		517	108	109				2	Cardiac & Cardiovascular Systems; Peripheral Vascular Disease	Cardiovascular System & Cardiology	367QE	WOS:000090072300516		
J	Toko, HH; Takimoto, E; Shiojima, I; Oka, T; Hiroi, Y; Terasaki, F; Kitaura, Y; Komuro, I				Toko, HH; Takimoto, E; Shiojima, I; Oka, T; Hiroi, Y; Terasaki, F; Kitaura, Y; Komuro, I			Csx/Nks2-5 plays a critical role in protecting cardiac myocytes in the adult heart	CIRCULATION			English	Meeting Abstract									Univ Tokyo, Grad Sch Med, Tokyo, Japan; Osaka Med Coll, Takatsuki, Osaka 569, Japan								0	0	0	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	530 WALNUT ST, PHILADELPHIA, PA 19106-3621 USA	0009-7322			CIRCULATION	Circulation	OCT 31	2000	102	18		S		525	110	110				1	Cardiac & Cardiovascular Systems; Peripheral Vascular Disease	Cardiovascular System & Cardiology	367QE	WOS:000090072300524		
J	Sata, M; Maejima, Y; Nakajima, H; Adachi, F; Aoyagi, T; Kimura, K; Hirata, Y				Sata, M; Maejima, Y; Nakajima, H; Adachi, F; Aoyagi, T; Kimura, K; Hirata, Y			A mouse model of vascular ballooning injury that induces rapid onset of medial cell apoptosis followed by reproducible neointimal hyperplasia	CIRCULATION			English	Meeting Abstract									Univ Tokyo, Tokyo, Japan								0	0	0	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	530 WALNUT ST, PHILADELPHIA, PA 19106-3621 USA	0009-7322			CIRCULATION	Circulation	OCT 31	2000	102	18		S		610	127	127				1	Cardiac & Cardiovascular Systems; Peripheral Vascular Disease	Cardiovascular System & Cardiology	367QE	WOS:000090072300609		
J	Kawashiri, MA; Tsukamoto, K; Secreto, A; Usher, DC; Pure, E; Rader, DJ				Kawashiri, MA; Tsukamoto, K; Secreto, A; Usher, DC; Pure, E; Rader, DJ			Apoe2 and apoE4 are less effective than ApoE3 in inhibiting atherosclerosis in LDL receptor deficient mice	CIRCULATION			English	Meeting Abstract									Univ Penn, Philadelphia, PA 19104 USA; Univ Tokyo, Tokyo, Japan; Univ Delaware, Newark, DE USA; Wistar Inst, Philadelphia, PA 19104 USA								0	0	0	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	530 WALNUT ST, PHILADELPHIA, PA 19106-3621 USA	0009-7322			CIRCULATION	Circulation	OCT 31	2000	102	18		S		705	145	145				1	Cardiac & Cardiovascular Systems; Peripheral Vascular Disease	Cardiovascular System & Cardiology	367QE	WOS:000090072300703		
J	Shindo, T; Kurihara, H; Maemura, K; Kurihara, Y; Wang, Y; Ebihara, A; Nishimatsu, H; Moriyama, N; Kimura, K				Shindo, T; Kurihara, H; Maemura, K; Kurihara, Y; Wang, Y; Ebihara, A; Nishimatsu, H; Moriyama, N; Kimura, K			Renal damage and salt-dependent hypertension in transgenic mice overexpressing endothelin-1	CIRCULATION			English	Meeting Abstract									Univ Tokyo, Tokyo, Japan								0	0	0	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	530 WALNUT ST, PHILADELPHIA, PA 19106-3621 USA	0009-7322			CIRCULATION	Circulation	OCT 31	2000	102	18		S		759	158	158				1	Cardiac & Cardiovascular Systems; Peripheral Vascular Disease	Cardiovascular System & Cardiology	367QE	WOS:000090072300757		
J	Shindo, TY; Kurihara, H; Kuno, K; Yokoyama, HS; Wang, YH; Moriyama, NB; Nishimatsu, HA; Matsushima, K				Shindo, TY; Kurihara, H; Kuno, K; Yokoyama, HS; Wang, YH; Moriyama, NB; Nishimatsu, HA; Matsushima, K			Adamts-1 gene targeting reveals its new roles in growth, fertility, and kidney morphology and function.	CIRCULATION			English	Meeting Abstract									Univ Tokyo, Tokyo, Japan; Kanazawa Univ, Kanazawa, Ishikawa 920, Japan								0	0	0	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	530 WALNUT ST, PHILADELPHIA, PA 19106-3621 USA	0009-7322			CIRCULATION	Circulation	OCT 31	2000	102	18		S		834	173	173				1	Cardiac & Cardiovascular Systems; Peripheral Vascular Disease	Cardiovascular System & Cardiology	367QE	WOS:000090072300832		
J	Imai, Y; Shindo, T; Maekawa, H; Morita, H; Oh-Hashi, Y; Kurihara, Y; Kurihara, H				Imai, Y; Shindo, T; Maekawa, H; Morita, H; Oh-Hashi, Y; Kurihara, Y; Kurihara, H			Effects of adrenomedullin overexpression on vascular neointimal formation in mice	CIRCULATION			English	Meeting Abstract									Univ Tokyo, Grad Sch Med, Tokyo, Japan; Univ Tokyo, Tokyo, Japan								0	2	2	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	530 WALNUT ST, PHILADELPHIA, PA 19106-3621 USA	0009-7322			CIRCULATION	Circulation	OCT 31	2000	102	18		S		884	183	183				1	Cardiac & Cardiovascular Systems; Peripheral Vascular Disease	Cardiovascular System & Cardiology	367QE	WOS:000090072300881		
J	Saito, S; Hiroi, Y; Zou, YZ; Kodoh, S; Mizukami, M; Yazaki, Y; Komuro, I				Saito, S; Hiroi, Y; Zou, YZ; Kodoh, S; Mizukami, M; Yazaki, Y; Komuro, I			beta-adrenergic stimulation induces cardiomyocyte apoptosis in vitro and in vivo through activation of calcineurin	CIRCULATION			English	Meeting Abstract									Univ Tokyo, Grad Sch Med, Tokyo, Japan								0	0	0	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	530 WALNUT ST, PHILADELPHIA, PA 19106-3621 USA	0009-7322			CIRCULATION	Circulation	OCT 31	2000	102	18		S		883	183	183				1	Cardiac & Cardiovascular Systems; Peripheral Vascular Disease	Cardiovascular System & Cardiology	367QE	WOS:000090072300880		
J	Yamashita, T; Murakawa, Y; Hayami, N; Fukui, EI; Ajiki, K; Kasaoka, Y				Yamashita, T; Murakawa, Y; Hayami, N; Fukui, EI; Ajiki, K; Kasaoka, Y			Suppressive effect of cibenzoline on the increased Kv1.5 gene expression by high-rate atrial pacing in rats: Prevention of short-term electrical remodeling by atrial fibrillation	CIRCULATION			English	Meeting Abstract									CV Inst, Tokyo, Japan; Univ Tokyo, Tokyo, Japan								0	0	0	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	530 WALNUT ST, PHILADELPHIA, PA 19106-3621 USA	0009-7322			CIRCULATION	Circulation	OCT 31	2000	102	18		S		942	194	194				1	Cardiac & Cardiovascular Systems; Peripheral Vascular Disease	Cardiovascular System & Cardiology	367QE	WOS:000090072300939		
J	Wakimoto, K; Kobayashi, K; Kuro-O, M; Yao, A; Oka, T; Kudoh, S; Nagai, R; Nabeshima, YI; Komuro, I				Wakimoto, K; Kobayashi, K; Kuro-O, M; Yao, A; Oka, T; Kudoh, S; Nagai, R; Nabeshima, YI; Komuro, I			Targeted disruption of Na+/Ca2+ exchanger gene leads to cardiomyocyte apoptosis and defects in heart beat	CIRCULATION			English	Meeting Abstract									Tanabe Seiyaku Co Ltd, Osaka, Japan; Univ Texas, Dallas, TX 75230 USA; Univ Tokyo, Grad Sch Med, Tokyo, Japan; Univ Tokyo, Tokyo, Japan; Kyoto Univ, Kyoto, Japan								0	0	0	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	530 WALNUT ST, PHILADELPHIA, PA 19106-3621 USA	0009-7322			CIRCULATION	Circulation	OCT 31	2000	102	18		S		969	199	199				1	Cardiac & Cardiovascular Systems; Peripheral Vascular Disease	Cardiovascular System & Cardiology	367QE	WOS:000090072300966		
J	Nagao, T; Yamaguchi, S; Okamura, Y; Adachi-Akahane, S				Nagao, T; Yamaguchi, S; Okamura, Y; Adachi-Akahane, S			Novel determinant of action of dihydropyridine agonists in voltage-dependent L-type Ca2+ channel alpha(1c) subunit	CIRCULATION			English	Meeting Abstract									Univ Tokyo, Tokyo, Japan; Univ Tokyo, Lab Pharmacol Toxicol, Tokyo, Japan; NIBHT, Tsukuba, Ibaraki, Japan								0	0	0	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	530 WALNUT ST, PHILADELPHIA, PA 19106-3621 USA	0009-7322			CIRCULATION	Circulation	OCT 31	2000	102	18		S		972	200	200				1	Cardiac & Cardiovascular Systems; Peripheral Vascular Disease	Cardiovascular System & Cardiology	367QE	WOS:000090072300969		
J	Sanada, S; Papst, PJ; Hatanaka, K; Shinozaki, Y; Node, K; Kim, J; Mori, H; Terada, N; Yoshida, KI; Hori, M				Sanada, S; Papst, PJ; Hatanaka, K; Shinozaki, Y; Node, K; Kim, J; Mori, H; Terada, N; Yoshida, KI; Hori, M			A role of activation of p38 mitogen-activated protein kinase followed by HSP27 translocation in the infarct size-limiting effect of ischemic preconditioning in vivo canine heart	CIRCULATION			English	Meeting Abstract									Osaka Univ, Grad Sch Med, Suita, Osaka, Japan; Natl Jewish Med Res Ctr, Denver, CO USA; Univ Tokyo, Grad Sch Med, Tokyo, Japan; Tokai Univ, Sch Med, Isehara, Kanagawa 25911, Japan; Univ Florida, Sch Med, Gainesville, FL USA								0	0	0	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	530 WALNUT ST, PHILADELPHIA, PA 19106-3621 USA	0009-7322			CIRCULATION	Circulation	OCT 31	2000	102	18		S		1025	212	212				1	Cardiac & Cardiovascular Systems; Peripheral Vascular Disease	Cardiovascular System & Cardiology	367QE	WOS:000090072301022		
J	Yamashita, H; Sugiura, S; Fujita, H; Yasuda, S; Saeki, Y; Chaen, S; Sugi, H				Yamashita, H; Sugiura, S; Fujita, H; Yasuda, S; Saeki, Y; Chaen, S; Sugi, H			Motor function of cardiac myosin depends on the light chain isoform composition	CIRCULATION			English	Meeting Abstract									Univ Tokyo, Tokyo, Japan; Univ Tokyo, Grad Sch Med, Tokyo, Japan; Tsurumi Univ, Yokohama, Kanagawa, Japan; Teikyo Univ, Tokyo 173, Japan								0	0	0	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	530 WALNUT ST, PHILADELPHIA, PA 19106-3621 USA	0009-7322			CIRCULATION	Circulation	OCT 31	2000	102	18		S		1045	216	216				1	Cardiac & Cardiovascular Systems; Peripheral Vascular Disease	Cardiovascular System & Cardiology	367QE	WOS:000090072301042		
J	Shindo, T; Kurihara, H; Kurihara, Y; Watatani, S; Nishimatsu, H; Moriyama, N; Kangawa, K; Minamino, N; Hirata, Y; Nagai, R				Shindo, T; Kurihara, H; Kurihara, Y; Watatani, S; Nishimatsu, H; Moriyama, N; Kangawa, K; Minamino, N; Hirata, Y; Nagai, R			Adrenomedullin gene targeting reveals its role in the circulatory homeostasis and vascular morphogenesis during development.	CIRCULATION			English	Meeting Abstract									Univ Tokyo, Tokyo, Japan; Natl Cardiovasc Ctr, Suita, Osaka 565, Japan; Natl Cardiovasc Ctr, Res Inst, Suita, Osaka 565, Japan								0	0	0	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	530 WALNUT ST, PHILADELPHIA, PA 19106-3621 USA	0009-7322			CIRCULATION	Circulation	OCT 31	2000	102	18		S		1059	218	218				1	Cardiac & Cardiovascular Systems; Peripheral Vascular Disease	Cardiovascular System & Cardiology	367QE	WOS:000090072301056		
J	Hiroi, Y; Kudoh, S; Oka, T; Monzen, K; Ikeda, Y; Hosoda, T; Niu, P; Nagai, R; Komuro, I				Hiroi, Y; Kudoh, S; Oka, T; Monzen, K; Ikeda, Y; Hosoda, T; Niu, P; Nagai, R; Komuro, I			Tbx5 associates with CSX/NKX2.5 and synergistically activates atrial natriuretic peptide (ANP) promoter.	CIRCULATION			English	Meeting Abstract									Univ Tokyo, Grad Sch Med, Tokyo, Japan; Univ Tokyo, Tokyo, Japan								0	0	0	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	530 WALNUT ST, PHILADELPHIA, PA 19106-3621 USA	0009-7322			CIRCULATION	Circulation	OCT 31	2000	102	18		S		1065	220	220				1	Cardiac & Cardiovascular Systems; Peripheral Vascular Disease	Cardiovascular System & Cardiology	367QE	WOS:000090072301062		
J	Saito, Y; Nakamura, T; Ohyama, Y; Sumino, H; Kurabayashi, M; Kuro-O, M; Nabeshima, YI; Nagai, R				Saito, Y; Nakamura, T; Ohyama, Y; Sumino, H; Kurabayashi, M; Kuro-O, M; Nabeshima, YI; Nagai, R			In vivo klotho gene delivery protects against endothelial dysfunction in multiple atherogenic risk factor syndrome	CIRCULATION			English	Meeting Abstract									Gunma Univ, Sch Med, Maebashi, Gumma 371, Japan; Univ Texas, Dallas, TX 75230 USA; Kyoto Univ, Kyoto, Japan; Univ Tokyo, Tokyo, Japan								0	1	1	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	530 WALNUT ST, PHILADELPHIA, PA 19106-3621 USA	0009-7322			CIRCULATION	Circulation	OCT 31	2000	102	18		S		1085	223	224				2	Cardiac & Cardiovascular Systems; Peripheral Vascular Disease	Cardiovascular System & Cardiology	367QE	WOS:000090072301081		
J	Oka, T; Kudoh, S; Hiroi, Y; Shiojima, I; Akazawa, H; Monzen, K; Komuro, I				Oka, T; Kudoh, S; Hiroi, Y; Shiojima, I; Akazawa, H; Monzen, K; Komuro, I			Krab-zinc finger protein, Zim1, associates with CSX and regulates cardiac-specific gene expressions	CIRCULATION			English	Meeting Abstract									Univ Tokyo, Grad Sch Med, Tokyo, Japan								0	0	0	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	530 WALNUT ST, PHILADELPHIA, PA 19106-3621 USA	0009-7322			CIRCULATION	Circulation	OCT 31	2000	102	18		S		1146	235	235				1	Cardiac & Cardiovascular Systems; Peripheral Vascular Disease	Cardiovascular System & Cardiology	367QE	WOS:000090072301142		
J	Aikawa, R; Zhu, W; Mizukami, M; Toko, H; Ichijo, H				Aikawa, R; Zhu, W; Mizukami, M; Toko, H; Ichijo, H			Oxidative stress induces cardiomyocyte apoptosis through the ASK1-p38MAPK pathway	CIRCULATION			English	Meeting Abstract									Univ Tokyo, Grad Sch Med, Tokyo, Japan; Tokyo Med & Dent Univ, Tokyo, Japan								0	0	0	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	530 WALNUT ST, PHILADELPHIA, PA 19106-3621 USA	0009-7322			CIRCULATION	Circulation	OCT 31	2000	102	18		S		1176	241	241				1	Cardiac & Cardiovascular Systems; Peripheral Vascular Disease	Cardiovascular System & Cardiology	367QE	WOS:000090072301172		
J	Sata, M; Maejima, Y; Nakajima, H; Adachi, F; Kimura, K; Sugiura, S; Fukino, K				Sata, M; Maejima, Y; Nakajima, H; Adachi, F; Kimura, K; Sugiura, S; Fukino, K			Genetic background influences ischemia-induced angiogenesis	CIRCULATION			English	Meeting Abstract									Univ Tokyo, Tokyo, Japan; Univ Tokyo, Grad Sch Med, Tokyo, Japan								0	0	0	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	530 WALNUT ST, PHILADELPHIA, PA 19106-3621 USA	0009-7322			CIRCULATION	Circulation	OCT 31	2000	102	18		S		1209	248	248				1	Cardiac & Cardiovascular Systems; Peripheral Vascular Disease	Cardiovascular System & Cardiology	367QE	WOS:000090072301205		
J	Kinugawa, K; Brown, DR; Lucas, H; Takahashi, T; Bristow, MR; Long, CS				Kinugawa, K; Brown, DR; Lucas, H; Takahashi, T; Bristow, MR; Long, CS			Signaling pathways related to p38 beta MAP kinase are responsible for IL-1 beta-induced hypertrophy in rat cardiac myocytes	CIRCULATION			English	Meeting Abstract									Univ Colorado, Hlth Sci Ctr, Denver, CO USA; Denver Hlth Med Ctr, Denver, CO USA; Univ Tokyo, Tokyo, Japan			bristow, michael/G-7850-2011					0	0	0	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	530 WALNUT ST, PHILADELPHIA, PA 19106-3621 USA	0009-7322			CIRCULATION	Circulation	OCT 31	2000	102	18		S		1417	289	289				1	Cardiac & Cardiovascular Systems; Peripheral Vascular Disease	Cardiovascular System & Cardiology	367QE	WOS:000090072301411		
J	Kowase, KK; Aihara, Y; Nagai, R				Kowase, KK; Aihara, Y; Nagai, R			BTEB2, a Kruppel-like transcription factor, regulates expression of the platelet-derived growth factor (PDGF)-alpha chain gene	CIRCULATION			English	Meeting Abstract									Gunma Univ, Sch Med, Maebashi, Gumma 371, Japan; Univ Tokyo, Tokyo, Japan								0	0	0	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	530 WALNUT ST, PHILADELPHIA, PA 19106-3621 USA	0009-7322			CIRCULATION	Circulation	OCT 31	2000	102	18		S		1494	305	305				1	Cardiac & Cardiovascular Systems; Peripheral Vascular Disease	Cardiovascular System & Cardiology	367QE	WOS:000090072301489		
J	Suzuki, M; Ishizaka, N; Takeshita, S; Minami, K; Tsukamoto, K; Ohno, M				Suzuki, M; Ishizaka, N; Takeshita, S; Minami, K; Tsukamoto, K; Ohno, M			Adenovirus-mediated heme oxygenase-1 gene transfer increases blood flow in the non-ischemic hindlimb of rat	CIRCULATION			English	Meeting Abstract									Univ Tokyo, Tokyo, Japan; Teikyo Univ, Sch Med, Tokyo 173, Japan								0	0	0	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	530 WALNUT ST, PHILADELPHIA, PA 19106-3621 USA	0009-7322			CIRCULATION	Circulation	OCT 31	2000	102	18		S		1632	333	333				1	Cardiac & Cardiovascular Systems; Peripheral Vascular Disease	Cardiovascular System & Cardiology	367QE	WOS:000090072301627		
J	Liang, YQ; Kim, S; Akishita, M; Yoshizumi, M; Hashimoto, M; Ako, J; Lijima, K; Ohike, Y; Watanabe, T; Sudoh, N; Toba, K; Ouchi, Y				Liang, YQ; Kim, S; Akishita, M; Yoshizumi, M; Hashimoto, M; Ako, J; Lijima, K; Ohike, Y; Watanabe, T; Sudoh, N; Toba, K; Ouchi, Y			Estrogen attenuates ovariectomy-induced body weight gain through estrogen receptor beta - in the central nervous system	CIRCULATION			English	Meeting Abstract									Univ Tokyo, Tokyo, Japan								0	0	0	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	530 WALNUT ST, PHILADELPHIA, PA 19106-3621 USA	0009-7322			CIRCULATION	Circulation	OCT 31	2000	102	18		S		1712	349	349				1	Cardiac & Cardiovascular Systems; Peripheral Vascular Disease	Cardiovascular System & Cardiology	367QE	WOS:000090072301707		
J	Nishida, M; Nagao, T; Kurose, H				Nishida, M; Nagao, T; Kurose, H			G(i)alpha and G(o)alpha are target proteins of reactive oxygen intermediates leading to activation of extracellular signal-regulated kinase	CIRCULATION			English	Meeting Abstract									Univ Tokyo, Tokyo, Japan								0	0	0	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	530 WALNUT ST, PHILADELPHIA, PA 19106-3621 USA	0009-7322			CIRCULATION	Circulation	OCT 31	2000	102	18		S		1727	352	352				1	Cardiac & Cardiovascular Systems; Peripheral Vascular Disease	Cardiovascular System & Cardiology	367QE	WOS:000090072301722		
J	Zhu, W; Shiojima, I; Oka, T; Monzen, K; Hiroi, Y; Hosoda, T; Zou, Y; Komuro, I				Zhu, W; Shiojima, I; Oka, T; Monzen, K; Hiroi, Y; Hosoda, T; Zou, Y; Komuro, I			Functional analyses of CSX/NKX2.5 mutations that cause human congenital heart disease	CIRCULATION			English	Meeting Abstract									Univ Tokyo, Grad Sch Med, Tokyo, Japan								0	0	0	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	530 WALNUT ST, PHILADELPHIA, PA 19106-3621 USA	0009-7322			CIRCULATION	Circulation	OCT 31	2000	102	18		S		1762	359	359				1	Cardiac & Cardiovascular Systems; Peripheral Vascular Disease	Cardiovascular System & Cardiology	367QE	WOS:000090072301757		
J	Uno, K; Takenaka, K; Kikuchi, A; Matsuzaki, M; Kuwada, Y; Sakurai, S; Asakawa, M; Nakahara, K; Sonoda, M				Uno, K; Takenaka, K; Kikuchi, A; Matsuzaki, M; Kuwada, Y; Sakurai, S; Asakawa, M; Nakahara, K; Sonoda, M			Quantitative analysis of microcirculation of finger in human by intravenous contrast echo	CIRCULATION			English	Meeting Abstract									Tokyo Univ Hosp, Tokyo 113, Japan; Aloka Co, Tokyo, Japan								0	0	0	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	530 WALNUT ST, PHILADELPHIA, PA 19106-3621 USA	0009-7322			CIRCULATION	Circulation	OCT 31	2000	102	18		S		2209	454	454				1	Cardiac & Cardiovascular Systems; Peripheral Vascular Disease	Cardiovascular System & Cardiology	367QE	WOS:000090072302204		
J	Sonoda, M; Takenaka, K; Sakurai, S				Sonoda, M; Takenaka, K; Sakurai, S			The center of global LV contraction becomes closer to the cardiac base in failing heart	CIRCULATION			English	Meeting Abstract									Tokyo Univ Hosp, Tokyo 113, Japan								0	0	0	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	530 WALNUT ST, PHILADELPHIA, PA 19106-3621 USA	0009-7322			CIRCULATION	Circulation	OCT 31	2000	102	18		S		2621	539	539				1	Cardiac & Cardiovascular Systems; Peripheral Vascular Disease	Cardiovascular System & Cardiology	367QE	WOS:000090072302615		
J	Kuwada, Y; Takenaka, K; Sonoda, M; Uno, K; Asakawa, M; Sakurai, S; Takahashi, T; Sasaki, K; Matsuzaki, M; Kikuchi, A; Amagai, R; Furudate, N				Kuwada, Y; Takenaka, K; Sonoda, M; Uno, K; Asakawa, M; Sakurai, S; Takahashi, T; Sasaki, K; Matsuzaki, M; Kikuchi, A; Amagai, R; Furudate, N			Myocardial strain rate imaging could detect subendocardial ischemia even at rest	CIRCULATION			English	Meeting Abstract									Tokyo Univ Hosp, Tokyo 113, Japan								0	0	0	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	530 WALNUT ST, PHILADELPHIA, PA 19106-3621 USA	0009-7322			CIRCULATION	Circulation	OCT 31	2000	102	18		S		2891	596	596				1	Cardiac & Cardiovascular Systems; Peripheral Vascular Disease	Cardiovascular System & Cardiology	367QE	WOS:000090072302883		
J	Kuwada, Y; Takenaka, K; Uno, K; Asakawa, M; Sakurai, S; Takahashi, T; Sasaki, K; Matsuzaki, M; Kikuchi, A; Amagai, R; Furudate, N; Watanabe, F				Kuwada, Y; Takenaka, K; Uno, K; Asakawa, M; Sakurai, S; Takahashi, T; Sasaki, K; Matsuzaki, M; Kikuchi, A; Amagai, R; Furudate, N; Watanabe, F			Anthracycline cardiotoxicity begins in the subendocardium: Study by myocardial strain rate imaging	CIRCULATION			English	Meeting Abstract									Tokyo Univ Hosp, Tokyo 113, Japan								0	0	0	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	530 WALNUT ST, PHILADELPHIA, PA 19106-3621 USA	0009-7322			CIRCULATION	Circulation	OCT 31	2000	102	18		S		2892	596	596				1	Cardiac & Cardiovascular Systems; Peripheral Vascular Disease	Cardiovascular System & Cardiology	367QE	WOS:000090072302884		
J	Terasawa, K; Fujimori, Y; Morio, H; Shiga, T; Matsuo, A; Osegawa, M; Morita, T; Uchida, Y				Terasawa, K; Fujimori, Y; Morio, H; Shiga, T; Matsuo, A; Osegawa, M; Morita, T; Uchida, Y			Evaluation of endothelial cell damages covering culprit coronary plaques by dye staining angioscopy in patients with acute coronary syndromes.	CIRCULATION			English	Meeting Abstract									Narita Red Cross Hosp, Narita, Japan; Univ Tokyo, Tokyo, Japan; Toho Univ, Sakura, Japan								0	1	1	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	530 WALNUT ST, PHILADELPHIA, PA 19106-3621 USA	0009-7322			CIRCULATION	Circulation	OCT 31	2000	102	18		S		3431	709	709				1	Cardiac & Cardiovascular Systems; Peripheral Vascular Disease	Cardiovascular System & Cardiology	367QE	WOS:000090072303423		
J	Kaneda, H; Taguchi, J; Hashimoto, H; Aizawa, T; Ohno, M				Kaneda, H; Taguchi, J; Hashimoto, H; Aizawa, T; Ohno, M			Microsatellite polymorphism in the heme oxygenase-1 gene promoter is associated with coronary artery disease susceptibility in Japanese diabetic patients	CIRCULATION			English	Meeting Abstract									Univ Tokyo, Tokyo, Japan; Teikyo Univ, Tokyo 173, Japan; CV Inst, Tokyo, Japan								0	1	1	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	530 WALNUT ST, PHILADELPHIA, PA 19106-3621 USA	0009-7322			CIRCULATION	Circulation	OCT 31	2000	102	18		S		3655	757	757				1	Cardiac & Cardiovascular Systems; Peripheral Vascular Disease	Cardiovascular System & Cardiology	367QE	WOS:000090072303647		
J	Shin, WS; Suzuki, JI; Tanaka, M; Hemmi, C; Toyo-Oka, T				Shin, WS; Suzuki, JI; Tanaka, M; Hemmi, C; Toyo-Oka, T			A novel homoplasmic mitochondrial gene mutation originated from single ancestor, genetic risk factor for cardiomyopathies	CIRCULATION			English	Meeting Abstract									Univ Tokyo, Tokyo, Japan; Gifu Intl Inst Biotech, Gifu, Japan								0	0	0	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	530 WALNUT ST, PHILADELPHIA, PA 19106-3621 USA	0009-7322			CIRCULATION	Circulation	OCT 31	2000	102	18		S		3679	762	762				1	Cardiac & Cardiovascular Systems; Peripheral Vascular Disease	Cardiovascular System & Cardiology	367QE	WOS:000090072303671		
J	Noma, K; Ohtsubo, H; Ohtsubo, E				Noma, K; Ohtsubo, H; Ohtsubo, E			ATLN elements, LINEs from Arabidopsis thaliana: identification and characterization	DNA RESEARCH			English	Article						Arabidopsis thaliana; non-LTR retrotransposon (LINE); target site duplication; translational control	NON-LTR RETROTRANSPOSONS; HUMAN L1 RETROTRANSPOSON; DROSOPHILA-MELANOGASTER; REVERSE TRANSCRIPTION; SEQUENCE-ANALYSIS; PROTEIN; RNA; CONTAINS; REGION; GENOME	Non-LTR retrotransposons (LINEs) are ubiquitous elements in the plant kingdom. Two hundred and nineteen LINE homologues (named ATLN) were identified in the A. thaliana genome, about 90% of which have been sequenced by a computer-aided homology search. Of these, the structures of 62 were analyzed in detail. Most, including those truncated for the 5' regions, were flanked by direct repeats of a sequence of 7-21 bp long, the target site sequence duplicated upon retrotransposition of each member. Thirty ATLN members had two consecutive open reading frames, corresponding to orf1 and orf2 essential for retrotransposition. The phylogenetic tree constructed from the amino acid sequences of the endonuclease domains of the Orf2 proteins showed that the ATLN members were grouped in two families (I and II) and that the members of each family could be further divided into several subfamilies. The members of each subfamily had several unique structural features in common in the intergenic region between orf1 and orf2 as well as in the downstream regions of orf2. Interestingly, orf2 in almost all the ATLN members is located in the -1 frame relative to orf1, indicative of the existence of such translational control mechanisms as translational coupling or frameshifting to produce an amount of Orf2 protein appropriate to that of Orf1. Moreover, the most proximal sequences in the 5' untranslated regions were non-homologous, even in members with the highest homology, unlike the LINEs in animals. The non-homologous sequences in the 5' untranslated regions might be acquired at or after transcription during retrotransposition of the ATLN elements.	Univ Tokyo, Inst Mol & Cellular Biosci, Bunkyo Ku, Tokyo 1130032, Japan	Ohtsubo, E (reprint author), Univ Tokyo, Inst Mol & Cellular Biosci, Bunkyo Ku, Tokyo 1130032, Japan.						AITSCHUL SF, 1990, J MOL BIOL, V215, P403; Gorlich D, 1996, SCIENCE, V271, P1513, DOI 10.1126/science.271.5255.1513; Hohjoh H, 1996, EMBO J, V15, P630; LUAN DD, 1993, CELL, V72, P595, DOI 10.1016/0092-8674(93)90078-5; BENNE R, 1986, CELL, V46, P819, DOI 10.1016/0092-8674(86)90063-2; Gesteland RF, 1996, ANNU REV BIOCHEM, V65, P741; Hata K, 1997, GENE, V189, P227, DOI 10.1016/S0378-1119(96)00856-6; SMITH TF, 1981, J MOL BIOL, V147, P195, DOI 10.1016/0022-2836(81)90087-5; LEETON PRJ, 1993, MOL GEN GENET, V237, P97; DINGWALL C, 1991, TRENDS BIOCHEM SCI, V16, P478, DOI 10.1016/0968-0004(91)90184-W; BURKE WD, 1987, MOL CELL BIOL, V7, P2221; Feng QH, 1996, CELL, V87, P905, DOI 10.1016/S0092-8674(00)81997-2; MATHIAS SL, 1991, SCIENCE, V254, P1808, DOI 10.1126/science.1722352; COVEY SN, 1986, NUCLEIC ACIDS RES, V14, P623, DOI 10.1093/nar/14.2.623; XIONG Y, 1990, EMBO J, V9, P3353; Kubis SE, 1998, PLANT MOL BIOL, V36, P821, DOI 10.1023/A:1005973932556; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; Noma K, 1997, GENES GENET SYST, V72, P131, DOI 10.1266/ggs.72.131; Berg DE, 1989, MOBILE DNA; Draper DE, 1996, ESCHERICHIA COLI SAL, P902; FAWCETT DH, 1986, CELL, V47, P1007, DOI 10.1016/0092-8674(86)90815-9; Felsenstein J, 1995, PHYLIP PHYLOGENY INF; FUETTERER J, 1987, TRENDS BIOCHEM SCI, V12, P92, DOI 10.1016/0968-0004(87)90044-2; GABRIEL A, 1993, REVERSE TRANSCRIPTAS, P275; GATENBY AA, 1989, P NATL ACAD SCI USA, V86, P4066, DOI 10.1073/pnas.86.11.4066; Hohjoh H, 1997, EMBO J, V16, P6034, DOI 10.1093/emboj/16.19.6034; HOHJOH H, 1990, NUCLEIC ACIDS RES, V18, P4099, DOI 10.1093/nar/18.14.4099; Hohjoh H, 1997, J MOL BIOL, V271, P7, DOI 10.1006/jmbi.1997.1159; Hutchison III C.A, 1989, MOBILE DNA, P593; Kazazian HH, 1998, NAT GENET, V19, P19, DOI 10.1038/ng0598-19; MCLEAN C, 1993, MOL CELL BIOL, V13, P1042; MINAKAMI R, 1992, NUCLEIC ACIDS RES, V20, P3039; Noma K, 1999, MOL GEN GENET, V261, P71; Ohtsubo E, 1996, CURR TOP MICROBIOL, V204, P1; PEARSON WR, 1988, P NATL ACAD SCI USA, V85, P2444, DOI 10.1073/pnas.85.8.2444; Quigley F, 1996, NUCLEIC ACIDS RES, V24, P4313, DOI 10.1093/nar/24.21.4313; Sassaman DM, 1997, NAT GENET, V16, P37, DOI 10.1038/ng0597-37; SCHWARZSOMMER Z, 1987, EMBO J, V6, P3873; SCOTT J, 1995, CELL, V81, P833, DOI 10.1016/0092-8674(95)90002-0; Woodcock DM, 1997, J BIOL CHEM, V272, P7810; Wright DA, 1996, GENETICS, V142, P569	41	9	10	UNIVERSAL ACADEMY PRESS INC	TOKYO	ORDER DEPT., C P O BOX 235, TOKYO, 100-8691, JAPAN	1340-2838			DNA RES	DNA Res.	OCT 31	2000	7	5					291	303		10.1093/dnares/7.5.291		13	Genetics & Heredity	Genetics & Heredity	403EJ	WOS:000167029400002		
J	Abe, J; Kitade, Y; Kuwano, K; Watanabe, T; Saga, N				Abe, J; Kitade, Y; Kuwano, K; Watanabe, T; Saga, N			Isolation of a cDNA encoding a homologue of ribosomal protein L36 in a marine green alga, Enteromorpha compressa	DNA RESEARCH			English	Article							PENAEUS-JAPONICUS		Tokai Univ, Ctr Adv Technol, Shizuoka 4248610, Japan; Nagasaki Univ, Fac Fisheries, Nagasaki 8528521, Japan; Univ Tokyo, Ocean Res Inst, Nakano Ku, Tokyo 1648639, Japan	Saga, N (reprint author), Tokai Univ, Ctr Adv Technol, Shizuoka 4248610, Japan.						ANDRES AJ, 1993, DEV BIOL, V160, P388, DOI 10.1006/dbio.1993.1315; Serikawa KA, 1999, PLANT MOL BIOL, V41, P785, DOI 10.1023/A:1006387107071; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; Lemieux C, 2000, NATURE, V403, P649, DOI 10.1038/35001059; APT KE, 1995, MOL GEN GENET, V246, P455, DOI 10.1007/BF00290449; Bucher P., 1994, ISMB, P53; CHAN YL, 1993, BIOCHEM BIOPH RES CO, V192, P849, DOI 10.1006/bbrc.1993.1492; CHAUDHARY BR, 1979, BOT MAR, V22, P229, DOI 10.1515/botm.1979.22.4.229; Delbruck S, 1997, YEAST, V13, P1199, DOI 10.1002/(SICI)1097-0061(199710)13:13<1199::AID-YEA167>3.0.CO;2-J; Hiraoka M, 1999, NIPPON SUISAN GAKK, V65, P302; Hofmann K, 1999, NUCLEIC ACIDS RES, V27, P215, DOI 10.1093/nar/27.1.215; OTAKA E, 1984, MOL GEN GENET, V195, P544, DOI 10.1007/BF00341461; PEARSON NJ, 1980, J BACTERIOL, V143, P1411; SAITOU N, 1987, MOL BIOL EVOL, V4, P406; Watanabe T, 1998, MOL MAR BIOL BIOTECH, V7, P259; Watanabe T, 1996, MOL MAR BIOL BIOTECH, V5, P299	16	1	2	UNIVERSAL ACADEMY PRESS INC	TOKYO	ORDER DEPT., C P O BOX 235, TOKYO, 100-8691, JAPAN	1340-2838			DNA RES	DNA Res.	OCT 31	2000	7	5					309	313		10.1093/dnares/7.5.309		5	Genetics & Heredity	Genetics & Heredity	403EJ	WOS:000167029400004		
J	Ohishi, H; Kishimoto, S; Nishi, T				Ohishi, H; Kishimoto, S; Nishi, T			Optical properties of polystyrene and polyarylate block copolymer and their control by morphology generation	JOURNAL OF APPLIED POLYMER SCIENCE			English	Article						polystyrene; polyarylate; block copolymer; phase morphology; birefringence; transparency	BIREFRINGENCE; POLYCARBONATE; BLENDS; DISKS	Relationship between phase morphology and optical properties of polystyrene and polyarylate (PS-PAr) block copolymers synthesized from telechelic polystyrene has been investigated. In the PS-PAr block copolymers, the PAr domains with higher melt viscosity were dispersed in the PS phase matrix with lower melt viscosity over the wide range of their composition from PS/PAr = 25/75 to 75/25 (wt ratio). The PAr domain size was dependent on the reactive ratio of PAr determined analogously by the mole fraction of the fed telechelic polystyrene. By controlling the mole fraction of the telechelic polystyrene more than 0.016 in synthesizing the PS-PAr block copolymer, the size of PAr domains could be reduced to the microscopic scale (smaller than 100 nm). Then, the PS-PAr block. copolymers exhibited almost the same transparency as PAr in spite of the large difference in the refractive index between the PS and the PAr phase. Birefringence free condition for the PS-PAr block copolymers was determined by not only the PS/PAr composition but also the balance in the degree of molecular orientation of these chains. The latter factor suggests that PS and PAr chains undergo inhomogeneous stress and relaxation history during the injection process. By controlling Mn (number average molecular weight) and weight fraction of the fed OH-PS-OH around 20 000 and 55 wt %, respectively, in the synthesis of the PS-PAr block copolymer, the PS-PAr block copolymer exhibited almost zero birefringence without any sacrifice of transparency. Because in the PS-PAr block copolymer low birefringence and high transparency can coexist by controlling the adequate feeding condition in the synthesis process, the PS-PAr block copolymer would be a promising material for optical applications, such as a substrate of optical disks or optical lenses. (C) 2000 John Wiley & Sons, Inc.	Nippon Steel Corp Ltd, Adv Technol Res Labs, Kawasaki, Kanagawa 211, Japan; Unitika Corp, Plast Dept, Ctr Res & Dev, Uji, Kozakura 611, Japan; Univ Tokyo, Dept Appl Phys, Sch Engn, Bunkyo Ku, Tokyo 113, Japan	Ohishi, H (reprint author), Nippon Steel Corp Ltd, Adv Technol Res Labs, 3-35-1 Ida Nakahara Ku, Kawasaki, Kanagawa 211, Japan.		Nishi, Toshio/A-8112-2010	Nishi, Toshio/0000-0001-7997-0875			Ohishi H, 2000, J POLYM SCI POL CHEM, V38, P299, DOI 10.1002/(SICI)1099-0518(20000115)38:2<299::AID-POLA4>3.0.CO;2-X; EGUIAZABAL JI, 1984, POLYM ENG SCI, V24, P608, DOI 10.1002/pen.760240813; Emmelius M., 1989, ANGEW CHEM, V101, P1475, DOI 10.1002/ange.19891011104; GOSSINK RG, 1989, INTEGR FUNDAM POLYM, V3, P355; HAHN BR, 1985, POLYMER, V26, P1619, DOI 10.1016/0032-3861(85)90273-3; HAYAKAWA S, 1976, RIKOUGAKU KISOKOUZA, P24; INOUE T, 1987, KINOU ZAIRYO, V3, P21; LANDRY CJT, 1991, POLYMER, V32, P44, DOI 10.1016/0032-3861(91)90560-6; MARCHANT AB, 1983, P SOC PHOTO-OPT INST, V421, P43; NIWA M, 1986, J MACROMOL SCI CHEM, VA23, P433; OHISHI H, 1993, NIPPON STEEL TECHNIC, V53, P39; Ohishi H, 1998, J POLYM SCI POL CHEM, V36, P2839, DOI 10.1002/(SICI)1099-0518(19981130)36:16<2839::AID-POLA2>3.0.CO;2-I; PISIPATI RM, 1995, PLASTIC ENG, P33; ROHRBACH P, 1993, MAKROMOL CHEM, V194, P1627; SAITO H, 1987, J POLYM SCI POL PHYS, V25, P1629, DOI 10.1002/polb.1987.090250806; SAITO H, 1988, J POLYM SCI POL PHYS, V26, P1761, DOI 10.1002/polb.1988.090260815; SIEBOURG W, 1990, POLYM ENG SCI, V30, P1133, DOI 10.1002/pen.760301804; TANAKA H, 1988, POLYM COMMUN, V29, P211; TANAKA T, 1991, J NONCRYST SOLIDS, V36, P781; TOYOTA T, 1985, PLASTICS, V36, P116; *UN CORP, CAT U POL; Ward I.M., 1975, STRUCTURE PROPERTIES; WIMBERGERFRIEDL R, 1990, POLYM ENG SCI, V30, P813, DOI 10.1002/pen.760301403	23	5	5	JOHN WILEY & SONS INC	NEW YORK	605 THIRD AVE, NEW YORK, NY 10158-0012 USA	0021-8995			J APPL POLYM SCI	J. Appl. Polym. Sci.	OCT 31	2000	78	5					953	961		10.1002/1097-4628(20001031)78:5<953::AID-APP30>3.0.CO;2-8		9	Polymer Science	Polymer Science	349QG	WOS:000089056700003		
J	Hayashi, M; Hashimoto, T; Hasegawa, H; Takenaka, M; Grull, H; Esker, AR; Weber, M; Satija, SK; Han, CC; Nagao, M				Hayashi, M; Hashimoto, T; Hasegawa, H; Takenaka, M; Grull, H; Esker, AR; Weber, M; Satija, SK; Han, CC; Nagao, M			Interface between a polysulfone and polyamide as studied by combined neutron reflectivity and small-angle neutron scattering techniques	MACROMOLECULES			English	Article							POLYMER-POLYMER INTERFACES; STAGE SPINODAL DECOMPOSITION; SPONGE-LIKE STRUCTURES; DIBLOCK COPOLYMERS; REACTION-KINETICS; LIGHT-SCATTERING; BLENDS; COMPATIBILIZATION; MIXTURES; LIQUIDS	Interfaces between the two phases formed in immiscible polymer pairs were studied by means of neutron reflectivity (NR) combined with small-angle neutron scattering (SANS). The interfacial widths evaluated by the two methods were compared for two systems: a nonreactive system composed of polyamide (PA) and polysulfone (PSU) and a reactive system composed of PA and PSU with a phthalic anhydride reactive end group (PSU-R) in which PSU-b-PA block copolymers can be formed at the interface. SANS measurements were made on bulk mixtures, and the NR measurements were performed on thin film bilayer stacks of PA and PSU or PSU-R. The intrinsic interfacial widths, WI,(diffuse), obtained from the two methods were compared for the samples that underwent similar annealing protocols and were quenched below the glass transition temperatures Tg's to room temperature. A consistent result for W-I,W-diffuse can be obtained for the two methods only after taking into account the following important factors: (i) the SANS intensity should be corrected for the frozen density heterogeneities within each phase as well as the frozen thermal composition fluctuations; (ii) the contribution of capillary wave fluctuations to a net (or observed) interfacial width, Wi,obs, is more significant for NR than SANS. Without the former correction, the SANS profiles at high scattering vector, q, showed asymptotic behavior of q(-n) (n < 4), giving an erroneous conclusion on WI,obs The WI,obs values obtained for the reactive system were found to be larger than those for the nonreactive system for both methods, reflecting block copolymer formation at the interfaces. The interfacial area density, <Sigma>, for the bulk mixture of the reactive system rapidly decreased with time and reached a constant value within ca. 2 min after annealing above the T-g's, while Sigma for the nonreactive system kept decreasing with time. This elucidates that the growth of the phase-separating domains in the reactive system was pinned by the formation of block copolymers at the interfaces during early annealing times.	Kyoto Univ, Grad Sch Engn, Dept Polymer Chem, Kyoto 6068501, Japan; NIST, Div Polymer, Gaithersburg, MD 20899 USA; NIST, Ctr Neutron Res, Gaithersburg, MD 20899 USA; BASF AG, Polymer Res Lab, D-67056 Ludwigshafen, Germany; Univ Tokyo, Inst Solid State Phys, Neutron Scattering Facil, Tokai, Ibaraki, Japan	Hashimoto, T (reprint author), Kyoto Univ, Grad Sch Engn, Dept Polymer Chem, Kyoto 6068501, Japan.						ANASTASIADIS SH, 1990, J CHEM PHYS, V92, P5677, DOI 10.1063/1.458499; PARRATT LG, 1954, PHYS REV, V95, P359, DOI 10.1103/PhysRev.95.359; Koriyama H, 1999, POLYMER, V40, P6381, DOI 10.1016/S0032-3861(98)00856-8; Darwin CG, 1914, PHILOS MAG, V27, P675; HELFAND E, 1975, J CHEM PHYS, V62, P1327, DOI 10.1063/1.430632; DEBYE P, 1949, J APPL PHYS, V20, P518, DOI 10.1063/1.1698419; BUFF FP, 1965, PHYS REV LETT, V15, P621, DOI 10.1103/PhysRevLett.15.621; LEIBLER L, 1988, MAKROMOL CHEM-M SYMP, V16, P1, DOI 10.1002/masy.19880160103; Darwin CG, 1914, PHILOS MAG, V27, P315; HELFAND E, 1972, J CHEM PHYS, V56, P3592, DOI 10.1063/1.1677735; Born M, 1926, Z PHYS, V37, P863, DOI 10.1007/BF01397477; EDWARDS SF, 1965, P PHYS SOC LOND, V85, P613, DOI 10.1088/0370-1328/85/4/301; Ewald PP, 1916, ANN PHYS-BERLIN, V49, P117; Ewald PP, 1917, ANN PHYS-BERLIN, V54, P519; Ewald PP, 1937, Z KRISTALLOGR, V97, P1; EWALD PP, 1917, ANN PHYSIK, V49, P1; Feng Y, 1996, MACROMOLECULES, V29, P3918, DOI 10.1021/ma951723j; FERNANDEZ ML, 1988, POLYMER, V29, P1923, DOI 10.1016/0032-3861(88)90162-0; FISCHER EW, 1993, PHYSICA A, V201, P183, DOI 10.1016/0378-4371(93)90416-2; Flory P.J., 1971, PRINCIPLES POLYM CHE; Fredrickson GH, 1996, PHYS REV LETT, V76, P3440, DOI 10.1103/PhysRevLett.76.3440; Fredrickson GH, 1996, MACROMOLECULES, V29, P7386, DOI 10.1021/ma960820p; HASEGAWA H, 1991, MACROMOLECULES, V24, P1813, DOI 10.1021/ma00008a019; Hashimoto T, 1997, PROG COLL POL SCI S, V106, P118, DOI 10.1007/BF01189504; Hashimoto T, 1998, NUOVO CIMENTO D, V20, P1947; HASHIMOTO T, 1991, J APPL CRYSTALLOGR, V24, P457, DOI 10.1107/S0021889891000444; HASHIMOTO T, 1994, PHYSICA A, V204, P261, DOI 10.1016/0378-4371(94)90430-8; Hayashi M., UNPUB; HAYASHI M, 2000, MACROMOLECULES, V17, P641; HELFAND E, 1975, MACROMOLECULES, V8, P552, DOI 10.1021/ma60046a032; Jiao JB, 1999, POLYMER, V40, P3585, DOI 10.1016/S0032-3861(98)00565-5; Jiao JB, 1999, MACROMOLECULES, V32, P6261, DOI 10.1021/ma981262c; Kerle T, 1996, PHYS REV LETT, V77, P1318, DOI 10.1103/PhysRevLett.77.1318; KOGA T, 1993, PHYSICA A, V198, P473, DOI 10.1016/0378-4371(93)90235-V; Laue M, 1931, ERG EXAKT NATURWISS, V10, P133; Mader D, 1997, J APPL POLYM SCI, V65, P567, DOI 10.1002/(SICI)1097-4628(19970718)65:3<567::AID-APP17>3.0.CO;2-U; OShaughnessy B, 1996, MACROMOLECULES, V29, P7230, DOI 10.1021/ma9601171; OShaughnessy B, 1996, PHYS REV LETT, V76, P3444, DOI 10.1103/PhysRevLett.76.3444; POROD G, 1951, KOLLOID Z Z POLYM, V124, P83, DOI 10.1007/BF01512792; POROD G, 1952, KOLLOID Z Z POLYM, V125, P51, DOI 10.1007/BF01519615; Rowlinson J. S., 1982, MOL THEORY CAPILLARY; Schoolenberg GE, 1998, POLYMER, V39, P765, DOI 10.1016/S0032-3861(97)00377-7; SCOTT C, 1994, J POLYM SCI POL PHYS, V32, P205, DOI 10.1002/polb.1994.090320201; SHULL KR, 1993, MACROMOLECULES, V26, P3929, DOI 10.1021/ma00067a031; STERRAZZA M, 1997, PHYS REV LETT, V78, P3693; Takeno H, 2000, POLYMER, V41, P1309, DOI 10.1016/S0032-3861(99)00298-0; TRIACCA VJ, 1991, POLYMER, V32, P1401, DOI 10.1016/0032-3861(91)90420-N; Welp K. A., 1999, J NEUTRON RES, V8, P37, DOI 10.1080/10238169908200235	48	6	6	AMER CHEMICAL SOC	WASHINGTON	1155 16TH ST, NW, WASHINGTON, DC 20036 USA	0024-9297			MACROMOLECULES	Macromolecules	OCT 31	2000	33	22					8375	8387		10.1021/ma000661g		13	Polymer Science	Polymer Science	370UL	WOS:000165140700040		
J	Nakamura, Y; Mera, Y; Maeda, K				Nakamura, Y; Mera, Y; Maeda, K			In situ scanning tunneling microscopic study of polymerization of C-60 clusters induced by electron injection from the probe tips	APPLIED PHYSICS LETTERS			English	Article							SOLID C-60; FILMS; FRAGMENTATION	Polymerization of C-60 clusters epitaxially grown on Si(111)-(7x7) substrates was found to be induced by electron injection from the probe tips of scanning tunneling microscopes (STM) as the sample bias was increased from +4.0 to +5.5 V, exhibiting an evolution behavior characterized by an incubation, a linear growth, and a saturation. The incubation time and the growth rate are dependent greatly on the sample site, which is explained by a model taking into account the pre-existing stress as the driving force of the polymerization and the internal stress built up as a consequence of polymerization producing a stress for backward reactions. (C) 2000 American Institute of Physics. [S0003-6951(00)01844-1].	Univ Tokyo, Grad Sch Engn, Dept Appl Phys, Bunkyo Ku, Tokyo 1136856, Japan	Nakamura, Y (reprint author), Univ Tokyo, Grad Sch Engn, Dept Appl Phys, Bunkyo Ku, Tokyo 1136856, Japan.		Mera, Yutaka/F-9470-2013; Nakamura, Yoshiaki/H-6852-2013				Hunsche S, 1996, PHYS REV LETT, V77, P1966, DOI 10.1103/PhysRevLett.77.1966; WANG Y, 1994, CHEM PHYS LETT, V217, P413, DOI 10.1016/0009-2614(93)E1409-A; RAO AM, 1993, SCIENCE, V259, P955; Dunn AW, 1997, J VAC SCI TECHNOL A, V15, P1478, DOI 10.1116/1.580565; HEBARD AF, 1993, APPL PHYS A-MATER, V57, P299, DOI 10.1007/BF00332606; Hunt MRC, 1999, PHYS REV B, V60, P5927, DOI 10.1103/PhysRevB.60.5927; IWASA Y, 1994, SCIENCE, V264, P1570, DOI 10.1126/science.264.5165.1570; Nakamura Y, 1999, REV SCI INSTRUM, V70, P3373, DOI 10.1063/1.1149921; Nakayama T, 1999, SURF REV LETT, V6, P1073, DOI 10.1142/S0218625X99001177; NUNEZREGUEIRO M, 1995, PHYS REV LETT, V74, P278, DOI 10.1103/PhysRevLett.74.278; Robinson APG, 1998, APPL PHYS LETT, V72, P1302, DOI 10.1063/1.120978; STROUT DL, 1993, CHEM PHYS LETT, V214, P576, DOI 10.1016/0009-2614(93)85686-I; ZHAO YB, 1994, APPL PHYS LETT, V64, P577, DOI 10.1063/1.111113	13	32	32	AMER INST PHYSICS	MELVILLE	2 HUNTINGTON QUADRANGLE, STE 1NO1, MELVILLE, NY 11747-4501 USA	0003-6951			APPL PHYS LETT	Appl. Phys. Lett.	OCT 30	2000	77	18					2834	2836	PII [S0003-6951(00)01844-1]	10.1063/1.1320865		3	Physics, Applied	Physics	366QV	WOS:000090016800018		
J	Tokunaga, T				Tokunaga, T			The role of turbidites on compaction and dewatering of underthrust sediments at the toe of the northern Barbados accretionary prism: new evidence from Logging While Drilling, ODP Leg 171A (vol 178, pg 385, 2000)	EARTH AND PLANETARY SCIENCE LETTERS			English	Correction									Univ Tokyo, Dept Geosyst Engn, Bunkyo Ku, Tokyo 1138656, Japan	Tokunaga, T (reprint author), Univ Tokyo, Dept Geosyst Engn, Bunkyo Ku, 7-3-1 Hongo, Tokyo 1138656, Japan.						Tokunaga T, 2000, EARTH PLANET SC LETT, V178, P385, DOI 10.1016/S0012-821X(00)00078-9	1	0	0	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	0012-821X			EARTH PLANET SC LETT	Earth Planet. Sci. Lett.	OCT 30	2000	182	2					199	199		10.1016/S0012-821X(00)00242-9		1	Geochemistry & Geophysics	Geochemistry & Geophysics	366ZG	WOS:000090035700007		
J	Masumori, T; Seino, H; Mizobe, Y; Hidai, M				Masumori, T; Seino, H; Mizobe, Y; Hidai, M			The cubane-type Mo2Ir2S4 cluster containing an organohydrazido(2(-)) ligand on the Mo site	INORGANIC CHEMISTRY			English	Article							RAY CRYSTAL-STRUCTURES; BRIDGED DOUBLE CUBANES; SULFIDO CLUSTERS; THIOMOLYBDATE COMPLEXES; NITROGENASE; MOLYBDENUM; DINITROGEN; REACTIVITIES; CHEMISTRY; DIIRIDIUM		Univ Tokyo, Inst Ind Sci, Minato Ku, Tokyo 1068558, Japan; Sci Univ Tokyo, Fac Ind Sci & Technol, Dept Mat Sci & Technol, Noda, Chiba 2788510, Japan	Mizobe, Y (reprint author), Univ Tokyo, Inst Ind Sci, Minato Ku, Tokyo 1068558, Japan.						COUCOUVANIS D, 1991, J AM CHEM SOC, V113, P5271, DOI 10.1021/ja00014a021; KIM JS, 1992, SCIENCE, V257, P1677, DOI 10.1126/science.1529354; CHAN MK, 1993, SCIENCE, V260, P792, DOI 10.1126/science.8484118; HIDAI M, 1995, CHEM REV, V95, P1115, DOI 10.1021/cr00036a008; LEIGH GJ, 1992, ACCOUNTS CHEM RES, V25, P177, DOI 10.1021/ar00016a001; Howard JB, 1996, CHEM REV, V96, P2965, DOI 10.1021/cr9500545; Hidai M, 2000, ACCOUNTS CHEM RES, V33, P46, DOI 10.1021/ar990016y; HARRIS S, 1989, POLYHEDRON, V8, P2843, DOI 10.1016/S0277-5387(00)86283-X; SUTTON D, 1993, CHEM REV, V93, P995, DOI 10.1021/cr00019a008; BOTTOMLEY F, 1994, ORGANOMETALLICS, V13, P370, DOI 10.1021/om00013a054; BUSTOS C, 1994, INORG CHEM, V33, P1427, DOI 10.1021/ic00085a035; CHALLEN PR, 1990, J AM CHEM SOC, V112, P8606, DOI 10.1021/ja00179a068; Coucouvanis D, 1998, ADV INORG CHEM, V45, P1, DOI 10.1016/S0898-8838(08)60024-0; COUCOUVANIS D, 1989, INORG CHEM, V28, P4181, DOI 10.1021/ic00322a001; DEMADIS KD, 1994, POLYHEDRON, V13, P3147, DOI 10.1016/S0277-5387(00)83684-0; DILWORTH JR, 1982, J AM CHEM SOC, V104, P365, DOI 10.1021/ja00365a099; DILWORTH JR, 1983, J CHEM SOC DALTON, P1489, DOI 10.1039/dt9830001489; Hernandez-Molina R, 1999, J CHEM SOC DALTON, P3137, DOI 10.1039/a904740i; Huang JS, 1998, INORG CHEM, V37, P2247, DOI 10.1021/ic971353a; Huang JS, 1997, J AM CHEM SOC, V119, P8662, DOI 10.1021/ja971401q; Johnson B. F. G., 1987, COMPREHENSIVE COORDI, V2, P99; Kahlal S, 1998, J CHEM SOC DALTON, P1229, DOI 10.1039/a706923e; Kochi T, 1999, J CHEM SOC DALTON, P2575, DOI 10.1039/a902999k; Kuwata S, 1998, ORGANOMETALLICS, V17, P3429, DOI 10.1021/om980214d; PALERMO RE, 1984, J AM CHEM SOC, V106, P2600, DOI 10.1021/ja00321a019; Seino H, 2000, B CHEM SOC JPN, V73, P631, DOI 10.1246/bcsj.73.631; SHAN H, 1992, J AM CHEM SOC, V114, P1526; Shan H, 1997, SCIENCE, V275, P1460, DOI 10.1126/science.275.5305.1460; Tang Z, 1998, INORG CHIM ACTA, V267, P73, DOI 10.1016/S0020-1693(97)05554-0; Tang Z, 1998, INORG CHEM, V37, P4909, DOI 10.1021/ic9806885	30	24	24	AMER CHEMICAL SOC	WASHINGTON	1155 16TH ST, NW, WASHINGTON, DC 20036 USA	0020-1669			INORG CHEM	Inorg. Chem.	OCT 30	2000	39	22					5002	5003		10.1021/ic991441q		2	Chemistry, Inorganic & Nuclear	Chemistry	372BF	WOS:000165213200005		
J	Zhong, ZJ; Seino, H; Mizobe, Y; Hidai, M; Verdaguer, M; Ohkoshi, S; Hashimoto, K				Zhong, ZJ; Seino, H; Mizobe, Y; Hidai, M; Verdaguer, M; Ohkoshi, S; Hashimoto, K			Crystal structure and magnetic properties of an octacyanometalate-based three-dimensional tungstate(V)-manganese(II) bimetallic assembly	INORGANIC CHEMISTRY			English	Article							MOLECULAR-FIELD THEORY; COBALT-IRON CYANIDE; DESIGN; TEMPERATURE; PHASE	A single crystal of the title compound [Mn-6(II)(H2O)(9){W-V(CN)(8)}4 . 13H(2)O](n) was synthesized in a hot aqueous solution containing octacyanotungstate, Na-3[W(CN)(8)]. 3H(2)O, and Mn(ClO4)(2). 6H(2)O. The compound crystallized in the monoclinic system, space group P2(1)/c with cell constants a 15.438(2) Angstrom, b= 14.691(2) Angstrom, c = 33.046(2) Angstrom, beta = 94.832(9)degrees, and Z = 4. The crystal consists of a W-V-CN-Mn-II linked three-dimensional network [{Mn-II-(H2O)}(3){Mn-II(H2O)(2)}(3){W-V(CN)(8)}(4)](n) and H2O molecules as crystal solvates. There are two kinds of W sites: one is close to a dodecahedron geometry with six bridging and two terminal CN ligands; the other is close to a bicapped trigonal prism with seven bridging and one terminal CN Iigands. The field-cooled magnetization measurement showed that the compound exhibits a spontaneous magnetization below T-c = 54 K. Further magnetization measurements on the field dependence reveal it to be a ferrimagnet where all of the Mn (II) ions are antiparallel to all the W-V ions.	Kanagawa Acad Sci & Technol, Takatsu Ku, Kawasaki, Kanagawa 213, Japan; Univ Tokyo, Inst Ind Sci, Minato Ku, Tokyo 1068558, Japan; Sci Univ Tokyo, Dept Mat Sci & Technol, Noda, Chiba 2788510, Japan; Univ Paris 06, CNRS, UNite 7071, Lab Chim Inorgan & Mat Mol, F-75252 Paris 05, France; Univ Tokyo, Adv Sci & Technol Res Ctr, Meguro Ku, Tokyo 1538904, Japan	Hashimoto, K (reprint author), Kanagawa Acad Sci & Technol, Takatsu Ku, 3-2-1 Sakato, Kawasaki, Kanagawa 213, Japan.		Hashimoto, Kazuhito/C-5011-2012	Hashimoto, Kazuhito/0000-0002-8384-8749			MALLAH T, 1993, SCIENCE, V262, P1554, DOI 10.1126/science.262.5139.1554; FERLAY S, 1995, NATURE, V378, P701, DOI 10.1038/378701a0; Larionova J, 2000, ANGEW CHEM INT EDIT, V39, P1605, DOI 10.1002/(SICI)1521-3773(20000502)39:9<1605::AID-ANIE1605>3.0.CO;2-5; MANRIQUEZ JM, 1991, SCIENCE, V252, P1415, DOI 10.1126/science.252.5011.1415; Zhong ZJ, 2000, J AM CHEM SOC, V122, P2952, DOI 10.1021/ja992622u; Ohkoshi S, 1999, J AM CHEM SOC, V121, P10591, DOI 10.1021/ja991473c; Sato O, 1996, SCIENCE, V271, P49, DOI 10.1126/science.271.5245.49; Sato O, 1996, SCIENCE, V272, P704, DOI 10.1126/science.272.5262.704; Ohkoshi S, 1999, PHYS REV LETT, V82, P1285, DOI 10.1103/PhysRevLett.82.1285; MILLER JS, 1994, ANGEW CHEM INT EDIT, V33, P385, DOI 10.1002/anie.199403851; Larionova J, 1998, J AM CHEM SOC, V120, P13088, DOI 10.1021/ja9739953; TAMAKI H, 1992, J AM CHEM SOC, V114, P6974, DOI 10.1021/ja00044a004; Sato O, 1999, INORG CHEM, V38, P4405, DOI 10.1021/ic980741p; Holmes SM, 1999, J AM CHEM SOC, V121, P5593, DOI 10.1021/ja990946c; Bleuzen A., 1999, MOL CRYST LIQ CRYST, V335, P253, DOI 10.1080/10587259908028870; Gatteschi D., 1991, MAGNETIC MOL MAT; HASHIMOTO, UNPUB; HATLEVIK O, 1999, ADV MATER, V9, P645; Kahn O., 1993, MOL MAGNETISM; Leipoldt J. G., 1993, ADV INORG CHEM, V40, P241, DOI 10.1016/S0898-8838(08)60185-3; MCKNIGHT GF, 1973, INORG CHEM, V12, P3007, DOI 10.1021/ic50130a055; *MOL STRUCT CORP, 1992, TEXS CRYST STRUCT AN; PRIBUSH RA, 1974, INORG CHEM, V13, P2556, DOI 10.1021/ic50141a007; Sato O., 1997, J ELECTROCHEM SOC, V144, P11; VERDAGUER M, UNPUB; WILLIAM RE, 1994, INORG CHEM, V33, P5165	26	129	131	AMER CHEMICAL SOC	WASHINGTON	1155 16TH ST, NW, WASHINGTON, DC 20036 USA	0020-1669			INORG CHEM	Inorg. Chem.	OCT 30	2000	39	22					5095	5101		10.1021/ic0005994		7	Chemistry, Inorganic & Nuclear	Chemistry	372BF	WOS:000165213200017		
J	Morandi, A; Negrini, F; Nitta, T; Oshima, S; Ribani, PL				Morandi, A; Negrini, F; Nitta, T; Oshima, S; Ribani, PL			Experimental analysis and circuit model of an inductive type high temperature superconducting fault current limiter	INTERNATIONAL JOURNAL OF MODERN PHYSICS B			English	Article; Proceedings Paper	10th National Congress on Superconductivity (SATT10))	MAY 09-12, 2000	FRASCATI, ITALY	ENEA CR Frascati, Air Liquide, Ansaldo CRIS, Assing, CNR GNSM, CESI, CRV, EDISON, Europa Metalli, Keithley Instruments, INFM, Leybold Vacuum, OCEM, Pheiffer Vacuum, Pirelli Cavi & Sistemi, Rial Vacuum, SIARS, SISTEC, Varian, A&G Venier				A basic inductive type high temperature superconducting fault current limiter prototype has been built and tested at the Department of Electrical Engineering of the University of Tokyo. The experimental static V-I characteristics shows a change in the impedance of the device when its limiting current is reached. A circuit model of the fault current limiter is developed by means of a non linear inductor with memory. A good agreement is obtained between numerical and experimental V-I characteristics. Dynamic characteristics are numerically studied by means of the circuit model.	Univ Bologna, Dept Elect Engn, I-40126 Bologna, Italy; Univ Tokyo, Dept Elect Engn, Nitta Lab, Tokyo, Japan	Morandi, A (reprint author), Univ Bologna, Dept Elect Engn, I-40126 Bologna, Italy.						[Anonymous], 1994, NUMERICAL METHODS SC; BASHKIROV YA, 1991, IEEE T MAGNETICS, V27; BOCH J, 1997, I PHYS C SERIES, V158; GEROLD J, 1997, ICEC, V17; MEEROVICH V, 1995, IEEE T APPL SUPERCON, V5; MEEROVICH V, 1997, I PHYS C SERIES, V158; MEEROVICH V, 1995, I PHYS C SERIES, V148	7	2	2	WORLD SCIENTIFIC PUBL CO PTE LTD	SINGAPORE	JOURNAL DEPT PO BOX 128 FARRER ROAD, SINGAPORE 912805, SINGAPORE	0217-9792			INT J MOD PHYS B	Int. J. Mod. Phys. B	OCT 30	2000	14	25-27					3171	3176		10.1142/S0217979200003496		6	Physics, Applied; Physics, Condensed Matter; Physics, Mathematical	Physics	391CZ	WOS:000166337700092		
J	Tamai, Y; Ishikawa, T; Bosl, MR; Mori, M; Nozaki, M; Baribault, H; Oshima, RG; Taketo, MM				Tamai, Y; Ishikawa, T; Bosl, MR; Mori, M; Nozaki, M; Baribault, H; Oshima, RG; Taketo, MM			Cytokeratins 8 and 19 in the mouse placental development	JOURNAL OF CELL BIOLOGY			English	Article						embryo; endoderm; epithelium; keratin; trophoblasts	AMINO-ACID-SEQUENCE; INTERMEDIATE FILAMENTS; CYTOSKELETAL ELEMENTS; MONOCLONAL-ANTIBODIES; TARGETED DISRUPTION; CULTURED-CELLS; GENE; MICE; EXPRESSION; KERATIN	To investigate the expression and biological roles of cytokeratin 19 (K19) in development and in adult tissues, we inactivated the mouse K19 gene (Krt1-19) by inserting a bacterial beta -galactosidase gene (lacZ) by homologous recombination in embryonic stem cells, and established germ line mutant mice. Both heterozygous and homozygous mutant mice were viable, fertile, and appeared normal. By 7.5-8.0 days post coitum (dpc), heterozygous mutant embryos expressed lacZ in the notochordal plate and hindgut diverticulum, reflecting the fact that the notochord and the gut endoderm are derived from the axial mesoderm-originated cells. In the adult mutant, lacZ was expressed mainly in epithelial tissues. To investigate the possible functional cooperation and synergy between K19 and K8, we then constructed compound homozygous mutants, whose embryos died similar to 10 dpc. The lethality resulted from defects in the placenta where both K19 and K8 are normally expressed. As early as 9.5 dpc, the compound mutant placenta had an excessive number of giant trophoblasts, but lacked proper labyrinthine trophoblast or spongiotrophoblast development, which apparently caused flooding of the maternal blood into the embryonic placenta. These results indicate that K19 and K8 cooperate in ensuring the normal development of placental tissues.	Univ Tokyo, Grad Sch Pharmaceut Sci, Lab Biomed Genet, Bunkyo Ku, Tokyo 1130033, Japan; Banyu Tsukuba Res Inst Merck, Tsukuba, Ibaraki 3002611, Japan; Natl Inst Radiol Sci, Inage Ku, Chiba 2638555, Japan; Osaka Univ, Inst Microbial Dis, Suita, Osaka 5650871, Japan; Burnham Inst, La Jolla, CA 92037 USA	Taketo, MM (reprint author), Univ Tokyo, Grad Sch Pharmaceut Sci, Lab Biomed Genet, Bunkyo Ku, Tokyo 1130033, Japan.						SHULL MM, 1992, NATURE, V359, P693, DOI 10.1038/359693a0; CROSS JC, 1994, SCIENCE, V266, P1508, DOI 10.1126/science.7985020; OSHIMA M, 1995, P NATL ACAD SCI USA, V92, P4482, DOI 10.1073/pnas.92.10.4482; SORIANO P, 1991, CELL, V64, P693, DOI 10.1016/0092-8674(91)90499-O; Caulin C, 2000, J CELL BIOL, V149, P17, DOI 10.1083/jcb.149.1.17; Yamamoto H, 1998, GENE DEV, V12, P1315, DOI 10.1101/gad.12.9.1315; GUILLEMOT F, 1994, NATURE, V371, P333, DOI 10.1038/371333a0; Magin TM, 1998, J CELL BIOL, V140, P1441, DOI 10.1083/jcb.140.6.1441; BARIBAULT H, 1994, GENE DEV, V8, P2964, DOI 10.1101/gad.8.24.2964; PUJOL JL, 1993, CANCER RES, V53, P61; Harada N, 1999, EMBO J, V18, P5931, DOI 10.1093/emboj/18.21.5931; Loranger A, 1997, AM J PATHOL, V151, P1673; Saga Y, 1996, DEVELOPMENT, V122, P2769; BADER BL, 1986, EMBO J, V5, P1865; BADER BL, 1988, EUR J CELL BIOL, V47, P300; BARIBAULT H, 1991, J CELL BIOL, V115, P1675, DOI 10.1083/jcb.115.6.1675; BARIBAULT H, 1993, GENE DEV, V7, P1191, DOI 10.1101/gad.7.7a.1191; BOLLER K, 1987, EUR J CELL BIOL, V43, P459; BOSCH FX, 1988, J CELL BIOL, V106, P1635, DOI 10.1083/jcb.106.5.1635; CALNEK D, 1993, DIFFERENTIATION, V53, P95, DOI 10.1111/j.1432-0436.1993.tb00649.x; COPP AJ, 1995, TRENDS GENET, V11, P87, DOI 10.1016/S0168-9525(00)89008-3; ECKERT RL, 1988, P NATL ACAD SCI USA, V85, P1114, DOI 10.1073/pnas.85.4.1114; FRANKE WW, 1982, DIFFERENTIATION, V23, P43, DOI 10.1111/j.1432-0436.1982.tb01266.x; FUCHS E, 1994, J CELL BIOL, V125, P511, DOI 10.1083/jcb.125.3.511; ICHINOSE Y, 1989, GENE, V80, P315; JACKSON BW, 1981, DIFFERENTIATION, V20, P203, DOI 10.1111/j.1432-0436.1981.tb01177.x; JACKSON BW, 1980, DIFFERENTIATION, V17, P161, DOI 10.1111/j.1432-0436.1980.tb01093.x; KASPER M, 1987, EUR J CANCER CLIN ON, V23, P137, DOI 10.1016/0277-5379(87)90007-1; KAUFMAN MH, 1992, ATLAS MOUSE DEV, P1; KEMLER R, 1981, J EMBRYOL EXP MORPH, V64, P45; KULESH DA, 1989, MOL CELL BIOL, V9, P1553; Kupriyanov S, 1998, BIOCHEM CELL BIOL, V76, P1017, DOI 10.1139/bcb-76-6-1017; LANE EB, 1983, NATURE, V303, P701, DOI 10.1038/303701a0; Luo JM, 1997, NATURE, V388, P778; LUSSIER M, 1989, GENE, V85, P435, DOI 10.1016/0378-1119(89)90437-X; LUSSIER M, 1990, GENE, V95, P203, DOI 10.1016/0378-1119(90)90363-V; MAGIN TM, 1997, SUBCELLULAR BIOCH; MCLEAN WHI, 1995, CURR OPIN CELL BIOL, V7, P118; MOLL R, 1982, CELL, V31, P11, DOI 10.1016/0092-8674(82)90400-7; Moll R., 1994, International Journal of Biological Markers, V9, P63; MOLL R, 1990, J CELL BIOL, V111, P567, DOI 10.1083/jcb.111.2.567; NOZAKI M, 1994, GENE, V138, P197, DOI 10.1016/0378-1119(94)90807-9; NOZAKI M, 1988, BIOCHEM BIOPH RES CO, V154, P890, DOI 10.1016/0006-291X(88)90223-9; QUINLAN RA, 1985, ANN NY ACAD SCI, V455, P282, DOI 10.1111/j.1749-6632.1985.tb50418.x; Rasmussen CA, 1999, PLACENTA, V20, P213, DOI 10.1053/plac.1998.0356; Riley P, 1998, NAT GENET, V18, P271, DOI 10.1038/ng0398-271; Rossant Janet, 1995, Seminars in Developmental Biology, V6, P237, DOI 10.1016/S1044-5781(06)80049-6; ROSSANT J, 1985, J EMBRYOL EXP MORPH, V86, P177; STASIAK PC, 1989, J INVEST DERMATOL, V92, P707, DOI 10.1111/1523-1747.ep12721500; STEINERT PM, 1988, ANNU REV BIOCHEM, V57, P593, DOI 10.1146/annurev.bi.57.070188.003113; Sun T. T., 1984, CANCER CELL, P169; TAKEMOTO Y, 1991, NUCLEIC ACIDS RES, V19, P2761, DOI 10.1093/nar/19.10.2761; TAMAI Y, 1991, GENE, V104, P169, DOI 10.1016/0378-1119(91)90247-9; VASSAR R, 1991, CELL, V64, P365, DOI 10.1016/0092-8674(91)90645-F; WU YJ, 1981, CELL, V25, P627, DOI 10.1016/0092-8674(81)90170-7	55	77	78	ROCKEFELLER UNIV PRESS	NEW YORK	1114 FIRST AVE, 4TH FL, NEW YORK, NY 10021 USA	0021-9525			J CELL BIOL	J. Cell Biol.	OCT 30	2000	151	3					563	572				10	Cell Biology	Cell Biology	369YC	WOS:000165094500008		
J	Fujikawa, K; Ishibaski, M				Fujikawa, K; Ishibaski, M			Chiral anomaly for a new class of lattice Dirac operators	NUCLEAR PHYSICS B			English	Article							EXACTLY MASSLESS QUARKS; GAUGE-THEORIES; INDEX THEOREM; FERMIONS; OVERLAP; QCD; INVARIANCE	A new class of lattice Dirac operators which satisfy the index theorem have been recently proposed on the basis of the algebraic relation gamma(5)(gamma(5)D) + (gamma(5)D)gamma(5) = 2a(2k+1)(gamma(5)D)(2k+2). Here k stands for a non-negative integer and k = 0 corresponds to the ordinary Ginsparg-Wilson relation. We analyze the chiral anomaly and index theorem for all these Dirac operators in an explicit elementary manner. We show that the coefficient of anomaly is independent of a small variation in the parameters r and mg, which characterize these Dirac operators, and the correct chiral anomaly is obtained in the (naive) continuum limit a --> 0. (C) 2000 Elsevier Science B.V. All rights reserved.	Univ Tokyo, Dept Phys, Bunkyo Ku, Tokyo 113, Japan	Fujikawa, K (reprint author), Univ Tokyo, Dept Phys, Bunkyo Ku, 7-3-1 Hongo, Tokyo 113, Japan.						ADAMS DH, HEPLAT9812003; Neuberger H, 1998, PHYS LETT B, V427, P353, DOI 10.1016/S0370-2693(98)00355-4; Kikukawa Y, 1999, PHYS LETT B, V448, P265, DOI 10.1016/S0370-2693(99)00021-0; KARSTEN LH, 1981, NUCL PHYS B, V183, P103, DOI 10.1016/0550-3213(81)90549-6; GINSPARG PH, 1982, PHYS REV D, V25, P2649, DOI 10.1103/PhysRevD.25.2649; Hasenfratz P, 1998, PHYS LETT B, V427, P125, DOI 10.1016/S0370-2693(98)00315-3; Neuberger H, 1998, PHYS LETT B, V417, P141, DOI 10.1016/S0370-2693(97)01368-3; FUJIKAWA K, 1979, PHYS REV LETT, V42, P1195, DOI 10.1103/PhysRevLett.42.1195; Fujikawa K, 1999, NUCL PHYS B, V546, P480, DOI 10.1016/S0550-3213(99)00042-5; Hernandez P, 1999, NUCL PHYS B, V552, P363, DOI 10.1016/S0550-3213(99)00213-8; AOKI S, 1986, NUCL PHYS B, V272, P281, DOI 10.1016/0550-3213(86)90003-9; AOKI S, 1987, PHYS REV D, V35, P1435, DOI 10.1103/PhysRevD.35.1435; ATIYAH M, 1973, INVENT MATH, V19, P279, DOI 10.1007/BF01425417; CHIU TW, HEPLAT0005005; Chiu TW, 1998, PHYS REV D, V58; FUJIKAWA K, 1980, PHYS REV D, V21, P2848, DOI 10.1103/PhysRevD.21.2848; FUJIKAWA K, IN PRESS NUCL PHYS B; Fujikawa K, 1999, PHYS REV D, V60; FUJIKAWA K, 1980, PHYS REV D, V22, P1499, DOI 10.1103/PhysRevD.22.1499; Haga K, 1997, PHYS REV D, V55, P5325, DOI 10.1103/PhysRevD.55.5325; Ishibashi M, 2000, NUCL PHYS B, V576, P501, DOI 10.1016/S0550-3213(00)00186-3; JACKIW R, 1977, PHYS REV D, V16, P1052, DOI 10.1103/PhysRevD.16.1052; KAWAMOTO N, 1981, NUCL PHYS B, V192, P100, DOI 10.1016/0550-3213(81)90196-6; Luscher M, 1999, NUCL PHYS B, V549, P295, DOI 10.1016/S0550-3213(99)00115-7; Neuberger H, 1999, PHYS REV D, V59; Neuberger H, 2000, PHYS REV D, V61, DOI 10.1103/PhysRevD.61.085015; RandjbarDaemi S, 1997, PHYS LETT B, V402, P134, DOI 10.1016/S0370-2693(97)00450-4; Suzuki H, 1999, PROG THEOR PHYS, V102, P141, DOI 10.1143/PTP.102.141	28	19	19	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	0550-3213			NUCL PHYS B	Nucl. Phys. B	OCT 30	2000	587	1-3					419	441		10.1016/S0550-3213(00)00473-9		23	Physics, Particles & Fields	Physics	362NK	WOS:000089783900018		
J	Keimer, B; Casa, D; Ivanov, A; Lynn, JW; von Zimmermann, M; Hill, JP; Gibbs, D; Taguchi, Y; Tokura, Y				Keimer, B; Casa, D; Ivanov, A; Lynn, JW; von Zimmermann, M; Hill, JP; Gibbs, D; Taguchi, Y; Tokura, Y			Spin dynamics and orbital state in LaTiO3	PHYSICAL REVIEW LETTERS			English	Article							LAMNO3; SCATTERING; CRYSTAL; YVO3	A neutron scattering study of the Mott-Hubbard insulator LaTiO3 (T-N = 132 K)reveals a spin wave spectrum that is well described by a nearest-neighbor superexchange constant J = 15.5 meV and a small Dzyaloshinskii-Moriya interaction (D = 1.1 meV). The nearly isotropic spin wave spectrum is surprising in view of the absence of a static Jahn-Teller distortion that could quench the orbital angular momentum, and it may indicate strong orbital fluctuations. A resonant x-ray scattering study has uncovered no evidence of orbital order in LaTiO3.	Max Planck Inst Festkorperforsch, D-70569 Stuttgart, Germany; Princeton Univ, Dept Phys, Princeton, NJ 08544 USA; Inst Max Von Laue Paul Langevin, F-38042 Grenoble, France; Natl Inst Stand & Technol, Ctr Neutron Res, Gaithersburg, MD 20899 USA; Brookhaven Natl Lab, Dept Phys, Upton, NY 11973 USA; Univ Tokyo, Dept Appl Phys, Tokyo 113, Japan	Keimer, B (reprint author), Max Planck Inst Festkorperforsch, D-70569 Stuttgart, Germany.		Taguchi, Yasujiro/A-3048-2010; Tokura, Yoshinori/C-7352-2009				Abragam A, 1970, ELECT PARAMAGNETIC R; Moussa F, 1996, PHYS REV B, V54, P15149, DOI 10.1103/PhysRevB.54.15149; Mizokawa T, 1999, PHYS REV B, V60, P7309, DOI 10.1103/PhysRevB.60.7309; Ren Y, 1998, NATURE, V396, P441; YILDIRIM T, 1995, PHYS REV B, V52, P10239, DOI 10.1103/PhysRevB.52.10239; Sandvik AW, 1998, PHYS REV LETT, V80, P5196, DOI 10.1103/PhysRevLett.80.5196; Murakami Y, 1998, PHYS REV LETT, V81, P582, DOI 10.1103/PhysRevLett.81.582; ANDERSON PW, 1952, PHYS REV, V86, P694, DOI 10.1103/PhysRev.86.694; Khaliullin G, 2000, PHYS REV LETT, V85, P3950, DOI 10.1103/PhysRevLett.85.3950; Mizokawa T, 1996, PHYS REV B, V54, P5368, DOI 10.1103/PhysRevB.54.5368; Solovyev I, 1996, PHYS REV LETT, V76, P4825, DOI 10.1103/PhysRevLett.76.4825; Reedyk M, 1997, PHYS REV B, V55, P1442, DOI 10.1103/PhysRevB.55.1442; MORIYA T, 1960, PHYS REV, V120, P91, DOI 10.1103/PhysRev.120.91; Brown P. J., 1995, INT TABLES CRYSTALLO, VC, P391; EITEL M, 1986, J LESS-COMMON MET, V116, P95, DOI 10.1016/0022-5088(86)90220-1; GORAL JP, 1983, J MAGN MAGN MATER, V37, P315, DOI 10.1016/0304-8853(83)90062-8; HAM FS, 1965, PHYS REV, V138, P1727; KULDA J, COMMUNICATIONB; MACFARLA.RM, 1968, PHYS REV, V166, P250, DOI 10.1103/PhysRev.166.250; MACLEAN DA, 1979, J SOLID STATE CHEM, V30, P35, DOI 10.1016/0022-4596(79)90127-0; NAKAO H, IN PRESS; Taguchi Y, 1999, PHYS REV B, V59, P7917, DOI 10.1103/PhysRevB.59.7917	22	149	149	AMERICAN PHYSICAL SOC	COLLEGE PK	ONE PHYSICS ELLIPSE, COLLEGE PK, MD 20740-3844 USA	0031-9007			PHYS REV LETT	Phys. Rev. Lett.	OCT 30	2000	85	18					3946	3949		10.1103/PhysRevLett.85.3946		4	Physics, Multidisciplinary	Physics	368ZA	WOS:000090146300051		
J	Numata, K; Bianc, GB; Ohishi, N; Sekiya, A; Otsuka, S; Kawabe, K; Ando, M; Tsubono, K				Numata, K; Bianc, GB; Ohishi, N; Sekiya, A; Otsuka, S; Kawabe, K; Ando, M; Tsubono, K			Measurement of the intrinsic mechanical loss of low-loss samples using a nodal support	PHYSICS LETTERS A			English	Article						thermal noise; quality factor; nodal support; fused silica; gravitational waves	QUALITY FACTOR	We measured the mechanical loss of cylindrical samples made of fused silica. The loss due to the support was excluded by using a nodal support technique. We evaluated separately the intrinsic loss of the material and the loss due to the surface roughness by systematically analyzing the measured losses. (C) 2000 Elsevier Science B.V. All rights reserved.	Univ Tokyo, Dept Phys, Bunkyo Ku, Tokyo 1130033, Japan	Numata, K (reprint author), Univ Tokyo, Dept Phys, Bunkyo Ku, 7-3-1 Hongo, Tokyo 1130033, Japan.		Kawabe, Keita/G-9840-2011; ANDO, MASAKI/G-4989-2014				SAULSON PR, 1990, PHYS REV D, V42, P2437, DOI 10.1103/PhysRevD.42.2437; ABRAMOVICI A, 1992, SCIENCE, V256, P325, DOI 10.1126/science.256.5055.325; BLAIR DG, 1991, DETECTION GRAVITATIO, P89; BRAGINSKY VB, 1985, SYSTEMS SMALL DISSIP, P21; DANZMANN K, 1994, 190 M PLANCK I QUANT; de Waard A, 2000, PHYSICA B, V280, P535, DOI 10.1016/S0921-4526(99)01854-2; DOUGLASS DH, 1977, P AC NAZ LINC INT S, P323; Gretarsson AM, 1999, REV SCI INSTRUM, V70, P4081, DOI 10.1063/1.1150040; HUTCHINSON JR, 1980, ASME J APPLIED MECHA, V47, P901; LOGAN JE, 1992, PHYS LETT A, V170, P352, DOI 10.1016/0375-9601(92)90886-Q; MCMAHON GW, 1964, J ACOUST SOC AM, V36, P85, DOI 10.1121/1.1918918; Rowan S, 2000, PHYS LETT A, V265, P5, DOI 10.1016/S0375-9601(99)00874-9; Startin WJ, 1998, REV SCI INSTRUM, V69, P3681, DOI 10.1063/1.1149159; SUZUKI T, 1978, PHYS LETT A, V67, P2, DOI 10.1016/0375-9601(78)90549-2; Taniwaki M, 1998, PHYS LETT A, V246, P37, DOI 10.1016/S0375-9601(98)00426-5; TSUBONO K, 1995, P 1 E AM C GRAV WAV, P112; *VIRGO COLL, 1997, VIRGO FIN DES REP	17	19	19	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	0375-9601			PHYS LETT A	Phys. Lett. A	OCT 30	2000	276	1-4					37	46		10.1016/S0375-9601(00)00646-0		10	Physics, Multidisciplinary	Physics	375TK	WOS:000165417200008		
J	Liu, AQ; Zhao, B; Chollet, F; Zou, Q; Asundi, A; Fujita, H				Liu, AQ; Zhao, B; Chollet, F; Zou, Q; Asundi, A; Fujita, H			Micro-opto-mechanical grating switches	SENSORS AND ACTUATORS A-PHYSICAL			English	Article						micro-opto-electro-mechanical systems (MOEMs); micromirror; micrograting; optics switch; multiplexer; wavelength division multiplexing (WDM); passive optical network (PON)		This paper reports the design, fabrication, and testing of a Micro-opto-mechanical grating switch driven by electrostatic actuator for fiber-optic communication applications. It consists of two bounded silicon wafers. One input fiber with a hemispherical lens at its end and three photodetectors are mounted on the upper wafer. A movable platform with two,gratings and one mirror are fabricated on the lower wafer. When the movable platform is at a certain position, the input beam can be split into three beams by the gratings. The reflectivity of the mirror is about 85% while the efficiency in the three different order is 29%, 26%, and 26%. The switching speed is about 500 mus Details of the grating switching design, theoretical analysis, fabrication and experimental results are presented in this paper. (C) 2000 Elsevier Science B.V. All rights reserved.	Natl Univ Singapore, Inst Mat Res & Engn, MEMS Technol, Singapore 117206, Singapore; Nanyang Technol Univ, Sch Mech & Prod Engn, Singapore 639798, Singapore; Univ Tokyo, Inst Ind Sci, Minato Ku, Tokyo 106, Japan	Liu, AQ (reprint author), Natl Univ Singapore, Inst Mat Res & Engn, MEMS Technol, 3 Sci Link, Singapore 117206, Singapore.		CHOLLET, Franck/A-3994-2009; Asundi, Anand/A-3843-2011; 	Asundi, Anand/0000-0003-3835-4624			Burns DM, 1997, PROC IEEE MICR ELECT, P55, DOI 10.1109/MEMSYS.1997.581765; GLASER T, 1998, OPT LETT, V23, P2899; Glockner S, 1997, P SOC PHOTO-OPT INS, V3226, P76, DOI 10.1117/12.284577; Goodman J. W., 1998, INTRO FOURIER OPTICS; Hinton H.S., 1993, INTRO PHOTONIC SWITC; KOK YL, 1980, J OPT SOC AM A, P63; LEE SS, 1997, P 9 INT C SOL STAT S, P85; PAYNE DB, 1989, WDM TECHNIQUES BROAD; TOSHIYOSHI H, 1996, IEEE LEOS 1996 SUMM, P63	9	14	14	ELSEVIER SCIENCE SA	LAUSANNE	PO BOX 564, 1001 LAUSANNE, SWITZERLAND	0924-4247			SENSOR ACTUAT A-PHYS	Sens. Actuator A-Phys.	OCT 30	2000	86	1-2					127	134		10.1016/S0924-4247(00)00404-0		8	Engineering, Electrical & Electronic; Instruments & Instrumentation	Engineering; Instruments & Instrumentation	368PY	WOS:000090127700019		
J	Motoki, S; Adachi, J; Hikosaka, Y; Ito, K; Sano, M; Soejima, K; Yagishita, A; Raseev, G; Cherepkov, NA				Motoki, S; Adachi, J; Hikosaka, Y; Ito, K; Sano, M; Soejima, K; Yagishita, A; Raseev, G; Cherepkov, NA			K-shell photoionization of CO: I. Angular distributions of photoelectrons from fixed-in-space molecules	JOURNAL OF PHYSICS B-ATOMIC MOLECULAR AND OPTICAL PHYSICS			English	Article							ORIENTED MOLECULES; SCATTERING; CF3I	Angular distributions of photoelectrons from both C and O K-shells of the fixed-in-space CO molecule have been measured using the angle-resolved photoeletron-photoion coincidence technique. The measurements have been performed at several photon energies from the ionization thresholds up to about 30 eV above them, where the sigma* shape resonances occur. Experimental results are compared with the multiple-scattering calculations of Diil et al (1976 J. Chem. Phys. 65 3158) and with our new calculations in the relaxed-core Hartree-Fock approximation. Our calculations are in a better agreement with the experimental data though numerical discrepancies remain. The experimental angular distributions are fitted by the expansion in Legendre polynomials containing up to ten terms and the extracted parameters are compared with the corresponding theoretical values.	Univ Tokyo, Dept Chem, Bunkyo Ku, Tokyo 1130033, Japan; Inst Mat Struct Sci, Photon Factory, Tsukuba, Ibaraki 3050801, Japan; Japan Atom Energy Res Inst, Dept Synchrotron Radiat Res, Mikazuki, Hyogo 6795198, Japan; Niigata Univ, Grad Sch Sci & Technol, Niigata 95021, Japan; Univ Paris 11, CNRS, Photophys Mol Lab, F-91405 Orsay, France	Motoki, S (reprint author), Univ Tokyo, Dept Chem, Bunkyo Ku, Tokyo 1130033, Japan.		Hikosaka, Yasumasa/A-6328-2010	Hikosaka, Yasumasa/0000-0001-5898-4426			Shigemasa E, 1998, PHYS REV LETT, V80, P1622, DOI 10.1103/PhysRevLett.80.1622; DILL D, 1974, J CHEM PHYS, V61, P692, DOI 10.1063/1.1681947; DILL D, 1976, J CHEM PHYS, V65, P1130, DOI 10.1063/1.433187; SHIGEMASA E, 1995, PHYS REV LETT, V74, P359, DOI 10.1103/PhysRevLett.74.359; Cherepkov NA, 2000, J PHYS B-AT MOL OPT, V33, P4213, DOI 10.1088/0953-4075/33/20/302; Berkowitz J., 1979, PHOTOABSORPTION PHOT; Cherepkov NA, 2000, PHYS REV LETT, V84, P250, DOI 10.1103/PhysRevLett.84.250; CHEREPKOV NA, 1987, Z PHYS D ATOM MOL CL, V7, P271; Clementi E., 1974, Atomic Data and Nuclear Data Tables, V14, DOI 10.1016/S0092-640X(74)80016-1; DOWEK D, 2000, IN PRESS NUCL INSTRU; Downie P, 1999, PHYS REV LETT, V82, P2864, DOI 10.1103/PhysRevLett.82.2864; ELAND JHD, 1979, J CHEM PHYS, V70, P2926, DOI 10.1063/1.437831; Gessner O, 1999, J ELECTRON SPECTROSC, V101, P113, DOI 10.1016/S0368-2048(98)00421-6; Golovin AV, 1997, PHYS REV LETT, V79, P4554, DOI 10.1103/PhysRevLett.79.4554; GOLOVIN AV, 1992, Z PHYS D ATOM MOL CL, V24, P371; Hartree D R, 1957, CALCULATION ATOMIC S; LOW KG, 1985, CHEM PHYS, V100, P401; MCLEAN AD, 1974, IBM J RES DEV S, V12, P206; RASEEV G, 1992, SURF SCI, V269, P247; RASEEV G, 1980, COMPUT PHYS COMMUN, V20, P267, DOI 10.1016/0010-4655(80)90006-5; RASEEV G, 1991, HALF COLLISION RESON; RASEEV G, 1980, COMPUT PHYS COMMUN, V20, P275, DOI 10.1016/0010-4655(80)90007-7; SCHMIDT V, 1997, ELECT SPECTROMETRY A; SHIGEMASA E, 1993, PHYS REV A, V47, P1824, DOI 10.1103/PhysRevA.47.1824; SLATER JC, 1974, SELF CONSTANT FIELD, V4; Watanabe M, 1997, P SOC PHOTO-OPT INS, V3150, P58, DOI 10.1117/12.283983; WILHELMY I, 1994, CHEM PHYS, V185, P317, DOI 10.1016/0301-0104(94)00141-3; YAGISHITA A, 1998, 20 INT C PHYS EL AT, P149	28	56	56	IOP PUBLISHING LTD	BRISTOL	DIRAC HOUSE, TEMPLE BACK, BRISTOL BS1 6BE, ENGLAND	0953-4075			J PHYS B-AT MOL OPT	J. Phys. B-At. Mol. Opt. Phys.	OCT 28	2000	33	20					4193	4212		10.1088/0953-4075/33/20/301		20	Optics; Physics, Atomic, Molecular & Chemical	Optics; Physics	372JN	WOS:000165230700021		
J	Cherepkov, NA; Raseev, G; Adachi, J; Hikosaka, Y; Ito, K; Motoki, S; Sano, M; Soejima, K; Yagishita, A				Cherepkov, NA; Raseev, G; Adachi, J; Hikosaka, Y; Ito, K; Motoki, S; Sano, M; Soejima, K; Yagishita, A			K-shell photoionization of CO: II. Determination of dipole matrix elements and phase differences	JOURNAL OF PHYSICS B-ATOMIC MOLECULAR AND OPTICAL PHYSICS			English	Article							RESOLVED PHOTOELECTRON-SPECTROSCOPY; ANGULAR-DISTRIBUTIONS; CIRCULAR-DICHROISM; CROSS-SECTIONS; MOLECULAR PHOTOIONIZATION; PHOTOABSORPTION; APPROXIMATION; ELECTRONS; N-2	Using the experimental angular distributions of photoelectrons from the K-shells of an oriented CO molecule reported in a companion paper, we have performed a so-called complete experiment and determined 18 dynamical parameters (ten moduli of transition moments and eight phase differences) for the O K-shell, and 16 dynamical parameters (nine moduli of transition moments and seven phase differences) for the C K shell, and compared them with the results of our calculations in the relaxed-core Hartree-Fock (RCHF) approximation. The agreement between theory and experiment is only qualitative, therefore the model has to be improved by including electron correlations. From the analysis of experimental data we proved that the sigma* shape resonance is due to not only the f-wave, as was widely believed earlier, but is due to approximately equal contributions of three partial waves with 1 less than or equal to l less than or equal to 3 for the C R-shell, and four partial waves with 0 less than or equal to l less than or equal to 3 for the O K-shell, with a rather substantial contribution of other partial waves with I less than or equal to 5. From the analysis of the transition moments determined from the experiment it follows that several Cooper minima are likely to exist in partial photoionization cross sections, in particular, in the C 1s sigma --> epsilons sigma and in the O 1s sigma --> epsilond sigma transitions.	Inst Mat Struct Sci, Photon Factory, Tsukuba, Ibaraki 3050801, Japan; State Acad Aerosp Instrumentat, St Petersburg 190000, Russia; Univ Paris 11, CNRS, Photophys Mol Lab, F-91405 Orsay, France; Univ Tokyo, Dept Chem, Bunkyo Ku, Tokyo 1130033, Japan; Japan Atom Energy Res Inst, Dept Synchrotron Radiat Res, Mikazuki, Hyogo 6795198, Japan; Niigata Univ, Grad Sch Sci & Technol, Niigata 95021, Japan	Cherepkov, NA (reprint author), Inst Mat Struct Sci, Photon Factory, Oho 1-1, Tsukuba, Ibaraki 3050801, Japan.		Hikosaka, Yasumasa/A-6328-2010	Hikosaka, Yasumasa/0000-0001-5898-4426			DEHMER JL, 1975, PHYS REV LETT, V35, P213, DOI 10.1103/PhysRevLett.35.213; COOPER JW, 1962, PHYS REV, V128, P681, DOI 10.1103/PhysRev.128.681; FANO U, 1968, REV MOD PHYS, V40, P441, DOI 10.1103/RevModPhys.40.441; DEHMER JL, 1976, J CHEM PHYS, V65, P5327, DOI 10.1063/1.433034; Shigemasa E, 1998, PHYS REV LETT, V80, P1622, DOI 10.1103/PhysRevLett.80.1622; SHIGEMASA E, 1995, PHYS REV LETT, V74, P359, DOI 10.1103/PhysRevLett.74.359; DAVENPORT JW, 1976, PHYS REV LETT, V36, P945, DOI 10.1103/PhysRevLett.36.945; BANDARAGE G, 1993, PHYS REV A, V47, P1989, DOI 10.1103/PhysRevA.47.1989; Bederson B., 1969, Comments on Atomic and Molecular Physics, V1; BUDAU P, 1993, SURF SCI, V292, P67, DOI 10.1016/0039-6028(93)90391-V; CARLSON TA, 1983, J CHEM PHYS, V78, P638, DOI 10.1063/1.444820; CHEREPKOV NA, 1983, ADV ATOM MOL PHYS, V19, P395, DOI 10.1016/S0065-2199(08)60258-4; Cherepkov NA, 2000, PHYS REV LETT, V84, P250, DOI 10.1103/PhysRevLett.84.250; Gessner O, 1999, J ELECTRON SPECTROSC, V101, P113, DOI 10.1016/S0368-2048(98)00421-6; HATHERLY PA, 1995, J PHYS B-AT MOL OPT, V28, P2643, DOI 10.1088/0953-4075/28/13/016; HECKENKAMP C, 1986, Z PHYS D ATOM MOL CL, V2, P257; HEINZMANN U, 1996, VUV SOFT XRAY PHOTOI, P521; HEINZMANN U, 1980, J PHYS B-AT MOL OPT, V13, P4367, DOI 10.1088/0022-3700/13/22/011; Heiser F, 1997, PHYS REV LETT, V79, P2435, DOI 10.1103/PhysRevLett.79.2435; Ito K, 2000, PHYS REV LETT, V85, P46, DOI 10.1103/PhysRevLett.85.46; LEAHY DJ, 1992, J CHEM PHYS, V97, P4948, DOI 10.1063/1.463847; LYNCH DL, 1984, PHYS REV A, V30, P1561, DOI 10.1103/PhysRevA.30.1561; PADIAL N, 1978, J CHEM PHYS, V69, P2992, DOI 10.1063/1.437017; REID KL, 1992, PHYS REV LETT, V68, P3527, DOI 10.1103/PhysRevLett.68.3527; SCHIRMER J, 1990, PHYS REV A, V41, P283, DOI 10.1103/PhysRevA.41.283; SHIGEMASA E, 1993, PHYS REV A, V47, P1824, DOI 10.1103/PhysRevA.47.1824; STEPHENS JA, 1989, PHYS REV LETT, V62, P889, DOI 10.1103/PhysRevLett.62.889; WESTPHAL C, 1991, SURF SCI, V253, P205, DOI 10.1016/0039-6028(91)90593-H; WILHELMY I, 1994, CHEM PHYS, V185, P317, DOI 10.1016/0301-0104(94)00141-3	29	63	63	IOP PUBLISHING LTD	BRISTOL	DIRAC HOUSE, TEMPLE BACK, BRISTOL BS1 6BE, ENGLAND	0953-4075			J PHYS B-AT MOL OPT	J. Phys. B-At. Mol. Opt. Phys.	OCT 28	2000	33	20					4213	4236		10.1088/0953-4075/33/20/302		24	Optics; Physics, Atomic, Molecular & Chemical	Optics; Physics	372JN	WOS:000165230700022		
J	Kuroiwa, C; Vongphrachanh, P; Chosa, T; Murakami, H; Hashizume, M; Wakai, S; Tanaka, M				Kuroiwa, C; Vongphrachanh, P; Chosa, T; Murakami, H; Hashizume, M; Wakai, S; Tanaka, M			Risk of poliomyelitis importation and re-emergence in Laos	LANCET			English	Article								The declaration of poliomyelitis eradication in the western pacific region is scheduled for Oct 29, 2000, in Kyoto, Japan, Our survey in the border areas of the southeast Asia region, however, revealed that there remains a risk of re-emergence and importation of poliomyelitis into Lacs. We report the evidence based on our border area investigations during the past 4 years under the bilateral supervision of the governments of Laos and Japan.	Univ Tokyo, Grad Sch Med, Dept Int Community Hlth, Bunkyo Ku, Tokyo 1130033, Japan; Int Med Ctr Japan, Bur Int Cooperat, Tokyo, Japan; Japan Int Cooperat Agcy, Vientiane, Laos; Juntendo Univ, Sch Med, Dept Epidemiol, Tokyo 113, Japan; Minist Hlth, Natl Ctr Lab & Epidemiol, Vientiane, Laos; Univ Tsukuba, Tsukuba, Ibaraki 305, Japan	Wakai, S (reprint author), Univ Tokyo, Grad Sch Med, Dept Int Community Hlth, Bunkyo Ku, 7-3-1 Hongo, Tokyo 1130033, Japan.						HULL HF, 1994, LANCET, V343, P1331, DOI 10.1016/S0140-6736(94)92472-4; Kuroiwa C, 1999, J TROP PEDIATRICS, V45, P185, DOI 10.1093/tropej/45.3.185; PHOMPIDA S, 2000, NATL DOCUMENTATION C; *WHO, 2000, WKLY EPIDEMIOL RES, V75, P213; *WHO, 2000, 10 TECHN ADV M TAG E	5	6	6	LANCET LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0140-6736			LANCET	Lancet	OCT 28	2000	356	9240					1487	1488		10.1016/S0140-6736(00)02874-9		2	Medicine, General & Internal	General & Internal Medicine	367NA	WOS:000090067300015		
J	Matsunaga, S; Ohshima, T; Shibasaki, M				Matsunaga, S; Ohshima, T; Shibasaki, M			Immobilization of asymmetric multifunctional catalysts on an insoluble polymer	TETRAHEDRON LETTERS			English	Article						asymmetric catalyst; asymmetric synthesis; solid-phase synthesis; Michael reaction; linked-BINOL	ENANTIOSELECTIVE REACTIONS; COMPLEXES; LIGANDS	Polymer-supported linked-BINOL was synthesized to immobilize asymmetric catalysts with two BINOL units. The advantage of the polymer-supported linked-BINOL over randomly polymer-supported BINOL was confirmed by asymmetric Michael reaction. A novel polymer-supported La-Zn-linked-BINOL complex afforded the Michael adduct in good yield and moderate ee. (C) 2000 Elsevier Science Ltd. All rights reserved.	Univ Tokyo, Grad Sch Pharmaceut Sci, Bunkyo Ku, Tokyo 1130033, Japan	Shibasaki, M (reprint author), Univ Tokyo, Grad Sch Pharmaceut Sci, Bunkyo Ku, Tokyo 1130033, Japan.						Kobayashi S, 2000, ORG LETT, V2, P1225, DOI 10.1021/ol005656b; Annis DA, 1999, J AM CHEM SOC, V121, P4147, DOI 10.1021/ja984410n; Pu L, 1998, CHEM REV, V98, P2405, DOI 10.1021/cr970463w; Matsunaga S, 2000, J AM CHEM SOC, V122, P2252, DOI 10.1021/ja993650f; Nicolaou KC, 1998, J AM CHEM SOC, V120, P10814, DOI 10.1021/ja9823870; Yang XW, 2000, J ORG CHEM, V65, P295, DOI 10.1021/jo990771p; Yu HB, 2000, J AM CHEM SOC, V122, P6500, DOI 10.1021/ja000778k; Nozaki K, 1998, J AM CHEM SOC, V120, P4051, DOI 10.1021/ja973408d; Bayston DJ, 1998, J ORG CHEM, V63, P3137, DOI 10.1021/jo972330g; Fujii A, 1999, TETRAHEDRON LETT, V40, P8011, DOI 10.1016/S0040-4039(99)01663-9; Heckel A, 2000, ANGEW CHEM INT EDIT, V39, P163, DOI 10.1002/(SICI)1521-3773(20000103)39:1<163::AID-ANIE163>3.0.CO;2-J; Huang WS, 1997, J AM CHEM SOC, V119, P4313, DOI 10.1021/ja964285k; Kamitani J, 1998, CHEM LETT, P1047, DOI 10.1246/cl.1998.1047; Kim YS, 2000, J AM CHEM SOC, V122, P6506, DOI 10.1021/ja001036u; Seebach D, 1996, HELV CHIM ACTA, V79, P1710, DOI 10.1002/hlca.19960790621; Shibasaki M., 1997, ANGEW CHEM INT EDIT, V36, P1236, DOI DOI 10.1002/ANIE.199712361; Shuttleworth SJ, 2000, SYNTHESIS-STUTTGART, P1035; Uozumi Y, 1998, TETRAHEDRON LETT, V39, P8303, DOI 10.1016/S0040-4039(98)01812-7	18	74	76	PERGAMON-ELSEVIER SCIENCE LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND	0040-4039			TETRAHEDRON LETT	Tetrahedron Lett.	OCT 28	2000	41	44					8473	8478		10.1016/S0040-4039(00)01486-6		6	Chemistry, Organic	Chemistry	370YE	WOS:000165150200015		
J	Goto, K; Hino, Y; Kawashima, T; Kaminaga, M; Yano, E; Yamamoto, G; Takagi, N; Nagase, S				Goto, K; Hino, Y; Kawashima, T; Kaminaga, M; Yano, E; Yamamoto, G; Takagi, N; Nagase, S			Synthesis and crystal structure of a stable S-nitrosothiol bearing a novel steric protection group and of the corresponding S-nitrothiol	TETRAHEDRON LETTERS			English	Article						S-nitrosothiol; S-nitrothiol; X-ray crystal structures; theoretical studies	SULFENIC ACID; FUNCTIONALITY	The molecular structure of a stable S-nitrosothiol bearing a novel trityl-type steric protection group was established by X-ray crystallographic analysis together with that of the corresponding S-nitrothiol. It was found that the S-nitrosothiol exists as a mixture of the syn and anti isomers with respect to the C-S-N-O linkage in the crystalline state, in agreement with the theoretical calculation on Ph3CSNO. (C) 2000 Elsevier Science Ltd. All rights reserved.	Univ Tokyo, Grad Sch Sci, Dept Chem, Bunkyo Ku, Tokyo 1130033, Japan; Kitasato Univ, Sch Sci, Dept Chem, Sagamihara, Kanagawa 2288555, Japan; Tokyo Metropolitan Univ, Grad Sch Sci, Dept Chem, Hachioji, Tokyo 1920397, Japan	Goto, K (reprint author), Univ Tokyo, Grad Sch Sci, Dept Chem, Bunkyo Ku, 7-3-1 Hongo, Tokyo 1130033, Japan.						Goto K, 1997, J AM CHEM SOC, V119, P1460, DOI 10.1021/ja962994s; Arulsamy N, 1999, J AM CHEM SOC, V121, P7115, DOI 10.1021/ja9901314; GOTO K, 1995, ANGEW CHEM INT EDIT, V34, P1124, DOI 10.1002/anie.199511241; ARTZ JD, 1996, J CHEM SOC CHEM COMM, P927; CARNAHAN GE, 1978, ACTA CRYSTALLOGR B, V34, P2645, DOI 10.1107/S0567740878008857; FELDMAN PL, 1993, CHEM ENG NEWS, V20, P26; FIELD L, 1978, J CHEM SOC CHEM COMM, P249, DOI 10.1039/c39780000249; Goto K, 1997, LIEBIGS ANN-RECL, P2393; Goto K, 1998, CHEM COMMUN, P1915, DOI 10.1039/a805449e; KIM YH, 1993, PHOSPHORUS SULFUR, V74, P249, DOI 10.1080/10426509308038111; LYN D, 1999, ACCOUNTS CHEM RES, V32, P869; OAE S, 1980, B CHEM SOC JPN, V53, P775, DOI 10.1246/bcsj.53.775; Saiki T, 1996, J ORG CHEM, V61, P2924, DOI 10.1021/jo960068q; Saiki T, 1997, ANGEW CHEM INT EDIT, V36, P2223, DOI 10.1002/anie.199722231	14	41	42	PERGAMON-ELSEVIER SCIENCE LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND	0040-4039			TETRAHEDRON LETT	Tetrahedron Lett.	OCT 28	2000	41	44					8479	8483		10.1016/S0040-4039(00)01487-8		5	Chemistry, Organic	Chemistry	370YE	WOS:000165150200016		
J	Nakajima, T; Hirao, K				Nakajima, T; Hirao, K			Numerical illustration of third-order Douglas-Kroll method: atomic and molecular properties of superheavy element 112	CHEMICAL PHYSICS LETTERS			English	Article							MANY-ELECTRON ATOMS; RELATIVISTIC CORRECTIONS; PERTURBATION-THEORY; CHEMISTRY; SCHEME	The recently proposed third-order Douglas-Kroll method (DK3) is applied to superheavy element 112, the hydride of 112, and its ions. The results are compared to the second-order DK (DK2) results. The effect of the third-order scalar relativistic corrections with the DK3 Hamiltonian is found to be relatively small for the valence-shell properties of element 112, (112)H, and its ions although DK3 represents a significant improvement over DK2 for the inner core shells. (C) 2000 Elsevier Science B.V. All rights reserved.	Univ Tokyo, Grad Sch Engn, Dept Appl Chem, Tokyo 1138656, Japan	Nakajima, T (reprint author), Univ Tokyo, Grad Sch Engn, Dept Appl Chem, Tokyo 1138656, Japan.						ANDERSSON K, 1997, MOLCAS VERSION 4; Seth M, 1999, J CHEM PHYS, V111, P6422, DOI 10.1063/1.480168; JANSEN G, 1989, PHYS REV A, V39, P6016, DOI 10.1103/PhysRevA.39.6016; Seth M, 1997, J CHEM PHYS, V106, P3623, DOI 10.1063/1.473437; SAMZOW R, 1992, J CHEM PHYS, V96, P1227, DOI 10.1063/1.462210; SUCHER J, 1980, PHYS REV A, V22, P348, DOI 10.1103/PhysRevA.22.348; VANLENTHE E, 1993, J CHEM PHYS, V99, P4597; BUENKER RJ, 1984, CHEM PHYS, V84, P1, DOI 10.1016/0301-0104(84)80001-4; PYYKKO P, 1988, CHEM REV, V88, P563, DOI 10.1021/cr00085a006; FOLDY LL, 1950, PHYS REV, V78, P29, DOI 10.1103/PhysRev.78.29; MALLI GL, 1993, PHYS REV A, V47, P143, DOI 10.1103/PhysRevA.47.143; DOUGLAS M, 1974, ANN PHYS-NEW YORK, V82, P89, DOI 10.1016/0003-4916(74)90333-9; ELIAV E, 1995, PHYS REV A, V52, P2765, DOI 10.1103/PhysRevA.52.2765; HOFFMANN S, 1996, Z PHYS A, V354, P229; KUTZELNIGG W, 1989, Z PHYS D ATOM MOL CL, V11, P15; KUTZELNIGG W, 1990, Z PHYS D ATOM MOL CL, V15, P27; LIE GC, 1974, J CHEM PHYS, V60, P1275, DOI 10.1063/1.1681192; Nakajima T, 1999, CHEM PHYS LETT, V304, P271, DOI 10.1016/S0009-2614(99)00304-8; NAKAJIMA T, 2000, J CHEM PHYS, V113; Nakajima T, 1999, CHEM PHYS LETT, V302, P383, DOI 10.1016/S0009-2614(99)00150-5; Seth M, 1996, CHEM PHYS LETT, V250, P461, DOI 10.1016/0009-2614(96)00039-5	21	50	50	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	0009-2614			CHEM PHYS LETT	Chem. Phys. Lett.	OCT 27	2000	329	5-6					511	516		10.1016/S0009-2614(00)01035-6		6	Chemistry, Physical; Physics, Atomic, Molecular & Chemical	Chemistry; Physics	371EA	WOS:000165164000027		
J	Hansen, JL; Servant, G; Baranski, TJ; Fujita, T; Iiri, T; Haunso, S; Sheikh, SP				Hansen, JL; Servant, G; Baranski, TJ; Fujita, T; Iiri, T; Haunso, S; Sheikh, SP			Functional reconstitution of the angiotensin II type 2 receptor and G(i) activation	CIRCULATION RESEARCH			English	Article						AT(2); angiotensin II type 2 receptor; G(i) activation	PROTEIN-KINASE; AT(2) RECEPTOR; NG108-15 CELLS; INHIBITION; EXPRESSION; APOPTOSIS; CLONING; MUTANT; GROWTH	On the basis of the patterns of conserved amino acid sequence, the angiotensin II type 2 (AT(2)) receptor belongs to the family of serpentine receptors, which relay signals from extracellular stimuli to heterotrimeric G proteins. However, the AT(2) receptor signal transduction mechanisms are poorly understood. We have measured AT(2)-triggered activation of purified heterotrimeric proteins in urea-extracted membranes from cultured COS-7 cells expressing the recombinant receptor. This procedure removes contaminating GTP-binding proteins without inactivating the serpentine receptor. Binding studies using [I-125] angiotensin (Ang) II revealed a single binding site with a K-d=0.45 and a capacity of 627 fmol/mg protein in the extracted membranes. The AT(2) receptor caused a rapid activation of alpha(i) and alpha(o), but not of alpha(q) and alpha(s), as measured by radioactive guanosine 5'-3-O-(thio)triphosphate (GTP gammaS) binding. Activation required the presence of activated receptors, beta gamma, and alpha subunits. As a first step aimed at developing an in vitro assay to examine AT(2) receptor pharmacology, we tested a battery of Ang II-related ligands for their ability to promote AT(1) or AT(2) receptor-catalyzed G(i) activation. Two proteolytic fragments of Ang II, Ang III and Ang1-7, also promoted activation of alpha(i) through the AT(2) receptor. Furthermore, we found that [Sar(1),Ala(8)]Ang II is an antagonist for both AT(1) and AT(2) receptors and that CPG42112 behaves as a partial agonist for the AT(2) receptor. In combination with previous observations, these results show that the AT(2) receptor is fully capable of activating G(i) and provides a new tool for exploring AT(2) receptor pharmacology and interactions with G-protein trimers.	Univ Copenhagen, Rigshosp 9312, Mol Cardiol Lab, DK-2100 Copenhagen, Denmark; Univ Copenhagen, Dept Med B, DK-2100 Copenhagen, Denmark; Univ Calif San Francisco, Cardiovasc Res Inst, San Francisco, CA 94143 USA; Washington Univ, Sch Med, Dept Internal Med, St Louis, MO 63110 USA; Washington Univ, Sch Med, Dept Mol Biol & Pharmacol, Div Endocrinol Diabet & Metab, St Louis, MO 63110 USA; Univ Tokyo, Sch Med, Tokyo 113, Japan; Univ Tokyo, Dept Endocrinol & Nephrol, Tokyo 113, Japan	Sheikh, SP (reprint author), Univ Copenhagen, Rigshosp 9312, Mol Cardiol Lab, Juliane Mariesvej 20, DK-2100 Copenhagen, Denmark.						Hamm HE, 1998, J BIOL CHEM, V273, P669, DOI 10.1074/jbc.273.2.669; Horiuchi M, 1997, J BIOL CHEM, V272, P19022, DOI 10.1074/jbc.272.30.19022; Zhang JS, 1996, J BIOL CHEM, V271, P15026; Hayashida W, 1996, J BIOL CHEM, V271, P21985; BUISSON B, 1995, J BIOL CHEM, V270, P1670; Strawn WB, 1999, HYPERTENSION, V33, P207; Matsubara H, 1998, CIRC RES, V83, P1182; KANG J, 1994, AM J PHYSIOL-CELL PH, V267, pC1389; Abbas A, 1997, HYPERTENSION, V30, P217; KOZASA T, 1995, J BIOL CHEM, V270, P1734; Fischer TA, 1998, AM J PHYSIOL-HEART C, V275, pH906; Gendron L, 1999, MOL ENDOCRINOL, V13, P1615, DOI 10.1210/me.13.9.1615; TIMMERMANS PBMWM, 1993, PHARMACOL REV, V45, P205; Bedecs K, 1997, BIOCHEM J, V325, P449; MUKOYAMA M, 1993, J BIOL CHEM, V268, P24539; Stroth U, 1998, MOL BRAIN RES, V53, P187, DOI 10.1016/S0169-328X(97)00298-2; Lehtonen JYA, 1999, MOL ENDOCRINOL, V13, P1051, DOI 10.1210/me.13.7.1051; ERNST OP, 1995, J BIOL CHEM, V270, P10580; CAMARGO LAD, 1999, REGUL PEPTIDES, V82, P91; Dulin NO, 1998, P NATL ACAD SCI USA, V95, P8098, DOI 10.1073/pnas.95.14.8098; Griendling K K, 1994, Adv Pharmacol, V28, P269, DOI 10.1016/S1054-3589(08)60498-6; Hein L, 1998, J MOL MED-JMM, V76, P756, DOI 10.1007/s001090050277; Hellmich MR, 1997, P NATL ACAD SCI USA, V94, P751, DOI 10.1073/pnas.94.2.751; Iiri T, 1997, P NATL ACAD SCI USA, V94, P5656, DOI 10.1073/pnas.94.11.5656; JAISWAL N, 1991, HYPERTENSION, V17, P1115; Ozawa Y, 1996, BIOCHEM BIOPH RES CO, V228, P328, DOI 10.1006/bbrc.1996.1661; SASAKI K, 1991, NATURE, V351, P230, DOI 10.1038/351230a0; Schelman WR, 1997, MOL BRAIN RES, V48, P197, DOI 10.1016/S0169-328X(97)00093-4; SERVANT G, 1993, MOL PHARMACOL, V43, P677; Sheikh SP, 1999, J BIOL CHEM, V274, P17033, DOI 10.1074/jbc.274.24.17033; WONG SKF, 1994, J BIOL CHEM, V269, P18968	31	52	53	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	530 WALNUT ST, PHILADELPHIA, PA 19106-3621 USA	0009-7330			CIRC RES	Circ.Res.	OCT 27	2000	87	9					753	759				7	Cardiac & Cardiovascular Systems; Hematology; Peripheral Vascular Disease	Cardiovascular System & Cardiology; Hematology	372DJ	WOS:000165218800008		
J	Kodera, Y; Takeyama, K; Murayama, A; Suzawa, M; Masuhiro, Y; Kato, S				Kodera, Y; Takeyama, K; Murayama, A; Suzawa, M; Masuhiro, Y; Kato, S			Ligand type-specific interactions of peroxisome proliferator-activated receptor gamma with transcriptional coactivators	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PPAR-GAMMA; NUCLEAR RECEPTORS; DIFFERENTIATION; COMPLEX; REQUIRES; BINDING	The nuclear peroxisome proliferator-activated receptor gamma (PPAR gamma) is a member of the nuclear receptor superfamily and acts as a ligand-dependent transcription factor mediating adipocyte differentiation, cell proliferation and inflammatory processes, and modulation of insulin sensitivity. Members of the 160-kDa protein (SRC-1/TIF2/AIB-1) family of coactivators, CBP/p300 and TRAP220/DRIP205, are shown to interact directly with PPAR gamma and potentiate nuclear receptor transactivation function in a ligand-dependent fashion. Because PPAR gamma ligands exert partially overlapping but distinct subsets of biological action through PPAR gamma binding, we wished to examine whether interactions between PPAR gamma and known coactivators were induced to the same extent by different classes of PPAR gamma ligand. The natural ligand 15-deoxy-Delta 12,14-prostaglandin J(2) induced PPAR gamma interactions with all coactivators tested (SRC-1, TIF2, AIB-1, p300, TRAP220/DRIP205) in yeast and mammalian two-hybrid assays, as well as in a glutathione S-transferase pull-down assay. However, under the same conditions troglitazone, a synthetic PPAR gamma ligand that acts as an antidiabetic agent, did not induce PPAR gamma interactions with any of the coactivators. Our findings suggest that ligand binding may alter PPAR gamma structure in a ligand type-specific way, resulting in distinct PPAR gamma -coactivator interactions.	Univ Tokyo, Inst Mol & Cellular Biosci, Bunkyo Ku, Tokyo 1130032, Japan	Kato, S (reprint author), Univ Tokyo, Inst Mol & Cellular Biosci, Bunkyo Ku, Yayoi 1-1-1, Tokyo 1130032, Japan.						Puigserver P, 1999, SCIENCE, V286, P1368, DOI 10.1126/science.286.5443.1368; Chen HW, 1999, CELL, V98, P675, DOI 10.1016/S0092-8674(00)80054-9; Yanase T, 1997, BIOCHEM BIOPH RES CO, V233, P320, DOI 10.1006/bbrc.1997.6446; Puigserver P, 1998, CELL, V92, P829, DOI 10.1016/S0092-8674(00)81410-5; FORMAN BM, 1995, CELL, V83, P803, DOI 10.1016/0092-8674(95)90193-0; Shiau AK, 1998, CELL, V95, P927, DOI 10.1016/S0092-8674(00)81717-1; Heery DM, 1997, NATURE, V387, P733; Adams M, 1997, J CLIN INVEST, V100, P3149, DOI 10.1172/JCI119870; Anzick SL, 1997, SCIENCE, V277, P965, DOI 10.1126/science.277.5328.965; ONATE SA, 1995, SCIENCE, V270, P1354; Nagy L, 1998, CELL, V93, P229, DOI 10.1016/S0092-8674(00)81574-3; Kamei Y, 1996, CELL, V85, P403, DOI 10.1016/S0092-8674(00)81118-6; Yanagisawa J, 1999, SCIENCE, V283, P1317, DOI 10.1126/science.283.5406.1317; MANGELSDORF DJ, 1995, CELL, V83, P841, DOI 10.1016/0092-8674(95)90200-7; Rossi A, 2000, NATURE, V403, P103; Day C, 1999, DIABETIC MED, V16, P179, DOI 10.1046/j.1464-5491.1999.00023.x; Rachez C, 1999, NATURE, V398, P824; Takeyama KI, 1999, MOL CELL BIOL, V19, P1049; Lanz RB, 1999, CELL, V97, P17, DOI 10.1016/S0092-8674(00)80711-4; Zhu YJ, 1997, J BIOL CHEM, V272, P25500, DOI 10.1074/jbc.272.41.25500; Spencer TE, 1997, NATURE, V389, P194; Kersten S, 2000, NATURE, V405, P421; Oberfield JL, 1999, P NATL ACAD SCI USA, V96, P6102, DOI 10.1073/pnas.96.11.6102; Nolte RT, 1998, NATURE, V395, P137; Chakravarti D, 1996, NATURE, V383, P99, DOI 10.1038/383099a0; Takeyama K, 1997, SCIENCE, V277, P1827, DOI 10.1126/science.277.5333.1827; Glass CK, 2000, GENE DEV, V14, P121; Castillo G, 1999, EMBO J, V18, P3676, DOI 10.1093/emboj/18.13.3676; KATO S, 1995, MOL CELL BIOL, V15, P5858; Schulman IG, 1998, MOL CELL BIOL, V18, P3483; Spiegelman BM, 1998, DIABETES, V47, P507, DOI 10.2337/diabetes.47.4.507; Yanagi Y, 2000, BIOCHEM BIOPH RES CO, V269, P410, DOI 10.1006/bbrc.2000.2304	32	170	172	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	OCT 27	2000	275	43					33201	33204		10.1074/jbc.C000517200		4	Biochemistry & Molecular Biology	Biochemistry & Molecular Biology	368EK	WOS:000090104600005		
J	Yamauchi, T; Yamauchi, N; Ueki, K; Sugiyama, T; Waki, H; Miki, H; Tobe, K; Matsuda, S; Tsushima, T; Yamamoto, T; Fujita, T; Taketani, Y; Fukayama, M; Kimura, S; Yazaki, Y; Nagai, R; Kadowaki, T				Yamauchi, T; Yamauchi, N; Ueki, K; Sugiyama, T; Waki, H; Miki, H; Tobe, K; Matsuda, S; Tsushima, T; Yamamoto, T; Fujita, T; Taketani, Y; Fukayama, M; Kimura, S; Yazaki, Y; Nagai, R; Kadowaki, T			Constitutive tyrosine phosphorylation of ErbB-2 via Jak2 by autocrine secretion of prolactin in human breast cancer	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HER2/NEU-OVEREXPRESSING METASTATIC BREAST; RAS SIGNALING PATHWAY; GROWTH-HORMONE; NEU ONCOGENE; CARCINOMA-CELLS; FACTOR-RECEPTOR; EGF RECEPTOR; PROTEIN OVEREXPRESSION; MONOCLONAL-ANTIBODY; RECURRENT DISEASE	Overexpression of the oncogene for ErbB-2 is an unfavorable prognostic marker in human breast cancer. Its oncogenic potential appears to depend on the state of tyrosine phosphorylation, However, the mechanisms by which ErbB-2 is constitutively tyrosine-phospholylated in human breast cancer are poorly understood. We now show that human breast carcinoma samples with ErbB-2 overexpression have higher proliferative and metastatic activity in the presence of autocrine secretion of prolactin (PRL). By using a neutralizing antibody or dominant negative (DN) strategies or specific inhibitors, we also show that activation of Janus kinase Jak2 by autocrine secretion of PRL is one of the significant components of constitutive tyrosine phosphorylation of ErbB-2, its association with Grb2 and activation of mitogen-activated protein (MAP) kinase in human breast cancer cell lines that overexpress ErbB-2. Furthermore, the neutralizing anti-PRL antibody or erbB-2 antisense oligonucleotide or DN Jak2 or Jak2 inhibitor or DNRas or MAP kinase kinase inhibitor inhibits the proliferation of both untreated and PRL treated cells. Our results indicate that autocrine secretion of PRL stimulates tyrosine phosphorylation of ErbB-2 by Jak2, provides docking sites for Grb2 and stimulates Ras-MAP kinase cascade, thereby causing unrestricted cellular proliferation. The identification of this novel cross-talk between ErbB-2 and the autocrine growth stimulatory loop for PRL may provide new targets for therapeutic and preventive intervention of human breast cancer.	Univ Tokyo, Grad Sch Med, Dept Internal Med, Bunkyo Ku, Tokyo 113, Japan; Univ Tokyo, Grad Sch Med, Dept Pathol, Tokyo 113, Japan; Nagoya Univ, Sch Med, Dept Mol Pathogenesis, Nagoya, Aichi 466, Japan; Tokyo Womens Med Coll, Dept Internal Med 2, Tokyo 162, Japan; Univ Tokyo, Inst Med Sci, Dept Oncol, Tokyo 108, Japan; Univ Tokyo, Grad Sch Med, Dept Obstet & Gynecol, Tokyo 113, Japan; Int Med Ctr Japan, Tokyo 162, Japan	Kadowaki, T (reprint author), Univ Tokyo, Grad Sch Med, Dept Internal Med, Bunkyo Ku, 7-3-1 Hongo, Tokyo 113, Japan.						IHLE JN, 1995, TRENDS GENET, V11, P69, DOI 10.1016/S0168-9525(00)89000-9; Baselga J, 1996, J CLIN ONCOL, V14, P737; Wennbo H, 1997, J CLIN INVEST, V100, P2744, DOI 10.1172/JCI119820; Clark JW, 1996, INT J CANCER, V65, P186; Ng ST, 1997, NAT MED, V3, P1141, DOI 10.1038/nm1097-1141; SCHECHTER AL, 1985, SCIENCE, V229, P976, DOI 10.1126/science.2992090; PRESS MF, 1993, CANCER RES, V53, P4960; PADHY LC, 1982, CELL, V28, P865, DOI 10.1016/0092-8674(82)90065-4; OShea JJ, 1997, IMMUNITY, V7, P1, DOI 10.1016/S1074-7613(00)80505-1; Qiu Y, 1998, NATURE, V393, P83; PAIK S, 1990, J CLIN ONCOL, V8, P103; JANES PW, 1994, ONCOGENE, V9, P3601; CLEVENGER CV, 1995, AM J PATHOL, V146, P695; Meydan N, 1996, NATURE, V379, P645, DOI 10.1038/379645a0; COLOMER R, 1994, BRIT J CANCER, V70, P819, DOI 10.1038/bjc.1994.405; Andrulis IL, 1998, J CLIN ONCOL, V16, P1340; Pegram MD, 1998, J CLIN ONCOL, V16, P2659; Winston LA, 1995, J BIOL CHEM, V270, P30837; WEINER DB, 1989, NATURE, V339, P230, DOI 10.1038/339230a0; GULLICK WJ, 1991, BRIT J CANCER, V63, P434, DOI 10.1038/bjc.1991.100; COUSSENS L, 1985, SCIENCE, V230, P1132, DOI 10.1126/science.2999974; BARGMANN CI, 1986, NATURE, V319, P226, DOI 10.1038/319226a0; BARGMANN CI, 1986, CELL, V45, P649, DOI 10.1016/0092-8674(86)90779-8; BURGERING BMT, 1995, TRENDS BIOCHEM SCI, V20, P18, DOI 10.1016/S0968-0004(00)88944-6; Chu KC, 1996, J NATL CANCER I, V88, P1571, DOI 10.1093/jnci/88.21.1571; DSOUZA B, 1994, P NATL ACAD SCI USA, V91, P7202, DOI 10.1073/pnas.91.15.7202; EPSTEIN RJ, 1992, P NATL ACAD SCI USA, V89, P10435, DOI 10.1073/pnas.89.21.10435; ERWIN RA, 1995, ENDOCRINOLOGY, V136, P3512, DOI 10.1210/en.136.8.3512; FUH G, 1995, J BIOL CHEM, V270, P13133; GINSBURG E, 1995, CANCER RES, V55, P2591; Hortobagyi GN, 1998, NEW ENGL J MED, V339, P974; HUGHES JP, 1982, ENDOCRINOLOGY, V111, P827; KADOWAKI T, 1987, BIOCHEM BIOPH RES CO, V144, P699, DOI 10.1016/S0006-291X(87)80021-9; KING CR, 1988, EMBO J, V7, P1647; LEMOINE NR, 1990, ONCOGENE, V5, P227; MAGUIRE HC, 1989, SEMIN ONCOL, V16, P148; Miyake S, 1996, P NATL ACAD SCI USA, V93, P1320, DOI 10.1073/pnas.93.3.1320; Parker SL, 1997, CA-CANCER J CLIN, V47, P5, DOI 10.3322/canjclin.47.1.5; PATERSON MC, 1991, CANCER RES, V51, P556; Reynolds C, 1997, ENDOCRINOLOGY, V138, P5555, DOI 10.1210/en.138.12.5555; ROZAKISADCOCK M, 1992, NATURE, V360, P689, DOI 10.1038/360689a0; SEMBA K, 1985, P NATL ACAD SCI USA, V82, P6497, DOI 10.1073/pnas.82.19.6497; SHIH C, 1981, NATURE, V290, P261, DOI 10.1038/290261a0; SLAMON DJ, 1989, SCIENCE, V244, P707, DOI 10.1126/science.2470152; SLAMON DJ, 1987, SCIENCE, V235, P177, DOI 10.1126/science.3798106; STERN DF, 1988, MOL CELL BIOL, V8, P3969; SUDA Y, 1990, EMBO J, V9, P181; ULLRICH A, 1990, CELL, V61, P203, DOI 10.1016/0092-8674(90)90801-K; Watanabe S, 1996, J BIOL CHEM, V271, P12681; WEINER DB, 1989, ONCOGENE, V4, P1175; WIECHEN K, 1995, INT J CANCER, V63, P604, DOI 10.1002/ijc.2910630423; WRIGHT C, 1989, CANCER RES, V49, P2087; YAMAMOTO T, 1985, NATURE, V319, P220; Yamauchi N, 1996, INT J GYNECOL PATHOL, V15, P202, DOI 10.1097/00004347-199607000-00003; Yamauchi T, 1997, NATURE, V390, P91; Yamauchi T, 1998, J BIOL CHEM, V273, P15719, DOI 10.1074/jbc.273.25.15719; ZOLL B, 1992, J CANCER RES CLIN, V118, P468, DOI 10.1007/BF01629432	57	74	75	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	OCT 27	2000	275	43					33937	33944		10.1074/jbc.M000743200		8	Biochemistry & Molecular Biology	Biochemistry & Molecular Biology	368EK	WOS:000090104600104		
J	Yun, J; Lee, CK; Chang, IM; Takatsu, K; Hirano, T; Min, KR; Lee, MK; Kim, Y				Yun, J; Lee, CK; Chang, IM; Takatsu, K; Hirano, T; Min, KR; Lee, MK; Kim, Y			Differential inhibitory effects of sophoricoside analogs on bioactivity of several cytokines	LIFE SCIENCES			English	Article						proinflammatory cytokine; sophoricoside; genistin; genistein; orobol; immunosuppressive and anti-inflammatory effects	ENDOTHELIAL-CELLS; INTERLEUKIN-1; RECEPTOR; IL-1; CLONING; CHAIN	Effects of sophoricoside and its analogs on proinflammatory cytokines have been investigated. Sophoricoside, genistein and orobol exhibited inhibitory effects on IL-5, IL-3, GM-CSF and IL-6 bioactivities, Genistin showed inhibitory effects on IL-5 and IL-3 bioactivities, but did not inhibit GMCSF and IL-6 bioactivities. None of the sophoricoside analogs showed inhibitory effects on both IL-1 beta and TNF-alpha bioactivities. Among the compounds, sophoricoside exhibited the highest inhibitory effects on IL-5, IL-3 and IL-6 bioactivities with IC50 values of 1.9 muM, 6.9 muM and 6.0 muM, respectively and orobol did show on GM-CSF bioactivity with an IC50 value of 18.0 muM. The result would provide an additional mechanism by which the compounds exert immunosuppressive and anti-inflammatory effects. (C) 2000 Elsevier Science Inc. All rights reserved.	Chungbuk Natl Univ, Coll Pharm, Cheongju 361763, South Korea; Seoul Natl Univ, Nat Resources Res Inst, Seoul 110460, South Korea; Univ Tokyo, Inst Med Sci, Tokyo 1088639, Japan; Osaka Univ, Sch Med, Biomed Res Ctr, Suita, Osaka 565, Japan	Kim, Y (reprint author), Chungbuk Natl Univ, Coll Pharm, Cheongju 361763, South Korea.		Hirano, Toshio/C-8194-2009				SIRONI M, 1989, J IMMUNOL, V142, P549; CLARK SC, 1987, SCIENCE, V236, P1229, DOI 10.1126/science.3296190; GREENFEDER SA, 1995, J BIOL CHEM, V270, P13757; SIMS JE, 1994, CLIN IMMUNOL IMMUNOP, V72, P9, DOI 10.1006/clin.1994.1100; QUELLE FW, 1994, MOL CELL BIOL, V14, P4335; ENGELMANN H, 1990, J BIOL CHEM, V265, P1531; YAMASAKI K, 1988, SCIENCE, V241, P825, DOI 10.1126/science.3136546; Hibi M, 1996, J MOL MED-JMM, V74, P1, DOI 10.1007/BF00202068; SANDERSON CJ, 1992, BLOOD, V79, P3101; DINARELLO CA, 1986, J EXP MED, V163, P1433, DOI 10.1084/jem.163.6.1433; Dower S K, 1994, Ther Immunol, V1, P113; Fiedor P, 1998, TRANSPLANT P, V30, P537, DOI 10.1016/S0041-1345(97)01395-X; Flatman PW, 1996, AM J PHYSIOL-CELL PH, V271, pC255; GLEICH GJ, 1990, J ALLERGY CLIN IMMUN, V85, P422, DOI 10.1016/0091-6749(90)90151-S; HIRANO T, 1992, CHEM IMMUNOL, V51, P153; Hirano T, 1998, Int Rev Immunol, V16, P249, DOI 10.3109/08830189809042997; HOWELLS GL, 1988, IMMUNOL LETT, V19, P169, DOI 10.1016/0165-2478(88)90138-1; IHLE JN, 1995, ANNU REV IMMUNOL, V13, P369, DOI 10.1146/annurev.iy.13.040195.002101; Middleton E., 1994, FLAVONOIDS ADV RES 1, P619; Min B, 1999, PLANTA MED, V65, P408, DOI 10.1055/s-1999-14016; Pugh-Humphreys R G, 1998, CYTOKINE HDB, P885; TAKATSU K, 1995, INTERLEUKIN 5 ITS RE; TAVERNIER J, 1991, CELL, V66, P1175, DOI 10.1016/0092-8674(91)90040-6	23	22	23	PERGAMON-ELSEVIER SCIENCE LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND	0024-3205			LIFE SCI	Life Sci.	OCT 27	2000	67	23					2855	2863		10.1016/S0024-3205(00)00873-0		9	Medicine, Research & Experimental; Pharmacology & Pharmacy	Research & Experimental Medicine; Pharmacology & Pharmacy	371EB	WOS:000165164200007		
J	Ishida, K; Kato, T; Murakami, M; Watanabe, M; Watanabe, MF				Ishida, K; Kato, T; Murakami, M; Watanabe, M; Watanabe, MF			Microginins, zinc metalloproteases inhibitors from the cyanobacterium Microcystis aeruginosa	TETRAHEDRON			English	Article							ANGIOTENSIN-CONVERTING ENZYME; BACILLUS-LATEROSPORUS BMI156-14F1; STREPTOMYCES-AZUREUS MH663-2F6; LENS LEUCINE AMINOPEPTIDASE; NUCLEAR MAGNETIC-RESONANCE; HALOPHYTICA SUBSP EXILISIA; PHYSICOCHEMICAL PROPERTIES; BIOLOGICAL-ACTIVITIES; AMINO-ACIDS; BESTATIN	Eight new linear peptides, microginins 478 (1), 51-A (2), 51-B (3) and 91-A (4) to 91-E (8), congeners of mioroginin, were isolated from the cyanobacterium Microcystis aeruginosa. These structures were elucidated to be 1-8 on the basis of 2D NMR data and chemical degradation. These peptides inhibited aminopeptidase M (1, 2 and 6-8) and angiotensin-converting enzyme (1). Tnt: structure-activity relationship within a series of degradation and derivative products of microginin was investigated by the chemical studies. (C) 2000 Elsevier Science Ltd. All rights reserved.	Univ Tokyo, Grad Sch Agr & Life Sci, Lab Marine Biochem, Bunkyo Ku, Tokyo 1138657, Japan; Natl Sci Museum, Dept Bot, Tsukuba, Ibaraki 3050005, Japan; Rissho Univ, Fac Geoenvironm Sci, Dept Environm Syst, Shinagawa Ku, Tokyo 1418602, Japan	Murakami, M (reprint author), Univ Tokyo, Grad Sch Agr & Life Sci, Lab Marine Biochem, Bunkyo Ku, Tokyo 1138657, Japan.						UMEZAWA H, 1976, J ANTIBIOT, V29, P97; CHEUNG HS, 1980, J BIOL CHEM, V255, P401; CUSHMAN DW, 1977, BIOCHEMISTRY-US, V16, P5484, DOI 10.1021/bi00644a014; DALE JA, 1973, J AM CHEM SOC, V95, P512, DOI 10.1021/ja00783a034; BAX A, 1986, J MAGN RESON, V67, P565, DOI 10.1016/0022-2364(86)90395-1; MARFEY P, 1984, CARLSBERG RES COMMUN, V49, P591, DOI 10.1007/BF02908688; CUSHMAN DW, 1971, BIOCHEM PHARMACOL, V20, P1637, DOI 10.1016/0006-2952(71)90292-9; BAX A, 1986, J AM CHEM SOC, V108, P2093, DOI 10.1021/ja00268a061; Namikoshi M, 1996, J IND MICROBIOL BIOT, V17, P373, DOI 10.1007/BF01574768; SEKI E, 1995, NIPPON NOGEIK KAISHI, V69, P1013; OKINO T, 1993, TETRAHEDRON LETT, V34, P501, DOI 10.1016/0040-4039(93)85112-A; NISHIZAWA R, 1977, J MED CHEM, V20, P510, DOI 10.1021/jm00214a010; PATCHETT AA, 1980, NATURE, V288, P280, DOI 10.1038/288280a0; KASE H, 1987, J ANTIBIOT, V40, P450; OHTANI I, 1991, J AM CHEM SOC, V113, P4092, DOI 10.1021/ja00011a006; Aoyagi T, 1977, Jpn J Antibiot, V30 Suppl, P121; AOYAGI T, 1990, J ANTIBIOT, V43, P143; AOYAGI T, 1978, J ANTIBIOT, V31, P636; AOYAGI T, 1991, J ANTIBIOT, V44, P573; Bohacek R, 1996, J AM CHEM SOC, V118, P8231, DOI 10.1021/ja950818y; BURLEY SK, 1992, J MOL BIOL, V224, P113, DOI 10.1016/0022-2836(92)90580-D; BURLEY SK, 1991, P NATL ACAD SCI USA, V88, P6916, DOI 10.1073/pnas.88.16.6916; CANNELL R J P, 1988, Planta Medica, V54, P10, DOI 10.1055/s-2006-962319; FUTAGAWA S, 1973, B CHEM SOC JPN, V46, P3308, DOI 10.1246/bcsj.46.3308; HERRANZ R, 1992, J CHEM SOC PERK T 1, P1825, DOI 10.1039/p19920001825; Ishida K, 1998, TETRAHEDRON, V54, P13475, DOI 10.1016/S0040-4020(98)00826-6; Ishida K, 1997, TETRAHEDRON, V53, P10281, DOI 10.1016/S0040-4020(97)00684-4; Ishida K, 1996, TETRAHEDRON, V52, P9025, DOI 10.1016/0040-4020(96)00452-8; Kodani S, 1999, FEMS MICROBIOL LETT, V178, P343, DOI 10.1111/j.1574-6968.1999.tb08697.x; Kokkonen JO, 1999, CIRCULATION, V99, P1984; KUPCHAN SM, 1973, J ORG CHEM, V38, P178, DOI 10.1021/jo00941a049; MATSUNAGA S, 1995, J ORG CHEM, V60, P1177, DOI 10.1021/jo00110a020; MATSUURA F, 1994, TETRAHEDRON, V50, P11303, DOI 10.1016/S0040-4020(01)89431-X; NAKAMURA H, 1976, J ANTIBIOT, V29, P102; OPIE LH, 1992, ANGIOTENSIN CONVERTI; Seki E, 1996, NIPPON NOGEIK KAISHI, V70, P21; SUDA H, 1976, ARCH BIOCHEM BIOPHYS, V177, P196, DOI 10.1016/0003-9861(76)90429-X; SUDA H, 1976, J ANTIBIOT, V29, P100; TAYLOR A, 1993, BIOCHEMISTRY-US, V32, P784, DOI 10.1021/bi00054a007; UMEZAWA H, 1985, J ANTIBIOT, V38, P1629; UMEZAWA H, 1976, J ANTIBIOT, V29, P857; WATANABE MM, 1997, NIES COLLECTION LIST, P80; YAMATO M, 1986, J ANTIBIOT, V39, P44; YASUZAWA T, 1987, J ANTIBIOT, V40, P455; YOSHIDA S, 1991, J ANTIBIOT, V44, P579; YOSHIDA S, 1990, J ANTIBIOT, V43, P149; YOSHIDA S, 1991, J ANTIBIOT, V44, P683	47	28	29	PERGAMON-ELSEVIER SCIENCE LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND	0040-4020			TETRAHEDRON	Tetrahedron	OCT 27	2000	56	44					8643	8656		10.1016/S0040-4020(00)00770-5		14	Chemistry, Organic	Chemistry	366ZH	WOS:000090035800004		
J	Abbiendi, G; Ackerstaff, K; Ainsley, C; Akesson, PF; Alexander, G; Allison, J; Anderson, KJ; Arcelli, S; Asai, S; Ashby, SF; Axen, D; Azuelos, G; Bailey, I; Ball, AH; Barberio, E; Barlow, RJ; Baumann, S; Behnke, T; Bell, KW; Bella, G; Bellerive, A; Bentvelsen, S; Bethke, S; Biebel, O; Bloodworth, IJ; Bock, P; Bohme, J; Boeriu, O; Bonacorsi, D; Boutemeur, M; Braibant, S; Bright-Thomas, P; Brigliadori, L; Brown, RM; Burckhart, HJ; Cammin, J; Capiluppi, P; Carnegie, RK; Carter, AA; Carter, JR; Chang, CY; Charlton, DG; Ciocca, C; Clarke, PEL; Clay, E; Cohen, I; Cooke, OC; Couchman, J; Couyoumtzelis, C; Coxe, RL; Cuffiani, M; Dado, S; Dallavalle, GM; Dallison, S; de Roeck, A; Dervan, P; Desch, K; Dienes, B; Dixit, MS; Donkers, M; Dubbert, J; Duchovni, E; Duckeck, G; Duerdoth, IP; Estabrooks, PG; Etzion, E; Fabbri, F; Fanti, M; Feld, L; Ferrari, P; Fiedler, F; Fleck, I; Ford, M; Frey, A; Furtjes, A; Futyan, DI; Gagnon, P; Gary, JW; Gaycken, G; Geich-Gimbel, C; Giacomelli, G; Giacomelli, P; Glenzinski, D; Goldberg, J; Grandi, C; Graham, K; Gross, E; Grunhaus, J; Gruwe, M; Gunther, PO; Hajdu, C; Hanson, GG; Hansroul, M; Hapke, M; Harder, K; Harel, A; Hargrove, CK; Harin-Dirac, M; Hauke, A; Hauschild, M; Hawkes, CM; Hawkings, R; Hemingway, RJ; Hensel, C; Herten, G; Heuer, RD; Hildreth, MD; Hill, JC; Hocker, A; Hoffman, K; Homer, RJ; Honma, AK; Horvath, D; Hossain, KR; Howard, R; Huntemeyer, P; Igo-Kemenes, P; Ishii, K; Jacob, FR; Jawahery, A; Jeremie, H; Jones, CR; Jovanovic, P; Junk, TR; Kanaya, N; Kanzaki, J; Karapetian, G; Karlen, D; Kartvelishvili, V; Kawagoe, K; Kawamoto, T; Keeler, RK; Kellogg, RG; Kennedy, BW; Kim, DH; Klein, K; Klier, A; Kobayashi, T; Kobel, M; Kokott, TP; Komamiya, S; Kowalewski, RV; Kress, T; Krieger, P; von Krogh, J; Kuhl, T; Kupper, M; Kyberd, P; Lafferty, GD; Landsman, H; Lanske, D; Lawson, I; Layter, JG; Leins, A; Lellouch, D; Letts, J; Levinson, L; Liebisch, R; Lillich, J; List, B; Littlewood, C; Lloyd, AW; Lloyd, SL; Loebinger, FK; Long, GD; Losty, MJ; Lu, J; Ludwig, J; Macchiolo, A; Macpherson, A; Mader, W; Mannelli, M; Marcellini, S; Marchant, TE; Martin, AJ; Martin, JP; Martinez, G; Mashimo, T; Mattig, P; McDonald, WJ; McKenna, J; McMahon, TJ; McPherson, RA; Meijers, F; Mendez-Lorenzo, P; Merritt, FS; Mes, H; Michelini, A; Mihara, S; Mikenberg, G; Miller, DJ; Mohr, W; Montanari, A; Mori, T; Nagai, K; Nakamura, I; Neal, HA; Nisius, R; O'Neale, SW; Oakham, FG; Odorici, F; Ogren, HO; Oh, A; Okpara, A; Oreglia, MJ; Orito, S; Pasztor, G; Pater, JR; Patrick, GN; Patt, J; Pfeifenschneider, P; Pilcher, JE; Pinfold, J; Plane, DE; Poli, B; Polok, J; Przybycien, O; Quadt, A; Rembser, C; Rick, H; Robins, SA; Rodning, N; Roney, JM; Rosati, S; Roscoe, K; Rossi, AM; Rozen, Y; Runge, K; Runolfsson, O; Rust, DR; Sachs, K; Saeki, T; Sahr, O; Sarkisyan, EKG; Sbarra, C; Schaile, AD; Schaile, O; Scharff-Hansen, P; Schmitt, S; Schroder, M; Schumacher, M; Schwick, C; Scott, WG; Seuster, R; Shears, TG; Shen, BC; Shepherd-Themistocleous, CH; Sherwood, P; Siroli, GP; Skuja, A; Smith, AM; Snow, GA; Sobie, R; Soldner-Rembold, S; Spagnolo, S; Sproston, M; Stahl, A; Stephens, K; Stoll, K; Strom, D; Strohmer, R; Surrow, B; Talbot, SD; Tarem, S; Taylor, RJ; Teuscher, R; Thiergen, M; Thomas, J; Thomson, MA; Torrence, E; Towers, S; Trefzger, T; Trigger, I; Trocsanyi, Z; Tsur, E; Turner-Watson, MF; Ueda, I; Vannerem, P; Verzocchi, M; Voss, H; Vossebeld, J; Waller, D; Ward, CP; Ward, DR; Watkins, PM; Watson, AT; Watson, NK; Wells, PS; Wengler, T; Wermes, N; Wetterling, D; White, JS; Wilson, GW; Wilson, JA; Wyatt, TR; Yamashita, S; Zacek, V; Zer-Zion, D				Abbiendi, G; Ackerstaff, K; Ainsley, C; Akesson, PF; Alexander, G; Allison, J; Anderson, KJ; Arcelli, S; Asai, S; Ashby, SF; Axen, D; Azuelos, G; Bailey, I; Ball, AH; Barberio, E; Barlow, RJ; Baumann, S; Behnke, T; Bell, KW; Bella, G; Bellerive, A; Bentvelsen, S; Bethke, S; Biebel, O; Bloodworth, IJ; Bock, P; Bohme, J; Boeriu, O; Bonacorsi, D; Boutemeur, M; Braibant, S; Bright-Thomas, P; Brigliadori, L; Brown, RM; Burckhart, HJ; Cammin, J; Capiluppi, P; Carnegie, RK; Carter, AA; Carter, JR; Chang, CY; Charlton, DG; Ciocca, C; Clarke, PEL; Clay, E; Cohen, I; Cooke, OC; Couchman, J; Couyoumtzelis, C; Coxe, RL; Cuffiani, M; Dado, S; Dallavalle, GM; Dallison, S; de Roeck, A; Dervan, P; Desch, K; Dienes, B; Dixit, MS; Donkers, M; Dubbert, J; Duchovni, E; Duckeck, G; Duerdoth, IP; Estabrooks, PG; Etzion, E; Fabbri, F; Fanti, M; Feld, L; Ferrari, P; Fiedler, F; Fleck, I; Ford, M; Frey, A; Furtjes, A; Futyan, DI; Gagnon, P; Gary, JW; Gaycken, G; Geich-Gimbel, C; Giacomelli, G; Giacomelli, P; Glenzinski, D; Goldberg, J; Grandi, C; Graham, K; Gross, E; Grunhaus, J; Gruwe, M; Gunther, PO; Hajdu, C; Hanson, GG; Hansroul, M; Hapke, M; Harder, K; Harel, A; Hargrove, CK; Harin-Dirac, M; Hauke, A; Hauschild, M; Hawkes, CM; Hawkings, R; Hemingway, RJ; Hensel, C; Herten, G; Heuer, RD; Hildreth, MD; Hill, JC; Hocker, A; Hoffman, K; Homer, RJ; Honma, AK; Horvath, D; Hossain, KR; Howard, R; Huntemeyer, P; Igo-Kemenes, P; Ishii, K; Jacob, FR; Jawahery, A; Jeremie, H; Jones, CR; Jovanovic, P; Junk, TR; Kanaya, N; Kanzaki, J; Karapetian, G; Karlen, D; Kartvelishvili, V; Kawagoe, K; Kawamoto, T; Keeler, RK; Kellogg, RG; Kennedy, BW; Kim, DH; Klein, K; Klier, A; Kobayashi, T; Kobel, M; Kokott, TP; Komamiya, S; Kowalewski, RV; Kress, T; Krieger, P; von Krogh, J; Kuhl, T; Kupper, M; Kyberd, P; Lafferty, GD; Landsman, H; Lanske, D; Lawson, I; Layter, JG; Leins, A; Lellouch, D; Letts, J; Levinson, L; Liebisch, R; Lillich, J; List, B; Littlewood, C; Lloyd, AW; Lloyd, SL; Loebinger, FK; Long, GD; Losty, MJ; Lu, J; Ludwig, J; Macchiolo, A; Macpherson, A; Mader, W; Mannelli, M; Marcellini, S; Marchant, TE; Martin, AJ; Martin, JP; Martinez, G; Mashimo, T; Mattig, P; McDonald, WJ; McKenna, J; McMahon, TJ; McPherson, RA; Meijers, F; Mendez-Lorenzo, P; Merritt, FS; Mes, H; Michelini, A; Mihara, S; Mikenberg, G; Miller, DJ; Mohr, W; Montanari, A; Mori, T; Nagai, K; Nakamura, I; Neal, HA; Nisius, R; O'Neale, SW; Oakham, FG; Odorici, F; Ogren, HO; Oh, A; Okpara, A; Oreglia, MJ; Orito, S; Pasztor, G; Pater, JR; Patrick, GN; Patt, J; Pfeifenschneider, P; Pilcher, JE; Pinfold, J; Plane, DE; Poli, B; Polok, J; Przybycien, O; Quadt, A; Rembser, C; Rick, H; Robins, SA; Rodning, N; Roney, JM; Rosati, S; Roscoe, K; Rossi, AM; Rozen, Y; Runge, K; Runolfsson, O; Rust, DR; Sachs, K; Saeki, T; Sahr, O; Sarkisyan, EKG; Sbarra, C; Schaile, AD; Schaile, O; Scharff-Hansen, P; Schmitt, S; Schroder, M; Schumacher, M; Schwick, C; Scott, WG; Seuster, R; Shears, TG; Shen, BC; Shepherd-Themistocleous, CH; Sherwood, P; Siroli, GP; Skuja, A; Smith, AM; Snow, GA; Sobie, R; Soldner-Rembold, S; Spagnolo, S; Sproston, M; Stahl, A; Stephens, K; Stoll, K; Strom, D; Strohmer, R; Surrow, B; Talbot, SD; Tarem, S; Taylor, RJ; Teuscher, R; Thiergen, M; Thomas, J; Thomson, MA; Torrence, E; Towers, S; Trefzger, T; Trigger, I; Trocsanyi, Z; Tsur, E; Turner-Watson, MF; Ueda, I; Vannerem, P; Verzocchi, M; Voss, H; Vossebeld, J; Waller, D; Ward, CP; Ward, DR; Watkins, PM; Watson, AT; Watson, NK; Wells, PS; Wengler, T; Wermes, N; Wetterling, D; White, JS; Wilson, GW; Wilson, JA; Wyatt, TR; Yamashita, S; Zacek, V; Zer-Zion, D		OPAL Collaboration	First measurement of the inclusive branching ratio of b hadrons to phi masons in Z decays	PHYSICS LETTERS B			English	Article							MICROVERTEX DETECTOR; E+E ANNIHILATION; MONTE-CARLO; PHYSICS; FRAGMENTATION; LEP	The inclusive branching fraction of phi masons from the decay of b hadrons produced in Z decays was measured to be Br(b --> phiX) = 0.0282 +/- 0.0013 (stat.) +/- 0.0019 (syst.), using data collected by the OPAL detector at LEP. (C) 2000 Elsevier Science B.V. All rights reserved.	Univ Bologna, Dipartimento Fis, I-40126 Bologna, Italy; Ist Nazl Fis Nucl, I-40126 Bologna, Italy; Univ Birmingham, Sch Phys & Astron, Birmingham B15 2TT, W Midlands, England; Univ Bonn, Inst Phys, D-53115 Bonn, Germany; Univ Calif Riverside, Dept Phys, Riverside, CA 92521 USA; Univ Cambridge, Cavendish Lab, Cambridge CB3 0HE, England; Carleton Univ, Dept Phys, Ottawa Carleton Inst Phys, Ottawa, ON K1S 5B6, Canada; Carleton Univ, Ctr Res Particle Phys, Ottawa, ON K1S 5B6, Canada; CERN, European Org Nucl Res, CH-1211 Geneva 23, Switzerland; Univ Chicago, Enrico Fermi Inst, Chicago, IL 60637 USA; Univ Chicago, Dept Phys, Chicago, IL 60637 USA; Univ Freiburg, Fak Phys, D-79104 Freiburg, Germany; Univ Heidelberg, Inst Phys, D-69120 Heidelberg, Germany; Indiana Univ, Dept Phys, Bloomington, IN 47405 USA; Univ London Queen Mary & Westfield Coll, London E1 4NS, England; Rhein Westfal TH Aachen, Inst Phys 3, D-52056 Aachen, Germany; UCL, London WC1E 6BT, England; Univ Manchester, Dept Phys, Schuster Lab, Manchester M13 9PL, Lancs, England; Univ Maryland, Dept Phys, College Pk, MD 20742 USA; Univ Montreal, Phys Nucl Lab, Montreal, PQ H3C 3J7, Canada; Univ Oregon, Dept Phys, Eugene, OR 97403 USA; CLRC, Rutherford Appleton Lab, Didcot OX11 0QX, Oxon, England; Technion Israel Inst Technol, Dept Phys, IL-32000 Haifa, Israel; Tel Aviv Univ, Dept Phys & Astron, IL-69978 Tel Aviv, Israel; Univ Tokyo, Int Ctr Elementary Particle Phys, Tokyo 1130033, Japan; Univ Tokyo, Dept Phys, Tokyo 1130033, Japan; Kobe Univ, Kobe, Hyogo 6578501, Japan; Weizmann Inst Sci, Particle Phys Dept, IL-76100 Rehovot, Israel; Univ Hamburg, DESY, Inst Expt Phys 2, D-22607 Hamburg, Germany; Univ Victoria, Dept Phys, Victoria, BC V8W 3P6, Canada; Univ British Columbia, Dept Phys, Vancouver, BC V6T 1Z1, Canada; Univ Alberta, Dept Phys, Edmonton, AB T6G 2J1, Canada; Res Inst Particle & Nucl Phys, H-1525 Budapest, Hungary; Inst Nucl Res, H-4001 Debrecen, Hungary; Univ Munich, Sekt Phys, D-85748 Garching, Germany	Abbiendi, G (reprint author), Univ Bologna, Dipartimento Fis, I-40126 Bologna, Italy.	mette.stuwe@cern.ch	Trocsanyi, Zoltan/A-5598-2009; Horvath, Dezso/A-4009-2011; Stahl, Achim/E-8846-2011; Bailey, Ian/C-4011-2012; Giacomelli, Paolo/B-8076-2009; spagnolo, stefania/A-6359-2012; Montanari, Alessandro/J-2420-2012; Kartvelishvili, Vakhtang/K-2312-2013; Grandi, Claudio/B-5654-2015	Trocsanyi, Zoltan/0000-0002-2129-1279; Stahl, Achim/0000-0002-8369-7506; Bailey, Ian/0000-0002-8020-3662; spagnolo, stefania/0000-0001-7482-6348; Montanari, Alessandro/0000-0003-2748-6373; Grandi, Claudio/0000-0001-5998-3070			Abbiendi G, 1999, EUR PHYS J C, V8, P217, DOI 10.1007/s100520050460; Abbiendi G, 2000, EUR PHYS J C, V13, P1, DOI 10.1007/s100520000260; Abbiendi G, 2000, PHYS LETT B, V476, P233, DOI 10.1016/S0370-2693(00)00162-3; Ackerstaff K, 1998, EUR PHYS J C, V4, P19, DOI 10.1007/s100520050183; Ackerstaff K, 1997, Z PHYS C PART FIELDS, V74, P1, DOI 10.1007/s002880050366; AKERS R, 1995, Z PHYS C PART FIELDS, V66, P19; ALEXANDER G, 1991, Z PHYS C PART FIELDS, V52, P175; Alexander G, 1996, Z PHYS C PART FIELDS, V69, P543, DOI 10.1007/s002880050059; ALLPORT PP, 1993, NUCL INSTRUM METH A, V324, P34, DOI 10.1016/0168-9002(93)90964-J; ALLPORT PP, 1994, NUCL INSTRUM METH A, V346, P476, DOI 10.1016/0168-9002(94)90583-5; ALLISON J, 1992, NUCL INSTRUM METH A, V317, P47, DOI 10.1016/0168-9002(92)90593-S; PETERSON C, 1983, PHYS REV D, V27, P105, DOI 10.1103/PhysRevD.27.105; AHMET K, 1991, NUCL INSTRUM METH A, V305, P275; SJOSTRAND T, 1987, COMPUT PHYS COMMUN, V43, P367, DOI 10.1016/0010-4655(87)90054-3; MARCHESINI G, 1992, COMPUT PHYS COMMUN, V67, P465, DOI 10.1016/0010-4655(92)90055-4; BETHKE S, 1988, PHYS LETT B, V213, P235, DOI 10.1016/0370-2693(88)91032-5; SJOSTRAND T, 1994, COMPUT PHYS COMMUN, V82, P74, DOI 10.1016/0010-4655(94)90132-5; SJOSTRAND T, 1986, COMPUT PHYS COMMUN, V39, P347, DOI 10.1016/0010-4655(86)90096-2; COLLINS ME, 1994, GEODERMA, V61, P1, DOI 10.1016/0016-7061(94)90008-6; BARTEL W, 1986, Z PHYS C PART FIELDS, V33, P23; BEHNKE T, 1992, THESIS HAMBURG U; BORTOLETTO D, 1986, PHYS REV LETT, V56, P800, DOI 10.1103/PhysRevLett.56.800; HAUSCHILD M, 1992, NUCL INSTRUM METH A, V314, P74, DOI 10.1016/0168-9002(92)90501-T; *LEP COLL, 1996, NUCL INSTRUM METH A, V378, P101; Caso C, 1998, EUR PHYS J C, V3, P1, DOI 10.1007/s10052-998-0104-x; ROUDEAU P, 1993, 9303 LAL; SJOSTRAND T, 1988, INT J MOD PHYS A, V3, P751, DOI 10.1142/S0217751X88000345	27	3	3	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	0370-2693			PHYS LETT B	Phys. Lett. B	OCT 26	2000	492	1-2					13	22		10.1016/S0370-2693(00)01066-2		10	Astronomy & Astrophysics; Physics, Nuclear; Physics, Particles & Fields	Astronomy & Astrophysics; Physics	372GW	WOS:000165226800003		
J	Abbiendi, G; Ackerstaff, K; Ainsley, C; Akesson, PF; Alexander, G; Allison, J; Anderson, KJ; Arcelli, S; Asai, S; Ashby, SF; Axen, D; Azuelos, G; Bailey, I; Ball, AH; Barberio, E; Barlow, RJ; Batley, JR; Baumann, S; Behnke, T; Bell, KW; Bella, C; Bellerive, A; Bentvelsen, S; Bethke, S; Biebel, O; Bloodworth, IJ; Bock, P; Bohme, J; Boeriu, O; Bonacorsi, D; Boutemeur, M; Braibant, S; Bright-Thomas, P; Brigliadori, L; Brown, RM; Burckharth, HJ; Cammin, J; Capiluppi, P; Carnegie, RK; Carter, AA; Carter, JR; Chang, CY; Charlton, DG; Ciocca, C; Clarke, PEL; Clay, E; Cohen, I; Cooke, OC; Couchman, J; Couyoumtzelis, C; Cox, RL; Cuffiani, M; Dado, S; Dallavalle, GM; Dallison, S; Davis, R; de Roeck, A; Dervan, P; Desch, K; Dienes, B; Dixit, MS; Donkers, M; Dubbert, J; Duchovni, E; Duckeck, G; Duerdoth, IP; Estabrooks, PG; Etzion, E; Fabbri, F; Fanti, M; Faust, AA; Feld, L; Ferrari, P; Fiedler, F; Fleck, I; Ford, M; Frey, A; Furtjes, A; Futyan, DI; Gagnon, P; Gary, JW; Gaycken, G; Geich-Gimbel, C; Giacomelli, G; Giacomelli, P; Gingrich, DM; Glenzinski, D; Goldberg, J; Grandi, C; Graham, K; Gross, E; Grunhaus, J; Gruwe, M; Gunther, PO; Hajdu, C; Hanson, GG; Hansroul, M; Hapke, M; Harder, K; Harel, A; Hargrove, CK; Harin-Dirac, M; Hauke, A; Hauschild, M; Hawkes, CM; Hawkings, R; Hemingway, RJ; Hensel, C; Herten, G; Heuer, RD; Hildreth, MD; Hill, JC; Hobson, PR; Hocker, A; Hoffman, K; Homer, RJ; Honma, AK; Horvath, D; Hossain, KR; Howard, R; Huntemeyer, P; Igo-Kemenes, P; Imrie, DC; Ishii, K; Jacob, FR; Jawahery, A; Jeremie, H; Jones, CR; Jovanovic, P; Junk, TR; Kanaya, N; Kanzaki, J; Karapetian, G; Karlen, D; Kartvelishvili, V; Kawagoe, K; Kawamoto, T; Kayal, PI; Keller, RK; Kellogg, RG; Kennedy, BW; Kim, DH; Klein, K; Klier, A; Kobayashi, T; Kobel, M; Kokott, TP; Komamiya, S; Kowalewski, RV; Kress, T; Krieger, P; von Krogh, J; Kuhl, T; Kupper, M; Kyberd, P; Lafferty, GD; Landsman, H; Lanske, D; Lawson, I; Layter, JG; Leins, A; Lellouch, D; Letts, J; Levinson, L; Liebisch, R; Lillich, J; List, B; Littlewood, C; Lloyd, AW; Lloyd, SL; Loebinger, FK; Long, GD; Losty, MJ; Lu, J; Ludwig, J; Macchiolo, A; Macpherson, A; Mader, W; Mannelli, M; Marcellini, S; Marchant, TE; Martin, AJ; Martin, JP; Martinez, G; Mashimo, T; Mattig, P; McDonald, WJ; McKenna, J; McMahon, TJ; McPherson, RA; Meijers, F; Mendez-Lorenzo, P; Merritt, FS; Mes, H; Michelini, A; Mihara, S; Mikenberg, G; Miller, DJ; Mohr, W; Montanari, A; Mori, T; Nagai, K; Nakamura, I; Neal, HA; Nisius, R; O'Neale, SW; Oakham, FG; Odorici, F; Ogren, HO; Oh, A; Okpara, A; Oreglia, MJ; Orito, S; Pasztor, G; Pater, JR; Patrick, GN; Patt, J; Pfeifenschneider, P; Pilcher, JE; Pinfold, J; Plane, DE; Poli, B; Polok, J; Pooth, O; Przybycien, M; Quadt, A; Rembser, C; Rick, H; Robins, SA; Rodning, N; Roney, JM; Rosati, S; Roscoe, K; Rossi, AM; Rozen, Y; Runge, K; Runolfsson, O; Rust, DR; Sachs, K; Saeki, T; Sahr, O; Sang, WM; Sarkisyan, EKG; Sbarra, C; Schaile, AD; Schaile, O; Scharff-Hansen, P; Schmitt, S; Schroder, M; Schumacher, M; Schwick, C; Scott, WG; Seuster, R; Shears, TG; Shen, BC; Shepherd-Themistocleous, CH; Sherwood, P; Siroli, GP; Skuja, A; Smith, AM; Snow, GA; Sobie, R; Soldner-Rembold, S; Spagnolo, S; Sproston, M; Stahl, A; Stephens, K; Stoll, K; Strom, D; Strohmer, R; Surrow, B; Talbot, SD; Tarem, S; Taylor, RJ; Teuscher, R; Thiergen, M; Thomas, J; Thomson, MA; Torrence, E; Towers, S; Trefzger, T; Trigger, I; Trocsanyi, Z; Tsur, E; Turner-Watson, MF; Ueda, I; Vannerem, P; Verzocchi, M; Voss, H; Vossebeld, J; Waller, D; Ward, CP; Ward, DR; Watkins, PM; Watson, AT; Watson, NK; Wells, PS; Wengler, T; Wermes, N; Wetterling, D; White, JS; Wilson, GW; Wilson, JA; Wyatt, TR; Yamashita, S; Zacek, V; Zer-Zion, D				Abbiendi, G; Ackerstaff, K; Ainsley, C; Akesson, PF; Alexander, G; Allison, J; Anderson, KJ; Arcelli, S; Asai, S; Ashby, SF; Axen, D; Azuelos, G; Bailey, I; Ball, AH; Barberio, E; Barlow, RJ; Batley, JR; Baumann, S; Behnke, T; Bell, KW; Bella, C; Bellerive, A; Bentvelsen, S; Bethke, S; Biebel, O; Bloodworth, IJ; Bock, P; Bohme, J; Boeriu, O; Bonacorsi, D; Boutemeur, M; Braibant, S; Bright-Thomas, P; Brigliadori, L; Brown, RM; Burckharth, HJ; Cammin, J; Capiluppi, P; Carnegie, RK; Carter, AA; Carter, JR; Chang, CY; Charlton, DG; Ciocca, C; Clarke, PEL; Clay, E; Cohen, I; Cooke, OC; Couchman, J; Couyoumtzelis, C; Cox, RL; Cuffiani, M; Dado, S; Dallavalle, GM; Dallison, S; Davis, R; de Roeck, A; Dervan, P; Desch, K; Dienes, B; Dixit, MS; Donkers, M; Dubbert, J; Duchovni, E; Duckeck, G; Duerdoth, IP; Estabrooks, PG; Etzion, E; Fabbri, F; Fanti, M; Faust, AA; Feld, L; Ferrari, P; Fiedler, F; Fleck, I; Ford, M; Frey, A; Furtjes, A; Futyan, DI; Gagnon, P; Gary, JW; Gaycken, G; Geich-Gimbel, C; Giacomelli, G; Giacomelli, P; Gingrich, DM; Glenzinski, D; Goldberg, J; Grandi, C; Graham, K; Gross, E; Grunhaus, J; Gruwe, M; Gunther, PO; Hajdu, C; Hanson, GG; Hansroul, M; Hapke, M; Harder, K; Harel, A; Hargrove, CK; Harin-Dirac, M; Hauke, A; Hauschild, M; Hawkes, CM; Hawkings, R; Hemingway, RJ; Hensel, C; Herten, G; Heuer, RD; Hildreth, MD; Hill, JC; Hobson, PR; Hocker, A; Hoffman, K; Homer, RJ; Honma, AK; Horvath, D; Hossain, KR; Howard, R; Huntemeyer, P; Igo-Kemenes, P; Imrie, DC; Ishii, K; Jacob, FR; Jawahery, A; Jeremie, H; Jones, CR; Jovanovic, P; Junk, TR; Kanaya, N; Kanzaki, J; Karapetian, G; Karlen, D; Kartvelishvili, V; Kawagoe, K; Kawamoto, T; Kayal, PI; Keller, RK; Kellogg, RG; Kennedy, BW; Kim, DH; Klein, K; Klier, A; Kobayashi, T; Kobel, M; Kokott, TP; Komamiya, S; Kowalewski, RV; Kress, T; Krieger, P; von Krogh, J; Kuhl, T; Kupper, M; Kyberd, P; Lafferty, GD; Landsman, H; Lanske, D; Lawson, I; Layter, JG; Leins, A; Lellouch, D; Letts, J; Levinson, L; Liebisch, R; Lillich, J; List, B; Littlewood, C; Lloyd, AW; Lloyd, SL; Loebinger, FK; Long, GD; Losty, MJ; Lu, J; Ludwig, J; Macchiolo, A; Macpherson, A; Mader, W; Mannelli, M; Marcellini, S; Marchant, TE; Martin, AJ; Martin, JP; Martinez, G; Mashimo, T; Mattig, P; McDonald, WJ; McKenna, J; McMahon, TJ; McPherson, RA; Meijers, F; Mendez-Lorenzo, P; Merritt, FS; Mes, H; Michelini, A; Mihara, S; Mikenberg, G; Miller, DJ; Mohr, W; Montanari, A; Mori, T; Nagai, K; Nakamura, I; Neal, HA; Nisius, R; O'Neale, SW; Oakham, FG; Odorici, F; Ogren, HO; Oh, A; Okpara, A; Oreglia, MJ; Orito, S; Pasztor, G; Pater, JR; Patrick, GN; Patt, J; Pfeifenschneider, P; Pilcher, JE; Pinfold, J; Plane, DE; Poli, B; Polok, J; Pooth, O; Przybycien, M; Quadt, A; Rembser, C; Rick, H; Robins, SA; Rodning, N; Roney, JM; Rosati, S; Roscoe, K; Rossi, AM; Rozen, Y; Runge, K; Runolfsson, O; Rust, DR; Sachs, K; Saeki, T; Sahr, O; Sang, WM; Sarkisyan, EKG; Sbarra, C; Schaile, AD; Schaile, O; Scharff-Hansen, P; Schmitt, S; Schroder, M; Schumacher, M; Schwick, C; Scott, WG; Seuster, R; Shears, TG; Shen, BC; Shepherd-Themistocleous, CH; Sherwood, P; Siroli, GP; Skuja, A; Smith, AM; Snow, GA; Sobie, R; Soldner-Rembold, S; Spagnolo, S; Sproston, M; Stahl, A; Stephens, K; Stoll, K; Strom, D; Strohmer, R; Surrow, B; Talbot, SD; Tarem, S; Taylor, RJ; Teuscher, R; Thiergen, M; Thomas, J; Thomson, MA; Torrence, E; Towers, S; Trefzger, T; Trigger, I; Trocsanyi, Z; Tsur, E; Turner-Watson, MF; Ueda, I; Vannerem, P; Verzocchi, M; Voss, H; Vossebeld, J; Waller, D; Ward, CP; Ward, DR; Watkins, PM; Watson, AT; Watson, NK; Wells, PS; Wengler, T; Wermes, N; Wetterling, D; White, JS; Wilson, GW; Wilson, JA; Wyatt, TR; Yamashita, S; Zacek, V; Zer-Zion, D			A measurement of the tau mass and the first CPT test with tau leptons	PHYSICS LETTERS B			English	Article							MICROVERTEX DETECTOR; BRANCHING RATIOS; DECAYS; LEP	We measure the mass of the tau to be 1775.1 +/- 1.6(m(cn)(stat.)) +/- 1.0(m(cn)(sys.)) MeV using tau from Z(0) decays. To test CPT invariance we compare the masses of the positively and negatively charged tau. The relative mass difference is found to be smaller than 3.0 x 10(-3) at the 90%. confidence level. (C) 2000 Elsevier Science B.V. All rights reserved.	Ist Nazl Fis Nucl, I-40126 Bologna, Italy; Univ Bonn, Inst Phys, D-53115 Bonn, Germany; Univ Calif Riverside, Dept Phys, Riverside, CA 92521 USA; Univ Cambridge, Cavendish Lab, Cambridge CB3 0HE, England; Carleton Univ, Ottawa Carleton Inst Phys, Dept Phys, Ottawa, ON K1S 5B6, Canada; Carleton Univ, Ctr Res Particle Phys, Ottawa, ON K1S 5B6, Canada; CERN, European Org Nucl Res, CH-1211 Geneva 23, Switzerland; Univ Chicago, Enrico Fermi Inst, Chicago, IL 60637 USA; Univ Chicago, Dept Phys, Chicago, IL 60637 USA; Univ Freiburg, Fak Phys, D-79104 Freiburg, Germany; Univ Heidelberg, Inst Phys, D-69120 Heidelberg, Germany; Indiana Univ, Dept Phys, Bloomington, IN 47405 USA; Queen Mary Univ London, London E1 4NS, England; Tech Hsch Aachen, Inst Phys 3, D-52056 Aachen, Germany; UCL, London WC1E 6BT, England; Univ Manchester, Schuster Lab, Dept Phys, Manchester M13 9PL, Lancs, England; Univ Maryland, Dept Phys, College Pk, MD 20742 USA; Univ Montreal, Phys Nucl Lab, Montreal, PQ H3C 3J7, Canada; Univ Oregon, Dept Phys, Eugene, OR 97403 USA; Rutherford Appleton Lab, CLRC, Didcot OX11 0QX, Oxon, England; Technion Israel Inst Technol, Dept Phys, IL-32000 Haifa, Israel; Tel Aviv Univ, Dept Phys & Astron, IL-69978 Tel Aviv, Israel; Univ Birmingham, Sch Phys & Astron, Birmingham B15 2TT, W Midlands, England; Univ Tokyo, Int Ctr Elementary Particle Phys, Tokyo 1130033, Japan; Univ Tokyo, Dept Phys, Tokyo 1130033, Japan; Kobe Univ, Kobe, Hyogo 6578501, Japan; Weizmann Inst Sci, Dept Particle Phys, IL-76100 Rehovot, Israel; Univ Hamburg, DESY, Inst Expt Phys 2, D-22607 Hamburg, Germany; Univ Victoria, Dept Phys, Victoria, BC V8W 3P6, Canada; Univ British Columbia, Dept Phys, Vancouver, BC V6T 1Z1, Canada; Univ Alberta, Dept Phys, Edmonton, AB T6G 2J1, Canada; Res Inst Particle & Nucl Phys, H-1525 Budapest, Hungary; Inst Nucl Res, H-4001 Debrecen, Hungary; Univ Munich, Sekt Phys, D-85748 Garching, Germany; TRIUMF, Vancouver, BC V6T 2A3, Canada; Univ Bologna, Dipartmento Fis, I-40126 Bologna, Italy; Univ Mining & Met, Krakow, Poland; Univ Debrecen, Dept Expt Phys, Debrecen, Hungary	Abbiendi, G (reprint author), Max Planck Inst Phys & Astrophys, D-80805 Munich, Germany.	mette.stuwe@cern.ch	Trocsanyi, Zoltan/A-5598-2009; Horvath, Dezso/A-4009-2011; Stahl, Achim/E-8846-2011; Bailey, Ian/C-4011-2012; Giacomelli, Paolo/B-8076-2009; spagnolo, stefania/A-6359-2012; Montanari, Alessandro/J-2420-2012; Kartvelishvili, Vakhtang/K-2312-2013; Grandi, Claudio/B-5654-2015; 	Trocsanyi, Zoltan/0000-0002-2129-1279; Stahl, Achim/0000-0002-8369-7506; Bailey, Ian/0000-0002-8020-3662; spagnolo, stefania/0000-0001-7482-6348; Montanari, Alessandro/0000-0003-2748-6373; Grandi, Claudio/0000-0001-5998-3070; Giacomelli, Paolo/0000-0002-6368-7220; Lafferty, George/0000-0003-0658-4919; Abbiendi, Giovanni/0000-0003-4499-7562			AKERS R, 1994, PHYS LETT B, V328, P207, DOI 10.1016/0370-2693(94)90452-9; ALEXANDER G, 1991, PHYS LETT B, V266, P201, DOI 10.1016/0370-2693(91)90768-L; ALLISON J, 1995, Z PHYS C, V66, P31; ALLPORT PP, 1993, NUCL INSTRUM METH A, V324, P34, DOI 10.1016/0168-9002(93)90964-J; ALLPORT PP, 1994, NUCL INSTRUM METH A, V346, P476, DOI 10.1016/0168-9002(94)90583-5; Anastassov A, 1997, PHYS REV D, V55, P2559, DOI 10.1103/PhysRevD.55.2559; Anastassov A., 1998, PHYS REV D, VD D58; AHMET K, 1991, NUCL INSTRUM METH A, V305, P275; JADACH S, 1994, COMPUT PHYS COMMUN, V79, P503, DOI 10.1016/0010-4655(94)90190-2; Ackerstaff K, 1999, EUR PHYS J C, V7, P571, DOI 10.1007/s100520050430; JADACH S, 1993, COMPUT PHYS COMMUN, V76, P361, DOI 10.1016/0010-4655(93)90061-G; Bai JZ, 1996, PHYS REV D, V53, P20, DOI 10.1103/PhysRevD.53.20; ALBRECHT H, 1992, PHYS LETT B, V292, P221, DOI 10.1016/0370-2693(92)90634-G; BALLEST R, 1993, PHYS REV D, V47, P3671; ISGUR N, 1989, PHYS REV D, V39, P1357, DOI 10.1103/PhysRevD.39.1357; KUHN JH, 1990, Z PHYS C PART FIELDS, V48, P445, DOI 10.1007/BF01572024; Caso C, 1998, EUR PHYS J C, V3, P1, DOI 10.1007/s10052-998-0104-x	17	35	35	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	0370-2693			PHYS LETT B	Phys. Lett. B	OCT 26	2000	492	1-2					23	31		10.1016/S0370-2693(00)01022-4		9	Astronomy & Astrophysics; Physics, Nuclear; Physics, Particles & Fields	Astronomy & Astrophysics; Physics	372GW	WOS:000165226800004		
J	Miyazaki, T; Masuda, R; Furuta, S; Tsukamoto, K				Miyazaki, T; Masuda, R; Furuta, S; Tsukamoto, K			Feeding behaviour of hatchery-reared juveniles of the Japanese flounder following a period of starvation	AQUACULTURE			English	Article						Paralichthys olivaceus; feeding behaviour; starvation; predation; stock enhancement; flounder	PARALICHTHYS-OLIVACEUS LARVAE; STOCK ENHANCEMENT; VULNERABILITY; PREDATION; MORTALITY; WILD	The effect of starvation on feeding behaviour was studied in hatchery-reared juveniles of the Japanese flounder in the context of improving stock enhancement strategies. Fish (54.0 +/- 5.9 mm in total length) were deprived of food (mysids) for 1, 2, or 4 days, and their subsequent feeding behaviour was observed using a video camera. The phase of feeding action, the foraging pattern, the off-bottom duration, and the swimming speed were defined and analyzed. The feeding action was divided into four phases: aim, creep, attack, and return. The foraging patterns were classified into four types. The typical foraging pattern, with a single attack and a quick return to the initial position (type A), became less common as the fish were starved, while there was a greater incidence of slower returns (type B), returns to different positions (type C), and multiple feeding (type D). The frequency of the feeding action and the duration of off-bottom swimming increased as the food deprivation period increased, The swimming speed for creeping to the mysid prey increased, but that of the return decreased as the fish were starved. These changes in feeding behaviour under starvation may prolong the time flounder juveniles spend in the water column and may result in a higher risk of predation. In the stock enhancement program of Japanese flounder, starvation should be avoided to reduce predation and improve survival. (C) 2000 Elsevier Science B.V. All rights reserved.	Univ Tokyo, Ocean Res Inst, Tokyo 1640014, Japan; Tottori Prefectural Govt, Tottori 6808570, Japan	Miyazaki, T (reprint author), Natl Inst Radiol Sci, 3609 Isozaki, Hitachi, Ibaraki 3111202, Japan.						Furuta S, 1997, NIPPON SUISAN GAKK, V63, P886; Tanaka M, 1998, B MAR SCI, V62, P551; TANAKA M, 1989, NETH J SEA RES, V24, P57, DOI 10.1016/0077-7579(89)90170-1; Furuta S, 1998, NIPPON SUISAN GAKK, V64, P393; Masuda R, 1998, B MAR SCI, V62, P337; BAILEY KM, 1984, MAR BIOL, V83, P287, DOI 10.1007/BF00397461; Beukema J.J., 1968, BEHAAVIOUR, P1; BLAXTER J. H. S., 1963, JOUR CONS CONS PERM INTERNATL EXPLOR MER, V28, P211; CROY MI, 1991, ANIM BEHAV, V41, P161, DOI 10.1016/S0003-3472(05)80511-1; FOLKVORD A, 1986, FISH B-NOAA, V84, P859; FUIMAN LA, 1989, MAR ECOL PROG SER, V51, P291, DOI 10.3354/meps051291; Fujita T., 1993, SAIBAI GIKEN, V22, P67; FURUTA S, 1991, SAIBAI GIKEN, V19, P117; FURUTA S, 1992, SAIBAI, V64, P35; Furuta S, 1996, SURVIVAL STRATEGIES IN EARLY LIFE STAGES OF MARINE RESOURCES, P285; Howell D. C., 1997, STAT METHODS PSYCHOL; KAWAMURA G, 1989, NIPPON SUISAN GAKK, V55, P2079; LAURENCE GC, 1972, J FISH BIOL, V4, P73, DOI 10.1111/j.1095-8649.1972.tb05654.x; Miyazaki T, 1997, FISHERIES SCI, V63, P205; OCONNELL CP, 1976, J EXP MAR BIOL ECOL, V25, P285, DOI 10.1016/0022-0981(76)90130-1; RICE JA, 1987, CAN J FISH AQUAT SCI, V44, P467, DOI 10.1139/f87-055; THEILACKER GH, 1986, FISH B-NOAA, V84, P1; YAMADA H, 1989, SAIBAI GIKEN, V17, P129; Zar J. H., 1996, BIOSTATISTICAL ANAL	24	29	32	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	0044-8486			AQUACULTURE	Aquaculture	OCT 25	2000	190	1-2					129	138		10.1016/S0044-8486(00)00385-9		10	Fisheries; Marine & Freshwater Biology	Fisheries; Marine & Freshwater Biology	349AP	WOS:000089021900010		
J	Yoshinaga, T; Hagiwara, A; Tsukamoto, K				Yoshinaga, T; Hagiwara, A; Tsukamoto, K			Effect of periodical starvation on the life history of Brachionus plicatilis OF Muller (Rotifera): a possible strategy for population stability	JOURNAL OF EXPERIMENTAL MARINE BIOLOGY AND ECOLOGY			English	Article						Brachionus plicatilis; life-history parameters; population dynamics; Rotifera; starvation	REPRODUCTION; DYNAMICS; DAPHNIA	To estimate the changes in the life history of the rotifer Brachionus plicatilis O.F. Muller under starvation, we carried out an individual culture and determined the effects of periodical food deprivation on its asexual reproductive characteristics such as lifespan, reproductive period, age at first egg and offspring production, and lifetime fecundity (total number of offspring produced in her lifetime). Rotifers were fed for 1-3 h daily, and were then starved until the next day. Control animals were fed throughout their lifespan. Starved rotifers matured and produced their first offspring at an older age than the control animals. The periodical starvation resulted in a decrease in the lifetime fecundity to less than half that of the non-starved control. The reproductive period and lifespan were 2-3 times longer in the starved animals than in the control animals. The negative relationship between lifespan and lifetime fecundity is interpreted as a trade-off in an alternative life-history strategy of rotifers under starved conditions. The great decrease in fecundity and extension of lifespan enables rotifers to compensate to keep the population in equilibrium. (C) 2000 Elsevier Science BN. All rights reserved.	Univ Tokyo, Ocean Res Inst, Dept Marine Biosci, Nakano Ku, Tokyo 1648639, Japan; Nagasaki Univ, Fac Fisheries, Nagasaki 8528521, Japan	Yoshinaga, T (reprint author), Univ Tokyo, Ocean Res Inst, Dept Marine Biosci, Nakano Ku, 1-15-1 Minamidai, Tokyo 1648639, Japan.						SOLOMON ME, 1949, J ANIM ECOL, V18, P1, DOI 10.2307/1578; WASSER SK, 1983, Q REV BIOL, V58, P513, DOI 10.1086/413545; ATKINSON SN, 1995, FUNCT ECOL, V9, P559, DOI 10.2307/2390145; Begon M, 1986, POPULATION ECOLOGY U; ENESCO HE, 1989, MECH AGEING DEV, V48, P281, DOI 10.1016/0047-6374(89)90089-4; Hanazato Takayuki, 1997, Journal of the Faculty of Science Shinshu University, V32, P77; Hutchinson G. E., 1967, INTRO LAKE BIOL LIMN, V2; Ito Y., 1961, Bulletin of the National Institute of Agricultural Sciences Tokyo (Ser C), V13, P57; Keys A., 1950, BIOL HUMAN STARVATIO; KING CE, 1967, ECOLOGY, V48, P111, DOI 10.2307/1933423; KIRK KL, 1991, ECOLOGY, V72, P915, DOI 10.2307/1940593; Kirk KL, 1997, ECOLOGY, V78, P434, DOI 10.1890/0012-9658(1997)078[0434:LHRTVE]2.0.CO;2; Kirk KL, 1998, ECOLOGY, V79, P2456, DOI 10.1890/0012-9658(1998)079[2456:ECSPDA]2.0.CO;2; NOGRADY T, 1993, ROTIFERA, P1; Snell TW, 1998, HYDROBIOLOGIA, V368, P29, DOI 10.1023/A:1003248704763; SNELL TW, 1977, EVOLUTION, V31, P882, DOI 10.2307/2407451; SUBOW NN, 1931, OCEANOGRAPHICAL TABL, P208; TESSIER AJ, 1986, ECOLOGY, V67, P285, DOI 10.2307/1938573; TESSIER AJ, 1983, LIMNOL OCEANOGR, V28, P667; UTIDA S, 1941, MEM COLL AGR KYOTO U, V49, P21; Yoshinaga T, 1999, HYDROBIOLOGIA, V412, P103, DOI 10.1023/A:1003860502015; YOSHINAGA T, IN PRESS HYDROBIOLOG	22	33	34	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	0022-0981			J EXP MAR BIOL ECOL	J. Exp. Mar. Biol. Ecol.	OCT 25	2000	253	2					253	260		10.1016/S0022-0981(00)00268-9		8	Ecology; Marine & Freshwater Biology	Environmental Sciences & Ecology; Marine & Freshwater Biology	368VH	WOS:000090137800008		
J	Sekiya, R; Kiyo-oka, K; Imakubo, T; Kobayashi, K				Sekiya, R; Kiyo-oka, K; Imakubo, T; Kobayashi, K			Intramolecular migration of bulky substituents in the solid state: Vinylogous pinacol rearrangements induced thermally and by acid catalysis	JOURNAL OF THE AMERICAN CHEMICAL SOCIETY			English	Article							X-RAY-DIFFRACTION; CRYSTAL; CHEMISTRY; ESTER	A vinylogous pinacol rearrangement, involving an intramolecular 1,4-migration of the bulky thienothienyl substituent and a marked change of the crystal structure, was thermally induced in the solid state for thienothienyl-substituted 9,10-dihydroxy-9,10-dihydroanthracenes, 1 and 3 similar to8. When heated over 180 to similar to 240 degreesC, these crystals were transformed quantitatively, accompanying dehydration, to crystals of the anthrone derivatives without wetting or melting. Diol 8, which bears two isomeric thienothiophene rings, afforded only a single anthrone product. Compounds 1 and 8 formed a mixed crystal and its thermally induced reaction yielded two anthrone products that were attributable to intramolecular migration but afforded no anthrone derivative having the two substituents possible for the intermolecular combination. These results, along with the X-ray crystal structure of the mixed crystal, demonstrate that the rearrangement in the solid state proceeds intramolecularly. The 1,4-pinacol type rearrangements were also induced, along with the cis-trans isomerization, by cogrinding the diols with p-toluenesulfonic acid in a mortar at room temperature. The intramolecularity of the rearrangement was again proved by the use of the mixed crystal. The intervention of the carbocation in the solid-state grinding was ascertained by the UV/vis spectra. The time courses of the product distributions showed discrete profiles between the trans and cis diols, 1 and 3, respectively; for the trans diol 1, fast isomerization to the cis isomer and consecutive formation of the rearranged product via the cis isomer were observed. On the basis of these observations, the solid-state 1,4-rearrangement was deduced to occur preferentially via the cis configuration of the dihydroxy groups.	Univ Tokyo, Grad Sch Arts & Sci, Dept Chem, Meguro Ku, Tokyo 1538902, Japan	Kobayashi, K (reprint author), Univ Tokyo, Grad Sch Arts & Sci, Dept Chem, Meguro Ku, Tokyo 1538902, Japan.						ABARCA B, 1991, J ORG CHEM, V56, P3224, DOI 10.1021/jo00010a011; LUTY T, 1995, J AM CHEM SOC, V117, P2441, DOI 10.1021/ja00114a008; [Anonymous], 1991, STRUCTURE ANAL PROGR; Schmeyers J, 1998, J CHEM SOC PERK T 2, P989, DOI 10.1039/a704633b; Smrcina M, 1996, J AM CHEM SOC, V118, P487; Tanaka K, 2000, CHEM REV, V100, P1025, DOI 10.1021/cr940089p; Dunitz JD, 1998, J AM CHEM SOC, V120, P13274, DOI 10.1021/ja983285c; BURLA MC, 1989, J APPL CRYSTALLOGR, V22, P389, DOI 10.1107/S0021889889004103; COLLINS CJ, 1960, Q REV CHEM SOC, V14, P357, DOI 10.1039/qr9601400357; DEDELGADO GCD, 1991, ANGEW CHEM INT EDIT, V30, P420, DOI 10.1002/anie.199104201; DESIRAJU GR, 1989, J AM CHEM SOC, V111, P4838, DOI 10.1021/ja00195a040; DESSOLIN M, 1992, J CHEM SOC CHEM COMM, P132, DOI 10.1039/c39920000132; DESSOLIN M, 1986, J CHEM SOC CHEM COMM, P38, DOI 10.1039/c39860000038; ERREDE LA, 1981, J CHEM SOC PERK T 2, P233, DOI 10.1039/p29810000233; GOUD BS, 1995, J CHEM SOC PERK T 2, P325, DOI 10.1039/p29950000325; HAYASHI N, 1994, J CHEM SOC CHEM COMM, P2351, DOI 10.1039/c39940002351; KAUPP G, 1995, J PHYS ORG CHEM, V8, P545, DOI 10.1002/poc.610080805; KISHAN KVR, 1987, J ORG CHEM, V52, P4640; LEWIS TW, 1979, J AM CHEM SOC, V101, P5717, DOI 10.1021/ja00513a043; LEWIS TW, 1980, J AM CHEM SOC, V102, P4659, DOI 10.1021/ja00534a016; MENGER FM, 1984, TETRAHEDRON LETT, V25, P2311, DOI 10.1016/S0040-4039(01)80242-2; *MOL STRUCT CORP, 1995, SINGL CRYST STRUCT A; NADER FW, 1985, ANGEW CHEM INT EDIT, V24, P852, DOI 10.1002/anie.198508521; NARUCHI K, 1987, J CHEM SOC PERK T 2, P113, DOI 10.1039/p29870000113; PUCKETT SA, 1976, J AM CHEM SOC, V98, P787, DOI 10.1021/ja00419a026; Rickborn B., 1991, COMPREHENSIVE ORGANI, V3, P721; COHEN MD, 1964, J CHEM SOC, P1996, DOI 10.1039/jr9640001996; SINGH NB, 1994, J CHEM SOC PERK T 2, P361, DOI 10.1039/p29940000361; Smet M, 1999, TETRAHEDRON, V55, P7859, DOI 10.1016/S0040-4020(99)00406-8; SUKENIK CN, 1977, J AM CHEM SOC, V99, P851, DOI 10.1021/ja00445a030; Tanaka M, 1998, CHEM COMMUN, P1965, DOI 10.1039/a803496f; TASATO ML, 1984, J CHEM SOC P2, P1593; TODA F, 1989, J CHEM SOC PERK T 1, P209, DOI 10.1039/p19890000209; Toda F, 1995, ACCOUNTS CHEM RES, V28, P480, DOI 10.1021/ar00060a003; Toda F, 1998, ANGEW CHEM INT EDIT, V37, P2724, DOI 10.1002/(SICI)1521-3773(19981016)37:19<2724::AID-ANIE2724>3.0.CO;2-Y; Toyoshi Y, 1998, B CHEM SOC JPN, V71, P2817, DOI 10.1246/bcsj.71.2817	36	14	14	AMER CHEMICAL SOC	WASHINGTON	1155 16TH ST, NW, WASHINGTON, DC 20036 USA	0002-7863			J AM CHEM SOC	J. Am. Chem. Soc.	OCT 25	2000	122	42					10282	10288		10.1021/ja000788l		7	Chemistry, Multidisciplinary	Chemistry	368UZ	WOS:000090137000004		
J	Nakao, Y; Fujita, M; Warabi, K; Matsunaga, S; Fusetani, N				Nakao, Y; Fujita, M; Warabi, K; Matsunaga, S; Fusetani, N			Bioactive marine metabolites. Part 104. Miraziridine A, a novel cysteine protease inhibitor from the marine sponge Theonella aff. mirabilis	JOURNAL OF THE AMERICAN CHEMICAL SOCIETY			English	Article							C-13 ASSIGNMENTS; NMR; H-1		Univ Tokyo, Grad Sch Agr & Life Sci, Lab Aquat Nat Prod Chem, Bunkyo Ku, Tokyo 1138657, Japan	Fusetani, N (reprint author), Univ Tokyo, Grad Sch Agr & Life Sci, Lab Aquat Nat Prod Chem, Bunkyo Ku, Tokyo 1138657, Japan.		Fujita, Masaki/A-8464-2012				MARFEY P, 1984, CARLSBERG RES COMMUN, V49, P591, DOI 10.1007/BF02908688; Ford PW, 1999, J AM CHEM SOC, V121, P5899, DOI 10.1021/ja990582o; BAX A, 1986, J AM CHEM SOC, V108, P2093, DOI 10.1021/ja00268a061; BAX A, 1986, J AM CHEM SOC, V108, P8056, DOI 10.1021/ja00285a029; Fusetani N, 1999, BIOORG MED CHEM LETT, V9, P3397, DOI 10.1016/S0960-894X(99)00618-6; MATSUNAGA S, 1989, J AM CHEM SOC, V111, P2582, DOI 10.1021/ja00189a035; MATSUNAGA S, 1995, J ORG CHEM, V60, P1177, DOI 10.1021/jo00110a020; NAGANAWA H, 1975, J ANTIBIOT, V28, P828; NAKAO Y, IN PRESS TETRAHEDRON; PALMER JT, 1995, Patent No. 9523222; Schirmeister T, 1996, ARCH PHARM, V329, P239, DOI 10.1002/ardp.19963290504; SUMMERS MF, 1986, J AM CHEM SOC, V108, P4285, DOI 10.1021/ja00275a008; TSUBOTANI S, 1995, Patent No. 9528416; TSUBOYA S, 1996, Patent No. 09221470	14	41	43	AMER CHEMICAL SOC	WASHINGTON	1155 16TH ST, NW, WASHINGTON, DC 20036 USA	0002-7863			J AM CHEM SOC	J. Am. Chem. Soc.	OCT 25	2000	122	42					10462	10463		10.1021/ja001859j		2	Chemistry, Multidisciplinary	Chemistry	368UZ	WOS:000090137000027		
J	Minabe, T; Tryk, DA; Sawunyama, P; Kikuchi, Y; Hashimoto, K; Fujishima, A				Minabe, T; Tryk, DA; Sawunyama, P; Kikuchi, Y; Hashimoto, K; Fujishima, A			TiO2-mediated photodegradation of liquid and solid organic compounds	JOURNAL OF PHOTOCHEMISTRY AND PHOTOBIOLOGY A-CHEMISTRY			English	Article						titanium dioxide; photocatalyst; self-cleaning; reaction intermediates	PHOTO-KOLBE REACTION; TIO2 THIN-FILMS; PHOTOCATALYTIC OXIDATION; TITANIUM-DIOXIDE; STEARIC-ACID; GAS-PHASE; WATER; ELECTRON; PHOTOGENERATION; DECOMPOSITION	The photocatalytic degradation of several liquid and solid organic compounds, including polymers, with molecular weights covering a wide range from 600 to 500,000 was studied on TiO2 thin films on glass under UV illumination. Nearly exact agreement was found between the weight losses of the solid compounds octadecane and stearic acid and the weights of CO2 produced during photocatalytic degradation. No other gas-phase degradation product was detected for these two compounds other than CO2, which means that potentially harmful products are not expected to pose a problem. For convenient comparison of degradation rates for various compounds and measurement methods, the values were converted to numbers of moles of carbon reacted per square centimeter per hour. Under appropriate conditions (50 degreesC, relative humidity 10% in air), octadecane was completely decomposed (<400 ng cm(-2)). In contrast, stearic acid did not decompose completely, even after more than 80 h of UV illumination. This may be due to the formation of a photocatalytically inert reaction product that blocks the TiO2 surface. The decomposition rates for all of the compounds examined spanned less than two orders of magnitude, suggesting that the photocatalytic reactions involved are rather versatile. (C) 2000 Published by Elsevier Science B.V.	Univ Tokyo, Sch Engn, Dept Appl Chem, Bunkyo Ku, Tokyo 1138656, Japan; Kanagawa Acad Sci & Technol, Kanagawa 2430297, Japan; Univ Tokyo, Adv Sci & Technol Res Ctr, Meguro Ku, Tokyo 1538904, Japan	Minabe, T (reprint author), Univ Tokyo, Sch Engn, Dept Appl Chem, Bunkyo Ku, 7-3-1 Hongo, Tokyo 1138656, Japan.		Tryk, Donald/D-5931-2012; Fujishima, Akira/G-7701-2012; Hashimoto, Kazuhito/C-5011-2012	Tryk, Donald/0000-0003-4660-9674; Hashimoto, Kazuhito/0000-0002-8384-8749			SCHWITZGEBEL J, 1995, J PHYS CHEM-US, V99, P5633, DOI 10.1021/j100015a055; FUJISHIMA A, 1972, NATURE, V238, P37, DOI 10.1038/238037a0; HARBOUR JR, 1985, CAN J CHEM, V63, P204, DOI 10.1139/v85-032; Tatsuma T, 1999, J PHYS CHEM B, V103, P8033, DOI 10.1021/jp9918297; HASHIMOTO K, 1984, J PHYS CHEM-US, V88, P4083, DOI 10.1021/j150662a046; Nosaka Y, 1996, LANGMUIR, V12, P736, DOI 10.1021/la9509615; Kikuchi Y, 1997, J PHOTOCH PHOTOBIO A, V106, P51, DOI 10.1016/S1010-6030(97)00038-5; FUJIHIRA M, 1981, NATURE, V293, P206, DOI 10.1038/293206a0; EGERTON TA, 1979, J OIL COLOUR CHEM AS, V62, P386; Sitkiewitz S, 1996, NEW J CHEM, V20, P233; PAZ Y, 1995, J MATER RES, V10, P2842, DOI 10.1557/JMR.1995.2842; OLLIS DF, 1985, ENVIRON SCI TECHNOL, V19, P480, DOI 10.1021/es00136a002; Wang R, 1998, ADV MATER, V10, P135, DOI 10.1002/(SICI)1521-4095(199801)10:2<135::AID-ADMA135>3.0.CO;2-M; JAEGER CD, 1979, J PHYS CHEM-US, V83, P3146, DOI 10.1021/j100487a017; SAKATA T, 1984, J PHYS CHEM-US, V88, P2344, DOI 10.1021/j150655a032; FU XZ, 1995, APPL CATAL B-ENVIRON, V6, P209, DOI 10.1016/0926-3373(95)00017-8; Sopyan I, 1996, J ELECTROANAL CHEM, V415, P183, DOI 10.1016/S0022-0728(96)01007-8; Sawunyama P, 1997, J PHYS CHEM B, V101, P11000, DOI 10.1021/jp9730095; NACCACHE C, 1971, T FARADAY SOC, V67, P506, DOI 10.1039/tf9716700506; CAREY FA, 1990, ADV ORGANIC CHEM B, pCH12; FUJISHIMA A, 1996, S TIO2 PHOT PUR TREA; FUKAYAMA S, 1995, 187 M EL SOC EL SOC; FUKUZAWA S, 1968, J CATAL, V11, P364, DOI 10.1016/0021-9517(68)90060-2; GRAVELLE PC, 1971, DISCUSS FARADAY SOC, P140; Heller A, 1995, ACCOUNTS CHEM RES, V28, P503, DOI 10.1021/ar00060a006; ISHIBASHI K, 1998, J PHYS CHEM B, V102, P2118; KRAEUTLER B, 1977, J AM CHEM SOC, V99, P7729, DOI 10.1021/ja00465a065; NEGISHI N, 1995, CHEM LETT, P841, DOI 10.1246/cl.1995.841; Schwitzgebel J, 1997, J PHYS CHEM B, V101, P2621, DOI 10.1021/jp9624921; VOLTZ HG, 1972, FARBE LACK, V78, P1037	30	133	145	ELSEVIER SCIENCE SA	LAUSANNE	PO BOX 564, 1001 LAUSANNE, SWITZERLAND	1010-6030			J PHOTOCH PHOTOBIO A	J. Photochem. Photobiol. A-Chem.	OCT 24	2000	137	1					53	62		10.1016/S1010-6030(00)00350-6		10	Chemistry, Physical	Chemistry	366AM	WOS:000089982700008		
J	Nagawa, M; Ichikawa, M; Koyama, T; Shirai, H; Taniguchi, Y; Hongo, A; Tsuji, S; Nakano, Y				Nagawa, M; Ichikawa, M; Koyama, T; Shirai, H; Taniguchi, Y; Hongo, A; Tsuji, S; Nakano, Y			Organic solid-state distributed feedback dye laser with a nonmorphological modification grating	APPLIED PHYSICS LETTERS			English	Article							ELECTROLUMINESCENT DEVICE; TRANSPORT; DIODES; LAYER	We report an organic solid-state distributed feedback laser consisting of an organic active layer and a Bragg grating without morphological change. The active layer consists of 4-(dicyanomethylene)-2-methyl-6-(4-dimethylaminostryl)-4H-pyran as a laser dye, tris(8hydroxyquinoline) aluminum as a host, and poly(methyl methacrylate) as a binder. The threshold and linewidth of the laser are 400 mu J/cm(2) and 1.5 nm, respectively. With this laser, the Bragg grating exists out of the active layer and the grating surface is flat, which are very important for device fabrication and electric driving of the laser. (C) 2000 American Institute of Physics. [S0003-6951(00)03243-5].	Shinshu Univ, Dept Funct Polymer Sci, Ueda, Nagano 3868567, Japan; Hitachi Cable Ltd, Optoelect Syst Lab, Hitachi, Ibaraki 3191414, Japan; Hitachi Ltd, Cent Res Lab, Tokyo 1858601, Japan; Univ Tokyo, Dept Elect Engn, Tokyo 1138656, Japan	Nagawa, M (reprint author), Shinshu Univ, Dept Funct Polymer Sci, Ueda, Nagano 3868567, Japan.		Ichikawa, Musubu/K-3855-2012				KIDO J, 1995, SCIENCE, V267, P1332, DOI 10.1126/science.267.5202.1332; Bulovic V, 1998, SCIENCE, V279, P553, DOI 10.1126/science.279.5350.553; KUWABARA Y, 1994, ADV MATER, V6, P677, DOI 10.1002/adma.19940060913; Rogers JA, 1998, APPL PHYS LETT, V73, P1766, DOI 10.1063/1.122275; Yamamori A, 1998, APPL PHYS LETT, V72, P2147, DOI 10.1063/1.121304; ADACHI C, 1989, APPL PHYS LETT, V55, P1489, DOI 10.1063/1.101586; BURROWS PE, 1994, APPL PHYS LETT, V64, P2285, DOI 10.1063/1.111645; Berggren M, 1997, SYNTHETIC MET, V91, P65, DOI 10.1016/S0379-6779(98)80065-9; Hofmann R, 1996, APPL PHYS LETT, V69, P2068, DOI 10.1063/1.116882; McGehee MD, 1998, APPL PHYS LETT, V72, P1536, DOI 10.1063/1.121679; NAGAWA M, 1999, UNPUB P INT C ADV FI, P310; Okumura Y, 2000, CHEM LETT, P754, DOI 10.1246/cl.2000.754; TANG CW, 1987, APPL PHYS LETT, V51, P913, DOI 10.1063/1.98799; Uetsuka H, 1998, IEICE T ELECTRON, VE81C, P1205; UTAKA K, 1984, IEEE J QUANTUM ELECT, V20, P236, DOI 10.1109/JQE.1984.1072383; WALPITA LM, 1985, J OPT SOC AM A, V2, P595, DOI 10.1364/JOSAA.2.000595	16	36	38	AMER INST PHYSICS	MELVILLE	2 HUNTINGTON QUADRANGLE, STE 1NO1, MELVILLE, NY 11747-4501 USA	0003-6951			APPL PHYS LETT	Appl. Phys. Lett.	OCT 23	2000	77	17					2641	2643		10.1063/1.1320034		3	Physics, Applied	Physics	363ZQ	WOS:000089867900005		
J	Kawasaki, M; Yamaguchi, M; Yanagida, T				Kawasaki, M; Yamaguchi, M; Yanagida, T			Natural chaotic inflation in supergravity	PHYSICAL REVIEW LETTERS			English	Article							QUANTUM CORRECTIONS; UNIVERSE SCENARIO; DARK-MATTER; PERTURBATIONS; GRAVITINO	We propose a chaotic inflation model in supergravity. In the model the Kahler potential has a Nambu-Goldstone-type shift symmetry of the inflation chiral multiplet which ensures the flatness of the inflation potential beyond the Planck scale. We show that chaotic inflation naturally takes place by introducing a small breaking term of the shift symmetry in the superpotential. This may open a new branch of model building for inflationary cosmology in the framework of supergravity.	Univ Tokyo, Res Ctr Early Universe, Tokyo 1130033, Japan; Univ Tokyo, Dept Phys, Tokyo 1130033, Japan	Kawasaki, M (reprint author), Univ Tokyo, Res Ctr Early Universe, Tokyo 1130033, Japan.		Yanagida, Tsutomu/A-4394-2011				STAROBINSKY AA, 1982, PHYS LETT B, V117, P175, DOI 10.1016/0370-2693(82)90541-X; Halyo E, 1996, PHYS LETT B, V387, P43, DOI 10.1016/0370-2693(96)01001-5; GUTH AH, 1982, PHYS REV LETT, V49, P1110, DOI 10.1103/PhysRevLett.49.1110; Binetruy P, 1996, PHYS LETT B, V388, P241, DOI 10.1016/S0370-2693(96)01083-0; GONCHAROV AS, 1984, PHYS LETT B, V139, P27, DOI 10.1016/0370-2693(84)90027-3; LINDE AD, 1983, PHYS LETT B, V129, P177, DOI 10.1016/0370-2693(83)90837-7; NILLES HP, 1984, PHYS REP, V110, P1, DOI 10.1016/0370-1573(84)90008-5; POLARSKI D, 1992, NUCL PHYS B, V385, P623, DOI 10.1016/0550-3213(92)90062-G; KHLOPOV MY, 1984, PHYS LETT B, V138, P265, DOI 10.1016/0370-2693(84)91656-3; Chung DJH, 1998, PHYS REV LETT, V81, P4048, DOI 10.1103/PhysRevLett.81.4048; ELLIS J, 1992, NUCL PHYS B, V373, P399, DOI 10.1016/0550-3213(92)90438-H; Bennett C. L., 1996, ASTROPHYS J LETT, V464, P1; Chung DJH, 1999, PHYS REV D, V59; GONCHAROV AS, 1984, CLASSICAL QUANT GRAV, V1, pL75, DOI 10.1088/0264-9381/1/6/004; HAWKING SW, 1982, PHYS LETT B, V115, P295, DOI 10.1016/0370-2693(82)90373-2; KAWASAKI M, 1995, PROG THEOR PHYS, V93, P879; KOFMAN L, 1994, PHYS REV LETT, V73, P3185; LINDE AD, 1990, PARTICLE PHYSICS INF; Lyth DH, 1999, PHYS REP, V314, P1, DOI 10.1016/S0370-1573(98)00128-8; MURAYAMA H, 1994, PHYS REV D, V50, pR2356; Starobinsky A. A., 1982, P 2 SEM QUANT THEOR, P58; STAROBINSKII AA, 1985, SOV ASTRON LETT+, V11, P133; STEWART ED, 1995, PHYS REV D, V51, P6847, DOI 10.1103/PhysRevD.51.6847; Stewart ED, 1997, PHYS LETT B, V391, P34, DOI 10.1016/S0370-2693(96)01458-X; Stewart ED, 1997, PHYS REV D, V56, P2019, DOI 10.1103/PhysRevD.56.2019; THOOFT GT, 1980, RECENT DEV GAUGE THE	26	269	269	AMERICAN PHYSICAL SOC	COLLEGE PK	ONE PHYSICS ELLIPSE, COLLEGE PK, MD 20740-3844 USA	0031-9007			PHYS REV LETT	Phys. Rev. Lett.	OCT 23	2000	85	17					3572	3575		10.1103/PhysRevLett.85.3572		4	Physics, Multidisciplinary	Physics	366GN	WOS:000089996600007		
J	Togawa, Y; Abiru, R; Iwaya, K; Kitano, H; Maeda, A				Togawa, Y; Abiru, R; Iwaya, K; Kitano, H; Maeda, A			Direct observation of the washboard noise of a driven vortex lattice in a high-temperature superconductor, Bi2Sr2CaCu2Oy	PHYSICAL REVIEW LETTERS			English	Article							CHARGE-DENSITY WAVES; MOVING GLASS PHASE; FLUX-LINE-LATTICE; MELTING TRANSITION; PERIODIC MEDIA; BAND NOISE; ORDER; YBA2CU3O7-DELTA; VORTICES; DISORDER	We studied the conduction noise spectrum in the vortex state of a high-temperature superconductor, Bi2Sr2CaCu2Oy, subject to a uniform driving force. Two characteristic features, a broad-band noise (BBN) and a narrow-band noise (NBN), were observed in the vortex-solid phase. The origin of the large BBN was determined to be plastic motion of the vortices, whereas the NBN was found to originate from the washboard modulation of the translational velocity of the driven vortices. We believe this to be the first observation of washboard noise of de driven vortices in any superconductor.	Univ Tokyo, Dept Basic Sci, Meguro Ku, Tokyo 1538902, Japan; Japan Sci & Technol Corp, JST, CREST, Kawaguchi 3320012, Japan	Togawa, Y (reprint author), Univ Tokyo, Dept Basic Sci, Meguro Ku, 3-8-1 Kamaba, Tokyo 1538902, Japan.						Troyanovski AM, 1999, NATURE, V399, P665; Ryu S, 1996, PHYS REV LETT, V77, P5114, DOI 10.1103/PhysRevLett.77.5114; Schilling A, 1996, NATURE, V382, P791, DOI 10.1038/382791a0; PASTORIZA H, 1994, PHYS REV LETT, V72, P2951, DOI 10.1103/PhysRevLett.72.2951; Le Doussal P, 1998, PHYS REV B, V57, P11356, DOI 10.1103/PhysRevB.57.11356; Nattermann T, 2000, ADV PHYS, V49, P607, DOI 10.1080/000187300412257; ZELDOV E, 1995, NATURE, V375, P373, DOI 10.1038/375373a0; Giamarchi T, 1997, PHYS REV B, V55, P6577, DOI 10.1103/PhysRevB.55.6577; Dominguez D, 1997, PHYS REV LETT, V78, P2644, DOI 10.1103/PhysRevLett.78.2644; GRUNER G, 1988, REV MOD PHYS, V60, P1129, DOI 10.1103/RevModPhys.60.1129; GRUNER G, 1994, REV MOD PHYS, V66, P1, DOI 10.1103/RevModPhys.66.1; BLATTER G, 1994, REV MOD PHYS, V66, P1125, DOI 10.1103/RevModPhys.66.1125; Balents L, 1998, PHYS REV B, V57, P7705, DOI 10.1103/PhysRevB.57.7705; BALENTS L, 1995, PHYS REV LETT, V75, P4270, DOI 10.1103/PhysRevLett.75.4270; Balents L, 1997, PHYS REV LETT, V78, P751, DOI 10.1103/PhysRevLett.78.751; CLEM JR, 1981, PHYS REP, V75, P1, DOI 10.1016/0370-1573(81)90102-2; Crabtree GW, 1997, PHYS TODAY, V50, P38, DOI 10.1063/1.881715; Fendrich JA, 1996, PHYS REV LETT, V77, P2073, DOI 10.1103/PhysRevLett.77.2073; FIORY AT, 1971, PHYS REV LETT, V27, P501, DOI 10.1103/PhysRevLett.27.501; Giamarchi T, 1996, PHYS REV LETT, V76, P3408, DOI 10.1103/PhysRevLett.76.3408; Giamarchi T, 1997, PHYS REV LETT, V78, P752, DOI 10.1103/PhysRevLett.78.752; Hanaguri T, 1996, PHYSICA C, V263, P434, DOI 10.1016/0921-4534(96)00088-3; HARRIS JM, 1995, PHYS REV LETT, V74, P3684, DOI 10.1103/PhysRevLett.74.3684; KOSHELEV AE, 1994, PHYS REV LETT, V73, P3580, DOI 10.1103/PhysRevLett.73.3580; MAEDA A, 1985, J PHYS SOC JPN, V54, P1912, DOI 10.1143/JPSJ.54.1912; Maeda A, 1999, J LOW TEMP PHYS, V117, P1329, DOI 10.1023/A:1022564927088; Matsuda T, 1996, SCIENCE, V271, P1393, DOI 10.1126/science.271.5254.1393; MATSUKAWA H, 1989, SYNTHETIC MET, V29, pF343; Moon K, 1996, PHYS REV LETT, V77, P2778, DOI 10.1103/PhysRevLett.77.2778; Olson CJ, 1998, PHYS REV LETT, V81, P3757, DOI 10.1103/PhysRevLett.81.3757; Pardo F, 1998, NATURE, V396, P348; Sasagawa T, 1998, PHYS REV LETT, V80, P4297, DOI 10.1103/PhysRevLett.80.4297; Tsuboi T, 1998, PHYS REV LETT, V80, P4550, DOI 10.1103/PhysRevLett.80.4550; Tsuboi T, 1997, PHYS REV B, V55, pR8709; Welp U, 1996, PHYS REV LETT, V76, P4809, DOI 10.1103/PhysRevLett.76.4809; YARON U, 1995, NATURE, V376, P753, DOI 10.1038/376753a0	36	64	64	AMERICAN PHYSICAL SOC	COLLEGE PK	ONE PHYSICS ELLIPSE, COLLEGE PK, MD 20740-3844 USA	0031-9007			PHYS REV LETT	Phys. Rev. Lett.	OCT 23	2000	85	17					3716	3719		10.1103/PhysRevLett.85.3716		4	Physics, Multidisciplinary	Physics	366GN	WOS:000089996600043		
J	Hidaka, I; Nozaki, D; Yamamoto, Y				Hidaka, I; Nozaki, D; Yamamoto, Y			Functional stochastic resonance in the human brain: Noise induced sensitization of baroreflex system	PHYSICAL REVIEW LETTERS			English	Article							HEART-RATE; COLORED NOISE; PRESSURE; MECHANORECEPTORS; CRAYFISH; BENEFITS	We demonstrate experimentally that noise can enhance the homeostatic function in the human blood pressure regulatory system. The results show that the compensatory heart rate response to the weak periodic signal introduced at the venous blood pressure receptor is optimized by adding noise to the arterial blood pressure receptor. We conclude that this functional stochastic resonance most likely results from the interaction of noise with signal in the brain stem, where the neuronal inputs from these two different receptors first join together.	Univ Tokyo, Grad Sch Educ, Educ Physiol Lab, Bunkyo Ku, Tokyo 1130033, Japan; Natl Rehabil Ctr Disabled, Inst Res, Dept Motor Dysfunct, Tokorozawa, Saitama 3598555, Japan	Yamamoto, Y (reprint author), Univ Tokyo, Grad Sch Educ, Educ Physiol Lab, Bunkyo Ku, 7-3-1 Hongo, Tokyo 1130033, Japan.			Nozaki, Daichi/0000-0002-1338-8337			JOHNSON JM, 1974, CIRC RES, V34, P515; Russell DF, 1999, NATURE, V402, P291; ECKBERG DL, 1975, J LAB CLIN MED, V85, P167; Collins JJ, 1996, NATURE, V383, P770, DOI 10.1038/383770a0; Cordo P, 1996, NATURE, V383, P769, DOI 10.1038/383769a0; Nozaki D, 1999, PHYS REV LETT, V82, P2402, DOI 10.1103/PhysRevLett.82.2402; Simonotto E, 1997, PHYS REV LETT, V78, P1186, DOI 10.1103/PhysRevLett.78.1186; Suki B, 1998, NATURE, V393, P127, DOI 10.1038/30130; WIESENFELD K, 1995, NATURE, V373, P33, DOI 10.1038/373033a0; Gammaitoni L, 1998, REV MOD PHYS, V70, P223, DOI 10.1103/RevModPhys.70.223; Collins JJ, 1996, J NEUROPHYSIOL, V76, P642; Stacey WC, 2000, J NEUROPHYSIOL, V83, P1394; Richardson KA, 1998, CHAOS, V8, P599, DOI 10.1063/1.166341; ANDRESEN MC, 1994, ANNU REV PHYSIOL, V56, P93, DOI 10.1146/annurev.physiol.56.1.93; CLEVELAND WS, 1979, J AM STAT ASSOC, V74, P829, DOI 10.2307/2286407; DOUGLASS JK, 1993, NATURE, V365, P337, DOI 10.1038/365337a0; GAMMAITONI L, 1995, PHYS REV E, V52, P4691, DOI 10.1103/PhysRevE.52.4691; GINGL Z, 1995, EUROPHYS LETT, V29, P191, DOI 10.1209/0295-5075/29/3/001; Gluckman BJ, 1996, PHYS REV LETT, V77, P4098, DOI 10.1103/PhysRevLett.77.4098; GOLDBERGER A L, 1990, Scientific American, V262, P42; HIDAKA I, UNPUB; KUBOTA T, 1992, AM J PHYSIOL, V263, pH307; Levin JE, 1996, NATURE, V380, P165, DOI 10.1038/380165a0; MANCIA G, 1983, HDB PHYSL 2 2, V3, pCH2; MANDELL AJ, 1993, J STAT PHYS, V70, P355, DOI 10.1007/BF01053973; MARK AL, HDB PHYSL, pCH21; MUKAI S, 1995, J APPL PHYSIOL, V78, P212; TRIEDMAN JK, 1994, CIRCULATION, V89, P169; YAMAMOTO Y, 1994, AM J PHYSIOL, V266, pR40	29	102	103	AMERICAN PHYSICAL SOC	COLLEGE PK	ONE PHYSICS ELLIPSE, COLLEGE PK, MD 20740-3844 USA	0031-9007			PHYS REV LETT	Phys. Rev. Lett.	OCT 23	2000	85	17					3740	3743		10.1103/PhysRevLett.85.3740		4	Physics, Multidisciplinary	Physics	366GN	WOS:000089996600049		
J	Hazeki, N; Tukamoto, T; Goto, J; Kanazawa, I				Hazeki, N; Tukamoto, T; Goto, J; Kanazawa, I			Formic acid dissolves aggregates of an N-terminal huntingtin fragment containing an expanded polyglutamine tract: Applying to quantification of protein components of the aggregates	BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS			English	Article						formic acid; Huntington's disease; proteasome; aggregate	NEURONAL INTRANUCLEAR INCLUSIONS; NEURODEGENERATIVE DISEASES; NUCLEAR MATRIX; IN-VIVO; SUPPRESSION; CHAPERONE; REPEAT; BRAIN; MICE	Huntington's disease (HD) is caused by an expansion of the CAG repeat that encodes polyglutamine in huntingtin, Transient expression of an N-terminal huntingtin fragment containing an expanded polyglutamine tract induced formation of protein aggregates in cultured cells. The turnover of protein components in such aggregates has been difficult to study because of their insolubility in aqueous solutions. Here we describe a method of solubilizing the aggregates and quantifying their protein components. Insoluble pellets were collected from COS7 cells expressing an N-terminal huntingtin fragment containing an expanded polyglutamine tract and subjected to treatment with various detergent, acid, and alkaline reagents. Treatment with 100% formic acid at 37 degreesC for 30 min induced essentially complete dissociation of the aggregates to monomer, We used this solubilization technique to quantify huntingtin fusion protein in the aggregates formed in transient expression experiments. The frequency of aggregate formation increased when the proteasome inhibitor beta -lactone was added to culture media. However, the total amount of accumulated huntingtin fusion protein did not differ between cells cultured with or without beta -lactone, These results suggest that other protein components which are degraded by the proteasome, in addition to huntingtin, might be related to the dynamics of polyglutamine protein aggregates. (C) 2000 Academic Press.	Japan Sci & Technol Corp, CREST, Tokyo, Japan; Univ Tokyo, Grad Sch Med, Dept Neurol, Div Neurosci,Bunkyo Ku, Tokyo 1138655, Japan	Hazeki, N (reprint author), Japan Sci & Technol Corp, CREST, Tokyo, Japan.						Scherzinger E, 1997, CELL, V90, P549, DOI 10.1016/S0092-8674(00)80514-0; Lansbury PT, 1997, NEURON, V19, P1151, DOI 10.1016/S0896-6273(00)80406-7; PERUTZ MF, 1994, P NATL ACAD SCI USA, V91, P5355, DOI 10.1073/pnas.91.12.5355; FENTEANY G, 1995, SCIENCE, V268, P726, DOI 10.1126/science.7732382; Davies SW, 1997, CELL, V90, P537, DOI 10.1016/S0092-8674(00)80513-9; Skinner PJ, 1997, NATURE, V389, P971; Kahlem P, 1998, MOL CELL, V1, P595, DOI 10.1016/S1097-2765(00)80059-3; Ross CA, 1997, NEURON, V19, P1147, DOI 10.1016/S0896-6273(00)80405-5; Igarashi S, 1998, NAT GENET, V18, P111, DOI 10.1038/ng0298-111; Kalchman MA, 1996, J BIOL CHEM, V271, P19385; DiFiglia M, 1997, SCIENCE, V277, P1990, DOI 10.1126/science.277.5334.1990; Stenoien DL, 1999, HUM MOL GENET, V8, P731, DOI 10.1093/hmg/8.5.731; Cummings CJ, 1998, NAT GENET, V19, P148, DOI 10.1038/502; Wanker EE, 1999, METHOD ENZYMOL, V309, P375; TROTTIER Y, 1995, NATURE, V378, P403, DOI 10.1038/378403a0; Holmberg M, 1998, HUM MOL GENET, V7, P913, DOI 10.1093/hmg/7.5.913; Li M, 1998, ANN NEUROL, V44, P249, DOI 10.1002/ana.410440216; Paulson HL, 1997, NEURON, V19, P333, DOI 10.1016/S0896-6273(00)80943-5; Mangiarini L, 1996, CELL, V87, P493, DOI 10.1016/S0092-8674(00)81369-0; MASTERS CL, 1985, P NATL ACAD SCI USA, V82, P4245, DOI 10.1073/pnas.82.12.4245; Chai YH, 1999, HUM MOL GENET, V8, P673, DOI 10.1093/hmg/8.4.673; CIECHANOVER A, 1994, CELL, V79, P13, DOI 10.1016/0092-8674(94)90396-4; CRISTOFARO T, 1999, BIOCHEM BIOPH RES CO, V260, P150; Hazeki N, 1999, BIOCHEM BIOPH RES CO, V256, P361, DOI 10.1006/bbrc.1999.0337; Karpuj MV, 1999, P NATL ACAD SCI USA, V96, P7388, DOI 10.1073/pnas.96.13.7388; KITAMOTO T, 1987, LAB INVEST, V57, P230; MACDONALD ME, 1993, CELL, V72, P971, DOI 10.1016/0092-8674(93)90585-E; Perez MK, 1999, HUM MOL GENET, V8, P2377, DOI 10.1093/hmg/8.13.2377; Persichetti F, 1999, NEUROBIOL DIS, V6, P364, DOI 10.1006/nbdi.1999.0260	29	56	59	ACADEMIC PRESS INC	SAN DIEGO	525 B ST, STE 1900, SAN DIEGO, CA 92101-4495 USA	0006-291X			BIOCHEM BIOPH RES CO	Biochem. Biophys. Res. Commun.	OCT 22	2000	277	2					386	393		10.1006/bbrc.2000.3682		8	Biochemistry & Molecular Biology; Biophysics	Biochemistry & Molecular Biology; Biophysics	368FK	WOS:000090106900017		
J	Takahashi, N; Sasagawa, N; Suzuki, K; Ishiura, S				Takahashi, N; Sasagawa, N; Suzuki, K; Ishiura, S			The CUG-binding protein binds specifically to UG dinucleotide repeats in a yeast three-hybrid system	BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS			English	Article							3' UNTRANSLATED REGION; MESSENGER-RNA; MYOTONIC-DYSTROPHY; TRANSLATIONAL REGULATION; TRIPLET REPEAT; CTG REPEAT; GENE; LOCALIZATION; DEGRADATION; EUKARYOTES	The CUG-binding protein (CUG-BP) has been reported to be involved in the pathogenesis of myotonic dystrophy (DM) through binding to a CUG trinucleotide repeat located in the 3' untranslated region (3'UTR) of the DM protein kinase (DMPK) gene. We found that CUG-BP associates with long CUG; trinucleotide repeats ((CUG)(11)(CUG)(12)), but not with short repeats ((CUG)(12)) in a yeast three-hybrid system. On the other hand, CUG-BP+LYLQ, an alternatively spliced isoform of CUG-BP, does not associate with CUG trinucleotide repeats regardless of the repeat length. In addition to these findings, we found that CUG-BP and CUG-BP+LYLQ strongly and specifically associate with UG dinucleotide repeats. Deletion analyse of CUG-BP revealed that the absence of the first or third RNA-binding domain (RBD I and RED III, respectively) does not affect the interaction between CUG-BP and UG dinucleotide repeats. Loss of the second RNA-binding domain (RBD II) decreases the affinity of CUG-BP for UG dinucleotide repeats by about 40%. Unexpectedly, deletion of the linker domain most severely reduces the interaction, although this region does not contain a known RNA-binding motif, Our results suggest the possibility that both CUG-BP and CUG-BP+LYLQ associate with UG repeat-containing mRNAs and regulate such metabolic properties as mRNA localization, stability, and translation, and provide new insights into the pathogenesis of DM. (C) 2000 Academic Press.	Univ Tokyo, Grad Sch Arts & Sci, Dept Life Sci, Meguro Ku, Tokyo 1538902, Japan; Univ Tokyo, Inst Mol & Cellular Biosci, Dept Mol Biol, Lab Mol Struct & Funct,Bunkyo Ku, Tokyo 1130032, Japan	Ishiura, S (reprint author), Univ Tokyo, Grad Sch Arts & Sci, Dept Life Sci, Meguro Ku, 3-8-1 Komaba, Tokyo 1538902, Japan.						Adams Alison, 1997, P99; SenGupta DJ, 1996, P NATL ACAD SCI USA, V93, P8496, DOI 10.1073/pnas.93.16.8496; BURD CG, 1994, SCIENCE, V265, P615, DOI 10.1126/science.8036511; Roberts R, 1997, P NATL ACAD SCI USA, V94, P13221, DOI 10.1073/pnas.94.24.13221; Paillard L, 1998, EMBO J, V17, P278, DOI 10.1093/emboj/17.1.278; Timchenko NA, 1999, NUCLEIC ACIDS RES, V27, P4517, DOI 10.1093/nar/27.22.4517; KIMHA J, 1995, CELL, V81, P403, DOI 10.1016/0092-8674(95)90393-3; Webster PJ, 1997, GENE DEV, V11, P2510, DOI 10.1101/gad.11.19.2510; DECKER CJ, 1994, TRENDS BIOCHEM SCI, V19, P336, DOI 10.1016/0968-0004(94)90073-6; Choi DK, 1998, GENE, V223, P21, DOI 10.1016/S0378-1119(98)00364-3; BEELMAN CA, 1995, CELL, V81, P179, DOI 10.1016/0092-8674(95)90326-7; Colgan DF, 1997, GENE DEV, V11, P2755, DOI 10.1101/gad.11.21.2755; Lu XH, 1999, HUM MOL GENET, V8, P53, DOI 10.1093/hmg/8.1.53; MAHADEVAN M, 1992, SCIENCE, V255, P1253, DOI 10.1126/science.1546325; BROOK JD, 1992, CELL, V68, P799, DOI 10.1016/0092-8674(92)90154-5; JACKSON RJ, 1993, CELL, V74, P9, DOI 10.1016/0092-8674(93)90290-7; Timchenko LT, 1996, NUCLEIC ACIDS RES, V24, P4407, DOI 10.1093/nar/24.22.4407; Bashirullah A, 1998, ANNU REV BIOCHEM, V67, P335, DOI 10.1146/annurev.biochem.67.1.335; FU YH, 1992, SCIENCE, V255, P1256, DOI 10.1126/science.1546326; Philips AV, 1998, SCIENCE, V280, P737, DOI 10.1126/science.280.5364.737; CURTIS D, 1995, CELL, V81, P171, DOI 10.1016/0092-8674(95)90325-9; JACKSON RJ, 1990, CELL, V62, P15, DOI 10.1016/0092-8674(90)90235-7; Napierala M, 1997, J BIOL CHEM, V272, P31079, DOI 10.1074/jbc.272.49.31079; STJOHNSTON D, 1995, CELL, V81, P161, DOI 10.1016/0092-8674(95)90324-0	24	56	57	ACADEMIC PRESS INC	SAN DIEGO	525 B ST, STE 1900, SAN DIEGO, CA 92101-4495 USA	0006-291X			BIOCHEM BIOPH RES CO	Biochem. Biophys. Res. Commun.	OCT 22	2000	277	2					518	523		10.1006/bbrc.2000.3694		6	Biochemistry & Molecular Biology; Biophysics	Biochemistry & Molecular Biology; Biophysics	368FK	WOS:000090106900036		
J	Itakura, R; Hishikawa, A; Yamanouchi, K				Itakura, R; Hishikawa, A; Yamanouchi, K			Resonance-state selective photodissociation of OCS (2(1)Sigma(+)): Rotational and vibrational distributions of CO fragments	JOURNAL OF CHEMICAL PHYSICS			English	Article							PHOTOFRAGMENT EXCITATION SPECTROSCOPY; H2O PHOTODISSOCIATION; FANO PROFILES; VUV REGION; DYNAMICS; MOLECULES; OZONE; O-3; DISSOCIATION; PRODUCT	The rotational and vibrational state distributions of the CO fragments produced through the photodissociation of OCS in the vacuum ultraviolet (VUV) region (150-155 nm), OCS (2 (1)Sigma (+))--> CO (X (1)Sigma (+))+S(S-1), are derived for the three lowest quasi-bound vibrational resonances (upsilon*=0-2) in the 2 (1)Sigma (+) state. The rotational state distributions of the CO fragments in the upsilon (CO)=0 and 1 vibrational states are determined, respectively, by the analysis of the rotational structures in the laser-induced fluorescence (LIF) spectra of the A(1)Pi -X (1)Sigma (+)(0,0) and (1,1) transitions of CO. The rotational temperatures of CO in the upsilon (CO)=0 state are low (similar to 100 K) for all the three resonances, while those in the upsilon (CO)=1 state are substantially higher, i.e., 2210, 940, and 810 K for upsilon*=0, 1, and 2, respectively. The vibrational state distributions of CO are derived from the Doppler spectroscopy of the counterpart S(S-1) fragments. From the analysis of the observed Doppler profiles, it is found for all the three lowest vibrational resonances of OCS that the vibrational distributions are represented well by the Boltzmann-type distribution with a vibrational temperature of around 7000 K. On the basis of these new findings, the energy partitioning in the photodissociation process through these three vibrational resonances in the 2 (1)Sigma (+) state is discussed. (C) 2000 American Institute of Physics. [S0021-9606(00)01740-2].	Univ Tokyo, Sch Sci, Dept Chem, Bunkyo Ku, Tokyo 1130033, Japan	Yamanouchi, K (reprint author), Univ Tokyo, Sch Sci, Dept Chem, Bunkyo Ku, 7-3-1 Hongo, Tokyo 1130033, Japan.		Hishikawa, Akiyoshi/C-2251-2011	Hishikawa, Akiyoshi/0000-0002-4147-294X			ANDERSEN P, 1984, J CHEM PHYS, V80, P2548; HELLER EJ, 1981, ACCOUNTS CHEM RES, V14, P368, DOI 10.1021/ar00072a002; LEFORESTIER C, 1994, J CHEM PHYS, V101, P3806, DOI 10.1063/1.467498; FANO U, 1961, PHYS REV, V124, P1866, DOI 10.1103/PhysRev.124.1866; Hwang DW, 1999, J CHEM PHYS, V110, P4119, DOI 10.1063/1.478293; DIXON RN, 1986, J CHEM PHYS, V85, P1866, DOI 10.1063/1.451131; BRANDON JT, 1992, J CHEM PHYS, V97, P5246, DOI 10.1063/1.463824; DOUBLET ML, 1995, J CHEM PHYS, V103, P2538, DOI 10.1063/1.469675; ENGLE V, 1988, J CHEM PHYS, V88, P129; ENGLE V, 1992, J PHYS CHEM-US, V96, P3201; GREENE CH, 1983, J CHEM PHYS, V78, P6741, DOI 10.1063/1.444674; HALL GE, 1988, J CHEM PHYS, V88, P3682, DOI 10.1063/1.453868; Hishikawa A, 1997, J PHYS CHEM A, V101, P694, DOI 10.1021/jp962423m; HOUSTON PL, 1987, J PHYS CHEM-US, V91, P5388, DOI 10.1021/j100305a003; JOHNSON BR, 1989, PHYS REV LETT, V62, P1607, DOI 10.1103/PhysRevLett.62.1607; JOHNSON BR, 1989, J CHEM PHYS, V91, P7638, DOI 10.1063/1.457234; LEVENE HB, 1987, J CHEM PHYS, V87, P2583, DOI 10.1063/1.453097; LEVINE RD, 1974, ACCOUNTS CHEM RES, V7, P394; MCCARTHY MI, 1986, J PHYS CHEM-US, V90, P6759, DOI 10.1021/j100284a008; MOORE DS, 1983, J CHEM PHYS, V79, P1745, DOI 10.1063/1.446019; MORSE MD, 1981, J CHEM PHYS, V74, P4395, DOI 10.1063/1.441682; MUCKERMAN JT, 1989, J PHYS CHEM-US, V93, P179, DOI 10.1021/j100338a038; OGAI A, 1990, J CHEM PHYS, V93, P1107, DOI 10.1063/1.459174; Ohde K, 1996, J ELECTRON SPECTROSC, V79, P433, DOI 10.1016/0368-2048(96)02888-5; PIBEL CD, 1994, J CHEM PHYS, V101, P836, DOI 10.1063/1.468084; QIAN CXW, 1991, J PHYS CHEM-US, V95, P6763, DOI 10.1021/j100171a007; QIAN CXW, 1990, J CHEM PHYS, V92, P4296, DOI 10.1063/1.457789; RABALAIS JW, 1971, CHEM REV, V71, P73; REID SA, 1993, J PHYS CHEM-US, V97, P540, DOI 10.1021/j100105a004; Schinke R., 1993, PHOTODISSOCIATION DY; Steinfeld J.I., 1989, CHEM KINETICS DYNAMI; STRAUSS CE, 1989, J CHEM PHYS, V90, P5364, DOI 10.1063/1.456443; VALENTINI JJ, 1987, J CHEM PHYS, V86, P6745, DOI 10.1063/1.452374; WOYWOD B, 1987, J CHEM PHYS, V87, P2583; Yamanouchi K, 1997, ADV CHEM PHYS, V101, P789, DOI 10.1002/9780470141601.ch31; YAMANOUCHI K, 1995, J PHYS B-AT MOL OPT, V28, P133, DOI 10.1088/0953-4075/28/2/006; YAMANOUCHI K, 1995, B CHEM SOC JPN, V68, P2459, DOI 10.1246/bcsj.68.2459; ZAMIR E, 1984, CHEM PHYS LETT, V107, P217, DOI 10.1016/0009-2614(84)85117-9; Zare R. N., 1972, MOL PHOTOCHEM, V4	39	6	6	AMER INST PHYSICS	MELVILLE	2 HUNTINGTON QUADRANGLE, STE 1NO1, MELVILLE, NY 11747-4501 USA	0021-9606			J CHEM PHYS	J. Chem. Phys.	OCT 22	2000	113	16					6598	6607		10.1063/1.1310606		10	Physics, Atomic, Molecular & Chemical	Physics	368RL	WOS:000090131300015		
J	Han, YK; Hirao, K				Han, YK; Hirao, K			Structure and stability of Na6Pb clusters	JOURNAL OF CHEMICAL PHYSICS			English	Article							EFFECTIVE CORE POTENTIALS; SPIN-ORBIT OPERATORS; GEOMETRIC STRUCTURE; APPROXIMATION; ENERGIES; PB; EXCHANGE; GAS; TLH; NA	The geometric and electronic structures of the bimetallic cluster, Na6Pb, have been calculated using the density functional and coupled-cluster approaches, with a relativistic effective core potential and one-electron spin-orbit operators. Six possible isomeric Na6Pb structures (O-h, D-3h, D-3d, C-5 upsilon, C-3 upsilon, and C-2 upsilon) have been examined, and the highly symmetrical O-h structure was found to be the most stable form. The stabilities of the clusters correlate well with the Pb-Na bond distances and with the charge transfer from the Na-6 subsystem to the more electronegative Pb atom. The binding energies were found to vary according to the structure, with a spread of about 0.1 eV and 0.3 eV for the density functional and coupled-cluster calculations, respectively. These are of the same order, and somewhat smaller, as are found for the Na6Mg clusters (about 0.5 eV), demonstrating that the stabilization of the Na6Pb cluster is not particularly dependent on the geometric structures. At the same time, we found that the Na6Pb cluster is more stable as the symmetry is higher. (C) 2000 American Institute of Physics. [S0021-9606(00)31140-0].	Univ Tokyo, Grad Sch Engn, Dept Appl Chem, Tokyo 1138656, Japan	Han, YK (reprint author), Univ Tokyo, Grad Sch Engn, Dept Appl Chem, Tokyo 1138656, Japan.						ALBERT K, 1995, CHEM PHYS LETT, V245, P671, DOI 10.1016/0009-2614(95)01063-F; REED AE, 1988, CHEM REV, V88, P899, DOI 10.1021/cr00088a005; VISSCHER L, 1994, COMPUT PHYS COMMUN, V81, P120, DOI 10.1016/0010-4655(94)90115-5; ZHANG SB, 1987, PHYS REV B, V36, P3455, DOI 10.1103/PhysRevB.36.3455; KHANNA SN, 1995, PHYS REV B, V51, P13705, DOI 10.1103/PhysRevB.51.13705; Leininger T, 1996, J CHEM PHYS, V105, P1052, DOI 10.1063/1.471950; Dyall KG, 1998, THEOR CHEM ACC, V99, P366; Nash CS, 1999, J PHYS CHEM A, V103, P402, DOI 10.1021/jp982735k; HESS BA, 1986, PHYS REV A, V33, P3742, DOI 10.1103/PhysRevA.33.3742; BOYS SF, 1970, MOL PHYS, V19, P553, DOI 10.1080/00268977000101561; Balbas LC, 1996, PHYS REV B, V54, P2937, DOI 10.1103/PhysRevB.54.2937; BECKE AD, 1993, J CHEM PHYS, V98, P5648, DOI 10.1063/1.464913; BECKE AD, 1988, PHYS REV A, V38, P3098, DOI 10.1103/PhysRevA.38.3098; BONACICKOUTECKY V, 1994, CHEM PHYS, V186, P275, DOI 10.1016/0301-0104(94)00158-8; Chang JL, 1996, J CHEM PHYS, V104, P8043, DOI 10.1063/1.471521; DOUGLAS M, 1974, ANN PHYS-NEW YORK, V82, P89, DOI 10.1016/0003-4916(74)90333-9; FANTUCCI P, 1989, J CHEM PHYS, V91, P4229, DOI 10.1063/1.456802; FRISCH MJ, 1998, GAUSSIAN 98 REVISION, P75501; Han YK, 2000, CHEM PHYS LETT, V324, P453, DOI 10.1016/S0009-2614(00)00655-2; Han YK, 2000, J CHEM PHYS, V112, P2684, DOI 10.1063/1.480842; Han YK, 1999, J CHEM PHYS, V110, P9353, DOI 10.1063/1.478901; Jinlong Y., 1997, PHYS REV B, V55, P13293, DOI 10.1103/PhysRevB.55.13293; LEE CT, 1988, PHYS REV B, V37, P785, DOI 10.1103/PhysRevB.37.785; Lee HS, 1998, CHEM PHYS LETT, V293, P97, DOI 10.1016/S0009-2614(98)00760-X; LEE SY, 1992, J COMPUT CHEM, V13, P595, DOI 10.1002/jcc.540130509; MARSDEN CJ, 1995, CHEM PHYS LETT, V245, P475, DOI 10.1016/0009-2614(95)01038-B; Molina L. M., 1999, ADV QUANTUM CHEM, V33, P329; Moore C.E., 1958, 467 NBS, VIll; NESPER R, 1991, ANGEW CHEM INT EDIT, V30, P789, DOI 10.1002/anie.199107891; PERDEW JP, 1986, PHYS REV B, V33, P8822, DOI 10.1103/PhysRevB.33.8822; ROTHLISBERGER U, 1992, CHEM PHYS LETT, V198, P478, DOI 10.1016/0009-2614(92)80031-6; Schleyer PV, 1996, CHEM PHYS LETT, V255, P363, DOI 10.1016/0009-2614(96)00391-0; Slater J. C., 1974, QUANTUM THEORY MOL S, V4; VOSKO SH, 1980, CAN J PHYS, V58, P1200; Werner H.-J., MOLPRO IS PACKAGE AB; Woon D. E., UNPUB; YERETZIAN C, 1995, CHEM PHYS LETT, V237, P334, DOI 10.1016/0009-2614(95)00310-Z	37	4	4	AMER INST PHYSICS	MELVILLE	2 HUNTINGTON QUADRANGLE, STE 1NO1, MELVILLE, NY 11747-4501 USA	0021-9606			J CHEM PHYS	J. Chem. Phys.	OCT 22	2000	113	16					6613	6617		10.1063/1.1311298		5	Physics, Atomic, Molecular & Chemical	Physics	368RL	WOS:000090131300017		
J	Fuwa, H; Sasaki, M; Tachibana, K				Fuwa, H; Sasaki, M; Tachibana, K			Synthetic studies on a marine polyether toxin, gambierol: stereoselective synthesis of the FGH ring system via B-alkyl Suzuki coupling	TETRAHEDRON LETTERS			English	Article						coupling reactions; polyethers; Suzuki reactions; toxins	HIGHLY-ACTIVE CATALYST; ARYL CHLORIDES; ARYLBORONIC ACIDS; CP COMPOUNDS; CONSTRUCTION; FRAMEWORKS; AMINATION; STRATEGY; ANALOGS	A synthetic route to the FGH ring system of gambierol, a marine polyether toxin isolated from the dinoflagellate Gambierdiscus toxicus, has been developed. The present synthesis features B-alkyl Suzuki coupling of the F and H rings, followed by ring-closure of the G ring and stereoselective installation of 1,3-diaxial methyl groups at C21 and C23. (C) 2000 Elsevier Science Ltd. All rights reserved.	Univ Tokyo, Dept Chem, Grad Sch Sci, Bunkyo Ku, Tokyo 1130033, Japan; Japan Sci & Technol Corp, CREST, Bunkyo Ku, Tokyo 1130033, Japan	Sasaki, M (reprint author), Univ Tokyo, Dept Chem, Grad Sch Sci, Bunkyo Ku, Tokyo 1130033, Japan.		Fuwa, Haruhiko/D-1773-2010				Old DW, 1998, J AM CHEM SOC, V120, P9722, DOI 10.1021/ja982250+; Wolfe JP, 1999, J AM CHEM SOC, V121, P9550, DOI 10.1021/ja992130h; Shen W, 1997, TETRAHEDRON LETT, V38, P5575, DOI 10.1016/S0040-4039(97)01261-6; Trost BM, 1998, J AM CHEM SOC, V120, P6818, DOI 10.1021/ja981141s; SATAKE M, 1993, J AM CHEM SOC, V115, P361, DOI 10.1021/ja00054a061; Sasaki M, 1999, ORG LETT, V1, P1075, DOI 10.1021/ol990885n; Balog A, 1998, ANGEW CHEM INT EDIT, V37, P2675, DOI 10.1002/(SICI)1521-3773(19981016)37:19<2675::AID-ANIE2675>3.0.CO;2-O; Sasaki M, 1998, TETRAHEDRON LETT, V39, P9027, DOI 10.1016/S0040-4039(98)02025-5; Marshall JA, 1998, J ORG CHEM, V63, P7885, DOI 10.1021/jo9811423; Wolfe JP, 1999, ANGEW CHEM INT EDIT, V38, P2413, DOI 10.1002/(SICI)1521-3773(19990816)38:16<2413::AID-ANIE2413>3.0.CO;2-H; JOHNSON CR, 1993, J AM CHEM SOC, V115, P11014, DOI 10.1021/ja00076a079; Anderson JC, 1997, TETRAHEDRON, V53, P15123, DOI 10.1016/S0040-4020(97)10010-2; CAMPI EM, 1994, J CHEM SOC CHEM COMM, P2395, DOI 10.1039/c39940002395; CHELMER SR, 2000, ORG LETT, V2, P2695; Furstner A, 1998, J ORG CHEM, V63, P3072, DOI 10.1021/jo9800098; Kadota I, 1998, TETRAHEDRON LETT, V39, P6373, DOI 10.1016/S0040-4039(98)01312-4; Kadota I, 1998, TETRAHEDRON LETT, V39, P6369, DOI 10.1016/S0040-4039(98)01311-2; Kadota I, 1998, TETRAHEDRON LETT, V39, P6365, DOI 10.1016/S0040-4039(98)01310-0; Kadowaki C, 2000, TETRAHEDRON LETT, V41, P5769, DOI 10.1016/S0040-4039(00)00952-7; Kallan NC, 2000, ORG LETT, V2, P2687, DOI 10.1021/ol0062345; LEY SV, 1994, SYNTHESIS-STUTTGART, P639; Meng DF, 1999, ANGEW CHEM INT EDIT, V38, P3197, DOI 10.1002/(SICI)1521-3773(19991102)38:21<3197::AID-ANIE3197>3.0.CO;2-6; Meng DF, 1999, ANGEW CHEM INT EDIT, V38, P1485; Morohashi A, 1998, TETRAHEDRON LETT, V39, P97; Narukawa Y, 1997, TETRAHEDRON, V53, P539, DOI 10.1016/S0040-4020(96)00980-5; NICOLAOU KC, 1989, J AM CHEM SOC, V111, P5321, DOI 10.1021/ja00196a042; NICOLAOU KC, 1991, ANGEW CHEM INT EDIT, V30, P299, DOI 10.1002/anie.199102991; Ohba M, 1996, J AM CHEM SOC, V118, P8250, DOI 10.1021/ja960879b; Sasaki M, 2000, TETRAHEDRON LETT, V41, P1425, DOI 10.1016/S0040-4039(99)02307-2; SPESSARD GO, 1996, ORGANOMETALLIC CHEM, P171; TOMOOKA K, 1987, TETRAHEDRON LETT, V28, P6339, DOI 10.1016/S0040-4039(01)91368-1; Trauner D, 1999, ANGEW CHEM INT EDIT, V38, P3542, DOI 10.1002/(SICI)1521-3773(19991203)38:23<3542::AID-ANIE3542>3.0.CO;2-I; UENISHI JI, 1987, J AM CHEM SOC, V120, P9722; Zhu B, 2000, ORG LETT, V2, P2575, DOI 10.1021/ol006104w	34	55	56	PERGAMON-ELSEVIER SCIENCE LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND	0040-4039			TETRAHEDRON LETT	Tetrahedron Lett.	OCT 21	2000	41	43					8371	8375		10.1016/S0040-4039(00)01483-0		5	Chemistry, Organic	Chemistry	368NK	WOS:000090123600038		
J	Taruya, A; Suto, Y				Taruya, A; Suto, Y			Nonlinear stochastic biasing from the formation epoch distribution of dark halos	ASTROPHYSICAL JOURNAL			English	Article						cosmology : theory; dark matter; galaxies : clusters : general galaxies : formation; galaxies : halos; large-scale structure of universe	N-BODY SIMULATIONS; COSMOLOGICAL MASS-DISTRIBUTION; GALAXY FORMATION; HIERARCHICAL-MODELS; MERGER RATES; EVOLUTION; MATTER; FLUCTUATIONS; CONSTRAINTS; CLUSTERS	We propose a physical model for nonlinear stochastic biasing of one-point statistics resulting from the formation epoch distribution of dark halos. In contrast to previous works based on extensive numerical simulations, our model provides for the first time an analytic expression for the joint probability function. Specifically, we derive the joint probability function of halo and mass density contrasts from the extended Press-Schechter theory. Since this function is derived in the framework of the standard gravitational instability theory assuming the random Gaussianity of the primordial density field alone, we expect that the basic features of the nonlinear and stochastic biasing predicted from our model are fairly generic. As representative examples, we compute the various biasing parameters in cold dark matter models as a function of a redshift and a smoothing length. Our major findings are that (1) the biasing of the variance evolves strongly as redshift, while its scale dependence is generally weak, and a simple linear biasing model provides a reasonable approximation at roughly R greater than or similar to 2(1 + z) h(-1) Mpc; and (2) the stochasticity exhibits moderate scale dependence, especially on R less than or similar to 20 h(-1) Mpc, but is almost independent of z. Comparison with the previous numerical simulations shows good agreement with the above behavior, indicating that the nonlinear and stochastic nature of the halo biasing can be essentially understood by taking into account the distribution of the halo mass and the formation epoch.	Univ Tokyo, Sch Sci, Dept Phys, Tokyo 1130033, Japan; Univ Tokyo, Sch Sci, Res Ctr Early Universe, RESCEU, Tokyo 1130033, Japan	Taruya, A (reprint author), Univ Tokyo, Sch Sci, Dept Phys, Tokyo 1130033, Japan.						Kitayama T, 1996, ASTROPHYS J, V469, P480, DOI 10.1086/177797; LACEY C, 1993, MON NOT R ASTRON SOC, V262, P627; Matsubara T, 1999, ASTROPHYS J, V525, P543, DOI 10.1086/307931; BARDEEN JM, 1986, ASTROPHYS J, V304, P15, DOI 10.1086/164143; Catelan P, 1998, MON NOT R ASTRON SOC, V297, P692, DOI 10.1046/j.1365-8711.1998.01455.x; Dekel A, 1999, ASTROPHYS J, V520, P24, DOI 10.1086/307428; Scherrer RJ, 1998, ASTROPHYS J, V504, P607, DOI 10.1086/306113; Taylor AN, 2000, MON NOT R ASTRON SOC, V314, P92, DOI 10.1046/j.1365-8711.2000.03339.x; Kauffmann G, 1997, MON NOT R ASTRON SOC, V286, P795; PRESS WH, 1974, ASTROPHYS J, V187, P425, DOI 10.1086/152650; Tegmark M, 1998, ASTROPHYS J, V500, pL79, DOI 10.1086/311426; BERNARDEAU F, 1995, ASTROPHYS J, V443, P479, DOI 10.1086/175542; DAVIS M, 1985, ASTROPHYS J, V292, P371, DOI 10.1086/163168; Kitayama T, 1996, MON NOT R ASTRON SOC, V280, P638; Blanton M, 1999, ASTROPHYS J, V522, P590, DOI 10.1086/307660; KOFMAN L, 1994, ASTROPHYS J, V420, P44, DOI 10.1086/173541; Mo HJ, 1996, MON NOT R ASTRON SOC, V282, P347; COLES P, 1991, MON NOT R ASTRON SOC, V248, P1; LACEY C, 1994, MON NOT R ASTRON SOC, V271, P676; Klypin A, 1999, ASTROPHYS J, V516, P530, DOI 10.1086/307122; BOND JR, 1991, ASTROPHYS J, V379, P440, DOI 10.1086/170520; Kravtsov AV, 1999, ASTROPHYS J, V520, P437, DOI 10.1086/307495; BOWER RG, 1991, MON NOT R ASTRON SOC, V248, P332; CATELAN P, 1998, MNRAS, V502, pL1; COLES P, 1993, MON NOT R ASTRON SOC, V262, P1065; EFSTATHIOU G, 1988, MON NOT R ASTRON SOC, V235, P715; Fry J.N., 1996, APJ, V461, P65; Kaiser N., 1984, Astrophysical Journal. Letters to the Editor, V284; Kitayama T, 1997, ASTROPHYS J, V490, P557, DOI 10.1086/304915; Lee J, 1998, ASTROPHYS J, V500, P14, DOI 10.1086/305710; Magliocchetti M, 2000, MON NOT R ASTRON SOC, V314, P546, DOI 10.1046/j.1365-8711.2000.03314.x; Peacock J. A., 1996, MNRAS, V280, P19; Pen UL, 1998, ASTROPHYS J, V504, P601, DOI 10.1086/306098; Seaborne MD, 1999, MON NOT R ASTRON SOC, V309, P89, DOI 10.1046/j.1365-8711.1999.02796.x; SHETH RK, 1999, UNPUB MNRAS; SOMERVILLE RS, 2000, UNPUB MNRAS; SUTO Y, 1993, PROG THEOR PHYS, V90, P1173; Taruya A, 1999, ASTROPHYS J, V522, P46, DOI 10.1086/307612; Taruya A, 1999, ASTROPHYS J, V510, P541, DOI 10.1086/306634; Taruya A, 2000, ASTROPHYS J, V537, P37, DOI 10.1086/309007; TARUYA A, 2000, UNPUB PASJ	41	33	33	UNIV CHICAGO PRESS	CHICAGO	5720 SOUTH WOODLAWN AVE, CHICAGO, IL 60637-1603 USA	0004-637X			ASTROPHYS J	Astrophys. J.	OCT 20	2000	542	2	1				559	577		10.1086/317043		19	Astronomy & Astrophysics	Astronomy & Astrophysics	369YN	WOS:000165095500004		
J	Takahashi, T; Kataoka, J; Madejski, G; Mattox, J; Urry, CM; Wagner, S; Aharonian, F; Catanese, M; Chiappetti, L; Coppi, P; Degrange, B; Fossati, G; Kubo, H; Krawczynski, H; Makino, F; Marshall, H; Maraschi, L; Piron, F; Remillard, R; Takahara, F; Tashiro, M; Terasranta, H; Weekes, T				Takahashi, T; Kataoka, J; Madejski, G; Mattox, J; Urry, CM; Wagner, S; Aharonian, F; Catanese, M; Chiappetti, L; Coppi, P; Degrange, B; Fossati, G; Kubo, H; Krawczynski, H; Makino, F; Marshall, H; Maraschi, L; Piron, F; Remillard, R; Takahara, F; Tashiro, M; Terasranta, H; Weekes, T			Complex spectral variability from intensive multiwavelength monitoring of Markarian 421 in 1998	ASTROPHYSICAL JOURNAL			English	Article						BL Lacertae objects : general; BL Lacertae objects : individual (Markarian 421); X-rays : general	ACTIVE GALACTIC NUCLEI; X-RAY; ENERGY-DISTRIBUTIONS; RAPID VARIABILITY; BLAZARS; EMISSION; ACCELERATION; FLARE	We conducted a multifrequency campaign for the TeV blazar Markarian 421 in 1998 April. The campaign started from a pronounced high-amplitude flare recorded by BeppoSAX and Whipple; the ASCA observation started 3 days later. In the X-ray data, we detected multiple flares, occurring on timescales of about 1 day. ASCA data clearly reveal spectral variability. The comparison of the data from ASCA, the Extreme Ultraviolet Explorer, and the Rossi X-Ray Timing Explorer indicates that the variability amplitudes in the low-energy synchrotron component are larger at higher photon energies. In TeV gamma -rays, large intraday variations-which were correlated with the X-ray flux-were observed when results from three Cerenkov telescopes were combined. The rms variability of TeV gamma -rays was similar to that observed in hard X-rays, above 10 keV. The X-ray light curve reveals flares that are almost symmetric for most cases, implying that the dominant timescale is the light crossing time through the emitting region. The structure function analysis based on the continuous X-ray light curve of 7 days indicates that the characteristic timescale is similar to0.5 days. The analysis of ASCA light curves in various energy bands appears to show both soft (positive) and hard (negative) lags. These may not be real, as systematic effects could also produce these lags, which are all much smaller than an orbit. If the lags of both signs are red, these imply that the particle acceleration and X-ray cooling timescales are similar.	Inst Space & Astronaut Sci, Sagamihara, Kanagawa 2298510, Japan; Univ Tokyo, Dept Phys, Tokyo 1130033, Japan; NASA, Goddard Space Flight Ctr, High Energy Astrophys Lab, Greenbelt, MD 20771 USA; Univ Maryland, Dept Astron, College Pk, MD 20742 USA; Boston Univ, Dept Astron, Boston, MA 02215 USA; Space Telescope Sci Inst, Baltimore, MD 21218 USA; Landessternwarte Heidelberg, D-69117 Heidelberg, Germany; Max Planck Inst Kernphys, D-69029 Heidelberg, Germany; Harvard Smithsonian Ctr Astrophys, Fred Lawrence Whipple Observ, Amado, AZ 85645 USA; CNR, Inst Fis Cosm, I-20133 Milan, Italy; Yale Univ, Dept Astron, New Haven, CT 06520 USA; Ecole Polytech, Lab Phys Nucl Haute Energies, Palaiseau, France; Univ Calif San Diego, Ctr Astrophys & Space Sci, La Jolla, CA 92093 USA; Tokyo Inst Technol, Dept Phys, Tokyo 1528551, Japan; MIT, Ctr Space Res, Cambridge, MA 02139 USA; Osservatorio Astron Brera, I-20121 Milan, Italy; Osaka Univ, Dept Earth & Space Sci, Osaka, Japan; Metsahove Radio Observ, Kylmala, Finland	Takahashi, T (reprint author), Inst Space & Astronaut Sci, 3-1-1 Yoshinodai, Sagamihara, Kanagawa 2298510, Japan.		Fossati, Giovanni/A-5841-2009; Tashiro, Makoto/J-4562-2012; Urry, Claudia/G-7381-2011	Urry, Claudia/0000-0002-0745-9792			Aharonian F, 1999, ASTRON ASTROPHYS, V349, P29; Sambruna RM, 1996, ASTROPHYS J, V463, P444, DOI 10.1086/177260; Fossati G, 1998, MON NOT R ASTRON SOC, V299, P433, DOI 10.1046/j.1365-8711.1998.01828.x; URRY CM, 1995, PUBL ASTRON SOC PAC, V107, P803, DOI 10.1086/133630; Chiaberge M, 1999, MON NOT R ASTRON SOC, V306, P551, DOI 10.1046/j.1365-8711.1999.02538.x; Ghisellini G, 1998, MON NOT R ASTRON SOC, V301, P451, DOI 10.1046/j.1365-8711.1998.02032.x; GEORGE IM, 1988, MON NOT R ASTRON SOC, V232, P793; Inoue S, 1996, ASTROPHYS J, V463, P555, DOI 10.1086/177270; Ulrich MH, 1997, ANNU REV ASTRON ASTR, V35, P445, DOI 10.1146/annurev.astro.35.1.445; Wagner SJ, 1996, ASTRON J, V111, P2187, DOI 10.1086/117954; Kirk JG, 1998, ASTRON ASTROPHYS, V333, P452; EDELSON RA, 1988, ASTROPHYS J, V333, P646, DOI 10.1086/166773; Terasranta H, 1998, ASTRON ASTROPHYS SUP, V132, P305, DOI 10.1051/aas:1998297; Buckley JH, 1996, ASTROPHYS J, V472, pL9, DOI 10.1086/310352; Fossati G, 2000, ASTROPHYS J, V541, P166, DOI 10.1086/309430; Fossati G, 2000, ASTROPHYS J, V541, P153, DOI 10.1086/309422; Georganopoulos M, 1998, ASTROPHYS J, V506, pL11, DOI 10.1086/311627; Hayashida K, 1998, ASTROPHYS J, V500, P642, DOI 10.1086/305736; Kataoka J, 2000, ASTROPHYS J, V528, P243, DOI 10.1086/308154; KATAOKA J, 2000, UNPUB APJ; Kataoka J., 2000, THESIS U TOKYO; Kubo H, 1998, ASTROPHYS J, V504, P693, DOI 10.1086/306125; Macomb DJ, 1996, ASTROPHYS J, V459, pL111; MACOMB DJ, 1995, ASTROPHYS J, V449, pL99, DOI 10.1086/309646; Maraschi L, 1999, ASTROPHYS J, V526, pL81, DOI 10.1086/312370; SAMBRUNA RM, 2000, IN PRESS MEM SOC AST; Takahashi T, 1999, ASTROPART PHYS, V11, P177, DOI 10.1016/S0927-6505(99)00045-6; TAKAHASHI T, 1996, APJ, V470, P89; WAGNER SJ, 1995, ANNU REV ASTRON ASTR, V33, P163, DOI 10.1146/annurev.astro.33.1.163; Wagner S.J, 1996, A AS, V120, P495	30	70	70	UNIV CHICAGO PRESS	CHICAGO	5720 SOUTH WOODLAWN AVE, CHICAGO, IL 60637-1603 USA	0004-637X			ASTROPHYS J	Astrophys. J.	OCT 20	2000	542	2	2				L105	L109		10.1086/312929		5	Astronomy & Astrophysics	Astronomy & Astrophysics	369YQ	WOS:000165095700008		
J	Sakamoto, I; Kishida, S; Fukui, A; Kishida, M; Yamamoto, H; Hino, S; Michiue, T; Takada, S; Asashima, M; Kikuchi, A				Sakamoto, I; Kishida, S; Fukui, A; Kishida, M; Yamamoto, H; Hino, S; Michiue, T; Takada, S; Asashima, M; Kikuchi, A			A novel beta-catenin-binding protein inhibits beta-catenin-dependent Tcf activation and axis formation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							WNT SIGNALING PATHWAY; GLYCOGEN-SYNTHASE KINASE-3-BETA; TRANSCRIPTION FACTOR TCF; MOUSE FUSED LOCUS; F-BOX PROTEIN; NEGATIVE REGULATOR; XENOPUS EMBRYOS; FUNCTIONAL INTERACTION; PHOSPHATASE 2A; COMPLEX	beta -Catenin is efficiently phosphorylated by glycogen synthase kinase-3 beta in the Axin complex in the cytoplasm, resulting in the down-regulation. In response to Wnt, beta -catenin is stabilized and translocated into the nucleus where it stimulates gene expression through Tcf/Lef, Here we report a novel protein, designated Duplin (for axis duplication inhibitor), which negatively regulates the function of beta -catenin in the nucleus. Duplin was located in the nucleus. Duplin bound directly to the Armadillo repeats of beta -catenin, thereby inhibiting the binding of Tcf to beta -catenin. It did not affect the stability of beta -catenin but inhibited Wnt- or beta -catenin-dependent Tcf activation. Furthermore, expression of Duplin in Xenopus embryos inhibited the axis formation and beta -catenin-dependent axis duplication, and prevented the beta -catenin's ability to rescue ventralizing phenotypes induced by ultraviolet light irradiation. Thus, Duplin is a nuclear protein that inhibits beta -catenin signaling.	Kyoto Univ, Fac Sci, Ctr Mol & Dev Biol, Sakyo Ku, Kyoto 6068502, Japan; Hiroshima Univ, Sch Med, Dept Biochem, Minami Ku, Hiroshima 7348551, Japan; PRESTO, Japan Sci & Technol Corp, Hiroshima 7348551, Japan; Univ Tokyo, Dept Life Sci Biol, Meguro Ku, Tokyo 1538902, Japan; Univ Tokyo, CREST Project, Meguro Ku, Tokyo 1538902, Japan; Japan Sci & Technol Corp, ERATO, Kondoh Differentiat Signaling Project, Kyoto 6068305, Japan	Kikuchi, A (reprint author), Kyoto Univ, Fac Sci, Ctr Mol & Dev Biol, Sakyo Ku, Kyoto 6068502, Japan.		Fukui, Akimasa/F-5284-2011				Hart M, 1999, CURR BIOL, V9, P207, DOI 10.1016/S0960-9822(99)80091-8; KAO KR, 1988, DEV BIOL, V127, P64, DOI 10.1016/0012-1606(88)90189-3; Hsu W, 1999, J BIOL CHEM, V274, P3439, DOI 10.1074/jbc.274.6.3439; Yost C, 1996, GENE DEV, V10, P1443, DOI 10.1101/gad.10.12.1443; TAKEICHI M, 1991, SCIENCE, V251, P1451, DOI 10.1126/science.2006419; Fagotto F, 1999, J CELL BIOL, V145, P741, DOI 10.1083/jcb.145.4.741; Shibamoto S, 1998, GENES CELLS, V3, P659; Hecht A, 2000, EMBO J, V19, P1839, DOI 10.1093/emboj/19.8.1839; Behrens J, 1998, SCIENCE, V280, P596, DOI 10.1126/science.280.5363.596; Fagotto F, 1998, CURR BIOL, V8, P181, DOI 10.1016/S0960-9822(98)70082-X; KOZAK M, 1987, NUCLEIC ACIDS RES, V15, P8125, DOI 10.1093/nar/15.20.8125; Cadigan KM, 1997, GENE DEV, V11, P3286, DOI 10.1101/gad.11.24.3286; Behrens J, 1996, NATURE, V382, P638, DOI 10.1038/382638a0; Ikeda S, 2000, ONCOGENE, V19, P537, DOI 10.1038/sj.onc.1203359; Yamamoto H, 1999, J BIOL CHEM, V274, P10681, DOI 10.1074/jbc.274.16.10681; Molenaar M, 1996, CELL, V86, P391, DOI 10.1016/S0092-8674(00)80112-9; Waltzer L, 1998, NATURE, V395, P521; Cavallo RA, 1998, NATURE, V395, P604; Wodarz A, 1998, ANNU REV CELL DEV BI, V14, P59, DOI 10.1146/annurev.cellbio.14.1.59; Zorn AM, 1999, MOL CELL, V4, P487, DOI 10.1016/S1097-2765(00)80200-2; Kishida S, 1999, MOL CELL BIOL, V19, P4414; Kitagawa M, 1999, EMBO J, V18, P2401, DOI 10.1093/emboj/18.9.2401; Ikeda S, 1998, EMBO J, V17, P1371, DOI 10.1093/emboj/17.5.1371; Takemaru KI, 2000, J CELL BIOL, V149, P249, DOI 10.1083/jcb.149.2.249; Miller JR, 1999, ONCOGENE, V18, P7860; Rubinfeld B, 1997, SCIENCE, V275, P1790, DOI 10.1126/science.275.5307.1790; Dale TC, 1998, BIOCHEM J, V329, P209; Morin PJ, 1997, SCIENCE, V275, P1787, DOI 10.1126/science.275.5307.1787; Hart MJ, 1998, CURR BIOL, V8, P573, DOI 10.1016/S0960-9822(98)70226-X; Zeng L, 1997, CELL, V90, P181, DOI 10.1016/S0092-8674(00)80324-4; Kishida S, 1998, J BIOL CHEM, V273, P10823, DOI 10.1074/jbc.273.18.10823; Ishitani T, 1999, NATURE, V399, P798, DOI 10.1038/21674; Korinek V, 1997, SCIENCE, V275, P1784, DOI 10.1126/science.275.5307.1784; Seeling JM, 1999, SCIENCE, V283, P2089, DOI 10.1126/science.283.5410.2089; Brannon M, 1997, GENE DEV, V11, P2359, DOI 10.1101/gad.11.18.2359; Bauer A, 1998, P NATL ACAD SCI USA, V95, P14787, DOI 10.1073/pnas.95.25.14787; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1006/abio.1976.9999; Brannon M., 1999, DEVELOPMENT, V126, P159; FUNAYAMA N, 1995, J CELL BIOL, V128, P959, DOI 10.1083/jcb.128.5.959; GLUECKSOHNSCHOENHEIMER S, 1949, J EXP ZOOL, V110, P47, DOI 10.1002/jez.1401100105; HURT EC, 1993, FEBS LETT, V325, P76, DOI 10.1016/0014-5793(93)81417-X; Itoh K, 1998, CURR BIOL, V8, P591, DOI 10.1016/S0960-9822(98)70229-5; Kikuchi A, 1999, CYTOKINE GROWTH F R, V10, P255, DOI 10.1016/S1359-6101(99)00017-9; Kikuchi A, 1999, CELL SIGNAL, V11, P777, DOI 10.1016/S0898-6568(99)00054-6; Kishida M, 1999, ONCOGENE, V18, P979, DOI 10.1038/sj.onc.1202388; LEMAIRE P, 1995, CELL, V81, P85, DOI 10.1016/0092-8674(95)90373-9; Maniatis T, 1982, MOL CLONING LAB MANU; Moon RT, 1998, BIOESSAYS, V20, P536, DOI 10.1002/(SICI)1521-1878(199807)20:7<536::AID-BIES4>3.0.CO;2-I; Okazaki M, 1996, CANCER RES, V56, P2387; PERRY WL, 1995, GENETICS, V141, P321; Pizzuti A, 1996, HUM MOL GENET, V5, P953, DOI 10.1093/hmg/5.7.953; Sakanaka C, 1998, P NATL ACAD SCI USA, V95, P3020, DOI 10.1073/pnas.95.6.3020; SCHARF SR, 1980, DEV BIOL, V79, P181, DOI 10.1016/0012-1606(80)90082-2; Smalley MJ, 1999, EMBO J, V18, P2823, DOI 10.1093/emboj/18.10.2823; Tian Q, 1999, DEVELOPMENT, V126, P3371; Yamamoto H, 1998, MOL CELL BIOL, V18, P2867	56	52	54	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	OCT 20	2000	275	42					32871	32878		10.1074/jbc.M004089200		8	Biochemistry & Molecular Biology	Biochemistry & Molecular Biology	366KD	WOS:000090003800068		
J	Honda, S; Kashiwagi, M; Miyamoto, K; Takei, Y; Hirose, S				Honda, S; Kashiwagi, M; Miyamoto, K; Takei, Y; Hirose, S			Multiplicity, structures, and endocrine and exocrine natures of eel fucose-binding lectins	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							AFFINITY CHROMATOGRAPHY; SPECIFICITY; MARKERS; SERUM	Lectins, a group of proteins that bind to cell surface carbohydrates and play important roles in innate immunity, are widely used experimentally to distinguish cell types and to induce cell proliferation. Eel serum lectins have been useful as anti-H hemagglutinins and also in lectin histochemistry as fucose-binding lectins (fucolectins), but their structures have not been determined. Here we report the primary structures and the sites of synthesis of eel fucolectins. Eel serum fucolectins were separated by two-dimensional gel electrophoresis and sequenced. cDNA cloning, based on the amino acid sequence information, and Northern blot analysis indicated that 1) the fucose-binding lectins are secretory proteins and have unique structures among the lectins, exhibiting only weak similarities to frog pentraxin, horseshoe crab tachylectin-4, and fly fw protein; 2) there are at least seven closely related members; and 3) their messages are abundantly expressed in the liver and in significant levels in the gill and intestine. The lectin-producing hepatic cells were identified by immunostaining; in the gill, exocrine mucous cells were stained, suggesting that serum fucolectins derive from the liver. Using primary culture of eel hepatocytes, the message levels were shown to be increased by lipopolysaccharide, suggesting a role for fucolectins in host defense. SDS-polyacrylamide gel electrophoresis analysis showed that eel fucolectins have a SDS-resistant tetrameric structure consisting of two disulfide-linked dimers.	Tokyo Inst Technol, Dept Biol Sci, Midori Ku, Yokohama, Kanagawa 2268501, Japan; Univ Tokyo, Ocean Res Inst, Nakano Ku, Tokyo 1648639, Japan	Hirose, S (reprint author), Tokyo Inst Technol, Dept Biol Sci, Midori Ku, 4259 Nagatsuta Cho, Yokohama, Kanagawa 2268501, Japan.						SEERY LT, 1993, P ROY SOC B-BIOL SCI, V253, P263, DOI 10.1098/rspb.1993.0112; Adams MD, 2000, SCIENCE, V287, P2185, DOI 10.1126/science.287.5461.2185; Hoffmann JA, 1999, SCIENCE, V284, P1313, DOI 10.1126/science.284.5418.1313; LeshkoLindsay L, 1997, DEVELOPMENT, V124, P169; Saito T, 1997, J BIOL CHEM, V272, P30703, DOI 10.1074/jbc.272.49.30703; Baldus SE, 1996, GLYCOCONJUGATE J, V13, P585, DOI 10.1007/BF00731446; BEZKOROV.A, 1971, BIOCHEMISTRY-US, V10, P3761; DANGUY A, 1988, Biological Structures and Morphogenesis, V1, P93; DCruz OJ, 1996, FERTIL STERIL, V65, P843; Gabius HJ, 1998, BIOTECH HISTOCHEM, V73, P263, DOI 10.3109/10520299809141120; GERCKEN J, 1994, COMP BIOCHEM PHYS B, V108, P449, DOI 10.1016/0305-0491(94)90098-1; HAYASHI S, 1998, CELL TISSUE CULTURE, pA23; HAYASHI S, 1985, B JPN SOC SCI FISH, V51, P765; HOREJSI V, 1978, BIOCHIM BIOPHYS ACTA, V538, P299, DOI 10.1016/0304-4165(78)90358-6; Iwamatsu A, 1996, J BIOCHEM-TOKYO, V120, P29; JONSSON B, 1944, ACTA PATHOL MICROB S, V54, P456; JUDD WJ, 1980, CRC CR REV CL LAB SC, V12, P171, DOI 10.3109/10408368009108729; KATAFUCHI T, 1994, EUR J BIOCHEM, V222, P835, DOI 10.1111/j.1432-1033.1994.tb18930.x; KELLY C, 1984, BIOCHEM J, V220, P221; KONAMI Y, 1991, J BIOCHEM-TOKYO, V109, P650; MATSUMOT.I, 1974, BIOCHEMISTRY-US, V13, P582, DOI 10.1021/bi00700a028; Sengupta Susmita, 1997, Indian Journal of Experimental Biology, V35, P103; TAKEI Y, 1988, COMP BIOCHEM PHYS A, V91, P293, DOI 10.1016/0300-9629(88)90419-7; Wagner M, 1988, Acta Histochem Suppl, V36, P115; WATKINS WM, 1952, NATURE, V169, P825, DOI 10.1038/169825a0; XU XF, 1994, EXP PARASITOL, V79, P399, DOI 10.1006/expr.1994.1102	26	57	66	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	OCT 20	2000	275	42					33151	33157		10.1074/jbc.M002337200		7	Biochemistry & Molecular Biology	Biochemistry & Molecular Biology	366KD	WOS:000090003800104		
J	Zhou, YF; Matsuda, M; Mori, T; Sakamoto, S; Mitamura, T				Zhou, YF; Matsuda, M; Mori, T; Sakamoto, S; Mitamura, T			Effects of mifepristone (RU486) treatment on the development of uterine adenomyosis induced by pituitary grafting in mice	LIFE SCIENCES			English	Article						endometriosis; mifepristone; animal model; immunohistochemistry; von Willebrand factor	SHN MICE; PROGESTERONE; ENDOMETRIUM; RECEPTORS; PROLACTIN	To evaluate the effects of mifepristone (RU486) on the development of uterine adenomyosis induced by pituitary grafting (PG), 3 groups of mice receiving pituitary grafts at 7 weeks of age were given RU486 in food (20mg/kg chow) from 3-14 (RU486-3 group) or 10-14 (RU486-10 group) weeks of age, or were given no further treatment (PG control group), respectively. All the mice were killed at 14 weeks of age. The uterine weight was significantly decreased in both RU486-treated groups compared with the PG control group. The incidence of adenomyosis was also decreased significantly in both the RU486-3 group (0/10 mice) and RU486-10 group (2/10 mice) compared with the PG control group (7/9 mice). To look for vascular changes in the uterine tissues, which have been reported to be related to the development of adenomyosis, immunohistochemical staining of von Willebrand factor in the blood vessels was performed. The mean surface area and minor axis of blood vessels in the uterus were thereby found to be significantly decreased in the RU486-10 group compared to the PG control group. The results clearly indicated that RU486, a potent antiprogestin, could inhibit the genesis of uterine adenomyosis in mice, and at the same time caused shrinkage of the vascular system. As in humans, progesterone as well as the vascular system therefore appear to be important factors in the pathogenesis of uterine adenomyosis in this mouse model. (C) 2000 Elsevier Science Inc. All rights reserved.	Beijing Univ, Sch Clin Med 1, Dept Obstet & Gynecol, Beijing 100034, Peoples R China; Univ Tokyo, Grad Sch Sci, Dept Biol Sci, Tokyo 1130033, Japan; Tokyo Med & Dent Univ, Med Res Inst, Dept Endocrinol, Tokyo 1138510, Japan	Zhou, YF (reprint author), Beijing Univ, Sch Clin Med 1, Dept Obstet & Gynecol, Beijing 100034, Peoples R China.						AZZIZ R, 1989, OBSTET GYN CLIN N AM, V16, P221; Bayard F, 1995, CIBA F SYMP, V191, P122; DANIEL JC, 1988, J REPROD FERTIL, V84, P13; Ghosh D, 1998, J ENDOCRINOL, V157, P115, DOI 10.1677/joe.0.1570115; Grebenschikov N, 1997, INT J BIOL MARKER, V12, P6; HUSEBY RA, 1985, ENDOCRINOLOGY, V116, P1440; Koide SS, 1998, J REPROD MED, V43, P551; Matsuda M, 1996, LIFE SCI, V58, P1171, DOI 10.1016/0024-3205(96)00075-6; MORI T, 1989, COMP ASPECTS TUMOR D, P57; MORI T, 1981, LIFE SCI, V29, P1277, DOI 10.1016/0024-3205(81)90234-4; MORI T, 1984, ACTA ENDOCRINOL-COP, V107, P245; MORISON JIL, 1983, PLANT CELL ENVIRON, V6, P103, DOI 10.1111/j.1365-3040.1983.tb01882.x; NAGASAWA H, 1987, LAB ANIM SCI, V37, P200; NAGASAWA H, 1989, ANTICANCER RES, V9, P827; Ormandy CJ, 1997, J CLIN ENDOCR METAB, V82, P3692, DOI 10.1210/jc.82.11.3692; OSTRANDER PL, 1985, J NATL CANCER I, V74, P121; Ota H, 1998, HUM REPROD, V13, P715, DOI 10.1093/humrep/13.3.715; SINGTRIPOP T, 1992, LIFE SCI, V51, P1119, DOI 10.1016/0024-3205(92)90513-O; WANG JD, 1992, HUM REPROD, V7, P123; ZHOU YF, 1999, CYTOCHEM, V32, P387	20	6	9	PERGAMON-ELSEVIER SCIENCE LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND	0024-3205			LIFE SCI	Life Sci.	OCT 20	2000	67	22					2713	2720		10.1016/S0024-3205(00)00850-X		8	Medicine, Research & Experimental; Pharmacology & Pharmacy	Research & Experimental Medicine; Pharmacology & Pharmacy	367CG	WOS:000090043600006		
J	Zhu, LD; Saito, N; Abe, O; Okubo, T; Yamada, H; Kawahara, N; Asai, A; Kirino, T				Zhu, LD; Saito, N; Abe, O; Okubo, T; Yamada, H; Kawahara, N; Asai, A; Kirino, T			Changes in the apparent diffusion coefficient of water and T2 relaxation time in gerbil hippocampus after mild ischemia	NEUROREPORT			English	Article						cell death; cerebral ischemia; gerbil; magnetic resonance imaging; microtubule-associated protein 2	TRANSIENT CEREBRAL-ISCHEMIA; DELAYED NEURONAL DEATH; FOREBRAIN ISCHEMIA; T2-WEIGHTED MRI; BRAIN ISCHEMIA; RAT-BRAIN; INJURY; HISTOPATHOLOGY; EVOLUTION; LESIONS	Selective neuronal death of the hippocampal CAI area after mild ischemia is known as delayed neuronal death (DND). Progression of DND was evaluated using 7 T MRI in gerbils. in the CAI, the T2 relaxation time started to increase on day 3 and was significantly higher on day 4 than that of the control gerbils. However, the apparent diffusion coefficient of water (ADC) was significantly lower on day I than in the control and continued to decline up to day 4. Changes in T2 coincided with loss of MAP2 immunoreactivity, while the ADC decrease preceded these changes. After I month, the ADC had returned to within the normal range, while T2 had decreased to below the control level. These results suggest that MRI is useful for monitoring DND. NeuroReport 11:3333-3336 (C) 2000 Lippincott Williams & Wilkins.	Tokyo Univ Hosp, Dept Neurosurg, Bunkyo Ku, Tokyo 1138655, Japan; Tokyo Univ Hosp, Dept Radiol, Bunkyo Ku, Tokyo 1138655, Japan; Japan Sci & Technol Corp, CREST, Wako, Saitama, Japan	Saito, N (reprint author), Tokyo Univ Hosp, Dept Neurosurg, Bunkyo Ku, 7-3-1 Hongo, Tokyo 1138655, Japan.						Abe O, 2000, J CEREBR BLOOD F MET, V20, P726; MINTOROVITCH J, 1991, MAGNET RESON MED, V18, P39, DOI 10.1002/mrm.1910180106; SUZUKI R, 1983, ACTA NEUROPATHOL, V60, P207; YAMAMOTO K, 1986, BRAIN RES, V384, P1, DOI 10.1016/0006-8993(86)91212-6; KNIGHT RA, 1994, STROKE, V25, P1252; YAMAMOTO K, 1990, ACTA NEUROPATHOL, V80, P487; Dijkhuizen RM, 1998, STROKE, V29, P695; DESHPANDE J, 1992, EXP BRAIN RES, V88, P91, DOI 10.1007/BF02259131; Baird AE, 1998, J CEREBR BLOOD F MET, V18, P583; Canese R, 1997, MAGN RESON MATER PHY, V5, P139, DOI 10.1007/BF02592245; Dijkhuizen RM, 1999, J CEREBR BLOOD F MET, V19, P341; HOCKINGS PD, 1995, JMRI-J MAGN RESON IM, V5, P437, DOI 10.1002/jmri.1880050412; Ishimaru H, 1996, BRAIN RES, V726, P23, DOI 10.1016/S0006-8993(96)00294-6; KIRINO T, 1982, BRAIN RES, V239, P57, DOI 10.1016/0006-8993(82)90833-2; KIRINO T, 1990, BRAIN RES, V510, P17, DOI 10.1016/0006-8993(90)90722-N; KIRINO T, 1984, ACTA NEUROPATHOL, V62, P209; KNIGHT RA, 1991, STROKE, V22, P802; Lei H, 1998, NEUROSCI LETT, V257, P105, DOI 10.1016/S0304-3940(98)00815-5; LESIUK H, 1991, STROKE, V22, P896; MINEMATSU K, 1992, NEUROLOGY, V42, P235; MOSELEY ME, 1990, MAGNET RESON MED, V14, P330, DOI 10.1002/mrm.1910140218; SUTHERLAND GR, 1991, NEUROSCIENCE, V42, P171, DOI 10.1016/0306-4522(91)90157-J; TAKAHASHI M, 1994, ACT NEUR S, V60, P224; Virley D, 2000, J CEREBR BLOOD F MET, V20, P563	24	3	3	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	530 WALNUT ST, PHILADELPHIA, PA 19106-3621 USA	0959-4965			NEUROREPORT	Neuroreport	OCT 20	2000	11	15					3333	3336		10.1097/00001756-200010200-00014		4	Neurosciences	Neurosciences & Neurology	366MY	WOS:000090010200009		
J	Matsuda, Y; Ohki, K; Saito, T; Ajima, A; Kim, DS				Matsuda, Y; Ohki, K; Saito, T; Ajima, A; Kim, DS			Coincidence of ipsilateral ocular dominance peaks with orientation pinwheel centers in cat visual cortex	NEUROREPORT			English	Article						activity-dependent self-organization; car visual cortex; cortical columns; ocular dominance map; optical imaging; orientation map; pinwheel centers	MONKEY STRIATE CORTEX; SELF-ORGANIZATION; CORTICAL MAPS; SELECTIVITY; COLUMNS; EXPERIENCE; DOMAINS; LAYOUT; FRAMEWORK; KITTENS	Geometrical relationships among multiple cortical maps, such as those between ocular dominance and oriental:ion maps, are a prominent feature of the brain's functional architecture. It is also well known that there is a strong bias of cortical responses toward the contralateral eye during early postnatal development. We wondered therefore whether and how such an imbalance of cortical responsiveness in a developing animal might influence the mutual geometrical relationships between orientation and ocular dominance maps in adult animals. The results of our study indicate the existence of a strong tendency for the peaks of the ipsilateral eye domains to coincide with the location of point singularities (pinwheel centers) in orientation maps. No such relationship was found for the peaks of contralateral eye domains. Computational studies reproduced similar asymmetry in the coincidence under the contralateral eye bias of inputs. Our study raised the idea that the pinwheel centers play an important role for retaining the weaker ipsilateral eye inputs during normal development. NeuroReport 11:3337-3343 (C) 2000 Lippincott Williams & Wilkins.	RIKEN, BSI, Lab Visual Neurocomp, Wako, Saitama 3510198, Japan; Univ Tokyo, Sch Med, Dept Physiol, Tokyo, Japan; Waseda Univ, Dept Phys, Tokyo, Japan; NEC Informat Syst Ltd, Tsukuba, Ibaraki, Japan; Univ Minnesota, Sch Med, Ctr Magnet Resonance Res, Minneapolis, MN 55455 USA	Matsuda, Y (reprint author), RIKEN, BSI, Lab Visual Neurocomp, Wako, Saitama 3510198, Japan.		Kim, Dae-Shik/C-2071-2011				DURBIN R, 1990, NATURE, V343, P644, DOI 10.1038/343644a0; Crair MC, 1998, SCIENCE, V279, P566, DOI 10.1126/science.279.5350.566; BONHOEFFER T, 1995, EUR J NEUROSCI, V7, P1973, DOI 10.1111/j.1460-9568.1995.tb00720.x; Crair MC, 1997, J NEUROPHYSIOL, V77, P3381; TSO DY, 1986, J NEUROSCI, V6, P1160; RATZLAFF EH, 1991, J NEUROSCI METH, V36, P127, DOI 10.1016/0165-0270(91)90038-2; SOMERS DC, 1995, J NEUROSCI, V15, P5448; OBERMAYER K, 1993, J NEUROSCI, V13, P4114; HUBEL DH, 1962, J PHYSIOL-LONDON, V160, P106; ANDERSON PA, 1988, J NEUROSCI, V8, P2183; ALBUS K, 1984, J PHYSIOL-LONDON, V348, P153; BLASDEL GG, 1992, J NEUROSCI, V12, P3115; LEVAY S, 1978, J COMP NEUROL, V179, P223, DOI 10.1002/cne.901790113; Crair MC, 1997, NEURON, V19, P307, DOI 10.1016/S0896-6273(00)80941-1; SHATZ CJ, 1977, BRAIN RES, V131, P103, DOI 10.1016/0006-8993(77)90031-2; BARTFELD E, 1992, P NATL ACAD SCI USA, V89, P11905, DOI 10.1073/pnas.89.24.11905; Ohki K, 2000, CEREB CORTEX, V10, P593, DOI 10.1093/cercor/10.6.593; FREGNAC Y, 1978, J PHYSIOL-LONDON, V278, P27; BONHOEFFER T, 1993, J NEUROSCI, V13, P4157; Das A, 1999, NATURE, V399, P655; DOUGLAS RJ, 1995, SCIENCE, V269, P981, DOI 10.1126/science.7638624; Erwin E, 1998, J NEUROSCI, V18, P9870; Galuske RAW, 1996, EUR J NEUROSCI, V8, P1554, DOI 10.1111/j.1460-9568.1996.tb01618.x; Huebner M, 1997, J NEUROSCI, V17, P9270; Kim DS, 1999, NEUROREPORT, V10, P2515, DOI 10.1097/00001756-199908200-00015; Kohonen T., 1989, SELF ORG ASS MEMORY; LOEWEL S, 1994, J NEUROSCI, V14, P7451; Lowel S, 1998, EUR J NEUROSCI, V10, P2629; Maldonado PE, 1997, SCIENCE, V276, P1551, DOI 10.1126/science.276.5318.1551; Miyashita M, 1997, NEUROREPORT, V8, P1187, DOI 10.1097/00001756-199703240-00026; MIYASHITA M, 1992, NEUROREPORT, V3, P69, DOI 10.1097/00001756-199201000-00018; Piepenbrock C, 1997, NEURAL COMPUT, V9, P959, DOI 10.1162/neco.1997.9.5.959; SHATZ CJ, 1978, J PHYSIOL-LONDON, V281, P267; TANAKA S, 1990, NEURAL NETWORKS, V3, P625, DOI 10.1016/0893-6080(90)90053-N; TANAKA S, 1997, SOC NEUR ABSTR, V23	35	5	6	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	530 WALNUT ST, PHILADELPHIA, PA 19106-3621 USA	0959-4965			NEUROREPORT	Neuroreport	OCT 20	2000	11	15					3337	3343		10.1097/00001756-200010200-00015		7	Neurosciences	Neurosciences & Neurology	366MY	WOS:000090010200010		
J	Lambert, JC; Mann, D; Goumidi, L; Harris, J; Pasquier, F; Frigard, B; Cottel, D; Lendon, C; Iwatsubo, T; Amouyel, P; Chartier-Harlin, MC				Lambert, JC; Mann, D; Goumidi, L; Harris, J; Pasquier, F; Frigard, B; Cottel, D; Lendon, C; Iwatsubo, T; Amouyel, P; Chartier-Harlin, MC			A FE65 polymorphism associated with risk of developing sporadic late-onset Alzheimer's disease but not with A beta loading in brains	NEUROSCIENCE LETTERS			English	Article						Alzheimer; polymorphism; FE65; brain; A beta peptide	AMYLOID PRECURSOR PROTEIN; APOLIPOPROTEIN-E; GENE; DOMAIN; INTERACTS; LRP	The FE65 protein was previously described interacting with amyloid protein precursor (APP) and mediating its internalization. Hu et al. (Hum. Genet., 103 (1998) 295) recently reported that a deletion polymorphism in intron 13 of the FE65 gene may be protective for sporadic Alzheimer's disease (AD) forms and suggested that this deletion may modify splicing between exon 13 and 14 (the two exons encoding the interaction domain of FE65 with APP). We tested the im pact of this polymorphism in 646 controls and 639 sporadic AD cases. We were only able to detect a protective effect of the deletion in the population over 75 years (odds ratio = 0.53, 95% confidence interval (0.35-0.82), P = 0.002). Furthermore, no association of this polymorphism with A beta(40), A beta(42(43)) and total A beta loads were detected in 74 AD brains, although, we could expect that this deletion was associated with modifications of the APP metabolism. in conclusion, the FE65 gene may be a minor genetic determinant only for sporadic late-onset AD forms, although, we cannot conclude that this impact is mediated by a modulation of the APP process and/or A beta peptide deposition. (C) 2000 Elsevier Science Ireland Ltd. All rights reserved.	INSERM, Inst Pasteur, F-59045 Lille, France; Univ Birmingham, Mol Psychiat Dept, Div Neurosci, Queen Elizabeth Psychiat Hosp, Birmingham B15 2QZ, W Midlands, England; Univ Manchester, Clin Neurosci Res Grp, Dept Med, Manchester M13 9PT, Lancs, England; Ctr Hosp Reg & Univ Lille, Neurol Clin, Ctr Memoire, Hop Salengro, F-59037 Lille, France; Ctr Geriatr Wasquehal Molinel, F-59444 Wasquehal, France; Univ Tokyo, Fac Pharmaceut Sci, Dept Neuropathol & Neurosci, Tokyo 113, Japan	Chartier-Harlin, MC (reprint author), INSERM, Inst Pasteur, 1 Rue Prof Calmette,BP 245, F-59045 Lille, France.		Lambert, jean-charles/A-9553-2014; lambert, jean-charles/F-8787-2013				Farrer LA, 1997, JAMA-J AM MED ASSOC, V278, P1349, DOI 10.1001/jama.278.16.1349; Russo T, 1998, FEBS LETT, V434, P1, DOI 10.1016/S0014-5793(98)00941-7; EVANS KC, 1995, P NATL ACAD SCI USA, V92, P763, DOI 10.1073/pnas.92.3.763; Blacker D, 1998, NAT GENET, V19, P357; Hu QB, 1998, HUM GENET, V103, P295, DOI 10.1007/s004390050820; Bales KR, 1997, NAT GENET, V17, P263, DOI 10.1038/ng1197-263; Selkoe DJ, 1996, J BIOL CHEM, V271, P18295; Hardy J, 1997, TRENDS NEUROSCI, V20, P154, DOI 10.1016/S0166-2236(96)01030-2; Bressler SL, 1996, HUM MOL GENET, V5, P1589, DOI 10.1093/hmg/5.10.1589; Cruts M, 1998, HUM MOL GENET, V7, P43, DOI 10.1093/hmg/7.1.43; Ermekova KS, 1997, J BIOL CHEM, V272, P32869, DOI 10.1074/jbc.272.52.32869; Kang DE, 1997, NEUROLOGY, V49, P56; Lambert JC, 1998, LANCET, V351, P1787, DOI 10.1016/S0140-6736(05)78749-3; Mann DMA, 1997, NEUROSCI LETT, V221, P81, DOI 10.1016/S0304-3940(96)13294-8; Trommsdorff R, 1998, J BIOL CHEM, V273, P33556; Zambrano N, 1998, J BIOL CHEM, V273, P20128, DOI 10.1074/jbc.273.32.20128; Zambrano N, 1997, J BIOL CHEM, V272, P6399	17	28	29	ELSEVIER SCI IRELAND LTD	CLARE	CUSTOMER RELATIONS MANAGER, BAY 15, SHANNON INDUSTRIAL ESTATE CO, CLARE, IRELAND	0304-3940			NEUROSCI LETT	Neurosci. Lett.	OCT 20	2000	293	1					29	32		10.1016/S0304-3940(00)01477-4		4	Neurosciences	Neurosciences & Neurology	363HK	WOS:000089829500008		
J	Iwasawa, N; Shido, M; Maeyama, K; Kusama, H				Iwasawa, N; Shido, M; Maeyama, K; Kusama, H			Novel synthesis of pentacarbonylbenzopyranylidenetungsten(0) complexes and their Diels-Alder reaction with electron-rich alkenes	JOURNAL OF THE AMERICAN CHEMICAL SOCIETY			English	Article							TRANSITION-METAL COMPLEXES; ORGANIC SYNTHESES; CARBENE COMPLEXES; VINYLIDENE; CHROMIUM; TUNGSTEN		Tokyo Inst Technol, Dept Chem, Meguro Ku, Tokyo 1528551, Japan; Univ Tokyo, Dept Chem, Grad Sch Sci, Bunkyo Ku, Tokyo 1130033, Japan	Iwasawa, N (reprint author), Tokyo Inst Technol, Dept Chem, Meguro Ku, Tokyo 1528551, Japan.						Merlic CA, 1996, J AM CHEM SOC, V118, P11319, DOI 10.1021/ja962684+; McDonald FE, 1999, CHEM-EUR J, V5, P3103, DOI 10.1002/(SICI)1521-3765(19991105)5:11<3103::AID-CHEM3103>3.0.CO;2-N; WANG SLB, 1990, J AM CHEM SOC, V112, P4550, DOI 10.1021/ja00167a067; BRUCE MI, 1991, CHEM REV, V91, P197, DOI 10.1021/cr00002a005; Aumann R, 1996, J AM CHEM SOC, V118, P10853, DOI 10.1021/ja961020x; Bruneau C, 1999, ACCOUNTS CHEM RES, V32, P311, DOI 10.1021/ar980016i; AUMANN R, 1987, CHEM BER-RECL, V120, P537, DOI 10.1002/cber.19871200413; Aumann R, 1996, ORGANOMETALLICS, V15, P1257, DOI 10.1021/om950741m; BERKE H, 1981, Z NATURFORSCH B, V36, P929; BRUCE MI, 1983, ADV ORGANOMET CHEM, V22, P59; LICANDRO E, 1994, INORG CHIM ACTA, V220, P233, DOI 10.1016/0020-1693(94)03875-9; London S.J., 1985, J AM CHEM SOC, V107, P6739; Maeyama K, 1998, J AM CHEM SOC, V120, P1928, DOI 10.1021/ja973317g; Maeyama K, 1999, J ORG CHEM, V64, P1344, DOI 10.1021/jo981361o; Okamura W. H., 1991, COMPREHENSIVE ORGANI, V5, P699, DOI DOI 10.1016/B978-0-08-052349-1.00137-2; SZYMANSKA-BUZAR T, 1995, J ORGANOMET CHEM, V495, P163, DOI 10.1016/0022-328X(95)05482-5; Yu ZK, 1997, J ORGANOMET CHEM, V541, P187, DOI 10.1016/S0022-328X(97)00051-X	17	83	83	AMER CHEMICAL SOC	WASHINGTON	1155 16TH ST, NW, WASHINGTON, DC 20036 USA	0002-7863			J AM CHEM SOC	J. Am. Chem. Soc.	OCT 18	2000	122	41					10226	10227		10.1021/ja001481p		2	Chemistry, Multidisciplinary	Chemistry	368FT	WOS:000090107600049		
J	Shimoyama, M; Hayashi, D; Zou, YZ; Takimoto, E; Mizukami, M; Monzen, K; Kudoh, S; Hiroi, Y; Yazaki, Y; Nagai, R; Komuro, I				Shimoyama, M; Hayashi, D; Zou, YZ; Takimoto, E; Mizukami, M; Monzen, K; Kudoh, S; Hiroi, Y; Yazaki, Y; Nagai, R; Komuro, I			Calcineurin inhibitor attenuates the development and induces the regression of cardiac hypertrophy in rats with salt-sensitive hypertension	CIRCULATION			English	Article						hypertrophy; hemodynamics; hypertension	LEFT-VENTRICULAR MASS; DEPENDENT TRANSCRIPTIONAL PATHWAY; SKELETAL-MUSCLE HYPERTROPHY; PRESSURE-OVERLOAD; DILATED CARDIOMYOPATHY; MYOCYTE HYPERTROPHY; BLOOD-PRESSURE; HEART-FAILURE; BODY-MASS; DAHL RATS	Background-It remains unclear how hemodynamic overload induces cardiac hypertrophy. Recently, activation of calcium-dependent phosphatase, calcineurin, has been elucidated to induce cardiac hypertrophy. In the present study, we examined the role of calcineurin in load-induced cardiac hypertrophy by using Dahl salt-sensitive (DS) rats, which develop both pressure and volume overload when fed a high salt diet. Methods and Results-In the DS rat heart, the activity of calcineurin was increased and cardiac hypertrophy was induced by high salt diet. Treatment of DS rats with the calcineurin inhibitor FK506 (0.1 or 0.01 mg/kg twice daily) from the age of 6 weeks to 12 weeks inhibited the activation of calcineurin in the heart in a dose-dependent manner and attenuated the development of load-induced cardiac hypertrophy and fibrosis without change of hemodynamic parameters. Additionally, treatment with 0.1 mg/kg twice daily but not with 0.01 mg/kg twice daily of FK506 from the age of 12 weeks to 16 weeks induced regression of cardiac hypertrophy in DS rats. Load-induced reprogramming of gene expression was also suppressed by the FK506 treatment. Conclusions-These results suggest that calcineurin is involved in the development of cardiac hypertrophy in rats with salt-sensitive hypertension and that inhibition of calcineurin could induce regression of cardiac hypertrophy.	Univ Tokyo, Grad Sch Med, Dept Cardiovasc Med, Bunkyo Ku, Tokyo 1138655, Japan	Komuro, I (reprint author), Univ Tokyo, Grad Sch Med, Dept Cardiovasc Med, Bunkyo Ku, 7-3-1 Hongo, Tokyo 1138655, Japan.						Lin Q, 1997, SCIENCE, V276, P1404, DOI 10.1126/science.276.5317.1404; de la Pompa JL, 1998, NATURE, V392, P182; Molkentin JD, 1998, CELL, V93, P215, DOI 10.1016/S0092-8674(00)81573-1; Sussman MA, 1998, SCIENCE, V281, P1690, DOI 10.1126/science.281.5383.1690; MANN DL, 1989, CIRC RES, V64, P1079; Dunn SE, 1999, J BIOL CHEM, V274, P21908, DOI 10.1074/jbc.274.31.21908; Xia Y, 2000, J BIOL CHEM, V275, P1855, DOI 10.1074/jbc.275.3.1855; Sussman MA, 1999, AM J PATHOL, V155, P2101, DOI 10.1016/S0002-9440(10)65528-9; KATZ AM, 1990, NEW ENGL J MED, V322, P100; Ding B, 1999, CIRC RES, V84, P729; Semsarian C, 1999, NATURE, V400, P576; PENNICA D, 1995, P NATL ACAD SCI USA, V92, P1142, DOI 10.1073/pnas.92.4.1142; HIROTA H, 1995, P NATL ACAD SCI USA, V92, P4862, DOI 10.1073/pnas.92.11.4862; LEVY D, 1990, NEW ENGL J MED, V322, P1561, DOI 10.1056/NEJM199005313222203; Shioi T, 1997, CIRC RES, V81, P664; Chin ER, 1998, GENE DEV, V12, P2499, DOI 10.1101/gad.12.16.2499; Ranger AM, 1998, NATURE, V392, P186; Musaro A, 1999, NATURE, V400, P581; Harada K, 1998, CIRCULATION, V97, P1952; Mesaeli N, 1999, J CELL BIOL, V144, P857, DOI 10.1083/jcb.144.5.857; INOKO M, 1994, AM J PHYSIOL-HEART C, V267, pH2471; DAHL LK, 1962, NATURE, V194, P480, DOI 10.1038/194480b0; Bella JN, 1998, CIRCULATION, V98, P2538; Mende U, 1998, P NATL ACAD SCI USA, V95, P13893, DOI 10.1073/pnas.95.23.13893; ARAI M, 1991, CIRC RES, V69, P266; BERG BN, 1957, J GERONTOL, V12, P370; BERRIDGE MJ, 1995, BIOESSAYS, V17, P491, DOI 10.1002/bies.950170605; DANIELS SR, 1995, CIRCULATION, V92, P3249; KOMURO I, 1993, ANNU REV PHYSIOL, V55, P55, DOI 10.1146/annurev.physiol.55.1.55; KOTCHEN TA, 1991, AM J PHYSIOL, V261, pE692; Luo ZY, 1998, NAT MED, V4, P1092, DOI 10.1038/2578; Meguro T, 1999, CIRC RES, V84, P735; MONDON CE, 1993, HYPERTENSION, V21, P373; MULLER AG, 1998, SCIENCE, V282, pA1007; PFEFFER MA, 1984, HYPERTENSION, V6, P475; Shimoyama M, 1999, CIRCULATION, V100, P2449; SHREINER DP, 1969, AM J PHYSIOL, V217, P176; Taigen T, 2000, P NATL ACAD SCI USA, V97, P1196, DOI 10.1073/pnas.97.3.1196; YIN FCP, 1982, AM J PHYSIOL, V243, pH941; Zhang WG, 1999, CIRC RES, V84, P722	40	34	37	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	530 WALNUT ST, PHILADELPHIA, PA 19106-3621 USA	0009-7322			CIRCULATION	Circulation	OCT 17	2000	102	16					1996	2004				9	Cardiac & Cardiovascular Systems; Peripheral Vascular Disease	Cardiovascular System & Cardiology	363UW	WOS:000089856000023		
J	Michimoto, T; Aoki, T; Toh-e, A; Kikuchi, Y				Michimoto, T; Aoki, T; Toh-e, A; Kikuchi, Y			Yeast Pdr13p and Zuo1p molecular chaperones are new functional Hsp70 and Hsp40 partners	GENE			English	Article						DnaK-DnaJ pair; heat shock proteins; Saccharomyces cerevisiae	SACCHAROMYCES-CEREVISIAE; PROTEIN; TRANSLATION; DNAJ; TOM1	The deletion of the TOM1 gene encoding a putative ubiquitin ligase causes a temperature sensitive cellular growth in Saccharomyces cerevisiae. The arrested cells exhibit pleiotropic defects in nuclear division, maintenance of nuclear structure and heat stress responses. We previously identified a zuo1 mutation as an extragenic suppressor of the tom1 mutant. ZUO1 encodes a DnaJ-related Hsp40. Here we show that a recessive cold sensitive mutation in PDR13 coding for an Hsp70 suppressed the tom1 mutation. The pdr13 deletion mutant was sensitive to high osmolarity, just like the zuo1 deletion mutant. A zuo1 pdr13 double deletion mutant did not show additive phenotypes. Furthermore, a tagged-Zuo1p was co-immunoprecipitated with a tagged Pdr13p. Taken together, we propose that Pdr13p and Zuo1p are a new pair of Hsp70:Hsp40 molecular chaperones. In addition, Pdr13p co-sedimented with translating ribosomes and this association was independent of the presence of Zuo1p. (C) 2000 Elsevier Science B.V. All rights reserved.	Univ Tokyo, Grad Sch Sci, Dept Biol Sci, Bunkyo Ku, Tokyo 1130033, Japan	Kikuchi, Y (reprint author), Univ Tokyo, Grad Sch Sci, Dept Biol Sci, Bunkyo Ku, 7-3-1 Hongo, Tokyo 1130033, Japan.						Pfund C, 1998, EMBO J, V17, P3981, DOI 10.1093/emboj/17.14.3981; NELSON RJ, 1992, CELL, V71, P97, DOI 10.1016/0092-8674(92)90269-I; Hartl FU, 1996, NATURE, V381, P571, DOI 10.1038/381571a0; BAIM SB, 1985, MOL CELL BIOL, V5, P1839; BROACH JR, 1979, GENE, V8, P121, DOI 10.1016/0378-1119(79)90012-X; FRANTZ JD, 1995, J BIOL CHEM, V270, P9413; GIETZ RD, 1988, GENE, V74, P527, DOI 10.1016/0378-1119(88)90185-0; Hallstrom TC, 1998, MOL CELL BIOL, V18, P1147; Hallstrom TC, 2000, MOL MICROBIOL, V36, P402, DOI 10.1046/j.1365-2958.2000.01858.x; Kaiser C, 1994, METHODS YEAST GENETI; LIBEREK K, 1991, P NATL ACAD SCI USA, V88, P2874, DOI 10.1073/pnas.88.7.2874; Liu XD, 1999, J BIOL CHEM, V274, P26654, DOI 10.1074/jbc.274.38.26654; Lu Z, 1998, J BIOL CHEM, V273, P27824, DOI 10.1074/jbc.273.43.27824; LYMAN SK, 1995, J CELL BIOL, V131, P1163, DOI 10.1083/jcb.131.5.1163; Saleh A, 1998, J MOL BIOL, V282, P933, DOI 10.1006/jmbi.1998.2036; Sambrook J., 1989, MOL CLONING; SASAKI T, 2000, IN PRESS MOL CELL BI; Sasaki T, 2000, MOL GEN GENET, V262, P940, DOI 10.1007/PL00008662; Utsugi T, 1999, GENE, V234, P285, DOI 10.1016/S0378-1119(99)00197-3; UTSUGI T, 1995, BBA-GENE STRUCT EXPR, V1263, P285, DOI 10.1016/0167-4781(95)00123-X; Yan W, 1998, EMBO J, V17, P4809, DOI 10.1093/emboj/17.16.4809	21	12	15	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	0378-1119			GENE	Gene	OCT 17	2000	257	1					131	137		10.1016/S0378-1119(00)00381-4		7	Genetics & Heredity	Genetics & Heredity	374VW	WOS:000165365900013		
J	Stapert, HR; Nishiyama, N; Jiang, DL; Aida, T; Kataoka, K				Stapert, HR; Nishiyama, N; Jiang, DL; Aida, T; Kataoka, K			Polyion complex micelles encapsulating light-harvesting ionic dendrimer zinc porphyrins	LANGMUIR			English	Article							ACID) BLOCK-COPOLYMER; AQUEOUS-MEDIUM; CORE; OLIGONUCLEOTIDE; ARCHITECTURE; DELIVERY; DRUG	Core-shell type micelles with a hydrodynamic diameter of 52 nm composed of 38 molecules of zinc dendrimer porphyrin with 32 carboxylate groups on the periphery and 39 poly(ethylene glycol)-poly(L-lysine) (PEG-PLys) block copolymers were prepared at a stoichiometric mixing ratio. These micelles showed an unusually high stability against NaCl solutions due to the formation of hydrogen bonds at salt concentrations higher than 200 mM NaCl. In contrast, large aggregates of 250-300 nm diameter of a zinc dendrimer porphyrin were formed with 32 positively charged trimethylammonium groups and poly(ethylene glycol)-poly(aspartic acid) (PEG-PAsp) black copolymer. These aggregates lack the ability to form hydrogen bonds and almost completely dissociate at salt concentrations higher than 200 mM. Both polyion dendrimer micelle systems showed a high stability upon dilution with 150 mM NaCl without a critical association concentration being observed. Both polyion dendrimer micelle complexes have potential to be used as drug delivery systems for Light-harvesting ionic zinc dendrimer porphyrin sensitizers.	Univ Tokyo, Grad Sch Engn, Dept Mat Sci, Bunkyo Ku, Tokyo 1138656, Japan; Univ Tokyo, Grad Sch Engn, PRESTO, Bunkyo Ku, Tokyo 1138565, Japan; Univ Tokyo, Grad Sch Engn, Dept Chem & Biotechnol, Bunkyo Ku, Tokyo 1138565, Japan	Kataoka, K (reprint author), Univ Tokyo, Grad Sch Engn, Dept Mat Sci, Bunkyo Ku, 7-3-1 Hongo, Tokyo 1138656, Japan.		Aida, Takuzo/I-9117-2012; Nishiyama, Nobuhiro/F-1867-2014; Kataoka, Kazunori/K-7108-2012	Nishiyama, Nobuhiro/0000-0002-6886-9357; Kataoka, Kazunori/0000-0002-8591-413X			Yu K, 1996, MACROMOLECULES, V29, P6359, DOI 10.1021/ma960381u; Kabanov AV, 1996, MACROMOLECULES, V29, P6797, DOI 10.1021/ma960120k; McCaughan JS, 1999, DRUG AGING, V15, P49, DOI 10.2165/00002512-199915010-00005; KATAOKA K, 1993, J CONTROL RELEASE, V24, P119; Kakizawa Y, 1999, J AM CHEM SOC, V121, P11247, DOI 10.1021/ja993057y; Won YY, 1999, SCIENCE, V283, P960, DOI 10.1126/science.283.5404.960; HARADA A, 1995, MACROMOLECULES, V28, P5294, DOI 10.1021/ma00119a019; XU RL, 1991, MACROMOLECULES, V24, P87, DOI 10.1021/ma00001a014; Harada A, 1999, SCIENCE, V283, P65, DOI 10.1126/science.283.5398.65; Jenekhe SA, 1999, SCIENCE, V283, P372, DOI 10.1126/science.283.5400.372; Nishiyama N, 1999, LANGMUIR, V15, P377, DOI 10.1021/la980572l; DOUGLAS JF, 1990, MACROMOLECULES, V23, P4168, DOI 10.1021/ma00220a022; QUINTANA JR, 1993, MACROMOLECULES, V26, P606, DOI 10.1021/ma00056a009; WOLK SK, 1994, MACROMOLECULES, V27, P7613, DOI 10.1021/ma00104a016; Kataoka K, 1996, MACROMOLECULES, V29, P8556, DOI 10.1021/ma961217+; Harada A, 1998, MACROMOLECULES, V31, P288, DOI 10.1021/ma971277v; Vinogradov SV, 1998, BIOCONJUGATE CHEM, V9, P805, DOI 10.1021/bc980048q; Harada A, 1997, J MACROMOL SCI PURE, VA34, P2119, DOI 10.1080/10601329708010329; KABANOV AV, 1995, BIOCONJUGATE CHEM, V6, P639, DOI 10.1021/bc00036a001; YOKOYAMA M, 1987, MAKROMOL CHEM-RAPID, V8, P431; Katayose S, 1997, BIOCONJUGATE CHEM, V8, P702, DOI 10.1021/bc9701306; Khougaz K, 1996, MACROMOLECULES, V29, P3937, DOI 10.1021/ma9516145; Miller SM, 1987, POLYM CONTROLLED DRU, P1; Sadamoto R, 1996, J AM CHEM SOC, V118, P3978, DOI 10.1021/ja952855v; STAPERT HR, UNPUB; Tomalia D. A., 1997, CHEM IND, V11, P416; Tomioka N, 1998, ANGEW CHEM INT EDIT, V37, P1531, DOI 10.1002/(SICI)1521-3773(19980619)37:11<1531::AID-ANIE1531>3.3.CO;2-K; Tomoyose Y, 1996, MACROMOLECULES, V29, P5236, DOI 10.1021/ma960575+; TORCHILIN VR, 1995, ADV DRUG DELIV REV, V16, P3; TSUCHIDA E, 1980, J MACROMOL SCI PHYS, VB17, P683, DOI 10.1080/00222348008212832; Zhao D, 1998, ADV MATER, V10, P1380, DOI 10.1002/(SICI)1521-4095(199811)10:16<1380::AID-ADMA1380>3.0.CO;2-8; YOKOYAMA M, 1989, MAKROMOL CHEM, V190, P2041	32	76	77	AMER CHEMICAL SOC	WASHINGTON	1155 16TH ST, NW, WASHINGTON, DC 20036 USA	0743-7463			LANGMUIR	Langmuir	OCT 17	2000	16	21					8182	8188		10.1021/la000423e		7	Chemistry, Multidisciplinary; Chemistry, Physical; Materials Science, Multidisciplinary	Chemistry; Materials Science	362VX	WOS:000089799900044		
J	Shibayama, M; Tsujimoto, M; Ikkai, F				Shibayama, M; Tsujimoto, M; Ikkai, F			Static inhomogeneities in physical gels: Comparison of temperature-induced and concentration-induced sol-gel transition	MACROMOLECULES			English	Article							DYNAMIC LIGHT-SCATTERING; RED AQUEOUS-SOLUTIONS; POLY(N-ISOPROPYLACRYLAMIDE-CO-ACRYLIC ACID) GELS; SPATIAL INHOMOGENEITY; POLYACRYLAMIDE GELS; CROSS-LINKING; POLYMER GELS; FLUCTUATIONS; COMPLEXATION; HYDROGELS	The gel-sol transition of a physical gel comprising poly(vinyl alcohol), Congo Red, and water has been studied by static/dynamic light scattering (SLS/DLS). SLS speckle patterns appeared exclusively in the gel state as observed in chemical gels (i.e., covalent bonded gels). The speckle patterns disappeared when temperature (T) was raised or concentration (C) was lowered across the temperature-induced or concentration-induced gel-sol transition point. The time-intensity correlation function obtained by DLS showed a clear transition from a power law to a stretched exponential behavior at the transition point. The transition is discussed in conjunction with the site-bond percolation theory.	Univ Tokyo, Neutron Scattering Lab, Inst Solid State Phys, Tokai, Ibaraki 3191106, Japan; Kyoto Inst Technol, Dept Polymer Sci & Engn, Sakyo Ku, Kyoto 6068585, Japan	Shibayama, M (reprint author), Univ Tokyo, Neutron Scattering Lab, Inst Solid State Phys, Tokai, Ibaraki 3191106, Japan.		Shibayama, Mitsuhiro/E-1646-2015	Shibayama, Mitsuhiro/0000-0002-8683-5070			Rubinstein M, 1996, MACROMOLECULES, V29, P398, DOI 10.1021/ma9511917; SHIBAYAMA M, 1994, MACROMOLECULES, V27, P6383, DOI 10.1021/ma00100a023; MARTIN JE, 1988, PHYS REV LETT, V61, P373, DOI 10.1103/PhysRevLett.61.373; PUSEY PN, 1989, PHYSICA A, V157, P705, DOI 10.1016/0378-4371(89)90063-0; TANAKA T, 1973, J CHEM PHYS, V59, P5151, DOI 10.1063/1.1680734; SHIBAYAMA M, 1994, MACROMOLECULES, V27, P5060, DOI 10.1021/ma00096a031; WU XS, 1992, J POLYM SCI POL CHEM, V30, P2121, DOI 10.1002/pola.1992.080301005; Shibayama M, 1998, PHYSICA A, V249, P245, DOI 10.1016/S0378-4371(97)00472-X; Shibayama M, 1996, MACROMOLECULES, V29, P8746, DOI 10.1021/ma9609994; FRELTOFT T, 1986, PHYS REV B, V33, P269, DOI 10.1103/PhysRevB.33.269; JOOSTEN JGH, 1991, MACROMOLECULES, V24, P6690, DOI 10.1021/ma00025a021; Shibayama M, 1998, MACROMOL CHEM PHYSIC, V199, P1; Ikkai F, 1999, PHYS REV LETT, V82, P4946, DOI 10.1103/PhysRevLett.82.4946; Hirose H, 1998, MACROMOLECULES, V31, P5336, DOI 10.1021/ma980405s; CONIGLIO A, 1979, PHYS REV LETT, V42, P518, DOI 10.1103/PhysRevLett.42.518; SKOURI R, 1995, MACROMOLECULES, V28, P197, DOI 10.1021/ma00105a026; COHEN Y, 1992, J POLYM SCI POL PHYS, V30, P1055, DOI 10.1002/polb.1992.090300913; Dainty J. C., 1975, LASER SPECKLE RELATE; de Gennes P. G., 1979, SCALING CONCEPTS POL; FUJINO K, 1959, SEN-I GAKKAISHI, V15, P483; Hirotsu S, 1998, JPN J APPL PHYS 2, V37, pL284, DOI 10.1143/JJAP.37.L284; HORKAY F, 1993, MACROMOLECULES, V26, P3375, DOI 10.1021/ma00065a022; Ikkai F, 1998, KOBUNSHI RONBUNSHU, V55, P632; Ikkai F, 1996, J POLYM SCI POL PHYS, V34, P939, DOI 10.1002/(SICI)1099-0488(19960415)34:5<939::AID-POLB12>3.0.CO;2-C; KABRA BG, 1991, POLYM COMMUN, V32, P322; MALLAM S, 1989, MACROMOLECULES, V22, P3356, DOI 10.1021/ma00198a029; MARTIN JE, 1991, PHYS REV A, V43, P858, DOI 10.1103/PhysRevA.43.858; MUTHUKUMAR M, 1989, MACROMOLECULES, V22, P4656, DOI 10.1021/ma00202a050; Nisato G, 1995, FARADAY DISCUSS, V101, P133, DOI 10.1039/fd9950100133; NYSTROM B, 1992, POLYMER, V33, P2875, DOI 10.1016/0032-3861(92)90071-4; REN SZ, 1992, PHYS REV A, V45, P2416, DOI 10.1103/PhysRevA.45.2416; SCHOSSELER F, 1994, J PHYS II, V4, P1221, DOI 10.1051/jp2:1994196; Shibayama M, 1997, J CHEM PHYS, V107, P5227, DOI 10.1063/1.474886; Shibayama M, 1996, MACROMOLECULES, V29, P6535, DOI 10.1021/ma960320w; SHIBAYAMA M, 1994, MACROMOLECULES, V27, P1738, DOI 10.1021/ma00085a011; Shibayama M, 1994, POLYMER, V26, P5716; Takeda M, 2000, MACROMOLECULES, V33, P2909, DOI 10.1021/ma9921044	37	28	28	AMER CHEMICAL SOC	WASHINGTON	1155 16TH ST, NW, WASHINGTON, DC 20036 USA	0024-9297			MACROMOLECULES	Macromolecules	OCT 17	2000	33	21					7868	7876		10.1021/ma000563v		9	Polymer Science	Polymer Science	367ZH	WOS:000090092300029		
J	Ohtake, T; Takamitsu, Y; Ito-Akita, K; Kanie, K; Yoshizawa, M; Mukai, T; Ohno, H; Kato, T				Ohtake, T; Takamitsu, Y; Ito-Akita, K; Kanie, K; Yoshizawa, M; Mukai, T; Ohno, H; Kato, T			Liquid-crystalline ion-conductive materials: Self-organization behavior and ion-transporting properties of mesogenic dimers containing oxyethylene moieties complexed with metal salts	MACROMOLECULES			English	Article							POLYMER ELECTROLYTES; LITHIUM; CHAIN		Univ Tokyo, Grad Sch Engn, Dept Chem & Biotechnol, Bunkyo Ku, Tokyo 1138656, Japan; Tokyo Univ Agr & Technol, Dept Biotechnol, Tokyo 1848588, Japan	Kato, T (reprint author), Univ Tokyo, Grad Sch Engn, Dept Chem & Biotechnol, Bunkyo Ku, Tokyo 1138656, Japan.		Ohno, Hiroyuki/F-6459-2012; KIYOSHI, KANIE/F-6660-2014	Ohno, Hiroyuki/0000-0001-9716-3495; KIYOSHI, KANIE/0000-0003-1477-6515			Xu W, 1998, CHEM MATER, V10, P1951, DOI 10.1021/cm980109u; Hawker CJ, 1996, MACROMOLECULES, V29, P3831, DOI 10.1021/ma951909i; Ohtake T, 2000, CHEM MATER, V12, P782, DOI 10.1021/cm990706w; Bruce P. G., 1997, SOLID STATE ELECTROC; CAMERON GG, 1988, BRIT POLYM J, V20, P199, DOI 10.1002/pi.4980200307; Dias FB, 1998, ELECTROCHIM ACTA, V43, P1217, DOI 10.1016/S0013-4686(97)10022-6; Goodby JW, 1998, CHEM COMMUN, P2057, DOI 10.1039/a802762e; Hubbard HVSA, 1998, ELECTROCHIM ACTA, V43, P1239, DOI 10.1016/S0013-4686(97)10024-X; Imrie CT, 1999, ADV MATER, V11, P832, DOI 10.1002/(SICI)1521-4095(199907)11:10<832::AID-ADMA832>3.0.CO;2-Z; Lee M, 1996, MACROMOLECULES, V29, P5567, DOI 10.1021/ma951418y; OHNO H, 1995, POLYMER, V36, P891, DOI 10.1016/0032-3861(95)93124-5; Ohtake T, 1999, POLYM J, V31, P1155, DOI 10.1295/polymj.31.1155; PERCEC V, 1993, J CHEM SOC PERK T 1, P1411, DOI 10.1039/p19930001411; SHINKAI S, 1990, J CHEM SOC CHEM COMM, P303, DOI 10.1039/c39900000303; TOKUHISA H, 1994, MACROMOLECULES, V27, P1842, DOI 10.1021/ma00085a027; vanNostrum CF, 1996, CHEM COMMUN, P2385, DOI 10.1039/cc9960002385; Wright P. V., 1975, British Polymer Journal, V7, DOI 10.1002/pi.4980070505; Yoshizawa M, 1999, CHEM LETT, P889, DOI 10.1246/cl.1999.889	18	28	30	AMER CHEMICAL SOC	WASHINGTON	1155 16TH ST, NW, WASHINGTON, DC 20036 USA	0024-9297			MACROMOLECULES	Macromolecules	OCT 17	2000	33	21					8109	8111		10.1021/ma000878a		3	Polymer Science	Polymer Science	367ZH	WOS:000090092300059		
J	Kawasaki, H; Ara, K; Terashima, K				Kawasaki, H; Ara, K; Terashima, K			Scanning tunneling microscopy of plasma-solid surface interface	THIN SOLID FILMS			English	Article; Proceedings Paper	2nd International Workshop on Basic Aspects of Non-Equilibrium Plasmas Interacting with Surfaces (BANPIS-2000)	JAN 28-30, 2000	NAGASAKI, JAPAN	Japan Soc Promot Sci, Japan Soc Appl Phys, Div Plasma Electr, Assoc Super Adv Electr Technol, Izumi Sci & Technol Fdn		plasma; plasma-solid interface; STM; plasma etching		A plasma-solid surface reaction on the nanometer scale was observed in situ for the first time. This was achieved by employing special scanning tunneling microscopy (STM) that could be operated in a plasma environment. To prevent current due to noise from the plasma, the probe tip was coated with epoxy grease and insulating glass. The apex of the probe tip was sharpened by a focused ion beam (FIB). This special STM had sufficient stability and reproducibility to measure a 10 x 10 mum(2) region for more than 5 h in a plasma environment. Using this apparatus, sequential in situ STM images of highly oriented pyrolytic graphite (HOPG) were obtained in a radio-frequency (rf) (430 MHz) low-pressure (1 torr) air glow plasma. These images revealed that a projection of over 100 nm in height was etched by the plasma and removed. (C) 2000 Elsevier Science S.A. All rights reserved.	Univ Tokyo, Grad Sch Engn, Dept Met & Mat Sci, Bunkyo Ku, Tokyo 1138654, Japan	Kawasaki, H (reprint author), Univ Tokyo, Grad Sch Engn, Dept Met & Mat Sci, Bunkyo Ku, Hongo 7-3-1, Tokyo 1138654, Japan.						DOTE T, 1968, JPN J APPL PHYS, V7, P964, DOI 10.1143/JJAP.7.964; LIEBERMAN M, 1994, PRINCIPLES PLASMA DI; Terashima K, 1999, THIN SOLID FILMS, V345, P146, DOI 10.1016/S0040-6090(99)00098-X	3	1	1	ELSEVIER SCIENCE SA	LAUSANNE	PO BOX 564, 1001 LAUSANNE, SWITZERLAND	0040-6090			THIN SOLID FILMS	Thin Solid Films	OCT 17	2000	374	2					162	166		10.1016/S0040-6090(00)01147-0		5	Materials Science, Multidisciplinary; Materials Science, Coatings & Films; Physics, Applied; Physics, Condensed Matter	Materials Science; Physics	368MW	WOS:000090122100005		
J	Kato, T				Kato, T			Polymer/calcium carbonate layered thin-film composites	ADVANCED MATERIALS			English	Editorial Material							ORGANIC/INORGANIC COMPOSITES; CRYSTALLIZATION; MACROMOLECULES; NUCLEATION; GROWTH; CACO3	Formulation of the nacre of a shell is mimicked here to synthesize layered polymer/calcium carbonate composites such as that shown in the Figure. The combination of insoluble chitin or chitosan solid matrices with soluble acidic macromolecules such as poly(acrylic acid) is used to induce thin-film crystallization of CaCO3 on the solid matrices. The polymorph formed can also be controlled employing this method.	Univ Tokyo, Dept Chem & Biotechnol, Grad Sch Engn, Bunkyo Ku, Tokyo 113, Japan	Kato, T (reprint author), Univ Tokyo, Dept Chem & Biotechnol, Grad Sch Engn, Bunkyo Ku, Tokyo 113, Japan.						Kato T, 1999, CHEM LETT, P199; Weiner S, 1997, J MATER CHEM, V7, P689, DOI 10.1039/a604512j; Belcher AM, 1996, NATURE, V381, P56, DOI 10.1038/381056a0; KITANO Y, 1962, B CHEM SOC JPN, V35, P1973, DOI 10.1246/bcsj.35.1973; Aksay IA, 1996, SCIENCE, V273, P892, DOI 10.1126/science.273.5277.892; Falini G, 1997, CHEM-EUR J, V3, P1807, DOI 10.1002/chem.19970031113; Schaffer TE, 1997, CHEM MATER, V9, P1731, DOI 10.1021/cm960429i; Stupp SI, 1997, SCIENCE, V277, P1242, DOI 10.1126/science.277.5330.1242; Gower LB, 2000, J CRYST GROWTH, V210, P719, DOI 10.1016/S0022-0248(99)00749-6; FRITZ M, 1994, NATURE, V371, P49, DOI 10.1038/371049a0; MANN S, 1988, NATURE, V332, P119, DOI 10.1038/332119a0; Xu GF, 1998, J AM CHEM SOC, V120, P11977, DOI 10.1021/ja9819108; ADDADI L, 1992, ANGEW CHEM INT EDIT, V31, P153, DOI 10.1002/anie.199201531; Kato T, 1998, SUPRAMOL SCI, V5, P411, DOI 10.1016/S0968-5677(98)00041-8; Kato T, 2000, CHEM LETT, P186; LITVIN L, 1997, ADV MATER, V9, P124; MANN S, 1996, INORGANIC MAT, P255; Ozin GA, 2000, CHEM COMMUN, P419, DOI 10.1039/a905090f; Sugawara A, 2000, CHEM COMMUN, P487, DOI 10.1039/a909566g; WATABE N, 1965, J ULTRA MOL STRUCT R, V12, P351, DOI 10.1016/S0022-5320(65)80104-6; Zhang SK, 1998, LANGMUIR, V14, P6761, DOI 10.1021/la970962s	21	158	161	WILEY-V C H VERLAG GMBH	BERLIN	PO BOX 10 11 61, D-69451 BERLIN, GERMANY	0935-9648			ADV MATER	Adv. Mater.	OCT 16	2000	12	20					1543	1546		10.1002/1521-4095(200010)12:20<1543::AID-ADMA1543>3.0.CO;2-P		4	Chemistry, Multidisciplinary; Chemistry, Physical; Nanoscience & Nanotechnology; Materials Science, Multidisciplinary; Physics, Applied; Physics, Condensed Matter	Chemistry; Science & Technology - Other Topics; Materials Science; Physics	372QF	WOS:000165244300020		
J	Tachibana, H; Kishida, H; Tokura, Y				Tachibana, H; Kishida, H; Tokura, Y			Photoluminescence from pendant dye molecules mediated by exciton transport on helical polysilane chains	APPLIED PHYSICS LETTERS			English	Article							ULTRAVIOLET ELECTROLUMINESCENCE; SPECTRA; POLYMERS; DIODES; LIGHT; FILMS	We have synthesized helical polysilanes on which the pendant groups are partly substituted by dye molecules. The introduction of a few percent of dye molecules into the substituents enhances the luminescent efficiency of the visible region, by behaving as luminescence centers. We have demonstrated that the excitation energy is transferred efficiently by free excitons on the Si backbones to reach the luminescence centers, where energy transfer occurs from the exciton to the dye molecule, and as a result sensitized luminescence occurs. The exciton transfer is found to occur over 50-100 monomer units on the polysilane backbone. This approach will open the way to fabricating a wavelength-tunable luminous device by utilizing the exciton transport on Si chains. (C) 2000 American Institute of Physics. [S0003-6951(00)01842-8].	Joint Res Ctr Atom Technol, Tsukuba, Ibaraki 3058562, Japan; Natl Inst Mat & Chem Res, Tsukuba, Ibaraki 3058565, Japan; Univ Tokyo, Dept Appl Phys, Tokyo 1138656, Japan	Tachibana, H (reprint author), Joint Res Ctr Atom Technol, Tsukuba, Ibaraki 3058562, Japan.		Tokura, Yoshinori/C-7352-2009				FUJIKI M, 1994, J AM CHEM SOC, V116, P6017, DOI 10.1021/ja00092a082; MILLER RD, 1989, CHEM REV, V89, P1359, DOI 10.1021/cr00096a006; SEKI T, 1993, LANGMUIR, V9, P211, DOI 10.1021/la00025a041; Ebihara K, 1996, JPN J APPL PHYS 2, V35, pL1278; Fujiki M, 1998, CHIRALITY, V10, P667, DOI 10.1002/(SICI)1520-636X(1998)10:7<667::AID-CHIR12>3.0.CO;2-Y; Hasegawa T, 1996, PHYS REV B, V54, P11365, DOI 10.1103/PhysRevB.54.11365; Hattori R, 1996, JPN J APPL PHYS 2, V35, pL1509; KISHIDA H, 1995, J APPL PHYS, V78, P3362, DOI 10.1063/1.359962; KISHIDA H, 1994, APPL PHYS LETT, V65, P1358, DOI 10.1063/1.112051; NAKANO Y, 1993, J POLYM SCI POL CHEM, V31, P3361, DOI 10.1002/pola.1993.080311324; Suzuki H, 1996, ADV MATER, V8, P657, DOI 10.1002/adma.19960080812; TACHIBANA H, 1993, PHYS REV B, V47, P4363, DOI 10.1103/PhysRevB.47.4363; Yuan CH, 1997, APPL PHYS LETT, V71, P3326, DOI 10.1063/1.120326	13	9	9	AMER INST PHYSICS	MELVILLE	2 HUNTINGTON QUADRANGLE, STE 1NO1, MELVILLE, NY 11747-4501 USA	0003-6951			APPL PHYS LETT	Appl. Phys. Lett.	OCT 16	2000	77	16					2443	2445	PII [S0003-6951(00)01842-8]	10.1063/1.1318395		3	Physics, Applied	Physics	362HK	WOS:000089772400003		
J	Murata, M; Iwao, K; Miyoshi, Y; Nagasawa, Y; Yabu, M; Himeno, S; Imanishi, K; Ohsawa, M; Wada, H; Tominaga, S; Shimano, T; Kobayashi, T; Nakamura, Y				Murata, M; Iwao, K; Miyoshi, Y; Nagasawa, Y; Yabu, M; Himeno, S; Imanishi, K; Ohsawa, M; Wada, H; Tominaga, S; Shimano, T; Kobayashi, T; Nakamura, Y			Activation of the beta-catenin gene by interstitial deletions involving exon 3 as an early event in colorectal tumorigenesis	CANCER LETTERS			English	Article						beta-catenin; carcinogenesis; tumorigenesis; colorectal adenomas	FAMILIAL ADENOMATOUS POLYPOSIS; FUNCTIONAL INTERACTION; XENOPUS EMBRYOS; CYCLIN D1; APC GENE; MUTATIONS; CANCER; PATHWAY; CARCINOMAS; COMPLEX	beta -Catenin has been identified as an oncogene in several tumors including colorectal cancers. beta -Catenin gene is activated by interstitial deletions involving exon 3 in colorectal carcinomas of Japanese population, in contrast to amino acid substitutions detected among Caucasian population. The aim of this study was to examine the type and frequency of beta -catenin gene mutation during early stages of colorectal tumorigenesis. We screened 100 colorectal adenomas For somatic mutations in the beta -catenin gene by single-strand conformation polymorphism method, as well as polymerase chain reaction amplification. In cases with mutations, sequencing analyses and immunohistochemical staining were also performed. Somatic interstitial deletions of 272-413 bp, each of which included all parts of tron 3, were detected in three tumors. However, no adenoma carried missense mutations. We confirmed accumulation of aberrant beta -catenin protein in cytoplasm and nuclei of adenoma cells by immunohistochemical analysis. Our results suggested that activation of the beta -catenin gene by interstitial deletions involving exon 3 might be less frequent compared with frequent alterations of adenomatous polyposis coli (APC) gene, but could be an early event in colorectal tumorigenesis equivalent to APC gene alterations in the Japanese population. (C) 2000 Elsevier Science Ireland Ltd. All rights reserved.	Ikeda Municipal Hosp, Dept Surg, Ikeda, Osaka 5638510, Japan; Ikeda Municipal Hosp, Dept Pathol, Ikeda, Osaka 5638510, Japan; Osaka Univ, Sch Med, Biomed Res Ctr, Div Clin Genet,Dept Med Genet, Suita, Osaka 5650871, Japan; Ashiya Municipal Hosp, Dept Internal Med, Ashiya, Hyogo 6590012, Japan; Kawachi Gen Hosp, Dept Internal Med, Higashiosaka, Osaka 5780955, Japan; Univ Tokyo, Inst Med Sci, Ctr Human Genome, Lab Mol Med,Minato Ku, Tokyo 1088639, Japan	Murata, M (reprint author), Ikeda Municipal Hosp, Dept Surg, 3-1-18 Jyonan, Ikeda, Osaka 5638510, Japan.						GUMBINER BM, 1995, CURR OPIN CELL BIOL, V7, P634, DOI 10.1016/0955-0674(95)80104-9; Yost C, 1996, GENE DEV, V10, P1443, DOI 10.1101/gad.10.12.1443; Fukuchi T, 1998, CANCER RES, V58, P3526; Behrens J, 1998, SCIENCE, V280, P596, DOI 10.1126/science.280.5363.596; RUBINFELD B, 1993, SCIENCE, V262, P1731, DOI 10.1126/science.8259518; Rubinfeld B, 1996, SCIENCE, V272, P1023, DOI 10.1126/science.272.5264.1023; He TC, 1998, SCIENCE, V281, P1509, DOI 10.1126/science.281.5382.1509; Behrens J, 1996, NATURE, V382, P638, DOI 10.1038/382638a0; Palacios J, 1998, CANCER RES, V58, P1344; Shtutman M, 1999, P NATL ACAD SCI USA, V96, P5522, DOI 10.1073/pnas.96.10.5522; Miyoshi Y, 1998, ONCOL RES, V10, P591; Papkoff J, 1996, MOL CELL BIOL, V16, P2128; Molenaar M, 1996, CELL, V86, P391, DOI 10.1016/S0092-8674(00)80112-9; Ikeda S, 1998, EMBO J, V17, P1371, DOI 10.1093/emboj/17.5.1371; Tetsu O, 1999, NATURE, V398, P422; Rubinfeld B, 1997, SCIENCE, V275, P1790, DOI 10.1126/science.275.5307.1790; Morin PJ, 1997, SCIENCE, V275, P1787, DOI 10.1126/science.275.5307.1787; NAKAMURA Y, 1993, ADV CANCER RES, V62, P65, DOI 10.1016/S0065-230X(08)60315-2; Zurawel RH, 1998, CANCER RES, V58, P896; SU LK, 1993, SCIENCE, V262, P1734, DOI 10.1126/science.8259519; Sparks AB, 1998, CANCER RES, V58, P1130; Miyoshi Y, 1998, CANCER RES, V58, P2524; HULSKEN J, 1994, J CELL BIOL, V127, P2061, DOI 10.1083/jcb.127.6.2061; Coste desLa A, 1998, P NATL ACAD SCI USA, V95, P8847, DOI 10.1073/pnas.95.15.8847; FEARON ER, 1990, CELL, V61, P759, DOI 10.1016/0092-8674(90)90186-I; HSU SM, 1981, J HISTOCHEM CYTOCHEM, V29, P577; ICHII S, 1993, ONCOGENE, V8, P2399; Iwao K, 1998, CANCER RES, V58, P1021; SATO T, 1990, CANCER RES, V50, P7184; Takayama T, 1998, BRIT J CANCER, V77, P605, DOI 10.1038/bjc.1998.97; Voeller HJ, 1998, CANCER RES, V58, P2520	31	14	14	ELSEVIER SCI IRELAND LTD	CLARE	CUSTOMER RELATIONS MANAGER, BAY 15, SHANNON INDUSTRIAL ESTATE CO, CLARE, IRELAND	0304-3835			CANCER LETT	Cancer Lett.	OCT 16	2000	159	1					73	78		10.1016/S0304-3835(00)00533-4		6	Oncology	Oncology	396XM	WOS:000166663300010		
J	Hirose, K; Henningsen, U; Schliwa, M; Toyoshima, C; Shimizu, T; Alonso, M; Cross, RA; Amos, LA				Hirose, K; Henningsen, U; Schliwa, M; Toyoshima, C; Shimizu, T; Alonso, M; Cross, RA; Amos, LA			Structural comparison of dimeric Eg5, Neurospora kinesin (Nkin) and Ncd head-Nkin neck chimera with conventional kinesin	EMBO JOURNAL			English	Article						cryo-electron microscopy; Eg5; kinesin; microtubules; Ncd	CRYSTAL-STRUCTURE; MICROTUBULE-MOTOR; ELECTRON CRYOMICROSCOPY; MOTILITY; CONFORMATIONS; DOMAINS; PROCESSIVITY; MICROSCOPY; DIRECTION; PROTEIN	Cryo-electron microscopy and 3D image reconstruction of microtubules saturated with kinesin dimers has shown one head bound to tubulin, the other free. The free head of rat kinesin sits on the top right of the bound head (with the microtubule oriented plus-end upwards) in the presence of 5'-adenylylimido-diphosphate (AMPPNP) and on the top left in nucleotide-free solutions. To understand the relevance of this movement, we investigated other dimeric plus-end-directed motors: Neurospora kinesin (Nkin); Eg5, a slow non-processive kinesin; and a chimera of Ncd heads attached to Nkin necks. In the AMPPNP (ATP-like) state, all dimers have the free head to the top right, In the absence of nucleotide, the free head of an Nkin dimer appears to occupy alternative positions to either side of the bound head. Despite having the Nkin neck, the free head of the chimera was only seen to the top right of the bound head. Eg5 also has the free head mostly to the top right. We suggest that processive movement may require kinesins to move their heads in alternative ways.	MRC, Mol Biol Lab, Cambridge CB2 2QH, England; Marie Curie Res Inst, Surrey, England; Univ Munich, Adolf Butenandt Inst Zellbiol, Munich, Germany; Natl Inst Biosci & Human Technol, Tsukuba, Ibaraki 305, Japan; Univ Tokyo, Inst Mol & Cellular Biosci, Tokyo 113, Japan; Natl Inst Adv Interdisciplinary Res, Tsukuba, Ibaraki 3058562, Japan	Amos, LA (reprint author), MRC, Mol Biol Lab, Hills Rd, Cambridge CB2 2QH, England.		Cross, Robert/F-1798-2011; 	Cross, Robert/0000-0002-0004-7832; Amos, Linda/0000-0001-8305-5346			Nogales E, 1999, CELL, V96, P79, DOI 10.1016/S0092-8674(00)80961-7; Hancock WO, 1999, P NATL ACAD SCI USA, V96, P13147, DOI 10.1073/pnas.96.23.13147; Kull FJ, 1996, NATURE, V380, P550; Case RB, 1997, CELL, V90, P959, DOI 10.1016/S0092-8674(00)80360-8; Kozielski F, 1997, CELL, V91, P985, DOI 10.1016/S0092-8674(00)80489-4; Lockhart A, 1996, BIOCHEMISTRY-US, V35, P2365, DOI 10.1021/bi952318n; Rice S, 1999, NATURE, V402, P778, DOI 10.1038/45483; Sablin EP, 1996, NATURE, V380, P555, DOI 10.1038/380555a0; Crevel IMTC, 1997, J MOL BIOL, V273, P160, DOI 10.1006/jmbi.1997.1319; Arnal I, 1998, STRUCTURE, V6, P33, DOI 10.1016/S0969-2126(98)00005-7; Crevel I, 1999, EMBO J, V18, P5863, DOI 10.1093/emboj/18.21.5863; Endow SA, 1999, EUR J BIOCHEM, V262, P12, DOI 10.1046/j.1432-1327.1999.00339.x; Endow SA, 1998, SCIENCE, V281, P1200, DOI 10.1126/science.281.5380.1200; Henningsen U, 1997, NATURE, V389, P93; Hirose K, 1996, P NATL ACAD SCI USA, V93, P9539, DOI 10.1073/pnas.93.18.9539; Hirose K, 1999, MOL BIOL CELL, V10, P2063; Hirose K, 1999, CELL STRUCT FUNCT, V24, P277, DOI 10.1247/csf.24.277; Hirose K, 1998, J MOL BIOL, V278, P389, DOI 10.1006/jmbi.1998.1709; Kikkawa M, 2000, CELL, V100, P241, DOI 10.1016/S0092-8674(00)81562-7; Kozielski F, 1998, CURR BIOL, V8, P191, DOI 10.1016/S0960-9822(98)70083-1; Kozielski F, 1999, STRUCT FOLD DES, V7, P1407, DOI 10.1016/S0969-2126(00)80030-1; Marx A, 1998, EUR BIOPHYS J BIOPHY, V27, P455, DOI 10.1007/s002490050156; RAY S, 1993, J CELL BIOL, V121, P1083, DOI 10.1083/jcb.121.5.1083; Sablin EP, 1998, NATURE, V395, P813; Sack S, 1997, BIOCHEMISTRY-US, V36, P16155, DOI 10.1021/bi9722498; Stone DB, 1999, BIOCHEMISTRY-US, V38, P4938, DOI 10.1021/bi982374z	26	22	22	OXFORD UNIV PRESS	OXFORD	GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND	0261-4189			EMBO J	Embo J.	OCT 16	2000	19	20					5308	5314		10.1093/emboj/19.20.5308		7	Biochemistry & Molecular Biology; Cell Biology	Biochemistry & Molecular Biology; Cell Biology	364YP	WOS:000089921900005		
J	Kanaya, Y; Sadanaga, Y; Matsumoto, J; Sharma, UK; Hirokawa, J; Kajii, Y; Akimoto, H				Kanaya, Y; Sadanaga, Y; Matsumoto, J; Sharma, UK; Hirokawa, J; Kajii, Y; Akimoto, H			Daytime HO2 concentrations at Oki Island, Japan, in summer 1998: Comparison between measurement and theory	JOURNAL OF GEOPHYSICAL RESEARCH-ATMOSPHERES			English	Article							LASER-INDUCED FLUORESCENCE; TROPOSPHERIC OH RADICALS; POPCORN FIELD CAMPAIGN; MARINE BOUNDARY-LAYER; PHOTOCHEMISTRY EXPERIMENT; PEROXY-RADICALS; IDAHO-HILL; ATMOSPHERIC CHEMISTRY; OXIDIZING CAPACITY; CHEMICAL AMPLIFIER	The daytime variation of hydroperoxy (HO2) radical concentration was observed by an instrument based on laser-induced fluorescence with NO addition at Oki Island, Japan, in July/August 1998. Although OH was not detected due to the high detection limit of the instrument, HO2 was determined with the detection limit of 0.8 parts per trillion by volume (pptv) (S/N=2, integration time of 1 min). On average, HO2 showed a maximum concentration of around 9 pptv in the early afternoon hours. During the field campaign, chemical species and meteorological parameters such as O-3, CO, nonmethane hydrocarbons(C-2-C-6), NO/NO2, HCHO/CH3CHO, SO2 HNO3 and J(NO2) were also observed. Unfortunately, the absolute value of J((OD)-D-1) was not measured. Model calculations for radical concentrations were performed and they were compared to the observed hourly HO2 concentrations. On August 9 the calculated HO2 matched the observation very well within the uncertainties of observations (+/-26%, 1 sigma) and the model (+/-24%, 1 sigma). This indicates a good performance of model calculations in estimating HO2 under certain conditions with plenty of isoprene. On other days, however, model usually overestimated HO2 by a factor of 2, especially in the hours around noon. It is deduced that some important HOx loss chemistry is missing in the model, Although the cause of the discrepancy is not fully understood, possible mechanisms to explain the overestimation are studied. A hypothesis with additional loss of HO2 would be more plausible than that with additional OH loss. The additional loss rate for HO2 that can reduce the calculated HO2 to the measured level was computed for each hour. Its variation correlated well with those of H2O and some photochemical products. The possibilities of HO2 loss on aerosol surface, unknown acceleration of HO2 reactions in the presence of high H2O and HO2 reactions with carbonyl species are discussed.	Univ Tokyo, Adv Sci & Technol Res Ctr, Meguro Ku, Tokyo 1538904, Japan	Kanaya, Y (reprint author), Frontier Res Syst Global Change, Atmospher Composit Res Program, Kanazawa Ku, 3173-25 Showa Machi, Yokohama, Kanagawa 2360001, Japan.	yugo@frontier.esto.or.jp	Kanaya, Yugo/C-7446-2012; Hirokawa, Jun/H-8018-2012				Aloisio S, 2000, J PHYS CHEM A, V104, P3211, DOI 10.1021/jp993789c; Pochanart P, 1999, J GEOPHYS RES-ATMOS, V104, P3621, DOI 10.1029/1998JD100071; Allan BJ, 1999, J ATMOS CHEM, V33, P129, DOI 10.1023/A:1005917203307; Jacob DJ, 2000, ATMOS ENVIRON, V34, P2131, DOI 10.1016/S1352-2310(99)00462-8; Stockwell WR, 1997, J GEOPHYS RES-ATMOS, V102, P25847, DOI 10.1029/97JD00849; TANNER DJ, 1995, J GEOPHYS RES-ATMOS, V100, P2883, DOI 10.1029/94JD02609; Jenkin ME, 1997, ATMOS ENVIRON, V31, P81, DOI 10.1016/S1352-2310(96)00105-7; Aloisio S, 1999, J CHEM PHYS, V110, P9017, DOI 10.1063/1.478821; Jaffe DA, 1996, J GEOPHYS RES-ATMOS, V101, P2037, DOI 10.1029/95JD01699; Aloisio S, 1998, J PHYS CHEM A, V102, P1899, DOI 10.1021/jp972173p; CANTRELL CA, 1984, ANAL CHEM, V56, P1496, DOI 10.1021/ac00272a065; VEYRET B, 1989, J PHYS CHEM-US, V93, P2368, DOI 10.1021/j100343a033; ARMERDING W, 1995, J ATMOS SCI, V52, P3381, DOI 10.1175/1520-0469(1995)052<3381:MAALSF>2.0.CO;2; Armerding W, 1997, J GEOPHYS RES-ATMOS, V102, P10603, DOI 10.1029/96JD03714; ASCHMUTAT U, 1993, PHYSICOCHEMICAL BEHA, V2, P811; Atlas EL, 1996, J GEOPHYS RES-ATMOS, V101, P14531, DOI 10.1029/96JD01203; Brandenburger U, 1998, J ATMOS CHEM, V31, P181, DOI 10.1023/A:1005909328924; Brauers T, 1996, GEOPHYS RES LETT, V23, P2545, DOI 10.1029/96GL02204; BRUNE WH, 1995, J ATMOS SCI, V52, P3328, DOI 10.1175/1520-0469(1995)052<3328:MOAHIT>2.0.CO;2; Cantrell CA, 1996, J GEOPHYS RES-ATMOS, V101, P14643, DOI 10.1029/95JD01698; CANTRELL CA, 1992, J GEOPHYS RES-ATMOS, V97, P20671; Cantrell CA, 1997, J GEOPHYS RES-ATMOS, V102, P6369, DOI 10.1029/96JD01703; Cantrell CA, 1997, GEOPHYS RES LETT, V24, P2195, DOI 10.1029/97GL02100; Cantrell CA, 1996, J GEOPHYS RES-ATMOS, V101, P14653, DOI 10.1029/95JD03613; Carslaw N, 1999, J GEOPHYS RES-ATMOS, V104, P30257, DOI 10.1029/1999JD900782; Carslaw N, 1999, J GEOPHYS RES-ATMOS, V104, P30241, DOI 10.1029/1999JD900783; Carslaw N, 1997, J GEOPHYS RES-ATMOS, V102, P18917, DOI 10.1029/97JD00399; CHAN CY, 1990, J GEOPHYS RES-ATMOS, V95, P18569, DOI 10.1029/JD095iD11p18569; Clemitshaw KC, 1997, J GEOPHYS RES-ATMOS, V102, P25405, DOI 10.1029/97JD01902; Comes FJ, 1997, J ATMOS SCI, V54, P1886, DOI 10.1175/1520-0469(1997)054<1886:OFMACI>2.0.CO;2; Crawford MA, 1999, J PHYS CHEM A, V103, P365, DOI 10.1021/jp983150t; Creasey DJ, 1997, J CHEM SOC FARADAY T, V93, P2907, DOI 10.1039/a701469d; CROSLEY DR, 1995, J ATMOS SCI, V52, P3299, DOI 10.1175/1520-0469(1995)052<3299:TMOOAH>2.0.CO;2; DORN HP, 1995, J ATMOS SCI, V52, P3373, DOI 10.1175/1520-0469(1995)052<3373:ANISLL>2.0.CO;2; Dorn HP, 1996, GEOPHYS RES LETT, V23, P2537, DOI 10.1029/96GL02206; Ehhalt DH, 1999, PHYS CHEM CHEM PHYS, V1, P5401, DOI 10.1039/a905097c; Eisele FL, 1996, J GEOPHYS RES-ATMOS, V101, P14665, DOI 10.1029/95JD03654; EISELE FL, 1994, J GEOPHYS RES-ATMOS, V99, P18605, DOI 10.1029/94JD00740; Forberich O, 1999, J ATMOS CHEM, V33, P155, DOI 10.1023/A:1005973130335; Grenfell JL, 1999, J ATMOS CHEM, V33, P183, DOI 10.1023/A:1006009901180; HAMILTON EJ, 1977, INT J CHEM KINET, V9, P875, DOI 10.1002/kin.550090604; HARD TM, 1992, J GEOPHYS RES-ATMOS, V97, P9785; HARD TM, 1984, ENVIRON SCI TECHNOL, V18, P768, DOI 10.1021/es00128a009; HASTIE DR, 1991, ANAL CHEM, V63, P2048, DOI 10.1021/ac00018a029; Hofzumahaus A, 1996, GEOPHYS RES LETT, V23, P2541, DOI 10.1029/96GL02205; HOFZUMAHAUS A, 1992, J ATMOS CHEM, V15, P283, DOI 10.1007/BF00115399; Hofzumahaus A, 1997, GEOPHYS RES LETT, V24, P3039, DOI 10.1029/97GL02947; Hofzumahaus A, 1998, J ATMOS CHEM, V31, P227, DOI 10.1023/A:1006014707617; Holland F, 1998, J ATMOS CHEM, V31, P205, DOI 10.1023/A:1005868520002; Kajii Y, 1997, J GEOPHYS RES-ATMOS, V102, P28637, DOI 10.1029/97JD02013; Kanaya Y, 1999, GEOPHYS RES LETT, V26, P2179, DOI 10.1029/1999GL900475; KANAYA Y, 2000, IN PRESS J ATMOS CHE; KIRCHER CC, 1984, J PHYS CHEM-US, V88, P2082, DOI 10.1021/j150654a029; Komazaki Y, 1999, FRESEN J ANAL CHEM, V363, P686, DOI 10.1007/s002160051272; Lanzendorf EJ, 1997, GEOPHYS RES LETT, V24, P3037, DOI 10.1029/97GL02899; LII RR, 1981, J PHYS CHEM-US, V85, P2833, DOI 10.1021/j150619a027; LOGAN JA, 1981, J GEOPHYS RES-OC ATM, V86, P7210, DOI 10.1029/JC086iC08p07210; Mather JH, 1997, J GEOPHYS RES-ATMOS, V102, P6427, DOI 10.1029/96JD01702; McKeen SA, 1997, J GEOPHYS RES-ATMOS, V102, P6467, DOI 10.1029/96JD03322; MIHELCIC D, 1993, J ATMOS CHEM, V16, P313, DOI 10.1007/BF01032628; Mount GH, 1997, J GEOPHYS RES-ATMOS, V102, P6393, DOI 10.1029/96JD00401; Murphy DM, 1997, J GEOPHYS RES-ATMOS, V102, P6325, DOI 10.1029/96JD02552; NIKI H, 1985, INT J CHEM KINET, V17, P547, DOI 10.1002/kin.550170507; Penkett SA, 1999, J ATMOS CHEM, V33, P111, DOI 10.1023/A:1005969204215; POCHANART P, 1998, THESIS U TOKYO TOKYO; SANDER SP, 1984, J PHYS CHEM-US, V88, P1566, DOI 10.1021/j150652a025; Saylor RD, 1997, ATMOS ENVIRON, V31, P3653, DOI 10.1016/S1352-2310(97)00143-X; STEVENS JR, 1979, TRENDS NEUROSCI, V2, P102, DOI 10.1016/0166-2236(79)90041-9; STEVENS PS, 1994, J GEOPHYS RES-ATMOS, V99, P3543, DOI 10.1029/93JD03342; Tanner DJ, 1997, J GEOPHYS RES-ATMOS, V102, P6415, DOI 10.1029/96JD03919; Whitby K. T., 1980, ADV ENV SCI TECHNOL, V8, P477; Williams EJ, 1997, J GEOPHYS RES-ATMOS, V102, P6297, DOI 10.1029/96JD03252; Zenker T, 1998, J GEOPHYS RES-ATMOS, V103, P13615, DOI 10.1029/97JD03739	73	49	49	AMER GEOPHYSICAL UNION	WASHINGTON	2000 FLORIDA AVE NW, WASHINGTON, DC 20009 USA	2169-897X			J GEOPHYS RES-ATMOS	J. Geophys. Res.-Atmos.	OCT 16	2000	105	D19					24205	24222		10.1029/2000JD900308		18	Meteorology & Atmospheric Sciences	Meteorology & Atmospheric Sciences	366WM	WOS:000090029300003		
J	Hanamura, E; Dan, NT; Tanabe, Y				Hanamura, E; Dan, NT; Tanabe, Y			Optical excitations with even symmetry in insulating cuprates	JOURNAL OF PHYSICS-CONDENSED MATTER			English	Article							2-MAGNON RAMAN-SCATTERING; HIGH-TC SUPERCONDUCTORS; MOTT-HUBBARD SYSTEMS; ELECTRONIC-STRUCTURE; SPIN FLUCTUATIONS; CUO2 LAYER; LA2CUO4; DEPENDENCE; DYNAMICS; HOLE	An excitonic cluster model, which can take into account both the strong correlation effect of 3d electrons and the itinerant nature of electronic excitations, and consequently both the bound and unbound states of electrons and holes on the same footing, is applied to describe optical excitations with even symmetry in insulating cuprates, i.e. parent crystals of high-temperature superconductors. These states are observable in large-shift Raman scattering and two-photon absorption spectra.	Chitose Inst Sci & Technol, Chitose, Hokkaido 0668655, Japan; Univ Arizona, Ctr Opt Sci, Tucson, AZ 85721 USA; Univ Tokyo, Dept Appl Phys, Bunkyo Ku, Tokyo 113, Japan	Hanamura, E (reprint author), Chitose Inst Sci & Technol, 785-65 Bibi, Chitose, Hokkaido 0668655, Japan.						SUGAI S, 1989, PHYS REV B, V39, P4306, DOI 10.1103/PhysRevB.39.4306; KEIMER B, 1992, PHYS REV B, V46, P14034, DOI 10.1103/PhysRevB.46.14034; FALCK JP, 1992, PHYS REV LETT, V69, P1109, DOI 10.1103/PhysRevLett.69.1109; Blumberg G, 1996, PHYS REV B, V53, P11930; SHASTRY BS, 1990, PHYS REV LETT, V65, P1068, DOI 10.1103/PhysRevLett.65.1068; COOPER SL, 1990, PHYS REV B, V42, P10785, DOI 10.1103/PhysRevB.42.10785; ESKES H, 1990, PHYS REV B, V41, P288, DOI 10.1103/PhysRevB.41.288; TOKURA Y, 1990, PHYS REV B, V41, P11657, DOI 10.1103/PhysRevB.41.11657; ROMBERG H, 1990, Z PHYS B CON MAT, V78, P367, DOI 10.1007/BF01313317; Imada M, 1998, REV MOD PHYS, V70, P1039, DOI 10.1103/RevModPhys.70.1039; WELLS BO, 1995, PHYS REV LETT, V74, P964, DOI 10.1103/PhysRevLett.74.964; ARIMA T, 1991, PHYS REV B, V44, P917, DOI 10.1103/PhysRevB.44.917; BADER TR, 1968, PHYS REV, V171, P997, DOI 10.1103/PhysRev.171.997; BIRSS RR, 1964, SELECTED TOPICS SOLI, V3; COOPER SL, 1993, PHYS REV B, V47, P8233, DOI 10.1103/PhysRevB.47.8233; DIMMOCK JO, 1962, PHYS REV, V127, P391, DOI 10.1103/PhysRev.127.391; FUKUYAMA H, 1989, J PHYS SOC JPN, V58, P364, DOI 10.1143/JPSJ.58.364; HANAMURA E, 2000, PHYS REV B, V62, P7003; Hanamura E, 2000, J PHYS-CONDENS MAT, V12, pL345, DOI 10.1088/0953-8984/12/22/103; HERMAN F, 1987, PHYS REV B, V36, P6904, DOI 10.1103/PhysRevB.36.6904; HEYEN ET, 1992, PHYS REV B, V45, P3037, DOI 10.1103/PhysRevB.45.3037; INOUE M, 1965, J PHYS SOC JPN, V20, P363, DOI 10.1143/JPSJ.20.363; Inui T., 1990, SPRINGER SERIES SOLI, V78; Knoll P, 1996, J LOW TEMP PHYS, V105, P383, DOI 10.1007/BF00768416; LIU R, 1993, J PHYS CHEM SOLIDS, V54, P1347, DOI 10.1016/0022-3697(93)90192-T; LIU R, 1993, PHYS REV LETT, V71, P3709, DOI 10.1103/PhysRevLett.71.3709; LYONS KB, 1988, PHYS REV B, V37, P2353, DOI 10.1103/PhysRevB.37.2353; LYONS KB, 1989, PHYS REV B, V39, P9693, DOI 10.1103/PhysRevB.39.9693; LYONS KB, 1988, PHYS REV LETT, V60, P732, DOI 10.1103/PhysRevLett.60.732; MATSUKAWA H, 1989, J PHYS SOC JPN, V58, P2845, DOI 10.1143/JPSJ.58.2845; MATSUKAWA H, 1989, J PHYS SOC JPN, V58, P3687, DOI 10.1143/JPSJ.58.3687; MATSUKAWA H, 1990, J PHYS SOC JPN, V59, P1723, DOI 10.1143/JPSJ.59.1723; MATTHEISS LF, 1989, PHYS REV B, V40, P2217, DOI 10.1103/PhysRevB.40.2217; MCMAHAN AK, 1988, PHYS REV B, V38, P6650, DOI 10.1103/PhysRevB.38.6650; Mizuno Y, 1998, PHYS REV B, V58, P14713; Pothuizen JJM, 1997, PHYS REV LETT, V78, P717, DOI 10.1103/PhysRevLett.78.717; SALAMON D, 1995, PHYS REV B, V51, P6617, DOI 10.1103/PhysRevB.51.6617; SHASTRY BS, 1991, INT J MOD PHYS B, V5, P365, DOI 10.1142/S0217979291000237; SUGAI S, 1988, PHYS REV B, V38, P6436, DOI 10.1103/PhysRevB.38.6436; TIO T, 1990, PHYS REV B, V42, P10800; Tokura Y., 2000, COLOSSAL MAGNETORESI; Wang YY, 1996, PHYS REV LETT, V77, P1809, DOI 10.1103/PhysRevLett.77.1809; YOSHIDA M, 1992, PHYS REV B, V46, P6505, DOI 10.1103/PhysRevB.46.6505	43	5	5	IOP PUBLISHING LTD	BRISTOL	DIRAC HOUSE, TEMPLE BACK, BRISTOL BS1 6BE, ENGLAND	0953-8984			J PHYS-CONDENS MAT	J. Phys.-Condes. Matter	OCT 16	2000	12	41					8847	8862		10.1088/0953-8984/12/41/311		16	Physics, Condensed Matter	Physics	367YW	WOS:000090091100012		
J	Eguchi, T; Kanno, H				Eguchi, T; Kanno, H			Five-dimensional gauge theories and local mirror symmetry	NUCLEAR PHYSICS B			English	Article						mirror symmetry; Seiberg-Wittien theory; instanton expansion; supersymmetric gauge theory	FIELD-THEORIES; F-THEORY; TRANSITIONS; DUALITY	We study the dynamics of 5-dimensional gauge theory on M-4 x S-1 by compactifying type II/M theory on degenerate Calabi-Yau manifolds. We use the local mirror symmetry and shall show that the prepotential of the 5-dimensional SU(2) gauge theory without matter is given exactly by that of the type II string theory compactified on the local F-2, i.e., Hirzebruch surface F-2 lying inside a noncompact Calabi-Yau manifold. It is shown that our result reproduces the Seiberg-Witten theory at the 4-dimensional limit R --> 0 (R denotes the radius of S-1) and also the result of the uncompactified 5-dimensional theory at R --> infinity. We also discuss SU(2) gauge theory with 1 less than or equal to N-f less than or equal to 4 matter in vector representations and show that they are described by the geometry of the local F-2 blown up at N-f points. (C) 2000 Elsevier Science B,V. All rights reserved.	Hiroshima Univ, Grad Sch Sci, Dept Math, Higashihiroshima 739, Japan; Univ Tokyo, Fac Sci, Dept Phys, Tokyo 113, Japan	Kanno, H (reprint author), Hiroshima Univ, Grad Sch Sci, Dept Math, Higashihiroshima 739, Japan.						Katz S, 1997, NUCL PHYS B, V497, P146, DOI 10.1016/S0550-3213(97)00280-0; Katz S, 1997, NUCL PHYS B, V497, P173, DOI 10.1016/S0550-3213(97)00282-4; CADAVID AC, 1995, PHYS LETT B, V357, P76, DOI 10.1016/0370-2693(95)00891-N; Seiberg N, 1996, PHYS LETT B, V388, P753, DOI 10.1016/S0370-2693(96)01215-4; Morrison DR, 1997, NUCL PHYS B, V483, P229, DOI 10.1016/S0550-3213(96)00592-5; Lawrence A, 1998, NUCL PHYS B, V513, P239, DOI 10.1016/S0550-3213(97)00694-9; Witten E, 1996, NUCL PHYS B, V471, P195, DOI 10.1016/0550-3213(96)00212-X; Brandhuber A, 1997, PHYS LETT B, V415, P127, DOI 10.1016/S0370-2693(97)01249-5; Intriligator K, 1997, NUCL PHYS B, V497, P56, DOI 10.1016/S0550-3213(97)00279-4; Douglas MR, 1997, NUCL PHYS B, V497, P155, DOI 10.1016/S0550-3213(97)00281-2; Banks T, 1996, PHYS LETT B, V387, P278, DOI 10.1016/0370-2693(96)00808-8; Chiang T.-T., HEPTH9903053; Kanno H, 1998, NUCL PHYS B, V530, P73, DOI 10.1016/S0550-3213(98)00407-6; Katz S., 1998, ADV THEOR MATH PHYS, V1, P53; KLEMM A, 1992, INT J MOD PHYS A, V7, P6215, DOI 10.1142/S0217751X92002817; KLEMM A, HEPTH9407192; Klemm A., HEPTH9705131; Nekrasov N, 1998, NUCL PHYS B, V531, P323, DOI 10.1016/S0550-3213(98)00436-2; SEIBERG N, 1994, NUCL PHYS B, V426, P19, DOI 10.1016/0550-3213(94)90124-4; SEIBERG N, 1994, NUCL PHYS B, V431, P484, DOI 10.1016/0550-3213(94)90214-3; SEN A, 1996, NUCL PHYS B, V475, P526	21	12	12	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	0550-3213			NUCL PHYS B	Nucl. Phys. B	OCT 16	2000	586	1-2					331	345		10.1016/S0550-3213(00)00375-8		15	Physics, Particles & Fields	Physics	361UE	WOS:000089741900016		
J	Kirihara, K; Nakata, T; Takata, M; Kubota, Y; Nishibori, E; Kimura, K; Sakata, M				Kirihara, K; Nakata, T; Takata, M; Kubota, Y; Nishibori, E; Kimura, K; Sakata, M			Covalent bonds in AlMnSi icosahedral quasicrystalline approximant	PHYSICAL REVIEW LETTERS			English	Article							MN-SI ALLOYS; AL-MN; CRYSTAL; SYSTEM; PHASE; CU	Electron density distributions were obtained using the maximum entropy method with synchrotron radiation powder data. In the metallic Al12Re, metallic bonding was observed for the icosahedral Al-12 cluster with central Re atom. In the nonmetallic alpha-AlMnSi 1/1 approximant, covalent bonds were found in the electron density distribution of the Mackay icosahedral cluster without central atom. Rather than the Hume-Rothery mechanism, the covalency of Al (Si) icosahedron and that between Al (Si) and Mn atoms is considered to be the origin of the pseudogap and nonmetallic behavior of alpha-AlMnSi.	Univ Tokyo, Dept Mat Sci, Tokyo 1138656, Japan; Shimane Univ, Dept Mat Sci, Matsue, Shimane 6908504, Japan; Osaka Womens Univ, Dept Nat Sci, Sakai, Osaka 5900035, Japan; Nagoya Univ, Dept Appl Phys, Nagoya, Aichi 4648603, Japan; Univ Tokyo, Dept Adv Mat Sci, Tokyo 1130033, Japan	Kirihara, K (reprint author), Univ Tokyo, Dept Mat Sci, Tokyo 1138656, Japan.		Takata, Masaki/M-1525-2014				Takata M, 1997, PHYS REV LETT, V78, P3330, DOI 10.1103/PhysRevLett.78.3330; FUJIWARA T, 1989, PHYS REV B, V40, P942, DOI 10.1103/PhysRevB.40.942; HENLEY CL, 1986, PHILOS MAG B, V53, pL59; Weinert M, 1998, PHYS REV B, V58, P9732, DOI 10.1103/PhysRevB.58.9732; GONG XG, 1991, PHYS REV B, V43, P14277, DOI 10.1103/PhysRevB.43.14277; ELSER V, 1985, PHYS REV LETT, V55, P2883, DOI 10.1103/PhysRevLett.55.2883; KIMURA K, 1989, J PHYS SOC JPN, V58, P2472, DOI 10.1143/JPSJ.58.2472; Fujimori M, 1999, PHYS REV LETT, V82, P4452, DOI 10.1103/PhysRevLett.82.4452; BIGGS BD, 1990, PHYS REV LETT, V65, P2700, DOI 10.1103/PhysRevLett.65.2700; BELIN E, 1992, J PHYS-CONDENS MAT, V4, P1057, DOI 10.1088/0953-8984/4/4/016; BIGGS BD, 1992, EUROPHYS LETT, V19, P415, DOI 10.1209/0295-5075/19/5/012; Fujimori M, 1997, J SOLID STATE CHEM, V133, P310, DOI 10.1006/jssc.1997.7492; KIMURA K, 1998, P 6 INT C QUAS, P595; Kimura K, 1995, PROCEEDINGS OF THE 5TH INTERNATIONAL CONFERENCE ON QUASICRYSTALS, P730; Kimura K, 1999, QUASICRYSTALS STATE, P325; KIRIHARA K, IN PRESS MAT SCI E A; KLEIN T, 1990, EUROPHYS LETT, V13, P129, DOI 10.1209/0295-5075/13/2/006; KUMAZAWA S, 1993, J APPL CRYSTALLOGR, V26, P453, DOI 10.1107/S0021889892012883; Quivy A, 1996, J PHYS-CONDENS MAT, V8, P4223, DOI 10.1088/0953-8984/8/23/014; Sawada H., 1998, P 6 INT C QUAS, P329; SHIBUYA T, 1998, P 6 INT C QUAS, P700; Sugiyama K, 1998, ACTA CRYSTALLOGR C, V54, P445, DOI 10.1107/S0108270197015989; TAKATA M, 1995, NATURE, V377, P46, DOI 10.1038/377046a0; Takeuchi T, 1995, PROCEEDINGS OF THE 5TH INTERNATIONAL CONFERENCE ON QUASICRYSTALS, P534; Tamura R, 1995, PROCEEDINGS OF THE 5TH INTERNATIONAL CONFERENCE ON QUASICRYSTALS, P539; Toraya H, 1996, J SYNCHROTRON RADIAT, V3, P75, DOI 10.1107/S0909049595015500	26	53	54	AMERICAN PHYSICAL SOC	COLLEGE PK	ONE PHYSICS ELLIPSE, COLLEGE PK, MD 20740-3844 USA	0031-9007			PHYS REV LETT	Phys. Rev. Lett.	OCT 16	2000	85	16					3468	3471		10.1103/PhysRevLett.85.3468		4	Physics, Multidisciplinary	Physics	363YU	WOS:000089865900034		
J	Yui, H; Sawada, T				Yui, H; Sawada, T			Interaction of excess electrons with water molecules at the early stage of laser-induced plasma generation in water	PHYSICAL REVIEW LETTERS			English	Article							AB-INITIO; SPECTROSCOPY; CLUSTERS; PULSES; FEMTOSECOND; SOLVATION; ANIONS	Forward and backward stimulated Raman scattering (SRS) of OH stretching vibrations are measured when an intense 40 ps pulsed beam is focused into water. Characteristic features related to the interaction of OH groups with excess electrons generated by the strong laser irradiation are observed. The SRS spectra are indicative of the important role which excess electrons play in transient enhancement of the SRS at the initial stage of laser-induced plasma generation in water. The: hydration structures around the excess electrons in water are also discussed.	Univ Tokyo, Grad Sch Frontier Sci, Dept Adv Mat Sci, Bunkyo Ku, Tokyo 1130033, Japan	Sawada, T (reprint author), Univ Tokyo, Grad Sch Frontier Sci, Dept Adv Mat Sci, Bunkyo Ku, 7-3-1 Hongo, Tokyo 1130033, Japan.						TELLE HR, 1980, OPT COMMUN, V34, P287, DOI 10.1016/0030-4018(80)90035-8; Xantheas SS, 1996, J PHYS CHEM-US, V100, P9703, DOI 10.1021/jp960779s; COE JV, 1990, J CHEM PHYS, V92, P3980, DOI 10.1063/1.457805; MURNANE MM, 1991, SCIENCE, V251, P531, DOI 10.1126/science.251.4993.531; WALRAFEN GE, 1967, J CHEM PHYS, V47, P114, DOI 10.1063/1.1711834; GRAENER H, 1991, PHYS REV LETT, V66, P2092, DOI 10.1103/PhysRevLett.66.2092; CRAWFORD B, 1952, J CHEM PHYS, V20, P977, DOI 10.1063/1.1700660; Yui H, 1999, PHYS REV LETT, V82, P4110, DOI 10.1103/PhysRevLett.82.4110; Assel M, 2000, CHEM PHYS LETT, V317, P13, DOI 10.1016/S0009-2614(99)01369-X; Bailey CG, 1996, J PHYS CHEM-US, V100, P16782, DOI 10.1021/jp962268b; BARNETT RN, 1989, PHYS REV LETT, V62, P106, DOI 10.1103/PhysRevLett.62.106; BOWEN KH, 1987, STRUCTURE SMALL MOL; GRAENER H, 1993, J CHEM PHYS, V98, P36, DOI 10.1063/1.464629; KEVAN L, 1981, ACCOUNTS CHEM RES, V14, P138, DOI 10.1021/ar00065a002; Kim KS, 1996, PHYS REV LETT, V76, P956, DOI 10.1103/PhysRevLett.76.956; Lee S, 1996, CHEM PHYS LETT, V254, P128, DOI 10.1016/0009-2614(96)00300-4; LONG FH, 1990, PHYS REV LETT, V64, P1469, DOI 10.1103/PhysRevLett.64.1469; OJAMAE L, 1994, J PHYS CHEM-US, V98, P4271, DOI 10.1021/j100067a011; Radziemski L. J., 1989, LASER INDUCED PLASMA; Shi XL, 1996, J PHYS CHEM-US, V100, P11903, DOI 10.1021/jp961261r; STUART BC, 1996, PHYS REV B, V53, P53; STUART BC, 1995, PHYS REV LETT, V74, P2248, DOI 10.1103/PhysRevLett.74.2248; YUI H, IN PRESS	23	30	30	AMER PHYSICAL SOC	COLLEGE PK	ONE PHYSICS ELLIPSE, COLLEGE PK, MD 20740-3844 USA	0031-9007	1079-7114		PHYS REV LETT	Phys. Rev. Lett.	OCT 16	2000	85	16					3512	3515		10.1103/PhysRevLett.85.3512		4	Physics, Multidisciplinary	Physics	363YU	WOS:000089865900045		
J	Nishio, Y; Nagata, S; Umeda, M; Shirai, R; Yokogawa, T; Ihara, S; Fukui, Y				Nishio, Y; Nagata, S; Umeda, M; Shirai, R; Yokogawa, T; Ihara, S; Fukui, Y			Quantification of phosphatidylinositol 3,4,5-trisphosphate by liposome lysis assay with specific monoclonal antibodies	ANALYTICAL BIOCHEMISTRY			English	Article							KINASE; 3-KINASE		Univ Tokyo, Grad Sch Agr & Life Sci, Dept Appl Biol Chem, Bunkyo Ku, Tokyo 1138657, Japan; Tokyo Metropolitan Inst Med Sci, Dept Mol Biodynam, Bunkyo Ku, Tokyo 1138613, Japan; Nara Inst Sci & Technol, Res & Educ Ctr Mat Sci, Ikoma 6300101, Japan	Fukui, Y (reprint author), Univ Tokyo, Grad Sch Agr & Life Sci, Dept Appl Biol Chem, Bunkyo Ku, 1-1-1 Yayoi, Tokyo 1138657, Japan.		Fukui, Yasuhisa/E-8806-2010				Leevers SJ, 1999, CURR OPIN CELL BIOL, V11, P219, DOI 10.1016/S0955-0674(99)80029-5; Inukai K, 2000, BIOCHEM J, V346, P483, DOI 10.1042/0264-6021:3460483; Coffer PJ, 1998, BIOCHEM J, V335, P1; FUKUI Y, 1991, ONCOGENE, V6, P407; Fukui Y, 1998, J BIOCHEM-TOKYO, V124, P1; KIMURA K, 1994, J BIOL CHEM, V269, P18961; MIYAZAWA A, 1988, MOL IMMUNOL, V25, P1025; Shirai R, 1998, TETRAHEDRON LETT, V39, P9485, DOI 10.1016/S0040-4039(98)02151-0	8	4	4	ACADEMIC PRESS INC	SAN DIEGO	525 B ST, STE 1900, SAN DIEGO, CA 92101-4495 USA	0003-2697			ANAL BIOCHEM	Anal. Biochem.	OCT 15	2000	285	2					270	273		10.1006/abio.2000.4777		4	Biochemical Research Methods; Biochemistry & Molecular Biology; Chemistry, Analytical	Biochemistry & Molecular Biology; Chemistry	367NW	WOS:000090069200014		
J	Koresawa, M; Kikuchi, K; Mizukami, S; Kojima, H; Urano, Y; Higuchi, T; Nagano, T				Koresawa, M; Kikuchi, K; Mizukami, S; Kojima, H; Urano, Y; Higuchi, T; Nagano, T			Development of a time-resolved fluorometric detection system using diffusion-enhanced energy transfer	ANALYTICAL CHEMISTRY			English	Article							FLUORESCENCE; EUROPIUM; TERBIUM; DNA	A novel detection system using both emission energy transfer and time-resolved fluorometry (TRF) was developed, with a europium chelate as the energy donor and a novel fluorophore SNR1, excitable with long-wavelength light corresponding to europium emission, as the energy acceptor. When the donor and acceptor molecules were mixed in solution, energy transfer was observed without direct attachment of the donor and the acceptor, via a diffusion-enhanced energy-transfer mechanism. Thus, the acceptor emission can be detected as a long-lifetime fluorescence in TRF. When the fluorescence properties of the acceptor molecule are changed by interaction with an enzyme or other bioactive molecule, the change can be detected as a long-lived sensitized emission. If we develop or select suitable acceptor molecules, this simple and convenient system should be applicable to a nide variety of bioactive molecules. Since it is based on TRF, it can be used for high-resolution assay.	Univ Tokyo, Grad Sch Pharmaceut Sci, Bunkyo Ku, Tokyo 1130033, Japan	Nagano, T (reprint author), Univ Tokyo, Grad Sch Pharmaceut Sci, Bunkyo Ku, 7-3-1 Hongo, Tokyo 1130033, Japan.		Kikuchi, Kazuya/D-2370-2009; Urano, Yasuteru/H-1380-2012				ALFRED JK, 1998, DRUG DISCOV TODAY, V3, P333; SELVIN PR, 1994, J AM CHEM SOC, V116, P6029, DOI 10.1021/ja00092a088; BREJC K, 1995, J MOL BIOL, V249, P424, DOI 10.1006/jmbi.1995.0307; Farrar SJ, 1999, J BIOL CHEM, V274, P10100, DOI 10.1074/jbc.274.15.10100; Miyawaki A, 1997, NATURE, V388, P882; STRYER L, 1982, ANNU REV BIOPHYS BIO, V11, P203, DOI 10.1146/annurev.bb.11.060182.001223; MATHIS G, 1993, CLIN CHEM, V39, P1953; THOMAS DD, 1978, P NATL ACAD SCI USA, V75, P5746, DOI 10.1073/pnas.75.12.5746; Gordon GW, 1998, BIOPHYS J, V74, P2702; Zlokarnik G, 1998, SCIENCE, V279, P84, DOI 10.1126/science.279.5347.84; MUNKHOLM C, 1990, J AM CHEM SOC, V112, P2608, DOI 10.1021/ja00163a021; Chen JY, 1999, BIOCONJUGATE CHEM, V10, P311, DOI 10.1021/bc980113w; Cummings RT, 1999, ANAL BIOCHEM, V269, P79, DOI 10.1006/abio.1999.4021; EIS PS, 1993, BIOCHEMISTRY-US, V32, P13852, DOI 10.1021/bi00213a014; FORESTER T, 1948, ANN PHYS, V2, P55; Heyduk E, 1999, J BIOL CHEM, V274, P3315, DOI 10.1074/jbc.274.6.3315; Heyduk E, 1997, J BIOL CHEM, V272, P19763, DOI 10.1074/jbc.272.32.19763; Heyduk E, 1997, ANAL BIOCHEM, V248, P216, DOI 10.1006/abio.1997.2148; LI M, 1995, J AM CHEM SOC, V117, P8132, DOI 10.1021/ja00136a010; Meer B.V., 1994, RESONANCE ENERGY TRA; MUJUMDAR RB, 1993, BIOCONJUGATE CHEM, V4, P105, DOI 10.1021/bc00020a001; Stenroos K, 1998, CYTOKINE, V10, P495, DOI 10.1006/cyto.1997.0321; Uchiyama H, 1996, J BIOL CHEM, V271, P380	23	8	8	AMER CHEMICAL SOC	WASHINGTON	1155 16TH ST, NW, WASHINGTON, DC 20036 USA	0003-2700			ANAL CHEM	Anal. Chem.	OCT 15	2000	72	20					4904	4907		10.1021/ac000356t		4	Chemistry, Analytical	Chemistry	364ZW	WOS:000089924800019		
J	Lee, SH; Kajii, Y; Akimoto, H				Lee, SH; Kajii, Y; Akimoto, H			Improvement of the new NO detection method using laser-induced two-photon ionization with a TOF mass spectrometer	ENVIRONMENTAL SCIENCE & TECHNOLOGY			English	Article							OZONE PRODUCTION; DISTRIBUTIONS; TROPOSPHERE; INSTRUMENT; JAPAN	We have developed a new method to detect low concentrations of tropospheric NO, using laser induced two-photon ionization (Lee, S.-H.; Hirokawa, J.; Yoshizumi, Y.; Akimoto, H. Rev. Sci. Instrum. 1997, 68,2891). This method uses a frequency-doubled pulsed-dye laser operating near 226 nm to photoionize MO by resonance enhanced two-photon ionization via its A(2)X(2) (0,0) band. This work reports our recent results regarding the improvement of the overall instrumental performance obtained by applying a time-of-flight (TOF) mass spectrometer and further discusses the water vapor influence in this method. NO ion signals were discriminated efficiently from the other ions generated by impurities in the ionization cell by using a TOF mass spectrometer. The obtained sensitivity of this method was 10 pptv (S/N = 2), at a laser power of 44 muJ and an integration time of 1 min. Also, the background signal was decreased from 5 to 0.25 Hz as compared to the previous study, indicating that a nearly signal-limited condition was obtained, which enables NO detection free from background noise. In our laser ionization instrument, the uncertainty in NO ion intensity caused by the fluctuation of laser power was deviated less than 3% from a long-term average. Moreover, by comparison with the ozone-chemiluminescence method, water vapor influence has been investigated by introducing humid sampling gases into the molecular beam. As the relative humidity in the sampling gases varied from 0 to 85% at room temperature, no significant change in the NO detection efficiency was observed. This demonstrates an important advantage over the ozone-chemiluminescence method, although further field intercomparisons are required to certify the applicability of this new NO ionization method into the atmospheric study.	Univ Tokyo, Adv Sci & Technol Res Ctr, Tokyo 153, Japan	Lee, SH (reprint author), NOAA, Aeron Lab, R AL7, Boulder, CO 80303 USA.		Lee, Shan-Hu/F-9913-2014				ADAMS A, 1972, J PHYS E SCI INSTRUM, V5, P156, DOI 10.1088/0022-3735/5/2/020; ADAMS A, 1972, J PHYS E SCI INSTRUM, V5, P150, DOI 10.1088/0022-3735/5/2/019; Akimoto H., 1994, CHEM ATMOSPHERE ITS, P261; CRUTZEN PJ, 1991, TELLUS A, V43, P136, DOI 10.1034/j.1600-0870.1991.00012.x; LIU SC, 1987, J GEOPHYS RES-ATMOS, V92, P4191, DOI 10.1029/JD092iD04p04191; Lee S, 1998, GEOPHYS RES LETT, V25, P1637, DOI 10.1029/98GL01224; Jaffe DA, 1996, J GEOPHYS RES-ATMOS, V101, P2037, DOI 10.1029/95JD01699; BRADSHAW JD, 1985, J GEOPHYS RES-ATMOS, V90, P2861, DOI 10.1029/JD090iD07p12861; Davis DD, 1996, J GEOPHYS RES-ATMOS, V101, P2111, DOI 10.1029/95JD02755; DICKERSON RR, 1984, REV SCI INSTRUM, V55, P1995, DOI 10.1063/1.1137694; HOELL JM, 1994, REV SCI INSTRUM, V65, P1858; KING DS, 1985, J CHEM PHYS, V82, P3629, DOI 10.1063/1.448896; Lee SH, 1997, REV SCI INSTRUM, V68, P2891, DOI 10.1063/1.1148213; LEVY DH, 1977, CHEM BIOCH APPL LASE, V2, pCH1; Logan J A, 1985, J GEOPHYS RES, V90, P10; MCNEAL RJ, 1983, EOS T AGU, V64, P561; MILLER JC, 1987, J CHEM PHYS, V86, P3166, DOI 10.1063/1.452027; PARKER DH, 1983, ULTRASENSITIVE LASER; RIDLEY BA, 1985, J GEOPHYS RES, V90, P843; SANDHOLM ST, 1990, J GEOPHYS RES-ATMOS, V95, P10155, DOI 10.1029/JD095iD07p10155; SIMEONSSON JB, 1994, ANAL CHEM, V66, P2272, DOI 10.1021/ac00086a012; TANNER RL, 1983, INT J ENVIRON AN CH, V13, P323, DOI 10.1080/03067318308071602; TSUJI K, 1995, LASER CHEM, V15, P157, DOI 10.1155/1995/17083; WENNBERG PO, 1994, REV SCI INSTRUM, V65, P1858, DOI 10.1063/1.1144835; Willey W. E., 1955, REV SCI INSTRUM, V26, P1150	25	6	6	AMER CHEMICAL SOC	WASHINGTON	1155 16TH ST, NW, WASHINGTON, DC 20036 USA	0013-936X			ENVIRON SCI TECHNOL	Environ. Sci. Technol.	OCT 15	2000	34	20					4434	4438		10.1021/es990879m		5	Engineering, Environmental; Environmental Sciences	Engineering; Environmental Sciences & Ecology	365UZ	WOS:000089970000028		
J	Kasaba, Y; Terasawa, T; Tsubouchi, K; Mukai, T; Saito, Y; Matsumoto, H; Kojima, H; Steinberg, J; McComas, D; Skoug, R; Matsui, H; Hoshino, M				Kasaba, Y; Terasawa, T; Tsubouchi, K; Mukai, T; Saito, Y; Matsumoto, H; Kojima, H; Steinberg, J; McComas, D; Skoug, R; Matsui, H; Hoshino, M			Magnetosheath electrons in anomalously low density solar wind observed by Geotail	GEOPHYSICAL RESEARCH LETTERS			English	Article								We present an overview of the magnetosheath electron observations above 60 eV in the anomalously low density solar wind on 11 May 1999 observed by Geotail. We observed anisotropic 'strahl' component not only in the solar wind but also in the magnetosheath. Strahl, is observed during the interval of 6-21h UT and most enhanced in the interval surrounding the solar wind density minimum in 18-19h UT. Its temperature seems positively correlated to its flux. We also evaluate the density and temperature of low energy isotropic component. The variation of density is associated with proton density. Its temperature is continuous, and suddenly decreased after the density minimum in similar to 18-19h UT. We also compared our downstream data with upstream one observed by the ACE spacecraft. We conclude that the electron acceleration and heating at the bow shock is executed in the ordinal mechanisms even in the low density solar wind.	Inst Space & Astronaut Sci, Sagamihara, Kanagawa 2298510, Japan; Univ Tokyo, Dept Earth & Planetary Sci, Tokyo 1130033, Japan; Kyoto Univ, Radio Sci Ctr Space & Atmosphere, Uji, Kyoto 6110011, Japan; Univ Calif Los Alamos Natl Lab, Los Alamos, NM 87545 USA; Tokyo Inst Technol, Tokyo 1528511, Japan	Kasaba, Y (reprint author), Inst Space & Astronaut Sci, Sagamihara, Kanagawa 2298510, Japan.		Tsubouchi, Ken/B-9343-2015	Tsubouchi, Ken/0000-0003-1963-1112			FELDMAN WC, 1975, J GEOPHYS RES-SPACE, V80, P4181, DOI 10.1029/JA080i031p04181; McComas DJ, 1998, SPACE SCI REV, V86, P563, DOI 10.1023/A:1005040232597; MUKAI T, 1994, J GEOMAGN GEOELECTR, V46, P669; PHILLIPS JL, 1989, J GEOPHYS RES, V94, P6563, DOI 10.1029/JA094iA06p06563; ROSENBAUER H, 1977, J GEOPHYS-Z GEOPHYS, V42, P561; SCHWARTZ SJ, 1988, J GEOPHYS RES, V93, P12923, DOI 10.1029/JA093iA11p12923; TERASAWA T, 2000, IN PRESS GEOPHYS RES; THOMSEN MF, 1987, J GEOPHYS RES, V92, P10119, DOI 10.1029/JA092iA09p10119	8	5	6	AMER GEOPHYSICAL UNION	WASHINGTON	2000 FLORIDA AVE NW, WASHINGTON, DC 20009 USA	0094-8276			GEOPHYS RES LETT	Geophys. Res. Lett.	OCT 15	2000	27	20					3253	3256		10.1029/2000GL000086		4	Geosciences, Multidisciplinary	Geology	365RR	WOS:000089964700006		
J	Iizuka, S; Matsuura, T; Yamagata, T				Iizuka, S; Matsuura, T; Yamagata, T			The Indian Ocean SST dipole simulated in a coupled general circulation model	GEOPHYSICAL RESEARCH LETTERS			English	Article							DYNAMICS	We are successful in simulating the recently discovered ocean-atmosphere coupled phenomenon called the Indian Ocean Dipole for the first time, using a coupled general circulation model without flux correction. During the analyzed 50 years of model integration, the anomalous climate events have appeared 8 times over the Indian Ocean (IO). They are characterized by the cooling of the sea surface temperature (SST) in the southeastern tropical IO and the warming of the SST in the western tropical IO, associated with the anomalous easterly winds along the equator. The spatial pattern of the anomalous SST shows an east-west dipole mode (DM) structure that is similar to the recent reports. The simulated DM events are independent of the El Nino simulated in the same model. The heat budget analysis shows that the tropical air-sea interaction, which is strongly influenced by ocean dynamics, is crucial in generating the model DM events.	Natl Res Inst Earth Sci & Disaster Prevent, Tsukuba, Ibaraki 305, Japan; Frontier Res Syst Global Change, Inst Global Change Res, Tokyo, Japan; Univ Tokyo, Grad Sch Sci, Dept Earth & Planetary Sci, Tokyo, Japan	Iizuka, S (reprint author), Natl Res Inst Earth Sci & Disaster Prevent, Tsukuba, Ibaraki 305, Japan.	iizuka@ess.bosai.go.jp; matsuura@ess.bosai.go.jp; yamagata@eps.s.u-tokyo.ac.jp	Yamagata, Toshio/A-1807-2009				Yu LS, 1999, GEOPHYS RES LETT, V26, P735, DOI 10.1029/1999GL900072; Behera SK, 1999, GEOPHYS RES LETT, V26, P3001, DOI 10.1029/1999GL010434; Xie PP, 1996, J CLIMATE, V9, P840, DOI 10.1175/1520-0442(1996)009<0840:AOGMPU>2.0.CO;2; Saji NH, 1999, NATURE, V401, P360, DOI 10.1038/43855; Murtugudde R, 2000, J GEOPHYS RES-OCEANS, V105, P3295, DOI 10.1029/1999JC900294; Webster PJ, 1999, NATURE, V401, P356, DOI 10.1038/43848; HELLERMAN S, 1983, J PHYS OCEANOGR, V13, P1093, DOI 10.1175/1520-0485(1983)013<1093:NMWSOT>2.0.CO;2; CLARKE AJ, 1993, J PHYS OCEANOGR, V23, P386, DOI 10.1175/1520-0485(1993)023<0386:OADOSA>2.0.CO;2; Matsuura T, 1999, GEOPHYS RES LETT, V26, P1755, DOI 10.1029/1999GL900329; Philander S. G., 1990, NINO NINA SO OSCILLA; Reynolds R. W., 1995, J CLIMATOL, V8, P1572; Vinayachandran PN, 1999, GEOPHYS RES LETT, V26, P1613, DOI 10.1029/1999GL900179; Yamagata T, 1996, J GEOPHYS RES-OCEANS, V101, P12465, DOI 10.1029/95JC03623	13	82	88	AMER GEOPHYSICAL UNION	WASHINGTON	2000 FLORIDA AVE NW, WASHINGTON, DC 20009 USA	0094-8276			GEOPHYS RES LETT	Geophys. Res. Lett.	OCT 15	2000	27	20					3369	3372		10.1029/2000GL011484		4	Geosciences, Multidisciplinary	Geology	365RR	WOS:000089964700035		
J	Sako, T; Aoki, D; Yamanouchi, K; Iachello, F				Sako, T; Aoki, D; Yamanouchi, K; Iachello, F			Algebraic force-field Hamiltonian expansion approach to linear polyatomic molecules	JOURNAL OF CHEMICAL PHYSICS			English	Article							ROTATION-VIBRATION SPECTRA; FERMI RESONANCE-SPECTRA; VIBRON MODEL; TRIATOMIC-MOLECULES; BENDING VIBRATIONS; SPECTROSCOPY; INTENSITIES; SO2	The algebraic force-field Hamiltonian expansion recently proposed for vibrations of bent triatomic molecules [T. Sako, K. Yamanouchi, and F. Iachello, Chem. Phys. Lett. 299, 35 (1999)] is extended to linear polyatomic molecules by introducing operators constructed from the unitary algebra U(3). A comparison with the conventional force-field method is made by fitting the experimental vibrational-level energies of CO2. The results show that the algebraic Hamiltonian in local coordinates reproduces the level-energies with a smaller root-mean-square deviation and much faster convergence. (C) 2000 American Institute of Physics. [S0021-9606(00)01339-8].	Univ Tokyo, Sch Sci, Dept Chem, Bunkyo Ku, Tokyo 1130033, Japan; Yale Univ, Sloane Lab, Ctr Theoret Phys, New Haven, CT 06520 USA	Yamanouchi, K (reprint author), Univ Tokyo, Sch Sci, Dept Chem, Bunkyo Ku, 7-3-1 Hongo, Tokyo 1130033, Japan.						VANROOSMALEN OS, 1983, J CHEM PHYS, V79, P2515, DOI 10.1063/1.446164; Iachello F, 1996, J CHEM PHYS, V104, P6956, DOI 10.1063/1.471412; IACHELLO F, 1991, PHYS REV LETT, V66, P2976, DOI 10.1103/PhysRevLett.66.2976; VANROOSMALEN OS, 1984, J CHEM PHYS, V81, P5986, DOI 10.1063/1.447600; WATTSON RB, 1986, J MOL SPECTROSC, V119, P83, DOI 10.1016/0022-2852(86)90203-1; IACHELLO F, 1981, CHEM PHYS LETT, V78, P581, DOI 10.1016/0009-2614(81)85262-1; CHEDIN A, 1984, J MOL SPECTROSC, V107, P333, DOI 10.1016/0022-2852(84)90013-4; Frank A, 1996, ANN PHYS-NEW YORK, V252, P211, DOI 10.1006/aphy.1996.0129; IACHELLO F, 1982, J CHEM PHYS, V77, P3046, DOI 10.1063/1.444228; IACHELLO F, 1991, J MOL SPECTROSC, V149, P132, DOI 10.1016/0022-2852(91)90148-4; IACHELLO F, 1991, CHEM PHYS LETT, V187, P500, DOI 10.1016/0009-2614(91)80290-E; IACHELLO F, 1990, J MOL SPECTROSC, V142, P85, DOI 10.1016/0022-2852(90)90293-Y; IACHELLO F, 1993, CHEM PHYS LETT, V205, P285, DOI 10.1016/0009-2614(93)89244-C; IACHELLO F, 1991, J MOL SPECTROSC, V146, P56, DOI 10.1016/0022-2852(91)90370-P; Iachello F, 1995, ALGEBRAIC THEORY MOL; KELLMAN ME, 1990, J CHEM PHYS, V93, P5821, DOI 10.1063/1.459577; PerezBernal F, 1997, J MOL SPECTROSC, V184, P1, DOI 10.1006/jmsp.1997.7296; Sako T, 1997, CHEM PHYS LETT, V264, P403, DOI 10.1016/S0009-2614(96)01346-2; Sako T, 1999, CHEM PHYS LETT, V299, P35, DOI 10.1016/S0009-2614(98)01222-6; SUZUKI I, 1968, J MOL SPECTROSC, V25, P479, DOI 10.1016/S0022-2852(68)80018-9; SUZUKI I, 1975, B CHEM SOC JPN, V48, P3565, DOI 10.1246/bcsj.48.3565; Wilson E. B., 1980, MOL VIBRATIONS; XIAO L, 1990, J CHEM PHYS, V93, P5805, DOI 10.1063/1.459576	23	12	12	AMER INST PHYSICS	MELVILLE	2 HUNTINGTON QUADRANGLE, STE 1NO1, MELVILLE, NY 11747-4501 USA	0021-9606			J CHEM PHYS	J. Chem. Phys.	OCT 15	2000	113	15					6063	6069		10.1063/1.1309525		7	Physics, Atomic, Molecular & Chemical	Physics	359WN	WOS:000089635200007		
J	You, YZ				You, YZ			Implications of the deep circulation and ventilation of the Indian Ocean on the renewal mechanism of North Atlantic Deep Water	JOURNAL OF GEOPHYSICAL RESEARCH-OCEANS			English	Article							THERMOCLINE CIRCULATION; HYDROGRAPHIC SECTION; NEUTRAL SURFACES; SOUTHERN-OCEAN; SOMALI CURRENT; WORLDS OCEANS; BASIN; MASSES; BOTTOM; FLOW	In the Indian Ocean sector of the "great ocean conveyor" scheme the North Atlantic Deep Water (NADW) replacement is realized by the transformation of the sinking Circumpolar Deep Water (CDW) from the Southern Ocean to a prevailingly upward flow in the northern Indian Ocean. This water - mass transformation scenario has been studied by using hydrographic data including potential temperature, salinity, dissolved oxygen, and nutrients in a water - mass mixing model and by calculation of dianeutral velocity. The model comprises a mixing system of three major deep water masses, NADW, CDW, and North Indian Deep Water. This third water mass is introduced as a virtual water mass to represent the aged CDW. The assumption is feasible as the artificial water mass can be eliminated on the deepest sigma(N)=28.12 neutral surface, characterized by isopycnal mixing. The experiment is fulfilled when a conservative variable, initial phosphate PO4o, is introduced and all conservative parameters are used in the mixing scheme. The sigma(N)=28.12 surface provides a major isopycnal transition path of CDW to the northern Indian Ocean, and thus CDW is transformed to an upward flow. Dominant dianeutral upwelling is detected on all four neutral surfaces north of 30 degrees S, showing increasingly strong dianeutral velocity toward shallower surfaces. With the water - mass mixing pattern and spreading path, dianeutral circulation, and dynamical information of the acceleration potential (10 m(2) s(-2)) mapped on neutral surfaces a schematic of deep water circulation and Ventilation of the Indian Ocean emerges from this study. The contribution of NADW is largely limited to the southwest Indian Ocean. The northward CDW is found mainly in two paths: one in the western Indian Ocean (apparent between 2000 and 3000 m) through the western Crozet and Madagascar Basins, and farther north into the Somali Basin and Arabian Basin and another in the Central Indian Basin (apparent below 3000 m where ridge blocking becomes effective in the west and NADW salinity reaches a maximum). While the major path switches from west to the central basin in the deeper layer (3000-3500 m), the flow in the western Indian Ocean reverses southward. North of the Southeast Indian Ridge, the deep path bifurcates, from which point the eastern branch feeds the deep western boundary flow in the West Australian Basin. Except for part of the transformed CDW, which is contributed to the upward flow in the north, the return flow of CDW is found on the eastern side of these basins.	Museum Natl Hist Nat, Lab Oceanog Phys, F-75231 Paris, France; Univ Tokyo, Ctr Climate Syst Res, Tokyo, Japan	You, YZ (reprint author), Univ New S Wales, Sch Math, Ctr Environm Modelling & Predict, Sydney, NSW 2052, Australia.						You YZ, 1998, J MAR RES, V56, P1029, DOI 10.1357/002224098765173455; Jackett DR, 1997, J PHYS OCEANOGR, V27, P237, DOI 10.1175/1520-0485(1997)027<0237:ANDVFT>2.0.CO;2; Park YH, 1998, J MARINE SYST, V17, P5, DOI 10.1016/S0924-7963(98)00026-8; MCDOUGALL TJ, 1987, J PHYS OCEANOGR, V17, P1950, DOI 10.1175/1520-0485(1987)017<1950:NS>2.0.CO;2; ANDERSON LA, 1994, GLOBAL BIOGEOCHEM CY, V8, P65, DOI 10.1029/93GB03318; MANTYLA AW, 1995, J GEOPHYS RES-OCEANS, V100, P2417, DOI 10.1029/94JC02564; TOOLE JM, 1993, DEEP-SEA RES PT I, V40, P1973, DOI 10.1016/0967-0637(93)90042-2; STOMMEL H, 1960, DEEP-SEA RES, V6, P140; GORDON AL, 1987, DEEP-SEA RES, V34, P565, DOI 10.1016/0198-0149(87)90006-9; WARREN BA, 1974, DEEP-SEA RES, V21, P1, DOI 10.1016/0011-7471(74)90015-1; MANTYLA AW, 1983, DEEP-SEA RES, V30, P805, DOI 10.1016/0198-0149(83)90002-X; Beal LM, 1997, DEEP-SEA RES PT I, V44, P1715, DOI 10.1016/S0967-0637(97)00033-2; TOMCZAK M, 1989, J GEOPHYS RES-OCEANS, V94, P16141, DOI 10.1029/JC094iC11p16141; YOU Y, 1993, DEEP-SEA RES PT I, V40, P13, DOI 10.1016/0967-0637(93)90052-5; EMERY WJ, 1986, OCEANOL ACTA, V9, P383; MCDOUGALL TJ, 1992, DEEP-SEA RES, V39, P1931, DOI 10.1016/0198-0149(92)90006-F; BROECKER WS, 1985, J GEOPHYS RES-OCEANS, V90, P6925, DOI 10.1029/JC090iC04p06925; Broeker W.S., 1991, OCEANOGRAPHY, V4, P79, DOI DOI 10.5670/0CEAN0G.1991.07); CALLAHAN JE, 1972, DEEP-SEA RES, V19, P563, DOI 10.1016/0011-7471(72)90040-X; PARK YH, 1993, J GEOPHYS RES-OCEANS, V98, P12361, DOI 10.1029/93JC00938; CHARRIAUD E, 1993, 9301 IFRTF, P53; Clowes AJ, 1935, NATURE, V136, P936, DOI 10.1038/136936a0; COOK MF, 1992, 29 RRS; Deacon G.E.R., 1937, DISCOVERY REP, V15, P1, DOI DOI 10.1016/0198-0149(82)90058-9; FIEUX M, 1994, DEEP-SEA RES PT I, V41, P1091, DOI 10.1016/0967-0637(94)90020-5; FIEUX M, 1986, DEEP-SEA RES, V33, P415, DOI 10.1016/0198-0149(86)90124-X; Gordon A.I., 1967, ANTARCTIC MAP FOLIO, V6; Gordon A.L., 1982, SO OCEAN ATLAS; Johnson GC, 1998, J GEOPHYS RES-OCEANS, V103, P30973, DOI 10.1029/1998JC900027; JOHNSON GC, 1991, DEEP-SEA RES, V38, P637, DOI 10.1016/0198-0149(91)90003-X; JOHNSON GC, 1991, DEEP-SEA RES, V38, P653, DOI 10.1016/0198-0149(91)90004-Y; Mamayev O., 1975, TEMPERATURE SALINITY; MCDOUGALL TJ, 1990, J GEOPHYS RES-OCEANS, V95, P13263, DOI 10.1029/JC095iC08p13263; OLSON DB, 1993, DEEP-SEA RES PT II, V40, P673, DOI 10.1016/0967-0645(93)90051-N; Park YH, 1997, DEEP-SEA RES PT II, V44, P963, DOI 10.1016/S0967-0645(97)00004-0; POISSON A, 1988, 8506 MD INDIGO TAAF; POLLARD RT, 1987, 244 I OC SCI; READ JF, 1993, J GEOPHYS RES-OCEANS, V98, P12281, DOI 10.1029/93JC00436; Redfield A.C., 1963, SEA, P26; Schmitz W. J., 1996, WHOI9608, VII; SCHOTT F, 1983, PROG OCEANOGR, V12, P357, DOI 10.1016/0079-6611(83)90014-9; SCHOTT F, 1989, DEEP-SEA RES, V36, P1191, DOI 10.1016/0198-0149(89)90100-3; SPENCER DW, 1982, GEOSECS INDIAN OCEAN, V6; SVERDRUP HU, 1942, OCEANS THEIR PHYSICS; SVERDRUP HU, 1940, BANZAR EXPEDITION 19, V3, P89; TAFT BA, 1963, J MAR RES, V21, P129; Warren B., 1966, DEEP-SEA RES, V13, P825; WARREN BA, 1992, MAR GEOL, V104, P279, DOI 10.1016/0025-3227(92)90102-N; WARREN BA, 1981, DEEP-SEA RES, V28, P759; Weiss R. F., 1983, GEOSECS INDIAN OCEAN, V5; WHITWORTH T, 1987, J GEOPHYS RES-OCEANS, V92, P6462, DOI 10.1029/JC092iC06p06462; Wust G., 1935, WISSENSCHAFTLICHE ER, V6; Wyrtki K., 1973, ECOL STUD, V3, P18; Wyrtki K., 1971, OCEANOGRAPHIC ATLAS; YOU Y, 1990, J GEOPHYS RES-OCEANS, V95, P13235, DOI 10.1029/JC095iC08p13235; You YZ, 1997, J GEOPHYS RES-OCEANS, V102, P10391, DOI 10.1029/96JC03600; You YZ, 1996, DEEP-SEA RES PT I, V43, P291, DOI 10.1016/0967-0637(96)00007-6; You YZ, 1999, DEEP-SEA RES PT I, V46, P109, DOI 10.1016/S0967-0637(98)00058-2	58	28	28	AMER GEOPHYSICAL UNION	WASHINGTON	2000 FLORIDA AVE NW, WASHINGTON, DC 20009 USA	0148-0227			J GEOPHYS RES-OCEANS	J. Geophys. Res.-Oceans	OCT 15	2000	105	C10					23895	23926		10.1029/2000JC900105		32	Oceanography	Oceanography	364YE	WOS:000089921000001		
J	Ueda, H; Inoue, M; Takeshima, H; Iwasawa, Y				Ueda, H; Inoue, M; Takeshima, H; Iwasawa, Y			Enhanced spinal nociceptin receptor expression develops morphine tolerance and dependence	JOURNAL OF NEUROSCIENCE			English	Article						nociceptin/orphanin FQ; morphine; tolerance; dependence; plasticity; nonpeptidic antagonist	GAMMA-S BINDING; MICE LACKING; ORPHANIN-FQ; ANALGESIA; NEUROPEPTIDE; POTENTIATION; INJECTIONS; AGONIST; BRAIN; CORD	The tolerance and dependence after chronic medication with morphine are thought to be representative models for studying the plasticity, including the remodeling of neuronal networks. To test the hypothesis that changes in neuronal plasticity observed in opioid tolerance or dependence are derived from increased activity of the anti-opioid nociceptin system, the effects of chronic treatments with morphine were examined using nociceptin receptor knock-out (NOR-/-) mice and a novel nonpeptidic NOR antagonist, J-113397, which shows a specific and potent NOR antagonist activity in in vitro [S-35] GTP gamma S binding assay and in vivo peripheral nociception test. The NOR-/- mice showed marked resistance to morphine analgesic tolerance without affecting morphine analgesic potency in tail-pinch and tail-flick tests. The NOR-/- mice also showed marked attenuation of morphine-induced physical dependence, manifested as naloxone-precipitated withdrawal symptoms after repeated morphine treatments. Similar marked attenuation of morphine tolerance was also observed by single subcutaneous (10 mg/kg) or intrathecal (1 nmol) injection of J-113397, which had been given 60 min before the test in morphine-treated ddY mice. However, the intracerebroventricular injection (up to 3 nmol) did not affect the tolerance. On the other hand, morphine dependence was markedly attenuated by J-113397 that had been subcutaneously given 60 min before naloxone challenge. There was also observed a parallel enhancement of NOR gene expression only in the spinal cord during chronic morphine treatments. Together, these findings suggest that the spinal NOR system develops anti-opioid plasticity observed on morphine tolerance and dependence.	Nagasaki Univ, Sch Pharmaceut Sci, Dept Mol Pharmacol & Neurosci, Nagasaki 8528521, Japan; Univ Tokyo, Fac Med, Dept Pharmacol, Tokyo 1130033, Japan; Banyu Tsukuba Res Inst, Tsukuba, Ibaraki 3002611, Japan	Ueda, H (reprint author), Nagasaki Univ, Sch Pharmaceut Sci, Dept Mol Pharmacol & Neurosci, 1-14 Bunkyo Machi, Nagasaki 8528521, Japan.						Tian JH, 1997, BRIT J PHARMACOL, V120, P676, DOI 10.1038/sj.bjp.0700942; Ueda H, 1997, NEUROSCI LETT, V237, P136, DOI 10.1016/S0304-3940(97)00832-X; Kawamoto H, 1999, J MED CHEM, V42, P5061, DOI 10.1021/jm990517p; Pan ZZ, 2000, NEURON, V26, P515, DOI 10.1016/S0896-6273(00)81183-6; Zhu YX, 1999, NEURON, V24, P243, DOI 10.1016/S0896-6273(00)80836-3; Inoue M, 1998, P NATL ACAD SCI USA, V95, P10949, DOI 10.1073/pnas.95.18.10949; Gelot A, 1998, BRAIN RES, V808, P166, DOI 10.1016/S0006-8993(98)00665-9; TRUJILLO KA, 1995, NEUROPSYCHOPHARMACOL, V13, P301, DOI 10.1016/0893-133X(95)00088-U; Manabe T, 1998, NATURE, V394, P577; TRUJILLO KA, 1991, SCIENCE, V251, P85, DOI 10.1126/science.1824728; MEUNIER JC, 1995, NATURE, V377, P532, DOI 10.1038/377532a0; REINSCHEID RK, 1995, SCIENCE, V270, P792, DOI 10.1126/science.270.5237.792; Heinricher MM, 1997, J NEUROPHYSIOL, V78, P3351; Inoue M, 1999, J PHARMACOL EXP THER, V291, P308; Kakizawa K, 1998, PEPTIDES, V19, P755, DOI 10.1016/S0196-9781(97)00482-8; Maldonado R, 1996, SCIENCE, V273, P657, DOI 10.1126/science.273.5275.657; Mitchell JM, 2000, NAT NEUROSCI, V3, P47; Nishi M, 1997, EMBO J, V16, P1858, DOI 10.1093/emboj/16.8.1858; Ozaki S, 2000, EUR J PHARMACOL, V387, pR17, DOI 10.1016/S0014-2999(99)00822-5; Shimohira I, 1997, NEUROSCI LETT, V237, P113, DOI 10.1016/S0304-3940(97)00807-0; Ueda H, 1999, JPN J PHARMACOL, V79, P263, DOI 10.1254/jjp.79.263; Wang JL, 1999, REGUL PEPTIDES, V79, P159, DOI 10.1016/S0167-0115(98)00161-X; WAY EL, 1993, OPIOIDS, V2, P573; YEUNG JC, 1980, J PHARMACOL EXP THER, V215, P633; Yoshida A, 1999, BIOCHEM BIOPH RES CO, V259, P78, DOI 10.1006/bbrc.1999.0627; ZIMMERMANN M, 1983, PAIN, V16, P109, DOI 10.1016/0304-3959(83)90201-4	26	84	86	SOC NEUROSCIENCE	WASHINGTON	11 DUPONT CIRCLE, NW, STE 500, WASHINGTON, DC 20036 USA	0270-6474			J NEUROSCI	J. Neurosci.	OCT 15	2000	20	20					7640	7647				8	Neurosciences	Neurosciences & Neurology	361ZC	WOS:000089753300021		
J	Tanaka, R; Murota, K				Tanaka, R; Murota, K			Symmetric failures in symmetric control systems	LINEAR ALGEBRA AND ITS APPLICATIONS			English	Article						symmetry; fault-tolerance; controllability; group representation	FAULT-TOLERANCE; DESIGN	This paper discusses the fault-tolerance of symmetric systems with respect to controllability, which is a fundamental characteristic of control systems. In particular, we reveal the underlying mathematical mechanism of the loss of controllability for symmetric systems induced by failures. Based on the decomposition of the symmetric systems into subsystems under the symmetry, the controllability of the entire system can be discussed by checking that of each subsystem. The analysis of the fault-tolerance in this paper is an extension of this idea with the aid of the chain-adapted transformation matrix for the decomposition. The result is shown as a necessary condition for symmetric systems to retain the controllability despite some symmetric failures. We also discuss sufficient conditions. (C) 2000 Published by Elsevier Science Inc. All rights reserved.	Keio Univ, Dept Appl Phys & Physicoinformat, Kohoku Ku, Yokohama, Kanagawa 2238533, Japan; Univ Tokyo, Dept Math Engn & Informat Phys, Tokyo 1138654, Japan	Tanaka, R (reprint author), Keio Univ, Dept Appl Phys & Physicoinformat, Kohoku Ku, Yokohama, Kanagawa 2238533, Japan.						AKERS SB, 1987, IEEE T COMPUT, V36, P885; VEILLETTE RJ, 1992, IEEE T AUTOMAT CONTR, V37, P290, DOI 10.1109/9.119629; GLUMOV VM, 1989, AUTOMAT REM CONTR, V49, P1109; GOLUBITSKY M., 1988, SINGULARITIES GROUPS, VII; GRIZZLE JW, 1985, IEEE T AUTOMAT CONTR, V30, P248, DOI 10.1109/TAC.1985.1103927; HAZEWINKEL M, 1983, INT J CONTROL, V37, P1371, DOI 10.1080/00207178308933051; HUISMAN LM, 1994, IEEE T PARALL DISTR, V5, P94, DOI 10.1109/71.262592; IKEDA K, 1991, INT J SOLIDS STRUCT, V27, P1551; Iwata S., 1993, JAPAN J IND APPL MAT, V10, P97; Karavay MF, 1996, AUTOMAT REM CONTR+, V57, P899; Kettle S. F., 1995, SYMMETRY STRUCTURE; LING J, 1994, J OPTIMIZ THEORY APP, V82, P219, DOI 10.1007/BF02191852; LUNZE J, 1986, INT J CONTROL, V44, P1617, DOI 10.1080/00207178608933690; Miller W., 1972, SYMMETRY GROUPS THEI; NIJMEIJER H, 1985, MATH SYST THEORY, V18, P79, DOI 10.1007/BF01699462; Sattinger D. H., 1979, LECT NOTES MATH, V762; SILJAK DD, 1980, INT J CONTROL, V31, P303, DOI 10.1080/00207178008961043; SUNDARESHAN MK, 1991, AUTOMATICA, V27, P383, DOI 10.1016/0005-1098(91)90086-H; Tanaka R., 1999, Transactions of the Society of Instrument and Control Engineers, V35; Tanaka R, 2000, INT J CONTROL, V73, P254, DOI 10.1080/002071700219795; Tanaka R., 1997, Transactions of the Society of Instrument and Control Engineers, V33; VANDERSCHAFT A, 1981, SYST CONTROL LETT, V1, P108, DOI 10.1016/S0167-6911(81)80046-1; Wigner E.P., 1959, GROUP THEORY ITS APP; XIAOPING L, 1992, AUTOMATICA, V28, P1037; Zachariasen W. H., 1967, THEORY XRAY DIFFRACT	25	3	4	ELSEVIER SCIENCE INC	NEW YORK	655 AVENUE OF THE AMERICAS, NEW YORK, NY 10010 USA	0024-3795			LINEAR ALGEBRA APPL	Linear Alg. Appl.	OCT 15	2000	318	1-3					145	172		10.1016/S0024-3795(00)00161-0		28	Mathematics, Applied; Mathematics	Mathematics	363NJ	WOS:000089841200011		
J	Mohri, T; Mabuchi, M; Nakamura, M; Asahina, T; Iwasaki, H; Aizawa, T; Higashi, K				Mohri, T; Mabuchi, M; Nakamura, M; Asahina, T; Iwasaki, H; Aizawa, T; Higashi, K			Microstructural evolution and superplasticity of rolled Mg-9Al-1Zn	MATERIALS SCIENCE AND ENGINEERING A-STRUCTURAL MATERIALS PROPERTIES MICROSTRUCTURE AND PROCESSING			English	Article						magnesium alloys; grain refinement; dynamic recrystallization; superplasticity	STRAIN-RATE SUPERPLASTICITY; CONTINUOUS RECRYSTALLIZATION; DEFORMATION CHARACTERISTICS; DYNAMIC RECRYSTALLIZATION; COPPER ALLOY; MG ALLOY; MAGNESIUM; BEHAVIOR; MECHANISMS; ZR	Microstructural evolution and superplasticity of a Mg-9Al-1Zn alloy rolled at 673 K were investigated at 573 K and 1.5 x 10(-3) s(-1). The grain size of the as-rolled Mg alloy was 39.5 mu m. However, the grain size of the specimen deformed to a true strain of 0.6 was 9.1 mu m. The grain refinement was attributed to dynamically continuous recrystallization during an initial stage of tensile test. Stabilization of subgrain boundaries by fine particles and stimulation of continuous recrystallization by prior warm-deformation were not needed to attain dynamically continuous recrystallization in the Mg alloy. As a result of the grain refinement, the rolled Mg alloy exhibited superplastic behavior. (C) 2000 Elsevier Science S.A. All rights reserved.	Natl Ind Res Inst Nagoya, Dept Mat Proc, Kita Ku, Nagoya, Aichi 4628510, Japan; Nagoya Municipal Ind Res Inst, Prod Technol Dept, Proc Technol Res Off, Atsuta Ku, Nagoya, Aichi 4560058, Japan; Himeji Inst Technol, Dept Mat Sci & Engn, Coll Engn, Himeji, Hyogo 6712201, Japan; Univ Tokyo, Dept Met, Grad Sch Engn, Bunkyo Ku, Tokyo 1138656, Japan; Univ Osaka Prefecture, Dept Met & Mat Sci, Coll Engn, Sakai, Osaka 5998531, Japan	Mabuchi, M (reprint author), Natl Ind Res Inst Nagoya, Dept Mat Proc, Kita Ku, Hirate Cho, Nagoya, Aichi 4628510, Japan.						Liu J, 1996, ACTA MATER, V44, P4647; ION SE, 1982, ACTA METALL MATER, V30, P1909, DOI 10.1016/0001-6160(82)90031-1; Mabuchi M, 1996, ACTA MATER, V44, P4611, DOI 10.1016/1359-6454(96)00072-9; Yang XY, 1996, MATER T JIM, V37, P1379; KAIBYSHEV R, 1994, Z METALLKD, V85, P738; Mabuchi M, 1997, MATER SCI TECH SER, V13, P825; BARK B, 1998, P MAGN ALL THEIR APP, P495; Becker J, 1998, P MAGN ALL THEIR APP, P15; BRICKNELL RH, 1979, ACTA METALL MATER, V27, P1303, DOI 10.1016/0001-6160(79)90199-8; BRICKNELL RH, 1979, METALL TRANS A, V10, P1257, DOI 10.1007/BF02811981; CACERES CH, 1984, ACTA METALL MATER, V32, P415, DOI 10.1016/0001-6160(84)90115-9; DECKER R, 1998, P MAGN ALL THEIR APP, P545; FURUSHIRO N, 1991, P INT C SUP ADV MAT, P557; GHOSH AK, 1979, METALL TRANS A, V10, P699, DOI 10.1007/BF02658391; Grimes R., 1976, MET TECHNOL, V3, P154; GUDMUNDSSON H, 1991, ACTA METALL MATER, V39, P19, DOI 10.1016/0956-7151(91)90325-U; HALLS SJ, 1988, ACTA METALL, V36, P1229; HIGASHI K, 1990, P RECR 90, P711; Imai T, 1997, SCRIPTA MATER, V36, P611, DOI 10.1016/S1359-6462(96)00429-0; VALIEV RZ, 1983, ACTA METALL MATER, V31, P2121, DOI 10.1016/0001-6160(83)90031-7; LANGDON TG, 1994, MAT SCI ENG A-STRUCT, V174, P225, DOI 10.1016/0921-5093(94)91092-8; LANGDON TG, 1982, METALL TRANS A, V13, P689, DOI 10.1007/BF02642383; LEE EU, 1970, METALL TRANS, V1, P1399; Mabuchi M, 1996, PHILOS MAG A, V74, P887; Magers D., 1998, P MAGN ALL THEIR APP, P105; MATSUKI K, 1988, Z METALLKD, V79, P231; McNelley TR, 1997, METALL MATER TRANS A, V28, P1879, DOI 10.1007/s11661-997-0118-2; MCNELLEY TR, 1986, METALL TRANS A, V17, P1035, DOI 10.1007/BF02661269; METENIER P, 1990, MAT SCI ENG A-STRUCT, V125, P195, DOI 10.1016/0921-5093(90)90169-4; Mwembela A, 1997, SCRIPTA MATER, V37, P1789, DOI 10.1016/S1359-6462(97)00344-8; NES E, 1978, J MATER SCI, V13, P2052, DOI 10.1007/BF00552917; Nieh TG, 1998, ACTA MATER, V46, P2789, DOI 10.1016/S1359-6454(97)00452-7; NIEH TG, 1995, SCRIPTA METALL MATER, V32, P1133, DOI 10.1016/0956-716X(94)00016-B; PILLING J, 1989, SUPERPLASTICITY CRYS, P159; SELLARS CM, 1978, PHILOS T R SOC A, V288, P147, DOI 10.1098/rsta.1978.0010; SHEI SA, 1981, J MATER SCI, V16, P2988, DOI 10.1007/BF00540303; SOLBERG JK, 1991, MAT SCI ENG A-STRUCT, V134, P1201, DOI 10.1016/0921-5093(91)90955-M; TAKUDA H, 1992, J MATER SCI, V27, P937, DOI 10.1007/BF01197645; Uoya A, 1996, J MATER RES, V11, P2731, DOI 10.1557/JMR.1996.0346; Watts B. M., 1976, Metal Science, V10; YANG X, 1995, J JAPAN I METALS, V559, P612	41	139	170	ELSEVIER SCIENCE SA	LAUSANNE	PO BOX 564, 1001 LAUSANNE, SWITZERLAND	0921-5093			MAT SCI ENG A-STRUCT	Mater. Sci. Eng. A-Struct. Mater. Prop. Microstruct. Process.	OCT 15	2000	290	1-2					139	144		10.1016/S0921-5093(00)00959-X		6	Nanoscience & Nanotechnology; Materials Science, Multidisciplinary; Metallurgy & Metallurgical Engineering	Science & Technology - Other Topics; Materials Science; Metallurgy & Metallurgical Engineering	345YA	WOS:000088841800016		
J	Asakawa, H				Asakawa, H			Excitation gap of an antiferromagnetic Heisenberg chain with multiple decorations	PHYSICA A			English	Article						quantum spin chain; Heisenberg model	QUANTUM RENORMALIZATION-GROUPS; IMPURITIES; LADDERS; MODEL	A one-dimensional spin-1/2 antiferromagnetic Heisenberg model with multiple decorations is introduced. The low-lying properties of the decorated quantum spin chain are discussed. In the continuum and semiclassical limit of the present model, the non-linear sigma model with a topological term is derived and the conjecture for the low-lying state is proposed. Validity of the conjecture seems to be supported by the perturbational expansions and by the density matrix renormalization group calculations. (C) 2000 Elsevier Science B.V. All rights reserved.	Univ Tokyo, Inst Solid State Phys, Minato Ku, Tokyo 1068666, Japan	Asakawa, H (reprint author), Univ Tokyo, Inst Solid State Phys, Minato Ku, Roppongi 7-22-1, Tokyo 1068666, Japan.						Affleck I., 1989, FIELDS STRINGS CRITI; WHITE SR, 1992, PHYS REV LETT, V69, P2863, DOI 10.1103/PhysRevLett.69.2863; HALDANE FDM, 1983, PHYS REV LETT, V50, P1153, DOI 10.1103/PhysRevLett.50.1153; WHITE SR, 1993, PHYS REV B, V48, P10345, DOI 10.1103/PhysRevB.48.10345; Laukamp M, 1998, PHYS REV B, V57, P10755, DOI 10.1103/PhysRevB.57.10755; HALDANE FDM, 1983, PHYS LETT A, V93, P464, DOI 10.1016/0375-9601(83)90631-X; MANOUSAKIS E, 1991, REV MOD PHYS, V63, P1, DOI 10.1103/RevModPhys.63.1; Asakawa H, 1999, J PHYS-CONDENS MAT, V11, P493, DOI 10.1088/0953-8984/11/2/014; Daggotto E., 1996, SCIENCE, V271, P618; Fradkin E., 1991, FIELD THEORIES CONDE; IGARASHI J, 1995, PHYS REV B, V51, P5814, DOI 10.1103/PhysRevB.51.5814; MIYASHITA S, 1993, PHYS REV B, V48, P913, DOI 10.1103/PhysRevB.48.913; Senechal D, 1995, PHYS REV B, V52, P15319, DOI 10.1103/PhysRevB.52.15319; Sierra G, 1996, J PHYS A-MATH GEN, V29, P3299, DOI 10.1088/0305-4470/29/12/032; TSVELIK AM, 1994, PHYS REV LETT, V72, P1048, DOI 10.1103/PhysRevLett.72.1048	15	0	0	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	0378-4371			PHYSICA A	Physica A	OCT 15	2000	286	1-2					181	188		10.1016/S0378-4371(00)00189-8		8	Physics, Multidisciplinary	Physics	363JM	WOS:000089832600012		
J	Hasegawa, T; Mochida, T; Kondo, R; Kagoshima, S; Iwasa, Y; Akutagawa, T; Nakamura, T; Saito, G				Hasegawa, T; Mochida, T; Kondo, R; Kagoshima, S; Iwasa, Y; Akutagawa, T; Nakamura, T; Saito, G			Mixed-stack organic charge-transfer complexes with intercolumnar networks	PHYSICAL REVIEW B			English	Article							NEUTRAL-IONIC TRANSITION; PHASE-TRANSITION; P-CHLORANIL; TETRATHIAFULVALENE; TTF; BIS(ETHYLENEDIOXY)TETRATHIAFULVALENE; CONDUCTORS; COMPOUND; CRYSTALS; SOLIDS	We report synthesis and examination of the electronic properties of an isomorphous series of mixed-stack organic charge-transfer complexes, composed of [bis(ethylenedithio) tetrathiafulvalene] (BEDT-TTF)-based electron donors and electron accepters of halogen-substituted tetracyanoquinodimethanes (TCNQ's). Single crystals of (BEDT-TTF)(Me,TCNQ), (BEDT-TTF)(CIMeTCNQ), and (BEDO-TTF)(Cl(2)TCNQ) were investigated as to their crystal structures, and optical and magnetic properties. The intermolecular overlaps between the stacked columns were comparable to the face-to-face overlap between the donor and the acceptor molecules inside the stacks. As seen from the optical and magnetic measurements, the (BEDT-TTF)(Me,TCNQ) and (BEDT-TTF)(ClMeTCNQ) complexes were neutral, while the (BEDO-TTF)(Cl(2)TCNQ), complex was found to be ionic. Among these complexes, anomalous magnetic properties were observed in the ionic complex of (BEDO-TTF)(Cl(2)TCNQ). (BEDO-TTF)(CI,TCNQ) is a magnetic insulator with Curie-Weiss behavior in magnetic susceptibility followed by a sharp drop at around 120 K, which is in sharp contrast to conventional "spin-Peierls-type'' nonmagnetic mixed-stack ionic compounds.	Hokkaido Univ, Res Inst Elect Sci, Sapporo, Hokkaido 0600812, Japan; Toho Univ, Dept Chem, Funabashi, Chiba 2748510, Japan; Univ Tokyo, Dept Basic Sci, Tokyo 1538902, Japan; Japan Adv Inst Sci & Technol, Ishikawa 9231292, Japan; Kyoto Univ, Dept Chem, Kyoto 6068502, Japan	Hasegawa, T (reprint author), Hokkaido Univ, Res Inst Elect Sci, Sapporo, Hokkaido 0600812, Japan.		Nakamura, Takayoshi/A-5251-2012; Mochida, Tomoyuki/F-8555-2012; Iwasa, Yoshihiro/C-1719-2009	Mochida, Tomoyuki/0000-0002-3446-2145; 			WHELAND RC, 1976, J AM CHEM SOC, V98, P3916, DOI 10.1021/ja00429a030; TORRANCE JB, 1981, PHYS REV LETT, V46, P253, DOI 10.1103/PhysRevLett.46.253; TOKURA Y, 1989, PHYS REV LETT, V63, P2405, DOI 10.1103/PhysRevLett.63.2405; Horiuchi S, 1998, J AM CHEM SOC, V120, P7379, DOI 10.1021/ja981327r; GIRLANDO A, 1985, SOLID STATE COMMUN, V54, P753, DOI 10.1016/0038-1098(85)90279-0; Hasegawa T, 1997, SOLID STATE COMMUN, V103, P489, DOI 10.1016/S0038-1098(97)00226-3; CHAPPELL JS, 1981, J AM CHEM SOC, V103, P2442, DOI 10.1021/ja00399a066; Mori T, 1998, B CHEM SOC JPN, V71, P2509, DOI 10.1246/bcsj.71.2509; MAYERLE JJ, 1979, ACTA CRYSTALLOGR B, V35, P2988, DOI 10.1107/S0567740879011110; AOKI S, 1993, PHYS REV B, V48, P626, DOI 10.1103/PhysRevB.48.626; GEISER U, 1988, ACTA CRYSTALLOGR C, V44, P1544; Guinneau P., 1997, SYNTHETIC MET, V86, P1973; Hasegawa T, 1997, CHEM COMMUN, P1377, DOI 10.1039/a700994a; Horiuchi S, 1996, J AM CHEM SOC, V118, P8604, DOI 10.1021/ja960393v; Ishida M, 1999, PHYS REV LETT, V83, P596, DOI 10.1103/PhysRevLett.83.596; Ishiguro T., 1998, ORGANIC SUPERCONDUCT; IWASA Y, 1990, PHYS REV B, V42, P2374, DOI 10.1103/PhysRevB.42.2374; KAGOSHIMA S, 1988, SPRINGER SERIES SOLI, V72; Katan C, 1999, J PHYS-CONDENS MAT, V11, P4163, DOI 10.1088/0953-8984/11/21/305; Katan C, 1998, COMP MATER SCI, V10, P325, DOI 10.1016/S0927-0256(97)00103-1; Kondo R, 1999, CHEM LETT, P333; LemeeCailleau MH, 1997, PHYS REV LETT, V79, P1690, DOI 10.1103/PhysRevLett.79.1690; METZGER RM, 1985, J AM CHEM SOC, V107, P117, DOI 10.1021/ja00287a021; MITANI T, 1984, PHYS REV LETT, V53, P842, DOI 10.1103/PhysRevLett.53.842; Mochida T, 1997, SYNTHETIC MET, V86, P1797, DOI 10.1016/S0379-6779(97)80908-3; *MOL STRUCT CORP, 1992, TEXS CRYST STRUCT AN; NAGAOSA N, 1986, J PHYS SOC JPN, V55, P2745, DOI 10.1143/JPSJ.55.2745; PAINELLI A, 1988, PHYS REV B, V37, P5748, DOI 10.1103/PhysRevB.37.5748; SAITO G, 1980, B CHEM SOC JPN, V53, P2141, DOI 10.1246/bcsj.53.2141; SOOS ZG, 1978, PHYS REV B, V18, P1991, DOI 10.1103/PhysRevB.18.1991; SOOS ZG, 1983, EXTENDED LINEAR CHAI, V3; SUZUKI T, 1989, J AM CHEM SOC, V111, P3108, DOI 10.1021/ja00190a079; TORRANCE JB, 1987, NATO ASI B, V155, P113; UNO M, 1985, TETRAHEDRON LETT, V26, P1553, DOI 10.1016/S0040-4039(00)98550-2	34	30	30	AMER PHYSICAL SOC	COLLEGE PK	ONE PHYSICS ELLIPSE, COLLEGE PK, MD 20740-3844 USA	1098-0121	1550-235X		PHYS REV B	Phys. Rev. B	OCT 15	2000	62	15					10059	10066		10.1103/PhysRevB.62.10059		8	Physics, Condensed Matter	Physics	365YB	WOS:000089977100044		
J	Takeda, J; Nakajima, K; Kurita, S; Tomimoto, S; Saito, S; Suemoto, T				Takeda, J; Nakajima, K; Kurita, S; Tomimoto, S; Saito, S; Suemoto, T			Time-resolved luminescence spectroscopy by the optical Kerr-gate method applicable to ultrafast relaxation processes	PHYSICAL REVIEW B			English	Article							SUM FREQUENCY GENERATION; SELF-TRAPPING PROCESS; BETA-CAROTENE; FLUORESCENCE; COMPLEX; LIFETIME; PULSES; STATE	We have developed a femtosecond time-resolved luminescence spectroscopy by the optical Kerr-gate (OKG) method to investigate ultrafast carrier dynamics and relaxation processes of materials. Solid glasses with a high nonlinear refractive index were used as the Kerr media to obtain a subpicosecond time resolution. When a quartz plate was used as the Kerr medium. the Kerr efficiency and the instrumental response time of our spectroscopic system were 5-10% and similar to 250 fs, respectively. By employing the OKG method, we revealed the internal conversion from S-2 to S-1 state of beta -carotene with a low fluorescence quantum yield and an ultrafast fluorescence decay time, and the lifetime of the S-2 state was determined to be 210 fs. An advantage of the OKG method relative to the conventional up-conversion technique is its ability to directly obtain time-resolved luminescence spectra, and thus the OKG method might be superior to the up-conversion technique to investigate ultrafast carrier dynamics and relaxation processes of materials.	Yokohama Natl Univ, Fac Engn, Dept Phys, Yokohama, Kanagawa 2408501, Japan; Univ Tokyo, Inst Solid State Phys, Chiba 2778581, Japan	Takeda, J (reprint author), Yokohama Natl Univ, Fac Engn, Dept Phys, Yokohama, Kanagawa 2408501, Japan.		TAKEDA, JUN/G-6373-2011				Albrecht H.-St., 1992, Applied Physics B (Photophysics and Laser Chemistry), VB55, DOI 10.1007/BF00333081; ALBRECHT HS, 1993, APPL OPTICS, V32, P6659, DOI 10.1364/AO.32.006659; RIGHINI R, 1993, SCIENCE, V262, P1386, DOI 10.1126/science.262.5138.1386; HUDSON BS, 1982, EXCITED STATES, V6, P1; ADAIR R, 1989, PHYS REV B, V39, P3337, DOI 10.1103/PhysRevB.39.3337; KANDORI H, 1994, J AM CHEM SOC, V116, P2671, DOI 10.1021/ja00085a078; SHAH J, 1988, IEEE J QUANTUM ELECT, V24, P276, DOI 10.1109/3.124; BLOCK D, 1986, SOLID STATE COMMUN, V59, P527, DOI 10.1016/0038-1098(86)90051-7; BONDAREV SL, 1989, J PHOTOCH PHOTOBIO A, V46, P315, DOI 10.1016/1010-6030(89)87048-0; BRUN A, 1991, J PHYS D APPL PHYS, V24, P1225, DOI 10.1088/0022-3727/24/8/001; Duguay M. A., 1969, Optics Communications, V1, DOI 10.1016/0030-4018(69)90049-2; Fleming G. R., 1986, CHEM APPL ULTRAFAST, P124; GILLBRO T, 1989, CHEM PHYS LETT, V158, P312, DOI 10.1016/0009-2614(89)87342-7; HUDSON BS, 1972, CHEM PHYS LETT, V14, P299, DOI 10.1016/0009-2614(72)80119-2; HULIN D, 1984, APPL PHYS LETT, V45, P993, DOI 10.1063/1.95443; Iwai S, 1998, J CHEM PHYS, V109, P5963, DOI 10.1063/1.477221; Kanematsu Y, 2000, J LUMIN, V87-9, P917, DOI 10.1016/S0022-2313(99)00472-X; NAGAI M, 2000, J LUMIN, V87, P1926; SHAH J, 1987, APPL PHYS LETT, V50, P1307, DOI 10.1063/1.97890; SHREVE AP, 1991, CHEM PHYS LETT, V178, P89, DOI 10.1016/0009-2614(91)85058-5; Takeda J, 2000, J LUMIN, V87-9, P927, DOI 10.1016/S0022-2313(99)00476-7; Tomimoto S, 1999, PHYS REV B, V60, P7961, DOI 10.1103/PhysRevB.60.7961; Tomimoto S, 1998, PHYS REV LETT, V81, P417, DOI 10.1103/PhysRevLett.81.417; WATANABE J, 1993, CEM PHYS LETT, V213, P3151	24	75	76	AMER PHYSICAL SOC	COLLEGE PK	ONE PHYSICS ELLIPSE, COLLEGE PK, MD 20740-3844 USA	1098-0121	1550-235X		PHYS REV B	Phys. Rev. B	OCT 15	2000	62	15					10083	10087		10.1103/PhysRevB.62.10083		5	Physics, Condensed Matter	Physics	365YB	WOS:000089977100047		
J	Neudert, R; Drechsler, SL; Malek, J; Rosner, H; Kielwein, M; Hu, Z; Knupfer, M; Golden, MS; Fink, J; Nucker, N; Merz, M; Schuppler, S; Motoyama, N; Eisaki, H; Uchida, S; Domke, M; Kaindl, G				Neudert, R; Drechsler, SL; Malek, J; Rosner, H; Kielwein, M; Hu, Z; Knupfer, M; Golden, MS; Fink, J; Nucker, N; Merz, M; Schuppler, S; Motoyama, N; Eisaki, H; Uchida, S; Domke, M; Kaindl, G			Four-band extended Hubbard Hamiltonian for the one-dimensional cuprate Sr2CuO3: Distribution of oxygen holes and its relation to strong intersite Coulomb interaction	PHYSICAL REVIEW B			English	Article							X-RAY-ABSORPTION; UNOCCUPIED ELECTRONIC-STRUCTURE; SPIN-CHARGE SEPARATION; HIGH-TC SUPERCONDUCTIVITY; CU-O CHAINS; MAGNETIC-PROPERTIES; INCREMENTAL EXPANSIONS; INTERACTION PARAMETERS; PHASE-SEPARATION; FINE-STRUCTURE	We have carried out experimental and theoretical studies of the unoccupied electronic structure of Sr2CuO3, which can be regarded as the best realization of a one-dimensional model system containing cuprate chains. In the polarization-dependent x-ray absorption spectra, the contributions to the upper Hubbard band from states originating from the two inequivalent oxygen sites are energetically well separated. Theoretical analysis of the measured hole distribution within cluster calculations reveals a markedly enhanced effective nearest-neighbor intersite Coulomb interaction, V(pd)similar to2 to 3 eV, or sizable contributions from next-nearest-neighbor interactions, provided a finite on-site energy difference of the two inequivalent oxygen sites Delta (pp) is taken into account. Including next-nearest-neighbor interactions, reasonable agreement can be achieved with recent electron energy-loss spectroscopy data from the same compound. The 2p oxygen orbital analysis of the unoccupied electronic structure of the single-chain cuprate Sr2CuO3 reveals strong similarities with that of the double chain compound SrCuO2.	Inst Festkorperphys & Werkstofforsch Dresden, D-01171 Dresden, Germany; Forschungszentrum Karlsruhe, Inst Nukl Festkorperphys, D-76021 Karlsruhe, Germany; Univ Tokyo, Dept Superconduct, Bunkyo Ku, Tokyo 113, Japan; Free Univ Berlin, Inst Phys Expt, D-14195 Berlin, Germany	Drechsler, SL (reprint author), Inst Festkorperphys & Werkstofforsch Dresden, POB 27016, D-01171 Dresden, Germany.	drechsler@ifw-dresden.de	Hu, Zhiwei/B-8635-2008; Golden, Mark/D-3469-2011; Fink, Joerg/A-6003-2012; Malek, Jiri/G-7223-2014				ALIGIA AA, 1995, PHYS REV B, V52, P13601, DOI 10.1103/PhysRevB.52.13601; AMI T, 1995, PHYS REV B, V51, P5994, DOI 10.1103/PhysRevB.51.5994; Mizuno Y, 1998, PHYS REV B, V57, P5326, DOI 10.1103/PhysRevB.57.5326; Feiner LF, 1996, PHYS REV B, V53, P8751, DOI 10.1103/PhysRevB.53.8751; BARRIQUAND F, 1994, PHYS REV B, V50, P16649, DOI 10.1103/PhysRevB.50.16649; DOMKE M, 1992, REV SCI INSTRUM, V63, P80, DOI 10.1063/1.1142615; Kim C, 1997, PHYS REV B, V56, P15589, DOI 10.1103/PhysRevB.56.15589; Maiti K, 1997, EUROPHYS LETT, V37, P359, DOI 10.1209/epl/i1997-00157-x; Haffner S, 1998, PHYS REV B, V57, P3672, DOI 10.1103/PhysRevB.57.3672; ZAANEN J, 1985, PHYS REV LETT, V55, P418, DOI 10.1103/PhysRevLett.55.418; Dagotto E, 1996, SCIENCE, V271, P618, DOI 10.1126/science.271.5249.618; HYBERTSEN MS, 1990, PHYS REV B, V41, P11068, DOI 10.1103/PhysRevB.41.11068; TJENG LH, 1992, PHYS REV B, V45, P8205, DOI 10.1103/PhysRevB.45.8205; EMERY VJ, 1987, PHYS REV LETT, V58, P2794, DOI 10.1103/PhysRevLett.58.2794; HYBERTSEN MS, 1992, PHYS REV B, V45, P10032, DOI 10.1103/PhysRevB.45.10032; FINK J, 1994, J ELECTRON SPECTROSC, V66, P395, DOI 10.1016/0368-2048(93)01857-B; JAKLEVIC J, 1977, SOLID STATE COMMUN, V23, P679, DOI 10.1016/0038-1098(77)90548-8; ALIGIA AA, 1994, PHYS REV B, V49, P524, DOI 10.1103/PhysRevB.49.524; Kojima KM, 1997, PHYS REV LETT, V78, P1787, DOI 10.1103/PhysRevLett.78.1787; Motoyama N, 1996, PHYS REV LETT, V76, P3212, DOI 10.1103/PhysRevLett.76.3212; TEO BK, 1979, J AM CHEM SOC, V101, P2815, DOI 10.1021/ja00505a003; Rosner H, 1997, PHYS REV B, V56, P3402, DOI 10.1103/PhysRevB.56.3402; HYBERTSEN MS, 1989, PHYS REV B, V39, P9028, DOI 10.1103/PhysRevB.39.9028; TROGER L, 1992, PHYS REV B, V46, P3283, DOI 10.1103/PhysRevB.46.3283; NUCKER N, 1995, PHYS REV B, V51, P8529, DOI 10.1103/PhysRevB.51.8529; MCMAHAN AK, 1990, PHYS REV B, V42, P6268, DOI 10.1103/PhysRevB.42.6268; Raimondi R, 1996, PHYS REV B, V53, P8774, DOI 10.1103/PhysRevB.53.8774; Kim C, 1996, PHYS REV LETT, V77, P4054, DOI 10.1103/PhysRevLett.77.4054; Drechsler SL, 1997, PHYS REV B, V55, P606, DOI 10.1103/PhysRevB.55.606; Drechsler SL, 1999, J LOW TEMP PHYS, V117, P407, DOI 10.1023/A:1022534103636; ESKES GH, 1989, PHYSICA C, V41, P424; Fujisawa H, 1998, SOLID STATE COMMUN, V106, P543, DOI 10.1016/S0038-1098(98)00099-4; Grevin B, 1998, PHYS REV LETT, V80, P2405, DOI 10.1103/PhysRevLett.80.2405; HIRSCH JE, 1989, NATO ADV STUDY I B, V155, P71; Knupfer M, 1997, PHYS REV B, V55, pR7291; KOTHEKAR N, 1995, PHYS REV B, V51, P5899, DOI 10.1103/PhysRevB.51.5899; KROL A, 1992, PHYS REV B, V45, P2581, DOI 10.1103/PhysRevB.45.2581; KROL A, UNPUB; KRUGER C, 1992, J SOLID STATE CHEM, V96, P67, DOI 10.1016/S0022-4596(05)80298-1; MAITI K, 1998, THESIS U BANGALORE; Maiti K, 1998, PHYS REV B, V57, P1572, DOI 10.1103/PhysRevB.57.1572; MALEK J, CONDMAT9710112; Malek J, 1998, JETP LETT+, V67, P1052, DOI 10.1134/1.567791; Malek J, 1999, PHYS REV B, V59, pR5273, DOI 10.1103/PhysRevB.59.R5273; Matsushita Y, 1994, J SOLID STATE CHEM, V114, P289; Merz M, 1997, PHYS REV B, V55, P9160, DOI 10.1103/PhysRevB.55.9160; Mizuno Y, 1998, PHYS REV B, V58, P14713; Neudert R, 1999, PHYS REV B, V60, P13413, DOI 10.1103/PhysRevB.60.13413; Neudert R, 1998, PHYS REV LETT, V81, P657, DOI 10.1103/PhysRevLett.81.657; OHTA Y, 1991, PHYS REV B, V43, P2968, DOI 10.1103/PhysRevB.43.2968; Okada K, 1997, J PHYS SOC JPN, V66, P341, DOI 10.1143/JPSJ.66.341; OLES AM, 1991, PHYS REV B, V44, P9531, DOI 10.1103/PhysRevB.44.9531; ROSNER H, UNPUB; ROSNER H, 1999, THESIS U TECHNOLOGY; Rosner H, 1998, PHYS REV B, V57, P13660, DOI 10.1103/PhysRevB.57.13660; RUSHAN H, 1989, PHYS REV B, V39, P9200, DOI 10.1103/PhysRevB.39.9200; SCHLUTER HB, 1992, PHYS REV B, V45, P7588; SHIN YJ, 1992, Z ANORG ALLG CHEM, V616, P201, DOI 10.1002/zaac.19926161033; Simon ME, 1996, PHYS REV B, V54, pR3780; SIMON ME, 1993, PHYSICA C, V206, P297, DOI 10.1016/0921-4534(93)90529-Y; Simon ME, 1996, PHYS REV B, V53, P15327, DOI 10.1103/PhysRevB.53.15327; STECHEL EB, 1988, PHYS REV B, V38, P4632, DOI 10.1103/PhysRevB.38.4632; TOHYAMA T, 1991, J PHYS SOC JPN, V60, P53, DOI 10.1143/JPSJ.60.53; WAIDACHER C, 1999, THESIS U TECHNOLOGY; YASUHARA H, UNPUB; YU JJ, 1991, PHYSICA C, V172, P467, DOI 10.1016/0921-4534(91)90215-K	66	22	22	AMER PHYSICAL SOC	COLLEGE PK	ONE PHYSICS ELLIPSE, COLLEGE PK, MD 20740-3844 USA	1098-0121	1550-235X		PHYS REV B	Phys. Rev. B	OCT 15	2000	62	16					10752	10765		10.1103/PhysRevB.62.10752		14	Physics, Condensed Matter	Physics	369GY	WOS:000165058600029		
J	Katsufuji, T; Tokura, Y				Katsufuji, T; Tokura, Y			Coexistence of two components in the optical spectra of CeTiO3.04 in the antiferromagnetic metallic phase	PHYSICAL REVIEW B			English	Article							SUPERCONDUCTING ENERGY-GAP; SPIN-DENSITY-WAVE; CONDUCTIVITY; FREQUENCY; YBA2CU3O7	The optical spectra of CeTiO3.04. which undergoes a phase transition from a paramagnetic metal to an antiferromagnetic metal, are investigated with changing temperature (T). In the paramagnetic phase, optical conductivity shows a T-dependent feature up to 1 eV, which can be attributed to the T-dependent scattering rate. In the antiferromagnetic phase, on the other hand, optical conductivity reduces its low-energy weight below 0.4 eV, but no gaplike structure appears. A two-component model, where the spectrum is a sum of a metallic and an insulating component, gives a simple explanation for the change of the optical spectra in the antiferromagnetic metallic phase.	Univ Tokyo, Dept Appl Phys, Tokyo 1138656, Japan	Katsufuji, T (reprint author), Univ Tokyo, Dept Adv Mat Sci, Tokyo 1138656, Japan.		Tokura, Yoshinori/C-7352-2009				THOMAS GA, 1994, PHYS REV LETT, V73, P1529, DOI 10.1103/PhysRevLett.73.1529; BAO W, 1993, PHYS REV LETT, V71, P766, DOI 10.1103/PhysRevLett.71.766; ORENSTEIN J, 1990, PHYS REV B, V42, P6342, DOI 10.1103/PhysRevB.42.6342; SCHLESINGER Z, 1990, PHYS REV LETT, V65, P801, DOI 10.1103/PhysRevLett.65.801; BONN DA, 1988, PHYS REV LETT, V61, P1305, DOI 10.1103/PhysRevLett.61.1305; ALLEN JW, 1977, PHYS REV B, V15, P2952, DOI 10.1103/PhysRevB.15.2952; Moreo A, 2000, PHYS REV LETT, V84, P5568, DOI 10.1103/PhysRevLett.84.5568; BARKER AS, 1968, PHYS REV LETT, V20, P384, DOI 10.1103/PhysRevLett.20.384; CARTER SA, 1991, PHYS REV LETT, V67, P3440, DOI 10.1103/PhysRevLett.67.3440; Degiorgi L, 1996, PHYS REV LETT, V76, P3838, DOI 10.1103/PhysRevLett.76.3838; Katsufuji T, 1997, PHYS REV B, V56, P10145, DOI 10.1103/PhysRevB.56.10145; Katsufuji T, 1999, PHYS REV B, V60, P7673, DOI 10.1103/PhysRevB.60.7673; MATTHEIS.LF, 1972, PHYS REV B, V6, P4718, DOI 10.1103/PhysRevB.6.4718; NOH TW, 1986, PHYS REV B, V33, P3793, DOI 10.1103/PhysRevB.33.3793; OVERHAUSER AW, 1962, PHYS REV, V128, P1437, DOI 10.1103/PhysRev.128.1437; ROMERO DB, 1992, PHYS REV LETT, V68, P1590, DOI 10.1103/PhysRevLett.68.1590; SCHLESINGER Z, 1990, PHYS REV B, V41, P11237, DOI 10.1103/PhysRevB.41.11237	17	4	4	AMER PHYSICAL SOC	COLLEGE PK	ONE PHYSICS ELLIPSE, COLLEGE PK, MD 20740-3844 USA	1098-0121	1550-235X		PHYS REV B	Phys. Rev. B	OCT 15	2000	62	16					10797	10801		10.1103/PhysRevB.62.10797		5	Physics, Condensed Matter	Physics	369GY	WOS:000165058600035		
J	Karino, S; Yoshida, S; Yoshida, S; Eriguchi, Y				Karino, S; Yoshida, S; Yoshida, S; Eriguchi, Y			R-mode oscillations of rapidly rotating Newtonian stars: A new numerical scheme and its application to the spin evolution of neutron stars	PHYSICAL REVIEW D			English	Article							GRAVITATIONAL-RADIATION LIMIT; RELATIVISTIC STARS; SECULAR INSTABILITY; BAROCLINIC STARS; STELLAR MODELS; RADIO PULSARS; POLYTROPES; BIRTHRATE; MATTER	We have developed a new numerical scheme to solve r-mode oscillations of vapidly rotating polytropic stars in Newtonian gravity. In this scheme, Euler perturbations of the density, three components of the velocity are treated as four unknown quantities together with the oscillation frequency. For the basic equations of oscillations, the compatibility equations are used instead of the linearized equations of motion. By using this scheme, we have solved the classical r-mode oscillations of rotational equilibrium sequences of polytropes with the polytropic indices N = 0.5, 1.0, and 1.5 for m = 2, 3, and 4 modes. Here m is the rank of the spherical harmonics Y-i(m). These results have been applied to investigate the evolution of uniformly rotating hot young neutron stars by considering the effect of gravitational radiation and viscosity. We have found that the maximum angular velocities of neutron stars are around 10-20 % of the Keplerian angular velocity irrespective of the softness of matter. This confirms the results obtained from the analysis of r-modes with the slow rotation approximation employed by many authors.	Univ Tokyo, Grad Sch Arts & Sci, Dept Earth Sci & Astron, Tokyo 1538902, Japan; Tohoku Univ, Grad Sch Sci, Inst Astron, Sendai, Miyagi 9808578, Japan	Karino, S (reprint author), Univ Tokyo, Grad Sch Arts & Sci, Dept Earth Sci & Astron, Tokyo 1538902, Japan.		Yoshida, Shin'ichirou/G-2396-2011				IPSER JR, 1991, ASTROPHYS J, V373, P213, DOI 10.1086/170039; BAYM G, 1979, ANNU REV ASTRON ASTR, V17, P415, DOI 10.1146/annurev.aa.17.090179.002215; Andersson N, 1999, ASTROPHYS J, V510, P846, DOI 10.1086/306625; Owen BJ, 1998, PHYS REV D, V58, DOI 10.1103/PhysRevD.58.084020; Spruit H, 1998, NATURE, V393, P139, DOI 10.1038/30168; LINDBLOM L, 1995, ASTROPHYS J, V444, P804, DOI 10.1086/175653; Lockitch KH, 1999, ASTROPHYS J, V521, P764, DOI 10.1086/307580; Lindblom L, 1998, PHYS REV LETT, V80, P4843, DOI 10.1103/PhysRevLett.80.4843; FRIEDMAN JL, 1978, ASTROPHYS J, V222, P281, DOI 10.1086/156143; PAPALOIZOU J, 1978, MON NOT R ASTRON SOC, V182, P423; LORIMER DR, 1993, MON NOT R ASTRON SOC, V263, P403; Andersson N, 1998, ASTROPHYS J, V502, P708, DOI 10.1086/305919; PETHICK CJ, 1992, REV MOD PHYS, V64, P1133, DOI 10.1103/RevModPhys.64.1133; SAWYER RF, 1989, PHYS REV D, V39, P3804, DOI 10.1103/PhysRevD.39.3804; Friedman JL, 1998, ASTROPHYS J, V502, P714, DOI 10.1086/305920; FLOWERS E, 1979, ASTROPHYS J, V230, P847, DOI 10.1086/157145; Stergioulas N, 1998, ASTROPHYS J, V492, P301, DOI 10.1086/305030; Bildsten L, 2000, ASTROPHYS J, V529, pL33, DOI 10.1086/312454; Andersson N, 1999, ASTROPHYS J, V516, P307, DOI 10.1086/307082; PROVOST J, 1981, ASTRON ASTROPHYS, V94, P126; Bryan G. H., 1889, PHILOS T R SOC A, V180, P187, DOI DOI 10.1098/RSTA.1889.0006; CHANDRAS.S, 1970, PHYS REV LETT, V24, P611, DOI 10.1103/PhysRevLett.24.611; ERIGUCHI Y, 1991, ASTRON ASTROPHYS, V248, P435; ERIGUCHI Y, 1985, ASTRON ASTROPHYS, V146, P260; FRIEDENTHAL JH, 1993, CIVIL PROCEDURE, P55; FRIEDMAN JL, IN PRESS PROG THEOR; FRIEDMAN JL, 1992, PHILOS T ROY SOC A, V340, P391, DOI 10.1098/rsta.1992.0074; HO WCG, ASTROPH9912296; Kojima Y, 1998, MON NOT R ASTRON SOC, V293, P49, DOI 10.1046/j.1365-8711.1998.01119.x; Kojima Y, 1999, ASTROPHYS J, V520, P788, DOI 10.1086/307481; LINDBLOM L, 1997, P 14 INT C GEN REL G, P237; LINDBLOM L, 1997, RELATIVISTIC ASTROPH; Lindblom L, 1999, PHYS REV D, V59, DOI 10.1103/PhysRevD.59.044009; NARAYAN R, 1987, ASTROPHYS J, V319, P162, DOI 10.1086/165442; REZZOLLA L, ASTROPH9911188; SAIO H, 1982, ASTROPHYS J, V256, P717, DOI 10.1086/159945; Shapiro S. L., 1983, BLACK HOLES WHITE DW; Uryu K, 1995, MON NOT R ASTRON SOC, V277, P1411; Uryu K, 1996, MON NOT R ASTRON SOC, V282, P653; URYU K, 1994, MON NOT R ASTRON SOC, V269, P24; Yoshida S, 2000, ASTROPHYS J, V529, P997, DOI 10.1086/308312; YOSHIDA S, ASTROPH9910532; YOSHIDA S, 1995, ASTROPHYS J, V438, P830, DOI 10.1086/175126	43	5	5	AMERICAN PHYSICAL SOC	COLLEGE PK	ONE PHYSICS ELLIPSE, COLLEGE PK, MD 20740-3844 USA	0556-2821			PHYS REV D	Phys. Rev. D	OCT 15	2000	62	8							084012			11	Astronomy & Astrophysics; Physics, Particles & Fields	Astronomy & Astrophysics; Physics	365YC	WOS:000089977200037		
J	Yanase, M; Ikeda, H; Matsui, A; Maekawa, H; Noiri, E; Tomiya, T; Arai, M; Yano, T; Shibata, M; Ikebe, M; Fujiwara, K; Rojkind, M; Ogata, I				Yanase, M; Ikeda, H; Matsui, A; Maekawa, H; Noiri, E; Tomiya, T; Arai, M; Yano, T; Shibata, M; Ikebe, M; Fujiwara, K; Rojkind, M; Ogata, I			Lysophosphatidic acid enhances collagen gel contraction by hepatic stellate cells: Association with Rho-kinase	BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS			English	Article						hepatic stellate cells; collagen gel contraction; lysoposphatidic acid; Rho-kinase; focal adhesion; actomyosin-interaction; electric cell-substrate imedance sensor	BINDING PROTEIN-RHO; ACTIN STRESS FIBERS; SMOOTH-MUSCLE; FOCAL ADHESIONS; SERINE/THREONINE KINASE; ENDOTHELIAL-CELLS; GROWTH-FACTORS; NITRIC-OXIDE; 3T3 CELLS; RECEPTOR	We studied the effect of lysophosphatidic acid (LPA) on collagen gel contraction by cultured rat hepatic stellate cells (HSCs) in association with the function of Rho-kinase, one of the target molecules of small GTPase Rho, Binding studies showed a single class-binding site of LPA on HSCs. LPA enhanced the contraction of a collagen lattice seeded with HSCs, LPA increased the number of HSCs with polygonal morphology that contained actin stress fibers, and enhanced the phosphorylation of myosin light chain and the assembly of focal adhesion kinase and RhoA around fibronectin-coated beads seeded on HSCs. The electric cell-substrate impedance sensor system showed that LPA enhanced adhesion of HSC to extracellular substrate. All the effects of LPA were suppressed by Y-27632, Rho-kinase inhibitor. These data support the notion that LPA is involved in modulating HSC morphology, its attachment to surrounding extracellular matrix and its contraction by a mechanism involving Rho-kinase. (C) 2000 Academic Press.	Univ Tokyo, Fac Med, Dept Gastroenterol, Bunkyo Ku, Tokyo 1130033, Japan; Univ Tokyo, Fac Med, Dept Nephrol, Tokyo 1130033, Japan; Saitama Med Sch, Dept Internal Med 3, Moroyama, Saitama 3500451, Japan; Med & Biol Labs, Nagano 3960002, Japan; Univ Massachusetts, Med Ctr, Dept Physiol, Worcester, MA 01655 USA; Yeshiva Univ Albert Einstein Coll Med, Marion Bessin Liver Res Ctr, Bronx, NY 10461 USA	Ogata, I (reprint author), Univ Tokyo, Fac Med, Dept Gastroenterol, Bunkyo Ku, 7-3-1 Hongo, Tokyo 1130033, Japan.						An SZ, 1997, BIOCHEM BIOPH RES CO, V231, P619, DOI 10.1006/bbrc.1997.6150; Itoh K, 1999, NAT MED, V5, P221, DOI 10.1038/5587; Bissell DM, 1998, J GASTROENTEROL, V33, P295, DOI 10.1007/s005350050087; Ishizaki T, 1996, EMBO J, V15, P1885; GIAEVER I, 1984, P NATL ACAD SCI-BIOL, V81, P3761, DOI 10.1073/pnas.81.12.3761; Nakagawa O, 1996, FEBS LETT, V392, P189, DOI 10.1016/0014-5793(96)00811-3; Yoshii A, 1999, AM J RESP CELL MOL, V20, P1190; An SZ, 1998, J BIOL CHEM, V273, P7906, DOI 10.1074/jbc.273.14.7906; Matsui T, 1996, EMBO J, V15, P2208; Uehata M, 1997, NATURE, V389, P990, DOI 10.1038/40187; Moolenaar WH, 1997, CURR OPIN CELL BIOL, V9, P168, DOI 10.1016/S0955-0674(97)80059-2; LEUNG T, 1995, J BIOL CHEM, V270, P29051; Hirose M, 1998, J CELL BIOL, V141, P1625, DOI 10.1083/jcb.141.7.1625; ROCKEY DC, 1993, J CLIN INVEST, V92, P1795, DOI 10.1172/JCI116769; Narumiya S, 1997, FEBS LETT, V410, P68, DOI 10.1016/S0014-5793(97)00317-7; RIDLEY AJ, 1992, CELL, V70, P389, DOI 10.1016/0092-8674(92)90163-7; Amano M, 1997, SCIENCE, V275, P1308, DOI 10.1126/science.275.5304.1308; Bandoh K, 1999, J BIOL CHEM, V274, P27776, DOI 10.1074/jbc.274.39.27776; FOURCADE O, 1995, CELL, V80, P919, DOI 10.1016/0092-8674(95)90295-3; Sasagawa T, 1999, LIPIDS, V34, P17, DOI 10.1007/s11745-999-332-5; MONTESANO R, 1988, P NATL ACAD SCI USA, V85, P4894, DOI 10.1073/pnas.85.13.4894; Hecht JH, 1996, J CELL BIOL, V135, P1071, DOI 10.1083/jcb.135.4.1071; Kranenburg O, 1997, J CELL SCI, V110, P2417; Siess W, 1999, P NATL ACAD SCI USA, V96, P6931, DOI 10.1073/pnas.96.12.6931; Xu Y, 1998, JAMA-J AM MED ASSOC, V280, P719, DOI 10.1001/jama.280.8.719; Kimura K, 1996, SCIENCE, V273, P245, DOI 10.1126/science.273.5272.245; BARRY ST, 1994, J CELL SCI, V107, P2033; Chihara K, 1997, J BIOL CHEM, V272, P25121, DOI 10.1074/jbc.272.40.25121; Clancy RM, 1997, J CLIN INVEST, V100, P1789, DOI 10.1172/JCI119706; CURTIS ASG, 1992, J CELL SCI, V101, P427; CYWES R, 1993, HEPATOLOGY, V18, P635, DOI 10.1016/0270-9139(93)90366-U; FRIEDMAN SL, 1987, ANAL BIOCHEM, V161, P1233; FRIEDMAN SL, 1993, NEW ENGL J MED, V328, P1828; FUKAMI K, 1992, J BIOL CHEM, V267, P10988; Goetzl EJ, 1998, FASEB J, V12, P1589; HUGHES RD, 1985, CLIN SCI, V68, P701; IKEBE M, 1985, J BIOL CHEM, V260, P27; Ikeda H, 1998, BIOCHEM BIOPH RES CO, V248, P436, DOI 10.1006/bbrc.1998.8983; LUZZATTO G, 1987, ACTA HAEMATOL-BASEL, V77, P101; Noiri E, 1997, J BIOL CHEM, V272, P1747; THOMSON FJ, 1994, MOL PHARMACOL, V45, P718; TOKUMURA A, 1994, AM J PHYSIOL, V267, pC204; Valet P, 1998, J CLIN INVEST, V101, P1431, DOI 10.1172/JCI806; VANDERBEND RL, 1992, EMBO J, V11, P2495; WAKE K, 1999, LIVER DIS HEPATIC SI, P56	45	50	52	ACADEMIC PRESS INC	SAN DIEGO	525 B ST, STE 1900, SAN DIEGO, CA 92101-4495 USA	0006-291X			BIOCHEM BIOPH RES CO	Biochem. Biophys. Res. Commun.	OCT 14	2000	277	1					72	78		10.1006/bbrc.2000.3634		7	Biochemistry & Molecular Biology; Biophysics	Biochemistry & Molecular Biology; Biophysics	367PJ	WOS:000090070400013		
J	Kojima, N; Kinoshita, T; Kamiya, A; Nakamura, K; Nakashima, K; Taga, T; Miyajima, A				Kojima, N; Kinoshita, T; Kamiya, A; Nakamura, K; Nakashima, K; Taga, T; Miyajima, A			Cell density-dependent regulation of hepatic development by a gp 130-independent pathway	BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS			English	Article						hepatic development; cell density; oncostatin M; gp130; STAT3; knockout mouse; metabolic function	FETAL-RAT HEPATOCYTES; MESSENGER-RNA LEVELS; ACUTE-PHASE RESPONSE; GENE-EXPRESSION; PRIMARY CULTURES; TRANSCRIPTIONAL CONTROL; SIGNAL TRANSDUCER; ALBUMIN GENE; ONCOSTATIN-M; LIVER	We previously demonstrated that oncostatin M (OSM) promotes hepatic development in concert with glucocorticoid. The livers from mice deficient for gp130, a signaling subunit of the OSM receptor, displayed reduced expression of hepatic differentiation marker and defective glycogenic function. However, these phenotypes were not completely abolished in gp130(-/-) mice, suggesting that there is an alternative pathway regulating hepatic development in vivo. To test this possibility, we cultured gp130(-/-) fetal hepatic cells and investigated a signal that induces hepatic differentiation. When hepatocytes were forced to interact with each other by inoculating cells at high densities, hepatic differentiation was induced even in the absence of gp130. Moreover, cells stimulated with OSM and/or cultured at a high density possess many other metabolic functions. These observations suggest that fetal hepatic cells acquire multiple characteristics of differentiated hepatocytes in response to the signals generated by cell-cell contacts as well as by OSM. (C) 2000 Academic Press.	Univ Tokyo, Inst Mol & Cellular Biosci, Bunkyo Ku, Tokyo 1130032, Japan; Teikyo Univ, Biotechnol Res Ctr, KAST Stem Cell Regulat Project, Miyamae Ku, Kawasaki, Kanagawa 2160001, Japan; Tokyo Med & Dent Univ, Med Res Inst, Dept Mol Cell Biol, Chiyoda Ku, Tokyo 1010062, Japan	Miyajima, A (reprint author), Univ Tokyo, Inst Mol & Cellular Biosci, Bunkyo Ku, Tokyo 1130032, Japan.						ANDUS T, 1987, FEBS LETT, V221, P18, DOI 10.1016/0014-5793(87)80344-7; Fuchs M, 1996, J BIOL CHEM, V271, P16712; Yoshida K, 1996, P NATL ACAD SCI USA, V93, P407, DOI 10.1073/pnas.93.1.407; Kumar NM, 1996, CELL, V84, P381, DOI 10.1016/S0092-8674(00)81282-9; Yap AS, 1997, ANNU REV CELL DEV BI, V13, P119, DOI 10.1146/annurev.cellbio.13.1.119; BRADYKALNAY SM, 1995, J CELL BIOL, V130, P977, DOI 10.1083/jcb.130.4.977; Kamiya A, 1999, EMBO J, V18, P2127, DOI 10.1093/emboj/18.8.2127; PANDURO A, 1987, GENE DEV, V1, P1172, DOI 10.1101/gad.1.10.1172; GAULDIE J, 1987, P NATL ACAD SCI USA, V84, P7251, DOI 10.1073/pnas.84.20.7251; Kinoshita T, 1999, P NATL ACAD SCI USA, V96, P7265, DOI 10.1073/pnas.96.13.7265; Barbason H, 1979, Arch Toxicol Suppl, P157; DARLINGTON GJ, 1986, J CELL BIOL, V103, P787, DOI 10.1083/jcb.103.3.787; DINARELLO CA, 1984, NEW ENGL J MED, V311, P1413; FLAIM KE, 1985, AM J PHYSIOL, V249, pE447; HABER BA, 1995, J CLIN INVEST, V95, P832, DOI 10.1172/JCI117733; KIM SK, 1995, CURR OPIN CELL BIOL, V7, P641, DOI 10.1016/0955-0674(95)80105-7; LAMERS WH, 1985, EUR J BIOCHEM, V146, P475, DOI 10.1111/j.1432-1033.1985.tb08675.x; MORRIS SM, 1989, ARCH BIOCHEM BIOPHYS, V269, P175, DOI 10.1016/0003-9861(89)90097-0; NAGAO M, 1986, BIOCHIM BIOPHYS ACTA, V867, P179, DOI 10.1016/0167-4781(86)90032-1; NAKAMURA T, 1983, J BIOCHEM-TOKYO, V94, P1029; NAKAMURA T, 1983, P NATL ACAD SCI-BIOL, V80, P7229, DOI 10.1073/pnas.80.23.7229; NODA C, 1994, BBA-GENE STRUCT EXPR, V1217, P163, DOI 10.1016/0167-4781(94)90030-2; NODA C, 1983, J BIOL CHEM, V258, P1520; NODA C, 1990, BIOCHEM BIOPH RES CO, V168, P335, DOI 10.1016/0006-291X(90)91713-3; PEAVY DE, 1978, P NATL ACAD SCI USA, V75, P5879, DOI 10.1073/pnas.75.12.5879; PELES E, 1995, CELL, V82, P251, DOI 10.1016/0092-8674(95)90312-7; PERLMUTTER DH, 1986, J CLIN INVEST, V78, P1349, DOI 10.1172/JCI112721; SHELLY LL, 1989, J CELL BIOL, V109, P3403, DOI 10.1083/jcb.109.6.3403; Siddiqui MU, 1999, HEPATOLOGY, V29, P1147, DOI 10.1002/hep.510290443; SPAGNOLI D, 1983, ARCH BIOCHEM BIOPHYS, V226, P182, DOI 10.1016/0003-9861(83)90283-7; TILGHMAN SM, 1982, P NATL ACAD SCI-BIOL, V79, P5254, DOI 10.1073/pnas.79.17.5254; Tonks NK, 1996, CELL, V87, P365, DOI 10.1016/S0092-8674(00)81357-4; URANO Y, 1986, J BIOL CHEM, V261, P3244; YAMANAKA N, 1993, HEPATOLOGY, V18, P79, DOI 10.1016/0270-9139(93)90510-T	34	38	39	ACADEMIC PRESS INC	SAN DIEGO	525 B ST, STE 1900, SAN DIEGO, CA 92101-4495 USA	0006-291X			BIOCHEM BIOPH RES CO	Biochem. Biophys. Res. Commun.	OCT 14	2000	277	1					152	158		10.1006/bbrc.2000.3635		7	Biochemistry & Molecular Biology; Biophysics	Biochemistry & Molecular Biology; Biophysics	367PJ	WOS:000090070400027		
J	Kim, DW; Matsuzawa, H				Kim, DW; Matsuzawa, H			Requirement for the COOH-terminal pro-sequence in the translocation of aqualysin I across the cytoplasmic membrane in Escherichia coli	BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS			English	Article						aqualysin I; serine protease; C-terminal pro-sequence; protein secretion; protein translocation; intramolecular chaperone	ALKALINE SERINE PROTEASE; SUBTILISIN-TYPE PROTEASE; THERMUS-AQUATICUS YT-1; EXTRACELLULAR SECRETION; IGA PROTEASE; GENE; THERMOPHILUS; PURIFICATION; INVOLVEMENT; CHAPERONES	Aqualysin I from Thermus aquaticus YT-1 is an extracellular subtilisin-type serine protease. The protease is synthesized as a distinct precursor composed of four functional domains: an N-terminal signal sequence, an N-terminal pro-sequence, a protease domain, and a C-terminal pro-sequence. The N-terminal pro-sequence is essential for the production of active aqualysin I while the C-terminal pro-sequence is required for extracellular secretion of aqualysin I. In an E. coli expression system, the function of C-terminal pro-sequence in the translocation of aqualysin I across the cytoplasmic membrane was investigated. More than 60-70% of the total activity was detected in the cytoplasmic fraction in the deletion mutations of the C-terminal pro-sequence while less than 30% was found in this fraction in wild type. In addition, in vitro processing of aqualysin I precursors with these mutations to a mature form promptly occurred and the folding into active aqualysin I was rapid. These results suggest that the C-terminal pro-sequence, probably in conjunction with the signal sequence, facilitates the translocation of the precursor across the cytoplasmic membrane by preventing the precursor from taking on an active conformation. (C) 2000 Academic Press.	Univ Tokyo, Dept Biotechnol, Bunkyo Ku, Tokyo 113, Japan	Kim, DW (reprint author), Yale Univ, Sch Med, Howard Hughes Med Inst, BCMM 245,295 Congress Ave, New Haven, CT 06510 USA.	dong-wook.kim@yale.edu					SCHRODER H, 1993, EMBO J, V12, P4137; POHLNER J, 1987, NATURE, V325, P458, DOI 10.1038/325458a0; KLAUSER T, 1990, EMBO J, V9, P1991; SHINDE U, 1993, TRENDS BIOCHEM SCI, V18, P442, DOI 10.1016/0968-0004(93)90146-E; CORNELIS P, 1982, MOL GEN GENET, V186, P507, DOI 10.1007/BF00337957; GAITANARIS GA, 1994, MOL MICROBIOL, V14, P861, DOI 10.1111/j.1365-2958.1994.tb01322.x; Kim DW, 1997, BIOCHEM BIOPH RES CO, V231, P535, DOI 10.1006/bbrc.1996.5899; Kim DW, 1997, FEMS MICROBIOL LETT, V157, P39, DOI 10.1111/j.1574-6968.1997.tb12750.x; Kurosaka K, 1996, MOL MICROBIOL, V20, P385, DOI 10.1111/j.1365-2958.1996.tb02625.x; KWON ST, 1988, EUR J BIOCHEM, V173, P491, DOI 10.1111/j.1432-1033.1988.tb14025.x; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; LEE YC, 1994, FEMS MICROBIOL LETT, V120, P69; LEE YC, 1991, AGR BIOL CHEM TOKYO, V55, P3027; LEE YC, 1992, FEMS MICROBIOL LETT, V92, P73, DOI 10.1016/0378-1097(92)90544-X; MATSUZAWA H, 1983, AGR BIOL CHEM TOKYO, V47, P25; MATSUZAWA H, 1988, EUR J BIOCHEM, V171, P441, DOI 10.1111/j.1432-1033.1988.tb13809.x; OHNISHI Y, 1994, J BIOL CHEM, V269, P32800; SAMBROOK J, 1989, MOL CLONING LAB MANU; SHINDE U, 1995, INTRAMOLECULAR CHAPE; TERADA I, 1990, J BIOL CHEM, V265, P6576	20	19	19	ACADEMIC PRESS INC ELSEVIER SCIENCE	SAN DIEGO	525 B ST, STE 1900, SAN DIEGO, CA 92101-4495 USA	0006-291X	1090-2104		BIOCHEM BIOPH RES CO	Biochem. Biophys. Res. Commun.	OCT 14	2000	277	1					216	220		10.1006/bbrc.2000.3657		5	Biochemistry & Molecular Biology; Biophysics	Biochemistry & Molecular Biology; Biophysics	367PJ	WOS:000090070400037		
J	Nagata, D; Suzuki, E; Nishimatsu, H; Yoshizumi, M; Mano, T; Walsh, K; Sata, M; Kakoki, M; Goto, A; Omata, M; Hirata, Y				Nagata, D; Suzuki, E; Nishimatsu, H; Yoshizumi, M; Mano, T; Walsh, K; Sata, M; Kakoki, M; Goto, A; Omata, M; Hirata, Y			Cyclin a downregulation and p21(cip1) upregulation correlate with GATA-6-induced growth arrest in glomerular mesangial cells	CIRCULATION RESEARCH			English	Article						cell cycle; transcription factors; kidney; gene transfer; cyclin-dependent kinases	DEPENDENT KINASE INHIBITOR; TRANSCRIPTION FACTOR; POTENTIAL MEDIATOR; IN-VIVO; PROLIFERATION; GENE; DIFFERENTIATION; EXPRESSION; PROTEIN; SIGNALS	The GATA-6 transcription factor is reported to be expressed in vascular myocytes, Because glomerular mesangial cells (GMCs) and vascular myocytes have similar properties, we examined whether GATA-6 was expressed in cultured GMCs and whether overexpression of GATA-6 induced cell cycle arrest in GMCs, using a recombinant adenovirus that expresses GATA-6 (Ad GATA-6). GATA-6 expression in GMCs was downregulated when quiescent GMCs were stimulated by serum to reenter the cell cycle. [H-3]thymidine uptake was inhibited in GMCs infected with Ad GATA-6 in a dose- and time-dependent manner. The expression of cyclin A protein was decreased and that of the cyclin-dependent kinase inhibitor p21(cip1) was increased in GMCs infected with Ad GATA-6. Although the expression of p21(cip1) transcripts did not change remarkably, p21(cip1) protein was stabilized in GMCs infected with Ad GATA-6, suggesting a post-transcriptional regulation of p21(cip1) expression. Northern blot analysis showed that expression of the cyclin A transcript was decreased in Ad GATA-6-infected cells, whereas this decrease of cyclin A was not observed in GMCs derived from D21(cip1) null mice. Our results demonstrate that GATA-6 is endogenously expressed in GMCs and that overexpression of GATA-6 can induce cell cycle arrest. Our results also show that GATA-6-induced cell cycle arrest is associated with inhibition of cyclin A expression and p21(cip1) upregulation. Finally, our results indicate that the GATA-6-induced suppression of cyclin A expression depends on the presence of p21(cip1).	Univ Tokyo, Fac Med, Dept Internal Med 2, Bunkyo Ku, Tokyo 1138655, Japan; Univ Tokyo, Fac Med, Dept Urol, Bunkyo Ku, Tokyo 1138655, Japan; Univ Tokyo, Fac Med, Dept Geriatr, Bunkyo Ku, Tokyo 1138655, Japan; Tufts Univ, Sch Med, St Elizabeths Med Ctr, Div Cardiovasc Res, Boston, MA 02111 USA	Suzuki, E (reprint author), Univ Tokyo, Fac Med, Dept Internal Med 2, Bunkyo Ku, 7-3-1 Hongo, Tokyo 1138655, Japan.						PEVNY L, 1991, NATURE, V349, P257, DOI 10.1038/349257a0; ELDEIRY WS, 1993, CELL, V75, P817, DOI 10.1016/0092-8674(93)90500-P; TSAI FY, 1994, NATURE, V371, P221, DOI 10.1038/371221a0; LEE MH, 1995, GENE DEV, V9, P639, DOI 10.1101/gad.9.6.639; PANDOLFI PP, 1995, NAT GENET, V11, P40, DOI 10.1038/ng0995-40; HALEVY O, 1995, SCIENCE, V267, P1018, DOI 10.1126/science.7863327; SIMON MC, 1995, NAT GENET, V11, P9, DOI 10.1038/ng0995-9; Kuo CT, 1997, GENE DEV, V11, P1048, DOI 10.1101/gad.11.8.1048; Somasundaram K, 1997, NATURE, V389, P187; Smith RC, 1997, GENE DEV, V11, P1674, DOI 10.1101/gad.11.13.1674; SHERR CJ, 1995, GENE DEV, V9, P1149, DOI 10.1101/gad.9.10.1149; Liu M, 1996, GENE DEV, V10, P142, DOI 10.1101/gad.10.2.142; Olson MF, 1998, NATURE, V394, P295; Pippin JW, 1997, J CLIN INVEST, V100, P2512, DOI 10.1172/JCI119793; Morrisey EE, 1998, GENE DEV, V12, P3579, DOI 10.1101/gad.12.22.3579; Terada Y, 1997, J AM SOC NEPHROL, V8, P51; DRENCKHAHN D, 1990, AM J PATHOL, V137, P1343; Maeshima Y, 1998, J CLIN INVEST, V101, P2589, DOI 10.1172/JCI429; MICHAEL AF, 1980, KIDNEY INT, V17, P141, DOI 10.1038/ki.1980.18; Miyake S, 1996, P NATL ACAD SCI USA, V93, P1320, DOI 10.1073/pnas.93.3.1320; Nagata D, 1999, KIDNEY INT, V55, P1259, DOI 10.1046/j.1523-1755.1999.00361.x; Perlman H, 1998, J BIOL CHEM, V273, P13713, DOI 10.1074/jbc.273.22.13713; PINES J, 1995, BIOCHEM J, V308, P697; POLYAK K, 1994, CELL, V78, P59, DOI 10.1016/0092-8674(94)90572-X; Reiter JF, 1999, GENE DEV, V13, P2983, DOI 10.1101/gad.13.22.2983; Suzuki E, 1996, GENOMICS, V38, P283, DOI 10.1006/geno.1996.0630; Suzuki E, 1999, CIRC RES, V84, P611; Timchenko NA, 1996, GENE DEV, V10, P804, DOI 10.1101/gad.10.7.804	28	25	26	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	530 WALNUT ST, PHILADELPHIA, PA 19106-3621 USA	0009-7330			CIRC RES	Circ.Res.	OCT 13	2000	87	8					699	704				6	Cardiac & Cardiovascular Systems; Hematology; Peripheral Vascular Disease	Cardiovascular System & Cardiology; Hematology	369AP	WOS:000090149900012		
J	Taira, Y; Kubo, T; Natori, S				Taira, Y; Kubo, T; Natori, S			Participation of transcription elongation factor XSII-K1 in mesoderm-derived tissue development in Xenopus laevis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							RNA-POLYMERASE-II; FACTOR-S-II; ASCITES TUMOR-CELLS; FACTOR-SII; EUKARYOTIC TRANSCRIPTION; MOLECULAR-CLONING; DEPENDENT TRANSCRIPTION; STIMULATORY FACTOR; MESSENGER-RNA; FACTOR TFIIS	We isolated a cDNA clone for a novel member of the S-II family of transcription elongation factors from;Xenopus laevis. This S-II, named XSII-K1, is assumed to be the Xenopus homologue of mouse SII-K1 that we reported previously (Taira, Y., Kubo, T., and Natori, S. (1998) Genes Cells 3, 289-296). Expression of the XSII-K1 gene was found to be restricted to mesoderm-derived tissues such as liver, kidney, and skeletal muscle. Contrary to the general S-II gene, expression of the XSII-K1 gene was not detected in embryos at stages earlier than 11. The animal cap assay revealed that activin A, but not basic fibroblast growth factor, induced expression of the XSII-K1 gene and that it participated in the expression of mesoderm-specific genes such as Xbra and X alpha-actin. This is the first demonstration that the regulation at the level of transcription elongation is included in the development of mesoderm-derived tissues.	Univ Tokyo, Grad Sch Pharmaceut Sci, Bunkyo Ku, Tokyo 1130033, Japan; RIKEN, Inst Phys & Chem Res, Natori Special Lab, Wako, Saitama 3510198, Japan	Natori, S (reprint author), Univ Tokyo, Grad Sch Pharmaceut Sci, Bunkyo Ku, Tokyo 1130033, Japan.						IZBAN MG, 1993, J BIOL CHEM, V268, P12864; Reines D, 1996, TRENDS BIOCHEM SCI, V21, P351, DOI 10.1016/S0968-0004(96)10045-1; REINES D, 1989, J BIOL CHEM, V264, P10799; Takebayashi K, 1997, EMBO J, V16, P384, DOI 10.1093/emboj/16.2.384; KOZAK M, 1991, J CELL BIOL, V115, P887, DOI 10.1083/jcb.115.4.887; Shilatifard A, 1996, SCIENCE, V271, P1873, DOI 10.1126/science.271.5257.1873; REINES D, 1992, J BIOL CHEM, V267, P15516; BRADSHER JN, 1993, J BIOL CHEM, V268, P25587; IZBAN MG, 1992, GENE DEV, V6, P1342, DOI 10.1101/gad.6.7.1342; MARSHALL NF, 1995, J BIOL CHEM, V270, P12335; ASO T, 1995, SCIENCE, V269, P1439, DOI 10.1126/science.7660129; BRADSHER JN, 1993, J BIOL CHEM, V268, P25594; BENGAL E, 1991, MOL CELL BIOL, V11, P1195; BURATOWSKI S, 1995, SCIENCE, V270, P1773, DOI 10.1126/science.270.5243.1773; CHEN HC, 1992, GENE, V116, P253, DOI 10.1016/0378-1119(92)90522-Q; CORNELL RA, 1995, DEVELOPMENT, V121, P2429; DJE MK, 1990, NUCLEIC ACIDS RES, V18, P3489, DOI 10.1093/nar/18.12.3489; GARRETT KP, 1994, P NATL ACAD SCI USA, V91, P5237, DOI 10.1073/pnas.91.12.5237; GU WG, 1995, J BIOL CHEM, V270, P11238, DOI 10.1074/jbc.270.19.11238; GU WG, 1993, J BIOL CHEM, V268, P25604; GUO HL, 1993, J BIOL CHEM, V268, P18762; GURDON JB, 1985, J EMBRYOL EXP MORPH, V89, P125; Hatada S, 1997, GENE, V203, P183, DOI 10.1016/S0378-1119(97)00512-X; HIRASHIMA S, 1988, J BIOL CHEM, V263, P3858; HORIKOSHI M, 1984, J BIOL CHEM, V259, P608; Ito T, 1996, FEBS LETT, V385, P21, DOI 10.1016/0014-5793(96)00340-7; KANAI A, 1991, J BIOCHEM-TOKYO, V109, P674; KASSAVETIS GA, 1993, SCIENCE, V259, P944, DOI 10.1126/science.7679800; KEPHART DD, 1994, J BIOL CHEM, V269, P13536; Kugawa F, 1996, BIOCHEM BIOPH RES CO, V222, P541, DOI 10.1006/bbrc.1996.0780; Labhart P, 1998, GENOMICS, V52, P278, DOI 10.1006/geno.1998.5449; MARSHALL NF, 1992, MOL CELL BIOL, V12, P2078; MARSHALL TK, 1990, NUCLEIC ACIDS RES, V18, P6293, DOI 10.1093/nar/18.21.6293; NAKANISHI T, 1992, J BIOL CHEM, V267, P13200; NATORI S, 1982, MOL CELL BIOCHEM, V46, P173; Orphanides G, 1996, GENE DEV, V10, P2657, DOI 10.1101/gad.10.21.2657; Plant KE, 1996, NUCLEIC ACIDS RES, V24, P3514, DOI 10.1093/nar/24.18.3514; PRINCE DH, 1989, MOL CELL BIOLL, V9, P1465; REINES D, 1992, J BIOL CHEM, V267, P3795; REINES D, 1993, P NATL ACAD SCI USA, V90, P1917, DOI 10.1073/pnas.90.5.1917; Roeder RG, 1998, COLD SPRING HARB SYM, V63, P201, DOI 10.1101/sqb.1998.63.201; SEKIMIZU K, 1979, BIOCHEMISTRY-US, V18, P1582, DOI 10.1021/bi00575a031; SEKIMIZU K, 1982, J BIOL CHEM, V257, P2719; SIVARAMAN L, 1990, J BIOL CHEM, V265, P14554; SLACK JMW, 1990, PHILOS T ROY SOC B, V327, P75, DOI 10.1098/rstb.1990.0044; SMITH JC, 1991, CELL, V67, P79, DOI 10.1016/0092-8674(91)90573-H; Taira Y, 1998, GENES CELLS, V3, P289, DOI 10.1046/j.1365-2443.1998.00188.x; UENO K, 1979, NATURE, V277, P145, DOI 10.1038/277145a0; Verrijzer CP, 1996, TRENDS BIOCHEM SCI, V21, P338, DOI 10.1016/0968-0004(96)10044-X; XU QH, 1994, J BIOL CHEM, V269, P3100; Yokota C, 1998, J BIOCHEM-TOKYO, V123, P339	51	5	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	OCT 13	2000	275	41					32011	32015		10.1074/jbc.M003920200		5	Biochemistry & Molecular Biology	Biochemistry & Molecular Biology	363VT	WOS:000089858900064		
J	Komine, M; Rao, LMS; Kaneko, T; Tomic-Canic, M; Tamaki, K; Freedberg, IM; Blumenberg, M				Komine, M; Rao, LMS; Kaneko, T; Tomic-Canic, M; Tamaki, K; Freedberg, IM; Blumenberg, M			Inflammatory versus proliferative processes in epidermis - Tumor necrosis factor alpha induces K6b keratin synthesis through a transcriptional complex containing NF kappa B and C/EBP ss	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SYNERGISTICALLY ACTIVATE TRANSCRIPTION; GROWTH-FACTOR-ALPHA; NUCLEAR-FACTOR; TNF RECEPTOR; HUMAN SKIN; NUDE-MICE; PACHYONYCHIA-CONGENITA; ICAM-1 EXPRESSION; PSORIATIC SKIN; FAMILY MEMBERS	Epidermal keratinocytes respond to injury by becoming activated, i.e. hyperproliferative, migratory, and proinflammatory. These processes are regulated by growth factors and cytokines. One of the markers of activated keratinocytes is keratin K6. We used a novel organ culture system to show that tumor necrosis factor alpha (TNF alpha) induces the expression of K6 protein and mRNA in human skin. Multiple isoforms of K6 are encoded by distinct genes and have distinct patterns of expression. By having shown previously that proliferative signals, such as epidermal growth factor (EGF), induce expression of the cytoskeletal protein keratin K6b, we here demonstrate that the same isoform, K6b, is also induced by TNF alpha, a proinflammatory cytokine. Specifically, TNF alpha induces the transcription of the K6b gene promoter. By using co-transfection, specific inhibitors, and antisense oligonucleotides, we have identified NF kappa B and C/EBP beta as the transcription factors that convey the TNFa! signal. Both transcription factors are necessary for the induction of K6b by TNFa and act as a complex, although only C/EBP beta binds the K6b promoter DNA. By using transfection, site-directed mutagenesis, and footprinting, we have mapped the site that responds to TNF alpha, NF kappa B, and C/EBP beta. This site is separate from the one responsive to EGF and AP1. Our results show that the proinflammatory (TNF alpha) and the proliferative (EGF) signals in epidermis separately and independently regulate the expression of the same K6b keratin isoform. Thus, the cytoskeletal responses in epidermal cells can be precisely tuned by separate proliferative and inflammatory signals to fit the nature of the injuries that caused them.	NYU, Med Ctr, Dept Biochem, New York, NY 10016 USA; NYU, Med Ctr, Ronald O Perelman Dept Dermatol, New York, NY 10016 USA; NYU, Med Ctr, Dept Cell Biol, New York, NY 10016 USA; NYU, Med Ctr, Kaplan Comprehens Canc, New York, NY 10016 USA; Univ Tokyo, Fac Med, Dept Dermatol, Bunkyo Ku, Tokyo 113, Japan	Blumenberg, M (reprint author), NYU, Med Ctr, Dept Biochem, New York, NY 10016 USA.						Liu ZG, 1996, CELL, V87, P565, DOI 10.1016/S0092-8674(00)81375-6; Song HY, 1997, P NATL ACAD SCI USA, V94, P9792, DOI 10.1073/pnas.94.18.9792; WOODWORTH CD, 1995, P NATL ACAD SCI USA, V92, P2840, DOI 10.1073/pnas.92.7.2840; Wagner BL, 1998, MOL CELL BIOL, V18, P1369; Komine M, 1996, J INVEST DERMATOL, V107, P569, DOI 10.1111/1523-1747.ep12582820; VERMA IM, 1995, GENE DEV, V9, P2723, DOI 10.1101/gad.9.22.2723; JIANG CK, 1994, MOL CELL BIOL, V14, P4759; Wang XZ, 1996, SCIENCE, V272, P1347, DOI 10.1126/science.272.5266.1347; Chen PL, 1996, GENE DEV, V10, P2794, DOI 10.1101/gad.10.21.2794; Regnier CH, 1997, CELL, V90, P373, DOI 10.1016/S0092-8674(00)80344-X; Tomic-Canic M, 1998, J DERMATOL SCI, V17, P167, DOI 10.1016/S0923-1811(98)00016-4; Zandi E, 1998, SCIENCE, V281, P1360, DOI 10.1126/science.281.5381.1360; DiDonato J, 1996, MOL CELL BIOL, V16, P1295; Kondo S, 1997, EUR J IMMUNOL, V27, P1713, DOI 10.1002/eji.1830270718; KUNSCH C, 1994, J IMMUNOL, V153, P153; KOPP E, 1994, SCIENCE, V265, P956, DOI 10.1126/science.8052854; Shu HB, 1996, P NATL ACAD SCI USA, V93, P13973, DOI 10.1073/pnas.93.24.13973; Zhong HH, 1997, CELL, V89, P413, DOI 10.1016/S0092-8674(00)80222-6; TANAKA T, 1995, CELL, V80, P353, DOI 10.1016/0092-8674(95)90418-2; NESTLE FO, 1994, J INVEST DERMATOL, V103, P569, DOI 10.1111/1523-1747.ep12396876; JIANG CK, 1993, P NATL ACAD SCI USA, V90, P6786, DOI 10.1073/pnas.90.14.6786; Li ZW, 1999, J EXP MED, V189, P1839, DOI 10.1084/jem.189.11.1839; AKIRA S, 1990, EMBO J, V9, P1897; MUTASIM DF, 1993, J INVEST DERMATOL, V101, P624, DOI 10.1111/1523-1747.ep12366084; MATSUSAKA T, 1993, P NATL ACAD SCI USA, V90, P10193, DOI 10.1073/pnas.90.21.10193; STEIN B, 1993, MOL CELL BIOL, V13, P7191; BEG AA, 1993, MOL CELL BIOL, V13, P3301; BARKER JNWN, 1991, LANCET, V337, P211, DOI 10.1016/0140-6736(91)92168-2; Li QT, 1999, SCIENCE, V284, P321, DOI 10.1126/science.284.5412.321; Takeda K, 1999, SCIENCE, V284, P313, DOI 10.1126/science.284.5412.313; Qin JZ, 1999, J BIOL CHEM, V274, P37957, DOI 10.1074/jbc.274.53.37957; Hu YL, 1999, SCIENCE, V284, P316, DOI 10.1126/science.284.5412.316; Marino MW, 1997, P NATL ACAD SCI USA, V94, P8093, DOI 10.1073/pnas.94.15.8093; Zhu SY, 1999, MOL CELL BIOL, V19, P7181; KUTSCH CL, 1993, J INVEST DERMATOL, V101, P79, DOI 10.1111/1523-1747.ep12360119; Klement JF, 1996, MOL CELL BIOL, V16, P2341; Seitz CS, 1998, P NATL ACAD SCI USA, V95, P2307, DOI 10.1073/pnas.95.5.2307; RON D, 1992, GENE DEV, V6, P439, DOI 10.1101/gad.6.3.439; Bernerd Francoise, 1993, Gene Expression, V3, P187; BHORA FY, 1995, J SURG RES, V59, P236, DOI 10.1006/jsre.1995.1160; BOWDEN PE, 1995, NAT GENET, V10, P363, DOI 10.1038/ng0795-363; BRASIER AR, 1990, EMBO J, V9, P3933; DICKINSON AM, 1994, BONE MARROW TRANSPL, V13, P65; Gilhar A, 1996, CLIN EXP IMMUNOL, V106, P134, DOI 10.1046/j.1365-2249.1996.d01-802.x; GRIFFITHS CEM, 1989, J AM ACAD DERMATOL, V20, P617, DOI 10.1016/S0190-9622(89)70073-6; HSU W, 1993, MOL CELL BIOL, V13, P2515; JIANG CK, 1991, J INVEST DERMATOL, V97, P969, DOI 10.1111/1523-1747.ep12491889; KATARANOVSKI M, 1999, ACTA DERM-VENEREOL, V8, P131; KLAMPFER L, 1994, MOL CELL BIOL, V14, P6561; KRISTENSEN M, 1993, CLIN EXP IMMUNOL, V94, P354; Kupper TS, 1995, J INVEST DERMATOL, V105, P62; Ma SH, 1997, GENE EXPRESSION, V6, P361; Magae J, 1997, ONCOGENE, V15, P759, DOI 10.1038/sj.onc.1201251; Maniatis T., 1989, MOL CLONING LAB MANU; Matsumoto K, 1997, EXP DERMATOL, V6, P13, DOI 10.1111/j.1600-0625.1997.tb00140.x; Maytin EV, 1998, J INVEST DERMATOL, V110, P238, DOI 10.1046/j.1523-1747.1998.00123.x; MIDDLETON MH, 1995, J INVEST DERMATOL, V104, P489, DOI 10.1111/1523-1747.ep12605923; Mink S, 1996, P NATL ACAD SCI USA, V93, P6635, DOI 10.1073/pnas.93.13.6635; MIYAMOTO S, 1995, ADV CANCER RES, V66, P255, DOI 10.1016/S0065-230X(08)60257-2; NAKAJIMA T, 1993, P NATL ACAD SCI USA, V90, P2207, DOI 10.1073/pnas.90.6.2207; Natesan S, 1997, NATURE, V390, P349, DOI 10.1038/37019; NAVARRO JM, 1995, J BIOL CHEM, V270, P21362; NICKOLOFF BJ, 1993, AM J PATHOL, V143, P325; NISHIO Y, 1993, MOL CELL BIOL, V13, P1854; NOVAK TJ, 1990, MOL CELL BIOL, V10, P6325; Oh HS, 1998, J INVEST DERMATOL, V110, P939, DOI 10.1046/j.1523-1747.1998.00199.x; OXHOLM A, 1988, BRIT J DERMATOL, V118, P369, DOI 10.1111/j.1365-2133.1988.tb02430.x; PILLAI S, 1989, J CLIN INVEST, V83, P816, DOI 10.1172/JCI113963; RANDOLPH RK, 1993, J BIOL CHEM, V268, P9198; RAY A, 1995, DNA CELL BIOL, V14, P795, DOI 10.1089/dna.1995.14.795; REUNING U, 1995, NUCLEIC ACIDS RES, V23, P3887, DOI 10.1093/nar/23.19.3887; Rothnagel JA, 1999, DIFFERENTIATION, V65, P119, DOI 10.1046/j.1432-0436.1999.6520119.x; SCHERMER A, 1989, DIFFERENTIATION, V42, P103, DOI 10.1111/j.1432-0436.1989.tb00611.x; Schweizer Juergen, 1993, P33; SELLS SF, 1995, MOL CELL BIOL, V15, P682; SIMON M, 1984, CELL, V36, P827, DOI 10.1016/0092-8674(84)90032-1; Smith FJD, 1998, HUM MOL GENET, V7, P1143, DOI 10.1093/hmg/7.7.1143; STEIN B, 1993, MOL CELL BIOL, V13, P3964; Takahashi K, 1997, J BIOL CHEM, V272, P11979, DOI 10.1074/jbc.272.18.11979; Takahashi K, 1998, GENOMICS, V53, P170, DOI 10.1006/geno.1998.5476; TAKAHASHI K, 1995, J BIOL CHEM, V270, P18581; TOMIC M, 1990, NUCLEIC ACIDS RES, V18, P1656, DOI 10.1093/nar/18.6.1656; TRAUTWEIN C, 1993, NATURE, V364, P544, DOI 10.1038/364544a0; TREFZER U, 1991, J INVEST DERMATOL, V97, P911, DOI 10.1111/1523-1747.ep12491668; VALYINAGY I, 1992, J INVEST DERMATOL, V99, P350, DOI 10.1111/1523-1747.ep12616672; WEISS RA, 1984, J CELL BIOL, V98, P1397, DOI 10.1083/jcb.98.4.1397; WETZELS RHW, 1991, AM J PATHOL, V138, P751; White PJ, 1999, J INVEST DERMATOL, V112, P887, DOI 10.1046/j.1523-1747.1999.00593.x; Wojcik SM, 1999, DIFFERENTIATION, V65, P97, DOI 10.1046/j.1432-0436.1999.6520097.x	89	50	51	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	OCT 13	2000	275	41					32077	32088		10.1074/jbc.M001253200		12	Biochemistry & Molecular Biology	Biochemistry & Molecular Biology	363VT	WOS:000089858900073		
J	Tokeshi, M; Minagawa, T; Kitamori, T				Tokeshi, M; Minagawa, T; Kitamori, T			Integration of a microextraction system - Solvent extraction of a Co-2-nitroso-5-dimethylaminophenol complex on a microchip	JOURNAL OF CHROMATOGRAPHY A			English	Article; Proceedings Paper	13th International Symposium on High Performance Capillary Electrophoresis and Related Microscale Techniques (HPCE 2000)	FEB 20-24, 2000	SAARBRIICKEN, GERMANY	Deutsch Forsch GmbH, Minist Bildung, Kultur & Wissensch Saarland		extraction methods; microchips; instrumentation; thermal lens microscopy; metal complexes; nitrosodimethylaminophenol; cobalt	CHIPS	A newly designed microchannel for solvent extraction was fabricated in a quartz glass chip and applied to solvent extraction of a Co-2-nitroso-5-dimethylaminophenol complex. The aqueous solution of Co complex and toluene were introduced into the microchannel, and the Co complex extracted in toluene was detected by thermal lens microscopy (TLM). The Co complex was quickly extracted into toluene when the flow was stopped. The observed extraction time, ca. 50 s, was almost equivalent to the value calculated using the diffusion distance and diffusion coefficient. The dependence of the TLM signal on the concentration of the Co complex showed good linearity in the range of 1.10(-7)-1.10(-6) M. (C) 2000 Elsevier Science B.V. All rights reserved.	Kanagawa Acad Sci & Technol, Integrated Chem Project, Takatsu Ku, Kanagawa 2130012, Japan; Univ Tokyo, Grad Sch Engn, Dept Appl Chem, Bunkyo Ku, Tokyo 1138656, Japan	Kitamori, T (reprint author), Kanagawa Acad Sci & Technol, Integrated Chem Project, Takatsu Ku, 3-2-1 Sakado, Kanagawa 2130012, Japan.		Tokeshi, Manabu/B-6257-2012				Burns MA, 1998, SCIENCE, V282, P484, DOI 10.1126/science.282.5388.484; Sato K, 2000, ANAL CHEM, V72, P1144, DOI 10.1021/ac991151r; Tokeshi M, 2000, ANAL CHEM, V72, P1711, DOI 10.1021/ac991147f; Bialkowski S. E., 1996, PHOTOTHERMAL SPECTRO; HARRISON DJ, 1998, MICRO TOTAL ANAL SYS; Khaledi M.G., 1998, HIGH PERFORMANCE CAP; Lide D.R., 1997, CRC HDB CHEM PHYSICS, P5; MOTOMIZU S, 1971, ANAL CHIM ACTA, V56, P415, DOI 10.1016/S0003-2670(01)80931-4; MOTOMIZU S, 1972, ANALYST, V97, P986, DOI 10.1039/an9729700986; Regnier FE, 1999, TRENDS BIOTECHNOL, V17, P101, DOI 10.1016/S0167-7799(98)01294-3; SalimiMoosavi H, 1997, J AM CHEM SOC, V119, P8716, DOI 10.1021/ja971735f; Sato K, 1999, ANAL SCI, V15, P641, DOI 10.2116/analsci.15.641; Sato K, 2000, ANAL SCI, V16, P455, DOI 10.2116/analsci.16.455; Sato K, 1999, ANAL SCI, V15, P525, DOI 10.2116/analsci.15.525; THAYER AM, 1999, C E NEWS        0212, P28; Tokeshi M, 1999, J LUMIN, V83-4, P261, DOI 10.1016/S0022-2313(99)00109-X	16	85	86	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	0021-9673			J CHROMATOGR A	J. Chromatogr. A	OCT 13	2000	894	1-2					19	23		10.1016/S0021-9673(00)00683-X		5	Biochemical Research Methods; Chemistry, Analytical	Biochemistry & Molecular Biology; Chemistry	364ZX	WOS:000089924900004		
J	Tanaka, Y; Slyadnev, MN; Hibara, A; Tokeshi, M; Kitamori, T				Tanaka, Y; Slyadnev, MN; Hibara, A; Tokeshi, M; Kitamori, T			Non-contact photothermal control of enzyme reactions on a microchip by using a compact diode laser	JOURNAL OF CHROMATOGRAPHY A			English	Article; Proceedings Paper	13th International Symposium on High Performance Capillary Electrophoresis and Related Microscale Techniques (HPCE 2000)	FEB 20-24, 2000	SAARBRIICKEN, GERMANY	Deutsch Forsch GmbH, Minist Bildung, Kultur & Wissensch Saarland		microchips; microchannels; thermal lens detection; instrumentation; diaminobenzidine tetrahydrochloride; peroxidase; enzymes; hydrogen peroxide	PCR AMPLIFICATION; DNA; INTEGRATION; SYSTEMS; REACTOR	Photothermal temperature control of an enzyme-catalyzed reaction in a microchip using a diode laser was demonstrated. A laser beam with energy of 10 mW was used to irradiate an absorbing target placed on top of the microchip cover plate. Theoretical calculations have shown that temperature in the microchannel can be locally increased by 5-7 degrees C during short time intervals, due to heat released by the target. The rate of the enzyme reaction, which was initially inhibited due to cooling of the chip to low temperature, was increased when the target was irradiated. The products were detected by a thermal lens microscope. The product concentration was shown to depend on irradiation time, laser intensity and substrate concentration. Reaction characteristics (rate constant of the reaction) were then derived from these dependencies. The reaction volume and absolute quantity of the reaction product were estimated as 10 nl and 100 fmol, respectively. It was also demonstrated that a direct solvent heating method using infrared radiation could control the reaction in the microchannel. (C) 2000 Elsevier Science B.V. All rights reserved.	Univ Tokyo, Dept Appl Chem, Sch Engn, Bunkyo Ku, Tokyo 1138656, Japan; Kanagawa Acad Sci & Technol, Integrated Chem Project, Kawasaki, Kanagawa 2130012, Japan	Kitamori, T (reprint author), Univ Tokyo, Dept Appl Chem, Sch Engn, Bunkyo Ku, 7-3-1 Hongo, Tokyo 1138656, Japan.		Tokeshi, Manabu/B-6257-2012; Tanaka, Yuki/F-9506-2013; Hibara, Akihide/B-9294-2015	Hibara, Akihide/0000-0003-0258-3361			Kenis PJA, 1999, SCIENCE, V285, P83, DOI 10.1126/science.285.5424.83; Sato K, 2000, ANAL CHEM, V72, P1144, DOI 10.1021/ac991151r; Oda RP, 1998, ANAL CHEM, V70, P4361, DOI 10.1021/ac980452i; Kopp MU, 1998, SCIENCE, V280, P1046, DOI 10.1126/science.280.5366.1046; Tokeshi M, 2000, ANAL CHEM, V72, P1711, DOI 10.1021/ac991147f; Arora A, 1997, ANAL COMMUN, V34, P393, DOI 10.1039/a706974j; Bialkowski S. E., 1996, PHOTOTHERMAL SPECTRO; Chiem NH, 1998, CLIN CHEM, V44, P591; Eijkel JCT, 1998, J CHROMATOGR A, V815, P265, DOI 10.1016/S0021-9673(98)00459-2; Guo ZX, 1999, ANAL CHIM ACTA, V379, P63, DOI 10.1016/S0003-2670(98)00625-4; Mullis KB, 1994, POLYM CHAIN REACTION; SalimiMoosavi H, 1997, J AM CHEM SOC, V119, P8716, DOI 10.1021/ja971735f; Sato K, 1999, ANAL SCI, V15, P641, DOI 10.2116/analsci.15.641; Sato K, 2000, ANAL SCI, V16, P455, DOI 10.2116/analsci.16.455; Sato K, 1999, ANAL SCI, V15, P525, DOI 10.2116/analsci.15.525; Swerdlow H, 1997, ANAL CHEM, V69, P848, DOI 10.1021/ac961104o; Waters LC, 1998, ANAL CHEM, V70, P5172, DOI 10.1021/ac980447e; Woolley AT, 1996, ANAL CHEM, V68, P4081, DOI 10.1021/ac960718q	18	76	76	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	0021-9673			J CHROMATOGR A	J. Chromatogr. A	OCT 13	2000	894	1-2					45	51		10.1016/S0021-9673(00)00593-8		7	Biochemical Research Methods; Chemistry, Analytical	Biochemistry & Molecular Biology; Chemistry	364ZX	WOS:000089924900007		
J	Sakovich, SY; Tsuchida, T				Sakovich, SY; Tsuchida, T			Symmetrically coupled higher-order nonlinear Schrodinger equations: singularity analysis and integrability	JOURNAL OF PHYSICS A-MATHEMATICAL AND GENERAL			English	Article							PAINLEVE ANALYSIS; OPTICAL SOLITONS; SOLITARY WAVES; SYSTEMS; DISPERSION; BRIGHT	The integrability of a system of two symmetrically coupled higher-order nonlinear Schrodinger equations with parameter coefficients is tested by means of singularity analysis. It is proven that the system passes the Painleve test for integrability only in ten distinct cases, of which two are new. For one of the new cases, a Lax pair and a multi-held generalization are obtained; for the other one, the equations of the system are uncoupled by a nonlinear transformation.	Natl Acad Sci, Inst Phys, Minsk, Byelarus; Univ Tokyo, Grad Sch Sci, Dept Phys, Bunkyo Ku, Tokyo 1130033, Japan	Sakovich, SY (reprint author), Natl Acad Sci, Inst Phys, PO 72, Minsk, Byelarus.						Agrawal G. P., 1995, NONLINEAR FIBER OPTI; Porsezian K, 1996, PHYS REV LETT, V76, P3955, DOI 10.1103/PhysRevLett.76.3955; SASA N, 1991, J PHYS SOC JPN, V60, P409, DOI 10.1143/JPSJ.60.409; CLARKSON PA, 1987, J PHYS A-MATH GEN, V20, P2003, DOI 10.1088/0305-4470/20/8/020; Gedalin M, 1997, PHYS REV LETT, V78, P448, DOI 10.1103/PhysRevLett.78.448; NIJHOF JHB, 1992, J PHYS A-MATH GEN, V25, P2403, DOI 10.1088/0305-4470/25/8/047; Mihalache D, 1997, PHYS REV E, V56, P1064, DOI 10.1103/PhysRevE.56.1064; KAUP DJ, 1978, J MATH PHYS, V19, P798, DOI 10.1063/1.523737; HIROTA R, 1973, J MATH PHYS, V14, P805, DOI 10.1063/1.1666399; KODAMA Y, 1987, IEEE J QUANTUM ELECT, V23, P510, DOI 10.1109/JQE.1987.1073392; KODAMA Y, 1985, J STAT PHYS, V39, P597, DOI 10.1007/BF01008354; PORSEZIAN K, 1994, PHYS REV E, V50, P1543, DOI 10.1103/PhysRevE.50.1543; Sakovich SY, 1997, J PHYS SOC JPN, V66, P2527, DOI 10.1143/JPSJ.66.2527; WEISS J, 1983, J MATH PHYS, V24, P522, DOI 10.1063/1.525721; CHEN HH, 1979, PHYS SCRIPTA, V20, P490, DOI 10.1088/0031-8949/20/3-4/026; Park QH, 1999, PHYS REV E, V59, P2373, DOI 10.1103/PhysRevE.59.2373; Tsuchida T, 1999, PHYS LETT A, V257, P53, DOI 10.1016/S0375-9601(99)00272-8; JIMBO M, 1982, PHYS LETT A, V92, P59, DOI 10.1016/0375-9601(82)90291-2; SAHADEVAN R, 1986, J PHYS A-MATH GEN, V19, P1783, DOI 10.1088/0305-4470/19/10/019; TASGAL RS, 1992, J MATH PHYS, V33, P1208, DOI 10.1063/1.529732; Radhakrishnan R, 1995, J PHYS A-MATH GEN, V28, P7299, DOI 10.1088/0305-4470/28/24/025; Tsuchida T, 1998, J PHYS SOC JPN, V67, P1175, DOI 10.1143/JPSJ.67.1175; ATHORNE C, 1987, J PHYS A-MATH GEN, V20, P1377, DOI 10.1088/0305-4470/20/6/021; Goktas U, 1997, J SYMB COMPUT, V24, P591, DOI 10.1006/jsco.1997.0154; Kovalevskaya Sofya, 1889, ACTA MATH, V12, P177; Nakkeeran K, 1998, PHYS REV LETT, V80, P1425, DOI 10.1103/PhysRevLett.80.1425; SAKOVICH SY, 2000, ARXIVNLINSI0002023; SAKOVICH SY, 2000, ARXIVNLINSI0004025; SVINOLUPOV SI, 1994, THEOR MATH PHYS+, V100, P959, DOI 10.1007/BF01016758; Tsuchida T, 1999, INVERSE PROBL, V15, P1363, DOI 10.1088/0266-5611/15/5/317; Wolfram S, 1999, MATH BOOK; YAJIMA N, 1975, PROG THEOR PHYS, V54, P1576, DOI 10.1143/PTP.54.1576	32	26	26	IOP PUBLISHING LTD	BRISTOL	DIRAC HOUSE, TEMPLE BACK, BRISTOL BS1 6BE, ENGLAND	0305-4470			J PHYS A-MATH GEN	J. Phys. A-Math. Gen.	OCT 13	2000	33	40					7217	7226		10.1088/0305-4470/33/40/316		10	Physics, Multidisciplinary; Physics, Mathematical	Physics	368GL	WOS:000090109300016		
J	Itoh, K; Yumoto, M; Uno, A; Kurauchi, T; Kaga, K				Itoh, K; Yumoto, M; Uno, A; Kurauchi, T; Kaga, K			Temporal stream of cortical representation for auditory spatial localization in human hemispheres	NEUROSCIENCE LETTERS			English	Article						sound localization; magnetoencephalography; middle-latency responses; interaural time difference; auditory cortex; right hemisphere; human brain mapping	INTERAURAL TIME DIFFERENCE; CORTEX; SYSTEM; FIELDS	We measured human evoked magnetic fields to binaural sounds with an interaural time delay as a cue for auditory localization. By analyzing the topography of auditon/-evoked magnetic fields in the middle-latency, we demonstrated that particular cortical regions represent the direction of sound localization by their activity level. Upon presenting a binaural sound, the first representations were found in the middle frontal region as well as the superior temporal region of the right hemisphere approximately 19 ms after the stimulation, but their patterns differed. Other cortical regions including the prefrontal and parietal spatial areas were affected within roughly 60 ms. The results showed that the right hemisphere is dominant even in the preattentive stage of auditory spatial processing of sounds from different directions. (C) 2000 Elsevier Science Ireland Ltd. All rights reserved.	Univ Tokyo, Sch Med, Dept Speech & Cognit Sci, Tokyo 1130033, Japan; Univ Tokyo, Sch Med, Dept Clin Lab, Tokyo 1130033, Japan; Natl Ctr Neurol & Psychiat, NIMH, Chiba 2720827, Japan; Univ Tokyo, Sch Med, Dept Otolaryngol, Tokyo 1130033, Japan	Itoh, K (reprint author), Univ Tokyo, Sch Med, Dept Speech & Cognit Sci, Tokyo 1130033, Japan.						Cohen YE, 1999, TRENDS NEUROSCI, V22, P128, DOI 10.1016/S0166-2236(98)01295-8; LEHMANN D, 1980, ELECTROEN CLIN NEURO, V48, P609, DOI 10.1016/0013-4694(80)90419-8; Baumgart F, 1999, NATURE, V400, P724, DOI 10.1038/23390; Romanski LM, 1999, NAT NEUROSCI, V2, P1131, DOI 10.1038/16056; Alho K, 1999, COGNITIVE BRAIN RES, V7, P335, DOI 10.1016/S0926-6410(98)00036-6; Joris PX, 1998, NEURON, V21, P1235, DOI 10.1016/S0896-6273(00)80643-1; Corbetta M, 2000, NAT NEUROSCI, V3, P292, DOI 10.1038/73009; Hackett TA, 1999, BRAIN RES, V817, P45, DOI 10.1016/S0006-8993(98)01182-2; Bushara KO, 1999, NAT NEUROSCI, V2, P759; Weeks RA, 1999, NEUROSCI LETT, V262, P155, DOI 10.1016/S0304-3940(99)00062-2; Darwin CJ, 1998, J ACOUST SOC AM, V103, P1080, DOI 10.1121/1.421221; Furukawa S, 2000, J NEUROSCI, V20, P1216; Goff W. R., 1978, EVOKED ELECT ACTIVIT, P505; GOMES H, 1995, J COGNITIVE NEUROSCI, V7, P81, DOI 10.1162/jocn.1995.7.1.81; Griffiths TD, 2000, HUM BRAIN MAPP, V9, P72, DOI 10.1002/(SICI)1097-0193(200002)9:2<72::AID-HBM2>3.0.CO;2-9; ITOH K, 1985, BIOL CYBERN, V52, P229, DOI 10.1007/BF00336979; MCEVOY L, 1994, HEARING RES, V78, P249, DOI 10.1016/0378-5955(94)90031-0; Recanzone GH, 2000, J NEUROPHYSIOL, V83, P2723; Yamada K, 1996, HEARING RES, V101, P173, DOI 10.1016/S0378-5955(96)00144-X; Yund EW, 1999, BRAIN LANG, V66, P358, DOI 10.1006/brln.1998.2034	20	19	21	ELSEVIER SCI IRELAND LTD	CLARE	CUSTOMER RELATIONS MANAGER, BAY 15, SHANNON INDUSTRIAL ESTATE CO, CLARE, IRELAND	0304-3940			NEUROSCI LETT	Neurosci. Lett.	OCT 13	2000	292	3					215	219		10.1016/S0304-3940(00)01465-8		5	Neurosciences	Neurosciences & Neurology	361VF	WOS:000089744400019		
J	Ohkoshi, S; Mizuno, M; Hung, G; Hashimoto, K				Ohkoshi, S; Mizuno, M; Hung, G; Hashimoto, K			Magnetooptical effects of room temperature molecular-based magnetic films composed of vanadium hexacyanochromates	JOURNAL OF PHYSICAL CHEMISTRY B			English	Letter							PRUSSIAN BLUE ANALOGS; CHROMIUM POLYCYANIDES; ORDERING TEMPERATURE; CYANIDE; TRANSITION	We electrochemically synthesized film-type vanadium hexacyanochromate-based magnets with high critical temperatures (T-c): K(0.31)(I)V(0.49)(II)V(III)0.51[Cr-III(CN)6](0.94).6.5H(2)O (1) (T-c = 310 K) and (K0.61V0.97VIII0.03)-V-I-V-II[Cr-III(CN)(6)](0.88). 7.2H(2)O(0.4)C(2)H(5)OH (2) (T-c = 345 K). The colors of these films were blue and dark blue. For film 1, the Faraday ellipticity (FE) spectra showed a weak negative peak (A) and a strong negative peak (B) around 550 nm (-640 deg cm(-1) at 50 K) and 660 nm (-2300 deg cm(-1) at 50 K), respectively. In the Faraday rotation (FR) spectra, two dispersive-shaped lines were observed at the same wavelength. Simulation of these spectra showed that the observed spectra can be classified as the paramagnetic type of Faraday effects. For film 2, the Faraday effect was observed even above room temperature. In its FE spectra, two negative peaks were observed around 530 nm (-850 deg cm(-1) at 50 K) and 660 nm (-300 deg cm(-1) at 50 K), respectively. These FE peak positions are close to the peak positions of A and B for film 1, suggesting that the origins of the Faraday effects of 1 and 2 are the same. Based on stoichiometric coefficients of the obtained films, A and B bands were assigned to the intervalence transfer (IT) bands of V-II-NC-Cr-III and Vm-NC-Crm, respectively. The present Faraday spectra in the ferromagnetic region are the first to be observed among molecular-based magnets.	Univ Tokyo, Adv Sci & Technol Res Ctr, Meguro Ku, Tokyo 1538904, Japan	Hashimoto, K (reprint author), Univ Tokyo, Adv Sci & Technol Res Ctr, Meguro Ku, 4-6-1 Komaba, Tokyo 1538904, Japan.		Hashimoto, Kazuhito/C-5011-2012	Hashimoto, Kazuhito/0000-0002-8384-8749			MALLAH T, 1993, SCIENCE, V262, P1554, DOI 10.1126/science.262.5139.1554; FERLAY S, 1995, NATURE, V378, P701, DOI 10.1038/378701a0; Dujardin E, 1998, J AM CHEM SOC, V120, P11347, DOI 10.1021/ja974076f; Ohkoshi S, 1997, PHYS REV B, V56, P11642, DOI 10.1103/PhysRevB.56.11642; Ohkoshi S, 1999, PHYS REV B, V60, P12820, DOI 10.1103/PhysRevB.60.12820; Hatlevik O, 1999, ADV MATER, V11, P914, DOI 10.1002/(SICI)1521-4095(199908)11:11<914::AID-ADMA914>3.0.CO;2-T; Ohkoshi S, 1999, J AM CHEM SOC, V121, P10591, DOI 10.1021/ja991473c; Sato O, 1996, SCIENCE, V271, P49, DOI 10.1126/science.271.5245.49; Sato O, 1996, SCIENCE, V272, P704, DOI 10.1126/science.272.5262.704; MILLER JS, 1994, ANGEW CHEM INT EDIT, V33, P385, DOI 10.1002/anie.199403851; Ohkoshi S, 1999, J ELECTROANAL CHEM, V473, P245, DOI 10.1016/S0022-0728(99)00173-4; ENTLEY WR, 1994, INORG CHEM, V33, P5165, DOI 10.1021/ic00101a003; ITAYA K, 1986, ACCOUNTS CHEM RES, V19, P162, DOI 10.1021/ar00126a001; GADET V, 1992, J AM CHEM SOC, V114, P9213, DOI 10.1021/ja00049a078; Holmes SM, 1999, J AM CHEM SOC, V121, P5593, DOI 10.1021/ja990946c; Awaga K, 1998, CHEM PHYS LETT, V293, P352, DOI 10.1016/S0009-2614(98)00799-4; Buschmann WE, 1997, ADV MATER, V9, P645, DOI 10.1002/adma.19970090812; Buschmann WE, 1999, CHEM-EUR J, V5, P3019; Day P, 1999, PHILOS T R SOC A, V357, P2851; Gatteschi D., 1991, MAGNETIC MOL MAT; GRIEBLER WD, 1982, Z NATURFORSCH B, V87, P832; HODEN AN, 1956, PHYS REV, V102, P1463; Kahn O., 1993, MOL MAGNETISM; Mallinson J., 1993, FDN MAGNETIC RECORDI; Ohkoshi S, 1998, J AM CHEM SOC, V120, P5349, DOI 10.1021/ja980732f; Ohkoshi S, 1999, CHEM PHYS LETT, V314, P210, DOI 10.1016/S0009-2614(99)01166-5; Sugano S., 2000, MAGNETO OPTICS; Verdaguer M., 1999, COORDIN CHEM REV, V190, P1023, DOI 10.1016/S0010-8545(99)00156-3; Verdaguer M., 1993, C COORD CHEM, V14, P19; WILLIAM RE, 1995, SCIENCE, V268, P397; WOLFE R, 1970, J APPL PHYS, V41, P1218, DOI 10.1063/1.1658881; Zvezdin A. K., 1997, MODERN MAGNETOOPTICS	32	84	84	AMER CHEMICAL SOC	WASHINGTON	1155 16TH ST, NW, WASHINGTON, DC 20036 USA	1089-5647			J PHYS CHEM B	J. Phys. Chem. B	OCT 12	2000	104	40					9365	9367		10.1021/jp002002b		3	Chemistry, Physical	Chemistry	367XR	WOS:000090087600001		
J	Iwasaki, H; Motobayashi, T; Akiyoshi, H; Ando, Y; Fukuda, N; Fujiwara, H; Fulop, Z; Hahn, KI; Higurashi, Y; Hirai, M; Hisanaga, I; Iwasa, N; Kijima, T; Mengoni, A; Minemura, T; Nakamura, T; Notani, M; Ozawa, S; Sagawa, H; Sakurai, H; Shimoura, S; Takeuchi, S; Teranishi, T; Yanagisawa, Y; Ishihara, M				Iwasaki, H; Motobayashi, T; Akiyoshi, H; Ando, Y; Fukuda, N; Fujiwara, H; Fulop, Z; Hahn, KI; Higurashi, Y; Hirai, M; Hisanaga, I; Iwasa, N; Kijima, T; Mengoni, A; Minemura, T; Nakamura, T; Notani, M; Ozawa, S; Sagawa, H; Sakurai, H; Shimoura, S; Takeuchi, S; Teranishi, T; Yanagisawa, Y; Ishihara, M			Low-lying intruder 1(-) state in Be-12 and the melting of the N=8 shell closure	PHYSICS LETTERS B			English	Article							COULOMB DISSOCIATION; LI-11; EXCITATION; NUCLEUS; SPECTROSCOPY; TRANSITIONS	Inelastic scattering of the neutron-rich nucleus Be-12 on lead and carbon targets has been studied by measuring de-excitation gamma rays in coincidence with scattered Be-12. The strong gamma -ray transition from the state at E-x = 2.68(3) MeV following El Coulomb excitation was observed for the lead target, leading to an assignment of J(pi) = 1(-) for the excited state. The low excitation energy of this intruder 1(-) state and the deduced large B(El; O-g.s.(+) --> 1(-)) value of 0.051(13)e(2) fm(2) provide a consistent picture of the N = 8 shell melting in Be-12. (C) 2000 Elsevier Science B.V. All rights reserved.	Univ Tokyo, Dept Phys, Bunkyo Ku, Tokyo 1130033, Japan; Rikkyo Univ, Dept Phys, Tokyo 1718501, Japan; RIKEN, Inst Phys & Chem Res, Wako, Saitama 3510198, Japan; ENEA, Div Appl Phys, I-40129 Bologna, Italy; Uiv Aizu, Ctr Math Sci, Fukushima 9658580, Japan	Iwasaki, H (reprint author), Univ Tokyo, Dept Phys, Bunkyo Ku, 7-3-1 Hongo, Tokyo 1130033, Japan.		Fulop, Zsolt/B-2262-2008; Teranishi, Takashi/D-2166-2012; Shimoura, Susumu/E-8692-2012; Mengoni, Alberto/I-1497-2012; SAKURAI, HIROYOSHI/G-5085-2014; Nakamura, Takashi/N-5390-2015	Shimoura, Susumu/0000-0003-4741-2865; Mengoni, Alberto/0000-0002-2537-0038; 			ANNE R, 1995, Z PHYS A-HADRON NUCL, V352, P397, DOI 10.1007/BF01299757; BERTULANI CA, 1988, PHYS REP, V163, P299, DOI 10.1016/0370-1573(88)90142-1; Korsheninnikov AA, 1997, PHYS REV LETT, V78, P2317, DOI 10.1103/PhysRevLett.78.2317; IEKI K, 1993, PHYS REV LETT, V70, P730, DOI 10.1103/PhysRevLett.70.730; BERTULANI CA, 1994, PHYS REV C, V49, P2688, DOI 10.1103/PhysRevC.49.2688; Zinser M, 1997, NUCL PHYS A, V619, P151, DOI 10.1016/S0375-9474(97)00134-6; SHIMOURA S, 1995, PHYS LETT B, V348, P29, DOI 10.1016/0370-2693(95)00131-4; Iwasaki H, 2000, PHYS LETT B, V481, P7, DOI 10.1016/S0370-2693(00)00428-7; AJZENBERGSELOVE F, 1990, NUCL PHYS A, V506, P1, DOI 10.1016/0375-9474(90)90271-M; TALMI I, 1960, PHYS REV LETT, V4, P469, DOI 10.1103/PhysRevLett.4.469; Aoi N, 1997, NUCL PHYS A, V616, pC181; BARRETTE J, 1988, PHYS LETT B, V209, P182, DOI 10.1016/0370-2693(88)90929-X; BERNAS M, 1982, PHYS LETT B, V116, P7, DOI 10.1016/0370-2693(82)90023-5; Bonaccorso A, 1997, NUCL PHYS A, V615, P245, DOI 10.1016/S0375-9474(97)00013-4; Endt P. M., 1979, Atomic Data and Nuclear Data Tables, V23, DOI 10.1016/0092-640X(79)90020-2; FORTUNE HT, 1994, PHYS REV C, V50, P1355, DOI 10.1103/PhysRevC.50.1355; FRAUERBACH M, 1997, PHYS REV C, V56, pR1; KARACH A, 1992, WOMEN STUD INT FORUM, V15, P309, DOI 10.1016/0277-5395(92)90109-9; Kobayashi T., 1992, NUCL PHYS A, V538, P343, DOI 10.1016/0375-9474(92)90784-H; Mau NV, 1996, NUCL PHYS A, V607, P163; MILLENER DJ, 1983, PHYS REV C, V28, P497, DOI 10.1103/PhysRevC.28.497; MOTOBAYASHI T, 1991, PHYS LETT B, V264, P259, DOI 10.1016/0370-2693(91)90345-Q; MOTOBAYASHI T, 1994, P TOURS S NUCL PHYS, P61; NAKAMURA T, 1994, PHYS LETT B, V331, P296, DOI 10.1016/0370-2693(94)91055-3; RAYNAL J, UNPUB COUPLED CHANNE; SACKETT D, 1993, PHYS REV C, V48, P118, DOI 10.1103/PhysRevC.48.118; SAGAWA H, 1995, Z PHYS A-HADRON NUCL, V351, P385, DOI 10.1007/BF01291143; Suzuki T, 1997, PHYS REV C, V56, P847, DOI 10.1103/PhysRevC.56.847; Suzuki T, 2000, NUCL PHYS A, V662, P282, DOI 10.1016/S0375-9474(99)00364-4; ZAHAR M, 1994, PHYS REV C, V49, P1540, DOI 10.1103/PhysRevC.49.1540; CERN PROGRAM LIB LON	31	145	147	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	0370-2693			PHYS LETT B	Phys. Lett. B	OCT 12	2000	491	1-2					8	14		10.1016/S0370-2693(00)01017-0		7	Astronomy & Astrophysics; Physics, Nuclear; Physics, Particles & Fields	Astronomy & Astrophysics; Physics	366ZD	WOS:000090035400002		
J	Babu, KS; Yanagida, T				Babu, KS; Yanagida, T			Natural mass generation for the sterile neutrino	PHYSICS LETTERS B			English	Article							DYNAMICAL SUPERSYMMETRY BREAKING; BURST	We point out that there is a serious cosmological problem in the supersymmetric standard model if a sterile neutrino is responsible for the solar neutrino oscillation, and propose a possible solution to this problem. We show that our solution induces naturally a mass of order 10(-4) eV for the sterile neutrino, which is deeply related to the mechanism of supersymmetry breaking. (C) 2000 Elsevier Science B.V. All rights reserved.	Oklahoma State Univ, Dept Phys, Stillwater, OK 74078 USA; Univ Tokyo, Dept Phys, Tokyo 1130033, Japan; Univ Tokyo, Res Ctr Early Universe, Tokyo 1130033, Japan	Babu, KS (reprint author), Oklahoma State Univ, Dept Phys, Stillwater, OK 74078 USA.		Yanagida, Tsutomu/A-4394-2011				ARAFUNE J, 1987, PHYS LETT B, V194, P477, DOI 10.1016/0370-2693(87)90220-6; BANKS T, 1994, PHYS REV D, V49, P779, DOI 10.1103/PhysRevD.49.779; Izawa KI, 1996, PROG THEOR PHYS, V95, P829, DOI 10.1143/PTP.95.829; COUGHLAN GD, 1983, PHYS LETT B, V131, P59, DOI 10.1016/0370-2693(83)91091-2; ARAFUNE J, 1987, PHYS REV LETT, V59, P1864, DOI 10.1103/PhysRevLett.59.1864; ARKANIHAMED N, HEPPH0006312; BARGER V, HEPPH0008019; Benakli K, 1997, PHYS REV LETT, V79, P4314, DOI 10.1103/PhysRevLett.79.4314; BORZUMATI F, HEPPH0007018; FOOT R, 1992, MOD PHYS LETT A, V7, P2567, DOI 10.1142/S0217732392004031; Gell-Mann M., 1979, Supergravity; GONZALEZGARCIA MC, 2000, ICHEP 2000 OS JUL; Izawa K, 1995, PROG THEOR PHYS, V94, P1105, DOI 10.1143/PTP.94.1105; Kawasaki M., COMMUNICATION; MILLS G, 2000, NEUTR 20000 19 INT C; SOBEL H, 2000, NEUTR 20000 19 INT C; SUZUKI Y, 2000, NEUTR 2000 19 INT C; Yanagida T., 1979, WORKSH UN THEOR, P95	18	13	13	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	0370-2693			PHYS LETT B	Phys. Lett. B	OCT 12	2000	491	1-2					148	150		10.1016/S0370-2693(00)01030-3		3	Astronomy & Astrophysics; Physics, Nuclear; Physics, Particles & Fields	Astronomy & Astrophysics; Physics	366ZD	WOS:000090035400021		
J	Sakurai, H; Izuoka, A; Sugawara, T				Sakurai, H; Izuoka, A; Sugawara, T			Design, preparation, and electronic structure of high-spin cation diradicals derived from amine-based spin-polarized donors	JOURNAL OF THE AMERICAN CHEMICAL SOCIETY			English	Article							RADICAL-ION SALTS; NITRONYL-NITROXIDE; GROUND-STATE; MAGNETIC-PROPERTIES; FERROMAGNETIC INTERACTION; MOLECULAR MAGNETISM; ORGANIC-MOLECULES; CRYSTAL-STRUCTURE; CT COMPLEXES; TRIMETHYLENEMETHANE	Amine-based donor radicals, such as dimethylamino-, diethylamino- and morpholinonitronyl nitroxides, were synthesized, and their donor abilities were examined by cyclic voltammetry. ESR spectra of the singly oxidized donor radicals showed ground state triplet signals derived from the cation radicals of these donor radicals. The result was interpreted by the presence of the ferromagnetic coupling between the generated pi -spin and the localized unpaired electron on the radical unit. According to the molecular orbital calculations, the ferromagnetic coupling between these two spins is originated from the space sharing nature between SOMO which is localized on the radical unit and SOMO' which is derived from HOMO of the donor radical upon one-electron oxidation. Therefore, the cation-radicals of these donor radicals can be regarded as a heteroanalogue of trimethylenemethane. p- and m-dimethylaminophenyl nitronyl nitroxides were synthesized in order to expand the pi -electronic structure of the donor unit, and the singly oxidized species were also found to afford triplet ESR signals. The origin of the ferromagnetic coupling of these aminophenyl nitronyl nitroxides was discussed on the same basis. Charge transfer complexes of some of the donor radicals with chloranil or 2,3-dichloro-5,6-dicyano-1,4-benzoquinone were prepared, and the conducting and magnetic properties were examined.	Univ Tokyo, Grad Sch Arts & Sci, Dept Basic Sci, Tokyo 1538902, Japan	Sugawara, T (reprint author), Univ Tokyo, Grad Sch Arts & Sci, Dept Basic Sci, 3-8-1 Komaba, Tokyo 1538902, Japan.						ULLMAN EF, 1972, J AM CHEM SOC, V94, P7049, DOI 10.1021/ja00775a031; RAJCA S, 1995, J AM CHEM SOC, V117, P9172, DOI 10.1021/ja00141a008; OVCHINNIKOV AA, 1978, THEOR CHIM ACTA, V47, P297, DOI 10.1007/BF00549259; Rajca A, 1999, J AM CHEM SOC, V121, P6308, DOI 10.1021/ja990881d; DOWD P, 1966, J AM CHEM SOC, V88, P2587, DOI 10.1021/ja00963a039; [Anonymous], 1991, STRUCTURE ANAL PROGR; MILLER JS, 1994, ANGEW CHEM INT EDIT, V33, P385, DOI 10.1002/anie.199403851; Ishiguro K, 1997, J AM CHEM SOC, V119, P3625, DOI 10.1021/ja963289m; Hamachi K, 1998, B CHEM SOC JPN, V71, P2937, DOI 10.1246/bcsj.71.2937; Cramer CJ, 1996, J PHYS CHEM-US, V100, P9664, DOI 10.1021/jp953697x; Selby TD, 1998, J AM CHEM SOC, V120, P12155, DOI 10.1021/ja9821091; Nakatsuji S, 1999, J MATER CHEM, V9, P1747, DOI 10.1039/a900295b; BORDEN WT, 1977, J AM CHEM SOC, V99, P4587, DOI 10.1021/ja00456a010; Wenthold PG, 1996, J AM CHEM SOC, V118, P475, DOI 10.1021/ja9532547; KUMAI R, 1994, J AM CHEM SOC, V116, P4523, DOI 10.1021/ja00089a070; GATTESCHI D, 1994, ADV MATER, V6, P635, DOI 10.1002/adma.19940060903; RAJCA A, 1994, CHEM REV, V94, P871, DOI 10.1021/cr00028a002; Sakurai H, 1996, CHEM LETT, P879, DOI 10.1246/cl.1996.879; Nakazaki J, 1999, TETRAHEDRON LETT, V40, P5027, DOI 10.1016/S0040-4039(99)00925-9; AWAGA K, 1990, CHEM MATER, V2, P535, DOI 10.1021/cm00011a014; BASEMAN RJ, 1976, J AM CHEM SOC, V98, P5726, DOI 10.1021/ja00434a068; Beurskens PT, 1994, DIRDIF 94 PROGRAM SY; BOOCOCK DGB, 1968, J AM CHEM SOC, V90, P6873, DOI 10.1021/ja01026a072; Bushby RJ, 1998, J CHEM SOC PERK T 2, P1069, DOI 10.1039/a706235d; CANESCHI A, 1994, J MATER CHEM, V4, P319, DOI 10.1039/jm9940400319; Cense J.-M., 1989, TETRAHEDRON COMPUTER, V2, P65, DOI 10.1016/0898-5529(89)90030-4; Cocker W, 1938, J CHEM SOC, P751, DOI 10.1039/jr9380000751; DORMANN E, 1987, J AM CHEM SOC, V109, P2594, DOI 10.1021/ja00243a009; DOUGHERTY DA, 1991, ACCOUNTS CHEM RES, V24, P88, DOI 10.1021/ar00003a005; FELLER D, 1981, J CHEM PHYS, V74, P2256, DOI 10.1063/1.441387; HOSOKOSHI Y, 1995, THESIS U TOKYO; HOSOKOSHI Y, 1994, J MATER CHEM, V4, P1219, DOI 10.1039/jm9940401219; ISHIDA T, 1993, MOL CRYST LIQ CRYST, V232, P99, DOI 10.1080/10587259308035703; Itoh K, 1967, CHEM PHYS LETT, V1, P235, DOI 10.1016/0009-2614(67)85061-9; Iwamura H., 1990, ADV PHYS ORG CHEM, V26, P179, DOI DOI 10.1016/S0065-3160(08)60046-5; KOLLMAR C, 1993, ACCOUNTS CHEM RES, V26, P259, DOI 10.1021/ar00029a006; Kumai R, 1996, MOL CRYST LIQ CRYST, V279, P133, DOI 10.1080/10587259608042185; Lahti P. M., 1999, MAGNETIC PROPERTIES; Lahti PM, 1998, J AM CHEM SOC, V120, P5122, DOI 10.1021/ja980120v; LAHTI PM, 1999, MAGNETIC PROPERTIES, P61; LAMCHEN M, 1966, J CHEM SOC C, P2300, DOI 10.1039/j39660002300; Li JB, 1998, J CHEM SOC PERK T 2, P1045, DOI 10.1039/a706267b; Matsuda K, 1996, B CHEM SOC JPN, V69, P1483, DOI 10.1246/bcsj.69.1483; Matsuda K, 2000, CHEM LETT, P16; MILLER JS, 1986, J AM CHEM SOC, V108, P4459, DOI 10.1021/ja00275a036; Nakamura T, 1996, J AM CHEM SOC, V118, P8684, DOI 10.1021/ja954233f; NAKAMURA Y, 1991, CHEM LETT, P69, DOI 10.1246/cl.1991.69; Nakazaki J, 2000, CHEM PHYS LETT, V319, P385, DOI 10.1016/S0009-2614(00)00143-3; Nishide H, 1998, ANGEW CHEM INT EDIT, V37, P2400, DOI 10.1002/(SICI)1521-3773(19980918)37:17<2400::AID-ANIE2400>3.0.CO;2-0; NOGAMI T, 1995, CHEM LETT, P635, DOI 10.1246/cl.1995.635; Okada K, 1997, J AM CHEM SOC, V119, P5740, DOI 10.1021/ja9635084; Sakurai H, 1997, MOL CRYST LIQ CRYS A, V306, P415, DOI 10.1080/10587259708044596; Sato K, 1997, J AM CHEM SOC, V119, P6607, DOI 10.1021/ja963372+; Sheldrick G.M., 1985, CRYSTALLOGRAPHIC COM, V3, P175; Sugano T., 1991, SYNTHETIC MET, V41-43, P3281; Sugawara T, 1997, MOL CRYST LIQ CRYS A, V305, P41, DOI 10.1080/10587259708045045; SUGIMOTO T, 1995, MOL CRYST LIQ CRYST, V272, P183, DOI 10.1080/10587259508055287; SUGIMOTO T, 1993, MOL CRYST LIQ CRYST, V232, P117; TODA F, 1995, CHEM LETT, P861, DOI 10.1246/cl.1995.861; TSUCHIYA M, 1969, B CHEM SOC JPN, V42, P1756, DOI 10.1246/bcsj.42.1756; WASSERMA.E, 1967, J AM CHEM SOC, V89, P5076, DOI 10.1021/ja00995a066; Wienk MM, 1997, J AM CHEM SOC, V119, P4492, DOI 10.1021/ja963772x; YAMAGUCHI K, 1992, CHEM PHYS LETT, V191, P237, DOI 10.1016/0009-2614(92)85294-K; YAMAGUCHI K, 1991, SYNTHETIC MET, V41, P3631; YAMAGUCHI K, 1990, CHEM PHYS LETT, V166, P408, DOI 10.1016/0009-2614(90)85052-E; ZHELUDEV A, 1994, J AM CHEM SOC, V116, P2019, DOI 10.1021/ja00084a048; 1973, Patent No. 3740412	67	50	52	AMER CHEMICAL SOC	WASHINGTON	1155 16TH ST, NW, WASHINGTON, DC 20036 USA	0002-7863			J AM CHEM SOC	J. Am. Chem. Soc.	OCT 11	2000	122	40					9723	9734		10.1021/ja994547t		12	Chemistry, Multidisciplinary	Chemistry	367UB	WOS:000090078900019		
J	Alimonti, G; Aihara, H; Alexander, J; Asano, Y; Bakich, A; Bozek, A; Banas, E; Browder, T; Dragic, J; Fukunaga, C; Gordon, A; Guler, H; Everton, C; Heenan, E; Haba, J; Hazumi, M; Hastings, N; Hara, T; Hojo, T; Higuchi, T; Iwai, G; Ishino, H; Jalocha, P; Korotuschenko, K; Kaneko, J; Kapusta, P; Kawasaki, T; Lange, JS; Li, Y; Marlow, D; Moloney, G; Moffitt, L; Mori, S; Matsubara, T; Nakadaira, T; Nakamura, T; Natkaniec, Z; Okuno, S; Olsen, S; Ostrowicz, W; Palka, H; Peak, LS; Ryuko, J; Rozanska, M; Sevior, M; Shimada, J; Sumisawa, K; Stock, R; Stanic, S; Swain, S; Taylor, G; Takasaki, F; Tajima, H; Trabelsi, K; Tamura, N; Tanaka, J; Tanaka, M; Takahashi, S; Tomura, T; Tsuboyama, T; Tsujita, Y; Varner, G; Varvell, KE; Watanabe, Y; Yamamoto, H; Yamada, Y; Yokoyama, M; Zhao, H; Zontar, D				Alimonti, G; Aihara, H; Alexander, J; Asano, Y; Bakich, A; Bozek, A; Banas, E; Browder, T; Dragic, J; Fukunaga, C; Gordon, A; Guler, H; Everton, C; Heenan, E; Haba, J; Hazumi, M; Hastings, N; Hara, T; Hojo, T; Higuchi, T; Iwai, G; Ishino, H; Jalocha, P; Korotuschenko, K; Kaneko, J; Kapusta, P; Kawasaki, T; Lange, JS; Li, Y; Marlow, D; Moloney, G; Moffitt, L; Mori, S; Matsubara, T; Nakadaira, T; Nakamura, T; Natkaniec, Z; Okuno, S; Olsen, S; Ostrowicz, W; Palka, H; Peak, LS; Ryuko, J; Rozanska, M; Sevior, M; Shimada, J; Sumisawa, K; Stock, R; Stanic, S; Swain, S; Taylor, G; Takasaki, F; Tajima, H; Trabelsi, K; Tamura, N; Tanaka, J; Tanaka, M; Takahashi, S; Tomura, T; Tsuboyama, T; Tsujita, Y; Varner, G; Varvell, KE; Watanabe, Y; Yamamoto, H; Yamada, Y; Yokoyama, M; Zhao, H; Zontar, D			The BELLE silicon vertex detector	NUCLEAR INSTRUMENTS & METHODS IN PHYSICS RESEARCH SECTION A-ACCELERATORS SPECTROMETERS DETECTORS AND ASSOCIATED EQUIPMENT			English	Article; Proceedings Paper	7th International Conference on Instrumentation for Colliding Beam Physics (INSTR99)	NOV 15-19, 1999	HAMAMATSU, JAPAN	Japanese Minist Educ Sci Sports & Culture, Inoue Fdn Sci, Res Fdn Opt Sci & Technol, Fdn High Energy Accelerator Sci		B-factory; BELLE; silicon vertex detector; radiation tolerance; impact parameter	READOUT; DESIGN	A silicon vertex detector has been developed for the BELLE experiment at the KEK B-factory to be used to determine the relative displacements of B-meson decay vertices for CP violation measurements. The device has been successfully installed and operated with high-luminosity beam conditions. The average strip yield is larger than 96%, including the preamplifier electronics yield and the detector is currently working stably with a signal-to-noise ratio of 17-40. The measured impact parameter resolution agrees with expectations based on Monte Carlo simulations, and the measured D-0 lifetime is in good agreement with the particle data roup's average of other measurements. Several B --> J/psiK events produced at the Y(4S) resonance have been detected and separate decay vertices have been found. (C) 2000 Elsevier Science B.V. All rights reserved.	High Energy Accelerator Res Org, Inst Particle & Nucl Studies, Tsukuba, Ibaraki 3050801, Japan; Univ Tokyo, Dept Phys, Bunkyo Ku, Tokyo 1130033, Japan; Univ Hawaii, Dept Phys & Astron, Honolulu, HI 96822 USA; Univ Tsukuba, Inst Appl Phys, Tsukuba, Ibaraki 3058573, Japan; Univ Sydney, Sch Phys, Sydney, NSW 2006, Australia; Inst Nucl Phys, PL-30055 Krakow, Poland; Univ Melbourne, Sch Phys, Parkville, Vic 3079, Australia; Tokyo Metropolitan Univ, Grad Sch Sci, Hachioji, Tokyo 1920397, Japan; Osaka Univ, Grad Sch Sci, Toyonaka, Osaka 5600043, Japan; Niigata Univ, Dept Phys, Niigata 9502181, Japan; Tokyo Inst Technol, Dept Phys, Tokyo 1528551, Japan; Princeton Univ, Dept Phys, Princeton, NJ 08544 USA; Univ Frankfurt, Inst Nucl Phys, D-60054 Frankfurt, Germany; Kanagawa Univ, Fac Engn, Yokohama, Kanagawa 2218686, Japan	Tanaka, M (reprint author), High Energy Accelerator Res Org, Inst Particle & Nucl Studies, Oho 1-1, Tsukuba, Ibaraki 3050801, Japan.		Aihara, Hiroaki/F-3854-2010; Yokoyama, Masashi/A-4458-2011; Marlow, Daniel/C-9132-2014; Ishino, Hirokazu/C-1994-2015	Aihara, Hiroaki/0000-0002-1907-5964; Yokoyama, Masashi/0000-0003-2742-0251; Ishino, Hirokazu/0000-0002-8623-4080			[Anonymous], 1995, 951 KEK; Fast J, 1999, NUCL INSTRUM METH A, V435, P9, DOI 10.1016/S0168-9002(99)00405-2; NYGARD E, 1991, NUCL INSTRUM METH A, V301, P506, DOI 10.1016/0168-9002(91)90018-L; Tanaka M, 1999, NUCL INSTRUM METH A, V432, P422, DOI 10.1016/S0168-9002(99)00504-5; TOKER O, 1994, NUCL INSTRUM METH A, V340, P572, DOI 10.1016/0168-9002(94)90140-6; TSUBOYAMA T, 1999, P 8 INT WORKSH VERT	6	24	24	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	0168-9002			NUCL INSTRUM METH A	Nucl. Instrum. Methods Phys. Res. Sect. A-Accel. Spectrom. Dect. Assoc. Equip.	OCT 11	2000	453	1-2					71	77		10.1016/S0168-9002(00)00608-2		7	Instruments & Instrumentation; Nuclear Science & Technology; Physics, Particles & Fields; Spectroscopy	Instruments & Instrumentation; Nuclear Science & Technology; Physics; Spectroscopy	366PA	WOS:000090012700011		
J	Suzuki, A; Park, H; Aoki, S; Echigo, S; Fujii, K; Hara, T; Iwashita, T; Kitamura, M; Kohama, M; Kume, G; Onchi, M; Otaki, T; Sato, K; Takatsuki, M; Takenaka, K; Tanaka, Y; Tashiro, K; Inagaki, T; Kato, I; Mukai, S; Nakaya, T; Nishikawa, K; Sasao, N; Shima, A; Yokoyama, H; Chikamatsu, T; Hayato, Y; Ishida, T; Ishii, T; Ishino, H; Jeon, EJ; Kobayashi, T; Lee, SB; Nakamura, K; Oyama, Y; Sakai, A; Sakuda, M; Tumakov, V; Fukuda, S; Fukuda, Y; Ishizuka, M; Itow, Y; Kajita, T; Kameda, J; Kaneyuki, K; Kobayashi, K; Kobayashi, Y; Koshio, Y; Miura, M; Moriyama, S; Nakahata, M; Nakayama, S; Obayashi, Y; Okada, A; Sakurai, N; Shiozawa, M; Suzuki, Y; Takeuchi, H; Takeuchi, Y; Totsuka, Y; Toshito, T; Yamada, S; Miyano, K; Nakamura, M; Tamura, N; Nakano, I; Yoshida, M; Kadowaki, T; Kishi, S; Yokoyama, H; Maruyama, T; Etoh, M; Nishijima, K; Bhang, HC; Khang, BH; Kim, BJ; Kim, HI; Kim, JH; Kim, SB; So, H; Yoo, JH; Choi, JH; Jang, HI; Jang, JS; Kim, JY; Lim, IT; Pac, MY; Kearns, E; Scholberg, K; Stone, JL; Sulak, LR; Walter, CW; Casper, D; Gajewski, W; Kropp, W; Mine, S; Sobel, H; Vagins, M; Matsuno, S; Hill, J; Jung, CK; Martens, K; Mauger, C; McGrew, C; Sharkey, E; Yanagisawa, C; Berns, H; Boyd, S; Wilkes, J; Kielczewska, D; Golebiewska, U				Suzuki, A; Park, H; Aoki, S; Echigo, S; Fujii, K; Hara, T; Iwashita, T; Kitamura, M; Kohama, M; Kume, G; Onchi, M; Otaki, T; Sato, K; Takatsuki, M; Takenaka, K; Tanaka, Y; Tashiro, K; Inagaki, T; Kato, I; Mukai, S; Nakaya, T; Nishikawa, K; Sasao, N; Shima, A; Yokoyama, H; Chikamatsu, T; Hayato, Y; Ishida, T; Ishii, T; Ishino, H; Jeon, EJ; Kobayashi, T; Lee, SB; Nakamura, K; Oyama, Y; Sakai, A; Sakuda, M; Tumakov, V; Fukuda, S; Fukuda, Y; Ishizuka, M; Itow, Y; Kajita, T; Kameda, J; Kaneyuki, K; Kobayashi, K; Kobayashi, Y; Koshio, Y; Miura, M; Moriyama, S; Nakahata, M; Nakayama, S; Obayashi, Y; Okada, A; Sakurai, N; Shiozawa, M; Suzuki, Y; Takeuchi, H; Takeuchi, Y; Totsuka, Y; Toshito, T; Yamada, S; Miyano, K; Nakamura, M; Tamura, N; Nakano, I; Yoshida, M; Kadowaki, T; Kishi, S; Yokoyama, H; Maruyama, T; Etoh, M; Nishijima, K; Bhang, HC; Khang, BH; Kim, BJ; Kim, HI; Kim, JH; Kim, SB; So, H; Yoo, JH; Choi, JH; Jang, HI; Jang, JS; Kim, JY; Lim, IT; Pac, MY; Kearns, E; Scholberg, K; Stone, JL; Sulak, LR; Walter, CW; Casper, D; Gajewski, W; Kropp, W; Mine, S; Sobel, H; Vagins, M; Matsuno, S; Hill, J; Jung, CK; Martens, K; Mauger, C; McGrew, C; Sharkey, E; Yanagisawa, C; Berns, H; Boyd, S; Wilkes, J; Kielczewska, D; Golebiewska, U			Design, construction, and operation of SciFi tracking detector for K2K experiment	NUCLEAR INSTRUMENTS & METHODS IN PHYSICS RESEARCH SECTION A-ACCELERATORS SPECTROMETERS DETECTORS AND ASSOCIATED EQUIPMENT			English	Article; Proceedings Paper	7th International Conference on Instrumentation for Colliding Beam Physics (INSTR99)	NOV 15-19, 1999	HAMAMATSU, JAPAN	Japanese Minist Educ Sci Sports & Culture, Inoue Fdn Sci, Res Fdn Opt Sci & Technol, Fdn High Energy Accelerator Sci			OSCILLATION	We describe the construction and performance of a scintillating fiber detector used in the near detector for the K2K (KEK to Kamioka, KEK E362) long baseline neutrino oscillation experiment. The detector uses 3.7 m long and 0.692 mm diameter scintillating fiber coupled to image-intensifier tubes (IIT), and a CCD camera readout system. Fiber sheet production and detector construction beg-an in 1997, and the detector was commissioned in March 1999. Results from the first K2K runs confirm good initial performance: position resolution is estimated to be about 0.8 mm, and track finding efficiency is 98 +/- 2% for long tracks (i.e., those which intersect more than 5 fiber planes). The hit efficiency was estimated to be 92 +/- 2% using cosmic-ray muons, after noise reduction at the offline stage. The possibility of using the detector for particle identification is also discussed. (C) 2000 Published by Elsevier Science B.V. All rights reserved.	Kobe Univ, Kobe, Hyogo, Japan; Kyoto Univ, Kyoto, Japan; KEK, High Energy Accelerator Res Org, Tsukuba, Ibaraki, Japan; Univ Tokyo, Inst Cosm Ray Res, Tanashi, Tokyo, Japan; Niigata Univ, Niigata, Japan; Okayama Univ, Okayama, Japan; Osaka Univ, Toyonaka, Osaka 560, Japan; Sci Univ Tokyo, Noda, Chiba 278, Japan; Tohoku Univ, Sendai, Miyagi 980, Japan; Tokai Univ, Kanagawa 2591100, Japan; Seoul Natl Univ, Seoul, South Korea; Chonnam Natl Univ, Kwangju, South Korea; Dongshin Univ, Naju, South Korea; Boston Univ, Boston, MA 02215 USA; Univ Calif Irvine, Irvine, CA USA; Univ Hawaii, Honolulu, HI 96822 USA; SUNY Stony Brook, Stony Brook, NY 11794 USA; Univ Washington, Seattle, WA 98195 USA; Warsaw Univ, Warsaw, Poland	Suzuki, A (reprint author), Kobe Univ, Kobe, Hyogo, Japan.		Koshio, Yusuke/C-2847-2015; Nakamura, Kenzo/F-7174-2010; Sobel, Henry/A-4369-2011; Obayashi, Yoshihisa/A-4472-2011; Aoki, Shigeki/L-6044-2015; Suzuki, Yoichiro/F-7542-2010; Martens, Kai/A-4323-2011; Mukai, Sada-atsu/A-2380-2013; Kim, Soo-Bong/B-7061-2014; Sakurai, Nobuyuki/M-5009-2014; Ishino, Hirokazu/C-1994-2015	Koshio, Yusuke/0000-0003-0437-8505; Mukai, Sada-atsu/0000-0001-9909-9116; Sakurai, Nobuyuki/0000-0002-1002-217X; Ishino, Hirokazu/0000-0002-8623-4080			Annis P, 1998, NUCL INSTRUM METH A, V412, P19, DOI 10.1016/S0168-9002(98)00276-9; ANSORGE RE, 1988, NUCL INSTRUM METH A, V265, P33, DOI 10.1016/0168-9002(88)91052-2; Fukuda Y, 1998, PHYS REV LETT, V81, P1562, DOI 10.1103/PhysRevLett.81.1562; *CERN PROGR LIBR, 1995, GEANT DET DESC SIM T; FRUHWIRTH R, 1987, NUCL INSTRUM METH A, V262, P444, DOI 10.1016/0168-9002(87)90887-4; ISHIKAWA S, 1995, HOSHASEN, V21, P85; NAKANO T, 1992, IEEE T NUCL SCI, V39; Nishikawa K, 1999, NUCL PHYS B-PROC SUP, V77, P198, DOI 10.1016/S0920-5632(99)00418-1	8	45	45	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	0168-9002			NUCL INSTRUM METH A	Nucl. Instrum. Methods Phys. Res. Sect. A-Accel. Spectrom. Dect. Assoc. Equip.	OCT 11	2000	453	1-2					165	176		10.1016/S0168-9002(00)00624-0		12	Instruments & Instrumentation; Nuclear Science & Technology; Physics, Particles & Fields; Spectroscopy	Instruments & Instrumentation; Nuclear Science & Technology; Physics; Spectroscopy	366PA	WOS:000090012700027		
J	Akiba, Y; Begay, R; Burwood-Hoy, J; Chappell, RB; Crook, DW; Ebisu, K; Emery, MS; Ferrierra, J; Frawley, AD; Hamagaki, H; Hara, H; Hayano, RS; Hemmick, TK; Hibino, M; Hutter, R; Kennedy, M; Kikuchi, J; Matsumoto, T; Moscone, GG; Nagasaka, Y; Nishimura, S; Oyama, K; Sakaguchi, T; Salomone, S; Shigaki, K; Tanaka, Y; Walker, JW; Wintenberg, AL; Young, GR				Akiba, Y; Begay, R; Burwood-Hoy, J; Chappell, RB; Crook, DW; Ebisu, K; Emery, MS; Ferrierra, J; Frawley, AD; Hamagaki, H; Hara, H; Hayano, RS; Hemmick, TK; Hibino, M; Hutter, R; Kennedy, M; Kikuchi, J; Matsumoto, T; Moscone, GG; Nagasaka, Y; Nishimura, S; Oyama, K; Sakaguchi, T; Salomone, S; Shigaki, K; Tanaka, Y; Walker, JW; Wintenberg, AL; Young, GR			The PHENIX ring imaging Cherenkov detector	NUCLEAR INSTRUMENTS & METHODS IN PHYSICS RESEARCH SECTION A-ACCELERATORS SPECTROMETERS DETECTORS AND ASSOCIATED EQUIPMENT			English	Article; Proceedings Paper	7th International Conference on Instrumentation for Colliding Beam Physics (INSTR99)	NOV 15-19, 1999	HAMAMATSU, JAPAN	Japanese Minist Educ Sci Sports & Culture, Inoue Fdn Sci, Res Fdn Opt Sci & Technol, Fdn High Energy Accelerator Sci				The PHENIX experiment at RHIC is primarily a lepton and photon detector. Electron detection takes place in the two central arms of PHENIX, with the primary electron identifier in each arm being a ring imaging Cherenkov detector. This paper contains a description of the two identical RICH detectors and of their expected performance. (C) 2000 Published by Elsevier Science B.V. All rights reserved.	Florida State Univ, Tallahassee, FL 32306 USA; SUNY Stony Brook, Stony Brook, NY 11794 USA; High Energy Accelerator Res Org, Tsukuba, Ibaraki 3050801, Japan; Nagasaki Inst Appl Sci, Nagasaki 8510193, Japan; Oak Ridge Natl Lab, Oak Ridge, TN 37831 USA; Univ Tokyo, Ctr Nucl Study, Tokyo 1880002, Japan; Univ Tokyo, Dept Phys, Tokyo 1130033, Japan; Waseda Univ, Tokyo 1698555, Japan	Frawley, AD (reprint author), Florida State Univ, Tallahassee, FL 32306 USA.		HAMAGAKI, HIDEKI/G-4899-2014; Hayano, Ryugo/F-7889-2012				EGLE W, 1990, OPT ENG, V29, P1267; Morrison DP, 1998, NUCL PHYS A, V638, p565C, DOI 10.1016/S0375-9474(98)00390-X	2	4	4	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	0168-9002			NUCL INSTRUM METH A	Nucl. Instrum. Methods Phys. Res. Sect. A-Accel. Spectrom. Dect. Assoc. Equip.	OCT 11	2000	453	1-2					279	283		10.1016/S0168-9002(00)00645-8		5	Instruments & Instrumentation; Nuclear Science & Technology; Physics, Particles & Fields; Spectroscopy	Instruments & Instrumentation; Nuclear Science & Technology; Physics; Spectroscopy	366PA	WOS:000090012700047		
J	Sakaguchi, T; Akiba, Y; Ebisu, K; Frank, S; Hamagaki, H; Hara, H; Hayano, RS; Hibino, M; Jones, JP; Kametani, S; Kikuchi, J; Matsumoto, T; Moscone, CG; Nishimura, S; Oyama, K; Shigaki, K; Tanaka, Y; Ushiroda, T; Walker, JW; Wintenberg, AL; Young, GR				Sakaguchi, T; Akiba, Y; Ebisu, K; Frank, S; Hamagaki, H; Hara, H; Hayano, RS; Hibino, M; Jones, JP; Kametani, S; Kikuchi, J; Matsumoto, T; Moscone, CG; Nishimura, S; Oyama, K; Shigaki, K; Tanaka, Y; Ushiroda, T; Walker, JW; Wintenberg, AL; Young, GR			Development of front end electronics for PHENIX RICH	NUCLEAR INSTRUMENTS & METHODS IN PHYSICS RESEARCH SECTION A-ACCELERATORS SPECTROMETERS DETECTORS AND ASSOCIATED EQUIPMENT			English	Article; Proceedings Paper	7th International Conference on Instrumentation for Colliding Beam Physics (INSTR99)	NOV 15-19, 1999	HAMAMATSU, JAPAN	Japanese Minist Educ Sci Sports & Culture, Inoue Fdn Sci, Res Fdn Opt Sci & Technol, Fdn High Energy Accelerator Sci			IMAGING CHERENKOV DETECTOR	A new front-end electronics (FEE) for PHENIX Ring Imaging Cherenkov Detector (RICH) has been developed. It consists of custom-made Backplane, Controller module. Readout module and AMU/ADC module, which are capable of processing signals from 5120 Photo-Multiplier Tubes (PMTs). Several tests have been carried out, and RICH FEE was proved to satisfy the requirement of PHENIX experiment. The charge spectrum due to single photo-electron was successfully observed as well. (C) 2000 Elsevier Science B.V. All rights reserved.	Univ Tokyo, Grad Sch Sci, Ctr Nucl Study, Bunkyo Ku, Tokyo 1130033, Japan; High Energy Accelerator Res Org, Tsukuba, Ibaraki 3050801, Japan; Nagasaki Inst Appl Sci, Nagasaki 8510193, Japan; Oak Ridge Natl Lab, Oak Ridge, TN 37831 USA; Univ Tokyo, Grad Sch Sci, Dept Phys, Bunkyo Ku, Tokyo 1130033, Japan; Waseda Univ, Adv Res Inst Sci & Engn, Shinjuku Ku, Tokyo 1698555, Japan	Oyama, K (reprint author), Univ Tokyo, Grad Sch Sci, Ctr Nucl Study, Bunkyo Ku, 7-3-1 Hongo, Tokyo 1130033, Japan.		Hayano, Ryugo/F-7889-2012; HAMAGAKI, HIDEKI/G-4899-2014				Akiba Y, 1999, NUCL INSTRUM METH A, V433, P143, DOI 10.1016/S0168-9002(99)00319-8; Emery MS, 1997, IEEE T NUCL SCI, V44, P374, DOI 10.1109/23.603674; TANAKA Y, IN PRESS NUCL INSTR; Wintenberg AL, 1998, IEEE T NUCL SCI, V45, P758, DOI 10.1109/23.682631	4	2	2	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	0168-9002			NUCL INSTRUM METH A	Nucl. Instrum. Methods Phys. Res. Sect. A-Accel. Spectrom. Dect. Assoc. Equip.	OCT 11	2000	453	1-2					382	385		10.1016/S0168-9002(00)00661-6		4	Instruments & Instrumentation; Nuclear Science & Technology; Physics, Particles & Fields; Spectroscopy	Instruments & Instrumentation; Nuclear Science & Technology; Physics; Spectroscopy	366PA	WOS:000090012700063		
J	Sakamoto, H; Fukunaga, C; Hasuko, K; Ichimiya, R; Ikeno, M; Kano, H; Kobayashi, T; Kurashige, H; Levinson, L; Lupu, N; Niki, T; Nishida, S; Ohska, TK; Sasaki, O; Takeshita, T; Toya, D; Ye, B				Sakamoto, H; Fukunaga, C; Hasuko, K; Ichimiya, R; Ikeno, M; Kano, H; Kobayashi, T; Kurashige, H; Levinson, L; Lupu, N; Niki, T; Nishida, S; Ohska, TK; Sasaki, O; Takeshita, T; Toya, D; Ye, B			Readout system for the ATLAS end cap muon trigger chamber	NUCLEAR INSTRUMENTS & METHODS IN PHYSICS RESEARCH SECTION A-ACCELERATORS SPECTROMETERS DETECTORS AND ASSOCIATED EQUIPMENT			English	Article; Proceedings Paper	7th International Conference on Instrumentation for Colliding Beam Physics (INSTR99)	NOV 15-19, 1999	HAMAMATSU, JAPAN	Japanese Minist Educ Sci Sports & Culture, Inoue Fdn Sci, Res Fdn Opt Sci & Technol, Fdn High Energy Accelerator Sci		readout system; source-synchronous transmission; FPGA; ASIC		A readout system for the ATLAS end cap muon trigger chamber has been developed. The system has a star architecture and a source synchronous serial communication is employed for the data path. FPGA modules are developed for prototyping and trial fabrication of ASIC is on going. (C) 2000 Elsevier Science B.V. All rights reserved.	Kyoto Univ, Dept Phys, Kyoto 6068502, Japan; KEK, High Energy Accelerator Res Org, Tsukuba, Ibaraki 3050801, Japan; Univ Tokyo, Int Ctr Elementary Particle Phys, Tokyo 1130033, Japan; Tokyo Metropolitan Univ, Dept Phys, Hachioji, Tokyo 1920397, Japan; Shinshu Univ, Dept Phys, Matsumoto, Nagano 3908621, Japan; Kobe Univ, Dept Phys, Kobe, Hyogo 6578501, Japan; Univ Sci & Technol China, Dept Modern Phys, Hefei 230027, Anhui, Peoples R China; Weizmann Inst Sci, Weizmann Inst, IL-76100 Rehovot, Israel; Technion Israel Inst Technol, IL-32000 Haifa, Israel	Sakamoto, H (reprint author), Kyoto Univ, Dept Phys, Kyoto 6068502, Japan.		Kurashige, Hisaya/H-4916-2012				*ATLAS, 1998, CERNLHCC9814 ATLAS T; The ATLAS Muon Collaboration, 1997, CERNLHCC9722 ATLAS	2	6	6	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	0168-9002			NUCL INSTRUM METH A	Nucl. Instrum. Methods Phys. Res. Sect. A-Accel. Spectrom. Dect. Assoc. Equip.	OCT 11	2000	453	1-2					430	432		10.1016/S0168-9002(00)00677-X		3	Instruments & Instrumentation; Nuclear Science & Technology; Physics, Particles & Fields; Spectroscopy	Instruments & Instrumentation; Nuclear Science & Technology; Physics; Spectroscopy	366PA	WOS:000090012700071		
J	Thapliya, R; Kamiya, T				Thapliya, R; Kamiya, T			Optimization of multichannel parallel joint transform correlator for accelerated pattern recognition	APPLIED OPTICS			English	Article							SPATIAL LIGHT-MODULATOR; LIQUID-CRYSTAL	The multibeam parallel joint transform correlator for optical pattern recognition, which was recently proposed by the authors [Appl. Opt. 37, 5408 (1998)], can increase parallelism without accumulating zero-order background level at the first Fourier transform plane. To evaluate the throughput capability, an experimental trial was made, achieving a 67-ms recognition rate per face per channel, which is limited by the response of the optically addressed liquid-crystal spatial light modulator. A general design theory is developed for dense packing of the optical channels for a given spatial light modulator resolution, considering the bandwidth requirement of the target image. throughput with state-of-the-art device technology is discussed. Then the condition for submillisecond (C) 2000 Optical Society of America. OCIS codes: 170.2580, 100.0100, 100.4550, 100.5010, 110.4190, 100.1160.	Univ Tokyo, Dept Elect Engn, Bunkyo Ku, Tokyo 1138656, Japan	Thapliya, R (reprint author), Fuji Zerox Co Ltd, Dept Ecosyst Res & Dev, Opt Syst Technol Dev Unit, New Business Ctr,430 Sakai, Kanagawa 2590157, Japan.	kamiyatk@niad.ac.jp					Wang RKK, 1996, APPL OPTICS, V35, P286, DOI 10.1364/AO.35.000286; JAVIDI B, 1988, APPL OPTICS, V27, P663, DOI 10.1364/AO.27.000663; Thapliya R, 1998, APPL OPTICS, V37, P5408, DOI 10.1364/AO.37.005408; Lu GW, 1997, APPL OPTICS, V36, P470, DOI 10.1364/AO.36.000470; MILLER DAB, 1984, APPL PHYS LETT, V45, P13, DOI 10.1063/1.94985; Yaroslavsky LP, 1997, APPL OPTICS, V36, P4816, DOI 10.1364/AO.36.004816; Cohen GB, 1997, APPL OPTICS, V36, P455, DOI 10.1364/AO.36.000455; Goodman J. W., 1996, INTRO FOURIER OPTICS; JAVIDI B, 1991, APPL OPTICS, V30, P4234, DOI 10.1364/AO.30.004234; JAVIDI B, 1989, APPL OPTICS, V28, P236; Kodate K, 1999, APPL OPTICS, V38, P3060, DOI 10.1364/AO.38.003060; LEE SL, 1996, THESIS STANFORD U ST; LI J, 1994, OPT ENG, V33, P3302, DOI 10.1117/12.173569; Lu GW, 1996, APPL OPTICS, V35, P304, DOI 10.1364/AO.35.000304; MUKOHZAKA N, 1994, APPL OPTICS, V33, P2804, DOI 10.1364/AO.33.002804; THAPLIYA R, 1999, THESIS U TOKYO TOKYO; Williams D., 1988, Journal of Physics D (Applied Physics), V21, DOI 10.1088/0022-3727/21/10S/045; YU W, 1997, 1997 OSA TECHNICAL D, V8, P55; ZHAN Q, 1993, JPN J APPL PHYS 1, V32, P3471, DOI 10.1143/JJAP.32.3471; Zhong S, 1997, APPL OPTICS, V36, P1776, DOI 10.1364/AO.36.001776; HAMAMATSU FLC SLM MO; EXAMPLE TEXAS INTSTR	22	5	5	OPTICAL SOC AMER	WASHINGTON	2010 MASSACHUSETTS AVE NW, WASHINGTON, DC 20036 USA	1559-128X	2155-3165		APPL OPTICS	Appl. Optics	OCT 10	2000	39	29					5309	5317		10.1364/AO.39.005309		9	Optics	Optics	362JR	WOS:000089775300005		
J	Saito, Y; Okano, T; Gaill, F; Chanzy, H; Putaux, JL				Saito, Y; Okano, T; Gaill, F; Chanzy, H; Putaux, JL			Structural data on the intra-crystalline swelling of beta-chitin	INTERNATIONAL JOURNAL OF BIOLOGICAL MACROMOLECULES			English	Article						beta-chitin; alpha-chitin; Tevnia jerichonana; intracrystalline swelling; FTIR	ALPHA-CHITIN	The intra-crystalline swelling of the highly crystalline beta-chitin from Tevnia jerichonana was investigated by X-ray crystallography and Fourier transform infrared (FTIR) spectroscopy, using hydrogenated and deuterated hydrochloric acids as swelling agents. Three levels of swelling were identified that could be defined as inter- and intra-sheet swelling. A moderate and reversible swelling in water and methanol gave crystalline beta-chitin cystallosolvates, namely dihydrate and methanolate, respectively. In these, an inter-sheet swelling was observed, corresponding to an expansion of only the b parameter of the unit cell of beta-chitin. Under these swelling conditions, the use of deuterated reagents had no effect on the amide N-H ... O=C hydrogen bonds that hold the structure of beta-chitin together, but only induced a partial and reversible deuteration of the chitin hydroxymethyl groups. A more severe swelling - but still reversible - occurred with 6 N HCl or DCl, which converted the crystals of beta-chitin into a paracrystalline gel-like product resulting from inter-sheet + intra-sheet swelling. With this acid strength, the deuteration pattern indicated that a fraction of the amide hydrogen bonds was broken and became susceptible to an irreversible deuteration. A very severe and irreversible swelling occurred with 8 N HCl or DCl. In that case, the inter- and intra-sheet swelling was extensive to the point where all memory of the parallel-chain P-chitin was lost. In addition, this swelling was accompanied by a drastic and rapid depolymerization. The treatment with 8 N HCl led invariably to crystalline alpha-chitin when the samples were neutralized. (C) 2000 Elsevier Science B.V. All rights reserved.	Univ Grenoble 1, CNRS, Ctr Rech Macromol Vegetales, F-38041 Grenoble 9, France; Univ Tokyo, Grad Sch Agr & Life Sci, Bunkyo Ku, Tokyo 1138657, Japan; Univ Paris 06, Biol Marine Lab, F-75005 Paris, France	Putaux, JL (reprint author), Univ Grenoble 1, CNRS, Ctr Rech Macromol Vegetales, BP 53, F-38041 Grenoble 9, France.	putaux@cermav.cnrs.fr	Chanzy, Henri/A-3526-2012; Putaux, Jean-Luc/A-3488-2012	Putaux, Jean-Luc/0000-0002-9760-5369			FALK M, 1966, CAN J CHEMISTRY, V44, P2269, DOI 10.1139/v66-342; KURITA K, 1994, J POLYM SCI POL CHEM, V32, P1027, DOI 10.1002/pola.1994.080320603; MINKE R, 1978, J MOL BIOL, V120, P167, DOI 10.1016/0022-2836(78)90063-3; HEFFELFINGER CJ, 1960, J POLYM SCI, V47, P289, DOI 10.1002/pol.1960.1204714926; GALAT A, 1979, ACTA BIOCHIM POL, V26, P303; GAILL F, 1992, J STRUCT BIOL, V109, P116, DOI 10.1016/1047-8477(92)90043-A; PEARSON FG, 1960, J POLYM SCI, V43, P101, DOI 10.1002/pol.1960.1204314109; GARDNER KH, 1975, BIOPOLYMERS, V14, P1581, DOI 10.1002/bip.1975.360140804; BLACKWEL.J, 1969, BIOPOLYMERS, V7, P281, DOI 10.1002/bip.1969.360070302; CHANZY H, 1986, HOLZFORSCHUNG, V40, P25; Clark GL, 1936, J PHYS CHEM-US, V40, P863, DOI 10.1021/j150376a001; Herrick F. W., 1983, J APPL POLYM SCI APP, V37, P993; Kurita K., 1997, ADV CHITIN SCI, V2, P320; Lewin M, 1971, J POLYM SCI        C, V36, P213; LOTMAR W, 1950, EXPERIENTIA, V6, P58, DOI 10.1007/BF02174818; RUDALL K. M., 1963, ADVAN INSECT PHYSIOL, V1, P257, DOI 10.1016/S0065-2806(08)60177-0; Rudall K.M., 1973, BIOL REV, V49, P597; Saito Y, 1997, ADV CHITIN SCI, P507; Saito Y, 1997, MACROMOLECULES, V30, P3867, DOI 10.1021/ma961787+; SCHLEICHER H, 1974, J POLYM SCI S, V47, P251; TAKAI M, 1992, ACS S SERIES, V489, P38; Terbojevich M., 1997, CHITIN HDB, P87; WADE RH, 1974, TEXT RES J, V44, P941, DOI 10.1177/004051757404401204; WADSWORTH LC, 1979, TEXT RES J, V49, P424, DOI 10.1177/004051757904900709	24	52	52	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	0141-8130	1879-0003		INT J BIOL MACROMOL	Int. J. Biol. Macromol.	OCT 10	2000	28	1					81	88		10.1016/S0141-8130(00)00147-1		8	Biochemistry & Molecular Biology; Chemistry, Applied; Polymer Science	Biochemistry & Molecular Biology; Chemistry; Polymer Science	365DL	WOS:000089933100010		
J	Onishi, H; Konishi, K; Fujiwara, K; Hayakawa, K; Tanokura, M; Martinez, HM; Morales, MF				Onishi, H; Konishi, K; Fujiwara, K; Hayakawa, K; Tanokura, M; Martinez, HM; Morales, MF			On the tryptophan residue of smooth muscle myosin that responds to binding of nucleotide	PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA			English	Article							DEPENDENT ADENOSINE-TRIPHOSPHATASE; RABBIT SKELETAL-MUSCLE; CHICKEN GIZZARD; MOTOR FUNCTION; HEAD; SUBFRAGMENT-1; PURIFICATION; PHOSPHATE; SCALLOP; ATPASE	Initially, we asked which (of 10) smooth muscle myosin head residues responds to MgADP or MgATP binding with enhanced fluorescence emission (Trp-441 and Trp-512 were leading candidates)? To decide, we prepared sham-mutated smooth muscle heavy meromyosin (HMM), W441F HMM, and W512F HMM. On adding MgATP, emission of wild-type and W441F HMMs increased by 25-27%, but that of W512F HMM by 5%. So, in myosin, 512 is the "sensitive Trp." Unexpectedly, properties of W512F HMM [elevated Ca2+-ATPase, depressed EDTA (K+)-ATPase. no regulation of its basal or actin-activated Mg2+-ATPase by phosphorylation of its "regulatory" light chain, limited actin activation, and inability to move actin filaments in a motility assay] are strikingly like those of smooth muscle myosin reacted at Cys-717 with thiol reagent. From crystallography-based [Houdusse, A., Kalabakis, V. N., Himmel, D., Szent-Gyorgyi, A. G, & Cohen, C. (1999) Cell 97, 459-470] simulations, we found that in wild-type HMM with MgADP added, Trp-512 is in a "hydrophobic pocket." but that pocket becomes distorted in W512F HMM. We think that there is a "path of influence" from 512 to 717 to the active site. We suggest that the mutational changes at 512 are transmitted along this path to Cys-717, where they induce changes similar to those caused by reacting wild-type HMM with thiol reagent.	Natl Cardiovasc Ctr, Res Inst, Dept Struct Anal, Suita, Osaka 5658565, Japan; Hokkaido Univ, Grad Sch Sci, Div Chem, Sapporo, Hokkaido 0600810, Japan; Univ Tokyo, Grad Sch Agr Life Sci, Tokyo 1138657, Japan; Univ Calif San Francisco, San Francisco, CA 94143 USA; Univ Pacific, San Francisco, CA 94115 USA	Onishi, H (reprint author), Natl Cardiovasc Ctr, Res Inst, Dept Struct Anal, Suita, Osaka 5658565, Japan.						ADELSTEIN RS, 1981, J BIOL CHEM, V256, P7501; Konno K, 2000, P NATL ACAD SCI USA, V97, P1461, DOI 10.1073/pnas.030523997; ONISHI H, 1995, P NATL ACAD SCI USA, V92, P704, DOI 10.1073/pnas.92.3.704; BAGSHAW CR, 1974, BIOCHEM J, V141, P351; BAGSHAW CR, 1974, BIOCHEM J, V141, P331; Batra R, 1999, BIOL CHEM, V380, P1017, DOI 10.1515/BC.1999.126; BOTTS J, 1984, P NATL ACAD SCI-BIOL, V81, P2060, DOI 10.1073/pnas.81.7.2060; CHANDRA TS, 1985, J BIOL CHEM, V260, P202; HIRATSUKA T, 1992, J BIOL CHEM, V267, P14949; Houdusse A, 1999, CELL, V97, P459, DOI 10.1016/S0092-8674(00)80756-4; JOHNSON WC, 1991, P NATL ACAD SCI USA, V88, P9748, DOI 10.1073/pnas.88.21.9748; Kojima S, 1999, BIOCHEMISTRY-US, V38, P11670, DOI 10.1021/bi990081f; KUNKEL TA, 1987, METHOD ENZYMOL, V154, P367; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; LANZETTA PA, 1979, ANAL BIOCHEM, V100, P95, DOI 10.1016/0003-2697(79)90115-5; Li XD, 1998, J BIOL CHEM, V273, P27404, DOI 10.1074/jbc.273.42.27404; MAITA T, 1987, P NATL ACAD SCI USA, V84, P416, DOI 10.1073/pnas.84.2.416; MORITA F, 1967, J BIOL CHEM, V242, P4501; OHNO T, 1989, MUSCLE ENERGETICS, P69; ONISHI H, 1985, J BIOCHEM-TOKYO, V98, P81; SPUDICH JA, 1971, J BIOL CHEM, V246, P4866; TORGERSON PM, 1984, BIOCHEMISTRY-US, V23, P3002, DOI 10.1021/bi00308a024; WERBER MM, 1987, BIOCHEMISTRY-US, V26, P2903, DOI 10.1021/bi00384a035; WERBER MM, 1972, BIOCHEMISTRY-US, V11, P2872, DOI 10.1021/bi00765a021; YANAGISAWA M, 1987, J MOL BIOL, V198, P143, DOI 10.1016/0022-2836(87)90302-0; YAZAWA M, 1980, J BIOCHEM-TOKYO, V87, P1313	26	17	18	NATL ACAD SCIENCES	WASHINGTON	2101 CONSTITUTION AVE NW, WASHINGTON, DC 20418 USA	0027-8424			P NATL ACAD SCI USA	Proc. Natl. Acad. Sci. U. S. A.	OCT 10	2000	97	21					11203	11208		10.1073/pnas.200362897		6	Multidisciplinary Sciences	Science & Technology - Other Topics	363GA	WOS:000089825700018		
J	Kawakami, K; Shima, A; Kawakami, N				Kawakami, K; Shima, A; Kawakami, N			Identification of a functional transposase of the Tol2 element, an Ac-like element from the Japanese medaka fish, and its transposition in the zebrafish germ lineage	PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA			English	Article							INSERTIONAL MUTAGENESIS; TRANSGENIC ZEBRAFISH; ORYZIAS-LATIPES; DANIO-RERIO; TC1-LIKE TRANSPOSON; ANTIRRHINUM-MAJUS; DNA-SEQUENCE; MAIZE; GENE; TRANSMISSION	The Tol2 element of the medaka fish Oryzias latipes belongs to the hAT family of transposons (hobo/Ac/Tam3). We report here identification of a functional transposase of Tol2 that is capable of catalyzing its transposition in the germ line of zebrafish Danio rerio. A transcript produced from Tol2 encodes a putative transposase, Zebrafish fertilized eggs were coinjected with mRNA transcribed in vitro, using cDNA of the Tol2 transcript as a template and a plasmid DNA harboring a mutant Tol2. which had a deletion in the putative transposase gene but retained necessary cis sequences. The injected fish were raised to adulthood and mated to noninjected fish, and genomic DNA of the progeny fish were analyzed by PCR and Southern hybridization. Half of F-1 fish obtained from one of eight injected fish contained the Tol2 DNA in their genomes but not the vector portion. Among these F-1 fish, Tol2 insertions at four different loci were identified, and some F-1 fish carried two or three different Tol2 insertions, indicating that the germ line of the founder fish is highly mosaic. Sequencing analyses revealed that, in all cases, Tol2 was surrounded by zebrafish genomic sequences, and an 8-bp duplication was created at the target site, indicating that Tol2 was integrated in the zebrafish genome through transposition. This study identifies an autonomous member of a DNA-based transposable element from a vertebrate genome. The Tol2 transposon system should thus be used to develop novel transgenesis and insertional mutagenesis methods in zebrafish and possibly in other fishes.	Univ Tokyo, Inst Med Sci, Dept Tumor Biol, Minato Ku, Tokyo 1088639, Japan; Univ Tokyo, Grad Sch Frontier Sci, Dept Integrated Biosci, Bunkyo Ku, Tokyo 1130033, Japan	Kawakami, K (reprint author), Univ Tokyo, Inst Med Sci, Dept Tumor Biol, Minato Ku, 4-6-1 Shirokanedai, Tokyo 1088639, Japan.						Kawakami K, 1998, GENE, V225, P17, DOI 10.1016/S0378-1119(98)00537-X; Gaiano N, 1996, P NATL ACAD SCI USA, V93, P7777, DOI 10.1073/pnas.93.15.7777; Amsterdam A, 1999, GENE DEV, V13, P2713, DOI 10.1101/gad.13.20.2713; Higashijima S, 1997, DEV BIOL, V192, P289, DOI 10.1006/dbio.1997.8779; MCCLINTOCK B, 1950, P NATL ACAD SCI USA, V36, P344, DOI 10.1073/pnas.36.6.344; STUART GW, 1988, DEVELOPMENT, V103, P403; LIN S, 1994, SCIENCE, V265, P666, DOI 10.1126/science.8036514; Ivics Z, 1997, CELL, V91, P501, DOI 10.1016/S0092-8674(00)80436-5; Long QM, 1997, DEVELOPMENT, V124, P4105; Kawakami K, 1999, GENE, V240, P239, DOI 10.1016/S0378-1119(99)00444-8; Allende ML, 1996, GENE DEV, V10, P3141, DOI 10.1101/gad.10.24.3141; Gaiano N, 1996, NATURE, V383, P829, DOI 10.1038/383829a0; FEDOROFF N, 1983, CELL, V35, P235, DOI 10.1016/0092-8674(83)90226-X; CANTATORE P, 1994, J MOL EVOL, V39, P589, DOI 10.1007/BF00160404; Becker TS, 1998, DEVELOPMENT, V125, P4369; DORING HP, 1984, NATURE, V307, P127, DOI 10.1038/307127a0; Fadool JM, 1998, P NATL ACAD SCI USA, V95, P5182, DOI 10.1073/pnas.95.9.5182; HEHL R, 1991, PLANT MOL BIOL, V16, P369, DOI 10.1007/BF00020572; HEIERHORST J, 1992, P NATL ACAD SCI USA, V89, P6798, DOI 10.1073/pnas.89.15.6798; HENIKOFF S, 1992, New Biologist, V4, P382; Ivics Z, 1996, P NATL ACAD SCI USA, V93, P5008, DOI 10.1073/pnas.93.10.5008; Kawakami K, 1996, TRENDS GENET, V12, P9, DOI 10.1016/S0168-9525(96)90083-9; Kawakami K, 2000, CURR BIOL, V10, P463, DOI 10.1016/S0960-9822(00)00444-9; Koga A, 1995, MOL GEN GENET, V249, P400; Koga A, 1999, GENET RES, V73, P7, DOI 10.1017/S0016672398003620; Koga A, 1996, NATURE, V383, P30, DOI 10.1038/383030a0; Koga A, 1999, FEBS LETT, V461, P295, DOI 10.1016/S0014-5793(99)01479-9; MCCLINTOCK B, 1951, COLD SPRING HARB SYM, V16, P13; MCGINNIS W, 1983, CELL, V34, P75, DOI 10.1016/0092-8674(83)90137-X; MULLERNEUMANN M, 1984, MOL GEN GENET, V198, P19, DOI 10.1007/BF00328695; OOSUMI T, 1995, NATURE, V378, P672, DOI 10.1038/378672a0; POHLMAN RF, 1984, CELL, V37, P635, DOI 10.1016/0092-8674(84)90395-7; RADICE AD, 1994, MOL GEN GENET, V244, P606; RAZ F, 1997, CURR BIOL, V8, P82; SOMMER H, 1985, MOL GEN GENET, V199, P225, DOI 10.1007/BF00330263; STRECK RD, 1986, EMBO J, V5, P3615; SUTTON WD, 1984, SCIENCE, V223, P1265, DOI 10.1126/science.223.4642.1265; TOMITA H, 1975, MEDAKA KILLIFISH BIO, P251	38	216	232	NATL ACAD SCIENCES	WASHINGTON	2101 CONSTITUTION AVE NW, WASHINGTON, DC 20418 USA	0027-8424			P NATL ACAD SCI USA	Proc. Natl. Acad. Sci. U. S. A.	OCT 10	2000	97	21					11403	11408		10.1073/pnas.97.21.11403		6	Multidisciplinary Sciences	Science & Technology - Other Topics	363GA	WOS:000089825700052		
J	Matsuhira, K; Hinatsu, Y; Tenya, K; Sakakibara, T				Matsuhira, K; Hinatsu, Y; Tenya, K; Sakakibara, T			Low temperature magnetic properties of frustrated pyrochlore ferromagnets Ho2Sn2O7 and Ho2Ti2O7	JOURNAL OF PHYSICS-CONDENSED MATTER			English	Letter							SPIN-GLASS; CRITICAL-BEHAVIOR; CU97CO3 ALLOY; PARTICLES	AC and DC magnetic susceptibilities have been measured on frustrated pyrochlore ferromagnets Ho2Sn2O7 and Ho2Ti2O7 at temperatures down to 100 mK. In the AC magnetic susceptibility, a dramatic drop of chi' (in-phase component) and a single maximum of chi " (quadrature component) are observed at around 1 K. The frequency dependence of these peak positions indicates the presence of a slow magnetic relaxation at low temperature, whose relaxation time obeys the Arrhenius formula with the energy barrier E-b = 19.6 K and 27.5 K for Ho2Sn2O7 and Ho2Ti2O7, respectively. Strong irreversibility is also observed in the temperature dependence of the DC magnetization of Ho2Sn2O7 at 1 kOe below T-p similar to 0.75 K; the zero-field-cooling (ZFC) curve indicates a very sharp peak at T-p, whereas the field-cooling curve has no anomaly at T-p and increases monotonically with decreasing T. In the DC magnetization process of the ZFC state at 0.46 K, a steep increase of the moment occurs above 2 kOe, and the irreversibility disappears at around similar to 15 kOe where the moment ferromagnetically saturates. These results indicate a clustering of magnetic moment whose size is of the order of a few tetrahedra, consistent with a recently proposed 'spin ice' model.	Hokkaido Univ, Grad Sch Sci, Div Chem, Sapporo, Hokkaido 0600810, Japan; Hokkaido Univ, Grad Sch Sci, Div Phys, Sapporo, Hokkaido 0600810, Japan; Univ Tokyo, Inst Solid State Phys, Kashiwa, Chiba 2778581, Japan	Matsuhira, K (reprint author), Hokkaido Univ, Grad Sch Sci, Div Chem, Sapporo, Hokkaido 0600810, Japan.						Harris MJ, 1998, PHYS REV LETT, V81, P4496, DOI 10.1103/PhysRevLett.81.4496; SESSOLI R, 1993, NATURE, V365, P141, DOI 10.1038/365141a0; Harris MJ, 1997, PHYS REV LETT, V79, P2554, DOI 10.1103/PhysRevLett.79.2554; SAKAKIBARA T, 1994, JPN J APPL PHYS 1, V33, P5067, DOI 10.1143/JJAP.33.5067; Shimakawa Y, 1996, NATURE, V379, P53, DOI 10.1038/379053a0; NAGATA S, 1979, PHYS REV B, V19, P1633, DOI 10.1103/PhysRevB.19.1633; Siddharthan R, 1999, PHYS REV LETT, V83, P1854, DOI 10.1103/PhysRevLett.83.1854; Gingras MJP, 1997, PHYS REV LETT, V78, P947, DOI 10.1103/PhysRevLett.78.947; GUNNARSSON K, 1988, PHYS REV LETT, V61, P754, DOI 10.1103/PhysRevLett.61.754; HOLTZBERG F, 1979, J APPL PHYS, V50, P1717, DOI 10.1063/1.327246; GAULIN BD, 1992, PHYS REV LETT, V69, P3244, DOI 10.1103/PhysRevLett.69.3244; GOLDFARB RB, 1981, PHYS REV B, V24, P1360, DOI 10.1103/PhysRevB.24.1360; BITOH T, 1995, J PHYS SOC JPN, V64, P1305, DOI 10.1143/JPSJ.64.1305; BITOH T, 1995, J PHYS SOC JPN, V64, P1311, DOI 10.1143/JPSJ.64.1311; DORMANN JL, 1983, J MAGN MAGN MATER, V35, P117, DOI 10.1016/0304-8853(83)90470-5; MATSUHIRA K, IN PRESS; PALING L, 1945, NATURE CHEM BOND, P301; Takeda K., 1998, Physical Review B (Condensed Matter), V57, DOI 10.1103/PhysRevB.57.R11062	18	95	95	IOP PUBLISHING LTD	BRISTOL	DIRAC HOUSE, TEMPLE BACK, BRISTOL BS1 6BE, ENGLAND	0953-8984			J PHYS-CONDENS MAT	J. Phys.-Condes. Matter	OCT 9	2000	12	40					L649	L656		10.1088/0953-8984/12/40/103		8	Physics, Condensed Matter	Physics	367YL	WOS:000090090000003		
J	Shimada, H; Delsing, P				Shimada, H; Delsing, P			Current mirror effect and correlated cooper-pair transport in coupled arrays of small Josephson junctions	PHYSICAL REVIEW LETTERS			English	Article							SMALL TUNNEL-JUNCTIONS; ONE-DIMENSIONAL ARRAYS; QUANTUM PHASE-TRANSITIONS; ELECTRON-HOLE TRANSPORT; CHARGE SOLITONS; CHAINS	We have measured the transport properties of capacitively coupled one-dimensional arrays of small aluminum Josephson junctions. Under suitable biasing conditions, the samples act as current mirrors; the currents in the two arrays couple to each other and become equally large. The coupling is found both for currents flowing in the same direction and in opposite directions. We have also measured the time dependent fluctuations of the currents in the two arrays, and we find a strong correlation or anticorrelation of the fluctuations depending on the relative direction of the two currents.	Chalmers Univ Technol, Microtechnol Ctr Chalmers MC2, Dept Microelect & Nanosci, S-41296 Gothenburg, Sweden; Univ Gothenburg, S-41296 Gothenburg, Sweden; Univ Tokyo, Cryogen Ctr, Bunkyo Ku, Tokyo 1130032, Japan	Shimada, H (reprint author), Chalmers Univ Technol, Microtechnol Ctr Chalmers MC2, Dept Microelect & Nanosci, S-41296 Gothenburg, Sweden.		Delsing, Per/F-7288-2010	Delsing, Per/0000-0002-1222-3506			Amakawa S, 1997, JPN J APPL PHYS 1, V36, P4166, DOI 10.1143/JJAP.36.4166; Hermon Z, 1996, PHYS REV B, V54, P1234, DOI 10.1103/PhysRevB.54.1234; Nazarov YV, 1998, PHYS REV LETT, V81, P653, DOI 10.1103/PhysRevLett.81.653; USTINOV AV, 1993, PHYS REV B, V48, P10614, DOI 10.1103/PhysRevB.48.10614; GRONBECHJENSEN N, 1994, PHYS REV B, V50, P6352, DOI 10.1103/PhysRevB.50.6352; AVERIN DV, 1991, PHYS REV LETT, V66, P2818, DOI 10.1103/PhysRevLett.66.2818; Averin D. V., 1991, MESOSCOPIC PHENOMENA, P173; Choi MS, 1998, J PHYS-CONDENS MAT, V10, P9783, DOI 10.1088/0953-8984/10/43/022; Choi MS, 1998, PHYS REV LETT, V81, P4240, DOI 10.1103/PhysRevLett.81.4240; Choi MS, 2000, J PHYS-CONDENS MAT, V12, P943, DOI 10.1088/0953-8984/12/6/316; Delsing P., 1997, P 6 INT SUP EL C, V1, P98; Delsing P., 1996, P 1 INT S ADV PHYS F, P116; Delsing P, 1996, CZECH J PHYS, V46, P2359, DOI 10.1007/BF02571171; DELSING P, 1992, SINGLE CHARGE TUNNEL, P117; Haviland DB, 1996, PHYS REV B, V54, pR6857; Haviland DB, 1996, J VAC SCI TECHNOL A, V14, P1839, DOI 10.1116/1.580346; HAVILAND DB, 1991, EUROPHYS LETT, V16, P103, DOI 10.1209/0295-5075/16/1/018; Hey R, 1997, PHYS REV B, V55, P4231, DOI 10.1103/PhysRevB.55.4231; Hu GY, 1996, PHYS REV B, V54, P1522, DOI 10.1103/PhysRevB.54.1522; Hu GY, 1998, J APPL PHYS, V84, P6713, DOI 10.1063/1.368997; Matters M, 1997, PHYS REV LETT, V78, P2469, DOI 10.1103/PhysRevLett.78.2469; Orlov AO, 1998, APPL PHYS LETT, V73, P2787, DOI 10.1063/1.122591; ZORIN AB, 1995, REV SCI INSTRUM, V66, P4296, DOI 10.1063/1.1145385	23	18	18	AMERICAN PHYSICAL SOC	COLLEGE PK	ONE PHYSICS ELLIPSE, COLLEGE PK, MD 20740-3844 USA	0031-9007			PHYS REV LETT	Phys. Rev. Lett.	OCT 9	2000	85	15					3253	3256		10.1103/PhysRevLett.85.3253		4	Physics, Multidisciplinary	Physics	362ZH	WOS:000089807800047		
J	Annaka, M; Motokawa, K; Sasaki, S; Nakahira, T; Kawasaki, H; Maeda, H; Amo, Y; Tominaga, Y				Annaka, M; Motokawa, K; Sasaki, S; Nakahira, T; Kawasaki, H; Maeda, H; Amo, Y; Tominaga, Y			Salt-induced volume phase transition of poly(N-isopropylacrylamide) gel	JOURNAL OF CHEMICAL PHYSICS			English	Article							N-ISOPROPYLACRYLAMIDE GELS; LIQUID WATER; BEHAVIOR; DENSITY	The salt effect on the phase transition of N-isopropylacrylamide (NIPA) gel was studied. The swelling behavior of the NIPA gel strongly depends on the salt concentration and is well described as a function of the chemical potential difference of water molecules in solution from that at the transition. From the analysis of the OH stretching, Raman spectra in water and in various aqueous solutions in terms of collective proton motions reveals that the presence of salts tends to disrupt or distort the water molecules in hydrophobic hydration shell around the NIPA gel. This leads to inducing the growth of the cluster shell around the salts, which leads to gel collapse. The volume phase transitions due to the different types of perturbation (temperature, salt) are induced by the same mechanism, hydrophobic hydration and dehydration, and therefore can be described in a unified manner in terms of the chemical potential and the collective proton motions of water molecules. (C) 2000 American Institute of Physics. [S0021-9606(00)52037-6].	Chiba Univ, Dept Mat Technol, Chiba 2638522, Japan; Kyushu Univ, Grad Sch Sci, Dept Chem, Fukuoka 8128581, Japan; Univ Tokyo, Adv Sci & Technol Res Ctr, Tokyo 1530041, Japan; Ochanomizu Univ, Grad Sch Humanities & Sci, Tokyo 1128610, Japan	Annaka, M (reprint author), Chiba Univ, Dept Mat Technol, Chiba 2638522, Japan.						HIROTSU S, 1987, J CHEM PHYS, V87, P1392, DOI 10.1063/1.453267; HIROTSU S, 1987, J PHYS SOC JPN, V56, P233, DOI 10.1143/JPSJ.56.233; INOMATA H, 1992, LANGMUIR, V8, P687, DOI 10.1021/la00038a064; HIROKAWA Y, 1984, J CHEM PHYS, V81, P6379, DOI 10.1063/1.447548; ERGIN YV, 1983, MAGNITNYE SVOISTVA I; GREEN JL, 1986, J PHYS CHEM-US, V90, P3958, DOI 10.1021/j100408a027; GREEN JL, 1986, CHEM PHYS LETT, V130, P67, DOI 10.1016/0009-2614(86)80427-4; GREEN JL, 1987, J PHYS CHEM-US, V91, P1684, DOI 10.1021/j100290a079; HeadGordon T, 1997, BIOPHYS J, V73, P2106; KAMINSKY M, 1957, DISCUSS FARADAY SOC, P171; KAUZMANN W, 1969, STRUCTURE PROPERTIES; Kawasaki H, 1996, J PHYS CHEM-US, V100, P16282, DOI 10.1021/jp961219w; Pertsemlidis A, 1996, P NATL ACAD SCI USA, V93, P10769, DOI 10.1073/pnas.93.20.10769; SAMOILOV OY, 1957, DISCUSS FARADAY SOC, P141; Sasaki S, 1997, MACROMOLECULES, V30, P1847, DOI 10.1021/ma961114r; SUZUKI A, 1993, ADV POLYM SCI, V110, P226; Suzuki Y, 1996, POLYM GELS NETW, V4, P129, DOI 10.1016/0966-7822(95)00014-3; WALLEY E, 1977, CAN J CHEM, V55, P3429; WEAST CW, 1978, CRC HDB CHEM PHYSICS, pD219	19	64	66	AMER INST PHYSICS	MELVILLE	2 HUNTINGTON QUADRANGLE, STE 1NO1, MELVILLE, NY 11747-4501 USA	0021-9606			J CHEM PHYS	J. Chem. Phys.	OCT 8	2000	113	14					5980	5985	PII [S0021-9606(00)52037-6]	10.1063/1.1290135		6	Physics, Atomic, Molecular & Chemical	Physics	357WU	WOS:000089524400044		
J	Kageyama, T; Nakamura, M; Matsuo, A; Yamasaki, Y; Takakura, Y; Hashida, M; Kanai, Y; Naito, M; Tsuruo, T; Minato, N; Shimohama, S				Kageyama, T; Nakamura, M; Matsuo, A; Yamasaki, Y; Takakura, Y; Hashida, M; Kanai, Y; Naito, M; Tsuruo, T; Minato, N; Shimohama, S			The 4F2hc/LAT1 complex transports L-DOPA across the blood-brain barrier	BRAIN RESEARCH			English	Article						L-DOPA; blood-brain barrier; system L; 4F2hc; LAT1	AMINO-ACID-TRANSPORT; 4F2 HEAVY-CHAIN; ENDOTHELIAL-CELLS; PARKINSONS-DISEASE; HUMAN ERYTHROCYTES; BROAD-SPECIFICITY; MEMBRANE-PROTEIN; P-GLYCOPROTEIN; EXPRESSION; SYSTEM	L-DOPA is transported across the blood-brain barrier (BBB) by an amino acid transporter, system L. Recently, it has been demonstrated that system L consists of two subunits, 4F2hc and either LAT1 or LAT2. 4F2hc/LAT1 and 4F2hc/LAT2 show different transport characteristics, while their distribution in the brain has not been determined. To clarify whether 4F2hc/LAT1 participates in L-DOPA transport across the BBB, we first examined the expression of 4F2hc/LAT1 in the mouse brain capillary endothelial cell line, MBEC4, as an in vitro BBB model. Northern hybridization and immunoblotting revealed that both 4F2hc and LAT1 are expressed and form a heterodimer in MBEC4 cells. To confirm whether 4F2hc/LAT1 acts as system L to transport L-DOPA, we characterized L-DOPA uptake into the cells. The uptake process was time-dependent, temperature-sensitive, and Na+-independent. Neutral amino acids with bulky side chains and a bicyclic amino acid, 2-aminobicyclo-[2,2,1]-heptane-2-carboxylic acid (BCH), inhibited L-DOPA uptake into MBEC4 cells to a great extent, while an acidic amino acid, basic amino acids, and glycine had no effect. Other neutral amino acids, such as alanine, asparagine, glutamine, serine, and threonine inhibited L-DOPA uptake by 40-70% at most. These characteristics are more compatible with those of 4F2hc/LAT1, rather than those of 4F2hc/LAT2. Finally, immunohistochemistry;with anti-LAT1 antibody demonstrated that LAT1 is predominantly expressed in the microvessels of the central nervous system. This is the first report showing that the 4F2hc/LAT1 complex participates in L-DOPA transport across the BBB. (C) 2000 Elsevier Science B.V. All rights reserved.	Kyoto Univ, Grad Sch Med, Dept Neurol, Sakyo Ku, Kyoto 6068507, Japan; Kyoto Univ, Grad Sch Pharmaceut Sci, Dept Drug Delivery Res, Kyoto, Japan; Kyorin Univ, Sch Med, Dept Pharmacol & Toxicol, Tokyo, Japan; Japan Sci & Technol Corp, PRESTO, Tokyo, Japan; Univ Tokyo, Inst Mol & Cellular Biosci, Tokyo, Japan; Kyoto Univ, Grad Sch Med, Dept Immunol & Cell Biol, Kyoto, Japan	Shimohama, S (reprint author), Kyoto Univ, Grad Sch Med, Dept Neurol, Sakyo Ku, 54 Shogoin Kawaharacho, Kyoto 6068507, Japan.						ALBERT Z, 1966, ACTA HISTOCHEM, V25, P312; MENA I, 1975, NEW ENGL J MED, V292, P181, DOI 10.1056/NEJM197501232920404; Kanai Y, 1998, J BIOL CHEM, V273, P23629, DOI 10.1074/jbc.273.37.23629; Prasad PD, 1999, BIOCHEM BIOPH RES CO, V255, P283, DOI 10.1006/bbrc.1999.0206; CORDONCARDO C, 1989, P NATL ACAD SCI USA, V86, P695, DOI 10.1073/pnas.86.2.695; TATSUTA T, 1992, J BIOL CHEM, V267, P20383; Segawa H, 1999, J BIOL CHEM, V274, P19745, DOI 10.1074/jbc.274.28.19745; WADE LA, 1975, J NEUROCHEM, V25, P837, DOI 10.1111/j.1471-4159.1975.tb04415.x; WILLIAMS SK, 1980, J NEUROCHEM, V35, P374, DOI 10.1111/j.1471-4159.1980.tb06274.x; Mastroberardino L, 1998, NATURE, V395, P288; JANZER RC, 1987, NATURE, V325, P253, DOI 10.1038/325253a0; Nakamura E, 1999, J BIOL CHEM, V274, P3009, DOI 10.1074/jbc.274.5.3009; Boado RJ, 1999, P NATL ACAD SCI USA, V96, P12079, DOI 10.1073/pnas.96.21.12079; Pineda M, 1999, J BIOL CHEM, V274, P19738, DOI 10.1074/jbc.274.28.19738; Sato H, 1999, J BIOL CHEM, V274, P11455, DOI 10.1074/jbc.274.17.11455; PARDRIDGE WM, 1975, BIOCHIM BIOPHYS ACTA, V401, P128, DOI 10.1016/0005-2736(75)90347-8; Arthur F E, 1987, Brain Res, V433, P155; Broer S, 1995, BIOCHEM J, V312, P863; CHRISTEN.HN, 1969, J BIOL CHEM, V244, P1510; DEVES R, 1992, J PHYSIOL-LONDON, V454, P491; DEVES R, 1993, J PHYSIOL-LONDON, V468, P753; DJURICIC BM, 1977, BRAIN RES, V138, P561, DOI 10.1016/0006-8993(77)90694-1; DOYLE FA, 1992, BIOCHIM BIOPHYS ACTA, V1104, P55, DOI 10.1016/0005-2736(92)90131-5; Gomes P, 1999, BRAIN RES, V829, P143, DOI 10.1016/S0006-8993(99)01387-6; HARDEBO JE, 1979, ACTA PHYSIOL SCAND, V107, P161, DOI 10.1111/j.1748-1716.1979.tb06456.x; Kawai K, 1996, NUCL MED BIOL, V23, P251, DOI 10.1016/0969-8051(95)02054-3; Kurth MC, 1997, NEUROLOGY, V48, P81; LOWRY OH, 1951, J BIOL CHEM, V193, P265; ORLOWSKI M, 1974, SCIENCE, V184, P66, DOI 10.1126/science.184.4132.66; PARMACEK MS, 1989, NUCLEIC ACIDS RES, V17, P1915, DOI 10.1093/nar/17.5.1915; Pfeiffer R, 1999, EMBO J, V18, P49, DOI 10.1093/emboj/18.1.49; SHIRAI A, 1994, BBA-MOL CELL RES, V1222, P400, DOI 10.1016/0167-4889(94)90047-7; STEVENS BR, 1982, J MEMBRANE BIOL, V66, P213, DOI 10.1007/BF01868496; Torrents D, 1998, J BIOL CHEM, V273, P32437, DOI 10.1074/jbc.273.49.32437; Tsai MJ, 1996, J NEUROSCI RES, V43, P490, DOI 10.1002/(SICI)1097-4547(19960215)43:4<490::AID-JNR10>3.0.CO;2-6; VANWINKLE LJ, 1985, J BIOL CHEM, V260, P2118; YAMAOKA K, 1981, J PHARMACOBIO-DYNAM, V4, P879	37	87	97	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	0006-8993			BRAIN RES	Brain Res.	OCT 6	2000	879	1-2					115	121		10.1016/S0006-8993(00)02758-X		7	Neurosciences	Neurosciences & Neurology	362DG	WOS:000089762900015		
J	Han, YK; Hirao, K				Han, YK; Hirao, K			Two-component coupled-cluster calculations for the hydride of element 111: on the performance of relativistic effective core potentials	CHEMICAL PHYSICS LETTERS			English	Article							SPIN-ORBIT OPERATORS; 2-COMPONENT CALCULATIONS; SUPERHEAVY ELEMENTS; PROGRAM PACKAGE; APPROXIMATION; MOLECULES; CHEMISTRY; ENERGY; AU-2; GOLD	We have calculated bond lengths, harmonic vibrational frequencies, and dissociation energies for (111)H using relativistic effective core potentials (RECP) including one-electron spin-orbit operators at the Hartree-Fock and coupled-cluster levels of theory. The spectroscopic constants calculated using shape-consistent RECPs compare favorably with available four-component results, but energy-consistent RECPs are found to underestimate the spin-orbit effects. The best computed(estimated) spectroscopic constants of (111)H are 1.512(1.524) Angstrom, 2668(2647) cm(-1), and 2.87(2.77) eV for R-e, omega(e), and D-e, respectively. The calculated spin-orbit effects (+0.009 Angstrom, -113 cm(-1), and -0.64 eV) are modest, although the molecule has a closed-shell electronic structure. (C) 2000 Elsevier Science B.V. All rights reserved.	Univ Tokyo, Grad Sch Engn, Dept Appl Chem, Tokyo 1138656, Japan	Han, YK (reprint author), Univ Tokyo, Grad Sch Engn, Dept Appl Chem, Tokyo 1138656, Japan.						DOLG M, 1993, J PHYS CHEM-US, V97, P5852, DOI 10.1021/j100124a012; Seth M, 1997, J CHEM PHYS, V106, P3623, DOI 10.1063/1.473437; VISSCHER L, 1994, COMPUT PHYS COMMUN, V81, P120, DOI 10.1016/0010-4655(94)90115-5; Seth M, 2000, CHEM PHYS LETT, V318, P314, DOI 10.1016/S0009-2614(00)00034-8; ELIAV E, 1994, PHYS REV LETT, V73, P3203, DOI 10.1103/PhysRevLett.73.3203; Nash CS, 1997, J CHEM PHYS, V106, P5133, DOI 10.1063/1.473992; Liu WJ, 1997, THEOR CHEM ACC, V96, P75, DOI 10.1007/s002140050207; PITZER RM, 1988, J PHYS CHEM-US, V92, P3061, DOI 10.1021/j100322a011; BECKE AD, 1988, PHYS REV A, V38, P3098, DOI 10.1103/PhysRevA.38.3098; FRISCH MJ, 1998, GAUSSIAN 98 REVISION, P75501; Han YK, 1999, J PHYS CHEM A, V103, P9109, DOI 10.1021/jp9917953; Han YK, 1999, INT J QUANTUM CHEM, V72, P139, DOI 10.1002/(SICI)1097-461X(1999)72:2<139::AID-QUA6>3.0.CO;2-T; Han YK, 2000, J CHEM PHYS, V112, P2684, DOI 10.1063/1.480842; Han YK, 1999, J CHEM PHYS, V110, P9353, DOI 10.1063/1.478901; HAN YK, 2000, CHEM PHYS LETT, V324, P450; Han YK, 1999, J PHYS CHEM A, V103, P1104, DOI 10.1021/jp983665k; Han YK, 1999, J CHEM PHYS, V110, P8969, DOI 10.1063/1.478814; Lee HS, 1998, CHEM PHYS LETT, V293, P97, DOI 10.1016/S0009-2614(98)00760-X; LEE SY, 1992, J COMPUT CHEM, V13, P595, DOI 10.1002/jcc.540130509; LIU W, IN PRESS ADV QUANTUM; Liu WJ, 1999, J CHEM PHYS, V110, P3730, DOI 10.1063/1.478237; PERDEW JP, 1986, PHYS REV B, V33, P8822, DOI 10.1103/PhysRevB.33.8822; Seth M, 1996, CHEM PHYS LETT, V250, P461, DOI 10.1016/0009-2614(96)00039-5; SETH M, 1998, THESIS U AUCKLAND; van Wullen C, 1998, J CHEM PHYS, V109, P392, DOI 10.1063/1.476576; VISSCHER L, 1991, INT J QUANTUM CHEM S, V25, P131; Wesendrup R, 1999, J CHEM PHYS, V110, P9457, DOI 10.1063/1.478911	27	8	8	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	0009-2614			CHEM PHYS LETT	Chem. Phys. Lett.	OCT 6	2000	328	4-6					453	458		10.1016/S0009-2614(00)00955-6		6	Chemistry, Physical; Physics, Atomic, Molecular & Chemical	Chemistry; Physics	363LE	WOS:000089836500022		
J	Yamada, H; Kotaki, H; Itoh, T; Sawada, Y; Iga, T				Yamada, H; Kotaki, H; Itoh, T; Sawada, Y; Iga, T			Effect of anti-inflammatory bowel disease drug, E3040, on urate transport in rat renal brush border membrane vesicles	EUROPEAN JOURNAL OF PHARMACOLOGY			English	Article						E3040; urate uptake; brush border membrane vesicle; (rat)	URICOSURIC ACTION; AMINOHIPPURATE; SECRETION; MECHANISM; MODEL	To confirm the assumption that 6-hydroxy-5,7-dimethyl-2-methylamino-4-(3-pyridylmethyl)benzothiazole (E3040) acts on urate reabsorption by inhibiting urate-anion exchange at the luminal membrane of renal tubules, we investigated the inhibitory effect of E3040 and its two conjugated metabolites on hydroxyl ion (OH-) gradient-dependent urate uptake into brush border membrane vesicles from rat renal cortex and compared it with other uricosuric agents. The order of potency was AA193 (5-chloro-7,8-dihydro-3-phenylfuro[2,3-g]-1,2-benzisoxazole-7-carboxylic acid)> benzbromarone > E3040 > probenecid > E3040 sulfate > E3040 glucuronide. Furthermore, kinetic analysis revealed that E3040 may be a competitive inhibitor of the OH- gradient-dependent uptake of urate into brush border membrane vesicles. (C) 2000 Elsevier Science B.V. All rights reserved.	Tokyo Univ Hosp, Fac Med, Dept Pharm, Tokyo 113, Japan; Kyushu Univ, Fac Pharmaceut Sci, Fukuoka 812, Japan	Yamada, H (reprint author), Univ Tokyo, Inst Med Sci, Res Hosp, Dept Pharm, 4-6-1 Shirokanedai, Tokyo 1080071, Japan.						BESSEY OA, 1946, J BIOL CHEM, V164, P321; ROCHRAMEL F, 1994, AM J PHYSIOL, V266, pF797; QUIGLEY JP, 1969, BIOCHIM BIOPHYS ACTA, V173, P456, DOI 10.1016/0005-2736(69)90010-8; Kakkar T, 1999, DRUG METAB DISPOS, V27, P756; BLOMSTEDT JW, 1980, J CLIN INVEST, V65, P931, DOI 10.1172/JCI109748; DAN T, 1991, N-S ARCH PHARMACOL, V343, P532; DAN T, 1990, EUR J PHARMACOL, V187, P303, DOI 10.1016/0014-2999(90)90357-C; DIAMOND HS, 1978, HDB EXPT PHARM, V51, P459; FRANKFURT SJ, 1977, P SOC EXP BIOL MED, V155, P554; GUGGINO SE, 1983, AM J PHYSIOL, V244, pF612; Itoh T, 1998, BIOPHARM DRUG DISPOS, V19, P251; Jorgensen P L, 1974, Methods Enzymol, V32, P277; KAHN AM, 1983, AM J PHYSIOL, V244, pF56; Kahn AM, 1985, AM J PHYSIOL, V249, P789; KAHN AM, 1983, AM J PHYSIOL, V245, pF151; KESSLER M, 1978, BIOCHIM BIOPHYS ACTA, V506, P136, DOI 10.1016/0005-2736(78)90440-6; KRAMP RA, 1975, AM J PHYSIOL, V228, P875; WEIMAN EJ, 1976, KIDNEY INT, V10, P295; Yamada H, 1999, BIOPHARM DRUG DISPOS, V20, P77, DOI 10.1002/(SICI)1099-081X(199903)20:2<77::AID-BDD154>3.0.CO;2-D; Yamada H, 1999, BIOPHARM DRUG DISPOS, V20, P271, DOI 10.1002/(SICI)1099-081X(199907)20:5<271::AID-BDD185>3.0.CO;2-I; YAMAOKA K, 1985, J PHARMACOBIO-DYNAM, V8, P246	21	4	4	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	0014-2999			EUR J PHARMACOL	Eur. J. Pharmacol.	OCT 6	2000	406	1					45	48		10.1016/S0014-2999(00)00626-9		4	Pharmacology & Pharmacy	Pharmacology & Pharmacy	360YB	WOS:000089694000006		
J	Kuno, A; Kaneko, S; Ohtsuki, H; Ito, S; Fujimoto, Z; Mizuno, H; Hasegawa, T; Taira, K; Kusakabe, I; Hayashi, K				Kuno, A; Kaneko, S; Ohtsuki, H; Ito, S; Fujimoto, Z; Mizuno, H; Hasegawa, T; Taira, K; Kusakabe, I; Hayashi, K			Novel sugar-binding specificity of the type XIII xylan-binding domain of a family F/10 xylanase from Streptomyces olivaceoviridis E-86	FEBS LETTERS			English	Article						type XIII xylan-binding domain; carbohydrate-binding motif; ricin super family; xylanase; Streptomyces olivaceoviridis	RICIN-B-CHAIN; GLYCOSYL HYDROLASES; MUTATIONAL ANALYSIS; BETA-XYLANASE; PROTEINS; ABILITY	The type XIII xylan-binding domain (XBD) of a family F/10 xylanase (FXYN) from Streptomyces olivaceoviridis E-86 was found to be structurally similar to the ricin B chain which recognizes the non-reducing end of galactose and specifically binds to galactose containing sugars. The crystal structure of XBD [Fujimoto, Z. et al. (2000) J. Mol. Biol. 300, 575-585] indicated that the whole structure of XBD is very similar to the ricin B chain and the amino acids which form the galactose-binding sites are highly conserved between the XBD and the ricin B chain. However, our investigation of the binding abilities of wt FXYN and its truncated mutants towards xylan demonstrated that the XBD bound xylose-based polysaccharides, Moreover, it was found that the sugar-binding unit of the XBD was a trimer, which was demonstrated in a releasing assay using sugar ranging in size from xylose to xyloheptaose. These results indicated that the binding specificity of the XBD was different from those of the same family lectins such as the ricin B chain. Somewhat surprisingly, it was found that lactose could release the XBD from insoluble xylan to a level half of that observed for xylobiose, indicating thai the XBD also possessed the same galactose recognition site as the ricin B chain. It appears that the sugar-binding pocket of the XBD has evolved from the ancient ricin super family lectins to bind additional sugar targets, resulting in the differences observed in the sugar-binding specificities between the lectin group (containing the ricin B chain) and the enzyme group. (C) 2000 Federation of European Biochemical Societies. Published by Elsevier Science B.V. All rights reserved.	Yamagata Univ, Fac Sci, Dept Mat & Biol Chem, Yamagata 9908560, Japan; Natl Inst Adv Interdisciplinary Res, Tsukuba, Ibaraki 3058562, Japan; Minist Agr Forestry & Fisheries, Natl Food Res Inst, Tsukuba, Ibaraki 3058062, Japan; Natl Inst Agrobiol Resources, Dept Biotechnol, Tsukuba, Ibaraki 3058602, Japan; Univ Tokyo, Grad Sch Engn, Dept Chem & Biotechnol, Tokyo 1138656, Japan; Univ Tsukuba, Inst Appl Biochem, Tsukuba, Ibaraki 3058572, Japan	Kuno, A (reprint author), Yamagata Univ, Fac Sci, Dept Mat & Biol Chem, Yamagata 9908560, Japan.			Fujimoto, Zui/0000-0002-3551-6854			SPHYRIS N, 1995, J BIOL CHEM, V270, P20292; MONTFORT W, 1987, J BIOL CHEM, V262, P5398; Charnock SJ, 1997, J BIOL CHEM, V272, P2942, DOI 10.1074/jbc.272.5.2942; Kaneko S, 2000, BIOSCI BIOTECH BIOCH, V64, P741, DOI 10.1271/bbb.64.741; HENRISSAT B, 1993, BIOCHEM J, V293, P781; SOMOGYI M, 1952, J BIOL CHEM, V195, P19; WALES R, 1991, J BIOL CHEM, V266, P19172; Hirabayashi J, 1998, J BIOL CHEM, V273, P14450, DOI 10.1074/jbc.273.23.14450; Davies GJ, 1997, BIOCHEM J, V321, P557; TAKEO K, 1995, CARBOHYD RES, V277, P231, DOI 10.1016/0008-6215(95)00214-E; RUTENBER E, 1991, PROTEINS, V10, P260, DOI 10.1002/prot.340100310; Fujimoto Z, 2000, J MOL BIOL, V300, P575, DOI 10.1006/jmbi.2000.3877; RUTENBER E, 1987, NATURE, V326, P624, DOI 10.1038/326624a0; TAHIROV TH, 1995, J MOL BIOL, V250, P354, DOI 10.1006/jmbi.1995.0382; Charnock SJ, 1998, J BIOL CHEM, V273, P32187, DOI 10.1074/jbc.273.48.32187; Fujimoto Z, 1997, J BIOCHEM-TOKYO, V121, P826; Tomme P, 1995, Adv Microb Physiol, V37, P1, DOI 10.1016/S0065-2911(08)60143-5; Kaneko S, 1999, FEBS LETT, V460, P61, DOI 10.1016/S0014-5793(99)01318-6; Kuno A, 1999, FEBS LETT, V450, P299, DOI 10.1016/S0014-5793(99)00498-6; Kuno A, 1998, J FERMENT BIOENG, V86, P434, DOI 10.1016/S0922-338X(98)80147-5; KUSAKABE I, 1977, NIPPON NOGEIKAGAKU K, V51, P429; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; YOSHIDA S, 1994, BIOSCI BIOTECH BIOCH, V58, P2068	23	20	20	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	0014-5793			FEBS LETT	FEBS Lett.	OCT 6	2000	482	3					231	236		10.1016/S0014-5793(00)02067-6		6	Biochemistry & Molecular Biology; Biophysics; Cell Biology	Biochemistry & Molecular Biology; Biophysics; Cell Biology	363RA	WOS:000089847300013		
J	Fukuda, M; Kabayama, H; Mikoshiba, K				Fukuda, M; Kabayama, H; Mikoshiba, K			Drosophila AD3 mutation of synaptotagmin impairs calcium-dependent self-oligomerization activity	FEBS LETTERS			English	Article						synaptotagmin; C2 domain; self-oligomerization; exocytosis; synaptic vesicle	HIGH-POLYPHOSPHATE BINDING; SQUID GIANT SYNAPSE; C2B DOMAIN; INOSITOL-1,3,4,5-TETRAKISPHOSPHATE BINDING; NEUROTRANSMITTER RELEASE; PHOSPHOLIPID-BINDING; TRANSMITTER RELEASE; ANTIBODY INJECTION; VESICLE; EXOCYTOSIS	Genetic analysis of a Drosophila synaptotagmin (Syt) I mutant (AD3) has revealed that Tyr-334 within the C2B domain is essential for efficient Ca2+-dependent neurotransmitter release. However, little is known as to why a missense mutation (Tyr-334-Asn) disrupts the function of the C2B domain at the molecular level. Here, we present evidence that a Tyr-312 to Asn substitution in mouse Syt II, which corresponds to the Drosophila AD3 mutation, completely impairs Ca2+-dependent self-oligomerization activity mediated by the C2B domain but allows partial interaction with wild-type proteins in a Ca2+-dependent manner. This observation is consistent with the fact that the AD3 allele is homozygous lethal but complements another mutant phenotype. We also showed that the Ca2+-dependent C2B self-oligomerization is inhibited by inositol 1,3,4,5-tetrakisphosphate, a potent inhibitor of neurotransmitter release. All of these findings strongly support the idea that self-oligomerization of Syt I or II is essential for neurotransmitter release in vivo. (C) 2000 Federation of European Biochemical Societies. Published by Elsevier Science B.V. All rights reserved.	RIKEN, Brain Sci Inst, Dev Neurobiol Lab, Wako, Saitama 3510198, Japan; Univ Tokyo, Inst Med Sci, Dept Basic Med Sci, Div Mol Neurobiol,Minato Ku, Tokyo 1088639, Japan	Fukuda, M (reprint author), RIKEN, Brain Sci Inst, Dev Neurobiol Lab, 2-1 Hirosawa, Wako, Saitama 3510198, Japan.		Fukuda, MItsunori/I-1511-2015				BOMMERT K, 1993, NATURE, V363, P163, DOI 10.1038/363163a0; ELFERINK LA, 1993, CELL, V72, P153, DOI 10.1016/0092-8674(93)90059-Y; FUKUDA M, 1995, P NATL ACAD SCI USA, V92, P10708, DOI 10.1073/pnas.92.23.10708; LITTLETON JT, 1994, P NATL ACAD SCI USA, V91, P10888, DOI 10.1073/pnas.91.23.10888; Gerona RRL, 2000, J BIOL CHEM, V275, P6328, DOI 10.1074/jbc.275.9.6328; MIKOSHIBA K, 1995, P NATL ACAD SCI USA, V92, P10703, DOI 10.1073/pnas.92.23.10703; GEPPERT M, 1994, CELL, V79, P717, DOI 10.1016/0092-8674(94)90556-8; Chapman ER, 1998, J BIOL CHEM, V273, P32966, DOI 10.1074/jbc.273.49.32966; Sudhof TC, 1996, NEURON, V17, P379, DOI 10.1016/S0896-6273(00)80171-3; ZHANG JZ, 1994, CELL, V78, P751, DOI 10.1016/S0092-8674(94)90442-1; Schiavo G, 1998, BIOCHEM BIOPH RES CO, V248, P1, DOI 10.1006/bbrc.1998.8527; Schiavo G, 1996, P NATL ACAD SCI USA, V93, P13327, DOI 10.1073/pnas.93.23.13327; Sheng ZH, 1997, P NATL ACAD SCI USA, V94, P5405, DOI 10.1073/pnas.94.10.5405; DAVLETOV BA, 1993, J BIOL CHEM, V268, P26386; Schiavo G, 1997, P NATL ACAD SCI USA, V94, P997, DOI 10.1073/pnas.94.3.997; SUDHOF TC, 1995, NATURE, V375, P645, DOI 10.1038/375645a0; DIANTONIO A, 1994, NEURON, V12, P909, DOI 10.1016/0896-6273(94)90342-5; LI C, 1995, NATURE, V375, P594, DOI 10.1038/375594a0; Sutton RB, 1999, J CELL BIOL, V147, P589, DOI 10.1083/jcb.147.3.589; Mizutani A, 2000, J BIOL CHEM, V275, P9823, DOI 10.1074/jbc.275.13.9823; Schivell AE, 1996, J BIOL CHEM, V271, P27770; Fukuda M, 1996, J BIOL CHEM, V271, P8430; BROSE N, 1992, SCIENCE, V256, P1021, DOI 10.1126/science.1589771; CHAPMAN ER, 1994, J BIOL CHEM, V269, P5735; Chapman ER, 1996, J BIOL CHEM, V271, P5844; Charvin N, 1997, EMBO J, V16, P4591, DOI 10.1093/emboj/16.15.4591; Damer CK, 1996, J NEUROCHEM, V67, P1661; FUKUDA M, 1995, J BIOL CHEM, V270, P26523; FUKUDA M, IN PRESS J BIOCH TOK; Fukuda M, 1997, BIOCHEM J, V323, P421; Fukuda M, 1997, BIOESSAYS, V19, P593, DOI 10.1002/bies.950190710; Fukuda M, 2000, J BIOL CHEM, V275, P28180; Fukuda M, 1999, J BIOL CHEM, V274, P31421, DOI 10.1074/jbc.274.44.31421; FUKUDA M, 1994, J BIOL CHEM, V269, P29206; Fukuda M, 1999, J BIOL CHEM, V274, P31428, DOI 10.1074/jbc.274.44.31428; Ibata K, 1998, J BIOL CHEM, V273, P12267, DOI 10.1074/jbc.273.20.12267; Lang JC, 1997, EMBO J, V16, P5837, DOI 10.1093/emboj/16.19.5837; LITTLETON JT, 1995, TRENDS NEUROSCI, V18, P177; LLINAS R, 1994, P NATL ACAD SCI USA, V91, P12990, DOI 10.1073/pnas.91.26.12990; Marqueze B, 2000, BIOCHIMIE, V82, P409, DOI 10.1016/S0300-9084(00)00220-0; Mehrotra B, 1997, J BIOL CHEM, V272, P4237; MIZUSHIMA S, 1990, NUCLEIC ACIDS RES, V18, P5332; Mizutani A, 1997, BIOCHEM BIOPH RES CO, V240, P128, DOI 10.1006/bbrc.1997.7578; Mochida S, 1997, NEUROSCIENCE, V77, P937; NIINOBE M, 1994, BIOCHEM BIOPH RES CO, V205, P1036, DOI 10.1006/bbrc.1994.2770; NONET ML, 1993, CELL, V73, P1291, DOI 10.1016/0092-8674(93)90357-V; OharaImaizumi M, 1997, P NATL ACAD SCI USA, V94, P287, DOI 10.1073/pnas.94.1.287; Osborne SL, 1999, J BIOL CHEM, V274, P59, DOI 10.1074/jbc.274.1.59; SCHIAVO G, 1995, NATURE, V378, P733, DOI 10.1038/378733a0; Sugita S, 1996, J BIOL CHEM, V271, P1262; Thomas DM, 1998, J NEUROSCI, V18, P3511	51	25	25	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	0014-5793			FEBS LETT	FEBS Lett.	OCT 6	2000	482	3					269	272		10.1016/S0014-5793(00)02064-0		4	Biochemistry & Molecular Biology; Biophysics; Cell Biology	Biochemistry & Molecular Biology; Biophysics; Cell Biology	363RA	WOS:000089847300021		
J	Hasty, AH; Shimano, H; Yahagi, N; Amemiya-Kudo, M; Perrey, S; Yoshikawa, T; Osuga, J; Okazaki, H; Tamura, Y; Iizuka, Y; Shionoiri, F; Ohashi, K; Harada, K; Gotoda, T; Nagai, R; Ishibashi, S; Yamada, N				Hasty, AH; Shimano, H; Yahagi, N; Amemiya-Kudo, M; Perrey, S; Yoshikawa, T; Osuga, J; Okazaki, H; Tamura, Y; Iizuka, Y; Shionoiri, F; Ohashi, K; Harada, K; Gotoda, T; Nagai, R; Ishibashi, S; Yamada, N			Sterol regulatory element-binding protein-1 is regulated by glucose at the transcriptional level	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							POLYUNSATURATED FATTY-ACIDS; LIPOPROTEIN RECEPTOR PROMOTER; LIPOGENIC GENE-EXPRESSION; SREBP-1C MESSENGER-RNA; DIFFERENTIATION FACTOR-1; SYNTHASE PROMOTER; CULTURED-CELLS; INSULIN; LIVERS; ACTIVATION	In vivo studies suggest that sterol regulatory element-binding protein (SREBP)-1 plays a key role in the upregulation of lipogenic genes in the livers of animals that have consumed excess amounts of carbohydrates. In light of this, we sought to use an established mouse hepatocyte cell line, H2-35, to further define the mechanism by which glucose regulates nuclear SREBP-1 levels, First, we show that these cells transcribe high levels of SREBP-1c that are increased 4-fold upon differentiation from a prehepatocyte to a hepatocyte phenotype, making them an ideal cell culture model for the study of SREBP-1c induction. Second, we demonstrate that the presence of precursor and mature forms of SREBP-1 protein are positively regulated by medium glucose concentrations ranging from 5.5 to 25 mM, and are also regulated by insulin, with the amount of insulin in the fetal bovine serum being sufficient for maximal stimulation of SREBP-1 expression. Third, we show that the increase in SREBP-1 protein is due to an increase in SREBP-1 mRNA, Reporter gene analysis of the SREBP-1c promoter demonstrated a glucose-dependent induction of transcription. In contrast, expression of a fixed amount of the precursor form of SREBP-1c protein showed that glucose does not influence its cleavage. Fourth, we demonstrate that the glucose induction of SREBP could not be reproduced by fructose, xylose, or galactose nor by glucose analogs a-deoxy glucose and 3-O-methyl glucopyranose. These data provide strong evidence for the induction of SREBP-1c mRNA by glucose leading to increased mature protein in the nucleus, thus providing a potential mechanism for the up-regulation of lipogenic genes by glucose in vivo.	Univ Tsukuba, Inst Clin Med, Dept Internal Med, Tsukuba, Ibaraki 3058575, Japan; Univ Tokyo, Dept Metab Dis, Tokyo 1138655, Japan	Shimano, H (reprint author), Univ Tsukuba, Inst Clin Med, Dept Internal Med, 1-1-1 Tennodai, Tsukuba, Ibaraki 3058575, Japan.		Yahagi, Naoya/D-2360-2014	Yahagi, Naoya/0000-0002-1823-1865			YOKOYAMA C, 1993, CELL, V75, P187, DOI 10.1016/S0092-8674(05)80095-9; Shimano H, 1996, J CLIN INVEST, V98, P1575, DOI 10.1172/JCI118951; Ntambi JM, 1996, BIOCHEM BIOPH RES CO, V220, P990, DOI 10.1006/bbrc.1996.0520; Kim JB, 1996, GENE DEV, V10, P1096, DOI 10.1101/gad.10.9.1096; DIPERSIO CM, 1991, MOL CELL BIOL, V11, P4405; GOODRIDGE AG, 1987, ANNU REV NUTR, V7, P157; Ericsson J, 1997, J BIOL CHEM, V272, P7298; Horton JD, 1998, P NATL ACAD SCI USA, V95, P5987, DOI 10.1073/pnas.95.11.5987; KIM JB, 1995, MOL CELL BIOL, V15, P2582; Shimomura I, 1997, J CLIN INVEST, V99, P838, DOI 10.1172/JCI119247; TOWLE HC, 1995, J BIOL CHEM, V270, P23235; Kim HJ, 1999, J BIOL CHEM, V274, P25892, DOI 10.1074/jbc.274.36.25892; Magana MM, 1996, J BIOL CHEM, V271, P32689; Shimomura I, 1999, J BIOL CHEM, V274, P30028, DOI 10.1074/jbc.274.42.30028; Shimano H, 1997, J CLIN INVEST, V100, P2115, DOI 10.1172/JCI119746; Sakai J, 1996, CELL, V85, P1037, DOI 10.1016/S0092-8674(00)81304-5; Shimano H, 1997, J CLIN INVEST, V99, P846, DOI 10.1172/JCI119248; Brown MS, 1997, CELL, V89, P331, DOI 10.1016/S0092-8674(00)80213-5; Wang XD, 1996, EMBO J, V15, P1012; Foretz M, 1999, P NATL ACAD SCI USA, V96, P12737, DOI 10.1073/pnas.96.22.12737; Streicher R, 1996, J BIOL CHEM, V271, P7128; Alessi DR, 1998, BBA-MOL CELL BIOL L, V1436, P151, DOI 10.1016/S0005-2760(98)00133-7; Shepherd PR, 1998, BIOCHEM J, V333, P471; Shimano H, 1999, J BIOL CHEM, V274, P35832, DOI 10.1074/jbc.274.50.35832; Wang JL, 1998, NATURE, V393, P684, DOI 10.1038/31474; Foretz M, 1999, MOL CELL BIOL, V19, P3760; WANG XD, 1993, J BIOL CHEM, V268, P14497; Brown MS, 1999, P NATL ACAD SCI USA, V96, P11041, DOI 10.1073/pnas.96.20.11041; Sato R, 1996, J BIOL CHEM, V271, P26461; Wang D, 1998, J BIOL CHEM, V273, P25420, DOI 10.1074/jbc.273.39.25420; Kolm-Litty V, 1998, J CLIN INVEST, V101, P160, DOI 10.1172/JCI119875; Rawson RB, 1999, J BIOL CHEM, V274, P28549, DOI 10.1074/jbc.274.40.28549; Sato R, 2000, J BIOL CHEM, V275, P12497, DOI 10.1074/jbc.275.17.12497; Kim JB, 1998, J CLIN INVEST, V101, P1, DOI 10.1172/JCI1411; Yahagi N, 1999, J BIOL CHEM, V274, P35840, DOI 10.1074/jbc.274.50.35840; DOIRON B, 1994, J BIOL CHEM, V269, P10213; Guan GM, 1997, J BIOL CHEM, V272, P10295; HASAN MT, 1994, SOMAT CELL MOLEC GEN, V20, P183, DOI 10.1007/BF02254759; Herbert L, 1996, J CLIN INVEST, V98, P930; Hua XX, 1996, J BIOL CHEM, V271, P10379; Koo SH, 2000, J BIOL CHEM, V275, P5200, DOI 10.1074/jbc.275.7.5200; Kotzka J, 2000, J LIPID RES, V41, P99; Mater MK, 1999, J BIOL CHEM, V274, P32725, DOI 10.1074/jbc.274.46.32725; McClain DA, 1996, DIABETES, V45, P1003, DOI 10.2337/diabetes.45.8.1003; Mourrieras F, 1997, BIOCHEM J, V326, P345; Shimomura L, 1999, P NATL ACAD SCI USA, V96, P13656; Tabor DE, 1998, J BIOL CHEM, V273, P22052, DOI 10.1074/jbc.273.34.22052; Takemoto M, 1999, BIOCHEM BIOPH RES CO, V258, P722, DOI 10.1006/bbrc.1999.0701; Thewke DP, 1998, J BIOL CHEM, V273, P21402, DOI 10.1074/jbc.273.33.21402; Worgall TS, 1998, J BIOL CHEM, V273, P25537, DOI 10.1074/jbc.273.40.25537; ZARET KS, 1988, P NATL ACAD SCI USA, V85, P9076, DOI 10.1073/pnas.85.23.9076; ZARET KS, 1990, MOL CELL BIOL, V10, P4582	52	103	112	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	OCT 6	2000	275	40					31069	31077		10.1074/jbc.M003335200		9	Biochemistry & Molecular Biology	Biochemistry & Molecular Biology	362DE	WOS:000089762700047		
J	Amemiya-Kudo, M; Shimano, H; Yoshikawa, T; Yahagi, N; Hasty, AH; Okazaki, H; Tamura, Y; Shionoiri, F; Iizuka, Y; Ohashi, K; Osuga, J; Harada, K; Gotoda, T; Sato, R; Kimura, S; Ishibashi, S; Yamada, N				Amemiya-Kudo, M; Shimano, H; Yoshikawa, T; Yahagi, N; Hasty, AH; Okazaki, H; Tamura, Y; Shionoiri, F; Iizuka, Y; Ohashi, K; Osuga, J; Harada, K; Gotoda, T; Sato, R; Kimura, S; Ishibashi, S; Yamada, N			Promoter analysis of the mouse sterol regulatory element-binding protein-1c gene	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							POLYUNSATURATED FATTY-ACIDS; SREBP-1C MESSENGER-RNA; TRANSGENIC MICE; CHOLESTEROL-SYNTHESIS; TRANSCRIPTION FACTOR; SYNTHASE PROMOTER; ADIPOSE-TISSUE; CULTURED-CELLS; NF-Y; EXPRESSION	Recent data suggest that sterol regulatory-binding protein (SREBP)-1c plays a key role in the transcriptional regulation of different lipogenic genes mediating lipid synthesis as a key regulator of fuel metabolism. SREBP-1c regulates its downstream genes by changing its own mRNA level, which led us to sequence and analyze the promoter region of the mouse SREBP-1c gene. A cluster of putative binding sites of several transcription factors composed of an NF-Y site, an E-box, a sterol-regulatory element 3, and an Spl site were located at -90 base pairs of the SREBP-1c promoter. Luciferase reporter gene assays indicated that this SRE complex is essential to the basal promoter activity and confers responsiveness to activation by nuclear SREBPs, Deletion and mutation analyses suggest that the NF-Y site and SRE3 in the SRE complex are responsible for SREBP activation, although the other sites were also involved in the basal activity. Gel mobility shift assays demonstrate that SREBP-1 binds to the SRE3, Taken together, these findings implicate a positive loop production of SREBP-1c through the SRE complex, possibly leading to the overshoot in induction of SREBP-1c and its downstream genes seen in the livers of refed mice. Furthermore, reporter assays using larger upstream fragments indicated another region that was inducible by addition of sterols. The presence of the SRE complex and a sterol-inducible region in the same promoter suggests a novel regulatory Link between cholesterol and fatty acid synthesis.	Univ Tsukuba, Inst Clin Med, Dept Internal Med, Tsukuba, Ibaraki 3058575, Japan; Univ Tokyo, Grad Sch Agr & Life Sci, Dept Metab Dis, Fac Med, Tokyo 1138655, Japan; Univ Tokyo, Grad Sch Agr & Life Sci, Dept Appl Biol Chem, Tokyo 1138655, Japan	Shimano, H (reprint author), Univ Tsukuba, Inst Clin Med, Dept Internal Med, 1-1-1 Tennodai, Tsukuba, Ibaraki 3058575, Japan.		Yahagi, Naoya/D-2360-2014	Yahagi, Naoya/0000-0002-1823-1865			ANDERSSON S, 1989, J BIOL CHEM, V264, P8222; Shimomura I, 1998, GENE DEV, V12, P3182, DOI 10.1101/gad.12.20.3182; Xu J, 1999, J BIOL CHEM, V274, P23577, DOI 10.1074/jbc.274.33.23577; SANCHEZ HB, 1995, J BIOL CHEM, V270, P1161; Shimano H, 1996, J CLIN INVEST, V98, P1575, DOI 10.1172/JCI118951; Kim JB, 1996, GENE DEV, V10, P1096, DOI 10.1101/gad.10.9.1096; GOODRIDGE AG, 1987, ANNU REV NUTR, V7, P157; Horton JD, 1998, P NATL ACAD SCI USA, V95, P5987, DOI 10.1073/pnas.95.11.5987; KIM JB, 1995, MOL CELL BIOL, V15, P2582; Shimomura I, 1997, J CLIN INVEST, V99, P838, DOI 10.1172/JCI119247; Kim HJ, 1999, J BIOL CHEM, V274, P25892, DOI 10.1074/jbc.274.36.25892; Magana MM, 1996, J BIOL CHEM, V271, P32689; Hasty AH, 2000, J BIOL CHEM, V275, P31069, DOI 10.1074/jbc.M003335200; Shimano H, 1997, J CLIN INVEST, V100, P2115, DOI 10.1172/JCI119746; Sakai J, 1996, CELL, V85, P1037, DOI 10.1016/S0092-8674(00)81304-5; Shimano H, 1997, J CLIN INVEST, V99, P846, DOI 10.1172/JCI119248; Brown MS, 1997, CELL, V89, P331, DOI 10.1016/S0092-8674(00)80213-5; Soukas A, 2000, GENE DEV, V14, P963; Horton JD, 1998, J CLIN INVEST, V101, P2331, DOI 10.1172/JCI2961; Foretz M, 1999, P NATL ACAD SCI USA, V96, P12737, DOI 10.1073/pnas.96.22.12737; Shimano H, 1999, J BIOL CHEM, V274, P35832, DOI 10.1074/jbc.274.50.35832; Foretz M, 1999, MOL CELL BIOL, V19, P3760; WANG XD, 1993, J BIOL CHEM, V268, P14497; Brown MS, 1999, P NATL ACAD SCI USA, V96, P11041, DOI 10.1073/pnas.96.20.11041; Magana MM, 2000, J BIOL CHEM, V275, P4726, DOI 10.1074/jbc.275.7.4726; HILLGARTNER F, 1995, PHYSIOL REV, V75, P47; Ericsson J, 1996, P NATL ACAD SCI USA, V93, P945, DOI 10.1073/pnas.93.2.945; Kim JB, 1998, J CLIN INVEST, V101, P1, DOI 10.1172/JCI1411; Yahagi N, 1999, J BIOL CHEM, V274, P35840, DOI 10.1074/jbc.274.50.35840; Ericsson J, 1996, J BIOL CHEM, V271, P24359; Heinemeyer T., 1998, NUCLEIC ACIDS RES, V26, P364, DOI DOI 10.1093/NAR/26.1.362; JACKSON SM, 1995, J BIOL CHEM, V270, P21445; Koo SH, 2000, J BIOL CHEM, V275, P5200, DOI 10.1074/jbc.275.7.5200; Shimomura L, 1999, P NATL ACAD SCI USA, V96, P13656; Thewke DP, 1998, J BIOL CHEM, V273, P21402, DOI 10.1074/jbc.273.33.21402; TIMCHENKO N, 1995, MOL CELL BIOL, V15, P1192; Worgall TS, 1998, J BIOL CHEM, V273, P25537, DOI 10.1074/jbc.273.40.25537; Xiong SB, 2000, P NATL ACAD SCI USA, V97, P3948, DOI 10.1073/pnas.040574197	38	155	157	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	OCT 6	2000	275	40					31078	31085		10.1074/jbc.M005353200		8	Biochemistry & Molecular Biology	Biochemistry & Molecular Biology	362DE	WOS:000089762700048		
J	Nagasawa, K; Kitamura, K; Yasui, A; Nimura, Y; Ikeda, K; Hirai, M; Matsukage, A; Nakanishi, M				Nagasawa, K; Kitamura, K; Yasui, A; Nimura, Y; Ikeda, K; Hirai, M; Matsukage, A; Nakanishi, M			Identification and characterization of human DNA polymerase beta 2, a DNA polymerase beta-related enzyme	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							BASE-EXCISION-REPAIR; OVARIAN-CANCER; LONG ARM; GENE; MUTATIONS; BRCA1; PROTEINS; RNA; CHROMOSOME-10; REQUIREMENT	The BRCA1 COOH terminus (BRCT) motif is present in many nuclear proteins that contribute to cell cycle regulation or DNA repair. Polymerase chain reaction-based screening with degenerate primers targeted to the BRCT motif resulted in the isolation of a human cDNA for a previously unidentified DNA polymerase (designated DNA polymerase beta 2) that is closely related to DNA polymerase beta (Pol beta). The predicted Pol beta 2 protein contains a BRCT motif in its NH2-terminal region; its COOH-terminal region exhibits 33% sequence identity to a corresponding region of human Pol beta. The Pol beta 2 gene is expressed in a tissue-specific manner, with transcripts being most abundant in testis. A fusion con struct comprising Pol beta 2 and green fluorescent protein exhibited a predominantly nuclear localization in transfected HeLa cells. Recombinant human Pol beta 2 from insect cells exhibited substantial DNA polymerase activity, but it did not possess terminal deoxyribonucleotidyl transferase activity. A truncated Pd beta 2 mutant lacking the BRCT motif retained substantial DNA polymerase activity, whereas a mutant Pol beta 2 with two alanine point mutations within the DNA polymerase active site did not. These results indicate that Pol beta 2 is a Pol beta-related DNA polymerase with a BRCT motif that is dispensable for its polymerase activity.	Nagoya City Univ, Sch Med, Dept Biochem, Mizuho Ku, Nagoya, Aichi 4678601, Japan; Natl Inst Longev Sci, Dept Geriatr Res, Obu, Aichi 4748522, Japan; Natl Chubu Hosp, Dept Surg, Obu, Aichi 4748511, Japan; Nagoya Univ, Sch Med, Dept Surg, Nagoya, Aichi 4648550, Japan; Univ Tokyo, Grad Sch Sci, Dept Biol Sci, Tokyo 113, Japan; Aichi Canc Ctr, Res Inst, Cell Biol Lab, Nagoya, Aichi 4648681, Japan	Nakanishi, M (reprint author), Nagoya City Univ, Sch Med, Dept Biochem, Mizuho Ku, 1 Kawasumi, Nagoya, Aichi 4678601, Japan.						Albarosa R, 1996, AM J HUM GENET, V58, P1260; Iwanaga A, 1999, MUTAT RES-DNA REPAIR, V435, P121, DOI 10.1016/S0921-8777(99)00036-1; WIEBAUER K, 1990, P NATL ACAD SCI USA, V87, P5842, DOI 10.1073/pnas.87.15.5842; Cappellen D, 1997, ONCOGENE, V14, P3059, DOI 10.1038/sj.onc.1201154; Klungland A, 1997, EMBO J, V16, P3341, DOI 10.1093/emboj/16.11.3341; THOMPSON LH, 1990, MOL CELL BIOL, V10, P6160; Bork P, 1997, FASEB J, V11, P68; MIKI Y, 1994, SCIENCE, V266, P66, DOI 10.1126/science.7545954; LARIMER FW, 1989, J BACTERIOL, V171, P230; Callebaut I, 1997, FEBS LETT, V400, P25, DOI 10.1016/S0014-5793(96)01312-9; Sobol RW, 1996, NATURE, V379, P183, DOI 10.1038/379183a0; SAKA Y, 1993, CELL, V74, P383, DOI 10.1016/0092-8674(93)90428-S; LINDELL TJ, 1970, SCIENCE, V170, P447, DOI 10.1126/science.170.3956.447; FRIEDMAN LS, 1994, NAT GENET, V8, P399, DOI 10.1038/ng1294-399; MATSUMOTO Y, 1995, SCIENCE, V269, P699, DOI 10.1126/science.7624801; Bhattacharyya N, 1999, DNA CELL BIOL, V18, P549, DOI 10.1089/104454999315097; BIENSTOCK RJ, 1996, CANCER RES, V56, P1539; DATE T, 1991, BIOCHEMISTRY-US, V30, P5286, DOI 10.1021/bi00235a023; DOBASHI Y, 1994, CANCER RES, V54, P2827; Ford S, 1998, CANCER GENET CYTOGEN, V102, P6, DOI 10.1016/S0165-4608(97)00250-1; HAMMOND RA, 1990, BIOCHEMISTRY-US, V29, P286, DOI 10.1021/bi00453a039; HIRAI M, 1994, CYTOGENET CELL GENET, V66, P149, DOI 10.1159/000133687; Holt JT, 1996, NAT GENET, V12, P298, DOI 10.1038/ng0396-298; HORTON JK, 1995, NUCLEIC ACIDS RES, V23, P3810, DOI 10.1093/nar/23.19.3810; Kim SK, 1998, ONCOGENE, V17, P1749, DOI 10.1038/sj.onc.1202073; Matsuzaki J, 1996, MOL CARCINOGEN, V15, P38, DOI 10.1002/(SICI)1098-2744(199601)15:1<38::AID-MC6>3.0.CO;2-O; MIKI T, 1993, NATURE, V362, P462, DOI 10.1038/362462a0; Mizushina Y, 1998, BIOCHEM J, V330, P1325; Oda N, 1996, J BIOL CHEM, V271, P13816; PELLETIER H, 1994, SCIENCE, V264, P1891, DOI 10.1126/science.7516580; Plug AW, 1997, P NATL ACAD SCI USA, V94, P1327, DOI 10.1073/pnas.94.4.1327; WANG LM, 1992, CANCER RES, V52, P4824; WILSON SH, 1990, EUKARYOTIC NUCLEUS, V1, P199; WILSON S, 1988, BIOCHIM BIOPHYS ACTA, V949, P149, DOI 10.1016/0167-4781(88)90078-4; WILSON SH, 1992, DNA REPAIR MECH, V35, P343; Yan ZJ, 1995, BIOCHEM MOL BIOL INT, V37, P175; ZHANG X, 1998, EMBO J, V21, P6404	37	57	59	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	OCT 6	2000	275	40					31233	31238		10.1074/jbc.M004263200		6	Biochemistry & Molecular Biology	Biochemistry & Molecular Biology	362DE	WOS:000089762700069		
J	Chikazu, D; Hakeda, Y; Ogata, N; Nemoto, K; Itabashi, A; Takato, T; Kumegawa, M; Nakamura, K; Kawaguchi, H				Chikazu, D; Hakeda, Y; Ogata, N; Nemoto, K; Itabashi, A; Takato, T; Kumegawa, M; Nakamura, K; Kawaguchi, H			Fibroblast growth factor (FGF)-2 directly stimulates mature osteoclast function through activation of FGF receptor 1 and p42/p44 MAP kinase	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							OSTEOBLASTIC MC3T3-E1 CELLS; MESSENGER-RNA LEVELS; BONE-RESORPTION; PROTEIN-KINASE; CATHEPSIN-K; MATRIX METALLOPROTEINASE-9; MOLECULAR-CLONING; TYROSINE KINASE; IN-VITRO; C-SRC	We previously reported that fibroblast growth factor-2 (FGF-S) acts not only on osteoblasts 60 stimulate osteoclastic bone resorption indirectly but also on mature osteoclasts directly. In this study, we investigated the mechanism of this direct action of FGF-S on mature osteoclasts using mouse and rabbit osteoclast culture systems. FGF-S stimulated pit formation resorbed by isolated rabbit osteoclasts moderately from low concentrations (greater than or equal to 10(-12) M)) whereas at high concentrations (greater than or equal to 10(-9) d it showed stimulation on pit formation resorbed by unfractionated bone cells very potently. FGF-S (greater than or equal to 10(-12) M) also increased cathepsin K and MMP-9 mRNA levels in mouse and rabbit osteoclasts. Among FGF receptors (FGFR1 to 4) only FGFR1 was detected on isolated mouse osteoclasts, whereas all FGFRs were identified on mouse osteoblasts. FGF-P (greater than or equal to 10(-12) M) upregulated the phosphorylation of cellular proteins, including p42/p44 mitogen-activated protein (MAP) kinase, and increased the kinase activity of immunoprecipitated FGFR1 in mouse osteoclasts. The stimulation of FGF-2 on mouse and rabbit osteoclast functions was abrogated by PD-98059, a specific inhibitor of p42/p44 MAP kinase. These results strongly suggest that FGF-2 acts directly on mature osteoclasts through activation of FGFR1 and p42/p44 MAP kinase, causing the stimulation of bone resorption at physiological or pathological concentrations.	Univ Tokyo, Grad Sch Med, Dept Orthopaed Surg, Tokyo 1138655, Japan; Univ Tokyo, Grad Sch Med, Dept Oral & Maxillofacial Surg, Tokyo 1138655, Japan; Saitama Med Sch, Clin Lab, Iruma, Saitama 3500495, Japan; Meikai Univ, Sch Dent, Dept Oral Anat, Sakado, Saitama 3500248, Japan	Kawaguchi, H (reprint author), Univ Tokyo, Grad Sch Med, Dept Orthopaed Surg, Hongo 7-3-1, Tokyo 1138655, Japan.						AKATSU T, 1992, J BONE MINER RES, V7, P1297; Manabe N, 1999, RHEUMATOLOGY, V38, P714, DOI 10.1093/rheumatology/38.8.714; JIMI E, 1995, ENDOCRINOLOGY, V136, P808, DOI 10.1210/en.136.2.808; CANALIS E, 1988, J CLIN INVEST, V81, P1572, DOI 10.1172/JCI113490; Sato T, 1997, J CELL SCI, V110, P589; KAWAGUCHI H, 1995, J CLIN INVEST, V96, P923, DOI 10.1172/JCI118140; TEZUKA K, 1994, J BIOL CHEM, V269, P1106; DUDLEY DT, 1995, P NATL ACAD SCI USA, V92, P7686, DOI 10.1073/pnas.92.17.7686; KAWAGUCHI H, 1994, ENDOCRINOLOGY, V135, P774, DOI 10.1210/en.135.2.774; Kouhara H, 1997, CELL, V89, P693, DOI 10.1016/S0092-8674(00)80252-4; Azuma Y, 2000, J BIOL CHEM, V275, P4858, DOI 10.1074/jbc.275.7.4858; LANDGREN E, 1995, ONCOGENE, V10, P2027; Insogna KL, 1997, J CLIN INVEST, V100, P2476, DOI 10.1172/JCI119790; Deng CX, 1996, CELL, V84, P911, DOI 10.1016/S0092-8674(00)81069-7; NAKAMURA T, 1995, ENDOCRINOLOGY, V136, P1276, DOI 10.1210/en.136.3.1276; ALESSI DR, 1995, J BIOL CHEM, V270, P27489; Kato T, 1998, J ORTHOPAED RES, V16, P654, DOI 10.1002/jor.1100160605; Nakagawa N, 1999, BIOCHEM BIOPH RES CO, V265, P158, DOI 10.1006/bbrc.1999.1601; Okazaki H, 1999, CALCIFIED TISSUE INT, V64, P542, DOI 10.1007/s002239900646; Kobayashi K, 2000, J EXP MED, V191, P275, DOI 10.1084/jem.191.2.275; Webster MK, 1996, MOL CELL BIOL, V16, P4081; SHIANG R, 1994, CELL, V78, P335, DOI 10.1016/0092-8674(94)90302-6; Hurley MM, 1998, BONE, V22, P309, DOI 10.1016/S8756-3282(97)00292-5; TEZUKA K, 1994, J BIOL CHEM, V269, P15006; Kameda T, 1996, BIOCHEM BIOPH RES CO, V220, P515, DOI 10.1006/bbrc.1996.0436; JOHNSON DE, 1993, ADV CANCER RES, V60, P1; Nakamura T, 1998, J BONE MINER RES, V13, P942, DOI 10.1359/jbmr.1998.13.6.942; LEE JC, 1994, NATURE, V372, P739, DOI 10.1038/372739a0; CUENDA A, 1995, FEBS LETT, V364, P229, DOI 10.1016/0014-5793(95)00357-F; ROUSSEAU F, 1994, NATURE, V371, P252, DOI 10.1038/371252a0; ASPENBERG P, 1989, ACTA ORTHOP SCAND, V60, P473, DOI 10.3109/17453678909149323; Baron R, 1996, REV RHUM, V63, P633; CHIKAZU D, 1999, J BONE MINER RES  S1, V14, pS306; COUGHLIN SR, 1988, J BIOL CHEM, V263, P988; GLOBUS RK, 1989, ENDOCRINOLOGY, V124, P1539; HURLEY MM, 1994, J BIOL CHEM, V269, P9392; HURLEY MM, 1993, J BIOL CHEM, V268, P5588; INAOKA T, 1995, BIOCHEM BIOPH RES CO, V206, P89, DOI 10.1006/bbrc.1995.1013; Inui T, 1997, J BIOL CHEM, V272, P8109; Kawaguchi H, 2000, J BONE MINER RES, V15, P466, DOI 10.1359/jbmr.2000.15.3.466; Klint P, 1999, ONCOGENE, V18, P3354, DOI 10.1038/sj.onc.1202680; KLINT P, 1995, J BIOL CHEM, V270, P23337; Kozawa O, 1999, J CELL BIOCHEM, V74, P479, DOI 10.1002/(SICI)1097-4644(19990901)74:3<479::AID-JCB15>3.0.CO;2-9; Nakamura K, 1997, J ORTHOPAED RES, V15, P307, DOI 10.1002/jor.1100150222; Nakamura YS, 1998, STEM CELLS, V16, P229; OKADA Y, 1995, LAB INVEST, V72, P311; RIFKIN DB, 1989, J CELL BIOL, V109, P1, DOI 10.1083/jcb.109.1.1; RODAN SB, 1989, J BIOL CHEM, V264, P19934; Sato T, 1998, J BONE MINER RES, V13, P59, DOI 10.1359/jbmr.1998.13.1.59; SIMMONS HA, 1991, J BONE MINER RES, V6, P1301; Suzuki A, 1996, J CELL BIOCHEM, V63, P491, DOI 10.1002/(SICI)1097-4644(19961215)63:4<491::AID-JCB10>3.0.CO;2-H; TEZUKA K, 1992, BONE MINER, V17, P347; Schwartz M A, 1992, Prog Med Chem, V29, P271, DOI 10.1016/S0079-6468(08)70011-0; Votta BJ, 1997, J BONE MINER RES, V12, P1396, DOI 10.1359/jbmr.1997.12.9.1396; ZHAN X, 1994, J BIOL CHEM, V269, P20221	55	74	77	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	OCT 6	2000	275	40					31444	31450		10.1074/jbc.M910132199		7	Biochemistry & Molecular Biology	Biochemistry & Molecular Biology	362DE	WOS:000089762700098		
J	Saiki, T; Goto, K; Tokitoh, N; Goto, M; Okazaki, R				Saiki, T; Goto, K; Tokitoh, N; Goto, M; Okazaki, R			Syntheses and structures of novel m-xylylene-bridged calix[6]arenes: stabilization of a sulfenic acid in the cavity of calix[6]arene	JOURNAL OF ORGANOMETALLIC CHEMISTRY			English	Article						calix[6]arenes; sulfenic acids; steric protection; x-ray analysis; conformational analysis	CONCAVE REAGENTS; BEARING; FUNCTIONALITY; REACTIVITY; OXIDATION; SKELETON; BASICITY; THIOL	The syntheses and structures of novel bridged calix[6]arenes 1 with inwardly directed functional groups in the cavity, and application of the bicyclic framework to the stabilization of a sulfenic acid are described. It was found that, unlike their precursors 2, the tetramethoxy compounds 1 have a tendency to adopt the 1,a,3-alternate conformation at least in the crystalline state, except when the central functionality has a large steric demand. Thermolysis of sulfoxide Ig at 80 degrees C in toluene afforded the stable sulfenic acid Ih almost quantitatively; the structure was determined by X-ray analysis. The SOH group was found to be directed into the cavity and surrounded by the calix[6]arene macrocycle with the 1,2,3-alternate conformation, being protected from self-condensation leading to the corresponding thiosulfinate. The high stability of Ih demonstrates that the framework of the bridged calix[6]arene can effectively regulate the reactivity of the functional group fixed in the cavity. (C) 2000 Elsevier Science S.A. All rights reserved.	Univ Tokyo, Grad Sch Sci, Dept Chem, Bunkyo Ku, Tokyo 113, Japan; Natl Inst Mat & Chem Res, Tsukuba, Ibaraki 305, Japan	Okazaki, R (reprint author), Japan Womens Univ, Fac Sci, Dept Chem & Biol Sci, Bunkyo Ku, 2-8-1 Mejirodai, Tokyo 1128681, Japan.						Akine S, 1999, B CHEM SOC JPN, V72, P2781, DOI 10.1246/bcsj.72.2781; Akine S, 2000, J INCL PHENOM MACRO, V36, P119; Akine S, 2000, TETRAHEDRON LETT, V41, P897, DOI 10.1016/S0040-4039(99)02171-1; ALLISON WS, 1976, ACCOUNTS CHEM RES, V9, P293, DOI 10.1021/ar50104a003; KANAMATHAREDDY S, 1993, J AM CHEM SOC, V115, P6572, DOI 10.1021/ja00068a014; CASNATI A, 1995, TETRAHEDRON, V51, P591, DOI 10.1016/0040-4020(94)00918-K; CLAIBORNE A, 1993, FASEB J, V7, P1483; Goto K, 1997, J AM CHEM SOC, V119, P1460, DOI 10.1021/ja962994s; GOTO K, 1995, ANGEW CHEM INT EDIT, V34, P1124, DOI 10.1002/anie.199511241; Beurskens P. T., 1992, DIRDIF PROGRAM SYSTE; Boyer PD, 1970, ENZYMES; BURLA MC, 1989, J APPL CRYSTALLOGR, V22, P389, DOI 10.1107/S0021889889004103; CLAIBORNE A, 1992, TRENDS BIOCHEM SCI, V17, P183, DOI 10.1016/0968-0004(92)90263-9; DAVIS FA, 1986, J ORG CHEM, V51, P1033, DOI 10.1021/jo00357a017; Gutsche C. D., 1989, CALIXARENES MONOGRAP; Gutsche C. D., 1998, CALIXARENES REVISITE; Hogg D. R., 1990, CHEM SULPHENIC ACIDS, P361, DOI 10.1002/9780470772287.ch9; Ishii A, 1996, J AM CHEM SOC, V118, P12836, DOI 10.1021/ja962995k; Kice J.L., 1980, ADV PHYS ORG CHEM, V17, P65; MACHIGUCHI T, 1994, J AM CHEM SOC, V116, P407, DOI 10.1021/ja00080a061; MAIN P, 1978, MULTAN 78; OTSUKA H, 1995, J ORG CHEM, V60, P4862, DOI 10.1021/jo00120a033; OTSUKA H, 1994, J ORG CHEM, V59, P1542, DOI 10.1021/jo00085a048; Pochini A., 1996, COMPREHENSIVE SUPRAM, V2, P103; Ross H, 1996, TETRAHEDRON, V52, P10879, DOI 10.1016/0040-4020(96)00614-X; ROSS H, 1998, J CHEM SOC T2, P1313; ROSS H, 1995, ANGEW CHEM INT EDIT, V34, P2555, DOI 10.1002/anie.199525551; Ross H, 1996, LIEBIGS ANN, P1367; Saiki T, 1996, CHEM LETT, P993, DOI 10.1246/cl.1996.993; Saiki T, 2000, B CHEM SOC JPN, V73, P1893, DOI 10.1246/bcsj.73.1893; Saiki T, 1996, TETRAHEDRON LETT, V37, P4039, DOI 10.1016/0040-4039(96)00756-3; Saiki T, 1996, J ORG CHEM, V61, P2924, DOI 10.1021/jo960068q; Saiki T, 1997, ANGEW CHEM INT EDIT, V36, P2223, DOI 10.1002/anie.199722231; TOKITOH N, 1995, J CHEM SOC CHEM COMM, P1899, DOI 10.1039/c39950001899; TRIPOLT R, 1993, Z NATURFORSCH B, V48, P1212; Vicens J., 1991, CALIXARENES VERSATIL; YOSHIMURA T, 1992, J CHEM SOC CHEM COMM, P1337, DOI 10.1039/c39920001337	37	11	11	ELSEVIER SCIENCE SA	LAUSANNE	PO BOX 564, 1001 LAUSANNE, SWITZERLAND	0022-328X			J ORGANOMET CHEM	J. Organomet. Chem.	OCT 6	2000	611	1-2					146	157		10.1016/S0022-328X(00)00322-3		12	Chemistry, Inorganic & Nuclear; Chemistry, Organic	Chemistry	364LZ	WOS:000089895000022		
J	Iwaoka, M; Komatsu, H; Tomoda, S				Iwaoka, M; Komatsu, H; Tomoda, S			Structural characteristics of areneselenenyl bromide and areneselenenyl chloride stabilized by hypervalent coordination with a halide anion in the solid state	JOURNAL OF ORGANOMETALLIC CHEMISTRY			English	Article						areneselenenyl bromide; areneselenenyl chloride; hypervalent interaction; structural correlation; packing force	INTRAMOLECULAR NONBONDED INTERACTION; CRYSTAL-STRUCTURE DATA; NMR-SPECTROSCOPY; REACTION PATHS; SELENIUM; DERIVATIVES; SE-77	Solid-state molecular structures of 2-[(N-cyclohexyl-N-methylamino)methyl]be bromide (ArSeBr) and chloride (ArSeCl), stabilized by hypervalent coordination with a halide anion (Br- or Cl-, respectively), were determined by X-ray diffraction method. By comparing bond parameters of the observed hypervalent Br-Se Br fragment with those reported previously for other organoselenium compounds, which have a similar T-shaped selenium fragment, it was revealed that there is decent hyperbolic relationship between the two linear Se-Br atomic distances in the solid state, reflecting the possibility of a pathway for the addition reaction of benzeneselenenyl bromide (PhSeBr) in solution. In addition, the existence of significant bond-shortening (similar to 0.1 Angstrom) due to intermolecular weak packing interactions was strongly suggested by comparison of the extrapolated Se-Br covalent bond length (2.220 Angstrom) in the solid state with that reported for PhSeBr (2.325 Angstrom) in the gas phase. Ab initio molecular orbital calculations at the RHF/6-31G(d,p) level using Ahlrichs pVDZ basis sets for Se and Br estimated the perturbation energy in the solid state to be roughly 1.5 kcal mol(-1) independent of the packing structure. (C) 2000 Elsevier Science S.A. All rights reserved.	Univ Tokyo, Grad Sch Arts & Sci, Dept Life Sci, Meguro Ku, Tokyo 1538902, Japan	Tomoda, S (reprint author), Univ Tokyo, Grad Sch Arts & Sci, Dept Life Sci, Meguro Ku, 4-6-1 Komaba, Tokyo 1538902, Japan.						ALLEN FH, 1991, J CHEM INF COMP SCI, V31, P187, DOI 10.1021/ci00002a004; [Anonymous], 1992, J CHEM PHYS; ALTOMARE A, 1994, J APPL CRYSTALLOGR, V27, P435, DOI 10.1107/S002188989400021X; Iwaoka M, 1996, J AM CHEM SOC, V118, P8077, DOI 10.1021/ja953358h; VOGLER S, 1991, Z NATURFORSCH B, V46, P1625; MARQUARDT DW, 1963, J SOC IND APPL MATH, V11, P431; Landrum GA, 1998, ANGEW CHEM INT EDIT, V37, P1887, DOI 10.1002/(SICI)1521-3773(19980803)37:13/14<1887::AID-ANIE1887>3.0.CO;2-0; BURGI HB, 1973, INORG CHEM, V12, P2321; BAIWIR PM, 1975, ACTA CRYSTALLOGR B, V31, P2188; BECKE AD, 1993, J CHEM PHYS, V98, P5648, DOI 10.1063/1.464913; Bigoli F, 1998, EUR J INORG CHEM, P137; BJORNEVAG S, 1984, ACTA CHEM SCAND A, V38, P175, DOI 10.3891/acta.chem.scand.38a-0175; BRITTON D, 1981, J AM CHEM SOC, V103, P2971, DOI 10.1021/ja00401a011; Burgi H., 1994, STRUCTURE CORRELATIO, V1; BURGI HB, 1975, ANGEW CHEM INT EDIT, V14, P460, DOI 10.1002/anie.197504601; CLEGG W, 1992, J CHEM SOC DALTON, P1967, DOI 10.1039/dt9920001967; BURGI HB, 1983, ACCOUNTS CHEM RES, V16, P153; Farrugia LJ, 1997, J APPL CRYSTALLOGR, V30, P565, DOI DOI 10.1107/S0021889897003117; FRISCH MJ, 1995, GAUSSIAN; GEISER U, 1994, INORG CHEM, V33, P5101, DOI 10.1021/ic00100a040; HAUGE S, 1992, ACTA CHEM SCAND, V46, P1166, DOI 10.3891/acta.chem.scand.46-1166; HECKMANN G, 1993, CHEM BER-RECL, V126, P1071, DOI 10.1002/cber.19931260502; LARSEN S, 1984, ACTA CHEM SCAND A, V38, P289, DOI 10.3891/acta.chem.scand.38a-0289; IWAOKA M, 1995, J ORG CHEM, V60, P5299, DOI 10.1021/jo00121a058; IWAOKA M, 1992, PHOSPHORUS SULFUR, V67, P125, DOI 10.1080/10426509208045827; IWAOKA M, 1995, ENCYC REAGENTS ORGAN; Iwaoka M, 1998, CHEM LETT, P969, DOI 10.1246/cl.1998.969; Jung A, 1997, Z NATURFORSCH B, V52, P345; Kaur R, 1996, J CHEM SOC DALTON, P2719, DOI 10.1039/dt9960002719; Komatsu H, 1999, CHEM COMMUN, P205, DOI 10.1039/a808126c; MIURA M, 1995, J CHEM SOC PERK T 1, P1719, DOI 10.1039/p19950001719; ROESKY HW, 1985, J CHEM SOC DALTON, P565, DOI 10.1039/dt9850000565; Sheldrick G. M., 1997, SHELXL 97 PROGRAM RE; ZARIPOV NM, 1984, DOKL AKAD NAUK SSSR+, V278, P664; ZARIPOV NM, 1980, ZH STRUKT KHIM, V21, P37	35	22	22	ELSEVIER SCIENCE SA	LAUSANNE	PO BOX 564, 1001 LAUSANNE, SWITZERLAND	0022-328X			J ORGANOMET CHEM	J. Organomet. Chem.	OCT 6	2000	611	1-2					164	171		10.1016/S0022-328X(00)00434-4		8	Chemistry, Inorganic & Nuclear; Chemistry, Organic	Chemistry	364LZ	WOS:000089895000024		
J	Kawashima, T				Kawashima, T			Small ring compounds containing highly coordinate Group 14 elements	JOURNAL OF ORGANOMETALLIC CHEMISTRY			English	Article						Peterson-type reactions; homo-Brook rearrangement; pentacoordinate 1,2-oxasiletanide; pentacoordinate 1,1-oxastannetanide; pentacoordinate 1,2-oxagermetanide; olefin formation; X-ray crystallographic analysis	HOMO-BROOK REARRANGEMENT; PETERSON REACTION; CRYSTAL-STRUCTURE; HYPERVALENT SILICON; WITTIG REACTION; PENTACOORDINATE 1,2-OXASILETANIDES; OLEFINATION REACTION; ORGANIC-SYNTHESIS; SILYL GROUP; GAS-PHASE	Syntheses, structures, thermolyses of pentacoordinate 1,2-oxasiletanides (1), K+ 18-crown-6, {[-C6H4-C(CF3)(2)O-]SiPh-C-[(CHRCRRO)-R-1-O-2-]}(-), pentacoordinate1,2-oxastannetanides (2), K+, 18-crown-6, {Ph3Sn[-CH(SPh)(CRRO)-R-1-O-2-]}(-), pentacoordinate 1,2-oxagermetanide (3), K+ 18-crown-6, {[-C6H4-C(CF3)(2)O-]GePh[-CH(CH2-t-Bu)C(CF3)(2)O-]}(-), germylalkoxide (4), K+ 18-crown-6, Ph3GeCH(CH2-t-Bu)C(CF3)(2)O-, pentacoordinate siprobi[1,2-oxasiletanide] (5), (DBUH+)-H-., {PhSi[-CH2C-(CF3)(2)O-](2)}(-) are summarized. All compounds except for spirobi[1,2-oxasiletanide] 5, which underwent home-Brook rearrangement, gave the corresponding olefins upon heating, indicating that they are intermediates of Peterson-type reactions. However, it was found that 1,2-oxasiletanides bearing the Martin ligand, which usually undergo the Peterson reaction, can afford the home-Brook rearrangement products depending on the substituent at the 3-position and the reaction conditions, demonstrating that the Peterson reaction and home-Brook rearrangement proceed via a common intermediate, a pentacoordinate 1,2-oxasiletanide. Crystal structures of these compounds are also presented. (C) 2000 Elsevier Science S.A. All rights reserved.	Univ Tokyo, Grad Sch Sci, Dept Chem, Bunkyo Ku, Tokyo 1130033, Japan	Kawashima, T (reprint author), Univ Tokyo, Grad Sch Sci, Dept Chem, Bunkyo Ku, 7-3-1 Hongo, Tokyo 1130033, Japan.						Ager D. J., 1990, ORG REACTIONS, V38, P1; AGER DJ, 1984, SYNTHESIS-STUTTGART, P384; ANDERSON DG, 1986, ANGEW CHEM INT EDIT, V25, P107, DOI 10.1002/anie.198601071; Mitzel NW, 1998, J AM CHEM SOC, V120, P7320, DOI 10.1021/ja980933j; Kira M, 1996, J AM CHEM SOC, V118, P10303, DOI 10.1021/ja961913p; WRIGHT A, 1974, J AM CHEM SOC, V96, P3227, DOI 10.1021/ja00817a032; KAWASHIMA T, 1992, J AM CHEM SOC, V114, P7598, DOI 10.1021/ja00045a063; WRIGHT A, 1974, J AM CHEM SOC, V96, P3214, DOI 10.1021/ja00817a030; Ichinohe M, 1999, ANGEW CHEM INT EDIT, V38, P2194, DOI 10.1002/(SICI)1521-3773(19990802)38:15<2194::AID-ANIE2194>3.0.CO;2-L; Iwamoto T, 1999, J AM CHEM SOC, V121, P886, DOI 10.1021/ja983623+; KAWASHIMA T, 1992, J AM CHEM SOC, V114, P4008, DOI 10.1021/ja00036a078; YAMAMOTO Y, 1989, TETRAHEDRON LETT, V30, P725, DOI 10.1016/S0040-4039(01)80293-8; WEST R, 1971, J AM CHEM SOC, V93, P282, DOI 10.1021/ja00730a065; PEROZZI EF, 1981, J ORG CHEM, V46, P1049, DOI 10.1021/jo00319a001; MARYANOFF BE, 1989, CHEM REV, V89, P863, DOI 10.1021/cr00094a007; LINDERMAN RJ, 1990, J AM CHEM SOC, V112, P2392, DOI 10.1021/ja00162a048; Sekiguchi A, 1999, J AM CHEM SOC, V121, P11587, DOI 10.1021/ja9923080; BROOK AG, 1974, ACCOUNTS CHEM RES, V7, P77, DOI 10.1021/ar50075a003; BROOK AG, 1987, ORGANOMETALLICS, V6, P1246, DOI 10.1021/om00149a021; CHUIT C, 1999, CHEM HYPERVALENT COM, pCH4; Colvin E. W, 1981, SILICON ORGANIC SYNT, P141; CONLIN RT, 1996, COMPREHENSIVE HE 2 B, V1, P1175; Damrauer R, 1996, J ORGANOMET CHEM, V521, P93, DOI 10.1016/0022-328X(96)06169-4; DENMARK SE, 1990, ORGANOMETALLICS, V9, P3015, DOI 10.1021/om00162a006; ENGLEHARDT LM, 1991, J CHEM SOC CHEM COMM, P930, DOI 10.1039/c39910000930; Gosney I., 1979, ORGANOPHOSPHORUS REA, P17; HUDRLIK PF, 1982, J AM CHEM SOC, V104, P6809, DOI 10.1021/ja00388a069; HUDRLIK PF, 1989, J ORG CHEM, V54, P5613, DOI 10.1021/jo00284a041; HUDRLIK PF, 1975, J AM CHEM SOC, V97, P1464, DOI 10.1021/ja00839a031; HUDRLIK PF, 1979, TETRAHEDRON LETT, P2237; HUDRLIK PF, 1975, J ORG CHEM, V40, P2263, DOI 10.1021/jo00903a036; KARSCH HH, 1995, J AM CHEM SOC, V117, P5160, DOI 10.1021/ja00123a022; KAUFFMANN T, 1980, TOP CURR CHEM, V92, P109; KAUFFMANN T, 1982, CHEM BER-RECL, V115, P1818, DOI 10.1002/cber.19821150515; KAUFFMANN T, 1982, ANGEW CHEM INT EDIT, V21, P410, DOI 10.1002/anie.198204101; KAWASHIMA T, 1993, ANGEW CHEM INT EDIT, V32, P869, DOI 10.1002/anie.199308691; Kawashima T., 1999, CHEM HYPERVALENT COM; Kawashima T, 1998, ORGANOMETALLICS, V17, P367, DOI 10.1021/om970459a; Kawashima T, 1996, SYNLETT, P600; KAWASHIMA T, 1999, ADV STRAINED INTERES, V1, P7; KAWASHIMA T, 1995, J ORGANOMET CHEM, V499, P143, DOI 10.1016/0022-328X(95)00302-7; KAWASHIMA T, 1994, J ORG CHEM, V59, P491, DOI 10.1021/jo00081a036; KAWASHIMA T, 1994, J AM CHEM SOC, V116, P4509, DOI 10.1021/ja00089a063; Kawashima T, 1997, ANGEW CHEM INT EDIT, V36, P2500, DOI 10.1002/anie.199725001; KAWASHIMA T, 1993, J AM CHEM SOC, V115, P2507, DOI 10.1021/ja00059a056; KAWASHIMA T, 1994, ANGEW CHEM INT EDIT, V33, P2094, DOI 10.1002/anie.199420941; LINDERMAN RJ, 1988, J ORG CHEM, V53, P2878, DOI 10.1021/jo00247a053; Lukevics E., 1996, COMPREHENSIVE HE 2 B, V1B, P867; Maercker A., 1965, ORG REACTIONS, V14, P270; MARTIN JC, 1983, SCIENCE, V221, P509, DOI 10.1126/science.221.4610.509; MARTIN JC, 1976, SCIENCE, V191, P154, DOI 10.1126/science.191.4223.154; MARYANOFF BE, 1986, PHOSPHORUS SULFUR, V27, P167, DOI 10.1080/03086648608072769; Morgon NH, 1997, J AM CHEM SOC, V119, P1708, DOI 10.1021/ja963382a; NAGANUMA K, 2000, THESIS U TOKYO TOKYO; NAGANUMA K, 1999, 12 INT S ORG CHEM SE, P173; Naganuma K, 1999, CHEM LETT, P1139, DOI 10.1246/cl.1999.1139; PEREYRE JP, 1987, TIN ORGANIC SYNTHESI, P176; ROSKAMP E, 1996, COMPREHENSIVE HETE A, V1, P305; SATO F, 1983, J CHEM SOC CHEM COMM, P165, DOI 10.1039/c39830000165; SHELDRICK WS, 1977, Z NATURFORSCH B, V32, P22; SHINOKUBO H, 1993, TETRAHEDRON LETT, V34, P1951, DOI 10.1016/S0040-4039(00)91972-5; SHINOKUBO H, 1995, CHEM LETT, P461, DOI 10.1246/cl.1995.461; SILVA MLP, 1995, J MASS SPECTROM, V30, P733; Smith D. J. H., 1979, COMPREHENSIVE ORGANI, V2, P1316; STEVENSON WH, 1985, J AM CHEM SOC, V107, P6340, DOI 10.1021/ja00308a030; SULLIVAN SA, 1981, J AM CHEM SOC, V103, P480, DOI 10.1021/ja00392a048; Tokitoh N., 1996, COMPREHENSIVE HETE A, V1A, P457, DOI 10.1016/B978-008096518-5.00015-0; VANDENANCKER T, 1990, J CHEM SOC CHEM COMM, P1006, DOI 10.1039/c39900001006; VEDEJS E, 1994, TOP STEREOCHEM, V21, P1, DOI 10.1002/9780470147306.ch1; Weber W. P, 1983, SILICON REAGENTS ORG, P58; WILSON SR, 1983, J ORG CHEM, V48, P4143, DOI 10.1021/jo00170a064; YAMAMOTO K, 1983, TETRAHEDRON LETT, V24, P1997, DOI 10.1016/S0040-4039(00)81826-2; YAMAMOTO K, 1985, TETRAHEDRON LETT, V26, P4505, DOI 10.1016/S0040-4039(00)88942-X	73	20	20	ELSEVIER SCIENCE SA	LAUSANNE	PO BOX 564, 1001 LAUSANNE, SWITZERLAND	0022-328X			J ORGANOMET CHEM	J. Organomet. Chem.	OCT 6	2000	611	1-2					256	263		10.1016/S0022-328X(00)00491-5		8	Chemistry, Inorganic & Nuclear; Chemistry, Organic	Chemistry	364LZ	WOS:000089895000034		
J	Sugimori, M; Fukuoka, H; Imoto, H; Saito, T				Sugimori, M; Fukuoka, H; Imoto, H; Saito, T			Preparation and crystal structure of chromium silicon selenide containing a B-12 icosahedron with a tunnel structure	JOURNAL OF ORGANOMETALLIC CHEMISTRY			English	Article						selenide; silicon; B-12-icosahedron; tunnel structure		Chromium silicon boron selenide has been prepared by the reaction of chromium diboride and selenium in an evacuated silica tube at a high temperature. The compound is obtained as single crystals in a low yield. The X-ray studies have shown that the structure consists of the three-dimensional framework with a large tunnel;md the filling component in the tunnels. The former is made of Si coordinated by four silicon atoms, chromium atoms coordinated by six selenium atoms, and B-12 icosahedra. The filling component has a strongly disordered structure and estimated to be a chain of B2Se3. Analysis of the occupational factors of the filling component has indicated that the composition of the compound is CrSi3(B-12)Se-12.(B2Se3)(1.33). (C) 2000 Published by Elsevier Science S.A. All rights reserved.	Univ Tokyo, Sch Sci, Dept Chem, Tokyo 1130033, Japan	Imoto, H (reprint author), Utsunomiya Univ, Fac Engn, Dept Appl Chem, 7-1-2 Yoto, Utsunomiya, Tochigi 3218585, Japan.		Fukuoka, Hiroshi/J-2103-2015				DIERCKS H, 1977, ANGEW CHEM INT EDIT, V16, P313, DOI 10.1002/anie.197703131; WUNDERLICH JA, 1960, J AM CHEM SOC, V82, P4427, DOI 10.1021/ja01501a076; Kuper J, 1997, ANGEW CHEM INT EDIT, V36, P1903, DOI 10.1002/anie.199719031; NORTH ACT, 1968, ACTA CRYSTALL A-CRYS, VA 24, P351, DOI 10.1107/S0567739468000707; PETERS J, 1982, ACTA CRYSTALLOGR B, V38, P1270, DOI 10.1107/S0567740882005469; HOARD JL, 1958, J AM CHEM SOC, V80, P4507, DOI 10.1021/ja01550a019; Imoto H., 1999, Journal of the Crystallographic Society of Japan, V41; KATSUYAMA S, 1990, MATER RES BULL, V25, P913, DOI 10.1016/0025-5408(90)90070-I; KENNARD CHL, 1983, J SOLID STATE CHEM, V47, P103; OKEEFFE M, 1996, CRYST STRUCT, V1, P12; SLEIGHT AW, 1969, INORG CHEM, V8, P566, DOI 10.1021/ic50073a032; WEHMEIER FH, 1970, INORG CHEM, V9, P2152	12	1	1	ELSEVIER SCIENCE SA	LAUSANNE	PO BOX 564, 1001 LAUSANNE, SWITZERLAND	0022-328X			J ORGANOMET CHEM	J. Organomet. Chem.	OCT 6	2000	611	1-2					547	550		10.1016/S0022-328X(00)00407-1		4	Chemistry, Inorganic & Nuclear; Chemistry, Organic	Chemistry	364LZ	WOS:000089895000069		
J	Tamura, M; Urano, Y; Kikuchi, K; Higuchi, T; Hirobe, M; Nagano, T				Tamura, M; Urano, Y; Kikuchi, K; Higuchi, T; Hirobe, M; Nagano, T			Synthesis and superoxide dismutase activity of novel iron complexes	JOURNAL OF ORGANOMETALLIC CHEMISTRY			English	Article						superoxide; superoxide dismutase; iron complex	MACROCYCLIC POLYAMINE COMPLEXES; ENDOTHELIAL-CELL INJURY; IN-VITRO; REPERFUSION INJURY; METAL-COMPLEXES; MIMICS; COPPER(II); MODEL; VIVO; MN	We have previously shown that the Fe(II) tetrakis-N,N,N',N'-(2-pyridylmethyl)ethylenediamine complex (Fe(II)TPEN) has high superoxide dismutase (SOD) activity, using the xanthine-xanthine oxidase-cytochrome c method (cyt, c method) [J. Biol. Chem. 264 (1989) 9243-9249]. X-ray analysis showed that Fe(II)TPEN has two different coordination structures, one in which Fe(II) is coordinated with six nitrogens of TPEN and one in which Fe(II) is coordinated with five nitrogens of TPEN and one oxygen of sulfate anion as the counter anion [Chem. Pharm. Bull. 48 (2000) 223-230]. To investigate the relationship between these two structures and SOD activity, we synthesized novel Fe(II) complexes of TPEN analogues and measured their SOD activity by the cyt. c method. The Fe(II) tetrakis-N,N,N',N'-(2-pyridylmethyl)trim complex (Fe(II)TPTN) and the Fe(II) tris(2-pyridylmethyl)triazacyclononane complex (Fe(II)TPTCN) had no SOD activity (IC50 = > 100 mu M), probably because these two complexes have undistorted steric structure with no easily substituted ligand. On the other hand, other Fe(II) complexes with unsaturated coordination or an easily substituted ligand had high SOD activity (IC50 = 0.4-20 mu M). The results indicate that the substitution reaction of a ligand with superoxide or the coordination of superoxide is essential for Fe(IT)TPEN analogue complexes to have SOD activity. Moreover, we examined the effect of steric hindrance of the ligands on the SOD activity and the stability of the iron complexes to oxygen. (C) 2000 Elsevier Science S.A. All rights reserved.	Univ Tokyo, Grad Sch Pharmaceut Sci, Bunkyo Ku, Tokyo 1130033, Japan	Nagano, T (reprint author), Univ Tokyo, Grad Sch Pharmaceut Sci, Bunkyo Ku, Tokyo 1130033, Japan.		Kikuchi, Kazuya/D-2370-2009; Urano, Yasuteru/H-1380-2012				FAULKNER KM, 1994, J BIOL CHEM, V269, P23471; Hirano T, 2000, CHEM PHARM BULL, V48, P223; CHANG HR, 1990, J AM CHEM SOC, V112, P6814, DOI 10.1021/ja00175a012; BAUDRY M, 1993, BIOCHEM BIOPH RES CO, V192, P964, DOI 10.1006/bbrc.1993.1509; WADA K, 1994, BIOL PHARM BULL, V17, P701; CHRISTIANSEN L, 1986, INORG CHEM, V25, P2813, DOI 10.1021/ic00236a031; GOLDSTEIN S, 1983, J AM CHEM SOC, V105, P7276, DOI 10.1021/ja00363a012; MCCORD JM, 1969, J BIOL CHEM, V244, P6049; RILEY DP, 1994, J AM CHEM SOC, V116, P387, DOI 10.1021/ja00080a051; BEYER W, 1991, PROG NUCLEIC ACID RE, V40, P221, DOI 10.1016/S0079-6603(08)60843-0; BHUYAN KC, 1991, ARCH BIOCHEM BIOPHYS, V288, P523; BLACK SC, 1994, J PHARMACOL EXP THER, V270, P1208; DARR DJ, 1988, FREE RADICAL BIO MED, V4, P357, DOI 10.1016/0891-5849(88)90087-1; Day BJ, 1995, J PHARMACOL EXP THER, V275, P1227; FAULKNER KM, 1994, ARCH BIOCHEM BIOPHYS, V310, P341, DOI 10.1006/abbi.1994.1176; FRIEDRICHS GS, 1994, FASEB J, V7, P2457; HARDY MM, 1994, J BIOL CHEM, V269, P18535; ITAMI C, 1993, BIOCHEM BIOPH RES CO, V197, P536, DOI 10.1006/bbrc.1993.2512; KIMURA E, 1981, BIOCHIM BIOPHYS ACTA, V678, P172, DOI 10.1016/0304-4165(81)90203-8; KIMURA E, 1983, BIOCHIM BIOPHYS ACTA, V745, P37, DOI 10.1016/0167-4838(83)90167-X; KIMURA E, 1986, INORG CHEM, V25, P242; KITAJIMA N, 1993, INORG CHEM, V32, P1879, DOI 10.1021/ic00062a001; LENGFELDER E, 1979, BIOCHIM BIOPHYS ACTA, V567, P492, DOI 10.1016/0005-2744(79)90135-9; LIU ZX, 1994, ARCH BIOCHEM BIOPHYS, V315, P74, DOI 10.1006/abbi.1994.1473; NAGANO T, 1989, J BIOL CHEM, V264, P9243; NAKAGAWA M, 1994, CHEM LETT, P1721, DOI 10.1246/cl.1994.1721; SATO H, 1992, SYNTHESIS-STUTTGART, P539; WADA K, 1994, ARCH BIOCHEM BIOPHYS, V310, P2; YAMAGUCHI KS, 1986, FEBS LETT, V197, P249, DOI 10.1016/0014-5793(86)80336-2; YOUNES M, 1978, BIOCHEM BIOPH RES CO, V81, P567	30	28	28	ELSEVIER SCIENCE SA	LAUSANNE	PO BOX 564, 1001 LAUSANNE, SWITZERLAND	0022-328X			J ORGANOMET CHEM	J. Organomet. Chem.	OCT 6	2000	611	1-2					586	592		10.1016/S0022-328X(00)00394-6		7	Chemistry, Inorganic & Nuclear; Chemistry, Organic	Chemistry	364LZ	WOS:000089895000075		
J	Kawasawa, Y; Kume, K; Nakade, S; Haga, H; Izumi, T; Shimizu, T				Kawasawa, Y; Kume, K; Nakade, S; Haga, H; Izumi, T; Shimizu, T			Brain-specific expression of novel G-protein-coupled receptors, with homologies to Xenopus PSP24 and human GPR45	BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS			English	Article						G-protein-coupled receptor; cloning; brain; in situ hybridization; Purkinje cells; olfactory neuron	LYSOPHOSPHATIDIC ACID; GENERATION; DISCOVERY; CLONING	From mouse genomic libraries and human brain cDNA, we cloned three novel G-protein-coupled receptors (GPCRs), which have about 55-70% homologies with Xenopus PSP24 (xPSP24). Together with another human cDNA (GPR45) cloned by Marchese ed al. (Genomics 56, 12-21, 1999). they comprise a family of mammalian PSP24s. Therefore, we termed these clones mouse PSP24 alpha, beta, and human PSP24 alpha, beta. The homologies between alpha and beta isoforms were 54% for human and 51% for mouse clones. None of these clones shares sequence similarities with any known mammalian GPCRs, thus forming a unique gene family. Northern blot demonstrated that both of the mouse transcripts were predominantly expressed in the brain. In situ hybridization of brain sections showed that the expression was observed in neuronal cells, such as olfactory mitral cells, cortical neurons, hippocampal pyramidal cells, and Purkinje cells in the cerebellum. We suggest that mammalian PSP24 is a distinct GPCR family and plays a role in the brain function. (C) 2000 Academic Press.	Univ Tokyo, Fac Med, Dept Biochem & Mol Biol, Bunkyo Ku, Tokyo 1130033, Japan; Japan Sci & Technol Corp, CREST, Yokohama, Kanagawa, Japan; Ono Pharmaceut Co Ltd, Exploratory Res Labs, Minase Res Inst, Osaka 6188585, Japan	Shimizu, T (reprint author), Univ Tokyo, Fac Med, Dept Biochem & Mol Biol, Bunkyo Ku, Tokyo 1130033, Japan.						Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Erickson JP, 1998, J BIOL CHEM, V273, P1506, DOI 10.1074/jbc.273.3.1506; Bargmann CI, 1998, SCIENCE, V282, P2028, DOI 10.1126/science.282.5396.2028; Morris AJ, 1999, PHYSIOL REV, V79, P1373; CAVINESS VS, 1973, J COMP NEUROL, V151, P113, DOI 10.1002/cne.901510203; Bourne HR, 1997, CURR OPIN CELL BIOL, V9, P134, DOI 10.1016/S0955-0674(97)80054-3; Chun Jerold, 1999, Cell Biochemistry and Biophysics, V30, P213, DOI 10.1007/BF02738068; DONNELLY D, 1994, RECEPTOR CHANNEL, V2, P61; Fischer DJ, 1998, MOL PHARMACOL, V54, P979; Guo Z, 1996, P NATL ACAD SCI USA, V93, P14367, DOI 10.1073/pnas.93.25.14367; HONDA Z, 1991, NATURE, V349, P342, DOI 10.1038/349342a0; KAWASAWA Y, 2000, BIOCH RES COMMUN, V274, P957; Marchese A, 1999, GENOMICS, V56, P12, DOI 10.1006/geno.1998.5655; Sato S, 1999, ARCH DERMATOL RES, V291, P614, DOI 10.1007/s004030050463; Stadel JM, 1997, TRENDS PHARMACOL SCI, V18, P430, DOI 10.1016/S0165-6147(97)90676-3; Wilson S, 1998, BRIT J PHARMACOL, V125, P1387, DOI 10.1038/sj.bjp.0702238	16	12	15	ACADEMIC PRESS INC	SAN DIEGO	525 B ST, STE 1900, SAN DIEGO, CA 92101-4495 USA	0006-291X			BIOCHEM BIOPH RES CO	Biochem. Biophys. Res. Commun.	OCT 5	2000	276	3					952	956		10.1006/bbrc.2000.3569		5	Biochemistry & Molecular Biology; Biophysics	Biochemistry & Molecular Biology; Biophysics	362TL	WOS:000089794300023		
J	Kawasawa, Y; Kume, K; Izumi, T; Shimizu, T				Kawasawa, Y; Kume, K; Izumi, T; Shimizu, T			Mammalian PSP24s (alpha and beta isoforms) are not responsive to lysophosphatidic acid in mammalian expression systems	BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS			English	Article						G-protein-coupled receptor; PSP24; LPA; Edg; GTP gamma S binding assay; SRE reporter gene assay; PC12 cells	PROTEIN-COUPLED RECEPTOR; HUMAN ENDOTHELIAL-CELLS; NERVE GROWTH-FACTOR; MOLECULAR-CLONING; CELLULAR-RESPONSES; CHROMOSOMAL LOCALIZATION; SPHINGOSINE 1-PHOSPHATE; LYMPHOID-TISSUE; XENOPUS OOCYTES; FAMILY	Xenopus PSP24 (xPSP24) is a G-protein-coupled receptor which was originally identified as a functional lysophosphatidic acid (LPA) receptor. We obtained two different types (alpha and beta) of mammalian homologues of xPSP24 and found that these receptors are highly expressed in the brain (Kawasawa ct al., Biochem. Biophys. Res. Commun. 276, 952-956, 2000), These receptor did not respond to LPA by GTP gamma S binding assays, while Edg2 or Edg4 showed responses to LPA under the same assay conditions. Furthermore, a sensitive reporter gene assay using PC12 cells with serum response element promoter failed to detect any response of mammalian PSP24s to various concentrations of LPA. Thus, unlike xPSP24, we conclude that PSP24s are not functional LPA receptors in mammalian systems. (C) 2000 Academic Press.	Univ Tokyo, Fac Med, Dept Biochem & Mol Biol, Bunkyo Ku, Tokyo 1130033, Japan; Japan Sci & Technol Corp, CREST, Yokohama, Kanagawa, Japan	Shimizu, T (reprint author), Univ Tokyo, Fac Med, Dept Biochem & Mol Biol, Bunkyo Ku, Tokyo 1130033, Japan.						Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; An SZ, 1997, FEBS LETT, V417, P279, DOI 10.1016/S0014-5793(97)01301-X; Kaupmann K, 1998, NATURE, V396, P683; Saito Y, 1999, NATURE, V400, P265; Erickson JP, 1998, J BIOL CHEM, V273, P1506, DOI 10.1074/jbc.273.3.1506; McLatchie LM, 1998, NATURE, V393, P333; Jordan BA, 1999, NATURE, V399, P697; CONKLIN BR, 1993, NATURE, V363, P274, DOI 10.1038/363274a0; Gonda K, 1999, BIOCHEM J, V337, P67, DOI 10.1042/0264-6021:3370067; Hinuma S, 1998, NATURE, V393, P272, DOI 10.1038/30515; Sakurai T, 1998, CELL, V92, P573, DOI 10.1016/S0092-8674(00)80949-6; HLA T, 1990, J BIOL CHEM, V265, P9308; Ames RS, 1999, NATURE, V401, P282, DOI 10.1038/45809; An SZ, 1998, J BIOL CHEM, V273, P7906, DOI 10.1074/jbc.273.14.7906; MOOLENAAR WH, 1995, J BIOL CHEM, V270, P12949; Fukushima N, 1998, P NATL ACAD SCI USA, V95, P6151, DOI 10.1073/pnas.95.11.6151; Moolenaar WH, 1997, CURR OPIN CELL BIOL, V9, P168, DOI 10.1016/S0955-0674(97)80059-2; Lynch KR, 1999, NATURE, V399, P789; White JH, 1998, NATURE, V396, P679; Dwyer ND, 1998, CELL, V93, P455, DOI 10.1016/S0092-8674(00)81173-3; Kojima M, 1999, NATURE, V402, P656, DOI 10.1038/45230; Trapaidze N, 1996, J BIOL CHEM, V271, P29279; Bandoh K, 1999, J BIOL CHEM, V274, P27776, DOI 10.1074/jbc.274.39.27776; Hecht JH, 1996, J CELL BIOL, V135, P1071, DOI 10.1083/jcb.135.4.1071; Morris AJ, 1999, PHYSIOL REV, V79, P1373; Jones KA, 1998, NATURE, V396, P674, DOI 10.1038/25348; TOKUMURA A, 1995, PROG LIPID RES, V34, P151, DOI 10.1016/0163-7827(95)00001-G; Mao JH, 1998, J BIOL CHEM, V273, P27118, DOI 10.1074/jbc.273.42.27118; REINSCHEID RK, 1995, SCIENCE, V270, P792, DOI 10.1126/science.270.5237.792; OFFERMANNS S, 1995, J BIOL CHEM, V270, P15175; CHANGELIAN PS, 1989, P NATL ACAD SCI USA, V86, P377, DOI 10.1073/pnas.86.1.377; Chun Jerold, 1999, Cell Biochemistry and Biophysics, V30, P213, DOI 10.1007/BF02738068; Fischer DJ, 1998, MOL PHARMACOL, V54, P979; Möhler H, 1999, Trends Pharmacol Sci, V20, P87, DOI 10.1016/S0165-6147(99)01323-1; Glickman M, 1999, MOL CELL NEUROSCI, V14, P141, DOI 10.1006/mcne.1999.0776; GONNET GH, 1994, COMPUTATIONAL METHOD; Graler MH, 1999, CURR TOP MICROBIOL, V246, P131; Graler MH, 1998, GENOMICS, V53, P164, DOI 10.1006/geno.1998.5491; Guo Z, 1996, P NATL ACAD SCI USA, V93, P14367, DOI 10.1073/pnas.93.25.14367; HLA T, 1990, BIOCHEM BIOPH RES CO, V167, P637, DOI 10.1016/0006-291X(90)92072-8; HONDA Z, 1991, NATURE, V349, P342, DOI 10.1038/349342a0; Im DS, 2000, J BIOL CHEM, V275, P14281, DOI 10.1074/jbc.275.19.14281; KAWASAWA Y, 1998, FASEB J, V12, P869; Kawasawa Y, 2000, BIOCHEM BIOPH RES CO, V276, P952, DOI 10.1006/bbrc.2000.3569; Lee MJ, 1998, SCIENCE, V279, P1552, DOI 10.1126/science.279.5356.1552; MACLENNAN AJ, 1994, MOL CELL NEUROSCI, V5, P201, DOI 10.1006/mcne.1994.1024; Macrae AD, 1996, MOL BRAIN RES, V42, P245, DOI 10.1016/S0169-328X(96)00128-3; Marchese A, 1999, GENOMICS, V56, P12, DOI 10.1006/geno.1998.5655; Masana MI, 1995, RECEPTOR CHANNEL, V3, P255; MOOLENAAR WH, 1995, CURR OPIN CELL BIOL, V7, P203, DOI 10.1016/0955-0674(95)80029-8; Okamoto H, 1999, BIOCHEM BIOPH RES CO, V260, P203, DOI 10.1006/bbrc.1999.0886; Schwarz R., 1979, ATLAS PROTEIN SEQ S3, V5, P353; TIGYI G, 1990, P NATL ACAD SCI USA, V87, P1521, DOI 10.1073/pnas.87.4.1521; Windh RT, 1999, J BIOL CHEM, V274, P27351, DOI 10.1074/jbc.274.39.27351; Xu Y, 2000, NAT CELL BIOL, V2, P261, DOI 10.1038/35010529; Yamaguchi F, 1996, BIOCHEM BIOPH RES CO, V227, P608, DOI 10.1006/bbrc.1996.1553; Yamazaki Y, 2000, BIOCHEM BIOPH RES CO, V268, P583, DOI 10.1006/bbrc.2000.2162	57	14	14	ACADEMIC PRESS INC	SAN DIEGO	525 B ST, STE 1900, SAN DIEGO, CA 92101-4495 USA	0006-291X			BIOCHEM BIOPH RES CO	Biochem. Biophys. Res. Commun.	OCT 5	2000	276	3					957	964		10.1006/bbrc.2000.3570		8	Biochemistry & Molecular Biology; Biophysics	Biochemistry & Molecular Biology; Biophysics	362TL	WOS:000089794300024		
J	Sato, T; Shirane, K; Kido, M; Furukawa, K				Sato, T; Shirane, K; Kido, M; Furukawa, K			Correlated gene expression between beta-1,4-galactosyltransferase V and N-acetylglucosaminyltransferase V in human cancer cell lines	BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS			English	Article							MOUSE MELANOMA-CELLS; HAMSTER-KIDNEY CELLS; TRANSCRIPTIONAL REGULATION; LINKED OLIGOSACCHARIDES; TUMOR-METASTASIS; CDNA CLONING; UDP-GAL; GLYCOSYLATION; GLYCANS; PROGRESSION	Since our previous study showed that the gene expression level of beta-1,4-galactosyltransferase (beta-1,4-GalT) V is only increased in mouse NIH3T3 transformant and that beta-1,4-GalT V preferentially galactosylates the GlcNAc beta 1 --> 6Man branch of oligosaccharides [Shirane ef al. (1999) Biochem. Biophys. Res. Commun. 265, 434-438], whether its gene expression is correlated with malignant transformation was investigated. Northern blot analysis of beta-1,4-GalTs I, II, III, TV, V, and VI and N-acetylglucosaminyltransferase (GlcNAcT)V in human cancer cell lines showed that the gene expression levels of beta-1,4-GaIT V but not other beta-1,4-GalTs are strongly correlated with those of GlcNAcT V whose activity was shown to increase by malignant transformation, These results indicate that beta-1,4-GalT V is involved in the galactosylation of highly branched oligosaccharides characteristic of malignantly transformed cells, (C) 2000 Academic Press.	Tokyo Metropolitan Inst Gerontol, Dept Biosignal Res, Itabashi Ku, Tokyo 1730015, Japan; Univ Tokyo, Dept Gastroenterol, Fac Med, Bunkyo Ku, Tokyo 1138655, Japan	Furukawa, K (reprint author), Tokyo Metropolitan Inst Gerontol, Dept Biosignal Res, Itabashi Ku, Tokyo 1730015, Japan.						Almeida R, 1997, J BIOL CHEM, V272, P31979, DOI 10.1074/jbc.272.51.31979; BAENZIGER JU, 1979, J BIOL CHEM, V254, P9795; FEIZI T, 1985, NATURE, V314, P53, DOI 10.1038/314053a0; DENNIS JW, 1987, SCIENCE, V236, P582, DOI 10.1126/science.2953071; YOUSEFI S, 1991, J BIOL CHEM, V266, P1772; Granovsky M, 2000, NAT MED, V6, P306; Ohyama C, 1999, EMBO J, V18, P1516, DOI 10.1093/emboj/18.6.1516; Amado M, 1999, BBA-GEN SUBJECTS, V1473, P35, DOI 10.1016/S0304-4165(99)00168-3; Shimodaira K, 1997, CANCER RES, V57, P5201; CUMMINGS RD, 1982, J BIOL CHEM, V257, P13421; Asano M, 1997, EMBO J, V16, P1850, DOI 10.1093/emboj/16.8.1850; Nomura T, 1998, J BIOL CHEM, V273, P13570, DOI 10.1074/jbc.273.22.13570; DENNIS JW, 1989, CANCER RES, V49, P945; ZHENG MZ, 1994, J BIOL CHEM, V269, P12325; Furukawa K, 1999, BBA-GEN SUBJECTS, V1473, P54, DOI 10.1016/S0304-4165(99)00169-5; Dennis JW, 1999, BBA-GEN SUBJECTS, V1473, P21, DOI 10.1016/S0304-4165(99)00167-1; ARANGO J, 1988, J CELL BIOCHEM, V37, P225, DOI 10.1002/jcb.240370209; Asada M, 1997, CANCER RES, V57, P1073; Bhavanandan VP, 1995, BIOL SIALIC ACIDS, P145; Buckhaults P, 1997, J BIOL CHEM, V272, P19575, DOI 10.1074/jbc.272.31.19575; FRANKS LM, 1997, INTRO CELLULAR MOL B, P1; Sato Takeshi, 2000, Research Communications in Biochemistry and Cell and Molecular Biology, V4, P3; GUO S, 2000, P 2 INT S GLYC TOR C; Hakomori S, 1996, CANCER RES, V56, P5309; HART IR, 1992, LANCET, V339, P1453, DOI 10.1016/0140-6736(92)92039-I; Kang R, 1996, J BIOL CHEM, V271, P26706; Kido M, 2000, ACTA HISTOCHEM CYTOC, V33, P215, DOI 10.1267/ahc.33.215; Kobata A., 1984, BIOL CARBOHYDRATES, V2, P87; LU Y, 1993, MOL CELL BIOCHEM, V122, P85, DOI 10.1007/BF00925741; MIYOSHI E, 1995, J BIOL CHEM, V270, P6216; MIYOSHI E, 1993, CANCER RES, V53, P3899; PALCIC MM, 1990, J BIOL CHEM, V265, P6758; PIERCE M, 1986, J BIOL CHEM, V261, P772; SAITO H, 1995, EUR J BIOCHEM, V233, P18, DOI 10.1111/j.1432-1033.1995.018_1.x; Sato T, 1998, P NATL ACAD SCI USA, V95, P472, DOI 10.1073/pnas.95.2.472; Sato T, 1998, BIOCHEM BIOPH RES CO, V244, P637, DOI 10.1006/bbrc.1998.8327; Seko A, 1996, CANCER RES, V56, P3468; SHIRANE K, 1995, BBA-MOL CELL RES, V1268, P285, DOI 10.1016/0167-4889(95)00087-9; Shirane K, 1999, BIOCHEM BIOPH RES CO, V265, P434, DOI 10.1006/bbrc.1999.1684; SYMINGTON BE, 1989, J BIOL CHEM, V264, P13258; Takizawa M, 1999, BBA-MOL CELL BIOL L, V1438, P301, DOI 10.1016/S1388-1981(99)00051-7; van Die I, 1999, FEBS LETT, V450, P52, DOI 10.1016/S0014-5793(99)00462-7; YAMASHITA K, 1984, J BIOL CHEM, V259, P834	43	34	37	ACADEMIC PRESS INC	SAN DIEGO	525 B ST, STE 1900, SAN DIEGO, CA 92101-4495 USA	0006-291X			BIOCHEM BIOPH RES CO	Biochem. Biophys. Res. Commun.	OCT 5	2000	276	3					1019	1023		10.1006/bbrc.2000.3594		5	Biochemistry & Molecular Biology; Biophysics	Biochemistry & Molecular Biology; Biophysics	362TL	WOS:000089794300033		
J	Long, Z; Lee, JA; Okamoto, T; Nimura, N; Imai, K; Homma, H				Long, Z; Lee, JA; Okamoto, T; Nimura, N; Imai, K; Homma, H			D-aspartate in a prolactin-secreting clonal strain of rat pituitary tumor cells (GH(3))	BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS			English	Article						D-aspartate; pituitary gland; prolactin; thyrotropin-releasing hormone; GH(3) cells	THYROTROPIN-RELEASING-HORMONE; AMINO-ACID RECEPTOR; GROWTH-HORMONE; D-SERINE; GLUTAMATE RECEPTORS; MELATONIN SYNTHESIS; PANCREATIC-ISLETS; SEX STEROIDS; LEYDIG-CELLS; LOCALIZATION	D-Aspartate (D-Asp) is found in prolactin (PRL)containing cells of the rat anterior pituitary gland [Lee et al., Brain Res. 838, 193-199, 1999]. In order to determine whether D-Asp is actually produced by the anterior pituitary gland and whether it plays a physiological role in PRL function, a PRL-secreting clonal strain of rat pituitary tumor cells (GH(3)) was employed in this study. HPLC analysis and immunocytochemical staining detected the presence and synthesis of D-Asp in the cytoplasm of these cells. In addition, thyrotropin-releasing hormone-stimulated PRL secretion was increased in a dose-dependent fashion by D-Asp from these cells. These results suggest that the anterior pituitary gland synthesizes D-Asp and that D-Asp acts as a messenger in this gland, (C) 2000 Academic Press.	Univ Tokyo, Grad Sch Pharmaceut Sci, Bunkyo Ku, Tokyo 1130033, Japan; Kitasato Univ, Sch Pharmaceut Sci, Minato Ku, Tokyo 1088641, Japan; Taipei Med Coll, Sch Pharm, Dept Pharmaceut Anal, Taipei 110, Taiwan	Homma, H (reprint author), Univ Tokyo, Grad Sch Pharmaceut Sci, Bunkyo Ku, 7-3-1 Hongo, Tokyo 1130033, Japan.						Sakai K, 1998, ARCH BIOCHEM BIOPHYS, V351, P96, DOI 10.1006/abbi.1997.0539; HASHIMOTO A, 1995, EUR J NEUROSCI, V7, P1657, DOI 10.1111/j.1460-9568.1995.tb00687.x; KUENG W, 1989, ANAL BIOCHEM, V182, P16, DOI 10.1016/0003-2697(89)90710-0; Lee JA, 1997, BIOCHEM BIOPH RES CO, V231, P505, DOI 10.1006/bbrc.1996.5902; BRANN DW, 1995, NEUROENDOCRINOLOGY, V61, P213, DOI 10.1159/000126843; INAGAKI N, 1995, FASEB J, V9, P686; Sakai K, 1998, BRAIN RES, V808, P65, DOI 10.1016/S0006-8993(98)00599-X; Weaver CD, 1996, J BIOL CHEM, V271, P12977; Nagata Y, 1999, FEBS LETT, V454, P317, DOI 10.1016/S0014-5793(99)00840-6; DUNLOP DS, 1986, BIOCHEM BIOPH RES CO, V141, P27, DOI 10.1016/S0006-291X(86)80329-1; Schell MJ, 1997, P NATL ACAD SCI USA, V94, P2013, DOI 10.1073/pnas.94.5.2013; Wolosker H, 1999, P NATL ACAD SCI USA, V96, P13409, DOI 10.1073/pnas.96.23.13409; Gegelashvili G, 1998, BRAIN RES BULL, V45, P233, DOI 10.1016/S0361-9230(97)00417-6; SCHONBRUNN A, 1980, J CELL BIOL, V85, P786, DOI 10.1083/jcb.85.3.786; Lee JA, 1999, BRAIN RES, V838, P193, DOI 10.1016/S0006-8993(99)01718-7; Ishio S, 1998, NEUROSCI LETT, V249, P143, DOI 10.1016/S0304-3940(98)00414-5; Long ZQ, 1998, FEBS LETT, V434, P231, DOI 10.1016/S0014-5793(98)00986-7; HAUG E, 1976, ENDOCRINOLOGY, V99, P1482; Imai K, 1996, BIOMED CHROMATOGR, V10, P303, DOI 10.1002/(SICI)1099-0801(199611)10:6<303::AID-BMC624>3.0.CO;2-B; TASHJIAN AH, 1971, BIOCHEM BIOPH RES CO, V43, P516, DOI 10.1016/0006-291X(71)90644-9; Nagata Y, 1999, FEBS LETT, V444, P160, DOI 10.1016/S0014-5793(99)00045-9; Sakai K, 1997, BIOCHEM BIOPH RES CO, V235, P433, DOI 10.1006/bbrc.1997.6783; Takigawa Y, 1998, BIOCHEM BIOPH RES CO, V248, P641, DOI 10.1006/bbrc.1998.8971; GERSHENGORN MC, 1986, ANNU REV PHYSIOL, V48, P515; BANCROFT FC, 1971, EXP CELL RES, V64, P125, DOI 10.1016/0014-4827(71)90201-1; BERTRAND G, 1993, EUR J PHARMACOL, V237, P45, DOI 10.1016/0014-2999(93)90091-U; BHAT GK, 1995, NEUROENDOCRINOLOGY, V62, P178, DOI 10.1159/000127003; GOURDJI D, 1979, FEBS LETT, V104, P165, DOI 10.1016/0014-5793(79)81107-2; Hamase K, 1997, BBA-GEN SUBJECTS, V1334, P214, DOI 10.1016/S0304-4165(96)00095-5; Hashimoto A, 1997, PROG NEUROBIOL, V52, P325, DOI 10.1016/S0301-0082(97)00019-1; HASHIMOTO A, 1993, FEBS LETT, V331, P4, DOI 10.1016/0014-5793(93)80286-4; KIYAMA H, 1993, MOL BRAIN RES, V19, P262, DOI 10.1016/0169-328X(93)90039-R; LINDSTROM P, 1992, ENDOCRINOLOGY, V131, P1903, DOI 10.1210/en.131.4.1903; LOGIN IS, 1990, LIFE SCI, V47, P2269, DOI 10.1016/0024-3205(90)90158-N; NIIMI M, 1994, NEUROENDOCRINOLOGY, V60, P173, DOI 10.1159/000126748; OZAWA S, 1986, PHYSIOL REV, V66, P887; PRAGER D, 1988, ENDOCRINOLOGY, V122, P2946; TASHJIAN AH, 1970, J CELL BIOL, V47, P61, DOI 10.1083/jcb.47.1.61; VILLALOBOS C, 1995, FASEB J, V9, P815; Weaver CD, 1998, J BIOL CHEM, V273, P1647, DOI 10.1074/jbc.273.3.1647; Yamada H, 1998, J NEUROSCI, V18, P2056; ZANISI M, 1991, J STEROID BIOCHEM, V40, P155, DOI 10.1016/0960-0760(91)90178-8; ZANISI M, 1994, P SOC EXP BIOL MED, V206, P431	43	36	37	ACADEMIC PRESS INC	SAN DIEGO	525 B ST, STE 1900, SAN DIEGO, CA 92101-4495 USA	0006-291X			BIOCHEM BIOPH RES CO	Biochem. Biophys. Res. Commun.	OCT 5	2000	276	3					1143	1147		10.1006/bbrc.2000.3573		5	Biochemistry & Molecular Biology; Biophysics	Biochemistry & Molecular Biology; Biophysics	362TL	WOS:000089794300051		
J	Masuda, H; Yasui, K; Watanabe, M; Nishio, K; Rao, TN; Fujishima, A				Masuda, H; Yasui, K; Watanabe, M; Nishio, K; Rao, TN; Fujishima, A			Fabrication of ordered diamond/metal nanocomposite structures	CHEMISTRY LETTERS			English	Article							PARTICLES; FILMS	Highly ordered diamond/Au nanocomposite structures were fabricated by preparing a honeycomb structured diamond film and subsequent Au deposition into holes by vacuum deposition. The cross-sectional SEM image of the composite film showed Au nanodots at the bottom of the holes. The optical absorption spectrum of the composite film showed a characteristic absorption due to the surface plasmon resonance at the wavelength of similar to 520 nm, indicating the possible application of honeycomb diamond in optoelectronics.	Tokyo Metropolitan Univ, Dept Appl Chem, Hachioji, Tokyo 1920397, Japan; Univ Tokyo, Dept Appl Chem, Bunkyo Ku, Tokyo 1138656, Japan	Masuda, H (reprint author), Tokyo Metropolitan Univ, Dept Appl Chem, 1-1 Minamiosawa, Hachioji, Tokyo 1920397, Japan.		Fujishima, Akira/G-7701-2012				Masuda H, 2000, ADV MATER, V12, P444, DOI 10.1002/(SICI)1521-4095(200003)12:6<444::AID-ADMA444>3.0.CO;2-K; HACHE F, 1986, J OPT SOC AM B, V3, P1647; CAHAN B. D., 1970, S FARADAY SOC, V4, P36, DOI 10.1039/sf9700400036; CRAIGHEAD HG, 1984, APPL PHYS LETT, V44, P1134, DOI 10.1063/1.94667; FUKUMI K, 1991, JPN J APPL PHYS, V30, P742; Geis MW, 1998, NATURE, V393, P431, DOI 10.1038/30900; FOJTIK A, 1993, BER BUNSEN PHYS CHEM, V97, P252; TZENG Y, 1991, APPL DIAMOND FILMS R; WANG XH, 1990, P SOC PHOTO-OPT INS, V1325, P160, DOI 10.1117/12.22455; XU J, 1997, ANAL CHEM A, V591; Yoshino T, 1996, JPN J APPL PHYS 2, V35, pL1512	11	8	9	CHEMICAL SOC JAPAN	TOKYO	1-5 KANDA-SURUGADAI CHIYODA-KU, TOKYO, 101-8307, JAPAN	0366-7022	1348-0715		CHEM LETT	Chem. Lett.	OCT 5	2000		10					1112	1113		10.1246/cl.2000.1112		2	Chemistry, Multidisciplinary	Chemistry	372BY	WOS:000165214800001		
J	Li, M; Indra, AK; Warot, X; Brocard, J; Messaddeq, N; Kato, S; Metzger, D; Chambon, P				Li, M; Indra, AK; Warot, X; Brocard, J; Messaddeq, N; Kato, S; Metzger, D; Chambon, P			Skin abnormalities generated by temporally controlled RXR alpha mutations in mouse epidermis	NATURE			English	Article							VITAMIN-D-RECEPTOR; TRANSGENIC MICE; ACID RECEPTOR; MUTANT MICE; PPAR-ALPHA; EXPRESSION; GENE; DIFFERENTIATION; MORPHOGENESIS; MUTAGENESIS	Nuclear receptors for retinoids (RARs) and vitamin D (VDR), and for some other ligands (TRs, PPARs and LXRs), may be critical in the development and homeostasis of mammalian epidermis(1-8). It is believed that these receptors form heterodimers with retinoid X receptors (RXRs) to act as transcriptional regulators(9,10). However, most genetic approaches aimed at establishing their physiological functions in the skin have been inconclusive owing either to pleiotropic effects and redundancies between receptor isotypes in gene knockouts, or to equivocal interpretation of dominant-negative mutant studies in transgenic mice(1,13-15). Moreover, knockout of RXR alpha, the main skin RXR isotype, is lethal in utero before skin formation(11,12,16,17). Here we have resolved these problems by developing an efficient technique to create spatiotemporally controlled somatic mutations in the mouse. We used tamoxifen-inducible Cre-ER(T) recombinases(18,19) to ablate RXR alpha selectively in adult mouse keratinocytes. We show that RXR alpha has key roles in hair cycling, probably through RXR/VDR heterodimers, and in epidermal keratinocyte proliferation and differentiation.	Coll France, INSERM, CNRS, Inst Genet & Biol Mol & Cellulaire, F-67404 Illkirch Graffenstaden, France; Univ Tokyo, Inst Mol & Cellular Biosci, Bunkyo Ku, Tokyo 113, Japan; Japan Sci & Technol, CREST, Kawaguchi, Saitama 332, Japan	Chambon, P (reprint author), Coll France, INSERM, CNRS, Inst Genet & Biol Mol & Cellulaire, BP 163, F-67404 Illkirch Graffenstaden, France.	chambon@igbmc.u-strasbg.fr					Wang XM, 1997, P NATL ACAD SCI USA, V94, P219, DOI 10.1073/pnas.94.1.219; METZGER D, 1995, P NATL ACAD SCI USA, V92, P6991, DOI 10.1073/pnas.92.15.6991; REICHRATH J, 1994, BRIT J DERMATOL, V131, P477; Braissant O, 1996, ENDOCRINOLOGY, V137, P354, DOI 10.1210/en.137.1.354; Hanley K, 2000, J INVEST DERMATOL, V114, P545, DOI 10.1046/j.1523-1747.2000.00895.x; Indra AK, 1999, NUCLEIC ACIDS RES, V27, P4324, DOI 10.1093/nar/27.22.4324; SUCOV HM, 1994, GENE DEV, V8, P1007, DOI 10.1101/gad.8.9.1007; Komuves LG, 1998, J INVEST DERMATOL, V111, P429, DOI 10.1046/j.1523-1747.1998.00296.x; Chambon P, 1996, FASEB J, V10, P940; Li YC, 1997, P NATL ACAD SCI USA, V94, P9831, DOI 10.1073/pnas.94.18.9831; KASTNER P, 1995, CELL, V83, P859, DOI 10.1016/0092-8674(95)90202-3; Li YC, 1998, ENDOCRINOLOGY, V139, P4391, DOI 10.1210/en.139.10.4391; Yoshizawa T, 1997, NAT GENET, V16, P391, DOI 10.1038/ng0897-391; Porter RM, 1998, J INVEST DERMATOL, V110, P951, DOI 10.1046/j.1523-1747.1998.00218.x; Kastner P, 1996, GENE DEV, V10, P80, DOI 10.1101/gad.10.1.80; KASTNER P, 1994, CELL, V78, P987, DOI 10.1016/0092-8674(94)90274-7; Wendling O, 1999, P NATL ACAD SCI USA, V96, P547, DOI 10.1073/pnas.96.2.547; Fisher GJ, 1996, FASEB J, V10, P1002; Brocard J, 1997, P NATL ACAD SCI USA, V94, P14559, DOI 10.1073/pnas.94.26.14559; Feng X, 1997, GENE DEV, V11, P59, DOI 10.1101/gad.11.1.59; Hanley K, 1997, J CLIN INVEST, V100, P705, DOI 10.1172/JCI119583; Hanley K, 2000, J BIOL CHEM, V275, P11484, DOI 10.1074/jbc.275.15.11484; IMAKADO S, 1995, GENE DEV, V9, P317, DOI 10.1101/gad.9.3.317; MANGELSDORF DJ, 1995, CELL, V83, P835, DOI 10.1016/0092-8674(95)90199-X; Mascrez B, 1998, DEVELOPMENT, V125, P4691; METZGER D, IN PRESS METHODS; Panteleyev AA, 1998, EXP DERMATOL, V7, P249; SAITOU M, 1995, NATURE, V374, P159, DOI 10.1038/374159a0; Sundberg JP, 1996, DERMATOL CLIN, V14, P619, DOI 10.1016/S0733-8635(05)70389-2; VASSAR R, 1989, P NATL ACAD SCI USA, V86, P1563, DOI 10.1073/pnas.86.5.1563	30	203	214	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	OCT 5	2000	407	6804					633	636				5	Multidisciplinary Sciences	Science & Technology - Other Topics	362HP	WOS:000089772800048		
J	Suzuki, T; Katoh, H; Tsuchio, Y; Hasegawa, A; Kurabayashi, M; Ohira, A; Hiramori, K; Sakomura, Y; Kasanuki, H; Hori, S; Aikawa, N; Abe, S; Tei, C; Nakagawa, Y; Nobuyoshi, M; Misu, K; Sumiyoshi, T; Nagai, R				Suzuki, T; Katoh, H; Tsuchio, Y; Hasegawa, A; Kurabayashi, M; Ohira, A; Hiramori, K; Sakomura, Y; Kasanuki, H; Hori, S; Aikawa, N; Abe, S; Tei, C; Nakagawa, Y; Nobuyoshi, M; Misu, K; Sumiyoshi, T; Nagai, R			Diagnostic implications of elevated levels of smooth-muscle myosin heavy-chain protein in acute aortic dissection - The smooth muscle myosin heavy chain study	ANNALS OF INTERNAL MEDICINE			English	Article							ACUTE MYOCARDIAL-INFARCTION; STENT-GRAFT PLACEMENT; TRANSESOPHAGEAL ECHOCARDIOGRAPHY; IMMUNOASSAY; SERUM	Background: A rapid 30-minute assay of circulating smooth-muscle myosin heavy-chain protein has been developed as a biochemical diagnostic tool for aortic dissection. Objective: To determine the sensitivity and specificity of this assay. Design: Cross-sectional study. Setting: 8 major cardiovascular centers in Japan. Patients: 95 patients with acute aortic dissection, 48 patients with acute myocardial infarction, and 131 healthy volunteers. Measurements: Levels of circulating smooth-muscle myosin heavy-chain protein. Results: Patients with acute aortic dissection who presented within 3 hours after onset had elevated levels of circulating smooth-muscle myosin heavy-chain protein, In these patients, the assay had a sensitivity of 90.9%, a specificity of 98% compared with healthy volunteers, and a specificity of 83% compared with patients who had acute myocardial infarction; the clinical decision limit was 2.5 mu g/L. All patients with proximal lesions had elevated levels of smooth-muscle myosin heavy-chain protein, and only patients with distal lesions had decreased levels (<2.5 mu g/L). Conclusions: Levels of smooth-muscle myosin heavy-chain protein can be used to diagnose aortic dissection soon after symptom onset. The assay had the greatest diagnostic value in patients with proximal lesions.	Univ Tokyo, Grad Sch Med, Dept Cardiovasc Med, Bunkyo Ku, Tokyo 1138655, Japan; Tokyo Womens Med Univ, Tokyo, Japan; Keio Univ, Tokyo, Japan; Sakakibara Heart Inst, Tokyo, Japan; Gunma Univ, Gunma, Japan; Iwate Med Univ, Morioka, Iwate 020, Japan; Kagoshima Univ, Kagoshima 890, Japan; Kokura Mem Hosp, Kokurakita Ku, Kokura, Japan	Suzuki, T (reprint author), Univ Tokyo, Grad Sch Med, Dept Cardiovasc Med, Bunkyo Ku, 7-3-1 Hongo, Tokyo 1138655, Japan.						WHEAT MW, 1965, J THORAC CARDIOV SUR, V50, P364; ERBEL R, 1993, CIRCULATION, V87, P1604; Nienaber CA, 1999, NEW ENGL J MED, V340, P1539, DOI 10.1056/NEJM199905203402003; Hagan PG, 2000, JAMA-J AM MED ASSOC, V283, P897, DOI 10.1001/jama.283.7.897; ERBEL R, 1989, LANCET, V1, P457; NIENABER CA, 1993, NEW ENGL J MED, V328, P1, DOI 10.1056/NEJM199301073280101; SPITTELL PC, 1993, MAYO CLIN PROC, V68, P642; KATUS HA, 1989, J MOL CELL CARDIOL, V21, P1349, DOI 10.1016/0022-2828(89)90680-9; Dake MD, 1999, NEW ENGL J MED, V340, P1546, DOI 10.1056/NEJM199905203402004; DEBAKEY ME, 1955, ANN SURG, V142, P586, DOI 10.1097/00000658-195510000-00005; GROS BJ, 1996, CARDIOL REV, V4, P112, DOI 10.1097/00045415-199603000-00011; HAMM CW, 1994, NEW ENGL J MED, V331, P607, DOI 10.1056/NEJM199409013310910; ISSELBACHER EM, 1997, HEART DIS TXB CARDIO; KATOH H, 1995, LANCET, V345, P191, DOI 10.1016/S0140-6736(95)90194-9; KATOH H, 1995, J IMMUNOL METHODS, V185, P57, DOI 10.1016/0022-1759(95)00104-I; KERSTINGSOMMERHOFF BA, 1988, RADIOLOGY, V166, P651; NIENABER CA, 1992, CIRCULATION, V85, P434; Sebastia C, 1999, RADIOGRAPHICS, V19, P45; Suzuki T, 1996, CIRCULATION, V93, P1244; vonKodolitsch Y, 1997, Z KARDIOL, V86, P469	20	57	60	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819			ANN INTERN MED	Ann. Intern. Med.	OCT 3	2000	133	7					537	541				5	Medicine, General & Internal	General & Internal Medicine	360QG	WOS:000089678300006		
J	Fukuda, H; Arai, M; Kuwajima, K				Fukuda, H; Arai, M; Kuwajima, K			Folding of green fluorescent protein and the cycle3 mutant	BIOCHEMISTRY			English	Article							INCLUSION-BODY FORMATION; HUMAN LYSOZYME; STABILITY; VARIANTS; EXPRESSION; MUTATIONS; BEHAVIOR; DISEASE	Although the correct folding of green fluorescent protein (GFP) is required for formation of the chromophore, it is known that wild-type GFP cannot mature efficiently in vivo in Escherichia coli at 37 degrees C or higher temperatures that the jellyfish in the Pacific Northwest have never experienced. Recently, by random mutagenesis by the polymerase chain reaction (PCR) method, a mutant called Cycle3 was constructed. This mutant had three mutations, F99S, M153T, and V163A, on or near the surface of the GFP molecule and was able to mature correctly even at 37 degrees C [Crameri et al. (1996) Nat. Biotechnol. 143, 315-319]. In the present study, we investigated the differences in their folding behavior in vitro. We observed the folding and unfolding reactions of both wild-type GFP and the Cycle3 mutant by using green fluorescence as an indicator of the formation of the native structure and examining hydrogen-exchange reactions by Fourier transform infrared spectroscopy. Both proteins showed unusually slow refolding and unfolding rates, and their refolding rates were almost identical under the native state at 25 and at 35 degrees C. On the other hand, aggregation studies in vitro showed that wild-type GFP had a strong tendency to aggregate, while the Cycle3 mutant did not. These results indicated that the ability to mature efficiently in vivo at 37 degrees C was not due to the improved folding and that reduced hydrophobicity on the surface of the Cycle3 mutant was a more critical factor for efficient maturation in vivo.	Univ Tokyo, Sch Sci, Dept Phys, Bunkyo Ku, Tokyo 1130033, Japan	Kuwajima, K (reprint author), Univ Tokyo, Sch Sci, Dept Phys, Bunkyo Ku, 7-3-1 Hongo, Tokyo 1130033, Japan.	huwajima@phys.s.u-to-kyo.ac.jp	Arai, Munehito/A-1258-2012				Crameri A, 1996, NAT BIOTECHNOL, V14, P315, DOI 10.1038/nbt0396-315; HURLE MR, 1994, P NATL ACAD SCI USA, V91, P5446, DOI 10.1073/pnas.91.12.5446; Miesenbock G, 1998, NATURE, V394, P192, DOI 10.1038/28190; Yang F, 1996, NAT BIOTECHNOL, V14, P1246, DOI 10.1038/nbt1096-1246; PRASHER DC, 1992, GENE, V111, P229, DOI 10.1016/0378-1119(92)90691-H; WARD WW, 1982, PHOTOCHEM PHOTOBIOL, V35, P803, DOI 10.1111/j.1751-1097.1982.tb02651.x; PACE CN, 1995, PROTEIN SCI, V4, P2411; Kelly JW, 1996, CURR OPIN STRUC BIOL, V6, P11, DOI 10.1016/S0959-440X(96)80089-3; Ormo M, 1996, SCIENCE, V273, P1392; Harper JD, 1997, ANNU REV BIOCHEM, V66, P385, DOI 10.1146/annurev.biochem.66.1.385; KRAULIS PJ, 1991, J APPL CRYSTALLOGR, V24, P946, DOI 10.1107/S0021889891004399; Wetzel R, 1997, ADV PROTEIN CHEM, V50, P183, DOI 10.1016/S0065-3233(08)60322-8; HEIM R, 1994, P NATL ACAD SCI USA, V91, P12501, DOI 10.1073/pnas.91.26.12501; Makino Y, 1997, J BIOL CHEM, V272, P12468, DOI 10.1074/jbc.272.19.12468; Siemering KR, 1996, CURR BIOL, V6, P1653, DOI 10.1016/S0960-9822(02)70789-6; HEIM R, 1995, NATURE, V373, P663, DOI 10.1038/373663b0; Booth DR, 1997, NATURE, V385, P787, DOI 10.1038/385787a0; BOKMAN SH, 1981, BIOCHEM BIOPH RES CO, V101, P1372, DOI 10.1016/0006-291X(81)91599-0; Cormack BP, 1996, GENE, V173, P33, DOI 10.1016/0378-1119(95)00685-0; WARD WW, 1982, BIOCHEMISTRY-US, V21, P4535, DOI 10.1021/bi00262a003; Betts S, 1997, ADV PROTEIN CHEM, V50, P243, DOI 10.1016/S0065-3233(08)60323-X; Canet D, 1999, BIOCHEMISTRY-US, V38, P6419, DOI 10.1021/bi983037t; CHALFIE M, 1994, SCIENCE, V263, P802, DOI 10.1126/science.8303295; Chan W, 1996, FOLD DES, V1, P77, DOI 10.1016/S1359-0278(96)00017-X; CHRUNYK BA, 1993, J BIOL CHEM, V268, P18053; CUBITT AB, 1995, NAT BIOTECHNOL, V13, P151; Cubitt AB, 1999, METHOD CELL BIOL, V58, P19; DELAGRAVE S, 1995, NAT BIOTECHNOL, V13, P151; Funahashi J, 1996, J BIOCHEM, V120, P1216; Heim Roger, 1996, Current Biology, V6, P178, DOI 10.1016/S0960-9822(02)00450-5; HVIDT AASE, 1966, ADVANCE PROTEIN CHEM, V21, P287, DOI 10.1016/S0065-3233(08)60129-1; Kelly JW, 1997, ADV PROTEIN CHEM, V50, P161, DOI 10.1016/S0065-3233(08)60321-6; Kimata Y, 1997, BIOCHEM BIOPH RES CO, V232, P69, DOI 10.1006/bbrc.1997.6235; Pace C N, 1986, Methods Enzymol, V131, P266; Yamasaki M, 1999, J BIOL CHEM, V274, P35293, DOI 10.1074/jbc.274.50.35293	35	118	118	AMER CHEMICAL SOC	WASHINGTON	1155 16TH ST, NW, WASHINGTON, DC 20036 USA	0006-2960			BIOCHEMISTRY-US	Biochemistry	OCT 3	2000	39	39					12025	12032		10.1021/bi000543l		8	Biochemistry & Molecular Biology	Biochemistry & Molecular Biology	360XW	WOS:000089693500023		
J	Akishita, M; Iwai, M; Wu, L; Zhang, LN; Ouchi, Y; Dzau, VJ; Horiuchi, M				Akishita, M; Iwai, M; Wu, L; Zhang, LN; Ouchi, Y; Dzau, VJ; Horiuchi, M			Inhibitory effect of angiotensin II type 2 receptor on coronary arterial remodeling after aortic banding in mice	CIRCULATION			English	Article						angiotensin; receptors; muscle, smooth; myocytes; collagen	LEFT-VENTRICULAR HYPERTROPHY; INTERSTITIAL FIBROSIS; CARDIAC-HYPERTROPHY; HUMAN HEART; RAT; HYPERTENSION; EXPRESSION; GROWTH; SYSTEM; FIBROBLASTS	Background-The renin-angiotensin system is thought to be critical for the development of cardiac hypertrophy, whereas the role of the angiotensin II type 2 (AT(2)) receptor in the process is not defined. Using the AT(2) receptor-null (Agtr2-) mouse, we tested the hypothesis that the AT(2) receptor could exert an antigrowth effect in cardiac hypertrophy. Methods and Results-Cardiac hypertrophy was induced by suprarenal abdominal aortic banding in 10- to 12-week-old Agtr2- and wild-type (Agtr2+) mice for 6 or 12 weeks. Carotid arterial pressure was not different between the strains, although aortic banding increased arterial pressure by approximate to 40 mm Hg. Aortic banding increased the heart-weight/body-weight ratio and the cross-sectional area of cardiomyocytes by 15%, resulting in comparable cardiomyocyte hypertrophy in the 2 strains. In contrast, coronary arterial thickening and perivascular fibrosis, determined by the media/lumen-area ratio and the collagen/vessel-area ratio, respectively, were 50% greater in Agtr2- than in Agtr2+ mice after banding, whereas these parameters were similar in sham-operated mice. Radioligand binding studies using the whole heart and immunohistochemistry showed that AT(2) receptor expression was limited and localized in the coronary artery and perivascular region. Conclusions-These results suggest that the AT(2) receptor mediates an inhibitory effect on coronary arterial remodeling, such as medial hypertrophy and perivascular fibrosis in response to pressure overload, and an activation of the renin-angiotensin system.	Ehime Univ, Sch Med, Dept Med Biochem, Shigenobu, Ehime 7910295, Japan; Harvard Univ, Brigham & Womens Hosp, Sch Med, Dept Med, Boston, MA 02115 USA; Kyorin Univ, Sch Med, Dept Geriatr Med, Tokyo, Japan; Univ Tokyo, Grad Sch Med, Dept Geriatr Med, Tokyo, Japan	Horiuchi, M (reprint author), Ehime Univ, Sch Med, Dept Med Biochem, Shigenobu, Ehime 7910295, Japan.						Akishita M, 2000, PHYSIOL GENOMICS, V2, P13; Siragy HM, 1999, P NATL ACAD SCI USA, V96, P6506, DOI 10.1073/pnas.96.11.6506; HEIN L, 1995, NATURE, V377, P744, DOI 10.1038/377744a0; BRILLA CG, 1990, CIRC RES, V67, P1355; ICHIKI T, 1995, NATURE, V377, P748, DOI 10.1038/377748a0; BRILLA CG, 1991, CIRC RES, V69, P107; KAMBAYASHI Y, 1993, J BIOL CHEM, V268, P24543; SUZUKI J, 1993, CIRC RES, V73, P439; Booz GW, 1996, HYPERTENSION, V28, P635; Yamada T, 1996, P NATL ACAD SCI USA, V93, P156, DOI 10.1073/pnas.93.1.156; Masaki H, 1998, J CLIN INVEST, V101, P527, DOI 10.1172/JCI1885; WEBER KT, 1991, CIRCULATION, V83, P1849; Akishita M, 1999, J CLIN INVEST, V103, P63, DOI 10.1172/JCI5182; Huang XC, 1996, J BIOL CHEM, V271, P15635; Wharton J, 1998, J PHARMACOL EXP THER, V284, P323; PFEFFER JM, 1982, P NATL ACAD SCI-BIOL, V79, P3310, DOI 10.1073/pnas.79.10.3310; NAKAJIMA M, 1995, P NATL ACAD SCI USA, V92, P10663, DOI 10.1073/pnas.92.23.10663; Siragy HM, 1997, J CLIN INVEST, V100, P264, DOI 10.1172/JCI119531; Harada K, 1998, CIRCULATION, V97, P1952; vanKesteren CAM, 1997, J MOL CELL CARDIOL, V29, P2147, DOI 10.1006/jmcc.1997.0448; Tsutsumi Y, 1998, CIRC RES, V83, P1035; DZAU VJ, 1993, ARCH INTERN MED, V153, P937, DOI 10.1001/archinte.153.8.937; MUKOYAMA M, 1993, J BIOL CHEM, V268, P24539; STOLL M, 1995, J CLIN INVEST, V95, P651, DOI 10.1172/JCI117710; BAKER KM, 1990, AM J PHYSIOL, V259, P324; GARAVAGLIA GE, 1988, AM J CARDIOL, V62, P912, DOI 10.1016/0002-9149(88)90892-2; LOPEZ JJ, 1994, AM J PHYSIOL, V267, pH844; NAKASHIMA Y, 1984, AM J CARDIOL, V53, P1044, DOI 10.1016/0002-9149(84)90634-9; VITULLO JC, 1993, HYPERTENSION, V21, P406; Wang ZQ, 1998, HYPERTENSION, V32, P78; YAMADA T, 1998, LIFE SCI, V63, P289; Yamazaki T, 1997, CIRC RES, V81, P639	32	82	90	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	530 WALNUT ST, PHILADELPHIA, PA 19106-3621 USA	0009-7322			CIRCULATION	Circulation	OCT 3	2000	102	14					1684	1689				6	Cardiac & Cardiovascular Systems; Peripheral Vascular Disease	Cardiovascular System & Cardiology	359CB	WOS:000089593000016		
J	Watanabe, M; Yoshida, K; Hida, M; Kato, H; Uchida, K; Yamaguchi, R; Tateyama, S; Sugano, S				Watanabe, M; Yoshida, K; Hida, M; Kato, H; Uchida, K; Yamaguchi, R; Tateyama, S; Sugano, S			Cloning, expression analysis, and chromosomal mapping of GTPBP2, a novel member of the G protein family	GENE			English	Article						G protein; GTPBP2; in situ hybridization; phylogenetic tree	COMPLETE GENOME SEQUENCE; ADP-RIBOSYLATION FACTOR; CADHERIN SUPERFAMILY; BINDING PROTEIN; ALIGNMENT; GTPASES; GENES	We have identified a novel gene encoding a protein bearing GTP-binding motifs, the characteristics of GTP-binding proteins (G proteins). The deduced amino acid sequence exhibited the highest overall homology with GTPBP1 and its mouse orthologue GP-I. Hence, we named the gene GTPBP2. The mouse orthologue of this gene, Gtpbp2, showed 98% identity with GTPBP2 over the entire protein (the HGMW-approved nomenclature symbol is GTPBP2 and mouse orthologue is Gtpbp2). A phylogenetic analysis showed GTPBP2 and homologous G proteins (GTPBP1, AGP-1, and CGP-1) did not belong to major G protein families. They formed a distinct branch in the phylogenetic tree, suggesting that they constitute a novel G protein family. A 2.9 kb mRNA was predominantly detected in the testis along with various other organs. In situ hybridization analysis revealed that Gtpbp2 was predominantly expressed in spermatocytes and round-spermatids in the testis. These novel genes were localized to human chromosome 6p21.1-2 and mouse chromosome 17qC-D. (C) 2000 Elsevier Science B.V. All rights reserved.	Univ Tokyo, Dept Virol, Inst Med Sci, Tokyo, Japan; Univ Tokyo, Dept Sci Biol, Grad Sch Sci, Tokyo, Japan; Rockefeller Univ, Biochem & Mol Biol Lab, New York, NY 10021 USA; Miyazaki Univ, Fac Agr, Dept Vet Pathol, Miyazaki 88921, Japan	Sugano, S (reprint author), Univ Tokyo, Dept Virol, Inst Med Sci, Tokyo, Japan.	ssugano@ims.u-tokyo.ac.jp					Yoshida K, 1998, GENOMICS, V49, P458, DOI 10.1006/geno.1998.5271; Yoshida K, 1999, FEBS LETT, V460, P93, DOI 10.1016/S0014-5793(99)01309-5; BOURNE HR, 1990, NATURE, V348, P125, DOI 10.1038/348125a0; Hall A, 1998, SCIENCE, V279, P509, DOI 10.1126/science.279.5350.509; Smith DR, 1997, J BACTERIOL, V179, P7135; SIMON MI, 1991, SCIENCE, V252, P802, DOI 10.1126/science.1902986; Klenk HP, 1997, NATURE, V390, P364; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; BURGERING BMT, 1995, TRENDS BIOCHEM SCI, V20, P18, DOI 10.1016/S0968-0004(00)88944-6; C elegans Sequencing Consortium, 1998, SCIENCE, V282, P2012, DOI 10.1126/science.282.5396.2012; FELSENSTEIN J, 1985, EVOLUTION, V39, P783, DOI 10.2307/2408678; Hirai M, 1996, GENOMICS, V34, P263, DOI 10.1006/geno.1996.0283; Huang YJ, 1996, MOL CELL BIOL, V16, P130; JURNAK F, 1990, CELL, V60, P525, DOI 10.1016/0092-8674(90)90652-U; KAZIRO Y, 1991, ANNU REV BIOCHEM, V60, P349, DOI 10.1146/annurev.biochem.60.1.349; KOSTYU DD, 1994, CRIT REV IMMUNOL, V14, P29; LACAL JC, 1998, RAS SUPERFAMILY GTPA; Moroianu J, 1997, CRIT REV EUKAR GENE, V7, P61; [Anonymous], 1990, METHOD ENZYMOL; PFEFFER SR, 1994, CURR OPIN CELL BIOL, V6, P522, DOI 10.1016/0955-0674(94)90071-X; ROWLANDS T, 1994, SCIENCE, V264, P1326, DOI 10.1126/science.8191287; SAITOU N, 1987, MOL BIOL EVOL, V4, P406; Senju S, 1997, BIOCHEM BIOPH RES CO, V231, P360, DOI 10.1006/bbrc.1997.6103; SERAFINI T, 1991, CELL, V67, P239, DOI 10.1016/0092-8674(91)90176-Y	24	4	6	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	0378-1119	1879-0038		GENE	Gene	OCT 3	2000	256	1-2					51	58		10.1016/S0378-1119(00)00346-2		8	Genetics & Heredity	Genetics & Heredity	371GG	WOS:000165170000007		
J	Ohtsubo, Y; Nagata, Y; Kimbara, K; Takagi, M; Ohta, A				Ohtsubo, Y; Nagata, Y; Kimbara, K; Takagi, M; Ohta, A			Expression of the bph genes involved in biphenyl/PCB degradation in Pseudomonas sp KKS102 induced by the biphenyl degradation intermediate, 2-hydroxy-6-oxo-6-phenylhexa-2,4-dienoic acid	GENE			English	Article						aromatic compound; biodegradation; inducer; transcriptional regulation	SP STRAIN KKS102; POLYCHLORINATED-BIPHENYLS; LYSR FAMILY; IDENTIFICATION; HOMOLOGY	The bph genes involved in PCB/biphenyl degradation in Pseudomonas sp. KKS102 are clustered as bphEGFA1A2A3BCDA4R. The bph genes are inducibly expressed in the presence of biphenyl. In order to understand the induction more fully, the inducer of bph gene expression was investigated. To identify the inducer molecule, we constructed four deletion mutants of the structural genes and analyzed the inducibility of the bphE gene in each mutant strain. In the wild-type cell and the bphD deletion mutant, the levels of the bphE transcript were enhanced in the presence of biphenyl. On the other hand, in the bphA, bphB, and bphC deletion mutants, levels of the bphE transcript were not enhanced in the presence of biphenyl. These results demonstrated that the series of reactions catalyzed by biphenyl dioxygenase (BphA), dihydrodiol dehydrogenase (BphB), and 2,3-dihydroxybiphenyl dioxygenase (BphC) are necessary to convert biphenyl to the inducer. It is known that these reactions convert biphenyl to 2-hydroxy-6-oxo-6-phenylhexa-2,4-dienoic acid (HOPDA), and it was found that the expression of the bph genes was induced by purified HOPDA. These results clearly indicate that HOPDA is the inducer of the bph genes in KKS102. (C) 2000 Elsevier Science B.V. All rights reserved.	Univ Tokyo, Dept Biotechnol, Bunkyo Ku, Tokyo 1138657, Japan; Railway Tech Res Inst, Kokubunji, Tokyo 1858540, Japan; Univ Tokyo, Biotechnol Res Ctr, Tokyo, Japan	Ohta, A (reprint author), Univ Tokyo, Dept Biotechnol, Bunkyo Ku, 1-1-1 Yayoi, Tokyo 1138657, Japan.						TAKESHITA S, 1987, GENE, V61, P63, DOI 10.1016/0378-1119(87)90365-9; Seah SYK, 1998, J BIOL CHEM, V273, P22943, DOI 10.1074/jbc.273.36.22943; SCHELL MA, 1993, ANNU REV MICROBIOL, V47, P597, DOI 10.1146/annurev.micro.47.1.597; Brenner Vladimir, 1994, Biodegradation, V5, P359, DOI 10.1007/BF00696470; FUKUDA M, 1994, BIOCHEM BIOPH RES CO, V202, P850, DOI 10.1006/bbrc.1994.2008; Furukawa Kensuke, 1994, Biodegradation, V5, P289, DOI 10.1007/BF00696466; Hopwood DA, 1985, GENETIC MANIPULATION; KIKUCHI Y, 1994, J BACTERIOL, V176, P4269; KIKUCHI Y, 1994, J BACTERIOL, V176, P1689; KIMBARA K, 1988, AGR BIOL CHEM TOKYO, V52, P2885; KIMBARA K, 1989, J BACTERIOL, V171, P2740; MEER JR, 1992, MICROBIOL REV, V56, P677; Nikawa J, 1998, NUCLEIC ACIDS RES, V26, P860, DOI 10.1093/nar/26.3.860; ROTHMEL RK, 1990, J BACTERIOL, V172, P922; ROTHSTEIN SJ, 1981, CELL, V23, P191, DOI 10.1016/0092-8674(81)90284-1; SCHELL MA, 1985, GENE, V36, P301, DOI 10.1016/0378-1119(85)90185-4	16	26	31	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	0378-1119			GENE	Gene	OCT 3	2000	256	1-2					223	228		10.1016/S0378-1119(00)00349-8		6	Genetics & Heredity	Genetics & Heredity	371GG	WOS:000165170000023		
J	Gaigneaux, EM; Fukui, K; Iwasawa, Y				Gaigneaux, EM; Fukui, K; Iwasawa, Y			Morphology of crystalline alpha-MoO3 thin films spin-coated on Si (100)	THIN SOLID FILMS			English	Article						molybdenum oxide; model catalyst; spin-coating; crystallisation	MOLYBDENUM TRIOXIDE; AMORPHOUS FILMS; SUBSTRATE-TEMPERATURE; MOO3; OXIDE; DEPOSITION; OXIDATION; SPECTROSCOPY; MICROSCOPY; THICKNESS	Thin films of crystalline alpha -MoO3 with thicknesses between 35 and 150 nm were prepared on Si (100) wafers by spin-coating of peroxo-polymolybdic solutions. Variations of the morphology of the films with spin-coating conditions and thermal treatments applied afterwards were investigated by means of confocal laser Raman spectroscopy, X-ray diffraction and scanning electron microscopy. Thickness and uniformity of the films, and size, anisotropy and orientation of alpha -MoO3 crystals with respect to the Si substrate can be tuned by adequately adjusting the concentration of the precursor solution, the solvent, and the spin-rate during spin-coating. Size, anisotropy and orientation of crystals are nevertheless interconnected and cannot be tuned independently. The three variables are themselves dictated by the thickness of the films. However, the choice of the solvent used for the precursor solution seems to provide some additional flexibility in the tuning of the morphology of alpha -MoO3 crystals, while the minimum thickness required to obtain stable crystalline alpha -MoO3 films under the conditions we used for calcination is estimated to be 35 nm. (C) 2000 Elsevier Science S.A. All rights reserved.	Univ Tokyo, Grad Sch Sci, Dept Chem, Bunkyo Ku, Tokyo 1130033, Japan	Iwasawa, Y (reprint author), Univ Tokyo, Grad Sch Sci, Dept Chem, Bunkyo Ku, Tokyo 1130033, Japan.		Fukui, Ken-ichi/E-1455-2011				Agnihotry SA, 1996, B ELECTROCHEM, V12, P707; Miyata N, 1996, THIN SOLID FILMS, V281, P218, DOI 10.1016/0040-6090(96)08617-8; MEYERHOFER D, 1978, J APPL PHYS, V49, P3993, DOI 10.1063/1.325357; JULIEN C, 1995, J CRYST GROWTH, V156, P235, DOI 10.1016/0022-0248(95)00269-3; MESTL G, 1994, J PHYS CHEM-US, V98, P11269, DOI 10.1021/j100095a007; [Anonymous], 1996, POWD DIFFR FIL; KUIPERS EW, 1993, CATAL LETT, V17, P71, DOI 10.1007/BF00763929; DOORNKAMP C, 1995, J MATER RES, V10, P411, DOI 10.1557/JMR.1995.0411; Livage J, 1996, SOLID STATE IONICS, V84, P205, DOI 10.1016/0167-2738(96)00018-5; Mutschall D, 1996, SENSOR ACTUAT B-CHEM, V36, P320, DOI 10.1016/S0925-4005(97)80089-5; Gurlo A, 1998, SENSOR ACTUAT B-CHEM, V47, P92, DOI 10.1016/S0925-4005(98)00033-1; TATIBOUET JM, 1983, J CATAL, V82, P240, DOI 10.1016/0021-9517(83)90136-7; AJITO K, 1995, J PHYS CHEM-US, V99, P16383, DOI 10.1021/j100044a028; Abdellaoui A, 1997, THIN SOLID FILMS, V304, P39, DOI 10.1016/S0040-6090(97)00092-8; ANWAR M, 1989, J MATER SCI, V24, P3087, DOI 10.1007/BF01139023; VANHARDEVELD RM, 1995, APPL SURF SCI, V84, P339, DOI 10.1016/0169-4332(95)00010-0; ANWAR M, 1989, J MATER SCI, V24, P2387; ANWAR M, 1989, J MATER SCI, V24, P1660, DOI 10.1007/BF01105688; Bolt PH, 1996, CATAL LETT, V36, P183; BOUFKER K, 1995, J APPL ELECTROCHEM, V25, P797, DOI 10.1007/BF00648636; BRAITHWAITE ER, 1994, MOLYBDENUM OUTLINE I, P662; BRUCKMAN K, 1987, J CATAL, V104, P71, DOI 10.1016/0021-9517(87)90337-X; CRONIN JP, 1993, SOL ENERG MAT SOL C, V29, P371, DOI 10.1016/0927-0248(93)90096-L; Ferroni M, 1998, SENSOR ACTUAT B-CHEM, V48, P285, DOI 10.1016/S0925-4005(98)00057-4; GAGNEAUX EM, 2000, APPL CATAL A-GEN, V202, P265; GAIGNEAUX E, 1997, THESIS U CATHOLIQUE; Gaigneaux EM, 1998, CURR OPIN SOLID ST M, V3, P343, DOI 10.1016/S1359-0286(98)80043-0; Gaigneaux EM, 1997, STUD SURF SCI CATAL, V110, P185; GAIGNEAUX EM, 1998, DGMK TAGUNSBUICHT, V9803, P181; Geretovszky Z, 1997, APPL SURF SCI, V109, P467, DOI 10.1016/S0169-4332(96)00786-6; Gorenstein A, 1996, SOLID STATE IONICS, V86-8, P977, DOI 10.1016/0167-2738(96)00237-8; Haber J, 1997, CATAL TODAY, V33, P119, DOI 10.1016/S0920-5861(96)00107-1; HINOKUMA K, 1992, SOLID STATE IONICS, V53, P507, DOI 10.1016/0167-2738(92)90421-K; Iwasawa Y, 1996, STUD SURF SCI CATAL, V101, P21; Julien C, 1995, IONICS, V1, P316, DOI 10.1007/BF02390214; Julien C, 1996, IONICS, V2, P169, DOI 10.1007/BF02376017; KUDO T, 1984, NATURE, V312, P537, DOI 10.1038/312537a0; KURUSU Y, 1981, B CHEM SOC JPN, V54, P293, DOI 10.1246/bcsj.54.293; Li YM, 1996, SOLID STATE IONICS, V86-8, P1295, DOI 10.1016/0167-2738(96)00304-9; Li YM, 1995, SOL ENERG MAT SOL C, V39, P179, DOI 10.1016/0927-0248(95)00050-X; Li YX, 1999, P SOC PHOTO-OPT INS, V3892, P364, DOI 10.1117/12.364505; Munro B, 1998, J SOL-GEL SCI TECHN, V13, P673, DOI 10.1023/A:1008684720378; Orel B, 1998, SENSOR ACTUAT B-CHEM, V50, P234, DOI 10.1016/S0925-4005(98)00241-X; Sakai Y, 1998, SURF REV LETT, V5, P1199, DOI 10.1142/S0218625X98001535; SMITH MR, 1993, J CATAL, V141, P124, DOI 10.1006/jcat.1993.1124; Street SC, 1997, J VAC SCI TECHNOL A, V15, P1717, DOI 10.1116/1.580926; Takahashi I, 1996, JPN J APPL PHYS 2, V35, pL438, DOI 10.1143/JJAP.35.L438; TAKAKUSAGI S, UNPUB; Wang ZC, 1998, P SOC PHOTO-OPT INS, V3175, P247, DOI 10.1117/12.300679; Yamaguchi Y, 1999, J MOL CATAL A-CHEM, V141, P129, DOI 10.1016/S1381-1169(98)00256-8; YAMANAKA K, 1986, JPN J APPL PHYS 1, V25, P1420, DOI 10.1143/JJAP.25.1420; YEBKA B, 1999, P MAT RES SOC S, V548, P99; ZHOU B, 1991, J CATAL, V132, P183, DOI 10.1016/0021-9517(91)90256-4	53	21	21	ELSEVIER SCIENCE SA	LAUSANNE	PO BOX 564, 1001 LAUSANNE, SWITZERLAND	0040-6090			THIN SOLID FILMS	Thin Solid Films	OCT 3	2000	374	1					49	58				10	Materials Science, Multidisciplinary; Materials Science, Coatings & Films; Physics, Applied; Physics, Condensed Matter	Materials Science; Physics	368MU	WOS:000090121800007		
J	Einaga, Y; Gu, ZZ; Hayami, S; Fujishima, A; Sato, O				Einaga, Y; Gu, ZZ; Hayami, S; Fujishima, A; Sato, O			Reversible photoinduced switching of magnetic properties at room temperature of iron oxide particles in self-assembled films containing azobenzene	THIN SOLID FILMS			English	Article						organized organic assemblies; mesoscopic inorganic structures; nano-films; magnetic properties; optical control	PRUSSIAN BLUE; GAMMA-FE2O3; INTERFACES	The use of organized organic assemblies to direct the formation of mesoscopic inorganic structures presents many possibilities in the development of new functional materials. We have designed nano-films containing iron oxide particles, which exhibit magnetic properties at room temperature, and azobenzene by use of an alternate adsorption technique. Photoisomerization of the film was accompanied by a geometrically confined structural change, as reflected by changes in the electrostatic field. As a result, we were able to control the magnetic properties of this film by photoillumination at room temperature. (C) 2000 Elsevier Science S.A. All rights reserved.	Univ Tokyo, Fac Engn, Dept Appl Chem, Bunkyo Ku, Tokyo 1138656, Japan; KSP, Kanagawa Acad Sci & Technol, Takatsu Ku, Kawasaki, Kanagawa 2130012, Japan	Fujishima, A (reprint author), Univ Tokyo, Fac Engn, Dept Appl Chem, Bunkyo Ku, 7-3-1 Hongo, Tokyo 1138656, Japan.		Fujishima, Akira/G-7701-2012; Einaga, Yasuaki/F-1833-2014				Kang YS, 1996, CHEM MATER, V8, P2209, DOI 10.1021/cm960157j; HEALY TW, 1978, ADV COLLOID INTERFAC, V9, P303, DOI 10.1016/0001-8686(78)85002-7; OKADA H, 1990, CHEM MATER, V2, P89, DOI 10.1021/cm00008a001; Shin JY, 1999, LANGMUIR, V15, P4404, DOI 10.1021/la981477f; OZIN GA, 1992, ADV MATER, V4, P612, DOI 10.1002/adma.19920041003; Sato O, 1996, SCIENCE, V272, P704, DOI 10.1126/science.272.5262.704; Einaga Y, 1999, J AM CHEM SOC, V121, P3745, DOI 10.1021/ja982450l; MANN S, 1993, SCIENCE, V261, P1286, DOI 10.1126/science.261.5126.1286; EIGEN M, 1971, NATURWISSENSCHAFTEN, V58, P465; SAGIV J, 1980, J AM CHEM SOC, V102, P92, DOI 10.1021/ja00521a016; ADAMSON AW, 1978, J AM CHEM SOC, V100, P1298, DOI 10.1021/ja00472a049; FENDLER JH, 1987, CHEM REV, V87, P877, DOI 10.1021/cr00081a002; KONG W, 1994, MACROMOL RAPID COMM, V15, P405, DOI 10.1002/marc.1994.030150503; ZIOLO RF, 1992, SCIENCE, V257, P219, DOI 10.1126/science.257.5067.219; Sato O, 1997, J ELECTROCHEM SOC, V144, pL11, DOI 10.1149/1.1837356; GRIFFITH.J, 1972, CHEM SOC REV, V1, P481, DOI 10.1039/cs9720100481; HEYWOOD BR, 1994, ADV MATER, V6, P9, DOI 10.1002/adma.19940060103; Jeffrey G. A., 1997, INTRO HYDROGEN BONDI; Kimizuka N, 1996, ADV MATER, V8, P89, DOI 10.1002/adma.19960080119; KRAMPITZ G, 1988, ANGEW CHEM INT EDIT, V27, P1145, DOI 10.1002/anie.198811451; LVOV Y, 1994, CHEM LETT, P2323, DOI 10.1246/cl.1994.2323; Mallinson J.C., 1987, FDN MAGNETIC RECORDI; Mingotaud C, 1999, LANGMUIR, V15, P289, DOI 10.1021/la981177y; SHIMOMURA M, 1983, BER BUNSEN PHYS CHEM, V87, P1134; Yamada S, 1997, JPN J APPL PHYS 2, V36, pL1110	25	9	11	ELSEVIER SCIENCE SA	LAUSANNE	PO BOX 564, 1001 LAUSANNE, SWITZERLAND	0040-6090			THIN SOLID FILMS	Thin Solid Films	OCT 3	2000	374	1					109	113		10.1016/S0040-6090(00)01050-6		5	Materials Science, Multidisciplinary; Materials Science, Coatings & Films; Physics, Applied; Physics, Condensed Matter	Materials Science; Physics	368MU	WOS:000090121800016		
J	Ikegawa, S; Ohashi, H; Ogata, T; Honda, A; Tsukahara, M; Kubo, T; Kimizuka, M; Shimode, M; Hasegawa, T; Nishimura, G; Nakamura, Y				Ikegawa, S; Ohashi, H; Ogata, T; Honda, A; Tsukahara, M; Kubo, T; Kimizuka, M; Shimode, M; Hasegawa, T; Nishimura, G; Nakamura, Y			Novel and recurrent EBP mutations in X-linked dominant chondrodysplasia punctata	AMERICAN JOURNAL OF MEDICAL GENETICS			English	Article						chondrodysplasia punctata; skeletal dysplasia; EBP mutation; X inactivation; steroid metabolism	STEROL ISOMERASE; BINDING-PROTEIN; HAPPLE-SYNDROME	Chondrodysplasia punctata (CDP) is a heterogeneous group of skeletal dysplasias characterized by stippled epiphyses. A subtype of CDP, X-linked dominant chondrodysplasia punctata (CDPX2), known also as Conradi-Hunermann-Happle syndrome, is a rare skeletal dysplasia characterized by short stature, craniofacial defects, cataracts, ichthyosis, coarse hair, and alopecia. The cause of CDPX2 was unknown until recent identification of mutations in the gene encoding Delta(8),Delta(7) sterol isomerase emopamil-binding protein (EBP). Twelve different EBP mutations have been reported in 14 patients with CDPX2 or unclassified CDP, but with no evidence of correlation between phenotype and nature of the mutation. To characterize additional mutations and investigate possible phenotype-genotype correlation, we sequenced the entire EBP gene in 8 Japanese individuals with CDP; 5 of them presented with a CDPX2 phenotypes, We found EBP mutations in all 5 CDPX2 individuals, but none in non-CDPX2 individuals. Three of these CDPX2 individuals carried novel nonsense mutations in EBP and the other two, separate missense mutations that had been reported also in different ethnic groups. Our results, combined with previous information, suggest all EBP mutations that produce truncated proteins result in typical CDPX2, whereas the phenotypes resulted from missense mutations are not always typical for CDPX2. Patients with nonsense mutations showed abnormal sterol profiles consistent with a defect in Delta(8),Delta(7) sterol isomerase, X-inactivation patterns of the patients showed no skewing, an observation that supports the assumption that inactivation of the EBP gene occurs at random in affected individuals. Am. J. Med. Genet. 94:300-305, 2000. (C) 2000 Wiley-Liss, Inc.	Univ Tokyo, Inst Med Sci, Ctr Human Genome, Lab Genome Med, Tokyo, Japan; Natl Rehabilitat Ctr Disabled Children, Dept Orthoped, Tokyo, Japan; Keio Univ, Sch Med, Dept Pediat, Tokyo, Japan; Univ Tsukuba, Dept Gastroenterol, Tsukuba, Ibaraki 305, Japan; Yamaguchi Univ, Sch Allied Hlth Sci, Yamaguchi, Japan; NTT Kanto Med Ctr, Dept Orthopaed, Tokyo, Japan	Ikegawa, S (reprint author), Univ Tokyo, RIKEN, SNP Res Ctr, Lab Bone & Joint Dis,Minato Ku, 4-6-1 Shirokanedai, Tokyo 1088639, Japan.		Hasegawa, Tomonobu/L-3331-2013				MOEBIUS FF, 1994, J BIOL CHEM, V269, P29314; ALLEN RC, 1992, AM J HUM GENET, V51, P1229; Braverman N, 1999, NAT GENET, V22, P291; HAPPLE R, 1979, HUM GENET, V53, P65, DOI 10.1007/BF00289453; Derry JMJ, 1999, NAT GENET, V22, P286, DOI 10.1038/10350; HAPPLE R, 1995, AM J MED GENET, V57, P493, DOI 10.1002/ajmg.1320570327; HOLMES RD, 1987, NEW ENGL J MED, V316, P1608; Honda A, 1997, AM J MED GENET, V68, P282, DOI 10.1002/(SICI)1096-8628(19970131)68:3<282::AID-AJMG7>3.0.CO;2-O; International Working Group on Constitutional Diseases of Bone, 1998, AM J MED GENET, V79, P376; Kelley RI, 1999, AM J MED GENET, V83, P213, DOI 10.1002/(SICI)1096-8628(19990319)83:3<213::AID-AJMG15>3.0.CO;2-C; Schindelhauer D, 1996, GENOME RES, V6, P1056, DOI 10.1101/gr.6.11.1056; Silve S, 1996, J BIOL CHEM, V271, P22434; TINT GS, 1982, J LIPID RES, V23, P597; TRAUPE H, 1992, HUM GENET, V89, P659	14	42	44	WILEY-LISS	NEW YORK	DIV JOHN WILEY & SONS INC, 605 THIRD AVE, NEW YORK, NY 10158-0012 USA	0148-7299			AM J MED GENET	Am. J. Med. Genet.	OCT 2	2000	94	4					300	305		10.1002/1096-8628(20001002)94:4<300::AID-AJMG7>3.0.CO;2-3		6	Genetics & Heredity	Genetics & Heredity	354YD	WOS:000089358100007		
J	Seo, BB; Kim, CH; Yamanouchi, K; Takahashi, M; Sawasaki, T; Tachi, C; Tojo, H				Seo, BB; Kim, CH; Yamanouchi, K; Takahashi, M; Sawasaki, T; Tachi, C; Tojo, H			Co-injection of restriction enzyme with foreign DNA into the pronucleus for elevating production efficiencies of transgenic animals	ANIMAL REPRODUCTION SCIENCE			English	Article						co-injection; transgenic mice; restriction enzyme; PCR; transgenesis	MAMMALIAN-CELLS; MICE; RECOMBINATION; SELECTION; EMBRYOS; GENE	The microinjection method for production of transgenic farm animals requires specialized techniques and results in intolerably low production efficiencies. We investigated whether or not co-injection of foreign DNA constructs with restriction endonuclease into the pronucleus of mouse zygotes would improve the integration frequencies of foreign DNA into the host genome. Two kinds of DNA constructs that have no EcoRI site in their sequences were used for co-microinjection. With reference to the results of experiments in which EcoRI alone was injected at various amounts varying from 10(-9) to 10(-5) U/nucleus, the amount of 5 x 10(-8) U/nucleus that showed survival rate of 60.6% was used for the co-injection with DNA. Successful transgenesis of co-injected embryos was identified by DpnI-Bal31 digestion method for single embryos and by PCR method for pups born, respectively. The overall efficiency for the integration of foreign DNA in single embryos and live-born pups obtained by the co-injection procedures were 17.9% compared with 9.1% obtained by the injection of DNA alone. The results suggest that co-injection of foreign genes with restriction enzyme may elevate the integration rate of foreign genes into host genomes. (C) 2000 Elsevier Science B.V. All rights reserved.	Univ Tokyo, Grad Sch Agr & Life Sci, Lab Appl Genet, Tokyo 1138657, Japan; Univ Tokyo, Grad Sch Agr & Life Sci, Vet Physiol Lab, Tokyo 1138657, Japan; Univ Tokyo, Expt Stn Bioanim Sci, Tokai, Ibaraki 3190106, Japan; Azabu Univ, Sch Vet Med & Life Sci, Lab Dev & Reprod Biotechnol, Sagamihara, Kanagawa 2290006, Japan	Tojo, H (reprint author), Univ Tokyo, Grad Sch Agr & Life Sci, Lab Appl Genet, Tokyo 1138657, Japan.	atojo@mail.ecc.u-tokyo.ac.jp					BRINSTER RL, 1985, P NATL ACAD SCI USA, V82, P4438, DOI 10.1073/pnas.82.13.4438; FELGNER PL, 1987, P NATL ACAD SCI USA, V84, P7413, DOI 10.1073/pnas.84.21.7413; GODWIN AR, 1994, P NATL ACAD SCI USA, V91, P12554, DOI 10.1073/pnas.91.26.12554; BEHR JP, 1989, P NATL ACAD SCI USA, V86, P6982, DOI 10.1073/pnas.86.18.6982; PURSEL VG, 1989, SCIENCE, V244, P1281, DOI 10.1126/science.2499927; BISHOP JO, 1989, MOL BIOL MED, V6, P283; PAGE RL, 1995, TRANSGENIC RES, V4, P353, DOI 10.1007/BF01973753; BRENNEMAN M, 1996, P NATL ACAD SCI USA, V85, P836; Hase Wakako, 1996, Journal of Reproduction and Development, V42, P265, DOI 10.1262/jrd.42.265; HILL K G, 1992, Theriogenology, V37, P222, DOI 10.1016/0093-691X(92)90291-X; Hogan B, 1994, MANIPULATING MOUSE E; IKEDA A, 1994, ENDOCR J, V41, P525; Inuzuka H, 1999, MOL REPROD DEV, V54, P121, DOI 10.1002/(SICI)1098-2795(199910)54:2<121::AID-MRD3>3.0.CO;2-T; Kano Kiyoshi, 1998, Journal of Reproduction and Development, V44, P253, DOI 10.1262/jrd.44.253; Kato M, 1999, MOL REPROD DEV, V54, P43, DOI 10.1002/(SICI)1098-2795(199909)54:1<43::AID-MRD6>3.0.CO;2-N; KATSUBE K, 1993, BIOCHEM BIOPH RES CO, V194, P97; KRIMPENFORT P, 1991, BIO-TECHNOL, V9, P844, DOI 10.1038/nbt0991-844; PHILLIPS JW, 1994, MOL CELL BIOL, V14, P5794; Seo BB, 1997, REPROD FERT DEVELOP, V9, P263, DOI 10.1071/R96086; Tojo Hideaki, 1993, Journal of Reproduction and Development, V39, P145; WARD JF, 1988, PROG NUCLEIC ACID RE, V35, P95, DOI 10.1016/S0079-6603(08)60611-X	21	13	14	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	0378-4320			ANIM REPROD SCI	Anim. Reprod. Sci.	OCT 2	2000	63	1-2					113	122		10.1016/S0378-4320(00)00148-2		10	Agriculture, Dairy & Animal Science; Reproductive Biology	Agriculture; Reproductive Biology	354CC	WOS:000089311400010		
J	Koizumi, M; Akahori, K; Ohmine, T; Tsutsumi, S; Sone, J; Kosaka, T; Kaneko, M; Kimura, S; Shimada, K				Koizumi, M; Akahori, K; Ohmine, T; Tsutsumi, S; Sone, J; Kosaka, T; Kaneko, M; Kimura, S; Shimada, K			Biologically active oligodeoxyribonucleotides. Part 12: N-2-methylation of 2 '-deoxyguanosines enhances stability of parallel G-quadruplex and anti-HIV-1 activity	BIOORGANIC & MEDICINAL CHEMISTRY LETTERS			English	Article							VIRUS TYPE-1 ACTIVITY; BEARING 3'-END-MODIFICATION; 5'-END-MODIFICATION; GUANOSINE; R-95288; TGGGAG	2'-Deoxyguanosine residues of a 3',5'-end-modified hexadeoxyribonucleotide (R-95288) with anti-HIV-1 activity were substituted with N-2-methyl-2'-deoxyguanosine (m(2)dG). These modified oligodeoxyribonucleotides (ODNs) showed a 2-fold higher activity than R-95288. Also, the CD spectra of these ODNs indicated that the m(2)dG modification stabilized the tertiary structure of the G-quadruplex. (C) 2000 Elsevier Science Ltd. All rights reserved.	Sankyo Co Ltd, Exploratory Chem Res Labs, Tokyo 1408710, Japan; Sankyo Co Ltd, Biol Res Labs, Tokyo 1408710, Japan; Sankyo Co Ltd, Biomed Res Labs, Tokyo 1408710, Japan; Univ Tokyo, Inst Med Sci, Dept Infect Dis, Tokyo 108, Japan; Tokyo Univ Hosp, Dept Infect Control & Prevent, Tokyo 113, Japan; Tokyo Senbai Hosp, Tokyo 108, Japan	Koizumi, M (reprint author), Sankyo Co Ltd, Exploratory Chem Res Labs, Tokyo 1408710, Japan.						Agatsuma T, 1997, ANTIVIR RES, V34, P121, DOI 10.1016/S0166-3542(97)01032-2; Agatsuma T, 1997, ANTIVIR CHEM CHEMOTH, V8, P429; Hotoda H, 1998, J MED CHEM, V41, P3655, DOI 10.1021/jm970658w; WYATT JR, 1994, P NATL ACAD SCI USA, V91, P1356, DOI 10.1073/pnas.91.4.1356; HOTODA H, 1994, NUCLEOS NUCLEOT, V13, P1375, DOI 10.1080/15257779408012159; Koizumi M, 1997, BIOORGAN MED CHEM, V5, P2235, DOI 10.1016/S0968-0896(97)00161-2; He GX, 1998, J MED CHEM, V41, P2234, DOI 10.1021/jm970434d; Osborne SE, 1997, CHEM REV, V97, P349, DOI 10.1021/cr960009c; BRIDSON PK, 1979, BIOORG CHEM, V8, P339, DOI 10.1016/0045-2068(79)90061-0; BROOM AD, 1967, J AM CHEM SOC, V89, P3612, DOI 10.1021/ja00990a047; KATAHIRA M, 1995, NUCL ACIDS S SER, V34, P197; Koizumi M, 1998, BIOORGAN MED CHEM, V6, P2469, DOI 10.1016/S0968-0896(98)80021-7; Rife JP, 1998, NUCLEIC ACIDS RES, V26, P3640, DOI 10.1093/nar/26.16.3640; UCHIYAMA Y, 1994, J MOL BIOL, V243, P782, DOI 10.1016/0022-2836(94)90047-7; WATANABE T, 1996, SEIKAGAKU, V68, P941	15	15	16	PERGAMON-ELSEVIER SCIENCE LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND	0960-894X			BIOORG MED CHEM LETT	Bioorg. Med. Chem. Lett.	OCT 2	2000	10	19					2213	2216		10.1016/S0960-894X(00)00432-7		4	Chemistry, Medicinal; Chemistry, Organic	Pharmacology & Pharmacy; Chemistry	357GK	WOS:000089490000015		
J	Kobayashi, S; Busujima, T; Nagayama, S				Kobayashi, S; Busujima, T; Nagayama, S			A novel classification of Lewis acids on the basis of activity and selectivity	CHEMISTRY-A EUROPEAN JOURNAL			English	Article						acidity; Lewis acids; periodic table	ORGANIC-SYNTHESIS; CATALYSTS; WATER; SUBSTITUTION; COMPLEXES; ALDEHYDES; ALDIMINES	Group 3-15 metal chlorides (Lewis acids) were classified on the basis of activity and aldehyde- and aldimine-selectivity in an addition reaction of a silyl enol ether. Based on the experimental results, metal chlorides (Lewis acids) were classified as follows: A, active; B, weak; C, inactive for the activation of the aldehyde and/or aldimines. Groups A and B were further divided into A-1 or B-1 (aldehyde-selective), A-2 or B-2 (aldimine-selective), and A-3 or B-3 (neutral). The final classification is as follows: A-1, BCl3, AlCl3, TiCl4, GaCl3, ZrCl4, SnCl4, SbCl5, SbCl5, HfCl4, ReCl5; A-2, ScCl3, FeCl3, InCl3, BiCl3; A-3, NbCl5, MoCl3, MoCl5, SnCl2, TaCl5, WCl5, WCl6, ReCl3, TlCl3; B-1, none; B-2, SiCl4, FeCl2, CoCl2, CuCl, CuCl2, GeCl4, YCl3, OsCl3, PtCl2; B-3, ZnCl2, RuCl3; C, VCl3, CrCl3, MnCl2, NiCl2, RhCl3, PdCl2, AgCl, CdCl2, IrCl3, AuCl, HgCl2, HgCl, PbCl2. This classification has revealed several new fundamental aspects of elements (metal chlorides) as Lewis acids.	Univ Tokyo, CREST, JST, Grad Sch Pharmaceut Sci,Bunkyo Ku, Tokyo 1130033, Japan	Kobayashi, S (reprint author), Univ Tokyo, CREST, JST, Grad Sch Pharmaceut Sci,Bunkyo Ku, Tokyo 1130033, Japan.		Kobayashi, Shu/E-9214-2012				JOHNSON LK, 1995, J AM CHEM SOC, V117, P6414, DOI 10.1021/ja00128a054; Annis DA, 1999, J AM CHEM SOC, V121, P4147, DOI 10.1021/ja984410n; CHILDS RF, 1982, CAN J CHEM, V60, P801, DOI 10.1139/v82-117; Ferraris D, 1998, J ORG CHEM, V63, P4568, DOI 10.1021/jo980558d; PEARSON RG, 1963, J AM CHEM SOC, V85, P3533, DOI 10.1021/ja00905a001; OLAH GA, 1972, J AM CHEM SOC, V94, P7448, DOI 10.1021/ja00776a030; Kobayashi S, 1998, J AM CHEM SOC, V120, P8287, DOI 10.1021/ja980715q; BRAGA AL, 1999, J ORG CHEM, P562; CORRIU R, 1968, TETRAHEDRON LETT, V23, P2759; DETERS JF, 1968, J AM CHEM SOC, V90, P4583, DOI 10.1021/ja01019a013; Engberts JBFN, 1996, RECL TRAV CHIM PAY B, V115, P457; House H. O., 1972, MODERN SYNTHETIC REA; Kiindig E. P., 1999, ANGEW CHEM INT EDIT, V38, P1219, DOI 10.1002/(SICI)1521-3773(19990503)38:9<1219::AID-ANIE1219>3.0.CO;2-D; Kobayashi S, 1999, EUR J ORG CHEM, P15; Kobayashi S, 1997, J AM CHEM SOC, V119, P10049, DOI 10.1021/ja971153y; KOBAYASHI S, 1994, SYNLETT, P689; Kobayashi S, 1997, J ORG CHEM, V62, P232, DOI 10.1021/jo962010h; Kundig E. P., 1999, ANGEW CHEM, V111, P1297; LASZLO P, 1990, J AM CHEM SOC, V112, P8750, DOI 10.1021/ja00180a017; LUO YR, 1991, INORG CHEM, V30, P1676, DOI 10.1021/ic00007a051; MUKAIYAM.T, 1973, CHEM LETT, P1011, DOI 10.1246/cl.1973.1011; MUKAIYAMA T, 1991, B CHEM SOC JPN, V64, P2524, DOI 10.1246/bcsj.64.2524; OJIMA I, 1987, TETRAHEDRON LETT, P3643; SATCHELL DP, 1969, CHEM REV, V69, P251, DOI 10.1021/cr60259a001; Schinzer D., 1989, SELECTIVITIES LEWIS; Yamamoto H., 1999, LEWIS ACID REAGENTS	26	122	122	WILEY-V C H VERLAG GMBH	BERLIN	MUHLENSTRASSE 33-34, D-13187 BERLIN, GERMANY	0947-6539			CHEM-EUR J	Chem.-Eur. J.	OCT 2	2000	6	19					3491	3494		10.1002/1521-3765(20001002)6:19<3491::AID-CHEM3491>3.3.CO;2-G		4	Chemistry, Multidisciplinary	Chemistry	363PT	WOS:000089844300002		
J	Hesse, M; Franz, T; Tamai, Y; Taketo, MM; Magin, TM				Hesse, M; Franz, T; Tamai, Y; Taketo, MM; Magin, TM			Targeted deletion of keratins 18 and 19 leads to trophoblast fragility and early embryonic lethality	EMBO JOURNAL			English	Article						embryonic lethal; intermediate filaments; keratin; knockout; trophoblast giant cell	INTERMEDIATE-SIZED FILAMENTS; BHLH TRANSCRIPTION FACTOR; MICE LACKING DESMIN; TRANSGENIC MICE; NEUROFILAMENT SUBUNIT; CYTOSKELETAL ELEMENTS; MOUSE EMBRYOGENESIS; HUMAN CYTOKERATINS; NF-H; DESMOSOMES	It has been reported previously that keratin 8 (K8)deficient mice of one strain die from a liver defect at around E12.5, while those of another strain suffer from colorectal hyperplasia, These findings have generated considerable confusion about the function of Kg, K18 and K19 that are co-expressed in the mouse blastocyst and internal epithelia, To resolve this issue, we produced mice doubly deficient for K18 and K19 leading to complete loss of keratin filaments in early mouse development. These embryos died at around day E9.5 with 100% penetrance, The absence of keratins caused cytolysis restricted to trophoblast giant cells, followed by haematomas in the trophoblast layer. Up to that stage, embryonic development proceeded unaffected in the absence of keratin filaments. K18/19-deficient mouse embryos die earlier than any other intermediate filament knockouts reported so far, suggesting that keratins, in analogy to their well established role in epidermis, are essential for the integrity of a specialized embryonic epithelium. Our data also offer a rationale to explore the involvement of keratin mutations in early abortions during human pregnancies.	Univ Bonn, Inst Genet, Abt Mol Genet, D-53117 Bonn, Germany; Univ Bonn, Bonner Forum Biomed, D-53117 Bonn, Germany; Univ Bonn, Inst Anat, D-53115 Bonn, Germany; Banyu Tsukuba Res Inst Merck, Tsukuba, Ibaraki 3002611, Japan; Univ Tokyo, Grad Sch Pharmaceut Sci, Bunkyo Ku, Tokyo, Japan	Magin, TM (reprint author), Univ Bonn, Inst Genet, Abt Mol Genet, D-53117 Bonn, Germany.						LARUE L, 1994, P NATL ACAD SCI USA, V91, P8263, DOI 10.1073/pnas.91.17.8263; Ruiz P, 1996, J CELL BIOL, V135, P215, DOI 10.1083/jcb.135.1.215; Tang KQ, 2000, BIOCHEMISTRY-US, V39, P3185, DOI 10.1021/bi992664v; CROSS JC, 1994, SCIENCE, V266, P1508, DOI 10.1126/science.7985020; LLOYD C, 1995, J CELL BIOL, V129, P1329, DOI 10.1083/jcb.129.5.1329; Caulin C, 2000, J CELL BIOL, V149, P17, DOI 10.1083/jcb.149.1.17; Sullivan T, 1999, J CELL BIOL, V147, P913, DOI 10.1083/jcb.147.5.913; TAKEICHI M, 1995, CURR OPIN CELL BIOL, V7, P619, DOI 10.1016/0955-0674(95)80102-2; GUILLEMOT F, 1994, NATURE, V371, P333, DOI 10.1038/371333a0; Magin TM, 1998, J CELL BIOL, V140, P1441, DOI 10.1083/jcb.140.6.1441; KU NO, 1995, J CELL BIOL, V131, P1303, DOI 10.1083/jcb.131.5.1303; Kowalczyk AP, 1999, INT REV CYTOL, V185, P237; Gallicano GI, 1998, J CELL BIOL, V143, P2009, DOI 10.1083/jcb.143.7.2009; BARIBAULT H, 1994, GENE DEV, V8, P2964, DOI 10.1101/gad.8.24.2964; Huelsken J, 2000, J CELL BIOL, V148, P567, DOI 10.1083/jcb.148.3.567; Fuchs E, 1998, SCIENCE, V279, P514, DOI 10.1126/science.279.5350.514; PEKNY M, 1995, EMBO J, V14, P1590; Harada N, 1999, EMBO J, V18, P5931, DOI 10.1093/emboj/18.21.5931; Milner DJ, 1996, J CELL BIOL, V134, P1255, DOI 10.1083/jcb.134.5.1255; Ku NO, 1996, J CLIN INVEST, V98, P1034, DOI 10.1172/JCI118864; WILCOX AJ, 1988, NEW ENGL J MED, V319, P189, DOI 10.1056/NEJM198807283190401; HAEGEL H, 1995, DEVELOPMENT, V121, P3529; BADER BL, 1991, J CELL BIOL, V115, P1293, DOI 10.1083/jcb.115.5.1293; Bancroft J. D., 1994, MANUAL HISTOLOGICAL; BARIBAULT H, 1993, GENE DEV, V7, P1191, DOI 10.1101/gad.7.7a.1191; Bierkamp C, 1996, DEV BIOL, V180, P780, DOI 10.1006/dbio.1996.0346; BRULET P, 1980, P NATL ACAD SCI-BIOL, V77, P4113, DOI 10.1073/pnas.77.7.4113; Colucci-Guyon E, 1999, GLIA, V25, P33, DOI 10.1002/(SICI)1098-1136(19990101)25:1<33::AID-GLIA4>3.0.CO;2-J; Corden L D, 1996, Exp Dermatol, V5, P297, DOI 10.1111/j.1600-0625.1996.tb00133.x; DAYA D, 1991, AM J CLIN PATHOL, V95, P137; Elder GA, 1998, J CELL BIOL, V143, P195, DOI 10.1083/jcb.143.1.195; Elder GA, 1998, J CELL BIOL, V141, P727, DOI 10.1083/jcb.141.3.727; Firulli AB, 1998, NAT GENET, V18, P266, DOI 10.1038/3073; FUCHS E, 1994, ANNU REV BIOCHEM, V63, P345, DOI 10.1146/annurev.biochem.63.1.345; GOMI H, 1995, NEURON, V14, P29, DOI 10.1016/0896-6273(95)90238-4; HATZFELD M, 1985, J CELL BIOL, V101, P1826, DOI 10.1083/jcb.101.5.1826; HATZFELD M, 1990, J CELL SCI, V97, P317; HERRMANN H, 1998, INTERMEDIATE FILAMEN; JACKSON BW, 1981, DIFFERENTIATION, V20, P203, DOI 10.1111/j.1432-0436.1981.tb01177.x; JACKSON BW, 1980, DIFFERENTIATION, V17, P161, DOI 10.1111/j.1432-0436.1980.tb01093.x; KOUKLIS PD, 1994, J CELL BIOL, V127, P1049, DOI 10.1083/jcb.127.4.1049; Ku NO, 1999, AM J PHYSIOL-GASTR L, V277, pG1108; Ku NO, 1998, J CELL BIOL, V143, P2023, DOI 10.1083/jcb.143.7.2023; KULESH DA, 1989, MOL CELL BIOL, V9, P1553; Li ZL, 1996, DEV BIOL, V175, P362, DOI 10.1006/dbio.1996.0122; MAGIN TM, 1990, EUR J CELL BIOL, V53, P333; Magin TM, 2000, PROTOPLASMA, V211, P140, DOI 10.1007/BF01304482; MOLL R, 1982, CELL, V31, P11, DOI 10.1016/0092-8674(82)90400-7; OSHIMA RG, 1983, DEV BIOL, V99, P447, DOI 10.1016/0012-1606(83)90294-4; PAULIN D, 1980, EXP CELL RES, V130, P297, DOI 10.1016/0014-4827(80)90006-3; Porter RM, 1996, J CELL BIOL, V132, P925, DOI 10.1083/jcb.132.5.925; Rao MV, 1998, J CELL BIOL, V143, P171, DOI 10.1083/jcb.143.1.171; Riley P, 1998, NAT GENET, V18, P271, DOI 10.1038/ng0398-271; RUGH R, 1968, MOUSE ITS REPRODUCTI; SCHWARZ HA, 1890, GESAMMELTE MATH ABHA, V1, P6; STEINERT PM, 1976, J MOL BIOL, V108, P547, DOI 10.1016/S0022-2836(76)80136-2; Stumptner C, 2000, AM J PATHOL, V156, P77, DOI 10.1016/S0002-9440(10)64708-6; Suzuki N, 1998, P NATL ACAD SCI USA, V95, P5027, DOI 10.1073/pnas.95.9.5027; Zhu QZ, 1998, J CELL BIOL, V143, P183, DOI 10.1083/jcb.143.1.183	59	107	108	OXFORD UNIV PRESS	OXFORD	GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND	0261-4189			EMBO J	Embo J.	OCT 2	2000	19	19					5060	5070		10.1093/emboj/19.19.5060		11	Biochemistry & Molecular Biology; Cell Biology	Biochemistry & Molecular Biology; Cell Biology	362RM	WOS:000089792100003		
J	Nagano, T; Kuwata, S; Ishii, Y; Hidai, M				Nagano, T; Kuwata, S; Ishii, Y; Hidai, M			Sulfido-bridged titanium-iridium heterobimetallic complexes derived from an iridium hydrosulfido complex	ORGANOMETALLICS			English	Article							DIRHODIUM COMPLEXES; TRANSITION-METALS; CLUSTERS; RH; REACTIVITY; DIIRIDIUM; IR; CP-ASTERISK-MCL(MU(2)-SH)(2)MCP-ASTERISK-CL; DEPROTONATION; TRINUCLEAR	Reactions of [Cp*Ir(SH)(2)(PMe3)] (1; Cp* = eta(5)-C5Me5) with [CpTiCl3](Cp = eta(5)-C5H5) and [TiCl4(thf)(2)] in the presence of triethylamine afforded the sulfido-bridged titanium-iridium heterobimetallic complexes [CpTiCl(mu(2)-S)(2)Ir-(PMe3)Cp*] (2) and [TiCl2(mu(2)-S)(2)Ir(PMe3)Cp*] (3), respectively.	Univ Tokyo, Grad Sch Engn, Dept Chem & Biotechnol, Bunkyo Ku, Tokyo 1138656, Japan; Sci Univ Tokyo, Fac Ind Sci & Technol, Dept Mat Sci & Technol, Noda, Chiba 2788510, Japan	Kuwata, S (reprint author), Univ Tokyo, Grad Sch Engn, Dept Chem & Biotechnol, Bunkyo Ku, Tokyo 1138656, Japan.		Kuwata, Shigeki/C-4920-2011	Kuwata, Shigeki/0000-0002-3165-9882			Amemiya T, 1999, CHEM COMMUN, P711, DOI 10.1039/a901002e; NADASDI TT, 1993, INORG CHEM, V32, P347, DOI 10.1021/ic00055a022; Casado MA, 1998, ORGANOMETALLICS, V17, P3414, DOI 10.1021/om980307v; FLACK HD, 1983, ACTA CRYSTALLOGR A, V39, P876, DOI 10.1107/S0108767383001762; Hernandez-Gruel MAF, 1999, ANGEW CHEM INT EDIT, V38, P2769, DOI 10.1002/(SICI)1521-3773(19990917)38:18<2769::AID-ANIE2769>3.0.CO;2-N; [Anonymous], 1974, INT TABLES XRAY CRYS, V4; Casado MA, 1999, ORGANOMETALLICS, V18, P5299, DOI 10.1021/om990623p; WARK TA, 1989, ORGANOMETALLICS, V8, P2836, DOI 10.1021/om00114a017; Kabashima S, 2000, ANGEW CHEM INT EDIT, V39, P1128, DOI 10.1002/(SICI)1521-3773(20000317)39:6<1128::AID-ANIE1128>3.0.CO;2-6; Casado MA, 1999, ORGANOMETALLICS, V18, P3025, DOI 10.1021/om990154r; ALTOMARE A, 1994, J APPL CRYSTALLOGR, V27, P435, DOI 10.1107/S002188989400021X; Hidai M, 2000, ACCOUNTS CHEM RES, V33, P46, DOI 10.1021/ar990016y; Hagadorn JR, 1997, INORG CHEM, V36, P2928, DOI 10.1021/ic970413+; Kabashima S, 1999, J AM CHEM SOC, V121, P7837, DOI 10.1021/ja990034a; [Anonymous], 1992, INT TABLES XRAY CRYS, VC; Atencio R, 1996, J ORGANOMET CHEM, V514, P103, DOI 10.1016/0022-328X(95)05994-Z; Beurskens PT, 1994, DIRDIF 94 PROGRAM SY; CORWIN DT, 1995, INORG CHIM ACTA, V229, P335, DOI 10.1016/0020-1693(94)04263-U; COTTON FA, 1989, J AM CHEM SOC, V111, P2148, DOI 10.1021/ja00188a031; DOBBS DA, 1994, INORG CHEM, V33, P5329, DOI 10.1021/ic00101a027; MAUE PG, 1988, Z NATURFORSCH B, V43, P1213; Hashizume K, 1996, ORGANOMETALLICS, V15, P3303, DOI 10.1021/om960193s; Hernandez-Gruel MAF, 1999, EUR J INORG CHEM, P2047; Hernandez-Gruel M. A. F., 1999, ANGEW CHEM, V111, P2935, DOI 10.1002/(SICI)1521-3757(19990917)111:18<2935::AID-ANGE2935>3.0.CO;2-B; KABASHIMA S, 2000, ANGEW CHEM, V112, P1150, DOI 10.1002/(SICI)1521-3757(20000317)112:6<1150::AID-ANGE1150>3.0.CO;2-0; KALCK P, 1993, ORGANOMETALLICS, V12, P1021, DOI 10.1021/om00028a014; KLEIN DP, 1990, J AM CHEM SOC, V112, P2022, DOI 10.1021/ja00161a070; Kochi T, 1999, J CHEM SOC DALTON, P2575, DOI 10.1039/a902999k; Kochi T, 1999, CHEM LETT, P1279, DOI 10.1246/cl.1999.1279; KRUG V, 1988, Z NATURFORSCH B, V43, P1501; Kuwata S, 1998, CHEM LETT, P885, DOI 10.1246/cl.1998.885; KUWATA S, IN PRESS COORD CHEM; Lundmark PJ, 1996, ORGANOMETALLICS, V15, P3631, DOI 10.1021/om960358x; MANZER LE, 1982, INORG SYN, V21, P135; Masui D, 1998, CHEM LETT, P717, DOI 10.1246/cl.1998.717; *MOL STRUCT CORP, 1992, TEXS CRYST STRUCT AN; STEPHAN DW, 1989, COORDIN CHEM REV, V95, P41, DOI 10.1016/0010-8545(89)80002-5; Tang Z, 1998, INORG CHIM ACTA, V267, P73, DOI 10.1016/S0020-1693(97)05554-0; Tang Z, 1997, ORGANOMETALLICS, V16, P151, DOI 10.1021/om960769d; Tang Z, 1998, INORG CHEM, V37, P4909, DOI 10.1021/ic9806885	40	20	20	AMER CHEMICAL SOC	WASHINGTON	1155 16TH ST, NW, WASHINGTON, DC 20036 USA	0276-7333			ORGANOMETALLICS	Organometallics	OCT 2	2000	19	20					4176	4178		10.1021/om000417d		3	Chemistry, Inorganic & Nuclear; Chemistry, Organic	Chemistry	362CR	WOS:000089761500024		
J	Mochida, T; Suzuki, S; Moriyama, H; Terao, H; Sugawara, T				Mochida, T; Suzuki, S; Moriyama, H; Terao, H; Sugawara, T			Tetra-n-butylammonium bis(1,2-dimercaptoethene-1,2-dicarbo-nitrilato-S,S ')nickel(III)	ACTA CRYSTALLOGRAPHICA SECTION C-CRYSTAL STRUCTURE COMMUNICATIONS			English	Article								The crystal structure of the title compound, (C16H36N)[Ni(C4N2S2)(2)], shows stacking of the dimerized anions, surrounded by columns of cations.	Toho Univ, Fac Sci, Dept Chem, Chiba 2748510, Japan; Univ Tokyo, Dept Basic Sci, Meguro Ku, Tokyo 1538902, Japan; PRESTO, JST, Osaka, Japan	Mochida, T (reprint author), Toho Univ, Fac Sci, Dept Chem, Miyama 2-2-1, Chiba 2748510, Japan.		Mochida, Tomoyuki/F-8555-2012	Mochida, Tomoyuki/0000-0002-3446-2145			Coomber AT, 1996, NATURE, V380, P144, DOI 10.1038/380144a0; EISENBER.R, 1965, INORG CHEM, V4, P605, DOI 10.1021/ic50027a001; KOBAYASHI A, 1977, B CHEM SOC JPN, V50, P2650, DOI 10.1246/bcsj.50.2650; MAHADEVAN C, 1984, ACTA CRYSTALLOGR C, V40, P2032, DOI 10.1107/S0108270184010519; *MOL STRUCT CORP, 1999, MSC AFC DIFFR CONTR; Molecular Structure Corporation, 1999, TEXSAN; SALUSCHKE S, 1996, UNPUB; Sheldrick G. M., 1997, SHELXL97; Spek AL, 2000, PLATON	9	12	12	MUNKSGAARD INT PUBL LTD	COPENHAGEN	35 NORRE SOGADE, PO BOX 2148, DK-1016 COPENHAGEN, DENMARK	0108-2701			ACTA CRYSTALLOGR C	Acta Crystallogr. Sect. C-Cryst. Struct. Commun.	OCT	2000	56		10				1183	1184		10.1107/S0108270100009094		2	Chemistry, Multidisciplinary; Crystallography	Chemistry; Crystallography	374TT	WOS:000165361000004		
J	Nakamura, S; Ono, F; Hamano, M; Odagiri, K; Kubo, M; Komatsuzaki, K; Terao, K; Shinagawa, M; Takahashi, K; Yoshikawa, Y				Nakamura, S; Ono, F; Hamano, M; Odagiri, K; Kubo, M; Komatsuzaki, K; Terao, K; Shinagawa, M; Takahashi, K; Yoshikawa, Y			Immunohistochemical detection of apolipoprotein E within prion-associated lesions in squirrel monkey brains	ACTA NEUROPATHOLOGICA			English	Article						amyloid; apolipoprotein E; prion; squirrel monkey	CREUTZFELDT-JAKOB-DISEASE; ALZHEIMERS-DISEASE; SENILE PLAQUES; CYNOMOLGUS MONKEYS; AMYLOID ANGIOPATHY; ALLELIC VARIATION; PROTEIN; DEPOSITION; ANTIBODIES; CONSTITUENTS	The interaction of various amyloid precursors and apolipoprotein E (apoE) is important for Congophilic amyloid formation. As for cerebral amyloidoses, although the correlation between amyloid beta protein (A beta) and apoE in Alzheimer's disease (AD) has been clarified, the interaction of prion protein isoform (PrPsc) and apoE in several types of prion diseases (PDs) has not been examined in detail. ApoE colocalization has been confirmed in Congophilic PrPsc plaques, but to clarify the participation of apoE in the early stage of PDs, apoE deposition in immature lesions without Congophilic amyloid in PDs needs to be examined. In the present study two squirrel monkeys were inoculated with mouse PrPsc derived from sheep scrapie, and showed signs of severe spongiform degeneration. These lesions were immunohistochemically characterized as patchy perivacuolar and diffuse synaptic lesions without Congophilic amyloid. The central portion of the assemblies involving a few patchy perivacuolar lesions was detected by methenamine silver staining and appeared as a plaque-like lesion. ApoE was colocalized in all the plaque-like lesions and in half of the patchy perivacuolar lesions, but not in any diffuse synaptic lesions. These immunohistochemical characteristics indicated that apoE colocalization occurred in moderate mature lesions in PDs, and apoE might play an important role in the aggregation of PrPsc after a conformational change from cellular PrP isoform to PrPsc.	Nippon Vet & Anim Sci Univ, Dept Vet Pathol, Tokyo 1808602, Japan; Univ Tokyo, Grad Sch Agr & Life Sci, Dept Biomed Sci, Bunkyo Ku, Tokyo 1138657, Japan; Corp Prod & Res Lab Primates, Tsukuba, Ibaraki 3050843, Japan; Natl Inst Anim Hlth, Syst Diagnost Res Div, Tsukuba, Ibaraki 3050856, Japan; Natl Inst Infect Dis, Tsukuba Primate Ctr, Tsukuba, Ibaraki 3050843, Japan; Obihiro Univ Agr & Vet Med, Dept Publ Hlth, Obihiro, Hokkaido 0808555, Japan	Nakamura, S (reprint author), Nippon Vet & Anim Sci Univ, Dept Vet Pathol, 1-7-1 Kyonan Cho, Tokyo 1808602, Japan.						IWATSUBO T, 1994, NEURON, V13, P45, DOI 10.1016/0896-6273(94)90458-8; IGNATIUS MJ, 1986, P NATL ACAD SCI USA, V83, P1125, DOI 10.1073/pnas.83.4.1125; SCHATZL HM, 1995, J MOL BIOL, V245, P362, DOI 10.1006/jmbi.1994.0030; REBECK GW, 1993, NEURON, V11, P575; SCHMECHEL DE, 1993, P NATL ACAD SCI USA, V90, P9649, DOI 10.1073/pnas.90.20.9649; Tatzelt J, 1996, NEUROLOGY, V47, P449; NAMBA Y, 1991, BRAIN RES, V541, P163, DOI 10.1016/0006-8993(91)91092-F; BUDKA H, 1995, BRAIN PATHOL, V5, P459, DOI 10.1111/j.1750-3639.1995.tb00625.x; MAHLEY RW, 1988, SCIENCE, V240, P622, DOI 10.1126/science.3283935; PRUSINER SB, 1991, SCIENCE, V252, P1515, DOI 10.1126/science.1675487; SELKOE DJ, 1991, NEURON, V6, P487, DOI 10.1016/0896-6273(91)90052-2; GEARING M, 1994, P NATL ACAD SCI USA, V91, P9382, DOI 10.1073/pnas.91.20.9382; WISNIEWSKI T, 1992, NEUROSCI LETT, V135, P235, DOI 10.1016/0304-3940(92)90444-C; CASTANO EM, 1995, LAB INVEST, V73, P457; Gearing M, 1997, NEUROBIOL AGING, V18, P139, DOI 10.1016/S0197-4580(97)00012-2; GIBBS CJ, 1972, NATURE, V236, P73, DOI 10.1038/236073a0; HALLIDAY G, 1994, ACTA NEUROPATHOL, V87, P174; KITAMOTO T, 1992, AM J PATHOL, V141, P271; NAKAGAWA Y, 1995, NEUROSCI LETT, V187, P209, DOI 10.1016/0304-3940(95)11366-5; Nakamura S, 1996, EXP ANIM TOKYO, V45, P199, DOI 10.1538/expanim.45.199; Nakamura S, 1996, J MED PRIMATOL, V25, P294; ONODERA T, 1990, JPN J VET SCI, V52, P439; PICKERINGBROWN SM, 1995, NEUROSCI LETT, V187, P127, DOI 10.1016/0304-3940(95)11353-3; PODURI A, 1994, AM J PATHOL, V144, P1183; SALVATORE M, 1995, NEUROSCI LETT, V199, P95, DOI 10.1016/0304-3940(95)12030-8; TAGLIAVINI F, 1991, NEUROSCI LETT, V128, P117, DOI 10.1016/0304-3940(91)90773-M; Uchida K, 1997, ACTA NEUROPATHOL, V93, P277; YOKOYAMA T, 1995, CLIN DIAGN LAB IMMUN, V2, P172; Yokoyama T, 1996, ARCH VIROL, V141, P763, DOI 10.1007/BF01718334	29	10	11	SPRINGER-VERLAG	NEW YORK	175 FIFTH AVE, NEW YORK, NY 10010 USA	0001-6322			ACTA NEUROPATHOL	Acta Neuropathol.	OCT	2000	100	4					365	370				6	Clinical Neurology; Neurosciences; Pathology	Neurosciences & Neurology; Pathology	341KW	WOS:000088590400003		
J	Takegoshi, H; Murofushi, T				Takegoshi, H; Murofushi, T			Vestibular evoked myogenic potentials in patients with spinocerebellar degeneration	ACTA OTO-LARYNGOLOGICA			English	Article						Machado-Joseph disease; saccule; spinocerebellar degeneration; vestibular; vestibulo-collic; vestibulo-ocular	MACHADO-JOSEPH-DISEASE; GUINEA-PIG; NERVE; RESPONSES; NEURONS; REFLEX; CLICKS; CATS	To estimate vestibulo-collic reflexes in patients with spinocerebellar degeneration (SCD), vestibular evoked myogenic potentials (VEMPs) were recorded in 16 patients with SCD and in 9 normal subjects. The patients with SCD were classified into three groups: those with olivo-ponto-cerebellar ataxia (OPCA; n = 10) those with cortical cerebellar atrophy (CCA, n = 3); and those with Machado-Joseph disease (MJD; n = 3). While all of the patients with OPCA and CCA showed biphasic responses (p13-n23), 2 of the 3 patients with MJD showed abnormal VEMPs bilaterally. Three sides in these 2 patients showed an absence of VEMPs. and one side showed a remarkably delayed p13. These two patients showed little response in caloric tests. These results suggest that the vestibulo-collic reflex as well as the vestibule-ocular reflex could be damaged in MJD patients but preserved in OPCA and CCA patients.	Univ Tokyo, Dept Otolaryngol, Tokyo 113, Japan; Univ Tokyo, Fac Med, Tokyo 113, Japan; Univ Tokyo, Branch Hosp, Dept Otolaryngol, Bunkyo Ku, Tokyo, Japan	Takegoshi, H (reprint author), Univ Tokyo, Branch Hosp, Dept Otolaryngol, Bunkyo Ku, 3-28-6 Mejirodai, Tokyo, Japan.						Murofushi T, 1998, ARCH OTOLARYNGOL, V124, P509; COLEBATCH JG, 1992, NEUROLOGY, V42, P1635; MINOR LB, 1990, EXP BRAIN RES, V83, P9; COLEBATCH JG, 1994, J NEUROL NEUROSUR PS, V57, P190, DOI 10.1136/jnnp.57.2.190; MCCUE MP, 1994, J NEUROSCI, V14, P6058; Kushiro K, 1999, EXP BRAIN RES, V126, P410, DOI 10.1007/s002210050747; MUROFUSHI T, 1995, EXP BRAIN RES, V103, P174; Murofushi T, 1996, ARCH OTOLARYNGOL, V122, P845; DIDIER A, 1989, HEARING RES, V37, P123, DOI 10.1016/0378-5955(89)90034-8; FARRIS BK, 1986, ARCH NEUROL-CHICAGO, V43, P1050; Halmagyi G M, 1995, Acta Otolaryngol Suppl, V520 Pt 1, P1; HALMAGYI GM, 1994, BAILLIERE CLIN NEUR, V3, P485; MALLINSON AI, 1986, J OTOLARYNGOL, V15, P184; MARKHAM CH, 1996, DISORDERS VESTIBULAR, P48; Murofushi T, 1995, Acta Otolaryngol Suppl, V520 Pt 1, P136; Murofushi T, 1996, EXP BRAIN RES, V111, P149; Murofushi T, 1997, ACTA OTO-LARYNGOL, V117, P66, DOI 10.3109/00016489709117994; Nakagawa H, 1993, Acta Otolaryngol Suppl, V504, P130; NYBERGHANSEN R, 1964, J COMP NEUROL, V122, P369, DOI 10.1002/cne.901220307; OZEKI H, 1998, ORL J OTORHINOLARYNG, V549, P1; SHIMIZU N, 1990, J NEUROL, V237, P393, DOI 10.1007/BF00314728; Soong B, 1998, CAN J NEUROL SCI, V25, P59; SUDARSKY L, 1995, CLIN NEUROSCI, V3, P17; Uchino Y, 1997, J NEUROPHYSIOL, V77, P3003; WOODS BT, 1992, MOVEMENT DISORDERS N, P276	25	17	20	TAYLOR & FRANCIS AS	OSLO	CORT ADELERSGT 17, PO BOX 2562, SOLLI, 0202 OSLO, NORWAY	0001-6489			ACTA OTO-LARYNGOL	Acta Oto-Laryngol.	OCT	2000	120	7					821	824				4	Otorhinolaryngology	Otorhinolaryngology	382XF	WOS:000165852100006		
J	Sheykholeslami, K; Kaga, K; Murofushi, T; Hughes, DW				Sheykholeslami, K; Kaga, K; Murofushi, T; Hughes, DW			Vestibular function in auditory neuropathy	ACTA OTO-LARYNGOLOGICA			English	Article						auditory-evokes brainstem responses; neural hearing loss; otoacoustic emissions; vestibular-evoked myogenic potentials	OTOACOUSTIC EMISSIONS; GUINEA-PIG; HEARING-LOSS; RESPONSES; POTENTIALS; NEURONS; CLICKS; EARS	Auditory neuropathy is characterized by mild-to-moderate pure-tone hearing loss, poor speech discrimination out of proportion with this loss, absent or abnormal auditory brainstem responses and normal outer hair cell function as measured by otoacoustic emissions and cochlear microphonics. We followed three patients in our clinic whom we classified as auditory neuropathy patients. These patients also complained of balance disorders and we report our auditory and vestibular system analyses of these patients. The data presented herein include results of audiometric tests (serial pure-tone audiometry and speech discrimination tests), otoacoustic emissions. auditory-evoked brainstem responses and vestibular function tests (clinical tests of balance, electronystagmography, damped relation tests and vestibular-evoked myogenic potentials). In all patients, pure-tone audiometry revealed mild-to-moderate sensorineural hearing loss, markedly poor speech discrimination scores and absent auditory-evoked brainstem responses, all in the presence of normal otoacoustic emissions. Balance rests (caloric tests and damped rotation test) were abnormal. Saccades, smooth pursuit eye movements and optokinetic nystagmus were normal in all patients. Neurological and motor system evaluations were normal in all patients. These three auditory neuropathy patients manifest a disorder of cochlear nerve function in the presence of normal outer hair cell activity. They additionally manifest a disorder of the vestibular nerve and its end organs. We conclude that, in patients with isolated auditory neuropathy, the vestibular branch of the VIIIth cranial nerve and its innervated structures may also be affected. We suggest the use of the term "cochlear neuropathy" to characterize those patients with involvement of only the auditory branch of the VIIIth cranial nerve and its innervation.	Univ Tokyo, Fac Med, Dept Otolaryngol, Bunkyo Ku, Tokyo 1130033, Japan; Eastmoreland Hosp, Portland, OR USA	Sheykholeslami, K (reprint author), Univ Tokyo, Fac Med, Dept Otolaryngol, Bunkyo Ku, 7-3-1 Hongo, Tokyo 1130033, Japan.						Starr A, 1998, EAR HEARING, V19, P169, DOI 10.1097/00003446-199806000-00001; COLEBATCH JG, 1992, NEUROLOGY, V42, P1635; Starr A, 1996, BRAIN, V119, P741, DOI 10.1093/brain/119.3.741; Nicholson G, 1996, J NEUROL NEUROSUR PS, V61, P43, DOI 10.1136/jnnp.61.1.43; BALOH RW, 1989, NEUROLOGY, V39, P272; Kalaydjieva L, 1996, NAT GENET, V14, P214, DOI 10.1038/ng1096-214; Kaga K, 1996, SCAND AUDIOL, V25, P233, DOI 10.3109/01050399609074960; MUROFUSHI T, 1995, EXP BRAIN RES, V103, P174; Murofushi T, 1996, ARCH OTOLARYNGOL, V122, P845; DAVIS H, 1979, AUDIOLOGY, V18, P445; Deltenre P, 1997, EVOKED POTENTIAL, V104, P17, DOI 10.1016/S0168-5597(96)96635-6; Doyle KJ, 1998, LARYNGOSCOPE, V108, P1374, DOI 10.1097/00005537-199809000-00022; Halmagyi G M, 1995, Acta Otolaryngol Suppl, V520 Pt 1, P1; KAGA K, 1981, ANN NY ACAD SCI, V374, P412, DOI 10.1111/j.1749-6632.1981.tb30887.x; KEMP DT, 1990, EAR HEARING, V11, P93; Konradsson KS, 1996, AUDIOLOGY, V35, P217; Murofushi T, 1996, EXP BRAIN RES, V111, P149; Murofushi T, 1997, ACTA OTO-LARYNGOL, V117, P66, DOI 10.3109/00016489709117994; NELSON DA, 1992, J SPEECH HEAR RES, V35, P1142; ROBINETTE MS, 1997, OTOACOUSTIC EMISSION, P205; Stein Laszlo, 1996, Seminars in Hearing, V17, P197, DOI 10.1055/s-0028-1083049; WORTHINGTON DW, 1980, EAR HEARING, V1, P281, DOI 10.1097/00003446-198009000-00009	22	12	27	TAYLOR & FRANCIS AS	OSLO	CORT ADELERSGT 17, PO BOX 2562, SOLLI, 0202 OSLO, NORWAY	0001-6489			ACTA OTO-LARYNGOL	Acta Oto-Laryngol.	OCT	2000	120	7					849	854		10.1080/000164800750061714		6	Otorhinolaryngology	Otorhinolaryngology	382XF	WOS:000165852100011		
J	Lauss, B; Augsburger, M; Beer, G; Bianco, S; Bragadireanu, AM; Bregant, M; Breunlich, WH; Cargnelli, M; Chatellard, D; Egger, JP; Fabbri, FL; Gartner, B; Guaraldo, C; Hayano, RS; Iliescu, M; Ishiwatari, T; Ito, TM; Iwasaki, M; King, R; Knowles, P; Koike, T; Lauss, B; Lucherini, V; Marton, J; Milotti, E; Mulhauser, F; Nakamura, SN; Petrascu, C; Ponta, T; Sanderson, AC; Schaller, LA; Schellenberg, L; Schneuwly, H; Seki, R; Tomono, D; Yoneyama, T; Zavattini, E; Zmeskal, J				Lauss, B; Augsburger, M; Beer, G; Bianco, S; Bragadireanu, AM; Bregant, M; Breunlich, WH; Cargnelli, M; Chatellard, D; Egger, JP; Fabbri, FL; Gartner, B; Guaraldo, C; Hayano, RS; Iliescu, M; Ishiwatari, T; Ito, TM; Iwasaki, M; King, R; Knowles, P; Koike, T; Lauss, B; Lucherini, V; Marton, J; Milotti, E; Mulhauser, F; Nakamura, SN; Petrascu, C; Ponta, T; Sanderson, AC; Schaller, LA; Schellenberg, L; Schneuwly, H; Seki, R; Tomono, D; Yoneyama, T; Zavattini, E; Zmeskal, J			The DEAR experiment on DA Phi NE	ACTA PHYSICA POLONICA B			English	Article; Proceedings Paper	6th International Workshop on Production, Properties and Interaction of Mesons (MESON 2000)	MAY, 2000	KRAKOW, POLAND	Jagellonian Univ, Inst Phys, Forsch Zentrum, INFN LNF, Inst Nucl Phys Cracow, Polish Acad Sci, Comm Phys				The DEAR project is one of the first experiments at the new DA Phi NE phi -factory at the Laboratori Nazionali di Frascati dell'INFN. The objective of DEAR is a precise determination of the isospin-dependent kaon-nucleon scattering lengths, through a 1% measurement of the K (alpha) line shift in kaonic hydrogen and the first observation of the line shift in kaonic deuterium.	Univ Fribourg, Inst Phys, CH-1700 Fribourg, Switzerland; Austrian Acad Sci, Inst Medium Energy Phys, A-1010 Vienna, Austria; Univ Victoria, Dept Phys & Astron, Victoria, BC, Canada; Ist Nazl Fis Nucl, Lab Nazl Frascati, I-00044 Frascati, Italy; Univ Trieste, Dipartimento Fis, I-34127 Trieste, Italy; Ist Nazl Fis Nucl, Sez Trieste, Trieste, Italy; Tokyo Inst Technol, Tokyo 152, Japan; Univ Tokyo, Dept Phys, Tokyo 113, Japan; KEK, High Energy Accelerator Res Org, Tokyo, Japan; Inst Phys & Nucl Engn Horia Hulubei, Dept High Energy Phys, Bucharest, Romania; Univ Neuchatel, Inst Phys, CH-2000 Neuchatel, Switzerland; CALTECH, WK Kellogg Radiat Lab, Pasadena, CA 91125 USA; Calif State Univ Northridge, Dept Phys & Astrophys, Northridge, CA 91330 USA	Lauss, B (reprint author), Univ Fribourg, Inst Phys, CH-1700 Fribourg, Switzerland.		Ishiwatari, Tomoichi/I-6541-2013; Iliescu, Mihail Antoniu/F-9091-2014; Iwasaki, Faculty of Science/M-8433-2014; Marton, Johann/H-2668-2012; Hayano, Ryugo/F-7889-2012	Ishiwatari, Tomoichi/0000-0002-0102-5520; Iliescu, Mihail Antoniu/0000-0002-9648-3451; Iwasaki, Faculty of Science/0000-0002-3460-9469; Marton, Johann/0000-0001-5139-7720; 			DESER S, 1954, PHYS REV, V96, P774, DOI 10.1103/PhysRev.96.774; TRUEMAN TL, 1961, NUCL PHYS, V26, P57, DOI 10.1016/0029-5582(61)90115-8; AUGSBURGER M, 1998, IR9 DEAR; AUSGBURGER M, 1999, IN PRESS NUCL INST A; Bianco S, 1999, RIV NUOVO CIMENTO, V22, P1; BRAGADIREANU M, 2000, IR17 DEAR; BRAGADIREANU M, 2000, IR16 DEAR; Egger J.-P., 1993, Particle World, V3; DELOFF A, 1976, PHYS REV C, V13, P730, DOI 10.1103/PhysRevC.13.730; EGGER JP, 1999, HYPERFINE INTERACT, V118, P291; GUARALDO C, 1999, P DAPHINE 99 WORKSH; GUARALDO C, IN PRESS FRASCATI PH; LAUSS B, 1999, IR13 DEAR; LAUSS B, 1999, IR11 DEAR; LAUSS B, 2000, IR19 DEAR; LAUSS B, 1999, IR12 DEAR; LAUSS B, 1999, IR10 DAR; REYA E, 1974, REV MOD PHYS, V46, P545, DOI 10.1103/RevModPhys.46.545; SEKI R, 1969, PHYS REV, V182, P1773, DOI 10.1103/PhysRev.182.1773	19	0	0	ACTA PHYSICA POLONICA B, JAGELLONIAN UNIV, INST PHYSICS	KRAKOW	REYMONTA 4, 30-059 KRAKOW, POLAND	0587-4254			ACTA PHYS POL B	Acta Phys. Pol. B	OCT-NOV	2000	31	10-11					2257	2264				8	Physics, Multidisciplinary	Physics	374DZ	WOS:000165330300023		
J	Kubo, K; Kanehisa, H; Takeshita, D; Kawakami, Y; Fukashiro, S; Fukunaga, T				Kubo, K; Kanehisa, H; Takeshita, D; Kawakami, Y; Fukashiro, S; Fukunaga, T			In vivo dynamics of human medial gastrocnemius muscle-tendon complex during stretch-shortening cycle exercise	ACTA PHYSIOLOGICA SCANDINAVICA			English	Article						fascicle length; medial gastrocnemius muscle; plantar flexion; tendon structures; ultrasonography	ELASTIC ENERGY; TRICEPS SURAE; EFFICIENCY; MOMENT; WORK; BEHAVIOR; WALKING; STRAIN; LENGTH; FORCE	The purpose of this study was to investigate the dynamics of human muscle-tendon complex (MTC) during stretch-shortening cycle exercises through in vivo observation. A total of seven male subjects performed dorsi flexion followed by plantar flexion at two different frequencies, 0.3 Hz (slow) and 1.0 Hz (fast), in a toe-standing position. The fascicle length (L-F) of the medial gastrocnemius muscle during the movements was determined using a real-time ultrasonography in vivo. The L-F at the switching phase from dorsi to plantar flexion was significantly shorter in the fast exercise (54.4 +/- 5.5 mm) than in the slow one (58.2 +/- 5.4 mm), suggesting that the elongation of tendon structures at that time was significantly greater in the former than in the latter. Furthermore, at the initial stage of plantar flexion during the fast movement, the L-F hardly changed with a rapid shortening of tendon structures at that time. The observed relation between MTC length and force showed that the behaviour of tendon structures contributed to 20.2 and 42.5% of the total amount of work completed during plantar flexion phase in the slow and fast movements, respectively. Thus, the present results suggest that tendon structures make the dynamics of MTC more efficient during stretch-shortening cycle exercises by changing their lengths.	Univ Tokyo, Dept Life Sci Sports Sci, Meguro Ku, Tokyo 1538902, Japan	Kubo, K (reprint author), Univ Tokyo, Dept Life Sci Sports Sci, Meguro Ku, Komaba 3-8-1, Tokyo 1538902, Japan.		fukunaga, tetsuo/C-6635-2009				ANDERSON FC, 1993, J BIOMECH, V26, P1413, DOI 10.1016/0021-9290(93)90092-S; KOMI PV, 1978, MED SCI SPORT EXER, V10, P261; LIEBER RL, 1991, AM J PHYSIOL, V261, pC86; Narici MV, 1996, J PHYSIOL-LONDON, V496, P287; Roberts TJ, 1997, SCIENCE, V275, P1113, DOI 10.1126/science.275.5303.1113; Schenau GJV, 1997, J APPL BIOMECH, V13, P389; Kubo K, 1999, J APPL PHYSIOL, V87, P2090; CAVAGNA GA, 1970, J APPL PHYSIOL, V29, P279; HOF AL, 1983, J BIOMECH, V16, P523, DOI 10.1016/0021-9290(83)90067-2; RUGG SG, 1990, J BIOMECH, V23, P495, DOI 10.1016/0021-9290(90)90305-M; GRIFFITHS RI, 1991, J PHYSIOL-LONDON, V436, P219; Ichinose Y, 1997, ACTA ANAT, V159, P78; Fukunaga T, 1996, J APPL PHYSIOL, V80, P158; BELLI A, 1992, ACTA PHYSIOL SCAND, V144, P401, DOI 10.1111/j.1748-1716.1992.tb09313.x; BENEDICT J V, 1968, Journal of Biomechanics, V1, P53, DOI 10.1016/0021-9290(68)90038-9; BOBBERT MF, 1986, J BIOMECH, V19, P887, DOI 10.1016/0021-9290(86)90184-3; BOSCO C, 1982, INT J SPORTS MED, V3, P137, DOI 10.1055/s-2008-1026076; Cavagna G A, 1977, Exerc Sport Sci Rev, V5, P89; MCCAW ST, 1995, J BIOMECH, V28, P985, DOI 10.1016/0021-9290(94)00151-S; ETTEMA GJC, 1989, J BIOMECH, V22, P1209, DOI 10.1016/0021-9290(89)90223-6; FUNATO K, 1984, BIOMECHANICS, P60; Greive DW, 1978, BIOMECHANICS A, VVI, P405; Hoffer JA, 1989, PROG BRAIN RES, V80, P75; Ito L, 1998, J APPL PHYSIOL, V85, P1230; Kubo K, 1999, JPN J PHYS FIT SPORT, V48, P597; THYS H, 1975, PFLUG ARCH EUR J PHY, V354, P281, DOI 10.1007/BF00584651; VOIGT M, 1995, J BIOMECH, V28, P281, DOI 10.1016/0021-9290(94)00071-B; Winter DA., 1990, BIOMECHANICS MOTOR C; ZUURBIER CJ, 1992, J BIOMECH, V25, P1017, DOI 10.1016/0021-9290(92)90037-2	29	38	40	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0001-6772			ACTA PHYSIOL SCAND	Acta Physiol. Scand.	OCT	2000	170	2					127	135		10.1046/j.1365-201x.2000.00768.x		9	Physiology	Physiology	377UW	WOS:000165545500006		
J	Izumi, J; Suzuji, M				Izumi, J; Suzuji, M			Oxygen selectivity on Na-A type zeolite at low temperature	ADSORPTION-JOURNAL OF THE INTERNATIONAL ADSORPTION SOCIETY			English	Article						Na-A type zeolite; Na-A pellets; oxygen selectivity; low temperature; rate selective adsorbent; pressure swing adsorption		Na-A type zeolite (Na-A) shows favorable selectivity for nitrogen in an oxygen-nitrogen bi-component system at room temperature and also it is known that oxygen selectivity is dominated by differences in adsorption rates. In this study, the oxygen adsorption behavior of Na-A pellets at low temperature was evaluated. When temperature decreased, oxygen selectivity was enhanced as a result of the difference in adsorption rates. It was also strongly suggested that the oxygen equilibrium adsorbed amount of Na-A pellets was larger than that of nitrogen below 213 K. Na-A pellets are expected to be a good oxygen adsorbent for oxygen-nitrogen separation from air by pressure swing adsorption (PSA).	Mitsubishi Heavy Ind Co Ltd, Nagasaki R&D Ctr, Nagasaki 8510392, Japan; Univ Tokyo, Inst Ind Sci, Minato Ku, Tokyo 106, Japan							BRECK DW, 1959, SCI AM, V280, P85; CHIHARA K, 1977, THESIS U TOKYO; DEMONTGAREUIL P, 1960, Patent No. 3155468; IZUMI J, 1987, Patent No. 026808; KNAEBEL KS, 1987, AICHE J, V33, P2; RUTHVEN DM, 1988, PRINCIPLES ADSORPTIO, P28; 1966, Patent No. 3282028	7	9	9	KLUWER ACADEMIC PUBL	DORDRECHT	SPUIBOULEVARD 50, PO BOX 17, 3300 AA DORDRECHT, NETHERLANDS	0929-5607			ADSORPTION	Adsorpt.-J. Int. Adsorpt. Soc.	OCT	2000	6	3					205	212		10.1023/A:1008933110044		8	Chemistry, Physical; Engineering, Chemical	Chemistry; Engineering	358CM	WOS:000089539700002		
J	Maruyama, T; Mitsui, H; Maekawa, H; Yamada, H; Hirayama, M; Iino, S; Yasuda, K; Koike, K; Kimura, S; Milich, DR				Maruyama, T; Mitsui, H; Maekawa, H; Yamada, H; Hirayama, M; Iino, S; Yasuda, K; Koike, K; Kimura, S; Milich, DR			Emergence of the precore mutant late in chronic hepatitis B infection correlates with the severity of liver injury and mutations in the core region	AMERICAN JOURNAL OF GASTROENTEROLOGY			English	Article							E-ANTIGEN; NUCLEOTIDE-SEQUENCE; VIRUS-INFECTION; TRANSGENIC MICE; FULMINANT-HEPATITIS; IMMUNE-RESPONSE; WILD-TYPE; T-CELLS; DNA; ANTIBODY	OBJECTIVE: The reason that precore negative mutants (e-minus DNA) gradually become predominant in some patients during chronic hepatitis B virus infection is not clear. Theoretically, as long as both e-plus and e-minus DNA share the same epitopes in the core region, HBcAg-specific cytotoxic T lymphocytes (CTLs) cannot distinguish between the target peptides expressed by e-plus and e-minus DNA. Therefore, e-minus DNA may be accompanied by additional mutations in the core region, which may affect cytotoxic T lymphocyte recognition. To examine this possibility, the sequences of the precore and the entire core region of the hepatitis B virus genome were analyzed from paired serum samples in CH-B patients who experienced HBeAg to anti-HBe seroconversion (SC). METHODS: Patients were divided into two groups. Group A patients (n = 17) genome-converted to e-minus DNA in the precore region, which abolished HBeAg secretion within 3-4 yr after SC. Group B patients (n = 16) retained precore wild-type DNA for more than 3-4 yr after SC. To investigate the impact of the emergence of precore mutant type DNA on liver injury, alanine aminotransferase (ACT) levels were also examined. RESULTS: ALT flares were more severe among patients in group A than in group B. The average mean ALT level during the HBeAg negative phase of chronic infection was 54 +/- 38 in group A and 28 +/- 24 in group B. The average maximal ALT level during the HBeAg negative phase was 235 +/- 249 in group A and 83 +/- 106 in group B. Furthermore, all 17 patients in group A developed new core mutants during genome conversion. The average number of mutations in the core gene was 0.9 +/- 1.2 before genome conversion (e-plus DNA dominant phase) and increased to 2.8 +/- 1.3 for the 3-4 yr during genome conversion (e-minus DNA dominant phase). In contrast, only 56% (nine of 16) of patients in group B developed new core mutations after the loss of HBeAg. The average number of mutations in the core gene was 1.8 +/- 1.3 before SC (HBeAg-positive and e-plus DNA dominant phase), and decreased to 1.1 +/- 1.1 for 3-4 yr after seroconversion (anti-HBe-positive and e-plus DNA dominant phase). CONCLUSIONS: These data indicate that the emergence of a predominant precore negative genotype late in chronic hepatitis B virus infection is associated with the selection of additional mutations in the core gene, as well as with liver injury. (Am J Gastroenterol 2000;95:2894-2904. (C) 2000 by Am. Coll. of Gastroenterology).	Univ Tokyo, Fac Med, Dept Internal Med 1, Tokyo 113, Japan; St Marianna Univ, Sch Med, Inst Med Sci, Kanagawa, Japan; Scripps Res Inst, Dept Mol Biol, La Jolla, CA 92037 USA	Milich, DR (reprint author), Vaccine Res Inst, 3030 Sci Pk Rd, San Diego, CA 92121 USA.						AKAHANE Y, 1990, GASTROENTEROLOGY, V99, P1113; Maruyama T, 1998, HEPATOLOGY, V27, P245, DOI 10.1002/hep.510270137; CHEN HS, 1992, J VIROL, V66, P5682; LIANG TJ, 1991, NEW ENGL J MED, V324, P1705, DOI 10.1056/NEJM199106133242405; Milich DR, 1998, J IMMUNOL, V160, P2013; OU JH, 1986, P NATL ACAD SCI USA, V83, P1578, DOI 10.1073/pnas.83.6.1578; LAMBERTS C, 1993, J VIROL, V67, P3756; CARMAN WF, 1989, LANCET, V2, P588; Tsai SL, 1996, J CLIN INVEST, V97, P577, DOI 10.1172/JCI118450; OKAMOTO H, 1990, J VIROL, V64, P1298; OMATA M, 1991, NEW ENGL J MED, V324, P1699, DOI 10.1056/NEJM199106133242404; BEASLEY RP, 1981, LANCET, V2, P1129; BRUNETTO MR, 1991, P NATL ACAD SCI USA, V88, P4186, DOI 10.1073/pnas.88.10.4186; EHATA T, 1992, J CLIN INVEST, V89, P332, DOI 10.1172/JCI115581; Kuhober A, 1996, J IMMUNOL, V156, P3687; BERTOLETTI A, 1991, P NATL ACAD SCI USA, V88, P10445, DOI 10.1073/pnas.88.23.10445; Bozkaya H, 1996, HEPATOLOGY, V24, P32, DOI 10.1002/hep.510240107; BRUSS V, 1988, VIROLOGY, V163, P268, DOI 10.1016/0042-6822(88)90266-8; Chen M, 2000, J VIROL, V74, P7587, DOI 10.1128/JVI.74.16.7587-7599.2000; Diepolder HM, 1999, GASTROENTEROLOGY, V116, P650, DOI 10.1016/S0016-5085(99)70187-3; EHATA T, 1993, J CLIN INVEST, V91, P1206, DOI 10.1172/JCI116281; FATTOVICH G, 1995, HEPATOLOGY, V22, P1355, DOI 10.1016/0270-9139(95)90136-1; FERRARI C, 1986, CLIN EXP IMMUNOL, V66, P497; Guidotti LG, 1996, J VIROL, V70, P7056; JUNG MC, 1995, J VIROL, V69, P3358; LASKUS T, 1995, DIGEST DIS SCI, V40, P1, DOI 10.1007/BF02063933; MAGNIUS LO, 1972, J IMMUNOL, V109, P1017; MARUYAMA T, 1993, J CLIN INVEST, V91, P2586, DOI 10.1172/JCI116497; MILICH DR, 1987, J IMMUNOL, V139, P1223; MILICH DR, 1994, J IMMUNOL, V152, P455; MILICH DR, 1995, EUR J IMMUNOL, V25, P1663, DOI 10.1002/eji.1830250628; Minami M, 1996, GASTROENTEROLOGY, V111, P691, DOI 10.1053/gast.1996.v111.pm8780574; NAOUMOV NV, 1995, GASTROENTEROLOGY, V108, P505, DOI 10.1016/0016-5085(95)90080-2; TERAZAWA S, 1991, PEDIATR RES, V29, P5, DOI 10.1203/00006450-199101000-00002; Townsend K, 1997, J VIROL, V71, P3365; Zhang YY, 1999, J VIROL, V73, P3616	36	18	19	ELSEVIER SCIENCE INC	NEW YORK	655 AVENUE OF THE AMERICAS, NEW YORK, NY 10010 USA	0002-9270			AM J GASTROENTEROL	Am. J. Gastroenterol.	OCT	2000	95	10					2894	2904		10.1016/S0002-9270(00)01994-8		11	Gastroenterology & Hepatology	Gastroenterology & Hepatology	364JC	WOS:000089888400034		
J	Tanaka, T; Ohnishi, Y; Yamada, R; Nakamura, Y				Tanaka, T; Ohnishi, Y; Yamada, R; Nakamura, Y			Large-scale SNP (single nucleotide polymorphism) discovery project in Japan.	AMERICAN JOURNAL OF HUMAN GENETICS			English	Meeting Abstract									Univ Tokyo, Ctr Human Genome, Inst Med Sci, Tokyo, Japan								0	0	0	UNIV CHICAGO PRESS	CHICAGO	5720 SOUTH WOODLAWN AVE, CHICAGO, IL 60637-1603 USA	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	OCT	2000	67	4		2		121	34	34				1	Genetics & Heredity	Genetics & Heredity	355TA	WOS:000089400700124		
J	Ichikawa, Y; Goto, J; Hattori, M; Toyoda, A; Ishii, K; Jeong, SY; Hashida, H; Masuda, N; Ogata, K; Suzuki, Y; Sugano, S; Kasai, F; Hirai, M; Maciel, P; Rouleau, GA; Sakaki, Y; Kanazawa, I				Ichikawa, Y; Goto, J; Hattori, M; Toyoda, A; Ishii, K; Jeong, SY; Hashida, H; Masuda, N; Ogata, K; Suzuki, Y; Sugano, S; Kasai, F; Hirai, M; Maciel, P; Rouleau, GA; Sakaki, Y; Kanazawa, I			The human MJD gene: genomic structure, transcripts, and expression.	AMERICAN JOURNAL OF HUMAN GENETICS			English	Meeting Abstract									Univ Tokyo, Tokyo, Japan; Japan Sci & Tech Corp, CREST, Saitama, Japan; RIKEN Genom Sci Ctr, Kanagawa, Japan; IBMC, UnIGENe, Porto, Portugal; McGill Univ, Montreal, PQ H3A 2T5, Canada								0	0	0	UNIV CHICAGO PRESS	CHICAGO	5720 SOUTH WOODLAWN AVE, CHICAGO, IL 60637-1603 USA	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	OCT	2000	67	4		2		1073	200	200				1	Genetics & Heredity	Genetics & Heredity	355TA	WOS:000089400701073		
J	Ohashi, J; Tokunaga, K				Ohashi, J; Tokunaga, K			Effects of difference in allele frequency between marker and disease variant and linkage disequilibrium between them on the power of genomewide association studies of complex disease genes.	AMERICAN JOURNAL OF HUMAN GENETICS			English	Meeting Abstract									Univ Tokyo, Dept Human Gen, Grad Sch Med, Tokyo, Japan			OHASHI, JUN/G-5907-2015					0	0	0	UNIV CHICAGO PRESS	CHICAGO	5720 SOUTH WOODLAWN AVE, CHICAGO, IL 60637-1603 USA	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	OCT	2000	67	4		2		1236	228	228				1	Genetics & Heredity	Genetics & Heredity	355TA	WOS:000089400701239		
J	Taylor, TD; Watanabe, H; Gun, K; Sun, J; Sakaki, Y				Taylor, TD; Watanabe, H; Gun, K; Sun, J; Sakaki, Y			An automated system for sequence analysis, annotation, and comparison.	AMERICAN JOURNAL OF HUMAN GENETICS			English	Meeting Abstract									RIKEN, Genom Sci Ctr, Human Genome Res Grp, Sagamihara, Kanagawa, Japan; Univ Tokyo, Ctr Human Genome, Tokyo, Japan			Taylor, Todd/A-7121-2009	Taylor, Todd/0000-0003-4247-6253				0	0	0	UNIV CHICAGO PRESS	CHICAGO	5720 SOUTH WOODLAWN AVE, CHICAGO, IL 60637-1603 USA	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	OCT	2000	67	4		2		1404	257	257				1	Genetics & Heredity	Genetics & Heredity	355TA	WOS:000089400701403		
J	Ohnishi, Y; Tanaka, T; Yamada, R; Hori, M; Nakamura, Y				Ohnishi, Y; Tanaka, T; Yamada, R; Hori, M; Nakamura, Y			Systematic survey of SNPs (single nucleotide polymorphisms) in the candidate responsible genes for myocardial infarction in the Japanese population.	AMERICAN JOURNAL OF HUMAN GENETICS			English	Meeting Abstract									Univ Tokyo, Hum Genome Ctr, Inst Med Sci, Minato Ku, Tokyo, Japan; Osaka Univ, Dep Internal Med & Therapeut, Suita, Osaka, Japan								0	0	0	UNIV CHICAGO PRESS	CHICAGO	5720 SOUTH WOODLAWN AVE, CHICAGO, IL 60637-1603 USA	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	OCT	2000	67	4		2		1678	304	304				1	Genetics & Heredity	Genetics & Heredity	355TA	WOS:000089400701678		
J	Ikari, K; Furushima, K; Maeda, S; Koga, H; Komiya, S; Harata, S; Inoue, I				Ikari, K; Furushima, K; Maeda, S; Koga, H; Komiya, S; Harata, S; Inoue, I			Genome-wide search for the ossification of the posterior longitudinal ligament.	AMERICAN JOURNAL OF HUMAN GENETICS			English	Meeting Abstract									Univ Tokyo, Lab Genet Diag, IMS, Minato Ku, Tokyo, Japan; Hirosaki Univ, Dept Orthoped Surg, Hirosaki, Aomori, Japan; Kagoshima Univ, Dept Orthoped Surg, Kagoshima 890, Japan								0	0	0	UNIV CHICAGO PRESS	CHICAGO	5720 SOUTH WOODLAWN AVE, CHICAGO, IL 60637-1603 USA	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	OCT	2000	67	4		2		1803	325	325				1	Genetics & Heredity	Genetics & Heredity	355TA	WOS:000089400701806		
J	Tamari, M; Watanabe, O; Onouchi, Y; Shiomoto, Y; Hiraoka, I; Inoue, I; Nakamura, Y				Tamari, M; Watanabe, O; Onouchi, Y; Shiomoto, Y; Hiraoka, I; Inoue, I; Nakamura, Y			Mapping of suppressor gene for dermatitis of NOA (Naruto Research Institute Otsuka Atrichia) mice, an animal model of allergic dermatitis.	AMERICAN JOURNAL OF HUMAN GENETICS			English	Meeting Abstract									Univ Tokyo, Inst Med Sci, Lab Genet Diag, Tokyo, Japan; Otsuka Pharmaceut Factory, Naruto Res Inst, Naruto, Tokushima, Japan			Tamari, Mayumi/N-5378-2015					0	0	0	UNIV CHICAGO PRESS	CHICAGO	5720 SOUTH WOODLAWN AVE, CHICAGO, IL 60637-1603 USA	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	OCT	2000	67	4		2		1812	326	326				1	Genetics & Heredity	Genetics & Heredity	355TA	WOS:000089400701811		
J	Yamada, R; Tanaka, T; Ohnishi, Y; Yamamoto, K; Nakamura, Y				Yamada, R; Tanaka, T; Ohnishi, Y; Yamamoto, K; Nakamura, Y			An efficient SNP discovery procedure used in our association studies of rheumatoid arthritis.	AMERICAN JOURNAL OF HUMAN GENETICS			English	Meeting Abstract									Univ Tokyo, Inst Med Sci, Ctr Human Genome, Mol Med Lab, Tokyo, Japan; Univ Tokyo, Dept Allergy & Rheumatol, Tokyo, Japan								0	0	0	UNIV CHICAGO PRESS	CHICAGO	5720 SOUTH WOODLAWN AVE, CHICAGO, IL 60637-1603 USA	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	OCT	2000	67	4		2		1868	336	336				1	Genetics & Heredity	Genetics & Heredity	355TA	WOS:000089400701869		
J	Sato, T; Yamada, M; Oyake, M; Shimohata, T; Nakao, K; Nakamura, K; Katsuki, M; Takahashi, H; Tsuji, S				Sato, T; Yamada, M; Oyake, M; Shimohata, T; Nakao, K; Nakamura, K; Katsuki, M; Takahashi, H; Tsuji, S			Neuronal intranuclear accumulation of mutant DRPLA protein with expanded polyglutamine stretches and transcriptional dysregulation in DRPLA transgenic mice (Q129).	AMERICAN JOURNAL OF HUMAN GENETICS			English	Meeting Abstract									Niigata Univ, Brain Res Inst, Dept Neurol, Niigata 951, Japan; Niigata Univ, Dept Pathol, Brain Res Inst, Niigata, Japan; Univ Tokyo, Inst Med Sci, Ctr Med Expt, Tokyo, Japan								0	0	0	UNIV CHICAGO PRESS	CHICAGO	5720 SOUTH WOODLAWN AVE, CHICAGO, IL 60637-1603 USA	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	OCT	2000	67	4		2		1905	342	342				1	Genetics & Heredity	Genetics & Heredity	355TA	WOS:000089400701907		
J	Nakajima, T; Ishigami, T; Nakazawa, I; Emi, M; Umemura, S; Inoue, I; Lalouel, JM				Nakajima, T; Ishigami, T; Nakazawa, I; Emi, M; Umemura, S; Inoue, I; Lalouel, JM			Sequence variants in a 14.4-kb region of the human angiotensinogen gene for more details of molecular etiology of essential hypertension.	AMERICAN JOURNAL OF HUMAN GENETICS			English	Meeting Abstract									Univ Tokyo, Inst Med Sci, Lab Genet Diag, Tokyo, Japan; Yokohama City Univ, Yokohama, Kanagawa 232, Japan; Nippon Med Sch, Dept Mol Biol, Inst Gerontol, Kawasaki, Kanagawa, Japan; Univ Utah, Howard Hughes Med Inst, Dept Human Genet, Salt Lake City, UT USA								0	0	0	UNIV CHICAGO PRESS	CHICAGO	5720 SOUTH WOODLAWN AVE, CHICAGO, IL 60637-1603 USA	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	OCT	2000	67	4		2		1915	344	344				1	Genetics & Heredity	Genetics & Heredity	355TA	WOS:000089400701918		
J	Ishiguro, H; Yamada, K; Sawada, H; Nishii, K; Ichino, N; Sawada, M; Kurosawa, Y; Matsushita, N; Kobayashi, K; Goto, J; Kanazawa, I; Nagatsu, T				Ishiguro, H; Yamada, K; Sawada, H; Nishii, K; Ichino, N; Sawada, M; Kurosawa, Y; Matsushita, N; Kobayashi, K; Goto, J; Kanazawa, I; Nagatsu, T			Somatic instability of CAG repeat occurs in the HD gene knock-in mouse.	AMERICAN JOURNAL OF HUMAN GENETICS			English	Meeting Abstract									Fujita Hlth Univ, Sch Med, Inst Comprehens Med Sci, Toyoake, Aichi 4701192, Japan; Fukushima Med Univ, Sch Med, Inst Biomed Sci, Fukushima 9601295, Japan; Univ Tokyo, Dept Neurol, Div Neurosci, Grad Sch Med, Tokyo 1138655, Japan								0	0	0	UNIV CHICAGO PRESS	CHICAGO	5720 SOUTH WOODLAWN AVE, CHICAGO, IL 60637-1603 USA	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	OCT	2000	67	4		2		1941	348	348				1	Genetics & Heredity	Genetics & Heredity	355TA	WOS:000089400701943		
J	Tokunaga, K; Kuroki, K; Tsuchiya, N; Yamaguchi, A; Tsao, BP; Grossman, JM; Fukazawa, T; Hashimoto, H				Tokunaga, K; Kuroki, K; Tsuchiya, N; Yamaguchi, A; Tsao, BP; Grossman, JM; Fukazawa, T; Hashimoto, H			Significant association between CD19 polymorphism and systemic lupus erythematosus.	AMERICAN JOURNAL OF HUMAN GENETICS			English	Meeting Abstract									Univ Tokyo, Grad Sch Med, Dept Human Genet, Tokyo, Japan; Univ Calif Los Angeles, Los Angeles, CA 90024 USA; Juntendo Univ, Tokyo, Japan			Kuroki, Kimiko/F-6906-2012					0	0	0	UNIV CHICAGO PRESS	CHICAGO	5720 SOUTH WOODLAWN AVE, CHICAGO, IL 60637-1603 USA	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	OCT	2000	67	4		2		1973	353	353				1	Genetics & Heredity	Genetics & Heredity	355TA	WOS:000089400701974		
J	Hohjoh, H; Terada, N; Kawashima, M; Honda, Y; Tokunaga, K				Hohjoh, H; Terada, N; Kawashima, M; Honda, Y; Tokunaga, K			Association of the tumor necrosis factor-alpha (TNF-alpha) and its receptor 2 (TNFR2) genes with human narcolepsy.	AMERICAN JOURNAL OF HUMAN GENETICS			English	Meeting Abstract									Univ Tokyo, Grad Sch Med, Tokyo, Japan; Seiwa Hosp, Neuropsychiat Res Inst, Tokyo, Japan								0	0	0	UNIV CHICAGO PRESS	CHICAGO	5720 SOUTH WOODLAWN AVE, CHICAGO, IL 60637-1603 USA	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	OCT	2000	67	4		2		1979	354	354				1	Genetics & Heredity	Genetics & Heredity	355TA	WOS:000089400701979		
J	Kinoshita, A; Saito, T; Ghadami, M; Tomita, H; Makita, Y; Yamada, K; Ikegawa, S; Nishimura, G; Fukushima, Y; Murray, JC; Taniguchi, N; Niikawa, N; Yoshiura, K				Kinoshita, A; Saito, T; Ghadami, M; Tomita, H; Makita, Y; Yamada, K; Ikegawa, S; Nishimura, G; Fukushima, Y; Murray, JC; Taniguchi, N; Niikawa, N; Yoshiura, K			Domain-specific mutations in the human transforming growth factor beta 1 gene (TGFB1) result in Camurati-Engelmann disease.	AMERICAN JOURNAL OF HUMAN GENETICS			English	Meeting Abstract									Nagasaki Univ, Sch Med, Dept Human Genet, Nagasaki 852, Japan; Osaka Univ, Sch Med, Dept Biochem, Osaka, Japan; Univ Tokyo, Inst Med Sci, Ctr Human Genome, Tokyo, Japan; Shinshu Univ, Sch Med, Dept Med Genet, Tokyo, Japan; Univ Iowa, Dept Pediat & Biol Sci, Iowa City, IA 52242 USA								0	0	0	UNIV CHICAGO PRESS	CHICAGO	5720 SOUTH WOODLAWN AVE, CHICAGO, IL 60637-1603 USA	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	OCT	2000	67	4		2		2067	370	370				1	Genetics & Heredity	Genetics & Heredity	355TA	WOS:000089400702070		
J	Sasaki, J; Ishikawa, K; Kobayashi, K; Kondo-Iida, E; Sakakihara, Y; Fukayama, M; Mizusawa, H; Takashima, S; Nakamura, Y; Toda, T				Sasaki, J; Ishikawa, K; Kobayashi, K; Kondo-Iida, E; Sakakihara, Y; Fukayama, M; Mizusawa, H; Takashima, S; Nakamura, Y; Toda, T			Neuronal expression of the fukutin gene.	AMERICAN JOURNAL OF HUMAN GENETICS			English	Meeting Abstract									Osaka Univ, Grad Sch Med, Div Clin Genet, Suita, Osaka 565, Japan; Univ Tokyo, Inst Med Sci, Ctr Human Genome, Minato Ku, Tokyo, Japan; Univ Tokyo, Fac Med, Dept Pediat, Bunkyo Ku, Tokyo 113, Japan; Univ Tokyo, Fac Med, Dept Pathol, Bunkyo Ku, Tokyo 113, Japan; Tokyo Med & Dent Univ, Dept Neurol, Bunkyo Ku, Tokyo 113, Japan; Natl Ctr Neurol & Psychiat, Natl Inst Neurosci, Kodaira, Tokyo 187, Japan								0	0	0	UNIV CHICAGO PRESS	CHICAGO	5720 SOUTH WOODLAWN AVE, CHICAGO, IL 60637-1603 USA	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	OCT	2000	67	4		2		2102	376	376				1	Genetics & Heredity	Genetics & Heredity	355TA	WOS:000089400702103		
J	Nakamura, K; Jeong, SY; Ichikawa, Y; Nagashima, K; Nagashima, T; Goto, J; Ikeda, S; Kanazawa, I				Nakamura, K; Jeong, SY; Ichikawa, Y; Nagashima, K; Nagashima, T; Goto, J; Ikeda, S; Kanazawa, I			SCA13, a novel autosomal dominant cerebellar ataxia caused by the expanded polyglutamine in TATA-binding protein identified with 1C2 antibody immunoscreening.	AMERICAN JOURNAL OF HUMAN GENETICS			English	Meeting Abstract									Univ Tokyo, Dept Neurol, Bunkyo Ku, Tokyo, Japan; Japan Sci & Technol Corp, CREST, Tokyo, Japan; Hokkaido Univ, Sch Med, Lab Mol & Cellular Pathol, Sapporo, Hokkaido 060, Japan; Shinshu Univ, Dept Internal Med 3, Nagano, Japan								0	2	2	UNIV CHICAGO PRESS	CHICAGO	5720 SOUTH WOODLAWN AVE, CHICAGO, IL 60637-1603 USA	0002-9297			AM J HUM GENET	Am. J. Hum. Genet.	OCT	2000	67	4		2		2185	389	389				1	Genetics & Heredity	Genetics & Heredity	355TA	WOS:000089400702186		
J	Langdon, C; Kerr, C; Hassen, M; Hara, T; Arsenault, AL; Richards, CD				Langdon, C; Kerr, C; Hassen, M; Hara, T; Arsenault, AL; Richards, CD			Murine oncostatin M stimulates mouse synovial fibroblasts in vitro and induces inflammation and destruction in mouse joints in vivo	AMERICAN JOURNAL OF PATHOLOGY			English	Article							LEUKEMIA INHIBITORY FACTOR; ACUTE-PHASE PROTEINS; RHEUMATOID-ARTHRITIS; IN-VITRO; ALPHA(1)-PROTEINASE INHIBITOR; SIGNAL TRANSDUCER; TISSUE INHIBITOR; EPITHELIAL-CELLS; IL-6 EXPRESSION; GROWTH-FACTOR	Oncostatin M (OSM) is st multifunctional cytokine, a member of the interleukin-6/leukemia inhibitory factor (IL-6/LIF) family, that can regulate a number of connective-tissue cell types irt vitro including cartilage and synovial tissue-derived fibroblasts, however its role in joint inflammation in vivo is not clear. We have analyzed murine OSM (muOSM) activity in vitro and kt vivo in mouse joint tissue, to determine the potential role of this cytokine in local joint inflammation and pathology. The effects of muOSM and other IL-6/LIF cytokines on mouse synovial fibroblast cultures were assessed in vitro and showed induction of monocyte chemotactic protein-1, interleukin-6, and tissue inhibitor metalloproteinase-1, as well as enhancement of colony growth in soft agarose culture. Other IL-6/LIF cytokines including IL-6, LIF, or cardiotrophin-1, did not have such effects when tested at relatively high concentrations (20 ng/ml), To assess effects of muOSM in articular joints in vivo, we used recombinant adenovirus expressing muOSM cDNA. (AdmuOSM) and injected purified recombinant virus (10(6) to 10(8) pfu) intra-articularly into the knees of various mouse strains. Histological analysis revealed dramatic alterations in the synovium but not in synovium of knees treated with the control virus Ad-d170 or knees treated with Adm-IL-6 encoding biologically active murine IL-6, AdmuOSM effects were characterized by increases in the synovial cell proliferation, infiltration of mononuclear cells, and increases in extracellular matrix deposition that were evident at day 4, but much more marked at days 7, 14, and 21 after administration. The synovium took on characteristics similar to pannus and appeared to contact and invade cartilage. Collectively, these results provide good evidence that OSM regulates synovial fibroblast function differently than other IL-6-type cytokines, and can induce a proliferative invasive phenotype of synovium in vivo in mice on overexpression, We suggest that OSM may contribute to pathology in arthritis.	McMaster Univ, Dept Pathol & Mol Med, Hamilton, ON L8N 3Z5, Canada; Univ Tokyo, Inst Mol & Cellular Biosci, Tokyo, Japan	Richards, CD (reprint author), McMaster Univ, Dept Pathol & Mol Med, HSC-4H17,1200 Main St W, Hamilton, ON L8N 3Z5, Canada.						Auguste P, 1997, J BIOL CHEM, V272, P15760, DOI 10.1074/jbc.272.25.15760; Miossec P, 1997, ARTHRITIS RHEUM, V40, P2105, DOI 10.1002/art.1780401203; Richards CD, 1997, J IMMUNOL, V159, P2431; Dinarello CA, 1996, BLOOD, V87, P2095; Hara T, 1998, DEV BIOL, V201, P144, DOI 10.1006/dbio.1998.8990; PENNICA D, 1995, P NATL ACAD SCI USA, V92, P1142, DOI 10.1073/pnas.92.4.1142; Kamiya A, 1999, EMBO J, V18, P2127, DOI 10.1093/emboj/18.8.2127; LAFYATIS R, 1989, J CLIN INVEST, V83, P1267, DOI 10.1172/JCI114011; XING Z, 1994, J IMMUNOL, V153, P4059; Mukouyama YS, 1998, IMMUNITY, V8, P105, DOI 10.1016/S1074-7613(00)80463-X; RICHARDS CD, 1992, J IMMUNOL, V148, P1731; Cichy J, 1997, J BIOL CHEM, V272, P8250; Feldmann M, 1996, CELL, V85, P307, DOI 10.1016/S0092-8674(00)81109-5; Gong JH, 1997, J EXP MED, V186, P131, DOI 10.1084/jem.186.1.131; Mosley B, 1996, J BIOL CHEM, V271, P32635; HIRANO T, 1988, EUR J IMMUNOL, V18, P1797, DOI 10.1002/eji.1830181122; Tanaka M, 1999, BLOOD, V93, P804; Kerr C, 1999, J INTERF CYTOK RES, V19, P1195, DOI 10.1089/107999099313145; Firestein GS, 1996, ARTHRITIS RHEUM, V39, P1781, DOI 10.1002/art.1780391103; Okamoto H, 1997, ARTHRITIS RHEUM, V40, P1096, DOI 10.1002/art.1780400614; Lindberg RA, 1998, MOL CELL BIOL, V18, P3357; Imamura F, 1998, ARTHRITIS RHEUM, V41, P1979; Wallace PM, 1999, J IMMUNOL, V162, P5547; Ichihara M, 1997, BLOOD, V90, P165; Yoshimura A, 1996, EMBO J, V15, P1055; Nita I, 1996, ARTHRITIS RHEUM, V39, P820, DOI 10.1002/art.1780390515; AREND WP, 1995, ARTHRITIS RHEUM, V38, P151, DOI 10.1002/art.1780380202; Botelho FM, 1998, J BIOL CHEM, V273, P5211, DOI 10.1074/jbc.273.9.5211; BROWN TJ, 1993, BLOOD, V82, P33; BROWN TJ, 1991, J IMMUNOL, V147, P2175; Bruce A. Gregory, 1992, Progress in Growth Factor Research, V4, P157, DOI 10.1016/0955-2235(92)90029-H; BUCALA R, 1991, J EXP MED, V173, P569, DOI 10.1084/jem.173.3.569; Cawston TE, 1998, ARTHRITIS RHEUM, V41, P1760, DOI 10.1002/1529-0131(199810)41:10<1760::AID-ART8>3.0.CO;2-M; CAWSTON TE, 1995, BIOCHEM BIOPH RES CO, V215, P377, DOI 10.1006/bbrc.1995.2476; CHOMCZYNSKI P, 1987, ANAL BIOCHEM, V162, P156, DOI 10.1006/abio.1987.9999; GROVE RI, 1993, P NATL ACAD SCI USA, V90, P823, DOI 10.1073/pnas.90.3.823; HAMILTON JA, 1983, J RHEUMATOL, V10, P845; HAMILTON JA, 1991, BIOCHEM BIOPH RES CO, V180, P652, DOI 10.1016/S0006-291X(05)81115-5; HONSSIAU F, 1988, ARTHRITIS RHEUM, V31, P784; Hui W, 1996, CYTOKINE, V8, P495, DOI 10.1006/cyto.1996.0067; Hui W, 1998, CYTOKINE, V10, P220, DOI 10.1006/cyto.1997.0279; Langdon C, 1997, ARTHRITIS RHEUM, V40, P2139, DOI 10.1002/art.1780401207; Levy JB, 1996, ENDOCRINOLOGY, V137, P1159, DOI 10.1210/en.137.4.1159; LIU JW, 1994, CYTOKINE, V6, P272, DOI 10.1016/1043-4666(94)90023-X; MILES SA, 1992, SCIENCE, V255, P1432, DOI 10.1126/science.1542793; MOSMANN T, 1983, J IMMUNOL METHODS, V65, P55, DOI 10.1016/0022-1759(83)90303-4; NAIR BC, 1992, SCIENCE, V255, P1430, DOI 10.1126/science.1542792; NORDAN RP, 1996, CURRENT PROTOCOLS S, V17; RICHARDS CD, 1994, CYTOKINE, V6, P40, DOI 10.1016/1043-4666(94)90006-X; Richards CD, 1996, J IMMUNOL, V156, P343; RICHARDS CD, 1993, J IMMUNOL, V150, P5596; ROLLINS BJ, 1991, MOL CELL BIOL, V11, P3125; Sallenave JM, 1997, J INTERF CYTOK RES, V17, P337, DOI 10.1089/jir.1997.17.337; Sawchuk SJ, 1996, HUM GENE THER, V7, P499, DOI 10.1089/hum.1996.7.4-499; Shoyab M, 1998, CYTOKINES, P401, DOI 10.1016/B978-012498340-3/50028-2; YOCUM DE, 1988, AM J PATHOL, V132, P38; ZVAIFLER NJ, 1994, ARTHRITIS RHEUM, V37, P783, DOI 10.1002/art.1780370601	57	70	71	AMER SOC INVESTIGATIVE PATHOLOGY, INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3993 USA	0002-9440			AM J PATHOL	Am. J. Pathol.	OCT	2000	157	4					1187	1196		10.1016/S0002-9440(10)64634-2		10	Pathology	Pathology	362CN	WOS:000089761200016		
J	Osuga, Y; Koga, K; Tsutsumi, O; Igarashi, T; Okagaki, R; Takai, Y; Matsumi, H; Hiroi, H; Fujiwara, T; Momoeda, M; Yano, T; Taketani, Y				Osuga, Y; Koga, K; Tsutsumi, O; Igarashi, T; Okagaki, R; Takai, Y; Matsumi, H; Hiroi, H; Fujiwara, T; Momoeda, M; Yano, T; Taketani, Y			Stem cell factor (SCF) concentrations in peritoneal fluid of women with or without endometriosis	AMERICAN JOURNAL OF REPRODUCTIVE IMMUNOLOGY			English	Article						C-kit; endometriosis; peritoneal fluid; stem cell factor	C-KIT LIGAND; MAST-CELLS; GROWTH-FACTOR; TNF-ALPHA; INTERLEUKIN-6; EXPRESSION; CYTOKINE; DISEASE; INFLAMMATION; COLLAGEN	PROBLEM: In the quest for possible involvement of stem cell factor (SCF), a cytokine known to have multiple effects, in the pathogenesis of endometriosis, we evaluated concentrations of SCF in peritoneal fluid (PF) of women with or without endometriosis. METHOD OF STUDY: SCF concentrations in PF collected from women undergoing laparoscopy were measured, using a specific enzyme-linked immunosorbent assay (ELISA). Reverse transcription-polymerase chain reaction (RT-PCR) analysis to detect gene expression of c-kit, the receptor for SCF, was performed using the endometriotic tissue and the eutopic endometrium collected during the operation. RESULTS: SCF concentrations in PF of women with endometriosis were significantly higher compared to women without endometriosis. Looking at SCF concentrations in PF of women with endometriosis stratified by disease stage, women with stage I and II exhibited relatively higher SCF levels in PF, whereas SCF levels in PF with stage III and IV were comparable with those without endometriosis. The expression of mRNA for c-kit was detected in both the endometriotic tissue and the eutopic endometrium. CONCLUSION: We demonstrated an elevation in SCF levels in PF associated with endometriosis and the presence of its receptor in endometriotic tissues. Given the known pleiotropic properties of SCF, the present results suggest that SCF might play a role in the pathogenesis of endometriosis.	Univ Tokyo, Dept Obstet & Gynecol, Tokyo 1138655, Japan; Japan Sci & Technol, CREST, Kawaguchi 3320012, Japan	Taketani, Y (reprint author), Univ Tokyo, Dept Obstet & Gynecol, Tokyo 1138655, Japan.						Cairns JA, 1997, J CLIN INVEST, V99, P1313, DOI 10.1172/JCI119290; Kofford MW, 1997, J BIOL CHEM, V272, P7127; DASTYCH J, 1994, J IMMUNOL, V152, P213; HALME J, 1988, J CLIN ENDOCR METAB, V66, P1044; Ishizuka T, 1998, J IMMUNOL, V161, P3624; EISERMANN J, 1988, FERTIL STERIL, V50, P573; GALLI SJ, 1994, ADV IMMUNOL, V55, P1; WITTE ON, 1990, CELL, V63, P5, DOI 10.1016/0092-8674(90)90280-R; YARDEN Y, 1987, EMBO J, V6, P3341; Maurer M, 1998, J EXP MED, V188, P2343, DOI 10.1084/jem.188.12.2343; Kauma S, 1996, J CLIN ENDOCR METAB, V81, P1261, DOI 10.1210/jc.81.3.1261; Overton C, 1996, HUM REPROD, V11, P380; Lyman SD, 1998, BLOOD, V91, P1101; Sampson JA, 1927, AM J OBSTET GYNECOL, V14, P422; Armbrust T, 1997, J HEPATOL, V26, P1042, DOI 10.1016/S0168-8278(97)80113-4; Brito JM, 1997, J LEUKOCYTE BIOL, V62, P389; Ho HN, 1997, AM J REPROD IMMUNOL, V38, P400; Punnonen J, 1996, AM J OBSTET GYNECOL, V174, P1522, DOI 10.1016/S0002-9378(96)70600-2; Fantuzzi G, 1998, EUR CYTOKINE NETW, V9, P85; Gagari E, 1997, BLOOD, V89, P2654; Gazvani MR, 1998, HUM REPROD, V13, P1957, DOI 10.1093/humrep/13.7.1957; Hiragun T, 1998, J INVEST DERMATOL, V111, P213, DOI 10.1046/j.1523-1747.1998.00260.x; Kim HM, 1998, IMMUNOLOGY, V94, P242, DOI 10.1046/j.1365-2567.1998.00499.x; KOENIG A, 1994, BLOOD, V83, P2836; KOUTSILIERIS M, 1991, FERTIL STERIL, V56, P888; LIM YT, 1993, FERTIL STERIL, V59, P912; Matsuzaki S, 1998, AM J REPROD IMMUNOL, V40, P291; RIER SE, 1994, FERTIL STERIL, V61, P294; Skrzypczak J, 1995, ANN NY ACAD SCI, V762, P496; TAKETANI Y, 1992, AM J OBSTET GYNECOL, V167, P265; The American Fertility Society, 1985, FERTIL STERIL, V43, P351; Vliagoftis H, 1997, J ALLERGY CLIN IMMUN, V100, P435	32	30	34	MUNKSGAARD INT PUBL LTD	COPENHAGEN	35 NORRE SOGADE, PO BOX 2148, DK-1016 COPENHAGEN, DENMARK	8755-8920			AM J REPROD IMMUNOL	Am. J. Reprod. Immunol.	OCT	2000	44	4					231	235		10.1111/j.8755-8920.2000.440407.x		5	Immunology; Reproductive Biology	Immunology; Reproductive Biology	363GG	WOS:000089826300007		
J	Hong, SH; Kadosawa, T; Mochizuki, M; Matsunaga, S; Nishimura, R; Sasaki, N				Hong, SH; Kadosawa, T; Mochizuki, M; Matsunaga, S; Nishimura, R; Sasaki, N			Effect of all-trans and 9-cis retinoic acid on growth and metastasis of xenotransplanted canine osteosarcoma cells in athymic mice	AMERICAN JOURNAL OF VETERINARY RESEARCH			English	Article							VITAMIN-A; PROMYELOCYTIC LEUKEMIA; HUMAN-MELANOMA; BREAST-CANCER; CARCINOMA; INTERFERON; LINE; DIFFERENTIATION; COMBINATION; INHIBITION	Objective-To determine effects of all-trans and 9-cis retinoic acid (RA) on tumor growth and metastatic ability of canine osteosarcoma cells transplanted into athymic (nude) mice. Animals-Forty-five 5-week-old female BALB/c nude mice. Procedure-1 X 10(7) POS osteosarcoma cells were transplanted subcutaneously into the intrascapular region of mice. All-trans RA (3 or 30 mu g/kg of body weight in 0.1 mi of sesame oil), 9-cis RA (3 or 30 mg/kg in 0.1 mi of sesame oil), or sesame oil (0.1 mi, control treatment) were administered intragastrically 5 d/wk for 4 weeks beginning 3 days after transplantation (n = 4 mice/group) or after formation of a palpable tumor (5 mice/group). Tumor weight was estimated weekly by measuring tumor length and width, and retinoid toxic effects were evaluated daily. Two weeks after the final treatment, mice were euthanatized, and number of mice with pulmonary metastases was determined. Results-Adverse treatment effects were not detected. Tumor weight was less in mice treated with either dose of 9-cis RA than in control mice, although this difference was not significant. Treatment with 30 mg of 9-cis RA/kg initiated after tumor formation significantly reduced the incidence of pulmonary metastasis, compared with the control group. Conclusions and Clinical Relevance-9-cis RA decreased the incidence of pulmonary metastasis in nude mice transplanted with canine osteosarcoma cells and may be a potential adjunct therapy for treatment of osteosarcoma in dogs.	NCI, Pediat Oncol Branch, Div Clin Sci, Bethesda, MD 20892 USA; Univ Tokyo, Grad Sch Agr & Life Sci, Div Vet Anim Sci, Lab Vet Surg, Tokyo 1138657, Japan; Univ Tokyo, Vet Med Ctr, Tokyo 1138657, Japan; Hokkaido Univ, Grad Sch Vet Med, Dept Vet Clin Sci, Lab Vet Surg, Sapporo, Hokkaido 0600818, Japan	Hong, SH (reprint author), NCI, Pediat Oncol Branch, Div Clin Sci, 10-13N240, Bethesda, MD 20892 USA.						ABB J, 1982, INT J CANCER, V30, P307, DOI 10.1002/ijc.2910300309; Allende LM, 1997, IMMUNOLOGY, V90, P388, DOI 10.1046/j.1365-2567.1997.00360.x; MALKOVSKY M, 1983, P NATL ACAD SCI-BIOL, V80, P6322, DOI 10.1073/pnas.80.20.6322; HUANG ME, 1988, BLOOD, V72, P567; MARTIN SJ, 1990, CLIN EXP IMMUNOL, V79, P448; LEVIN AA, 1992, NATURE, V355, P359, DOI 10.1038/355359a0; ANZANO MA, 1994, CANCER RES, V54, P4614; BREITMAN TR, 1980, P NATL ACAD SCI-BIOL, V77, P2936, DOI 10.1073/pnas.77.5.2936; HEYMAN RA, 1992, CELL, V68, P397, DOI 10.1016/0092-8674(92)90479-V; DENNERT G, 1978, EUR J IMMUNOL, V8, P23, DOI 10.1002/eji.1830080106; FRAKER LD, 1986, CANCER IMMUNOL IMMUN, V21, P114; FRAKER LD, 1984, CANCER RES, V44, P5757; FREY JR, 1991, CANCER LETT, V57, P223, DOI 10.1016/0304-3835(91)90161-A; GOLDFARB RH, 1981, J IMMUNOL, V126, P2129; Gottardis MM, 1996, BREAST CANCER RES TR, V38, P85, DOI 10.1007/BF01803787; HALTER SA, 1988, CANCER RES, V48, P3733; Hong SH, 2000, AM J VET RES, V61, P69, DOI 10.2460/ajvr.2000.61.69; IGARASHI T, 1989, BRIT J CANCER, V59, P356, DOI 10.1038/bjc.1989.71; KADOSAWA T, 1994, J VET MED SCI, V56, P1167; LACROIX A, 1980, J CLIN INVEST, V65, P586, DOI 10.1172/JCI109703; LIPPMAN SM, 1992, J NATL CANCER I, V84, P241, DOI 10.1093/jnci/84.4.241; LOTAN R, 1981, ANN NY ACAD SCI, V359, P150, DOI 10.1111/j.1749-6632.1981.tb12744.x; LOTAN R, 1979, CANCER RES, V39, P1014; OVEJERA AA, 1977, P 2 INT WORKSH NUD M, P451; RETTURA G, 1975, J NATL CANCER I, V54, P1489; SCHLEICHER RL, 1988, CANCER RES, V48, P1465; SHALINSKY DR, 1995, CANCER RES, V55, P3183; Sporn M B, 1984, J Natl Cancer Inst, V73, P1381; TOMITA Y, 1982, J NATL CANCER I, V68, P823; WETHERALL NT, 1982, SCAN ELECT MICROSC, V4, P1565	30	4	4	AMER VETERINARY MEDICAL ASSOC	SCHAUMBURG	1931 N MEACHAM RD SUITE 100, SCHAUMBURG, IL 60173-4360 USA	0002-9645			AM J VET RES	Am. J. Vet. Res.	OCT	2000	61	10					1241	1244		10.2460/ajvr.2000.61.1241		4	Veterinary Sciences	Veterinary Sciences	362RG	WOS:000089791600014		
J	Sorouraddin, HM; Hibara, A; Proskurnin, MA; Kitamori, T				Sorouraddin, HM; Hibara, A; Proskurnin, MA; Kitamori, T			Integrated FIA for the determination of ascorbic acid and dehydroascorbic acid in a microfabricated glass-channel by thermal-lens microscopy	ANALYTICAL SCIENCES			English	Article							FLOW-INJECTION DETERMINATION; SINGLE BIOLOGICAL CELL; PHOTOTHERMAL MICROSCOPY; VITAMIN-C; CAPILLARY ELECTROPHORESIS; LIQUID-CHROMATOGRAPHY; PHOTOOXIDATION; ANTIOXIDANT; COMPLEX	An on-chip chemical micro-determination device, integrating the FIA system, was applied to L-ascorbic acid (AA) and dehydroascorbic acid (DHAA) determination. Microchannels having a 250x100 mum cross-section were fabricated in a quarts glass chip as a component in an integrated FIA system. They were put to use for flow, mixing, reaction, and detection. The reaction system was a coupled redox-complexation reaction between AA and a 1,10-phenantroline-Fe(III) mixture. Sample solutions were introduced into micro-channels by micro-syringes, the flow rate was controlled by a micro-syringe pump, and the reagents, were mixed by molecular diffusion. A photothermal microscope was used for the ultra-sensitive detection of the non-fluorescent reaction product (ferroin). For DHAA determination, dithiothreithol was used as a reducing agent and the total AA was determined. The DHAA quantity was calculated by subtraction. This method allows for the determination of AA with a linear range of up to 40 muM. The RSD for 25 muM AA (n=5) is 1%, and the limit of detection (LOD) is 0.1 muM. The procedure was successfully applied to determining the AA and DHAA content of urine and AA in vitamin C tablets. The results agree well with those obtained by reference methods.	Univ Tokyo, Sch Engn, Dept Appl Chem, Bunkyo Ku, Tokyo 1138656, Japan; Kanagawa Acad Sci & Technol, Integrated Chem Project, Takatsu Ku, Kawasaki, Kanagawa 2130012, Japan; Tabriz Univ, Fac Chem, Tabriz, Iran; Moscow State Univ, Anal Chem Div, Moscow, Russia	Kitamori, T (reprint author), Univ Tokyo, Sch Engn, Dept Appl Chem, Bunkyo Ku, Tokyo 1138656, Japan.		Hibara, Akihide/B-9294-2015; Proskurnin, Mikhail/E-9704-2011	Hibara, Akihide/0000-0003-0258-3361; Proskurnin, Mikhail/0000-0001-5577-6883			ROBERTSON JD, 1991, CLIN SCI, V80, P611; Sato K, 2000, ANAL CHEM, V72, P1144, DOI 10.1021/ac991151r; FUNG YS, 1992, ANAL CHIM ACTA, V261, P375, DOI 10.1016/0003-2670(92)80216-T; BODE AM, 1990, CLIN CHEM, V36, P1807; Liang ZH, 1996, ANAL CHEM, V68, P1040, DOI 10.1021/ac950768f; Carr AC, 1999, AM J CLIN NUTR, V69, P1086; LYKKESFELDT J, 1995, ANAL BIOCHEM, V229, P329, DOI 10.1006/abio.1995.1421; Tokeshi M, 2000, ANAL CHEM, V72, P1711, DOI 10.1021/ac991147f; BESADA A, 1987, TALANTA, V34, P731, DOI 10.1016/0039-9140(87)80229-1; BISHOP E, 1972, INDICATORS, P543; BURITS CA, 1994, CLIN CHEM, P1311; Cheregi M, 1997, ANAL LETT, V30, P2625; Fernandes JCB, 1998, ANAL CHIM ACTA, V366, P11, DOI 10.1016/S0003-2670(97)00564-3; HARADA M, 1993, ANAL CHEM, V65, P2938, DOI 10.1021/ac00068a037; Harada M, 1999, ANAL SCI, V15, P647, DOI 10.2116/analsci.15.647; HARADA M, 1995, ANAL CHIM ACTA, V299, P343, DOI 10.1016/0003-2670(94)00314-C; Issopoulos PB, 1997, FRESEN J ANAL CHEM, V357, P317, DOI 10.1007/s002160050160; Kimura H, 1997, ANAL SCI, V13, P729, DOI 10.2116/analsci.13.729; KOLTHOFF IM, 1969, QUANTITATIVE CHEM AN, P167; MANZ A, 1994, FRESEN J ANAL CHEM, V348, P567, DOI 10.1007/BF00323934; Mawatari K, 1998, ANAL CHEM, V70, P5037, DOI 10.1021/ac980250m; MCGOWN EL, 1982, ANAL BIOCHEM, V119, P55, DOI 10.1016/0003-2697(82)90664-9; Pereira AV, 1998, TALANTA, V47, P11, DOI 10.1016/S0039-9140(98)00047-2; PEREZRUIZ T, 1995, ANAL CHIM ACTA, V308, P299, DOI 10.1016/0003-2670(94)00527-S; PerezRuiz T, 1997, ANALYST, V122, P115, DOI 10.1039/a606841c; Sato K, 1999, ANAL SCI, V15, P641, DOI 10.2116/analsci.15.641; Sato K, 1999, ANAL SCI, V15, P525, DOI 10.2116/analsci.15.525; SULTAN SM, 1994, TALANTA, V41, P125, DOI 10.1016/0039-9140(94)80177-0; YebraBiurrun MD, 1997, MIKROCHIM ACTA, V126, P53, DOI 10.1007/BF01242660; Zheng JJ, 1999, ANAL SCI, V15, P223, DOI 10.2116/analsci.15.223; 1995, US PHARMACOPOEIA, V23, P130; 1998, BRIT PHARMACOPOEIA, P47	32	51	53	JAPAN SOC ANALYTICAL CHEMISTRY	TOKYO	26-2 NISHIGOTANDA 1 CHOME SHINAGAWA-KU, TOKYO, 141, JAPAN	0910-6340			ANAL SCI	Anal. Sci.	OCT	2000	16	10					1033	1037		10.2116/analsci.16.1033		5	Chemistry, Analytical	Chemistry	368HE	WOS:000090111000006		
J	Matsumoto, J; Muraoka, H; Washitani, I				Matsumoto, J; Muraoka, H; Washitani, I			Ecophysiological mechanisms used by Aster kantoensis, an endangered species, to withstand high light and heat stresses of its gravelly floodplain habitat	ANNALS OF BOTANY			English	Article						Aster kantoensis Kitam.; gravelly floodplain; high light stress; leaf temperature; photosynthesis; shoot architecture; transpiration	MIDDAY STOMATAL CLOSURE; MEDITERRANEAN TYPE SCLEROPHYLLS; WATER-STRESS; ENVIRONMENTAL CHAMBER; LEAF TEMPERATURE; INDUCED DAMAGE; ARBUTUS-UNEDO; GAS-EXCHANGE; PHOTOINHIBITION; PHOTOSYNTHESIS	Aster kantocensis Kitam., an endangered plant species of the family Compositae, is a local endemic to the gravelly floodplains of a few rivers in central Japan. The successful growth of A. kantoensis is mainly restricted to sparsely vegetated sites where, due to lack of continuous vegetation, high radiant energy input results in stressful conditions with excessive light and heat. To reveal the ecophysiological characteristics which enable the species to cope with such environmental stresses, we measured leaf temperature, shoot architecture and photosynthetic and transpirational responses together with the microclimate of the natural habitat. Even under sunny summer conditions, the leaf temperature of A. kantoensis was much lower (35-39 degrees C) than the soil surface temperature (max. 60 degrees C). The relationship between leaf position (height from the ground) and leaf temperature showed that the caulescent rosette form of A. kantoensis helps avoid leaf overheating. Moreover, in situ gas exchange measurements revealed that the high transpirational capacity (as high as 10 mmol H2O m(-1) s(-1)) was effective in controlling leaf temperature. as long as the soil water supply was not severely limited. Since it has effective mechanisms to avoid the multiple stresses indigenous to its gravelly floodplain habitat, A. kantoensis can maintain a high photosynthetic rate (up to 30 mu mol CO2 m(-1) s(-1)) without any midday depression under sunny summer conditions. (C) 2000 Annals of Botany Company.	Univ Tokyo, Inst Agr & Life Sci, Bunkyo Ku, Tokyo 1138657, Japan; Univ Tsukuba, Grad Sch Environm Sci, Tsukuba, Ibaraki 3058572, Japan; Gifu Univ, Inst Basin Ecosyst Studies, Gifu 5011193, Japan	Washitani, I (reprint author), Univ Tokyo, Inst Agr & Life Sci, Bunkyo Ku, Tokyo 1138657, Japan.						LUDLOW MM, 1984, PLANTA, V161, P505, DOI 10.1007/BF00407082; Washitani I, 1997, BIOL CONSERV, V82, P67, DOI 10.1016/S0006-3207(97)00014-1; TENHUNEN JD, 1982, OECOLOGIA, V55, P165, DOI 10.1007/BF00384483; FARQUHAR GD, 1982, ANNU REV PLANT PHYS, V33, P317, DOI 10.1146/annurev.pp.33.060182.001533; Valladares F, 1997, PLANT CELL ENVIRON, V20, P25, DOI 10.1046/j.1365-3040.1997.d01-8.x; EHLERINGER J, 1982, AM J BOT, V69, P670, DOI 10.2307/2442956; EHLERINGER J, 1980, SCIENCE, V210, P1094, DOI 10.1126/science.210.4474.1094; POWLES SB, 1984, ANNU REV PLANT PHYS, V35, P15, DOI 10.1146/annurev.pp.35.060184.000311; HSIAO TC, 1973, ANNU REV PLANT PHYS, V24, P519, DOI 10.1146/annurev.pp.24.060173.002511; BJORKMAN O, 1995, ECOPHYSIOLOGY PHOTOS; BJORKMAN OB, 1981, ENCY PLANT PHYSL A, V12; COWAN IR, 1982, ENCY PLANT PHYSL B, V12; Ehleringer JR, 1989, PLANT PHYSL ECOLOGY; EHLERINGER JR, 1988, AM J BOT, V75, P680, DOI 10.2307/2444201; *END PLANT SURV GR, 1989, RED DAT BOOK JAP VAS; *ENV AG GOV JAP, 1997, JAP PLANT RED LIST; FIELD CB, 1981, PLANT PHYSL ECOLOGY; FOSTER JR, 1992, TREE PHYSIOL, V11, P133; GAMON JA, 1990, PLANT CELL ENVIRON, V13, P267, DOI 10.1111/j.1365-3040.1990.tb01311.x; Goldstein G, 1996, OECOLOGIA, V106, P298, DOI 10.1007/BF00334557; KAO WY, 1992, PLANT CELL ENVIRON, V15, P703, DOI 10.1111/j.1365-3040.1992.tb01012.x; Kramer P. J., 1983, WATER RELATIONS PLAN; LANGE OL, 1982, FLORA, V172, P563; LARCHER W, 1989, FLORA, V183, P115; LAURIE S, 1994, PLANT SCI, V100, P147, DOI 10.1016/0168-9452(94)90070-1; MATSUMOTO J, 2000, ANN BOT, V1246; MIYAWAKI A, 1994, NEW REVISED EDITION; Muraoka H, 1998, ANN BOT-LONDON, V82, P297, DOI 10.1006/anbo.1998.0682; Muraoka H, 2000, PLANT CELL ENVIRON, V23, P235, DOI 10.1046/j.1365-3040.2000.00547.x; Norman J. M., 1989, PLANT PHYSL ECOLOGY; Osmond CB, 1994, PHOTOINHIBITION PHOT; SCHMITT P, 1993, MED CHEM RES, V3, P24; Schulze E.-D., 1982, ENCY PLANT PHYSL B; SIMS DA, 1994, PLANT CELL ENVIRON, V17, P889, DOI 10.1111/j.1365-3040.1994.tb00318.x; Takenaka A, 1996, BIOL CONSERV, V78, P345, DOI 10.1016/S0006-3207(96)00036-5; TENHUNEN JD, 1981, OECOLOGIA, V50, P5, DOI 10.1007/BF00378788; TENHUNEN JD, 1984, PLANTA, V162, P193, DOI 10.1007/BF00397440	37	14	20	ACADEMIC PRESS LTD	LONDON	24-28 OVAL RD, LONDON NW1 7DX, ENGLAND	0305-7364			ANN BOT-LONDON	Ann. Bot.	OCT	2000	86	4					777	785		10.1006/anbo.2000.1245		9	Plant Sciences	Plant Sciences	359EY	WOS:000089599600010		
J	Matsumoto, J; Muraoka, H; Washitani, I				Matsumoto, J; Muraoka, H; Washitani, I			Whole plant carbon gain of an endangered herbaceous species Aster kantoensis and the influence of shading by an alien grass Eragrostis curvula in its gravelly floodplain habitat	ANNALS OF BOTANY			English	Article						Aster kantoensis Kitam.; Eragrostis curvula Nees; biomass distribution; carbon gain; gravelly floodplain; respiration; shading; whole plant photosynthesis	ALOCASIA-MACRORRHIZA; PHOTOSYNTHESIS; BALANCE; LIGHT; INVASION; DROUGHT; LEAVES	Aster kantoensis, an endangered plant species, is endemic to gravelly floodplains of a few large rivers in central Japan. In recent years, competitive exclusion by alien perennial grasses in its natural habitat has been suspected to be one of the major factors threatening this species. In the River Kinu, increased shading by the perennial alien grass Eragrostis curvula reduces light availability for A. kantoensis. To reveal the influence of shading on the establishment and growth of A. kantoensis rosettes, the potential carbon gain of A. kantoensis in its natural habitat was estimated using microenvironmental data and whole plant photosynthetic and respiratory responses to light and temperature. Whole plant CO2 exchange responses were measured with a specifically designed 'double chamber', which enabled measurement of the CO2 gas exchange rates of the foliage (F) and the culm (C; stem and roots) separately. It was demonstrated that in a plant with average C/F ratio, positive carbon gain could be maintained only in the microsites where the relative PPFD (photosynthetically active photon flux density) was above 15 or 30% of unshaded conditions in early- or mid-summer, respectively. Increasing C/F ratio, caused by an increase in root biomass as an adaptive response to drought, resulted in a large reduction in the carbon gain irrespective of microsite, weather and season. The high light requirement of A. katoensis is interpreted as a cost of the morphological responses necessary to avoid stresses characteristic of this gravelly floodplain habitat. (C) 2000 Annals of Botany Company.	Univ Tokyo, Inst Agr & Life Sci, Bunkyo Ku, Tokyo 1138657, Japan; Univ Tsukuba, Grad Sch Environm Sci, Tsukuba, Ibaraki 3058572, Japan; Gifu Univ, Inst Basin Ecosyst Studies, Gifu 5011193, Japan	Washitani, I (reprint author), Univ Tokyo, Inst Agr & Life Sci, Bunkyo Ku, Tokyo 1138657, Japan.						TERASHIMA I, 1995, PLANT CELL ENVIRON, V18, P1111, DOI 10.1111/j.1365-3040.1995.tb00623.x; Washitani I, 1997, BIOL CONSERV, V82, P67, DOI 10.1016/S0006-3207(97)00014-1; CHAZDON RL, 1986, J ECOL, V74, P995, DOI 10.2307/2260229; GIVNISH TJ, 1988, AUST J PLANT PHYSIOL, V15, P63; PlantyTabacchi AM, 1996, CONSERV BIOL, V10, P598, DOI 10.1046/j.1523-1739.1996.10020598.x; SIMS DA, 1994, PLANT CELL ENVIRON, V17, P881, DOI 10.1111/j.1365-3040.1994.tb00317.x; Holmes PM, 1997, J APPL ECOL, V34, P317, DOI 10.2307/2404879; VITOUSEK PM, 1987, SCIENCE, V238, P802, DOI 10.1126/science.238.4828.802; Pearcy RW, 1987, FUNCT ECOL, V1, P169, DOI 10.2307/2389419; GIFFORD RM, 1981, ANNU REV PLANT PHYS, V32, P485, DOI 10.1146/annurev.pp.32.060181.002413; EVANS JR, 1989, OECOLOGIA, V78, P9, DOI 10.1007/BF00377192; Cronk Q. C. B., 1995, PLANT INVADERS; EVANS GM, 1991, JOINING SCI, V1, P2; FIELD CB, 1981, PLANT PHYSL ECOLOGY; FINN GA, 1980, CROP SCI, V20, P431; Fitter A.H., 1994, EXPLOITATION ENV HET; HEILMEIER H, 1997, PLANT RESOURCE ALLOC; IWAKI HIDEO, 1958, JAPANESE JOUR BOT, V16, P210; MATSUMOTO J, 2000, ANN BOT; MCCREE KJ, 1986, PHOTOSYNTHETICA, V20, P82; Miller DP, 1996, HORTSCIENCE, V31, P944; MIYAWAKI A, 1994, NEW REVISED EDITION; Muraoka H, 1997, OECOLOGIA, V112, P26, DOI 10.1007/s004420050279; Nakatsubo T, 1997, JAPANESE J CONSERVAT, V2, P179; Norman J. M., 1989, PLANT PHYSL ECOLOGY; Osada T., 1993, ILLUSTRATED GRASSES; SCHULZE ED, 1986, AUST J PLANT PHYSIOL, V13, P127; SIMS DA, 1991, OECOLOGIA, V86, P447, DOI 10.1007/BF00317615; SISSON WB, 1989, J ECOL, V77, P799, DOI 10.2307/2260986; Takenaka A, 1996, BIOL CONSERV, V78, P345, DOI 10.1016/S0006-3207(96)00036-5; TANG Y-H, 1988, Ecological Research, V3, P253, DOI 10.1007/BF02348584; Thornley J.H.M, 1976, MATH MODELS PLANT PH; Washitani I, 1993, ALIEN PLANTS ANIMALS; WOODWARD RG, 1976, PHOTOSYNTHETICA, V10, P274	34	17	20	ACADEMIC PRESS LTD	LONDON	24-28 OVAL RD, LONDON NW1 7DX, ENGLAND	0305-7364			ANN BOT-LONDON	Ann. Bot.	OCT	2000	86	4					787	797		10.1006/anbo.2000.1246		11	Plant Sciences	Plant Sciences	359EY	WOS:000089599600011		
J	Inoue, Y; Yoshikawa, K; Yokoyama, I; Ohtomo, K				Inoue, Y; Yoshikawa, K; Yokoyama, I; Ohtomo, K			Estimation of Tc-99m-MAG3 clearance by single-sample methods and camera-based methods	ANNALS OF NUCLEAR MEDICINE			English	Article						Tc-99m-MAG3; renal function; camera-based method; single-sample method	RENAL-FUNCTION; CHILDREN; ADULTS; TECHNETIUM-99M-MAG3; ORTHOIODOHIPPURATE; RENOGRAPHY	We compared single-sample methods, proposed by Russell et al. and Bubeck ct al., and camera-based methods in calculating Tc-99m-MAG3 clearance, and determined camera-based methods that provide estimates comparable to those measured by the Russell method. Twenty-one patients underwent Tc-99m-MAG3 renal scintigraphy, and clearance was measured by the Russell method and Bubeck method. Various renogram parameters were determined based on the slept: of the renogram and area under the renogram, and correlated with the clearance measured by the Russell method. Camera-based clearance was calculated with the obtained regression equations and with equations determined previously using the Bubeck method as a standard. The Bubeck method provided lower measures than the Russell method in high renal function. Clearance measured by die Russell method was well correlated with renogram parameters, and clearance calculated with the obtained regression equation was comparable to that measured by the Russell method. When camera-based clearance was predicted with the previous equation, it was lower than the result obtained by the Russell method in high function. In conclusion, there are systematic differences in Tc-99m-MAG3 clearance calculated by different methods. The camera-based methods obtained in this study appear to facilitate: comparison of results obtained by the Russell method and camera-based method.	Univ Tokyo, Inst Med Sci, Dept Radiol, Minato Ku, Tokyo 1088639, Japan; Univ Tokyo, Dept Internal Med 2, Tokyo, Japan	Inoue, Y (reprint author), Univ Tokyo, Inst Med Sci, Dept Radiol, Minato Ku, 4-6-1 Shirokanedai, Tokyo 1088639, Japan.						HAYCOCK GB, 1978, J PEDIATR-US, V93, P62, DOI 10.1016/S0022-3476(78)80601-5; Blaufox MD, 1996, J NUCL MED, V37, P1883; BUBECK B, 1992, EUR J NUCL MED, V19, P511; Dagli MS, 1997, J NUCL MED, V38, P1285; Inoue Y, 1999, J NUCL MED, V40, P793; Itoh K, 1996, J NUCL MED, V37, P71; ITOH K, 1993, NUCL MED COMMUN, V14, P644, DOI 10.1097/00006231-199308000-00004; Oriuchi N, 1998, CLIN NEPHROL, V50, P289; Russell CD, 1999, J NUCL MED, V40, P1122; Russell CD, 1996, J NUCL MED, V37, P588; Taylor A, 1997, RADIOLOGY, V204, P47; TAYLOR A, 1993, J NUCL MED, V34, P1766; TAYLOR A, 1995, J NUCL MED, V36, P1689	13	1	1	JAPANESE SOCIETY NUCLEAR MEDICINE	TOKYO	C/O JAPAN RADIOISOTOPE ASSOC, 28-45 HON-KOMAGOME 2-CHOME, BUNKYO-KU, TOKYO, 113-0021, JAPAN	0914-7187			ANN NUCL MED	Ann. Nucl. Med.	OCT	2000	14	5					329	332		10.1007/BF02988691		4	Radiology, Nuclear Medicine & Medical Imaging	Radiology, Nuclear Medicine & Medical Imaging	374LC	WOS:000165345800002		
J	Takushima, A; Asato, H; Harii, K				Takushima, A; Asato, H; Harii, K			Endoscopic-assisted harvest of the temporoparietal fascial flap	ANNALS OF PLASTIC SURGERY			English	Article							TOTAL RECONSTRUCTION; EAR RECONSTRUCTION; CARTILAGE GRAFTS; AURICLE	Elevation of the temporoparietal fascial flap by conventional T or Y incisions in the temporal region frequently leaves conspicuous scarring, hair thinning, or baldness. To avoid such undesirable effects, endoscopic-assisted harvest of the temporoparietal fascial flap was performed in 9 patients with microtia. Through two horizontal incisions in the temporal region, the temporoparietal fascia was dissected, and the flap was harvested using bipolar scissors and coagulating shears. Flaps were dissected and harvested successfully without any complications in 7 patients, although extra incisions were required to facilitate coagulation in 2 patients. The authors introduce this harvesting technique and describe some representative cases. Using endoscopic guidance, this is a versatile, safe procedure with minimal morbidity, and is applicable to other reconstructive procedures that require a temporoparietal fascial flap, including the free flap.	Univ Tokyo, Grad Sch Med, Dept Plast & Reconstruct Surg, Bunkyo Ku, Tokyo 113, Japan	Takushima, A (reprint author), Univ Tokyo, Grad Sch Med, Dept Plast & Reconstruct Surg, Bunkyo Ku, 7-3-1 Hongo, Tokyo 113, Japan.						AMARAL JF, 1994, SURG LAPAROSC ENDOSC, V4, P92; NAGATA S, 1994, PLAST RECONSTR SURG, V93, P254, DOI 10.1097/00006534-199402000-00004; UPTON J, 1986, J HAND SURG-AM, V11A, P475; FOX JW, 1976, PLAST RECONSTR SURG, V58, P663, DOI 10.1097/00006534-197612000-00001; BRENT B, 1983, PLAST RECONSTR SURG, V72, P141, DOI 10.1097/00006534-198308000-00003; BRENT B, 1992, PLAST RECONSTR SURG, V90, P355; Byrd H S, 1980, Ann Plast Surg, V4, P191, DOI 10.1097/00000637-198004030-00004; BYRD HS, 1990, ENCY FLAPS, P27; ELLIS DS, 1992, PLAST RECONSTR SURG, V89, P606, DOI 10.1097/00006534-199204000-00003; HIRASE Y, 1994, J HAND SURG-AM, V19A, P864, DOI 10.1016/0363-5023(94)90203-8; Mohammad JA, 1998, ANN PLAS SURG, V41, P600, DOI 10.1097/00000637-199812000-00004; NAGATA S, 1993, PLAST RECONSTR SURG, V92, P187, DOI 10.1097/00006534-199308000-00001; PANJE W R, 1991, Ear Nose and Throat Journal, V70, P311	13	6	6	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	530 WALNUT ST, PHILADELPHIA, PA 19106-3621 USA	0148-7043			ANN PLAS SURG	Ann. Plast. Surg.	OCT	2000	45	4					382	385		10.1097/00000637-200045040-00005		4	Surgery	Surgery	360WY	WOS:000089691400006		
J	Ellingsen, T; Elling, P; Olson, A; Elling, H; Baandrup, U; Matsushima, K; Deleuran, B; Stengaard-Pedersen, K				Ellingsen, T; Elling, P; Olson, A; Elling, H; Baandrup, U; Matsushima, K; Deleuran, B; Stengaard-Pedersen, K			Monocyte chemoattractant protein 1 (MCP-1) in temporal arteritis and polymyalgia rheumatica	ANNALS OF THE RHEUMATIC DISEASES			English	Article							GIANT-CELL ARTERITIS; SMOOTH-MUSCLE CELLS; ENDOTHELIAL-CELLS; DISEASE-ACTIVITY; PERIPHERAL-BLOOD; EXPRESSION; RECEPTORS	Objective-To examine the localisation of monocyte chemoattractant protein 1 (MCP-1) in the inflamed vessel wall in temporal arteritis (TA) and to measure MCP-1 in plasma both in patients with TA and patients with polymyalgia rheumatica (PMR). Methods-By immunohistochemical techniques MCP-1 was localised to the vessel wall in patients with TA. In TA, PMR, and healthy controls MCP-1 was quantified by enzyme linked immunosorbent assay (ELISA) in plasma. Results-MCP-1 was localised to the majority of mononuclear cells, some smooth muscle cells, and giant cells in the arterial biopsy specimens from 12 patients with histologically verified TA. In all sections, including the vasa vasorum, the endothelium stained positive. In the intima 73% (range 57-91%), in the media 49% (range 32-67%), and in the adventitia 74% (range of 62-91%) of all cells stained positive. In plasma MCP-1 was significantly raised in untreated TA (n=33) and untreated PMR (n=27) compared with healthy controls (n=12). Untreated TA plasma levels of MCP-1 (mean 391 pg/ml (range 82-778 pg/ml)) were similar to untreated PMR plasma levels (mean 402 pg/ml (range 29-1153 pg/ml)), and no significant difference was found between the two groups of patients. In both patients with TA and patients with PMR no correlation was found between the plasma level of MCP-1 and the erythrocyte sedimentation rate, haemoglobin concentration, and CD4/ CD8 ratio. Conclusions-These results show that MCP-1 plays a part in the disease processes of TA and PMR.	Aarhus Univ Hosp, Dept Rheumatol, DK-8000 Aarhus C, Denmark; Randers Cty Hosp, Dept Internal Med, Randers, Denmark; Viborg Cty Hosp, Dept Rheumatol, Viborg, Denmark; Arhus Community Hosp, Dept Pathol, Arhus, Denmark; Univ Tokyo, Sch Med, Dept Mol Prevent Med, Tokyo, Japan	Stengaard-Pedersen, K (reprint author), Aarhus Univ Hosp, Dept Rheumatol, DK-8000 Aarhus C, Denmark.						ELLIS ME, 1983, ANN RHEUM DIS, V42, P168, DOI 10.1136/ard.42.2.168; ROLLINS BJ, 1990, AM J PATHOL, V136, P1229; WANG JM, 1991, ARTERIOSCLER THROMB, V11, P1166; NELKEN NA, 1991, J CLIN INVEST, V88, P1121, DOI 10.1172/JCI115411; WEYAND CM, 1994, ANN INTERN MED, V121, P484; Deleuran M, 1996, J DERMATOL SCI, V13, P228, DOI 10.1016/S0923-1811(96)00539-7; SICA A, 1990, J IMMUNOL, V144, P3034; BERLINER JA, 1986, ARTERIOSCLEROSIS, V6, P254; Boiardi L, 1996, BRIT J RHEUMATOL, V35, P642; DASGUPTA B, 1989, ANN RHEUM DIS, V48, P307, DOI 10.1136/ard.48.4.307; ELLING H, 1985, J RHEUMATOL, V12, P306; Elling P, 1996, BRIT J RHEUMATOL, V35, P649; Hashimoto S, 1998, CLIN EXP IMMUNOL, V111, P604; Hayes IM, 1998, ARTERIOSCL THROM VAS, V18, P397; IDA N, 1994, CYTOKINE, V6, P32, DOI 10.1016/1043-4666(94)90005-1; Inadera H, 1999, J INTERF CYTOK RES, V19, P1179, DOI 10.1089/107999099313127; LOWENSTEIN MB, 1983, ARTHRITIS RHEUM, V26, P925, DOI 10.1002/art.1780260717; MALLYA RK, 1985, ARTHRITIS RHEUM, V28, P383, DOI 10.1002/art.1780280405; NORDBORG E, 1992, Current Opinion in Rheumatology, V4, P23; REINECKE RD, 1969, ARCH OPHTHALMOL-CHIC, V82, P446; ROCHE NE, 1993, ARTHRITIS RHEUM, V36, P1286, DOI 10.1002/art.1780360913; SALVARANI C, 1992, J RHEUMATOL, V19, P1100; SALVARANI C, 1994, J RHEUMATOL, V21, P1865; TAKEYA M, 1993, HUM PATHOL, V24, P534, DOI 10.1016/0046-8177(93)90166-E; VALENTE AJ, 1988, BIOCHEMISTRY-US, V27, P4162, DOI 10.1021/bi00411a039; WENZEL UO, 1995, CIRC RES, V77, P503	26	22	24	BRITISH MED JOURNAL PUBL GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0003-4967			ANN RHEUM DIS	Ann. Rheum. Dis.	OCT	2000	59	10					775	780		10.1136/ard.59.10.775		6	Rheumatology	Rheumatology	361JJ	WOS:000089719700004		
J	Ohtsuka, T; Takamoto, S; Nakajima, J; Miyairi, T; Kotsuka, Y				Ohtsuka, T; Takamoto, S; Nakajima, J; Miyairi, T; Kotsuka, Y			Minimally invasive limited pericardiectomy: The hybrid approach	ANNALS OF THORACIC SURGERY			English	Article							RESECTION; DISEASE	This communication describes our clinical experience with the hybrid method, a video-assisted anterior minithoracotomy approach developed for minimally invasive limited pericardiectomy to treat 8 patients with massive pericardial effusion. The average operating time was 37.2 minutes, and there was no procedure-related morbidity or mortality. The mean follow-up period was 5.6 months, and there have been no recurrences. The hybrid approach can be accomplished irrespective of pleural adhesions. It eliminates the need for hemi-pulmonary collapse, making it more advantageous than the totally port-access thoracoscopic approach. (C) 2000 by The Society of Thoracic Surgeons.	Univ Tokyo, Dept Cardiothorac Surg, Bunkyo Ku, Tokyo 1138655, Japan	Ohtsuka, T (reprint author), Univ Tokyo, Dept Cardiothorac Surg, Bunkyo Ku, 7-3-1 Hongo, Tokyo 1138655, Japan.						PIEHLER JM, 1985, J THORAC CARDIOV SUR, V90, P506; CACCAVALE RJ, 1993, THORACOSCOPIC SURG, P177; HAZELRIGG SR, 1993, ANN THORAC SURG, V56, P792; Ohtsuka T, 1998, ANN THORAC SURG, V65, P855, DOI 10.1016/S0003-4975(97)01366-0; SANTOS GH, 1977, ANN THORAC SURG, V23, P467	5	3	3	ELSEVIER SCIENCE INC	NEW YORK	655 AVENUE OF THE AMERICAS, NEW YORK, NY 10010 USA	0003-4975			ANN THORAC SURG	Ann. Thorac. Surg.	OCT	2000	70	4					1429	1430		10.1016/S0003-4975(00)01852-X		2	Cardiac & Cardiovascular Systems; Respiratory System; Surgery	Cardiovascular System & Cardiology; Respiratory System; Surgery	365AE	WOS:000089925600078		
J	Tarasenko, O; Ohashi, J; Kitaev, M; Alisherov, A; Tyurebaeva, B; Kutukeev, T; Tokunaga, K				Tarasenko, O; Ohashi, J; Kitaev, M; Alisherov, A; Tyurebaeva, B; Kutukeev, T; Tokunaga, K			Polymorphisms of HLA-A and -B genes in the Kyrgyz population	ANTHROPOLOGICAL SCIENCE			English	Article						anthropology; HLA-A; HLA-B; HLA haplotype; Kyrgyz	PHYLOGENETIC TREES; HAPLOTYPES; ANTIGENS	Polymorphisms of HLA-A, and -B antigens were investigated in the Kprgyz population living in the northeastern part of Central Asia. Serological typing for HLA-A and -B loci was performed in 157 healthy unrelated blood donors. The frequent HLA-A antigens were A2 (29.2%), A24 (20.6%), and A1 (10.4%). For HLA-B loci, B51 (10.6%), B17 (9.1%), B13 (8.7%), and B35 (8.5%) were predominant. Multidimensional scaling and phylogenetic analysis were performed based on the gene frequencies of HLA-A and -B. In the multidimensional scaling for 24 worldwide populations, Kyrgyz situated itself close to other Central Asian populations. In the phylogenetic tree, Kyrgyz were included in the cluster of Central Asian, while they located close to the European cluster. Four HLA-A-B haplotypes, A2-B blank (5.7%), A2-B13 (4.7%), A24-B51 (3.9%), and A2-B17 (3.7%) were observed at frequencies of more than 3%. These haplotypes, except for A2-B blank have been observed in European and/or Asian populations. The present results well agree with the hypothesis, which has been proposed in morphological studies, that Kyrgyz have been derived from not only Mongoloid but also Caucasoid ancestors.	Univ Tokyo, Grad Sch Med, Dept Human Genet, Bunkyo Ku, Tokyo 1130033, Japan; Kyrgyz Res Inst TB, Dept Immunol, Bishkek, Kyrgyzstan; Blood Bank Kyrgyz Republ, Bishkek, Kyrgyzstan	Tarasenko, O (reprint author), Univ Tokyo, Grad Sch Med, Dept Human Genet, Bunkyo Ku, 7-3-1 Hongo, Tokyo 1130033, Japan.	life_light@hotmail.com	OHASHI, JUN/G-5907-2015				ABRAMZON S, 1971, KYRGYZS THEIR ETHNOG; Alexeev LP, 1992, HLA 1991, V1, P666; ALEXEEV VP, 1961, ARTICLES ANTHR, V71, P107; ALEXEEV VP, 1984, ANTHR ASIAN PART USS; FernandezVina MA, 1997, TISSUE ANTIGENS, V50, P233; Comas D, 1998, AM J HUM GENET, V63, P1824, DOI 10.1086/302133; TERASAKI PI, 1964, NATURE, V204, P998, DOI 10.1038/204998b0; BANNAI M, 1999, IN PRESS TISSUE ANTI; CAVALISFORZA LL, 1994, HIST GEOGRAPHY HUMAN; CHIMGE N, 1996, TISSUE ANTIGENS, V49, P477; Chimge NO, 1999, AM J HUM BIOL, V11, P603, DOI 10.1002/(SICI)1520-6300(199909/10)11:5<603::AID-AJHB4>3.0.CO;2-C; DEBETS G, 1956, T KYRGYZ ARCHAEOLOGI, P3; IBRAIMOV A, 1992, RESPUBLICA      0218, P3; Imanishi T., 1992, HLA 1991, V1, P1065; Imanishi T, 1992, HLA 1991, V1, P76; LIN M, 1997, HLA 1997, P259; MIKLASHEVSKAYA N, 1959, T KYRGYZ ARCHAEOLOGI, V1, P370; NEI M, 1983, J MOL EVOL, V19, P153, DOI 10.1007/BF02300753; NEI M, 1993, MOL BIOL EVOL, V10, P927; OKLADNIKOV A, 1972, ROLE NOMADIC PEOPLE; OTORBAEV K, 1994, KYRGHYZSTAN; Park MH, 1998, TISSUE ANTIGENS, V51, P347; SAITOU N, 1987, MOL BIOL EVOL, V4, P406; SHIMIZU Y, 1999, SILK ROAD CENTRAL AS; TANAKA H, 1997, GENETIC DIVERSITY HL, V1, P285; TOKUNAGA K, 1995, TISSUE ANTIGENS, V45, P98, DOI 10.1111/j.1399-0039.1995.tb02424.x	26	1	1	ANTHROPOLOGICAL SOC NIPPON	TOKYO	C/O GALILEO INC, URBAN-OHTSUKA BLDG, 3RD FL, 3-21-10 KITA-OHTSUKA, TOSHIMA-KU, TOKYO, 170-0004, JAPAN	0918-7960	1348-8570		ANTHROPOL SCI	Anthropol. Sci.	OCT	2000	108	4					293	303				11	Anthropology; Evolutionary Biology	Anthropology; Evolutionary Biology	383JP	WOS:000165879600001		
J	Aoki, K; Tuljapurkar, S				Aoki, K; Tuljapurkar, S			Hanihara's conundrum revisited: Theoretical estimates of the immigration into Japan during the 1,000 year period from 300 BC to AD 700	ANTHROPOLOGICAL SCIENCE			English	Article						growth rate; autoregressive time-series; immigration	POPULATION	Prehistoric Japanese population is believed to have increased from 75,800 in 300 B.C. to 5,399,800 in A.D. 700 - a 70-fold increase in 1,000 years. The rate of natural increase - hereafter called the annual growth rate - likely averaged 0.1% during this period. A closed population growing at this rate would have experienced only a 2.7-fold increase, so that the deficit must have been balanced by immigration, and the question is how much? Hanihara (1987), who assumed constant growth and immigration rates, arrived at an estimate of over 3,000 immigrants per year - an "unacceptably" high level of immigration. In this paper, we modify Hanihara's original model to permit the annual growth rate to vary around the long term average of 0.1%. Specifically, we model the annual growth rate as an autoregressive time-series with normally distributed random shocks. When the autoregressive coefficient, b, and the standard deviation of the random shocks, h, are large, the requisite level of immigration may be substantially reduced. In particular, with b = 0.9 and h = 0.1, 50 immigrants per year may suffice. Time-series data on crude birth and death rates are available from historical-demographic studies. Unfortunately, the parameters b and h estimated from these data may not be large enough for the predicted reductions to occur.	Univ Tokyo, Grad Sch Sci, Div Anthropol, Tokyo, Japan; Mt View Res, Los Altos, CA USA	Aoki, K (reprint author), Univ Tokyo, Dept Sci Biol, Bunkyo Ku, Hongo 7-3-1, Tokyo 1130033, Japan.						Ammerman A. J., 1984, NEOLITHIC TRANSITION; LEE RD, 1987, DEMOGRAPHY, V24, P443, DOI 10.2307/2061385; Keilman N, 2000, EUR J POPUL, V16, P41, DOI 10.1023/A:1006385413134; LEWONTIN RC, 1969, P NATL ACAD SCI USA, V62, P1056, DOI 10.1073/pnas.62.4.1056; Tuljapurkar S, 1997, MATH COMPUT MODEL, V26, P39, DOI 10.1016/S0895-7177(97)00168-4; Aoki K, 1996, THEOR POPUL BIOL, V50, P1, DOI 10.1006/tpbi.1996.0020; BIRDSELL JB, 1957, COLD SPRING HARB SYM, V22, P47; CARNEIRO RL, 1966, AM ANTHROPOL, V68, P179; Davis K., 1951, POPULATION INDIA PAK; Hanihara K, 1991, JAPAN REV, V2, P1; HANIHARA K, 1987, J ANTHROPOL SOC NIP, V95, P391; HASSAN FA, 1973, CURR ANTHROPOL, V14, P535, DOI 10.1086/201380; KOYAMA S, 1984, JOMON AGE; Koyama S, 1978, SENRI ETHNOLOGICAL S, V2, P1; McEvedy C., 1978, ATLAS WORLD POPULATI; NAKABASHI T, 1993, PROTOJAPANESE, P30; TSUYA NO, 1997, EURASIA PROJECT POPU, V16; TSUYA NO, 2000, IN PRESS POPULATION; Tuljapurkar S, 1999, INT J FORECASTING, V15, P259, DOI 10.1016/S0169-2070(98)00082-X; YAMAGUCHI B, 1982, J ANTHROPOL SOC NIP, V90, P77; YAMAGUCHI B, 1987, Bulletin of the National Science Museum Series D (Anthropology), V13, P1; YOSHIZAKI M, 1995, ARCHAEOLOGY Q, V50, P18	22	1	1	ANTHROPOLOGICAL SOC NIPPON	TOKYO	C/O GALILEO INC, URBAN-OHTSUKA BLDG, 3RD FL, 3-21-10 KITA-OHTSUKA, TOSHIMA-KU, TOKYO, 170-0004, JAPAN	0918-7960	1348-8570		ANTHROPOL SCI	Anthropol. Sci.	OCT	2000	108	4					305	319				15	Anthropology; Evolutionary Biology	Anthropology; Evolutionary Biology	383JP	WOS:000165879600002		
J	Tarucha, S; Austing, DG; Sasaki, S; Tokura, Y; van der Wiel, W; Kouwenhoven, LP				Tarucha, S; Austing, DG; Sasaki, S; Tokura, Y; van der Wiel, W; Kouwenhoven, LP			Effects of Coulomb interactions on spin states in vertical semiconductor quantum dots	APPLIED PHYSICS A-MATERIALS SCIENCE & PROCESSING			English	Article							MAXIMUM-DENSITY DROPLET; MAGNETIC-FIELD; ELECTRONIC-PROPERTIES; ADDITION SPECTRUM; ATOMS	The effects of direct Coulomb and exchange interactions on spin states are studied for quantum dots contained in circular and rectangular mesas. For a circular mesa a spin-triplet favored by these interactions is observed at zero and nonzero magnetic fields. We tune and measure the relative strengths of these interactions as a function of the number of confined electrons. We find that electrons tend to have parallel spins when they occupy nearly degenerate single-particle states. We use a magnetic field to adjust the single-particle state degeneracy, and find that the spin-configurations in an arbitrary magnetic field are well explained in terms of two-electron singlet and triplet states. For a rectangular mesa we observe no signatures of the spin-triplet at zero magnetic field. Due to the anisotropy in the lateral confinement single-particle state degeneracy present in the circular mesa is lifted, and Coulomb interactions become weak. We evaluate the degree of the anisotropy by measuring the magnetic field dependence of the energy spectrum for the ground and excited states, and find that at zero magnetic field the spin-singlet is more significantly favored by the lifting of level degeneracy than by the reduction in the Coulomb interaction. We also find that the spin-triplet is recovered by adjusting the level degeneracy with magnetic field.	Univ Tokyo, Dept Phys, Bunkyo Ku, Tokyo 1130033, Japan; Univ Tokyo, ERATO Mesoscop Correlat Project, Bunkyo Ku, Tokyo 1130033, Japan; NTT, Basic Res Labs, Atsugi, Kanagawa 2430198, Japan; Delft Univ Technol, Dept Appl Phys, NL-2600 GA Delft, Netherlands; Delft Univ Technol, ERATO Mesoscop Correlat Project, NL-2600 GA Delft, Netherlands	Tarucha, S (reprint author), Univ Tokyo, Dept Phys, Bunkyo Ku, 7-3-1 Hongo, Tokyo 1130033, Japan.		Tokura, Yasuhiro/A-5550-2011; TARUCHA, SEIGO/I-7030-2012; van der Wiel, Wilfred/F-8812-2014	van der Wiel, Wilfred/0000-0002-3479-8853			Altshuler B. L., 1991, MESOSCOPIC PHENOMENA; MCEUEN PL, 1992, PHYS REV B, V45, P11419, DOI 10.1103/PhysRevB.45.11419; Hawrylak P, 1999, PHYS REV B, V59, P2801, DOI 10.1103/PhysRevB.59.2801; Tarucha S, 1996, PHYS REV LETT, V77, P3613, DOI 10.1103/PhysRevLett.77.3613; Eto M, 1997, JPN J APPL PHYS 1, V36, P3924, DOI 10.1143/JJAP.36.3924; Meirav U, 1996, SEMICOND SCI TECH, V11, P255, DOI 10.1088/0268-1242/11/3/003; MADHAV AV, 1994, PHYS REV B, V49, P8163, DOI 10.1103/PhysRevB.49.8163; Kouwenhoven LP, 1997, SCIENCE, V278, P1788, DOI 10.1126/science.278.5344.1788; Austing DG, 1999, PHYS REV B, V60, P11514, DOI 10.1103/PhysRevB.60.11514; ASHOORI RC, 1993, PHYS REV LETT, V71, P613, DOI 10.1103/PhysRevLett.71.613; AUSING DG, 1999, JPN J APPL PHYS, V38, P372; AUSTING DG, 1995, SEMICOND SCI TECHNO, V11, P1995; Ezaki T, 1998, SEMICOND SCI TECH, V13, pA1, DOI 10.1088/0268-1242/13/8A/002; Fock V, 1928, Z PHYS, V47, P446, DOI 10.1007/BF01390750; KOSKINEN M, 1997, PHYS REV LETT, V79, P1817; Lee IH, 1998, PHYS REV B, V57, P9035, DOI 10.1103/PhysRevB.57.9035; MACDONALD AH, 1993, AUST J PHYS, V46, P345; MCEUEN PL, 1993, PHYSICA B, V189, P70, DOI 10.1016/0921-4526(93)90147-X; Natori A, 1997, JPN J APPL PHYS 1, V36, P3960, DOI 10.1143/JJAP.36.3960; Oosterkamp TH, 1999, PHYS REV LETT, V82, P2931, DOI 10.1103/PhysRevLett.82.2931; REED MA, 1993, SCI AM, V268, P118; Reimann SM, 1999, PHYS REV B, V59, P1613, DOI 10.1103/PhysRevB.59.1613; Reimann SM, 1999, EUR PHYS J D, V9, P105, DOI 10.1007/s100530050407; Rontani M, 1999, PHYS REV B, V59, P10165, DOI 10.1103/PhysRevB.59.10165; Sasaki S, 1998, PHYSICA B, V256, P157, DOI 10.1016/S0921-4526(98)00486-4; SOHN LL, 1997, P NATO ADV STUD I E, V345, P105; Steffens O, 1998, EUROPHYS LETT, V42, P529, DOI 10.1209/epl/i1998-00276-4; Stewart DR, 1997, SCIENCE, V278, P1784, DOI 10.1126/science.278.5344.1784; SU B, 1992, PHYS REV B, V46, P7644, DOI 10.1103/PhysRevB.46.7644; Tamura H, 1998, PHYSICA B, V249, P210, DOI 10.1016/S0921-4526(98)00100-8; TARUCHA S, 1992, P INT WORKSH SCI TEC, P243; Tarucha S, 1998, PHYSICA E, V3, P112, DOI 10.1016/S1386-9477(98)00225-2; Tarucha S, 1997, JPN J APPL PHYS 1, V36, P3917, DOI 10.1143/JJAP.36.3917; WAGNER M, 1992, PHYS REV B, V45, P1951, DOI 10.1103/PhysRevB.45.1951; Wojs A, 1996, PHYS REV B, V53, P10841, DOI 10.1103/PhysRevB.53.10841	35	23	23	SPRINGER-VERLAG	NEW YORK	175 FIFTH AVE, NEW YORK, NY 10010 USA	0947-8396			APPL PHYS A-MATER	Appl. Phys. A-Mater. Sci. Process.	OCT	2000	71	4					367	378		10.1007/s003390000550		12	Materials Science, Multidisciplinary; Physics, Applied	Materials Science; Physics	359GA	WOS:000089602100002		
J	Minh, TB; Nakata, H; Watanabe, M; Tanabe, S; Miyazaki, N; Jefferson, TA; Prudente, M; Subramanian, A				Minh, TB; Nakata, H; Watanabe, M; Tanabe, S; Miyazaki, N; Jefferson, TA; Prudente, M; Subramanian, A			Isomer-specific accumulation and toxic assessment of polychlorinated biphenyls, including coplanar congeners, in cetaceans from the North Pacific and Asian coastal waters	ARCHIVES OF ENVIRONMENTAL CONTAMINATION AND TOXICOLOGY			English	Article							PERSISTENT ORGANOCHLORINE CONTAMINANTS; WHALES DELPHINAPTERUS-LEUCAS; MUSSELS PERNA-VIRIDIS; HONG-KONG; AQUATIC ECOSYSTEMS; RISK ASSESSMENT; MARINE MAMMALS; PCBS; SEA; DOLPHINS	To elucidate the global distribution and toxicological impacts of polychlorinated biphenyls (PCBs) on cetaceans, the present study determined the concentrations of individual PCB congeners, including toxic non-ortho (IU PAC Nos. 77, 126, 169) and mono-ortho (IUPAC Nos. 105, 118, 156) coplanar congeners, in the blubber of 10 species of adult male odontocetes collected from several locations in the North Pacific Ocean and along coastal waters of Japan, Hong Kong, the Philippines, and India during 1985-1997. Total PCB concentrations in cetaceans from temperate and cold waters were higher than those in cetaceans from tropical regions. Residue levels were found to be the highest in Fraser's dolphins collected off Kii Peninsula, Japan, and hump-backed dolphins from Hong Kong, reflecting Serious marine pollution by PCBs in industrialized Asian countries. Penta- and hexa-chlorobiphenyls were the predominant PCB congeners, accounting for about 70% of the total PCBs. 2,3,7,8-Tetrachlorodibenzo-p-dioxin equivalents (TEQs) of non- and mono-ortho coplanar PCBs in the blubber of cetaceans ranged from 36 (in spinner dolphins from the Philippines) to 510 pg/g wet weight (in hump-backed dolphins from Hong Kong). Toxic evaluation of coplanar PCBs using the TEQ concept indicates an greater impact on cetaceans from mid-latitudes. Toxicity contribution of mono-ortho congener IUPAC 118 was prominent in species from high latitude oceans, such as the Bering Sea and the North Pacific, whereas non-ortho congener IUPAC 126 accounted for the highest contribution in cetaceans from lower latitude regions, such as the Philippines and India. The estimated TEQ concentrations in the blubber of some cetacean species, such as northern right whale dolphin and Pacific white-sided dolphin from the northern North Pacific, Dall's porpoise from the Japan Sea, striped dolphin off Sanriku and Fraser's dolphin off Kii Peninsula, Japan, hump-backed dolphin and finless porpoise from Hong Kong, exceeded the levels associated with immunosuppression in harbour seals.	Ehime Univ, Ctr Marine Environm Studies, Matsuyama, Ehime 7908566, Japan; Kumamoto Univ, Grad Sch Nat Sci & Technol, Dept Environm Sci, Kumamoto 8608555, Japan; Univ Tokyo, Ocean Res Inst, Otsuchi Marine Res Ctr, Otsuchi, Iwate 0281102, Japan; Natl Marine Fisheries Serv, SW Fisheries Sci Ctr, NOAA, La Jolla, CA 92038 USA; Ocean Pk Conservat Fdn, Aberdeen, Hong Kong, Peoples R China; De La Salle Univ, Sci Educ Dept, Manila 1004, Philippines; Annamalai Univ, Ctr Adv Study Marine Biol, Parangipettai 608502, India	Tanabe, S (reprint author), Ehime Univ, Ctr Marine Environm Studies, Tarumi 3-5-7, Matsuyama, Ehime 7908566, Japan.		Tanabe, Shinsuke/G-6950-2013; 	Miyazaki, Nobuyuki/0000-0001-8094-683X			AGUILAR A, 1994, SCI TOTAL ENVIRON, V154, P237, DOI 10.1016/0048-9697(94)90091-4; Giesy JP, 1998, CRIT REV TOXICOL, V28, P511, DOI 10.1080/10408449891344263; IWATA H, 1994, ENVIRON POLLUT, V85, P15, DOI 10.1016/0269-7491(94)90234-8; TANABE S, 1987, ENVIRON POLLUT, V47, P41, DOI 10.1016/0269-7491(87)90120-5; CORSOLINI S, 1995, MAR ENVIRON RES, V40, P33, DOI 10.1016/0141-1136(94)00003-8; ROSS PS, 1995, ENVIRON HEALTH PERSP, V103, P162, DOI 10.2307/3432272; SAFE SH, 1994, CRIT REV TOXICOL, V24, P87, DOI 10.3109/10408449409049308; DUNNIVANT FM, 1992, ENVIRON SCI TECHNOL, V26, P1567, DOI 10.1021/es00032a012; Kannan K, 1998, ENVIRON SCI TECHNOL, V32, P1169, DOI 10.1021/es970914u; IWATA H, 1993, ENVIRON SCI TECHNOL, V27, P1080, DOI 10.1021/es00043a007; Van den Berg M, 1998, ENVIRON HEALTH PERSP, V106, P775, DOI 10.1289/ehp.98106775; TANABE S, 1988, MAR MAMMAL SCI, V4, P103, DOI 10.1111/j.1748-7692.1988.tb00191.x; Boon JP, 1997, ARCH ENVIRON CON TOX, V33, P298, DOI 10.1007/s002449900257; Aono S, 1997, ENVIRON POLLUT, V98, P81, DOI 10.1016/S0269-7491(97)00105-X; CARVADINE M, 1995, WHALES DOLPHINS PROP; Colborn T, 1996, REV ENVIRON CONTAM T, V146, P91; De Guise S, 1998, J TOXICOL ENV HEAL A, V55, P479, DOI 10.1080/009841098158287; FALANDYSZ J, 1994, ARCH ENVIRON CON TOX, V26, P267; Watanabe M, 2000, ENVIRON TOXICOL CHEM, V19, P1566, DOI 10.1897/1551-5028(2000)019<1566:PBOPTC>2.3.CO;2; HEIDEJORGENSEN MP, 1992, DIS AQUAT ORGAN, V13, P37, DOI 10.3354/dao013037; Jarman WM, 1996, MAR POLLUT BULL, V32, P426, DOI 10.1016/0025-326X(96)83973-7; Kannan K, 1997, ENVIRON SCI TECHNOL, V31, P296, DOI 10.1021/es960657d; KANNAN K, 1993, ARCH ENVIRON CON TOX, V25, P227; KANNAN N, 1989, ENVIRON POLLUT, V62, P223, DOI 10.1016/0269-7491(89)90189-9; KANNAN N, 1989, ARCH ENVIRON CON TOX, V18, P850; KANNAN N, 1989, ENVIRON POLLUT, V56, P65, DOI 10.1016/0269-7491(89)90122-X; LONGANATHAN BG, 1990, MAR POLLUT B, V21, P435; MARTINEAU D, 1987, ARCH ENVIRON CON TOX, V16, P137; Minh TB, 1999, MAR POLLUT BULL, V39, P383, DOI 10.1016/S0025-326X(99)00066-1; Muir DCG, 1996, ENVIRON POLLUT, V93, P219, DOI 10.1016/0269-7491(96)00006-1; Nakata H, 1998, ENVIRON TOXICOL CHEM, V17, P1745, DOI 10.1897/1551-5028(1998)017<1745:POCIRS>2.3.CO;2; Nakata H, 1997, ENVIRON POLLUT, V95, P57, DOI 10.1016/S0269-7491(96)00092-9; STORRHANSEN E, 1993, ARCH ENVIRON CON TOX, V25, P328; SWART RD, 1994, AMBIO, V23, P155; TANABE S, 1987, INT J ENVIRON AN CH, V29, P199, DOI 10.1080/03067318708079836; TANABE S, 1988, ENVIRON POLLUT, V50, P5, DOI 10.1016/0269-7491(88)90183-2; TANABE S, 1994, SCI TOTAL ENVIRON, V154, P163, DOI 10.1016/0048-9697(94)90086-8; Tanabe Shinsuke, 1992, P161; Tanabe S, 1997, MAR POLLUT BULL, V34, P712, DOI 10.1016/S0025-326X(97)00015-5; Tillitt DE, 1996, ENVIRON SCI TECHNOL, V30, P283, DOI 10.1021/es9503140; WAGEMANN R, 1984, 1279 DEP FISH OC FIS; Wakimoto T., 1971, J ENV POLLUT CONTROL, V7, P511; WATANABE S, 1989, MAR ENVIRON RES, V27, P51, DOI 10.1016/0141-1136(89)90018-4; YAMASHITA N, 1993, ENVIRON POLLUT, V79, P163, DOI 10.1016/0269-7491(93)90066-W	44	42	52	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	0090-4341			ARCH ENVIRON CON TOX	Arch. Environ. Contam. Toxicol.	OCT	2000	39	3					398	410				13	Environmental Sciences; Toxicology	Environmental Sciences & Ecology; Toxicology	352QA	WOS:000089228300017		
J	Toshima, S; Hasegawa, A; Kurabayashi, M; Itabe, H; Takano, T; Sugano, J; Shimamura, K; Kimura, J; Michishita, I; Suzuki, T; Nagai, R				Toshima, S; Hasegawa, A; Kurabayashi, M; Itabe, H; Takano, T; Sugano, J; Shimamura, K; Kimura, J; Michishita, I; Suzuki, T; Nagai, R			Circulating oxidized low density lipoprotein levels - A biochemical risk marker for coronary heart disease	ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY			English	Article						oxidized low density lipoprotein; coronary heart disease; risk factors	ATHEROSCLEROTIC LESIONS; MONOCLONAL-ANTIBODY; ENDOTHELIAL-CELLS; ATHEROGENESIS; CHOLESTEROL; PHOSPHATIDYLCHOLINES; PEROXIDATION; MACROPHAGES; EXPRESSION; INCREASE	Recent studies have established oxidative modification of low density lipoprotein (LDL) as an important atherogenic factor. We examined the clinical relevance of circulating oxidized LDL (OxLDL) levels in atherosclerotic disease by an enzyme immunoassay with use of specific antibodies against OxLDL (FOH1a/DLH3) and apolipoprotein B, Plasma OxLDL levels were significantly higher in patients with coronary heart disease (n=65) than in control subjects (n=181; 201.3+/-11.2 versus 112.4+/-3.3 U/dL, respectively; P<0.01). OxLDL levels were not associated with age, sex, total cholesterol, or apolipoprotein B levels in normal control subjects. Our results suggest that circulating OxLDL may be a possible biochemical risk marker for coronary heart disease.	Univ Tokyo, Grad Sch Med, Dept Cardiovasc Med, Bunkyo Ku, Tokyo 1138655, Japan; Gunma Univ, Sch Med, Dept Internal Med 2, Gunma, Japan; Saiseikai Maebashi Hosp, Dept Internal Med, Gunma, Japan; Gunma Chuoh Gen Hosp, Dept Internal Med, Gunma, Japan; Teikyo Univ, Fac Pharmaceut Sci, Dept Microbiol & Mol Pathol, Sagamiko, Kanagawa 19901, Japan; Vessel Res Lab Co Ltd, Kanagawa, Japan; Yokohama Sakae Kyosai Hosp, Dept Internal Med, Kanagawa, Japan	Nagai, R (reprint author), Univ Tokyo, Grad Sch Med, Dept Cardiovasc Med, Bunkyo Ku, 7-3-1 Hongo, Tokyo 1138655, Japan.						Palinski W, 1996, J CLIN INVEST, V98, P800, DOI 10.1172/JCI118853; Itabe H, 1996, J BIOL CHEM, V271, P33208; MCMURRAY HF, 1993, J CLIN INVEST, V92, P1004, DOI 10.1172/JCI116605; GOLDSTEIN JL, 1979, P NATL ACAD SCI USA, V76, P333, DOI 10.1073/pnas.76.1.333; BERLINER JA, 1995, CIRCULATION, V91, P2488; CHISOLM GM, 1994, P NATL ACAD SCI USA, V91, P11452, DOI 10.1073/pnas.91.24.11452; CUSHING SD, 1990, P NATL ACAD SCI USA, V87, P5134, DOI 10.1073/pnas.87.13.5134; RAJAVASHISTH TB, 1990, NATURE, V344, P254, DOI 10.1038/344254a0; HAMILTON TA, 1990, J IMMUNOL, V144, P2343; Itabe H, 1996, J LIPID RES, V37, P45; Steinberg D, 1997, CIRCULATION, V95, P1062; YLAHERTTUALA S, 1989, J CLIN INVEST, V84, P1086, DOI 10.1172/JCI114271; BERLINER JA, 1990, J CLIN INVEST, V85, P1260, DOI 10.1172/JCI114562; Holvoet P, 1996, THROMB HAEMOSTASIS, V76, P663; MORROW JD, 1995, NEW ENGL J MED, V332, P1198, DOI 10.1056/NEJM199505043321804; ROSS R, 1993, NATURE, V362, P801, DOI 10.1038/362801a0; Holvoet P, 1998, CIRCULATION, V98, P1487; Bui MN, 1996, AM HEART J, V131, P663, DOI 10.1016/S0002-8703(96)90268-9; Deckert V, 1997, CIRCULATION, V95, P723; HOLVOET P, 1995, J CLIN INVEST, V95, P2611, DOI 10.1172/JCI117963; ITABE H, 1994, J BIOL CHEM, V269, P15274; KUGIYAMA K, 1993, CIRC RES, V73, P335; MOREL DW, 1983, J LIPID RES, V24, P1070; OU ZL, 1995, ANAL BIOCHEM, V227, P289, DOI 10.1006/abio.1995.1283; PENN MS, 1994, ATHEROSCLEROSIS, V108, pS21, DOI 10.1016/0021-9150(94)90150-3; PUURUNEN M, 1994, ARCH INTERN MED, V154, P2605, DOI 10.1001/archinte.154.22.2605; Shoji T, 2000, ATHEROSCLEROSIS, V148, P171, DOI 10.1016/S0021-9150(99)00218-X; STEINBERG D, 1989, NEW ENGL J MED, V320, P915; WITZTUM JL, 1993, BRIT HEART J, V69, pS12; WITZTUM JL, 1991, J CLIN INVEST, V88, P1785, DOI 10.1172/JCI115499; Ziouzenkova O, 1999, J BIOL CHEM, V274, P18916, DOI 10.1074/jbc.274.27.18916	31	232	253	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	530 WALNUT ST, PHILADELPHIA, PA 19106-3621 USA	1079-5642			ARTERIOSCL THROM VAS	Arterioscler. Thromb. Vasc. Biol.	OCT	2000	20	10					2243	2247				5	Hematology; Peripheral Vascular Disease	Hematology; Cardiovascular System & Cardiology	368GY	WOS:000090110400014		
J	Ihn, H; Tamaki, K				Ihn, H; Tamaki, K			Increased phosphorylation of transcription factor Sp1 in scleroderma fibroblasts - Association with increased expression of the type I collagen gene	ARTHRITIS AND RHEUMATISM			English	Article							GROWTH-FACTOR-BETA; PROGRESSIVE SYSTEMIC-SCLEROSIS; ALPHA-1(I) PROCOLLAGEN GENE; NORMAL DERMAL FIBROBLASTS; SKIN FIBROBLASTS; MESSENGER-RNA; TGF-BETA; BINDING; CELLS; ACTIVATION	Objective. To determine the potential roles of transcription factors Sp1 and Sp3 in the increased expression of the human alpha 2(I) collagen gene in scleroderma fibroblasts. Methods, Dermal fibroblasts from 7 patients with diffuse systemic sclerosis (SSc; scleroderma) of recent onset and from 7 healthy individuals were studied, The levels of expression of alpha 2(I) procollagen, Sp1, and Sp3 messenger RNA (mRNA), with or without stimulation by transforming growth factor beta (TGF beta) or oncostatin M (OSM), were evaluated by Northern blot analysis, and the respective protein levels were determined by immunoblotting. The DNA binding activity of nuclear proteins recognizing the cis-acting elements in the human alpha 2(I) collagen promoter was examined by gel mobility shift assays. The levels of Sp1 phosphorylation were investigated by immunoprecipitation using an antiphosphoserine-specific antibody. Results. SSc fibroblasts showed basal alpha 2(I) collagen mRNA levels that were similar to 3 times higher than those in normal fibroblasts, TGF beta or OSM increased human alpha 2(I) collagen mRNA expression in normal dermal fibroblasts, but these cytokines failed to increase alpha 2(I) collagen mRNA levels in SSc fibroblasts. There were no significant differences in the levels of expression of Sp1 or Sp3 between SSc and normal fibroblasts. However, increased Sp1 phosphorylation was detected in SSc fibroblasts compared with normal fibroblasts, Mithramycin, a specific inhibitor of Spl binding, abolished the increased expression of the alpha 2(I) collagen gene in SSc fibroblasts, in a dose-dependent manner. Conclusion. These results demonstrate the involvement of Sp1 in the up-regulation of expression of the alpha 2(I) collagen gene in SSc fibroblasts.	Univ Tokyo, Fac Med, Dept Dermatol, Bunkyo Ku, Tokyo 113, Japan	Ihn, H (reprint author), Univ Tokyo, Fac Med, Dept Dermatol, Bunkyo Ku, 7-3-1 Hongo, Tokyo 113, Japan.						ABRAHAM D, 1991, ARTHRITIS RHEUM, V34, P1164, DOI 10.1002/art.1780340913; Alevizopoulos A, 1995, GENE DEV, V9, P3051, DOI 10.1101/gad.9.24.3051; Alevizopoulos A, 1996, J BIOL CHEM, V271, P29672; Ihn H, 1996, J BIOL CHEM, V271, P26717; YAMAKAGE A, 1992, J EXP MED, V175, P1227, DOI 10.1084/jem.175.5.1227; Chung KY, 1996, J BIOL CHEM, V271, P3272; BLUME SW, 1991, J CLIN INVEST, V88, P1613, DOI 10.1172/JCI115474; KIRK TZ, 1995, J BIOL CHEM, V270, P3423; VUORIO E, 1990, ANNU REV BIOCHEM, V59, P837, DOI 10.1146/annurev.biochem.59.1.837; PELTONEN J, 1990, ARTHRITIS RHEUM, V33, P1829, DOI 10.1002/art.1780331211; KIKUCHI K, 1992, BIOCHEM BIOPH RES CO, V187, P45, DOI 10.1016/S0006-291X(05)81456-1; HAGEN G, 1994, EMBO J, V13, P3843; LEROY EC, 1974, J CLIN INVEST, V54, P880, DOI 10.1172/JCI107827; Ihn H, 1997, BRIT J RHEUMATOL, V36, P1270; ANDREWS NC, 1991, NUCLEIC ACIDS RES, V19, P2499, DOI 10.1093/nar/19.9.2499; Black AR, 1999, J BIOL CHEM, V274, P1207, DOI 10.1074/jbc.274.3.1207; BOAST S, 1990, J BIOL CHEM, V265, P13351; Collins M, 1997, BIOCHEM J, V322, P199; DAngelo DD, 1996, J BIOL CHEM, V271, P19696; DUNCAN MR, 1995, J INVEST DERMATOL, V104, P128, DOI 10.1111/1523-1747.ep12613623; FALANGA V, 1987, J INVEST DERMATOL, V89, P100, DOI 10.1111/1523-1747.ep12580445; GAY RE, 1980, ARTHRITIS RHEUM, V23, P190, DOI 10.1002/art.1780230209; Hitraya EG, 1998, ARTHRITIS RHEUM, V41, P2048, DOI 10.1002/1529-0131(199811)41:11<2048::AID-ART21>3.0.CO;2-X; Hitraya EG, 1996, ARTHRITIS RHEUM, V39, P1347, DOI 10.1002/art.1780390812; Ihn H, 1997, NUCLEIC ACIDS RES, V25, P3712, DOI 10.1093/nar/25.18.3712; Ihn H, 1997, J BIOL CHEM, V272, P24666, DOI 10.1074/jbc.272.39.24666; INAGAKI Y, 1994, J BIOL CHEM, V269, P14828; Jelaska A, 1996, ARTHRITIS RHEUM, V39, P1338, DOI 10.1002/art.1780390811; KAHARI VM, 1987, FEBS LETT, V215, P331, DOI 10.1016/0014-5793(87)80172-2; KORN J H, 1991, Current Opinion in Rheumatology, V3, P947, DOI 10.1097/00002281-199112000-00009; KUBO T, 1995, CANCER RES, V55, P3860; KULOZIK M, 1990, J CLIN INVEST, V86, P917, DOI 10.1172/JCI114793; LeRoy EC, 1992, CECIL TXB MED, P1530; LEROY EC, 1992, ANN RHEUM DIS, V51, P286, DOI 10.1136/ard.51.2.286; LUDNICKA L, 1994, J CLIN INVEST, V93, P1709; MERCHANT JL, 1995, J BIOL CHEM, V270, P6314; RAMIREZ F, 1990, FASEB J, V4, P1616; RIPPE RA, 1995, HEPATOLOGY, V22, P241, DOI 10.1016/0270-9139(95)90378-X; TAMAKI T, 1995, J BIOL CHEM, V270, P4299; VENEPALLY P, 1995, J BIOL CHEM, V270, P25402; XU WD, 1991, J RHEUMATOL, V18, P241	41	40	41	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	530 WALNUT ST, PHILADELPHIA, PA 19106-3621 USA	0004-3591			ARTHRITIS RHEUM	Arthritis Rheum.	OCT	2000	43	10					2240	2247		10.1002/1529-0131(200010)43:10<2240::AID-ANR11>3.0.CO;2-2		8	Rheumatology	Rheumatology	362BC	WOS:000089757900011		
J	Inaba, H; Miyaji, K; Kaneko, Y; Ohtsuka, T; Ezure, M; Tambara, K; Takamoto, S; Omata, S				Inaba, H; Miyaji, K; Kaneko, Y; Ohtsuka, T; Ezure, M; Tambara, K; Takamoto, S; Omata, S			Use of tactile stiffness to detect fatigue in the latissimus dorsi muscle	ARTIFICIAL ORGANS			English	Article						tactile sensor; latissimus dorsi muscle; cardiomyoplasty; preconditioning; fatigue resistance; relationship between tension and stiffness	SKELETAL-MUSCLE; DYNAMIC CARDIOMYOPLASTY; SENSOR; PARAMETERS	In clinical settings, no method has been established to examine the fatigue of a latissimus dorsi muscle (LDM) preconditioned for cardiomyoplasty. We examined the feasibility of measuring muscle stiffness (tactile stiffness) to evaluate muscle fatigue in situ using our tactile sensor. We stimulated canine LDM with burst pacing and monitored both stiffness and tension to determine their relationship. In both dissected LDM and LDM in situ, the decrements of these parameters during burst pacing were compared between preconditioned and unconditioned LDM. In measurement in situ, the sensor probe was placed on the LDM through a small incision. Strong statistical correlation was shown between stiffness and tension (r = 0.935). In decrements of stiffness in situ, there were statistically significant differences between preconditioned and unconditioned LDM. Our tactile sensor system can provide an efficient method for evaluating fatigue of muscles in situ without measuring muscle tension.	Univ Tokyo, Fac Med, Dept Cardiothorac Surg, Tokyo 113, Japan; Nihon Univ, Coll Engn, Fukushima, Japan	Inaba, H (reprint author), 23 Allee Toison Dor, F-94000 Creteil, France.						ACKER MA, 1987, SCIENCE, V236, P324, DOI 10.1126/science.2951849; Valencic V, 1997, ARTIF ORGANS, V21, P240; HIGUCHI H, 1995, BIOPHYS J, V69, P1000; SALMONS S, 1992, BRIT HEART J, V68, P333; CAPADAY C, 1995, EXP BRAIN RES, V104, P287; CARPENTIER A, 1993, J THORAC CARDIOV SUR, V106, P42; CARPENTIER A, 1991, BAKKEN RES, V3, P105; CHACHQUES JC, 1991, BAKKEN RES, V3, P77; Constantinou CE, 1996, NEUROUROL URODYNAM, V15, P85, DOI 10.1002/(SICI)1520-6777(1996)15:1<85::AID-NAU9>3.0.CO;2-B; GRANDJEAN PA, 1991, BAKKEN RES, V3, P39; Guldner NW, 1997, J THORAC CARDIOV SUR, V114, P1097, DOI 10.1016/S0022-5223(97)70025-4; Hara K., 1996, 14 SENS S, P101; Kaga N, 1996, AM J OBSTET GYNECOL, V175, P713; Kaneko S, 1996, Int J Urol, V3, P379, DOI 10.1111/j.1442-2042.1996.tb00557.x; KANEKO Y, 1998, HEART REPLACEMENT AR, V6, P257; Kaneko Y, 1997, ANN THORAC SURG, V63, P477; KRAFT T, 1995, BIOPHYS J, V68, P2404; Miyaji K, 1998, J AM COLL CARDIOL, V31, P1165, DOI 10.1016/S0735-1097(98)00063-1; Miyaji K, 1997, CANCER, V80, P1920, DOI 10.1002/(SICI)1097-0142(19971115)80:10<1920::AID-CNCR8>3.0.CO;2-R; Mizrahi J, 1997, ARTIF ORGANS, V21, P236; OHTSUKA T, 1995, ANN THORAC SURG, V60, P610, DOI 10.1016/0003-4975(95)00483-2; OMATA S, 1992, SENSOR ACTUAT A-PHYS, V35, P9, DOI 10.1016/0924-4247(92)87002-X; SALMONS S, 1976, NATURE, V263, P30, DOI 10.1038/263030a0; Tang ATM, 1999, ANN THORAC SURG, V68, P46, DOI 10.1016/S0003-4975(99)00313-6	24	3	3	WILEY-BLACKWELL	MALDEN	COMMERCE PLACE, 350 MAIN ST, MALDEN 02148, MA USA	0160-564X			ARTIF ORGANS	Artif. Organs	OCT	2000	24	10					808	815		10.1046/j.1525-1594.2000.06551.x		8	Engineering, Biomedical; Transplantation	Engineering; Transplantation	371CG	WOS:000165159800007		
J	Zheng, W; Tsvetanov, ZI; Schneider, DP; Fan, XH; Becker, RH; Davis, M; White, RL; Strauss, MA; Anderson, JE; Annis, J; Bahcall, NA; Connolly, AJ; Csabai, I; Davidsen, AF; Fukugita, M; Gunn, JE; Heckman, TM; Hennessy, GS; Ivezic, Z; Knapp, GR; Lupton, RH; Peng, E; Szalay, AS; Thakar, AR; Yanny, B; York, DG				Zheng, W; Tsvetanov, ZI; Schneider, DP; Fan, XH; Becker, RH; Davis, M; White, RL; Strauss, MA; Anderson, JE; Annis, J; Bahcall, NA; Connolly, AJ; Csabai, I; Davidsen, AF; Fukugita, M; Gunn, JE; Heckman, TM; Hennessy, GS; Ivezic, Z; Knapp, GR; Lupton, RH; Peng, E; Szalay, AS; Thakar, AR; Yanny, B; York, DG			Five high-redshift quasars discovered in commissioning imaging data of the Sloan Digital Sky Survey	ASTRONOMICAL JOURNAL			English	Article						quasars : general; surveys	FIELD MULTICOLOR SURVEY; LUMINOSITY FUNCTION; GALAXY; SPECTROPHOTOMETRY; SPECTRUM; EMISSION; SYSTEM	We report the discovery of five quasars with redshifts of 4.67-5.27 and z'-band magnitudes of 19.5-20.7 (M(B) similar to -27). All were originally selected as distant quasar candidates in optical/near-infrared photometry from the Sloan Digital Sky Survey (SDSS), and most were confirmed as probable high-redshift quasars by supplementing the SDSS data with J and K measurements. The quasars possess strong, broad Ly alpha emission lines, with the characteristic sharp cutoff on the blue side produced by Ly alpha forest absorption. Three quasars contain strong, broad absorption features, and one of them exhibits very strong N v emission. The amount of absorption produced by the Lya forest increases toward higher redshift, and that in the z = 5.27 object (D(A) approximate to 0.7) is consistent with a smooth extrapolation of the absorption seen in lower redshift quasars. The high luminosity of these objects relative to most other known objects at z greater than or similar to 5 makes them potentially valuable as probes of early quasar properties and of the intervening intergalactic medium.	Johns Hopkins Univ, Dept Phys & Astron, Baltimore, MD 21218 USA; Penn State Univ, Dept Astron & Astrophys, University Pk, PA 16802 USA; Princeton Univ Observ, Princeton, NJ 08544 USA; Univ Calif Davis, Dept Phys, Davis, CA 95616 USA; Univ Calif Berkeley, Dept Astron, Berkeley, CA 94720 USA; Space Telescope Sci Inst, Baltimore, MD 21218 USA; Fermilab Natl Accelerator Lab, Batavia, IL 60510 USA; Univ Pittsburgh, Dept Phys & Astron, Pittsburgh, PA 15260 USA; Eotvos Lorand Univ, Dept Phys Complex Syst, H-1117 Budapest, Hungary; Univ Tokyo, Inst Cosm Ray Res, Tanashi, Tokyo 1888502, Japan; Inst Adv Study, Princeton, NJ 08540 USA; USN Observ, Washington, DC 20392 USA; Univ Chicago, Ctr Astron & Astrophys, Chicago, IL 60637 USA	Zheng, W (reprint author), Johns Hopkins Univ, Dept Phys & Astron, Baltimore, MD 21218 USA.		Csabai, Istvan/F-2455-2012; 	Csabai, Istvan/0000-0001-9232-9898			Hu EM, 1998, ASTROPHYS J, V502, pL99, DOI 10.1086/311506; Zheng W, 1997, ASTROPHYS J, V475, P469, DOI 10.1086/303560; Lupton RH, 1999, ASTRON J, V118, P1406, DOI 10.1086/301004; FRANCIS PJ, 1991, ASTROPHYS J, V373, P465, DOI 10.1086/170066; Ramsey LW, 1998, P SOC PHOTO-OPT INS, V3352, P34, DOI 10.1117/12.319287; Fukugita M, 1996, ASTRON J, V111, P1748, DOI 10.1086/117915; SCHMIDT M, 1995, ASTRON J, V110, P68, DOI 10.1086/117497; Kennefick JD, 1995, ASTRON J, V110, P2553, DOI 10.1086/117711; WARREN SJ, 1994, ASTROPHYS J, V421, P412, DOI 10.1086/173660; Schlegel DJ, 1998, ASTROPHYS J, V500, P525, DOI 10.1086/305772; York DG, 2000, ASTRON J, V120, P1579, DOI 10.1086/301513; SCHMIDT M, 1963, NATURE, V197, P1040, DOI 10.1038/1971040a0; Gunn JE, 1998, ASTRON J, V116, P3040, DOI 10.1086/300645; Chen HW, 1999, NATURE, V398, P586, DOI 10.1038/19251; DJORGOVSKI SG, 1999, BAAS, V31, P1235; Epps HW, 1998, P SOC PHOTO-OPT INS, V3355, P48, DOI 10.1117/12.316803; Fan XH, 1999, ASTRON J, V117, P2528, DOI 10.1086/300848; Fan XH, 1999, ASTRON J, V118, P1, DOI 10.1086/300944; Fan XH, 2000, ASTRON J, V119, P1, DOI 10.1086/301191; Haiman Z, 1998, ASTROPHYS J, V503, P505, DOI 10.1086/306017; HILL GJ, 2000, UNPUB; Hu EM, 1999, ASTROPHYS J, V522, pL9, DOI 10.1086/312205; IRWIN M, 1991, ASTR SOC P, V21, P117; Leggett SK, 1996, ASTROPHYS J SUPPL S, V104, P117, DOI 10.1086/192295; Leggett SK, 2000, ASTROPHYS J, V535, P965, DOI 10.1086/308887; OKE JB, 1982, ASTROPHYS J, V255, P11, DOI 10.1086/159797; PRESS WH, 1993, ASTROPHYS J, V418, P585, DOI 10.1086/173419; SCHMIDT M, 1987, ASTROPHYS J, V321, pL7, DOI 10.1086/184996; Schneider DP, 2000, PUBL ASTRON SOC PAC, V112, P6; SCHNEIDER DP, 1991, ASTRON J, V101, P2004, DOI 10.1086/115825; Stern D, 2000, ASTROPHYS J, V533, pL75, DOI 10.1086/312614; TSYETANOV Z, 2000, UNPUB; WARREN SJ, 1991, ASTROPHYS J SUPPL S, V76, P23, DOI 10.1086/191564; Weymann RJ, 1998, ASTROPHYS J, V505, pL95, DOI 10.1086/311625; Yahata N, 2000, ASTROPHYS J, V538, P493, DOI 10.1086/309143	35	45	45	IOP PUBLISHING LTD	BRISTOL	DIRAC HOUSE, TEMPLE BACK, BRISTOL BS1 6BE, ENGLAND	0004-6256			ASTRON J	Astron. J.	OCT	2000	120	4					1607	1611		10.1086/301570		5	Astronomy & Astrophysics	Astronomy & Astrophysics	364GQ	WOS:000089884400001		
J	Amenomori, M; Ayabe, S; Caidong; Danzengluobu; Ding, LK; Feng, ZY; Fu, Y; Guo, HW; He, M; Hibino, K; Hotta, N; Huang, Q; Huo, AX; Izu, K; Jia, HY; Kajino, F; Kasahara, K; Katayose, Y; Labaciren; Li, JY; Lu, H; Lu, SL; Luo, GX; Meng, XR; Mizutani, K; Mu, J; Nanjo, H; Nishizawa, M; Ohnishi, M; Ohta, I; Ouchi, T; Peng, ZR; Ren, JR; Saito, T; Sakata, M; Sasaki, T; Shi, ZZ; Shibata, M; Shiomi, A; Shirai, T; Suga, Y; Sugimoto, H; Taira, K; Tan, YH; Tateyama, N; Torii, S; Utsugi, T; Wang, CR; Wang, H; Xu, XW; Yamamoto, Y; Yu, GC; Yuan, AF; Yuda, T; Zhang, CS; Zhang, HM; Zhang, JL; Zhang, NJ; Zhang, XY; Zhaxiciren; Zhaxisangzhu				Amenomori, M; Ayabe, S; Caidong; Danzengluobu; Ding, LK; Feng, ZY; Fu, Y; Guo, HW; He, M; Hibino, K; Hotta, N; Huang, Q; Huo, AX; Izu, K; Jia, HY; Kajino, F; Kasahara, K; Katayose, Y; Labaciren; Li, JY; Lu, H; Lu, SL; Luo, GX; Meng, XR; Mizutani, K; Mu, J; Nanjo, H; Nishizawa, M; Ohnishi, M; Ohta, I; Ouchi, T; Peng, ZR; Ren, JR; Saito, T; Sakata, M; Sasaki, T; Shi, ZZ; Shibata, M; Shiomi, A; Shirai, T; Suga, Y; Sugimoto, H; Taira, K; Tan, YH; Tateyama, N; Torii, S; Utsugi, T; Wang, CR; Wang, H; Xu, XW; Yamamoto, Y; Yu, GC; Yuan, AF; Yuda, T; Zhang, CS; Zhang, HM; Zhang, JL; Zhang, NJ; Zhang, XY; Zhaxiciren; Zhaxisangzhu			A study of the shadowing of galactic cosmic rays by the sun in a quiet phase of solar activity with the Tibet air shower array	ASTROPHYSICAL JOURNAL			English	Article						cosmic rays; interplanetary medium; magnetic fields; solar-terrestrial relations; solar wind	HELIOSPHERIC MAGNETIC-FIELD; HELIOGRAPHIC LATITUDES; SECTOR STRUCTURE; ULYSSES	We have shown that the Sun's shadow by high-energy cosmic rays moves year by year and its, behavior is correlated with a time variation of the large-scale structure of the solar and interplanetary magnetic fields. The solar activity was near minimum in the period from 1996 through 1997. Using the data obtained with the Tibet air shower array, we examined the shadowing of cosmic rays by the Sun in this quiet phase of the solar cycle and found that the Sun's shadow was just in the apparent direction of the Sun, though it was observed at the position considerably away from the Sun to the southwest in the period between 1990 and 1993. It is known that the magnetic pole of the equivalent solar dipole was reversed during the previous active phase, and near solar minimum the dipole was aligned with the rotating axis, preserving its N-pole on the north pole side of the Sun. This causes the solar magnetic field to shift the Sun's shadow to the east. Thus, the observed results suggest that the shift of the Sun's shadow due to the solar magnetic field was pushed back by the effect of the geomagnetic field, since the geomagnetic field always makes the shadow shift to the west. We discuss the Sun's shadow observed during the period near solar minimum in 1996-1997 and compare it with the simulation results.	Hirosaki Univ, Dept Phys, Hirosaki, Aomori 0368561, Japan; Saitama Univ, Dept Phys, Urawa, Saitama 3388570, Japan; Tibet Univ, Dept Math & Phys, Lhasa 850000, Peoples R China; Acad Sinica, Lab Cosm Ray & High Energy Astrophys, Inst High Energy Phys, Beijing 100039, Peoples R China; SW Jiaotong Univ, Dept Phys, Chengdu 610031, Peoples R China; Shandong Univ, Dept Phys, Jinan 250100, Peoples R China; Kanagawa Univ, Fac Engn, Yokohama, Kanagawa 2218686, Japan; Utsunomiya Univ, Fac Educ, Utsunomiya, Tochigi 3218505, Japan; Univ Tokyo, Inst Cosm Ray Res, Kashiwa, Chiba 2778582, Japan; Konan Univ, Dept Phys, Kobe, Hyogo 6588501, Japan; Shibaura Inst Technol, Fac Syst Engn, Omiya, Saitama 3308570, Japan; Yokohama Natl Univ, Fac Engn, Yokohama, Kanagawa 2400067, Japan; Yunnan Univ, Dept Phys, Kunming 650091, Peoples R China; Natl Inst Informat, Tokyo 1018430, Japan; Tokyo Metropolitan Coll Aeronaut Engn, Tokyo 1160003, Japan; Shonan Inst Technol, Fujisawa, Kanagawa 2518511, Japan; Nagoya Univ, Solar Terr Environm Lab, Nagoya, Aichi 4648601, Japan	Amenomori, M (reprint author), Hirosaki Univ, Dept Phys, Hirosaki, Aomori 0368561, Japan.			KATAYOSE, Yusaku/0000-0003-4836-7621			AMENOMORI M, 1993, ASTROPHYS J, V415, pL147, DOI 10.1086/187054; AMENOMORI M, 1993, PHYS REV D, V47, P2675, DOI 10.1103/PhysRevD.47.2675; Amenomori M, 1996, ASTROPHYS J, V464, P954, DOI 10.1086/177382; BALOGH A, 1995, SCIENCE, V268, P1007, DOI 10.1126/science.268.5213.1007; AMENOMORI M, 1992, PHYS REV LETT, V69, P2468, DOI 10.1103/PhysRevLett.69.2468; Fisk LA, 1996, J GEOPHYS RES, V101, P15547, DOI 10.1029/96JA01005; FISK LA, 1997, P 25 INT COSM RAY C, V8, P27; Parker E. N., 1963, INTERPLANETARY DYNAM; SAITO T, 1975, SCI REP TOHOKU U   5, V23, P37; SCHULZ M, 1973, ASTROPHYS SPACE SCI, V24, P371, DOI 10.1007/BF02637162; SMITH EJ, 1995, GEOPHYS RES LETT, V22, P3317, DOI 10.1029/95GL02826; SMITH EJ, 1995, SCIENCE, V268, P1005, DOI 10.1126/science.7754377; SMITH EJ, 1978, J GEOPHYS RES-SPACE, V83, P717, DOI 10.1029/JA083iA02p00717; SUGA Y, 1999, P 26 INT COSM RAY C, V7, P202; SVALGAARD L, 1978, ANNU REV ASTRON ASTR, V16, P429, DOI 10.1146/annurev.aa.16.090178.002241; WILCOX JM, 1965, J GEOPHYS RES, V70, P5783	16	18	18	UNIV CHICAGO PRESS	CHICAGO	5720 SOUTH WOODLAWN AVE, CHICAGO, IL 60637-1603 USA	0004-637X			ASTROPHYS J	Astrophys. J.	OCT 1	2000	541	2	1				1051	1058		10.1086/309479		8	Astronomy & Astrophysics	Astronomy & Astrophysics	363FT	WOS:000089825000048		
J	Vekstein, G; Katsukawa, Y				Vekstein, G; Katsukawa, Y			Scaling laws for a nanoflare-heated solar corona	ASTROPHYSICAL JOURNAL			English	Article						MHD; Sun : corona; Sun : flares	CURRENT SHEETS; MAGNETIC-FIELDS; PLASMA; ENERGETICS; DYNAMICS; YOHKOH; LOOPS	The concept that the solar corona is heated by numerous small flarelike events dubbed "nanoflares" is considered. The hot corona is viewed as an ensemble of high-temperature elemental magnetic filaments created within the coronal magnetic field by randomly distributed impulsive heating events. It is shown that such an approach allows us to predict various signatures of X-ray coronal loops without specifying the details of the heating process. In particular, the dependence of the temperature, filling factor, and emission measure on the length of the loop and strength of the coronal magnetic field is derived. The obtained scaling laws fit reasonably with observational data.	Univ Manchester, Inst Sci & Technol, Dept Phys, Manchester M60 1QD, Lancs, England; Univ Tokyo, Sch Sci, Dept Astron, Bunkyo Ku, Tokyo 1130033, Japan	Vekstein, G (reprint author), Univ Manchester, Inst Sci & Technol, Dept Phys, Manchester M60 1QD, Lancs, England.						SERIO S, 1991, ASTRON ASTROPHYS, V241, P197; Parnell CE, 2000, ASTROPHYS J, V529, P554, DOI 10.1086/308271; ANTIOCHOS SK, 1978, ASTROPHYS J, V220, P1137, DOI 10.1086/155999; CARGILL PJ, 1995, ASTROPHYS J, V439, P1034, DOI 10.1086/175240; SHIMIZU T, 1995, PUBL ASTRON SOC JPN, V47, P251; KOPP RA, 1993, ASTROPHYS J, V418, P496, DOI 10.1086/173411; Krucker S, 1998, ASTROPHYS J, V501, pL213, DOI 10.1086/311474; Vekstein GE, 1998, PHYS PLASMAS, V5, P1506, DOI 10.1063/1.872809; ROSNER R, 1978, ASTROPHYS J, V220, P643, DOI 10.1086/155949; Cargill PJ, 1997, ASTROPHYS J, V478, P799, DOI 10.1086/303816; Shimizu T, 1997, ASTROPHYS J, V486, P1045, DOI 10.1086/304542; CARGILL PJ, 1994, ASTROPHYS J, V422, P381, DOI 10.1086/173733; CARGILL PJ, 1993, SOL PHYS, V147, P263, DOI 10.1007/BF00690717; GALEEV AA, 1984, HDB PLASMA PHYSICS; GOLUB L, 1980, ASTROPHYS J, V238, P343, DOI 10.1086/157990; LOW BC, 1988, ASTROPHYS J, V324, P574, DOI 10.1086/165918; Moore RL, 1999, ASTROPHYS J, V526, P505, DOI 10.1086/307969; PARKER EN, 1988, ASTROPHYS J, V330, P474, DOI 10.1086/166485; PARKER EN, 1972, ASTROPHYS J, V174, P499, DOI 10.1086/151512; Priest E. R., 1982, SOLAR MAGNETOHYDRODY; Ulmschneider P., 1991, MECH CHROMOSPHERIC C; VANBALLEGOOIJEN AA, 1988, GEOPHYS ASTRO FLUID, V41, P181, DOI 10.1080/03091928808208850; Vekstein G, 1999, PHYS PLASMAS, V6, P2897, DOI 10.1063/1.873247; VEKSTEIN G, 1991, ASTRON ASTROPHYS, V243, P492; Vekstein GE, 1996, MAGNETODYNAMIC PHENOMENA IN THE SOLAR ATMOSPHERE, P29	25	23	23	UNIV CHICAGO PRESS	CHICAGO	5720 SOUTH WOODLAWN AVE, CHICAGO, IL 60637-1603 USA	0004-637X			ASTROPHYS J	Astrophys. J.	OCT 1	2000	541	2	1				1096	1103		10.1086/309480		8	Astronomy & Astrophysics	Astronomy & Astrophysics	363FT	WOS:000089825000051		
J	Nakasato, N; Shigeyama, T				Nakasato, N; Shigeyama, T			Metal enrichment of the primordial interstellar medium through three-dimensional hydrodynamical evolution of the first supernova remnant	ASTROPHYSICAL JOURNAL			English	Article						galaxies : ISM; hydrodynamics; ISM : abundances; ISM : structure; methods : numerical; supernova remnants	CHEMICAL EVOLUTION; POOR STARS; GALAXY	The long-term evolution of supernova (SN) remnants in the primordial interstellar medium (ISM) with an inhomogeneous structure is calculated to investigate metal enrichment of the primordial gas. For this purpose, we have constructed a parallel three-dimensional hydrodynamics code incorporating the radiative cooling and self-gravity. The self-gravity and radiative cooling develop the inhomogeneous structure of the ISM from a small perturbation with a power-law spectrum. The resultant density ranges from 0.5 to 10(6) cm(-3). Calculations for an SN with the progenitor mass of 20 M-circle dot are performed as the first step of a series of our study. It is found from the results that a single SN distributes some of the newly synthesized heavy elements into a dense filament of the ISM with densities ranging from 100 to 10(4) cm(-3) depending on where the SN explodes. Thus, the metallicity [Mg/H] of the dense filaments polluted by the SN ejecta becomes -2.7 +/- 0.5. From these filaments, the first Population LI stars will form. This value is in accordance with previous analytical work by Shigeyama & Tsujimoto with an accuracy of similar to 0.3 dex.	Univ Tokyo, Grad Sch Sci, Res Ctr Early Universe, Bunkyo Ku, Tokyo 1130033, Japan	Nakasato, N (reprint author), Univ Tokyo, Grad Sch Sci, Res Ctr Early Universe, Bunkyo Ku, Tokyo 1130033, Japan.	nakasato@astron.s.u-tokyo.ac.jp; shigeyama@astron.s.u-tokyo.ac.jp	SHIGEYAMA, TOSHIKAZU/G-4894-2014				Abel T, 1998, ASTROPHYS J, V508, P518, DOI 10.1086/306410; Strang G., 1968, SIAM Journal on Numerical Analysis, V5, DOI 10.1137/0705041; COLELLA P, 1984, J COMPUT PHYS, V54, P174, DOI 10.1016/0021-9991(84)90143-8; RYU DS, 1993, ASTROPHYS J, V414, P1, DOI 10.1086/173051; AUDOUZE J, 1995, ASTROPHYS J, V451, pL49, DOI 10.1086/309687; Shigeyama T, 1998, ASTROPHYS J, V507, pL135, DOI 10.1086/311699; TSUJIMOTO T, 1995, MON NOT R ASTRON SOC, V277, P945; Truelove JK, 1999, ASTROPHYS J SUPPL S, V120, P299, DOI 10.1086/313176; CIOFFI DF, 1988, ASTROPHYS J, V334, P252, DOI 10.1086/166834; Plewa T, 1999, ASTRON ASTROPHYS, V342, P179; Ryan SG, 1996, ASTROPHYS J, V471, P254, DOI 10.1086/177967; MCWILLIAM A, 1995, ASTRON J, V109, P2757, DOI 10.1086/117486; CHEVALIER RA, 1977, ANNU REV ASTRON ASTR, V15, P175, DOI 10.1146/annurev.aa.15.090177.001135; Godunov S.K., 1959, MAT SBORNIK, V47, P271; Hnatyk B, 1999, ASTRON ASTROPHYS, V344, P295; Nakasato N, 2000, ASTROPHYS J, V535, P776, DOI 10.1086/308855; SUTHERLAND RS, 1993, ASTROPHYS J SUPPL S, V88, P253, DOI 10.1086/191823; Toro E. F., 1997, RIEMANN SOLVERS NUME; ZELDOVIC.YB, 1970, ASTRON ASTROPHYS, V5, P84	19	13	13	IOP PUBLISHING LTD	BRISTOL	TEMPLE CIRCUS, TEMPLE WAY, BRISTOL BS1 6BE, ENGLAND	0004-637X	1538-4357		ASTROPHYS J	Astrophys. J.	OCT 1	2000	541	2	2				L59	L62		10.1086/312901		4	Astronomy & Astrophysics	Astronomy & Astrophysics	363FX	WOS:000089825400007		
J	Deguchi, S; Fujii, T; Izumiura, H; Kameya, O; Nakada, Y; Nakashima, J				Deguchi, S; Fujii, T; Izumiura, H; Kameya, O; Nakada, Y; Nakashima, J			SiO maser survey of the Galactic disk IRAS sources. III. -10 degrees < l < 15 degrees AND vertical bar b vertical bar <= 3 degrees, a central part of the Galaxy	ASTROPHYSICAL JOURNAL SUPPLEMENT SERIES			English	Article						circumstellar matter; Galaxy : kinematics and dynamics; masers; radio lines : stars; stars : late-type	NEAR-INFRARED PHOTOMETRY; OH/IR STARS; DYNAMICAL MODEL; MILKY-WAY; BULGE; BAR; CATALOG; KINEMATICS; EMISSION; SILICATE	A survey has been made in the SiO J = 1-0, nu = 1 and 2 transitions (similar to 43 GHz) for the color-selected IRAS sources in the central region of the Galaxy, -10 degrees < l < 15 degrees (except \l\ less than or equal to 3 degrees) and \b\ less than or equal to 3 degrees, with the Nobeyama 45 m telescope. We have detected 124 out of 200 observed sources in SiO masers. Distances to the sources range approximately from 2 to 11 kpc, if estimated from the IRAS 12 and 25 mum flux densities. Radial velocities of the detected sources spread between +/-260 km s(-1). The distribution of SiO sources in the longitude-velocity diagram is compared with the H I contours. A number of sources are out of the H I limiting velocities; a group of negative-velocity (similar to -200 to -80 km s(-1)) sources is found at l = 3 degrees -12 degrees region. The subsamples of sources exhibit negative and positive shifts of the average radial velocity depending on distance, suggesting evidence of a streaming motion of stars in the bulge bar.	Natl Astron Observ, Nobeyama Radio Observ, Minamisa Ku, Nagano 3841305, Japan; Univ Tokyo, Fac Sci, Dept Astron, Bunkyo Ku, Tokyo 1130032, Japan; Univ Tokyo, Fac Sci, Astron Inst, Kiso Observ, Tokyo 1818588, Japan; Natl Astron Observ, Okayama Astrophys Observ, Okayama 7190232, Japan; Natl Astron Observ, Mizusawa Astrogeodynam Observ, Mizusawa, Iwate 0230861, Japan; Grad Univ Adv Studies, Dept Astron Sci, Nobeyama Radio Observ, Nagano 3841305, Japan; Osaka Kyoiku Univ, Astron Inst, Osaka 5828582, Japan	Deguchi, S (reprint author), Natl Astron Observ, Nobeyama Radio Observ, Minamisa Ku, Nagano 3841305, Japan.		Nakashima, Jun-ichi/D-3113-2009	Nakashima, Jun-ichi/0000-0003-3324-9462			ALLEN LE, 1993, ASTROPHYS J, V411, P188, DOI 10.1086/172818; LESQUEREN AM, 1992, ASTRON ASTROPHYS, V254, P133; DWEK E, 1995, ASTROPHYS J, V445, P716, DOI 10.1086/175734; Sevenster MN, 1997, ASTRON ASTROPHYS SUP, V122, P79, DOI 10.1051/aas:1997294; Sylvester RJ, 1998, MON NOT R ASTRON SOC, V301, P1083, DOI 10.1046/j.1365-8711.1998.02078.x; Weiner BJ, 1999, ASTROPHYS J, V524, P112, DOI 10.1086/307786; Hog E, 1998, ASTRON ASTROPHYS, V335, pL65; Beichman C. A., 1988, INFRARED ASTRONOMICA, V1; BLUM RD, 1994, ASTROPHYS J, V422, P111, DOI 10.1086/173708; Burton W. B., 1985, Astronomy & Astrophysics Supplement Series, V62; Deguchi S, 2000, ASTROPHYS J SUPPL S, V128, P571, DOI 10.1086/313393; Deguchi S, 1998, PUBL ASTRON SOC JPN, V50, P597; Deguchi S, 1999, PUBL ASTRON SOC JPN, V51, P355; Freudenreich HT, 1998, ASTROPHYS J, V492, P495, DOI 10.1086/305065; Giuricin G., 1983, Astronomy & Astrophysics Supplement Series, V54; GUGLIELMO F, 1993, ASTRON ASTROPHYS SUP, V99, P31; HABING HJ, 1985, ASTRON ASTROPHYS, V152, pL1; Honma M, 1997, PUBL ASTRON SOC JPN, V49, P453; Izumiura H, 1999, ASTROPHYS J SUPPL S, V125, P257, DOI 10.1086/313266; IZUMIURA H, 1995, ASTROPHYS J, V453, P837, DOI 10.1086/176445; IZUMIURA H, 1995, ASTROPHYS J SUPPL S, V98, P271, DOI 10.1086/192161; IZUMIURA H, 1994, ASTROPHYS J, V437, P419, DOI 10.1086/175006; JURA M, 1990, ASTROPHYS J, V364, P663, DOI 10.1086/169449; LEPINE JRD, 1995, ASTRON ASTROPHYS, V299, P453; LYNCH DK, 1990, ASTRON J, V100, P719, DOI 10.1086/115554; MULDER WA, 1986, ASTRON ASTROPHYS, V157, P148; Nikolaev S, 1997, ASTROPHYS J, V487, P885, DOI 10.1086/304639; NOGUCHI K, 1993, PUBL ASTRON SOC JPN, V45, P65; Olnon F. M., 1986, Astronomy & Astrophysics Supplement Series, V65; Perryman, 1997, ASTRON ASTROPHYS, V323, pL 49; Press W.H., 1988, NUMERICAL RECIPES; Sevenster M, 1999, MON NOT R ASTRON SOC, V307, P584, DOI 10.1046/j.1365-8711.1999.02672.x; Sitko ML, 1999, ASTROPHYS J, V510, P408, DOI 10.1086/306586; HEKKERT PL, 1989, ASTRON ASTROPHYS SUP, V78, P399; HEKKERT PTL, 1991, ASTRON ASTROPHYS SUP, V90, P327; VANDERVEEN WECJ, 1990, ASTRON ASTROPHYS, V231, P404; van Houten CJ, 1999, ASTRON ASTROPHYS SUP, V137, P113, DOI 10.1051/aas:1999241; VANLANGEVELDE HJ, 1990, ASTRON ASTROPHYS, V239, P193; VOLK K, 1989, ASTRON J, V98, P931, DOI 10.1086/115188; WEINBERG MD, 1992, ASTROPHYS J, V384, P81, DOI 10.1086/170853; XIONG GZ, 1994, ASTRON ASTROPHYS SUP, V108, P661; Zhao HS, 1996, MON NOT R ASTRON SOC, V283, P149	42	25	25	UNIV CHICAGO PRESS	CHICAGO	5720 SOUTH WOODLAWN AVE, CHICAGO, IL 60637-1603 USA	0067-0049			ASTROPHYS J SUPPL S	Astrophys. J. Suppl. Ser.	OCT	2000	130	2					351	379		10.1086/317353		29	Astronomy & Astrophysics	Astronomy & Astrophysics	378HX	WOS:000165579900004		
J	Kuriyama, K; Ueno, T; Ballard, RE; Cowings, PS; Toscano, WB; Watenpaugh, DE; Hargens, AR				Kuriyama, K; Ueno, T; Ballard, RE; Cowings, PS; Toscano, WB; Watenpaugh, DE; Hargens, AR			Cerebrovascular responses during lower body negative pressure-induced presyncope	AVIATION SPACE AND ENVIRONMENTAL MEDICINE			English	Article						orthostatic tolerance; human; cerebral blood flow velocity; cerebral tissue oxygenation; lower body negative pressure; fainting	CEREBRAL HEMODYNAMICS; ORTHOSTATIC STRESS; BLOOD-PRESSURE; AUTOREGULATION; FLOW	Background: Reduced orthostatic tolerance is commonly observed after spaceflight, occasionally causing presyncopal symptoms which may be due to low cerebral blood flow (CBF). It has been suggested that CBF decreases in early stages of exposure to orthostatic stress. The purpose of this study was to investigate cerebrovascular responses during presyncope induced by lower body negative pressure (LBNP). Hypothesis: Although CBF decreases during LBNP exposure, blood pressure (BP) or heart rate (HR) contributes more to induce presyncopal conditions. Methods: Eight healthy male volunteers were exposed to LBNP in steps of 10 mm Hg every 3 min until presyncopal symptoms were detected. Electrocardiogram (ECG) was monitored continuously and arterial BP was measured by arterial tonometry. CBF velocity at the middle cerebral artery was measured by transcranial Doppler sonography (TCD). Cerebral tissue oxygenation was detected using near-infrared spectroscopy (NIRS). We focused our investigation on the data obtained during the final 2 min before the presyncopal endpoint. Results: BP gradually decreased from 2 min to 10 s before the endpoint and fell more rapidly during the final 10 s. HR did not change significantly during presyncope. CBF velocity did not change significantly, while cerebral tissue oxygenation decreased prior to the presyncopal endpoint in concert with BP. Our results suggest that CBF is maintained in the middle cerebral artery during presyncope, while BP decreases rapidly. Conclusions: Cerebrovascular hemodynamics are relatively well maintained while arterial hypotension occurs just prior to syncope.	Univ Tokyo, Fac Med, Sch Hlth Sci & Nursing, Dept Hlth Adm,Bunkyo Ku, Tokyo 113, Japan; NASA, Gravitat Res Branch, Ames Res Ctr, Moffett Field, CA 94035 USA	Hargens, AR (reprint author), Univ Calif San Diego, Dept Orthopaed, 350 Dickinson St,8894, San Diego, CA 92103 USA.						PAULSON OB, 1990, CEREBROVAS BRAIN MET, V2, P161; GLAISTER DH, 1990, AVIAT SPACE ENVIR MD, V61, P99; GILLER CA, 1992, J NEUROSURG, V76, P961, DOI 10.3171/jns.1992.76.6.0961; BONDAR RL, 1995, STROKE, V26, P1794; Zhang R, 1997, J APPL PHYSIOL, V83, P2139; JOBSIS FF, 1977, SCIENCE, V198, P1264, DOI 10.1126/science.929199; LEVINE BD, 1994, CIRCULATION, V90, P298; BONDAR RL, 1994, J CLIN PHARMACOL, V34, P584; CHANCE B, 1988, P NATL ACAD SCI USA, V85, P4971, DOI 10.1073/pnas.85.14.4971; Du Boulay G, 1973, Neuroradiology, V5, P37; GILLER CA, 1993, NEUROSURGERY, V32, P737; GRUBB BP, 1991, CIRCULATION, V84, P1157; Hayashida K, 1996, J NUCL MED, V37, P1; JOBSIS FF, 1977, J APPL PHYSIOL, V43, P858; PAULSON OB, 1972, NEUROLOGY, V22, P286; RAICHLE ME, 1972, EUR NEUROL, V6, P1; Rowell L, 1993, HUMAN CARDIOVASCULAR, P37; UENO T, 1993, AVIAT SPACE ENVIR MD, V64, P1006; Warkentin S, 1992, Clin Auton Res, V2, P119, DOI 10.1007/BF01819667; Watenpaugh DE, 1996, HDB PHYSIOL SECT 4, VI, P631	20	9	9	AEROSPACE MEDICAL ASSOC	ALEXANDRIA	320 S HENRY ST, ALEXANDRIA, VA 22314-3579 USA	0095-6562			AVIAT SPACE ENVIR MD	Aviat. Space Environ. Med.	OCT	2000	71	10					1033	1038				6	Public, Environmental & Occupational Health; Medicine, General & Internal; Sport Sciences	Public, Environmental & Occupational Health; General & Internal Medicine; Sport Sciences	356ZA	WOS:000089473000007		
J	Yonekura, K; Eto, Y; Yokoyama, I; Matsumoto, A; Sugiura, S; Momomura, S; Kirimoto, T; Hayashi, Y; Omata, M; Aoyagi, T				Yonekura, K; Eto, Y; Yokoyama, I; Matsumoto, A; Sugiura, S; Momomura, S; Kirimoto, T; Hayashi, Y; Omata, M; Aoyagi, T			Inhibition of carnitine synthesis modulates protein contents of the cardiac sarcoplasmic reticulum Ca2+-ATPase and hexokinase type I in rat hearts with myocardial infarction	BASIC RESEARCH IN CARDIOLOGY			English	Article						carnitine inhibition; 3-(2,2,2-trimethyl-hydrazinium) propionate; sarcoplasmic; reticulum Ca2+-ATPase; hexokinase; myocardial infarction	GENE-EXPRESSION; FAILURE; ETOMOXIR; PERFORMANCE; HYPERTROPHY	It was previously reported that inhibition of carnitine synthesis by 3-(2,2,2-trimethyl-hydrazinium) propionate (MET-88) restores left ventricular (LV) systolic and diastolic function in rats with myocardial infarction (MI). Preservation of the calcium uptake function of sarcoplasmic reticulum Ca2+-ATPase (SERCA2) is one of the possible mechanisms by which MET-88 alleviates hemodynamic dysfunction. To test this hypothesis, the effects of MET-88 on protein content of SERCA2 were evaluated using the same rat model of heart failure. Myocardial protein content of hexokinase, which is one of the key enzymes of glucose utilization, was also measured. Either MET-88 (MET-88 group) ora placebo (MI group) was administered for 20 days to rats with MI induced by coronary artery ligation. The control group underwent sham surgery (no Ligation) and received placebo. In LV myocardial homogenates, the myocardial SERCA2 protein content was 32 % lower (p < 0.05) in the MI group than in the control group. However, in the MET-88 group myocardial SERCA2 content was the same as in the control group. Hexokinase I protein content was 29 % lower (p < 0.05) in the MI group compared with the control. In contrast, hexokinase II protein content did not differ significantly among the three groups. Consequently, inhibition of carnitine synthesis ameliorates depression of SERCA2 and hexokinase I protein content which may reduce tissue damage caused by MI.	Univ Tokyo, Dept Cardiovasc Med, Bunkyo Ku, Tokyo 1138655, Japan; Taisho Pharmaceut Co Ltd, Tokushima, Japan	Aoyagi, T (reprint author), Univ Tokyo, Dept Cardiovasc Med, Bunkyo Ku, 7-3-1 Hongo, Tokyo 1138655, Japan.						Afzal N, 1996, CAN J CARDIOL, V12, P1065; XU KY, 1995, CIRC RES, V77, P88; Turcani M, 1997, CIRCULATION, V96, P3681; HASENFUSS G, 1994, CIRC RES, V75, P434; REINAUER H, 1990, J CLIN CHEM CLIN BIO, V28, P335; ARAI M, 1993, CIRC RES, V72, P463; Aoyagi T, 1997, J CARDIOVASC PHARM, V30, P468, DOI 10.1097/00005344-199710000-00010; ASAKA N, 1998, FUNDAM CLIN PHARM, V12, P185; ETO Y, 1997, EUR HEART J SUPPL, V18, P435; Grynberg A, 1996, J CARDIOVASC PHARM, V28, pS11; Gupta RC, 1997, AM J PHYSIOL-HEART C, V273, pH12; He HP, 1997, J CLIN INVEST, V100, P380, DOI 10.1172/JCI119544; MERCADIER JJ, 1990, J CLIN INVEST, V85, P305, DOI 10.1172/JCI114429; RUPP H, 1992, J APPL PHYSIOL, V72, P352; RUPP H, 1992, FASEB J, V6, P2349; STUDER R, 1994, CIRC RES, V75, P443; TAKAHASHI T, 1992, J CLIN INVEST, V90, P927, DOI 10.1172/JCI115969; Turcani M, 1999, BRIT J PHARMACOL, V126, P501, DOI 10.1038/sj.bjp.0702312; VETTER R, 1994, AM J PHYSIOL-HEART C, V267, pH2091; ZarainHerzberg A, 1996, FASEB J, V10, P1303	20	12	12	DR DIETRICH STEINKOPFF VERLAG	DARMSTADT	PLATZ DER DEUTSCHEN EINHEIT 25, D-64293 DARMSTADT, GERMANY	0300-8428			BASIC RES CARDIOL	Basic Res. Cardiol.	OCT	2000	95	5					343	348		10.1007/s003950070032		6	Cardiac & Cardiovascular Systems	Cardiovascular System & Cardiology	368FL	WOS:000090107000001		
J	Nomura, K; Imai, H; Koumura, T; Kobayashi, T; Nakagawa, Y				Nomura, K; Imai, H; Koumura, T; Kobayashi, T; Nakagawa, Y			Mitochondrial phospholipid hydroperoxide glutathione peroxidase inhibits the release of cytochrome c from mitochondria by suppressing the peroxidation of cardiolipin in hypoglycaemia-induced apoptosis	BIOCHEMICAL JOURNAL			English	Article						cardiolipin hydroperoxide; 2-deoxyglucose; lipid peroxidation; 10-N-nonyl Acridine Orange	PROGRAMMED CELL-DEATH; LIPID-PEROXIDATION; OXIDATIVE INJURY; OVEREXPRESSION; BINDING; DYSFUNCTION; PROTEIN; GENERATION; MECHANISM; REQUIRES	Cytochrome c (cyt. c) is a proapoptotic factor that binds preferentially to cardiolipin (CL), a mitochondrial lipid, but not to cardiolipin hydroperoxide (CL-OOH). Cyt. c that had bound to CL liposomes was liberated on peroxidation of the liposomes by a radical. The generation of CL-OOH in mitochondria occurred before the release of cyt. c in rat basophile leukaemia (RBL)2H3 cells that had been induced to undergo apoptosis by exposure to hypoglycaemia with 2-deoxyglucose (2DG). The amount of cyt. c bound to CL prepared from the mitochondria of 2DG-treated cells was lower than that of untreated cells. The release of cyt. c was completely suppressed when the production of CL-OOH in mitochondria was inhibited by the overexpression of mitochondrial phospholipid hydroperoxide glutathione peroxidase (PHGPx). The fluorescence from CL-labelling dye (10-N-nonyl Acridine Orange) decreased on the induction of apoptosis by 2DG. However, no decrease in fluorescence was observed in PHGPx-overexpressing cells. Cyt. c was released from mitochondria that had been isolated from control cells on peroxidation by t-butylhydroperoxide, but no similar liberation of cyt. c from mitochondria isolated from mitochondrial PHGPx-overexpressing cells was observed. These findings suggest that the generation of CL-OOH in mitochondria might be a primary event that triggers the release of cyt. c from mitochondria in the apoptotic process in which mitochondrial PHGPx participates as an anti-apoptotic factor by preventing the formation of CL-OOH.	Kitasato Univ, Sch Pharmaceut Sci, Minato Ku, Tokyo 1088641, Japan; Univ Tokyo, Grad Sch Pharmaceut Sci, Dept Hlth Chem, Bunkyo Ku, Tokyo 1130033, Japan; RIKEN, Inst Phys & Chem Res, Sphingolipid Funct Lab, Wako, Saitama 3510198, Japan	Nakagawa, Y (reprint author), Kitasato Univ, Sch Pharmaceut Sci, Minato Ku, 5-9-1 Shirokane, Tokyo 1088641, Japan.		Kobayashi, Toshihide/B-6298-2015	Kobayashi, Toshihide/0000-0002-4811-7270			RYTOMAA M, 1995, J BIOL CHEM, V270, P3197; HOCH FL, 1992, BIOCHIM BIOPHYS ACTA, V1113, P71, DOI 10.1016/0304-4157(92)90035-9; Majima HJ, 1998, J BIOL CHEM, V273, P8217, DOI 10.1074/jbc.273.14.8217; Kroemer G, 1998, ANNU REV PHYSIOL, V60, P619, DOI 10.1146/annurev.physiol.60.1.619; Reed JC, 1998, ONCOGENE, V17, P3225; YAMAMOTO Y, 1994, METHOD ENZYMOL, V233, P319; HOFFMANN B, 1994, J BIOL CHEM, V269, P1940; Emoto K, 1996, P NATL ACAD SCI USA, V93, P12867, DOI 10.1073/pnas.93.23.12867; GALLET PF, 1995, EUR J BIOCHEM, V228, P113, DOI 10.1111/j.1432-1033.1995.tb20238.x; Crompton M, 1999, BIOCHEM J, V341, P233, DOI 10.1042/0264-6021:3410233; Manna SK, 1998, J BIOL CHEM, V273, P13245, DOI 10.1074/jbc.273.21.13245; Zhang P, 1997, J BIOL CHEM, V272, P30615, DOI 10.1074/jbc.272.49.30615; BLIGH EG, 1959, CAN J BIOCHEM PHYS, V37, P911; Tan SL, 1998, J CELL BIOL, V141, P1423, DOI 10.1083/jcb.141.6.1423; ROVERI A, 1994, BBA-PROTEIN STRUCT M, V1208, P211, DOI 10.1016/0167-4838(94)90106-6; Skulachev VP, 1998, FEBS LETT, V423, P275, DOI 10.1016/S0014-5793(98)00061-1; Arai M, 1999, J BIOL CHEM, V274, P4924, DOI 10.1074/jbc.274.8.4924; Shidoji Y, 1999, BIOCHEM BIOPH RES CO, V264, P343, DOI 10.1006/bbrc.1999.1410; BROWN LR, 1977, BIOCHIM BIOPHYS ACTA, V468, P389, DOI 10.1016/0005-2736(77)90290-5; Susin SA, 1999, NATURE, V397, P441; RYTOMAA M, 1994, J BIOL CHEM, V269, P1770; Li P, 1997, CELL, V91, P479, DOI 10.1016/S0092-8674(00)80434-1; Kruman I, 1998, J NEUROSCI RES, V51, P293, DOI 10.1002/(SICI)1097-4547(19980201)51:3<293::AID-JNR3>3.0.CO;2-B; ZAMZAMI N, 1995, J EXP MED, V182, P367, DOI 10.1084/jem.182.2.367; GarciaRuiz C, 1997, J BIOL CHEM, V272, P11369; Bai JX, 1999, J BIOL CHEM, V274, P26217, DOI 10.1074/jbc.274.37.26217; Polyak K, 1997, NATURE, V389, P300, DOI 10.1038/38525; Nomura K, 1999, J BIOL CHEM, V274, P29294, DOI 10.1074/jbc.274.41.29294; Kiningham KK, 1999, FASEB J, V13, P1601; Keller JN, 1998, J NEUROSCI, V18, P687; Thomas RL, 1999, J BIOL CHEM, V274, P30580, DOI 10.1074/jbc.274.43.30580; Arai M, 1996, BIOCHEM BIOPH RES CO, V227, P433, DOI 10.1006/bbrc.1996.1525; Chiba N, 1999, BIOL PHARM BULL, V22, P1047; DEMEL RA, 1989, J BIOL CHEM, V264, P3988; Ferlini C, 1999, EXP CELL RES, V247, P160, DOI 10.1006/excr.1998.4343; GODEAS C, 1994, BBA-BIOMEMBRANES, V1191, P147, DOI 10.1016/0005-2736(94)90242-9; HEIMBURG T, 1991, BIOCHEMISTRY-US, V30, P9084, DOI 10.1021/bi00101a025; Imai H, 1996, BIOCHEM BIOPH RES CO, V222, P432, DOI 10.1006/bbrc.1996.0762; IMAI H, 1995, J BIOCHEM-TOKYO, V118, P1061; Imai H, 1998, J BIOL CHEM, V273, P1990, DOI 10.1074/jbc.273.4.1990; IMAI H, 1994, J IMMUNOL, V153, P2290; Jemmerson R, 1999, BIOCHEMISTRY-US, V38, P3599, DOI 10.1021/bi9809268; Lieberthal W, 1998, AM J PHYSIOL-RENAL, V275, pF691; MAJIMA E, 1993, J BIOL CHEM, V268, P22181; Martinou JC, 1999, NATURE, V399, P411, DOI 10.1038/20804; PARINANDI NL, 1988, CHEM PHYS LIPIDS, V49, P215, DOI 10.1016/0009-3084(88)90009-6; REIPERT S, 1995, EXP CELL RES, V221, P281, DOI 10.1006/excr.1995.1376; Shenker BJ, 1999, TOXICOL APPL PHARM, V157, P23, DOI 10.1006/taap.1999.8652; URSINI F, 1985, BIOCHIM BIOPHYS ACTA, V839, P62, DOI 10.1016/0304-4165(85)90182-5; Ushmorov A, 1999, BLOOD, V93, P2342; VIK SB, 1981, P NATL ACAD SCI-BIOL, V78, P1456, DOI 10.1073/pnas.78.3.1456; Yamaji A, 1998, J BIOL CHEM, V273, P5300, DOI 10.1074/jbc.273.9.5300	52	240	248	PORTLAND PRESS	LONDON	59 PORTLAND PLACE, LONDON W1N 3AJ, ENGLAND	0264-6021			BIOCHEM J	Biochem. J.	OCT 1	2000	351		1				183	193		10.1042/0264-6021:3510183		11	Biochemistry & Molecular Biology	Biochemistry & Molecular Biology	364RW	WOS:000089907600021		
J	Cartan, CK; Miyashita, T				Cartan, CK; Miyashita, T			Extraordinary web and silk properties of Cyrtarachne (Araneae, Araneidae): a possible link between orb-webs and bolas	BIOLOGICAL JOURNAL OF THE LINNEAN SOCIETY			English	Article						spider; web structure; viscid threads; prey capture; evolution	WEAVING SPIDERS; CAPTURE THREADS; CYCLOSA SPIDERS; PREY; PERCEPTION; STICKINESS; EVOLUTION; PATTERN; WATER; SPUN	Cyrtarachne is an orb-weaving spider of the sub-family Cyrtarachninae (Araneidae), which includes the triangle-web-building Pasilobus and the bolas spiders. We found that web and thread characteristics of Cyrtarachne differed greatly from those of typical orb-webs. Web diameter, sticky spiral spacing, breaking strength and stickiness of thread, thread diameter and droplet diameter were significantly different from those of other members of Araneidae. It is especially worth noting that the diameter was approximately four times, and the breaking strength seven to ten times larger in Cyrtarachne viscid threads than in those of other araneids. Kinetic energy-absorbing ability of Cyrtarachne threads was much greater than in that of other species, and close to the amount of kinetic energy generated by flying moths. Viscid material of threads was peculiar because its adhesiveness decreased to zero in a few hours. Moreover, SEM photos revealed them to be covered with thin scales of material: while threads of other araneids were smooth. These two facts suggest that the viscid material of Cyrtarachne threads may be different from those of other orb-weavers. As web-building, hunting behaviour and prey composition of different species of Cyrtarachninae are quite similar to each other, we hypothesize that these extraordinary web and thread characteristics of Cyrtarachne are shared by the other members of this sub-family. Because these characteristics differ in many ways from those of typical araneid orb-webs, there appears to have been a great leap in evolution between Cyrtarachne and the other Araneidae. (C) 2000 The Linnean Society of London.	Univ Tokyo, Sch Agr & Life Sci, Lab Biodivers Sci, Bunkyo Ku, Tokyo 1138657, Japan	Cartan, CK (reprint author), Univ Tokyo, Sch Agr & Life Sci, Lab Biodivers Sci, Bunkyo Ku, Yayoi 1-1-1, Tokyo 1138657, Japan.						CRAIG CL, 1994, ANIM BEHAV, V47, P1087, DOI 10.1006/anbe.1994.1147; VOLLRATH F, 1989, NATURE, V340, P305, DOI 10.1038/340305a0; PETERS HM, 1995, NATURWISSENSCHAFTEN, V82, P380, DOI 10.1007/BF01134566; CRAIG CL, 1986, ANIM BEHAV, V34, P54, DOI 10.1016/0003-3472(86)90006-0; CRAIG CL, 1990, ECOLOGY, V71, P616, DOI 10.2307/1940315; YEARGAN KV, 1988, OECOLOGIA, V74, P524, DOI 10.1007/BF00380049; Scharff N, 1997, ZOOL J LINN SOC-LOND, V120, P355, DOI 10.1111/j.1096-3642.1997.tb01281.x; SANDOVAL CP, 1994, FUNCT ECOL, V8, P701, DOI 10.2307/2390229; Chacon P., 1980, Bulletin of the British Arachnological Society, V5, P29; CLYNE D, 1973, Australian Entomological Magazine, V1, P23; CRAIG CL, 1990, ANIM BEHAV, V39, P135, DOI 10.1016/S0003-3472(05)80733-X; CRAIG CL, 1987, BIOL J LINN SOC, V30, P135, DOI 10.1111/j.1095-8312.1987.tb00294.x; CRAIG CL, 1985, J THEOR BIOL, V115, P201, DOI 10.1016/S0022-5193(85)80096-5; EBERHARD W G, 1986, P70; EBERGARD W G, 1980, Psyche (Cambridge), V87, P143, DOI 10.1155/1980/81062; EDMONDS DT, 1992, P ROY SOC B-BIOL SCI, V248, P145, DOI 10.1098/rspb.1992.0055; EISNER T, 1964, SCIENCE, V146, P1058, DOI 10.1126/science.146.3647.1058; Elgar MA, 1996, AUST J ECOL, V21, P464, DOI 10.1111/j.1442-9993.1996.tb00633.x; Foelix RF, 1996, BIOL SPIDERS; GILLESPIE RG, 1981, ANIM BEHAV, V29, P953, DOI 10.1016/S0003-3472(81)80033-4; Miyashita T, 1999, FUNCT ECOL, V13, P307, DOI 10.1046/j.1365-2435.1999.00318.x; Miyashita T, 1997, J ZOOL, V242, P137; NENTWIG W, 1982, OECOLOGIA, V53, P412, DOI 10.1007/BF00389023; OPELL BD, 1994, FUNCT ECOL, V8, P85, DOI 10.2307/2390115; Opell BD, 1996, AM NAT, V148, P630, DOI 10.1086/285944; Opell BD, 1997, BIOL J LINN SOC, V62, P443, DOI 10.1111/j.1095-8312.1997.tb01635.x; ROBINSON MH, 1975, ZOOL J LINN SOC-LOND, V56, P301, DOI 10.1111/j.1096-3642.1975.tb00272.x; ROBINSON MH, 1972, J NAT HIST, V6, P687, DOI 10.1080/00222937200770631; RYPSTRA AL, 1983, OECOLOGIA, V59, P312, DOI 10.1007/BF00378855; SHINKAI A, 1985, ATYPUS, V86, P9; SHINKAI A, 1982, ATYPUS, V100, P4; SIMONBRUNET B, 1994, SILKEN WEB NATURAL H; STOWE M K, 1986, P101; Suginaga A, 1963, ATYPUS, V31, P13; TANAKA K, 1991, OECOLOGIA, V86, P8, DOI 10.1007/BF00317382; YEARGAN KV, 1994, ANNU REV ENTOMOL, V39, P81	36	7	7	ACADEMIC PRESS LTD	LONDON	24-28 OVAL RD, LONDON NW1 7DX, ENGLAND	0024-4066			BIOL J LINN SOC	Biol. J. Linnean Soc.	OCT	2000	71	2					219	235		10.1111/j.1095-8312.2000.tb01255.x		17	Evolutionary Biology	Evolutionary Biology	368DC	WOS:000090101600003		
J	Sota, T; Kusumoto, F; Kubota, K				Sota, T; Kusumoto, F; Kubota, K			Consequences of hybridization between Ohomopterus insulicola and O-arrowianus (Coleoptera, Carabidae) in a segmented river basin: parallel formation of hybrid swarms	BIOLOGICAL JOURNAL OF THE LINNEAN SOCIETY			English	Article						carabid beetles; cline; hybridization; hybrid zone; hybrid swarm; genitalia; geographic variation; Ohomopterus	BEETLES	A putative hybrid zone between flightless carabid beetles, Carabus (Ohomopterus) insulicola and C. (O.) arrowianus nakamurai in the Ina Valley central Honshu, japan, was studied using experimental hybridization and morphological analysis. The principal morphological character analysed was a functional part of the male genitalia (the copulatory piece), which is also the key diagnostic character in taxonomy. The habitat of the carabid beetles is fragmented hv the Tenryu River, which runs through the Ina Valley: and its tributaries. Ohomopterus insulicola and O. a. nakamurai occur in the upstream and downstream areas of the river basin, respectively, and a putative hybrid swarm (O. insulicola ssp. pseudinsulicola) is found in the boundary area on the east side of the Tenryu River. Experimental hybridization between O, insulicola and O. a. nakamurai resulted in F-1 offspring that were morphologically similar to O. i. pseudinsulicola. Pre-zygotic reproductive isolation was incomplete, although the F-1 males had a dysfunction in sperm production and were almost sterile. Only a single F-1 pair produced F-2. Backcrosses of F-1 females of males of the parental species resulted in offspring that were similar to the parental species in genital morphology. Based on the discriminant function for the shape of the copulatory piece resulting from the experimental hybridization, we demonstrate that similar hybrid swarms exist on both sides of the Tenryu River, but in locations 25 km apart. This demonstrates parallelism in hybridization events with similar consequences. The hybrid swarms consisted of beetles with intermediate morphological characters and did not contain obvious parental forms. The establishment of such intermediate populations may have been facilitated by selection for fertile hybrids in segregated local sites in the absence of frequent immigration of parental species. This study suggests that a segmented river basin provides an opportunity for establishing novel evolutionary lineages resulting from hybridization. (C) 2000 The Linnean Society of London.	Kyoto Univ, Fac Sci, Dept Zool, Sakyo Ku, Kyoto 6068502, Japan; Shinshu Univ, Fac Sci, Dept Biol, Matsumoto, Nagano 3908521, Japan; Univ Tokyo, Div Agr & Agr Life Sci, Lab Forest Zool, Tokyo 1138657, Japan	Sota, T (reprint author), Kyoto Univ, Fac Sci, Dept Zool, Sakyo Ku, Kyoto 6068502, Japan.						Kubota K, 1998, RES POPUL ECOL, V40, P213, DOI 10.1007/BF02763406; Sota T, 1998, EVOLUTION, V52, P1507, DOI 10.2307/2411321; Haldane JBS, 1922, J GENET, V12, P101, DOI 10.1007/BF02983075; BARTON NH, 1985, ANNU REV ECOL SYST, V16, P113, DOI 10.1146/annurev.es.16.110185.000553; ARNOLD ML, 1997, NATURAL HIBRIDIZATIO; BURTON H, 1989, NATURE, V341, P497; BURTON H, 1993, HYBRID ZONES EVOLUTI, P13; Harrison R.G., 1990, Oxford Surveys in Evolutionary Biology, V7, P69; HARRISON RG, 1993, HYBRID ZONES AND THE EVOLUTIONARY PROCESS, P3; Ishikawa Ryosuke, 1994, Bulletin of the Biogeographical Society of Japan, V49, P105; Ishikawa R., 1978, Bulletin of the National Science Museum Series A (Zoology), V4, P45; ISHIKAWA R, 1991, EVOLUTION CARABUS; ISHIKAWA R, 1973, Bulletin of the National Science Museum (Tokyo), V16, P191; Ishikawa R., 1985, COLEOPTERA JAPAN COL, VII, P14; Ishikawa R., 1966, Bulletin of the National Science Museum Tokyo, V9, P9; ISHIKAWA R, 1987, Kontyu, V55, P202; KUBOTA K, 1991, Japanese Journal of Entomology, V59, P323; KUBOTA K, 1988, KONTYU TOKYO, V56, P370; LIEBHERR JK, 1998, B MUSEO REGIONAL SCI, P107; MOSSAKOWSKI D, 1986, CARBID BEETLES THEIR, P285; RIESEBERG LH, 1993, HYBRID ZONES AND THE EVOLUTIONARY PROCESS, P70; SOTA T, 1985, Kontyu, V53, P370; *STATS, 1994, STATISTICA; Su ZH, 1996, J MOL EVOL, V43, P662, DOI 10.1007/BF02202114	24	25	27	ACADEMIC PRESS LTD	LONDON	24-28 OVAL RD, LONDON NW1 7DX, ENGLAND	0024-4066			BIOL J LINN SOC	Biol. J. Linnean Soc.	OCT	2000	71	2					297	313		10.1111/j.1095-8312.2000.tb01259.x		17	Evolutionary Biology	Evolutionary Biology	368DC	WOS:000090101600007		
J	Murakami, M; Kashiwakura, I; Hayase, Y; Takahashi, TA; Tagaki, Y				Murakami, M; Kashiwakura, I; Hayase, Y; Takahashi, TA; Tagaki, Y			Effect of murine kidney extracts on the proliferation of hematopoietic progenitor cells in human umbilical cord blood	BIOLOGICAL & PHARMACEUTICAL BULLETIN			English	Article						kidney; megakaryocyte; CD34(+) cells; umbilical cord blood	C-MPL LIGAND; HUMAN-BONE-MARROW; COLONY-STIMULATING FACTOR; SERUM-FREE CULTURE; EX-VIVO EXPANSION; HUMAN MEGAKARYOCYTES; STEM-CELLS; IN-VITRO; MONOCLONAL-ANTIBODY; PLATELET PRODUCTION	We examined the effect of murine kidney extract (MKE) on the clonal growth of highly purified CD34(+) hematopoietic progenitor cells from human umbilical ford blood. MKE did not affect the total number of colonies of erythroid burst-forming units (BFU-E). granulocyte-macrophage colony-forming units (CFU-GM) or granulocyte-erythroid-macrophage-megakaryocyte colony-forming units (CFU-Mix/CFU-GEMM) in a methyl-cellulose culture with exogenous recombinant human granulocyte colany-stimulating factor; granulocyte-macrophage colony-stimulating factor, interleukin-3, stem cell factor and erythropoietin. MKE significantly increased the proportion of BFU-E- or CFU-Mix-derived colonies, and suppressed the formation CFU-GM-derived felonies depending on the MKE dose. However, because of an increase in small megakaryocyte colonies derived from mature CFU-Meg MKE increased bl approximately 40% the growth of megakaryocyte colony-forming units (CFU-Meg) in plasma clot culture stimulated by recombinant human thrombopoietin. Also MKE promoted an increase in hyperploid megakaryocytes, suggesting that the active factor(s) in MKE acts on the mature CFU-Meg and promotes the maturation of megakaryocytes, Gel-filtration high performance liquid chromatography. of MKE showed that the promoting factor(s) in MKE was approximately 45 kDa, These results indicate that the factor(s) detected in MKE influence human hematopoiesis in vitro, especially thrombopoiesis.	Hokkaido Coll Pharm, Lab Radiopharmaceut Sci, Otaru, Hokkaido 0470264, Japan; Univ Tokyo, Inst Med Sci, Cell Proc Dept, Minato Ku, Tokyo 1080071, Japan	Murakami, M (reprint author), Hokkaido Coll Pharm, Lab Radiopharmaceut Sci, 7-1 Katsuraoka Cho, Otaru, Hokkaido 0470264, Japan.	miho-c-m@hokuyakudai.ac.jp	Kashiwakura, Ikuo/F-2080-2013				AN E, 1994, EXP HEMATOL, V22, P149; LOK S, 1994, NATURE, V369, P565, DOI 10.1038/369565a0; NATHAN C, 1991, J CELL BIOL, V113, P981, DOI 10.1083/jcb.113.5.981; BROXMEYER HE, 1989, P NATL ACAD SCI USA, V86, P3828, DOI 10.1073/pnas.86.10.3828; LevLehman E, 1997, BLOOD, V89, P3644; GIANNI AM, 1989, LANCET, V2, P580; BROUDY VC, 1995, BLOOD, V85, P1719; TOROKSTORB B, 1988, BLOOD, V72, P373; ROBERTS R, 1988, NATURE, V332, P376, DOI 10.1038/332376a0; DESAUVAGE FJ, 1994, NATURE, V369, P533, DOI 10.1038/369533a0; SIMMONS PJ, 1991, BLOOD, V78, P2848; OGAWA M, 1993, BLOOD, V81, P2844; SHERIDAN WP, 1992, LANCET, V339, P640, DOI 10.1016/0140-6736(92)90795-5; Kashiwakura I, 2000, RADIAT RES, V153, P144, DOI 10.1667/0033-7587(2000)153[0144:RSOMCF]2.0.CO;2; SIMMONS PJ, 1991, BLOOD, V78, P55; MAXWELL AP, 1990, BRIT J HAEMATOL, V74, P535, DOI 10.1111/j.1365-2141.1990.tb06347.x; Bamba T, 1996, YAKUGAKU ZASSHI, V116, P719; BARTLEY TD, 1994, CELL, V77, P1117, DOI 10.1016/0092-8674(94)90450-2; BRENNAN JK, 1981, BLOOD, V58, P803; BRIDDELL RA, 1991, BLOOD, V78, P2854; BURSTEIN SA, 1992, J CELL PHYSIOL, V153, P305, DOI 10.1002/jcp.1041530210; CAROW CE, 1993, BLOOD, V81, P942; Choi ES, 1996, BRIT J HAEMATOL, V95, P227; Conrad PD, 1998, J LEUKOCYTE BIOL, V64, P147; Debili Najet, 1997, P217; Fisher JW, 1997, P SOC EXP BIOL MED, V216, P358; Hagiwara T, 1998, EXP HEMATOL, V26, P228; Han ZC, 1996, J CELL PHYSIOL, V168, P97; HAO QL, 1995, BLOOD, V86, P3745; HOFFMAN R, 1989, BLOOD, V74, P1196; ISHIBASHI T, 1987, J CLIN INVEST, V79, P286, DOI 10.1172/JCI112796; Ito T, 1996, BRIT J HAEMATOL, V94, P387, DOI 10.1046/j.1365-2141.1996.d01-1813.x; KASHIWAKURA I, 1995, BIOL PHARM BULL, V18, P1476; LONG MW, 1992, EXP HEMATOL, V20, P288; LOWRY OH, 1951, J BIOL CHEM, V193, P265; MEISTER B, 1993, EUR J PEDIATR, V152, P569, DOI 10.1007/BF01954082; MIYAZAKI H, 1992, EXP HEMATOL, V20, P855; Murakami M, 1999, BIOL PHARM BULL, V22, P1153; NISHIHIRA H, 1993, NIHON SHOUNI KETSUEK, V7, P558; Norol F, 1998, BLOOD, V91, P830; SAKAGUCHI M, 1987, EXP HEMATOL, V15, P1028; SASAYAMA N, 1999, BLOOD S1, V94, P2553; Schattner M, 1998, STEM CELLS, V16, P61; Schattner M, 1996, STEM CELLS, V14, P207; Schipper LF, 1998, BRIT J HAEMATOL, V101, P425; SEGAL GM, 1988, J CELL PHYSIOL, V137, P537, DOI 10.1002/jcp.1041370320; Shanks JH, 1996, J PATHOL, V179, P283; SICZKOWSKI M, 1992, BLOOD, V80, P912; SIENA S, 1993, EXP HEMATOL, V21, P1583; Takahashi TA, 1996, RES COMMUN MOL PATH, V91, P185; Tao H, 1999, EXP HEMATOL, V27, P293, DOI 10.1016/S0301-472X(98)00050-2; WILLIAMS N, 1982, J CELL PHYSIOL, V110, P101, DOI 10.1002/jcp.1041100116; WILLIAMS N, 1990, EXP HEMATOL, V18, P69; YONEMURA Y, 1992, EXP HEMATOL, V20, P1011; YUEN E, 1986, EXP HEMATOL, V14, P771; ZEIGLER FC, 1994, BLOOD, V84, P4045	56	1	1	PHARMACEUTICAL SOC JAPAN	TOKYO	2-12-15 SHIBUYA, SHIBUYA-KU, TOKYO, 150-0002, JAPAN	0918-6158			BIOL PHARM BULL	Biol. Pharm. Bull.	OCT	2000	23	10					1136	1142				7	Pharmacology & Pharmacy	Pharmacology & Pharmacy	360XU	WOS:000089693300003		
J	Fujiwara, M; Kato, T; Yamazaki, T; Yamasaki, K; Nagayama, K				Fujiwara, M; Kato, T; Yamazaki, T; Yamasaki, K; Nagayama, K			NMR structure of ribonuclease HI from Escherichia coli	BIOLOGICAL & PHARMACEUTICAL BULLETIN			English	Article						ribonuclease H; NOE; solution structure; distance geometry	MOLECULAR-DYNAMICS SIMULATION; NUCLEAR-MAGNETIC-RESONANCE; DISTANCE GEOMETRY; ACTIVE-SITE; PROTEINS; N-15; COMBINATION; ASSIGNMENTS; RELAXATION; RESIDUES	The solution structure of ribonuclease HI (RNase HI) from Escherichia coli (E. coli), a protein of 155 residues, was determined. Three-dimensional nuclear Overhauser enhancement spectroscopy (NOESY) was used to obtain 1424 distance constraints between individually assigned polypeptide chain hydrogen atoms. Supplemental geometric constraints of 90 phi angles and 12 chi(1), angles, and the distance constraints of 66 hydrogen bonds were experimentally derived. Using the DADAS90 program that calculates structures in dihedral angle space, 15 structures satisfying almost all constraints were obtained. The average root mean square deviation (RMSD) from the mean structure was 0.75 Angstrom for backbone atoms. The RMSD for backbone atoms between the representative NMR structure with the smallest constraint violation and crystal structures was within 1.2 Angstrom. Although the NMR and crystal structures thus resemble one another, a significant discrepancy was observed in a region termed 'basic protrusion' The discrepancy observed in NMR experiments is explained by fluctuation in this region.	JEOL DATUM Ltd, Analyt Engn Dept, Akishima, Tokyo 1960022, Japan; Osaka Univ, Inst Prot Res, Suita, Osaka 5650871, Japan; Prot Engn Res Inst, Suita, Osaka 5650874, Japan; Univ Tokyo, Grad Sch Arts & Sci, Meguro Ku, Tokyo 1538902, Japan	Fujiwara, M (reprint author), JEOL DATUM Ltd, Analyt Engn Dept, 1156 Nakagami Cho, Akishima, Tokyo 1960022, Japan.	masako@jeol.co.jp					KATAYANAGI K, 1992, J MOL BIOL, V223, P1029, DOI 10.1016/0022-2836(92)90260-Q; BRAUN W, 1985, J MOL BIOL, V186, P611, DOI 10.1016/0022-2836(85)90134-2; DOOLITTLE RF, 1989, Q REV BIOL, V64, P1, DOI 10.1086/416128; YANG W, 1990, SCIENCE, V249, P1398, DOI 10.1126/science.2169648; MANDEL AM, 1995, J MOL BIOL, V246, P144, DOI 10.1006/jmbi.1994.0073; RAMACHANDRAN GN, 1963, J MOL BIOL, V7, P95; KANAYA S, 1990, J BIOL CHEM, V265, P4615; BRAUN W, 1987, Q REV BIOPHYS, V19, P115; BROOKS CL, 1988, PROTEINS THEORETICAL, P194; Crouch R. J., 1982, NUCLEASES, P211; ENDO S, 1991, NATO ADV SCI I A-LIF, V225, P233; ISHIMA R, 1995, J BIOMOL NMR, V6, P217; Kashiwagi T, 1996, PROTEIN ENG, V9, P857, DOI 10.1093/protein/9.10.857; KATAYANAGI K, 1993, J BIOL CHEM, V268, P22092; NAGAYAMA K, 1990, J BIOCHEM-TOKYO, V108, P149; NEMETHY G, 1983, J PHYS CHEM-US, V87, P1883, DOI 10.1021/j100234a011; ODA Y, 1993, J BIOL CHEM, V268, P88; OTTING G, 1989, J MAGN RESON, V85, P586, DOI 10.1016/0022-2364(89)90249-7; Philippopoulos M, 1999, PROTEINS, V36, P87, DOI 10.1002/(SICI)1097-0134(19990701)36:1<87::AID-PROT8>3.0.CO;2-R; VUISTER GW, 1993, J AM CHEM SOC, V115, P5334, DOI 10.1021/ja00065a071; WAGNER G, 1987, J MOL BIOL, V196, P611, DOI 10.1016/0022-2836(87)90037-4; WAKO H, 1995, COMPUT PHYS COMMUN, V91, P233, DOI 10.1016/0010-4655(95)00050-P; Wuthrich K., 1986, NMR PROTEINS NUCL AC; YAMASAKI K, 1995, BIOCHEMISTRY-US, V34, P6587, DOI 10.1021/bi00020a003; YAMAZAKI T, 1993, BIOCHEMISTRY-US, V32, P5656, DOI 10.1021/bi00072a023; YAMAZAKI T, 1991, BIOCHEMISTRY-US, V30, P6036, DOI 10.1021/bi00238a030	26	7	7	PHARMACEUTICAL SOC JAPAN	TOKYO	2-12-15 SHIBUYA, SHIBUYA-KU, TOKYO, 150-0002, JAPAN	0918-6158			BIOL PHARM BULL	Biol. Pharm. Bull.	OCT	2000	23	10					1147	1152				6	Pharmacology & Pharmacy	Pharmacology & Pharmacy	360XU	WOS:000089693300005		
J	Nishiyama, K; Suzuki, H; Tokuda, H				Nishiyama, K; Suzuki, H; Tokuda, H			Role of the non-essential region encompassing the N-terminal two transmembrane stretches of Escherichia coli SecE	BIOSCIENCE BIOTECHNOLOGY AND BIOCHEMISTRY			English	Article						protein translocation; proteoliposome; FtsH; SecE; Escherichia coli	PROTEIN TRANSLOCATION ACTIVITY; CYTOPLASMIC MEMBRANE; SYNTHETIC LETHALITY; SECRETORY MACHINERY; CROSS-LINKING; DOUBLE MUTANT; RECONSTITUTION; FTSH; PURIFICATION; SUFFICIENT	SecE is an essential component of the protein translocation machinery of Escherichia coli and has three transmembrane stretches. An N-terminal region (SecE-N) encompassing the first two transmembrane stretches is dispensable for protein translocation but a SecE derivative (SecE-C) lacking this region is very unstable. We show here that FtsH, the AAA (ATPases associated with diverse cellular activities) family protease, causes the instability of SecE-C. SecE-C became stable when SecE-N was to-expressed. Deletion of the N-terminal region of SecE also rendered the SecE-SecY-SecG complex unstable. In spite of these alterations, the N-terminal region of SecE had little stimulatory effect on protein translocation in vivo or in vitro.	Univ Tokyo, Inst Mol & Cellular Biosci, Bunkyo Ku, Tokyo 1130032, Japan	Tokuda, H (reprint author), Univ Tokyo, Inst Mol & Cellular Biosci, Bunkyo Ku, 1-1-1 Yayoi, Tokyo 1130032, Japan.	htokuda@iam.u-tokyo.ac.jp					Nishiyama K, 1999, EMBO J, V18, P1049, DOI 10.1093/emboj/18.4.1049; Nishiyama K, 1998, BIOCHEM BIOPH RES CO, V251, P894, DOI 10.1006/bbrc.1998.9573; Harris CR, 1999, J BACTERIOL, V181, P3438; KIHARA A, 1995, P NATL ACAD SCI USA, V92, P4532, DOI 10.1073/pnas.92.10.4532; BRUNDAGE L, 1990, CELL, V62, P649, DOI 10.1016/0092-8674(90)90111-Q; GARDEL C, 1990, EMBO J, V9, P3209; Duong F, 1997, EMBO J, V16, P2756, DOI 10.1093/emboj/16.10.2756; TANI K, 1990, J BIOL CHEM, V265, P17341; Manting EH, 2000, EMBO J, V19, P852, DOI 10.1093/emboj/19.5.852; AKITA M, 1990, J BIOL CHEM, V265, P8164; Fekkes P, 1999, MICROBIOL MOL BIOL R, V63, P161; MATSUYAMA S, 1990, FEBS LETT, V269, P96, DOI 10.1016/0014-5793(90)81128-B; Nishiyama KI, 1996, CELL, V85, P71, DOI 10.1016/S0092-8674(00)81083-1; Economou A, 1995, CELL, V83, P1171, DOI 10.1016/0092-8674(95)90143-4; HARTMANN E, 1994, NATURE, V367, P654, DOI 10.1038/367654a0; NISHIYAMA K, 1993, EMBO J, V12, P3409; LOPILATO J, 1986, MOL GEN GENET, V205, P285, DOI 10.1007/BF00430440; BABA T, 1994, P NATL ACAD SCI USA, V91, P4539, DOI 10.1073/pnas.91.10.4539; BEGG KJ, 1992, J BACTERIOL, V174, P2416; FLOWER AM, 1994, J BACTERIOL, V176, P5607; FLOWER AM, 1995, EMBO J, V14, P884; HANADA M, 1994, J BIOL CHEM, V269, P23625; Kaufmann A, 1999, BIOCHEMISTRY-US, V38, P9115, DOI 10.1021/bi990539d; LOWRY OH, 1951, J BIOL CHEM, V193, P265; Matsumoto G, 1997, EMBO J, V16, P6384, DOI 10.1093/emboj/16.21.6384; MATSUYAMA S, 1993, EMBO J, V12, P265; NISHIYAMA K, 1991, BIOCHIM BIOPHYS ACTA, V1065, P89, DOI 10.1016/0005-2736(91)90015-Z; NISHIYAMA K, 1992, J BIOL CHEM, V267, P7170; NISHIYAMA K, 1995, BIOCHEM BIOPH RES CO, V217, P217, DOI 10.1006/bbrc.1995.2766; SCHATZ PJ, 1989, GENE DEV, V3, P1035, DOI 10.1101/gad.3.7.1035; SCHATZ PJ, 1991, EMBO J, V10, P1749; SHIBUI T, 1988, AGR BIOL CHEM TOKYO, V52, P983; Suzuki H, 1998, MOL MICROBIOL, V29, P331, DOI 10.1046/j.1365-2958.1998.00937.x; TOKUDA H, 1991, FEBS LETT, V279, P233, DOI 10.1016/0014-5793(91)80156-W; TOMOYASU T, 1995, EMBO J, V14, P2551; VIITANEN P, 1986, METHOD ENZYMOL, V125, P429; YAMADA H, 1989, J BIOL CHEM, V264, P1723	37	7	7	TAYLOR & FRANCIS LTD	ABINGDON	4 PARK SQUARE, MILTON PARK, ABINGDON OX14 4RN, OXON, ENGLAND	0916-8451	1347-6947		BIOSCI BIOTECH BIOCH	Biosci. Biotechnol. Biochem.	OCT	2000	64	10					2121	2127		10.1271/bbb.64.2121		7	Biochemistry & Molecular Biology; Biotechnology & Applied Microbiology; Chemistry, Applied; Food Science & Technology	Biochemistry & Molecular Biology; Biotechnology & Applied Microbiology; Chemistry; Food Science & Technology	370AT	WOS:000165100500014		
J	Nonaka, G; Ishikawa, T; Liu, TT; Nakajima, H; Kitamoto, K				Nonaka, G; Ishikawa, T; Liu, TT; Nakajima, H; Kitamoto, K			Genetic analysis of growth inhibition of yeast cells caused by expression of Aspergillus oryzae RNase T1	BIOSCIENCE BIOTECHNOLOGY AND BIOCHEMISTRY			English	Article						Aspergillus oryzae; RNase T1; Saccharomyces cerevisiae; secretory pathway	SACCHAROMYCES-CEREVISIAE; NUCLEOTIDE-SEQUENCE; CDNA CLONE; RESIDUES; PROTEASE	Even though most fungal hydrolytic enzymes have been successfully secreted in S. cerevisiae cells by expression of corresponding cDNA, overexpression of A. oryzae RNase T1 causes severe growth inhibition in yeast. We observed that yeast strains carrying RNase T1 cDNA under control of the GAL1 promoter with a single-copy vector were able to grow on galactose medium while those with a multi-copy vector were not. It was found that overexpression of three mutated versions of RNase T1 with low enzymatic activity did not affect the growth. We also observed that expression of RNase T1 without a signal sequence severely inhibited growth of the transformant even on the single-copy plasmid. Subcellular fractionation showed that overexpressed myc-tagged RNase T1 was localized in the membrane fraction. In the yeast secretory pathway, while the mutants defective in translocation into the ER, ER-Golgi trafficking and vacuole formation had severe growth inhibition during expression of RNase T1 from the single-copy plasmid. These results suggest that a mislocalization of active RNase T1 in cytosol by overflow from the secretory apparatus has toxic effects on the host cells.	Univ Tokyo, Dept Biotechnol, Bunkyo Ku, Tokyo 1138657, Japan	Kitamoto, K (reprint author), Univ Tokyo, Dept Biotechnol, Bunkyo Ku, Yayoi 1-1-1, Tokyo 1138657, Japan.	akitamo@mail.ecc.u-tokyo.ac.jp					NISHIKAWA S, 1987, BIOCHEMISTRY-US, V26, P8620, DOI 10.1021/bi00400a019; Hiller MM, 1996, SCIENCE, V273, P1725, DOI 10.1126/science.273.5282.1725; CHIRISTIANSON TW, 1922, GENE, V110, P119; EVAN GI, 1985, MOL CELL BIOL, V5, P3610; FUJII T, 1995, BIOSCI BIOTECH BIOCH, V59, P1869; HARA S, 1992, ASPERGILLUS BIOL IND, P33; Hashimoto H, 1997, BIOCHEM BIOPH RES CO, V241, P682, DOI 10.1006/bbrc.1997.7888; HATA Y, 1991, AGR BIOL CHEM TOKYO, V55, P941; Hata Y, 1998, GENE, V207, P127, DOI 10.1016/S0378-1119(97)00612-4; HEINEMANN U, 1982, NATURE, V229, P27; IKEHARA M, 1986, P NATL ACAD SCI USA, V83, P4695, DOI 10.1073/pnas.83.13.4695; Lee BR, 1995, APPL MICROBIOL BIOT, V44, P425; NAGASHIMA T, 1992, BIOSCI BIOTECH BIOCH, V56, P207; QUAAS R, 1989, NUCLEIC ACIDS RES, V17, P3318, DOI 10.1093/nar/17.8.3318; SIKORSKI RJ, 1989, GENETICS, V112, P19; SUGIO S, 1985, FEBS LETT, V183, P115, DOI 10.1016/0014-5793(85)80966-2; TAKAHASHI K, 1985, J BIOCH, V98, P845; TANAKA K, 1985, EMBO J, V1, P495; TATSUMI H, 1991, MOL GEN GENET, V228, P97; TATSUMI H, 1989, MOL GEN GENET, V219, P33	20	4	5	TAYLOR & FRANCIS LTD	ABINGDON	4 PARK SQUARE, MILTON PARK, ABINGDON OX14 4RN, OXON, ENGLAND	0916-8451	1347-6947		BIOSCI BIOTECH BIOCH	Biosci. Biotechnol. Biochem.	OCT	2000	64	10					2152	2158		10.1271/bbb.64.2152		7	Biochemistry & Molecular Biology; Biotechnology & Applied Microbiology; Chemistry, Applied; Food Science & Technology	Biochemistry & Molecular Biology; Biotechnology & Applied Microbiology; Chemistry; Food Science & Technology	370AT	WOS:000165100500018		
J	Akimoto, T; Sasaki, S; Ikebukuro, K; Karube, I				Akimoto, T; Sasaki, S; Ikebukuro, K; Karube, I			Effect of incident angle of light on sensitivity and detection limit for layers of antibody with surface plasmon resonance spectroscopy	BIOSENSORS & BIOELECTRONICS			English	Article						surface plasmon resonance; spectroscopy; immunosensor; sensitivity; antibody layer	SENSOR; BINDING; PROTEIN; EXCITATION; PRINCIPLES; BIOSENSOR; TOOL; SPR	The effect of the incident angle of light on sensitivity and the detection limit for surface-plasmon resonance spectroscopy were examined. The sensitivities and the detection limit were experimentally measured using an antibody as a modeled analyte in the incident angles of a light region of 66-76 degrees. The results showed that the sensitivity of a smaller incident angle was higher than that of a larger one. For instance, the sensitivity of a 66 degrees incident angle was three times higher than that of a 76 degrees incident angle. The detection limit with a 66 degrees incident angle was one-tenth of that with a 76 degrees incident angle. These sensitivities and detection limits were compared with those of a commercially produced surface-plasmon resonance instrument. This comparison demonstrated that a wavelength resolution of the order of less than 10(-2) nm was necessary to obtain satisfactory sensitivities and detection limits. In addition, the refractive index and thickness of the antibody layer formed on a sensor surface was proposed by experimental results and theoretical calculation. (C) 2000 Elsevier Science S.A. All rights reserved.	Univ Tokyo, Adv Sci & Technol Res Ctr, Meguro Ku, Tokyo 1538904, Japan	Karube, I (reprint author), Univ Tokyo, Adv Sci & Technol Res Ctr, Meguro Ku, 4-6-1 Komaba, Tokyo 1538904, Japan.		Ikebukuro, Kazunori/B-9957-2013	Ikebukuro, Kazunori/0000-0003-2838-0562			Akimoto T, 1999, APPL OPTICS, V38, P4058, DOI 10.1364/AO.38.004058; DEFEIJTER JA, 1978, BIOPOLYMERS, V17, P1759, DOI 10.1002/bip.1978.360170711; Kunz U, 1996, SENSOR ACTUAT B-CHEM, V32, P149, DOI 10.1016/0925-4005(96)80124-9; RAHN JR, 1995, LANGMUIR, V11, P650, DOI 10.1021/la00002a049; MATSUBARA K, 1988, APPL OPTICS, V27, P1160, DOI 10.1364/AO.27.001160; JORGENSON RC, 1994, SENSOR ACTUAT A-PHYS, V43, P44, DOI 10.1016/0924-4247(93)00661-M; KOOYMAN RPH, 1988, ANAL CHIM ACTA, V213, P35, DOI 10.1016/S0003-2670(00)81337-9; STENBERG E, 1991, J COLLOID INTERF SCI, V143, P513, DOI 10.1016/0021-9797(91)90284-F; Salamon Z, 1997, BBA-REV BIOMEMBRANES, V1331, P117, DOI 10.1016/S0304-4157(97)00004-X; KANO H, 1994, APPL OPTICS, V33, P5166, DOI 10.1364/AO.33.005166; Yeatman EM, 1996, BIOSENS BIOELECTRON, V11, P635, DOI 10.1016/0956-5663(96)83298-2; INNES RA, 1987, J PHYS F MET PHYS, V17, P277, DOI 10.1088/0305-4608/17/1/031; Kolomenskii AA, 1997, APPL OPTICS, V36, P6539, DOI 10.1364/AO.36.006539; Oudshoorn RGC, 1996, THIN SOLID FILMS, V284, P836, DOI 10.1016/S0040-6090(95)08459-2; SAMBLES JR, 1991, CONTEMP PHYS, V32, P173, DOI 10.1080/00107519108211048; Gaus K, 1998, BIOSENS BIOELECTRON, V13, P1307, DOI 10.1016/S0956-5663(98)00094-3; Homola J, 1997, SENSOR ACTUAT B-CHEM, V41, P207, DOI 10.1016/S0925-4005(97)80297-3; JORGENSON RC, 1993, SENSOR ACTUAT B-CHEM, V12, P213, DOI 10.1016/0925-4005(93)80021-3; KRETSCHM.E, 1971, Z PHYS, V241, P313, DOI 10.1007/BF01395428; Laricchia-Robbio L, 1998, BIOSENS BIOELECTRON, V13, P1055, DOI 10.1016/S0956-5663(98)00065-7; LIEDBERG B, 1983, SENSOR ACTUATOR, V4, P299, DOI 10.1016/0250-6874(83)85036-7; LUKOSZ W, 1991, BIOSENS BIOELECTRON, V6, P215, DOI 10.1016/0956-5663(91)80006-J; Raether H., 1988, SURFACE PLASMONS SMO; SUN XC, 1989, JPN J APPL PHYS 1, V28, P1725, DOI 10.1143/JJAP.28.1725; Vikinge TP, 1998, BIOSENS BIOELECTRON, V13, P1257, DOI 10.1016/S0956-5663(98)00085-2; WOHLHUETER RM, 1994, J IMMUNOL, V153, P181; ZIMMERMANN RM, 1990, J COLLOID INTERF SCI, V139, P268, DOI 10.1016/0021-9797(90)90462-W	27	30	30	ELSEVIER ADVANCED TECHNOLOGY	OXFORD	OXFORD FULFILLMENT CENTRE THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND	0956-5663			BIOSENS BIOELECTRON	Biosens. Bioelectron.	OCT	2000	15	7-8					355	362		10.1016/S0956-5663(00)00091-9		8	Biophysics; Biotechnology & Applied Microbiology; Chemistry, Analytical; Electrochemistry; Nanoscience & Nanotechnology	Biophysics; Biotechnology & Applied Microbiology; Chemistry; Electrochemistry; Science & Technology - Other Topics	369QV	WOS:000165079200004		
J	Chee, GJ; Nomura, Y; Ikebukuro, K; Karube, I				Chee, GJ; Nomura, Y; Ikebukuro, K; Karube, I			Optical fiber biosensor for the determination of low biochemical oxygen demand	BIOSENSORS & BIOELECTRONICS			English	Article						BOD sensor; biosensor; Pseudomonas putida; artificial wastewater; optical fiber sensor; fluorescence	BOD SENSOR; DISSOLVED-OXYGEN; MICROBIAL SENSOR; BACTERIA; PH	An optical fiber biosensor was developed for the evaluation of low Biochemical Oxygen Demand (BOD) values in river waters. Artificial wastewater (AWW) solution was employed as standards for the calibration of the BOD sensor. The response time of the sensor was 15 min, and the optimal BOD response was observed at 30 degreesC, pH 7.0. A linear relationship was obtained between the output voltage and BOD, values, and the range of determination was 1-10 mg l(-1) BOD. The sensor response was almost not influenced by chloride ion up to 1000 mg l(-1), and also not affected by heavy metal ions (Fe(3+), Cu(2+), Mn(2+), Cr(3+), Zn(2+)). The BOD of river waters was estimated by using the optical fiber biosensor, and good correlation between the sensor and BOD, test was obtained (r(2) = 0.971). (C) 2000 Elsevier Science S.A. All rights reserved.	Univ Tokyo, Adv Sci & Technol Res Ctr, Meguro Ku, Tokyo 1538904, Japan	Karube, I (reprint author), Univ Tokyo, Adv Sci & Technol Res Ctr, Meguro Ku, 4-6-1 Komaba, Tokyo 1538904, Japan.	karube@bio.rcast.u-tokyo.ac.jp	Ikebukuro, Kazunori/B-9957-2013	Ikebukuro, Kazunori/0000-0003-2838-0562			BAMBOT SB, 1994, BIOTECHNOL BIOENG, V43, P1139, DOI 10.1002/bit.260431119; ROGERS KR, 1995, BIOSENS BIOELECTRON, V10, P533, DOI 10.1016/0956-5663(95)96929-S; Yang Z, 1996, APPL MICROBIOL BIOT, V46, P10, DOI 10.1007/s002530050776; PREININGER C, 1994, ANAL CHEM, V66, P1841, DOI 10.1021/ac00083a011; Ferguson JA, 1997, ANAL CHIM ACTA, V340, P123, DOI 10.1016/S0003-2670(96)00510-7; HASTINGS JW, 1985, ADV MICROB PHYSIOL, V26, P235, DOI 10.1016/S0065-2911(08)60398-7; Chee GJ, 1999, ANAL CHIM ACTA, V379, P185, DOI 10.1016/S0003-2670(98)00680-1; BAMBOT SB, 1995, BIOSENS BIOELECTRON, V10, P643, DOI 10.1016/0956-5663(95)96941-Q; COLLINS YE, 1989, FACTORS AFFECTING TO, P31; GERHARDT P, 1981, AM SOC MICROBIOL; HARTMEIER W, 1993, 6 EUR C BIOT FIR 13; HIKUMA M, 1979, EUR J APPL MICROBIOL, V8, P289, DOI 10.1007/BF00508793; HYUN CK, 1993, BIOTECHNOL BIOENG, V41, P1107, DOI 10.1002/bit.260411114; Japanese Industrial Standard (JIS), 1990, K3602 JIS; KARUBE I, 1989, ANAL LETT, V22, P791; KARUBE I, 1977, J FERMENT TECHNOL, V55, P243; KULYS J, 1980, BIOTECHNOL BIOENG, V22, P221, DOI 10.1002/bit.260220116; LAKOWICZ JR, 1993, SENSOR ACTUAT B-CHEM, V11, P133, DOI 10.1016/0925-4005(93)85248-9; Lee SK, 1997, ANALYST, V122, P81, DOI 10.1039/a604885d; Lee Y. H., 1979, ADV BIOCHEM ENG, V13, P35; LI XM, 1994, SENSOR ACTUAT B-CHEM, V21, P143, DOI 10.1016/0925-4005(94)80016-2; *MIN CONSTR, 1992, RIV BUR; MURAKAMI K, 1421 PUBL WORKS RES; OHKI A, 1994, INT J ENVIRON AN CH, V56, P261, DOI 10.1080/03067319408034106; Qian ZR, 1998, WATER RES, V32, P801, DOI 10.1016/S0043-1354(97)00278-9; RandersEichhorn L, 1997, BIOTECHNOL BIOENG, V55, P921, DOI 10.1002/(SICI)1097-0290(19970920)55:6&lt;921::AID-BIT9&gt;3.0.CO;2-I; RIEDEL K, 1997, FRONTIERS BIOSENSORI, V2; RIEDEL K, 1990, WATER RES, V24, P883, DOI 10.1016/0043-1354(90)90138-V; RIEDEL K, 1988, APPL MICROBIOL BIOT, V28, P316; SAKAI Y, 1995, J FERMENT BIOENG, V80, P300, DOI 10.1016/0922-338X(95)90836-O; Sangeetha S, 1996, ELECTROANAL, V8, P698, DOI 10.1002/elan.1140080718; STRAND SE, 1984, J WATER POLLUT CON F, V56, P464; TAN TC, 1992, SENSOR ACTUAT B-CHEM, V8, P167, DOI 10.1016/0925-4005(92)80175-W; TAN TC, 1993, SENSOR ACTUAT B-CHEM, V10, P137, DOI 10.1016/0925-4005(93)80037-C; TANAKA H, 1994, WATER SCI TECHNOL, V30, P215; Towe BC, 1996, BIOSENS BIOELECTRON, V11, P799, DOI 10.1016/0956-5663(96)85931-8; Yang Z, 1997, SENSOR ACTUAT B-CHEM, V45, P217, DOI 10.1016/S0925-4005(97)00296-7	37	50	57	ELSEVIER ADVANCED TECHNOLOGY	OXFORD	OXFORD FULFILLMENT CENTRE THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND	0956-5663			BIOSENS BIOELECTRON	Biosens. Bioelectron.	OCT	2000	15	7-8					371	376		10.1016/S0956-5663(00)00093-2		6	Biophysics; Biotechnology & Applied Microbiology; Chemistry, Analytical; Electrochemistry; Nanoscience & Nanotechnology	Biophysics; Biotechnology & Applied Microbiology; Chemistry; Electrochemistry; Science & Technology - Other Topics	369QV	WOS:000165079200006		
J	Ji, HS; McNiven, S; Lee, KH; Saito, T; Ikebukuro, K; Karube, I				Ji, HS; McNiven, S; Lee, KH; Saito, T; Ikebukuro, K; Karube, I			Increasing the sensitivity of piezoelectric odour sensors based on molecularly imprinted polymers	BIOSENSORS & BIOELECTRONICS			English	Article						odorant sensors; piezoelectric quartz crystal; molecular imprinting	QUARTZ-CRYSTAL MICROBALANCE; SYNTHETIC CHEMORECEPTIVE MEMBRANES; NETWORK PATTERN-RECOGNITION; INTERCALATION BASED SENSORS; ODOROUS SUBSTANCES; CARBON-DIOXIDE; UNUSUAL LIPIDS; GAS SENSORS; THIN-FILMS; GEOSMIN	The molecular imprinting technique has been used to create sensors with a predetermined selectivity for molecules in the gas phase. Based on previous results, piezoelectric quartz crystals were first coated with a layer of nylon, to provide increased sensitivity, and then a layer of a polymer imprinted with 2-methylisoborneol (MIB) was applied to endow the device with selectivity. The response of the 'imprinted' sensor was significantly higher than the response of the 'non-imprinted' sensor at MIB concentrations above 10 ppb. Our new sensor is thus 20 times more sensitive than our previous device. At concentrations greater than 10 ppb, the response of the 'non-imprinted' sensor to geosmin, another odorant often accompanying MIB, was significantly higher than the response of the 'imprinted' sensor. A number of other odorants were examined and, as in our previous work, the responses of the 'non-imprinted' sensors were found to be to greater than the responses of the 'imprinted' sensors. (C) 2000 Elsevier Science S.A. All rights reserved.	Univ Tokyo, Adv Sci & Technol Res Ctr, Meguro Ku, Tokyo 1538904, Japan	Karube, I (reprint author), Univ Tokyo, Adv Sci & Technol Res Ctr, Meguro Ku, 4-6-1 Komaba, Tokyo 1538904, Japan.		Ikebukuro, Kazunori/B-9957-2013	Ikebukuro, Kazunori/0000-0003-2838-0562			SELLERGREN B, 1994, TETRAHEDRON-ASYMMETR, V5, P1403, DOI 10.1016/0957-4166(94)80096-0; Wu TZ, 1999, BIOSENS BIOELECTRON, V14, P9, DOI 10.1016/S0956-5663(98)00086-4; Lee SW, 1998, LANGMUIR, V14, P2857, DOI 10.1021/la9801763; CHANG SM, 1991, ANAL CHIM ACTA, V249, P323, DOI 10.1016/S0003-2670(00)83003-2; NICHOLLS IA, 1995, TRENDS BIOTECHNOL, V13, P47, DOI 10.1016/S0167-7799(00)88904-0; CAREY WP, 1986, ANAL CHEM, V58, P3077, DOI 10.1021/ac00127a037; Brousseau LC, 1997, ANAL CHEM, V69, P679, DOI 10.1021/ac960630c; WULFF G, 1995, ANGEW CHEM INT EDIT, V34, P1812, DOI 10.1002/anie.199518121; GERBER NN, 1977, J CHEM ECOL, V3, P475, DOI 10.1007/BF00988190; Mosbach K, 1996, BIO-TECHNOL, V14, P163, DOI 10.1038/nbt0296-163; WARD MD, 1990, SCIENCE, V249, P1000, DOI 10.1126/science.249.4972.1000; KING WH, 1964, ANAL CHEM, V36, P1735, DOI 10.1021/ac60215a012; Matsui J, 1996, J ORG CHEM, V61, P5414, DOI 10.1021/jo9516805; Dickert FL, 1996, ADV MATER, V8, P987, DOI 10.1002/adma.19960081209; POLAK EH, 1992, CHEM SENSES, V17, P23, DOI 10.1093/chemse/17.1.23; VLATAKIS G, 1993, NATURE, V361, P645, DOI 10.1038/361645a0; [Anonymous], 1994, TRENDS POLYM SCI; Pollak FC, 1996, APPL ENVIRON MICROB, V62, P1295; Bodenhofer K, 1997, NATURE, V387, P577; BORJESSON TS, 1993, J AGR FOOD CHEM, V412, P104; Brandrup J, 1999, POLYM HDB, pV/87; Brousseau LC, 1997, ANAL CHEM, V69, P688, DOI 10.1021/ac9606315; Budavari S., 1996, MERCK INDEX; CAREY WP, 1987, ANAL CHEM, V59, P1529, DOI 10.1021/ac00138a010; CAREY WP, 1986, ANAL CHEM, V58, P149, DOI 10.1021/ac00292a036; CHUNG SY, 1991, J AGR FOOD CHEM, V39, P764, DOI 10.1021/jf00004a030; CHUNG SY, 1990, J AGR FOOD CHEM, V38, P410, DOI 10.1021/jf00092a015; Craven MA, 1996, TRAC-TREND ANAL CHEM, V15, P486, DOI 10.1016/S0165-9936(96)00061-1; Dickert FL, 1998, ADV MATER, V10, P149, DOI 10.1002/(SICI)1521-4095(199801)10:2<149::AID-ADMA149>3.0.CO;2-2; EMA K, 1989, SENSOR ACTUATOR, V18, P291, DOI 10.1016/0250-6874(89)87036-2; GOPEL W, 1995, SENSOR ACTUAT B-CHEM, V24, P17, DOI 10.1016/0925-4005(95)85007-4; Grate JW, 1996, ANAL CHEM, V68, P913, DOI 10.1021/ac950518z; GUILBAULT GG, 1988, CRIT REV ANAL CHEM, V19, P1; GUILBAULT GG, 1983, ANAL CHEM, V55, P1682, DOI 10.1021/ac00261a010; HAUPTMANN P, 1993, SENSOR ACTUAT A-PHYS, V37-8, P309, DOI 10.1016/0924-4247(93)80052-I; HUANG C, 1996, J AWWA           APR, P116; Ji HS, 1999, ANAL CHIM ACTA, V387, P39, DOI 10.1016/S0003-2670(99)00068-9; Ji HS, 1999, ANAL CHIM ACTA, V390, P93, DOI 10.1016/S0003-2670(99)00258-5; KORTH W, 1992, WATER SCI TECHNOL, V25, P115; KORTH W, 1991, WATER RES, V25, P319, DOI 10.1016/0043-1354(91)90012-F; Kriz D, 1997, ANAL CHEM, V69, P345; KUROSAWA S, 1992, LANGMUIR, V8, P254, DOI 10.1021/la00037a047; LIDE DR, 1994, CRC HDB CHEM PHYSICS; MATSUNO G, 1995, IEEE T INSTRUM MEAS, V44, P739, DOI 10.1109/19.387321; Matsuura K, 1996, THIN SOLID FILMS, V273, P61, DOI 10.1016/0040-6090(95)06769-8; MCCALLUM JJ, 1989, ANALYST, V114, P1173, DOI 10.1039/an9891401173; MURAMATSU H, 1991, ANAL CHIM ACTA, V251, P135, DOI 10.1016/0003-2670(91)87126-R; OKAHATA Y, 1990, B CHEM SOC JPN, V63, P3082, DOI 10.1246/bcsj.63.3082; OKAHATA Y, 1990, ANAL CHEM, V62, P1431, DOI 10.1021/ac00213a017; PIRBAZARI M, 1992, WATER SCI TECHNOL, V25, P81; ROSEN A A, 1970, Water Treatment and Examination, V19, P106; SAUERBREY G, 1959, Z PHYS, V155, P206, DOI 10.1007/BF01337937; SCHMAUTZ A, 1992, SENSOR ACTUAT B-CHEM, V6, P38, DOI 10.1016/0925-4005(92)80028-V; Steinke J, 1995, ADV POLYM SCI, V123, P80; Yano K, 1997, ANAL CHIM ACTA, V340, P41, DOI 10.1016/S0003-2670(96)00522-3; Yano K, 1998, BIOSENS BIOELECTRON, V13, P397, DOI 10.1016/S0956-5663(97)00115-2; Yokouchi H, 1996, SENSOR MATER, V8, P69	57	30	36	ELSEVIER ADVANCED TECHNOLOGY	OXFORD	OXFORD FULFILLMENT CENTRE THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND	0956-5663			BIOSENS BIOELECTRON	Biosens. Bioelectron.	OCT	2000	15	7-8					403	409		10.1016/S0956-5663(00)00097-X		7	Biophysics; Biotechnology & Applied Microbiology; Chemistry, Analytical; Electrochemistry; Nanoscience & Nanotechnology	Biophysics; Biotechnology & Applied Microbiology; Chemistry; Electrochemistry; Science & Technology - Other Topics	369QV	WOS:000165079200010		
J	Kanamaru, T; Okabe, Y				Kanamaru, T; Okabe, Y			Stochastic resonance in a pulse neural network with a propagational time delay	BIOSYSTEMS			English	Article; Proceedings Paper	International Workshop on Neuronal Coding '99	OCT 11-15, 1999	OSAKA, JAPAN			Stochastic Resonance; FitzHugh-Nagumo equation; correlation coefficient; propagational time delay; noise-induced deterministic firing	SPIKE TRAINS; NOISE; CRAYFISH; MODELS	Stochastic resonance in a coupled FitzHugh-Nagumo equation with a propagational time delay is investigated. With an appropriate set of parameter values, i.e. the frequency of the periodic input, the propagational time delay, and the coupling strength, a deterministic firing induced by additive noise is observed, and its dependence on the number of neurons is examined. It is also found that a network composed of two assemblies shows a competitive behavior under control of the noise intensity. (C) 2000 Elsevier Science Ireland Ltd. All rights reserved.	Univ Tokyo, Adv Sci & Technol Res Ctr, Meguro Ku, Tokyo 1538904, Japan	Kanamaru, T (reprint author), Univ Tokyo, Adv Sci & Technol Res Ctr, Meguro Ku, 4-6-1 Komaba, Tokyo 1538904, Japan.						COLLINS JJ, 1995, NATURE, V376, P236, DOI 10.1038/376236a0; Pei X, 1996, J NEUROPHYSIOL, V76, P3002; Gammaitoni L, 1998, REV MOD PHYS, V70, P223, DOI 10.1103/RevModPhys.70.223; WIESENFELD K, 1994, PHYS REV LETT, V72, P2125, DOI 10.1103/PhysRevLett.72.2125; LONGTIN A, 1993, J STAT PHYS, V70, P309, DOI 10.1007/BF01053970; Bulsara AR, 1996, PHYS REV E, V53, P3958, DOI 10.1103/PhysRevE.53.3958; DOUGLASS JK, 1993, NATURE, V365, P337, DOI 10.1038/365337a0; DYKMAN MI, 1995, NUOVO CIMENTO D, V17, P661, DOI 10.1007/BF02451825; Kanamaru T, 1999, PHYS LETT A, V255, P23, DOI 10.1016/S0375-9601(99)00161-9; Mato G, 1998, PHYS REV E, V58, P876, DOI 10.1103/PhysRevE.58.876; Mato G, 1999, PHYS REV E, V59, P3339, DOI 10.1103/PhysRevE.59.3339; PALM G, 1988, BIOL CYBERN, V59, P1, DOI 10.1007/BF00336885; SAKUMURA Y, 1998, P 5 INT C NEUR INF P, P951; Shimokawa T, 1999, PHYS REV E, V59, P3427, DOI 10.1103/PhysRevE.59.3427; Wiesenfeld K, 1998, CHAOS, V8, P539, DOI 10.1063/1.166335	15	9	9	ELSEVIER SCI IRELAND LTD	CLARE	CUSTOMER RELATIONS MANAGER, BAY 15, SHANNON INDUSTRIAL ESTATE CO, CLARE, IRELAND	0303-2647			BIOSYSTEMS	Biosystems	OCT-DEC	2000	58	1-3					101	107		10.1016/S0303-2647(00)00112-X		7	Biology; Mathematical & Computational Biology	Life Sciences & Biomedicine - Other Topics; Mathematical & Computational Biology	384PG	WOS:000165953600014		
J	Watanabe, M; Takahashi, Y; Aihara, K				Watanabe, M; Takahashi, Y; Aihara, K			Associative memory model with temporal spike coding and active dendrite	BIOSYSTEMS			English	Article; Proceedings Paper	International Workshop on Neuronal Coding '99	OCT 11-15, 1999	OSAKA, JAPAN			temporal coding; active dendrite; storage capacity; associative memory	COINCIDENCE DETECTOR	We propose a neuron model whose internal state is integrated on a two dimensional phase space composed of time and dendritic space. Here, the postsynaptic potential is given as a curved surface on the phase space. Using the proposed neuron model, we introduce a continuous-time associative memory model with spike propagation delay and multiple synaptic sites on the dendrite. We show by numerical simulation that the memory capacity is doubled due to the effects of temporal spike coding and active dendrite compared to the sparse coding associative memory model. (C) 2000 Elsevier Science Ireland Ltd. All rights reserved.	Univ Tokyo, Grad Sch Engn, Dept Quantum Engn & Syst Sci, Bunkyo Ku, Tokyo 113, Japan; Japan Sci & Technol Corp, CREST, Kawaguchi, Saitama, Japan; Univ Tokyo, Grad Sch Engn, Dept Math Engn & Informat Phys, Bunkyo Ku, Tokyo 113, Japan	Watanabe, M (reprint author), Univ Tokyo, Grad Sch Engn, Dept Quantum Engn & Syst Sci, Bunkyo Ku, 7-3-1 Hongo, Tokyo 113, Japan.						ABELES M, 1982, ISRAEL J MED SCI, V18, P83; ANDERSON J A, 1972, Mathematical Biosciences, V14, P197, DOI 10.1016/0025-5564(72)90075-2; SOFTKY WR, 1993, J NEUROSCI, V13, P334; AMARI S, 1989, NEURAL NETWORKS, V2, P451, DOI 10.1016/0893-6080(89)90043-9; SOFTKY W, 1994, NEUROSCIENCE, V58, P13, DOI 10.1016/0306-4522(94)90154-6; Hopfield J J, 1982, P NATIONAL ACADEMY S, V79, P2445; KOHONEN T, 1972, IEEE T COMPUT, VC 21, P353; KONIG P, 1996, TINS, V19, P30; NAKANO K, 1972, IEEE T SYST MAN CYB, V2, P381; SHERRINGTON CS, 1906, INTERACTIVE ACTION N; Fujii H, 1996, NEURAL NETWORKS, V9, P1303, DOI 10.1016/S0893-6080(96)00054-8; VAADIA E, 1987, NEURONAL COOPERATIVI; Watanabe M, 1998, BIOL CYBERN, V78, P87, DOI 10.1007/s004220050416; Watanabe M, 1997, NEURAL NETWORKS, V10, P1353, DOI 10.1016/S0893-6080(97)00037-3	14	1	1	ELSEVIER SCI IRELAND LTD	CLARE	CUSTOMER RELATIONS MANAGER, BAY 15, SHANNON INDUSTRIAL ESTATE CO, CLARE, IRELAND	0303-2647			BIOSYSTEMS	Biosystems	OCT-DEC	2000	58	1-3					259	263		10.1016/S0303-2647(00)00130-1		5	Biology; Mathematical & Computational Biology	Life Sciences & Biomedicine - Other Topics; Mathematical & Computational Biology	384PG	WOS:000165953600032		
J	Matsuda, H; Tsukada, M; Aihara, T; Tatsuno, M; Aihara, K				Matsuda, H; Tsukada, M; Aihara, T; Tatsuno, M; Aihara, K			Chaotic stimulus dependent long-term potentiation in the hippocampal CA1 area	BIOSYSTEMS			English	Article; Proceedings Paper	International Workshop on Neuronal Coding '99	OCT 11-15, 1999	OSAKA, JAPAN			long-term potentiation (LTP); hippocampal CA1 neurons; chaotic stimulus (CS)	RABBIT FOLLOWING STIMULATION; SYNAPTIC TRANSMISSION; LASTING POTENTIATION; PERFORANT PATH; DENTATE AREA; INDUCTION; NEURONS; DEPRESSION; RESPONSES; MEMORY	In our previous report [Tsukada, M., Aihara, T., Saito, H., Kato, H., 1996. Neural Netw. 9, 1357-1365], the temporal pattern sensitivity of long-term potentiation (LTP) in hippocampal CA1 neurons was estimated by using Markov chain stimuli (MS) with different values of the serial correlation coefficient rho (1) between successive interstimulus-intervals. In this paper, the effect of chaotic stimuli (CS) on induction of LTP in the hippocampal CA1 area was investigated in comparison with that of MS and periodic pattern stimuli (PS). The CS were produced by a modified Bernoulli map, so that interstimulus sequences with various values of rho (1) can be generated by changing the parameter B. These stimuli had an identical first order statistics (mean interstimulus-interval), but their higher order statistics such as the serial correlation coefficients were different. The LTP induced by CS at B = 2 was significantly larger in magnitude than that of PS and MS, and also depended on the initial value of CS at B = 2 and 3. These results suggest that chaotic signals play an important role for memory coding in the hippocampal CA1 network. (C) 2000 Elsevier Science Ireland Ltd. All rights reserved.	Tamagawa Univ, Res Inst, Brain Sci Res Ctr, Tokyo 1948610, Japan; Tamagawa Univ, Fac Engn, Tokyo 1948610, Japan; Inst Phys & Chem Res, RIKEN, Brain Sci Inst, Wako, Saitama 3510198, Japan; Univ Tokyo, Grad Sch Engn, Bunkyo Ku, Tokyo 1138656, Japan; Japan Sci & Technol Corp, CREST, Kawaguchi, Saitama 3320012, Japan	Tsukada, M (reprint author), Tamagawa Univ, Res Inst, Brain Sci Res Ctr, 6-1-1 Tamagawagakuen, Tokyo 1948610, Japan.						Aihara T, 1997, HIPPOCAMPUS, V7, P416, DOI 10.1002/(SICI)1098-1063(1997)7:4<416::AID-HIPO7>3.0.CO;2-G; ARTOLA A, 1993, TRENDS NEUROSCI, V16, P480, DOI 10.1016/0166-2236(93)90081-V; ROSE GM, 1986, NEUROSCI LETT, V69, P244, DOI 10.1016/0304-3940(86)90487-8; MCNAUGHTON BL, 1987, TRENDS NEUROSCI, V10, P408, DOI 10.1016/0166-2236(87)90011-7; Fujii S, 1996, EXP BRAIN RES, V111, P305; BLISS TVP, 1973, J PHYSIOL-LONDON, V232, P331; DUNWIDDIE T, 1978, J PHYSIOL-LONDON, V276, P353; BLISS TVP, 1993, NATURE, V361, P31, DOI 10.1038/361031a0; BLISS TVP, 1973, J PHYSIOL-LONDON, V232, P357; HAYASHI H, 1995, BRAIN RES, V686, P194, DOI 10.1016/0006-8993(95)00485-9; ITO K, 1989, BIOMED RES-TOKYO, V10, P111; Tatsuno M, 1997, J PHYS SOC JPN, V66, P572, DOI 10.1143/JPSJ.66.572; Tsukada M, 1996, NEURAL NETWORKS, V9, P1357, DOI 10.1016/S0893-6080(96)00047-0; TSUKADA M, 1991, P IJCNN 91 INT JOINT, V3, P213; TSUKADA M, 1990, VISION, MEMORY AND THE TEMPORAL LOBE, P251; TSUKADA M, 1994, BIOL CYBERN, V70, P495, DOI 10.1007/BF00198802; YAMAMOTO C, 1981, EXP NEUROL, V74, P122, DOI 10.1016/0014-4886(81)90153-9	17	1	1	ELSEVIER SCI IRELAND LTD	CLARE	CUSTOMER RELATIONS MANAGER, BAY 15, SHANNON INDUSTRIAL ESTATE CO, CLARE, IRELAND	0303-2647			BIOSYSTEMS	Biosystems	OCT-DEC	2000	58	1-3					273	279		10.1016/S0303-2647(00)00132-5		7	Biology; Mathematical & Computational Biology	Life Sciences & Biomedicine - Other Topics; Mathematical & Computational Biology	384PG	WOS:000165953600034		
J	Suzuki, T; Hashimoto, S; Toyoda, N; Nagai, S; Yamazaki, N; Dong, HY; Sakai, J; Yamashita, T; Nukiwa, T; Matsushima, K				Suzuki, T; Hashimoto, S; Toyoda, N; Nagai, S; Yamazaki, N; Dong, HY; Sakai, J; Yamashita, T; Nukiwa, T; Matsushima, K			Comprehensive gene expression profile of LPS-stimulated human monocytes by SAGE	BLOOD			English	Article							SERIAL ANALYSIS; BLOOD MONOCYTES; MESSENGER-RNA; SEPTIC SHOCK; LIPOPOLYSACCHARIDE; CELLS; GROWTH; PATHOGENESIS; MACROPHAGES; ADENOSINE	Monocytes play a pivotal role in various human infectious and inflammatory diseases. To reveal a whole picture of pathophysiologic function of activated human monocytes, this study used the serial analysis of gene expression (SAGE) procedure in lipopolysaccharide (LPS)-stimulated human monocytes. A total of 35 874 tags corresponding to more than 12 000 different transcripts were sequenced. Comparison of gene expression profile with that of resting monocytes revealed the LPS-inducible gene expression profile. Many cytokines and chemokines, including interleukin (IL)-6, IL-1 alpha, IL-1 beta, tumor necrosis factor (TNF)-alpha, macrophage inflammatory protein (MIP)-1 beta, MIP-2 beta, MIP-2 alpha, liver and activation-regulated chemokine (LARC), MIP-1 alpha, thymus and activation-regulated chemokine (TARC), macrophage-derived chemokine (MDC), regulated on activation, normal T cell expressed and secreted (RANTES), growth-regulated oncogene (GRO) alpha, and IL-8, were observed in the highest inducible transcripts. Other genes encoding plasminogen activator inhibitor type 2 (PAI-2), Hc-gp39, apolipoproteins, malate dehydrogenase, matrix metalloproteinase-9 (MMP-9), and cyclooxygenase (COX2) were also highly elevated in LPS-stimulated monocytes. Moreover, upregulation of Naf1 beta, IL-7 receptor, adenosine receptor A2a, and many novel genes was newly identified. These results suggest that the LPS-inducible gene products may be involved In cell activation and migration, angiogenesis, tissue remodeling, and metabolism, and thus may orchestrate the inflammatory reactions. On the other hand, the expression of numerous sets of novel genes was discovered to be down-regulated on LPS stimulation. This study represents the first comprehensive analysis of LPS-inducible gene expression in human monocytes and provides tremendous novel information for the function of LPS-activated monocytes and targets for diagnosing, monitoring, and treating sepsis and various human infectious and inflammatory diseases.(Blood. 2000;96:2584-2591) (C) 2000 by The American Society of Hematology.	Univ Tokyo, Sch Med, Dept Mol Prevent Med, Bunkyo Ku, Tokyo 1130033, Japan; Univ Tokyo, Sch Med, CREST, Bunkyo Ku, Tokyo 1130033, Japan; Tohoku Univ, Inst Dev Aging & Canc, Dept Resp Oncol & Mol Med, Sendai, Miyagi, Japan	Matsushima, K (reprint author), Univ Tokyo, Sch Med, Dept Mol Prevent Med, Bunkyo Ku, 7-3-1 Hongo, Tokyo 1130033, Japan.						Yang RB, 1998, NATURE, V395, P284; GLAUSER MP, 1991, LANCET, V338, P732; HLA T, 1992, P NATL ACAD SCI USA, V89, P7384, DOI 10.1073/pnas.89.16.7384; VELCULESCU VE, 1995, SCIENCE, V270, P484, DOI 10.1126/science.270.5235.484; Baggiolini M, 1998, NATURE, V392, P565, DOI 10.1038/33340; WILHELM SM, 1989, J BIOL CHEM, V264, P17213; PARRILLO JE, 1990, ANN INTERN MED, V113, P227; ALDERSON MR, 1991, J EXP MED, V173, P923, DOI 10.1084/jem.173.4.923; BOUMA MG, 1994, J IMMUNOL, V153, P4159; Hashimoto S, 1999, BLOOD, V94, P837; Hibi K, 1998, CANCER RES, V58, P5690; Kirschning CJ, 1998, J EXP MED, V188, P2091, DOI 10.1084/jem.188.11.2091; Qureshi ST, 1999, J EXP MED, V189, P615, DOI 10.1084/jem.189.4.615; WEBB AC, 1987, J EXP MED, V166, P77, DOI 10.1084/jem.166.1.77; POTEMPA J, 1994, J BIOL CHEM, V269, P15957; Rollins BJ, 1997, BLOOD, V90, P909; Zhou P, 1998, BLOOD, V92, P3226; KOZOPAS KM, 1993, P NATL ACAD SCI USA, V90, P3516, DOI 10.1073/pnas.90.8.3516; POLVERINI PJ, 1977, NATURE, V269, P804, DOI 10.1038/269804a0; LIANG P, 1992, SCIENCE, V257, P967, DOI 10.1126/science.1354393; LEIBOVICH SJ, 1987, NATURE, V329, P630, DOI 10.1038/329630a0; Arras M, 1998, J CLIN INVEST, V101, P40, DOI 10.1172/JCI119877; OLAH ME, 1995, ANNU REV PHARMACOL, V35, P581, DOI 10.1146/annurev.pharmtox.35.1.581; Zhang L, 1997, SCIENCE, V276, P1268, DOI 10.1126/science.276.5316.1268; Polyak K, 1997, NATURE, V389, P300, DOI 10.1038/38525; Velculescu VE, 1997, CELL, V88, P243, DOI 10.1016/S0092-8674(00)81845-0; Karima R, 1999, MOL MED TODAY, V5, P123, DOI 10.1016/S1357-4310(98)01430-0; BONE RC, 1991, ANN INTERN MED, V115, P457; Chen HX, 1998, J EXP MED, V188, P1657, DOI 10.1084/jem.188.9.1657; FRATERSCHRODER M, 1987, P NATL ACAD SCI USA, V84, P5277, DOI 10.1073/pnas.84.15.5277; FUHLBRIGGE RC, 1987, J IMMUNOL, V138, P3799; Fukushi M, 1999, FEBS LETT, V442, P83, DOI 10.1016/S0014-5793(98)01631-7; Hashimoto S, 1999, BLOOD, V94, P845; HASKILL S, 1988, J IMMUNOL, V140, P1690; Madden SL, 1997, ONCOGENE, V15, P1079, DOI 10.1038/sj.onc.1201091; MATRISIAN LM, 1990, TRENDS GENET, V6, P121, DOI 10.1016/0168-9525(90)90126-Q; MERTEN MD, 1995, FEBS LETT, V369, P202, DOI 10.1016/0014-5793(95)00748-X; Poltorak A, 1998, SCIENCE, V282, P2085, DOI 10.1126/science.282.5396.2085; SCOTT MRD, 1983, CELL, V34, P557, DOI 10.1016/0092-8674(83)90388-4; STANDIFORD TJ, 1992, J IMMUNOL, V149, P2035; ULEVITCH RJ, 1995, ANNU REV IMMUNOL, V13, P437, DOI 10.1146/annurev.iy.13.040195.002253; WAHL SM, 1989, J CELL BIOCHEM, V40, P193, DOI 10.1002/jcb.240400208; WELGUS HG, 1990, J CLIN INVEST, V86, P1496, DOI 10.1172/JCI114867; Worthington MT, 1996, P NATL ACAD SCI USA, V93, P13754, DOI 10.1073/pnas.93.24.13754; ZIEGLER SF, 1991, J IMMUNOL, V147, P2234	45	159	164	AMER SOC HEMATOLOGY	WASHINGTON	1900 M STREET. NW SUITE 200, WASHINGTON, DC 20036 USA	0006-4971			BLOOD	Blood	OCT 1	2000	96	7					2584	2591				8	Hematology	Hematology	358HL	WOS:000089552500039		
J	Shiobara, S; Nakao, S; Ueda, M; Yamazaki, H; Takahashi, S; Asano, S; Yabe, H; Kato, S; Imoto, S; Maruta, A; Yoshida, T; Gondo, H; Morishima, Y; Kodera, Y				Shiobara, S; Nakao, S; Ueda, M; Yamazaki, H; Takahashi, S; Asano, S; Yabe, H; Kato, S; Imoto, S; Maruta, A; Yoshida, T; Gondo, H; Morishima, Y; Kodera, Y			Donor leukocyte infusion for Japanese patients with relapsed leukemia after allogeneic bone marrow transplantation: lower incidence of acute graft-versus-host disease and improved outcome	BONE MARROW TRANSPLANTATION			English	Article						DLI; GVL; outcome; Japanese; BMT	CHRONIC MYELOGENOUS LEUKEMIA; ADOPTIVE IMMUNOTHERAPY; UNRELATED DONORS; MYELOID-LEUKEMIA; CELL THERAPY; TRANSFUSIONS; LYMPHOCYTES; TOXICITY; EFFICACY; BMT	To clarify the role of donor leukocyte infusion (DLI) in the treatment of leukemia relapsing after allo-BMT, data from 100 patients were collected from 46 facilities in Japan and analyzed with respect to the efficacy and adverse effects of donor leukocyte infusion. Complete remission was achieved in 11 of 12 (91%) patients with relapsed chronic myelogenous leukemia (CML) in chronic phase, three of 11 (27%) with CML in the acute phase, eight of 21 (38%) with acute myelogenous leukemia (AML), six of 23 (25%) with acute lymphoblastic leukemia (ALL) and five of 11 (45%) with myelodysplastic syndrome (MDS). The probability of remaining in CR at 3 years was 82% in CML patients in the chronic phase, but 0% in those with CML in the acute phase, 7% in those with AML, 0% with ALL and 33% with MDS, Acute GVHD (greater than or equal to 2) developed in 31 of 89 (34%) patients with HLA-identical related donors and was fatal for seven (7%). Cytopenia developed in 21 of 94 (22%) with no associated fatalities. When the outcome of patients with CML in CP and MDS was analyzed, development of GVHD, cytopenia, or both, was associated with a higher GVL effect (15 of 16, 93%) than in those without adverse affects tone of 6, 17%). A leukocyte dose of 5 x 10(7)/kg of recipient body weight appeared to be optimal as an initial dose of DLI. Given the relatively low incidence of acute GVHD and the similar GVL effect, DLI may be more beneficial to patients in Japan with recurrent leukemia than to those in Western countries.	Kanazawa Univ Hosp, Div Transfus Med, Kanazawa, Ishikawa 920, Japan; Kanazawa Univ Hosp, Dept Med, Kanazawa, Ishikawa 920, Japan; Ishikawa Cent Hosp, Div Immunohematol, Kanazawa, Ishikawa, Japan; Univ Tokyo, Inst Med Sci, Dept Internal Med, Tokyo, Japan; Tohkai Univ, Sch Med, Dept Pediat, Nagoya, Aichi, Japan; Hyogo Med Ctr Adults, Kobe, Hyogo, Japan; Kanagawa Canc Ctr, Kanagawa, Japan; Toyama Prefectural Cent Hosp, Toyama, Japan; Kyushu Univ Hosp, Dept Internal Med 1, Fukuoka, Japan; Nagoya Canc Ctr, Nagoya, Aichi, Japan; Japanese Red Cross Nagoya First Hosp, Div Hematol, Nagoya, Aichi, Japan	Shiobara, S (reprint author), Kanazawa Univ Hosp, Div Transfus Med, 13-1 Takara Machi, Kanazawa, Ishikawa 920, Japan.						MACKINNON S, 1995, BLOOD, V86, P1261; Alyea EP, 1998, BLOOD, V91, P3671; Yazaki M, 1997, BONE MARROW TRANSPL, V19, P393, DOI 10.1038/sj.bmt.1700663; WEIDEN PL, 1979, NEW ENGL J MED, V300, P1068, DOI 10.1056/NEJM197905103001902; Collins RH, 1997, J CLIN ONCOL, V15, P433; DROBYSKI WR, 1993, BLOOD, V82, P2310; KOLB HJ, 1990, BLOOD, V76, P2462; KOLB HJ, 1995, BLOOD, V86, P2041; Sasazuki T, 1998, NEW ENGL J MED, V339, P1177, DOI 10.1056/NEJM199810223391701; COLLIS JO, 1992, BLOOD, V79, P1379; HELG C, 1993, BONE MARROW TRANSPL, V12, P125; Kodera Y, 1999, BONE MARROW TRANSPL, V24, P995, DOI 10.1038/sj.bmt.1702027; MORISHIMA Y, 1995, BONE MARROW TRANSPL, V15, P235; Ogawa H, 1998, BONE MARROW TRANSPL, V21, P525, DOI 10.1038/sj.bmt.1701123; Slavin S, 1996, BLOOD, V87, P2195; Slavin S, 1995, EXP HEMATOL, V23, P1553; SULLIVAN KM, 1989, NEW ENGL J MED, V320, P828, DOI 10.1056/NEJM198903303201303; WAGNER FF, 1995, TRANSFUSION, V35, P284, DOI 10.1046/j.1537-2995.1995.35495216075.x	18	46	47	NATURE PUBLISHING GROUP	BASINGSTOKE	HOUNDMILLS, BASINGSTOKE RG21 6XS, HAMPSHIRE, ENGLAND	0268-3369			BONE MARROW TRANSPL	Bone Marrow Transplant.	OCT	2000	26	7					769	774		10.1038/sj.bmt.1702596		6	Biophysics; Oncology; Hematology; Immunology; Transplantation	Biophysics; Oncology; Hematology; Immunology; Transplantation	362TP	WOS:000089794600010		
J	Ishii, T; Manabe, A; Ebihara, Y; Ueda, T; Yoshina, H; Mitsui, T; Hisakawa, H; Yagasaki, H; Kikuchi, A; Yoshimasu, T; Tanaka, T; Takahashi, T; Masunaga, A; Sugita, K; Nakahata, T; Asano, S; Tsuji, K				Ishii, T; Manabe, A; Ebihara, Y; Ueda, T; Yoshina, H; Mitsui, T; Hisakawa, H; Yagasaki, H; Kikuchi, A; Yoshimasu, T; Tanaka, T; Takahashi, T; Masunaga, A; Sugita, K; Nakahata, T; Asano, S; Tsuji, K			Improvement in bronchiolitis obliterans organizing pneumonia in a child after allogeneic bone marrow transplantation by a combination of oral prednisolone and low dose erythromycin	BONE MARROW TRANSPLANTATION			English	Article						bone marrow transplantation; BOOP; chronic GVHD; erythromycin	PULMONARY COMPLICATIONS	We report a 13-year-old boy who developed dyspnea at rest 1 year after the occurrence of cGVHD following an allogeneic bone marrow transplant (BMT), Pulmonary function data, imaging studies, lung biopsy, and bronchoalveolar lavage were consistent with the diagnosis of bronchiolitis obliterans organizing pneumonia (BOOP), Although reports suggest that oral methylprednisolone or methylprednisolone pulse therapies improve BOOP after BMT, we treated our patient with a combination of oral prednisolone (1 mg/kg) and low dose erythromycin (10 mg/kg) to avoid the side-effects of high-dose steroids. With this therapy, our patient showed clinical and radiological improvements within 1 week, The steroids were tapered off 12 months later and erythromycin was given for 14 months, We conclude that therapy consisting of a combination of oral prednisolone and low-dose erythromycin for BOOP after BMT may minimize the dose and duration of steroid use.	Univ Tokyo, Inst Med Sci, Dept Pediat Hematol Oncol, Minato Ku, Tokyo, Japan; Univ Tokyo, Inst Med Sci, Dept Cell Transfus, Minato Ku, Tokyo, Japan; Univ Tokyo, Inst Med Sci, Dept Infect Dis, Minato Ku, Tokyo, Japan; Univ Tokyo, Inst Med Sci, Dept Pathol, Minato Ku, Tokyo, Japan; Dokkyo Med Sch, Dept Pediat, Mibu, Tochigi, Japan	Tsuji, K (reprint author), Univ Tokyo, Inst Med Sci, Dept Pediat Hematol Oncol, Minato Ku, 4-6-1 Shirokanedai, Tokyo, Japan.						Kleinau I, 1997, BONE MARROW TRANSPL, V19, P841, DOI 10.1038/sj.bmt.1700755; KROWKA MJ, 1985, CHEST, V87, P237, DOI 10.1378/chest.87.2.237; CHAN CK, 1990, CLIN CHEST MED, V11, P323; CORDONNIER C, 1986, CANCER, V58, P1047, DOI 10.1002/1097-0142(19860901)58:5<1047::AID-CNCR2820580512>3.0.CO;2-Y; GARY RE, 1995, BLOOD, V10, P65; HAMILTON PJ, 1986, THORAX, V41, P497, DOI 10.1136/thx.41.7.497; ICHIKAWA Y, 1992, AM REV RESPIR DIS, V146, P196; Ichikawa Yoichiro, 1993, Kurume Medical Journal, V40, P65; MUKAE H, 1995, CHEST, V108, P123, DOI 10.1378/chest.108.1.123; NOBLE PW, 1989, WESTERN J MED, V150, P443; Palmas A, 1998, BRIT J HAEMATOL, V100, P680, DOI 10.1046/j.1365-2141.1998.00617.x	11	23	25	NATURE PUBLISHING GROUP	BASINGSTOKE	HOUNDMILLS, BASINGSTOKE RG21 6XS, HAMPSHIRE, ENGLAND	0268-3369			BONE MARROW TRANSPL	Bone Marrow Transplant.	OCT	2000	26	8					907	910		10.1038/sj.bmt.1702642		4	Biophysics; Oncology; Hematology; Immunology; Transplantation	Biophysics; Oncology; Hematology; Immunology; Transplantation	366ZM	WOS:000090036200016		
J	Asano, Y; Minagawa, K; Okuda, A; Matsui, T; Ando, K; Kondo-Iida, E; Kobayashi, O; Toda, T; Nonaka, I; Tanizawa, T				Asano, Y; Minagawa, K; Okuda, A; Matsui, T; Ando, K; Kondo-Iida, E; Kobayashi, O; Toda, T; Nonaka, I; Tanizawa, T			A case of Walker-Warburg syndrome	BRAIN & DEVELOPMENT			English	Article						Walker-Warburg syndrome; type II lissencephaly; Fukuyama-type congenital muscular dystrophy	CONGENITAL MUSCULAR-DYSTROPHY; FUKUYAMA-TYPE	Walker-Warburg syndrome (WWS) is an autosomal recessive disorder characterized by type II lissencephaly, cerebellar and retinal anomalies, and congenital muscular dystrophy. We report a female diagnosed with WWS based on clinical criteria. This patient was found to have fetal hydrocephalus on ultrasonography at 29 weeks of gestation, and exhibited severs hypotonia, ocular malformations, and hydrocephalus at birth. MRI revealed type II lissencephaly, hydrocephalus, and other severe brain malformations. Genetic analysis was performed to distinguish WWS from severe Fukuyama-type congenital muscular dystrophy (FCMD), which has numerous findings in common. This revealed no expression of the founder haplotype or single-stranded conformation polymorphism (SSCP) abnormalities. Since the life expectancy of patients with FCMD is longer, differential diagnosis should be performed precisely. (C) 2000 Elsevier Science B.V. All rights reserved.	Hyogo Coll Med, Dept Pediat, Nishinomiya, Hyogo 6638501, Japan; Hyogo Coll Med, Dept Radiol, Nishinomiya, Hyogo 6638501, Japan; Univ Tokyo, Inst Med Sci, Ctr Human Genome, Lab Genome Med,Minato Ku, Tokyo 1088639, Japan; Natl Def Sch Med, Dept Pediat, Tokorozawa, Saitama 3590042, Japan; Natl Ctr Neurol & Psychiat, Natl Inst Neurosci, Dept Ultrastruct Res, Tokyo 1878502, Japan	Asano, Y (reprint author), 64-3-B-201 Yamauchi Cho, Sasayama, Hyogo 6692337, Japan.						DOBYNS WB, 1989, AM J MED GENET, V32, P195, DOI 10.1002/ajmg.1320320213; Kobayashi K, 1998, NATURE, V394, P388; DOBYNS WB, 1993, BRAIN DEV-JPN, V15, P242, DOI 10.1016/0387-7604(93)90074-I; Fukuyama Y, 1960, PAEDIATR U TOKYO, V4, P5; FUKUYAMA Y, 1981, BRAIN DEV-JPN, V3, P1; KIMURA S, 1993, BRAIN DEV-JPN, V15, P182, DOI 10.1016/0387-7604(93)90063-E; Kondo E, 1996, AM J MED GENET, V66, P169, DOI 10.1002/(SICI)1096-8628(19961211)66:2<169::AID-AJMG8>3.0.CO;2-M; TODA T, 2000, SHINKEI KENKYU NO SH, V44, P223; TODA T, 1993, NAT GENET, V5, P283, DOI 10.1038/ng1193-283	9	4	4	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	0387-7604			BRAIN DEV-JPN	Brain Dev.	OCT	2000	22	7					454	457		10.1016/S0387-7604(00)00181-9		4	Clinical Neurology	Neurosciences & Neurology	387HZ	WOS:000166118300010		
J	Sugita, S; Taguchi, C; Takase, H; Sagawa, K; Sueda, J; Fukushi, K; Hikita, N; Watanabe, T; Itoh, K; Mochizuki, M				Sugita, S; Taguchi, C; Takase, H; Sagawa, K; Sueda, J; Fukushi, K; Hikita, N; Watanabe, T; Itoh, K; Mochizuki, M			Soluble Fas ligand and soluble Fas in ocular fluid of patients with uveitis	BRITISH JOURNAL OF OPHTHALMOLOGY			English	Article							TUMOR-NECROSIS-FACTOR; AQUEOUS-HUMOR; MEDIATED CYTOTOXICITY; IMMUNE PRIVILEGE; EXPRESSION; CELLS; APOPTOSIS; ANTIGEN; MECHANISM; MOLECULE	Aims-To investigate the presence of soluble Fas ligand (sFasL) and soluble Fas (sFas) in ocular fluid of patients with uveitis. Methods-Samples of aqueous humour (AH, n=17), vitreous fluid (n=9), and serum (n=60) were collected from patients with uveitis which included Behcet's disease, Vogt-Koyanagi-Harada disease, sarcoidosis, human T lymphotropic virus type 1 (HTLV-I) uveitis, sympathetic ophthalmia, HLA-B27 associated acute anterior uveitis, and ocular toxoplasmosis. The AH of patients with age related cataract without uveitis obtained during cataract surgery was used as controls (n=20). The amounts of sFasL and sFas were measured by enzyme linked immunosorbent assay. Results-Significant amounts of sFasL were detected in AH of patients with age related cataract (non-uveitis group). sFasL was also detected in AH of patients with uveitis, though the amounts were slightly lower than those in the non-uveitis group. On the other hand, the levels of sFas in AH of patients with uveitis were significantly higher than those in controls. As for the disease activity, the levels of sFasL and sFas in the vitreous fluid of patients with active uveitis were significantly higher than those in inactive uveitis. sFasL in the serum of healthy donors and patients with uveitis was below detectable levels, except for patients with HTLV-I uveitis who had significant amounts of sFasL in the serum. The levels of sFas in the serum of patients with Behcet's disease, sarcoidosis, and HTLV-I uveitis were significantly higher than those of healthy donors. Conclusions-sFasL is present in the AH of non-uveitic eyes with age related cataract. Intraocular levels of sFasL and sFas are significantly increased in uveitis, particularly in active uveitis. These data suggest that intraocular sFasL and sFas may have a regulatory role in uveitis.	Tokyo Med & Dent Univ, Grad Sch Med, Dept Visual Sci, Tokyo, Japan; Kurume Univ, Sch Med, Dept Ophthalmol, Fukuoka, Japan; Kurume Univ, Sch Med, Dept Immunol, Fukuoka, Japan; Kurume Univ, Sch Med, Dept Transfus Med, Fukuoka, Japan; Univ Tokyo, Inst Med Sci, Dept Pathol, Tokyo, Japan	Sugita, S (reprint author), Tokyo Med & Dent Univ, Grad Sch, Dept Ophthalmol & Visual Sci, Bunkyou Ku, 1-5-45 Yushima, Tokyo 1130034, Japan.						GRIFFITH TS, 1995, SCIENCE, V270, P1189, DOI 10.1126/science.270.5239.1189; ARASE H, 1995, J EXP MED, V181, P1235, DOI 10.1084/jem.181.3.1235; SUDA T, 1993, CELL, V75, P1169, DOI 10.1016/0092-8674(93)90326-L; SMITH CA, 1994, CELL, V76, P959, DOI 10.1016/0092-8674(94)90372-7; BELLGRAU D, 1995, NATURE, V377, P630, DOI 10.1038/377630a0; YONEHARA S, 1989, J EXP MED, V169, P1747, DOI 10.1084/jem.169.5.1747; NUSSENBLATT RB, 1985, OPHTHALMOLOGY, V92, P467; Tanaka M, 1998, NAT MED, V4, P31, DOI 10.1038/nm0198-031; DiGirolamo N, 1996, CURR EYE RES, V15, P1060; SUDA T, 1995, J IMMUNOL, V154, P3806; TANAKA M, 1995, EMBO J, V14, P1129; Clark LB, 1996, ADV IMMUNOL, V63, P43; NAGATA S, 1995, SCIENCE, V267, P1449, DOI 10.1126/science.7533326; ABREUMARTIN MT, 1995, J IMMUNOL, V155, P4147; TAYLOR AW, 1994, J IMMUNOL, V153, P1080; BARKER CF, 1977, ADV IMMUNOL, V25, P1; TAYLOR AW, 1992, CURR EYE RES, V11, P1199, DOI 10.3109/02713689208999545; CHENG JH, 1994, SCIENCE, V263, P1759, DOI 10.1126/science.7510905; CASCINO I, 1995, J IMMUNOL, V154, P2706; COUSINS SW, 1991, INVEST OPHTH VIS SCI, V32, P2201; CRAIG BT, 1995, SCIENCE, V267, P1456; HANABUCHI S, 1994, P NATL ACAD SCI USA, V91, P4930, DOI 10.1073/pnas.91.11.4930; KAYAGAKI N, 1995, J EXP MED, V182, P1777, DOI 10.1084/jem.182.6.1777; KNISELY TL, 1994, INVEST OPHTH VIS SCI, V35, P3711; Lens SMA, 1996, EUR J IMMUNOL, V26, P2964, DOI 10.1002/eji.1830261223; NAKAMURA S, 1997, J JPN OPHTHALMOL SOC, V101, P975; Ono A, 1997, INVEST OPHTH VIS SCI, V38, P676; RAJENDRA SA, 1996, J IMMUNOL, V156, P2667; Tanaka M, 1996, NAT MED, V2, P317, DOI 10.1038/nm0396-317; WATANABEFUKUNAGA R, 1992, J IMMUNOL, V148, P1274	30	33	34	BRITISH MED JOURNAL PUBL GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0007-1161			BRIT J OPHTHALMOL	Br. J. Ophthalmol.	OCT	2000	84	10					1130	1134		10.1136/bjo.84.10.1130		5	Ophthalmology	Ophthalmology	361JQ	WOS:000089720300012		
J	Morifuji, T				Morifuji, T			A remark on the eta-invariant for automorphisms of hyperelliptic Riemann surfaces	BULLETIN OF THE AUSTRALIAN MATHEMATICAL SOCIETY			English	Article							MAPPING TORI; REDUCIBILITY	We give a characterisation for the vanishing of the eta -invariant of prime order automorphisms of hyperelliptic Riemann surfaces through the mapping torus construction. To this end, we introduce a notion of s-symmetry for finite order surface automorphisms.	Univ Tokyo, Grad Sch Math Sci, Meguro Ku, Tokyo 1538914, Japan							AKITA T, UNPUB; ATIYAH MF, 1975, MATH PROC CAMBRIDGE, V77, P43, DOI 10.1017/S0305004100049410; Broughton S. A., 1990, J PURE APPL ALGEBRA, V69, P233; Casson A.J., 1988, AUTOMORPHISMS SURFAC; Farkas H. M., 1980, GRADUATE TEXTS MATH, V71; GILMAN J, 1983, P LOND MATH SOC, V47, P27; MEYERHOFF R, 1990, DUKE MATH J, V61, P747, DOI 10.1215/S0012-7094-90-06127-7; Morifuji T, 1997, TOPOL APPL, V75, P41, DOI 10.1016/S0166-8641(96)00082-X; Morifuji T, 1997, J KNOT THEOR RAMIF, V6, P827, DOI 10.1142/S0218216597000467; Morifuji T, 1998, P AM MATH SOC, V126, P1945, DOI 10.1090/S0002-9939-98-04297-X; RADEMACHER H, 1971, CARUS MATH MONOGRAPH, V16	11	1	1	AUSTRALIAN MATHEMATICS PUBL ASSOC INC	CANBERRA	MATHEMATICS DEPT AUSTRALIAN NATIONAL UNIV, CANBERRA, ACT 0200, AUSTRALIA	0004-9727			B AUST MATH SOC	Bull. Aust. Math. Soc.	OCT	2000	62	2					177	182				6	Mathematics	Mathematics	366FK	WOS:000089994000001		
J	Kawada, A; Mitamura, S; Matsuo, J; Tsuchiya, T; Kobayashi, S				Kawada, A; Mitamura, S; Matsuo, J; Tsuchiya, T; Kobayashi, S			Friedel-Crafts reactions catalyzed by rare earth metal trifluoromethanesulfonates	BULLETIN OF THE CHEMICAL SOCIETY OF JAPAN			English	Article							SUPERCRITICAL CARBON-DIOXIDE; SILYL ENOL ETHERS; DIELS-ALDER REACTIONS; COMMERCIAL FORMALDEHYDE SOLUTION; MANNICH-TYPE REACTIONS; LEWIS-ACID CATALYSTS; SINGLE CHIRAL SOURCE; LANTHANIDE TRIFLATE; FACILE SYNTHESIS; MICELLAR SYSTEMS	Rare earth metal trifluoromethanesulfonates (rare earth metal triflates, RE(OTf)(3)) were found to be efficient catalysts for Friedel-Crafts acylation and alkylation. In the presence of a catalytic amount of RE(OTf)(3), acylation of aromatic compounds having electron-donating substituents such as anisole, thioanisole, and mesitylene with acid anhydrides proceeded smoothly to afford the corresponding aromatic ketones in high yields. Although RE(OTf)(3) alone is not effective for acylation of less reactive aromatics such as toluene, the combination of RE(OTf)(3) and lithium perchlorate (LiClO4) enhanced the catalytic activity dramatically. Friedel-Crafts acylation reactions using rare earth metal perfluoroalkanesulfonates were also successfully performed in supercritical carbon dioxide (scCO(2)). Moreover, in the presence of a catalytic amount of RE(OTf)(3), aromatic compounds reacted with benzyl chloride smoothly to afford the corresponding alkylation products in high yields. In these reactions, RE(OTf)(3) could be easily recovered after the reactions were completed and could be reused without loss of activity.	Nippon Steel Chem Co Ltd, Res & Dev Labs, Tobata Ku, Kitakyushu, Fukuoka 8048503, Japan; Univ Tokyo, CREST, Japan Sci & Technol Corp, JST,Grad Sch Pharmaceut Sci,Bunkyo Ku, Tokyo 1130033, Japan	Kobayashi, S (reprint author), Sci Univ Tokyo, Fac Sci, Dept Appl Chem, Shinjyuku Ku, Tokyo 1628601, Japan.		Kobayashi, Shu/E-9214-2012				AKPORIAYE DE, 1993, STUD SURF SCI CATAL, V78, P521; Kainz S, 1997, ANGEW CHEM INT EDIT, V36, P1628, DOI 10.1002/anie.199716281; INANAGA J, 1995, NEW J CHEM, V19, P707; Jacob B, 1999, J MOL CATAL A-CHEM, V139, P43, DOI 10.1016/S1381-1169(98)00187-3; KOBAYASHI S, 1994, J ORG CHEM, V59, P3590, DOI 10.1021/jo00092a017; OLAH GA, 1962, J AM CHEM SOC, V84, P2733, DOI 10.1021/ja00873a019; KOBAYASHI S, 1994, J AM CHEM SOC, V116, P4083, DOI 10.1021/ja00088a056; Hadida S, 1997, J AM CHEM SOC, V119, P7406, DOI 10.1021/ja971120i; SAVAGE PE, 1995, AICHE J, V41, P1723, DOI 10.1002/aic.690410712; Kobayashi S, 1997, TETRAHEDRON LETT, V38, P4559, DOI 10.1016/S0040-4039(97)00854-X; HACHIYA I, 1993, J ORG CHEM, V58, P6958, DOI 10.1021/jo00077a009; GORE PH, 1955, CHEM REV, V55, P229, DOI 10.1021/cr50002a001; Shezad N, 1999, TETRAHEDRON LETT, V40, P2221, DOI 10.1016/S0040-4039(99)00176-8; KUSAMA H, 1995, B CHEM SOC JPN, V68, P2379, DOI 10.1246/bcsj.68.2379; OLAH GA, 1963, J AM CHEM SOC, V85, P1328, DOI 10.1021/ja00892a025; MORLEY JO, 1977, J CHEM SOC PERK T 2, P601, DOI 10.1039/p29770000601; Jessop PG, 1999, CHEM REV, V99, P475, DOI 10.1021/cr970037a; KOBAYASHI S, 1994, TETRAHEDRON, V50, P11623, DOI 10.1016/S0040-4020(01)85657-X; Tsuchimoto T, 1997, J ORG CHEM, V62, P6997, DOI 10.1021/jo970599u; Avedikian A. M., 1974, B SOC CHIM FR, V11, P2652; BAUM K, 1975, J ORG CHEM, V40, P81, DOI 10.1021/jo00889a018; BURK MJ, 1995, J AM CHEM SOC, V117, P8277, DOI 10.1021/ja00136a029; BURTON H, 1950, J CHEM SOC, P1203, DOI 10.1039/jr9500001203; BURTON H, 1951, J CHEM SOC, P529, DOI 10.1039/jr9510000529; BURTON H, 1951, J CHEM SOC, P522, DOI 10.1039/jr9510000522; BURTON H, 1950, J CHEM SOC, P2034, DOI 10.1039/jr9500002034; Carroll MA, 1998, CHEM COMMUN, P1395, DOI 10.1039/a802235f; Cotton F.A., 1988, ADV INORG CHEM, P973; CUTTER RA, 1952, J AM CHEM SOC, V74, P5475; EFFENBERGER F, 1988, CHEM BER-RECL, V121, P117, DOI 10.1002/cber.19881210118; EFFENBER.F, 1972, ANGEW CHEM INT EDIT, V11, P300, DOI 10.1002/anie.197203001; FOSBERG JH, 1987, J ORG CHEM, V52, P1017; FUJIYAMA S, 1978, HYDROCARB PROCESS, V57, P147; HACHIYA I, 1995, TETRAHEDRON LETT, V36, P409, DOI 10.1016/0040-4039(94)02221-V; HACHIYA I, 1995, B CHEM SOC JPN, V68, P2053, DOI 10.1246/bcsj.68.2053; HARVEY G, 1992, COLLECT CZECH CHEM C, V57, P862, DOI 10.1135/cccc19920862; Hashizume N., 1996, CARBOHYDR LETT, V2, P157; HINO M, 1978, CHEM LETT, P325, DOI 10.1246/cl.1978.325; JACQUELINE I, 1991, ENCY CHEM TECHNOLOGY, V2, P213; KAWADA A, 1994, SYNLETT, P545; KAWADA A, 1993, J CHEM SOC CHEM COMM, P1157, DOI 10.1039/c39930001157; Kawada A, 1996, CHEM COMMUN, P183, DOI 10.1039/cc9960000183; KAWADA A, 1994, Patent No. 06263656; KOBAYASHI S, 1992, TETRAHEDRON LETT, V33, P1625, DOI 10.1016/S0040-4039(00)91691-5; Kobayashi S, 1999, SYNLETT, P545; Kobayashi S, 1999, EUR J ORG CHEM, P15; Kobayashi S, 1996, TETRAHEDRON LETT, V37, P5569, DOI 10.1016/0040-4039(96)01158-6; KOBAYASHI S, 1993, TETRAHEDRON LETT, V34, P3755, DOI 10.1016/S0040-4039(00)79220-3; KOBAYASHI S, 1994, B CHEM SOC JPN, V67, P2342, DOI 10.1246/bcsj.67.2342; KOBAYASHI S, 1995, SYNLETT, P233; Kobayashi S, 1997, B CHEM SOC JPN, V70, P267, DOI 10.1246/bcsj.70.267; Kobayashi S, 1996, TETRAHEDRON LETT, V37, P3731, DOI 10.1016/0040-4039(96)00671-5; Kobayashi S, 1998, TETRAHEDRON LETT, V39, P9211, DOI 10.1016/S0040-4039(98)02100-5; Kobayashi S, 1997, SYNLETT, P115; Kobayashi S, 1998, CHEM COMMUN, P981, DOI 10.1039/a801464g; Kobayashi S, 1998, CHEM COMMUN, P19, DOI 10.1039/a706498e; Kobayashi S, 1998, SYNLETT, P1019; KOBAYASHI S, 1995, TETRAHEDRON LETT, V36, P5773, DOI 10.1016/0040-4039(95)01096-Z; KOBAYASHI S, 1992, TETRAHEDRON LETT, V33, P6815, DOI 10.1016/S0040-4039(00)61783-5; KOBAYASHI S, 1991, CHEM LETT, P2187, DOI 10.1246/cl.1991.2187; KOBAYASHI S, 1994, SYNLETT, P689; Kobayashi S, 1999, SYNLETT, P138; Kobayashi S, 1996, TETRAHEDRON LETT, V37, P2809, DOI 10.1016/0040-4039(96)00435-2; Kobayashi S, 1997, CHEM LETT, P1039; Kobayashi S, 1997, CHEM LETT, P831, DOI 10.1246/cl.1997.831; Kotsuki H, 1999, SYNTHESIS-STUTTGART, P603; Kulkarni SJ, 1998, STUD SURF SCI CATAL, V113, P151; Ishitani H, 1996, J ORG CHEM, V61, P1902, DOI 10.1021/jo951924l; Manabe K, 1999, J ORG CHEM, V64, P8054, DOI 10.1021/jo991009q; Matsuo J, 2000, CHEM LETT, P178; MINE N, 1986, CHEM LETT, P357, DOI 10.1246/cl.1986.357; Morgenstern DA, 1996, ACS SYM SER, V626, P132; Morita DK, 1998, CHEM COMMUN, P1397, DOI 10.1039/a802621a; MUKAIYAMA T, 1991, CHEM LETT, P1059, DOI 10.1246/cl.1991.1059; MUKAIYAMA T, 1992, CHEM LETT, P435, DOI 10.1246/cl.1992.435; MUKAIYAMA T, 1986, CHEM LETT, P165, DOI 10.1246/cl.1986.165; Nagayama S, 1998, CHEM LETT, P685, DOI 10.1246/cl.1998.685; Noller CR, 1924, J AM CHEM SOC, V46, P1889, DOI 10.1021/ja01673a017; NOMIYA K, 1980, B CHEM SOC JPN, V53, P2089, DOI 10.1246/bcsj.53.2089; Olah G. A., 1968, J AM CHEM SOC, V88, P3313; Olah G. A., 1964, FRIEDEL CRAFTS RELAT, VI; OLAH GA, 1983, J ORG CHEM, V48, P3359, DOI 10.1021/jo00167a052; OLAH GA, 1983, J ORG CHEM, V48, P3360, DOI 10.1021/jo00167a053; OLAH GA, 1964, FRIEDEL CRAFTS REL 1, V3, P72; OLAH GA, 1964, J AM CHEM SOC, V86, P2203, DOI 10.1021/ja01065a020; Oyamada H, 1998, SYNLETT, P249; Pandey AK, 1997, CATAL LETT, V44, P129, DOI 10.1023/A:1018964722746; PIVSAART S, 1994, J CHEM SOC PERK T 1, P1703, DOI 10.1039/p19940001703; Renslo AR, 1997, J ORG CHEM, V62, P4530, DOI 10.1021/jo9704523; RICHARD F, 1993, STUD SURF SCI CATAL, V78, P601; Richard F, 1996, J CATAL, V159, P427, DOI 10.1006/jcat.1996.0106; Smith K, 1998, J MOL CATAL A-CHEM, V134, P121, DOI 10.1016/S1381-1169(98)00028-4; Sreekumar R, 1997, SYNTHETIC COMMUN, V27, P777, DOI 10.1080/00397919708004197; SUBRAMANIAM B, 1986, IND ENG CHEM PROC DD, V25, P1, DOI 10.1021/i200032a001; THOM KF, 1971, Patent No. 3615169; VANBEKKUM H, 1994, STUD SURF SCI CATAL, V83, P379; Weinstein RD, 1996, J PHYS CHEM-US, V100, P12337, DOI 10.1021/jp960180s; YAMAGUCHI T, 1982, CHEM LETT, P1229, DOI 10.1246/cl.1982.1229	98	84	84	CHEMICAL SOC JAPAN	TOKYO	1-5 KANDA-SURUGADAI CHIYODA-KU, TOKYO, 101-8307, JAPAN	0009-2673	1348-0634		B CHEM SOC JPN	Bull. Chem. Soc. Jpn.	OCT	2000	73	10					2325	2333		10.1246/bcsj.73.2325		9	Chemistry, Multidisciplinary	Chemistry	378XJ	WOS:000165610400021		
J	Iida, M				Iida, M			A systematic method for analyzing borehole recordings to estimate the wavefield in the lakebed zone of Mexico City	BULLETIN OF THE SEISMOLOGICAL SOCIETY OF AMERICA			English	Article							GRAVITY-WAVES; LONG-DURATION; S-WAVES; VALLEY; INCIDENT; ARRAY; JAPAN	During the 1985 Michoacan earthquake (M-s = 8.1), large-amplitude seismograms with extremely long duration (hundreds of seconds) were recorded in the lakebed zone of Mexico City. In spite of numerous studies, the lakebed seismograms are not well understood. In the present study, we develop a systematic method for analyzing borehole recordings and apply it to recordings at depths of 0 and 102 m at the Roma station to interpret the wavefield in the lakebed zone. The target frequency (period) range is between 0.2 and 3.3 Hz (0.3 and 5.0 sec). We cross-correlate the surface and borehole strong-motion seismograms and identify body- and surface-wave portions in the main motions. Then, we interpret the surface waves as fundamental-mode Love waves by calculating theoretical amplitude ratios for different-scale structures. Using a statistical time-series model with an information criterion, we separate S- and Love-wave portions from the surface recordings. Love waves are dominant, and are recognized even in the early time section. Finally, we attempt to explain S-wave transfer functions between the surface and borehole recordings by considering subsidence of soft surficial deposits for several years on the basis of a three-dimensional finite-element technique. This simulation demonstrates effects of the subsidence on amplification of S waves.	Univ Tokyo, Earthquake Res Inst, Bunkyo Ku, Tokyo 1130032, Japan	Iida, M (reprint author), Univ Tokyo, Earthquake Res Inst, Bunkyo Ku, 1-1-1 Yayoi, Tokyo 1130032, Japan.						Akaike H., 1976, ADV CASE STUDIES SYS, P27; Alfaro M.C., 1997, SOILS FOUND, V37, P33; CHAVEZGARCIA FJ, 1994, SOIL DYN EARTHQ ENG, V13, P229, DOI 10.1016/0267-7261(94)90028-0; Bodin P, 1997, B SEISMOL SOC AM, V87, P528; Bard PY, 1988, EARTHQ SPECTRA, V4, P609, DOI 10.1193/1.1585493; BERGADO DT, 1995, COMPUT GEOTECH, V17, P447, DOI 10.1016/0266-352X(95)94915-D; CHAVEZGARCIA FJ, 1993, B SEISMOL SOC AM, V83, P1637; CHAVEZGARCIA FJ, 1993, B SEISMOL SOC AM, V83, P1656; CHAVEZGARCIA FJ, 1995, B SEISMOL SOC AM, V85, P1116; FUKUSHIMA Y, 1992, B SEISMOL SOC AM, V82, P148; GUTIERREZ CA, 1994, RG0194 CTR NAC PREV; Iida M, 1999, J GEOPHYS RES-SOL EA, V104, P7329, DOI 10.1029/1999JB900017; IIDA M, 1994, P 9 JAP EARTHQ ENG S, V3, pE121; Iida M, 1999, J GEOTECH GEOENVIRON, V125, P727, DOI 10.1061/(ASCE)1090-0241(1999)125:9(727); KAWASE H, 1989, B SEISMOL SOC AM, V79, P1361; Kinoshita S, 1999, B SEISMOL SOC AM, V89, P484; KOBAYASHI H, 1987, RELATIONSHIPS MICROT, P144; LOMNITZ C, 1990, GEOPHYS J INT, V102, P569, DOI 10.1111/j.1365-246X.1990.tb04583.x; Lomnitz C, 1999, B SEISMOL SOC AM, V89, P14; MARSAL RJ, 1975, 0775 U NAT AUT MEX; ORDAZ M, 1992, P INT S EFF SURF GEO, V1, P155; ROMO MP, 1995, 3 INT C REC ADV GEOT, V2, P1039; ROMO MP, 1988, 9501 UNAM I ENG; Sanchez-Sesma FJ, 1988, EARTHQ SPECTRA, V4, P569; Satoh T, 1995, B SEISMOL SOC AM, V85, P1770; SELIGMAN TH, 1989, GEOPHYS J INT, V99, P789, DOI 10.1111/j.1365-246X.1989.tb02058.x; Singh S. K., 1988, EARTHQ SPECTRA, V4, P653, DOI 10.1193/1.1585496; SINGH SK, 1993, B SEISMOL SOC AM, V83, P1298; *YAM ARCH ENG INC, 1990, EST SUBS PROY CTR PR	29	5	5	SEISMOLOGICAL SOC AMER	EL CERRITO	PLAZA PROFESSIONAL BLDG, SUITE 201, EL CERRITO, CA 94530 USA	0037-1106			B SEISMOL SOC AM	Bull. Seismol. Soc. Amer.	OCT	2000	90	5					1268	1280		10.1785/0119970173		13	Geochemistry & Geophysics	Geochemistry & Geophysics	372TR	WOS:000165250600010		
J	Hosoi, T; Ametani, A; Kiuchi, K; Kaminogawa, S				Hosoi, T; Ametani, A; Kiuchi, K; Kaminogawa, S			Improved growth and viability of lactobacilli in the presence of Bacillus subtilis (natto), catalase, or subtilisin	CANADIAN JOURNAL OF MICROBIOLOGY			English	Article						Bacillus subtilis (natto); Lactobacillus; probiotic; catalase; subtilisin	ESCHERICHIA-COLI-B; ACIDOPHILUS; PURIFICATION; MICROFLORA; BACTERIA; PEROXIDASE	In an effort to demonstrate the potential usefulness of Bacillus subtilis (natto) as a probiotic, we examined the effect of this organism on the growth of three strains of lactobacilli co-cultured aerobically in vitro. Addition of B. subtilis (natto) to the culture medium resulted in an increase in the number of viable cells of all lactobacilli tested. Since B. subtilis (natto) can produce catalase, which has been reported to exhibit a similar growth-promoting effect on lactobacilli, we also examined the effect of bovine catalase on the growth of Lactobacillus reuteri JCM 1112 and L. acidophilus JCM 1132. Both catalase and B. subtilis (natto) enhanced the growth of L. reuteri JCM 1112, whereas B. subtilis (natto) but not catalase enhanced the growth of L. acidophilus JCM 1132. In a medium containing 0.1 mM hydrogen peroxide, its toxic effect on L. reuteri JCM 1112 was abolished by catalase or B. subtilis (natto). In addition, a serine protease from B. licheniformis, subtilisin, improved the growth and viability of L. reuteri JCM 1112 and L. acidophilus JCM 1132 in the absence of hydrogen peroxide. These results indicate that B. subtilis (natto) enhances the growth and (or) viability of lactobacilli, possibly through production of catalase and subtilisin.	Tokyo Metropolitan Food Technol Res Ctr, Chiyoda Ku, Tokyo 1010025, Japan; Univ Tokyo, Dept Appl Biol Chem, Bunkyo Ku, Tokyo 1138657, Japan; Kyoritsu Womens Univ, Fac Home Econ, Dept Food Sci & Nutr, Chiyoda Ku, Tokyo 1018433, Japan	Hosoi, T (reprint author), Tokyo Metropolitan Food Technol Res Ctr, Chiyoda Ku, 1-9 Kanda Sakuma Cho, Tokyo 1010025, Japan.						Halliwell B, 1996, ANNU REV NUTR, V16, P33, DOI 10.1146/annurev.nutr.16.1.33; Holzapfel WH, 1998, INT J FOOD MICROBIOL, V41, P85, DOI 10.1016/S0168-1605(98)00044-0; Gomes AMP, 1998, J DAIRY SCI, V81, P2817; Van Loo J, 1999, BRIT J NUTR, V81, P121; Diplock AT, 1998, BRIT J NUTR, V80, pS77; KATO T, 1992, BIOSCI BIOTECH BIOCH, V56, P1166; Salminen S, 1998, BRIT J NUTR, V80, pS147; Klein G, 1998, INT J FOOD MICROBIOL, V41, P103, DOI 10.1016/S0168-1605(98)00049-X; MITSUOKA T, 1965, ZENTBL BAKTERIOLOG P, V195, P455; Dave RI, 1998, J DAIRY SCI, V81, P2804; ZHENG HY, 1994, J INFECT DIS, V170, P1209; CLAIBORNE A, 1979, J BIOL CHEM, V254, P1664; CLAIBORNE A, 1979, J BIOL CHEM, V254, P4245; COLLINS EB, 1980, J DAIRY SCI, V63, P353; Collins M.D., 1999, AM J CLIN NUTR, V69, P1052; FITZSIMMONS N, 1994, MICROBIOS, V80, P125; Goldin BR, 1998, BRIT J NUTR, V80, pS203; GONZALEZ SN, 1991, CHEM PHARM BULL, V39, P1065; GONZALEZ SN, 1989, CHEM PHARM BULL, V37, P3026; Hosoi T, 1999, CAN J MICROBIOL, V45, P59, DOI 10.1139/cjm-45-1-59; ICHISHIMA E, 1986, BIOCHIM BIOPHYS ACTA, V869, P178, DOI 10.1016/0167-4838(86)90292-X; JIRAPHOCAKUL S, 1990, POULTRY SCI, V69, P1966; KAMATA H, 1989, AGR BIOL CHEM TOKYO, V53, P2695; KONO Y, 1983, J BACTERIOL, V155, P742; KONO Y, 1983, J BIOL CHEM, V258, P6015; LOEWEN PC, 1988, BIOCHEM CELL BIOL, V66, P707; LOEWEN PC, 1987, J BACTERIOL, V169, P3601; LOEWEN PC, 1987, BIOCHEM CELL BIOL, V65, P939; Maruta Kiyoshi, 1996, Animal Science and Technology, V67, P403; Maruta Kiyoshi, 1996, Animal Science and Technology, V67, P273; MURATA H, 1977, NIPPON JUISHIKAI ZAS, V30, P645; NAKAMURA T, 1992, BIOSCI BIOTECH BIOCH, V56, P1869; OZAWA K, 1981, JPN J VET SCI, V43, P771; Sartor RB, 1997, ALIMENT PHARM THERAP, V11, P17; SAXENA SN, 1994, INT J FOOD MICROBIOL, V21, P271, DOI 10.1016/0168-1605(94)90034-5; TAKAMINE F, 1995, MICROBIOL IMMUNOL, V39, P11; WILKINS TD, 1978, J CLIN MICROBIOL, V8, P553; YOUSTEN AA, 1975, J BACTERIOL, V123, P242	38	37	46	NATL RESEARCH COUNCIL CANADA	OTTAWA	RESEARCH JOURNALS, MONTREAL RD, OTTAWA, ONTARIO K1A 0R6, CANADA	0008-4166			CAN J MICROBIOL	Can. J. Microbiol.	OCT	2000	46	10					892	897		10.1139/cjm-46-10-892		6	Biochemistry & Molecular Biology; Biotechnology & Applied Microbiology; Immunology; Microbiology	Biochemistry & Molecular Biology; Biotechnology & Applied Microbiology; Immunology; Microbiology	357WL	WOS:000089523700004		
J	Kanda, Y; Yamamoto, R; Chizuka, A; Hamaki, T; Suguro, M; Arai, C; Matsuyama, T; Takezako, N; Miwa, A; Kern, W; Kami, M; Akiyama, H; Hirai, H; Togawa, A				Kanda, Y; Yamamoto, R; Chizuka, A; Hamaki, T; Suguro, M; Arai, C; Matsuyama, T; Takezako, N; Miwa, A; Kern, W; Kami, M; Akiyama, H; Hirai, H; Togawa, A			Prophylactic action of oral fluconazole against fungal infection in neutropenic patients - A meta-analysis of 16 randomized, controlled trials	CANCER			English	Article						fluconazole; neutropenia; meta-analysis; fungal infection; prophylaxis; randomized controlled study; chemotherapy; bone marrow transplantation	BONE-MARROW TRANSPLANTATION; REMISSION INDUCTION THERAPY; AMPHOTERICIN-B; ACUTE-LEUKEMIA; CANCER-PATIENTS; GRANULOCYTOPENIC PATIENTS; HEMATOLOGICAL MALIGNANCIES; ANTIFUNGAL PROPHYLAXIS; SURVEILLANCE CULTURES; DOUBLE-BLIND	BACKGROUND. Fluconazole is used widely for fungal prophylaxis. Although studies with bone marrow transplantation (BMT) recipients clearly showed the usefulness of oral fluconazole, results of the studies in neutropenic patients other than BMT recipients have been inconsistent. Therefore, the authors performed a metaanalysis to evaluate the efficacy of fluconazole prophylaxis during chemotherapy-induced neutropenia. METHODS. The authors identified reports that were not restricted to those in English and not restricted to published trials through MEDLINE, CANCERLIT, or the data base of the Pfizer company. The authors included prospective, randomized studies comparing oral fluconazole with placebo, no treatment, or oral polyenes as prophylaxis for fungal infections in neutropenic patients. Two independent authors extracted data from 16 trials with 3734 patients enrolled. The outcome measures were the development of fungal-related death, systemic and superficial fungal infections, the use of empiric intravenous amphotericin-B, and infections or colonization with fluconazole-resistant fungi. The summarized odds ratios (ORs) were calculated using the Mantel-Haenszel method and the DerSimonian-Laird method. RESULTS. Prophylactic fluconazole was not effective in reducing fungal-related death or in reducing proven, systemic fungal infections in non-BMT patients (OR, 0.91; 95% confidence interval [CI], 0.30-2.82 and OR, 0.85; 95% CI, 0.47-1.55, respectively). However, fluconazole was very effective in reducing superficial fungal infections (OR, 0.44; 95% CI, 0.24-0.80), even when it was given in lower doses (50-200 mg per day). There was no increase in proven, systemic infection of fluconazole-resistant fungi, although colonization of those fungi increased. When the results were combined in studies in which the incidence of systemic fungal infections was > 15%, fluconazole was effective in reducing such infections (OR, 0.23; 95% CI, 0.15-0.36). CONCLUSIONS. The current analyses failed to find an effect of fluconazole on both fatal fungal infection and systemic fungal infection in non-BMT patients. Further studies on severely neutropenic patients are warranted because prophylactic fluconazole seemed to be effective when the incidence of systemic fungal infection was expected to be > 15%. Cancer 2000;89:1611-25. (C) 2000 American Cancer Society.	Natl Canc Ctr Hosp, Stem Cell Transplant Unit, Chuo Ku, Tokyo 1040045, Japan; Int Med Ctr japan, Dept Hematol, Tokyo, Japan; Univ Tokyo, Dept Cell Therapy & Transplantat Med, Tokyo, Japan; Univ Munich, Univ Hosp Grosshadern, Dept Internal Med 3, Munich, Germany; Toranomon Hosp, Dept Hematol, Tokyo, Japan; Tokyo Metropolitan Komagome Hosp, Div Hematol, Tokyo, Japan	Kanda, Y (reprint author), Natl Canc Ctr Hosp, Stem Cell Transplant Unit, Chuo Ku, 5-1-1 Tsukiji, Tokyo 1040045, Japan.		Kern, Winfried/H-7119-2012				AISNER J, 1979, ANN INTERN MED, V90, P4; AKIYAMA H, 1993, MYCOSES, V36, P373; Albengres E, 1998, DRUG SAFETY, V18, P83, DOI 10.2165/00002018-199818020-00001; ALTMAN DG, 1991, PRACTICAL STAT MED R, P167; SLAVIN MA, 1995, J INFECT DIS, V171, P1545; RINALDI MG, 1991, REV INFECT DIS, V13, P493; SCHIMPFF SC, 1975, ANN INTERN MED, V82, P351; GERSON SL, 1984, ANN INTERN MED, V100, P345; GOODMAN JL, 1992, NEW ENGL J MED, V326, P845, DOI 10.1056/NEJM199203263261301; Anaissie EJ, 1996, CLIN INFECT DIS, V23, P964; Johansen HK, 1999, JAMA-J AM MED ASSOC, V282, P1752, DOI 10.1001/jama.282.18.1752; BODEY GP, 1994, CANCER, V73, P2099, DOI 10.1002/1097-0142(19940415)73:8<2099::AID-CNCR2820730814>3.0.CO;2-N; BUCHANAN AG, 1985, CLIN INVEST MED, V8, P139; CHANDRASEKAR PH, 1994, J ANTIMICROB CHEMOTH, V33, P309, DOI 10.1093/jac/33.2.309; CHANDRASEKAR PH, 1994, CHEMOTHERAPY, V40, P136; COOK DJ, 1995, J CLIN EPIDEMIOL, V48, P161; DENNING DW, 1991, CHEMOTHERAPY S1, V38, P43; DERSIMONIAN R, 1986, CONTROL CLIN TRIALS, V7, P177, DOI 10.1016/0197-2456(86)90046-2; EGGER T, 1995, SUPPORT CARE CANCER, V3, P139, DOI 10.1007/BF00365855; ELLIS ME, 1994, EUR J CLIN MICROBIOL, V13, P3, DOI 10.1007/BF02026116; ELLIS ME, 1994, J ANTIMICROB CHEMOTH, V33, P1223, DOI 10.1093/jac/33.6.1223; FEUSNER J, 1994, P ASCO, V13, P1533; Finke R, 1990, Mycoses, V33 Suppl 1, P42; Gotzsche PC, 1997, BRIT MED J, V314, P1238; GRANINGER W, 1993, J INFECTION, V26, P133, DOI 10.1016/0163-4453(93)92761-K; GREENLAND S, 1990, STAT MED, V9, P247, DOI 10.1002/sim.4780090307; Groll AH, 1997, J ANTIMICROB CHEMOTH, V40, P855, DOI 10.1093/jac/40.6.855; HOPPE JE, 1994, PEDIATR HEMAT ONCOL, V11, P207, DOI 10.3109/08880019409141658; HORN R, 1985, REV INFECT DIS, V7, P646; IOANNIDIS JPA, 1995, ANN INTERN MED, V122, P856; JORGENSEN CJ, 1989, NOUV REV FR HEMATOL, V31, P327; Kern W, 1998, CANCER, V83, P291, DOI 10.1002/(SICI)1097-0142(19980715)83:2<291::AID-CNCR13>3.3.CO;2-C; LEVINE AS, 1973, NEW ENGL J MED, V288, P477, DOI 10.1056/NEJM197303082881001; MENICHETTI F, 1994, ANN INTERN MED, V120, P913; MEUNIER F, 1991, DRUG INVEST, V3, P258; NINANE J, 1994, EUR J CLIN MICROBIOL, V13, P330, DOI 10.1007/BF01974614; PHILPOTTHOWARD JN, 1993, J ANTIMICROB CHEMOTH, V31, P973, DOI 10.1093/jac/31.6.973; Rotstein C, 1999, CLIN INFECT DIS, V28, P331, DOI 10.1086/515128; ROZENBERGARSKA M, 1991, J ANTIMICROB CHEMOTH, V27, P369, DOI 10.1093/jac/27.3.369; SANDFORD GR, 1980, J INFECT DIS, V142, P503; SCHAFFNER A, 1995, J INFECT DIS, V172, P1035; SCHWARTZ RS, 1984, CANCER, V53, P411, DOI 10.1002/1097-0142(19840201)53:3<411::AID-CNCR2820530308>3.0.CO;2-E; SCHWARTZ S, 1994, BLOOD, V84, pA306; UZUN O, 1995, BLOOD, V86, P2063; VANTWOUT JW, 1988, J ANTIMICROB CHEMOTH, V21, P665; WILLIAMS C, 1977, MED PEDIATR ONCOL, V3, P275, DOI 10.1002/mpo.2950030309; WINGARD JR, 1991, NEW ENGL J MED, V325, P1274, DOI 10.1056/NEJM199110313251803; WINSTON DJ, 1984, EXP HEMATOL, V12, P205; WINSTON DJ, 1993, ANN INTERN MED, V118, P495; YAMAC K, 1995, POSTGRAD MED J, V71, P284	50	95	100	WILEY-LISS	NEW YORK	DIV JOHN WILEY & SONS INC, 605 THIRD AVE, NEW YORK, NY 10158-0012 USA	0008-543X			CANCER	Cancer	OCT 1	2000	89	7					1611	1625		10.1002/1097-0142(20001001)89:7<1611::AID-CNCR27>3.3.CO;2-2		15	Oncology	Oncology	355WJ	WOS:000089411300027		
J	Yuge, M; Nagai, H; Uchida, T; Murate, T; Hayashi, Y; Hotta, T; Saito, H; Kinoshita, T				Yuge, M; Nagai, H; Uchida, T; Murate, T; Hayashi, Y; Hotta, T; Saito, H; Kinoshita, T			hSNF5/INI1 gene mutations in lymphoid malignancy	CANCER GENETICS AND CYTOGENETICS			English	Article							B-CELL LYMPHOMAS; SWI-SNF COMPLEX; SWI/SNF COMPLEX; CLINICAL CORRELATIONS; CYTOGENETIC ANALYSIS; CHROMATIN STRUCTURE; RHABDOID TUMOR; MUTANT P53; WILD-TYPE; YEAST	hSNF5/INI1 is one of the components of the SWI/SNF multiprotein complex that is necessary for the transcriptional activation of several genes and functions by altering chromatin structure. This gene has been thought to be one of the tumor suppressor genes (TSGs) because deletions or mutations were reported in malignant rhabdoid tumors and atypical teratoid and rhabdoid tumors. To evaluate the hSNF5/INI1 gene as a TSG in lymphoid malignancies, we performed a mutational analysis in 23 patients with non-Hodgkin lymphoma (NHL): 24 with acute lymphoblastic leukemia (ALL), 24 with multiple myeloma (MM), 24 with adult T-cell lymphoma/leukemia (ATLL), and 19 with lymphoid cell lines, by polymerase chain reaction-single-strand conformational polymorphism (PCR-SSCP) analysis. Nonsense and missense mutations were found in 1 NHL case and 2 cell lines. Mutations from this NHL case proved to be somatic in origin. These data indicated that alterations in the hSNF5/INI1 gene might be involved in the pathogenesis of lymphoid malignancies. (C) 2000 Elsevier Science Inc. All rights reserved.	Nagoya Univ, Sch Med, Dept Internal Med 1, Showa Ku, Nagoya, Aichi 466, Japan; Univ Tokyo, Fac Med, Dept Pediat, Tokyo 113, Japan; Tokai Univ, Sch Med, Dept Internal Med 4, Kanagawa 2591100, Japan	Nagai, H (reprint author), Nagoya Univ, Sch Med, Dept Internal Med 1, Showa Ku, 65 Tsurumai Cho, Nagoya, Aichi 466, Japan.						Versteege I, 1998, NATURE, V394, P203, DOI 10.1038/28212; TSUJIMOTO Y, 1985, SCIENCE, V228, P1440, DOI 10.1126/science.3874430; Cheng SWG, 1999, NAT GENET, V22, P102; Mitelman F, 1997, NAT GENET, V15, P417, DOI 10.1038/ng0497supp-417; HIRSCHHORN JN, 1992, GENE DEV, V6, P2288, DOI 10.1101/gad.6.12a.2288; KALPANA GV, 1994, SCIENCE, V266, P2002, DOI 10.1126/science.7801128; Harris NL, 1999, J CLIN ONCOL, V17, P3835; CARLSON M, 1994, CURR OPIN CELL BIOL, V6, P396, DOI 10.1016/0955-0674(94)90032-9; Wang WD, 1996, EMBO J, V15, P5370; KNUDSON AG, 1971, P NATL ACAD SCI USA, V68, P820, DOI 10.1073/pnas.68.4.820; MILNER J, 1991, CELL, V65, P765, DOI 10.1016/0092-8674(91)90384-B; Morozov A, 1998, P NATL ACAD SCI USA, V95, P1120, DOI 10.1073/pnas.95.3.1120; Rosty C, 1998, GENE CHROMOSOME CANC, V21, P82, DOI 10.1002/(SICI)1098-2264(199802)21:2<82::AID-GCC2>3.0.CO;2-3; COTE J, 1994, SCIENCE, V265, P53, DOI 10.1126/science.8016655; Biegel JA, 1999, CANCER RES, V59, P74; BARON BW, 1993, P NATL ACAD SCI USA, V90, P5262, DOI 10.1073/pnas.90.11.5262; Biegel JA, 1996, GENE CHROMOSOME CANC, V16, P94, DOI 10.1002/(SICI)1098-2264(199606)16:2<94::AID-GCC3>3.0.CO;2-Y; Burns LG, 1997, BBA-GENE STRUCT EXPR, V1350, P159; Calasanz MJ, 1997, GENE CHROMOSOME CANC, V18, P84, DOI 10.1002/(SICI)1098-2264(199702)18:2<84::AID-GCC2>3.0.CO;2-X; Grand F, 1999, CANCER RES, V59, P3870; Ichikawa A, 1997, NEW ENGL J MED, V337, P529, DOI 10.1056/NEJM199708213370804; ICHIKAWA A, 1992, BLOOD, V79, P2701; Kingston RE, 1996, GENE DEV, V10, P905, DOI 10.1101/gad.10.8.905; LAURENT BC, 1990, MOL CELL BIOL, V10, P5616; Maniatis T, 1992, MOL CLONING LAB MANU; MILNER J, 1991, MOL CELL BIOL, V11, P12; MOTOKURA T, 1991, NATURE, V350, P512, DOI 10.1038/350512a0; OFFIT K, 1991, BLOOD, V77, P1508; ORITA M, 1989, P NATL ACAD SCI USA, V86, P2766, DOI 10.1073/pnas.86.8.2766; PETERSON CL, 1995, TRENDS BIOCHEM SCI, V20, P143, DOI 10.1016/S0968-0004(00)88990-2; PETERSON CL, 1994, P NATL ACAD SCI USA, V91, P2905, DOI 10.1073/pnas.91.8.2905; ROWLEY JD, 1990, SEMIN HEMATOL, V27, P122; UCHIDA T, 1995, BLOOD, V86, P2724	33	30	30	ELSEVIER SCIENCE INC	NEW YORK	655 AVENUE OF THE AMERICAS, NEW YORK, NY 10010 USA	0165-4608			CANCER GENET CYTOGEN	Cancer Genet. Cytogenet.	OCT 1	2000	122	1					37	42		10.1016/S0165-4608(00)00274-0		6	Oncology; Genetics & Heredity	Oncology; Genetics & Heredity	373KA	WOS:000165287100008		
J	Nakamura, K; Furugori, E; Esaki, Y; Arai, T; Sawabe, M; Okayasu, I; Fujiwara, M; Kammori, M; Mafune, K; Kato, M; Oshimura, M; Sasajima, K; Takubo, K				Nakamura, K; Furugori, E; Esaki, Y; Arai, T; Sawabe, M; Okayasu, I; Fujiwara, M; Kammori, M; Mafune, K; Kato, M; Oshimura, M; Sasajima, K; Takubo, K			Correlation of telomere lengths in normal and cancers tissue in the large bowel	CANCER LETTERS			English	Article						telomere shortening; large intestine; aging; colon carcinoma	SEQUENCE; AGE; DNA	The hypothesis that telomeres in colorectal cancer cells exhibit age-related shortening, as in normal cells of the colorectal epithelium, was tested with samples of non-cancerous mucosa and cancer tissue from 124 patients (aged 29-97 years). Shortening with aging could be demonstrated for both normal and cancer tissues; regression analysis showed rates for length reduction of 44 and 50 base pair/year. respectively. Straight, essentially parallel. lines were obtained for the two cases. normal tissue values being about 2 kilobase pairs (kbp) higher, with a significant correlation between data at the individual patient level. (C) 2000 Elsevier Science Ireland Ltd. All rights reserved.	Tokyo Metropolitan Inst Gerontol, Dept Clin Pathol, Itabashi Ku, Tokyo 1730015, Japan; Tokyo Metropolitan Geriatr Hosp, Dept Pathol, Itabashi Ku, Tokyo 1730015, Japan; Kitasato Univ, Fac Med, Dept Pathol, Sagamihara, Kanagawa 2280829, Japan; Tokyo Red Cross, Med Ctr, Dept Pathol, Shibuya Ku, Tokyo 1500012, Japan; Univ Tokyo, Fac Med, Dept Surg 3, Bunkyo Ku, Tokyo 1128688, Japan; Univ Tokyo, Fac Med, Dept Surg 2, Bunkyo Ku, Tokyo 1130033, Japan; Tottori Univ, Sch Life Sci, Dept Mol & Cell Genet, Yonago, Tottori 6838503, Japan; Nippon Med Sch, Dept Surg 1, Bunkyo Ku, Tokyo 1130022, Japan	Nakamura, K (reprint author), Tokyo Metropolitan Inst Gerontol, Dept Clin Pathol, Itabashi Ku, 32-5 Sakaecho, Tokyo 1730015, Japan.						Takagi S, 1999, CANCER, V86, P1431, DOI 10.1002/(SICI)1097-0142(19991015)86:8<1431::AID-CNCR7>3.0.CO;2-R; Greider CW, 1996, ANNU REV BIOCHEM, V65, P337, DOI 10.1146/annurev.bi.65.070196.002005; MOYZIS RK, 1988, P NATL ACAD SCI USA, V85, P6622, DOI 10.1073/pnas.85.18.6622; Zhu JY, 1999, P NATL ACAD SCI USA, V96, P3723, DOI 10.1073/pnas.96.7.3723; LINDSEY J, 1991, MUTAT RES, V256, P45, DOI 10.1016/0921-8734(91)90032-7; HARLEY CB, 1990, NATURE, V345, P458, DOI 10.1038/345458a0; Frenck RW, 1998, P NATL ACAD SCI USA, V95, P5607, DOI 10.1073/pnas.95.10.5607; HAYFLICK L, 1965, EXP CELL RES, V37, P614, DOI 10.1016/0014-4827(65)90211-9; Engelhardt M, 1997, CLIN CANCER RES, V3, P1931; HASTIE ND, 1990, NATURE, V346, P866, DOI 10.1038/346866a0; LEVY MZ, 1992, J MOL BIOL, V225, P951, DOI 10.1016/0022-2836(92)90096-3; CHANG E, 1995, P NATL ACAD SCI USA, V92, P11190, DOI 10.1073/pnas.92.24.11190; Kinouchi Y, 1998, J GASTROENTEROL, V33, P343, DOI 10.1007/s005350050094; BLACKBURN EH, 1991, NATURE, V350, P569, DOI 10.1038/350569a0; VAZIRI H, 1993, AM J HUM GENET, V52, P661; EASTWOOD GL, 1977, GASTROENTEROLOGY, V72, P962; FURUGORI E, 2000, IN PRESS J CANC RES, P126; Hiyama E, 1996, INT J ONCOL, V9, P453; KIM NW, 1994, SCIENCE, V266, P2011, DOI 10.1126/science.7605428; MARQUESP.JP, 1965, AM J ANAT, V117, P73, DOI 10.1002/aja.1001170106; Sprung CN, 1999, EXP CELL RES, V247, P29, DOI 10.1006/excr.1998.4293; TAKUBO K, 2000, IN PRESS J GERONTO A, V55; Takubo K, 1999, AGE, V22, P95, DOI 10.1007/s11357-999-0011-6	23	40	40	ELSEVIER SCI IRELAND LTD	CLARE	CUSTOMER RELATIONS MANAGER, BAY 15, SHANNON INDUSTRIAL ESTATE CO, CLARE, IRELAND	0304-3835			CANCER LETT	Cancer Lett.	OCT 1	2000	158	2					179	184		10.1016/S0304-3835(00)00521-8		6	Oncology	Oncology	396XL	WOS:000166663200010		
J	Mun, HS; Aosai, F; Norose, K; Chen, M; Hata, H; Tagawa, Y; Iwakura, Y; Byun, DS; Yano, A				Mun, HS; Aosai, F; Norose, K; Chen, M; Hata, H; Tagawa, Y; Iwakura, Y; Byun, DS; Yano, A			Toxoplasma gandii Hsp70 as a danger signal in Toxoplasma gondii-infected mice	CELL STRESS & CHAPERONES			English	Article							IFN-GAMMA; ANTIGEN; IMMUNITY; PROTEIN; MACROPHAGES; LYMPHOCYTES; TACHYZOITES; BRADYZOITES; CONVERSION; HSP30/BAG1	Toxoplasma gondii Hsp70, T gondii Hsp30/bag1, and surface antigen 1 messenger RNAs were shown to be useful in analyzing stage conversion of T gondii between bradyzoites and tachyzoites. The high-level expression of T gondii Hsp70 was correlated with mortality in interferon-gamma knockout mice infected with T gondii. T gondii Hsp70 inhibited the induction of nitric oxide release by peritoneal macrophages of T gondii-infected mice. These findings identify T gondii Hsp70 as a danger signal during lethal, acute T gondii infection.	Chiba Univ, Sch Med, Dept Parasitol, Chuo Ku, Chiba 2608670, Japan; Univ Tokyo, Inst Med Sci, Ctr Med Expt, Tokyo, Japan; Univ Pukyong, Dept Fac Food Sci & Biotechnol, Pusan, South Korea	Yano, A (reprint author), Chiba Univ, Sch Med, Dept Parasitol, Chuo Ku, 1-8-1 Inohana, Chiba 2608670, Japan.		Tagawa, Yoh-ichi/F-7216-2011; Iwakura, Yoichiro/E-5457-2011				DeckertSchluter M, 1996, LAB INVEST, V75, P827; KHAN IA, 1991, J IMMUNOL, V147, P3501; Chen W, 1999, J IMMUNOL, V162, P3212; FOURIE AM, 1994, J BIOL CHEM, V269, P30470; LANGERMANS JAM, 1992, J IMMUNOL, V148, P568; Weiss LM, 1998, INFECT IMMUN, V66, P3295; GAZZINELLI R, 1992, J IMMUNOL, V149, P175; BOHNE W, 1993, INFECT IMMUN, V61, P1141; Scharton-Kersten T, 1998, J IMMUNOL, V160, P2565; Luo WT, 1997, J PARASITOL, V83, P1070, DOI 10.2307/3284364; BOHNE W, 1994, INFECT IMMUN, V62, P1761; Tagawa Y, 1997, J IMMUNOL, V159, P1418; BOHNE W, 1995, MOL MICROBIOL, V16, P1221, DOI 10.1111/j.1365-2958.1995.tb02344.x; BURG JL, 1988, J IMMUNOL, V141, P3584; DENAGEL DC, 1992, IMMUNOL TODAY, V13, P86, DOI 10.1016/0167-5699(92)90147-Y; DENKERS EY, 1993, J EXP MED, V178, P1465, DOI 10.1084/jem.178.5.1465; Gross U, 1997, BEHRING I MITT, V99, P97; Gross U, 1996, PARASITOL TODAY, V12, P30, DOI 10.1016/0169-4758(96)80642-9; He N., 1997, Japanese Journal of Tropical Medicine and Hygiene, V25, P59; HUNTER CA, 1995, IMMUNOLOGY, V84, P16; Kobayashi M, 1999, J PARASITOL, V85, P973, DOI 10.2307/3285841; Luo Wentian, 1996, Tropical Medicine, V38, P27; MANARA GC, 1993, BLOOD, V82, P2865; Mun HS, 1999, MICROBIOL IMMUNOL, V43, P471; Silva NM, 1998, INFECT IMMUN, V66, P3959; VANBUSKIRK A, 1989, J EXP MED, V170, P1799, DOI 10.1084/jem.170.6.1799; Yamashita K, 1998, INFECT IMMUN, V66, P4651; Yang J-M, 1997, J POLYM RES, V4, P41, DOI 10.1007/s10965-006-0006-2; Yano A, 1998, ICOPA IX - 9TH INTERNATIONAL CONGRESS OF PARASITOLOGY, P457	29	37	39	CELL STRESS SOC INTERNATIONAL	STORRS	UNIV CONNECTICUT, DEPT M C B, 75 NORTH EAGLEVILLE RD, U-44, STORRS, CT 06269-3044 USA	1355-8145			CELL STRESS CHAPERON	Cell Stress Chaperones	OCT	2000	5	4					328	335		10.1379/1466-1268(2000)005<0328:TGHAAD>2.0.CO;2		8	Cell Biology	Cell Biology	361RM	WOS:000089737100007		
J	Morita, M; Kurochkin, IV; Motojima, K; Goto, S; Takano, T; Okamura, S; Sato, R; Yokota, S; Imanaka, T				Morita, M; Kurochkin, IV; Motojima, K; Goto, S; Takano, T; Okamura, S; Sato, R; Yokota, S; Imanaka, T			Insulin-degrading enzyme exists inside of rat liver peroxisomes and degrades oxidized proteins	CELL STRUCTURE AND FUNCTION			English	Article						insulin-degrading enzyme; subcellular localization; peroxisomes; proteolysis; oxidized proteins	DEGRADATION; MEMBRANE; PEPTIDE; POLYPEPTIDE; EXPRESSION; PROTEASE; CLONING; CELLS	Insulin-degrading enzyme (IDE) was detected by immunoblot analysis in highly purified rat liver peroxisomes. IDE in the peroxisomal fraction was resistant to proteolysis by trypsin and chymotrypsin under conditions where the peroxisomal membranes remained intact. After sonication of the peroxisomal fraction, IDE was recovered in the supernatant fraction. Further, the localization of IDE in the peroxisomes was shown by immunoelectron microscopy. In addition, IDE isolated from peroxisomes degraded insulin as well as oxidized lysozyme as a model substrate for oxidized proteins. These results suggest that IDE exists in an active form in the matrix of rat liver peroxisomes and is involved in elimination of oxidized proteins in peroxisomes.	Toyama Med & Pharmaceut Univ, Fac Pharmaceut Sci, Toyama 9300194, Japan; Toho Univ, Sch Pharmaceut Sci, Dept Biochem, Funabashi, Chiba 2748510, Japan; Teikyo Univ, Fac Pharmaceut Sci, Dept Microbiol & Mol Pathol, Sagamiko, Kanagawa 1990145, Japan; Univ Tokyo, Grad Sch Agr & Life Sci, Dept Appl Biol Chem, Bunkyo Ku, Tokyo 1138657, Japan; Yamanashi Med Univ, Biol Lab, Tamaho, Yamanashi 4093898, Japan	Imanaka, T (reprint author), Toyama Med & Pharmaceut Univ, Fac Pharmaceut Sci, 2630 Sugitani, Toyama 9300194, Japan.	imanaka@ms.toyama-mpu.ac.jp					AFFHOLTER JA, 1990, MOL ENDOCRINOL, V4, P1125; ALEXSON SEH, 1985, J CELL BIOL, V101, P294, DOI 10.1083/jcb.101.1.294; AMARCOSTESEC A, 1974, J CELL BIOL, V61, P202; Qiu WQ, 1998, J BIOL CHEM, V273, P32730, DOI 10.1074/jbc.273.49.32730; Seta KA, 1997, BIOCHEM BIOPH RES CO, V231, P167, DOI 10.1006/bbrc.1997.6066; Nakamura A, 1996, J BIOCHEM, V119, P768; LEIGHTON F, 1968, J CELL BIOL, V37, P482, DOI 10.1083/jcb.37.2.482; Singh I, 1996, ANN NY ACAD SCI, V804, P612, DOI 10.1111/j.1749-6632.1996.tb18648.x; DUCKWORTH WC, 1988, ENDOCR REV, V9, P319; Authier F, 1996, CLIN INVEST MED, V19, P149; BECKER AB, 1995, METHOD ENZYMOL, V248, P693; FUJIKI Y, 1982, J CELL BIOL, V93, P103, DOI 10.1083/jcb.93.1.103; KUROCHKIN IV, 1994, FEBS LETT, V345, P33, DOI 10.1016/0014-5793(94)00387-4; HAMEL FG, 1991, DIABETES, V40, P436, DOI 10.2337/diabetes.40.4.436; ARAI K, 1991, J BIOCHEM-TOKYO, V110, P541; AUTHIER F, 1994, J BIOL CHEM, V269, P3010; AUTHIER F, 1995, P NATL ACAD SCI USA, V92, P3859, DOI 10.1073/pnas.92.9.3859; Authier F, 1996, BIOCHEM J, V319, P149; BAUMEISTER H, 1993, FEBS LETT, V317, P250, DOI 10.1016/0014-5793(93)81286-9; DE DUVE C., 1955, BIOCHEM JOUR, V60, P604; FAGAN JM, 1991, BIOCHEM J, V277, P779; GARCIA JV, 1989, J CELL BIOL, V109, P1301, DOI 10.1083/jcb.109.3.1301; GOLDFINE ID, 1984, DIABETES, V33, P64, DOI 10.2337/diabetes.33.1.64; GRISOLIA S, 1976, BIOCHEM BIOPH RES CO, V70, P22, DOI 10.1016/0006-291X(76)91103-7; IMANAKA T, 1991, BIOCHIM BIOPHYS ACTA, V1062, P264, DOI 10.1016/0005-2736(91)90401-S; KUO WL, 1990, MOL ENDOCRINOL, V4, P1580; MULLER D, 1992, BIOCHEMISTRY-US, V31, P11138; SHII K, 1985, J BIOL CHEM, V260, P6053; SMALL GM, 1988, ANAL BIOCHEM, V169, P405, DOI 10.1016/0003-2697(88)90304-1; STAMELLOS KD, 1992, J BIOL CHEM, V267, P5560; Usuda N, 1996, ANN NY ACAD SCI, V804, P297, DOI 10.1111/j.1749-6632.1996.tb18624.x; YOKOTA S, 1987, PEROXISOMES BIOL MED, P115	32	38	38	JAPAN SOC CELL BIOLOGY	KYOTO	C/O NAKANISHI PRINTING SHIMODACHIURI OGAWA HIGASHI, KAMIGYO-KU, KYOTO, 602-8048, JAPAN	0386-7196	1347-3700		CELL STRUCT FUNCT	Cell Struct. Funct.	OCT	2000	25	5					309	315		10.1247/csf.25.309		7	Cell Biology	Cell Biology	403TV	WOS:000167059300004		
J	Namikoshi, M; Kobayashi, H; Yoshimoto, T; Meguro, S; Akano, K				Namikoshi, M; Kobayashi, H; Yoshimoto, T; Meguro, S; Akano, K			Isolation and characterization of bioactive metabolites from marine-derived filamentous fungi collected from tropical and sub-tropical coral reefs	CHEMICAL & PHARMACEUTICAL BULLETIN			English	Article						bioactive metabolite; paecilospirone; marine fungi; isolation; phomopsidin; marine natural product	NATURAL-PRODUCTS; MICROORGANISMS; BIOSYNTHESIS	Two new compounds, paecilospirone(1) and phomopsidin (2), and seven known compounds, chaetoglobosin A (3), griseofulvin (4), fusarielin A (5), fusapyrone (6), deoxyfusapyrone (7), and verrucarins J (8) and I. acetate (9), have been isolated and characterized from marine-derived fungi collected in tropical and sub-tropical coral reef environments. The utility of marine-derived fungi as a source of bioactive secondary metabolites is discussed.	Tokyo Univ Fisheries, Dept Ocean Sci, Minato Ku, Tokyo 1088477, Japan; Univ Tokyo, Inst Mol & Cellular Biosci, Bunkyo Ku, Tokyo 1130032, Japan	Namikoshi, M (reprint author), Tokyo Univ Fisheries, Dept Ocean Sci, Minato Ku, Tokyo 1088477, Japan.	namikosh@tokyo-u-fish.ac.jp					Abrell LM, 1996, TETRAHEDRON LETT, V37, P2331, DOI 10.1016/0040-4039(96)00277-8; LIBERRA K, 1995, PHARMAZIE, V50, P583; SEKITA S, 1973, TETRAHEDRON LETT, P2109; KOBAYASHI J, 1993, CHEM REV, V93, P1753, DOI 10.1021/cr00021a005; Pietra F, 1997, NAT PROD REP, V14, P453, DOI 10.1039/np9971400453; DAVIDSON BS, 1995, CURR OPIN BIOTECH, V6, P284, DOI 10.1016/0958-1669(95)80049-2; KOBAYASHI H, 1995, J ANTIBIOT, V48, P42; Ishiyama M, 1997, TALANTA, V44, P1299, DOI 10.1016/S0039-9140(97)00017-9; BOHNER B, 1965, HELV CHIM ACTA, V48, P1079, DOI 10.1002/hlca.19650480515; BRIAN PW, 1949, ANN BOT-LONDON, V13, P59; CHAIET L, 1991, Patent No. 5008187; CLARKLEWIS JW, 1975, AUST J CHEM, V28, P1145; Cole R. J., 1981, HDB TOXIC FUNGAL MET, P152; Evidente Antonio, 1994, Natural Toxins, V2, P4, DOI 10.1002/nt.2620020103; GILL M, 1994, NAT PROD REP, V11, P67, DOI 10.1039/np9941100067; Ichihara A, 1997, BIOSCI BIOTECH BIOCH, V61, P12; JARVIS BB, 1981, J ANTIBIOT, V34, P120; Kobayashi H, 1996, J ANTIBIOT, V49, P873; Namikoshi M, 2000, CHEM LETT, P308, DOI 10.1246/cl.2000.308; Namikoshi M, 1997, J ANTIBIOT, V50, P890; OIKAWA H, 1995, J CHEM SOC CHEM COMM, P1321, DOI 10.1039/c39950001321; Turner W. B., 1983, FUNGAL METABOLITES, P55; WAKUI F, 1995, Patent No. 07126211; YOSHIZAWA T, 1993, NIPPON KAGAKU KAISHI, P482	24	36	37	PHARMACEUTICAL SOC JAPAN	TOKYO	2-12-15 SHIBUYA, SHIBUYA-KU, TOKYO, 150-0002, JAPAN	0009-2363			CHEM PHARM BULL	Chem. Pharm. Bull.	OCT	2000	48	10					1452	1457				6	Chemistry, Medicinal; Chemistry, Multidisciplinary; Pharmacology & Pharmacy	Pharmacology & Pharmacy; Chemistry	360ZB	WOS:000089696300012		
J	Takahashi, H; Sou, S; Yamasaki, R; Sodeoka, M; Hashimoto, Y				Takahashi, H; Sou, S; Yamasaki, R; Sodeoka, M; Hashimoto, Y			alpha-glucosidase inhibitors with a phthalimide skeleton: Structure-activity relationship study	CHEMICAL & PHARMACEUTICAL BULLETIN			English	Article						alpha-glucosidase; enzyme inhibitor; phthalimide; tetrachlorophthalimide; structure-activity relationship	NECROSIS-FACTOR-ALPHA; BIOLOGICAL RESPONSE MODIFIERS; PRODUCTION-REGULATING ACTIVITY; AMINOPEPTIDASE-N INHIBITORS; INDUCED INSULIN-RESISTANCE; CYCLIC IMIDE SKELETON; THALIDOMIDE; GLYCOSIDASES; POTENT; INVASION	alpha-Glucosidase inhibitors with a phthalimide skeleton were prepared. Structure-activity relationship studies indicated a critical role for the hydrophobicity of the substituent at the nitrogen atom of the phthalimide skeleton. Introduction of electron-withdrawing groups, including a nitro group and chlorine, influenced the activity. Optimization studies led us to design 4,5,6,7-tetrachluro-N-phenylphthalimide (CPOP) and its N-phenylalkyl derivatives. CPOP and 4.5,6,7-tetrachloro-N-(4-phenylbutyl)phthalimide (CP4P) proved to be more potent alpha-glucosidase inhibitors than the known inhibitor 1-deoxynojirimycin.	Univ Tokyo, Inst Mol & Cellular Biosci, Bunkyo Ku, Tokyo 1130032, Japan	Hashimoto, Y (reprint author), Univ Tokyo, Inst Mol & Cellular Biosci, Bunkyo Ku, 1-1-1 Yayoi, Tokyo 1130032, Japan.	hashimoto@iam.u-tokyo.ac.jp	Sodeoka, Mikiko/A-9952-2008	Sodeoka, Mikiko/0000-0002-1344-364X			Miyachi H, 1997, BIOORG MED CHEM LETT, V7, P1483, DOI 10.1016/S0960-894X(97)00249-7; FEINSTEIN R, 1993, J BIOL CHEM, V268, P26055; Watanabe J, 1997, BIOSCI BIOTECH BIOCH, V61, P177; GRUTERS RA, 1987, NATURE, V330, P74, DOI 10.1038/330074a0; TRUSCHEIT E, 1981, ANGEW CHEM INT EDIT, V20, P744, DOI 10.1002/anie.198107441; Mehta A, 1998, FEBS LETT, V430, P17, DOI 10.1016/S0014-5793(98)00525-0; Shibata Y, 1996, CHEM PHARM BULL, V44, P156; Uysal KT, 1997, NATURE, V389, P610, DOI 10.1038/39335; MCCULLOCH DK, 1983, DIABETES CARE, V6, P483, DOI 10.2337/diacare.6.5.483; Asano N, 1998, J MED CHEM, V41, P2565, DOI 10.1021/jm970836l; BERNACKI RJ, 1985, CANCER METAST REV, V4, P81, DOI 10.1007/BF00047738; ELBEIN AD, 1984, ARCH BIOCHEM BIOPHYS, V235, P579, DOI 10.1016/0003-9861(84)90232-7; Hashimoto Y, 1998, CURR MED CHEM, V5, P163; INOUYE S, 1968, TETRAHEDRON, V24, P2125, DOI 10.1016/0040-4020(68)88115-3; Kagechika H, 1999, BIOL PHARM BULL, V22, P1010; KANG MS, 1989, ANAL BIOCHEM, V181, P109, DOI 10.1016/0003-2697(89)90401-6; KARPAS A, 1988, P NATL ACAD SCI USA, V85, P9229, DOI 10.1073/pnas.85.23.9229; KOMORI A, 1993, CANCER RES, V53, P3462; LAJOLO FM, 1984, NUTR REP INT, V30, P45; LEGLER G, 1990, ADV CARBOHYD CHEM BI, V48, P319, DOI 10.1016/S0065-2318(08)60034-7; MADARIAGA H, 1988, DIGEST DIS SCI, V33, P1020, DOI 10.1007/BF01536000; MAKONKAWKEYOON S, 1993, P NATL ACAD SCI USA, V90, P5974, DOI 10.1073/pnas.90.13.5974; Miyachi H, 1997, BIOORGAN MED CHEM, V5, P2095, DOI 10.1016/S0968-0896(97)00148-X; Miyachi H, 1998, J MED CHEM, V41, P263, DOI 10.1021/jm970624o; Miyachi H, 1997, J MED CHEM, V40, P2858, DOI 10.1021/jm970109q; Miyachi H, 1997, YAKUGAKU ZASSHI, V117, P91; PLASAD SS, 1987, BIOCHEM BIOPH RES CO, V148, P206; SASAKI K, 1995, BIOL PHARM BULL, V18, P1228; SHIBATA Y, 1995, CHEM PHARM BULL, V43, P177; Shimazawa R, 1999, BIOORG MED CHEM LETT, V9, P559, DOI 10.1016/S0960-894X(99)00034-7; Shimazawa R, 1999, J ENZYM INHIB, V14, P259; Shimazawa R, 1999, BIOL PHARM BULL, V22, P224; Shimazawa R, 1999, J SYN ORG CHEM JPN, V57, P92; Shiozaki M, 1998, TETRAHEDRON, V54, P15167, DOI 10.1016/S0040-4020(98)00966-1; Sou S., 2000, BIOORG MED CHEM LETT, V10, P1083; Stephens JM, 1997, J BIOL CHEM, V272, P971; VandenBroek LAGM, 1996, J PHARM PHARMACOL, V48, P172; vonBoehmer H, 1997, P NATL ACAD SCI USA, V94, P8926, DOI 10.1073/pnas.94.17.8926; WALKER JM, 1993, APPL BIOCHEM BIOTECH, V38, P141, DOI 10.1007/BF02916417	39	32	32	PHARMACEUTICAL SOC JAPAN	TOKYO	2-12-15 SHIBUYA, SHIBUYA-KU, TOKYO, 150-0002, JAPAN	0009-2363			CHEM PHARM BULL	Chem. Pharm. Bull.	OCT	2000	48	10					1494	1499				6	Chemistry, Medicinal; Chemistry, Multidisciplinary; Pharmacology & Pharmacy	Pharmacology & Pharmacy; Chemistry	360ZB	WOS:000089696300020		
J	Ohta, K; Kawachi, E; Inoue, N; Fukasawa, H; Hashimoto, Y; Itai, A; Kagechika, H				Ohta, K; Kawachi, E; Inoue, N; Fukasawa, H; Hashimoto, Y; Itai, A; Kagechika, H			Retinoidal pyrimidinecarboxylic acids. Unexpected diaza-substituent effects in retinobenzoic acids	CHEMICAL & PHARMACEUTICAL BULLETIN			English	Article						retinoid; retinoic acid receptor; retinoid X receptor; pyrimidine	PROMYELOCYTIC LEUKEMIA-CELLS; PALLADIUM-CATALYZED AMINATION; X-RECEPTOR; AROMATIC AMIDES; DIFFERENTIATION; HL-60; ANALOGS; LIGANDS; RXR; RAR	Several pyridine- and pyrimidine-carboxylic acids were synthesized as ligand candidates fur retinoid nuclear receptors, retinoic acid receptors (RARs) and retinoic X receptors (RXRs), Although the pyridine derivatives, 6-[(5,6,7.8-tetrahyro-5,5,8,8-tetramethyl-2-naphthalenyl)carbamoyl]pyridine-3-carboxylic acid (2b) and 6-[(5,6,7,8-tetrahydro-5,5,8,8-tetramethyl-2-naphthalenyl) carboxamido]pyridine-3-carboxylic acid (5b) are more potent than the corresponding benzoic acid-type retinoids, Am80 (2a) and Am580 (5a), the replacement of the benzene ring of Am580 (5a), Am555 (6a), or Am55 (7a) with a pyrimidine ring caused loss of the retinoidal activity both in HL-60 cell differentiation assay and in RAR transactivation assay using COS-1 tells. On the other hand, pyrimidine analogs (PA series, 10 and 11) of potent RXR agonists (retinoid synergists) with a diphenylamine skeleton (DA series. 8 and 9) exhibited potent retinoid synergistic activity in HL-60 cell differentiation assay and activated RXRs, Among the synthesized compounds, 2-[N-n-propyl-N-(5,6,7,8-tetrahydro-5,5,8,8-tetramethyl-2- naphthalenyl)amino]pyrimidine-5-carboxylic acid (PA013, 10c) is most active retinoid synergist in HL-60 assay.	Univ Tokyo, Grad Sch Pharmaceut Sci, Bunkyo Ku, Tokyo 1130033, Japan; Univ Tokyo, Inst Mol & Cellular Biosci, Bunkyo Ku, Tokyo 1130032, Japan; Inst Med Mol Design, Bunkyo Ku, Tokyo 1130033, Japan	Kagechika, H (reprint author), Univ Tokyo, Grad Sch Pharmaceut Sci, Bunkyo Ku, 7-3-1 Hongo, Tokyo 1130033, Japan.	kage@mol.f.u-tokyo.ac.jp					BOEHM MF, 1994, J MED CHEM, V37, P2930, DOI 10.1021/jm00044a014; COLLINS SJ, 1977, NATURE, V270, P347, DOI 10.1038/270347a0; Minucci S, 1997, MOL CELL BIOL, V17, P644; Zacheis D, 1999, J MED CHEM, V42, P4434, DOI 10.1021/jm990292i; HUANG ME, 1988, BLOOD, V72, P567; KAGECHIKA H, 1989, J MED CHEM, V32, P2292, DOI 10.1021/jm00130a011; CASTAIGNE S, 1990, BLOOD, V76, P1704; Marcoux JF, 1997, J ORG CHEM, V62, P1568, DOI 10.1021/jo9622946; Wolfe JP, 1997, J ORG CHEM, V62, P1264, DOI 10.1021/jo961915s; KAGECHIKA H, 1988, J MED CHEM, V31, P2182, DOI 10.1021/jm00119a021; BOEHM MF, 1995, J MED CHEM, V38, P3146, DOI 10.1021/jm00016a018; Chambon P, 1996, FASEB J, V10, P940; COLLINS SJ, 1979, J EXP MED, V149, P969, DOI 10.1084/jem.149.4.969; Beijer FH, 1998, ANGEW CHEM INT EDIT, V37, P75, DOI 10.1002/(SICI)1521-3773(19980202)37:1/2<75::AID-ANIE75>3.0.CO;2-R; Ohta K, 1998, BIOL PHARM BULL, V21, P544; HASHIMOTO Y, 1990, BIOCHEM BIOPH RES CO, V166, P1300, DOI 10.1016/0006-291X(90)91007-F; Apfel CM, 1995, J BIOL CHEM, V270, P30765; BEARD RL, 1995, BIOORG MED CHEM LETT, V5, P2729, DOI 10.1016/0960-894X(95)00455-3; Beard RL, 1996, J MED CHEM, V39, P3556, DOI 10.1021/jm960386h; CHANDRARATNA RAS, 1995, BIOORG MED CHEM LETT, V5, P523, DOI 10.1016/0960-894X(95)00065-2; Chen JY, 1996, NATURE, V382, P819, DOI 10.1038/382819a0; Cunliffe W. J., 1984, RETINOID THERAPY; DAWSON MI, 1995, J MED CHEM, V38, P3368, DOI 10.1021/jm00017a021; Dhar A, 1999, J MED CHEM, V42, P3602, DOI 10.1021/jm9900974; Ebisawa M, 1999, CHEM PHARM BULL, V47, P1348; ELLIS CN, 1987, J AM ACAD DERMATOL, V16, P267, DOI 10.1016/S0190-9622(87)70037-1; GIGUERE V, 1990, MOL CELL BIOL, V10, P2335; GRIFFIN RJ, 1992, J CHEM SOC PERK T 1, P1811, DOI 10.1039/p19920001811; Hashimoto Y, 1996, BIOL PHARM BULL, V19, P1322; ISHIBASHI Y, 1995, RINSHO IYAKU, V11, P747; KAGECHIKA H, 1984, CHEM PHARM BULL, V32, P4209; Kikuchi K, 2000, J MED CHEM, V43, P409, DOI 10.1021/jm990063w; Kikuchi K, 2000, BIOORG MED CHEM LETT, V10, P619, DOI 10.1016/S0960-894X(00)00066-4; KOEFFLER HP, 1983, BLOOD, V62, P709; KRCHNAK V, 1975, COLLECT CZECH CHEM C, V40, P1396; KREUTZBERGER A, 1981, ARCH PHARM, V314, P391, DOI 10.1002/ardp.19813140503; Krueger GG, 1998, ARCH DERMATOL, V134, P57, DOI 10.1001/archderm.134.1.57; LEHMANN JM, 1992, SCIENCE, V258, P1944, DOI 10.1126/science.1335166; MANGELSDORF DJ, 1995, CELL, V83, P835, DOI 10.1016/0092-8674(95)90199-X; OERTLI AG, 1992, HELV CHIM ACTA, V75, P184, DOI 10.1002/hlca.19920750116; Roy Bidyut, 1995, Molecular and Cellular Biology, V15, P6481; Sporn M.B., 1994, RETINOIDS; TAKAHASHI N, 1982, OPHTHALMIC RES, V14, P63; TAKAMIZAWA A, 1959, YAKUGAKU ZASSHI, V79, P664; TAKAMIZAWA A, 1964, CHEM PHARM BULL, V12, P804; UMEMIYA H, 1997, J MED CHEM, V40, P422; UMEMIYA H, 1995, CHEM PHARM BULL, V43, P1827; Umemiya H, 1997, BIOCHEM BIOPH RES CO, V233, P121, DOI 10.1006/bbrc.1997.6414	48	43	43	PHARMACEUTICAL SOC JAPAN	TOKYO	2-12-15 SHIBUYA, SHIBUYA-KU, TOKYO, 150-0002, JAPAN	0009-2363			CHEM PHARM BULL	Chem. Pharm. Bull.	OCT	2000	48	10					1504	1513				10	Chemistry, Medicinal; Chemistry, Multidisciplinary; Pharmacology & Pharmacy	Pharmacology & Pharmacy; Chemistry	360ZB	WOS:000089696300022		
J	Tamura, M; Urano, Y; Kikuchi, K; Higuchi, T; Hirobe, M; Nagano, T				Tamura, M; Urano, Y; Kikuchi, K; Higuchi, T; Hirobe, M; Nagano, T			Superoxide dismutase activity of iron(II)TPEN complex and its derivatives	CHEMICAL & PHARMACEUTICAL BULLETIN			English	Article						superoxide; Fe-TPEN; Fe complex; superoxide dismutase; SOD mimic; reactive species	MACROCYCLIC POLYAMINE COMPLEXES; ENDOTHELIAL-CELL INJURY; IN-VITRO; REPERFUSION INJURY; MIMICS; COPPER(II); MODEL; VIVO; IRON; MN	Superoxide is involved in the pathogenesis of various diseases, such as inflammation, ischemia-reperfusion injury and carcinogenesis. Superoxide dismutases (SODs) catalyze the disproportionation reaction of superoxide to produce oxygen and hydrogen peroxide, and can protect living cells against the toxicity of free radicals derived from oxygen, Thus, SODs and their functional mimics have potential value as pharmaceuticals. We have previously reported that Fe(II)tetrakis-N,N,N',N'-(2-pyridylmethyl)ethylenediamine (Fe(II)TPEN) has an excellent SOD activity (IC50=0.5 mu M) among many iron complexes examined (J, Biol, Chem., 264, 9243-9249 (1989)), Fe(Il)TPEN can act like native SOD in living cells, and protect Escherichia coli cells from free radical toxicity caused by paraquat. In order to develop more effective SOD functional mimics, we synthesized Fe(II)TPEN derivatives with electron-donating or electron-withdrawing groups at the I-position of all pyridines of TPEN, and measured the SOD activities and the redox potentials of these complexes, Fe(II) tetrakis-N,N,N',N"-(4-methoxy;2-pyridylmethyl)ethylenediamine (Fe(II)(4MeO)(4)TPEN) had the highest SOD activity (IC50=0.1 mu M) among these iron-based SOD mimics. In addition. a good correlation was found between the redox potential and the SOD activity of 15 Fe(II) complexes, including iron-based SOD mimics reported in the previous paper (J, Organometal. Chem., in press). iron-based SOD mimics may be clinically applicable, because these complexes are generally tissue-permeable and show low toxicity. Therefore our findings should be significant for the development of clinically useful SOD mimics.	Univ Tokyo, Grad Sch Pharmaceut Sci, Bunkyo Ku, Tokyo 1130033, Japan	Nagano, T (reprint author), Univ Tokyo, Grad Sch Pharmaceut Sci, Bunkyo Ku, Tokyo 1130033, Japan.	tlong@mol.f.u-tokyo.ac.jp	Kikuchi, Kazuya/D-2370-2009; Urano, Yasuteru/H-1380-2012				FAULKNER KM, 1994, J BIOL CHEM, V269, P23471; BAUDRY M, 1993, BIOCHEM BIOPH RES CO, V192, P964, DOI 10.1006/bbrc.1993.1509; WADA K, 1994, BIOL PHARM BULL, V17, P701; GOLDSTEIN S, 1983, J AM CHEM SOC, V105, P7276, DOI 10.1021/ja00363a012; Riley DP, 1999, CHEM REV, V99, P2573, DOI 10.1021/cr980432g; MCCORD JM, 1969, J BIOL CHEM, V244, P6049; RILEY DP, 1994, J AM CHEM SOC, V116, P387, DOI 10.1021/ja00080a051; BULL C, 1985, J AM CHEM SOC, V107, P3295, DOI 10.1021/ja00297a040; ASHIMORI A, 1990, CHEM PHARM BULL, V38, P2446; BEYER W, 1991, PROG NUCLEIC ACID RE, V40, P221, DOI 10.1016/S0079-6603(08)60843-0; BHUYAN KC, 1991, ARCH BIOCHEM BIOPHYS, V288, P523; BLACK SC, 1994, J PHARMACOL EXP THER, V270, P1208; BULTER J, 1975, BIOCHIM BIOPHYS ACTA, V488, P215; DARR DJ, 1988, FREE RADICAL BIO MED, V4, P357, DOI 10.1016/0891-5849(88)90087-1; Day BJ, 1995, J PHARMACOL EXP THER, V275, P1227; DELOISSE M, 1995, J CHEM SOC CHEM COMM, P949; FAULKNER KM, 1994, ARCH BIOCHEM BIOPHYS, V310, P341, DOI 10.1006/abbi.1994.1176; FRIEDRICHS GS, 1994, FASEB J, V7, P2457; HARDY MM, 1994, J BIOL CHEM, V269, P18535; ITAMI C, 1993, BIOCHEM BIOPH RES CO, V197, P536, DOI 10.1006/bbrc.1993.2512; KIMURA E, 1986, INORG CHEM, V25, P2242, DOI 10.1021/ic00233a029; KIMURA E, 1981, BIOCHIM BIOPHYS ACTA, V678, P172, DOI 10.1016/0304-4165(81)90203-8; KIMURA E, 1983, BIOCHIM BIOPHYS ACTA, V745, P37, DOI 10.1016/0167-4838(83)90167-X; KITAJIMA N, 1993, INORG CHEM, V32, P1879, DOI 10.1021/ic00062a001; LENGFELDER E, 1979, BIOCHIM BIOPHYS ACTA, V567, P492, DOI 10.1016/0005-2744(79)90135-9; LIU ZX, 1994, ARCH BIOCHEM BIOPHYS, V315, P74, DOI 10.1006/abbi.1994.1473; MCCORD J M, 1986, Journal of Free Radicals in Biology and Medicine, V2, P307, DOI 10.1016/S0748-5514(86)80029-0; NAGANO T, 1989, J BIOL CHEM, V264, P9243; NAGANO T, 1991, FREE RADICAL RES COM, V12-3, P221, DOI 10.3109/10715769109145790; NAKAGAWA M, 1994, CHEM LETT, P1721, DOI 10.1246/cl.1994.1721; SATO H, 1992, SYNTHESIS-STUTTGART, P539; TAMURA M, IN PRESS J ORGANOMET; WADA K, 1994, ARCH BIOCHEM BIOPHYS, V310, P2; YAMAGUCHI KS, 1986, FEBS LETT, V197, P249, DOI 10.1016/0014-5793(86)80336-2; YOUNES M, 1978, BIOCHEM BIOPH RES CO, V81, P567	35	17	18	PHARMACEUTICAL SOC JAPAN	TOKYO	2-12-15 SHIBUYA, SHIBUYA-KU, TOKYO, 150-0002, JAPAN	0009-2363			CHEM PHARM BULL	Chem. Pharm. Bull.	OCT	2000	48	10					1514	1518				5	Chemistry, Medicinal; Chemistry, Multidisciplinary; Pharmacology & Pharmacy	Pharmacology & Pharmacy; Chemistry	360ZB	WOS:000089696300023		
J	Goto, M; Akimoto, K; Aoki, K; Shindo, M; Koga, K				Goto, M; Akimoto, K; Aoki, K; Shindo, M; Koga, K			Rate enhancement with high ratio of the monoalkylated product to the dialkylated product in the alkylation of the lithium enolate of 1-tetralone with reactive alkyl halides	CHEMICAL & PHARMACEUTICAL BULLETIN			English	Article						alkylation; bidentate amine; tridentate amine; tetradentate amine; pentadentate amine; rate enhancement	ENANTIOSELECTIVE ALKYLATION; BROMIDE; LIGAND; AMINES	The reactions of the lithium enolate of 1-tetralone with reactive alkyl halides were examined in the absence and in the presence of 3 eq of various ligands for the lithium. It is shown that the rates of the reactions are enhanced greatly in the presence a tetradentate amine (1,1,4,7,10,10-hexamethyltriethylenetetramine), and the ratio of the monoalkylated product to the dialkylated product is increased under shorter reaction times.	Univ Tokyo, Grad Sch Pharmaceut Sci, Bunkyo Ku, Tokyo 1130033, Japan	Koga, K (reprint author), Univ Tokyo, Grad Sch Pharmaceut Sci, Bunkyo Ku, Tokyo 1130033, Japan.	kkoga@ms.aist-nara.ac.jp					ADAMCZYK M, 1984, J ORG CHEM, V49, P4226, DOI 10.1021/jo00196a024; GILKERSON WR, 1979, J AM CHEM SOC, V101, P4096, DOI 10.1021/ja00509a015; IMAI M, 1994, J AM CHEM SOC, V116, P8829, DOI 10.1021/ja00098a061; BURDON MG, 1966, J AM CHEM SOC, V88, P5855, DOI 10.1021/ja00976a030; Caine D., 1991, COMPREHENSIVE ORGANI, V3; CAREY FA, 1990, ADV ORGANIC CHEM B, pCH1; CHATTERJEE A, 1975, J CHEM SOC P1, P934; Goto M, 1999, TETRAHEDRON LETT, V40, P8129, DOI 10.1016/S0040-4039(99)01721-9; HASEGAWA Y, 1993, TETRAHEDRON LETT, V34, P1963, DOI 10.1016/S0040-4039(00)91975-0; Imai M, 2000, TETRAHEDRON, V56, P179, DOI 10.1016/S0040-4020(99)00995-3; INOUE Y, 1986, B CHEM SOC JPN, V59, P885, DOI 10.1246/bcsj.59.885; JUARISTI E, 1993, SYNTHESIS-STUTTGART, P1271; MEKELBURGER HB, 1991, COMPREHENSIVE ORGANI, V2; MUKHOPADHYAY T, 1982, HELV CHIM ACTA, V65, P385, DOI 10.1002/hlca.19820650141; MURAKATA M, 1990, J CHEM SOC CHEM COMM, P1657, DOI 10.1039/c39900001657; Murakata M, 1998, TETRAHEDRON, V54, P2449, DOI 10.1016/S0040-4020(98)00009-X; NORMANT H, 1967, ANGEW CHEM INT EDIT, V6, P1046, DOI 10.1002/anie.196710461; Seebach D., 1995, MODERN SYNTHETIC MET, P1; SEEBACH D, 1988, ANGEW CHEM INT EDIT, V27, P1624, DOI 10.1002/anie.198816241; SEEBACH D, 1982, CHEM BER-RECL, V115, P1705, DOI 10.1002/cber.19821150505	20	5	5	PHARMACEUTICAL SOC JAPAN	TOKYO	2-12-15 SHIBUYA, SHIBUYA-KU, TOKYO, 150-0002, JAPAN	0009-2363			CHEM PHARM BULL	Chem. Pharm. Bull.	OCT	2000	48	10					1529	1531				3	Chemistry, Medicinal; Chemistry, Multidisciplinary; Pharmacology & Pharmacy	Pharmacology & Pharmacy; Chemistry	360ZB	WOS:000089696300026		
J	Hidai, Y; Kan, T; Fukuyama, T				Hidai, Y; Kan, T; Fukuyama, T			Total synthesis of polyamine toxin HO-416b and Agel-489 using a 2-nitrobenzenesulfonamide strategy	CHEMICAL & PHARMACEUTICAL BULLETIN			English	Article						2-nitrobenzenesulfonamide (Ns) group; protecting and activating group; alkylation; monoprotection; solid support	FUNNEL-WEB SPIDER; SECONDARY-AMINES	Total synthesis of spider toxins HO-416b (1) and Agel-489 (2) was accomplished using the 2-nitrobenzenesulfonamide (Ns) group as both a protecting and activating group. In this strategy, the C-N bonds were constructed by alkylation of sulfonamides with alkyl halides or Mitsunobu reaction with the corresponding alcohol. Beginning with monoprotection of the symmetrical diamine, the construction of the backbone from diamine 3 was efficiently accomplished in 7 steps for 13 and 9 steps for 29, Removal of the Ns group while the substrate was attached to a novel solid support enabled the efficient isolation of this highly polar compound.	Univ Tokyo, CREST, Japan Sci & Technol Corp, Grad Sch Pharmaceut Sci,Bunkyo Ku, Tokyo 1130033, Japan	Fukuyama, T (reprint author), Univ Tokyo, CREST, Japan Sci & Technol Corp, Grad Sch Pharmaceut Sci,Bunkyo Ku, 7-3-1 Hongo, Tokyo 1130033, Japan.	fukuyama@mol.f.u-tokyo.ac.jp					Fukuyama T, 1997, TETRAHEDRON LETT, V38, P5831, DOI 10.1016/S0040-4039(97)01334-8; FUKUYAMA T, 1995, TETRAHEDRON LETT, V36, P6373, DOI 10.1016/0040-4039(95)01316-A; Miller SC, 1997, J AM CHEM SOC, V119, P2301, DOI 10.1021/ja9635443; BOWMAN WR, 1995, COMPREHENSIVE ORGANI, V2, P340; BURTON H, 1955, J CHEM SOC, P3089, DOI 10.1039/jr9550003089; FIEDLER WJ, 1993, HELV CHIM ACTA, V76, P1511, DOI 10.1002/hlca.19930760412; Hidai Y, 1999, TETRAHEDRON LETT, V40, P4711, DOI 10.1016/S0040-4039(99)00851-5; JASYS VJ, 1992, J ORG CHEM, V57, P1814, DOI 10.1021/jo00032a039; JASYS VJ, 1990, J AM CHEM SOC, V112, P6696, DOI 10.1021/ja00174a037; Mueller A. L., 1995, ALKALOIDS, V46, P63, DOI 10.1016/S0099-9598(08)60286-2; NAKAGAWA HT, 1972, J MED CHEM, V15, P483; QUISTAD GB, 1991, TOXICON, V29, P329, DOI 10.1016/0041-0101(91)90286-Z; SANDLER SR, 1983, ORGANIC FUNCTIONAL G, V1, P377; Schafer A., 1994, ALKALOIDS, V45, P1, DOI 10.1016/S0099-9598(08)60276-X	14	40	40	PHARMACEUTICAL SOC JAPAN	TOKYO	2-12-15 SHIBUYA, SHIBUYA-KU, TOKYO, 150-0002, JAPAN	0009-2363			CHEM PHARM BULL	Chem. Pharm. Bull.	OCT	2000	48	10					1570	1576				7	Chemistry, Medicinal; Chemistry, Multidisciplinary; Pharmacology & Pharmacy	Pharmacology & Pharmacy; Chemistry	360ZB	WOS:000089696300034		
J	Takamura, M; Hamashima, Y; Usuda, H; Kanai, M; Shibasaki, M				Takamura, M; Hamashima, Y; Usuda, H; Kanai, M; Shibasaki, M			A catalytic asymmetric Strecker-type reaction promoted by Lewis acid-Lewis base bifunctional catalyst	CHEMICAL & PHARMACEUTICAL BULLETIN			English	Article						asymmetric catalysis; Strecker-type reaction; bifunctional catalyst; Lewis acid; Lewis base; amino acid	ENANTIOSELECTIVE SYNTHESIS; IMINES; GUANIDINE; CYANIDE	A general asymmetric Strecker-type reaction is reported, catalyzed by the Lewis acid-Lewis base bifunctional catalyst 1. The reaction of trimethylsilyl cyanide (TMSCN) with various fluorenyl imines, including n-aldimines and alpha,beta-unsaturated imines. proceeds with good to excellent enantioselectivities in the presence of a catalytic amount of phenol as additive (20 mol%) (catalytic system 1), The products were successfully converted to the corresponding amino acid derivatives in high yields without loss of enantiomeric purity, Furthermore, hydrogenation or dihydroxylation of the products from alpha,beta-unsaturated imines afforded saturated or functionalized aminonitriles also without loss of enantiomeric purity. The absolute configuration of the products and a control experiment using catalyst 2 supported the proposed dual activation of the imine and TMSCN by the Lewis acrid (Al) and the Le,vis base moiety (phosphine oxide) of 1. From the mechanistic studies including kinetic and NMR experiments of the catalytic species, the role of PhOH seems to he a proton source to protonate the anionic nitrogen of the intermediate, Specifically, we have found that TMSCN is more reactive than HCN in this catalytic sl stem, probably due to the activation ability of the phosphine oxide moiety of I toward TMSCN. This fact prompted us to develop the novel catalytic system 2, consisting of 1 (9 mol%), TMSCN (20 mol%) and HCN (1.2 mol eq), This new system afforded comparable results with obtained by system 1 (1 (9 mol%)-TMSCN (2 mol eq)-PhOH (20 mol%)).	Univ Tokyo, Grad Sch Pharmaceut Sci, Bunkyo Ku, Tokyo 1130033, Japan	Shibasaki, M (reprint author), Univ Tokyo, Grad Sch Pharmaceut Sci, Bunkyo Ku, Tokyo 1130033, Japan.	mshibasa@mol.f.u-tokyo.ac.jp					Sigman MS, 1998, J AM CHEM SOC, V120, P4901, DOI 10.1021/ja980139y; Porter JR, 2000, J AM CHEM SOC, V122, P2657, DOI 10.1021/ja994121e; Ishitani H, 1998, ANGEW CHEM INT EDIT, V37, P3186, DOI 10.1002/(SICI)1521-3773(19981204)37:22<3186::AID-ANIE3186>3.0.CO;2-E; Sigman MS, 1998, J AM CHEM SOC, V120, P5315, DOI 10.1021/ja980299+; Krueger CA, 1999, J AM CHEM SOC, V121, P4284, DOI 10.1021/ja9840605; Corey EJ, 1999, ORG LETT, V1, P157, DOI 10.1021/ol990623l; Sigman MS, 2000, ANGEW CHEM INT EDIT, V39, P1279, DOI 10.1002/(SICI)1521-3773(20000403)39:7<1279::AID-ANIE1279>3.0.CO;2-U; Hamashima Y, 1999, J AM CHEM SOC, V121, P2641, DOI 10.1021/ja983895c; Ishitani H, 2000, J AM CHEM SOC, V122, P762, DOI 10.1021/ja9935207; Iyer MS, 1996, J AM CHEM SOC, V118, P4910, DOI 10.1021/ja952686e; COREY EJ, 1989, TETRAHEDRON LETT, V30, P5227, DOI 10.1016/S0040-4039(01)93748-7; Kanai M, 2000, TETRAHEDRON LETT, V41, P2405, DOI 10.1016/S0040-4039(00)00174-X; MAI K, 1986, J ORG CHEM, V51, P3545, DOI 10.1021/jo00368a030; SASAKI Y, 1993, CHEM PHARM BULL, V41, P1391; Strecker A, 1850, LIEBIGS ANN CHEM, V75, P27	15	41	41	PHARMACEUTICAL SOC JAPAN	TOKYO	2-12-15 SHIBUYA, SHIBUYA-KU, TOKYO, 150-0002, JAPAN	0009-2363			CHEM PHARM BULL	Chem. Pharm. Bull.	OCT	2000	48	10					1586	1592				7	Chemistry, Medicinal; Chemistry, Multidisciplinary; Pharmacology & Pharmacy	Pharmacology & Pharmacy; Chemistry	360ZB	WOS:000089696300037		
J	Okamoto, H; Inishi, H; Nakamura, Y; Kohtani, S; Nakagaki, R				Okamoto, H; Inishi, H; Nakamura, Y; Kohtani, S; Nakagaki, R			Infrared and Raman spectra of 4-(dimethylamino)benzonitrile and isotopomers in the ground state and vibrational analysis	CHEMICAL PHYSICS			English	Article							CHARGE-TRANSFER STATE; AB-INITIO; EXCITED-STATES; 4-(N,N-DIMETHYLAMINO)BENZONITRILE; FREQUENCIES; DIMETHYLAMINOBENZONITRILE; AMINOBENZONITRILES; DERIVATIVES; SEPARATION; DYNAMICS	Vibrational analysis of 4-(dimethylamino)benzonitrile (DMABN) has been performed. Infrared and Raman spectra of DMABN and its four different isotope-labeled species have been recorded. Assignments of the vibrational bands are given on the basis of normal coordinate calculation on an empirical force field and of the Hartree-Fock and the density functional calculations. Most of the vibrational bands observed have been successfully assigned, and the isotope shifts are reasonably explained. It is clearly demonstrated from the measurements on the isotopomers that assignments of some bands in the literature are not correct. The characteristics of the empirical and the quantum-chemical force fields are compared. It has been found that the strong interaction between the dimethylamino group and the benzene ring is directly reflected in the force field. (C) 2000 Elsevier Science B.V. All rights reserved.	Univ Tokyo, Res Ctr Spectrochem, Dept Chem, Sch Sci,Bunkyo Ku, Tokyo 1130033, Japan; Kanazawa Univ, Fac Pharmaceut Sci, Kanazawa, Ishikawa 9200934, Japan	Okamoto, H (reprint author), Univ Tokyo, Res Ctr Spectrochem, Dept Chem, Sch Sci,Bunkyo Ku, 7-3-1 Hongo, Tokyo 1130033, Japan.						Akalin E, 2000, VIB SPECTROSC, V22, P3, DOI 10.1016/S0924-2031(99)00057-0; Parusel ABJ, 1998, J PHYS CHEM A, V102, P6297, DOI 10.1021/jp9800867; GRABOWSKI ZR, 1979, NOUV J CHIM, V3, P443; CASTELLAVENTURA M, 1994, SPECTROCHIM ACTA A, V50, P69, DOI 10.1016/0584-8539(94)80116-9; Wilson EB, 1934, PHYS REV, V45, P0706, DOI 10.1103/PhysRev.45.706; SHIMANOUCHI T, 1980, J PHYS CHEM REF DATA, V9, P1149; Il'ichev YV, 1998, J PHYS CHEM A, V102, P5670, DOI 10.1021/jp980426o; SERRANOANDRES L, 1995, J AM CHEM SOC, V117, P3189, DOI 10.1021/ja00116a024; KAJIMOTO O, 1993, CHEM PHYS LETT, V209, P357, DOI 10.1016/0009-2614(93)80030-S; Dreyer J, 2000, J AM CHEM SOC, V122, P2577, DOI 10.1021/ja992095e; BLATTER HM, 1961, J AM CHEM SOC, V83, P2203, DOI 10.1021/ja01470a043; WILLIAMS DJ, 1984, ANGEW CHEM INT EDIT, V23, P690, DOI 10.1002/anie.198406901; Brouwer AM, 1997, J PHYS CHEM A, V101, P3626, DOI 10.1021/jp970142o; CAPDEVIELLE P, 1989, SYNTHESIS-STUTTGART, P451; Chudoba C, 1999, CHEM PHYS LETT, V309, P357, DOI 10.1016/S0009-2614(99)00711-3; Foresman J.B., 1996, EXPLORING CHEM ELECT; FRISCH MJ, 1998, GAUSSIAN 98 REVISION, P75501; GATES PN, 1972, J CHEM SOC PERK T 2, P1607, DOI 10.1039/p29720001607; HAYASHI S, 1995, J PHYS CHEM-US, V99, P955, DOI 10.1021/j100003a018; HEINE A, 1994, ACTA CRYSTALLOGR B, V50, P363, DOI 10.1107/S0108768193008523; HUPPERT D, 1981, J CHEM PHYS, V75, P5714, DOI 10.1063/1.442008; JAMESON GB, 1994, ACTA CRYSTALLOGR B, V50, P703, DOI 10.1107/S0108768194002600; KATO S, 1990, J CHEM PHYS, V92, P7241, DOI 10.1063/1.458210; KOBAYASHI T, 1987, CHEM PHYS LETT, V141, P450, DOI 10.1016/0009-2614(87)85057-1; KUKHAR VP, 1974, SYNTHESIS-STUTTGART, P563; Kumar AP, 1997, SPECTROCHIM ACTA A, V53, P2049, DOI 10.1016/S1386-1425(97)00133-9; Kwok WM, 2000, J PHYS CHEM A, V104, P4188, DOI 10.1021/jp9927606; LEINHOS U, 1991, J PHYS CHEM-US, V95, P201; Lippert E., 1961, ANGEW CHEM, V73, P695, DOI 10.1002/ange.19610732103; Matsuura H., 1983, VIBRATIONAL SPECTRA, V12, P69; NAKASHIM.N, 1973, B CHEM SOC JPN, V46, P3016; NIU ZF, 1985, MOL PHYS, V55, P421, DOI 10.1080/00268978500101441; Okamoto H., UNPUB; Okamoto H, 2000, J PHYS CHEM A, V104, P4182, DOI 10.1021/jp992657g; POIZAT O, 1989, J CHEM PHYS, V90, P4697, DOI 10.1063/1.456615; RETTIG W, 1993, J PHYS CHEM-US, V97, P13500, DOI 10.1021/j100153a014; RETTIG W, 1986, ANGEW CHEM INT EDIT, V25, P971, DOI 10.1002/anie.198609711; ROTKIEWI.K, 1973, CHEM PHYS LETT, V19, P315, DOI 10.1016/0009-2614(73)80367-7; Schneider S, 1997, J RAMAN SPECTROSC, V28, P305, DOI 10.1002/(SICI)1097-4555(199705)28:5<305::AID-JRS97>3.0.CO;2-J; Scholes GD, 1997, CHEM PHYS LETT, V266, P521, DOI 10.1016/S0009-2614(97)00038-9; Scott AP, 1996, J PHYS CHEM-US, V100, P16502, DOI 10.1021/jp960976r; Sobolewski AL, 1998, J PHYS CHEM A, V102, P2716, DOI 10.1021/jp980435x; TASUMI M, 1986, J MOL STRUCT, V146, P383, DOI 10.1016/0022-2860(86)80306-4	43	44	45	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	0301-0104			CHEM PHYS	Chem. Phys.	OCT 1	2000	260	1-2					193	214		10.1016/S0301-0104(00)00243-3		22	Chemistry, Physical; Physics, Atomic, Molecular & Chemical	Chemistry; Physics	361BK	WOS:000089701700015		
J	Kusakabe, Y; Yasuoka, A; Asano-Miyoshi, M; Iwabuchi, K; Matsumoto, I; Arai, S; Emori, Y; Abe, K				Kusakabe, Y; Yasuoka, A; Asano-Miyoshi, M; Iwabuchi, K; Matsumoto, I; Arai, S; Emori, Y; Abe, K			Comprehensive study on G protein alpha-subunits in taste bud cells, with special reference to the occurrence of G alpha i2 as a major G alpha species	CHEMICAL SENSES			English	Article							IN-SITU HYBRIDIZATION; BETA-GAMMA-SUBUNITS; GTP-BINDING PROTEIN; MOLECULAR-CLONING; CULTURED-CELLS; NEURAL TISSUE; TRANSDUCTION; BITTER; IDENTIFICATION; EXPRESSION	Previous stud ies have identified many cDNA species that encode a variety of G protein alpha-subunits occurring in taste buds. These include the cDNA encoding a taste-bud-specific G alpha, gustducin (G(gust)) Here we carried out comprehensive analyses of G alpha species that occur in the taste buds of rat circumvallate papillae and also in their single cells isolated from the taste buds. Reverse transcriptase-polymerase chain reaction showed the presence of 10 kinds of G alpha cDNAs, including a splice variant of G alpha s, among which G(gust), G alpha s, G alpha i2 and G alpha i3 cDNAs were shown to be major species. In situ hybridization and immunohistochemistry showed that G alpha i2, as well as G(gust), expressed in a subset of taste bud cells, and the frequency of G alpha i2-expression appears to be higher than that of G(gust) Southern ana lyses of the amplified cDNA from single tells showed that each taste bud cell expresses multiple G alpha mRNA species. For example, some G alpha i2-positive cells also express one or more other G alpha species, including G alpha s, G alpha i3 and G(gust), and there is no apparent correlation in expression among the three G alpha species.	Univ Tokyo, Grad Sch Agr & Life Sci, Dept Appl Biol Chem, Bunkyo Ku, Tokyo 1138657, Japan; Univ Tokyo, Biooriented Technol Res Advancement Inst, Bunkyo Ku, Tokyo 1130033, Japan; Univ Tokyo, Fac Sci, Dept Biophys & Biochem, Bunkyo Ku, Tokyo 1130033, Japan; Tokyo Univ Agr, Fac Appl Biol Sci, Dept Nutr Sci, Setagaya Ku, Tokyo 1568502, Japan	Abe, K (reprint author), Univ Tokyo, Grad Sch Agr & Life Sci, Dept Appl Biol Chem, Bunkyo Ku, 1-1-1 Yayoi, Tokyo 1138657, Japan.						ABE K, 1993, FEBS LETT, V316, P253, DOI 10.1016/0014-5793(93)81302-G; ABE K, 1993, J BIOL CHEM, V268, P12033; TAUSSIG R, 1993, SCIENCE, V261, P218, DOI 10.1126/science.8327893; Wong GT, 1996, NATURE, V381, P796, DOI 10.1038/381796a0; AKABAS MH, 1988, SCIENCE, V242, P1047, DOI 10.1126/science.3194756; STRIEM BJ, 1989, BIOCHEM J, V260, P121; Yasuoka A, 1999, J BIOCHEM-TOKYO, V126, P866; Yang H, 1999, J HISTOCHEM CYTOCHEM, V47, P431; DULAC C, 1995, CELL, V83, P195, DOI 10.1016/0092-8674(95)90161-2; Lindemann B, 1996, PHYSIOL REV, V76, P719; KOFUJI P, 1995, P NATL ACAD SCI USA, V92, P6542, DOI 10.1073/pnas.92.14.6542; SCHAERENWIEMERS N, 1993, HISTOCHEMISTRY, V100, P431, DOI 10.1007/BF00267823; AVENET P, 1988, NATURE, V331, P351, DOI 10.1038/331351a0; Thomas MB, 1996, GENE, V178, P1, DOI 10.1016/0378-1119(96)00311-3; Asano-Miyoshi M, 1998, J BIOCHEM-TOKYO, V124, P927; BERHARDT SJ, 1996, J PHYSL, V490, P325; BRAND JG, 1991, PHYSIOL BEHAV, V49, P899, DOI 10.1016/0031-9384(91)90201-X; CAMPS M, 1992, NATURE, V360, P684, DOI 10.1038/360684a0; DELAY RJ, 1986, J COMP NEUROL, V253, P242, DOI 10.1002/cne.902530210; FEINSTEIN DL, 1992, GLIA, V5, P139, DOI 10.1002/glia.440050208; Hoon MA, 1999, CELL, V96, P541, DOI 10.1016/S0092-8674(00)80658-3; HWANG PM, 1990, P NATL ACAD SCI USA, V87, P7395, DOI 10.1073/pnas.87.19.7395; JONES DT, 1987, J BIOL CHEM, V262, P14241; Kusakabe Y, 1998, BBA-MOL CELL RES, V1403, P265, DOI 10.1016/S0167-4889(98)00062-7; MATSUOKA I, 1993, BIOCHEM BIOPH RES CO, V194, P504, DOI 10.1006/bbrc.1993.1848; MCLAUGHLIN SK, 1994, PHYSIOL BEHAV, V56, P1157, DOI 10.1016/0031-9384(94)90360-3; MCLAUGHLIN SK, 1992, NATURE, V357, P563, DOI 10.1038/357563a0; NUDEL U, 1983, NUCLEIC ACIDS RES, V11, P1759, DOI 10.1093/nar/11.6.1759; Ogura T, 1997, J NEUROSCI, V17, P3580; Sambrook J., 1989, MOL CLONING LAB MANU; SPIELMAN AI, 1996, AM J PHYSIOL, V270, P926; SPIELMAN AI, 1994, PHYSIOL BEHAV, V56, P1149, DOI 10.1016/0031-9384(94)90359-X; STONE LM, 1995, P NATL ACAD SCI USA, V92, P1916, DOI 10.1073/pnas.92.6.1916; TAL M, 1995, BIOCHEM BIOPH RES CO, V209, P752, DOI 10.1006/bbrc.1995.1563; Ueda H, 1998, J BIOCHEM-TOKYO, V124, P1033	35	50	51	OXFORD UNIV PRESS	OXFORD	GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND	0379-864X			CHEM SENSES	Chem. Senses	OCT	2000	25	5					525	531		10.1093/chemse/25.5.525		7	Behavioral Sciences; Food Science & Technology; Neurosciences; Physiology	Behavioral Sciences; Food Science & Technology; Neurosciences & Neurology; Physiology	364ED	WOS:000089878300005		
J	Mori, H; Sakurai, N; Tanaka, S; Moriyama, H; Mori, T; Kobayashi, H; Kobayashi, A				Mori, H; Sakurai, N; Tanaka, S; Moriyama, H; Mori, T; Kobayashi, H; Kobayashi, A			Control of electronic state by dihedral angle in theta-type bis(ethylenedithio)tetraselenafulvalene salts	CHEMISTRY OF MATERIALS			English	Article							PHYSICAL-PROPERTIES; MOLECULAR SUPERCONDUCTOR; ELECTRICAL-PROPERTIES; TRANSPORT-PROPERTIES; ORGANIC CONDUCTORS; METAL; CRYSTAL; ANIONS; KAPPA; M'=CO	Five theta -type BETS salts [BETS = bis(ethylenedithio)tetraselenafulvalene], theta -BETS2RbCo-(SCN)(4), theta -BETS2RbZn(SCN)(4), theta -BETS2CsCo(SCN)(4), theta -BETS2CsZn(SCN)(4), and theta -BETS2Ag-(CN)(2), have been newly prepared by the electrocrystallization method. The crystal structure analyses indicate that the former four salts are isostructural to BEDT-TTF analogues. [BEDT-TTF = bis(ethylenedithio)tetrathiafulvalene] However, the metal-insulator transition temperatures of theta -type BETS salts are much lower than those of isostructural BEDT-TTF salts, due to the smaller U/M (U, intramolecular Coulomb repulsion energy; W,bandwidth) of Se-atoms-introduced BETS salts. The electronic phase diagram of theta -type BETS salts indicate that the dihedral angles (theta) between BETS columns in the donor sheet control the electronic states; with decreasing dihedral angle (theta), the transverse interaction (t) increases, so that the larger bandwidth (W = 8t) makes the metal-insulator transition temperatures lower in the BETS salts. This phase diagram is universal for theta -type BETS salts as well as theta -type BEDT-TTF salts.	ISTEC, Koto Ku, Tokyo 1350062, Japan; Toho Univ, Fac Sci, Dept Chem, Chiba 2748510, Japan; Tokyo Inst Technol, Dept Organ & Polymer Mat, Tokyo 1528552, Japan; Inst Mol Sci, Okazaki, Aichi 4440867, Japan; Univ Tokyo, Sch Sci, Dept Chem, Tokyo 1130035, Japan	Mori, H (reprint author), ISTEC, Koto Ku, 1-10-13 Shinonome, Tokyo 1350062, Japan.						Mori H, 1998, PHYS REV B, V57, P12023, DOI 10.1103/PhysRevB.57.12023; Mori H, 1998, B CHEM SOC JPN, V71, P797, DOI 10.1246/bcsj.71.797; MORI T, 1984, B CHEM SOC JPN, V57, P627, DOI 10.1246/bcsj.57.627; MORI H, 1995, B CHEM SOC JPN, V68, P1136, DOI 10.1246/bcsj.68.1136; BENDER K, 1984, MOL CRYST LIQ CRYST, V108, P359, DOI 10.1080/00268948408078687; KINI AM, 1990, INORG CHEM, V29, P2555, DOI 10.1021/ic00339a004; Bogdanova OA, 1997, CHEM LETT, P675, DOI 10.1246/cl.1997.675; Ishiguro T., 1998, ORGANIC SUPERCONDUCT; KATO R, 1991, CHEM LETT, P1045, DOI 10.1246/cl.1991.1045; KATO R, 1991, SYNTHETIC MET, V41, P2093; NAITO T, 1991, CHEM LETT, P1945, DOI 10.1246/cl.1991.1945; KOBAYASHI H, 1986, CHEM LETT, P833, DOI 10.1246/cl.1986.833; KOBAYASHI H, 1986, CHEM LETT, P789, DOI 10.1246/cl.1986.789; Kobayashi H, 1997, SOLID STATE COMMUN, V103, P371, DOI 10.1016/S0038-1098(97)00172-5; Kobayashi H, 1997, SYNTHETIC MET, V85, P1595, DOI 10.1016/S0379-6779(97)80365-7; Montgomery L. K., 1993, SYNTHETIC MET, V55-57, P2090; Mori H, 1996, J PHYS I, V6, P1987, DOI 10.1051/jp1:1996194; MORI H, 1994, INT J MOD PHYS B, V8, P1, DOI 10.1142/S0217979294000026; Mori T, 1996, PHYSICA C, V264, P22, DOI 10.1016/0921-4534(96)80005-0; Naito T, 1997, B CHEM SOC JPN, V70, P107, DOI 10.1246/bcsj.70.107; Sheldrick G.M., 1985, CRYSTALLOGRAPHIC COM, V3, P175; TANAKA Y, COMMUNICATION; Williams J M, 1992, ORGANIC SUPERCONDUCT	23	11	11	AMER CHEMICAL SOC	WASHINGTON	1155 16TH ST, NW, WASHINGTON, DC 20036 USA	0897-4756			CHEM MATER	Chem. Mat.	OCT	2000	12	10					2984	2987		10.1021/cm000321+		4	Chemistry, Physical; Materials Science, Multidisciplinary	Chemistry; Materials Science	366YT	WOS:000090034400027		
J	Maeda, H; Niimi, T; Sato, S; Kawaguchi, H; Sugiura, Y; Mori, S; Ueda, R				Maeda, H; Niimi, T; Sato, S; Kawaguchi, H; Sugiura, Y; Mori, S; Ueda, R			Human herpesvirus 8 is not associated with sarcoidosis in Japanese patients	CHEST			English	Article						human herpesvirus 8; polymerase chain reaction; sarcoidosis	SARCOMA-ASSOCIATED HERPESVIRUS; KAPOSIS-SARCOMA; DNA-SEQUENCES; PERIPHERAL-BLOOD; AIDS; HUMAN-HERPESVIRUS-8; TISSUES; INTERLEUKIN-6; MACROPHAGES; PROTEIN-1	Study objectives: The etiology of sarcoidosis remains unknown, but recently it was reported that human herpesvirus 8 (HHV-8) may be detected in sarcoid tissue in a high proportion of patients. This study was performed to determine whether HHV-8 is implicated in sarcoidosis in Japan. Materials and methods: Peripheral blood mononuclear cells (PBMCs) were obtained from 100 patients with sarcoidosis and 100 healthy donors living in central Japan. Additionally, 19 samples of sarcoid tissue, 10 of tuberculous tissue, and 10 of lung cancers were examined. DNA was extracted from PBMC or tissue samples, and a hemi-nested polymerase chain reaction assay was performed for HHV-8 detection. Results: In the PBMC study, the detection rates for HHV-8 in patients with sarcoidosis and in normal donors were 2% and 1%, respectively, the difference not being significant (p > 0.99). In the tissue study, HHV-8 was detected in 10.5% of sarcoid and in 15% of nonsarcoid tissues, again not a significant difference (p > 0.99). Conclusions: From these results, we conclude that HHV-8 is not implicated in sarcoidosis in Japanese patients.	Nagoya City Univ, Sch Med, Dept Internal Med 2, Mizuho Ku, Aichi 4678601, Japan; Univ Tokyo, Inst Med Sci, Dept Pathol, Tokyo, Japan	Maeda, H (reprint author), Nagoya City Univ, Sch Med, Dept Internal Med 2, Mizuho Ku, 1 Kawasumi, Aichi 4678601, Japan.						STEFFEN M, 1993, J ALLERGY CLIN IMMUN, V91, P939, DOI 10.1016/0091-6749(93)90352-G; HUANG YQ, 1995, LANCET, V345, P759, DOI 10.1016/S0140-6736(95)90641-X; Sirianni MC, 1998, BLOOD, V91, P968; Baumer I, 1997, AM J RESP CELL MOL, V16, P171; WHITBY D, 1995, LANCET, V346, P799, DOI 10.1016/S0140-6736(95)91619-9; Newman LS, 1997, NEW ENGL J MED, V336, P1224, DOI 10.1056/NEJM199704243361706; Belec L, 1998, CHEST, V114, P948, DOI 10.1378/chest.114.3.948; Bigoni B, 1996, J INFECT DIS, V173, P542; Boshoff C, 1998, BLOOD, V91, P1671; Cesarman E, 1999, SEMIN CANCER BIOL, V9, P165, DOI 10.1006/scbi.1998.0118; CHANG Y, 1994, SCIENCE, V266, P1865, DOI 10.1126/science.7997879; Chauhan D, 1999, BLOOD, V93, P1482; DiAlberti L, 1997, J INFECT DIS, V175, P703; DiAlberti L, 1997, LANCET, V350, P1655, DOI 10.1016/S0140-6736(97)10102-7; Hashimoto S, 1998, CLIN EXP IMMUNOL, V111, P604; JAMES DG, 1994, SARCOIDOSIS OTHER GR, P597; Katano H, 1999, J MED VIROL, V59, P346, DOI 10.1002/(SICI)1096-9071(199911)59:3<346::AID-JMV15>3.0.CO;2-4; Lin K, 1998, J VIROL, V72, P6228; Marchioli CC, 1996, J CLIN MICROBIOL, V34, P2635; Nicholas J, 1997, NAT MED, V3, P287, DOI 10.1038/nm0397-287; Regamey N, 1998, Lancet, V351, P680, DOI 10.1016/S0140-6736(05)78472-5; Zong JC, 1997, J VIROL, V71, P2505	22	15	15	AMER COLL CHEST PHYSICIANS	NORTHBROOK	3300 DUNDEE ROAD, NORTHBROOK, IL 60062-2348 USA	0012-3692			CHEST	Chest	OCT	2000	118	4					923	927		10.1378/chest.118.4.923		5	Critical Care Medicine; Respiratory System	General & Internal Medicine; Respiratory System	366MC	WOS:000090008300010		
J	Zhang, Y; Yasuda, T; Wang, CR; Yoshimoto, T; Nagase, H; Takamoto, M; Tsubura, A; Kimura, M; Matsuzawa, A				Zhang, Y; Yasuda, T; Wang, CR; Yoshimoto, T; Nagase, H; Takamoto, M; Tsubura, A; Kimura, M; Matsuzawa, A			A pivotal role of cell-bound but not soluble CD4 molecules in full development of lupus-like manifestations in MRL-Fas(lprcg)/Fas(lprcg) mice	CLINICAL AND EXPERIMENTAL IMMUNOLOGY			English	Article						lupus nephritis; autoimmunity; MRL-Fas(lprcg) mice; CD4 molecules	MRL-LPR/LPR MICE; T-CELLS; MONOCLONAL-ANTIBODY; AUTOIMMUNE-DISEASE; MRL/LPR MICE; MURINE LUPUS; LPR MICE; LYMPHOPROLIFERATIVE SYNDROME; AUTOANTIBODY PRODUCTION; RHEUMATOID-FACTOR	The role of CD4 molecules in the autoimmune and lymphoproliferative syndrome caused by murine Fas mutations was studied using the novel systemic lupus erythematosus (SLE) model, MRL-Fas(lprcg)/ Fas(lprcg) (MRL-lpr(cg)) mice, in combination with the novel mutant CD4 gene producing soluble CD4 (sCD4) instead of membrane-bound CD4 (mCD4). For this purpose, various autoimmune manifestations were compared among MRL-lpr(cg) mice homozygous (CD4(s)-lpr(cg)), heterozygous (CD4(s/m)-lpr(cg)), and wild-type (CD4(m)-lpr(cg)) for the CD4 mutation. The mortality, glomerulonephritis, proteinuria, and lymphadenopathy were significantly ameliorated in CD4(s)-lpr(cg) compared with CD4(m)-lpr(cg) and CD4(s/m)- lpr(cg) mice, both being comparable in these clinical characteristics. In parallel with the clinical improvement, the serum levels of immunoglobulin, anti-DNA antibodies, anti-nuclear antibodies and immune complexes, and the extent of glomerular immune deposition, were significantly lower in the former. The results indicate that mCD4 is important and can not he replaced by sCD4 in full development of SLE-like manifestations, and suggest that CD4(+) T cells may aggravate the autoimmune disease by stimulating autoreactive B cells to produce autoantibodies through their helper activity in Fas mutant models. The sCD4 levels in the serum and spleen elevated with the increased accumulation of B210(+)CD4(-)CD8(-) (double-negative (DN)) T cells in CD4(s)-lpr(cg) mice. This, together with the significantly milder lymphadenopathy associated with lower DN T cell contents in CDC-lpr''* than CD4(m)-lpr(cg) mice, implies that some of abnormal DN T cells may be derived from cells of the CD4 lineage.	Univ Tokyo, Inst Med Sci, Lab Anim Res Ctr, Tokyo, Japan; Univ Tokyo, Inst Med Sci, Dept Allergol, Tokyo, Japan; Univ Tokyo, Inst Med Sci, Dept Internal Med, Tokyo, Japan; Tokyo Med Univ, Intractable Dis Res Ctr, Tokyo, Japan; Shinshu Univ, Sch Med, Dept Parasitol, Matsumoto, Nagano 390, Japan; Kansai Med Univ, Dept Pathol, Osaka, Japan	Matsuzawa, A (reprint author), 5-66-5 Heiwadai, Nagareyama, Chiba 2700157, Japan.						MATSUZAWA A, 1990, J EXP MED, V171, P519, DOI 10.1084/jem.171.2.519; COHEN PL, 1991, ANNU REV IMMUNOL, V9, P243, DOI 10.1146/annurev.iy.09.040191.001331; SANTORO TJ, 1988, J EXP MED, V167, P1713, DOI 10.1084/jem.167.5.1713; Tipping PG, 1998, AM J PATHOL, V152, P1541; NAPARSTEK Y, 1990, ARTHRITIS RHEUM, V33, P1554, DOI 10.1002/art.1780331013; SEAMAN WE, 1983, J IMMUNOL, V130, P1713; Haas C, 1997, J IMMUNOL, V158, P5484; THEOFILOPOULOS AN, 1985, ADV IMMUNOL, V37, P269, DOI 10.1016/S0065-2776(08)60342-9; FISHER GH, 1995, CELL, V81, P935, DOI 10.1016/0092-8674(95)90013-6; RIEUXLAUCAT F, 1995, SCIENCE, V268, P1347, DOI 10.1126/science.7539157; Gu LJ, 1998, J IMMUNOL, V161, P6999; HENRICKSON M, 1994, ARTHRITIS RHEUM, V37, P587, DOI 10.1002/art.1780370422; JABS DA, 1992, CELL IMMUNOL, V141, P496, DOI 10.1016/0008-8749(92)90166-M; JABS DA, 1994, CELL IMMUNOL, V154, P66, DOI 10.1006/cimm.1994.1057; JEVINKAR AM, 1994, J EXP MED, V179, P1137; KIMURA M, 1992, IMMUNOLOGY, V76, P498; Kimura M, 1994, Int Rev Immunol, V11, P193, DOI 10.3109/08830189409061727; KOH DR, 1995, EUR J IMMUNOL, V25, P2558, DOI 10.1002/eji.1830250923; LAOUAR Y, 1994, J IMMUNOL, V153, P3948; MERINO R, 1993, J IMMUNOL, V151, P6509; Nagase H, 1998, EUR J IMMUNOL, V28, P403, DOI 10.1002/(SICI)1521-4141(199802)28:02<403::AID-IMMU403>3.0.CO;2-5; NAGATA S, 1995, IMMUNOL TODAY, V16, P9; OHTEKI T, 1995, EUR J IMMUNOL, V25, P37, DOI 10.1002/eji.1830250108; OSULLIVAN FX, 1991, CLIN IMMUNOL IMMUNOP, V61, P421, DOI 10.1016/S0090-1229(05)80013-3; REHEMTULLA A, 1994, EUR J IMMUNOL, V24, P2213; REININGER L, 1990, P NATL ACAD SCI USA, V87, P10038, DOI 10.1073/pnas.87.24.10038; STEINBERG AD, 1980, J IMMUNOL, V125, P871; THEOFILOPOULOS AN, 1989, ADV IMMUNOL, V46, P61; Wang Y, 1997, AM J PATHOL, V151, P1791; WATANABEFUKUNAGA R, 1992, NATURE, V356, P314, DOI 10.1038/356314a0; WATSON ML, 1992, J EXP MED, V176, P1645, DOI 10.1084/jem.176.6.1645; WEBER S, 1993, EUR J IMMUNOL, V23, P511, DOI 10.1002/eji.1830230232; WOFSY D, 1985, J IMMUNOL, V134, P852; Yasuda T, 2000, LAB ANIM, V34, P46, DOI 10.1258/002367700780578019	34	4	4	BLACKWELL SCIENCE LTD	OXFORD	P O BOX 88, OSNEY MEAD, OXFORD OX2 0NE, OXON, ENGLAND	0009-9104			CLIN EXP IMMUNOL	Clin. Exp. Immunol.	OCT	2000	122	1					124	132		10.1046/j.1365-2249.2000.01347.x		9	Immunology	Immunology	363DE	WOS:000089818900020		
J	Itoh, K; Sasaki, Y; Fujii, H; Minami, H; Ohtsu, T; Wakita, H; Igarashi, T; Watanabe, Y; Onozawa, Y; Kashimura, M; Ohashi, Y				Itoh, K; Sasaki, Y; Fujii, H; Minami, H; Ohtsu, T; Wakita, H; Igarashi, T; Watanabe, Y; Onozawa, Y; Kashimura, M; Ohashi, Y			Study of dose escalation and sequence switching of administration of the combination of docetaxel and doxorubicin in advanced breast cancer	CLINICAL CANCER RESEARCH			English	Article							PHASE-I; ONCOLOGY-GROUP; PACLITAXEL; PHARMACOKINETICS; CISPLATIN; TAXOL; VITRO; TOPOTECAN	The objectives of the present study mere to evaluate whether a schedule-dependent pharmacokinetic and/or pharmacodynamic interaction exists between two sequences of docetaxel and doxorubicin administration and to determine the maximal tolerated dose (MTD) of this combination. Patients with chemotherapy-naive metastatic or recurrent advanced breast cancer were enrolled. In the crossover design, tandem dose escalation of docetaxel and doxorrbicin was performed. Docetaxel, in doses ranging from 50-70 mg/m(2), was administered for 1 h by drip infusion either just before or after a 5-min bolus i.v, injection of doxorubicin at dosages from 40-50 mg/m(2). The sequence of drug administration was switched after the first course in each patient, and the sequence of drug administration thereafter depended on the patient's choice. Twenty-five patients were initially assessable for toxicity. The MTD in the sequence of doxorubicin after docetaxel was 40 and 50 mg/m(2), respectively, with the dose-limiting toxicity of neutropenia. On the other hand, the MTD of the sequence of docetaxel after doxorubicin was 70 and 50 mg/m(2), respectively. The dose-limiting toxicities in this sequence were neutropenia and diarrhea, Duration of grade 4 neutropenia in the sequence of docetaxel followed by doxorubicin was significantly longer than that in the alternate sequence (P = 0,0062), However, there was no difference in pharmacokinetic parameters of docetaxel, doxorubicin, and doxorubicinol between the two sequences. The sequence of 50 mg/m(2) doxorubicin followed by 60 mg/m(2) docetaxel is recommended for subsequent clinical trials for practical reasons.	East Hosp, Natl Canc Ctr, Div Oncol & Hematol, Kashiwa, Chiba 2778577, Japan; Rhone Poulenc Rorer Japan Inc, Tokyo, Ibaraki 315, Japan; Univ Tokyo, Fac Med, Sch Hlth Sci & Nutr, Tokyo 1130033, Japan	Itoh, K (reprint author), East Hosp, Natl Canc Ctr, Div Oncol & Hematol, 6-5-1 Kashiwanoha, Kashiwa, Chiba 2778577, Japan.	kaito@east.ncc.go.jp					AHERN RP, 1993, BRIT J CANCER, V67, P801, DOI 10.1038/bjc.1993.146; Marre F, 1996, CANCER RES, V56, P1296; Huizing MT, 1997, J CLIN ONCOL, V15, P317; ROWINSKY EK, 1991, J CLIN ONCOL, V9, P1692; Bruno R, 1998, J CLIN ONCOL, V16, P187; CORTES JE, 1995, J CLIN ONCOL, V13, P2643; Gianni L, 1997, J CLIN ONCOL, V15, P1906; VERGNIOL JC, 1992, J CHROMATOGR-BIOMED, V582, P273, DOI 10.1016/0378-4347(92)80333-L; BAILLE P, 1998, P AM SOC CLIN ONCOL, V17, P189; Baker SD, 1997, PHARMACOTHERAPY, V17, pS126; BELLOTT R, 1998, P AN M AM SOC CLIN, V17, P221; BERG SL, 1994, J NATL CANCER I, V86, P143, DOI 10.1093/jnci/86.2.143; Colombo T, 1999, ANN ONCOL, V10, P391, DOI 10.1023/A:1008309916974; DIERAS V, 1997, ONCOLOGY HUNTINGT, V11, P29; D'Incalci M, 1998, SEMIN ONCOL, V25, P16; DOBBS NA, 1987, J CHROMATOGR-BIOMED, V420, P184, DOI 10.1016/0378-4347(87)80171-8; Holmes FA, 1996, J CLIN ONCOL, V14, P2713; Kennedy MJ, 1996, J CLIN ONCOL, V14, P783; KENNEDY MJ, 1997, P AN M AM SOC CLIN, V16, P240; Kennedy MJ, 1998, CLIN CANCER RES, V4, P349; Khayat David, 1997, Seminars in Oncology, V24, P19; National Cancer Institute, 1988, GUID REP ADV DRUG RE; OReilly S, 1997, J CLIN ONCOL, V15, P177; Pronk LC, 1997, J CLIN ONCOL, V15, P1071; Rowinsky EK, 1996, J CLIN ONCOL, V14, P3074; SLEDGE GW, 1994, SEMIN ONCOL, V21, P15; Taguchi T, 1994, JPN J CANC CHEMOTHER, V21, P1997; TALCHER AW, 1996, J CLIN ONCOL, V14, P95; TANIGAWARA Y, 1996, P AN M AM SOC CLIN, V15, P479; Valero Vicente, 1997, Seminars in Oncology, V24, P11; YAMAOKA K, 1981, J PHARMACOBIO-DYNAM, V4, P879	31	16	16	AMER ASSOC CANCER RESEARCH	PHILADELPHIA	615 CHESTNUT ST, 17TH FLOOR, PHILADELPHIA, PA 19106-4404 USA	1078-0432			CLIN CANCER RES	Clin. Cancer Res.	OCT	2000	6	10					4082	4090				9	Oncology	Oncology	365CV	WOS:000089931600040		
J	Shi, YZ; Hui, AM; Li, X; Takayama, T; Makuuchi, M				Shi, YZ; Hui, AM; Li, X; Takayama, T; Makuuchi, M			Overexpression of retinoblastoma protein predicts decreased survival and correlates with loss of p16(INK4) protein in gallbladder carcinomas	CLINICAL CANCER RESEARCH			English	Article							TUMOR-SUPPRESSOR GENES; CELL-CYCLE CONTROL; BLADDER-CANCER; HEPATOCELLULAR-CARCINOMA; SUSCEPTIBILITY GENE; K-RAS; EXPRESSION; PROGRESSION; INHIBITOR; P53	This study was designed to determine whether the level of retinoblastoma protein (pRb) expression predicts tumor progression and prognosis in gallbladder carcinomas (GBCs) and the relationship between pRb and p16(INK4) protein expression. The expression of these two proteins was evaluated immunohistochemically in 37 tumors from 36 patients with GBC. pRb loss and overexpression were observed in 5 (13.5%) and 18 (48.6%) of the 37 tumors, respectively. Both pRb loss and overexpression were significantly correlated with advanced TNM stage, lymph node metastasis, and tumor perineural invasion. Moreover, pRb overexpression was significantly associated with decreased overall survival (P = 0.001; log-rank test), Further analysis indicated that the influence of pRb overexpression on survival was independent of TNM stage and lymph node metastasis, Loss of p16(INK4) protein was observed in 28 of the 37 GBCs (75.7%), but was not significantly associated with any clinicopathological factors or survival, pRb overexpression was significantly associated,vith the loss of p16(INK4) protein (P < 0,0001), These results suggest that pRb overexpression significantly predicts decreased survival in GBCs.	Univ Tokyo, Grad Sch Med, Dept Surg, Hepato Biliary Pancreat Surg Div,Bunkyo Ku, Tokyo 1130033, Japan	Hui, AM (reprint author), Univ Tokyo, Grad Sch Med, Dept Surg, Hepato Biliary Pancreat Surg Div,Bunkyo Ku, 7-3-1 Hongo, Tokyo 1130033, Japan.		幕内, 雅敏/A-2140-2012				Ajiki T, 1996, GUT, V38, P426, DOI 10.1136/gut.38.3.426; LI Y, 1994, CANCER RES, V54, P6078; Ajiki T, 1996, HEPATO-GASTROENTEROL, V43, P521; WEINBERG RA, 1995, CELL, V81, P323, DOI 10.1016/0092-8674(95)90385-2; Fang XJ, 1998, ONCOGENE, V16, P1, DOI 10.1038/sj.onc.1201525; XIONG Y, 1993, NATURE, V366, P701, DOI 10.1038/366701a0; Harbour JW, 1999, CELL, V98, P859, DOI 10.1016/S0092-8674(00)81519-6; SHERR CJ, 1994, CELL, V79, P551, DOI 10.1016/0092-8674(94)90540-1; Zhang HS, 2000, CELL, V101, P79, DOI 10.1016/S0092-8674(00)80625-X; Benedict WF, 1999, ONCOGENE, V18, P1197, DOI 10.1038/sj.onc.1202452; Hall M, 1996, ADV CANCER RES, V68, P67, DOI 10.1016/S0065-230X(08)60352-8; Cote RJ, 1998, CANCER RES, V58, P1090; SERRANO M, 1993, NATURE, V366, P704, DOI 10.1038/366704a0; Hanada K, 1996, CANCER, V77, P452, DOI 10.1002/(SICI)1097-0142(19960201)77:3<452::AID-CNCR5>3.0.CO;2-M; HOROWITZ JM, 1990, P NATL ACAD SCI USA, V87, P2775, DOI 10.1073/pnas.87.7.2775; WISTUBA II, 1995, CANCER RES, V55, P2511; Matsuda Y, 1999, GASTROENTEROLOGY, V116, P394, DOI 10.1016/S0016-5085(99)70137-X; LUKAS J, 1995, NATURE, V375, P503, DOI 10.1038/375503a0; XU HJ, 1993, INT J CANCER, V53, P781, DOI 10.1002/ijc.2910530513; WADAYAMA B, 1994, CANCER RES, V54, P3042; CORDONCARDO C, 1994, AM J PATHOL, V144, P500; Geradts J, 1996, MODERN PATHOL, V9, P339; Grossman HB, 1998, CLIN CANCER RES, V4, P829; HENSEL CH, 1990, CANCER RES, V50, P3067; Hinds Philip W., 1994, Current Opinion in Genetics and Development, V4, P135, DOI 10.1016/0959-437X(94)90102-3; Hui AM, 2000, CANCER LETT, V154, P93, DOI 10.1016/S0304-3835(00)00385-2; Hui AM, 1999, INT J CANCER, V84, P604, DOI 10.1002/(SICI)1097-0215(19991222)84:6<604::AID-IJC11>3.0.CO;2-Y; Japanese Society of Biliary Surgery, 1993, GEN RUL SURG PATH ST; MATSUOKA S, 1995, GENE DEV, V9, P650, DOI 10.1101/gad.9.6.650; Sobin LH, 1997, TNM CLASSIFICATION M; TOYOSHIMA H, 1994, CELL, V78, P67, DOI 10.1016/0092-8674(94)90573-8; WEINBERG RA, 1991, SCIENCE, V254, P1138, DOI 10.1126/science.1659741	32	36	40	AMER ASSOC CANCER RESEARCH	BIRMINGHAM	PO BOX 11806, BIRMINGHAM, AL 35202 USA	1078-0432			CLIN CANCER RES	Clin. Cancer Res.	OCT	2000	6	10					4096	4100				5	Oncology	Oncology	365CV	WOS:000089931600042		
J	Nishio, M; Niimi, S				Nishio, M; Niimi, S			Changes over time in dysarthric patients with amyotrophic lateral sclerosis (ALS): a study of changes in speaking rate and maximum repetition rate (MRR)	CLINICAL LINGUISTICS & PHONETICS			English	Article						amyotrophic lateral sclerosis; dysarthria; speaking rate; maximum repetition rate (MRR)	SPEECH; INTELLIGIBILITY	Two cases of amyotrophic lateral sclerosis (ALS) were investigated over time, from a point when speech intelligibility is still at a high level until oral communication becomes almost impossible. Speech intelligibility, speaking rate, and maximum repetition rate (MRR) were examined. Great declines in speaking rate and MRR were observed over time. In addition, both speaking rate and MRR were considerably slower when compared to the control group even when speech intelligibility was still high. The latter finding indicates these parameters are more sensitive in reflecting functional changes in articulators, rather than speech intelligibility, at the early stage of the disease. These results are discussed in terms of an assessment and management system for ALS speakers.	Int Univ Hlth & Welf, Dept Speech Language Pathol & Audiol, Ohtawara, Tochigi 3248501, Japan; Univ Tokyo, Fac Med, Dept Speech Pathol, Tokyo, Japan	Nishio, M (reprint author), Int Univ Hlth & Welf, Dept Speech Language Pathol & Audiol, 2600-1 Kitakanemaru, Ohtawara, Tochigi 3248501, Japan.						TURNER GS, 1993, J SPEECH HEAR RES, V36, P1134; LANGMORE SE, 1994, J SPEECH HEAR RES, V37, P28; PETERSON GE, 1960, J ACOUST SOC AM, V32, P693, DOI 10.1121/1.1908183; ROSEN DR, 1993, NATURE, V362, P59, DOI 10.1038/362059a0; Aebischer P, 1996, NAT MED, V2, P696, DOI 10.1038/nm0696-696; Lai EC, 1997, NEUROLOGY, V49, P1621; HIROSE H, 1982, FOLIA PHONIATR, V34, P106; DARLEY FL, 1969, J SPEECH HEAR RES, V12, P246; DWORKIN JP, 1980, J SPEECH HEAR RES, V23, P828; ACKERMANN H, 1995, FOLIA PHONIATR LOGO, V47, P15; Berry W. R., 1983, CLIN DYSARTHRIA, P253; CALIGIURI MP, 1983, CLIN DYSARTHRIA, P267; CANTER GJ, 1963, J SPEECH HEAR DISORD, V28, P221; CANTER GJ, 1965, J SPEECH HEAR DISORD, V30, P217; CARROW E, 1974, ARCH OTOLARYNGOL, V100, P212; CROW E, 1989, RECENT ADVANCES IN CLINICAL DYSARTHRIA, P99; Fukusako Y., 1983, JPN J LOGOP PHONIATR, V24, P149; Goldman-Eisler Frieda, 1968, PSYCHOLINGUISTICS EX; GROSJEAN F, 1979, PHONETICA, V36, P98; HELM NA, 1979, J SPEECH HEAR DISORD, V44, P350; HIROSE H, 1978, J SPEECH HEAR DISORD, V43, P96; Imagawa H., 1989, ANN B RES I LOGOPEDI, V23, P173; KENT RD, 1991, J SPEECH HEAR RES, V34, P1269; KREUL EJ, 1972, J SPEECH HEAR RES, V15, P72; Lass N. J., 1971, TODAYS SPEECH, V19, P49; Linebaugh C. E., 1984, DYSARTHRIAS PHYSL AC, P197; Ludlow C. L., 1984, DYSARTHRIAS PHYSL AC, P163; Lundeen DJ, 1950, J SPEECH HEAR DISORD, V15, P54; MULLIGAN M, 1994, J SPEECH HEAR RES, V37, P496; PLATT LJ, 1980, J SPEECH HEAR RES, V23, P28; PORTNOY RA, 1982, J SPEECH HEAR DISORD, V47, P324; PTACEK PH, 1966, J SPEECH HEAR RES, V9, P353; SIGURD B, 1973, LANG SPEECH, V16, P373; TATSUMI IF, 1979, ANN B RILP, V13, P99; TIFFANY WR, 1980, J SPEECH HEAR RES, V23, P894; Trubetzkoy Nikolaj S., 1968, INTRO PRINCIPLES PHO; Yorkson K, 1993, J MED SPEECH-LANG PA, V1, P35; YORKSTON KM, 1981, J SPEECH HEAR DISORD, V46, P296; YORKSTON KM, 1978, J COMMUN DISORD, V11, P499, DOI 10.1016/0021-9924(78)90024-2; YORKSTON KM, 1981, J SPEECH HEAR DISORD, V46, P398; ZIEGLER W, 1986, BRIT J DISORD COMMUN, V21, P173; Ziegler W, 1996, NEUROLOGY, V47, P208	42	11	11	TAYLOR & FRANCIS LTD	LONDON	11 NEW FETTER LANE, LONDON EC4P 4EE, ENGLAND	0269-9206			CLIN LINGUIST PHONET	Clin. Linguist. Phon.	OCT	2000	14	7					485	497				13	Audiology & Speech-Language Pathology; Linguistics; Rehabilitation	Audiology & Speech-Language Pathology; Linguistics; Rehabilitation	369QP	WOS:000165078700001		
J	Ishihara, K; Iwasaki, Y; Ebihara, S; Shindo, Y; Nakabayashi, N				Ishihara, K; Iwasaki, Y; Ebihara, S; Shindo, Y; Nakabayashi, N			Photoinduced graft polymerization of 2-methacryloyloxyethyl phosphorylcholine on polyethylene membrane surface for obtaining blood cell adhesion resistance	COLLOIDS AND SURFACES B-BIOINTERFACES			English	Article						cell-adhesion resistance; protein adsorption; photopolymerization; phospholipid polymer; 2-methacryloyloxyethyl phosphorylcholine; biomembrane-like surface	PHOSPHOLIPID POLYMERS; PROTEIN ADSORPTION; PLATELET-ADHESION; COMPATIBILITY; PLASMA; POLYPROPYLENE; IMPROVEMENT; ACTIVATION; MONOMERS	Phospholipid polymer, poly[2-methacryloyloxyethyl phosphorylcholine (MPC)], was grafted with polyethylene (PE) membrane using photoinduced polymerization technique to make the membrane resistant to cell adhesion. The water contact angle on the PE membrane grafted with poly(MPC) decreased with an increase in the photopolymerization time. This decrease corresponded to the increase in the amount of poly(MPC) grafted on the PE surface. The same graft polymerization procedure was applied using other hydrophilic monomers, such as acrylamide (AAm), N-vinylpyrrolidone (VPy) and methacryloyl poly(ethylene glycol) (MPEG). These monomers were also polymerized to form grafted chains on the PE membrane, and the grafting was confirmed with X-ray photoelectron spectroscopy. Analysis of amount and distribution of plasma proteins at the plasma-contacting surface of the original and the modified PE membranes were analyzed using immunogold assay. The grafting of poly(MPC) and poly(VPy) on PE membrane reduced the plasma protein adsorption significantly compared with that on the original PE membrane. However, the PE membranes grafted with poly(AAm) or poly(MPEG) did not show any effects on protein adsorption. Platelet adhesion on the original and modified PE membranes from platelet-rich plasma was also examined. A large number of platelets adhered and activated on the original PE membrane. Crafting with poly(AAm) did not suppress platelet adhesion, but grafting with poly(MPC) or poly(VPy) on the PE membrane was effective in preventing platelet adhesion. It is concluded that the introduction of the phosphorylcholine group on the surface could decrease the cell adhesion to substrate polymer. (C) 2000 Elsevier Science B.V. All rights reserved.	Univ Tokyo, Grad Sch Engn, Dept Mat Sci, Bunkyo Ku, Tokyo 1138656, Japan; Tokyo Med & Dent Univ, Inst Biomat & Bioengn, Chiyoda Ku, Tokyo 1010062, Japan; Toho Univ, Dept Sci, Funabashi, Chiba 2741510, Japan			Iwasaki, Yasuhiko/D-6870-2011				UEDA T, 1992, POLYM J, V24, P1259, DOI 10.1295/polymj.24.1259; IKADA Y, 1981, J BIOMED MATER RES, V15, P697, DOI 10.1002/jbm.820150507; Ishihara K, 1999, BIOMATERIALS, V20, P1545, DOI 10.1016/S0142-9612(99)00052-6; YASUDA H, 1982, BIOMATERIALS, V3, P68, DOI 10.1016/0142-9612(82)90036-9; Ishihara K, 1998, J BIOMED MATER RES, V39, P323, DOI 10.1002/(SICI)1097-4636(199802)39:2<323::AID-JBM21>3.0.CO;2-C; LLANOS GR, 1993, J BIOMAT SCI-POLYM E, V4, P381; ISHIHARA K, 1990, POLYM J, V22, P355, DOI 10.1295/polymj.22.355; Baumgartner JN, 1997, BIOMATERIALS, V18, P831, DOI 10.1016/S0142-9612(96)00197-4; Brash JL, 1987, ACS S SERIES, V343; CHAIKOF EL, 1992, J BIOMED MATER RES, V26, P1163, DOI 10.1002/jbm.820260906; Holly FJ, 1979, J POLYM SCI PS, V66, P409; Horbett TA, 1995, ACS S SERIES, V602; IDE F, 1987, SURFACE MODIFICATION; Ishihara K, 1997, TRENDS POLYM SCI, V5, P401; ISHIHARA K, 1995, BIOMATERIALS, V16, P873, DOI 10.1016/0142-9612(95)94150-J; ISHIHARA K, 1992, BIOMATERIALS, V13, P145, DOI 10.1016/0142-9612(92)90062-S; ISHIHARA K, 1982, J APPL POLYM SCI, V27, P239, DOI 10.1002/app.1982.070270125; ISHIHARA K, 1991, J BIOMED MATER RES, V25, P1397, DOI 10.1002/jbm.820251107; ISHIHARA K, 1992, BIOMATERIALS, V13, P235, DOI 10.1016/0142-9612(92)90190-Y; ISHII K, 1993, CONCURRENT ENG AUTOM, P19; Iwasaki Y, 1999, BIOMATERIALS, V20, P2185, DOI 10.1016/S0142-9612(99)00123-4; Kohler AS, 1996, J BIOMED MATER RES, V32, P237, DOI 10.1002/(SICI)1097-4636(199610)32:2<237::AID-JBM13>3.0.CO;2-G; LIN SCH, 1984, J BIOL CHEM, V259, P9121; Marra KG, 1997, MACROMOLECULES, V30, P6483, DOI 10.1021/ma970481f; Merrill E. W., 1983, AM SOC ARTIF INTERN, V6, P60; Nakabayashi N, 1996, MACROMOL SYMP, V101, P405, DOI 10.1002/masy.19961010146; OGIWARA Y, 1981, J POLYM SCI POL LETT, V19, P457, DOI 10.1002/pol.1981.130190905; OGIWARA Y, 1988, J APPL POLYM SCI, V35, P1473, DOI 10.1002/app.1988.070350606; Papahadjopoulos D, 1978, LIPOSOMES THEIR USE; PARK K, 1991, J BIOMED MATER RES, V25, P407, DOI 10.1002/jbm.820250311; Ratner B. D., 1979, J POLYM SCI POLYM S, V66, P363; Sugiyama K, 1998, MACROMOL CHEM PHYSIC, V199, P1201, DOI 10.1002/(SICI)1521-3935(19980601)199:6<1201::AID-MACP1201>3.0.CO;2-6; SUZUKI M, 1986, FUNDAMENTAL APPL POL; TAZUKE S, 1978, MAKROMOL CHEM, V179, P2603; Tsuruta T., 1993, BIOMEDICAL APPL POLY; vanderHeiden AP, 1997, J BIOMED MATER RES, V37, P282, DOI 10.1002/(SICI)1097-4636(199711)37:2<282::AID-JBM19>3.0.CO;2-G; YAMADA K, 1992, J APPL POLYM SCI, V46, P1065, DOI 10.1002/app.1992.070460616	37	129	138	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	0927-7765			COLLOID SURFACE B	Colloid Surf. B-Biointerfaces	OCT	2000	18	3-4					325	335		10.1016/S0927-7765(99)00158-7		11	Biophysics; Chemistry, Physical; Materials Science, Biomaterials	Biophysics; Chemistry; Materials Science	345HG	WOS:000088810100014		
J	Emoto, K; Nagasaki, Y; Iijima, M; Kato, M; Kataoka, K				Emoto, K; Nagasaki, Y; Iijima, M; Kato, M; Kataoka, K			Preparation of non-fouling surface through the coating with core-polymerized block copolymer micelles having aldehyde-ended PEG shell	COLLOIDS AND SURFACES B-BIOINTERFACES			English	Article						polymeric micelle coating; X-ray photoelectron spsctroscopy; zeta-potential; BSA adsorption	POLY(ETHYLENE OXIDE); PROTEIN ADSORPTION; REACTIVE MICELLES; GRAFTING DENSITY; ANTICANCER DRUG; ADRIAMYCIN; IMMOBILIZATION; CIRCULATION; ATTACHMENT; CARRIER	A new type of surface modification with reactive polymeric micelle was carried out for the creation of non-fouling surface. Amphiphilic poly(ethylene glycol)-b-poly(D,L lactide) (PEG/PLA) copolymers possessing acetal group at PEG-end and methacryloyl group at PLA-end were quantitatively synthesized via an anionic polymerization technique. A micelle of narrow distribution was prepared from the block copolymer. Acetal groups on the micelle surface were quantitatively converted into aldehyde group by an acid treatment. The methacryloyl group located in the core of the micelle was polymerized via radical polymerization to form core-polymerized micelle having reactive aldehyde groups on the surface. The core-polymerized reactive micelle was coated to a primary amino-containing polypropylene (PP) plate that was prepared by a plasma treatment. A reductive amination reaction was employed for a conjugation of the reactive core-polymerized micelle on the surface via a covalent linkage. The coating was evaluated by X-ray photoelectron spectroscopy, zeta-potential measurement, and the adsorption of bovine serum albumin, and compared with the PEG-coating under the same condition. The ratio of peak from C-O bond to C-C-C bond indicated that the density of PEG on the surface was higher for the micelle coating than the linear PEG-coating. This is also confirmed by the zeta-potential measurement. By coating the amino-PP surface with micelle, the zeta-potential was remarkably decreased while the PEG-coating under the same condition decreased only appreciably, indicating that micelle coating efficiently masked the surface charge. Further, micelle-covered surface exhibited reduction of protein adsorption. The reduction of protein adsorption along with remarkably masked surface charge implies the high applicability of the micelle coatings to biomedical and bioanalytical applications. (C) 2000 Elsevier Science B.V. All rights reserved.	Univ Tokyo, Grad Sch Engn, Dept Mat Sci, Bunkyo Ku, Tokyo 1138656, Japan; Tokyo Univ Sci, Dept Mat Sci & Technol, Noda, Chiba 2788510, Japan		kataoka@bmw.mm.t.u-tokyo.ac.jp	Kataoka, Kazunori/K-7108-2012	Kataoka, Kazunori/0000-0002-8591-413X			SMITH PK, 1985, ANAL BIOCHEM, V150, P76, DOI 10.1016/0003-2697(85)90442-7; Spatz JP, 1996, MACROMOLECULES, V29, P3220, DOI 10.1021/ma951712q; HOLLAHAN JR, 1969, J APPL POLYM SCI, V13, P807, DOI 10.1002/app.1969.070130419; OSTERBERG E, 1995, J BIOMED MATER RES, V29, P741, DOI 10.1002/jbm.820290610; KWON G, 1994, J CONTROL RELEASE, V29, P17, DOI 10.1016/0168-3659(94)90118-X; DEGENNES PG, 1980, MACROMOLECULES, V13, P1069, DOI 10.1021/ma60077a009; YOKOYAMA M, 1994, J CONTROL RELEASE, V32, P269, DOI 10.1016/0168-3659(94)90237-2; KATAOKA K, 1993, J CONTROL RELEASE, V24, P119; Iijima M, 1999, MACROMOLECULES, V32, P1140, DOI 10.1021/ma9815962; Malmsten M, 1998, J COLLOID INTERF SCI, V202, P507, DOI 10.1006/jcis.1998.5513; Emoto K, 1999, LANGMUIR, V15, P5212, DOI 10.1021/la980918s; Sofia SJ, 1998, MACROMOLECULES, V31, P5059, DOI 10.1021/ma971016l; Nagasaki Y, 1998, MACROMOLECULES, V31, P1473, DOI 10.1021/ma971294k; YOKOYAMA M, 1991, CANCER RES, V51, P3229; YOKOYAMA M, 1990, CANCER RES, V50, P1693; Emoto K, 1996, ANAL CHEM, V68, P3751, DOI 10.1021/ac960114m; Huang SC, 1996, LANGMUIR, V12, P4292, DOI 10.1021/la951532+; YOKOYAMA M, 1990, J CONTROL RELEASE, V11, P269; Baskin A, 1980, J BIOMED MATER RES, V14, P393; Beamson G., 1992, HIGH RESOLUTION XPS; Farinha JPS, 1998, LANGMUIR, V14, P2291, DOI 10.1021/la970847h; Golander C. G., 1992, POLYETHYLENE GLYCOL, P221; HERREN BJ, 1987, J COLLOID INTERF SCI, V115, P46, DOI 10.1016/0021-9797(87)90007-5; Ho CH, 1998, LANGMUIR, V14, P3889, DOI 10.1021/la980148k; Karymov MA, 1996, LANGMUIR, V12, P4748, DOI 10.1021/la9604240; Kim JH, 1999, POLYM ADVAN TECHNOL, V10, P647, DOI 10.1002/(SICI)1099-1581(199911)10:11<647::AID-PAT918>3.0.CO;2-Y; LYMAN DJ, 1974, ANGEW CHEM, V86, P145, DOI 10.1002/ange.19740860403; LYMAN DJ, 1974, T AM SOC ART INT ORG, VB 20, P474; MALMSTEN M, 1996, J COLLOID INTERF SCI, V177, P505; NAGASAKI Y, 1995, BIOCONJUGATE CHEM, V6, P231, DOI 10.1021/bc00032a012; SCHOLZ C, 1995, MACROMOLECULES, V28, P7295, DOI 10.1021/ma00125a040; Sofia SJ, 1997, ACS SYM SER, V680, P342; Webber SE, 1998, J PHYS CHEM B, V102, P2618, DOI 10.1021/jp980386o	33	31	32	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	0927-7765			COLLOID SURFACE B	Colloid Surf. B-Biointerfaces	OCT	2000	18	3-4					337	346		10.1016/S0927-7765(99)00159-9		10	Biophysics; Chemistry, Physical; Materials Science, Biomaterials	Biophysics; Chemistry; Materials Science	345HG	WOS:000088810100015		
J	Brezin, E; Hikami, S				Brezin, E; Hikami, S			Characteristic polynomials of random matrices	COMMUNICATIONS IN MATHEMATICAL PHYSICS			English	Article							UNIVERSALITY	Number theorists have studied extensively the connections between the distribution of zeros of the Riemann zeta -function, and of some generalizations, with the statistics of the eigenvalues of large random matrices. It is interesting to compare the average moments of these functions in an interval to their counterpart in random matrices, which are the expectation values of the characteristic polynomials of the matrix. It turns out that these expectation values are quite interesting. For instance, the moments of order 2K scale, for unitary invariant ensembles, as the density of eigenvalues raised to the power K-2; the prefactor turns out to be a universal number, i.e. it is independent of the specific probability distribution. An equivalent behaviour and prefactor had been found, as a conjecture, within number theory. The moments of the characteristic determinants of random matrices are computed here as limits, at coinciding points, of multi-point correlators of determinants. These correlators are in fact universal in Dyson's scaling limit in which the difference between the points goes to zero, the size of the matrix goes to infinity, and their product remains finite.	CNRS, UMR 8549, Ecole Normale Super, Phys Theor Lab, F-75231 Paris 05, France; Univ Tokyo, Dept Basic Sci, Meguro Ku, Tokyo 153, Japan	Brezin, E (reprint author), CNRS, UMR 8549, Ecole Normale Super, Phys Theor Lab, 24 Rue Lhomond, F-75231 Paris 05, France.						AMBJORN J, 1990, MOD PHYS LETT A, V5, P1753, DOI 10.1142/S0217732390001992; Brezin E, 1996, NUCL PHYS B, V479, P697, DOI 10.1016/0550-3213(96)00394-X; ITZYKSON C, 1980, J MATH PHYS, V21, P411, DOI 10.1063/1.524438; Brezin E, 1999, PHYS REV B, V60, P3589, DOI 10.1103/PhysRevB.60.3589; DUISTERMAAT JJ, 1982, INVENT MATH, V69, P259, DOI 10.1007/BF01399506; Brezin E, 1997, PHYS REV E, V56, P264, DOI 10.1103/PhysRevE.56.264; BREZIN E, 1993, NUCL PHYS B, V402, P613, DOI 10.1016/0550-3213(93)90121-5; CONREY JB, HIGH MOMENTS RIEMANN; CONREY JB, 1998, THESIS PRINCETON U; DYSON FJ, 1972, J MATH PHYS, V13, P90, DOI 10.1063/1.1665857; GONEK SM, 1989, MATHEMATIKA, V36, P71; Harish-Chandra, 1956, Proc Natl Acad Sci U S A, V42, P252, DOI 10.1073/pnas.42.5.252; Katz N., 1999, AMS C PUBLICATIONS, V45; KEATING J, 1999, LECT ERWIN SCHRODING; Mehta M.L., 1991, RANDOM MATRICES; Montgomery H. L., 1973, P S PURE MATH, VXXIV, P181; Ramachandra K., 1980, HARDY RAMANUJAN J, V3, P1; Zinn-Justin P, 1998, COMMUN MATH PHYS, V194, P631, DOI 10.1007/s002200050372	18	92	93	SPRINGER-VERLAG	NEW YORK	175 FIFTH AVE, NEW YORK, NY 10010 USA	0010-3616			COMMUN MATH PHYS	Commun. Math. Phys.	OCT	2000	214	1					111	135		10.1007/s002200000256		25	Physics, Mathematical	Physics	371PJ	WOS:000165187100004		
J	Terada, S; Hirokawa, N				Terada, S; Hirokawa, N			Moving on to the cargo problem of microtubule-dependent motors in neurons	CURRENT OPINION IN NEUROBIOLOGY			English	Article							KINESIN SUPERFAMILY PROTEIN; SLOW AXONAL-TRANSPORT; LEFT-RIGHT ASYMMETRY; ORGANELLE TRANSPORT; CYTOPLASMIC DYNEIN; VERTEBRATE RETINA; DROSOPHILA; IDENTIFICATION; KIF3A; LOCALIZATION	Vigorous investigation has finally begun to shed light on the cargo problem of the microtubule-dependent motors, kinesin and dynein superfamily proteins. Biochemical observations have suggested that the potential cargoes of certain populations of motor proteins seem to be in vesicle-form, each vesicle possessing specific functional marker molecules. In addition to the close relationship between microtubule-dependent motors and cargoes in vesicle-form, kinesin has also been highlighted as an apparent driving force for another cargo in non-vesicle-form, cytoplasmic protein. On the basis of new biophysical and cell-biological evidence, the controversy over the movement of cytoplasmic cargoes has entered a new phase.	Univ Tokyo, Grad Sch Med, Dept Cell Biol & Anat, Bunkyo Ku, Tokyo 1130033, Japan	Terada, S (reprint author), Univ Tokyo, Grad Sch Med, Dept Cell Biol & Anat, Bunkyo Ku, 7-3-1 Hongo, Tokyo 1130033, Japan.						Okada Y, 2000, P NATL ACAD SCI USA, V97, P640, DOI 10.1073/pnas.97.2.640; Chang SH, 1999, NAT CELL BIOL, V1, P399; Nonaka S, 1998, CELL, V95, P829, DOI 10.1016/S0092-8674(00)81705-5; Signor D, 1999, J CELL BIOL, V147, P519, DOI 10.1083/jcb.147.3.519; Takeda S, 1999, J CELL BIOL, V145, P825, DOI 10.1083/jcb.145.4.825; Allen MJ, 1999, J NEUROSCI, V19, P9374; AIZAWA H, 1992, J CELL BIOL, V119, P1287, DOI 10.1083/jcb.119.5.1287; YAMAZAKI H, 1995, J CELL BIOL, V130, P1387, DOI 10.1083/jcb.130.6.1387; Setou M, 2000, SCIENCE, V288, P1796, DOI 10.1126/science.288.5472.1796; SEKINE Y, 1994, J CELL BIOL, V127, P187, DOI 10.1083/jcb.127.1.187; Tai AW, 1999, CELL, V97, P877, DOI 10.1016/S0092-8674(00)80800-4; Wang L, 2000, NAT CELL BIOL, V2, P137; Rahman A, 1999, J CELL BIOL, V146, P1277, DOI 10.1083/jcb.146.6.1277; Hirokawa N, 1998, SCIENCE, V279, P519, DOI 10.1126/science.279.5350.519; Yabe JT, 1999, J CELL SCI, V112, P3799; Martin M, 1999, MOL BIOL CELL, V10, P3717; Yang ZH, 1998, MOL BIOL CELL, V9, P249; Marszalek JR, 1999, J CELL BIOL, V145, P469, DOI 10.1083/jcb.145.3.469; Baas PW, 1997, TRENDS CELL BIOL, V7, P380, DOI 10.1016/S0962-8924(97)01148-3; Bowman AB, 1999, J CELL BIOL, V146, P165; BRADY ST, 1985, NATURE, V317, P73, DOI 10.1038/317073a0; Hirokawa N, 1997, TRENDS CELL BIOL, V7, P384, DOI 10.1016/S0962-8924(97)01133-1; Hoang E, 1999, EXP EYE RES, V69, P57, DOI 10.1006/exer.1999.0671; Kanai Y, 2000, J NEUROSCI, V20, P6374; Kikkawa M, 2000, CELL, V100, P241, DOI 10.1016/S0092-8674(00)81562-7; KONDO S, 1994, J CELL BIOL, V125, P1095, DOI 10.1083/jcb.125.5.1095; Li JY, 1999, J NEUROSCI RES, V58, P226, DOI 10.1002/(SICI)1097-4547(19991015)58:2<226::AID-JNR3>3.0.CO;2-X; LYE RJ, 1987, CELL, V51, P309, DOI 10.1016/0092-8674(87)90157-7; Muresan V, 1999, J NEUROSCI, V19, P1027; Murphey RK, 1999, DEV BIOL, V209, P86, DOI 10.1006/dbio.1999.9217; NICLAS J, 1994, NEURON, V12, P1059, DOI 10.1016/0896-6273(94)90314-X; Okada Y, 1999, SCIENCE, V283, P1152, DOI 10.1126/science.283.5405.1152; PASCHAL BM, 1987, J CELL BIOL, V105, P1273, DOI 10.1083/jcb.105.3.1273; Peretti D, 2000, J CELL BIOL, V149, P141, DOI 10.1083/jcb.149.1.141; Ray K, 1999, J CELL BIOL, V147, P507, DOI 10.1083/jcb.147.3.507; STEWART RJ, 1991, P NATL ACAD SCI USA, V88, P8470, DOI 10.1073/pnas.88.19.8470; Takeda S, 2000, J CELL BIOL, V148, P1255, DOI 10.1083/jcb.148.6.1255; TANAKA Y, 1995, J CELL SCI, V108, P1883; TERADA S, 2000, IN PRESS CELL; VALE RD, 1985, CELL, V42, P39, DOI 10.1016/S0092-8674(85)80099-4; Whitehead JL, 1999, EXP EYE RES, V69, P491, DOI 10.1006/exer.1999.0724; Yamazaki H, 1996, P NATL ACAD SCI USA, V93, P8443, DOI 10.1073/pnas.93.16.8443	42	39	39	CURRENT BIOLOGY LTD	LONDON	84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND	0959-4388			CURR OPIN NEUROBIOL	Curr. Opin. Neurobiol.	OCT	2000	10	5					566	573		10.1016/S0959-4388(00)00129-X		8	Neurosciences	Neurosciences & Neurology	373RF	WOS:000165302100005		
J	Narumi, S; Takeuchi, T; Kobayashi, Y; Konishi, K				Narumi, S; Takeuchi, T; Kobayashi, Y; Konishi, K			Serum levels of IFN-inducible protein-10 relating to the activity of systemic lupus erythematosus	CYTOKINE			English	Article						chemokine; ELISA; IP-10; rheumatoid arthritis; systemic lupus erythematosus	TISSUE-SPECIFIC EXPRESSION; CHEMOKINE RECEPTORS; INTERFERON-GAMMA; MESSENGER-RNA; CELLS; MICE; CYTOKINES; SUBSETS	IFN-inducible protein-10 (IP-10) is supposed to act as a specific chemoattractant for Th-1 cells. Since Th-1 cells and IFN-gamma are shown to be important for developing systemic lupus erythematosus (SLE), we examined the relationship between serum IP-10 levels and the disease activity. Serum IP-IO levels were markedly increased in the SLE patients depending on the level of disease activity, whereas not in the patients with rheumatoid arthritis (RA), On the other hand, serum MCP-I levels were increased to a similar extent both in RA and inactive SLE patients, and a little more elevated in active SLE patients. Serum IP-10 levels in SLE patients correlated positively and negatively with levels of anti-DNA antibody and complements, respectively, whereas MCP-1 levels correlated less or not at all, These results suggest that serum IP-10 levels could be a good indicator for the activity of SLE and that IP-10 could play an important immunological role in SLE. (C) 2000 Academic Press.	Univ Tokyo, Sch Med, Dept Mol Prevent Med, Bunkyo Ku, Tokyo 113, Japan; Saitama Med Coll, Dept Internal Med 2, Kawagoe, Saitama, Japan; JT Pharmaceut Frontier Labs, Yokohama, Kanagawa, Japan; Keio Univ, Sch Med, Dept Internal Med, Tokyo, Japan	Narumi, S (reprint author), Univ Tokyo, Sch Med, Dept Mol Prevent Med, Bunkyo Ku, 7-3-1 Hongo, Tokyo 113, Japan.						Narumi S, 1997, J IMMUNOL, V158, P5536; Qin SX, 1998, J CLIN INVEST, V101, P746, DOI 10.1172/JCI1422; Haas C, 1997, J IMMUNOL, V158, P5484; Bonecchi R, 1998, J EXP MED, V187, P129, DOI 10.1084/jem.187.1.129; Funauchi M, 1998, SCAND J RHEUMATOL, V27, P219; ManourySchwartz B, 1997, J IMMUNOL, V158, P5501; NARUMI S, 1992, J LEUKOCYTE BIOL, V52, P27; OHMORI Y, 1993, AM J PATHOL, V142, P861; PRUDHOMME GJ, 1995, MOL IMMUNOL, V32, P495, DOI 10.1016/0161-5890(95)00024-9; Reininger L, 1996, ANN MED INTERNE, V147, P467; Santiago ML, 1997, J EXP MED, V185, P65, DOI 10.1084/jem.185.1.65; Segal R, 1997, J IMMUNOL, V158, P3009; TAKEUCHI T, 1988, J CLIN INVEST, V82, P1288, DOI 10.1172/JCI113728; Tamaru M, 2000, CYTOKINE, V12, P299, DOI 10.1006/cyto.1999.0560; Tamaru M, 1998, BIOCHEM BIOPH RES CO, V251, P41, DOI 10.1006/bbrc.1998.9404	15	63	76	W B SAUNDERS CO	PHILADELPHIA	INDEPENDENCE SQUARE WEST CURTIS CENTER, STE 300, PHILADELPHIA, PA 19106-3399 USA	1043-4666			CYTOKINE	Cytokine	OCT	2000	12	10					1561	1565		10.1006/cyto.2000.0757		5	Biochemistry & Molecular Biology; Cell Biology; Immunology	Biochemistry & Molecular Biology; Cell Biology; Immunology	366JZ	WOS:000090003400016		
J	Sone, M; Suzuki, E; Hoshino, M; Hou, DM; Kuromi, H; Fukata, M; Kuroda, S; Kaibuchi, K; Nabeshima, Y; Hama, C				Sone, M; Suzuki, E; Hoshino, M; Hou, DM; Kuromi, H; Fukata, M; Kuroda, S; Kaibuchi, K; Nabeshima, Y; Hama, C			Synaptic development is controlled in the periactive zones of Drosophila synapses	DEVELOPMENT			English	Article						periactive zone; synapse; SIF; RAC; cell adhesion molecule; Drosophila	GDP-GTP EXCHANGERS; CELL-CELL ADHESION; FASCICLIN-II; FUNCTIONAL COMPONENTS; GENETIC DISSECTION; NEUROMUSCULAR-JUNCTIONS; SMALL GTPASES; DISCS-LARGE; RHO-FAMILY; MDCK CELLS	A cell-adhesion molecule fasciclin 2 (FAS2), which is required for synaptic growth and still life (SIF), an activator of RAC, were found to localize in the surrounding region of the active zone, defining the periactive zone in Drosophila neuromuscular synapses. beta PS integrin and discs large (DLG), both involved in synaptic development, also decorated the zone. However, shibire (SHI), the Drosophila dynamin that regulates endocytosis, was found in the distinct region. Mutant analyses showed that sif genetically interacted with Fas2 in synaptic growth and that the proper localization of SIF required FAS2, suggesting that they are components in related signaling pathways that locally function in the periactive zones. We propose that neurotransmission and synaptic growth are primarily regulated in segregated subcellular spaces, active zones and periactive zones, respectively.	NCNP, Natl Inst Neurosci, Dept Mol Genet, Tokyo 1878502, Japan; Japan Sci & Technol Corp, Core Res Evolut Sci & Technol, Tokyo, Japan; Univ Tokyo, Inst Med Sci, Tokyo 1088639, Japan; Kyoto Univ, Sch Med, Kyoto 6068501, Japan; Gunma Univ, Sch Med, Maebashi, Gumma 3718511, Japan; Nara Inst Sci & Technol, Ikoma 6300101, Japan; Hiroshima Univ, Sch Med, Hiroshima 7348551, Japan	Sone, M (reprint author), NCNP, Natl Inst Neurosci, Dept Mol Genet, 4-1-1 Ogawahigahsi, Tokyo 1878502, Japan.		KURODA, SHINYA/G-4961-2014				KOSAKA T, 1983, J NEUROBIOL, V14, P207, DOI 10.1002/neu.480140305; MICHIELS F, 1995, NATURE, V375, P338, DOI 10.1038/375338a0; Cremona O, 1997, CURR OPIN NEUROBIOL, V7, P323, DOI 10.1016/S0959-4388(97)80059-1; Kozma R, 1997, MOL CELL BIOL, V17, P1201; Luo LQ, 1996, NATURE, V379, P837, DOI 10.1038/379837a0; BRAND AH, 1993, DEVELOPMENT, V118, P401; Deitcher DL, 1998, J NEUROSCI, V18, P2028; SCHULZE KL, 1995, CELL, V80, P311, DOI 10.1016/0092-8674(95)90414-X; Uchida N, 1996, J CELL BIOL, V135, P767, DOI 10.1083/jcb.135.3.767; Tsunoda S, 1997, NATURE, V388, P243; ATWOOD HL, 1993, J NEUROBIOL, V24, P1008, DOI 10.1002/neu.480240803; LITTLETON JT, 1993, CELL, V74, P1125, DOI 10.1016/0092-8674(93)90733-7; Sanes JR, 1999, ANNU REV NEUROSCI, V22, P389, DOI 10.1146/annurev.neuro.22.1.389; Wan HI, 2000, NEURON, V26, P313, DOI 10.1016/S0896-6273(00)81166-6; Schuster CM, 1996, NEURON, V17, P641, DOI 10.1016/S0896-6273(00)80197-X; Uemura T, 1998, CELL, V93, P1095, DOI 10.1016/S0092-8674(00)81452-X; Lamoureux P, 1997, J CELL SCI, V110, P635; Prokop A, 1998, DEV BIOL, V196, P58, DOI 10.1006/dbio.1997.8830; CHEN MS, 1991, NATURE, V351, P583, DOI 10.1038/351583a0; Zhen M, 2000, NEURON, V26, P331, DOI 10.1016/S0896-6273(00)81167-8; Thomas U, 1997, NEURON, V19, P787, DOI 10.1016/S0896-6273(00)80961-7; Schuster CM, 1996, NEURON, V17, P655, DOI 10.1016/S0896-6273(00)80198-1; UMBACH JA, 1994, NEURON, V13, P899, DOI 10.1016/0896-6273(94)90255-0; LAHEY T, 1994, NEURON, V13, P823, DOI 10.1016/0896-6273(94)90249-6; Xu XZS, 1998, J CELL BIOL, V142, P545, DOI 10.1083/jcb.142.2.545; JIA XX, 1993, J NEUROBIOL, V24, P1025, DOI 10.1002/neu.480240804; Davis GW, 1996, NEURON, V17, P669, DOI 10.1016/S0896-6273(00)80199-3; Tejedor FJ, 1997, J NEUROSCI, V17, P152; VANDERBLIEK AM, 1991, NATURE, V351, P411, DOI 10.1038/351411a0; Koenig JH, 1996, J CELL BIOL, V135, P797, DOI 10.1083/jcb.135.3.797; Hall A, 1998, SCIENCE, V279, P509, DOI 10.1126/science.279.5350.509; YAKU H, 1994, BIOCHEM BIOPH RES CO, V198, P811, DOI 10.1006/bbrc.1994.1116; Stewart BA, 1996, J NEUROSCI, V16, P3877; Roos J, 1999, CURR BIOL, V9, P1411, DOI 10.1016/S0960-9822(00)80087-1; Fannon AM, 1996, NEURON, V17, P423, DOI 10.1016/S0896-6273(00)80175-0; SWEENEY ST, 1995, NEURON, V14, P341, DOI 10.1016/0896-6273(95)90290-2; Schaefer AM, 2000, NEURON, V26, P345, DOI 10.1016/S0896-6273(00)81168-X; GRENNINGLOH G, 1991, CELL, V67, P45, DOI 10.1016/0092-8674(91)90571-F; Ehler E, 1997, MOL CELL NEUROSCI, V9, P1, DOI 10.1006/mcne.1997.0602; Zito K, 1997, NEURON, V19, P1007, DOI 10.1016/S0896-6273(00)80393-1; vanLeeuwen FN, 1997, J CELL BIOL, V139, P797; HABETS GGM, 1994, CELL, V77, P537, DOI 10.1016/0092-8674(94)90216-X; Bajjalieh SM, 1999, CURR OPIN NEUROBIOL, V9, P321, DOI 10.1016/S0959-4388(99)80047-6; Keshishian H, 1996, ANNU REV NEUROSCI, V19, P545; Betz WJ, 1998, ANNU REV PHYSIOL, V60, P347, DOI 10.1146/annurev.physiol.60.1.347; Beumer KJ, 1999, DEVELOPMENT, V126, P5833; BROWER DL, 1984, P NATL ACAD SCI-BIOL, V81, P7485, DOI 10.1073/pnas.81.23.7485; Callebaut I, 1998, FEBS LETT, V441, P181, DOI 10.1016/S0014-5793(98)01541-5; Chang Q, 2000, NEURON, V26, P287, DOI 10.1016/S0896-6273(00)81161-7; DOTTI CG, 1990, CELL, V62, P63, DOI 10.1016/0092-8674(90)90240-F; Estes PS, 1996, J NEUROSCI, V16, P5443; Fanning AS, 1999, CURR OPIN CELL BIOL, V11, P432, DOI 10.1016/S0955-0674(99)80062-3; Gallo G, 1998, CURR BIOL, V8, pR80, DOI 10.1016/S0960-9822(98)70051-X; GOTWALS PJ, 1994, CURR OPIN CELL BIOL, V6, P734, DOI 10.1016/0955-0674(94)90101-5; GRIGLIATTI T, 1986, DROSOPHILA PRACTICAL, P39; HARDEN N, 1995, DEVELOPMENT, V121, P903; Harden N, 1996, MOL CELL BIOL, V16, P1896; HARIHARAN IK, 1995, EMBO J, V14, P292; Hordijk PL, 1997, SCIENCE, V278, P1464, DOI 10.1126/science.278.5342.1464; Hoshinoso M, 1999, J BIOL CHEM, V274, P17837, DOI 10.1074/jbc.274.25.17837; Hough CD, 1997, GENE DEV, V11, P3242, DOI 10.1101/gad.11.23.3242; Kuroda S, 1997, BIOCHEM BIOPH RES CO, V240, P430, DOI 10.1006/bbrc.1997.7675; LUO LQ, 1994, GENE DEV, V8, P1787, DOI 10.1101/gad.8.15.1787; MARTIN AR, 1955, J PHYSIOL-LONDON, V130, P114; Nagano T, 1998, J BIOCHEM-TOKYO, V124, P869; Sarner S, 2000, MOL CELL BIOL, V20, P158; Sone M, 1997, SCIENCE, V275, P543, DOI 10.1126/science.275.5299.543; SUZUKI E, 1994, J ELECTRON MICROSC, V43, P183; Takaishi K, 1997, J CELL BIOL, V139, P1047, DOI 10.1083/jcb.139.4.1047; Threadgill R, 1997, NEURON, V19, P625, DOI 10.1016/S0896-6273(00)80376-1; Van AL, 1997, GENE DEV, V11, P2295; VANVACTOR D, 1993, CELL, V73, P1137, DOI 10.1016/0092-8674(93)90643-5; Whitehead I.P., 1997, BIOCHIM BIOPHYS ACTA, V1332, P1; Winckler B, 1999, NEURON, V23, P637, DOI 10.1016/S0896-6273(01)80021-0	74	87	91	COMPANY OF BIOLOGISTS LTD	CAMBRIDGE	BIDDER BUILDING CAMBRIDGE COMMERCIAL PARK COWLEY RD, CAMBRIDGE CB4 4DL, CAMBS, ENGLAND	0950-1991			DEVELOPMENT	Development	OCT	2000	127	19					4157	4168				12	Developmental Biology	Developmental Biology	370KH	WOS:000165122000008		
J	Tsuji, T; Sato, A; Hiratani, I; Taira, M; Saigo, K; Kojima, T				Tsuji, T; Sato, A; Hiratani, I; Taira, M; Saigo, K; Kojima, T			Requirements of Lim1, a Drosophila LIM-homeobox gene, for normal leg and antennal development	DEVELOPMENT			English	Article						leg development; homeobox genes; LIM-homeobox genes; BarH1; BarH2; Fas2; aristaless; Lim1; Xlim1; Drosophila	HOMEODOMAIN PROTEIN; DISTAL-LESS; PROXIMODISTAL AXIS; FASCICLIN-II; NORMAL EYE; BOX GENES; EXPRESSION; ENCODES; WINGLESS; XENOPUS	During Drosophila leg development, the distal-most compartment (pretarsus) and its immediate neighbour (tarsal segment 5) are specified by a pretarsus-specific homeobox gene, aristaless, and tarsal-segment-specific Bar homeobox genes, respectively; the pretarsus/tarsal-segment boundary is formed by antagonistic interactions between Bar and pretarsus-specific genes that include apistaless (Kojima, T., Sate, M, and Saigo, K, (2000) Development 127, 769-778), Here, we show that Drosophila Lim1, a homologue of vertebrate Lim1 encoding a LIM-homeodomain protein, is involved in pretarsus specification and boundary formation through its activation of aristaless. Ectopic expression of Lim1 caused aristaless misexpression, while aristaless expression was significantly reduced in Lim1-null mutant clones. Pretarsus Lim1 expression was negatively regulated by Bar and abolished in leg discs lacking aristaless activity, which was associated with strong Bar misexpression in the presumptive pretarsus. No Lim1 misexpression occurred upon aristaless misexpression. The concerted function of Lim1 and aristaless was required to maintain Fasciclin 2 expression in border cells and form a smooth pretarsus/tarsal-segment boundary. Lim1 was also required for femur, coxa and antennal development.	Univ Tokyo, Grad Sch Sci, Dept Biophys & Biochem, Bunkyo Ku, Tokyo 1130033, Japan; Univ Tokyo, Grad Sch Sci, Dept Biol Sci, Bunkyo Ku, Tokyo 1130033, Japan	Kojima, T (reprint author), Univ Tokyo, Grad Sch Sci, Dept Biophys & Biochem, Bunkyo Ku, 7-3-1 Hongo, Tokyo 1130033, Japan.		TAIRA, MASANORI/G-4923-2014				Abu-Shaar M, 1998, DEVELOPMENT, V125, P3821; BARNES JD, 1994, DEV BIOL, V161, P168, DOI 10.1006/dbio.1994.1018; BRAND AH, 1993, DEVELOPMENT, V118, P401; Agulnick AD, 1996, NATURE, V384, P270, DOI 10.1038/384270a0; XU T, 1993, DEVELOPMENT, V117, P1223; DIAZBENJUMEA FJ, 1994, NATURE, V372, P175, DOI 10.1038/372175a0; Morcillo P, 1997, GENE DEV, V11, P2729, DOI 10.1101/gad.11.20.2729; Rieckhof GE, 1997, CELL, V91, P171, DOI 10.1016/S0092-8674(00)80400-6; CAMPBELL G, 1993, CELL, V74, P1113, DOI 10.1016/0092-8674(93)90732-6; FUSE N, 1994, GENE DEV, V8, P2270, DOI 10.1101/gad.8.19.2270; TAIRA M, 1994, NATURE, V372, P677, DOI 10.1038/372677a0; HINZ U, 1994, CELL, V76, P77, DOI 10.1016/0092-8674(94)90174-0; GRENNINGLOH G, 1991, CELL, V67, P45, DOI 10.1016/0092-8674(91)90571-F; TAIRA M, 1992, GENE DEV, V6, P356, DOI 10.1101/gad.6.3.356; Newsome TP, 2000, DEVELOPMENT, V127, P851; Morimura S, 1996, DEV BIOL, V177, P136, DOI 10.1006/dbio.1996.0151; Bryant P. J., 1978, GENETICS BIOL DROS C, V2c, P229; Campbell G, 1998, DEVELOPMENT, V125, P4483; COHEN SM, 1989, NATURE, V338, P432, DOI 10.1038/338432a0; Erkner A, 1999, DEV BIOL, V215, P221, DOI 10.1006/dbio.1999.9452; FASANO L, 1991, CELL, V64, P63, DOI 10.1016/0092-8674(91)90209-H; FUJII T, 1994, DEV DYNAM, V199, P73; Goto S, 1999, DEVELOPMENT, V126, P3407; HIGASHIJIMA S, 1992, GENE DEV, V6, P1005, DOI 10.1101/gad.6.6.1005; HIGASHIJIMA SI, 1992, GENE DEV, V6, P50, DOI 10.1101/gad.6.1.50; KINTNER CR, 1984, NATURE, V308, P67, DOI 10.1038/308067a0; KOJIMA T, 1991, P NATL ACAD SCI USA, V88, P4343, DOI 10.1073/pnas.88.10.4343; Kojima T, 2000, DEVELOPMENT, V127, P769; Lilly B, 1999, MECH DEVELOP, V88, P195, DOI 10.1016/S0925-4773(99)00189-6; LIN DM, 1994, NEURON, V13, P1055, DOI 10.1016/0896-6273(94)90045-0; MARDON G, 1994, DEVELOPMENT, V120, P3473; Sato A, 1999, DEVELOPMENT, V126, P4421; Sato M, 1999, DEVELOPMENT, V126, P1457; SCHNEITZ K, 1993, GENE DEV, V7, P114, DOI 10.1101/gad.7.1.114; TURNER DL, 1994, GENE DEV, V8, P1434, DOI 10.1101/gad.8.12.1434; WHITELEY M, 1992, MECH DEVELOP, V36, P117, DOI 10.1016/0925-4773(92)90063-P; Wu J, 1999, DEVELOPMENT, V126, P109	37	33	33	COMPANY OF BIOLOGISTS LTD	CAMBRIDGE	BIDDER BUILDING CAMBRIDGE COMMERCIAL PARK COWLEY RD, CAMBRIDGE CB4 4DL, CAMBS, ENGLAND	0950-1991			DEVELOPMENT	Development	OCT	2000	127	20					4315	4323				9	Developmental Biology	Developmental Biology	372KF	WOS:000165232300002		
J	Yaguchi, S; Kanoh, K; Amemiya, S; Katow, H				Yaguchi, S; Kanoh, K; Amemiya, S; Katow, H			Initial analysis of immunochemical cell surface properties, location and formation of the serotonergic apical ganglion in sea urchin embryos	DEVELOPMENT GROWTH & DIFFERENTIATION			English	Article						apical ganglion; neurogenesis; sea urchin embryo; serotonergic cells	NERVOUS-SYSTEM; STRONGYLOCENTROTUS-DROEBACHIENSIS; BILATERAL SYMMETRY; PISASTER-OCHRACEUS; PLUTEUS LARVA; ECTODERM; PROTEIN; ECHINOPLUTEUS; LOCALIZATION; ECHINODERMS	In the present study it was found that serotonergic epical ganglion (SAG)-forming cells in plutei of the sea urchin, Hemicentrotus pulcherrimus, possessed a characteristic pear shape with broad apical sides and a pointed basal side in the acron epithelium. The basal side extended axons through the space between the epithelium and the basal lamina toward the midline of the embryo that aligned parallel to the embryonic anteroposterior axis. Serotonergic epical ganglion-forming cells had epithelial cell surface-specific proteins on their entire surface. The SAG in 4-arm plutei was composed of a 4-cell trunk region that aligned at right angles to the embryonic anteroposterior axis, and forked into two branches of one to two cells at both ends. Two branches extended toward the oral and the other two toward the aboral region, respectively. Double-stained immunohistochemistry using antiserotonin antibodies and oral ectoderm-specific anti-Ecto V monoclonal antibody or aboral ectoderm-specific anti-Ars antibodies indicated that SAG was in the aboral ectoderm region. Serotonergic apical ganglion cells were first detected in late gastrulae and increased in number rapidly between 36 and 48 h after fertilization, and then slowly afterwards. A 5-bromo-2-deoxyuridine incorporation study indicated that none of the increased SAG cells were in the S phase during the aforementioned period, suggesting that SAG cells do not proliferate by cell division, but acquire the property in particular cells by transdifferentiation using a mechanism that has yet to be elucidated.	Tohoku Univ, Grad Sch Sci, Marine Biol Stn, Asamushi, Aomori 0393501, Japan; Univ Tokyo, Grad Sch Frontier Sci, Dept Integrat Biosci, Tokyo 1130033, Japan	Katow, H (reprint author), Tohoku Univ, Grad Sch Sci, Marine Biol Stn, Asamushi, Aomori 0393501, Japan.						Jefferies RPS, 1996, ACTA ZOOL-STOCKHOLM, V77, P101; Serafini T, 1996, CELL, V87, P1001, DOI 10.1016/S0092-8674(00)81795-X; BURKE RD, 1978, CELL TISSUE RES, V191, P233; BISGROVE BW, 1987, CELL TISSUE RES, V248, P335; BISGROVE BW, 1986, DEV GROWTH DIFFER, V28, P557; BURKE RD, 1986, BIOL BULL, V170, P450, DOI 10.2307/1541854; BURKE RD, 1983, CELL TISSUE RES, V229, P145; BUZNIKOV GA, 1964, J EMBRYOL EXP MORPH, V12, P563; CAMERON RA, 1993, DEV BIOL, V160, P369, DOI 10.1006/dbio.1993.1313; COFFMAN JA, 1990, DEV BIOL, V140, P93, DOI 10.1016/0012-1606(90)90056-O; Davidson EH, 1998, DEVELOPMENT, V125, P3269; Deutsch A., 1999, FUNDAMENTAL NEUROSCI, P193; GUSTAFSO.T, 1972, EXP CELL RES, V72, P115, DOI 10.1016/0014-4827(72)90573-3; HOLLAND PWH, 1991, PHILOS T ROY SOC B, V332, P185, DOI 10.1098/rstb.1991.0048; JEFFERIES RPS, 1991, CIBA F SYMP, V162, P94; KATOW H, 1995, EXP CELL RES, V218, P469, DOI 10.1006/excr.1995.1180; Katow H, 2000, DEV GROWTH DIFFER, V42, P9; KATOW H, 1980, J EXP ZOOL, V213, P231, DOI 10.1002/jez.1402130211; LACALLI TC, 1990, PHILOS T ROY SOC B, V330, P371, DOI 10.1098/rstb.1990.0206; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Lowe CJ, 1997, NATURE, V389, P718; Marg A, 1999, J CELL BIOL, V145, P865, DOI 10.1083/jcb.145.4.865; Mitsunaga-Nakatsubo K, 1998, J EXP ZOOL, V280, P220, DOI 10.1002/(SICI)1097-010X(19980215)280:3<220::AID-JEZ3>3.0.CO;2-P; MOSS C, 1994, J MAR BIOL ASSOC UK, V74, P61; NAKAJIMA Y, 1993, DEV GROWTH DIFFER, V35, P531; NAKAJIMA Y, 1987, ZOOL SCI, V4, P293; NAKAJIMA Y, 1986, DEV GROWTH DIFFER, V28, P531; RYBERG E, 1977, CELL TISSUE RES, V179, P157; RYBERG E, 1973, ZOOL SCR, V2, P163; SHIMIZUNISHIKAWA K, 1990, DEV GROWTH DIFFER, V32, P629; TOWBIN H, 1979, P NATL ACAD SCI USA, V76, P4350, DOI 10.1073/pnas.76.9.4350; VOLKMER H, 1997, MOL BIOL NEURON, P269; Wikramanayake AH, 1997, DEVELOPMENT, V124, P13; Zimmer C, 2000, SCIENCE, V287, P1576, DOI 10.1126/science.287.5458.1576	34	30	31	BLACKWELL SCIENCE ASIA	CARLTON	54 UNIVERSITY ST, P O BOX 378, CARLTON, VICTORIA 3053, AUSTRALIA	0012-1592			DEV GROWTH DIFFER	Dev. Growth Diff.	OCT	2000	42	5					479	488				10	Cell Biology; Developmental Biology	Cell Biology; Developmental Biology	375NE	WOS:000165405700005		
J	Fukui, A; Kishida, S; Kikuchi, A; Asashima, M				Fukui, A; Kishida, S; Kikuchi, A; Asashima, M			Effects of rat Axin domains on axis formation in Xenopus embryos	DEVELOPMENT GROWTH & DIFFERENTIATION			English	Article						adenomatous polyposis coli gene product; Axin; axis formation; beta-catenin; regulation of G-protein signaling domain	WNT SIGNALING PATHWAY; GLYCOGEN-SYNTHASE KINASE-3-BETA; ADENOMATOUS POLYPOSIS-COLI; F-BOX PROTEIN; BETA-CATENIN; FUNCTIONAL INTERACTION; NEGATIVE REGULATOR; TUMOR-SUPPRESSOR; NEURAL INDUCTION; LAEVIS EMBRYOS	Wnt signaling plays an important role in axis formation in early vertebrate development. Axin is one Wnt signaling regulator that inhibits this pathway. The effects of the injection of mRNA of several rat Axin (rAxin) mutants on axis formation in Xenopus embryos were examined. It was found that rAxin mutants containing only a regulation of G-protein signaling (RGS) domain fragment or with deletion of the RGS domain induced axis formation. Because the RGS domain is a major adenomatous polyposis coli gene product (APC)-binding domain, APC association with glycogen synthase kinase 3 beta (GSK3 beta) on the Axin molecule may be important in inhibition of axis formation. The ventralizing activities of wild-type rAxin and a mutant in which the Dishevelled and Axin (DIX) domain was deleted (Delta DIX mutant) were examined. Histological examination and gene expression revealed that the ventralizing activity of the Delta DIX mutant was weaker than that of wild-type rAxin. This finding suggests that the C-terminus of rAxin contributes to the inhibition of Wnt signaling in Xenopus embryos. Furthermore, an rAxin mutant that contained both the RGS and GSK3 beta -binding domains affected both the dorsal and ventral sides of blastomeres, mediated ectodermal fate and induced expansion of notochord and/or endoderm, but did not induce axis formation.	Univ Tokyo, Dept Life Sci Biol, Meguro Ku, Tokyo 1538902, Japan; Hiroshima Univ, Sch Med, Dept Biochem, Minami Ku, Hiroshima 7348551, Japan; Japan Sci & Technol Corp, Precursory Res Embryon Sci & Technol, Hiroshima, Japan; Japan Sci & Technol Corp, Core Res Evolut Sci & Technol, Tokyo, Japan	Asashima, M (reprint author), Univ Tokyo, Dept Life Sci Biol, Meguro Ku, 3-8-1 Komaba, Tokyo 1538902, Japan.		Fukui, Akimasa/F-5284-2011				Aberle H, 1997, EMBO J, V16, P3797, DOI 10.1093/emboj/16.13.3797; Hart M, 1999, CURR BIOL, V9, P207, DOI 10.1016/S0960-9822(99)80091-8; KAO KR, 1988, DEV BIOL, V127, P64, DOI 10.1016/0012-1606(88)90189-3; Hsu W, 1999, J BIOL CHEM, V274, P3439, DOI 10.1074/jbc.274.6.3439; Yost C, 1996, GENE DEV, V10, P1443, DOI 10.1101/gad.10.12.1443; Nusse R, 1997, CELL, V89, P321, DOI 10.1016/S0092-8674(00)80210-X; Fagotto F, 1999, J CELL BIOL, V145, P741, DOI 10.1083/jcb.145.4.741; Behrens J, 1998, SCIENCE, V280, P596, DOI 10.1126/science.280.5363.596; Willert K, 1999, DEVELOPMENT, V126, P4165; SASAI Y, 1994, CELL, V79, P779, DOI 10.1016/0092-8674(94)90068-X; Takebayashi K, 1997, EMBO J, V16, P384, DOI 10.1093/emboj/16.2.384; Rubinfeld B, 1996, SCIENCE, V272, P1023, DOI 10.1126/science.272.5264.1023; Cadigan KM, 1997, GENE DEV, V11, P3286, DOI 10.1101/gad.11.24.3286; Behrens J, 1996, NATURE, V382, P638, DOI 10.1038/382638a0; Eisaki A, 2000, BIOCHEM BIOPH RES CO, V271, P151, DOI 10.1006/bbrc.2000.2545; Nakamura T, 1998, GENES CELLS, V3, P395, DOI 10.1046/j.1365-2443.1998.00198.x; Winston JT, 1999, GENE DEV, V13, P270, DOI 10.1101/gad.13.3.270; Kikuchi A, 2000, BIOCHEM BIOPH RES CO, V268, P243, DOI 10.1006/bbrc.1999.1860; Yost C, 1998, CELL, V93, P1031, DOI 10.1016/S0092-8674(00)81208-8; Bhanot P, 1996, NATURE, V382, P225, DOI 10.1038/382225a0; Itoh K, 2000, MOL CELL BIOL, V20, P2228, DOI 10.1128/MCB.20.6.2228-2238.2000; Kishida S, 1999, MOL CELL BIOL, V19, P4414; Miller JR, 1996, GENE DEV, V10, P2527, DOI 10.1101/gad.10.20.2527; Kitagawa M, 1999, EMBO J, V18, P2401, DOI 10.1093/emboj/18.9.2401; Ikeda S, 1998, EMBO J, V17, P1371, DOI 10.1093/emboj/17.5.1371; Hart MJ, 1998, CURR BIOL, V8, P573, DOI 10.1016/S0960-9822(98)70226-X; Zeng L, 1997, CELL, V90, P181, DOI 10.1016/S0092-8674(00)80324-4; Kishida S, 1998, J BIOL CHEM, V273, P10823, DOI 10.1074/jbc.273.18.10823; Peifer M, 2000, SCIENCE, V287, P1606, DOI 10.1126/science.287.5458.1606; FERREIRO B, 1994, DEVELOPMENT, V120, P3649; GLUECKSOHNSCHOENHEIMER S, 1949, J EXP ZOOL, V110, P47, DOI 10.1002/jez.1401100105; Hedgepeth CM, 1999, MECH DEVELOP, V80, P147, DOI 10.1016/S0925-4773(98)00203-2; Hedgepeth CM, 1999, MOL CELL BIOL, V19, P7147; Itoh K, 1995, DEVELOPMENT, V121, P3979; Itoh K, 1998, CURR BIOL, V8, P591, DOI 10.1016/S0960-9822(98)70229-5; Kawahara K, 2000, J BIOL CHEM, V275, P8369, DOI 10.1074/jbc.275.12.8369; KINTNER CR, 1987, DEVELOPMENT, V99, P311; Kofron M, 1999, DEVELOPMENT, V126, P5759; OSBORNE HB, 1991, EUR J BIOCHEM, V202, P575, DOI 10.1111/j.1432-1033.1991.tb16410.x; POLAKIS P, 1997, BIOCHIM BIOPHYS ACTA, V1332, P127; Sakanaka C, 1998, P NATL ACAD SCI USA, V95, P3020, DOI 10.1073/pnas.95.6.3020; Sakanaka C, 1999, J BIOL CHEM, V274, P14090, DOI 10.1074/jbc.274.20.14090; Sokol SY, 1999, CURR OPIN GENET DEV, V9, P405, DOI 10.1016/S0959-437X(99)80061-6; Vleminckx K, 1997, J CELL BIOL, V136, P411, DOI 10.1083/jcb.136.2.411; WRIGHT CVE, 1990, DEVELOPMENT, V109, P225; Yamamoto H, 1998, MOL CELL BIOL, V18, P2867	46	10	11	BLACKWELL SCIENCE ASIA	CARLTON	54 UNIVERSITY ST, P O BOX 378, CARLTON, VICTORIA 3053, AUSTRALIA	0012-1592			DEV GROWTH DIFFER	Dev. Growth Diff.	OCT	2000	42	5					489	498				10	Cell Biology; Developmental Biology	Cell Biology; Developmental Biology	375NE	WOS:000165405700006		
J	Kume, S; Inoue, T; Mikoshiba, K				Kume, S; Inoue, T; Mikoshiba, K			G alpha s family G proteins activate IP3-Ca2+ signaling via G beta gamma and transduce ventralizing signals in Xenopus	DEVELOPMENTAL BIOLOGY			English	Article						G proteins; IP3; Ca2+; Xenopus; dorsoventral axis	INOSITOL 1,4,5-TRISPHOSPHATE RECEPTOR; HETEROTRIMERIC G-PROTEINS; PHOSPHOLIPASE-C ISOZYMES; INDUCED DNA-SYNTHESIS; LAEVIS OOCYTES; SEQUENCE DETERMINATION; ADRENERGIC-RECEPTOR; SPEMANN ORGANIZER; MOLECULAR-CLONING; GENE-EXPRESSION	During early embryonic development, IP3-Ca2+ signaling transduces ventral signaling at the time of dorsoventral axis formation. To identify molecules functioning upstream in this signal pathway, we examined effects of a panel of inhibitory antibodies against G alpha q/11, G alpha a/olf, or G alpha i/o/t/z. While all these antibodies showed direct inhibition of their targets, their effects on redirection of the ventral mesoderm to a dorsal fate varied. Anti-G alpha s/olf antibody showed strong induction of dorsal fate, anti-G alpha i/o/t/z antibody did so weakly, and anti-G alpha q/11 antibody was without effect. Injection of beta ARK, a G beta gamma inhibitor, mimicked the dorsalizing effect of anti-G alpha s/olf antibody, whereas injection of adenylyl cyclase inhibitors at a concentration which inhibited G alpha s-coupled cAMP increase did not do so. The activation of G alpha s-coupled receptor gave rise to Ca2+ transients. All these results suggest that activation of the G alpha s-coupled receptor relays dorsoventral signal to G beta gamma, which then stimulates PLC beta and then the IP3-Ca2+ system. This signaling pathway may play a crucial role in transducing ventral signals. (C) 2000 Academic Press.	Japan Sci & Technol Corp, Exploratory Res Adv Technol, Mikoshiba Calciosignal Net Project, Bunkyo Ku, Tokyo 1130021, Japan; Univ Tokyo, Inst Med Sci, Dept Mol Neurobiol, Minato Ku, Tokyo 1088639, Japan; RIKEN, Brain Res Inst, Wako, Saitama 3510198, Japan	Kume, S (reprint author), Japan Sci & Technol Corp, Exploratory Res Adv Technol, Mikoshiba Calciosignal Net Project, Bunkyo Ku, 2-28-2 Honkomagome, Tokyo 1130021, Japan.			Inoue, Takafumi/0000-0002-2728-0060			SASAI Y, 1995, NATURE, V376, P333, DOI 10.1038/376333a0; Dolmetsch RE, 1998, NATURE, V392, P933; ADAMS SR, 1991, NATURE, V349, P694, DOI 10.1038/349694a0; KRIEG PA, 1989, DEV BIOL, V133, P93, DOI 10.1016/0012-1606(89)90300-X; Lustig KD, 1996, DEVELOPMENT, V122, P3275; BERRIDGE MJ, 1984, BIOCHEM J, V220, P345; SASAI Y, 1994, CELL, V79, P779, DOI 10.1016/0092-8674(94)90068-X; ASHKENAZI A, 1987, SCIENCE, V238, P672, DOI 10.1126/science.2823384; Torres MA, 1996, J CELL BIOL, V133, P1123, DOI 10.1083/jcb.133.5.1123; Hedgepeth CM, 1997, DEV BIOL, V185, P82, DOI 10.1006/dbio.1997.8552; DeBernardi MA, 1996, P NATL ACAD SCI USA, V93, P4577, DOI 10.1073/pnas.93.10.4577; POENIE M, 1990, CELL CALCIUM, V11, P85, DOI 10.1016/0143-4160(90)90062-Y; Zimmerman LB, 1996, CELL, V86, P599, DOI 10.1016/S0092-8674(00)80133-6; Glinka A, 1997, NATURE, V389, P517; De Koninck P, 1998, SCIENCE, V279, P227, DOI 10.1126/science.279.5348.227; HAWES BE, 1995, J BIOL CHEM, V270, P17148; Lambright DG, 1996, NATURE, V379, P311, DOI 10.1038/379311a0; BENOVIC JL, 1989, SCIENCE, V246, P235, DOI 10.1126/science.2552582; Gawantka V, 1995, EMBO J, V14, P6268; LAMORTE VJ, 1993, J CELL BIOL, V121, P91, DOI 10.1083/jcb.121.1.91; SMITH WC, 1992, CELL, V70, P829, DOI 10.1016/0092-8674(92)90316-5; He X, 1997, SCIENCE, V275, P1652, DOI 10.1126/science.275.5306.1652; Klein PS, 1996, P NATL ACAD SCI USA, V93, P8455, DOI 10.1073/pnas.93.16.8455; Li WH, 1998, NATURE, V392, P936; Berridge MJ, 1997, NATURE, V386, P759, DOI 10.1038/386759a0; Slusarski DC, 1997, NATURE, V390, P410; Glinka A, 1998, NATURE, V391, P357; Zhu X, 1996, P NATL ACAD SCI USA, V93, P2827, DOI 10.1073/pnas.93.7.2827; Slusarski DC, 1997, DEV BIOL, V182, P114, DOI 10.1006/dbio.1996.8463; Kume S, 1997, SCIENCE, V278, P1940, DOI 10.1126/science.278.5345.1940; FUKUDA K, 1987, NATURE, V327, P623, DOI 10.1038/327623a0; Piccolo S, 1996, CELL, V86, P589, DOI 10.1016/S0092-8674(00)80132-4; STACHEL SE, 1993, DEVELOPMENT, V117, P1261; PERALTA EG, 1987, EMBO J, V6, P3923; ARRIZA JL, 1992, J NEUROSCI, V12, P4045; Ault KT, 1996, DEVELOPMENT, V122, P2033; BERRIDGE MJ, 1989, CELL, V59, P411, DOI 10.1016/0092-8674(89)90026-3; Bourne HR, 1997, CURR OPIN CELL BIOL, V9, P134, DOI 10.1016/S0955-0674(97)80054-3; BUSA WB, 1989, DEV BIOL, V132, P315, DOI 10.1016/0012-1606(89)90228-5; CHOMCZYNSKI P, 1987, ANAL BIOCHEM, V162, P156, DOI 10.1006/abio.1987.9999; CIAPA B, 1993, DEV BIOL, V159, P114, DOI 10.1006/dbio.1993.1225; DELAPENA P, 1995, J BIOL CHEM, V270, P3554; Filtz TM, 1996, J BIOL CHEM, V271, P31121; GALLO CJ, 1995, J CELL BIOL, V130, P275, DOI 10.1083/jcb.130.2.275; Gao P, 1996, J BIOL CHEM, V271, P30692; Giambarella U, 1997, EMBO J, V16, P4897, DOI 10.1093/emboj/16.16.4897; GRAFF JM, 1994, CELL, V79, P169, DOI 10.1016/0092-8674(94)90409-X; GUTOWSKI S, 1991, J BIOL CHEM, V266, P20519; GUTTRIDGE KL, 1995, P NATL ACAD SCI USA, V92, P1297, DOI 10.1073/pnas.92.5.1297; HASSEL M, 1996, DEV BIOL, P177; HEMMATIBRIVANLOU A, 1994, CELL, V77, P283, DOI 10.1016/0092-8674(94)90320-4; HURLEY JB, 1984, P NATL ACAD SCI-BIOL, V81, P6948, DOI 10.1073/pnas.81.22.6948; ITOH H, 1986, P NATL ACAD SCI USA, V83, P3776, DOI 10.1073/pnas.83.11.3776; KAO KR, 1986, NATURE, V322, P371, DOI 10.1038/322371a0; KOCH WJ, 1993, J BIOL CHEM, V268, P8256; KOCH WJ, 1994, J BIOL CHEM, V269, P6193; Kume S, 1997, MECH DEVELOP, V66, P157, DOI 10.1016/S0925-4773(97)00101-9; Kume S, 1999, CELL MOL LIFE SCI, V56, P296, DOI 10.1007/s000180050431; LIPPE C, 1991, COMP BIOCHEM PHYS C, V99, P209, DOI 10.1016/0742-8413(91)90101-X; MA HW, 1993, J BIOL CHEM, V268, P19915; MASLANSKI JA, 1992, SCIENCE, V256, P243, DOI 10.1126/science.1314424; MEINKOTH JL, 1992, J BIOL CHEM, V267, P13239; MITCHELL FM, 1991, FEBS LETT, V287, P171, DOI 10.1016/0014-5793(91)80043-3; Noh SJ, 1998, J CELL PHYSIOL, V176, P412, DOI 10.1002/(SICI)1097-4652(199808)176:2<412::AID-JCP20>3.0.CO;2-3; OLATE J, 1989, FEBS LETT, V244, P188, DOI 10.1016/0014-5793(89)81190-1; OLATE J, 1990, FEBS LETT, V268, P27, DOI 10.1016/0014-5793(90)80964-K; OTTE AP, 1992, DEVELOPMENT, V116, P141; PARK DG, 1993, J BIOL CHEM, V268, P4573; RENSDOMIANO S, 1995, FASEB J, V9, P1059; RHEE SG, 1992, J BIOL CHEM, V267, P12393; SHAPIRA H, 1994, FEBS LETT, V348, P89, DOI 10.1016/0014-5793(94)00570-2; STRATHMANN M, 1990, P NATL ACAD SCI USA, V87, P9113, DOI 10.1073/pnas.87.23.9113; STUTZ F, 1986, J MOL BIOL, V187, P349, DOI 10.1016/0022-2836(86)90438-9; SUGIMOTO K, 1985, FEBS LETT, V191, P235, DOI 10.1016/0014-5793(85)80015-6; TURNER DL, 1994, GENE DEV, V8, P1434, DOI 10.1101/gad.8.12.1434; Wilson BA, 1997, J BIOL CHEM, V272, P1268; YANG LJ, 1993, J BIOL CHEM, V268, P3739; YARDEN Y, 1986, P NATL ACAD SCI USA, V83, P6795, DOI 10.1073/pnas.83.18.6795	78	20	20	ACADEMIC PRESS INC	SAN DIEGO	525 B ST, STE 1900, SAN DIEGO, CA 92101-4495 USA	0012-1606			DEV BIOL	Dev. Biol.	OCT 1	2000	226	1					88	103		10.1006/dbio.2000.9849		16	Developmental Biology	Developmental Biology	361DB	WOS:000089705800007		
J	Tanaka, M; Komuro, I; Inagaki, H; Jenkins, NA; Copeland, NG; Izumo, S				Tanaka, M; Komuro, I; Inagaki, H; Jenkins, NA; Copeland, NG; Izumo, S			Nkx3.1, a murine homolog of Drosophila bagpipe, regulates epithelial ductal branching and proliferation of the prostate and palatine glands	DEVELOPMENTAL DYNAMICS			English	Article						homeobox; prostate cancer; prostate hypertrophy; tumor suppressor; NK2 domain	HOMEOBOX GENE; HEART DEVELOPMENT; EXPRESSION; MICE; CANCER; ROLES; ORGANOGENESIS; MORPHOGENESIS; DISRUPTION; FOREBRAIN	Nkx3.1 is a homeobox gene related to Drosophila bagpipe. Nkx3.1 is an early marker of the sclerotome and a subset of vascular:smooth muscle cells, and at later stages, this gene is expressed in the prostate, palatine glands, kidney, and restricted regions of the central nervous system. In the present study, we determined the chromosomal localization of Nkx3.1 and examined the function of Nkx3.1 in vivo by using gene targeting technique. Interestingly, Nkx3.1 mapped to the central region of the mouse chromosome 14 and was linked to Nkx2.6, a murine homolog of Drosophila tinman, Homozygous mutant mice for Nkx3.1 were viable and:fertile, and the phenotype was, unexpectedly, confined to the prostate and palatine glands. The homozygous mutant mice exhibited defective branching morphogenesis of the prostate and palatine glands. Moreover, epithelial cells of the mutant prostate and palatine glands showed significant hyperplasia, No abnormalities were detected in the sclerotome, blood vessels, kidney, or brain. These results indicate that Nkx3.1 plays a critical role in epithelial branching and proliferation in the prostate and palatine glands. However, we did not observe prostate cancer in homozygous mutant mice up to 2 years of age. Therefore, involvement of NKX3.1 in carcinogenesis in men needs to be carefully determined by further investigation, Published 2000 Wiley-Liss, Inc.(dagger).	Beth Israel Deaconess Med Ctr, Div Cardiovasc, Boston, MA 02215 USA; Harvard Univ, Sch Med, Dept Med, Boston, MA USA; Univ Tokyo, Fac Med, Dept Cardiovasc Med, Tokyo 113, Japan; Natl Ind Res Inst Nagoya, Dept Chem, Nagoya, Aichi 462, Japan; NCI, Mammalian Genet Lab, ABL Basic Res Program, Frederick Canc Res & Dev Ctr, Frederick, MD 21701 USA	Izumo, S (reprint author), Beth Israel Deaconess Med Ctr, Div Cardiovasc, SL-201,330 Brookline Ave, Boston, MA 02215 USA.						SUGIMURA Y, 1986, BIOL REPROD, V34, P961, DOI 10.1095/biolreprod34.5.961; Sussel L, 1998, DEVELOPMENT, V125, P2213; Briscoe J, 1999, NATURE, V398, P622; Pabst O, 1997, DEV DYNAM, V209, P29; Voeller HJ, 1997, CANCER RES, V57, P4455; LAZZARO D, 1991, DEVELOPMENT, V113, P1093; PANZER S, 1992, DEVELOPMENT, V114, P49; Kuo YM, 1996, DEVELOPMENT, V122, P1909; Vocke CD, 1996, CANCER RES, V56, P2411; Kimura S, 1996, GENE DEV, V10, P60, DOI 10.1101/gad.10.1.60; KOMURO I, 1993, P NATL ACAD SCI USA, V90, P8145, DOI 10.1073/pnas.90.17.8145; Tanaka M, 1999, DEVELOPMENT, V126, P1269; CUNHA GR, 1987, ENDOCR REV, V8, P338; He WW, 1997, GENOMICS, V43, P69, DOI 10.1006/geno.1997.4715; Sciavolino PJ, 1997, DEV DYNAM, V209, P127, DOI 10.1002/(SICI)1097-0177(199705)209:1<127::AID-AJA12>3.0.CO;2-Z; PRICE M, 1992, NEURON, V8, P241, DOI 10.1016/0896-6273(92)90291-K; Bieberich CJ, 1996, J BIOL CHEM, V271, P31779; Pabst O, 1999, DEVELOPMENT, V126, P2215; NAGY A, 1993, P NATL ACAD SCI USA, V90, P8424, DOI 10.1073/pnas.90.18.8424; AZPIAZU N, 1993, GENE DEV, V7, P1325, DOI 10.1101/gad.7.7b.1325; Bhatia-Gaur R, 1999, GENE DEV, V13, P966, DOI 10.1101/gad.13.8.966; Biben C, 1998, MECH DEVELOP, V73, P125, DOI 10.1016/S0925-4773(98)00037-9; COPELAND NG, 1994, GENOMICS, V22, P655, DOI 10.1006/geno.1994.1444; Harvey RP, 1996, DEV BIOL, V178, P203, DOI 10.1006/dbio.1996.0212; Jones NA, 1998, DEVELOPMENT, V125, P4163; LINTS TJ, 1993, DEVELOPMENT, V119, P969; LYONS I, 1995, GENE DEV, V9, P1654, DOI 10.1101/gad.9.13.1654; Tanaka M, 1998, DEV GENET, V22, P239, DOI 10.1002/(SICI)1520-6408(1998)22:3<239::AID-DVG6>3.3.CO;2-G; Tanaka M, 1999, MECH DEVELOP, V85, P179, DOI 10.1016/S0925-4773(99)00084-2; TRAPMAN J, 1994, CANCER RES, V54, P6061; Tribioli C, 1997, MECH DEVELOP, V65, P145, DOI 10.1016/S0925-4773(97)00067-1; TYBULEWICZ VLJ, 1991, CELL, V65, P1153, DOI 10.1016/0092-8674(91)90011-M	32	57	59	WILEY-LISS	NEW YORK	DIV JOHN WILEY & SONS INC, 605 THIRD AVE, NEW YORK, NY 10158-0012 USA	1058-8388			DEV DYNAM	Dev. Dyn.	OCT	2000	219	2					248	260		10.1002/1097-0177(2000)9999:9999<::AID-DVDY1054>3.3.CO;2-5		13	Anatomy & Morphology; Developmental Biology	Anatomy & Morphology; Developmental Biology	359TL	WOS:000089628100013		
J	Sakoda, H; Ogihara, T; Anai, M; Funaki, M; Inukai, K; Katagiri, H; Fukushima, Y; Onishi, Y; Ono, H; Fujishiro, M; Kikuchi, M; Oka, Y; Asano, T				Sakoda, H; Ogihara, T; Anai, M; Funaki, M; Inukai, K; Katagiri, H; Fukushima, Y; Onishi, Y; Ono, H; Fujishiro, M; Kikuchi, M; Oka, Y; Asano, T			Dexamethasone-induced insulin resistance in 3T3-L1 adipocytes is due to inhibition of glucose transport rather than insulin signal transduction	DIABETES			English	Article							PROTEIN-KINASE-B; L6 MUSCLE-CELLS; PHOSPHATIDYLINOSITOL 3-KINASE; RECEPTOR SUBSTRATE-1; SKELETAL-MUSCLE; GLUT4 TRANSLOCATION; DIFFERENTIAL REGULATION; GENE-EXPRESSION; DOWN-REGULATION; ANIMAL-MODELS	Glucocorticoids reportedly induce insulin resistance. In this study, we investigated the mechanism of glucocorticoid-induced insulin resistance using 3T3-L1 adipocytes in which treatment with dexamethasone has been shown to impair the insulin-induced increase in glucose uptake. In 3T3-L1 adipocytes treated with dexamethasone, the GLUT1 protein expression level was decreased by 30%, which possibly caused decreased basal glucose uptake. On the other hand, dexamethasone treatment did not alter the amount of GLUT4 protein in total cell lysates but decreased the insulin-stimulated GLUT4 translocation to the plasma membrane, which possibly caused decreased insulin-stimulated glucose uptake. Dexamethasone did not alter tyrosine phosphorylation of insulin receptors, and it significantly decreased protein expression and tyrosine phosphorylation of insulin receptor substrate (IRS)-1. Interestingly, however, protein expression and tyrosine phosphorylation of IRS-2 were increased. To investigate whether the reduced IRS-1 content is involved in insulin resistance, IRS-1 was overexpressed in dexamethasone-treated 3T3-L1 adipocytes using an adenovirus transfection system. Despite protein expression and phosphorylation levels of IRS-1 being normalized insulin-induced 2-deoxy-D-[H-3]glucose uptake impaired by dexamethasone showed no significant improvement. Subsequently, we examined the effect of dexamethasone on the glucose uptake increase induced by overexpression of GLUT2-tagged p110 alpha, constitutively active Akt (myristoylated Akt), oxidative stress (30 mU glucose oxidase for 2 h), 2 mmol/l 5 -aminoimidazole-4-carboxamide ribonucleoside for 30 min, and osmotic shock (600 mmol/l sorbitol for 30 min). Dexamethasone treatment clearly inhibited the increases in glucose uptake produced by these agents. Thus, in conclusion, the GLUT1 decrease may be involved in the dexamethasone-induced decrease in basal glucose transport activity, and the mechanism of dexamethasone- induced insulin resistance in glucose transport activity (rather than the inhibition of phosphatidylinositol 3-kinase activation resulting from a, decreased IRS-l content) is likely to underlie impaired glucose transporter regulation.	Univ Tokyo, Fac Med, Dept Internal Med 3, Bunkyo Ku, Tokyo 113, Japan; Asahi Life Fdn, Inst Adult Dis, Shinjuku Ku, Tokyo, Japan; Yamaguchi Univ, Sch Med, Dept Internal Med 3, Ube, Yamaguchi 755, Japan	Asano, T (reprint author), Univ Tokyo, Fac Med, Dept Internal Med 3, Bunkyo Ku, 7-3-1 Hongo, Tokyo 113, Japan.						Rudich A, 1998, DIABETES, V47, P1562, DOI 10.2337/diabetes.47.10.1562; Hayashi T, 1998, DIABETES, V47, P1369, DOI 10.2337/diabetes.47.8.1369; TURNBOW MA, 1994, J BIOL CHEM, V269, P2516; Anai M, 1998, DIABETES, V47, P13, DOI 10.2337/diabetes.47.1.13; PONS S, 1995, MOL CELL BIOL, V15, P4453; Kitamura T, 1998, MOL CELL BIOL, V18, P3708; SULLIVAN JE, 1994, FEBS LETT, V353, P33, DOI 10.1016/0014-5793(94)01006-4; GARVEY WT, 1989, ENDOCRINOLOGY, V124, P2063; SAAD MJA, 1992, J CLIN INVEST, V90, P1839, DOI 10.1172/JCI116060; Anai M, 1999, DIABETES, V48, P158, DOI 10.2337/diabetes.48.1.158; Weinstein SP, 1998, METABOLISM, V47, P3, DOI 10.1016/S0026-0495(98)90184-6; Chen D, 1999, MOL CELL BIOL, V19, P4684; Merrill GF, 1997, AM J PHYSIOL-ENDOC M, V273, pE1107; Jiang ZY, 1999, J CLIN INVEST, V104, P447, DOI 10.1172/JCI5971; Kerouz NJ, 1997, J CLIN INVEST, V100, P3164, DOI 10.1172/JCI119872; WEINSTEIN SP, 1995, DIABETES, V44, P441, DOI 10.2337/diabetes.44.4.441; Wang QH, 1999, MOL CELL BIOL, V19, P4008; Tirosh A, 1999, J BIOL CHEM, V274, P10595, DOI 10.1074/jbc.274.15.10595; PAGANO G, 1983, J CLIN INVEST, V72, P1814, DOI 10.1172/JCI111141; Hajduch E, 1998, DIABETES, V47, P1006, DOI 10.2337/diabetes.47.7.1006; Sakoda H, 1999, DIABETES, V48, P1365, DOI 10.2337/diabetes.48.7.1365; SAAD MJA, 1993, J CLIN INVEST, V92, P2065, DOI 10.1172/JCI116803; Kotani K, 1998, MOL CELL BIOL, V18, P6971; Kohn AD, 1996, J BIOL CHEM, V271, P31372; WHITE MF, 1994, J BIOL CHEM, V269, P1; Calera MR, 1998, J BIOL CHEM, V273, P7201, DOI 10.1074/jbc.273.13.7201; CARO JF, 1982, J CLIN INVEST, V69, P866, DOI 10.1172/JCI110526; Chen D, 1997, J BIOL CHEM, V272, P27401, DOI 10.1074/jbc.272.43.27401; CHU DT, 1990, BIOCHEM SOC T, V18, P1247; Coderre L, 1996, AM J PHYSIOL-ENDOC M, V271, pE643; CZECH MP, 1995, ANNU REV NUTR, V15, P441; DEPIRRO R, 1981, DIABETOLOGIA, V21, P149; Downward J, 1998, SCIENCE, V279, P673, DOI 10.1126/science.279.5351.673; Ewart H. Stephen, 1998, FEBS Letters, V425, P179; FOLLI F, 1993, J CLIN INVEST, V92, P1787, DOI 10.1172/JCI116768; Guilherme A, 1998, J BIOL CHEM, V273, P33119, DOI 10.1074/jbc.273.50.33119; HABER RS, 1992, DIABETES, V41, P728, DOI 10.2337/diabetes.41.6.728; HAJDUCH E, 1995, ENDOCRINOLOGY, V136, P4782, DOI 10.1210/en.136.11.4782; Imanaka T, 1998, J BIOL CHEM, V273, P25347, DOI 10.1074/jbc.273.39.25347; KAHN CR, 1980, METABOLISM, V29, P455, DOI 10.1016/0026-0495(80)90171-7; KAHN CR, 1978, ENDOCRINOLOGY, V103, P1054; KAHN CR, 1993, HORM RES, V39, P93, DOI 10.1159/000182793; Katagiri H, 1996, J BIOL CHEM, V271, P16987; Kim YB, 1999, J CLIN INVEST, V104, P733, DOI 10.1172/JCI6928; Meier R, 1998, EMBO J, V17, P7294, DOI 10.1093/emboj/17.24.7294; Ogihara T, 1997, J BIOL CHEM, V272, P12868, DOI 10.1074/jbc.272.19.12868; OLEFSKY JM, 1975, J CLIN INVEST, V56, P1499, DOI 10.1172/JCI108231; OLEFSKY JM, 1975, METABOLISM, V24, P517, DOI 10.1016/0026-0495(75)90076-1; OWEN OE, 1973, J CLIN INVEST, V52, P2596, DOI 10.1172/JCI107452; Rudich A, 1997, AM J PHYSIOL-ENDOC M, V272, pE935; SAAD MJA, 1994, MOL ENDOCRINOL, V8, P545, DOI 10.1210/me.8.5.545; SIVITZ WI, 1995, BIOCHEM BIOPH RES CO, V206, P51, DOI 10.1006/bbrc.1995.1008; TURNBOW MA, 1995, ENDOCRINOLOGY, V136, P1450, DOI 10.1210/en.136.4.1450; WEINSTEIN SP, 1993, METABOLISM, V42, P1365, DOI 10.1016/0026-0495(93)90139-F	54	110	125	AMER DIABETES ASSOC	ALEXANDRIA	1660 DUKE ST, ALEXANDRIA, VA 22314 USA	0012-1797			DIABETES	Diabetes	OCT	2000	49	10					1700	1708		10.2337/diabetes.49.10.1700		9	Endocrinology & Metabolism	Endocrinology & Metabolism	357QZ	WOS:000089513500011		
J	Umetani, N; Watanabe, T; Sasaki, S; Nagawa, H				Umetani, N; Watanabe, T; Sasaki, S; Nagawa, H			Rectosigmoidal adenomatous polyposis: A novel entity of polyposis? Report of a case	DISEASES OF THE COLON & RECTUM			English	Article						polyposis; carcinoma; adenoma; gene, APC; germline mutation; protein truncation test; single stranded conformation polymorphism	GERM-LINE MUTATIONS; APC GENE; FAMILIAL POLYPOSIS; SOMATIC MUTATIONS; COLORECTAL-CANCER; TUMORS; COLI; FAP; CHROMOSOME-5Q21; FORM	PURPOSE: We report a patient with rectosigmoidal adenomatous polyposis. METHODS: A 57-year-old male presented with a submucosally invasive well-differentiated adenocarcinoma in the rectum and approximately 100 adenomatous polyps with an extremely unusual distribution limited exclusively to the rectum and sigmoid colon. RESULTS: There was no family history of colorectal disease or any belated disorders. No extracolonic manifestations were found. Because this case was considered to be a discriminative phenotype of familial adenomatous polyposis, DNA from a peripheral sample of whole blood was screened for APC germline mutation by a combination of protein truncation test and single stranded conformation polymorphism, but no mutation was found. CONCLUSION: This patient may have a novel entity of adenomatous polyposis with a peculiar distribution. It may be caused by some genetic alteration other than APC mutation.	Univ Tokyo, Sch Med, Dept Surg Oncol, Bunkyo Ku, Tokyo 1138655, Japan	Umetani, N (reprint author), Univ Tokyo, Sch Med, Dept Surg Oncol, Bunkyo Ku, 7-3-1 Hongo, Tokyo 1138655, Japan.						SPIRIO L, 1993, CELL, V75, P951, DOI 10.1016/0092-8674(93)90538-2; Miyoshi Yasuo, 1992, Human Molecular Genetics, V1, P229; MIYAKI M, 1994, CANCER RES, V54, P3011; KINZLER KW, 1991, SCIENCE, V253, P661, DOI 10.1126/science.1651562; NISHISHO I, 1991, SCIENCE, V253, P665, DOI 10.1126/science.1651563; POWELL SM, 1993, NEW ENGL J MED, V329, P1982, DOI 10.1056/NEJM199312303292702; NAGASE H, 1992, CANCER RES, V52, P4055; MUTO T, 1975, CANCER, V36, P2251, DOI 10.1002/cncr.2820360944; O'Sullivan MJ, 1998, AM J CLIN PATHOL, V109, P521; Beroud C, 1996, NUCLEIC ACIDS RES, V24, P121, DOI 10.1093/nar/24.1.121; BURT RW, 1985, NEW ENGL J MED, V312, P1540, DOI 10.1056/NEJM198506133122403; BUSSEY HJR, 1987, SEMIN SURG ONCOL, V3, P67, DOI 10.1002/ssu.2980030204; DOBBIE Z, 1994, EUR J CANCER, V30A, P1709, DOI 10.1016/0959-8049(94)00294-F; Jagelman D G, 1989, Minerva Chir, V44, P1869; MIYOSHI Y, 1992, P NATL ACAD SCI USA, V89, P4452, DOI 10.1073/pnas.89.10.4452; MORSON BC, 1968, BRIT J SURG, V55, P725, DOI 10.1002/bjs.1800551003; NUGENT KP, 1994, GUT, V35, P1622, DOI 10.1136/gut.35.11.1622; OLSCHWANG S, 1993, CELL, V75, P959, DOI 10.1016/0092-8674(93)90539-3; STELLA A, 1993, AM J HUM GENET, V53, P1031; TOPS CMJ, 1993, AM J MED GENET, V47, P563, DOI 10.1002/ajmg.1320470425	20	0	0	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	530 WALNUT ST, PHILADELPHIA, PA 19106-3621 USA	0012-3706			DIS COLON RECTUM	Dis. Colon Rectum	OCT	2000	43	10					1439	1443		10.1007/BF02236642		5	Gastroenterology & Hepatology; Surgery	Gastroenterology & Hepatology; Surgery	363QK	WOS:000089845900017		
J	Shinozaki, M; Watanabe, T; Kubota, Y; Sawada, T; Nagawa, H; Muto, T				Shinozaki, M; Watanabe, T; Kubota, Y; Sawada, T; Nagawa, H; Muto, T			High proliferative activity is associated with dysplasia in ulcerative colitis	DISEASES OF THE COLON & RECTUM			English	Article						ulcerative colitis; dysplasia; Ki-67; proliferation; cancer	INFLAMMATORY BOWEL-DISEASE; MONOCLONAL-ANTIBODY KI-67; CELL-PROLIFERATION; NUCLEAR ANTIGEN; EXPRESSION; DIAGNOSIS; MUCOSA; PCNA	PURPOSE: Ulcerative colitis is associated with an increased risk of colorectal neoplasia. Markers of proliferation are reported to be valuable in the diagnosis of dysplasia in ulcerative colitis. However, it is not known whether dysplastic change or proliferative change occurs first. Whether abnormal proliferation is present in normal-seeming mucosa in ulcerative colitis was investigated. METHODS: Eighteen cancer or high-grade dysplasia specimens and 9 low-grade dysplasia specimens from 5 patients and 51 specimens from 31 patients without neoplasia were studied. Immunostaining with anti-gi 67 antibody was used to evaluate proliferative activity. Labeling index (in the superficial one-half of crypt) was calculated. Crypts with labeling index more than 0.3 were determined to have abnormal proliferation RESULTS: The mean +/- standard error of the mean labeling index in specimens negative for dysplasia (0.056 +/- 0.004) was significantly lower than that in low-grade dysplasia specimens (0.418 +/- 0.024) and that in high-grade dysplasia specimens (0.503 +/- 0.027; P < 0.0001). In specimens negative for dysplasia, only 4 (4 cases) of 339 (1.2 percent) crypts had abnormal proliferation, whereas the ratio of crypts with abnormal proliferation was 76 percent (54/71) in low-grade dysplasia and 92.1 percent (35/38) in high grade dysplasia. The labeling index in background mucosa was 0.139 +/- 0.009, which was significantly higher than that in specimens negative for dysplasia (P < 0.001). In background mucosa 15.7 percent of crypts showed abnormal proliferation. A follow-up study revealed that two of four cases developed cancer or high-grade dysplasia one and seven years after proliferative abnormality was detected in nondysplastic specimens. CONCLUSION: Ki-67 immunostaining can be an aid in the diagnosis of dysplasia. High proliferating activity in background mucose suggests that proliferating activity change precedes dysplasia detected with hematoxylin-and-eosin staining.	Univ Tokyo, Grad Sch Med, Dept Surg Oncol, Tokyo, Japan; Kikkoman Gen Hosp, Dept Surg, Chiba, Japan; Canc Inst Hosp, Dept Surg, Tokyo, Japan	Shinozaki, M (reprint author), 7-3-1 Hongo,Bunkyo Ku, Tokyo 1138655, Japan.						AGAWA S, 1988, DIS COLON RECTUM, V31, P387, DOI 10.1007/BF02564892; AJIOKA Y, 1995, J GASTROENTEROL, V30, P33; ANDREWS CW, 1992, HUM PATHOL, V23, P774, DOI 10.1016/0046-8177(92)90347-6; RIDDELL RH, 1983, HUM PATHOL, V14, P931, DOI 10.1016/S0046-8177(83)80175-0; GERDES J, 1984, J IMMUNOL, V133, P1710; GERDES J, 1991, AM J PATHOL, V138, P867; BIASCO G, 1984, CANCER RES, V44, P5450; BLEIBERG H, 1973, GASTROENTEROLOGY, V64, P383; EASTWOOD GL, 1973, GASTROENTEROLOGY, V64, P383; GERDES J, 1992, J PATHOL, V168, P85, DOI 10.1002/path.1711680114; ITZKOWITZ SH, 1995, GASTROENTEROLOGY, V109, P490, DOI 10.1016/0016-5085(95)90337-2; JOHNSTON PG, 1989, HUM PATHOL, V20, P696, DOI 10.1016/0046-8177(89)90158-5; Kullmann F, 1996, EUR J GASTROEN HEPAT, V8, P371, DOI 10.1097/00042737-199604000-00016; MASKENS AP, 1977, J NATL CANCER I, V58, P1221; Noffsinger AE, 1996, CANCER, V78, P2307, DOI 10.1002/(SICI)1097-0142(19961201)78:11<2307::AID-CNCR6>3.0.CO;2-J; POTTEN CS, 1992, GUT, V33, P525; SHETYE J, 1988, IN VIVO, V2, P403; SHINOZAKI M, 1994, GASTROENTEROLOGY, V106, pA440; SUZUKI K, 1990, GUT, V31, P1266, DOI 10.1136/gut.31.11.1266; Suzuki K, 1998, DIS COLON RECTUM, V41, P322, DOI 10.1007/BF02237486; THOR A, 1989, INT J CANCER, V43, P810, DOI 10.1002/ijc.2910430512	21	15	16	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	530 WALNUT ST, PHILADELPHIA, PA 19106-3621 USA	0012-3706			DIS COLON RECTUM	Dis. Colon Rectum	OCT	2000	43	10		S			S34	S39		10.1007/BF02237224		6	Gastroenterology & Hepatology; Surgery	Gastroenterology & Hepatology; Surgery	364CP	WOS:000089874700009		
J	Kato, Y; Igarashi, T; Sugiyama, Y				Kato, Y; Igarashi, T; Sugiyama, Y			Both cMOAT/MRP2 and another unknown transporter(s) are responsible for the biliary excretion of glucuronide conjugate of the nonpeptide angiotensin II antagonist, telmisaltan	DRUG METABOLISM AND DISPOSITION			English	Article							ATP-DEPENDENT TRANSPORT; MECHANISM; RATS	Canalicular multispecific organic anion transporter (cMOAT/MRP2) is known to play a major role in the transport of anionic xenobiotics including many types of glucuronide and glutathione conjugates across the bile canalicular membrane. In the present study, the biliary excretion of telmisartan (BIBR 277) and its glucuronide was examined in Sprague-Dawley rats (SDRs) and also in mutant strain Eisai-hyperbilirubinemic rats (EHBR), which have a hereditary defect in cMOAT/MRP2. Only a minimal difference was observed in the time profile of the plasma concentration of total radioactivity after administration of an i.v. bolus of BIBR 277. About 45% of the administered dose was excreted into bile up to 240 min in both strains, most of the radioactivity in the bile being BIBR 277 glucuronide. No significant difference was observed in the biliary excretion of BIBR 277 and its glucuronide between SDRs and EHBR although the plasma disappearance of BIBR 277 glucuronide was delayed in EHBR. To explain these data, the extent of glucuronidation of BIBR 277 by liver microsomes was examined in both strains. The V-max value for the formation of BIBR 277 glucuronide was 2 to 3 times higher in EHBR than in SDRs, whereas both strains had similar K-m values. After an i.v. bolus administration of BIBR 277 glucuronide, its plasma disappearance was delayed in EHBR, the biliary clearance in EHBR being about half that in SDRs. These results suggest that BIBR 277 glucuronide is transported by both cMOAT/MRP2 and another transporter that is also expressed in EHBR, and that the BIBR 277 glucuronidation is enhanced in EHBR, resulting in comparable excretion of glucuronide in both strains.	Univ Tokyo, Grad Sch Pharmaceut Sci, Bunkyo Ku, Tokyo 1130033, Japan	Sugiyama, Y (reprint author), Univ Tokyo, Grad Sch Pharmaceut Sci, Bunkyo Ku, Hongo 7-3-1, Tokyo 1130033, Japan.		KATO, Yukio/D-8396-2015				WIENEN W, 1993, BRIT J PHARMACOL, V110, P245; Huwyler J, 1996, BRIT J PHARMACOL, V118, P1879; Jedlitschky G, 1997, BIOCHEM J, V327, P305; Chu XY, 1997, J PHARMACOL EXP THER, V281, P304; ISHIKAWA T, 1990, J BIOL CHEM, V265, P19279; KOBAYASHI K, 1990, J BIOL CHEM, V265, P7737; Loe DW, 1996, J BIOL CHEM, V271, P9683; Sasabe H, 1998, J PHARMACOL EXP THER, V284, P1033; Vore M, 1996, AM J PHYSIOL-GASTR L, V271, pG791	9	6	6	AMER SOC PHARMACOLOGY EXPERIMENTAL THERAPEUTICS	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0090-9556			DRUG METAB DISPOS	Drug Metab. Dispos.	OCT	2000	28	10					1146	1148				3	Pharmacology & Pharmacy	Pharmacology & Pharmacy	357EX	WOS:000089486500002		
J	Kawahara, I; Kato, Y; Suzuki, H; Achira, M; Ito, K; Crespi, CL; Sugiyama, Y				Kawahara, I; Kato, Y; Suzuki, H; Achira, M; Ito, K; Crespi, CL; Sugiyama, Y			Selective inhibition of human cytochrome P450 3A4 by N-[2(R)-hydroxy-1(S)-indanyl]-5-[2(S)-(1,1-dimethylethylaminocarbonyl)-4-[(furo[2,3-B]pyridin-5-yl) methyl]piperazin-1-yl]-4(S)-hydroxy-2(R)-phenylmethylpentanamide and P-glycoprotein by valspodar in gene transfectant systems	DRUG METABOLISM AND DISPOSITION			English	Article							ORAL BIOAVAILABILITY; INTESTINAL METABOLISM; MULTIDRUG-RESISTANCE; TISSUE DISTRIBUTION; PROTEASE INHIBITOR; DRUG ABSORPTION; CYCLOSPORINE-A; SDZ PSC-833; IN-VITRO; KETOCONAZOLE	Our previous report showed that L754.394 and valspodar (PSC833) are potent inhibitors of midazolam hydroxylation in human jejunum microsomes and vectorial transport of vinblastine in Caco-2 cells, respectively. In the present study, to directly examine the interactions of these compounds as well as other substrates with CYP3A4 and P-glycoprotein (P-gp), we performed in vitro inhibition studies using recombinant CYP3A4-expressed microsomes and an MDR1-transfected cell line, LLC-MDR1, respectively. In CYP3A4-expressed microsomes, both L754.394 and ketoconazole, at a concentration less than 0.5 mu M, are the most potent inhibitors of the formation of 1'-hydroxymidazolam, a major metabolite of midazolam formed by CYP3A4. The greatest inhibitory effect on the transcellular transport of digoxin in LLC-MDR1 cells was observed in the presence of valspodar (< 0.1 mu M), followed by verapamil. From a comparison of the IC50 values, it was shown that L754.394 and valspodar exhibited the highest selectivity for CYP3A4 and P-gp, respectively. To demonstrate such specificity, both midazolam hydroxylation and digoxin transport were observed in CYP3A4 transfected Caco-2 cells, which coexpress both P-gp and CYP3A4, in the presence or absence of L754.394 (0.5 mu M) and valspodar (1.0 mu M). L754.394 almost completely inhibited midazolam hydroxylation, but not digoxin transport, whereas almost complete inhibition of digoxin transport was observed in the presence of valspodar, but inhibition of the hydroxylation was minimal. Thus, the present study has demonstrated that L754.394 has a specific inhibitory effect on CYP3A4, whereas valspodar is specific for P-gp.	Univ Tokyo, Grad Sch Pharmaceut Sci, Bunkyo Ku, Tokyo 1130033, Japan; Gentest Corp, Woburn, MA USA	Sugiyama, Y (reprint author), Univ Tokyo, Grad Sch Pharmaceut Sci, Bunkyo Ku, 7-3-1 Hongo, Tokyo 1130033, Japan.						ACHIRA M, 1999, PHARM SCI, V1; KOLARS JC, 1991, LANCET, V338, P1488, DOI 10.1016/0140-6736(91)92302-I; Floren LC, 1997, CLIN PHARMACOL THER, V62, P41, DOI 10.1016/S0009-9236(97)90150-8; WATANABE T, 1995, ACTA ONCOL, V34, P235; WU CY, 1995, CLIN PHARMACOL THER, V58, P492, DOI 10.1016/0009-9236(95)90168-X; Thummel KE, 1996, CLIN PHARMACOL THER, V59, P491, DOI 10.1016/S0009-9236(96)90177-0; Lown KS, 1997, J CLIN INVEST, V99, P2545, DOI 10.1172/JCI119439; Li AP, 1995, TOXICOLOGY, V104, P1, DOI 10.1016/0300-483X(95)03155-9; Chiba M, 1995, J PHARMACOL EXP THER, V275, P1527; Paine MF, 1997, J PHARMACOL EXP THER, V283, P1552; Lown KS, 1997, CLIN PHARMACOL THER, V62, P248, DOI 10.1016/S0009-9236(97)90027-8; DEWAZIERS I, 1990, J PHARMACOL EXP THER, V253, P387; Smith AJ, 1998, J NATL CANCER I, V90, P1161, DOI 10.1093/jnci/90.15.1161; BOHME M, 1993, FEBS LETT, V333, P193, DOI 10.1016/0014-5793(93)80403-H; Crespi CL, 1996, PHARMACEUT RES, V13, P1635, DOI 10.1023/A:1016428304366; GOMEZ DY, 1995, CLIN PHARMACOL THER, V58, P15, DOI 10.1016/0009-9236(95)90067-5; Gorski JC, 1998, CLIN PHARMACOL THER, V64, P133, DOI 10.1016/S0009-9236(98)90146-1; HUNTER J, 1993, PHARMACEUT RES, V10, P743, DOI 10.1023/A:1018972102702; Ito K, 1999, PHARMACEUT RES, V16, P225, DOI 10.1023/A:1018872207437; KELLER RP, 1992, INT J CANCER, V50, P593, DOI 10.1002/ijc.2910500418; LOWRY OH, 1951, J BIOL CHEM, V193, P265; SAITOH H, 1995, PHARMACEUT RES, V12, P1304, DOI 10.1023/A:1016217505990; SCHINKEL AH, 1995, J CLIN INVEST, V96, P1698, DOI 10.1172/JCI118214; Sparreboom A, 1997, P NATL ACAD SCI USA, V94, P2031, DOI 10.1073/pnas.94.5.2031; Terao T, 1996, J PHARM PHARMACOL, V48, P1083; vonMoltke LL, 1996, J CLIN PHARMACOL, V36, P783; WACHER VJ, 1995, MOL CARCINOGEN, V13, P129, DOI 10.1002/mc.2940130302; WATKINS PB, 1987, J CLIN INVEST, V80, P1029, DOI 10.1172/JCI113156; Zhang YC, 1998, J PHARMACOL EXP THER, V287, P246	29	16	16	AMER SOC PHARMACOLOGY EXPERIMENTAL THERAPEUTICS	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0090-9556			DRUG METAB DISPOS	Drug Metab. Dispos.	OCT	2000	28	10					1238	1243				6	Pharmacology & Pharmacy	Pharmacology & Pharmacy	357EX	WOS:000089486500017		
J	Tatsuma, T; Ikezawa, A; Ohko, Y; Miwa, T; Fujishima, A				Tatsuma, T; Ikezawa, A; Ohko, Y; Miwa, T; Fujishima, A			Photoelectrochemical microcell arrays	ELECTROCHEMICAL AND SOLID STATE LETTERS			English	Article								Photoelectrochemical microcell arrays are prepared on the basis of a two-dimensional array of polystyrene microparticles as a template. The microcell array consists of a TiO2 film with bowl-shaped hemispheric voids and gold microcathodes deposited on the brims of the voids. Some microcells are covered with gold domes. Ultraviolet irradiation in an AgNO3 aqueous solution resulted in deposition of silver on the gold brims and domes. (C) 2000 the Electrochemical Society. S1099-0062(00)06-029-6. All rights reserved.	Univ Tokyo, Sch Engn, Dept Appl Chem, Bunkyo Ku, Tokyo 1138656, Japan	Tatsuma, T (reprint author), Univ Tokyo, Sch Engn, Dept Appl Chem, Bunkyo Ku, Tokyo 1138656, Japan.		Fujishima, Akira/G-7701-2012; Tatsuma, Tetsu/B-8610-2015	Tatsuma, Tetsu/0000-0001-8738-9837			FUJISHIMA A, 1972, NATURE, V238, P37, DOI 10.1038/238037a0; Matsushita SI, 1998, LANGMUIR, V14, P6441, DOI 10.1021/la981106z; LINSEBIGLER AL, 1995, CHEM REV, V95, P735, DOI 10.1021/cr00035a013; Holland BT, 1998, SCIENCE, V281, P538, DOI 10.1126/science.281.5376.538; Wijnhoven JEGJ, 1998, SCIENCE, V281, P802, DOI 10.1126/science.281.5378.802; DENKOV ND, 1993, NATURE, V361, P26, DOI 10.1038/361026a0; Imhof A, 1997, NATURE, V389, P948; BRUAN PV, 1999, NATURE, V409, P603; MATUSHITA S, 1997, CHEM LETT, P925; Tatsuma T, 2000, ADV MATER, V12, P643, DOI 10.1002/(SICI)1521-4095(200005)12:9<643::AID-ADMA643>3.0.CO;2-7	10	5	5	ELECTROCHEMICAL SOC INC	PENNINGTON	65 SOUTH MAIN STREET, PENNINGTON, NJ 08534 USA	1099-0062			ELECTROCHEM SOLID ST	Electrochem. Solid State Lett.	OCT	2000	3	10					467	469				3	Electrochemistry; Materials Science, Multidisciplinary	Electrochemistry; Materials Science	344BJ	WOS:000088737500005		
J	Minabe, T; Fujishima, A; Nakajima, A; Watanabe, T; Hashimoto, K				Minabe, T; Fujishima, A; Nakajima, A; Watanabe, T; Hashimoto, K			Effects of thermal and evacuating treatments on photo-induced hydrophilic conversion at TiO2 surfaces	ELECTROCHEMISTRY			English	Article						hydrophilicity; contact angle; titanium dioxide	THIN-FILM PHOTOCATALYST; ACETALDEHYDE; DEGRADATION; OXIDATION; GLASS	It is well known that the amount of physisorbed water molecules decreases by thermal and evacuating treatments at anatase TiO2 surfaces. (1- 3)) However, the initial water contact angle of the anatase TiO2 surface coated on the glass was little changed (from 24 degrees +-/ 1 degrees to 23 degrees +/- 1 degrees) and the hydrophilicity did not change by the heating treatment at 150 degreesC for 1 hour. On the other hand, the value of its initial contact angle increased remarkably (from 24 degrees +/- 1 degrees to 67 degrees +/- 1 degrees), and the TiO2 surface was hydrophobicized by the evacuation at similar to 5x10(-6) Pa. These observations may show that not only the amount of physisorbed water molecules but also the structure, i.e., OH groups of TiO2 surfaces are related to the hydrophilicity. The photo-decreasing rate of the water contact angle under the ultra violet (UV) illumination at the anatase TiO2 surface (the photo-induced hydrophilic conversion rate) increased by the heating treatment at 150 degreesC for 1 hour. However, photo-induced hydrophilic conversion rates were little changed by the evacuating treatment at similar to 5x10(-6) Pa. These results suggest that the photo-induced hydrophilic conversion phenomena are not necessarily affected by the initial amount of physisorbed water molecules.	Univ Tokyo, Adv Sci & Technol Res Ctr, Meguro Ku, Tokyo 1538904, Japan; Univ Tokyo, Sch Engn, Dept Appl Chem, Bunkyo Ku, Tokyo 1138656, Japan	Hashimoto, K (reprint author), Univ Tokyo, Adv Sci & Technol Res Ctr, Meguro Ku, 4-6-1 Komaba, Tokyo 1538904, Japan.		Fujishima, Akira/G-7701-2012; Hashimoto, Kazuhito/C-5011-2012; Nakajima, Akira/B-9310-2015	Hashimoto, Kazuhito/0000-0002-8384-8749; Nakajima, Akira/0000-0003-0056-9283			Sopyan I, 1996, J PHOTOCH PHOTOBIO A, V98, P79, DOI 10.1016/1010-6030(96)04328-6; Wang R, 1997, NATURE, V388, P431, DOI 10.1038/41233; FUJISHIMA A, 1972, NATURE, V238, P37, DOI 10.1038/238037a0; Kikuchi Y, 1997, J PHOTOCH PHOTOBIO A, V106, P51, DOI 10.1016/S1010-6030(97)00038-5; Sunada K, 1998, ENVIRON SCI TECHNOL, V32, P726, DOI 10.1021/es970860o; Sitkiewitz S, 1996, NEW J CHEM, V20, P233; Wang R, 1998, ADV MATER, V10, P135, DOI 10.1002/(SICI)1521-4095(199801)10:2<135::AID-ADMA135>3.0.CO;2-M; Sakai N, 1998, LANGMUIR, V14, P5918, DOI 10.1021/la980623e; Sopyan I, 1996, J ELECTROANAL CHEM, V415, P183, DOI 10.1016/S0022-0728(96)01007-8; Watanabe T, 1999, THIN SOLID FILMS, V351, P260, DOI 10.1016/S0040-6090(99)00205-9; FUKUYAMA S, 1995, 187 M EL SOC REN NEV; Heller A, 1995, ACCOUNTS CHEM RES, V28, P503, DOI 10.1021/ar00060a006; Ishibashi K, 1998, J PHYS CHEM B, V102, P2117, DOI 10.1021/jp973401i; JONES P, 1972, J CHEM SOC FARAD T 1, V68, P907, DOI 10.1039/f19726800907; Minabe T, 1999, ELECTROCHEMISTRY, V67, P1132; MORIMOTO T, 1968, B CHEM SOC JPN, V41, P1533, DOI 10.1246/bcsj.41.1533; NEGISHI N, 1995, CHEM LETT, P841, DOI 10.1246/cl.1995.841; OKAZAKI S, 1971, J CHEM SOC JPN, V74, P1085; PARKIN ND, CHEMISORPTION CATALY; PRANK SN, 1977, J AM CHEM SOC, V99, P303; SOPYAN I, 1994, CHEM LETT, P723, DOI 10.1246/cl.1994.723; YONEYAMA H, 1981, B CHEM SOC JPN, V54, P1308, DOI 10.1246/bcsj.54.1308	22	7	7	ELECTROCHEMICAL SOC JAPAN	TOKYO	ARUSUICHIGAYA202, 4-8-30, KUDANMINAMI, CHIYODA-KU, TOKYO, 102-0074, JAPAN	1344-3542			ELECTROCHEMISTRY	Electrochemistry	OCT	2000	68	10					779	782				4	Electrochemistry	Electrochemistry	366PC	WOS:000090012900004		
J	Igarashi, T; Ogata, E; Maruyama, K; Fukuda, T; Azuma, J				Igarashi, T; Ogata, E; Maruyama, K; Fukuda, T; Azuma, J			Effect of calcimimetic agent, KRN568, on gastrin secretion in healthy subjects	ENDOCRINE JOURNAL			English	Article						calcimimetics; calcium-sensing receptor; gastrin	CALCIUM-SENSING RECEPTOR; PARATHYROID-HORMONE; HYPERPARATHYROIDISM; EXPRESSION; METABOLISM; INHIBITION; ALLELE	KRN568 is a calcimimetic compound which acts on the calcium sensing receptors (CaR) on the parathyroid gland to suppress secretion of PTH. A recent report has demonstrated that CaRs are expressed on cultured human antral gastrin cells and that gastrin secretion is stimulated by an increase in extracellular calcium level. However, the effect of KRN568 on serum gastrin levels has yet to be clinically assessed. We therefore studied the effect of this calcimimetic on gastrin secretion in healthy subjects enrolled in the phase 1 study for KRN568 currently carried out in Japan. Single doses of KRN568, ranging from 25 mg to 400 mg, were orally administered to 6 healthy male volunteers at fasting and after meal. One subject proved to be a poor metabolizer (PM) for this compound and showed more than 10-fold high concentrations of plasma KRN568 (fasting Cmax 90.8 and non-fasting 83.8 ng/ml) compared to the other 5 individuals (Cmax 6.5 +/- 2.2 and 7.4 +/- 1.6 ng/ml, respectively). Plasma gastrin levels showed mild but apparent increase (from 30 to 125 pg/ml) in this particular subject, while there were no significant increases in the other five people (from 34+/-6 to 63+/-3 pg/ml) after oral administration of 400 mg KRN568 at fasting. In the PM, administration of KRN568 resulted in extraordinarily high serum drug levels associated with transient increase of gastrin levels. This observation suggested that calcium-induced stimulation of gastrin secretion in human was mediated by a mechanism involving CaR. Potential side effects related to the increased gastrin secretion may be warranted in the practical use of this compound.	Univ Tokyo, Branch Hosp, Dept Internal Med, Bunkyo Ku, Tokyo 1128688, Japan; Canc Inst Hosp, Tokyo 1708455, Japan; Osaka Pharmacol Res Clin, Osaka 5650853, Japan; Osaka Univ, Grad Sch Pharmaceut Sci, Osaka 5650871, Japan	Igarashi, T (reprint author), Univ Tokyo, Branch Hosp, Dept Internal Med, Bunkyo Ku, 3-28-6 Mejirodai, Tokyo 1128688, Japan.						Nemeth EF, 1999, TRENDS ENDOCRIN MET, V10, P66, DOI 10.1016/S1043-2760(98)00119-2; LAMERS CBH, 1977, GUT, V18, P128, DOI 10.1136/gut.18.2.128; Sachse C, 1997, AM J HUM GENET, V60, P284; Nemeth EF, 1998, P NATL ACAD SCI USA, V95, P4040, DOI 10.1073/pnas.95.7.4040; STEEN VM, 1995, PHARMACOGENETICS, V5, P215, DOI 10.1097/00008571-199508000-00005; JOHANSSON I, 1994, MOL PHARMACOL, V46, P452; Antonsen JE, 1998, KIDNEY INT, V53, P223, DOI 10.1046/j.1523-1755.1998.00735.x; BLOOM SR, 1995, PRINCIPLES PRACTICE, P1499; Brown EM, 1998, ANNU REV MED, V49, P15; Cheng I, 1999, GASTROENTEROLOGY, V116, P118, DOI 10.1016/S0016-5085(99)70235-0; Coburn JW, 2000, CURR OPIN NEPHROL HY, V9, P123, DOI 10.1097/00041552-200003000-00005; Collins MT, 1998, J CLIN ENDOCR METAB, V83, P1083, DOI 10.1210/jc.83.4.1083; DEMORAIS SMF, 1994, MOL PHARMACOL, V46, P594; Fukuda T, 1999, BRIT J CLIN PHARMACO, V47, P450, DOI 10.1046/j.1365-2125.1999.00913.x; HOENSCH HP, 1985, EUR J CLIN PHARMACOL, V29, P199, DOI 10.1007/BF00547422; NISHIDA Y, 2000, IN PRESS PHARMACOGEN; Ray JM, 1997, J CLIN INVEST, V99, P2328, DOI 10.1172/JCI119413; Silverberg SJ, 1997, NEW ENGL J MED, V337, P1506, DOI 10.1056/NEJM199711203372104; Zhou Q, 1999, EUR J CLIN PHARMACOL, V55, P43, DOI 10.1007/s002280050590	19	16	16	JAPAN ENDOCRINE SOCIETY	TOKYO	C/O DEPT VETERINARY PHYSIOL, VET MED SCI, UNIV TOKYO, 1-1-1 YAYOI, BUNKYO-KU, TOKYO, 113, JAPAN	0918-8959			ENDOCR J	Endocr. J.	OCT	2000	47	5					517	523		10.1507/endocrj.47.517		7	Endocrinology & Metabolism	Endocrinology & Metabolism	369JP	WOS:000165062400002		
J	Villars, P; Brandenburg, K; Berndt, M; LeClair, S; Jackson, A; Pao, YH; Igelnik, B; Oxley, M; Bakshi, B; Chen, P; Iwata, S				Villars, P; Brandenburg, K; Berndt, M; LeClair, S; Jackson, A; Pao, YH; Igelnik, B; Oxley, M; Bakshi, B; Chen, P; Iwata, S			Interplay of large materials databases, semi-empirical methods, neuro-computing and first principle calculations for ternary compound former/nonformer prediction	ENGINEERING APPLICATIONS OF ARTIFICIAL INTELLIGENCE			English	Article						materials design; neural networks; compound prediction		A significant breakthrough has been achieved using materials databases, semi-empirical methods and neural networks to aid in the design of new materials, A collaborative, international, team discovered that a non-linear expression involving one elemental property parameter could be used to predict, with 99+% accuracy, the occurrence of a compound for any ternary materials system. This elemental property parameter, referred to as the Mendeleev Number, was conceived by D.G. Pettifor in 1984 to group binary compounds by structure type. The near term significance of this discovery is the obvious savings, in time and resources, relative to assessing the merits of future, yet-to-be-realized, materials systems. In longer term this breakthrough is the basis for both narrowing the search space for potentially beneficial new materials and enabeling the prediction of even more specific materials information such as stoichiometries, crystal structures and intrinsic properties. (C) 2000 Elsevier Science Ltd. All rights reserved.	Mat Phases Data Syst, CH-6354 Vitznau, Switzerland; Crystal Impact, Bonn, Germany; USAF, Res Lab, Mat & Mfg Directorate, Wright Patterson AFB, OH 45433 USA; Case Western Reserve Univ, Cleveland, OH 44106 USA; USAF, Inst Technol, Wright Patterson AFB, OH 45433 USA; Ohio State Univ, Columbus, OH 43210 USA; Wright State Univ, Fairborn, OH USA; Univ Tokyo, RACE, Tokyo, Japan	Villars, P (reprint author), Mat Phases Data Syst, CH-6354 Vitznau, Switzerland.						PETTIFOR DG, 1984, SOLID STATE COMMUN, V51, P31, DOI 10.1016/0038-1098(84)90765-8; Ashby M.F., 1992, MAT SELECTION MECH D; CHELIKOWSKI JR, 1991, ENCY APPL PHYSICS, V3, P1; Chen NY, 1998, ENG APPL ARTIF INTEL, V11, P669, DOI 10.1016/S0952-1976(98)00032-3; KISELYOVA NN, 1993, MRS BULL, V18, P40; Pao YH, 1998, J ALLOY COMPD, V279, P22, DOI 10.1016/S0925-8388(98)00608-2; SLATER JC, 1956, THEROY ALLOY PHASES; VILLARS P, 1995, INTERMETALLIC COMPOU, V1, pCH11	8	9	9	PERGAMON-ELSEVIER SCIENCE LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND	0952-1976			ENG APPL ARTIF INTEL	Eng. Appl. Artif. Intell.	OCT	2000	13	5					497	505		10.1016/S0952-1976(00)00028-2		9	Automation & Control Systems; Computer Science, Artificial Intelligence; Engineering, Multidisciplinary; Engineering, Electrical & Electronic	Automation & Control Systems; Computer Science; Engineering	358RN	WOS:000089571100002		
J	Urakawa, H; Yoshida, T; Nishimura, M; Ohwada, K				Urakawa, H; Yoshida, T; Nishimura, M; Ohwada, K			Characterization of depth-related population variation in microbial communities of a coastal marine sediment using 16S rDNA-based approaches and quinone profiling	ENVIRONMENTAL MICROBIOLOGY			English	Article							GRADIENT GEL-ELECTROPHORESIS; RIBOSOMAL-RNA SEQUENCES; BACTERIAL COMMUNITIES; PHYLOGENETIC ANALYSIS; ACTIVATED-SLUDGE; DIVERSITY; BACTERIOPLANKTON; IDENTIFICATION; ALIGNMENT; SEAWATER	Depth-related changes in whole-community structure were evaluated in a coastal marine sediment using a molecular fingerprinting method, terminal restriction fragment length polymorphism (T-RFLP) analysis, and a chemotaxonomic technique (quinone profiling). Dendrograms derived from both T-RFLP analysis and quinone profiling indicated a significant variation in microbial community structure between the 0-2 cm layer and deeper layers. This corresponded to the dramatic change in the redox potential, acid-volatile sulphide-sulphur and bacterial numbers observed at 0-2 cm and 2-4 cm depths. A significant change in the number of terminal restriction fragments (T-RFs) was also detected at this transition depth. However, the change in major T-RFs with depth was not seen in electropherograms. The population changes were primarily variations in minor ribotypes. Most quinone homologues were detected at all depths, although the quinone composition changed with depth, Therefore, quinone profiling also suggested that the depth-related variation was primarily attributable to minor bacterial groups rather than change in the major population structure. 16S rDNA clone library analysis revealed that clones belonging to the genera Vibrio and Serratia predominated as major bacterial groups at all depths. Our data suggested that the sediment community might result from sedimentation effects of sinking particles, overall, our results demonstrated that the combined methods of T-RFLP analysis and quinone profiling were effective for assessing depth-related microbial populations.	Univ Tokyo, Ocean Res Inst, Nakano Ku, Tokyo 1648639, Japan	Ohwada, K (reprint author), Univ Tokyo, Ocean Res Inst, Nakano Ku, 1-15-1 Minamidai, Tokyo 1648639, Japan.						ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1006/jmbi.1990.9999; Maidak BL, 1997, NUCLEIC ACIDS RES, V25, P109, DOI 10.1093/nar/25.1.109; Fuhrman JA, 1998, NATURE, V393, P410, DOI 10.1038/30839; DELONG EF, 1992, P NATL ACAD SCI USA, V89, P5685, DOI 10.1073/pnas.89.12.5685; Hiraishi A, 1996, J GEN APPL MICROBIOL, V42, P457, DOI 10.2323/jgam.42.457; Acinas SG, 1999, APPL ENVIRON MICROB, V65, P514; Muyzer G, 1998, ANTON LEEUW INT J G, V73, P127, DOI 10.1023/A:1000669317571; TORSVIK V, 1990, APPL ENVIRON MICROB, V56, P782; Moeseneder MM, 1999, APPL ENVIRON MICROB, V65, P3518; Moore LR, 1998, NATURE, V393, P464; Crump BC, 1999, APPL ENVIRON MICROB, V65, P3192; GIOVANNONI SJ, 1990, NATURE, V345, P60, DOI 10.1038/345060a0; AMANN RI, 1995, MICROBIOL REV, V59, P143; PORTER KG, 1980, LIMNOL OCEANOGR, V25, P943; Urakawa H, 1999, MICROBIOL-UK, V145, P3305; Hugenholtz P, 1998, J BACTERIOL, V180, P366; PACE NR, 1986, ADV MICROB ECOL, V9, P1; Osborn AM, 2000, ENVIRON MICROBIOL, V2, P39, DOI 10.1046/j.1462-2920.2000.00081.x; JORGENSEN BB, 1982, NATURE, V296, P643, DOI 10.1038/296643a0; Gray JP, 1996, APPL ENVIRON MICROB, V62, P4049; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; Llobet-Brossa E, 1998, APPL ENVIRON MICROB, V64, P2691; Pukall R, 1999, FEMS MICROBIOL ECOL, V28, P335, DOI 10.1016/S0168-6496(98)00117-2; Macnaughton SJ, 1999, APPL ENVIRON MICROB, V65, P3566; Liu WT, 1997, APPL ENVIRON MICROB, V63, P4516; Soballe B, 1999, MICROBIOL-UK, V145, P1817; AVANISSAGHAJANI E, 1994, BIOTECHNIQUES, V17, P144; Brunk CF, 1998, APPL ENVIRON MICROB, V64, P5064; Coastal Oceanography Research Committee Oceanographical Society of Japan, 1985, COAST OC JAP ISL; COLLINS MD, 1981, MICROBIOL REV, V45, P316; FENCHEL T, 1995, ECOLOGY EVOLUTION AN; HEDRICK DB, 1986, J MICROBIOL METH, V5, P243, DOI 10.1016/0167-7012(86)90049-7; Hiraishi A, 1999, APPL ENVIRON MICROB, V65, P198; Hiraishi A, 1998, APPL ENVIRON MICROB, V64, P992; IWASAKI M, 1998, MICROBES ENVIRON, V13, P67; KIMURA M, 1980, J MOL EVOL, V16, P111, DOI 10.1007/BF01731581; Kröger A, 1978, Methods Enzymol, V53, P579; Lane D.J., 1991, NUCL ACID TECHNIQUES, P115; Marsh TL, 1998, WATER SCI TECHNOL, V37, P455, DOI 10.1016/S0273-1223(98)00145-0; MASUCHI Y, 1998, MICROBES ENV, V13, P203; Minz D, 1999, APPL ENVIRON MICROB, V65, P4659; NOVITSKY JA, 1990, MAR ECOL PROG SER, V60, P161, DOI 10.3354/meps060161; Sahm K, 1999, ENVIRON MICROBIOL, V1, P65, DOI 10.1046/j.1462-2920.1999.00007.x; SAITOU N, 1987, MOL BIOL EVOL, V4, P406; SATO Y, 1987, B TOKAI REG FISH RES, V123, P1; UEDA T, 1995, EUR J SOIL SCI, V46, P415, DOI 10.1111/j.1365-2389.1995.tb01337.x; VELJI MI, 1986, CAN J MICROBIOL, V32, P121; Yokota A., 1992, B JFCC, V8, P136	48	84	89	BLACKWELL SCIENCE LTD	OXFORD	P O BOX 88, OSNEY MEAD, OXFORD OX2 0NE, OXON, ENGLAND	1462-2912			ENVIRON MICROBIOL	Environ. Microbiol.	OCT	2000	2	5					542	554		10.1046/j.1462-2920.2000.00137.x		13	Microbiology	Microbiology	374AU	WOS:000165322900007		
J	Takano-Ohmuro, H; Mukaida, M; Kominami, E; Morioka, K				Takano-Ohmuro, H; Mukaida, M; Kominami, E; Morioka, K			Autophagy in embryonic erythroid cells: its role in maturation	EUROPEAN JOURNAL OF CELL BIOLOGY			English	Article						erythrocyte; autophagy; lysosome; mitochondria; embryo; programmed cell death	MITOCHONDRIAL ATP SYNTHASE; CYTOCHROME-C; TERMINAL DIFFERENTIATION; SYRIAN-HAMSTER; SUBUNIT-C; BCL-2; APOPTOSIS; PROTEIN; DEGRADATION; RELEASE	Yolk sac-derived embryonic erythroid cells differentiate synchronously in the peripheral blood of Syrian hamster. The stage of differentiation on day 10 of gestation is equivalent to polychromatophilic erythroblast stage and that on day 13 is equivalent to the reticulocyte stage in adult animals. The cytoplasm of embryonic erythroid cells became scant and devoid of most organelles on day 12 of gestation. In addition, there were very few non-erythroid cells in circulation before day 13. Thus the embryonic erythroid cells serve a pure and synchronous system to study the mechanisms of terminal differentiation. The number of mitochondria in the embryonic erythroid cells decreased to about 10% of the initial number during the period between day 10 and day 12 of gestation. In contrast, the frequency of autophagy of mitochondria increased 4.6-fold in the same period. The cytochrome c content of the cell decreased as the mitochondria became extinct. However, release of cytochrome c into the cytoplasm was not detectable through day 10 - 13 of gestation, suggesting that the mitochondria were digested within a closed compartment. Decomposed mitochondria and ferritin particles were detected in lysosomes by electron microscopy on and after day 12 of gestation, which also suggested digestion in a closed compartment, Mitochondrial ATP synthase subunit c, which is known to be a protease-refractory protein, was retained in the cells even after the disappearance of mitochondria, indicating that most of the mitochondria were not extruded from the cells. The digestion of mitochondria in autolysosomes may allow the cells to escape from rapid apoptotic cell death through concomitant removal of mitochondrial death-promoting factors such as cytochrome c.	Tokyo Metropolitan Inst Med Sci, Dept Clin Genet, Bunkyo Ku, Tokyo 1138613, Japan; Juntendo Univ, Fac Med, Dept Biochem, Tokyo, Japan; Natl Def Med Coll, Dept Forens Med, Tokorozawa, Saitama, Japan; Univ Tokyo, Fac Med, Dept Pharmacol, Tokyo 113, Japan	Takano-Ohmuro, H (reprint author), Tokyo Metropolitan Inst Med Sci, Dept Clin Genet, Bunkyo Ku, 3-18-22 Honkomagome, Tokyo 1138613, Japan.		Kominami, Eiki/D-3802-2009				Adams JM, 1998, SCIENCE, V281, P1322, DOI 10.1126/science.281.5381.1322; ALBERTS B, 1989, MOL BIOL CELL, P952; Yang J, 1997, SCIENCE, V275, P1129, DOI 10.1126/science.275.5303.1129; Dunn William A. Jr., 1994, Trends in Cell Biology, V4, P139, DOI 10.1016/0962-8924(94)90069-8; KENT G, 1966, AM J PATHOL, V48, P831; Cai JY, 1998, BBA-BIOENERGETICS, V1366, P139, DOI 10.1016/S0005-2728(98)00109-1; Klionsky DT, 1999, ANNU REV CELL DEV BI, V15, P1, DOI 10.1146/annurev.cellbio.15.1.1; JACOBSON MD, 1995, NATURE, V374, P814, DOI 10.1038/374814a0; SHIMIZU S, 1995, NATURE, V374, P811, DOI 10.1038/374811a0; van Leyen K, 1998, NATURE, V395, P392; Bassnett S, 1997, J CELL BIOL, V137, P37, DOI 10.1083/jcb.137.1.37; BESSIS M, 1973, BLOOD CELLS THEIR UL, P110; BOUSSIOS T, 1985, P NATL ACAD SCI USA, V82, P2794, DOI 10.1073/pnas.82.9.2794; CASTOLDI EL, 1988, ATLAS BLOOD CELLS, P47; Dahm R, 1998, EUR J CELL BIOL, V75, P237; GHADIALLY FN, 1997, ULTRASTRUCT PATHOL, P680; Hagopian K, 1999, ANAL BIOCHEM, V273, P240, DOI 10.1006/abio.1999.4219; HEYNEN MJ, 1985, CELL TISSUE RES, V239, P235, DOI 10.1007/BF00214924; HEYNEN MJ, 1990, BLOOD CELL BIOCH, V1, P1; Kluck RM, 1997, SCIENCE, V275, P1132, DOI 10.1126/science.275.5303.1132; KOMINAMI E, 1992, J BIOCHEM-TOKYO, V111, P278; Kroemer G, 1999, BIOCH SOC S, V66, P1; MORIOKA K, 1991, ROUX ARCH DEV BIOL, V200, P86, DOI 10.1007/BF00637188; Morioka K, 1999, ACTA HISTOCHEM CYTOC, V32, P465; Morioka K, 1998, EXP CELL RES, V240, P206, DOI 10.1006/excr.1997.3927; MORIOKA K, 1993, DEV GROWTH DIFFER, V35, P569; RAPOPORT SM, 1990, BLOOD CELL BIOCH, V1, P151; SIMPSON CF, 1968, J CELL BIOL, V36, P103, DOI 10.1083/jcb.36.1.103; TakanoOhmuro H, 1996, CELL MOTIL CYTOSKEL, V34, P95, DOI 10.1002/(SICI)1097-0169(1996)34:2<95::AID-CM2>3.0.CO;2-H; Wolf CM, 1999, EXP CELL RES, V247, P505, DOI 10.1006/excr.1998.4380	30	58	58	URBAN & FISCHER VERLAG	JENA	BRANCH OFFICE JENA, P O BOX 100537, D-07705 JENA, GERMANY	0171-9335			EUR J CELL BIOL	Eur. J. Cell Biol.	OCT	2000	79	10					759	764		10.1078/0171-9335-00096		6	Cell Biology	Cell Biology	373LV	WOS:000165291700011		
J	De Rosa, SC; Zaretsky, MD; Dubs, JG; Roederer, M; Anderson, M; Green, A; Mitra, D; Watanabe, N; Nakamura, H; Tjioe, I; Deresinski, SC; Moore, WA; Ela, SW; Parks, D; Herzenberg, LA; Herzenberg, LA				De Rosa, SC; Zaretsky, MD; Dubs, JG; Roederer, M; Anderson, M; Green, A; Mitra, D; Watanabe, N; Nakamura, H; Tjioe, I; Deresinski, SC; Moore, WA; Ela, SW; Parks, D; Herzenberg, LA; Herzenberg, LA			N-acetylcysteine replenishes glutathione in HIV infection	EUROPEAN JOURNAL OF CLINICAL INVESTIGATION			English	Article						glutathione; GSH; GSH deficiency; HIV; N-acetylcysteine; NAC	HUMAN-IMMUNODEFICIENCY-VIRUS; ACETYL-L-CYSTEINE; OXIDATIVE STRESS; T-CELLS; KAPPA-B; INTRACELLULAR GLUTATHIONE; PARKINSONS-DISEASE; SEROPOSITIVE INDIVIDUALS; CEREBROSPINAL-FLUID; POSITIVE PATIENTS	Background Glutathione (GSH) deficiency is common in HIV-infected individuals and is associated with impaired T cell function and impaired survival. N-acetylcysteine (NAC) is used to replenish GSH that has been depleted by acetaminophen overdose. Studies here test oral administration of NAC for safe and effective GSH replenishment in HIV infection. Design Oral NAC administration in a randomized, 8-week double-blind, placebo-controlled trial followed by optional open-label drug for up to 24 weeks. Subjects HIV-infected, low GSH, CD4 T cells < 500 <mu>L-1, no active opportunistic infections or other debilitation; n = 81. Study conducted prior to introduction of protease inhibitors. Results Whole blood GSH levels in NAC arm subjects significantly increased from 0.88 mM to 0.98 mM, bringing GSH levels in NAG-treated subjects to 89% of uninfected controls (P = 0.03). Baseline GSH levels in the placebo group (0.91) remained essentially the same during the 8 week placebo-controlled trial. T cell GSH, adjusted for CD4 T cell count and beta2-microglobulin levels, also increased in the NAG-treated subjects (P = 0.04). Adverse effects were minimal and not significantly associated with NAC ingestion. Conclusion. NAC treatment for 8 weeks safely replenishes whole blood GSH and T cell GSH in HIV-infected individuals. Thus, NAC offers useful adjunct therapy to increase protection against oxidative stress, improve immune system function and increase detoxification of acetaminophen and other drugs. These findings suggest that NAC therapy could be valuable in other clinical situations in which GSH deficiency or oxidative stress plays a role in disease pathology, e.g. rheumatoid arthritis, Parkinson's disease, hepatitis, liver cirrhosis, septic shock and diabetes.	Stanford Univ, Sch Med, Dept Genet, Beckman Ctr, Stanford, CA 94305 USA; Univ Calif Berkeley, Berkeley, CA USA; NIH, Vaccine Res Ctr, Bethesda, MD 20892 USA; Univ Alabama, Ctr Comprehens Canc, Birmingham, AL 35294 USA; Univ Tokyo, Tokyo, Japan; Kyoto Univ, Inst Viral Res, Kyoto, Japan	De Rosa, SC (reprint author), Stanford Univ, Sch Med, Dept Genet, Beckman Ctr, B007, Stanford, CA 94305 USA.	leeherz@darwin.stanford.edu	Roederer, Mario/G-1887-2011				Adamson DC, 1996, SCIENCE, V274, P1917, DOI 10.1126/science.274.5294.1917; Akerlund B, 1996, EUR J CLIN PHARMACOL, V50, P457, DOI 10.1007/s002280050140; ANDERSON ME, 1985, METHOD ENZYMOL, V113, P548; Anderson ME, 1998, SEMIN LIVER DIS, V18, P415, DOI 10.1055/s-2007-1007174; Anderson MT, 1999, ANAL BIOCHEM, V272, P107, DOI 10.1006/abio.1999.4153; ANDERSON MT, 1996, HDB EXPT IMMUNOLOGY, V2; Aukrust P, 1999, J INFECT DIS, V179, P74, DOI 10.1086/314572; Jenner P, 1998, ANN NEUROL, V44, pS72; STAAL FJT, 1990, P NATL ACAD SCI USA, V87, P9943, DOI 10.1073/pnas.87.24.9943; Choi J, 2000, J BIOL CHEM, V275, P3693, DOI 10.1074/jbc.275.5.3693; Samiec PS, 1998, FREE RADICAL BIO MED, V24, P699, DOI 10.1016/S0891-5849(97)00286-4; JEANNIN P, 1995, J EXP MED, V182, P1785, DOI 10.1084/jem.182.6.1785; MEISTER A, 1994, J BIOL CHEM, V269, P9397; van Lieshout EMM, 1998, CARCINOGENESIS, V19, P1873, DOI 10.1093/carcin/19.10.1873; Pearce RKB, 1997, J NEURAL TRANSM, V104, P661, DOI 10.1007/BF01291884; Metnitz PGH, 1999, INTENS CARE MED, V25, P180, DOI 10.1007/s001340050813; Herzenberg LA, 1997, P NATL ACAD SCI USA, V94, P1967, DOI 10.1073/pnas.94.5.1967; Yucel D, 1998, CLIN CHEM, V44, P148; Jones DP, 1998, CLIN CHIM ACTA, V275, P175, DOI 10.1016/S0009-8981(98)00089-8; SCHRECK R, 1991, EMBO J, V10, P2247; Jones AL, 1998, J TOXICOL-CLIN TOXIC, V36, P277; Jenner P, 1996, NEUROLOGY, V47, pS161; RUFFMANN R, 1991, KLIN WOCHENSCHR, V69, P857, DOI 10.1007/BF01649460; Peterson JD, 1998, P NATL ACAD SCI USA, V95, P3071, DOI 10.1073/pnas.95.6.3071; DROGE W, 1992, IMMUNOL TODAY, V13, P211, DOI 10.1016/0167-5699(92)90156-2; Atzori L, 1998, MED SCI RES, V26, P375; Aukrust P, 1996, BLOOD, V88, P2626; Bains JS, 1997, BRAIN RES REV, V25, P335, DOI 10.1016/S0165-0173(97)00045-3; Barbaro G, 1997, SCAND J GASTROENTERO, V32, P1261, DOI 10.3109/00365529709028157; Bianchi G, 1997, J HEPATOL, V26, P606, DOI 10.1016/S0168-8278(97)80426-6; Breitkreutz R, 2000, AIDS RES HUM RETROV, V16, P203, DOI 10.1089/088922200309296; Breitkreutz R, 2000, J MOL MED-JMM, V78, P55, DOI 10.1007/s001090050382; Buetler TM, 1998, HEPATOLOGY, V28, P1551, DOI 10.1002/hep.510280615; BUHL R, 1989, LANCET, V2, P1294; Calabrese V, 1998, DRUG EXP CLIN RES, V24, P125; Calabresi P., 1985, GOODMAN GILMANS PHAR, P1247; CASTAGNA A, 1995, NEUROLOGY, V45, P1678; CHEN G, 1994, INT J IMMUNOPHARMACO, V16, P755, DOI 10.1016/0192-0561(94)90095-7; CLOTET B, 1995, J ACQ IMMUN DEF SYND, V9, P98, DOI 10.1097/00042560-199505010-00015; Cox D. R., 1984, ANAL SURVIVAL DATA; De Mattia G, 1998, DIABETOLOGIA, V41, P1392, DOI 10.1007/s001250051082; DEQUAY B, 1992, AIDS, V6, P815, DOI 10.1097/00002030-199208000-00008; DOLPHIN D, 1989, COENZYMES COFACTOR A, V3; DOLPHIN D, 1989, COENZYMES COFACTOR B, V3; Dominguez C, 1998, DIABETES CARE, V21, P1736, DOI 10.2337/diacare.21.10.1736; DROGE W, 1993, PHARMACOLOGY, V46, P61, DOI 10.1159/000139029; ECK HP, 1989, BIOL CHEM H-S, V370, P101, DOI 10.1515/bchm3.1989.370.1.101; Ehret A, 1996, J VIROL, V70, P6502; Esteban A, 1997, METHOD FIND EXP CLIN, V19, P129; GIORGI G, 1992, CURR THER RES CLIN E, V52, P461, DOI 10.1016/S0011-393X(05)80422-9; HARGROVE ME, 1993, CELL IMMUNOL, V149, P433, DOI 10.1006/cimm.1993.1168; Helbling B, 1996, EUR J CLIN INVEST, V26, P38, DOI 10.1046/j.1365-2362.1996.88237.x; HERZENBERG LA, 1999, LANCET, V354, P686; HOLDINESS MR, 1991, CLIN PHARMACOKINET, V20, P123, DOI 10.2165/00003088-199120020-00004; Holt S, 1999, LANCET, V353, P294, DOI 10.1016/S0140-6736(05)74933-3; IWATA S, 1994, J IMMUNOL, V152, P5633; Jahoor F, 1999, AM J PHYSIOL-ENDOC M, V276, pE205; *JMP, 1995, JMP STAT GRAPH GUID; Juurlink B H, 1998, J Spinal Cord Med, V21, P309; KALEBIC T, 1991, P NATL ACAD SCI USA, V88, P986, DOI 10.1073/pnas.88.3.986; Knapen MFCM, 1998, OBSTET GYNECOL, V92, P1012, DOI 10.1016/S0029-7844(98)00333-0; Kretzschmar M, 1998, EXP TOXICOL PATHOL, V50, P477; Look MP, 1998, EUR J CLIN INVEST, V28, P389; Malorni W, 1998, AIDS RES HUM RETROV, V14, P1589, DOI 10.1089/aid.1998.14.1589; Marmor M, 1997, AIDS, V11, P1389, DOI 10.1097/00002030-199711000-00014; Maurice MM, 1997, J IMMUNOL, V158, P1458; MIHM S, 1991, AIDS, V5, P497, DOI 10.1097/00002030-199105000-00004; MINERS JO, 1984, BIOCHEM PHARMACOL, V33, P2995, DOI 10.1016/0006-2952(84)90599-9; Pacht ER, 1997, CHEST, V112, P785, DOI 10.1378/chest.112.3.785; Pena LR, 1999, JPEN-PARENTER ENTER, V23, P1, DOI 10.1177/014860719902300101; POOT M, 1995, J CELL PHYSIOL, V163, P555, DOI 10.1002/jcp.1041630316; ROEDERER M, 1993, ANN NY ACAD SCI, V677, P113, DOI 10.1111/j.1749-6632.1993.tb38770.x; ROEDERER M, 1990, P NATL ACAD SCI USA, V87, P4884, DOI 10.1073/pnas.87.12.4884; ROEDERER M, 1991, INT IMMUNOL, V3, P933, DOI 10.1093/intimm/3.9.933; SALL J, 1996, HDB EXPT IMMUNOLOGY, V2; SAS, 1996, SAS STAT US GUID; *SAS I, 1996, CHANG ENH REL 6 11 S, P809; Sastre J, 1996, AGE, V19, P129, DOI 10.1007/BF02434082; SHAN XQ, 1990, PHARMACOL THERAPEUT, V47, P61, DOI 10.1016/0163-7258(90)90045-4; SLATTERY JT, 1987, CLIN PHARMACOL THER, V41, P413; SMILKSTEIN MJ, 1988, NEW ENGL J MED, V319, P1557, DOI 10.1056/NEJM198812153192401; SMITH CV, 1990, 6TH INT C AIDS SAN F, V2, P368; STAAL FJT, 1992, AIDS RES HUM RETROV, V8, P305, DOI 10.1089/aid.1992.8.305; STAAL FJT, 1992, LANCET, V339, P909, DOI 10.1016/0140-6736(92)90939-Z; TANIGUCHI N, 1989, MOL PERSPECTIVES CLI; THOMAS SHL, 1993, PHARMACOL THERAPEUT, V60, P91, DOI 10.1016/0163-7258(93)90023-7; Tsuyuki S, 1998, INT IMMUNOL, V10, P1501, DOI 10.1093/intimm/10.10.1501; Tsuyuki S, 1998, CLIN IMMUNOL IMMUNOP, V88, P192, DOI 10.1006/clin.1998.4574; van der Ven AJAM, 1998, EUR J CLIN INVEST, V28, P187; VINA J, 1986, LIFE CHEM REPORTS, V4, P1; WALKER RE, 1993, AM REV RESPIR DIS, V147, pA1004; WALKER RE, 1992, KEYST S PREV TREATM; WALKER RE, 1992, 8 INT AIDS C AMST; Wallig MA, 1998, DIGESTION, V59, P13, DOI 10.1159/000051439; Walmsley SL, 1997, AIDS, V11, P1689, DOI 10.1097/00002030-199714000-00005; WESTENDORP MO, 1995, EMBO J, V14, P546; WESTENDORP MO, 1994, J VIROL, V68, P4177; WHITE AC, 1994, J NUTR BIOCHEM, V5, P218, DOI 10.1016/0955-2863(94)90039-6; WITSCHI A, 1995, AIDS RES HUM RETROV, V11, P141, DOI 10.1089/aid.1995.11.141; YIM CY, 1994, J IMMUNOL, V152, P5796	100	113	115	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0014-2972			EUR J CLIN INVEST	Eur. J. Clin. Invest.	OCT	2000	30	10					915	929		10.1046/j.1365-2362.2000.00736.x		15	Medicine, General & Internal; Medicine, Research & Experimental	General & Internal Medicine; Research & Experimental Medicine	368TG	WOS:000090133200012		
J	Oku, T; Nakamura, S				Oku, T; Nakamura, S			Estimation of intestinal trehalase activity from a laxative threshold of trehalose and lactulose on healthy female subjects	EUROPEAN JOURNAL OF CLINICAL NUTRITION			English	Article						intestinal trehalase; trehalase activity; trehalose lactulose; insulin. tolerance lest		Objective: The purpose of present study is to investigate small intestinal trehalase activity and the ability to utilize trehalose in healthy Japanese subjects. Design: First, transitory laxative thresholds of trehalose and lactulose were estimated for each of 20 Japanese female subjects. Then, according to the difference between two relative laxative thresholds, small intestinal trehalase activity was estimated for each individual subject. Trehalose tolerance tests were then carried out on two groups with lower or higher trehalase activity. Setting: Department of Nutrition, Faculty of Medicine, University of Tokyo. Results: When 30 g of trehalose were administered orally to six subjects with the low trehalase activity, blood glucose and insulin levels scarcely elevated after loading. In contrast, when 50 g of trehalose were administered orally to six subjects with high trehalase activity, blood glucose levels quickly and significantly increased 30 min after loading (P < 0.01) and slightly decreased after 60 min, reducing quickly to a fasting level 90 min after loading. Blood insulin levels also peaked 30 min after administration. Yet, decreases in blood insulin levels in the trehalose loading experiment were delayed in comparison with the same amount of glucose ingestion, and peak insulin levels were significantly lower than those with glucose ingestion (P < 0.01). Conclusion: We conclude that subjects with high trehalase activity can effectively utilize trehalose which is ingested from the diet, and when a subject with low trehalase activity ingests a large amount of trehalose, a portion of the trehalose might pass through the small intestine and reach the large intestine where it is fermented completely by colonic bacteria. Therefore, the apparent digestibility of trehalose is similar in both subjects with low and high trehalase activities.	Univ Tokyo, Fac Med, Dept Nutr, Bunkyo Ku, Tokyo 1130033, Japan	Oku, T (reprint author), Siebold Univ Nagasaki, Dept Nutr & Hlth Sci, Nagayo, Nagasaki 8512195, Japan.						CLEGG JS, 1965, COMP BIOCHEM PHYSIOL, V14, P135, DOI 10.1016/0010-406X(65)90014-9; Sola-Penna M, 1998, ARCH BIOCHEM BIOPHYS, V360, P10, DOI 10.1006/abbi.1998.0906; LIVESEY JH, 1980, CLIN BIOCHEM, V13, P151, DOI 10.1016/S0009-9120(80)91040-1; Oku T, 1998, J NUTR SCI VITAMINOL, V44, P787; BERGOZ R, 1971, GASTROENTEROLOGY, V60, P909; BIRCH GG, 1963, ADV CARBOHYD CHEM, V18, P210; DAHLQVIST A, 1962, BIOCHIM BIOPHYS ACTA, V113, P624; DAHLQVIST A, 1962, J HISTOCHEM CYTOCHEM, V10, P294; Inoue Y, 1973, YAKUZAIGAKU, V33, P79; Koch EM, 1925, SCIENCE, V61, P570, DOI 10.1126/science.61.1587.570-a; Kunst A., 1984, METHOD ENZYMAT AN, P178; MADZAROV.J, 1973, GASTROENTEROLOGY, V65, P130; Mitsuoka T., 1972, ZBL BAKT HYG, V233, P333; Oku T, 1996, NUTR RES, V16, P577, DOI 10.1016/0271-5317(96)00036-X; OKU T, 1997, P IUFOST 96 REG S NO, P518; ROSER B, 1991, BIOL PHAM, V9, P47; SAITO N, 1997, JPN FOOD SCI, V11, P39; Tabuchi A., 1995, OYO TOSHITSU KAGAKU, V42, P401	18	16	16	NATURE PUBLISHING GROUP	BASINGSTOKE	HOUNDMILLS, BASINGSTOKE RG21 6XS, HAMPSHIRE, ENGLAND	0954-3007			EUR J CLIN NUTR	Eur. J. Clin. Nutr.	OCT	2000	54	10					783	788		10.1038/sj.ejcn.1601091		6	Nutrition & Dietetics	Nutrition & Dietetics	364YV	WOS:000089922400008		
J	Furuhata, Y; Kagaya, R; Hirabayashi, K; Ikeda, A; Chang, KT; Nishihara, M; Takahashi, M				Furuhata, Y; Kagaya, R; Hirabayashi, K; Ikeda, A; Chang, KT; Nishihara, M; Takahashi, M			Development of obesity in transgenic, rats with low circulating growth hormone levels: involvement of leptin resistance	EUROPEAN JOURNAL OF ENDOCRINOLOGY			English	Article							RECOMBINANT HUMAN GH; BODY-COMPOSITION; ADIPOSE-TISSUE; DIABETIC MICE; FOOD-INTAKE; GENE; RECEPTOR; INSULIN; DEFICIENCY; EXPRESSION	Background: Human growth hormone (hGH) transgenic (TG) rats have been produced in our laboratory. These TG rats are characterized by low circulating hGH levels, virtually no endogenous rGH secretion, and massive obesity. Objective: To elucidate how energy balance and leptin sensitivity contributed to the establishment of this obesity. Design and methods: Food intake, locomotor activity and leptin concentrations in serum and cerebrospinal fluid were measured in TG rats and their non-transgenic littermates (control). The effect of intraperitoneal and intracerebroventricular injection of leptin on food intake and body weight gain was also examined. Results: An increase in food intake and a decrease in locomotor activity were observed from 4 and 7 weeks of age, respectively, in the transgenic rats compared with control. Serum leptin concentrations of the transgenic rats were more than twice as high as those of control rats and were associated with an increased white adipose tissue mass and oh gene expression. Intraperitoneal injection of leptin significantly decreased food intake and body weight gain in control rats, but not in transgenic rats. Leptin concentration in the cerebrospinal fluid of transgenic rats was not different from that of control rats, and intracerebroventricular injection of leptin was similarly effective in reducing food intake and body weight gain as it was in control rats. Conclusions: These results suggest that the transgenic rats, whose GH secretion is suppressed, develop obesity due to early onset of an increase in food intake and a decrease in locomotor activity with leptin resistance resulting from deteriorating leptin transport from peripheral blood to cerebrospinal fluid.	Univ Tokyo, Dept Vet Physiol, Bunkyo Ku, Tokyo 1138657, Japan	Nishihara, M (reprint author), Univ Tokyo, Dept Vet Physiol, Bunkyo Ku, 1-1-1 Yayoi, Tokyo 1138657, Japan.						Bjarnason R, 1997, EUR J ENDOCRINOL, V137, P68, DOI 10.1530/eje.0.1370068; Chua SC, 1996, SCIENCE, V271, P994, DOI 10.1126/science.271.5251.994; Ghilardi N, 1996, P NATL ACAD SCI USA, V93, P6231, DOI 10.1073/pnas.93.13.6231; WuPeng XS, 1997, DIABETES, V46, P513, DOI 10.2337/diabetes.46.3.513; Rosenbaum M, 1996, J CLIN ENDOCR METAB, V81, P3424, DOI 10.1210/jc.81.9.3424; Caro JF, 1996, DIABETES, V45, P1455; Levin N, 1996, P NATL ACAD SCI USA, V93, P1726, DOI 10.1073/pnas.93.4.1726; Lee GH, 1996, NATURE, V379, P632, DOI 10.1038/379632a0; Chen H, 1996, CELL, V84, P491, DOI 10.1016/S0092-8674(00)81294-5; Schwartz MW, 1996, NAT MED, V2, P589, DOI 10.1038/nm0596-589; CHURCH GM, 1984, P NATL ACAD SCI-BIOL, V81, P1991, DOI 10.1073/pnas.81.7.1991; Hickey MS, 1996, BIOCHEM MOL MED, V59, P1, DOI 10.1006/bmme.1996.0056; BENGTSSON BA, 1993, J CLIN ENDOCR METAB, V76, P309, DOI 10.1210/jc.76.2.309; DEBOER H, 1995, ENDOCR REV, V16, P63, DOI 10.1210/er.16.1.63; Caro JF, 1996, LANCET, V348, P159, DOI 10.1016/S0140-6736(96)03173-X; DAVIDSON MB, 1987, ENDOCR REV, V8, P115; Banks WA, 1996, PEPTIDES, V17, P305, DOI 10.1016/0196-9781(96)00025-3; PELLEYMOUNTER MA, 1995, SCIENCE, V269, P540, DOI 10.1126/science.7624776; SALADIN R, 1995, NATURE, V377, P527, DOI 10.1038/377527a0; Hardie LJ, 1996, HORM METAB RES, V28, P685, DOI 10.1055/s-2007-979878; Bannai M, 1998, BRAIN RES PROTOC, V3, P83, DOI 10.1016/S1385-299X(98)00027-0; CUSIN I, 1995, DIABETES, V44, P1467, DOI 10.2337/diabetes.44.12.1467; Fisker S, 1997, METABOLISM, V46, P812, DOI 10.1016/S0026-0495(97)90128-1; Ikeda A, 1998, ENDOCRINOLOGY, V139, P3057, DOI 10.1210/en.139.7.3057; IKEDA A, 1994, ENDOCR J, V41, P523, DOI 10.1507/endocrj.41.523; Janssen YJH, 1997, EUR J ENDOCRINOL, V137, P650, DOI 10.1530/eje.0.1370650; LOUVEAU I, 1991, ANAL BIOCHEM, V196, P308, DOI 10.1016/0003-2697(91)90471-5; MURAKAMI T, 1995, BIOCHEM BIOPH RES CO, V209, P944, DOI 10.1006/bbrc.1995.1589; Paxinos G, 1986, RAT BRAIN STEREOTAXI; RICHELSEN B, 1994, AM J PHYSIOL, V266, pE211; SALMON F, 1989, NEW ENGL J MED, V321, P1797; Slieker LJ, 1996, J BIOL CHEM, V271, P5301; SNYDER DK, 1988, J CLIN ENDOCR METAB, V67, P54; Tartaglia LA, 1995, CELL, V83, P1263, DOI 10.1016/0092-8674(95)90151-5; ZHANG YY, 1994, NATURE, V372, P425, DOI 10.1038/372425a0	35	31	32	BIO SCIENTIFICA LTD	BRISTOL	16 THE COURTYARD, WOODLANDS, BRADLEY STOKE, BRISTOL BS32 4NQ, ENGLAND	0804-4643			EUR J ENDOCRINOL	Eur. J. Endocrinol.	OCT	2000	143	4					535	541		10.1530/eje.0.1430535		7	Endocrinology & Metabolism	Endocrinology & Metabolism	364AD	WOS:000089869100012		
J	Nishimura, Y; Shimojima, M; Miyazawa, T; Sato, E; Nakamura, K; Izumiya, Y; Ikeda, Y; Mikami, T; Takahashi, E				Nishimura, Y; Shimojima, M; Miyazawa, T; Sato, E; Nakamura, K; Izumiya, Y; Ikeda, Y; Mikami, T; Takahashi, E			Molecular cloning of the cDNAs encoding the feline B-lymphocyte activation antigen B7-1 (CD80) and B7-2 (CD86) homologues which interact with human CTLA4-Ig	EUROPEAN JOURNAL OF IMMUNOGENETICS			English	Article							T-CELL PROLIFERATION; COUNTER-RECEPTOR; EXPRESSION; CTLA-4; CD28	We cloned the cDNAs encoding the feline homologues of B-lymyhocyte activation antigens B7-1 (CD80) and B7-2 (CD86). We expressed recombinant feline CD80 and CD86 molecules by the baculovirus expression system, and demonstrated their binding ability to human CTLA4-murine immunoglobulin fusion protein. The B-cell activation antigens B7-1 (CD80) and B7-2 (CD86) are homologous molecules expressed on the antigen presenting cells, interact with the T-cell antigen CD28 and the cytotoxic T-lymphocyte-associated protein 4 (CTLA4), and play important roles in regulation of the immune system (Lenschow et al., 1996). Recently, we cloned the cDNAs encoding the feline CD28 (fCD28) (Nishimura et al., 1999) and CTLA4 (fCTLA4) (Nishimura et al., 2000) homologues which conserved the hexapeptide motif (MYPPPY) known as the important region for binding of CD28 to CD80 in humans (Peach ct al., 1994). However, there was no information about feline CD80 (fCD80) and CD86 (fCD86) molecules, and their function and role in feline immune system have not been discussed yet. In this study, we cloned and sequenced the cDNAs encoding the fCD80 and fCD86 homologues which interact with human CTLA4-murine immunoglobulin (Ig) fusion protein.	Univ Tokyo, Grad Sch Agr & Life Sci, Dept Vet Microbiol, Bunkyo Ku, Tokyo 1138657, Japan; Obihiro Univ, Res Ctr Protozoan Mol Immunol, Obihiro, Hokkaido, Japan	Takahashi, E (reprint author), Univ Tokyo, Grad Sch Agr & Life Sci, Dept Vet Microbiol, Bunkyo Ku, 1-1-1 Yayoi, Tokyo 1138657, Japan.						Lenschow DJ, 1996, ANNU REV IMMUNOL, V14, P233, DOI 10.1146/annurev.immunol.14.1.233; Maeda K, 1997, INT IMMUNOL, V9, P993, DOI 10.1093/intimm/9.7.993; FREEMAN GJ, 1993, J EXP MED, V178, P2185, DOI 10.1084/jem.178.6.2185; FREEMAN GJ, 1991, J EXP MED, V174, P625, DOI 10.1084/jem.174.3.625; PEACH RJ, 1994, J EXP MED, V180, P2049, DOI 10.1084/jem.180.6.2049; AZUMA M, 1993, NATURE, V366, P76, DOI 10.1038/366076a0; FREEMAN GJ, 1993, SCIENCE, V262, P909, DOI 10.1126/science.7694363; Nielsen H, 1997, PROTEIN ENG, V10, P1, DOI 10.1093/protein/10.1.1; FREEMAN GJ, 1989, J IMMUNOL, V143, P2714; GUO Y, 1995, J EXP MED, V181, P1345, DOI 10.1084/jem.181.4.1345; ISONO T, 1995, IMMUNOGENETICS, V42, P217; Maher SE, 1996, J IMMUNOL, V157, P3838; Nishimura Y, 2000, EUR J IMMUNOGENET, V27, P99, DOI 10.1046/j.1365-2370.2000.00194.x; Nishimura Y, 1998, VET IMMUNOL IMMUNOP, V65, P43, DOI 10.1016/S0165-2427(98)00145-7; Nishimura Y, 1999, IMMUNOGENETICS, V50, P369, DOI 10.1007/s002510050617; Parsons KR, 1999, IMMUNOGENETICS, V49, P231, DOI 10.1007/s002510050484	16	5	5	BLACKWELL SCIENCE LTD	OXFORD	P O BOX 88, OSNEY MEAD, OXFORD OX2 0NE, OXON, ENGLAND	0960-7420			EUR J IMMUNOGENET	Eur. J. Immunogenet.	OCT-DEC	2000	27	5-6					427	430		10.1046/j.1365-2370.2000.00221.x		4	Genetics & Heredity; Immunology	Genetics & Heredity; Immunology	375NL	WOS:000165406900003		
J	Kawamura, YJ; Umetani, N; Sunami, E; Watanabe, T; Masaki, T; Muto, T				Kawamura, YJ; Umetani, N; Sunami, E; Watanabe, T; Masaki, T; Muto, T			Effect of high ligation on the long-term result of patients with operable colon cancer, particularly those with limited nodal involvement	EUROPEAN JOURNAL OF SURGERY			English	Article						lymph node; dissection; nodal status; operative procedure; disease free survival; invasiveness; curative; number needed to treat	INFERIOR MESENTERIC-ARTERY; RECTAL-CANCER; SURVIVAL; DISSECTION; RECURRENCE; SURGERY	Objective: To find out what effect the extent of nodal dissection has on patients with operable colonic cancer. Design: Retrospective study. Setting: Teaching hospital, Japan. Patients: 564 consecutive patients who had potentially curative operations for colon cancer. Patients treated by limited nodal dissection, in which only pericolonic nodes were dissected, were excluded. Main outcome measures: Disease free survival classified by extent of nodal dissection. Results: High ligation gave no significant advantage when patients were subgrouped according to degree of nodal involvement. However, number of patients with aggressive involvement (including intermediate or central nodes) was small. 511 patients (91%) had limited nodal involvement (no nodal involvement or nodal involvement confined to pericolonic nodes). High ligation of the vessels gave no advantage even with meticulous subgrouping according to age, site, and depth of invasion. Conclusion: Most patients with colonic cancer had limited nodal involvement. High ligation did not affect the long term results in these patients, so, less invasive low ligation should be considered. A larger study will be necessary to clarify the indications for low and high ligation for patients with aggressive nodal involvement.	Univ Tokyo, Sch Med, Dept Surg Oncol, Tokyo 113, Japan	Kawamura, YJ (reprint author), Univ Tokyo, Sch Med, Dept Surg 1, Bunkyo Ku, 7-3-1 Hongo, Tokyo 1138655, Japan.						BONENKAMP JJ, 1995, LANCET, V345, P745, DOI 10.1016/S0140-6736(95)90637-1; PEZIM ME, 1984, ANN SURG, V200, P729, DOI 10.1097/00000658-198412000-00010; SURTEES P, 1990, BRIT J SURG, V77, P618, DOI 10.1002/bjs.1800770607; BACON H E, 1958, Dis Colon Rectum, V1, P457, DOI 10.1007/BF02633415; Broll R, 1997, DIS COLON RECTUM, V40, P1465, DOI 10.1007/BF02070713; FUKUSHIMA R, 1996, DIS COLON RECTUM S, V39, P29; GRINNELL RS, 1952, SURG GYNECOL OBSTET, V94, P526; GRINNELL RS, 1965, SURG GYNECOL OBSTETR, V120, P1031; Hida J, 1997, CANCER, V80, P188, DOI 10.1002/(SICI)1097-0142(19970715)80:2<188::AID-CNCR3>3.0.CO;2-Q; KEIGHLEY MRB, 1999, WILLIAMS NS SURG ANU; KOYAMA Y, 1984, JPN J CLIN ONCOL, V14, P623; MORGAN CN, 1959, SURG GYNECOL OBSTET, V108, P641; ROSI PA, 1962, SURG GYNECOL OBSTET, V114, P14; Slanetz CA, 1997, DIS COLON RECTUM, V40, P1205, DOI 10.1007/BF02055167; SULT GW, 1952, SURG GYNECOL OBSTET, V94, P223	15	21	26	TAYLOR & FRANCIS AS	OSLO	CORT ADELERSGT 17, PO BOX 2562, SOLLI, 0202 OSLO, NORWAY	1102-4151			EUR J SURG	Eur. J. Surg.	OCT	2000	166	10					803	807		10.1080/110241500447443		5	Surgery	Surgery	363ME	WOS:000089838800009		
J	Pfeifenschneider, P; Biebel, O; MovillaFernandez, PA; Abbiendi, G; Ackerstaff, K; Akesson, PF; Alexander, G; Allison, J; Anderson, KJ; Arcelli, S; Asai, S; Ashby, SF; Axen, D; Azuelos, G; Bailey, I; Ball, AH; Barberio, E; Barlow, RJ; Batley, JR; Baumann, S; Behnke, T; Bell, KW; Bella, G; Bellerive, A; Bentvelsen, S; Bethke, S; Biebel, O; Biguzzi, A; Bloodworth, IJ; Bock, P; Bohme, J; Boeriu, O; Bonacorsi, D; Boutemeur, M; Braibant, S; Bright-Thomas, P; Brigliadori, L; Brown, RM; Burckhart, HJ; Cammin, J; Capiluppi, P; Carnegie, RK; Carter, AA; Carter, JR; Chang, CY; Charlton, DG; Chrisman, D; Ciocca, C; Clarke, PEL; Clay, E; Cohen, I; Cooke, OC; Couchman, J; Couyoumtzelis, C; Coxe, RL; Cuffiani, M; Dado, S; Dallavalle, GM; Dallison, S; Davis, R; de Roeck, A; Dervan, P; Desch, K; Dienes, B; Dixit, MS; Donkers, M; Dubbert, J; Duchovni, E; Duckeck, G; Duerdoth, IP; Estabrooks, PG; Etzion, E; Fabbri, F; Fanfani, A; Fanti, M; Faust, AA; Feld, L; Ferrari, P; Fiedler, F; Fierro, M; Fleck, I; Frey, A; Furtjes, A; Futyan, DI; Gagnon, P; Gary, JW; Gaycken, G; Geich-Gimbel, C; Giacomelli, G; Giacomelli, P; Gingrich, DM; Glenzinski, D; Goldberg, J; Gorn, M; Grandi, C; Graham, K; Gross, E; Grunhaus, J; Gruwe, M; Gunther, PO; Hajdu, C; Hanson, GG; Hansroul, M; Hapke, M; Harder, K; Harel, A; Hargrove, CK; Harin-Dirac, M; Hauke, A; Hauschild, M; Hawkes, CM; Hawkings, R; Hemingway, RJ; Hensel, C; Herten, G; Heuer, RD; Hildreth, MD; Hill, JC; Hobson, PR; Hocker, A; Hoffman, K; Homer, RJ; Honma, AK; Horvath, D; Hossain, KR; Howard, R; Huntemeyer, P; Igo-Kemenes, P; Imrie, DC; Ishii, K; Jacob, FR; Jawahery, A; Jeremie, H; Jimack, M; Jones, CR; Jovanovic, P; Junk, TR; Kanaya, N; Kanzaki, J; Karapetian, G; Karlen, D; Kartvelishvili, V; Kawagoe, K; Kawamoto, T; Kayal, PI; Keeler, RK; Kellogg, RG; Kennedy, BW; Kim, DH; Klier, A; Kobayashi, T; Kobel, M; Kokott, TP; Kolrep, M; Komamiya, S; Kowalewski, RV; Kress, T; Krieger, P; von Krogh, J; Kuhl, T; Kupper, M; Kyberd, P; Lafferty, GD; Landsman, H; Lanske, D; Lawson, I; Layter, JG; Leins, A; Lellouch, D; Letts, J; Levinson, L; Liebisch, R; Lillich, J; List, B; Littlewood, C; Lloyd, AW; Lloyd, SL; Loebinger, FK; Long, GD; Losty, MJ; Lu, J; Ludwig, J; Macchiolo, A; Macpherson, A; Mader, W; Mannelli, M; Marcellini, S; Marchant, TE; Martin, AJ; Martin, JP; Martinez, G; Mashimo, T; Mattig, P; McDonald, WJ; McKenna, J; McMahon, TJ; McPherson, RA; Meijers, F; Mendez-Lorenzo, P; Merritt, FS; Mes, H; Meyer, I; Michelini, A; Mihara, S; Mikenberg, G; Miller, DJ; Mohr, W; Montanari, A; Mori, T; Nagai, K; Nakamura, I; Neal, HA; Nisius, R; O'Neale, SW; Oakham, FG; Odorici, F; Ogren, HO; Okpara, A; Oreglia, MJ; Orito, S; Pasztor, G; Pater, JR; Patrick, GN; Patt, J; Perez-Ochoa, R; Pfeifenschneider, P; Pilcher, JE; Pinfold, J; Plane, DE; Poli, B; Polok, J; Przybycien, M; Quadt, A; Rembser, C; Rick, H; Robins, SA; Rodning, N; Roney, JM; Rosati, S; Roscoe, K; Rossi, AM; Rozen, Y; Runge, K; Runolfsson, O; Rust, DR; Sachs, K; Saeki, T; Sahr, O; Sang, WM; Sarkisyan, EKG; Sbarra, C; Schaile, AD; Schaile, O; Scharff-Hansen, P; Schieck, J; Schmitt, S; Schoning, A; Schroder, M; Schumacher, M; Schwick, C; Scott, WG; Seuster, R; Shears, TG; Shen, BC; Shepherd-Themistocleous, CH; Sherwood, P; Siroli, GP; Skuja, A; Smith, AM; Snow, GA; Sobie, R; Soldner-Rembold, S; Spagnolo, S; Sproston, M; Stahl, A; Stephens, K; Stoll, K; Strom, D; Strohmer, R; Surrow, B; Talbot, SD; Tarem, S; Taylor, RJ; Teuscher, R; Thiergen, M; Thomas, J; Thomson, MA; Torrence, E; Towers, S; Trefzger, T; Trigger, I; Trocsanyi, Z; Tsur, E; Turner-Watson, MF; Ueda, I; Van Kooten, R; Vannerem, P; Verzocchi, M; Voss, H; Waller, D; Ward, CP; Ward, DR; Watkins, PM; Watson, AT; Watson, NK; Wells, PS; Wengler, T; Wermes, N; Wetterling, D; White, JS; Willson, GW; Wilson, JA; Wyatt, TR; Yamashita, S; Zacek, V; Zer-Zion, D				Pfeifenschneider, P; Biebel, O; MovillaFernandez, PA; Abbiendi, G; Ackerstaff, K; Akesson, PF; Alexander, G; Allison, J; Anderson, KJ; Arcelli, S; Asai, S; Ashby, SF; Axen, D; Azuelos, G; Bailey, I; Ball, AH; Barberio, E; Barlow, RJ; Batley, JR; Baumann, S; Behnke, T; Bell, KW; Bella, G; Bellerive, A; Bentvelsen, S; Bethke, S; Biebel, O; Biguzzi, A; Bloodworth, IJ; Bock, P; Bohme, J; Boeriu, O; Bonacorsi, D; Boutemeur, M; Braibant, S; Bright-Thomas, P; Brigliadori, L; Brown, RM; Burckhart, HJ; Cammin, J; Capiluppi, P; Carnegie, RK; Carter, AA; Carter, JR; Chang, CY; Charlton, DG; Chrisman, D; Ciocca, C; Clarke, PEL; Clay, E; Cohen, I; Cooke, OC; Couchman, J; Couyoumtzelis, C; Coxe, RL; Cuffiani, M; Dado, S; Dallavalle, GM; Dallison, S; Davis, R; de Roeck, A; Dervan, P; Desch, K; Dienes, B; Dixit, MS; Donkers, M; Dubbert, J; Duchovni, E; Duckeck, G; Duerdoth, IP; Estabrooks, PG; Etzion, E; Fabbri, F; Fanfani, A; Fanti, M; Faust, AA; Feld, L; Ferrari, P; Fiedler, F; Fierro, M; Fleck, I; Frey, A; Furtjes, A; Futyan, DI; Gagnon, P; Gary, JW; Gaycken, G; Geich-Gimbel, C; Giacomelli, G; Giacomelli, P; Gingrich, DM; Glenzinski, D; Goldberg, J; Gorn, M; Grandi, C; Graham, K; Gross, E; Grunhaus, J; Gruwe, M; Gunther, PO; Hajdu, C; Hanson, GG; Hansroul, M; Hapke, M; Harder, K; Harel, A; Hargrove, CK; Harin-Dirac, M; Hauke, A; Hauschild, M; Hawkes, CM; Hawkings, R; Hemingway, RJ; Hensel, C; Herten, G; Heuer, RD; Hildreth, MD; Hill, JC; Hobson, PR; Hocker, A; Hoffman, K; Homer, RJ; Honma, AK; Horvath, D; Hossain, KR; Howard, R; Huntemeyer, P; Igo-Kemenes, P; Imrie, DC; Ishii, K; Jacob, FR; Jawahery, A; Jeremie, H; Jimack, M; Jones, CR; Jovanovic, P; Junk, TR; Kanaya, N; Kanzaki, J; Karapetian, G; Karlen, D; Kartvelishvili, V; Kawagoe, K; Kawamoto, T; Kayal, PI; Keeler, RK; Kellogg, RG; Kennedy, BW; Kim, DH; Klier, A; Kobayashi, T; Kobel, M; Kokott, TP; Kolrep, M; Komamiya, S; Kowalewski, RV; Kress, T; Krieger, P; von Krogh, J; Kuhl, T; Kupper, M; Kyberd, P; Lafferty, GD; Landsman, H; Lanske, D; Lawson, I; Layter, JG; Leins, A; Lellouch, D; Letts, J; Levinson, L; Liebisch, R; Lillich, J; List, B; Littlewood, C; Lloyd, AW; Lloyd, SL; Loebinger, FK; Long, GD; Losty, MJ; Lu, J; Ludwig, J; Macchiolo, A; Macpherson, A; Mader, W; Mannelli, M; Marcellini, S; Marchant, TE; Martin, AJ; Martin, JP; Martinez, G; Mashimo, T; Mattig, P; McDonald, WJ; McKenna, J; McMahon, TJ; McPherson, RA; Meijers, F; Mendez-Lorenzo, P; Merritt, FS; Mes, H; Meyer, I; Michelini, A; Mihara, S; Mikenberg, G; Miller, DJ; Mohr, W; Montanari, A; Mori, T; Nagai, K; Nakamura, I; Neal, HA; Nisius, R; O'Neale, SW; Oakham, FG; Odorici, F; Ogren, HO; Okpara, A; Oreglia, MJ; Orito, S; Pasztor, G; Pater, JR; Patrick, GN; Patt, J; Perez-Ochoa, R; Pfeifenschneider, P; Pilcher, JE; Pinfold, J; Plane, DE; Poli, B; Polok, J; Przybycien, M; Quadt, A; Rembser, C; Rick, H; Robins, SA; Rodning, N; Roney, JM; Rosati, S; Roscoe, K; Rossi, AM; Rozen, Y; Runge, K; Runolfsson, O; Rust, DR; Sachs, K; Saeki, T; Sahr, O; Sang, WM; Sarkisyan, EKG; Sbarra, C; Schaile, AD; Schaile, O; Scharff-Hansen, P; Schieck, J; Schmitt, S; Schoning, A; Schroder, M; Schumacher, M; Schwick, C; Scott, WG; Seuster, R; Shears, TG; Shen, BC; Shepherd-Themistocleous, CH; Sherwood, P; Siroli, GP; Skuja, A; Smith, AM; Snow, GA; Sobie, R; Soldner-Rembold, S; Spagnolo, S; Sproston, M; Stahl, A; Stephens, K; Stoll, K; Strom, D; Strohmer, R; Surrow, B; Talbot, SD; Tarem, S; Taylor, RJ; Teuscher, R; Thiergen, M; Thomas, J; Thomson, MA; Torrence, E; Towers, S; Trefzger, T; Trigger, I; Trocsanyi, Z; Tsur, E; Turner-Watson, MF; Ueda, I; Van Kooten, R; Vannerem, P; Verzocchi, M; Voss, H; Waller, D; Ward, CP; Ward, DR; Watkins, PM; Watson, AT; Watson, NK; Wells, PS; Wengler, T; Wermes, N; Wetterling, D; White, JS; Willson, GW; Wilson, JA; Wyatt, TR; Yamashita, S; Zacek, V; Zer-Zion, D		JADE Collaboration; OPAL Collaboration	QCD analyses and determinations of alpha(s) in e(+)e(-) annihilation at energies between 35 and 189 GeV	EUROPEAN PHYSICAL JOURNAL C			English	Article							TO-LEADING ORDER; ELECTRON-POSITRON ANNIHILATION; HADRONIC-Z-DECAYS; E+E ANNIHILATION; MONTE-CARLO; CROSS-SECTIONS; PETRA ENERGIES; EVENT SHAPES; OPAL DETECTOR; LEP	We employ data taken by the JADE and OPAL experiments for an integrated QCD study in hadronic e(+)e(-) annihilations at c.m.s. energies ranging from 35 GeV through 189 GeV. The study is based on jet-multiplicity related observables. The observables are obtained to high jet resolution scales with the JADE, Durham, Cambridge and cone jet finders, and compared with the predictions of various QCD and Monte Carlo models. The strong coupling strength, alpha (s), is determined at each energy by fits of O(alpha (2)(s)) calculations, as well as matched O(alpha (2)(s)) and NLLA predictions, to the data. Matching schemes are compared, and the dependence of the results on the choice of the renormalization scale is investigated. The combination of the results using matched predictions gives alpha (s)(M-Z0) = 0.1187(-0.0019)(+0.0034). The strong coupling is also obtained, at lower precision, from O(alpha (2)(s)) fits of the c.m.s. energy evolution of some of the observables. A qualitative comparison is made between the data and a recent MLLA prediction for mean jet multiplicities.	Rhein Westfal TH Aachen, Inst Phys 3, D-52056 Aachen, Germany; Univ Birmingham, Sch Phys & Astron, Birmingham B15 2TT, W Midlands, England; Univ Bologna, Dipartimento Fis, I-40126 Bologna, Italy; Univ Bologna, Ist Nazl Fis Nucl, I-40126 Bologna, Italy; Univ Bonn, Inst Phys, D-53115 Bonn, Germany; Univ Calif Riverside, Dept Phys, Riverside, CA 92521 USA; Cavendish Lab, Cambridge CB3 0HE, England; Carleton Univ, Dept Phys, Ottawa Carleton Inst Phys, Ottawa, ON K1S 5B6, Canada; Carleton Univ, Ctr Res Particle Phys, Ottawa, ON K1S 5B6, Canada; CERN, European Org Particle Phys, CH-1211 Geneva 23, Switzerland; Univ Chicago, Enrico Fermi Inst, Chicago, IL 60637 USA; Univ Chicago, Dept Phys, Chicago, IL 60637 USA; Univ Freiburg, Fak Phys, D-79104 Freiburg, Germany; Heidelberg Univ, Inst Phys, D-69120 Heidelberg, Germany; Indiana Univ, Dept Phys, Bloomington, IN 47405 USA; Queen Mary Univ London, London E1 4NS, England; UCL, London WC1E 6BT, England; Univ Manchester, Dept Phys, Schuster Lab, Manchester M13 9PL, Lancs, England; Univ Maryland, Dept Phys, College Pk, MD 20742 USA; Univ Montreal, Phys Nucl Lab, Montreal, PQ H3C 3J7, Canada; Univ Oregon, Dept Phys, Eugene, OR 97403 USA; Rutherford Appleton Lab, CLRC, Didcot OX11 0QX, Oxon, England; Technion Israel Inst Technol, Dept Phys, IL-32000 Haifa, Israel; Tel Aviv Univ, Dept Phys & Astron, IL-69978 Tel Aviv, Israel; Univ Tokyo, Int Ctr Elementary Particle Phys, Tokyo 1130033, Japan; Univ Tokyo, Dept Phys, Tokyo 1130033, Japan; Kobe Univ, Kobe, Hyogo 6578501, Japan; Weizmann Inst Sci, Particle Phys Dept, IL-76100 Rehovot, Israel; Univ Hamburg, DESY, Inst Expt Phys 2, D-22607 Hamburg, Germany; Univ Victoria, Dept Phys, Victoria, BC V8W 3P6, Canada; Univ British Columbia, Dept Phys, Vancouver, BC V6T 1Z1, Canada; Univ Alberta, Dept Phys, Edmonton, AB T6G 2J1, Canada; Res Inst Particle & Nucl Phys, H-1525 Budapest, Hungary; Inst Nucl Res, H-4001 Debrecen, Hungary; Univ Munich, Sekt Phys, D-85748 Garching, Germany; TRIUMF, Vancouver, BC V6T 2A3, Canada; Inst Nucl Res, H-4001 Debrecen, Hungary; Univ Min & Met Krakow, Krakow, Poland; Univ Debrecen, Dept Expt Phys, H-4012 Debrecen, Hungary; Max Planck Inst, Munich, Germany	Pfeifenschneider, P (reprint author), Rhein Westfal TH Aachen, Inst Phys 3, Sommerfeldstr 26-28, D-52056 Aachen, Germany.		Trocsanyi, Zoltan/A-5598-2009; Horvath, Dezso/A-4009-2011; Stahl, Achim/E-8846-2011; Bailey, Ian/C-4011-2012; Giacomelli, Paolo/B-8076-2009; spagnolo, stefania/A-6359-2012; Montanari, Alessandro/J-2420-2012; Kartvelishvili, Vakhtang/K-2312-2013; Grandi, Claudio/B-5654-2015; 	Trocsanyi, Zoltan/0000-0002-2129-1279; Stahl, Achim/0000-0002-8369-7506; Bailey, Ian/0000-0002-8020-3662; spagnolo, stefania/0000-0001-7482-6348; Montanari, Alessandro/0000-0003-2748-6373; Grandi, Claudio/0000-0001-5998-3070; Watson, Nigel/0000-0002-8142-4678			ABREU P, 1993, Z PHYS C PART FIELDS, V59, P21; ABREU P, 1992, Z PHYS C PART FIELDS, V54, P55; Abreu P, 1999, PHYS LETT B, V456, P322, DOI 10.1016/S0370-2693(99)00472-4; Ackerstaff K, 1997, Z PHYS C PART FIELDS, V75, P193, DOI 10.1007/s002880050462; ACTON PD, 1993, Z PHYS C PART FIELDS, V59, P1; ACTON PD, 1992, Z PHYS C PART FIELDS, V55, P1; AKERS R, 1995, Z PHYS C PART FIELDS, V68, P531; AKERS R, 1994, Z PHYS C PART FIELDS, V63, P197; AKRAWY MZ, 1990, PHYS LETT B, V235, P389, DOI 10.1016/0370-2693(90)91983-I; Alexander G, 1996, Z PHYS C PART FIELDS, V72, P191, DOI 10.1007/s002880050237; ALEXANDER G, 1991, Z PHYS C, V52, P182; Alexander G, 1996, Z PHYS C PART FIELDS, V69, P543, DOI 10.1007/s002880050059; Bentvelsen S, 1998, EUR PHYS J C, V4, P623, DOI 10.1007/s100520050232; Acciarri M, 1997, PHYS LETT B, V404, P390, DOI 10.1016/S0370-2693(97)00647-3; WU SL, 1984, PHYS REP, V107, P59, DOI 10.1016/0370-1573(84)90033-4; AHMET K, 1991, NUCL INSTRUM METH A, V305, P275; DOKSHITZER YL, 1995, PHYS LETT B, V352, P451, DOI 10.1016/0370-2693(95)00548-Y; CHANDRAMOHAN T, 1981, NUCL PHYS B, V184, P365, DOI 10.1016/0550-3213(81)90224-8; Acciarri M, 1998, PHYS LETT B, V444, P569, DOI 10.1016/S0370-2693(98)01404-X; MARCHESINI G, 1992, COMPUT PHYS COMMUN, V67, P465, DOI 10.1016/0010-4655(92)90055-4; FARHI E, 1977, PHYS REV LETT, V39, P1587, DOI 10.1103/PhysRevLett.39.1587; BRANDT S, 1964, PHYS LETT, V12, P57, DOI 10.1016/0031-9163(64)91176-X; BETHKE S, 1988, PHYS LETT B, V213, P235, DOI 10.1016/0370-2693(88)91032-5; Campbell JM, 1999, EUR PHYS J C, V9, P245, DOI 10.1007/s100529900034; SJOSTRAND T, 1994, COMPUT PHYS COMMUN, V82, P74, DOI 10.1016/0010-4655(94)90132-5; Lupia S, 1998, PHYS LETT B, V418, P214, DOI 10.1016/S0370-2693(97)01388-9; Catani S, 1996, PHYS LETT B, V378, P287, DOI 10.1016/0370-2693(96)00425-X; BARTEL W, 1986, Z PHYS C PART FIELDS, V33, P23; LONNBLAD L, 1992, COMPUT PHYS COMMUN, V71, P15, DOI 10.1016/0010-4655(92)90068-A; ABE K, 1995, PHYS REV D, V51, P962, DOI 10.1103/PhysRevD.51.962; Barate R., 1998, Physics Reports, V294, DOI 10.1016/S0370-1573(97)00045-8; BARTEL W, 1983, PHYS LETT B, V129, P145, DOI 10.1016/0370-2693(83)90746-3; BARTEL W, 1979, PHYS LETT B, V88, P171, DOI 10.1016/0370-2693(79)90139-4; BENGTSSON HU, 1987, COMPUT PHYS COMMUN, V46, P43, DOI 10.1016/0010-4655(87)90036-1; BERENDS FA, 1995, COMPUT PHYS COMMUN, V85, P437, DOI 10.1016/0010-4655(94)00138-R; BETHKE S, 1992, NUCL PHYS B, V370, P310, DOI 10.1016/0550-3213(92)90289-N; BETHKE S, P 4 INT S RAD CORR R; Biebel O, 1999, PHYS LETT B, V459, P326, DOI 10.1016/S0370-2693(99)00733-9; BRAUNSCHWEIG W, 1988, PHYS LETT B, V214, P286, DOI 10.1016/0370-2693(88)91484-0; Buskulic D, 1997, Z PHYS C PART FIELDS, V73, P409, DOI 10.1007/s002880050330; CATANI S, 1991, PHYS LETT B, V269, P432, DOI 10.1016/0370-2693(91)90196-W; CATANI S, 1992, NUCL PHYS B, V407, P3; CATANI S, 1992, NUCL PHYS B, V377, P445, DOI 10.1016/0550-3213(92)90296-N; DECAMP D, 1992, PHYS LETT B, V284, P163, DOI 10.1016/0370-2693(92)91942-3; DISSERTORI G, 1995, PHYS LETT B, V361, P167, DOI 10.1016/0370-2693(95)01174-O; Dokshitzer Y. L., 1997, JHEP, V9708, P001, DOI [10.1088/1126-6708/1997/08/001, DOI 10.1088/1126-6708/1997/08/001]; ELSEN E, 1990, Z PHYS C PART FIELDS, V46, P349; Fujimoto J, 1997, COMPUT PHYS COMMUN, V100, P128, DOI 10.1016/S0010-4655(96)00126-9; KLUTH S, COMMUNICATION; LONNBLAD L, 1998, JHEP, V9808, P1; LUPIA S, COMMUNICATION; MAZZANTI P, 1993, NUCL PHYS B, V394, P267, DOI 10.1016/0550-3213(93)90015-H; Nagy Z, 1999, PHYS REV D, VD59; NAROSKA B, 1987, PHYS REP, V148, P67, DOI 10.1016/0370-1573(87)90031-7; ODORICO R, 1992, COMPUT PHYS COMMUN, V72, P238, DOI 10.1016/0010-4655(92)90151-N; Pfeifenschneider P, 1999, NUCL PHYS B-PROC SUP, V74, P34, DOI 10.1016/S0920-5632(99)00129-2; SJOSTRAND T, 1995, CERNTH711293; SOLA J, 1999, APPL QUANTUM FIELD T, P243; Webber B., COMMUNICATION	59	50	50	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	1434-6044	1434-6052		EUR PHYS J C	Eur. Phys. J. C	OCT	2000	17	1					19	51		10.1007/s100520000432		33	Physics, Particles & Fields	Physics	366LD	WOS:000090006100002		
J	Iwanami, A; Kato, N; Kasai, K; Kamio, S; Furukawa, SI; Fukuda, M; Nakagome, K; Okajima, Y; Isono, H; Kamijima, K				Iwanami, A; Kato, N; Kasai, K; Kamio, S; Furukawa, SI; Fukuda, M; Nakagome, K; Okajima, Y; Isono, H; Kamijima, K			P300 amplitude over temporal regions in schizophrenia: An investigation using Japanese subjects	EUROPEAN PSYCHIATRY			English	Meeting Abstract									Univ Tokyo, Fac Med, Dept Neuropsychiat, Tokyo 113, Japan; Gunma Univ, Dept Neuropsychiat, Fac Med, Gunma, Japan								0	0	0	EDITIONS SCIENTIFIQUES MEDICALES ELSEVIER	PARIS CEDEX 15	23 RUE LINOIS, 75724 PARIS CEDEX 15, FRANCE	0924-9338			EUR PSYCHIAT	Eur. Psychiat.	OCT	2000	15			2			420S	420S		10.1016/S0924-9338(00)94768-0		1	Psychiatry	Psychiatry	380YG	WOS:000165731700707		
J	Kyuwa, S; Ohsawa, K; Sato, H; Urano, T				Kyuwa, S; Ohsawa, K; Sato, H; Urano, T			Replication of enterotropic and polytropic murine coronaviruses in cultured cell lines of mouse origin	EXPERIMENTAL ANIMALS			English	Article						B16 cells; IC-21 cells; murine coronavirus; replication; TCID50	HEPATITIS-VIRUS INFECTION; SUCKLING MICE; IN-VITRO; RECEPTOR; GLYCOPROTEIN; STRAINS	To understand the virus-cell interactions that occur during murine coronavirus infection, six murine cell lines (A3-1M, B16, CMT-93, DBT, IC-21 and J774A.1) were inoculated with eight murine coronaviruses, including prototype strains of both polytropic and enterotropic biotypes, and new isolates. All virus strains produced a cytopathic effect (CPE) with cell-to-cell fusion in B16, DBT IC-21 and J774A.1 cells. The CPE was induced most rapidly in IC-21 cells and was visible microscopically in all cell lines tested. In contrast, the coronaviruses produced little CPE in A3-1M and CMT-93 cells. Although most virus-infected cells, except KQ3E-infected A3-1M, CMT-93 and J774A.1 cells, produced progeny viruses in the supernatants when assayed by plaque formation on DBT cells, the kinetics of Viral replication were dependent on both the cell line and virus strain; replication of prototype strains was higher than that of new isolates. There was no significant difference in replication of enterotropic and polytropic strains. B16 cells supported the highest level of viral replication. To determine the sensitivity of the cell lines to murine coronaviruses, the 50% tissue culture infectious dose of the coronaviruses was determined with B16, DBT, IC-21 and J774A.1 cells, and compared to that with DBT cells. The results indicate that IC-21 cells were the most sensitive to murine coronaviruses. These data suggest that B16 and IC-21 cells are suitable for large-scale preparation and isolation of murine coronaviruses, respectively.	Kumamoto Univ, Ctr Anim Resources & Dev, Div Microbiol & Genet, Kumamoto 9600811, Japan; Nagasaki Univ, Sch Med, Lab Anim Ctr Biomed Res, Nagasaki 8528523, Japan	Kyuwa, S (reprint author), Univ Tokyo, Grad Sch Agr & Life Sci, Dept Biomed Sci, Bunkyo Ku, 1-1-1 Yayoi, Tokyo 1138657, Japan.						ADAMI C, 1995, VIROLOGY, V209, P337, DOI 10.1006/viro.1995.1265; Kyuwa S, 1998, J VIROL, V72, P9286; BARTHOLD SW, 1984, ARCH VIROL, V81, P103, DOI 10.1007/BF01309300; BARTHOLD SW, 1982, LAB ANIM SCI, V32, P376; BARTHOLD SW, 1985, LAB ANIM SCI, V35, P613; Chen DS, 1995, P NATL ACAD SCI USA, V92, P12095, DOI 10.1073/pnas.92.26.12095; COMPTON SR, 1993, LAB ANIM SCI, V43, P15; COMPTON SR, 1995, J VIROL METHODS, V52, P301, DOI 10.1016/0166-0934(94)00161-9; Compton SR, 1998, ADV EXP MED BIOL, V440, P25; COMPTON SR, 1994, VIROLOGY, V203, P197, DOI 10.1006/viro.1994.1475; HIRANO N, 1974, ARCH GES VIRUSFORSCH, V44, P298, DOI 10.1007/BF01240618; Homberger FR, 1998, LAB ANIM SCI, V48, P50; Homberger FR, 1997, LAB ANIM, V31, P97, DOI 10.1258/002367797780600189; KYUWA S, 1990, SEMINARS VIROLOGY, V1, P273; Kyuwa S, 1997, EXP ANIM TOKYO, V46, P311, DOI 10.1538/expanim.46.311; Kyuwa S, 1996, J VET MED SCI, V58, P431; MANAKER RA, 1961, J NATL CANCER I, V27, P29; Okumura A, 1996, J VIROL, V70, P4146; SILAGI S, 1969, J CELL BIOL, V43, P263, DOI 10.1083/jcb.43.2.263; STOHLMAN SA, 1982, J GEN VIROL, V63, P265, DOI 10.1099/0022-1317-63-2-265; WEILAND E, 1978, J EXP MED, V148, P408, DOI 10.1084/jem.148.2.408; WILLIAMS RK, 1991, P NATL ACAD SCI USA, V88, P5533, DOI 10.1073/pnas.88.13.5533; YAMAGUCHI K, 1988, J VIROL, V62, P2505	23	1	1	INT PRESS EDITING CENTRE INC	TOKYO	1-2-3 SUGAMO, TOSHIMA-KU, TOKYO, 170 0002, JAPAN	1341-1357			EXP ANIM TOKYO	Exp. Anim.	OCT	2000	49	4					251	257		10.1538/expanim.49.251		7	Veterinary Sciences; Zoology	Veterinary Sciences; Zoology	363MH	WOS:000089839000002		
J	Yamanouchi, J; Nishida, E; Itagaki, S; Kawamura, S; Doi, K; Yoshikawa, Y				Yamanouchi, J; Nishida, E; Itagaki, S; Kawamura, S; Doi, K; Yoshikawa, Y			Aortic atheromatous lesions developed in APA hamsters with streptozotocin induced diabetes: A new animal model for diabetic atherosclerosis. 1. Histopathological studies	EXPERIMENTAL ANIMALS			English	Article						APA hamster; atheromatous lesion; diabetes; macroangiopathy	AMERICAN-HEART-ASSOCIATION; GLYCATION END-PRODUCTS; HYPERLIPIDEMIC HAMSTER; VASCULAR-LESIONS; COMPLICATIONS; MELLITUS; DISEASE; STROKE; GLOMERULOSCLEROSIS; ARTERIOSCLEROSIS	To develop an adequate animal model for atherosclerosis in large vessels of patients with diabetes, i.e. diabetic macroangiopathy, we induced diabetes in APA hamsters with a single injection of streptozotocin (SZ) and examined the aorta histopathologically and immunohistochemically. As a result, hyperglycemia and hyperlipidemia were continuously observed for 26 weeks after the SZ injection (WAI) in APA hamsters. Fatty streaks characterized by a subendothelial accumulation of many foam cells were observed limited to the aortic arches as early as 6 WAI. In addition to larger fatty streaks developing with the duration of diabetes, fibrous plaques and plaques containing calcium deposits or cholesterol clefts developed at 26 WAI. These lesions are generally similar to the atheromatous lesions developed in humans. Moreover, depositions of apolipoprotein E and advanced glycation end-products immunohistochemically detected in the lesions were very similar to those found in humans. The diabetic APA hamster is therefore considered to be a useful model for studying the formation of atheromatous lesions in diabetic patients.	Univ Tokyo, Grad Sch Agr & Life Sci, Dept Biomed Sci, Bunkyo Ku, Tokyo 1138657, Japan; Univ Tokyo, Grad Sch Agr & Life Sci, Dept Vet Pathol, Bunkyo Ku, Tokyo 1138657, Japan	Yoshikawa, Y (reprint author), Univ Tokyo, Grad Sch Agr & Life Sci, Dept Biomed Sci, Bunkyo Ku, Yayoi 1-1-1, Tokyo 1138657, Japan.						NISTOR A, 1987, ATHEROSCLEROSIS, V68, P159, DOI 10.1016/0021-9150(87)90106-7; BELLOSTA S, 1995, J CLIN INVEST, V96, P2170, DOI 10.1172/JCI118271; DIAMOND JR, 1988, KIDNEY INT, V33, P917, DOI 10.1038/ki.1988.87; NAGAO T, 1994, STROKE, V25, P766; STARY HC, 1994, CIRCULATION, V89, P2462; STARY HC, 1995, CIRCULATION, V92, P1355; SULLIVAN MP, 1993, LAB ANIM SCI, V43, P575; NAKAMURA Y, 1993, AM J PATHOL, V143, P1649; KUME S, 1995, AM J PATHOL, V147, P654; DONAHUE RP, 1992, DIABETES CARE, V15, P1141, DOI 10.2337/diacare.15.9.1141; Fazio S, 1997, P NATL ACAD SCI USA, V94, P4647, DOI 10.1073/pnas.94.9.4647; ROSENFELD ME, 1993, ARTERIOSCLER THROMB, V13, P1382; BISHOP RW, 1992, J LIPID RES, V33, P549; COTRAN RS, 1989, ROBBINS PATHOLOGIC D, P557; DI TM, 1996, NEUROLOGY, V46, P1560; DIAMOND JR, 1991, KIDNEY INT, V39, pS29; GOMEZ CR, 1990, STROKE, V21, P148; GOTO Y, 1990, ANN NY ACAD SCI, V598, P389, DOI 10.1111/j.1749-6632.1990.tb42309.x; GUYTON JR, 1993, AM J PATHOL, V143, P1444; HAN JS, 1990, J TOXICOL PATHOL, V3, P189; HAN JS, 1992, INT J EXP PATHOL, V73, P75; KARALIS DG, 1991, J AM COLL CARDIOL, V17, P73; KEANE WF, 1988, AM J NEPHROL, V8, P261, DOI 10.1159/000167599; KOWALA MC, 1995, AM J PATHOL, V146, P819; KUNJATHOOR VV, 1996, J CLIN INVEST, V97, P1769; Mendez J D, 1994, Arch Med Res, V25, P367; Milei J, 1996, Cardiologia, V41, P535; NATHAN DM, 1993, NEW ENGL J MED, V328, P1676, DOI 10.1056/NEJM199306103282306; NIHOYANNOPOULOS P, 1993, AM J CARDIOL, V71, P1208, DOI 10.1016/0002-9149(93)90647-U; NIKKARI ST, 1991, ARTERY, V18, P285; Nishida E, 1997, INT J EXP PATHOL, V78, P169, DOI 10.1046/j.1365-2613.1997.240354.x; OBRIEN KD, 1994, AM J PATHOL, V144, P538; Okeda T, 1996, Rinsho Byori, V44, P1027; OTTO J, 1995, ATHEROSCLEROSIS, V114, P19, DOI 10.1016/0021-9150(94)05457-T; PERICGOLIA L, 1983, ATHEROSCLEROSIS, V46, P57, DOI 10.1016/0021-9150(83)90164-8; Seaquist ER, 1998, POSTGRAD MED, V103, P61; Simionescu M, 1996, AM J PATHOL, V148, P997; Squadrito G, 1991, Ann Ital Med Int, V6, P126; STEINER G, 1985, ADV EXP MED BIOL, V189, P277; Tajima Y, 1968, EXP ANIM, V17, P27; TOYODA K, 1992, STROKE, V23, P1056; TUNICK PA, 1991, ANN INTERN MED, V115, P423; Vlassara H, 1997, DIABETES, V46, pS19; WEINBERGER J, 1983, STROKE, V14, P709; WU JT, 1993, J CLIN LAB ANAL, V7, P252, DOI 10.1002/jcla.1860070503	45	16	16	INT PRESS EDITING CENTRE INC	TOKYO	1-2-3 SUGAMO, TOSHIMA-KU, TOKYO, 170 0002, JAPAN	1341-1357			EXP ANIM TOKYO	Exp. Anim.	OCT	2000	49	4					259	266		10.1538/expanim.49.259		8	Veterinary Sciences; Zoology	Veterinary Sciences; Zoology	363MH	WOS:000089839000003		
J	Yamanouchi, J; Takatori, A; Itagaki, S; Kawamura, S; Yoshikawa, Y				Yamanouchi, J; Takatori, A; Itagaki, S; Kawamura, S; Yoshikawa, Y			APA hamster model for diabetic atherosclerosis. 2. Analysis of lipids and lipoproteins	EXPERIMENTAL ANIMALS			English	Article						APA hamster; diabetic atherosclerosis; lipoprotein; modified LDL	LOW-DENSITY-LIPOPROTEIN; GLYCATION END-PRODUCTS; LECITHIN-CHOLESTEROL ACYLTRANSFERASE; MONOCLONAL-ANTIBODY; IMMUNOHISTOCHEMICAL LOCALIZATION; OXIDATIVE STRESS; NITRIC-OXIDE; RISK-FACTORS; IN-VITRO; PLASMA	Syrian hamsters of the APA strain (APA hamsters) have recently been shown to have atheromatous lesions in the aortic arches under diabetic condition induced by a single injection of streptozotocin (SZ). In that model, fatty streaks, which are the initial lesions of atherogenesis, develop by 6 weeks after the injection (WAI). In this study, we evaluated plasma lipid concentrations and lipoprotein profiles in diabetic APA hamsters at 6 WAI to reveal the early stage of atherogenesis clinicopathologically. As a result, by biochemical analysis, hyperglycemic APA hamsters showed signs of hypercholesterolemia and hypertriglyceridemia. Low-density lipoprotein (LDL) cholesterol significantly increased, bur high-density lipoprotein (HDL) cholesterol significantly decreased. Agarose gel electrophoresis showed an obvious increase in the fractions of chylomicron, LDL and abnormal lipoprotein. Plasma LDL in diabetic animals was in a state more susceptible to oxidization. In addition, a significant increase in glycated LDL was also found in the diabetic animals by enzyme linked immunosorbent assay (ELISA). Moreover, lipid peroxidation product (4-hydroxynonenal (4 HNE))-adducted proteins and advanced glycation end-products (AGE) were immunohistochemically detected in the foam cells of the fatty streaks. These results revealed that diabetic APA hamsters had hyperlipidemia characterized by increases in chylomicron, LDL and abnormal lipoprotein, and suggested that oxidized LDL and/or glycated LDL might be actively uptaken by macrophages and play an important role in the initial stage of atherogenesis.	Univ Tokyo, Grad Sch Agr & Life Sci, Dept Biomed Sci, Bunkyo Ku, Tokyo 1138657, Japan	Yoshikawa, Y (reprint author), Univ Tokyo, Grad Sch Agr & Life Sci, Dept Biomed Sci, Bunkyo Ku, Yayoi 1-1-1, Tokyo 1138657, Japan.						Abe M, 1997, NUTRITION, V13, P417, DOI 10.1016/S0899-9007(97)91279-X; Abe M, 1991, Nihon Geka Gakkai Zasshi, V92, P1678; ANDREWS B, 1995, ATHEROSCLEROSIS, V112, P77, DOI 10.1016/0021-9150(94)05401-4; Toyokuni S, 1999, PATHOL INT, V49, P91, DOI 10.1046/j.1440-1827.1999.00829.x; Ihara Y, 1999, DIABETES, V48, P927, DOI 10.2337/diabetes.48.4.927; MAKITA Z, 1992, J BIOL CHEM, V267, P5133; PARTHASARATHY S, 1992, ANNU REV MED, V43, P219; BOYD HC, 1989, AM J PATHOL, V135, P815; HEINECKE JW, 1993, J LIPID RES, V34, P2051; Suzuki H, 1997, NATURE, V386, P292, DOI 10.1038/386292a0; TASHIRO T, 1992, NUTRITION, V8, P155; KOBAYASHI K, 1995, ENDOCR J, V42, P461, DOI 10.1507/endocrj.42.461; NAKAMURA Y, 1993, AM J PATHOL, V143, P1649; KUME S, 1995, AM J PATHOL, V147, P654; Toyokuni S, 1997, LAB INVEST, V76, P365; Kondo S, 1999, FREE RADICAL BIO MED, V27, P401, DOI 10.1016/S0891-5849(99)00087-8; BOWIE A, 1993, ATHEROSCLEROSIS, V102, P63, DOI 10.1016/0021-9150(93)90084-8; Rikitake Y, 1998, ATHEROSCLEROSIS, V136, P51, DOI 10.1016/S0021-9150(97)00186-X; ARBEENY CM, 1992, J LIPID RES, V33, P843; AVIRAM M, 1995, BIOCHEM BIOPH RES CO, V216, P501, DOI 10.1006/bbrc.1995.2651; BOLTON EJ, 1994, ATHEROSCLEROSIS, V106, P213, DOI 10.1016/0021-9150(94)90126-0; Casasco A, 1997, PLACENTA, V18, P249, DOI 10.1016/S0143-4004(97)80058-6; Chappey O, 1997, EUR J CLIN INVEST, V27, P97, DOI 10.1046/j.1365-2362.1997.710624.x; Chisholm JW, 1996, J LIPID RES, V37, P1086; DOBRIAN A, 1995, BBA-MOL BASIS DIS, V1270, P26, DOI 10.1016/0925-4439(94)00068-2; EBARA T, 1994, METABOLISM, V43, P299, DOI 10.1016/0026-0495(94)90096-5; Ginsberg HN, 1996, DIABETES, V45, pS27; GOTTO AM, 1992, AM J CARDIOL, V70, pH19, DOI 10.1016/0002-9149(92)91086-J; GUERIN M, 1993, ATHEROSCLEROSIS, V104, P195, DOI 10.1016/0021-9150(93)90191-V; Hamilton CA, 1997, PHARMACOL THERAPEUT, V74, P55, DOI 10.1016/S0163-7258(96)00202-1; HARDUIN P, 1995, J LIPID RES, V36, P919; Hiraga T, 1994, Nihon Rinsho, V52, P3096; KANAZAWA T, 1994, PATHOBIOLOGY, V62, P269, DOI 10.1159/000163920; Laakso M, 1996, ANN MED, V28, P341, DOI 10.3109/07853899608999091; Lamarche B, 1998, CAN J CARDIOL, V14, P841; LopesVirella MF, 1996, ANN MED, V28, P347, DOI 10.3109/07853899608999092; Lynn EG, 1997, CLIN EXP PHARMACOL P, V24, P973, DOI 10.1111/j.1440-1681.1997.tb02731.x; Lyons TJ, 1997, CURR OPIN LIPIDOL, V8, P174, DOI 10.1097/00041433-199706000-00008; MAZIERE C, 1995, FEBS LETT, V363, P277, DOI 10.1016/0014-5793(95)00332-4; MILLER JP, 1990, BAILLIERE CLIN ENDOC, V4, P807; NARAYANAN S, 1984, ANN CLIN LAB SCI, V14, P371; O K, 1995, J LIPID RES, V36, P2344; OKUBO M, 1996, DIABETES, pS123; PATSCH JR, 1977, J BIOL CHEM, V232, P2113; REGNSTROM J, 1992, LANCET, V339, P1183, DOI 10.1016/0140-6736(92)91129-V; ROTHENEDER M, 1986, BIOL CHEM H-S, V367, P1219, DOI 10.1515/bchm3.1986.367.2.1219; ROTHENEDER M, 1988, ANN BIOL CLIN-PARIS, V46, P30; SABESIN SM, 1982, GASTROENTEROLOGY, V83, P704; Schectman G, 1996, CLIN CHEM, V42, P732; SCHWENKE DC, 1995, ARTERIOSCL THROM VAS, V15, P1928; SEIDEL D, 1969, J CLIN INVEST, V48, P1211, DOI 10.1172/JCI106085; Seidel D, 1974, Horm Metab Res, VSuppl 4, P6; TOMSITS E, 1995, JPEN-PARENTER ENTER, V19, P369, DOI 10.1177/0148607195019005369; Tozer EC, 1997, CIRC RES, V80, P208; VIGNA GB, 1992, CIRCULATION, V85, P2205; Vlassara H, 1997, DIABETES, V46, pS19; WEINGAND KW, 1990, CLIN CHEM, V36, P575; Wilson TA, 1998, ATHEROSCLEROSIS, V140, P147, DOI 10.1016/S0021-9150(98)00132-4; WU JT, 1993, J CLIN LAB ANAL, V7, P252, DOI 10.1002/jcla.1860070503; Yamaguchi Y, 1998, ATHEROSCLEROSIS, V139, P323, DOI 10.1016/S0021-9150(98)00091-4; YAMAMURA T, 1993, SHIN SEIKAGAKU ZIKKE, P209; YAMANOUCHI J, 2000, IN PRESS EXP ANIM, P49; YEGIN A, 1995, ANN CLIN BIOCHEM, P459; YLA HS, 1989, J CLIN INVEST, V84, P1086	64	18	18	INT PRESS EDITING CENTRE INC	TOKYO	1-2-3 SUGAMO, TOSHIMA-KU, TOKYO, 170 0002, JAPAN	1341-1357			EXP ANIM TOKYO	Exp. Anim.	OCT	2000	49	4					267	274		10.1538/expanim.49.267		8	Veterinary Sciences; Zoology	Veterinary Sciences; Zoology	363MH	WOS:000089839000004		
J	Liang, JH; Sankai, T; Yoshida, T; Yoshikawa, Y				Liang, JH; Sankai, T; Yoshida, T; Yoshikawa, Y			Comparison of the effects of two fixatives for immunolocalization of testosterone in the testes of the cynomolgus monkey, mouse and rat	EXPERIMENTAL ANIMALS			English	Article						fixative; immunohistochemical; testosterone	LOCALIZATION; IMMUNOREACTIVITY	We compared the effect of two fixatives, Bouin's fixative and neutralized buffered 4% formaldehyde (10% formalin), for immunolocalization of testosterone in the testes of cynomolgus monkeys, mice and rats. In the samples fixed with Bouin's fixative, immunoreactive testosterone was defected as intense deposits in the cytoplasm of Leydig cells of monkeys and mice. Immunoreactive testosterone was detected not only in Leydig cells of rats but also moderately shown within tubules. Immunoreactive testosterone could not be detected in the testes of monkeys, mice or rats fixed with neutralized buffered formalin because of the poor morphology caused by the fixative. It is concluded that Bouin's fixative is a suitable fixative for immunolocalization of testosterone in the testes of cynomolgus monkeys, mice and rats.	Natl Inst Infect Dis, Tsukuba Primate Ctr, Tsukuba, Ibaraki 3050843, Japan; Univ Tokyo, Grad Sch Agr & Life Sci, Dept Biomed Sci, Bunkyo Ku, Tokyo 1138657, Japan	Yoshida, T (reprint author), Natl Inst Infect Dis, Tsukuba Primate Ctr, Hachimandai 1, Tsukuba, Ibaraki 3050843, Japan.						BENKOEL L, 1983, CELL MOL BIOL, V29, P199; BUBENIK GA, 1975, ENDOCRINOLOGY, V96, P63; CHAMNESS GC, 1980, J HISTOCHEM CYTOCHEM, V28, P792; HONJO S, 1985, J MED PRIMATOL, V14, P75; Liang JH, 1998, J MED PRIMATOL, V27, P10; Liang JH, 1999, J MED PRIMATOL, V28, P62; MOREL G, 1984, CELL TISSUE RES, V235, P159; PEUTE J, 1989, GEN COMP ENDOCR, V76, P63, DOI 10.1016/0016-6480(89)90033-6; RAJANIEMI H, 1981, J HISTOCHEM CYTOCHEM, V29, P813; SCHULZ R, 1989, J HISTOCHEM CYTOCHEM, V37, P1667; SCHULZ R, 1986, CELL TISSUE RES, V245, P629; SCHULZ R, 1988, GEN COMP ENDOCR, V72, P80, DOI 10.1016/0016-6480(88)90182-7; THOMPSON SA, 1985, HISTOCHEM J, V17, P493, DOI 10.1007/BF01003209; WONG LYM, 1984, HISTOCHEM J, V16, P687, DOI 10.1007/BF01003395; WOODS JE, 1966, GEN COMP ENDOCR, V7, P559, DOI 10.1016/0016-6480(66)90076-1	15	4	4	INT PRESS EDITING CENTRE INC	TOKYO	1-2-3 SUGAMO, TOSHIMA-KU, TOKYO, 170 0002, JAPAN	1341-1357			EXP ANIM TOKYO	Exp. Anim.	OCT	2000	49	4					301	304		10.1538/expanim.49.301		4	Veterinary Sciences; Zoology	Veterinary Sciences; Zoology	363MH	WOS:000089839000009		
J	Ohno, K; Narushima, S; Takeuchi, S; Itoh, K; Mitsuoka, T; Nakayama, H; Itoh, T; Hioki, K; Nomura, T				Ohno, K; Narushima, S; Takeuchi, S; Itoh, K; Mitsuoka, T; Nakayama, H; Itoh, T; Hioki, K; Nomura, T			Inhibitory effect of apple pectin and culture condensate of bifidobacterium longum on colorectal tumors induced by 1,2-dimethylhydrazine in transgenic mice harboring human prototype c-Ha-ras genes	EXPERIMENTAL ANIMALS			English	Article						c-Ha-ras gene; colorectal tumor; transgenic mice	CARCINOGENESIS	The number and tumor score of colorectal tumors induced by 1,2-dymethylhydrazine in transgenic (Tg) mice carrying human c-Ha-ras genes were significantly reduced by ingestion of apple pectin (AP) or a culture condensate of Bifidobacterium longum (MB) when compared with a control diet. There was no statistical difference in the incidence of colorectal tumors in Tg mice between the AP or MB diet and the control diet. This study demonstrated that Tg mice are a useful tool for screening inhibition of colorectal tumors by functional foods.	Univ Tokyo, Grad Sch Agr & Life Sci, Lab Vet Publ Hlth, Bunkyo Ku, Tokyo 1138657, Japan; Univ Tokyo, Grad Sch Agr & Life Sci, Lab Vet Pathol, Bunkyo Ku, Tokyo 1138657, Japan; Cent Inst Expt Anim, Miyamae Ku, Kawasaki, Kanagawa 2160001, Japan	Itoh, K (reprint author), Univ Tokyo, Grad Sch Agr & Life Sci, Lab Vet Publ Hlth, Bunkyo Ku, 1-1-1 Yayoi, Tokyo 1138657, Japan.						SAITOH A, 1990, ONCOGENE, V5, P1195; Yamamoto S, 1996, CARCINOGENESIS, V17, P2455, DOI 10.1093/carcin/17.11.2455; FUJISAWA T, 1990, BIFIDOBACTERIA MICRO, V9, P43; IZAWA M, 1992, CANCER RES, V52, P1628; KATSUKI M, 1989, MOL BIOL MED, V6, P567; Mitsuoka T, 1982, BIFIDOBACTERIA MICRO, V1, P3; Narushima S, 1998, EXP ANIM TOKYO, V47, P111, DOI 10.1538/expanim.47.111; OHKAMI H, 1995, JPN J CANCER RES, V86, P523; REDDY BS, 1986, DIET NUTRITION CANCE, P47; Suzuki T, 1997, J VET MED SCI, V59, P665, DOI 10.1292/jvms.59.665; Yamamoto S, 1997, LAB ANIM SCI, V47, P121	11	7	9	INT PRESS EDITING CENTRE INC	TOKYO	1-2-3 SUGAMO, TOSHIMA-KU, TOKYO, 170 0002, JAPAN	1341-1357			EXP ANIM TOKYO	Exp. Anim.	OCT	2000	49	4					305	307		10.1538/expanim.49.305		3	Veterinary Sciences; Zoology	Veterinary Sciences; Zoology	363MH	WOS:000089839000010		
J	Qiang, YW; Kitagawa, M; Higashi, M; Ishii, G; Morimoto, C; Harigaya, K				Qiang, YW; Kitagawa, M; Higashi, M; Ishii, G; Morimoto, C; Harigaya, K			Activation of mitogen-activated protein kinase through alpha 5/beta 1 integrin is required for cell cycle progression of B progenitor cell line, Reh, on human marrow stromal cells	EXPERIMENTAL HEMATOLOGY			English	Article						pro B cell; integrin alpha 5/beta 1; extracellular signal-regulated kinase; p27(Kip1)	BONE-MARROW; DEPENDENT KINASES; TYROSINE PHOSPHORYLATION; FIBRONECTIN RECEPTOR; T-CELLS; ADHESION; INHIBITOR; VLA-4; EXPRESSION; GROWTH	Objective. Attachment to bone marrow (BM) stromal cells is crucial for the normal growth and development of B-cell progenitors (pro-B), However, the molecular mechanisms by which contact facilitates the proliferation of pro-B cells are not completely understood. This study was performed to investigate this interaction. Materials and Methods, A model pro-B cell line (Reh) and a human BM stromal cell line (KM102) were used. Flow cytomery was used for cell cycle analysis. Western Blotting and immunoprecipitation were utilized to examine the levels of cyclin-dependent kinase (cdk) and p27(Kip1). Results. Attachment to both KM102 and normal BM stromal cells significantly promoted the growth of Reh cells. Pretreatment of Reh cells with anti-integrin beta 1 or alpha 5 monoclonal antibody (mAb), but not alpha 4 or ICAM-1 mAb, abrogated this enhancement of proliferation. Furthermore, stroma attachment resulted in shortening of the G(1) phase of cell cycle, significant increases cdk2 activity, degradation of cdk inhibitor p27-GST protein, and decrease in levels of p27(Kip1) protein. In addition, solid-phase cross-linking of alpha 5 via immobilized antibody also resulted in extracellular signal-regulated (ERK)-2 kinase phosphorylation, increase in cdk2 activity, decrease in levels of p27(Kip1) protein, and enhanced proliferation that was inhibited by treatment with PD98059, a specific ERK inhibitor. Conclusion. Integrin alpha 5 beta 1-mediated stroma contact promotes the proliferation of B-cell progenitors through the activation of ERK-2, which in turn modulates cell cycle regulation machinery including induction of cdk2 activity and degradation of p27(Kip1) and contributing to acceleration of the G(1) phase of cell cycle progression. (C) 2000 International Society for Experimental Hematology. Published by Elsevier Science Inc.	Chiba Univ, Sch Med, Dept Pathol, Div Mol & Tumor Pathol,Chuo Ku, Chiba 260, Japan; Univ Tokyo, Inst Med Sci, Tokyo, Japan	Harigaya, K (reprint author), Chiba Univ, Sch Med, Dept Pathol, Div Mol & Tumor Pathol,Chuo Ku, 1-8-1 Inohana, Chiba 260, Japan.		Ishii, Genichiro/E-2913-2012				ZHANG ZH, 1995, P NATL ACAD SCI USA, V92, P6161, DOI 10.1073/pnas.92.13.6161; Zhu XY, 1996, J CELL BIOL, V133, P391, DOI 10.1083/jcb.133.2.391; HARIGAYA K, 1985, P NATL ACAD SCI USA, V82, P3477, DOI 10.1073/pnas.82.10.3477; LEE MH, 1995, GENE DEV, V9, P639, DOI 10.1101/gad.9.6.639; MANABE A, 1994, BLOOD, V83, P758; Wary KK, 1998, CELL, V94, P625, DOI 10.1016/S0092-8674(00)81604-9; SHIMIZU Y, 1990, J IMMUNOL, V145, P59; PAGANO M, 1995, SCIENCE, V269, P682, DOI 10.1126/science.7624798; SHERR CJ, 1995, GENE DEV, V9, P1149, DOI 10.1101/gad.9.10.1149; Assoian RK, 1997, J CELL BIOL, V136, P1, DOI 10.1083/jcb.136.1.1; HYNES RO, 1992, CELL, V69, P11, DOI 10.1016/0092-8674(92)90115-S; Manie SN, 1996, BLOOD, V87, P1855; MATSUSHIME H, 1994, MOL CELL BIOL, V14, P2066; HARPER JW, 1993, CELL, V75, P805; HUHTALA P, 1995, J CELL BIOL, V129, P867, DOI 10.1083/jcb.129.3.867; Hegen M, 1997, IMMUNOLOGY, V90, P257, DOI 10.1046/j.1365-2567.1997.00053.x; Hirai A, 1997, J BIOL CHEM, V272, P13; Wary KK, 1996, CELL, V87, P733, DOI 10.1016/S0092-8674(00)81392-6; MIYAKE K, 1991, J EXP MED, V173, P599, DOI 10.1084/jem.173.3.599; BRADSTOCK K, 1993, BLOOD, V82, P3437; CLARK EA, 1995, SCIENCE, V268, P23; DAVIES J, 1995, J GENDER STUD, V4, P145; DAVIS LS, 1990, J IMMUNOL, V145, P785; DEFOUGEROLLES AR, 1994, J EXP MED, V179, P619, DOI 10.1084/jem.179.2.619; DORSHKIND K, 1990, ANNU REV IMMUNOL, V8, P111, DOI 10.1146/annurev.immunol.8.1.111; EI-Deiry W. S., 1993, CELL, V75, P817; FANG F, 1996, SCIENCE, V271, P49; Gong JG, 1998, J BIOL CHEM, V273, P1662, DOI 10.1074/jbc.273.3.1662; HANGST L, 1996, SCIENCE, V271, P1861; JACOBSEN K, 1990, EUR J IMMUNOL, V20, P2395, DOI 10.1002/eji.1830201106; JARRIS LJ, 1997, BLOOD, V90, P1626; JULIANO RL, 1993, J CELL BIOL, V120, P577, DOI 10.1083/jcb.120.3.577; KARIN M, 1995, J BIOL CHEM, V270, P16483; MCGINNES K, 1991, EXP HEMATOL, V19, P294; MEREDITH J, 1995, SCIENCE, V269, P1570, DOI 10.1126/science.7545312; MIYAKE K, 1992, J CELL BIOL, V119, P653, DOI 10.1083/jcb.119.3.653; MOREAU I, 1993, BLOOD, V81, P1170; Murti KG, 1996, EXP CELL RES, V226, P47, DOI 10.1006/excr.1996.0201; NOJIMA Y, 1995, CELL IMMUNOL, V161, P8, DOI 10.1006/cimm.1995.1002; POLYAK K, 1994, CELL, V78, P59, DOI 10.1016/0092-8674(94)90572-X; ROBERTS RA, 1987, J CELL PHYSIOL, V132, P203, DOI 10.1002/jcp.1041320204; RYAN DH, 1991, J CLIN INVEST, V88, P995, DOI 10.1172/JCI115403; Schofield KP, 1998, BLOOD, V91, P3230; Schulze A, 1996, MOL CELL BIOL, V16, P4632; SHAN N, 1998, BLOOD, V92, P3817; SHERR CJ, 1993, CELL, V73, P105; SYMINGTON BE, 1995, BIOCHEM BIOPH RES CO, V208, P126, DOI 10.1006/bbrc.1995.1314; SYMINGTON BE, 1992, J BIOL CHEM, V267, P25744; TOYOSHIMA H, 1994, CELL, V78, P67, DOI 10.1016/0092-8674(94)90573-8	49	17	19	ELSEVIER SCIENCE INC	NEW YORK	655 AVENUE OF THE AMERICAS, NEW YORK, NY 10010 USA	0301-472X			EXP HEMATOL	Exp. Hematol.	OCT	2000	28	10					1147	1157		10.1016/S0301-472X(00)00521-X		11	Hematology; Medicine, Research & Experimental	Hematology; Research & Experimental Medicine	364GR	WOS:000089884500006		
J	Pinyakong, O; Habe, H; Supaka, N; Pinpanichkarn, P; Juntongjin, K; Yoshida, T; Furihata, K; Nojiri, H; Yamane, H; Omori, T				Pinyakong, O; Habe, H; Supaka, N; Pinpanichkarn, P; Juntongjin, K; Yoshida, T; Furihata, K; Nojiri, H; Yamane, H; Omori, T			Identification of novel metabolites in the degradation of phenanthrene by Sphingomonas sp strain P2	FEMS MICROBIOLOGY LETTERS			English	Article						phenanthrene; Sphingomonas sp.; biodegradation; 5,6-benzocoumarin	GENETIC-CHARACTERIZATION; NAPHTHALENE; DIOXYGENASE; ANTHRACENE; CARBAZOLE; CLUSTER; KP7	Sphingomonas sp. strain P2, which is capable of utilizing phenanthrene as a sole carbon and energy source, was isolated from petroleum-contaminated soil in Thailand. Gas chromatography-mass spectrometry and H-1 and C-13 nuclear magnetic resonance analyses revealed two novel metabolites from the phenanthrene degradation pathway. One was identified as 5,6-benzocoumarin, which was derived by dioxygenation at the 1- and 2-positions of phenanthrene, and the other was determined to be 1,5-dihydroxy-2-naphthoic acid. Other metabolites from phenanthrene degradation were identified as 7,8-benzocoumarin, 1-hydroxy-2-naphthoic acid and coumarin. From these results. it is suggested that strain P2 call degrade phenanthrene via dioxygenation at both 1.2- and 3,4-positions followed by meta-cleavage. (C) 2000 Federation of European Microbiological Societies. Published by Elsevier Science B.V. All rights reserved.	Univ Tokyo, Biotechnol Res Ctr, Bunkyo Ku, Tokyo 1138657, Japan; Chulalongkorn Univ, Fac Sci, Dept Microbiol, Bangkok 10330, Thailand; Univ Tokyo, Dept Appl Biol Chem, Bunkyo Ku, Tokyo 1138657, Japan	Omori, T (reprint author), Univ Tokyo, Biotechnol Res Ctr, Bunkyo Ku, 1-1-1 Yayoi, Tokyo 1138657, Japan.						KIYOHARA H, 1978, J GEN MICROBIOL, V105, P69; EVANS WC, 1965, BIOCHEM J, V95, P819; JERINA DM, 1976, J AM CHEM SOC, V98, P5988, DOI 10.1021/ja00435a035; Iwabuchi T, 1997, J BACTERIOL, V179, P6488; YANG YJ, 1994, J BACTERIOL, V176, P2158; Iwabuchi T, 1998, J BACTERIOL, V180, P945; KIYOHARA H, 1976, AGR BIOL CHEM TOKYO, V40, P1075; Iwabuchi T, 1998, J BIOL CHEM, V273, P8332, DOI 10.1074/jbc.273.14.8332; OMORI T, 1992, APPL ENVIRON MICROB, V58, P911; GROSSER RJ, 1991, APPL ENVIRON MICROB, V57, P3462; Kim EB, 1997, FEMS MICROBIOL LETT, V153, P479, DOI 10.1016/S0378-1097(97)00292-9; KIYOHARA H, 1994, J BACTERIOL, V176, P2439; KUSK KO, 1981, BOT MAR, V24, P611, DOI 10.1515/botm.1981.24.11.611; Nojiri H, 1999, J BACTERIOL, V181, P3105; Patnaik P., 1992, COMPREHENSIVE GUIDE, P429; PIPE RK, 1986, AQUAT TOXICOL, V8, P65, DOI 10.1016/0166-445X(86)90073-1; Sambrook J., 1989, MOL CLONING LAB MANU; Suen WC, 1996, J BACTERIOL, V178, P4926; Sutherland J. B., 1995, MICROBIAL TRANSFORMA, P269	19	76	85	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	0378-1097			FEMS MICROBIOL LETT	FEMS Microbiol. Lett.	OCT 1	2000	191	1					115	121		10.1016/S0378-1097(00)00380-3		7	Microbiology	Microbiology	361FL	WOS:000089712300018		
J	Chu, LY; Qin, JJ; Chen, WM; Liu, PK; Lee, XZ				Chu, LY; Qin, JJ; Chen, WM; Liu, PK; Lee, XZ			Enhanced performance for crossflow microfiltration processes with tubular ceramic membrane	FILTRATION & SEPARATION			English	Article								The fluid flow pattern, the regeneration method and the regeneration cycle of crossflow microfiltration processes were optimised experimentally using tubular ceramic membranes to provide guidance far the design of an efficient membrane holder structure and technology for crossflow microfiltration. The results show that the outer helical flow pattern, combined with the regeneration method of backshock with compressed gas, can enhance the performance of crossflow microfiltration, i.e. the concentration polarisation and the membrane fouling in the crossflow microfiltration can be controlled effectively. Furthermore, the permeate flux remains stable for a long period of time with a shout backshock cycle.	Univ Tokyo, Nakao Lab, Dept Chem Syst Engn, Sch Engn,Bunkyo Ku, Tokyo 1138656, Japan	Chu, LY (reprint author), Univ Tokyo, Nakao Lab, Dept Chem Syst Engn, Sch Engn,Bunkyo Ku, 7-3-1 Hongo, Tokyo 1138656, Japan.		Chu, Liang-Yin/B-3915-2009				WINZELER HB, 1993, J MEMBRANE SCI, V80, P35, DOI 10.1016/0376-7388(93)85130-O; COLMAN DA, 1991, T ICHEME C, V69, P91; ILLIOS S, SEPARATION SCI TECHN, V25, P1307; JEFFREE MA, 1981, CLIN EXP DIAL A, V5, P373; KRONER KH, 1988, J MEMBRANE SCI, V36, P85, DOI 10.1016/0376-7388(88)80009-7; PEUCHOT MM, 1993, P 6 WORLD FILTR C JA, P326; VANDERWAAL MJ, 1989, J MEMBRANE SCI, V40, P243, DOI 10.1016/0376-7388(89)89008-8; VISUANATHAN C, 1989, SEPAR SCI TECHNOL, V24, P383; XU LP, 1997, POWDER TECHNOL, V3, P43; ZHAO ZA, 1995, FILTER SEPARATOR, P23; ZHEN C, 1997, MEMBRANE SCI TECHNOL, V17, P5; ZHEN LY, 1995, WATER TREATMENT TECH, V21, P125	12	0	0	ELSEVIER ADVANCED TECHNOLOGY	OXFORD	OXFORD FULFILLMENT CENTRE THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND	0015-1882			FILTR SEPARAT	Filtr. Sep.	OCT	2000	37	8					37	40				4	Engineering, Chemical	Engineering	365BU	WOS:000089929200008		
J	Okumura, T; Aida, K				Okumura, T; Aida, K			Fluctuations in hemolymph ecdysteroid levels during the reproductive and non-reproductive molt cycles in the giant freshwater prawn Macrobrachium rosenbergii	FISHERIES SCIENCE			English	Article						ecdysteroids; freshwater prawn; Macrobrachium rosenbergii; molting; ovarian development	PALAEMON-SERRATUS CRUSTACEA; WATER PRAWN; HOMARUS-AMERICANUS; OVARIAN DEVELOPMENT; METHYL FARNESOATE; SPIDER CRAB; EMBRYOGENESIS; LOBSTER; VITELLOGENESIS; METABOLITES	Hemolymph ecdysteroid levels were traced during the molt cycle in female giant freshwater prawn, Macrobrachium rosenbergii Levels were compared between the reproductive molt cycle, accompanied by ovarian development and oviposition following ecdysis, and the nonreproductive molt cycle, marked by the absence of ovarian development, to examine the involvement of ecdysteroids in ovarian development. Total ecdysteroid levels determined by radioimmunoassay (RIA) showed similar fluctuation patterns between both molt cycles. Levels were low during postmolt stages A-B and gradually decreased to low basal levels at intermolt stages C-0-C-1. Levels then increased during premolt stages D-0-D-2, reached a large peak at the early D-3 stage, and declined sharply prior to ecdysis. In addition, ecdysteroids in the hemolymph were analyzed using highperformance liquid chromatography combined with RIA in order to identify individual ecdysteroid species. During both molt cycles, 20-hydroxyecdysone, ecdysone and high polarity immunoreactive products were detected, and 20-hydroxyecdysone was the most predominant ecdysteroid. Fluctuations in all ecdysteroid species during each type of molt cycle paralleled those of total ecdysteroid levels, and did not show significant differences between the reproductive and non-reproductive molt cycles. These results suggest that ecdysteroids are not involved in ovarian development but in the molting process only.	Univ Tokyo, Grad Sch Agr & Life Sci, Dept Aquat Biosci, Bunkyo Ku, Tokyo 1130032, Japan	Okumura, T (reprint author), Japan Sea Natl Fisheries Res Inst, Niigata 9518121, Japan.		huang, zhenyuan/I-3122-2013; Okumura, Takuji/B-1115-2008	Okumura, Takuji/0000-0002-4337-6804			Jo QT, 1999, INVERTEBR REPROD DEV, V36, P79, DOI 10.1080/07924259.1999.9652681; LACHAISE F, 1981, H-S Z PHYSIOL CHEM, V362, P521, DOI 10.1515/bchm2.1981.362.1.521; Laufer H, 1998, GEN COMP ENDOCR, V111, P113, DOI 10.1006/gcen.1998.7109; LAUFER H, 1987, SCIENCE, V235, P202, DOI 10.1126/science.235.4785.202; MEUSY JJ, 1988, ZOOL SCI, V5, P217; BESSE G, 1971, CR ACAD SCI D NAT, V273, P1975; BLANCHET MF, 1975, EXPERIENTIA, V31, P865, DOI 10.1007/BF01938511; BUTENANDT A, 1954, Z NATURFORSCH B, V9, P389; CHAIX JC, 1982, GEN COMP ENDOCR, V47, P7, DOI 10.1016/0016-6480(82)90076-4; CHANG ES, 1988, ENDOCRINOLOGY SELECT, P258; Charniaux-Cotton H., 1988, Endocrinology of selected invertebrate types., P279; HAGEDORN RGH, 1983, ENDOCRINOLOGY INSECT, P271; Han Chang-Hee, 1993, Bulletin of the Korean Fisheries Society, V26, P76; HAN CH, 1988, THESIS U TOKYO TOKYO; JUSTO CC, 1991, NIPPON SUISAN GAKK, V57, P209; KOOLMAN J, 1983, ENDOCRINOLOGY INSECT, P179; LANOT R, 1989, INVERTEBR REPROD DEV, V16, P169, DOI 10.1080/07924259.1989.9672074; MEUSY JJ, 1977, GEN COMP ENDOCR, V33, P35, DOI 10.1016/0016-6480(77)90124-1; Okumura T, 2000, FISHERIES SCI, V66, P678, DOI 10.1046/j.1444-2906.2000.00108.x; OKUMURA T, 1992, ZOOL SCI, V9, P37; OKUMURA T, 1989, NIPPON SUISAN GAKK, V55, P2091; PICAUD JL, 1980, CR ACAD SCI D NAT, V290, P1019; SKINNER D M, 1985, P43; SNYDER MJ, 1991, BIOL BULL, V180, P475, DOI 10.2307/1542348; SNYDER MJ, 1991, GEN COMP ENDOCR, V83, P118, DOI 10.1016/0016-6480(91)90112-J; SNYDER MJ, 1991, GEN COMP ENDOCR, V81, P133, DOI 10.1016/0016-6480(91)90133-Q; SOUTY C, 1982, CR ACAD SCI III-VIE, V294, P1057; SOYEZ D, 1987, J EXP ZOOL, V244, P479, DOI 10.1002/jez.1402440314; SPINDLER KD, 1987, GEN COMP ENDOCR, V66, P116, DOI 10.1016/0016-6480(87)90356-X; SUZUKI S, 1986, BIOL BULL, V170, P350, DOI 10.2307/1541814; TOUIR A, 1974, CR ACAD SCI D NAT, V278, P119; WILDER MN, 1995, FISHERIES SCI, V61, P101; WILDER MN, 1991, ZOOL SCI, V8, P919; WILDER MN, 1990, GEN COMP ENDOCR, V80, P93, DOI 10.1016/0016-6480(90)90152-C; WYATT GR, 1991, INVERTEBR REPROD DEV, V20, P1, DOI 10.1080/07924259.1991.9672174; YOUNG NJ, 1993, GEN COMP ENDOCR, V90, P183, DOI 10.1006/gcen.1993.1073; YOUNG NJ, 1991, INVERTEBR REPROD DEV, V20, P201, DOI 10.1080/07924259.1991.9672200	37	11	11	JAPANESE SOC FISHERIES SCIENCE	TOKYO	C/O TOKYO UNIV FISHERIES, KONAN 4, MINATO, TOKYO, 108-8477, JAPAN	0919-9268			FISHERIES SCI	Fish. Sci.	OCT	2000	66	5					876	883		10.1046/j.1444-2906.2000.00142.x		8	Fisheries	Fisheries	370GK	WOS:000165115000012		
J	Inoue, JG; Miya, M; Tsukamoto, K; Nishida, M				Inoue, JG; Miya, M; Tsukamoto, K; Nishida, M			Complete mitochondrial DNA sequence of the Japanese sardine Sardinops melanostictus	FISHERIES SCIENCE			English	Article						complete mitochondrial DNA sequence; Japanese sardine; long-PCR; mitogenomics; Sardinops melanostictus	COMPLETE NUCLEOTIDE-SEQUENCE; BREAM PAGRUS-MAJOR; D-LOOP REGION; GENETIC-VARIATION; RFLP-ANALYSIS; GENOME; POPULATION; AMPLIFICATION; ORGANIZATION; VERTEBRATES	We determined the complete nucleotide sequence of the mitochondrial genome for a Japanese sardine, Sardinops melanostictus (Teleostei: Clupeiformes). The entire genome was purified by gene amplification using long polymerase chain reactions (PCR), and the products were subsequently used as templates for PCR with 30 sets of fish-versatile primers (including three species-specific primers) that amplify contiguous, overlapping segments of the entire genome. Direct sequencing of the PCR products demonstrated that the genome [16881 base pairs (bp)] contained the same 37 mitochondrial structural genes (two ribosomal RNA, 22 transfer RNA, and 13 protein-coding genes) as found in other vertebrates, with the gene order identical to that in typical vertebrates. A major non-coding region between the tRNA(Pro) and tRNA(Phe) genes (1200 bp) was considered as the control (D-loop) region, as it has several conservative blocks characteristic to this region.	Univ Tokyo, Ocean Res Inst, Nakano Ku, Tokyo 1648639, Japan; Nat Hist Museum & Inst, Dept Zool, Chuo Ku, Chiba 2608682, Japan	Inoue, JG (reprint author), Univ Tokyo, Ocean Res Inst, Nakano Ku, Tokyo 1648639, Japan.		Inoue, Jun/B-5840-2015	Inoue, Jun/0000-0003-4954-6373			MOORE WS, 1995, EVOLUTION, V49, P718, DOI 10.2307/2410325; DODA JN, 1981, P NATL ACAD SCI-BIOL, V78, P6116, DOI 10.1073/pnas.78.10.6116; TZENG CS, 1992, NUCLEIC ACIDS RES, V20, P4853, DOI 10.1093/nar/20.18.4853; BARNES WM, 1994, P NATL ACAD SCI USA, V91, P2216, DOI 10.1073/pnas.91.6.2216; Hurst CD, 1999, GENE, V239, P237, DOI 10.1016/S0378-1119(99)00425-4; Miya M, 1999, MAR BIOTECHNOL, V1, P416, DOI 10.1007/PL00011798; Jiang L, 1995, MOL MAR BIOL BIOTECH, V4, P353; GUTELL RR, 1993, NUCLEIC ACIDS RES, V21, P3055, DOI 10.1093/nar/21.13.3055; WILSON AC, 1985, BIOL J LINN SOC, V26, P375, DOI 10.1111/j.1095-8312.1985.tb02048.x; CHANG YS, 1994, J MOL EVOL, V38, P138, DOI 10.1007/BF00166161; ANDERSON S, 1981, NATURE, V290, P457, DOI 10.1038/290457a0; Sorenson MD, 1999, MOL PHYLOGENET EVOL, V12, P105, DOI 10.1006/mpev.1998.0602; MORITZ C, 1987, ANNU REV ECOL SYST, V18, P269, DOI 10.1146/annurev.ecolsys.18.1.269; CHENG S, 1994, NAT GENET, V7, P350, DOI 10.1038/ng0794-350; Zardoya R, 1995, J MOL EVOL, V41, P942; Noack K, 1996, GENETICS, V144, P1165; KUMAZAWA Y, 1993, J MOL EVOL, V37, P380; WALBERG MW, 1981, NUCLEIC ACIDS RES, V9, P5411, DOI 10.1093/nar/9.20.5411; KOCHER TD, 1989, P NATL ACAD SCI USA, V86, P6196, DOI 10.1073/pnas.86.16.6196; CHENG S, 1994, NATURE, V369, P684, DOI 10.1038/369684a0; PARRISH RH, 1989, CAN J FISH AQUAT SCI, V46, P2019, DOI 10.1139/f89-251; Asahida T, 1998, NIPPON SUISAN GAKK, V64, P377; AVISE JC, 1987, ANNU REV ECOL SYST, V18, P489, DOI 10.1146/annurev.ecolsys.18.1.489; Avise J.C., 1994, MOL MARKERS NATURAL; Dowling Thomas E., 1996, P249; Fujii T, 1997, FISHERIES SCI, V63, P906; Iguchi K, 1997, FISHERIES SCI, V63, P901; Iguchi K, 1999, FISHERIES SCI, V65, P63; Johansen S, 1996, MOL MAR BIOL BIOTECH, V5, P203; Kitaura J, 1998, FISHERIES SCI, V64, P538; Kumazawa Y, 1999, MOL BIOL EVOL, V16, P784; Murakami M, 1998, ZOOL SCI, V15, P335, DOI 10.2108/zsj.15.335; NAYLOR GJ, 1996, NATURE, V373, P565; Okazaki T, 1996, MAR BIOL, V126, P585, DOI 10.1007/BF00351325; Pitcher TJ, 1995, MOL GENETICS FISHERI; Tabata K, 1997, FISHERIES SCI, V63, P211; Tabata K, 1997, FISHERIES SCI, V63, P344; Tanaka M, 1997, B NATL RES I AQUAC S, V3, P77; Whitehead PJP, 1985, CLUPEOID FISHES WORL; Zardoya R, 1997, GENETICS, V146, P995; Zardoya R, 1996, GENETICS, V142, P1249	41	107	117	JAPANESE SOC FISHERIES SCIENCE	TOKYO	C/O TOKYO UNIV FISHERIES, KONAN 4, MINATO, TOKYO, 108-8477, JAPAN	0919-9268			FISHERIES SCI	Fish. Sci.	OCT	2000	66	5					924	932		10.1046/j.1444-2906.2000.00148.x		9	Fisheries	Fisheries	370GK	WOS:000165115000018		
J	Takagi, Y; Ishida, K; Mugiya, Y				Takagi, Y; Ishida, K; Mugiya, Y			Carbohydrates of the otolith organ in the rainbow trout Oncorhynchus mykiss detected by lectins	FISHERIES SCIENCE			English	Article						carbohydrate; endolymph; lectin histochemistry; Oncorhynchus mykiss; otolith matrix; rainbow trout	CALCIUM-CONCENTRATION RATIOS; VESTIBULAR END ORGANS; SACCULAR EPITHELIUM; INNER-EAR; OREOCHROMIS-NILOTICUS; FUNDULUS-HETEROCLITUS; COCCOLITHOPHORID ALGA; FISH OTOLITHS; 2 TELEOSTS; TILAPIA	A lectin-binding assay was applied to the rainbow trout, Oncorhynchus mykiss, sacculus in order to identify specific sugars in the otolith organ. The binding of biotinylated lectins to the sagitta, otolith membrane and saccular epithelial cells was detected by histochemistry, and their binding to the EDTA-soluble fraction of the otolith matrix and saccular endolymph was detected by dot-blot analysis. N-Acetylglucosamine (GlcNAc) and mannose (Man) were identified in the otolith matrix with both techniques. These data indicate that glycoproteins in the otolith matrix have N-glycosidically linked sugar chains. In the otolith membrane, GlcNAc and Man were identified in the subcupular meshwork, whereas only Man was identified in the gelatinous layer. This is in line with the hypothesis that a part of the subcupular meshwork is incorporated into the otolith as an organic matrix, The saccular epithelial cells reacted with at least one of the lectins which bound to the otolith matrix. The endolymph had the same reactivity with lectins as the otolith matrix. Thus, we suggest that otolith-matrix carbohydrates are produced in the saccular epithelial cells, secreted into the endolymph, and deposited onto the otolith.	Univ Tokyo, Ocean Res Inst, Otsuchi Marine Res Ctr, Otsuchi, Iwate 0281102, Japan; Hokkaido Univ, Fac Fisheries, Hakodate, Hokkaido 0418611, Japan	Takagi, Y (reprint author), Univ Tokyo, Ocean Res Inst, Otsuchi Marine Res Ctr, Otsuchi, Iwate 0281102, Japan.						Otake T, 1998, FISHERIES SCI, V64, P517; RADTKE RL, 1990, ENVIRON BIOL FISH, V27, P51, DOI 10.1007/BF00004904; GILLOYZAGA P, 1985, HEARING RES, V18, P269, DOI 10.1016/0378-5955(85)90043-7; MayerGostan N, 1997, CELL TISSUE RES, V289, P53, DOI 10.1007/s004410050851; DEGENS ET, 1969, MAR BIOL, V2, P105, DOI 10.1007/BF00347005; CARLSTROM DD, 1963, BIOL BULL, V125, P441, DOI 10.2307/1539358; PANNELLA G, 1971, SCIENCE, V173, P1124, DOI 10.1126/science.173.4002.1124; KALISH JM, 1989, J EXP MAR BIOL ECOL, V132, P151, DOI 10.1016/0022-0981(89)90126-3; Secor DH, 1996, ESTUARIES, V19, P778, DOI 10.2307/1352297; ASANO M, 1993, COMP BIOCHEM PHYS B, V104, P201, DOI 10.1016/0305-0491(93)90359-D; Baba K., 1991, P57; DUNKELBERGER DG, 1980, J MORPHOL, V163, P367, DOI 10.1002/jmor.1051630309; HSU SM, 1981, J HISTOCHEM CYTOCHEM, V29, P577; KABAKOFF B, 1990, J CELL BIOL, V111, P391, DOI 10.1083/jcb.111.2.391; KAWAKAMI H, 1995, HISTOCHEMISTRY CYTOC, P73; Lowenstein O., 1971, P207; MARSH ME, 1994, PROTOPLASMA, V177, P108, DOI 10.1007/BF01378985; MARSH ME, 1992, J BIOL CHEM, V267, P20507; Morales-Nin B., 1987, P331; MUGIYA Y, 1982, B JPN SOC SCI FISH, V48, P1225; MUGIYA Y, 1968, BULL JAP SOC SCI FISH, V34, P1096; Pisam M, 1998, CELL TISSUE RES, V294, P261, DOI 10.1007/s004410051176; RADTKE RL, 1989, COMP BIOCHEM PHYS A, V92, P189, DOI 10.1016/0300-9629(89)90151-5; RADTKE RL, 1988, ENVIRON BIOL FISH, V23, P205, DOI 10.1007/BF00004911; Radtke RL, 1998, POLAR BIOL, V19, P1; SAITOH S, 1989, T AM MICROSC SOC, V108, P223, DOI 10.2307/3226341; Sasagawa T, 1996, FISHERIES SCI, V62, P970; SCOTT JE, 1978, BIOCHEM J, V169, P697; SECOR DH, 1995, RECENT DEV FISH OTOL, P735; SOKOLOWSKI BHA, 1986, SCANNING ELECTRON MI, V4, P1635; SUGIYAMA S, 1991, HEARING RES, V55, P263, DOI 10.1016/0378-5955(91)90111-L; Takagi Y, 1997, ANAT REC, V248, P483, DOI 10.1002/(SICI)1097-0185(199708)248:4<483::AID-AR1>3.0.CO;2-N; Takagi Y, 2000, FISHERIES SCI, V66, P71, DOI 10.1046/j.1444-2906.2000.00010.x; Takagi Y, 1999, ANAT REC, V254, P322; TAKUMIDA M, 1989, J LARYNGOL OTOL, V103, P357, DOI 10.1017/S0022215100108953; TAKUMIDA M, 1989, ORL J OTO-RHINO-LARY, V51, P144; Tzeng WN, 1997, MAR ECOL PROG SER, V149, P73, DOI 10.3354/meps149073; WATABE N, 1982, J EXP MAR BIOL ECOL, V58, P127, DOI 10.1016/0022-0981(82)90100-9; ZHANG Z, 1992, J MORPHOL, V211, P213, DOI 10.1002/jmor.1052110210	39	6	6	JAPANESE SOC FISHERIES SCIENCE	TOKYO	C/O TOKYO UNIV FISHERIES, KONAN 4, MINATO, TOKYO, 108-8477, JAPAN	0919-9268			FISHERIES SCI	Fish. Sci.	OCT	2000	66	5					933	939		10.1046/j.1444-2906.2000.00149.x		7	Fisheries	Fisheries	370GK	WOS:000165115000019		
J	Kume, G; Yamaguchi, A; Aoki, I; Taniuchi, T				Kume, G; Yamaguchi, A; Aoki, I; Taniuchi, T			Reproductive biology of the cardinalfish Apogon lineatus in Tokyo Bay, Japan	FISHERIES SCIENCE			English	Article						Apogon lineatus; Apogonidae; fecundity; oocyte maturation; sexual maturity; spawning season; spermatogenesis	PATERNAL MOUTHBROODING FISH; FILIAL CANNIBALISM; FINAL MATURATION; OOCYTE MATURATION; FEEDING-HABITS; GROWTH; AGE; HYDRATION; DOEDERLEINI; TELEOSTS	Reproductive biology of Apogon lineatus in Tokyo Bay, Japan was studied by histological examination of the gonads and measurement of the gonadosomatic indices (GSI). The spawning season occurred during July-October, with both males and females attaining sexual maturity by the end of their first year (60.0 mm TL). It was indicated that A. lineatus is a multiple spawner by the presence of postovulatory follicles and primary-secondary yolk in the same ovaries during the spawning season and the asynchronism of the development of spermatogenesis. Batch fecundity ranged from 7983 to 19 316 eggs for fish of 76.0 mm TL to 106.0 mm TL, respectively, and increased linearly with fish total length. increases in oocyte diameter were not observed after the tertiary yolk stage, which suggested an adaptation to mouthbrooding, thereby efficiently utilizing the male's restricted buccal cavity to maximize the number of eggs mouthbrooded.	Univ Tokyo, Grad Sch Agr & Life Sci, Dept Aquat Biosci, Bunkyo Ku, Tokyo 1138657, Japan; Kyoto Womens Univ, Dept Food Nutr, Kyoto 6050926, Japan	Kume, G (reprint author), Univ Tokyo, Grad Sch Agr & Life Sci, Dept Aquat Biosci, Bunkyo Ku, Tokyo 1138657, Japan.						Okuda N, 1996, ENVIRON BIOL FISH, V45, P397, DOI 10.1007/BF00002532; LAFLEUR GJ, 1991, J EXP ZOOL, V258, P126, DOI 10.1002/jez.1402580114; MURAYAMA T, 1994, J FISH BIOL, V45, P235; KUWAMURA T, 1983, JPN J ICHTHYOL, V30, P61; Mylonas CC, 1997, J FISH BIOL, V50, P34, DOI 10.1006/jfbi.1996.0275; GREELEY MS, 1991, COMP BIOCHEM PHYS A, V100, P639, DOI 10.1016/0300-9629(91)90383-N; CRAIK JCA, 1984, J FISH BIOL, V24, P599, DOI 10.1111/j.1095-8649.1984.tb04830.x; FUJIISHI A, 1995, BY CATCH JAPANESE FI, P30; GREELEY MS, 1986, COMP BIOCHEM PHYS B, V84, P1, DOI 10.1016/0305-0491(86)90262-2; GRIER HJ, 1981, AM ZOOL, V21, P345; HAYASHI M, 1993, FISHES JAPAN PICTORI, P655; HIROSE K, 1976, J FISH RES BOARD CAN, V33, P989; Hoque MM, 1998, FISHERIES SCI, V64, P44; Hyndes GA, 1996, MAR BIOL, V126, P549, DOI 10.1007/BF00354637; Kume G, 1999, FISHERIES SCI, V65, P420; Kume G, 2000, ENVIRON BIOL FISH, V58, P233, DOI 10.1023/A:1007670410804; Kume G, 1998, FISHERIES SCI, V64, P921; Kuno Y, 1997, FISHERIES SCI, V63, P242; KURITA Y, 1995, FISHERIES SCI, V61, P1; KUWAMURA T, 1985, ENVIRON BIOL FISH, V13, P17, DOI 10.1007/BF00004852; KUWAMURA T, 1989, BREEDING BEHAV FISHE, P140; KUWAMURA T, 1987, JPN J ICHTHYOL, V33, P431; Lehodey P, 1997, MAR BIOL, V128, P17, DOI 10.1007/s002270050064; McDermott SF, 1997, FISH B-NOAA, V95, P321; MCPHERSON R, 1989, DEV GROWTH DIFFER, V31, P475; Oki D, 1998, FISHERIES SCI, V64, P191; Okuda N, 1997, BEHAV ECOL SOCIOBIOL, V41, P363, DOI 10.1007/s002650050397; Okuda N, 1998, EVOL ECOL, V12, P681, DOI 10.1023/A:1006533531952; Okuda N, 1996, ANIM BEHAV, V52, P307, DOI 10.1006/anbe.1996.0176; Okuda N, 1999, AM NAT, V153, P540, DOI 10.1086/303196; OMORI M, 1980, B SEIKAI REG FISH RE, V54, P113; SUZUKI K, 1987, B I OCEAN RES DEV TO, V5, P49; SUZUKI K, 1987, J FAC MAR SCI TECHNO, V24, P121; Thresher RE, 1984, REPROD REEF FISHES, P399; TOKIMURA M, 1985, THESIS U TOKY TOKYO; UENO S, 1987, J FAC MAR SCI TECHNO, V24, P111; WATANABE WO, 1986, J FISH BIOL, V28, P425, DOI 10.1111/j.1095-8649.1986.tb05180.x; YAMADA T, 1957, B FAC FISH NAGASAKI, V5, P80; Yamaguchi A, 1996, FISHERIES SCI, V62, P919; YAMAMOTO KnCHIRO, 1961, BULL FAC FISH HOKKAIDO UNIV, V12, P93	40	9	9	JAPANESE SOC FISHERIES SCIENCE	TOKYO	C/O TOKYO UNIV FISHERIES, KONAN 4, MINATO, TOKYO, 108-8477, JAPAN	0919-9268			FISHERIES SCI	Fish. Sci.	OCT	2000	66	5					947	954		10.1046/j.1444-2906.2000.00151.x		8	Fisheries	Fisheries	370GK	WOS:000165115000021		
J	Kohbara, J; Hidaka, I; Kuriyama, I; Yamashita, M; Ichikawa, M; Furukawa, K; Aida, K; Sanchez-Vazquez, FJ; Tabata, M				Kohbara, J; Hidaka, I; Kuriyama, I; Yamashita, M; Ichikawa, M; Furukawa, K; Aida, K; Sanchez-Vazquez, FJ; Tabata, M			Nocturnal/diurnal demand-feeding pattern of yellowtail Seriola quinqueradiata under different keeping conditions	FISHERIES SCIENCE			English	Article						demand-feeding; diel feeding pattern; diurnal; feeding behavior; nocturnal; Seriola quinqueradiata	TROUT ONCORHYNCHUS-MYKISS; DICENTRARCHUS-LABRAX L; EUROPEAN SEA BASS; RAINBOW-TROUT; SELF-FEEDERS; GROWTH; BEHAVIOR; RHYTHMS; SYSTEM; CONVERSION	Demand-feeding behavior of juvenile yellowtails was examined under two different light conditions: in an experimental room and in the outdoors. In the indoor experiment, five groups of 20 juvenile yellowtails (mean bodyweight, 16.0 g) were allocated individually to five 200 L cylindrical tanks set up in the experimental room. A rod-type tactile switch was used for activating the feeding device which delivered 5-10 pellets per actuation. Each tank was illuminated by an overhead fluorescent lamp with a LD 12:12 photoperiod regime. In the outdoor experiment, 69 juvenile yellowtails (mean bodyweight, 79.8 g) were allocated to a 7000 L cylindrical tank. A switch with a string that ends in a rubber, pellet-like knob was used. The feeding device delivered 90-120 pellets by activation of the switch. In both experiments, yellowtail learned demand-feeding within 1-3 days. The number of feeder actuations gradually increased during the experimental period in both experiments, presumably relating both to the rate of learning and to growth of the fish. The yellowtails in the indoor system showed a clear diurnal feeding pattern synchronizing to the given photoperiod, whereas those in the outdoor system showed a clear nocturnal feeding pattern also synchronizing to the outdoor natural photoperiod. Thus, the results showed that yellowtail has an ability for demand-feeding both in light and dark phases. These exact opposite results may have been caused by the difference in intensity of the luminance between the inside of the experimental room and the outdoors.	Mie Univ, Fac Bioresources, Tsu, Mie 5148507, Japan; Fisheries Res Inst Mie, Owase Branch Stn, Owase, Mie 5193602, Japan; Univ Tokyo, Grad Sch Agr & Life Sci, Dept Aquat Biosci, Bunkyo Ku, Tokyo 1138657, Japan; Univ Murcia, Fac Biol, Dept Physiol & Pharmacol, E-30100 Murcia, Spain; Teikyo Univ Sci & Technol, Dept Biosci, Yamanashi 4090100, Japan	Kohbara, J (reprint author), Mie Univ, Fac Bioresources, Tsu, Mie 5148507, Japan.						ADRON JW, 1973, J FISH BIOL, V5, P625, DOI 10.1111/j.1095-8649.1973.tb04497.x; ALANARA A, 1992, AQUACULTURE, V108, P347, DOI 10.1016/0044-8486(92)90118-5; Alanara A, 1996, AQUACULTURE, V145, P1, DOI 10.1016/S0044-8486(96)01346-4; ALOISI DB, 1994, PROG FISH CULT, V56, P40, DOI 10.1577/1548-8640(1994)056<0040:GOHRLT>2.3.CO;2; BRANNAS E, 1993, J FISH BIOL, V42, P209, DOI 10.1111/j.1095-8649.1993.tb00322.x; ALANARA A, 1992, AQUACULTURE, V108, P357, DOI 10.1016/0044-8486(92)90119-6; BOUJARD T, 1994, AQUAT LIVING RESOUR, V7, P211, DOI 10.1051/alr:1994023; GLASS CW, 1986, J FISH BIOL, V29, P71, DOI 10.1111/j.1095-8649.1986.tb05000.x; Sanchez-Vazquez FJ, 1998, CHRONOBIOL INT, V15, P607, DOI 10.3109/07420529808993197; Azzaydi M, 1998, AQUACULTURE, V163, P285, DOI 10.1016/S0044-8486(98)00238-5; SanchezVazquez FJ, 1995, J BIOL RHYTHM, V10, P256, DOI 10.1177/074873049501000308; Boujard T, 1996, AQUACULTURE, V139, P117, DOI 10.1016/0044-8486(95)01148-X; BOUJARD T, 1992, J FISH BIOL, V40, P535, DOI 10.1111/j.1095-8649.1992.tb02603.x; BRANNAS E, 1994, J FISH BIOL, V45, P423, DOI 10.1111/j.1095-8649.1994.tb01325.x; Eriksson L.-O., 1978, P69; LANDLESS PJ, 1976, AQUACULTURE, V7, P11, DOI 10.1016/0044-8486(76)90028-4; MITANI F, 1958, NIPPON SUISAN GAKK, V24, P182; OSHIMA I, 1987, PHYSIOL BEHAV, V43, P115; ROZIN P, 1961, AM J PHYSIOL, V201, P968; SANCHEZVAZQUEZ FJ, 1994, PHYSIOL BEHAV, V56, P789, DOI 10.1016/0031-9384(94)90244-5; SOMIYA H, 1991, FISH PHYSIOL, P403; TAKAHASHI M, 1984, Nippon Suisan Gakkaishi, V50, P1475; TAKAHASHI M, 1981, NIPPON SUISAN GAKK, V47, P1131; TAKAHASHI M, 1981, NIPPON SUISAN GAKK, V47, P1135	24	16	18	JAPANESE SOC FISHERIES SCIENCE	TOKYO	C/O TOKYO UNIV FISHERIES, KONAN 4, MINATO, TOKYO, 108-8477, JAPAN	0919-9268			FISHERIES SCI	Fish. Sci.	OCT	2000	66	5					955	962		10.1046/j.1444-2906.2000.00152.x		8	Fisheries	Fisheries	370GK	WOS:000165115000022		
J	Yokoyama, H; Wakabayashi, S				Yokoyama, H; Wakabayashi, S			Myxobolus aeglefini found in the skeletal muscle of porous-head eelpout Allolepis hollandi from the Sea of Japan	FISHERIES SCIENCE			English	Article						Allolepis hollandi; cartilage; Myxobolus aeglefini; myxosporean; Myxozoa; porous-head eelpout	HEMORRHAGIC THELOHANELLOSIS; MYXOSPOREA; MYXOZOA; CARP	A myxosporean parasite was found in the skeletal muscle of porous-head eelpout Allolepis hollandi (Zoarcidae: Perciformes) caught in the Sea of Japan. White pseudocysts, about 3 mm in size, were distributed randomly over the musculature, and gave a negative impact on the appearance of fish products. Fresh spores of the myxosporean were subspherical in shape, 12.0 (11.2-13.5) mum long, 11.0 (10.5-12.0) mum wide, and 7.7 (6.9-8.4) mum thick. Two almost equal polar capsules were 4.8 (3.9-5.4) mum long. A mucous envelope was present around the posterior part of spores. Histological observations revealed that the plasmodia were encased by the host's cartilaginous tissue. Based on spore morphology, tissue-preference and ecological characteristics, we identified the myxosporean as Myxobolus aeglefini Auerbach 1906. This is the first record of a myxosporean infection in porous-head eelpout.	Univ Tokyo, Grad Sch Agr & Life Sci, Dept Aquat Biosci, Bunkyo Ku, Tokyo 1138657, Japan; Toyama Prefectural Fisheries Expt Stn, Toyama 9368536, Japan	Yokoyama, H (reprint author), Univ Tokyo, Grad Sch Agr & Life Sci, Dept Aquat Biosci, Bunkyo Ku, Tokyo 1138657, Japan.						Sugiyama A, 1999, FISH PATHOL, V34, P39; LOM J, 1989, J FISH DIS, V12, P151, DOI 10.1111/j.1365-2761.1989.tb00287.x; Auerbach M., 1906, Zoologischer Anzeiger Leipzig, V30; KABATA Z, 1956, PARASITOLOGY, V27, P165; LANDSBERG JH, 1991, SYST PARASITOL, V18, P165, DOI 10.1007/BF00009358; Liyanage YS, 1998, FISH PATHOL, V33, P489; Lom J., 1995, P97; Lom J., 1992, PROTOZOAN PARASITES; Molnar Kalman, 1994, Parasitologia Hungarica, V27, P5; Nakabo T, 1993, FISHES JAPAN PICTORI; OGAWA K, 1992, J FISH BIOL, V41, P363, DOI 10.1111/j.1095-8649.1992.tb02665.x; Yokoyama H, 1998, FISH PATHOL, V33, P85; Yokoyama H, 1996, FISH PATHOL, V31, P19	13	4	4	JAPANESE SOC FISHERIES SCIENCE	TOKYO	C/O TOKYO UNIV FISHERIES, KONAN 4, MINATO, TOKYO, 108-8477, JAPAN	0919-9268			FISHERIES SCI	Fish. Sci.	OCT	2000	66	5					963	966		10.1046/j.1444-2906.2000.00153.x		4	Fisheries	Fisheries	370GK	WOS:000165115000023		
J	Masuda, R; Tsukamoto, K				Masuda, R; Tsukamoto, K			Onset of association behavior in striped jack, Pseudocaranx dentex, in relation to floating objects	FISHERY BULLETIN			English	Article							JUVENILES; FISHES		Kyoto Univ, Fisheries Res Stn, Kyoto 6250086, Japan; Univ Tokyo, Ocean Res Inst, Tokyo 1648639, Japan	Masuda, R (reprint author), Kyoto Univ, Fisheries Res Stn, Kyoto 6250086, Japan.						*AB CONC INC, 1992, STAT VIEW VERS 4 5 1; GOODING RM, 1967, PAC SCI, V21, P486; Masuda R, 1998, B MAR SCI, V62, P337; Masuda R, 1998, J FISH BIOL, V52, P483, DOI 10.1006/jfbi.1997.0597; KINGSFORD MJ, 1993, B MAR SCI, V53, P393; Clarke TA, 1998, B MAR SCI, V62, P947; GREENBLATT PR, 1979, FISH B-NOAA, V77, P147; HUNTER JR, 1968, J CONSEIL, V31, P427; Hunter J. R., 1967, Fishery Bulletin Fish and Wildlife Service US, V66, P13; IBRAHIM S, 1990, FISH RES, V9, P299, DOI 10.1016/0165-7836(90)90048-Z; MASUDA R, 1996, MAR FREHS BEHAV PHYS, P2875; Sakakura Y, 1997, FISHERIES SCI, V63, P37; SENTA T, 1965, STUDY SERIES, V13; TACHIHARA K, 1993, NIPPON SUISAN GAKK, V59, P1479; YABE H, 1950, NIPPON SUISAN GAKK, V16, P35; Zar J. H., 1996, BIOSTATISTICAL ANAL	16	10	10	NATL MARINE FISHERIES SERVICE SCIENTIFIC PUBL OFFICE	SEATTLE	7600 SAND POINT WAY NE BIN C15700, SEATTLE, WA 98115 USA	0090-0656			FISH B-NOAA	Fish. Bull.	OCT	2000	98	4					864	869				6	Fisheries	Fisheries	381EV	WOS:000165750100020		
J	Kambe, T; Hatakeyama, N				Kambe, T; Hatakeyama, N			Statistical laws and vortex structures in fully developed turbulence	FLUID DYNAMICS RESEARCH			English	Article							ISOTROPIC TURBULENCE; PROBABILITY DENSITY; HOMOGENEOUS TURBULENCE; VELOCITY DIFFERENCES; INTENSE VORTICITY; SCALING EXPONENTS; FILAMENTS; DISTRIBUTIONS; TEMPERATURE; INCREMENTS	Fully developed turbulence is structured with a number of intense elongated vortices. Recognizing that statistical laws are related to such structures, the flow field is modeled by an ensemble of strained vortices (i.e. Burgers vortices) distributing randomly in space, from which probability density functions (pdfs) for longitudinal and transversal components of velocity difference are derived by taking statistical averages ensuring isotropy and homogeneity for the velocity field. It is found that the pdfs tend to close-to-exponential forms at small scales, and that there exist two scaling ranges in the structure function of every order, which are identified as the viscous range and inertial range, respectively, with a transition scale between the two ranges being at the order of mean size of Burgers vortices. Velocity structure functions show scaling behaviors in the second interval corresponding to the inertial range with the scaling exponents close to those known in the experiments and direct numerical simulations. It is remarkable that the Kolmogorov's four-fifths law is observed to be valid in a small-scale range. The scaling exponents of higher order structure functions are numerically estimated up to the 25th order. It is found that asymptotic scaling exponents, as the order increases, are in good agreement with the behavior of a recent experiment. The above model analysis is considered to represent successfully the statistical behaviors at small scales (possibly less than the Taylor microscale) and higher orders. The present statistical analysis leads to scale-dependent probability density functions. (C) 2000 The Japan Society of Fluid Mechanics and Elsevier Science B.V. All rights reserved.	Univ Tokyo, Dept Phys, Bunkyo Ku, Tokyo 1130033, Japan	Kambe, T (reprint author), Univ Tokyo, Dept Phys, Bunkyo Ku, Tokyo 1130033, Japan.						Hatakeyama N, 1997, PHYS REV LETT, V79, P1257, DOI 10.1103/PhysRevLett.79.1257; Jimenez J, 1998, J FLUID MECH, V373, P255, DOI 10.1017/S0022112098002341; JIMENEZ J, 1993, J FLUID MECH, V255, P65, DOI 10.1017/S0022112093002393; Friedrich R, 1997, PHYS REV LETT, V78, P863, DOI 10.1103/PhysRevLett.78.863; Min IA, 1996, PHYS FLUIDS, V8, P1169, DOI 10.1063/1.868908; LUNDGREN TS, 1982, PHYS FLUIDS, V25, P2193, DOI 10.1063/1.863957; TOWNSEND AA, 1951, PROC R SOC LON SER-A, V208, P534, DOI 10.1098/rspa.1951.0179; SHE ZS, 1990, NATURE, V344, P226, DOI 10.1038/344226a0; SHE ZS, 1994, PHYS REV LETT, V72, P336, DOI 10.1103/PhysRevLett.72.336; ARAD I, 2000, COMMUNICATION; BATCHELOR GK, 1953, THEORY HOMOGENEOUS T, pCH5; Belin F, 1996, PHYSICA D, V93, P52, DOI 10.1016/0167-2789(95)00279-0; Belin F, 1996, J PHYS II, V6, P573, DOI 10.1051/jp2:1996198; BELIN F, 1999, P 2 MONT VER C FUND; Burgers J. M., 1948, ADV APPL MECH, V1, P171, DOI DOI 10.1016/S0065-2156(08)70100-5; CADOT O, 1995, PHYS FLUIDS, V7, P630, DOI 10.1063/1.868586; Castaing B, 1996, J PHYS II, V6, P105, DOI 10.1051/jp2:1996172; Ching ESC, 1996, PHYS REV E, V54, P6364, DOI 10.1103/PhysRevE.54.6364; DOUADY S, 1991, PHYS REV LETT, V67, P983, DOI 10.1103/PhysRevLett.67.983; Feller W., 1971, INTRO PROBABILITY TH, V2; Friedrich R, 1998, EUROPHYS LETT, V41, P153, DOI 10.1209/epl/i1998-00124-7; FRIEDRICH R, 2000, COMPLETE STAT CHARAC; Frisch U., 1995, TURBULENCE; HATAKEYAMA N, 1998, ADV TURBULENCE, V7, P339; HE G, 1998, CHAODYN9803029; He GW, 1998, PHYS LETT A, V245, P419, DOI 10.1016/S0375-9601(98)00468-X; He GW, 1998, PHYS REV LETT, V81, P4636, DOI 10.1103/PhysRevLett.81.4636; Hosokawa I, 1997, J PHYS SOC JPN, V66, P2961, DOI 10.1143/JPSJ.66.2961; Kambe T., 1995, Small-Scale Structures in Three-Dimensional Hydrodynamic and Magnetohydrodynamic Turbulence. Proceedings; Kambe T., 1984, Turbulence and Chaotic Phenomena in Fluids. Proceedings of the International Symposium; KAMBE T, 1984, J PHYS SOC JPN, V53, P13, DOI 10.1143/JPSJ.53.13; Kida S, 1998, J PHYS SOC JPN, V67, P2166, DOI 10.1143/JPSJ.67.2166; Kolmogoroff AN, 1941, CR ACAD SCI URSS, V32, P16; Kolmogoroff A, 1941, CR ACAD SCI URSS, V30, P301; LANDAU LD, 1987, FLUID MECH, V34; Lvov VS, 1997, PHYS REV LETT, V79, P2050, DOI 10.1103/PhysRevLett.79.2050; Noullez A, 1997, J FLUID MECH, V339, P287, DOI 10.1017/S0022112097005338; POPE SB, 1993, PHYS FLUIDS A-FLUID, V5, P1529, DOI 10.1063/1.858830; PRASKOVSKY A, 1994, PHYS REV LETT, V73, P3399, DOI 10.1103/PhysRevLett.73.3399; PULLIN DI, 1993, PHYS FLUIDS A-FLUID, V5, P126, DOI 10.1063/1.858798; RENNER C, 1999, P 2 MONT VER C FUND; Risken H., 1989, FOKKER PLANCK EQUATI; Saffman PG, 1996, PHYS FLUIDS, V8, P3072, DOI 10.1063/1.869081; SHE ZS, 1998, PROG THEOR PHYS, V130, P87, DOI 10.1143/PTPS.130.87; SINAI YG, 1989, PHYS REV LETT, V63, P1962, DOI 10.1103/PhysRevLett.63.1962; STOLOVITZKY G, 1993, PHYS REV E, V48, pR3217; Takahashi N, 1999, J PHYS SOC JPN, V68, P86, DOI 10.1143/JPSJ.68.86; Tanahashi M., 1997, P 11 S TURB SHEAR FL, V1, P4; van de Water W, 1999, J FLUID MECH, V387, P3, DOI 10.1017/S0022112099004814; VINCENT A, 1991, J FLUID MECH, V225, P1, DOI 10.1017/S0022112091001957; Yakhot V, 1998, PHYS REV E, V57, P1737, DOI 10.1103/PhysRevE.57.1737; YAMAMOTO K, 1998, COMMUNICATION; YAMAMOTO K, 1988, J PHYS SOC JPN, V57, P1532, DOI 10.1143/JPSJ.57.1532	53	6	6	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	0169-5983			FLUID DYN RES	Fluid Dyn. Res.	OCT	2000	27	4					247	267		10.1016/S0169-5983(00)00007-1		21	Mechanics; Physics, Fluids & Plasmas	Mechanics; Physics	342HW	WOS:000088640000004		
J	Tanaka, K; Wen, C; Yamada, K				Tanaka, K; Wen, C; Yamada, K			Design and evaluation of combined cycle system with solid oxide fuel cell and gas turbine	FUEL			English	Article						solid oxide fuel cell; combined cycle system; life cycle analysis; economics and environment	EFFICIENCY; TECHNOLOGY	This study describes the basic design/evaluation of a combined cycle power generation system using solid oxide fuel cells in conjunction with a gas turbine. Factors included are system performance and cost/energy pay-back times (CPT/EPT). Total generation efficiency (E-th) was analyzed from the standpoint of plant size, cell performance, working pressure/temperature, steam carbon ratio, fuel/air utilization ratios (U-f/U-a) and turbine inlet temperature (TIT). A calculation method for determining the system life cycle cost and input energy requirements is also proposed. Results show that Eth is higher than that for conventional power plants; it has a working temperature/pressure of 1073 K/0.4 MPa, E-th = 68.3% with CPT = 9.3 years and EPT = 0.71 years with load following capability from 60 to 121% nominal load. The main parameters for determining Eth, CPT and EPT were found to be working temperature, cell performance, U-a and TIT limitation. Also discussed in detail are development areas and targets. (C) 2000 Elsevier Science Ltd. All rights reserved.	Global Ind & Social Prog Res Inst, Tokyo 1050001, Japan; Univ Tokyo, Dept Chem Syst Engn, Tokyo 1138656, Japan; Shinshu Univ, Dept Fine Mat Engn, Nagano 3868567, Japan	Tanaka, K (reprint author), Global Ind & Social Prog Res Inst, 2-1-1 Toranomon, Tokyo 1050001, Japan.						ABUDULA A, 1997, DENKI KAGAKU, V10, P65; Fukunaga H, 1996, SOLID STATE IONICS, V86-8, P1179, DOI 10.1016/0167-2738(96)00284-6; ARCHER DH, 1996, P INT EN CONV ENG C, V2, P1117; BEVEC F, 1997, J POWER ENERGY A, V211, P359; BEVEC FP, 1996, 96GT447 ASME; HARVEY SP, 1994, J ENERG RESOUR-ASME, V116, P305, DOI 10.1115/1.2906458; HARVEY SP, 1994, J ENERG RESOUR-ASME, V116, P312, DOI 10.1115/1.2906459; MINKOV V, 1988, POWER ENG, V92, P35; NAMIE S, 1993, T JPN SOC MECH ENG-B, V59, P2702; Rokni M, 1993, ASME COGEN TURBO IGT, V8, P255; Singhal SC, 1997, ELEC SOC S, V97, P37; STEPHENSON D, 1997, 974T340 ASME; SUZUKI M, 1997, THESIS U TOKYO JAPAN; Tanaka K, 1998, KAGAKU KOGAKU RONBUN, V24, P597	14	47	50	ELSEVIER SCI LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND	0016-2361			FUEL	Fuel	OCT	2000	79	12					1493	1507		10.1016/S0016-2361(99)00293-8		15	Energy & Fuels; Engineering, Chemical	Energy & Fuels; Engineering	336GL	WOS:000088293500010		
J	Rand, MK; Ohtsuki, T				Rand, MK; Ohtsuki, T			EMG analysis of lower limb muscles in humans during quick change in running directions	GAIT & POSTURE			English	Article						gait modification; electromyography; open maneuver; cross maneuver; turning	WALKING; DELAY	Open and cross maneuvers for changing running direction were studied to characterize selective EMG activity between the maneuvers. Eleven subjects turned towards the right or the left during running. The gluteus medius modified foot trajectory of the leading leg during the open maneuver, whereas the sartorius worked modestly during the cross maneuver. Compared with the cross maneuver the open maneuver exhibited greater vastus medialis and gastrocnemius activity during the ground support phase, faster running speed and wider turning angle. These results suggest that the open maneuver is more effective than the cross maneuver for quickly changing running direction. (C) 2000 Elsevier Science B.V. All rights reserved.	Arizona State Univ, Motor Control Lab, Tempe, AZ 85287 USA; Univ Tokyo, Grad Sch Arts & Sci, Dept Life Sci, Meguro Ku, Tokyo 1538902, Japan	Rand, MK (reprint author), Arizona State Univ, Motor Control Lab, Box 870404, Tempe, AZ 85287 USA.						Andrews J R, 1977, Am J Sports Med, V5, P111, DOI 10.1177/036354657700500303; NORMAN RW, 1979, ACTA PHYSIOL SCAND, V106, P241, DOI 10.1111/j.1748-1716.1979.tb06394.x; PATLA AE, 1991, J EXP PSYCHOL HUMAN, V17, P603, DOI 10.1037/0096-1523.17.3.603; Zhou S, 1996, EUR J APPL PHYSIOL O, V72, P410, DOI 10.1007/BF00242269; Hase K, 1998, J NEUROPHYSIOL, V80, P255; CAVANAGH PR, 1979, EUR J APPL PHYSL, V42, P150; DUVALL EN, 1955, KINESIOLOGY ANATOMY, P60; Goto Y, 1975, ANN PHYS EDU OSAKA C, V11, P55; HAMILL J, 1987, INT J SPORT BIOMECH, V3, P276; HASAN SS, 1991, J ELECTROMYOGR KINES, V1, P218, DOI 10.1016/1050-6411(91)90037-6; KAHLE W, 1992, COLOR ATLAS TXB HUAN; Keppel G., 1991, DESIGN ANAL RESEARCH; MATSUSHITA M, 1970, RES B DEP ED NAGOYA, V14, P76; OHTSUKI T, 1987, BIOMECHANICS, V10, P629; OHTSUKI T, 1988, BIOMECHANICS, V11, P820; OHTSUKI T, 1989, P 12 INT C BIOM; Okamoto T, 1987, Electromyogr Clin Neurophysiol, V27, P173; SCHOT P, 1995, J ORTHOP SPORT PHYS, V22, P254; SIMONSEN EB, 1985, EUR J APPL PHYSIOL O, V54, P524, DOI 10.1007/BF00422964; TIBONE JE, 1986, AM J SPORT MED, V14, P276, DOI 10.1177/036354658601400406; VOS E J, 1991, Medicine and Science in Sports and Exercise, V23, P1187	21	29	29	ELSEVIER SCI IRELAND LTD	CLARE	CUSTOMER RELATIONS MANAGER, BAY 15, SHANNON INDUSTRIAL ESTATE CO, CLARE, IRELAND	0966-6362			GAIT POSTURE	Gait Posture	OCT	2000	12	2					169	183		10.1016/S0966-6362(00)00073-4		15	Neurosciences; Orthopedics; Sport Sciences	Neurosciences & Neurology; Orthopedics; Sport Sciences	359WZ	WOS:000089636200012		
J	Matsui, A; Postlewaite, A				Matsui, A; Postlewaite, A			Specialization of labor and the distribution of income	GAMES AND ECONOMIC BEHAVIOR			English	Article						division of labor; specialization of labor; income distribution	DIVISION	We analyze a model in which workers must be allocated to tasks to produce. There are differences among the workers in absolute ability that are independent of the activity they perform. We demonstrate a unique competitive equilibrium that determines both wages and the allocation of workers to tasks. The equilibrium wage has the property that workers assigned to the lowest "value-added" tasks will receive a "premium" above their identifiable contribution to value simply for filling these least valuable positions. We examine how the equilibrium wage function changes as the production process becomes more specialized and the division of labor increases. Classification Numbers: D31, D33, J31. (C) 2000 Academic Press.	Univ Tokyo, Fac Econ, Bunkyo Ku, Tokyo 1130033, Japan; Univ Penn, Dept Econ, Philadelphia, PA 19104 USA	Matsui, A (reprint author), Univ Tokyo, Fac Econ, Bunkyo Ku, Tokyo 1130033, Japan.						Roy AD, 1951, OXFORD ECON PAP, V3, P135; Stigler GJ, 1951, J POLIT ECON, V59, P185, DOI 10.1086/257075; ROSEN S, 1978, ECONOMICA, V45, P235, DOI 10.2307/2553070; BECKER GS, 1992, Q J ECON, V107, P1137, DOI 10.2307/2118383; KIM S, 1989, J POLIT ECON, V97, P692, DOI 10.1086/261622; MACDONALD GM, 1985, J POLIT ECON, V93, P277, DOI 10.1086/261300; Murphy Kevin M., 1986, THESIS U CHICAGO; SATTINGER M, 1993, J ECON LIT, V31, P831	8	0	0	ACADEMIC PRESS INC	SAN DIEGO	525 B ST, STE 1900, SAN DIEGO, CA 92101-4495 USA	0899-8256			GAME ECON BEHAV	Games Econ. Behav.	OCT	2000	33	1					72	89		10.1006/game.1999.0773		18	Economics	Business & Economics	364UP	WOS:000089911600005		
J	Ueda, N; Ohnishi, H; Kanamaru, C; Suzuki, J; Tsuchida, T; Mashima, H; Yasuda, H; Fujita, T				Ueda, N; Ohnishi, H; Kanamaru, C; Suzuki, J; Tsuchida, T; Mashima, H; Yasuda, H; Fujita, T			Kinesin is involved in regulation of rat pancreatic amylase secretion	GASTROENTEROLOGY			English	Article							CELLS; TRANSPORT; PHOSPHORYLATION; EXOCYTOSIS; PROTEINS; BINDING; RELEASE; KIDNEY; CHAINS; MOTOR	Background & Aims: Kinesin has recently been localized to zymogen granules of pancreatic acini and is suggested to participate in exocytosis of exocrine pancreas, We examined the function of kinesin in regulated exocytosis of pancreatic acini in this study, Methods: Kinesin function in exocytosis was examined by introducing hexahistidine-tagged recombinant kinesin protein and antikinesin monoclonal antibody into streptolysin-O-permeabilized acini. Intracellular localization of introduced recombinant kinesin was investigated by immunohistochemistry. Interaction between recombinant kinesin and the microtubule network was confirmed by nocodazole pretreatment of acini, Kinesin regulation by secretagogues was investigated by examining their effect on adenosine triphosphatase (ATPase) activity of endogenous kinesin, Results: Recombinant kinesin enhanced calcium-stimulated amylase release from streptolysin-O-permeabilized acini, Introduced recombinant kinesin was localized to both the microtubule network and zymogen granule, Nocodazole pretreatment of acini abolished the enhancing effect of recombinant kinesin on calcium-stimulated amylase release. Antikinesin antibody inhibited amylase release stimulated by the combination of calcium and cyclic adenosine monophosphate (cAMP) but not that stimulated by calcium alone, Secretin and 8-bromo-cAMP increased ATPase activity of endogenous kinesin. Conclusions: Kinesin plays a stimulatory role in regulated exocytosis of pancreatic acini and is involved in stimulus-secretion coupling through a cAMP-dependent pathway.	Univ Tokyo, Sch Med, Dept Internal Med 4, Bunkyo Ku, Tokyo 1128688, Japan	Ohnishi, H (reprint author), Univ Tokyo, Sch Med, Dept Internal Med 4, Bunkyo Ku, 3-28-6 Mejirodai, Tokyo 1128688, Japan.						Ohnishi H, 1996, AM J PHYSIOL-GASTR L, V271, pG531; BRADY ST, 1995, TRENDS CELL BIOL, V5, P159, DOI 10.1016/S0962-8924(00)88980-1; Buster D, 1991, J Cell Sci Suppl, V14, P109; CLOE NB, 1995, CURR OPIN CELL BIOL, V7, P55; HAMIO LT, 1995, TRENDS CELL BIOL, V5, P165; Hamm-Alvarez SF, 1998, PHYSIOL REV, V78, P1109; INGOLD AL, 1988, J CELL BIOL, V107, P2657, DOI 10.1083/jcb.107.6.2657; LAFONT F, 1994, NATURE, V372, P801; Marlowe KJ, 1998, EUR J CELL BIOL, V75, P140; MATTHIES HJG, 1993, J BIOL CHEM, V268, P11176; McNiven MA, 1999, GASTROENTEROLOGY, V116, P438, DOI 10.1016/S0016-5085(99)70142-3; MIDDLETON K, 1994, P NATL ACAD SCI USA, V91, P7212, DOI 10.1073/pnas.91.15.7212; MUALLEM S, 1995, J CELL BIOL, V128, P589, DOI 10.1083/jcb.128.4.589; Ohnishi H, 1997, J CLIN INVEST, V100, P3044, DOI 10.1172/JCI119859; Ohnishi H, 1999, GASTROENTEROLOGY, V116, P943, DOI 10.1016/S0016-5085(99)70078-8; Ohnishi H, 1997, J BIOL CHEM, V272, P16056, DOI 10.1074/jbc.272.25.16056; STEINHARDT RA, 1994, SCIENCE, V263, P390, DOI 10.1126/science.7904084; STOCK C, 1978, LAB INVEST, V38, P157; WAGNER ACC, 1994, DIGESTION, V55, P191; WILLIAMS JA, 1976, J CELL BIOL, V71, P795, DOI 10.1083/jcb.71.3.795	20	10	11	W B SAUNDERS CO	PHILADELPHIA	INDEPENDENCE SQUARE WEST CURTIS CENTER, STE 300, PHILADELPHIA, PA 19106-3399 USA	0016-5085			GASTROENTEROLOGY	Gastroenterology	OCT	2000	119	4					1123	1131		10.1053/gast.2000.18145		9	Gastroenterology & Hepatology	Gastroenterology & Hepatology	363RF	WOS:000089847800028		
J	Matsushita, M; Tsuchiya, N; Oka, T; Yamane, A; Tokunaga, K				Matsushita, M; Tsuchiya, N; Oka, T; Yamane, A; Tokunaga, K			New polymorphisms of human CD80 and CD86: lack of association with rheumatoid arthritis and systemic lupus erythematosus	GENES AND IMMUNITY			English	Article						CD28; CD80; CD86; SNP; promoter; rheumatoid arthritis; systemic lupus erythematosus	HOMODUPLEX FORMATION ASSAY; GENOMIC ORGANIZATION; MURINE HOMOLOG; T-CELLS; COSTIMULATORY MOLECULES; CHROMOSOMAL LOCATION; GENE VARIATIONS; GRAVES-DISEASE; B7.1 GENE; PCR-PHFA	The crucial role of costimulatory molecules, CD28, CTLA-4, CD80 and CD86, for T cell activation and inhibition has been established. In the previous study, we reported the results of a polymorphism screening of human CTLA-4 gene. In this study, we screened for polymorphisms of human CD28, CD80 and CD86 genes, and detected that polymorphisms were tested for the association with rheumatoid arthritis (RA) and systemic lupus erythematosus (SLE). Variations were identified in the coding regions of CD80 (452G/A, 614C/G and 864A/G) and CD86 (1057A/G), while no variation was observed in the coding region of CD28. The variations at CD80 position 452 and CD86 position 1057 were present in a substantial proportion of the Japanese population, and were considered to be single nucleotide polymorphisms within the coding sequence (cSNPs). CD80 864 (G-->A) leads to the amino acid substitution N186D, and CD86 1057 (A-->G) results in A304T substitution. Furthermore, in the analysis of CD80 5'-flanking region, six SNPs, -454C/A, -387T/C, -232G/A, -79G/C, -7T/C and +5C/A, and one insertion, -558ins (CATGA), were identified The combination of these variations was found to constitute four promoter alleles of CD80. None of the observed variations was significantly associated with RA or SLE. Further studies will be of particular interest to examine the functional difference of the promoter alleles for the transcriptional activity of CD80, as well as the evolutionary pathway of the four alleles.	Univ Tokyo, Grad Sch Med, Dept Human Genet, Bunkyo Ku, Tokyo 1130033, Japan; Wakunaga Pharmaceut Co Ltd, Biotechnol Res Inst, Hiroshima 7391105, Japan	Tsuchiya, N (reprint author), Univ Tokyo, Grad Sch Med, Dept Human Genet, Bunkyo Ku, 7-3-1 Hongo, Tokyo 1130033, Japan.			Tsuchiya, Naoyuki/0000-0002-6776-5580			Amett FC, 1988, ARTHRITIS RHEUM, V31, P315; GROSS JA, 1990, J IMMUNOL, V144, P3201; KRUMMEL MF, 1995, J EXP MED, V182, P459, DOI 10.1084/jem.182.2.459; NICKOLOFF BJ, 1994, BLOOD, V83, P2580; SHAHINIAN A, 1993, SCIENCE, V261, P609, DOI 10.1126/science.7688139; Fujiwara K, 1996, BRIT J HAEMATOL, V95, P198, DOI 10.1046/j.1365-2141.1996.d01-1871.x; Schaub M, 1999, J NEUROIMMUNOL, V96, P158, DOI 10.1016/S0165-5728(99)00022-3; FREEMAN GJ, 1993, J EXP MED, V178, P2185, DOI 10.1084/jem.178.6.2185; Greene JAL, 1996, J BIOL CHEM, V271, P26762; FREEMAN GJ, 1991, J EXP MED, V174, P625, DOI 10.1084/jem.174.3.625; Matsushita M, 1999, TISSUE ANTIGENS, V54, P578, DOI 10.1034/j.1399-0039.1999.540607.x; HARPER K, 1991, J IMMUNOL, V147, P1037; YANAGAWA T, 1995, J CLIN ENDOCR METAB, V80, P41, DOI 10.1210/jc.80.1.41; HATHCOCK KS, 1994, J EXP MED, V180, P631, DOI 10.1084/jem.180.2.631; Komata T, 1999, TISSUE ANTIGENS, V53, P527, DOI 10.1034/j.1399-0039.1999.530602.x; PEACH RJ, 1995, J BIOL CHEM, V270, P21181; Donner H, 1997, J CLIN ENDOCR METAB, V82, P4130, DOI 10.1210/jc.82.12.4130; KUCHROO VK, 1995, CELL, V80, P707, DOI 10.1016/0092-8674(95)90349-6; Hutloff A, 1999, NATURE, V397, P263; Nistico L, 1996, HUM MOL GENET, V5, P1075, DOI 10.1093/hmg/5.7.1075; Donner H, 1997, J CLIN ENDOCR METAB, V82, P143, DOI 10.1210/jc.82.1.143; RACKE MK, 1995, J CLIN INVEST, V96, P2195, DOI 10.1172/JCI118274; BOUSSIOTIS VA, 1993, P NATL ACAD SCI USA, V90, P11059, DOI 10.1073/pnas.90.23.11059; CORNELIS F, 1998, P NATL ACAD SCI USA, V95, P10740; Fong TC, 1996, J IMMUNOL, V157, P4442; Guo Y, 1998, MOL IMMUNOL, V35, P215, DOI 10.1016/S0161-5890(98)00041-8; Hagiwara K, 1999, IMMUNOGENETICS, V50, P363, DOI 10.1007/s002510050615; Hatta Y, 1999, IMMUNOGENETICS, V49, P280, DOI 10.1007/s002510050494; Hatta Y, 1999, GENES IMMUN, V1, P53, DOI 10.1038/sj.gene.6363639; Heinemeyer T., 1998, NUCLEIC ACIDS RES, V26, P364, DOI DOI 10.1093/NAR/26.1.362; Imanishi T, 1992, HLA 1991, V1, P76; INOBE M, 1994, BIOCHEM BIOPH RES CO, V200, P443, DOI 10.1006/bbrc.1994.1469; JELLIS CL, 1995, IMMUNOGENETICS, V42, P85; KATO H, 1999, GENES IMMUN, V1, P967; LAFAGEPOCHITALOFF M, 1990, IMMUNOGENETICS, V31, P198; LEE KP, 1990, J IMMUNOL, V145, P344; Matsushita M, 1999, IMMUNOGENETICS, V49, P577, DOI 10.1007/s002510050540; Matsushita M, 1999, TISSUE ANTIGENS, V54, P478, DOI 10.1034/j.1399-0039.1999.540505.x; Mena E, 1999, ACTA NEUROL SCAND, V100, P92; Miller SD, 1995, IMMUNITY, V3, P739, DOI 10.1016/1074-7613(95)90063-2; MORRON MP, 1997, HUM MOL GENET, V6, P1275; OKA T, 1994, NUCLEIC ACIDS RES, V22, P1541, DOI 10.1093/nar/22.9.1541; Reeves RH, 1997, MAMM GENOME, V8, P581, DOI 10.1007/s003359900508; SELVAKUMAR A, 1992, IMMUNOGENETICS, V36, P175, DOI 10.1007/BF00661094; Takasaki Y, 1998, J RHEUMATOL, V25, P1085; TAN EM, 1982, ARTHRITIS RHEUM, V25, P1271, DOI 10.1002/art.1780251101; Tokunaga K, 1996, PREHISTORIC MONGOLOI, P187; VERWILGHEN J, 1994, J IMMUNOL, V153, P1378; Zhao JL, 1996, J EXP MED, V183, P777, DOI 10.1084/jem.183.3.777	49	32	32	NATURE PUBLISHING GROUP	BASINGSTOKE	HOUNDMILLS, BASINGSTOKE RG21 6XS, HAMPSHIRE, ENGLAND	1466-4879			GENES IMMUN	Genes Immun.	OCT	2000	1	7					428	434		10.1038/sj.gene.6363704		7	Genetics & Heredity; Immunology	Genetics & Heredity; Immunology	362GM	WOS:000089770300004		
J	Hirano, HY; Sano, Y				Hirano, HY; Sano, Y			Comparison of Waxy gene regulation in the endosperm and pollen in Oryza sativa L.	GENES & GENETIC SYSTEMS			English	Article							BOUND STARCH SYNTHASE; AMYLOSE CONTENT; SPLICE SITES; WX GENE; RICE; EXPRESSION; LOCUS; ACCUMULATION; ALTERNATE; LEVEL	The Waxy (Wx) gene controls amylose synthesis in rice (Oryza sativa) and its expression is regulated organ-specifically. The Wx gene is expressed in the endosperm and pollen but not in other organs. In order to know whether Wx gene regulation is the same in the endosperm and pollen, we compared expression patterns of the rice Wx gene in these two organs by immunoblot analysis. We focused on the allelic differences (Wx(a) and Wx(b)), cool temperature response and effects of the mutation at the du loci. The results obtained are as follows. First, the quantitative regulation depending on two alleles, Wx(a) and Wx(b), Was common to both organs; Wx protein levels from the Wxa allele were about 10-fold higher than those from the Wx(b) allele in the pollen as well as in the endosperm. Second, in both the endosperm and pollen, expression of the Wx(b) gene, but not the Wx(a) gene, was enhanced in response to cool temperature. In contrast to these two types of regulation, analysis of two du mutants, 2035 (du2) and 76-3 (du2), revealed that the pattern of reduction in Wx protein levels in the pollen was distinct from that in the endosperm, suggesting that functions of the two du(+) genes differ in these two organs.	Univ Tokyo, Grad Sch Agr & Life Sci, Bunkyo Ku, Tokyo 1138657, Japan; Hokkaido Univ, Grad Sch Agr, Sapporo, Hokkaido 0608589, Japan	Hirano, HY (reprint author), Univ Tokyo, Grad Sch Agr & Life Sci, Bunkyo Ku, Tokyo 1138657, Japan.	ahirano@mail.ecc.u-tokyo.ac.jp	Hirano, Hiro-Yuki/G-4928-2014	Hirano, Hiro-Yuki/0000-0001-7364-8893			AMANO E, 1981, ENVIRON HEALTH PERSP, V37, P35; Isshiki M, 1998, PLANT J, V15, P133, DOI 10.1046/j.1365-313X.1998.00189.x; Larkin PD, 1999, PLANT MOL BIOL, V40, P719, DOI 10.1023/A:1006298608408; KLOSGEN RB, 1986, MOL GEN GENET, V203, P237, DOI 10.1007/BF00333960; Bligh HFJ, 1998, PLANT MOL BIOL, V38, P407, DOI 10.1023/A:1006021807799; Hirano HY, 1998, MOL BIOL EVOL, V15, P978; Cai XL, 1998, PLANT J, V14, P459, DOI 10.1046/j.1365-313X.1998.00126.x; NELSON O, 1995, ANNU REV PLANT PHYS, V46, P475, DOI 10.1146/annurev.arplant.46.1.475; Hirano HY, 1998, PLANT CELL PHYSIOL, V39, P807; SANO Y, 1985, J HERED, V76, P221; Harlow E.D., 1988, ANTIBODIES LAB MANUA; HIRANO HY, 1991, PLANT CELL PHYSIOL, V32, P989; Itoh K, 1997, MOL GEN GENET, V255, P351, DOI 10.1007/s004380050506; Marillonnet S, 1997, PLANT CELL, V9, P967, DOI 10.1105/tpc.9.6.967; Mikami I, 1999, EUPHYTICA, V105, P91, DOI 10.1023/A:1003457209225; OKUNO K, 1983, JPN J BREED, V33, P387; Sano Y., 1985, GAMMA FIELD S, V24, P63; SANO Y, 1984, THEOR APPL GENET, V68, P467, DOI 10.1007/BF00254822; Sano Y., 1991, RICE GENETICS, P11; YANO M, 1988, THEOR APPL GENET, V76, P183, DOI 10.1007/BF00257844	20	12	15	GENETICS SOC JAPAN	SHIZUOKA-KEN	NATIONAL INST GENETICS YATA 1111, MISHIMA, SHIZUOKA-KEN, 411-8540, JAPAN	1341-7568	1880-5779		GENES GENET SYST	Genes Genet. Syst.	OCT	2000	75	5					245	249		10.1266/ggs.75.245		5	Biochemistry & Molecular Biology; Genetics & Heredity	Biochemistry & Molecular Biology; Genetics & Heredity	401MP	WOS:000166931500003		
J	Yanai, H; Satoh, K; Matsumine, A; Akiyama, T				Yanai, H; Satoh, K; Matsumine, A; Akiyama, T			The colorectal tumour suppressor APC is present in the NMDA-receptor-PSD-95 complex in the brain	GENES TO CELLS			English	Article							NMDA RECEPTOR SUBUNITS; POSTSYNAPTIC DENSITY; GUANYLATE KINASES; PSD-95 FAMILY; BETA-CATENIN; PDZ DOMAIN; PROTEIN; MEMBRANE; BINDING; ASSOCIATION	Background: The synaptic protein PSD-95/SAP90 interacts with ion channels such as the N-methyl-D-aspartate-receptor (NMDA-R) via its PDZ domain, and is involved in their clustering. Moreover, it interacts with signalling molecules and plays an important role in coupling NMDA-R to pathways that control synaptic plasticity and learning. Results: We report that PSD-95 interacts with the adenomatous polyposis coli (APC) tumour suppressor protein via its PDZ domain. Furthermore, we found that PSD-95, NMDA-R and APC are contained in the same complex in vivo. PSD-95-NMDA-R-APC association was found to require two cysteine residues conserved in the amino-terminus of PSD-95 that are known to be critical for its multimerization. Conclusion: Our findings suggest that the PSD-95-NMDA-R-APC complex forms due to the multimerization of PSD-95 monomers, each of which can associate with either NMDA-R or APC. It is possible that APC is involved in the regulation of ion channel clustering and/or organization of signalling molecules.	Univ Tokyo, Inst Mol & Cellular Biosci, Lab Mol & Genet Informat, Bunkyo Ku, Tokyo 113, Japan; Osaka Univ, Inst Microbial Dis, Dept Oncogene Res, Suita, Osaka 565, Japan	Akiyama, T (reprint author), Univ Tokyo, Inst Mol & Cellular Biosci, Lab Mol & Genet Informat, Bunkyo Ku, 1-1-1 Yayoi, Tokyo 113, Japan.						Lau LF, 1996, J BIOL CHEM, V271, P21622; Kim JH, 1998, NEURON, V20, P683, DOI 10.1016/S0896-6273(00)81008-9; Takeuchi M, 1997, J BIOL CHEM, V272, P11943, DOI 10.1074/jbc.272.18.11943; Chen HJ, 1998, NEURON, V20, P895, DOI 10.1016/S0896-6273(00)80471-7; KIM E, 1995, NATURE, V378, P85, DOI 10.1038/378085a0; RUBINFELD B, 1993, SCIENCE, V262, P1731, DOI 10.1126/science.8259518; Sattler R, 1999, SCIENCE, V284, P1845, DOI 10.1126/science.284.5421.1845; Brenman JE, 1996, J NEUROSCI, V16, P7407; Cadigan KM, 1997, GENE DEV, V11, P3286, DOI 10.1101/gad.11.24.3286; KORNAU HC, 1995, SCIENCE, V269, P1737, DOI 10.1126/science.7569905; Ehlers MD, 1996, CURR OPIN CELL BIOL, V8, P484, DOI 10.1016/S0955-0674(96)80024-X; Topinka JR, 1998, NEURON, V20, P125, DOI 10.1016/S0896-6273(00)80440-7; Tezuka T, 1999, P NATL ACAD SCI USA, V96, P435, DOI 10.1073/pnas.96.2.435; El-Husseini AE, 2000, J CELL BIOL, V148, P159, DOI 10.1083/jcb.148.1.159; Miller JR, 1996, GENE DEV, V10, P2527, DOI 10.1101/gad.10.20.2527; Irie M, 1997, SCIENCE, V277, P1511, DOI 10.1126/science.277.5331.1511; Kim E, 1997, J CELL BIOL, V136, P669, DOI 10.1083/jcb.136.3.669; Niethammer M, 1996, J NEUROSCI, V16, P2157; Hunt CA, 1996, J NEUROSCI, V16, P1380; Migaud M, 1998, NATURE, V396, P433; SU LK, 1993, SCIENCE, V262, P1734, DOI 10.1126/science.8259519; MULLER BM, 1995, J NEUROSCI, V15, P2354; Muller BM, 1996, NEURON, V17, P255, DOI 10.1016/S0896-6273(00)80157-9; Kim E, 1996, NEURON, V17, P103, DOI 10.1016/S0896-6273(00)80284-6; Hsueh YP, 1997, NEURON, V18, P803, DOI 10.1016/S0896-6273(00)80319-0; Craven SE, 1998, CELL, V93, P495, DOI 10.1016/S0092-8674(00)81179-4; FALLON JR, 1994, TRENDS NEUROSCI, V17, P469, DOI 10.1016/0166-2236(94)90135-X; Hsueh YP, 1999, J BIOL CHEM, V274, P532, DOI 10.1074/jbc.274.1.532; Kinzler KW, 1996, CELL, V87, P159, DOI 10.1016/S0092-8674(00)81333-1; KISTNER U, 1993, J BIOL CHEM, V268, P4580; Marfatia SM, 1996, J CELL BIOL, V135, P753, DOI 10.1083/jcb.135.3.753; Matsumine A, 1996, SCIENCE, V272, P1020, DOI 10.1126/science.272.5264.1020; Niethammer M, 1998, NEURON, V20, P693, DOI 10.1016/S0896-6273(00)81009-0; POLAKIS P, 1997, BIOCHIM BIOPHYS ACTA, V1332, P127; Satoh K, 1997, GENES CELLS, V2, P415, DOI 10.1046/j.1365-2443.1997.1310329.x; Senda T, 1998, NEUROSCIENCE, V83, P857, DOI 10.1016/S0306-4522(97)00459-4; Sheng M, 1996, NEURON, V17, P575, DOI 10.1016/S0896-6273(00)80190-7; Stathakis DG, 1997, GENOMICS, V44, P71, DOI 10.1006/geno.1997.4848; Ziff EB, 1997, NEURON, V19, P1163, DOI 10.1016/S0896-6273(00)80409-2	39	26	27	BLACKWELL SCIENCE LTD	OXFORD	P O BOX 88, OSNEY MEAD, OXFORD OX2 0NE, OXON, ENGLAND	1356-9597			GENES CELLS	Genes Cells	OCT	2000	5	10					815	822		10.1046/j.1365-2443.2000.00368.x		8	Cell Biology; Genetics & Heredity	Cell Biology; Genetics & Heredity	363WW	WOS:000089861500004		
J	Nakanishi, M; Ando, H; Watanabe, N; Kitamura, K; Ito, K; Okayama, H; Miyamoto, T; Agui, T; Sasaki, M				Nakanishi, M; Ando, H; Watanabe, N; Kitamura, K; Ito, K; Okayama, H; Miyamoto, T; Agui, T; Sasaki, M			Identification and characterization of human Wee1B, a new member of the Wee1 family of Cdk-inhibitory kinases	GENES TO CELLS			English	Article							CYCLIN-DEPENDENT KINASES; CELL-CYCLE; TYROSINE PHOSPHORYLATION; M-PHASE; CDC2 PHOSPHORYLATION; FISSION YEAST; HELA-CELLS; HUMAN MYT1; THREONINE-14; ACTIVATION	Background: In eukaryotic cells, the kinase activity of the mitosis-promoting complex composed of cyclin B and Cdc2 (Cdk1) is negatively regulated by the phosphorylation of Cdk1 on threonine or tyrosine residues within its ATP binding domain. Results: We identified human Wee1B by searching a sequence database. The predicted human Wee1B protein comprises 561 amino acids. Northern blot analysis revealed that human Wee1B mRNA is particularly abundant in testis. Interestingly, RT-PCR using early embryos revealed that the Wee1B product was readily detectable at the mature oocyte, but abruptly disappeared at embryonic day 2.5, suggesting that the amount of Wee1B mRNA is dependent on the maternal expression. GFP-Wee1B showed a predominantly nuclear localization in HeLa cells. Human Wee1B was able to rescue the lethal phenotype of the fission yeast wee1-50 Delta mik1 mutant, and over-expression of the human protein in these cells resulted in cell elongation as a result of arrest of the cell cycle at the G(2)-M transition. Recombinant Wee1B effectively phosphorylated cyclin B-associated Cdk1 on tyrosine-15, resulting in an inactivation of the kinase activity of Cdk1. Conclusion: We identified human Wee1B as a novel Cdk1-inhibitory kinase. The identification of this new member of the Wee1 family suggests that inhibition of Cdk1 is mediated at multiple levels in mammals.	Nagoya City Univ, Sch Med, Dept Biochem, Mizuho Ku, Nagoya, Aichi 4678601, Japan; Nagoya City Univ, Sch Med, Ctr Expt Anim Sci, Mizuho Ku, Nagoya, Aichi 4678601, Japan; Riken Tsukuba Inst, Cell Sci & Gene Banking Div, Tsukuba, Ibaraki 3050074, Japan; Univ Tokyo, Grad Sch Med, Dept Biochem & Mol Biol, Bunkyo Ku, Tokyo 113, Japan	Nakanishi, M (reprint author), Nagoya City Univ, Sch Med, Dept Biochem, Mizuho Ku, 1 Kawasumi,Mizuho Cho, Nagoya, Aichi 4678601, Japan.						NURSE P, 1994, CELL, V79, P547, DOI 10.1016/0092-8674(94)90539-8; MUELLER PR, 1995, SCIENCE, V270, P86, DOI 10.1126/science.270.5233.86; DEBONDT HL, 1993, NATURE, V363, P595, DOI 10.1038/363595a0; SHERR CJ, 1994, CELL, V79, P551, DOI 10.1016/0092-8674(94)90540-1; MUELLER PR, 1995, MOL BIOL CELL, V6, P119; Liu F, 1997, MOL CELL BIOL, V17, P571; Iavarone A, 1997, NATURE, V387, P417; Dunphy William G., 1994, Trends in Cell Biology, V4, P202; HOFFMANN I, 1993, EMBO J, V12, P53; TERADA Y, 1995, NATURE, V376, P358, DOI 10.1038/376358a0; BOYLE WJ, 1991, METHOD ENZYMOL, V201, P110; Jin P, 1996, J CELL BIOL, V134, P963, DOI 10.1083/jcb.134.4.963; HONDA R, 1995, CHROMOSOME RES, V3, P300, DOI 10.1007/BF00713068; GOULD KL, 1991, EMBO J, V10, P3297; WATANABE N, 1995, EMBO J, V14, P1878; KREK W, 1991, EMBO J, V10, P3331; MORGAN DO, 1995, NATURE, V374, P131, DOI 10.1038/374131a0; LUNDGREN K, 1991, CELL, V64, P1111, DOI 10.1016/0092-8674(91)90266-2; Booher RN, 1997, J BIOL CHEM, V272, P22300, DOI 10.1074/jbc.272.35.22300; ATHERTONFESSLER S, 1993, MOL CELL BIOL, V13, P1675; DUCOMMUN B, 1991, EMBO J, V10, P3311; GOULD KL, 1989, NATURE, V342, P39, DOI 10.1038/342039a0; IGARASHI M, 1991, NATURE, V353, P80, DOI 10.1038/353080a0; Jinno S, 1999, ONCOGENE, V18, P565, DOI 10.1038/sj.onc.1202347; KIDDER GM, 1992, DEV GENET, V13, P319, DOI 10.1002/dvg.1020130502; LEE TH, 1991, CELL, V64, P415, DOI 10.1016/0092-8674(91)90649-J; MAUNDRELL K, 1990, J BIOL CHEM, V265, P10857; MCGOWAN CH, 1995, EMBO J, V14, P2166; Murakami MS, 1998, DEVELOPMENT, V125, P237; Nakajo N, 2000, GENE DEV, V14, P328; Nasmyth K, 1996, SCIENCE, V274, P1643, DOI 10.1126/science.274.5293.1643; NORBURY C, 1992, ANNU REV BIOCHEM, V61, P441; NURSE P, 1990, NATURE, V344, P503, DOI 10.1038/344503a0; PARKER LL, 1995, P NATL ACAD SCI USA, V92, P9638, DOI 10.1073/pnas.92.21.9638; SEBASTIAN B, 1993, P NATL ACAD SCI USA, V90, P3521, DOI 10.1073/pnas.90.8.3521; STRAUSFELD UP, 1994, CURR BIOL, V4, P876, DOI 10.1016/S0960-9822(00)00196-2; TANG Z, 1993, EMBO J, V14, P3427	37	28	33	BLACKWELL SCIENCE LTD	OXFORD	P O BOX 88, OSNEY MEAD, OXFORD OX2 0NE, OXON, ENGLAND	1356-9597			GENES CELLS	Genes Cells	OCT	2000	5	10					839	847		10.1046/j.1365-2443.2000.00367.x		9	Cell Biology; Genetics & Heredity	Cell Biology; Genetics & Heredity	363WW	WOS:000089861500006		
J	Kamei, Y; Takeda, Y; Teramoto, K; Tsutsumi, O; Taketani, Y; Watanabe, K				Kamei, Y; Takeda, Y; Teramoto, K; Tsutsumi, O; Taketani, Y; Watanabe, K			Human NB-2 of the contactin subgroup molecules: Chromosomal localization of the gene (CNTN5) and distinct expression pattern from other subgroup members	GENOMICS			English	Article							INTERSTITIAL DELETION; IMMUNOGLOBULIN SUPERFAMILY; RAT-BRAIN; LONG ARM; ADHESION; MUTATIONS; CLONING; TYPE-1B; FAMILY; MAPS	NB-2 is one of the neural recognition molecules in the contactin subgroup, which belongs to the immunoglobulin superfamily, In rat, the six molecules in this subgroup that have been reported to date are contactin, TAG-1, BIG-1, BIG-2, NB-2, and NB-3, We have isolated cDNAs encoding the two splicing isoforms of human NB-2, The long isoform of human NB-2 consists of 1100 amino acids residues that are 91% homologous to rat NB-2 at the amino acid sequence level. The short isoform lacks 74 amino acid residues between residues 19 and 93 of the long isoform, Among various regions of the adult human brain, high-level expression of NB-2 was detected in the amygdala and occipital lobe, whereas expression was low in the corpus callosum, caudate nucleus, and spinal cord. Although there were some differences, the expression pattern of NB-2 was the most similar to that of BIG-1 in the brain, Likewise, contactin and BIG-2 exhibited similar expression patterns. The expression of TAG-1 showed the least regional differences. The human NB-2 gene (CNTN5) was mapped to chromosome 11q21-q22.2 by fluorescence in situ hybridization, Our results suggest that the NB-2 gene may contribute to human neurological disorders, (C) 2000 Academic Press.	Tokyo Metropolitan Inst Gerontol, Dept Cell Recognit, Itabashi Ku, Tokyo 1730015, Japan; Univ Tokyo, Fac Med, Dept Obstet & Gynecol, Bunkyo Ku, Tokyo 1138655, Japan; Chugai Pharmaceut Co Ltd, Kita Ku, Tokyo 1158543, Japan; Univ Tokyo, Branch Hosp, Dept Obstet & Gynecol, Bunkyo Ku, Tokyo 1128688, Japan; CREST, Japan Sci & Technol, Kawaguchi, Saitama 3320012, Japan	Watanabe, K (reprint author), Tokyo Metropolitan Inst Gerontol, Dept Cell Recognit, Itabashi Ku, Tokyo 1730015, Japan.						HAYASAKA K, 1993, NAT GENET, V5, P31, DOI 10.1038/ng0993-31; STCLAIR D, 1990, LANCET, V336, P13, DOI 10.1016/0140-6736(90)91520-K; Berglund EO, 1999, NEURON, V24, P739, DOI 10.1016/S0896-6273(00)81126-5; YOSHIHARA Y, 1995, J NEUROBIOL, V28, P51, DOI 10.1002/neu.480280106; HAYASAKA K, 1993, NAT GENET, V5, P266, DOI 10.1038/ng1193-266; JACOBSEN P, 1973, HUM HERED, V23, P568, DOI 10.1159/000152624; KULKENS T, 1993, NAT GENET, V5, P35, DOI 10.1038/ng0993-35; ROSENTHAL A, 1992, NAT GENET, V2, P107, DOI 10.1038/ng1092-107; BERGLUND EO, 1994, GENOMICS, V21, P571, DOI 10.1006/geno.1994.1316; Angeloni D, 1999, AM J MED GENET, V86, P482, DOI 10.1002/(SICI)1096-8628(19991029)86:5<482::AID-AJMG15>3.0.CO;2-L; Ogawa J, 1996, NEUROSCI LETT, V218, P173, DOI 10.1016/S0304-3940(96)13156-6; BATEMAN JB, 1984, AM J OPHTHALMOL, V97, P11; CARNEVALE A, 1987, ANN GENET-PARIS, V30, P56; GUCSCEKIC M, 1989, J MED GENET, V26, P205, DOI 10.1136/jmg.26.3.205; Horelli-Kuitunen N, 1999, AM J MED GENET, V86, P416, DOI 10.1002/(SICI)1096-8628(19991029)86:5<416::AID-AJMG4>3.0.CO;2-S; HOSOYA H, 1995, NEUROSCI LETT, V186, P83, DOI 10.1016/0304-3940(95)11287-7; Kamei Y, 1998, J NEUROSCI RES, V51, P275, DOI 10.1002/(SICI)1097-4547(19980201)51:3<275::AID-JNR1>3.0.CO;2-D; KOZLOV SV, 1995, GENOMICS, V30, P141, DOI 10.1006/geno.1995.9892; Lee S, 2000, GENE, V245, P253, DOI 10.1016/S0378-1119(00)00031-7; Maziade M, 1995, AM J MED GENET, V60, P522, DOI 10.1002/ajmg.1320600607; McKee-Johnson JW, 1998, GENOMICS, V49, P371, DOI 10.1006/geno.1998.5274; Mock BA, 1996, GENOMICS, V34, P226, DOI 10.1006/geno.1996.0271; STRATTON RF, 1994, AM J MED GENET, V49, P294, DOI 10.1002/ajmg.1320490310; WONG EV, 1995, TRENDS NEUROSCI, V18, P168, DOI 10.1016/0166-2236(95)93896-6	24	20	24	ACADEMIC PRESS INC	SAN DIEGO	525 B ST, STE 1900, SAN DIEGO, CA 92101-4495 USA	0888-7543			GENOMICS	Genomics	OCT 1	2000	69	1					113	119		10.1006/geno.2000.6310		7	Biotechnology & Applied Microbiology; Genetics & Heredity	Biotechnology & Applied Microbiology; Genetics & Heredity	362YH	WOS:000089805500012		
J	Ando, N				Ando, N			An isolated umbilical point of the graph of a homogeneous polynomial	GEOMETRIAE DEDICATA			English	Article						homogeneous polynomials; umbilical points; indices		Suppose that the origin o of R-3 is an isolated umbilical point of the graph of a homogeneous polynomial in two real variables of degree k greater than or equal to 3. Then we see that the index of o is an element of the set {1 - k/2 + i}(i=0)([k/2]). Moreover, we see that each element of {1 - k/2 + i}(i=0)([k/2]) may be the index of o on the graph of a suitable homogeneous polynomial of degree k.	Univ Tokyo, Grad Sch Math Sci, Meguro Ku, Tokyo 1538914, Japan							GUTIERREZ C, 1997, PUBL MAT, V41, P169; Gutierrez C., 1982, ASTERISQUE, V98-99, P195; Hartman P., 1954, AM J MATH, V76, p502 , DOI 10.2307/2372698; HOPF H, 1954, LECT DIFFERENTIAL GE; KLOTZ T, 1959, COMMUN PUR APPL MATH, V12, P277, DOI 10.1002/cpa.3160120207	5	4	4	KLUWER ACADEMIC PUBL	DORDRECHT	SPUIBOULEVARD 50, PO BOX 17, 3300 AA DORDRECHT, NETHERLANDS	0046-5755			GEOMETRIAE DEDICATA	Geod. Dedic.	OCT	2000	82	1-3					115	137		10.1023/A:1005182230528		23	Mathematics	Mathematics	371UL	WOS:000165197600004		
J	Yim, MJ; Ono, T; Maenuma, K; Irimura, T				Yim, MJ; Ono, T; Maenuma, K; Irimura, T			Generation of libraries of genetically engineered plant lectins with diverse carbohydrate specificities	GLYCOBIOLOGY			English	Meeting Abstract									Univ Tokyo, Grad Sch Pharmaceut Sci, Tokyo, Japan								0	0	0	OXFORD UNIV PRESS INC	CARY	JOURNALS DEPT, 2001 EVANS RD, CARY, NC 27513 USA	0959-6658			GLYCOBIOLOGY	Glycobiology	OCT	2000	10	10				66	1094	1095				2	Biochemistry & Molecular Biology	Biochemistry & Molecular Biology	360JN	WOS:000089664300078		
J	Tsuiji, M; Fujimori, M; Maeda, A; Irimura, T				Tsuiji, M; Fujimori, M; Maeda, A; Irimura, T			Identification of transcription factors that regulate the expression of mouse macrophage C-type lectin (mMGL) gene	GLYCOBIOLOGY			English	Meeting Abstract									Univ Tokyo, Grad Sch Pharmaceut Sci, Lab Canc Biol & Mol Immunol, Tokyo 1130033, Japan								0	0	0	OXFORD UNIV PRESS INC	CARY	JOURNALS DEPT, 2001 EVANS RD, CARY, NC 27513 USA	0959-6658			GLYCOBIOLOGY	Glycobiology	OCT	2000	10	10				67	1095	+				2	Biochemistry & Molecular Biology	Biochemistry & Molecular Biology	360JN	WOS:000089664300079		
J	Takeuchi, H; Kato, K; Hassan, H; Clausen, H; Irimura, T				Takeuchi, H; Kato, K; Hassan, H; Clausen, H; Irimura, T			O-Glycosylation of a cluster of three consecutive threonines: distinct specificity of UDP-N-acetyl-D-galactosamine: polypeptide N-acetylgalactosaminyltransferase isoforms	GLYCOBIOLOGY			English	Meeting Abstract							RESIDUES		Univ Tokyo, Grad Sch Pharmaceut Sci, Lab Canc Biol & Mol Immunol, Bunkyo Ku, Tokyo 1130033, Japan; Univ Copenhagen, Sch Dent, Fac Hlth Sci, Dept Oral Diag, DK-2200 Copenhagen, Denmark							Iida S, 1999, FEBS LETT, V449, P230, DOI 10.1016/S0014-5793(99)00445-7; Iida S, 2000, BIOCHEM J, V347, P535, DOI 10.1042/0264-6021:3470535; Iida SI, 1999, J BIOL CHEM, V274, P10697, DOI 10.1074/jbc.274.16.10697	3	0	0	OXFORD UNIV PRESS INC	CARY	JOURNALS DEPT, 2001 EVANS RD, CARY, NC 27513 USA	0959-6658			GLYCOBIOLOGY	Glycobiology	OCT	2000	10	10				78	1098	1098				1	Biochemistry & Molecular Biology	Biochemistry & Molecular Biology	360JN	WOS:000089664300090		
J	Hirata, Y; Maeda, S; Mitsuno, Y; Akanuma, M; Yamaji, Y; Ogura, K; Yoshida, H; Shiratori, Y; Omata, M				Hirata, Y; Maeda, S; Mitsuno, Y; Akanuma, M; Yamaji, Y; Ogura, K; Yoshida, H; Shiratori, Y; Omata, M			Tyrosine phosphorylation of CagA of H-pylori isolates in Japan.	GUT			English	Meeting Abstract									Univ Tokyo, Tokyo, Japan								0	0	0	BRITISH MED JOURNAL PUBL GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0017-5749			GUT	Gut	OCT	2000	47			1			A27	A27				1	Gastroenterology & Hepatology	Gastroenterology & Hepatology	368RK	WOS:000090131200104		
J	Hirata, Y; Maeda, S; Mitsuno, Y; Akanuma, M; Yamaji, Y; Ogura, K; Yoshida, H; Shiratori, Y; Omata, M				Hirata, Y; Maeda, S; Mitsuno, Y; Akanuma, M; Yamaji, Y; Ogura, K; Yoshida, H; Shiratori, Y; Omata, M			Helicobacter pylori upregulates cyclin D1 expression through MAPK pathway.	GUT			English	Meeting Abstract									Univ Tokyo, Tokyo, Japan								0	0	0	BRITISH MED JOURNAL PUBL GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0017-5749			GUT	Gut	OCT	2000	47			1			A35	A35				1	Gastroenterology & Hepatology	Gastroenterology & Hepatology	368RK	WOS:000090131200134		
J	Maeda, S; Mitsuno, Y; Hirata, Y; Ogura, K; Akanuma, M; Yamaji, Y; Yoshida, H; Omata, M				Maeda, S; Mitsuno, Y; Hirata, Y; Ogura, K; Akanuma, M; Yamaji, Y; Yoshida, H; Omata, M			Association between cag pathogenicity island (cag PAI) status and gastric mucosal inflammation in H-pylori-infected patients and Mongolian gerbils.	GUT			English	Meeting Abstract									Univ Tokyo, Tokyo, Japan								0	0	0	BRITISH MED JOURNAL PUBL GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0017-5749			GUT	Gut	OCT	2000	47			1			A28	A28				1	Gastroenterology & Hepatology	Gastroenterology & Hepatology	368RK	WOS:000090131200107		
J	Maeda, S; Mitsuno, Y; Hirata, Y; Ogura, K; Yoshida, H; Shiratori, Y; Omata, M				Maeda, S; Mitsuno, Y; Hirata, Y; Ogura, K; Yoshida, H; Shiratori, Y; Omata, M			Status or cag pathogenicity island (PAI) is closely related to the degree of NF-kB activation and gastric mucosal inflammation.	GUT			English	Meeting Abstract									Univ Tokyo, Tokyo, Japan								0	0	0	BRITISH MED JOURNAL PUBL GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0017-5749			GUT	Gut	OCT	2000	47			1			A37	A37				1	Gastroenterology & Hepatology	Gastroenterology & Hepatology	368RK	WOS:000090131200145		
J	Yamaji, Y; Hirata, Y; Akanuma, M; Mitsuno, Y; Maeda, S; Ogura, K; Okamoto, M; Yoshida, H; Kawabe, T; Shiratori, Y; Ikuma, H; Saito, K; Yokouchi, K; Mitsushima, T; Omata, M				Yamaji, Y; Hirata, Y; Akanuma, M; Mitsuno, Y; Maeda, S; Ogura, K; Okamoto, M; Yoshida, H; Kawabe, T; Shiratori, Y; Ikuma, H; Saito, K; Yokouchi, K; Mitsushima, T; Omata, M			Gastric atrophy as an independent protective factor for reflux esophagitis: From a multivariate analysis of 4122 Japanese.	GUT			English	Meeting Abstract									Univ Tokyo, Tokyo, Japan; Kameda Gen Hosp, Chiba, Japan								0	0	0	BRITISH MED JOURNAL PUBL GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0017-5749			GUT	Gut	OCT	2000	47			1			A83	A84				2	Gastroenterology & Hepatology	Gastroenterology & Hepatology	368RK	WOS:000090131200298		
J	Yamaji, Y; Hirata, Y; Akanuma, M; Mitsuno, Y; Maeda, S; Ogura, K; Yoshida, H; Kawabe, T; Shiratori, Y; Ikuma, H; Saito, K; Yokouchi, K; Mitsushima, T; Omata, M				Yamaji, Y; Hirata, Y; Akanuma, M; Mitsuno, Y; Maeda, S; Ogura, K; Yoshida, H; Kawabe, T; Shiratori, Y; Ikuma, H; Saito, K; Yokouchi, K; Mitsushima, T; Omata, M			No relationship between colorectal neoplasm and Helicobacter pylori infection.	GUT			English	Meeting Abstract									Univ Tokyo, Tokyo, Japan; Kameda Gen Hosp, Chiba, Japan								0	0	0	BRITISH MED JOURNAL PUBL GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0017-5749			GUT	Gut	OCT	2000	47			1			A89	A89				1	Gastroenterology & Hepatology	Gastroenterology & Hepatology	368RK	WOS:000090131200318		
J	Iwai, M; Mori, T; Morikawa, T; Tanaka, S; Muramatsu, A; Okanoue, T; Kashima, K; Iwazawa, T; Tahara, H				Iwai, M; Mori, T; Morikawa, T; Tanaka, S; Muramatsu, A; Okanoue, T; Kashima, K; Iwazawa, T; Tahara, H			Gene therapy of ILI2 for multiple metastatic liver tumors.	HEPATOLOGY			English	Meeting Abstract									Univ Tokyo, Tokyo, Japan; W Japan NTT Hosp, Osaka, Japan; Kyoto Univ Med, Kyoto, Japan; Kyoto Prefectural Univ Med, Kyoto, Japan								0	0	0	W B SAUNDERS CO	PHILADELPHIA	INDEPENDENCE SQUARE WEST CURTIS CENTER, STE 300, PHILADELPHIA, PA 19106-3399 USA	0270-9139			HEPATOLOGY	Hepatology	OCT	2000	32	4	2			68	179A	179A				1	Gastroenterology & Hepatology	Gastroenterology & Hepatology	359PZ	WOS:000089622400069		
J	Kumashiro, R; Kubota, T; Iga, T; Koga, Y; Hino, T; Ide, T; Murashima, S; Sata, M				Kumashiro, R; Kubota, T; Iga, T; Koga, Y; Hino, T; Ide, T; Murashima, S; Sata, M			Homozygous mutantion of cytochrome P-4502C19 is associated with troglitazone-induced hepatitis.	HEPATOLOGY			English	Meeting Abstract									Kurume Univ, Fukuoka, Japan; Univ Tokyo, Tokyo, Japan								0	2	2	W B SAUNDERS CO	PHILADELPHIA	INDEPENDENCE SQUARE WEST CURTIS CENTER, STE 300, PHILADELPHIA, PA 19106-3399 USA	0270-9139			HEPATOLOGY	Hepatology	OCT	2000	32	4	2			137	197A	197A				1	Gastroenterology & Hepatology	Gastroenterology & Hepatology	359PZ	WOS:000089622400138		
J	Shiratori, Y; Shiina, S; Teratani, T; Imamura, M; Obi, S; Sato, S; Koike, Y; Tateishi, R; Yoshida, H; Omata, M				Shiratori, Y; Shiina, S; Teratani, T; Imamura, M; Obi, S; Sato, S; Koike, Y; Tateishi, R; Yoshida, H; Omata, M			Combination of tumor ablation and interferon (IFN) therapy remarkably improves prognosis and liver function in hepatitis C viral-hepatocellular carcinoma (HCC).	HEPATOLOGY			English	Meeting Abstract									Univ Tokyo, Tokyo, Japan								0	0	0	W B SAUNDERS CO	PHILADELPHIA	INDEPENDENCE SQUARE WEST CURTIS CENTER, STE 300, PHILADELPHIA, PA 19106-3399 USA	0270-9139			HEPATOLOGY	Hepatology	OCT	2000	32	4	2			174	206A	206A				1	Gastroenterology & Hepatology	Gastroenterology & Hepatology	359PZ	WOS:000089622400176		
J	Minagawa, M; Makuuchi, M; Takayama, T; Imamura, H				Minagawa, M; Makuuchi, M; Takayama, T; Imamura, H			A comparison between 5-year survivors and non-survivors after liver resection for metastatic colorectal cancer.	HEPATOLOGY			English	Meeting Abstract									Univ Tokyo, Tokyo, Japan			幕内, 雅敏/A-2140-2012					0	0	0	W B SAUNDERS CO	PHILADELPHIA	INDEPENDENCE SQUARE WEST CURTIS CENTER, STE 300, PHILADELPHIA, PA 19106-3399 USA	0270-9139			HEPATOLOGY	Hepatology	OCT	2000	32	4	2			271	229A	229A				1	Gastroenterology & Hepatology	Gastroenterology & Hepatology	359PZ	WOS:000089622400267		
J	Hoshida, Y; Omata, M				Hoshida, Y; Omata, M			Cost-effectiveness of interferon a after surgical resection of small hepatocellular carcinoma in hepatitis C virus-related compensated cirrhosis.	HEPATOLOGY			English	Meeting Abstract									Univ Tokyo, Tokyo, Japan								0	0	0	W B SAUNDERS CO	PHILADELPHIA	INDEPENDENCE SQUARE WEST CURTIS CENTER, STE 300, PHILADELPHIA, PA 19106-3399 USA	0270-9139			HEPATOLOGY	Hepatology	OCT	2000	32	4	2			305	237A	237A				1	Gastroenterology & Hepatology	Gastroenterology & Hepatology	359PZ	WOS:000089622400300		
J	Imamura, H; Kawasaki, S; Takayama, T; Miyagawa, S; Kobayashi, A; Makuuchi, M				Imamura, H; Kawasaki, S; Takayama, T; Miyagawa, S; Kobayashi, A; Makuuchi, M			Risk factors contributing to early and late phases of intrahepatic recurrence of hepatocellular carcinoma (HCC) after hepatectomy.	HEPATOLOGY			English	Meeting Abstract									Univ Tokyo, Tokyo, Japan; Shinshu Univ, Sch Med, Matsumoto, Nagano 390, Japan			幕内, 雅敏/A-2140-2012					0	0	0	W B SAUNDERS CO	PHILADELPHIA	INDEPENDENCE SQUARE WEST CURTIS CENTER, STE 300, PHILADELPHIA, PA 19106-3399 USA	0270-9139			HEPATOLOGY	Hepatology	OCT	2000	32	4	2			303	237A	237A				1	Gastroenterology & Hepatology	Gastroenterology & Hepatology	359PZ	WOS:000089622400299		
J	Hoshida, Y; Shiratori, Y; Koike, Y; Obi, S; Hamamura, K; Teratani, T; Shiina, S; Omata, M				Hoshida, Y; Shiratori, Y; Koike, Y; Obi, S; Hamamura, K; Teratani, T; Shiina, S; Omata, M			Hepatic volumetry to predict adverse events in percutaneous ablation of hepatocellular carcinoma.	HEPATOLOGY			English	Meeting Abstract									Univ Tokyo, Tokyo, Japan								0	0	0	W B SAUNDERS CO	PHILADELPHIA	INDEPENDENCE SQUARE WEST CURTIS CENTER, STE 300, PHILADELPHIA, PA 19106-3399 USA	0270-9139			HEPATOLOGY	Hepatology	OCT	2000	32	4	2			308	238A	238A				1	Gastroenterology & Hepatology	Gastroenterology & Hepatology	359PZ	WOS:000089622400302		
J	Arai, M; Tejima, K; Ikeda, H; Tomiya, T; Yanase, M; Inoue, Y; Nagashima, K; Lemasters, JJ; Fujiwara, K				Arai, M; Tejima, K; Ikeda, H; Tomiya, T; Yanase, M; Inoue, Y; Nagashima, K; Lemasters, JJ; Fujiwara, K			Ischemic preconditioning decreases superoxide production in kupffer cells after storage/reperfusion via an adenosine A(1) receptor pathway.	HEPATOLOGY			English	Meeting Abstract									Univ Tokyo, Tokyo, Japan; Univ N Carolina, Chapel Hill, NC 27515 USA; Saitama Med Sch, Moroyama, Saitama 35004, Japan								0	0	0	W B SAUNDERS CO	PHILADELPHIA	INDEPENDENCE SQUARE WEST CURTIS CENTER, STE 300, PHILADELPHIA, PA 19106-3399 USA	0270-9139			HEPATOLOGY	Hepatology	OCT	2000	32	4	2			353	249A	249A				1	Gastroenterology & Hepatology	Gastroenterology & Hepatology	359PZ	WOS:000089622400348		
J	Sasaki, M; Yamauchi, K; Haruta, I; Furukawa, T; Nakanishi, T; Takatsu, K; Tokushige, K; Hayashi, N				Sasaki, M; Yamauchi, K; Haruta, I; Furukawa, T; Nakanishi, T; Takatsu, K; Tokushige, K; Hayashi, N			Susceptibility of CD81+and CD81-human cell lines for hepatitis C virus by assessing an in vitro binding.	HEPATOLOGY			English	Meeting Abstract									Tokyo Womens Med Univ, Tokyo, Japan; Univ Tokyo, Tokyo, Japan								0	0	0	W B SAUNDERS CO	PHILADELPHIA	INDEPENDENCE SQUARE WEST CURTIS CENTER, STE 300, PHILADELPHIA, PA 19106-3399 USA	0270-9139			HEPATOLOGY	Hepatology	OCT	2000	32	4	2			443	272A	272A				1	Gastroenterology & Hepatology	Gastroenterology & Hepatology	359PZ	WOS:000089622400439		
J	Mitsui, H; Maruyama, T; Maekawa, H; Hirayama, M; Sawatari, T; Kimura, S; Hashimoto, N				Mitsui, H; Maruyama, T; Maekawa, H; Hirayama, M; Sawatari, T; Kimura, S; Hashimoto, N			Role of p38 mitogen-activated protein kinase in LPS/galactosamine-induced hepatic failure in rats.	HEPATOLOGY			English	Meeting Abstract									Univ Tokyo, Tokyo, Japan; Tokyo Teishin Hosp, Tokyo, Japan								0	0	0	W B SAUNDERS CO	PHILADELPHIA	INDEPENDENCE SQUARE WEST CURTIS CENTER, STE 300, PHILADELPHIA, PA 19106-3399 USA	0270-9139			HEPATOLOGY	Hepatology	OCT	2000	32	4	2			609	312A	312A				1	Gastroenterology & Hepatology	Gastroenterology & Hepatology	359PZ	WOS:000089622400596		
J	Inoue, Y; Tomiya, T; Yanase, M; Arai, M; Ikeda, H; Tejima, K; Nagashima, K; Ogata, I; Fujiwara, K				Inoue, Y; Tomiya, T; Yanase, M; Arai, M; Ikeda, H; Tejima, K; Nagashima, K; Ogata, I; Fujiwara, K			The role of P53 in hepatocyte proliferation in rats.	HEPATOLOGY			English	Meeting Abstract									Univ Tokyo, Dept Gastroenterol, Tokyo, Japan; Saitama Med Sch, Dept Internal Med 3, Moroyama, Saitama 35004, Japan								0	0	0	W B SAUNDERS CO	PHILADELPHIA	INDEPENDENCE SQUARE WEST CURTIS CENTER, STE 300, PHILADELPHIA, PA 19106-3399 USA	0270-9139			HEPATOLOGY	Hepatology	OCT	2000	32	4	2			657	324A	324A				1	Gastroenterology & Hepatology	Gastroenterology & Hepatology	359PZ	WOS:000089622400644		
J	Kato, J; Kato, N; Yoshida, H; Ono-Nita, SK; Shiratori, Y; Omata, M				Kato, J; Kato, N; Yoshida, H; Ono-Nita, SK; Shiratori, Y; Omata, M			Hepatitis C virus NS4A and NS4B proteins suppress translation in vivo.	HEPATOLOGY			English	Meeting Abstract									Univ Tokyo, Fac Med, Tokyo 113, Japan			Ono, Suzane/I-3107-2012					0	0	0	W B SAUNDERS CO	PHILADELPHIA	INDEPENDENCE SQUARE WEST CURTIS CENTER, STE 300, PHILADELPHIA, PA 19106-3399 USA	0270-9139			HEPATOLOGY	Hepatology	OCT	2000	32	4	2			678	329A	329A				1	Gastroenterology & Hepatology	Gastroenterology & Hepatology	359PZ	WOS:000089622400666		
J	Ona-Nita, SK; Kato, N; Shiratori, Y; Yoshida, H; Kato, J; Goto, T; Schinazi, RF; Carrilho, FJ; Omata, M				Ona-Nita, SK; Kato, N; Shiratori, Y; Yoshida, H; Kato, J; Goto, T; Schinazi, RF; Carrilho, FJ; Omata, M			Influence of B domain mutation (L528M) of the hepatitis B virus polymerase on replication ability and resistance to nucleoside analogues.	HEPATOLOGY			English	Meeting Abstract									Univ Tokyo, Tokyo, Japan; Emory Univ, VA Med Ctr, Decatur, GA USA; Univ Sao Paulo, Sao Paulo, Brazil			Carrilho, Flair/I-3046-2012					0	0	0	W B SAUNDERS CO	PHILADELPHIA	INDEPENDENCE SQUARE WEST CURTIS CENTER, STE 300, PHILADELPHIA, PA 19106-3399 USA	0270-9139			HEPATOLOGY	Hepatology	OCT	2000	32	4	2			935	393A	393A				1	Gastroenterology & Hepatology	Gastroenterology & Hepatology	359PZ	WOS:000089622400920		
J	Suzuki, H; Akita, H; Sugiyama, Y				Suzuki, H; Akita, H; Sugiyama, Y			Sinusoidal efflux of bile acids is mediated by multidrug resistance associated protein 3 (MRF3) under cholestatic conditions.	HEPATOLOGY			English	Meeting Abstract									Univ Tokyo, Tokyo, Japan							Konig J, 1999, HEPATOLOGY, V29, P1156, DOI 10.1002/hep.510290404; HIROHASHI, 2000, J BIOL CHEM, V275, P2905	2	1	1	W B SAUNDERS CO	PHILADELPHIA	INDEPENDENCE SQUARE WEST CURTIS CENTER, STE 300, PHILADELPHIA, PA 19106-3399 USA	0270-9139			HEPATOLOGY	Hepatology	OCT	2000	32	4	2			1074	428A	428A				1	Gastroenterology & Hepatology	Gastroenterology & Hepatology	359PZ	WOS:000089622401061		
J	Ito, K; Suzuki, H; Horie, T; Sugiyama, Y				Ito, K; Suzuki, H; Horie, T; Sugiyama, Y			Mechanism for the ATP-dependent transport of reduced glutathione by rat MRP2.	HEPATOLOGY			English	Meeting Abstract									Chiba Univ, Fac Pharm Sci, Chiba, Japan; Univ Tokyo, Tokyo, Japan								0	0	0	W B SAUNDERS CO	PHILADELPHIA	INDEPENDENCE SQUARE WEST CURTIS CENTER, STE 300, PHILADELPHIA, PA 19106-3399 USA	0270-9139			HEPATOLOGY	Hepatology	OCT	2000	32	4	2			1118	439A	439A				1	Gastroenterology & Hepatology	Gastroenterology & Hepatology	359PZ	WOS:000089622401105		
J	Ito, K; Suzuki, H; Sugiyama, Y				Ito, K; Suzuki, H; Sugiyama, Y			Potential transport activity of rat MRP2 for taurocholic acid.	HEPATOLOGY			English	Meeting Abstract									Chiba Univ, Fac Pharm Sci, Chiba, Japan; Univ Tokyo, Tokyo, Japan								0	1	1	W B SAUNDERS CO	PHILADELPHIA	INDEPENDENCE SQUARE WEST CURTIS CENTER, STE 300, PHILADELPHIA, PA 19106-3399 USA	0270-9139			HEPATOLOGY	Hepatology	OCT	2000	32	4	2			1130	442A	442A				1	Gastroenterology & Hepatology	Gastroenterology & Hepatology	359PZ	WOS:000089622401117		
J	Yoshida, H; Kato, N; Otsuka, M; Kato, J; Goto, T; Ono-Nita, SK; Shiratori, Y; Omata, M				Yoshida, H; Kato, N; Otsuka, M; Kato, J; Goto, T; Ono-Nita, SK; Shiratori, Y; Omata, M			The effect of hepatitis C virus core protein expressed under the tight control of tetracycline on NF-KB-dependent signaling.	HEPATOLOGY			English	Meeting Abstract									Univ Tokyo, Tokyo, Japan			Ono, Suzane/I-3107-2012					0	0	0	W B SAUNDERS CO	PHILADELPHIA	INDEPENDENCE SQUARE WEST CURTIS CENTER, STE 300, PHILADELPHIA, PA 19106-3399 USA	0270-9139			HEPATOLOGY	Hepatology	OCT	2000	32	4	2			1233	468A	468A				1	Gastroenterology & Hepatology	Gastroenterology & Hepatology	359PZ	WOS:000089622401219		
J	Yamashita, T; Kaneko, S; Kobayashi, K; Hashimoto, S; Matsushima, K				Yamashita, T; Kaneko, S; Kobayashi, K; Hashimoto, S; Matsushima, K			Serial analysis of gene expression in hepatocellular carcinoma complicated in chronic hepatitis C.	HEPATOLOGY			English	Meeting Abstract									Kanazawa Univ, Sch Med, Kanazawa, Ishikawa 920, Japan; Univ Tokyo, Sch Med, Tokyo, Japan								0	0	0	W B SAUNDERS CO	PHILADELPHIA	INDEPENDENCE SQUARE WEST CURTIS CENTER, STE 300, PHILADELPHIA, PA 19106-3399 USA	0270-9139			HEPATOLOGY	Hepatology	OCT	2000	32	4	2			1238	469A	469A				1	Gastroenterology & Hepatology	Gastroenterology & Hepatology	359PZ	WOS:000089622401225		
J	Tomiya, T; Ogata, I; Yamaoka, M; Yanase, M; Inoue, Y; Fujiwara, K				Tomiya, T; Ogata, I; Yamaoka, M; Yanase, M; Inoue, Y; Fujiwara, K			TGFA and HGF may stimulate protein production in hepatocytes independently, but the mitogenic activity of HGF may be dependent upon endogenous TGFA.	HEPATOLOGY			English	Meeting Abstract									Univ Tokyo, Tokyo, Japan; Saitama Med Sch, Dept Internal Med 3, Moroyama, Saitama, Japan; Univ Tokyo, Tokyo, Japan; Saitama Med Sch, Dept Internal Med 3, Moroyama, Saitama, Japan								0	0	0	W B SAUNDERS CO	PHILADELPHIA	INDEPENDENCE SQUARE WEST CURTIS CENTER, STE 300, PHILADELPHIA, PA 19106-3399 USA	0270-9139			HEPATOLOGY	Hepatology	OCT	2000	32	4	2			1289	482A	482A				1	Gastroenterology & Hepatology	Gastroenterology & Hepatology	359PZ	WOS:000089622401274		
J	Maruyama, T; Mitsui, H; Maekawa, H; Hirayama, M; Sawatari, T; Yamada, H; Hashimoto, N; Kimura, S; Milich, DR				Maruyama, T; Mitsui, H; Maekawa, H; Hirayama, M; Sawatari, T; Yamada, H; Hashimoto, N; Kimura, S; Milich, DR			Immune response to hepatitis C virus core protein: Localization of T cell and B cell recognition sites within hepatitis C virus core protein.	HEPATOLOGY			English	Meeting Abstract									Univ Tokyo, Tokyo, Japan; Scripps Res Inst, La Jolla, CA 92037 USA								0	0	0	W B SAUNDERS CO	PHILADELPHIA	INDEPENDENCE SQUARE WEST CURTIS CENTER, STE 300, PHILADELPHIA, PA 19106-3399 USA	0270-9139			HEPATOLOGY	Hepatology	OCT	2000	32	4	2			1538	544A	544A				1	Gastroenterology & Hepatology	Gastroenterology & Hepatology	359PZ	WOS:000089622401524		
J	Hoshida, Y; Shiratori, Y; Omata, M; Ohashi, Y				Hoshida, Y; Shiratori, Y; Omata, M; Ohashi, Y			Difficulties in conducting controlled trials in radical therapies for non-advanced hepatocellular carcinoma.	HEPATOLOGY			English	Meeting Abstract									Univ Tokyo, Tokyo, Japan								0	0	0	W B SAUNDERS CO	PHILADELPHIA	INDEPENDENCE SQUARE WEST CURTIS CENTER, STE 300, PHILADELPHIA, PA 19106-3399 USA	0270-9139			HEPATOLOGY	Hepatology	OCT	2000	32	4	2			1824	615A	615A				1	Gastroenterology & Hepatology	Gastroenterology & Hepatology	359PZ	WOS:000089622401809		
J	Hamamura, K; Dan, Y; Shiina, S; Teratani, T; Obi, S; Koike, Y; Yoshida, H; Shiratori, Y; Omata, M				Hamamura, K; Dan, Y; Shiina, S; Teratani, T; Obi, S; Koike, Y; Yoshida, H; Shiratori, Y; Omata, M			A caution to use tumor markers in assessing therapeutic effects of hepatocellular carcinoma.	HEPATOLOGY			English	Meeting Abstract									Univ Tokyo, Fac Med, Tokyo 113, Japan								0	0	0	W B SAUNDERS CO	PHILADELPHIA	INDEPENDENCE SQUARE WEST CURTIS CENTER, STE 300, PHILADELPHIA, PA 19106-3399 USA	0270-9139			HEPATOLOGY	Hepatology	OCT	2000	32	4	2			1836	618A	618A				1	Gastroenterology & Hepatology	Gastroenterology & Hepatology	359PZ	WOS:000089622401821		
J	Masaki, T; Shiratori, Y; Rengifo, W; Igarashi, K; Matsumoto, K; Nishioka, M; Hatanaka, Y; Omata, M				Masaki, T; Shiratori, Y; Rengifo, W; Igarashi, K; Matsumoto, K; Nishioka, M; Hatanaka, Y; Omata, M			Hepatocellular carcinoma cell cycle: Study of Long-Evans Cinnamon rats	HEPATOLOGY			English	Article							CDK-ACTIVATING KINASE; PROTEIN-KINASE; HEREDITARY HEPATITIS; CATALYTIC SUBUNIT; D-PENICILLAMINE; BREAST-CANCER; ANNEXIN-I; AMPLIFICATION; GENE; PHOSPHORYLATION	Amplification found in a number of cyclin genes, especially in cyclin D and E, is an important event process that takes place in cancers, including hepatocellular carcinoma (HCC), The activities of a nide range of cell cycle-related kinases remain obscure in HCC. The purpose of the present study is to determine the cyclins and kinase activities of HCC in Long-Evans Cinnamon (LEC) rats. Cyclin D1, E, A, H, Cdk1 (cyclin-dependent kinase; Cdc2), Cdk4, and Cdk6 protein levels were determined by Western blot analysis at different pathologic stages of liver tissues exhibiting HCC. Enzymatic activities of cyclin D1, E, A, Cdk4, Cdk6, Cdc2, Cdk7, and Wee1 kinase were measured by in-gel kinase assay. Protein levels and kinase activities of cyclin D1, E, Cdk4, cyclin A, and Wee1 increased proportionally with the development of HCC, especially in the transition process from chronic hepatitis to HCC. Although Cdc2 kinase activity was found to increase slightly from normal liver to chronic hepatitis, its activity remained unchanged in the process from chronic hepatitis to HCC, Cdk6 and Cdk7 activities remained unchanged in the process from normal liver to HCC, These data suggest that the increase in Cdc2 kinase may play a role in the process from normal liver to chronic hepatitis, whereas the predominant increase in cyclin D1, Cdk4, cyclin E, cyclin A, and Wee1 suggests involvement not only in the process from normal liver to chronic hepatitis, but also during transition into HCC.	Takamatsu Natl Hosp, Takamatsu, Kagawa 7610193, Japan; Univ Tokyo, Fac Med, Dept Gastroenterol, Tokyo 113, Japan; Kagawa Univ, Dept Internal Med 3, Kagawa, Japan; Univ Tokushima, Sch Med, Inst Expt Anim, Tokushima 770, Japan	Masaki, T (reprint author), Takamatsu Natl Hosp, Otsu 8,Shinden-cho, Takamatsu, Kagawa 7610193, Japan.						ZHANG YJ, 1993, BIOCHEM BIOPH RES CO, V196, P1010, DOI 10.1006/bbrc.1993.2350; STOLINE MR, 1981, AM STAT, V35, P134, DOI 10.2307/2683979; MATSUSHIME H, 1991, CELL, V65, P701, DOI 10.1016/0092-8674(91)90101-4; SHERR CJ, 1994, CELL, V79, P551, DOI 10.1016/0092-8674(94)90540-1; OLINER JD, 1992, NATURE, V358, P80, DOI 10.1038/358080a0; Masaki T, 1996, HEPATOLOGY, V24, P72, DOI 10.1002/hep.510240114; HUNTER T, 1994, CELL, V79, P573, DOI 10.1016/0092-8674(94)90543-6; SHERR CJ, 1993, CELL, V73, P1059, DOI 10.1016/0092-8674(93)90636-5; FISHER RP, 1994, CELL, V78, P713, DOI 10.1016/0092-8674(94)90535-5; BUCKLEY MF, 1993, ONCOGENE, V8, P2127; Kusano N, 1999, HEPATOLOGY, V29, P1858, DOI 10.1002/hep.510290636; Sherr CJ, 1996, SCIENCE, V274, P1672, DOI 10.1126/science.274.5293.1672; SERRANO M, 1993, NATURE, V366, P704, DOI 10.1038/366704a0; FESQUET D, 1993, EMBO J, V12, P3111; MATSUSHIME H, 1992, CELL, V71, P323, DOI 10.1016/0092-8674(92)90360-O; Masaki T, 1998, HEPATOLOGY, V27, P1257, DOI 10.1002/hep.510270511; OKUDA K, 1992, HEPATOLOGY, V15, P948, DOI 10.1002/hep.1840150532; Marone M, 1998, INT J CANCER, V75, P34, DOI 10.1002/(SICI)1097-0215(19980105)75:1<34::AID-IJC6>3.3.CO;2-A; NISHIDA N, 1994, CANCER RES, V54, P3107; WANG J, 1990, NATURE, V343, P555, DOI 10.1038/343555a0; Masaki T, 1999, HEPATOLOGY, V29, P379, DOI 10.1002/hep.510290239; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1006/abio.1976.9999; CARTWRIGHT CA, 1990, P NATL ACAD SCI USA, V87, P558, DOI 10.1073/pnas.87.2.558; CARTWRIGHT CA, 1994, J CLIN INVEST, V93, P509, DOI 10.1172/JCI117000; DEMETRICK DJ, 1994, CYTOGENET CELL GENET, V66, P72, DOI 10.1159/000133669; FISHER RP, 1994, CELL, V78, P723; Hui AM, 1996, HEPATOLOGY, V24, P575, DOI 10.1002/hep.510240319; HUNTER T, 1991, CELL, V66, P1071, DOI 10.1016/0092-8674(91)90028-W; Ito K, 1998, RNA, V4, P958, DOI 10.1017/S1355838298971874; JIANG W, 1993, P NATL ACAD SCI USA, V90, P9026, DOI 10.1073/pnas.90.19.9026; KANG JH, 1993, HEPATOLOGY, V18, P614; KEYOMARSI K, 1994, CANCER RES, V54, P380; KITAHARA K, 1995, INT J CANCER, V62, P25, DOI 10.1002/ijc.2910620107; LABBE JC, 1994, EMBO J, V13, P5155; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; LI Y, 1991, J CLIN INVEST, V87, P1858, DOI 10.1172/JCI115208; MARX J, 1994, SCIENCE, V263, P319, DOI 10.1126/science.8278804; MASAKI T, 1994, HEPATOLOGY, V20, P425, DOI 10.1016/0270-9139(94)90196-1; MOTOKURA T, 1991, NATURE, V350, P512, DOI 10.1038/350512a0; NOBORI T, 1994, NATURE, V368, P753, DOI 10.1038/368753a0; OCONNOR PM, 1992, CELL GROWTH DIFFER, V3, P43; PARDEE AB, 1989, SCIENCE, V246, P603, DOI 10.1126/science.2683075; PARKER LL, 1991, EMBO J, V10, P1255; REIFENBERGER G, 1995, CANCER RES, V55, P731; TAYA Y, 1995, MOL CELLS, V5, P191; THORGEIRSSON SS, 1992, JPN J CANCER RES, P83; TOGASHI Y, 1992, HEPATOLOGY, V15, P82, DOI 10.1002/hep.1840150116; TOWBIN H, 1979, P NATL ACAD SCI USA, V76, P4350, DOI 10.1073/pnas.76.9.4350; WANG J, 1992, ONCOGENE, V7, P1653	49	39	42	W B SAUNDERS CO	PHILADELPHIA	INDEPENDENCE SQUARE WEST CURTIS CENTER, STE 300, PHILADELPHIA, PA 19106-3399 USA	0270-9139			HEPATOLOGY	Hepatology	OCT	2000	32	4	1				711	720		10.1053/jhep.2000.17705		10	Gastroenterology & Hepatology	Gastroenterology & Hepatology	359PF	WOS:000089618700004		
J	Hoshida, Y; Shiratori, Y; Omata, M				Hoshida, Y; Shiratori, Y; Omata, M			Difficulties in conducting controlled trials in radical therapies for nonadvanced hepatocellular carcinoma	HEPATOLOGY			English	Letter							PERCUTANEOUS ETHANOL INJECTION; ORTHOTOPIC LIVER-TRANSPLANTATION; HEPATIC RESECTION; RETROSPECTIVE ANALYSIS; SURGICAL RESECTION; CIRRHOTIC-PATIENTS; HEPATECTOMY; EXPERIENCE; PROGNOSIS; SURVIVAL		Univ Tokyo, Fac Med, Dept Gastroenterol, Tokyo 113, Japan	Hoshida, Y (reprint author), Univ Tokyo, Fac Med, Dept Gastroenterol, Tokyo 113, Japan.						Sarasin FP, 1998, HEPATOLOGY, V28, P436, DOI 10.1002/hep.510280222; Llovet JM, 1999, HEPATOLOGY, V30, P1434, DOI 10.1002/hep.510300629; BISMUTH H, 1993, ANN SURG, V218, P145, DOI 10.1097/00000658-199308000-00005; SCHWARTZ ME, 1995, J AM COLL SURGEONS, V180, P596; Shiratori Y, 2000, ANN INTERN MED, V132, P517; Otto G, 1998, ANN SURG, V227, P424, DOI 10.1097/00000658-199803000-00015; Bruix J, 1996, GASTROENTEROLOGY, V111, P1018, DOI 10.1016/S0016-5085(96)70070-7; IZUMI R, 1994, GASTROENTEROLOGY, V106, P720; LIVRAGHI T, 1995, J HEPATOL, V22, P522, DOI 10.1016/0168-8278(95)80445-5; Bronowicki JP, 1996, J HEPATOL, V24, P293, DOI 10.1016/S0168-8278(96)80007-9; Yoshida H, 1999, ANN INTERN MED, V131, P174; Michel J, 1997, J HEPATOL, V26, P1274, DOI 10.1016/S0168-8278(97)80462-X; CASTELLS A, 1993, HEPATOLOGY, V18, P1121; DERSIMONIAN R, 1986, CONTROL CLIN TRIALS, V7, P177, DOI 10.1016/0197-2456(86)90046-2; IWATSUKI S, 1991, ANN SURG, V214, P221, DOI 10.1097/00000658-199109000-00005; KOTOH K, 1994, AM J GASTROENTEROL, V89, P194; Mazziotti A, 1998, HEPATO-GASTROENTEROL, V45, P1281; Ryu M, 1997, JPN J CLIN ONCOL, V27, P251, DOI 10.1093/jjco/27.4.251; Sakamoto M, 1998, JPN J CLIN ONCOL, V28, P604, DOI 10.1093/jjco/28.10.604; Sangro B, 1998, SURGERY, V124, P575, DOI 10.1067/msy.1998.90359; TAN KC, 1995, BRIT J SURG, V82, P253, DOI 10.1002/bjs.1800820239; Weimann A, 1999, TRANSPLANT P, V31, P500, DOI 10.1016/S0041-1345(98)01727-8; Yamamoto J, 1999, CANCER, V86, P1151, DOI 10.1002/(SICI)1097-0142(19991001)86:7<1151::AID-CNCR8>3.0.CO;2-V	23	11	13	W B SAUNDERS CO	PHILADELPHIA	INDEPENDENCE SQUARE WEST CURTIS CENTER, STE 300, PHILADELPHIA, PA 19106-3399 USA	0270-9139			HEPATOLOGY	Hepatology	OCT	2000	32	4	1				877	880		10.1053/jhep.2000.17918		4	Gastroenterology & Hepatology	Gastroenterology & Hepatology	359PF	WOS:000089618700035		
J	Kumaki, S; Ishii, N; Minegishi, M; Ohashi, Y; Hakozaki, I; Nonoyama, S; Imai, K; Morio, T; Tsuge, I; Sakiyama, Y; Miyanoshita, A; Miura, J; Mayumi, M; Heike, T; Katamura, K; Takada, H; Izumi, I; Kamizono, J; Hibi, S; Sasaki, H; Kimura, M; Kikuta, A; Date, Y; Sako, M; Tanaka, H; Sano, K; Sugamura, K; Tsuchiya, S				Kumaki, S; Ishii, N; Minegishi, M; Ohashi, Y; Hakozaki, I; Nonoyama, S; Imai, K; Morio, T; Tsuge, I; Sakiyama, Y; Miyanoshita, A; Miura, J; Mayumi, M; Heike, T; Katamura, K; Takada, H; Izumi, I; Kamizono, J; Hibi, S; Sasaki, H; Kimura, M; Kikuta, A; Date, Y; Sako, M; Tanaka, H; Sano, K; Sugamura, K; Tsuchiya, S			Characterization of the gamma c chain among 27 unrelated Japanese patients with X-linked severe combined immunodeficiency (X-SCID)	HUMAN GENETICS			English	Article							B-CELLS; INTERLEUKIN-4	X-linked severe combined immunodeficiency (X-SCID) is a rare fatal disease that is caused by mutations in the gene encoding the ye chain. In this study, 27 unrelated Japanese patients with X-SCID were examined in terms of their genetic mutations and surface expression of the ye chain. Among 25 patients examined, excluding two patients with lar ge deletions, 23 different mutations were identified in the IL2RG gene, including 10 novel mutations. One patient bearing an extracellular mutation and all three of the patients bearing intracellular mutations after exon 7 expressed the ye chain on the cell surface. Overall, 84% of patients lacked surface expression of the gammac chain leading to a diagnosis of X-SCID.	Tohoku Univ, Inst Dev Aging & Canc, Dept Pediat Oncol, Sendai, Miyagi 9808575, Japan; Tohoku Univ, Sch Med, Dept Immunol, Sendai, Miyagi 980, Japan; Tokyo Med & Dent Univ, Sch Med, Dept Pediat, Tokyo 113, Japan; Nagoya Univ, Sch Med, Nagoya, Aichi 466, Japan; Hokkaido Univ, Sch Med, Dept Human Gene Therapy, Sapporo, Hokkaido 060, Japan; Teineyama Keijinkai Hosp, Dept Pediat, Sapporo, Hokkaido, Japan; Asahikawa Red Cross Hosp, Dept Pediat, Asahikawa, Hokkaido, Japan; Fukui Med Univ, Sch Med, Dept Pediat, Fukui, Japan; Univ Tokyo, Inst Med Sci, Dept Stem Cell Regulat, Tokyo, Japan; Kyoto Univ, Grad Sch Med, Dept Pediat, Kyoto, Japan; Kyushu Univ, Fac Med, Dept Pediat, Fukuoka 812, Japan; Ibaraki Childrens Hosp, Dept Pediat, Mito, Ibaraki, Japan; Univ Occupat & Environm Hlth, Sch Med, Dept Pediat, Kitakyushu, Fukuoka 807, Japan; Kyoto Prefectural Univ, Dept Pediat, Kyoto 606, Japan; Kurashiki Cent Hosp, Dept Pediat, Kurashiki, Okayama 710, Japan; Shizuoka Childrens Hosp, Dept Allergy & Clin Immunol, Shizuoka, Japan; Fukushima Med Coll, Dept Pediat, Fukushima, Japan; Kurume Univ, Sch Med, Dept Pediat, Kurume, Fukuoka, Japan; Osaka City Gen Hosp, Dept Pediat, Osaka, Japan; Osaka Red Cross Hosp, Dept Pediat, Osaka, Japan; Kobe Univ, Sch Med, Dept Pediat, Kobe, Hyogo 650, Japan	Kumaki, S (reprint author), Tohoku Univ, Inst Dev Aging & Canc, Dept Pediat Oncol, 4-1 Seiryou Machi, Sendai, Miyagi 9808575, Japan.		Imai, Kohsuke/Q-2602-2015	Imai, Kohsuke/0000-0003-2132-8403			Sugamura K, 1996, ANNU REV IMMUNOL, V14, P179, DOI 10.1146/annurev.immunol.14.1.179; ISHII N, 1994, J IMMUNOL, V153, P1310; Izuhara K, 1996, J BIOL CHEM, V271, P619; Kumaki S, 1999, BLOOD, V93, P607; KUMAKI S, 1995, BLOOD, V86, P1428; MINEGISHI Y, 1995, HUM GENET, V96, P681, DOI 10.1007/BF00210299	6	8	8	SPRINGER-VERLAG	NEW YORK	175 FIFTH AVE, NEW YORK, NY 10010 USA	0340-6717			HUM GENET	Hum. Genet.	OCT	2000	107	4					406	408		10.1007/s004390000381		3	Genetics & Heredity	Genetics & Heredity	375UH	WOS:000165419300018		
J	Shimosawa, T; Shibagaki, Y; Kangawa, K; Kato, S; Kawai, J; Yamasaki, M; Fujita, T				Shimosawa, T; Shibagaki, Y; Kangawa, K; Kato, S; Kawai, J; Yamasaki, M; Fujita, T			Adrenomedullin and vasculitis, study with knock out mouse	HYPERTENSION			English	Meeting Abstract									Univ Tokyo, Tokyo, Japan; Natl Cardiovasc Res Inst, Osaka, Japan								0	0	0	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	530 WALNUT ST, PHILADELPHIA, PA 19106-3621 USA	0194-911X			HYPERTENSION	Hypertension	OCT	2000	36	4					727	727				1	Peripheral Vascular Disease	Cardiovascular System & Cardiology	368GT	WOS:000090109900422		
J	Kawaguchi, H; Nose, K; Sakurai, T				Kawaguchi, H; Nose, K; Sakurai, T			A super cut-off CMOS (SCCMOS) scheme for 0.5-V supply voltage with picoampere stand-by current	IEEE JOURNAL OF SOLID-STATE CIRCUITS			English	Article						DTMOS; leakage current; low power; low voltage; MTCMOS; stand-by current; VTCMOS		A super cut-off CMOS (SCCMOS) scheme is proposed and demonstrated by measurement to achieve high-speed and low stand-by current CMOS VLSIs in sub-1-V supply voltage regime. By overdriving the gate of a cut-off MOSFET, the SCCMOS suppresses leakage current below 1 pA per logic gate in a stand-by mode while high-speed operation in an active mode is possible with low-threshold voltage of 0.1-0.2 V, The SCCMOS pushes the low-voltage operation limit 0.2 V further down compared with conventional schemes while maintaining the same stand-by current level.	Univ Tokyo, Inst Ind Sci, Tokyo 1068558, Japan	Kawaguchi, H (reprint author), Univ Tokyo, Inst Ind Sci, 7-22-1 Roppongi, Tokyo 1068558, Japan.						Chan T. Y., 1987, IEDM, P718; FUSE T, 1997, ISSCC, P286; Kuroda T., 1996, ISSCC, P166; MUTOH S, 1995, IEEE J SOLID-ST CIRC, V30, P847, DOI 10.1109/4.400426; SASAKI Y, 1995, S VLSI CIRC, P123; Seta K., 1995, ISSCC, P318	6	87	88	IEEE-INST ELECTRICAL ELECTRONICS ENGINEERS INC	NEW YORK	345 E 47TH ST, NEW YORK, NY 10017-2394 USA	0018-9200			IEEE J SOLID-ST CIRC	IEEE J. Solid-State Circuit	OCT	2000	35	10					1498	1501		10.1109/4.871328		4	Engineering, Electrical & Electronic	Engineering	362LA	WOS:000089778400015		
J	Yamashita, S; Matsumoto, D				Yamashita, S; Matsumoto, D			Waveform reshaping based on injection locking of a distributed-feedback semiconductor laser	IEEE PHOTONICS TECHNOLOGY LETTERS			English	Article						injection locking; waveform reshaping		We propose a novel waveform reshaping technique based on injection locking of a distributed-feedback (DFB) semiconductor laser. We have successfully demonstrated the principle of operation by reshaping a distorted 1.8-Gb/s PRBS signal.	Univ Tokyo, Sch Frontier Sci, Dept Frontier Informat, Bunkyo Ku, Tokyo 1138656, Japan; Univ Tokyo, Sch Engn, Dept Elect Engn, Bunkyo Ku, Tokyo 1138656, Japan	Yamashita, S (reprint author), Univ Tokyo, Sch Frontier Sci, Dept Frontier Informat, Bunkyo Ku, Tokyo 1138656, Japan.						OLSSON NA, 1985, J LIGHTWAVE TECHNOL, V3, P63, DOI 10.1109/JLT.1985.1074146; HUI R, 1993, OPT LETT, V18, P1733, DOI 10.1364/OL.18.001733; HUI RQ, 1990, IEEE PHOTONIC TECH L, V2, P743, DOI 10.1109/68.60778; RYU S, 1995, ELECTRON LETT, V31, P1589, DOI 10.1049/el:19951060; Siegman A. E., 1986, LASERS; SIMON JC, 1998, P ECOC 98, V1, P467; WEICH K, 1994, ELECTRON LETT, V30, P493, DOI 10.1049/el:19940329; WYATT R, 1982, ELECTRON LETT, V18, P292, DOI 10.1049/el:19820199	8	10	10	IEEE-INST ELECTRICAL ELECTRONICS ENGINEERS INC	NEW YORK	345 E 47TH ST, NEW YORK, NY 10017-2394 USA	1041-1135			IEEE PHOTONIC TECH L	IEEE Photonics Technol. Lett.	OCT	2000	12	10					1388	1390				3	Engineering, Electrical & Electronic; Optics; Physics, Applied	Engineering; Optics; Physics	374PN	WOS:000165353700032		
J	Chen, LN; Aihara, K				Chen, LN; Aihara, K			Strange attractors in chaotic neural networks	IEEE TRANSACTIONS ON CIRCUITS AND SYSTEMS I-FUNDAMENTAL THEORY AND APPLICATIONS			English	Article						attracting set; chaos; homoclinic orbit; neural network; snap back repeller; strange attractor; topological transitivity	DYNAMICS; SYSTEMS	This paper aims to prove theoretically that transiently chaotic neural networks (TCNNs) have a strange attractor, which is generated by a bounded fixed point corresponding to a unique repeller in the case that absolute values of the self-feedback connection weights in TCNNs are sufficiently large, We provide sufficient conditions under which the fixed point actually evolves into a strange attractor by a homoclinic bifurcation, which results in complicated chaotic dynamics. The strange attractor of n-dimensional TCNNs is actually the global unstable set of the repeller, which is asymptotically stable, sensitively dependent on initial conditions and topologically transitive, The existence of the strange attractor implies that TCNNs have a globally searching ability for globally optimal solutions of the commonly used objective functions in combinatorial optimization problems when the size of the strange attractor is sufficiently large.	Osaka Sangyo Univ, Fac Engn, Osaka 5748530, Japan; Univ Tokyo, Grad Sch Complex Sci & Engn, Tokyo 1138656, Japan; Japan Sci & Technol Corp, CREST, Kawaguchi, Saitama 332, Japan	Chen, LN (reprint author), Osaka Sangyo Univ, Fac Engn, Osaka 5748530, Japan.						Adachi M, 1999, INT J BIFURCAT CHAOS, V9, P2157, DOI 10.1142/S0218127499001577; Adachi M, 1997, NEURAL NETWORKS, V10, P83, DOI 10.1016/S0893-6080(96)00061-5; AMARI S, 1972, IEEE T SYST MAN CYB, VSMC2, P643, DOI 10.1109/TSMC.1972.4309193; Chen LN, 1997, IEEE T POWER SYST, V12, P1481; SHIMADA I, 1979, PROG THEOR PHYS, V61, P1605, DOI 10.1143/PTP.61.1605; AIHARA K, 1990, PHYS LETT A, V144, P333, DOI 10.1016/0375-9601(90)90136-C; MAROTTO FR, 1978, J MATH ANAL APPL, V63, P199, DOI 10.1016/0022-247X(78)90115-4; BUESCU J, 1997, EXOTIC ATTRACTORS LI; CHEN LN, 1995, NEURAL NETWORKS, V8, P915, DOI 10.1016/0893-6080(95)00033-V; CHEN L, 1994, HARNESSING CHAOS, P347; CHEN L, 1995, DYNAMIC SYSTEMS CHAO, V1, P319; Chen LN, 1997, PHYSICA D, V104, P286, DOI 10.1016/S0167-2789(96)00302-8; Chen LN, 1999, IEEE T CIRCUITS-I, V46, P974; Devaney R. L., 1989, INTRO CHAOTIC DYNAMI; Eckmann J.-P., 1985, REV MOD PHYS, V57, P3; Guckenheimer J., 1983, NONLINEAR OSCILLATIO; Hirsch M., 1974, DIFFERENTIAL EQUATIO; HOPFIELD JJ, 1982, P NATL ACAD SCI-BIOL, V79, P2554, DOI 10.1073/pnas.79.8.2554; HOPFIELD JJ, 1984, P NATL ACAD SCI-BIOL, V81, P3088, DOI 10.1073/pnas.81.10.3088; Kuznetsov Y. A., 1995, ELEMENTS APPL BIFURC; LI TY, 1975, AM MATH MON, V82, P985, DOI 10.2307/2318254; MARCUS CM, 1989, PHYS REV A, V40, P501, DOI 10.1103/PhysRevA.40.501; MIRA C, 1995, CHAOTIC DYNAMICS 2 D; PETERSON C, 1993, MODERN HEURISTIC TEC; Peterson C., 1987, Complex Systems, V1; RAZAFIMANANTENA EA, 1997, ANAL DYNAMICS AIHARA; Rumelhart D., 1986, PARALLEL DISTRIBUTED, V1; HOPFIELD JJ, 1985, BIOL CYBERN, V52, P141; URABE M, 1965, ARCH RATION MECH AN, V72, P121	29	29	31	IEEE-INST ELECTRICAL ELECTRONICS ENGINEERS INC	NEW YORK	345 E 47TH ST, NEW YORK, NY 10017-2394 USA	1057-7122			IEEE T CIRCUITS-I	IEEE Trans. Circuits Syst. I-Fundam. Theor. Appl.	OCT	2000	47	10					1455	1468				14	Engineering, Electrical & Electronic	Engineering	378BL	WOS:000165561700002		
J	Yasuda, Y; Takamiya, M; Hiramoto, T				Yasuda, Y; Takamiya, M; Hiramoto, T			Separation of effects of statistical impurity number fluctuations and position distribution on Vth fluctuations in scaled MOSFETs	IEEE TRANSACTIONS ON ELECTRON DEVICES			English	Article						charge sharing factor; depletion region; FD SOI MOSFET; impurity; number fluctuation; position distribution; scaling; threshold voltage	THRESHOLD VOLTAGE; DOPANT	We have investigated the effect of the statistical "position" distribution of dopant atoms on threshold voltage (V-th) fluctuations in scaled MOSFETs. The effects of impurity "number'' fluctuations and impurity "position" distribution are successfully separated in two-dimensional simulation for fully-depleted (FD) SOI MOSFETs. It is found that the contribution by the position distribution is closely related to the charge sharing factor (CSF) and the effect of the impurity position distribution becomes dominant as CSF is degraded. Consequently, the contribution ratio of the impurity position distribution is kept almost constant when the device is properly scaled.	Univ Tokyo, Inst Ind Sci, Tokyo 1068558, Japan; Chuo Univ, Fac Sci & Engn, Tokyo 112, Japan; Univ Tokyo, VLSI Design & Educ Ctr, Tokyo 1068558, Japan	Yasuda, Y (reprint author), NEC Corp Ltd, Sagamihara, Kanagawa 2291198, Japan.						Mizuno T, 1996, JPN J APPL PHYS 1, V35, P842, DOI 10.1143/JJAP.35.842; Asenov A, 1998, IEEE T ELECTRON DEV, V45, P2505, DOI 10.1109/16.735728; Stolk PA, 1998, IEEE T ELECTRON DEV, V45, P1960, DOI 10.1109/16.711362; Tang XH, 1997, IEEE T VLSI SYST, V5, P369; *AV CORP, 1998, MED VER 4 1; *AV CORP, 1998, DAV VER 4 1; Frank D.J., 1999, S VLSI TECHN, P169; HOENEISE.B, 1972, SOLID STATE ELECTRON, V15, P819, DOI 10.1016/0038-1101(72)90103-7; KEYS RW, 1975, APPL PHYS, V8, P251; Kuhn C, 1997, INTERNATIONAL ELECTRON DEVICES MEETING - 1997, TECHNICAL DIGEST, P145, DOI 10.1109/IEDM.1997.650280; MIZUNO T, 1993, S VLSI, P41; NISHINOHARA K, 1992, IEEE T ELECTRON DEV, V39, P634, DOI 10.1109/16.123489; SHIMATANI T, 1997, P SIL NAN WORKSH, P16; Takeuchi K, 1997, INTERNATIONAL ELECTRON DEVICES MEETING - 1997, TECHNICAL DIGEST, P841, DOI 10.1109/IEDM.1997.650512; TAKEUCHI K, 1998, S VLSI TECHN, P72; Vasileska D., 1998, P 1998 6 INT WORKSH, P259; Wong H.-S., 1993, IEDM, P705; YASUDA Y, 1999, SNW99, P86	18	36	36	IEEE-INST ELECTRICAL ELECTRONICS ENGINEERS INC	NEW YORK	345 E 47TH ST, NEW YORK, NY 10017-2394 USA	0018-9383			IEEE T ELECTRON DEV	IEEE Trans. Electron Devices	OCT	2000	47	10					1838	1842		10.1109/16.870557		5	Engineering, Electrical & Electronic; Physics, Applied	Engineering; Physics	358RE	WOS:000089570300011		
J	Aoyama, T				Aoyama, T			Special issue on advanced internetworking based on photonic network technologies - Foreword	IEICE TRANSACTIONS ON COMMUNICATIONS			English	Editorial Material									Univ Tokyo, Dept Informat & Commun Engn, Tokyo, Japan	Aoyama, T (reprint author), Univ Tokyo, Dept Informat & Commun Engn, Tokyo, Japan.							0	3	3	IEICE-INST ELECTRONICS INFORMATION COMMUNICATIONS ENG	TOKYO	KIKAI-SHINKO-KAIKAN BLDG, 3-5-8, SHIBA-KOEN, MINATO-KU, TOKYO, 105-0011, JAPAN	0916-8516	1745-1345		IEICE T COMMUN	IEICE Trans. Commun.	OCT	2000	E83B	10					2151	2152				2	Engineering, Electrical & Electronic; Telecommunications	Engineering; Telecommunications	368WP	WOS:000090140700001		
J	Yasui, T; Kasahara, K; Nakano, Y				Yasui, T; Kasahara, K; Nakano, Y			Internetworking based on Wavelength Assignment Photonic Switching System (WAPS)	IEICE TRANSACTIONS ON COMMUNICATIONS			English	Article						WDM; photonic network; routers; IP; cut through; photonic switches		Wavelength Assignment Photonic Switching System (WAPS) provides a wavelength for an end-to-end communication. Tn this way the features of wavelength can be fully utilized by users. We will give an architectural proposal in which two types of connections over WAPS network are provided and are adaptively used according to service demand by customers. One is a connection established semi-permanently between edge routers and relay-routers and the other is a connection established on Row-by-flow basis between edge routers. We will compare with conventional router networks in terms of data-transfer time. Pre-processing time is a crucial issue in connection-oriented networks, and this is very much reduced thanks to the WAPS network structure.	Mitsubishi Elect Corp, Kamakura, Kanagawa 2478501, Japan; Univ Tokyo, Dept Elect Engn, Tokyo 1130052, Japan	Yasui, T (reprint author), Mitsubishi Elect Corp, Kamakura, Kanagawa 2478501, Japan.						Lin LY, 1998, IEEE PHOTONIC TECH L, V10, P525, DOI 10.1109/68.662582; HABARA K, 1977, IECEJ T, V60, P459; HIMENO A, 1996, P ECOC 96 OSL NORW S, V4, P149; Jourdan A, 1996, J LIGHTWAVE TECHNOL, V14, P1198, DOI 10.1109/50.511621; KUMAR VP, 1998, IEEE COMMUN MAG, V35, P152; Li T, 1999, IEEE COMMUN MAG, V37, P38, DOI 10.1109/35.809382; NEWMAN P, 1998, IEEE ACM T NETWORKIN, V6; Okamoto S, 1996, J LIGHTWAVE TECHNOL, V14, P1410, DOI 10.1109/50.511671; SASAYAMA K, 1992, P OFC, P10; Smith DA, 1996, J LIGHTWAVE TECHNOL, V14, P1005, DOI 10.1109/50.511601; Sugioka H., 1998, NTT R & D, V47; TAKAHASHI S, 1999, P ECOC1999, P50; Watanabe N., 1998, NTT R & D, V47; White PP, 1997, IEEE COMMUN MAG, V35, P100, DOI 10.1109/35.592102; YASUI T, 1994, IEICE T COMMUN, VE77B, P174; Yasui T, 1999, IEICE T COMMUN, VE82B, P306	16	4	4	IEICE-INST ELECTRONICS INFORMATION COMMUNICATIONS ENG	TOKYO	KIKAI-SHINKO-KAIKAN BLDG, 3-5-8, SHIBA-KOEN, MINATO-KU, TOKYO, 105-0011, JAPAN	0916-8516	1745-1345		IEICE T COMMUN	IEICE Trans. Commun.	OCT	2000	E83B	10					2312	2320				9	Engineering, Electrical & Electronic; Telecommunications	Engineering; Telecommunications	368WP	WOS:000090140700017		
J	Ma, BJ; Saitoh, M; Nakano, Y				Ma, BJ; Saitoh, M; Nakano, Y			Photon-induced waveguides for all-optical switching and wavelength conversion	IEICE TRANSACTIONS ON ELECTRONICS			English	Letter						photon-induced waveguide (PIG); guiding/antiguiding; all-optical digital wavelength converter; optical switching; semiconductor optical amplifier (SOA)	CONVERTER		Univ Tokyo, Dept Elect Engn, Tokyo 1138656, Japan	Ma, BJ (reprint author), Univ Tokyo, Dept Elect Engn, Tokyo 1138656, Japan.	bjma@hotaka.t.u-tokyo.ac.jp					Ghafouri-Shiraz H., 1996, FUNDAMENTALS LASER D; JOURDAN A, 1997, P INT OPT OPT FIBR C, V3; MA B, 1999, OPT AMPL THEIR APPL; Ma BJ, 1999, IEEE PHOTONIC TECH L, V11, P188; Marcuse D. M., 1974, THEORY DIELECTRIC OP; NAKATSUHARA K, 1998, OPT COMM C OECC 98 C; SATO R, 1998, OPT COMM C OECC 98 M; Spiekman LH, 1997, IEEE PHOTONIC TECH L, V9, P1349, DOI 10.1109/68.623259; Spiekman LH, 1998, IEEE PHOTONIC TECH L, V10, P1115, DOI 10.1109/68.701520	9	0	0	IEICE-INST ELECTRONICS INFORMATION COMMUNICATIONS ENG	TOKYO	KIKAI-SHINKO-KAIKAN BLDG, 3-5-8, SHIBA-KOEN, MINATO-KU, TOKYO, 105-0011, JAPAN	0916-8524	1745-1353		IEICE T ELECTRON	IEICE Trans. Electron.	OCT	2000	E83C	10					1683	1686				4	Engineering, Electrical & Electronic	Engineering	368WV	WOS:000090141200023		
J	Song, LT; Futamura, Y; Gluck, R; Hu, ZJ				Song, LT; Futamura, Y; Gluck, R; Hu, ZJ			Loop quasi-invariance code motion	IEICE TRANSACTIONS ON INFORMATION AND SYSTEMS			English	Article						loop quasi-invariance; code motion; program optimization; partial evaluation	TRANSFORMATIONS; GRAPH	Loop optimization plays an important role in compiler optimization and program transformation. Many sophisticated techniques such as loop-invariance code motion, loop restructuring and loop fusion have been developed. This paper introduces a novel technique called loop quasi-invariance code motion. It is a generalization of standard loop-invariance code motion, but based on loop quasi-invariance analysis. Loop quasi-invariance is similar iu standard loop-invariance but allows for a finite number of iterations before computations in a loop become invariant. In this paper we define the notion of loop quasi-invariance, present an algorithm for statically computing the optimal unfolding length in While-programs and give a transformation method. Our method carl increase the accuracy of program analyses and improve the efficiency of programs by making loops smaller and faster. Our technique is well-suited as supporting transformation in compilers, partial evaluators, and other program transformers.	Waseda Univ, Grad Sch Sci & Engn, Dept Informat & Comp Sci, Tokyo 1690072, Japan; Univ Tokyo, Dept Informat Engn, Tokyo 1130033, Japan	Song, LT (reprint author), Waseda Univ, Grad Sch Sci & Engn, Dept Informat & Comp Sci, Tokyo 1690072, Japan.						Aho A., 1986, COMPILERS PRINCIPLES; ANDERSEN LO, 1994, 9419 DIKU U COP DEP; WARSHALL S, 1962, J ACM, V9, P11, DOI 10.1145/321105.321107; BACON DF, 1994, ACM COMPUT SURV, V26, P345, DOI 10.1145/197405.197406; FLOYD RW, 1962, COMMUN ACM, V5, P345, DOI 10.1145/367766.368168; Bodik R., 1998, P ACM SIGPLAN 98 C P, P1, DOI 10.1145/277650.277653; BULYONKOV MA, 1996, P LNCS, V1110, P17; CYTRON R, 1991, ACM T PROGR LANG SYS, V13, P451, DOI 10.1145/115372.115320; CYTRON R, 1986, C REC 13 ACM S PRINC, P70; Glenstrup AJ, 1999, LECT NOTES COMPUT SC, V1706, P108; GLENSTRUP AJ, 1996, P LNCS, V1181, P273; GUPTA R, 1998, IEEE INT C COMP LANG, P230; HORNOF L, 1997, S PART EV SEM BAS PR, P63; JONES N, 1993, PARTIAL EVALUATION A; Metzger R., 1993, ACM Letters on Programming Languages and Systems, V2, DOI 10.1145/176454.176526; MEYER U, 1991, SIGPLAN NOTICES, V26, P94; Nielson F., 1999, PRINCIPLES PROGRAM A; Rosen B. K., 1988, Conference Record of the Fifteenth Annual ACM Symposium on Principles of Programming Languages; SONG LT, 1998, 15 NAT C SOFTW SOC B, V6, P221; Steffen B, 1996, LNCS, V1145, P22; STEFFEN B, 1990, LECT NOTES COMPUT SC, V432, P389; WEGMAN MN, 1991, ACM T PROGR LANG SYS, V13, P181, DOI 10.1145/103135.103136; ZIMA H, 1990, SUPERCOMPILER PARALL	23	1	1	IEICE-INST ELECTRONICS INFORMATION COMMUNICATIONS ENG	TOKYO	KIKAI-SHINKO-KAIKAN BLDG, 3-5-8, SHIBA-KOEN, MINATO-KU, TOKYO, 105-0011, JAPAN	1745-1361			IEICE T INF SYST	IEICE Trans. Inf. Syst.	OCT	2000	E83D	10					1841	1850				10	Computer Science, Information Systems; Computer Science, Software Engineering	Computer Science	368WW	WOS:000090141300002		
J	Sato, M; Suemori, H; Hata, N; Asagiri, M; Ogasawara, K; Nakao, K; Nakaya, T; Katsuki, M; Noguchi, S; Tanaka, N; Taniguchi, T				Sato, M; Suemori, H; Hata, N; Asagiri, M; Ogasawara, K; Nakao, K; Nakaya, T; Katsuki, M; Noguchi, S; Tanaka, N; Taniguchi, T			Distinct and essential roles of transcription factors IRF-3 and IRF-7 in response to viruses for IFN-alpha/beta gene induction	IMMUNITY			English	Article							BETA-INTERFERON GENE; NF-KAPPA-B; REGULATORY ELEMENTS; INDUCIBLE ENHANCER; POSITIVE FEEDBACK; VIRAL INDUCTION; FACTOR COMPLEX; A GENES; EXPRESSION; ACTIVATION	Induction of the interferon (IFN)-alpha/beta gene transcription in virus-infected cells is an event central to innate immunity. Mice lacking the transcription factor IRF-3 are more vulnerable to virus infection. In embryonic fibroblasts, virus-induced IFN-alpha/beta gene expression levels are reduced and the spectrum of the IFN-alpha mRNA subspecies altered. Furthermore, cells additionally defective in IRF-7 expression totally fail to induce these genes in response to infections by any of the virus types tested. In these cells, a normal profile of IFN-alpha/beta mRNA induction can be achieved by coexpressing both IRF-3 and IRF-7. These results demonstrate the essential and distinct roles of the two factors, which together ensure the transcriptional efficiency and diversity of IFN-alpha/beta genes for the antiviral response.	Univ Tokyo, Grad Sch Med, Dept Immunol, Bunkyo Ku, Tokyo 1130033, Japan; Univ Tokyo, Fac Med, Bunkyo Ku, Tokyo 1130033, Japan; Kanagawa Acad Sci & Technol, Bio Signal Pathway Project, Odawara, Kanagawa 2500862, Japan; Meiji Milk Prod Co Ltd, Odawara, Kanagawa 2500862, Japan; Univ Tokyo, Inst Med Sci, Dept DNA Biol & Embryo Engn, Minato Ku, Tokyo 1068639, Japan	Taniguchi, T (reprint author), Univ Tokyo, Grad Sch Med, Dept Immunol, Bunkyo Ku, Hongo 7-3-1, Tokyo 1130033, Japan.		Ogasawara, Kouetsu/G-9892-2011				FUJITA T, 1988, EMBO J, V7, P3397; FUJITA T, 1987, CELL, V49, P357, DOI 10.1016/0092-8674(87)90288-1; Tanaka N, 1998, GENES CELLS, V3, P29, DOI 10.1046/j.1365-2443.1998.00164.x; VISVANATHAN KV, 1989, EMBO J, V8, P1129; Yoneyama M, 1996, J BIOCHEM-TOKYO, V120, P160; Kimura T, 1996, GENES CELLS, V1, P115, DOI 10.1046/j.1365-2443.1996.08008.x; FUJITA T, 1989, NATURE, V337, P270, DOI 10.1038/337270a0; MIYAMOTO M, 1988, CELL, V54, P903, DOI 10.1016/S0092-8674(88)91307-4; MATSUYAMA T, 1993, CELL, V75, P83, DOI 10.1016/S0092-8674(05)80086-8; Lin RT, 1998, MOL CELL BIOL, V18, P2986; Sato M, 1998, FEBS LETT, V441, P106, DOI 10.1016/S0014-5793(98)01514-2; Sato M, 1998, FEBS LETT, V425, P112, DOI 10.1016/S0014-5793(98)00210-5; Marie I, 1998, EMBO J, V17, P6660, DOI 10.1093/emboj/17.22.6660; Rechsteiner M, 1996, TRENDS BIOCHEM SCI, V21, P267, DOI 10.1016/S0968-0004(96)10031-1; LENARDO MJ, 1989, CELL, V57, P287, DOI 10.1016/0092-8674(89)90966-5; FUJITA T, 1981, VIROLOGY, V112, P62, DOI 10.1016/0042-6822(81)90612-7; GOODBOURN S, 1988, P NATL ACAD SCI USA, V85, P1447, DOI 10.1073/pnas.85.5.1447; Yoneyama M, 1998, EMBO J, V17, P1087, DOI 10.1093/emboj/17.4.1087; Mamane Y, 1999, GENE, V237, P1, DOI 10.1016/S0378-1119(99)00262-0; Juang YT, 1998, P NATL ACAD SCI USA, V95, P9837, DOI 10.1073/pnas.95.17.9837; Wathelet MG, 1998, MOL CELL, V1, P507, DOI 10.1016/S1097-2765(00)80051-9; Schafer SL, 1998, J BIOL CHEM, V273, P2714, DOI 10.1074/jbc.273.5.2714; Takaoka A, 2000, SCIENCE, V288, P2357, DOI 10.1126/science.288.5475.2357; Ogasawara K, 1998, NATURE, V391, P700; Takaoka A, 1999, EMBO J, V18, P2480, DOI 10.1093/emboj/18.9.2480; Au WC, 1998, J BIOL CHEM, V273, P29210, DOI 10.1074/jbc.273.44.29210; CASTRILLO JL, 1986, MOL CELL BIOCHEM, V71, P53; Chu WM, 1999, IMMUNITY, V11, P721, DOI 10.1016/S1074-7613(00)80146-6; CIVAS A, 1991, NUCLEIC ACIDS RES, V19, P4497, DOI 10.1093/nar/19.16.4497; DeMaeyer E, 1988, INTERFERONS OTHER RE; DU W, 1993, CELL, V74, P887, DOI 10.1016/0092-8674(93)90468-6; DU W, 1992, P NATL ACAD SCI USA, V89, P2150, DOI 10.1073/pnas.89.6.2150; FAN CM, 1989, EMBO J, V8, P101; FUJITA T, 1989, NUCLEIC ACIDS RES, V17, P3335, DOI 10.1093/nar/17.9.3335; Genin P, 1995, NUCLEIC ACIDS RES, V23, P5055; GOODBOURN S, 1986, CELL, V45, P601, DOI 10.1016/0092-8674(86)90292-8; HARADA H, 1990, CELL, V63, P303, DOI 10.1016/0092-8674(90)90163-9; Harada H, 1996, GENES CELLS, V1, P995, DOI 10.1046/j.1365-2443.1996.870287.x; ICHII Y, 1986, NUCLEIC ACIDS RES, V14, P10117, DOI 10.1093/nar/14.24.10117; KAWAKAMI T, 1995, FEBS LETT, V358, P225, DOI 10.1016/0014-5793(94)01426-2; LEBLANC JF, 1990, MOL CELL BIOL, V10, P3987; MANIATIS T, 1992, TRANSCRIPTIONAL REGU, V2, P1193; Nguyen Hannah, 1997, Cytokine and Growth Factor Reviews, V8, P293, DOI 10.1016/S1359-6101(97)00019-1; NOURBAKHSH M, 1993, EMBO J, V12, P451; RAJ NBK, 1989, J BIOL CHEM, V264, P11149; ROBERTSON EJ, 1991, BIOL REPROD, V44, P238, DOI 10.1095/biolreprod44.2.238; ROGERS S, 1986, SCIENCE, V234, P364, DOI 10.1126/science.2876518; RYALS J, 1985, CELL, V41, P497, DOI 10.1016/S0092-8674(85)80023-4; SHAW GD, 1983, NUCLEIC ACIDS RES, V11, P555, DOI 10.1093/nar/11.3.555; STEWART WE, 1971, J VIROL, V7, P792; TANIGUCHI T, 1988, ANNU REV IMMUNOL, V6, P439; TANIGUCHI T, 2000, S QUANT BIOL, V64, P465; Vilcek J, 1996, FIELDS VIROLOGY, P375; WEISSMANN C, 1986, PROG NUCLEIC ACID RE, V33, P251, DOI 10.1016/S0079-6603(08)60026-4	54	784	809	CELL PRESS	CAMBRIDGE	1050 MASSACHUSETTES AVE, CIRCULATION DEPT, CAMBRIDGE, MA 02138 USA	1074-7613			IMMUNITY	Immunity	OCT	2000	13	4					539	548		10.1016/S1074-7613(00)00053-4		10	Immunology	Immunology	367UD	WOS:000090079100013		
J	Yanagisawa, H				Yanagisawa, H			Harbingers of rain: Land and life in South India	INDIAN ECONOMIC AND SOCIAL HISTORY REVIEW			English	Book Review									Univ Tokyo, Inst Oriental Culture, Tokyo, Japan	Yanagisawa, H (reprint author), Univ Tokyo, Inst Oriental Culture, Tokyo, Japan.						Vasavi A. R., 1999, HARBINGERS RAIN LAND	1	0	0	SAGE PUBLICATIONS PVT LTD	NEW DELHI	POST BOX 4125 M-32 MARKET, GREATER KAILASH-I, NEW DELHI 110 048, INDIA	0019-4646			INDIAN ECON SOC HIST	Indian Econ. Soc. Hist. Rev.	OCT-DEC	2000	37	4					479	481		10.1177/001946460003700404		3	History	History	402VT	WOS:000167009400004		
J	Tatsuno, I; Kimura, H; Okutani, A; Kanamaru, K; Abe, H; Nagai, S; Makino, K; Shinagawa, H; Yoshida, M; Sato, K; Nakamoto, J; Tobe, T; Sasakawa, C				Tatsuno, I; Kimura, H; Okutani, A; Kanamaru, K; Abe, H; Nagai, S; Makino, K; Shinagawa, H; Yoshida, M; Sato, K; Nakamoto, J; Tobe, T; Sasakawa, C			Isolation and characterization of mini-Tn5Km2 insertion mutants of enterohemorrhagic Escherichia coli O157 : H7 deficient in adherence to caco-2 cells	INFECTION AND IMMUNITY			English	Article							COMPLETE NUCLEOTIDE-SEQUENCE; HEMOLYTIC-UREMIC SYNDROME; GRAM-NEGATIVE BACTERIA; EPITHELIAL-CELLS; ENTEROCYTE EFFACEMENT; MOLECULAR EVOLUTION; SURFACE APPENDAGES; HEP-2 CELLS; HOST-CELLS; IN-VITRO	Adherence of enterohemorrhagic Escherichia coli (EHEC) to intestinal epithelium is essential for initiation of the infection. To identify genes involved in adherence, an EHEC O157:H7 strain (O157Sakai) was mutagenized by mini-Tn5Km2, where Km refers to kanamycin resistance, and 4,677 insertion mutants were screened for their ability to form microcolonies (MC) on Caco-2 cells. The less adherent mutants were divided into three groups: those with no adherent ability (designated as class 1 mutants, n = 10), those less adherent than the wild type (class 2 mutants, n = 16), and those unable to form MC but which adhered in a diffuse manner (class 3 mutants, n = 1). The sites of insertion in class 1 mutants were all found within genes of the locus for enterocyte effacement (LEE) thought to be required for type III protein secretion. Indeed, the class 1 mutants failed to secrete type III secreted proteins such as EspA and Tir into the culture medium. The insertions in class 2 mutants were outside the LEE, and all the mutants except one were able to secrete type III proteins into the culture medium. The class 3 mutant had the insertion in the tir gene in the LEE and was deficient in Tir and intimin expression, suggesting that in the absence of intimin-Tir, O157Sakai can still adhere to Caco-2 cells but in a diffused manner. This was confirmed by construction of a nonpolar eae (encoding intimin) mutant. Examination of the eae mutant together with O157Sakai and one of the class 1 mutants for the ability to form MC revealed that EHEC initially adhered diffusely at 1.5 h after infection. Following washing out of the nonadherent bacteria, while wild-type EHEC bacteria developed MC for another 2 to 3 h on Caco-2 cells, the eae mutant diffusely adhered throughout the infection without forming MC. MC with O157Sakai but not the diffusely adherent eae mutant could evoke F-actin condensation beneath the bacterium. Our results suggest that EHEC encodes additional adherence-associated loci and that the type III secreted proteins are involved in the initial diffuse adherence, while the intimin-Tir interaction is required for the subsequent development of MC.	Univ Tokyo, Inst Med Sci, Dept Microbiol & Immunol, Minato Ku, Tokyo 1088639, Japan; Univ Tokyo, Grad Sch Agr & Life Sci, Lab Vet Publ Hlth, Bunkyo Ku, Tokyo 1138657, Japan; Nippon Inst Biol Sci, Tokyo 1980024, Japan; Osaka Univ, Res Inst Microbial Dis, Dept Mol Microbiol, Suita, Osaka 5650871, Japan; Juntendo Univ, Sch Med, Div Electron Microscopy, Cent Lab Med Sci,Bunkyo Ku, Tokyo 1138421, Japan	Sasakawa, C (reprint author), Univ Tokyo, Inst Med Sci, Dept Microbiol & Immunol, Minato Ku, 4-6-1 Shirokanedai, Tokyo 1088639, Japan.	sasakawa@ims.u-tokyo.ac.jp					HITCHCOCK PJ, 1983, J BACTERIOL, V154, P269; DONNENBERG MS, 1992, INFECT IMMUN, V60, P3953; Perna NT, 1998, INFECT IMMUN, V66, P3810; RILEY LW, 1983, NEW ENGL J MED, V308, P681, DOI 10.1056/NEJM198303243081203; MARMUR J, 1961, J MOL BIOL, V3, P208; Frankel G, 1998, MOL MICROBIOL, V30, P911, DOI 10.1046/j.1365-2958.1998.01144.x; Puente JL, 1996, MOL MICROBIOL, V20, P87, DOI 10.1111/j.1365-2958.1996.tb02491.x; MILKMAN R, 1993, GENETICS, V133, P455; Rosenshine I, 1996, EMBO J, V15, P2613; SHORT JM, 1988, NUCLEIC ACIDS RES, V16, P7583, DOI 10.1093/nar/16.15.7583; MENARD R, 1993, J BACTERIOL, V175, P5899; Mellies JL, 1999, MOL MICROBIOL, V33, P296, DOI 10.1046/j.1365-2958.1999.01473.x; MCKEE ML, 1995, INFECT IMMUN, V63, P2070; MCKEE ML, 1995, INFECT IMMUN, V63, P3739; BOYCE TG, 1995, NEW ENGL J MED, V333, P364, DOI 10.1056/NEJM199508103330608; Knutton S, 1998, EMBO J, V17, P2166, DOI 10.1093/emboj/17.8.2166; Nataro JP, 1998, CLIN MICROBIOL REV, V11, P142; Kresse AU, 1999, INFECT IMMUN, V67, P4834; DELORENZO V, 1990, J BACTERIOL, V172, P6568; DELORENZO V, 1994, METHOD ENZYMOL, V235, P386; DIORIO C, 1995, J BACTERIOL, V177, P2050; DONNENBERG MS, 1993, J CLIN INVEST, V92, P1418, DOI 10.1172/JCI116718; Kenny B, 1997, CELL, V91, P511, DOI 10.1016/S0092-8674(00)80437-7; Blattner FR, 1997, SCIENCE, V277, P1453, DOI 10.1126/science.277.5331.1453; KNUTTON S, 1989, INFECT IMMUN, V57, P1290; Makino K, 1999, GENES GENET SYST, V74, P227, DOI 10.1266/ggs.74.227; CONLIN CA, 1992, J BACTERIOL, V174, P5881; Deibel C, 1998, MOL MICROBIOL, V28, P463, DOI 10.1046/j.1365-2958.1998.00798.x; DeVinney R, 1999, INFECT IMMUN, V67, P2389; Ebel F, 1998, MOL MICROBIOL, V30, P147, DOI 10.1046/j.1365-2958.1998.01046.x; ELLIOTT SJ, 1988, MOL MICROBIOL, V28, P1; Elliott SJ, 1999, INFECT IMMUN, V67, P4260; GRIFFIN PM, 1991, EPIDEMIOL REV, V13, P60; Kresse AU, 1998, J BACTERIOL, V180, P4370; Liu H, 1999, MOL MICROBIOL, V34, P67, DOI 10.1046/j.1365-2958.1999.01574.x; LOUIE M, 1993, INFECT IMMUN, V61, P4085; MAKINO K, 1998, DNA RES, V28, P1; McKee ML, 1996, INFECT IMMUN, V64, P2225; Metcalf WW, 1996, PLASMID, V35, P1, DOI 10.1006/plas.1996.0001; Nicholls L, 2000, MOL MICROBIOL, V35, P275, DOI 10.1046/j.1365-2958.2000.01690.x; Ohnishi M, 1999, DNA Res, V6, P361, DOI 10.1093/dnares/6.6.361; Paton AW, 1997, INFECT IMMUN, V65, P3799; PLAMANN MD, 1983, NUCLEIC ACIDS RES, V11, P2065, DOI 10.1093/nar/11.7.2065; STEFFES C, 1992, J BACTERIOL, V174, P3242; STOKER NG, 1982, GENE, V18, P335, DOI 10.1016/0378-1119(82)90172-X; Tarr PI, 2000, INFECT IMMUN, V68, P1400, DOI 10.1128/IAI.68.3.1400-1407.2000; Tobe T, 1999, MOL MICROBIOL, V33, P741, DOI 10.1046/j.1365-2958.1999.01522.x; Watanabe H, 1996, LANCET, V348, P831, DOI 10.1016/S0140-6736(05)65257-9	48	52	56	AMER SOC MICROBIOLOGY	WASHINGTON	1752 N ST NW, WASHINGTON, DC 20036-2904 USA	0019-9567			INFECT IMMUN	Infect. Immun.	OCT	2000	68	10					5943	5952		10.1128/IAI.68.10.5943-5952.2000		10	Immunology; Infectious Diseases	Immunology; Infectious Diseases	355QE	WOS:000089395700065		
J	Kikuchi, Y; Hirano, M; Seto, M; Takatsu, K				Kikuchi, Y; Hirano, M; Seto, M; Takatsu, K			Identification and characterization of a molecule, BAM11, that associates with the pleckstrin homology domain of mouse Btk	INTERNATIONAL IMMUNOLOGY			English	Article						IL-5; LTG19/ENL; signal transduction	BRUTONS-TYROSINE-KINASE; X-LINKED AGAMMAGLOBULINEMIA; B-CELLS; SRC FAMILY; PH DOMAIN; NUCLEAR-LOCALIZATION; BINDING-PROTEIN; CD38 LIGATION; SH3 DOMAIN; ACTIVATION	Bruton's tyrosine kinase (Btk) is required for normal a cell development and signal transduction through cell surface molecules, and its defects lead to X-linked immune deficiency in mice and X-linked agammaglobulinemia in humans. In this report, we will describe the identification and characterization of a molecule, BAM11, which binds to the pleckstrin homology domain of Btk. A sequence homology search revealed that BAM11 has 89% homology, at the amino acid level, to human LTG19/ENL, that was originally identified as one of the fusion partners involved in chromosomal translocations of 11q23, MLL/ALL-1/HRX, in leukemia cells. Deletion mutants demonstrated that the region of BAM11 required for binding to Btk was localized between amino acid residues 240 and 256, Forced expression of a truncated form of BAM11 (amino acids 246-368) inhibited IL-5-induced proliferation by 50%, whereas forced expression of full-length BAM11 in Y16 cells did not affect the IL-5 responsiveness. We have also shown that BAM11 (amino acids 246-368) inhibited the kinase activity of Btk. These results suggest that the binding of BAM11 to Btk plays a regulatory role in the Btk signal transduction pathway. A cell fractionation study and analysis using EGFP-fused Btk protein demonstrated that a proportion of Btk is present within the nucleus.	Univ Tokyo, Inst Med Sci, Dept Immunol, Minato Ku, Tokyo 1088639, Japan; Kitasato Inst, Ctr Basic Res, Lab Mol Immunol, Minato Ku, Tokyo 1088642, Japan; Aichi Canc Ctr, Dept Pathol, Chikusa Ku, Nagoya, Aichi 4648681, Japan	Takatsu, K (reprint author), Univ Tokyo, Inst Med Sci, Dept Immunol, Minato Ku, 4-6-1 Shirokanedai, Tokyo 1088639, Japan.						Hata D, 1998, J EXP MED, V187, P1235, DOI 10.1084/jem.187.8.1235; GO NF, 1990, J EXP MED, V172, P1625, DOI 10.1084/jem.172.6.1625; Yamadori T, 1999, P NATL ACAD SCI USA, V96, P6341, DOI 10.1073/pnas.96.11.6341; RAWLINGS DJ, 1993, SCIENCE, V261, P358, DOI 10.1126/science.8332901; Lemmon MA, 1996, CELL, V85, P621, DOI 10.1016/S0092-8674(00)81022-3; Bence K, 1997, NATURE, V389, P296, DOI 10.1038/38520; Rawlings DJ, 1996, SCIENCE, V271, P822, DOI 10.1126/science.271.5250.822; DINGWALL C, 1991, TRENDS BIOCHEM SCI, V16, P478, DOI 10.1016/0968-0004(91)90184-W; Yasue T, 1997, P NATL ACAD SCI USA, V94, P10307, DOI 10.1073/pnas.94.19.10307; Matsushita M, 1998, BIOCHEM BIOPH RES CO, V245, P337, DOI 10.1006/bbrc.1998.8420; Satterthwaite AB, 1998, SEMIN IMMUNOL, V10, P309, DOI 10.1006/smim.1998.0123; THOMAS JD, 1993, SCIENCE, V261, P355, DOI 10.1126/science.8332900; Takata M, 1996, J EXP MED, V184, P31, DOI 10.1084/jem.184.1.31; YAO L, 1994, P NATL ACAD SCI USA, V91, P9175, DOI 10.1073/pnas.91.19.9175; Kurosaki T, 1999, ANNU REV IMMUNOL, V17, P555, DOI 10.1146/annurev.immunol.17.1.555; TKACHUK DC, 1992, CELL, V71, P691, DOI 10.1016/0092-8674(92)90602-9; Li ZM, 1997, P NATL ACAD SCI USA, V94, P13820, DOI 10.1073/pnas.94.25.13820; Kurosaki T, 1997, J BIOL CHEM, V272, P15595, DOI 10.1074/jbc.272.25.15595; CHEN RH, 1992, MOL CELL BIOL, V12, P915; CHENG GH, 1994, P NATL ACAD SCI USA, V91, P8152, DOI 10.1073/pnas.91.17.8152; Fluckiger AC, 1998, EMBO J, V17, P1973, DOI 10.1093/emboj/17.7.1973; HITOSHI Y, 1993, INT IMMUNOL, V5, P1183, DOI 10.1093/intimm/5.9.1183; Joh T, 1996, ONCOGENE, V13, P1945; Kawakami Y, 1999, J LEUKOCYTE BIOL, V65, P286; KIKUCHI Y, 1995, P NATL ACAD SCI USA, V92, P11814, DOI 10.1073/pnas.92.25.11814; KOIKE M, 1995, INT IMMUNOL, V7, P21, DOI 10.1093/intimm/7.1.21; Li TJ, 1997, ONCOGENE, V15, P1375, DOI 10.1038/sj.onc.1201308; LI TJ, 1995, IMMUNITY, V2, P451, DOI 10.1016/1074-7613(95)90026-8; MAHAJAN S, 1995, MOL CELL BIOL, V15, P5304; MUSACCHIO A, 1993, TRENDS BIOCHEM SCI, V18, P343, DOI 10.1016/0968-0004(93)90071-T; Novina CD, 1999, MOL CELL BIOL, V19, P5014; Park H, 1996, IMMUNITY, V4, P515, DOI 10.1016/S1074-7613(00)80417-3; RUBNITZ JE, 1994, BLOOD, V84, P1747; SATO S, 1994, J EXP MED, V180, P2101, DOI 10.1084/jem.180.6.2101; Setoguchi R, 1998, IMMUNOL LETT, V64, P109, DOI 10.1016/S0165-2478(98)00086-8; Shashidharan P, 1999, NEUROREPORT, V10, P1149, DOI 10.1097/00001756-199904060-00045; SMITH CIE, 1994, IMMUNOL REV, V138, P159, DOI 10.1111/j.1600-065X.1994.tb00851.x; [Anonymous], 1990, METHOD ENZYMOL; TAKAKI S, 1993, J EXP MED, V177, P1523, DOI 10.1084/jem.177.6.1523; TAKAKI S, 1990, EMBO J, V9, P4367; TAKEMOTO Y, 1995, EMBO J, V14, P3403; TSUKADA S, 1993, CELL, V72, P279, DOI 10.1016/0092-8674(93)90667-F; TSUKADA S, 1994, CURR OPIN IMMUNOL, V6, P623, DOI 10.1016/0952-7915(94)90151-1; TSUKADA S, 1994, P NATL ACAD SCI USA, V91, P11256, DOI 10.1073/pnas.91.23.11256; VETRIE D, 1993, NATURE, V361, P226, DOI 10.1038/361226a0; YAMAGATA T, 1995, ISSCC DIG TECH PAP I, V38, P248, DOI 10.1109/ISSCC.1995.535542; YAMAMOTO K, 1993, ONCOGENE, V8, P2617; Yang WY, 1997, P NATL ACAD SCI USA, V94, P604, DOI 10.1073/pnas.94.2.604; Yao LB, 1999, J BIOL CHEM, V274, P19752, DOI 10.1074/jbc.274.28.19752; KAWAKAMI Y, 1994, MOL CELL BIOL, V14, P5108	50	17	17	OXFORD UNIV PRESS	OXFORD	GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND	0953-8178	1460-2377		INT IMMUNOL	Int. Immunol.	OCT	2000	12	10					1397	1408		10.1093/intimm/12.10.1397		12	Immunology	Immunology	362VP	WOS:000089799200004		
J	Nishikawa, Y; Ikeda, H; Fukumoto, S; Xuan, XN; Nagasawa, H; Otsuka, H; Mikami, T				Nishikawa, Y; Ikeda, H; Fukumoto, S; Xuan, XN; Nagasawa, H; Otsuka, H; Mikami, T			Immunisation of dogs with a canine herpesvirus vector expressing Neospora caninum surface protein, NcSRS2	INTERNATIONAL JOURNAL FOR PARASITOLOGY			English	Article						Neospora canium; NcSRS2; canine herpesvirus; vaccine; dog; vector; recombinant; definitive host; immunisation	TOXOPLASMA-GONDII INFECTION; P-30 ANTIGEN; MICE; PROTECTION; IMMUNIZATION; CONSTRUCTION; SAG1; GENE	In order to develop a vaccine against Neospora caninum in dogs, we constructed recombinant canine herpesvirus (CHV) expressing N. caninum surface protein, NcSRS2. Indirect immunofluorescence indicated that the antigenic structure of the recombinant NcSRS2 was similar to the authentic parasite protein. The dogs immunised with recombinant virus produced IgG antibody to N. caninum, and their sera recognised the parasite protein on Western blot. The dogs inoculated with recombinant virus showed no clinical symptoms and infectious CHV was not recovered from the dogs, suggesting that recombinant CHV expressing N. caninum proteins may lead to a vaccine against neosporosis in dogs. (C) 2000 Published by Elsevier Science Ltd. on behalf of the Australian Society for Parasitology.	Obihiro Univ, Natl Res Ctr Protozoan Dis, Obihiro, Hokkaido 0808555, Japan; Univ Tokyo, Dept Global Agr Sci, Bunkyo Ku, Tokyo 1130032, Japan	Mikami, T (reprint author), Obihiro Univ, Natl Res Ctr Protozoan Dis, Inada Cho, Obihiro, Hokkaido 0808555, Japan.						Angus CW, 2000, J INFECT DIS, V181, P317, DOI 10.1086/315186; Dubey JP, 1996, VET PARASITOL, V67, P1, DOI 10.1016/S0304-4017(96)01035-7; Nielsen HV, 1999, INFECT IMMUN, V67, P6358; NIWA H, 1991, GENE, V108, P193; Nishikawa Y, 2000, INT J PARASITOL, V30, P51, DOI 10.1016/S0020-7519(99)00162-9; McAllister MM, 1998, INT J PARASITOL, V28, P1473, DOI 10.1016/S0020-7519(98)00138-6; Petersen E, 1998, VACCINE, V16, P1283, DOI 10.1016/S0264-410X(98)00039-5; Howe DK, 1999, INT J PARASITOL, V29, P1489, DOI 10.1016/S0020-7519(99)00099-5; DARCY F, 1992, J IMMUNOL, V149, P3636; BARR BC, 1992, J VET DIAGN INVEST, V4, P365; Boothroyd JC, 1998, INT J PARASITOL, V28, P3, DOI 10.1016/S0020-7519(97)00182-3; BULOW R, 1991, J IMMUNOL, V147, P3496; De Marez T, 1999, INT J PARASITOL, V29, P1647, DOI 10.1016/S0020-7519(99)00154-X; Dubey JP, 1999, VET PARASITOL, V84, P349, DOI 10.1016/S0304-4017(99)00044-8; Dubey J P, 1990, J Vet Diagn Invest, V2, P230; Eperon S, 1999, PARASITE IMMUNOL, V21, P225, DOI 10.1046/j.1365-3024.1999.00223.x; Hemphill A, 1996, PARASITOL RES, V82, P497, DOI 10.1007/s004360050152; Motohashi T., 1966, Japanese Journal of Veterinary Science, V28, P307; NISHIKAWA Y, 2000, IN PRESS PARASITOL R; Nishikawa Y, 1999, J VET MED SCI, V61, P1113, DOI 10.1292/jvms.61.1113; TAKUMI A, 1990, JPN J VET SCI, V52, P241; WOODS LW, 1994, J VET DIAGN INVEST, V6, P508; Xuan XN, 1998, VACCINE, V16, P969, DOI 10.1016/S0264-410X(97)00285-5; Xuan XN, 1998, VIRUS GENES, V17, P25, DOI 10.1023/A:1008096832738; Yokoyama N, 1996, VACCINE, V14, P1657, DOI 10.1016/S0264-410X(96)00131-4	25	21	23	PERGAMON-ELSEVIER SCIENCE LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND	0020-7519			INT J PARASITOL	Int. J. Parasit.	OCT	2000	30	11					1167	1171		10.1016/S0020-7519(00)00111-9		5	Parasitology	Parasitology	367TD	WOS:000090076800006		
J	Judd, K; Aihara, K				Judd, K; Aihara, K			Generation, recognition and learning of recurrent signals by pulse propagation networks	INTERNATIONAL JOURNAL OF BIFURCATION AND CHAOS			English	Article							CHAOTIC NEURAL NETWORKS; LONG-TERM DEPRESSION; COINCIDENCE DETECTOR; DYNAMICS; CORTEX; NEURONS; POTENTIATION	Pulse propagation networks (PPN) are neural networks in which individual action potentials encode information. The dynamics of PPN depend not only on the synaptic weights of connections but also the delay in the propagation of action potentials between neural elements. It is known that PPN can perform complex computations and information processing by encoding information as the time intervals between action potential events. In this paper we approach the practical question of constructing PPN to generate, recognize and learn arbitrary recurrent signals. We present specific examples of networks that generate and recognize signals and also describe a learning algorithm that allows PPN to learn by self-organization. Finally we discuss the possible importance of dynamical fluctuations about the mean-activity field of a neural network.	Univ Western Australia, Dept Math, Perth, WA 6907, Australia; Univ Tokyo, Sch Engn, Dept Math Engn & Informat Phys, Bunkyo Ku, Tokyo 113, Japan; Japan Sci & Technol Corp, JST, CREST, Kawaguchi 332, Japan	Judd, K (reprint author), Univ Western Australia, Dept Math, Perth, WA 6907, Australia.		Judd, Kevin/E-7690-2010				ABELES M, 1982, ISRAEL J MED SCI, V18, P83; AERTSEN A, 1994, PHYSICA D, V75, P103, DOI 10.1016/0167-2789(94)90278-X; Aihara K, 1996, NEURAL NETWORKS, V9, P724, DOI 10.1016/S0893-6080(96)90013-1; Aihara K., 1995, HDB BRAIN THEORY NEU, P183; ANDERSON J A, 1972, Mathematical Biosciences, V14, P197, DOI 10.1016/0025-5564(72)90075-2; Markram H, 1997, SCIENCE, V275, P213, DOI 10.1126/science.275.5297.213; Gerstner W, 1996, NATURE, V383, P76, DOI 10.1038/383076a0; AIHARA K, 1990, PHYS LETT A, V144, P333, DOI 10.1016/0375-9601(90)90136-C; STANTON PK, 1989, NATURE, V339, P215, DOI 10.1038/339215a0; Schultz W, 1999, NEWS PHYSIOL SCI, V14, P249; VAADIA E, 1995, NATURE, V373, P515, DOI 10.1038/373515a0; ARTOLA A, 1990, NATURE, V347, P69, DOI 10.1038/347069a0; BLISS TVP, 1973, J PHYSIOL-LONDON, V232, P331; BERNANDER O, 1991, P NATL ACAD SCI USA, V88, P11569, DOI 10.1073/pnas.88.24.11569; Caianiello E. R., 1961, J THEOR BIOL, V2, P204; Hebb D., 1949, ORG BEHAV; HOPFIELD JJ, 1984, P NATL ACAD SCI-BIOL, V81, P3088, DOI 10.1073/pnas.81.10.3088; Ichinose N, 1998, INT J BIFURCAT CHAOS, V8, P2375, DOI 10.1142/S021812749800190X; Ichinose N, 1995, ELECTRON COMM JPN 3, V78, P52, DOI 10.1002/ecjc.4430781105; JUDD K, 1994, NEURAL NETWORKS, V7, P1491; JUDD KT, 1992, CONCEPT NEUROSCI, V3, P123; KOHONEN T, 1972, IEEE T COMPUT, VC 21, P353; MEES A, 1992, PHYS LETT A, V169, P41, DOI 10.1016/0375-9601(92)90802-S; NAKANO K, 1972, IEEE T SYST MAN CYB, V2, P381; SAKURAI Y, 1993, NEUROSCI LETT, V158, P181, DOI 10.1016/0304-3940(93)90259-N; Fujii H, 1996, NEURAL NETWORKS, V9, P1303, DOI 10.1016/S0893-6080(96)00054-8; Watanabe M, 1998, BIOL CYBERN, V78, P87, DOI 10.1007/s004220050416; Watanabe M, 1997, NEURAL NETWORKS, V10, P1353, DOI 10.1016/S0893-6080(97)00037-3	28	4	4	WORLD SCIENTIFIC PUBL CO PTE LTD	SINGAPORE	JOURNAL DEPT PO BOX 128 FARRER ROAD, SINGAPORE 912805, SINGAPORE	0218-1274			INT J BIFURCAT CHAOS	Int. J. Bifurcation Chaos	OCT	2000	10	10					2415	2428		10.1142/S0218127400001559		14	Mathematics, Interdisciplinary Applications; Multidisciplinary Sciences	Mathematics; Science & Technology - Other Topics	385DB	WOS:000165985700011		
J	Hashimoto, S; Murakami, Y; Taniguchi, K; Nagai, M				Hashimoto, S; Murakami, Y; Taniguchi, K; Nagai, M			Detection of epidemics in their early stage through infectious disease surveillance	INTERNATIONAL JOURNAL OF EPIDEMIOLOGY			English	Article						infectious disease; surveillance; epidemic	PUBLIC-HEALTH SURVEILLANCE; UNITED-STATES; INFLUENZA; MORTALITY; MORBIDITY; MEASLES; SYSTEM	Background. Surveillance of infectious diseases is done in many countries. The aims of such surveillance include the detection of epidemics. in the present study, the possibility of detecting an epidemic in its early stage using a simple method was evaluated for 16 infectious diseases. Methods: We used as an index the number of cases per week per sentinel medical institution in the area covered by a health centre in infectious disease surveillance in Japan in 1993-1997. Periods of epidemics in health centre areas were determined according to the reported indices. The simple method used for detecting the early stage of an epidemic is that if the index exceeds a critical value, then an epidemic will begin in the following 4 weeks. The sensitivity, specificity and positive predictive value for this epidemic warning were evaluated for given critical values. Results: When the specificity of the epidemic warning was more than 95%, the sensitivity was more than 60% in ten diseases, and more than 80% in four diseases (influenza-like illness, rubella, hand-foot-and-mouth disease, and herpangina). The positive predictive value was between 15.6% and 31.4% in these ten diseases. Conclusion: The early stage of epidemics of some infectious diseases might be detectable using this simple method.	Univ Tokyo, Sch Hlth Sci & Nursing, Dept Epidemiol & Prevent Hlth Sci, Bunkyo Ku, Tokyo 1130033, Japan; Oita Univ Nursing & Hlth Sci, Div Hlth Informat & Biostat, Oita, Japan; Natl Inst Infect Dis, Div Intelligence & Policies, Infect Dis Surveillance Ctr, Tokyo, Japan; Saitama Med Sch, Dept Publ Hlth, Moroyama, Saitama, Japan	Hashimoto, S (reprint author), Univ Tokyo, Sch Hlth Sci & Nursing, Dept Epidemiol & Prevent Hlth Sci, Bunkyo Ku, Hongo 7-3-1, Tokyo 1130033, Japan.						CLIFF AD, 1992, STAT MED, V11, P1409, DOI 10.1002/sim.4780111102; THACKER SB, 1994, AM J EPIDEMIOL, V140, P383; *CAN MIN HLTH, 1997, CAN COMMUN DIS REP, V23, pF1; CDC, 1997, MMWR-MORBID MORTAL W, V46, P1; CHOI K, 1981, AM J EPIDEMIOL, V113, P215; COSTAGLIOLA D, 1991, AM J PUBLIC HEALTH, V81, P97, DOI 10.2105/AJPH.81.1.97; MAR CD, 1995, AUST FAM PHYSICIAN, V24, P625; MATTER HC, 1995, J EPIDEMIOL COMMUN H, V49, P4, DOI 10.1136/jech.49.Suppl_1.4; NOBRE FF, 1994, INT J EPIDEMIOL, V23, P408, DOI 10.1093/ije/23.2.408; Ohshiro H, 1996, J Epidemiol, V6, pS81; SNACKEN R, 1992, EUR J EPIDEMIOL, V8, P485, DOI 10.1007/BF00146364; SPRENGER MJW, 1991, INT J EPIDEMIOL, V20, P1118, DOI 10.1093/ije/20.4.1118; STROUP DF, 1993, EPIDEMIOLOGY, V4, P435, DOI 10.1097/00001648-199309000-00009; STROUP DF, 1993, AM J EPIDEMIOL, V137, P373; THACKER SB, 1983, JAMA-J AM MED ASSOC, V249, P1181; TILLETT HE, 1982, J HYG-CAMBRIDGE, V88, P83	16	47	53	OXFORD UNIV PRESS	OXFORD	GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND	0300-5771			INT J EPIDEMIOL	Int. J. Epidemiol.	OCT	2000	29	5					905	910		10.1093/ije/29.5.905		6	Public, Environmental & Occupational Health	Public, Environmental & Occupational Health	376DX	WOS:000165443900020		
J	Endo, T; Kasagi, N; Suzuki, Y				Endo, T; Kasagi, N; Suzuki, Y			Feedback control of wall turbulence with wall deformation	INTERNATIONAL JOURNAL OF HEAT AND FLUID FLOW			English	Article; Proceedings Paper	1st International Symposium on Turbulence and Shear Flow Phenomena (TSFP-1)	SEP 12-15, 1999	SANTA BARBARA, CALIFORNIA			turbulence control; DNS; arrayed deformable actuators	MINIMAL FLOW UNIT; CHANNEL FLOW; DRAG REDUCTION; BOUNDARY-LAYERS	Direct numerical simulation of turbulent channel flow was made in order to evaluate feedback control with deformable walls. When the local wall velocity is determined by an active cancellation control scheme similar to that of Choi ct al. (Choi, H., Moin, P., Kim, J., 1994. J. Fluid Mech. 262, 75-110), the drag is decreased by about 12% with the wall deformation of the magnitude on the order of one viscous length. On the basis of the typical dimensions of the wall deformation thus obtained, a novel array of deformable actuators elongated in the streamwise direction is proposed. A new realizable control scheme by using wall information is developed based on physical arguments of the near-wall coherent structures. The location of quasi-streamwise vortices accompanied with streak meandering is successfully detected about 50 viscous lengths downstream from the sensing location, at which the spanwise gradients of wall shear stresses are measured. The wall velocity of each actuator is determined to counteract the wall-normal velocity induced by the streamwise vortices. By the present control scheme with the arrayed sensors and actuators, 10% drag reduction is achieved through selective manipulation of the streamwise vortices and streak meandering. It is also found that the energy input of the present control is one order of magnitude smaller than the pumping power saved. (C) 2000 Begell House Inc. Published by Elsevier Science Inc. All rights reserved.	Univ Tokyo, Dept Mech Engn, Bunkyo Ku, Tokyo 1138656, Japan	Endo, T (reprint author), RIKEN, Inst Phys & Chem Res, Comp & Informat Div, Hirosawa 2-1, Wako, Saitama 3510198, Japan.						CHOI HC, 1993, J FLUID MECH, V253, P509, DOI 10.1017/S0022112093001880; Kasagi N, 1998, INT J HEAT FLUID FL, V19, P125, DOI 10.1016/S0142-727X(97)10017-0; CHOI H, 1994, J COMPUT PHYS, V113, P1, DOI 10.1006/jcph.1994.1112; KIM J, 1987, J FLUID MECH, V177, P133, DOI 10.1017/S0022112087000892; LU SS, 1973, J FLUID MECH, V60, P481, DOI 10.1017/S0022112073000315; JIMENEZ J, 1991, J FLUID MECH, V225, P213, DOI 10.1017/S0022112091002033; Ho CM, 1996, J FLUID ENG-T ASME, V118, P437, DOI 10.1115/1.2817778; CANTWELL BJ, 1981, ANNU REV FLUID MECH, V13, P457, DOI 10.1146/annurev.fl.13.010181.002325; KRAVCHENKO AG, 1993, PHYS FLUIDS A-FLUID, V5, P3307, DOI 10.1063/1.858692; HAMILTON JM, 1995, J FLUID MECH, V287, P317, DOI 10.1017/S0022112095000978; CHOI H, 1994, J FLUID MECH, V262, P75, DOI 10.1017/S0022112094000431; Goldstein DB, 1998, J FLUID MECH, V363, P115, DOI 10.1017/S0022112098008921; Lee C, 1998, J FLUID MECH, V358, P245, DOI 10.1017/S002211209700815X; Lee C, 1997, PHYS FLUIDS, V9, P1740, DOI 10.1063/1.869290; BEWLEY TR, 1993, CTR ANN RES BRIEFS, P3; BROOKE JW, 1993, PHYS FLUIDS A-FLUID, V5, P1011, DOI 10.1063/1.858666; BUSHNELL DM, 1990, PROGR ASTRONAUTICS A, V123; Carlson HA, 1996, J FLUID MECH, V329, P341, DOI 10.1017/S0022112096008944; CHONG MS, 1990, PHYS FLUIDS A-FLUID, V2, P765, DOI 10.1063/1.857730; Demuren AO, 1998, AIAA J, V36, P31, DOI 10.2514/2.371; FORTUNA G, 1972, J FLUID MECH, V53, P575, DOI 10.1017/S0022112072000321; GAD-EL-HAK M., 1996, APPL MECH REV, V49, P365, DOI DOI 10.1115/1.3101931; GADELHAK M, 1994, AIAA J, V32, P1753, DOI 10.2514/3.12171; GADELLA M, 1994, FORTSCHR PHYS, V42, P261, DOI 10.1002/prop.2190420303; Grosjean C., 1998, Proceedings MEMS 98. IEEE. Eleventh Annual International Workshop on Micro Electro Mechanical Systems. An Investigation of Micro Structures, Sensors, Actuators, Machines and Systems (Cat. No.98CH36176), DOI 10.1109/MEMSYS.1998.659748; Jeong J, 1997, J FLUID MECH, V332, P185; JOHANSSON AV, 1991, J FLUID MECH, V224, P579, DOI 10.1017/S002211209100188X; Kasagi N., 1993, TURBULENT SHEAR FLOW, V8, P97; KASAGI N, 1995, INT J HEAT FLUID FL, V16, P2, DOI 10.1016/0142-727X(94)00006-X; KLINE SJ, 1989, HEMISPHERE; Mito Y, 1998, INT J HEAT FLUID FL, V19, P470, DOI 10.1016/S0142-727X(98)10025-5; Moin P., 1994, APPL MECH REV, V47, pS3, DOI DOI 10.1115/1.3124438; ROBINSON SK, 1991, ANNU REV FLUID MECH, V23, P601, DOI 10.1146/annurev.fluid.23.1.601; Schlichting H, 1960, BOUNDARY LAYER THEOR; Sendstad O., 1992, TF57 STANF U DEP MEC	35	40	45	ELSEVIER SCIENCE INC	NEW YORK	655 AVENUE OF THE AMERICAS, NEW YORK, NY 10010 USA	0142-727X			INT J HEAT FLUID FL	Int. J. Heat Fluid Flow	OCT	2000	21	5					568	575		10.1016/S0142-727X(00)00046-1		8	Thermodynamics; Engineering, Mechanical; Mechanics	Thermodynamics; Engineering; Mechanics	356RK	WOS:000089456400014		
J	Fujisawa, K; Iyori, H; Ohkawa, H; Konishi, S; Bessho, F; Shirahata, A; Miyazaki, S; Akatsuka, J				Fujisawa, K; Iyori, H; Ohkawa, H; Konishi, S; Bessho, F; Shirahata, A; Miyazaki, S; Akatsuka, J		Japanese Study Grp Childhood ITP	A prospective, randomized trial of conventional, dose-accelerated corticosteroids and intravenous immunoglobulin in children with newly diagnosed idiopathic thrombocytopenic purpura	INTERNATIONAL JOURNAL OF HEMATOLOGY			English	Article						idiopathic thrombocytopenic purpura; intravenous immunoglobulin; prednisolone; intracranial hemorrhage; childhood	IMMUNE GLOBULIN; ORAL PREDNISONE; CHILDHOOD; METHYLPREDNISOLONE; AUTOANTIBODIES; HEMORRHAGE; THERAPY	To determine the minimal essential treatment for childhood acute idiopathic thrombocytopenic purpura (ITP), a prospective, randomized trial was conducted focusing on hemorrhagic manifestation as well as platelet count. Subjects with a platelet count of <10 x 10(3)/<mu>L or 10 to 29 x 10(3)/muL and mucosal bleeding (group 1) were randomly assigned to receive intravenous immunoglobulin (IVIg) at 1 to 2 g/kg, conventional oral prednisolone (o-PSL) (2 mg/kg for 2 weeks), parenteral methylprednisolone (mPSL) (5 mg/kg for 5 days), or pulsed parenteral methylprednisolone (PmPSL) (30 mg/kg for 3 days). Subjects with a platelet count of 10 to 29 x 10(3)/muL without mucosal bleeding (group 2) were randomized to receive either o-PSL or no treatment. In subjects with a platelet count of 30 x 10(3)/muL or higher (group 3),patients undergoing no specific treatment were monitored. In group 1, Mg offered faster platelet enhancement compared with o-PSL and mPSL, although neither mPSL nor PmPSL showed any advantage, even over o-PSL. Platelet response was uniformly excellent when pretreatment platelet count was greater than or equal to 10 x 10(3)/muL. Furthermore, the presence or absence of mucosal bleeding in subjects with a platelet count <10 x 10(3)/<mu>L had no effect on the response to treatment. In group 2, platelet increase was indifferently attained with or without o-PSL. These data suggest that childhood acute ITP with a platelet count greater than or equal to 10 x 10(3)/muL may be left untreated or may be treated with o-PSL when mucosal bleeding is evident, whereas for those with a platelet count <10 x 10(3)/<mu>L, IVIg is the most predictable platelet enhancer. Thus, a platelet count of 10 x 10(3)/muL seems to be informative enough to decide whether to treat childhood acute ITP. Int J Hematol. 2000;72:376-383. (C) 2000 The Japanese Society of Hematology.	Jikei Univ, Sch Med, Dept Pediat, Minato Ku, Tokyo 1058461, Japan; Tokyo Med & Dent Univ, Dept Pediat, Tokyo 113, Japan; Nishinari Publ Hlth Care Ctr, Osaka, Japan; Univ Tokyo, Dept Pediat, Tokyo, Japan; Univ Occupat & Environm Hlth, Dept Pediat, Fukuoka, Japan; Saga Med Sch, Dept Pediat, Saga, Japan; Seitoku Univ, Dept Educ Early Childhood, Chiba, Japan	Fujisawa, K (reprint author), Jikei Univ, Sch Med, Dept Pediat, Minato Ku, 3-25-8 Nishi-shinbashi, Tokyo 1058461, Japan.						ALBAYRAK D, 1994, J PEDIATR-US, V125, P1004, DOI 10.1016/S0022-3476(05)82024-4; LILLEYMAN JS, 1994, ARCH DIS CHILD, V71, P251; Medeiros D, 1998, J PEDIATR-US, V133, P334, DOI 10.1016/S0022-3476(98)70265-3; BLANCHETTE V, 1994, LANCET, V344, P703, DOI 10.1016/S0140-6736(94)92205-5; BLANCHETTE VS, 1993, J PEDIATR-US, V123, P989, DOI 10.1016/S0022-3476(05)80400-7; REID MM, 1995, ARCH DIS CHILD, V72, P125; George JN, 1996, BLOOD, V88, P3; BEARDSLEY DS, 1993, HAEMATOLOGY INFANCY, P1573; BERCHTOLD P, 1989, BLOOD, V74, P1600; BRENNER B, 1988, NEUROSURGERY, V22, P761; BUSSEL JB, 1990, AM J HEMATOL, V33, P184, DOI 10.1002/ajh.2830330306; FUJISAWA K, 1993, BLOOD, V81, P1284; IMBACH P, 1985, LANCET, V2, P464; Mayer JLR, 1996, PEDIATR RES, V40, P615, DOI 10.1203/00006450-199610000-00017; Medeiros D, 1996, PEDIATR CLIN N AM, V43, P757, DOI 10.1016/S0031-3955(05)70431-4; OZSOYLU S, 1989, EUR J HAEMATOL, V42, P431; ROBB LG, 1990, ARCH DIS CHILD, V65, P502; ROSTHOJ S, 1996, ACTA PAEDIATR, V85, P10; TAMARY H, 1994, ACTA PAEDIATR, V83, P931, DOI 10.1111/j.1651-2227.1994.tb13175.x; WOODS VL, 1984, BLOOD, V64, P156	20	24	26	CARDEN JENNINGS PUBL CO LTD	CHARLOTTESVILLE	BLAKE CTR, STE 200, 1224 W MAIN ST, CHARLOTTESVILLE, VA 22903 USA	0925-5710			INT J HEMATOL	Int. J. Hematol.	OCT	2000	72	3					376	383				8	Hematology	Hematology	379CF	WOS:000165622800019		
J	Choi, SH; Kong, XT; Taki, T; Tsuchida, Y; Kawaguchi, H; Kato, H; Hanada, R; Look, AT; Hayashi, Y				Choi, SH; Kong, XT; Taki, T; Tsuchida, Y; Kawaguchi, H; Kato, H; Hanada, R; Look, AT; Hayashi, Y			Reduced or absent expression and codon 201(Gly/Arg) polymorphism of DCC gene in rhabdomyosarcoma and Ewing's sarcoma/PNET family	INTERNATIONAL JOURNAL OF MOLECULAR MEDICINE			English	Article						DCC gene; polymorphism; rhabdomyosarcoma; Ewing's sarcoma; PNET family	FREQUENT LOSS; CHROMOSOMAL TRANSLOCATIONS; ALVEOLAR RHABDOMYOSARCOMA; COLORECTAL CARCINOMAS; TUMOR; MUTATIONS; HETEROZYGOSITY; FUSION; NEUROBLASTOMA; ALLELOTYPE	Genetic alterations occurring in various chromosomes have been described in many human tumors. The DCC gene was originally identified in colorectal cancer and was reported as a tumor suppressor gene that might be related to tumor metastasis. We investigated 10 cell lines and 15 fresh tumors of childhood rhabdomyosarcoma, 7 cell lines of Ewing's sarcoma, and 4 cell lines of primitive neuroectodermal tumor (PNET) for the expression and mutation of DCC gene by RT-PCR analysis and PCR-single stranded conformation polymorphism (SSCP) analysis. Twenty-five pairs of primers were used for PCR-SSCP. Six of ten (60%) cell lines of rhabdomyosarcoma and 3 of 7 (43%) cell lines of Ewing's sarcoma showed reduced or absent expression of DCC gene. There was no mobility shift within 24 exons by SSCP analysis, although 3 types of polymorphism were found at codon 201 in exon 3. Direct sequencing of different bands showed types I, II, and I/II representative of codon 201(Gly), codon 201(Arg), and codon 201(Gly/Arg), respectively. The proportion of type I between fresh rhabdomyosarcoma and normal controls was not significant. Our results suggested that the inactivation of DCC gene may play a role in the pathogenesis of a subset of rhabdomyosarcoma and Ewing's sarcoma.	Univ Tokyo, Fac Med, Dept Pediat, Bunkyo Ku, Tokyo 1138655, Japan; Univ Tokyo, Fac Med, Dept Pediat Surg, Bunkyo Ku, Tokyo 1138655, Japan; Saitama Childrens Med Ctr, Div Hematol Oncol, Saitama, Japan; St Jude Childrens Res Hosp, Dept Expt Oncol, Memphis, TN 38105 USA	Tsuchida, Y (reprint author), Univ Tokyo, Fac Med, Dept Pediat, Bunkyo Ku, Hongo 7-3-1, Tokyo 1138655, Japan.						BREWSTER SF, 1994, BRIT J CANCER, V70, P697, DOI 10.1038/bjc.1994.376; DAVIS RJ, 1994, CANCER RES, V54, P2869; FEARON ER, 1990, SCIENCE, V247, P49, DOI 10.1126/science.2294591; AURIAS A, 1983, NEW ENGL J MED, V309, P496; MAURER HM, 1988, CANCER, V61, P209, DOI 10.1002/1097-0142(19880115)61:2<209::AID-CNCR2820610202>3.0.CO;2-L; TURCCAREL C, 1983, NEW ENGL J MED, V309, P497; MIYAKE K, 1993, BLOOD, V82, P927; TANAKA K, 1991, NATURE, V349, P340, DOI 10.1038/349340a0; KOMURO H, 1993, CANCER RES, V53, P5284; BARR FG, 1995, JAMA-J AM MED ASSOC, V273, P553, DOI 10.1001/jama.273.7.553; CHO KR, 1994, GENOMICS, V19, P525, DOI 10.1006/geno.1994.1102; FELIX CA, 1992, CANCER RES, V52, P2243; GALILI N, 1993, NAT GENET, V5, P230, DOI 10.1038/ng1193-230; GAO X, 1993, CANCER RES, V53, P2723; HOHNE MW, 1992, CANCER RES, V52, P2616; HONSAKO Y, 1993, GASTROENTEROLOGY, V104, pA411; IDA K, 1995, INT J CANCER, V63, P500, DOI 10.1002/ijc.2910630407; KAUFOS A, 1985, NATURE, V316, P330; KLINGELHUTZ AJ, 1995, ONCOGENE, V10, P1581; Kong XT, 1997, CANCER RES, V57, P3772; LAWLOR KG, 1992, CELL GROWTH DIFFER, V3, P609; LIPINSKI M, 1987, CANCER RES, V47, P183; MIYAKE S, 1994, CANCER RES, V54, P3007; Nobusawa Rieko, 1995, Stomach and Intestine, V30, P207; Ohnishi H, 1996, GENE CHROMOSOME CANC, V15, P187, DOI 10.1002/(SICI)1098-2264(199603)15:3<187::AID-GCC8>3.0.CO;2-Z; PATTERSON H, 1994, BRIT J CANCER, V69, P1052, DOI 10.1038/bjc.1994.207; Raney Jr RB, 1993, PRINCIPLES PRACTICE, P769; SCHECK AC, 1993, CANCER RES, V53, P5605; SHISEKI M, 1994, CANCER RES, V54, P5643; TAKITA J, 1995, ONCOGENE, V11, P1829; THOMPSON AM, 1993, BRIT J CANCER, V68, P64, DOI 10.1038/bjc.1993.287; UCHINO S, 1992, CANCER RES, V52, P3099; VOGELSTEIN B, 1989, SCIENCE, V244, P207, DOI 10.1126/science.2565047; Yang HW, 2000, INT J MOL MED, V5, P379; ZUCMAN J, 1993, EMBO J, V12, P4481	35	2	2	PROFESSOR D A SPANDIDOS	ATHENS	1, S MERKOURI ST, EDITORIAL OFFICE,, ATHENS 116 35, GREECE	1107-3756			INT J MOL MED	Int. J. Mol. Med.	OCT	2000	6	4					463	467				5	Medicine, Research & Experimental	Research & Experimental Medicine	356UE	WOS:000089460600014		
J	Yamamoto-Mitani, N; Tamura, M; Deguchi, Y; Ito, K; Sugishita, C				Yamamoto-Mitani, N; Tamura, M; Deguchi, Y; Ito, K; Sugishita, C			The attitude of Japanese family caregivers toward the elderly with dementia	INTERNATIONAL JOURNAL OF NURSING STUDIES			English	Article						family caregiving; caregiver attitude; family interaction; caregiver-elderly relationship	ALZHEIMERS-DISEASE; RELATIVES; QUALITY; EMOTION; IMPACT; BURDEN	This research examined family caregivers' attitudes toward their elderly relatives living with dementia. A convenience sample of fifty-nine Japanese caregivers was used. Caregiver attitudes were investigated multi-dimensionally (negative attitude, attitude of acceptance, and attitude of active interaction) using a questionnaire developed specifically for this study. The dimensions did not correlate with one another but were associated with different caregiver/elderly characteristics: i,e., negative attitude with short stay use, length of time caregivers and elderly relatives were living together and problem behaviors; attitude of acceptance with sleeping pill use and the type of relationship; and attitude of active interaction with dementia diagnosis. The results have implications for nurses in facilitating constructive caregiver attitudes. (C) 2000 Elsevier Science Ltd. All rights reserved.	Univ Tokyo, Fac Med, Dept Family Nursing, Bunkyo Ku, Tokyo 1130033, Japan; INt Univ Hlth & Welfare, Otawara, Tochigi 3248501, Japan; Yamanashi Prefecture Womens Coll, Kofu, Yamanashi 4000035, Japan; NTT Corp, Tokyo 1600023, Japan	Yamamoto-Mitani, N (reprint author), Univ Tokyo, Fac Med, Dept Family Nursing, Bunkyo Ku, 7-3-1 Hongo, Tokyo 1130033, Japan.	noriko-tky@umin.ac.jp					*AG RES CTR, 1998, KOUR SHAK KIS NENK; MONTGOMERY RJV, 1994, J GERONTOL, V49, pS62; KRAMER BJ, 1993, FAM RELAT, V42, P367, DOI 10.2307/585336; TERI L, 1992, PSYCHOL AGING, V7, P622, DOI 10.1037/0882-7974.7.4.622; ZARIT SH, 1980, GERONTOLOGIST, V20, P649; Juniper EF, 1997, J CLIN EPIDEMIOL, V50, P233, DOI 10.1016/S0895-4356(96)00377-0; WUEST J, 1994, J ADV NURS, V20, P437, DOI 10.1111/j.1365-2648.1994.tb02378.x; BERGENER SC, 1992, J GERONTOL B-PSYCHOL, V47, P242; COHEN CA, 1994, CAN J AGING, V13, P378, DOI 10.1017/S071498080000619X; *HLTH WELF STAT AS, 1998, KOK EIS DOK; *JAP ASS GER HLTH, 1998, ELD DEM CAR MAN; KINNEY JM, 1995, J APPL GERONTOL, V14, P3, DOI 10.1177/073346489501400101; KISHIKAWA Y, 1995, KYOTO FURITSU IDAI Z, V104, P999; Kobayashi S, 1993, J Gerontol Nurs, V19, P7; KOSBERG JI, 1990, GERONTOLOGIST, V30, P236; MILLER B, 1989, J APPL GERONTOLOGY, V0008; *MIN HLTH WELF, 1999, VIS NURS REP; ORBELL S, 1993, IRISH J PSYCHOL, V14, P99; ORFORD J, 1987, PSYCHOL MED, V17, P963; Ota K, 1996, Kango Kenkyu, V29, P71; Quayhagen MP, 1996, WESTERN J NURS RES, V18, P120, DOI 10.1177/019394599601800202; *RAND HOUS, 1988, RAND HOUS DICT; Robinson K M, 1990, Sch Inq Nurs Pract, V4, P189; SHEEHAN NW, 1988, FAM RELAT, V37, P92, DOI 10.2307/584436; Suwa S, 1996, Kango Kenkyu, V29, P203; TALKINGTONBOYER S, 1994, AM J FAM THER, V22, P57, DOI 10.1080/01926189408251297; TSURUTA S, 1995, RONEN SEISIN IGAKU Z, V6, P737; WALKER AJ, 1990, FAM RELAT, V38, P147; WORCESTER MI, 1983, RES NURS HEALTH, V6, P61, DOI 10.1002/nur.4770060205	29	2	3	PERGAMON-ELSEVIER SCIENCE LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND	0020-7489	1873-491X		INT J NURS STUD	Int. J. Nurs. Stud.	OCT	2000	37	5					415	422		10.1016/S0020-7489(00)00021-3		8	Nursing	Nursing	327ZW	WOS:000087825200005		
J	Inoue, K; Kohno, T; Takakura, S; Morishita, K; Takita, J; Hayashi, Y; Mizoguchi, H; Yokota, J				Inoue, K; Kohno, T; Takakura, S; Morishita, K; Takita, J; Hayashi, Y; Mizoguchi, H; Yokota, J			Alterations of the PPP1R3 gene in hematological malignancies	INTERNATIONAL JOURNAL OF ONCOLOGY			English	Article						protein phosphatase 1; PPP1R3; mutation; hematological malignancies; tumor suppressor gene	ACUTE LYMPHOBLASTIC-LEUKEMIA; CHROMOSOME BAND 7Q22; MYELOID DISORDERS; PROTEIN-PHOSPHORYLATION; HUMAN-LUNG; DELINEATION; DELETIONS; CANCERS; HETEROZYGOSITY; PHOSPHATASE	PPP1R3 (protein phosphatase 1, regulatory subunit 3) is a candidate tumor suppressor gene at chromosome 7q31, since nonsense and missense mutations of the PPP1R3 gene have been detected in a variety of human cancers. Loss of chromosome 7q is a recurrent abnormality in hematological malignancies, especially of myeloid lineage, and a common region of 7q deletions has been mapped to 7q31. Thus, it has been suggested that 7q31 harbors a tumor suppressor gene whose functional loss contributes to leukemogenesis. To evaluate the possible involvement of the PPP1R3 gene in the development of hematological malignancies, we examined 72 leukemia and lymphoma cell lines for alterations of the PPP1R3 gene by PCR-SSCP and direct sequence analyses. Mutations were detected in 1 (2.8%) of 36 myeloid cell lines, 4 (20.0%) of 20 B-lineage lymphoid cell lines and none of 16 T-lineage lymphoid cell lines. All the mutations were heterozygous, and they consisted of two missense mutations and three silent mutations. The PPP1R3 gene was expressed in cell lines of various cell lineages. These results indicate that PPP1R3 is not a major target of 7q deletions in myeloid leukemia, however, alterations of the PPP1R3 gene may contribute to the development of a subset of hematological malignancies.	Natl Canc Ctr, Res Inst, Div Biol, Chuo Ku, Tokyo 1040045, Japan; Tokyo Womens Med Coll, Dept Hematol, Tokyo 1628666, Japan; Miyazaki Med Coll, Dept Biochem 1, Miyazaki 8891692, Japan; Univ Tokyo, Fac Med, Dept Pediat, Tokyo 1038655, Japan	Yokota, J (reprint author), Natl Canc Ctr, Res Inst, Div Biol, Chuo Ku, 1-1 Tsukiji 5 Chome, Tokyo 1040045, Japan.						OHNISHI H, 1995, BLOOD, V86, P1269; Steck PA, 1997, NAT GENET, V15, P356, DOI 10.1038/ng0497-356; Wang SS, 1998, SCIENCE, V282, P284, DOI 10.1126/science.282.5387.284; Sakai A, 1998, BLOOD, V92, P3410; Kohno T, 1999, CANCER RES, V59, P4170; Kohno T, 1998, GENE CHROMOSOME CANC, V22, P152, DOI 10.1002/(SICI)1098-2264(199806)22:2<152::AID-GCC10>3.0.CO;2-S; MERMOUD JE, 1994, EMBO J, V13, P5679; Li J, 1997, SCIENCE, V275, P1943, DOI 10.1126/science.275.5308.1943; Calin GA, 2000, ONCOGENE, V19, P1191, DOI 10.1038/sj.onc.1203389; FUJIKI H, 1993, ADV CANCER RES, V61, P143; Kawamura M, 1999, LEUKEMIA RES, V23, P115, DOI 10.1016/S0145-2126(98)00146-5; CHEN YH, 1994, DIABETES, V43, P1234, DOI 10.2337/diabetes.43.10.1234; CHOMCZYNSKI P, 1987, ANAL BIOCHEM, V162, P156, DOI 10.1006/abio.1987.9999; Deloukas P, 1998, SCIENCE, V282, P744, DOI 10.1126/science.282.5389.744; Dohner K, 1998, BLOOD, V92, P4031; Faux MC, 1996, TRENDS BIOCHEM SCI, V21, P312, DOI 10.1016/S0968-0004(96)10040-2; Fischer K, 1998, RECENT RES CANCER, V144, P46; Fischer K, 1997, BLOOD, V89, P2036; Guo SX, 2000, LEUKEMIA RES, V24, P39, DOI 10.1016/S0145-2126(99)00158-7; HEIM S, 1992, LEUKEMIA RES, V16, P43, DOI 10.1016/0145-2126(92)90098-R; Kawabe T, 1997, NATURE, V385, P454, DOI 10.1038/385454a0; Kiuru-Kuhlefelt S, 1997, LEUKEMIA, V11, P2097, DOI 10.1038/sj.leu.2400881; Koike M, 1999, LEUKEMIA RES, V23, P307, DOI 10.1016/S0145-2126(98)00159-3; Kukita Y, 1997, HUM MUTAT, V10, P400, DOI 10.1002/(SICI)1098-1004(1997)10:5<400::AID-HUMU11>3.0.CO;2-3; Liang H, 1998, P NATL ACAD SCI USA, V95, P3781, DOI 10.1073/pnas.95.7.3781; Nakahara Y, 1998, LEUKEMIA, V12, P1277, DOI 10.1038/sj.leu.2401099; NEUMAN WL, 1992, BLOOD, V79, P1501; Parsons Ramon, 1998, Current Opinion in Oncology, V10, P88, DOI 10.1097/00001622-199801000-00014; Rubin Ethel, 1998, Frontiers in Bioscience, V3, pD1209; SAKAMOTO H, 1986, P NATL ACAD SCI USA, V83, P3997, DOI 10.1073/pnas.83.11.3997; Takakura S, 2000, ONCOGENE, V19, P836, DOI 10.1038/sj.onc.1203388; Tosi S, 1999, GENE CHROMOSOME CANC, V25, P384, DOI 10.1002/(SICI)1098-2264(199908)25:4<384::AID-GCC11>3.0.CO;2-D; Xia J, 1998, DIABETES, V47, P1519, DOI 10.2337/diabetes.47.9.1519; Zenklusen Jean C., 1999, Neoplasia (New York), V1, P16, DOI 10.1038/sj.neo.7900011	34	1	1	PROFESSOR D A SPANDIDOS	ATHENS	1, S MERKOURI ST, EDITORIAL OFFICE,, ATHENS 116 35, GREECE	1019-6439			INT J ONCOL	Int. J. Oncol.	OCT	2000	17	4					717	721				5	Oncology	Oncology	356TY	WOS:000089460000011		
J	Inaba, M; Kagami, S; Kanehiro, F; Hoshino, Y; Inoue, H				Inaba, M; Kagami, S; Kanehiro, F; Hoshino, Y; Inoue, H			A platform for robotics research based on the remote-brained robot approach	INTERNATIONAL JOURNAL OF ROBOTICS RESEARCH			English	Article						robot architecture; autonomous agent; humanoid; whole-body behaviors	VISION	Robots of the future will act in the real world. To realize robots with the common sense to do this will, it is generally believed, require massively parallel processing. This is a problem for those of us who want to do experiments with robots in the real world today-it is hard to build active, limber situated robots when they have to carry along heavy brains. Our answer is "remote-brained robots." A remote-brained robot is designed to have the brain and body separate, both conceptually and physically. It allows us to tie artificial intelligence (AI) with massive parallelism directly to the real world, enabling the verification of high-level AI techniques, which could previously only be used in simulation. Once the brain is placed remotely from the body, it encourages us to investigate many important research topics of embodied agents working in the real world. This paper describes such platform for future robotics and principal experiments done on the platform.	Univ Tokyo, Dept Mechano Informat, Bunkyo Ku, Tokyo, Japan	Inaba, M (reprint author), Univ Tokyo, Dept Mechano Informat, Bunkyo Ku, 7-3-1 Hongo, Tokyo, Japan.		Kagami, Satoshi/A-6841-2013				THORPE C, 1988, IEEE T PATTERN ANAL, V10, P362, DOI 10.1109/34.3900; BROOKS RA, 1993, MIT AI MEMO, V1439; Horswill Ian D., 1993, THESIS MIT CAMBRIDGE; INABA M, 1993, P INT C ADV ROB ICAR, P121; Inaba M., 1996, Proceedings of the 1996 IEEE/RSJ International Conference on Intelligent Robots and Systems. IROS 96. Robotic Intelligence Interacting with Dynamic Worlds (Cat. No.96CH35908), DOI 10.1109/IROS.1996.570622; Inaba M, 1996, IROS 96 - PROCEEDINGS OF THE 1996 IEEE/RSJ INTERNATIONAL CONFERENCE ON INTELLIGENT ROBOTS AND SYSTEMS - ROBOTIC INTELLIGENCE INTERACTING WITH DYNAMIC WORLDS, VOLS 1-3, P450, DOI 10.1109/IROS.1996.570816; INABA M, 1994, P IEEE RSJ GI INT C, P933; INABA M, 1993, 6 INT S INT FDN ROB, P335; Inaba M., 1996, Proceedings of the 1996 IEEE/RSJ International Conference on Intelligent Robots and Systems. IROS 96. Robotic Intelligence Interacting with Dynamic Worlds (Cat. No.96CH35908), DOI 10.1109/IROS.1996.570616; INABA M, 1995, P IEEE RSJ INT C INT, V3, P297, DOI 10.1109/IROS.1995.525899; INABA M, 1995, IEEE INT CONF ROBOT, P2193, DOI 10.1109/ROBOT.1995.525585; INABA M, 1996, PREPRINT ARTIFICIAL, V5, P278; INABA M, 1993, P IEEE RSJ INT WORKS, P1857; INABA M, 1993, P 1993 JSME INT C AD, P854; Inaba M., 1994, 1994 IEEE International Conference on MFI '94. Multisensor Fusion and Integration for Intelligent Systems (Cat. No.94TH06965), DOI 10.1109/MFI.1994.398380; Inoue H., 1985, P IJCAI 85 LOS ANGEL, P1231; INOUE H, 1993, P INT S IND ROB ISIR; Inoue H., 1983, P 1 INT S ROB RES IS, P163; INOUE H, 1994, HUMANOID AUTONOMOUS, P109; Inoue H., 1993, P INT JOINT C ART IN, P767; Inoue H., 1992, Proceedings. 1992 IEEE International Conference on Robotics And Automation (Cat. No.92CH3140-1), DOI 10.1109/ROBOT.1992.220020; Kagami S., 1996, Proceedings of the 1996 IEEE/RSJ International Conference on Intelligent Robots and Systems. IROS 96. Robotic Intelligence Interacting with Dynamic Worlds (Cat. No.96CH35908), DOI 10.1109/IROS.1996.568998; Kanehiro F., 1996, Proceedings of the 1996 IEEE/RSJ International Conference on Intelligent Robots and Systems. IROS 96. Robotic Intelligence Interacting with Dynamic Worlds (Cat. No.96CH35908), DOI 10.1109/IROS.1996.570617; KATO I, 1974, 1 CISM IFTOMM S THEO, V1, P11; KOIKE H, 1989, PARALLEL COMPUTER AR, V21; Kuniyoshi Y, 1989, P INT S IND ROB, P119; Kuniyoshi Y., 1990, Proceedings. IROS '90. IEEE International Workshop on Intelligent Robots and Systems '90. Towards a New Frontier of Applications (Cat. No.90TH0332-7), DOI 10.1109/IROS.1990.262444; Kuniyoshi Y., 1993, P INT JOINT C ART IN, P1600; MAES P, 1994, P AAAI 94 WORKSH PRO, P43; MATSUI T, 1994, P 12 C ROB SOC JAP, P3273; Matsui T., 1990, Journal of Information Processing, V13; MIURA H, 1983, 1 INT S ROB RES ISRR, P303; NILSSON M, 1986, P JAP LOG PROGR C IC, P209; RAIBERT MH, 1983, ROBOTICS RES, P279; SIMS K, 1994, P 4 INT WORKSH SYNTH, V4; Sugano S, 1985, J ROBOTICS SOC JAPAN, V3, P81; YUTA S, 1991, P 2 INT S EXPT ROB I	37	20	21	SAGE PUBLICATIONS LTD	LONDON	1 OLIVERS YARD, 55 CITY ROAD, LONDON EC1Y 1SP, ENGLAND	0278-3649	1741-3176		INT J ROBOT RES	Int. J. Robot. Res.	OCT	2000	19	10					933	954		10.1177/02783640022067878		22	Robotics	Robotics	357BA	WOS:000089477600004		
J	Usui, T; Amano, S; Oshika, T; Suzuki, K; Miyata, K; Araie, M; Heldin, P; Yamashita, H				Usui, T; Amano, S; Oshika, T; Suzuki, K; Miyata, K; Araie, M; Heldin, P; Yamashita, H			Expression regulation of hyaluronan synthase in corneal endothelial cells	INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE			English	Article							HUMAN TRABECULAR MESHWORK; TGF-BETA; TRANSFORMING GROWTH-FACTOR-BETA-1; GROWTH-FACTOR; ACTIVATION; MECHANISM; CLONING; PROTEINS; DISEASE	PURPOSE. Our previous study showed that hyaluronan synthase (HAS), the enzyme protein of hyaluronan (HA) biosynthesis, is expressed in ocular tissues including the corneal endothelium. In the current study, the mechanism that regulates HAS expression in bovine corneal endothelial cells (BCECs) was investigated. METHODS. Cultured BCECs were used. HAS expression in BCECs at the mRNA level was detected by reverse transcription-polymerase chain reaction (RT-PCR) and Northern blot analysis. The effects of transforming growth factor (TGF)-beta and platelet-derived growth factor (PDGF)-BB on HAS expression were examined by quantitative RT-PCR. The involvement of the Smad family (intracellular signal transducer of TGF-beta) was also investigated. The expression of HAS in BCECs at the protein level was confirmed by immunocytochemistry and Western blot analysis. RESULTS. Three HAS isoforms in BCECs were expressed at the mRNA level. The transcriptional sizes of each HAS in BCECs were 4.9 kb for HAS1, 2.8 kb for HAS2, and 1.6 kb for MASS. The expression of HAS2 at the mRNA level was stimulated by TGF-beta 1 and/or PDGF-BB treatment. In contrast, HAS1 and HAS3 expression was not affected by these growth factors. The additive effects of TGF-beta 1 and PDGF-BB were observed in the stimulation of the expression levels of HAS2. HAS2 upregulation by these growth factors was also detected by Western blot analysis. The stimulation of the expression of HAS2 at the mRNA level by TGF-beta was accelerated by the overexpression of Smad2, Smad3, and Smad4 and inhibited by that of Smad7, all of which were confirmed to be involved in the signal transduction from TGF-beta through HAS expression. CONCLUSIONS. Although three HAS isoforms were expressed in the corneal endothelial cells, the expression of HAS2 was upregulated by TGF-beta 1 and/or PDGF-BB. HAS2 expression was regulated by TGF-beta through Smad family members.	Yamagata Univ, Sch Med, Dept Ophthalmol, Yamagata 9909585, Japan; Univ Tokyo, Fac Med, Dept Ophthalmol, Tokyo 113, Japan; Miyata Eye Hosp, Miyazaki, Japan; Uppsala Univ, Dept Med & Physiol Chem, Ctr Biomed, Uppsala, Sweden	Yamashita, H (reprint author), Yamagata Univ, Sch Med, Dept Ophthalmol, 2-2-2 Iidanishi, Yamagata 9909585, Japan.						Spicer AP, 1997, J BIOL CHEM, V272, P8957; Kreuzer KA, 1999, CANCER RES, V59, P3171; Knepper PA, 1996, INVEST OPHTH VIS SCI, V37, P1360; HELDIN P, 1989, BIOCHEM J, V258, P919; Itano N, 1999, J BIOL CHEM, V274, P25085, DOI 10.1074/jbc.274.35.25085; KNUDSON CB, 1993, FASEB J, V7, P1233; Weigel PH, 1997, J BIOL CHEM, V272, P13997, DOI 10.1074/jbc.272.22.13997; Spicer AP, 1998, J BIOL CHEM, V273, P1923, DOI 10.1074/jbc.273.4.1923; Heldin CH, 1997, NATURE, V390, P465, DOI 10.1038/37284; Wittwer CT, 1997, BIOTECHNIQUES, V22, P176; Sugiyama Y, 1998, J INVEST DERMATOL, V110, P116; WRANA JL, 1994, NATURE, V370, P341, DOI 10.1038/370341a0; Lerner LE, 1997, INVEST OPHTH VIS SCI, V38, P1222; Usui T, 1999, INVEST OPHTH VIS SCI, V40, P563; LAURENT TC, 1992, FASEB J, V6, P2397; Jacobson A, 2000, BIOCHEM J, V348, P29, DOI 10.1042/0264-6021:3480029; Tlapak-Simmons VL, 1998, J BIOL CHEM, V273, P26100, DOI 10.1074/jbc.273.40.26100; HELDIN P, 1992, BIOCHEM J, V283, P165; Asplund T, 1998, BBA-GEN SUBJECTS, V1380, P377, DOI 10.1016/S0304-4165(98)00010-5; Drubaix I, 1997, EXP EYE RES, V64, P301, DOI 10.1006/exer.1996.0212; FITZSIMMONS TD, 1994, INVEST OPHTH VIS SCI, V35, P2774; HARFSTRAND A, 1992, J CATARACT REFR SURG, V18, P265; HAUBECK HD, 1995, ARTHRITIS RHEUM, V38, P669, DOI 10.1002/art.1780380515; Itano N, 1996, J BIOL CHEM, V271, P9875; LAURENT UBG, 1983, ARCH OPHTHALMOL-CHIC, V101, P129; LODISH H, 1995, MOL CELL BIOL, P1136; Miyauchi S, 1996, CURR EYE RES, V15, P131, DOI 10.3109/02713689608997405; Nakamura M, 1997, EXP EYE RES, V64, P1043, DOI 10.1006/exer.1997.0302; Nishida Y, 1999, J BIOL CHEM, V274, P21893, DOI 10.1074/jbc.274.31.21893; PREHM P, 1983, BIOCHEM J, V211, P191; Shyjan AM, 1996, J BIOL CHEM, V271, P23395; Spicer AP, 1996, J BIOL CHEM, V271, P23400; SUZUKI M, 1995, BIOCHEM J, V307, P817; Usui T, 1998, INVEST OPHTH VIS SCI, V39, P1981; Watanabe K, 1996, J BIOL CHEM, V271, P22945	35	25	26	ASSOC RESEARCH VISION OPHTHALMOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0146-0404			INVEST OPHTH VIS SCI	Invest. Ophthalmol. Vis. Sci.	OCT	2000	41	11					3261	3267				7	Ophthalmology	Ophthalmology	358PZ	WOS:000089567600004		
J	Niki, E; Noguchi, N				Niki, E; Noguchi, N			Evaluation of antioxidant capacity. What capacity is being measured by which method?	IUBMB LIFE			English	Review							LOW-DENSITY-LIPOPROTEIN; ALPHA-TOCOPHERYL HYDROQUINONE; VITAMIN-E; LIPID-PEROXIDATION; BETA-CAROTENE; PHENOLIC ANTIOXIDANTS; LIPOSOMAL MEMBRANES; MODEL BIOMEMBRANES; SCREENING-TEST; OXIDATION		Univ Tokyo, Adv Sci & Technol Res Ctr, Meguro Ku, Tokyo 1538904, Japan; Utsunomiya Univ, Dept Appl Chem, Utsunomiya, Tochigi 3218585, Japan	Noguchi, N (reprint author), Univ Tokyo, Adv Sci & Technol Res Ctr, Meguro Ku, 4-6-1 Komaba, Tokyo 1538904, Japan.						Ancerewicz J, 1998, FREE RADICAL BIO MED, V25, P113, DOI 10.1016/S0891-5849(98)00072-0; Pryor WA, 2000, NUTR REV, V58, P39; Heinecke JW, 1998, ATHEROSCLEROSIS, V141, P1, DOI 10.1016/S0021-9150(98)00173-7; CILLARD J, 1980, J AM OIL CHEM SOC, V57, P252, DOI 10.1007/BF02668254; SUZUKI YJ, 1993, BIOCHEM BIOPH RES CO, V193, P277, DOI 10.1006/bbrc.1993.1620; BOWRY VW, 1992, BIOCHEM J, V288, P341; BURTON GW, 1984, SCIENCE, V224, P569, DOI 10.1126/science.6710156; BURTON GW, 1981, J AM CHEM SOC, V103, P6472, DOI 10.1021/ja00411a035; Barclay LRC, 1999, J AM CHEM SOC, V121, P6226, DOI 10.1021/ja990878u; Keaney JF, 1999, FASEB J, V13, P965; Prior RL, 1999, FREE RADICAL BIO MED, V27, P1173, DOI 10.1016/S0891-5849(99)00203-8; Pryor WA, 2000, FREE RADICAL BIO MED, V28, P141, DOI 10.1016/S0891-5849(99)00224-5; WAYNER DDM, 1985, FEBS LETT, V187, P33, DOI 10.1016/0014-5793(85)81208-4; RICEEVANS C, 1994, METHOD ENZYMOL, V234, P279; NIKI E, 1984, J BIOL CHEM, V259, P4177; TERAO J, 1986, LIPIDS, V21, P255, DOI 10.1007/BF02536407; Arteel GE, 1999, FEBS LETT, V445, P226, DOI 10.1016/S0014-5793(99)00073-3; SATO K, 1990, ARCH BIOCHEM BIOPHYS, V279, P402, DOI 10.1016/0003-9861(90)90508-V; Cynshi O, 1998, P NATL ACAD SCI USA, V95, P10123, DOI 10.1073/pnas.95.17.10123; BARCLAY LRC, 1993, CAN J CHEM, V71, P1, DOI 10.1139/v93-001; PRYOR WA, 1993, J ORG CHEM, V58, P3521, DOI 10.1021/jo00065a013; Ricciarelli R, 1998, BIOCHEM J, V334, P243; ESTERBAUER H, 1989, FREE RADICAL RES COM, V6, P67, DOI 10.3109/10715768909073429; Arnao MB, 1999, FREE RADICAL RES, V31, P89, DOI 10.1080/10715769900301371; BARCLAY LRC, 1989, CAN J CHEM, V67, P1366; BORS W, 1984, BIOCHIM BIOPHYS ACTA, V796, P312, DOI 10.1016/0005-2760(84)90132-2; Diaz MN, 1997, NEW ENGL J MED, V337, P408; Gotoh N, 1996, FREE RADICAL RES, V24, P123; IOKU K, 1995, BBA-BIOMEMBRANES, V1234, P99, DOI 10.1016/0005-2736(94)00262-N; LARANJINHA J, 2000, LIFE, V48, P57; MAIORINO M, 1993, FEBS LETT, V330, P174, DOI 10.1016/0014-5793(93)80267-X; MITSUTA K, 1990, B CHEM SOC JPN, V63, P187, DOI 10.1246/bcsj.63.187; MUKAI K, 1987, B CHEM SOC JPN, V60, P2163, DOI 10.1246/bcsj.60.2163; Neuzil J, 1997, P NATL ACAD SCI USA, V94, P7885, DOI 10.1073/pnas.94.15.7885; NIKI E, 1986, CHEM LETT, P1573, DOI 10.1246/cl.1986.1573; Noguchi N, 1997, ARCH BIOCHEM BIOPHYS, V347, P141, DOI 10.1006/abbi.1997.0331; Noguchi N, 1997, ARCH BIOCHEM BIOPHYS, V342, P236, DOI 10.1006/abbi.1997.9994; NOGUCHI N, 1992, BIOCHEM PHARMACOL, V44, P39, DOI 10.1016/0006-2952(92)90035-H; Noguchi Noriko, 2000, Free Radical Biology and Medicine, V28, P1538, DOI 10.1016/S0891-5849(00)00256-2; ROMAY C, 1996, J BRAZ ASS ADV SCI, V48, P86; Shi HL, 1998, LIPIDS, V33, P365, DOI 10.1007/s11745-998-0216-8; Shi HL, 1999, FREE RADICAL BIO MED, V27, P334, DOI 10.1016/S0891-5849(99)00053-2; Sies H, 1997, Adv Pharmacol, V38, P229; TAKAHASHI M, 1988, J NUTR SCI VITAMINOL, V34, P25; TRABER MG, 1995, AM J CLIN NUTR, V62, P1501; TSUCHIHASHI H, 1995, ARCH BIOCHEM BIOPHYS, V323, P137, DOI 10.1006/abbi.1995.0019; Valgimigli L, 1999, J ORG CHEM, V64, P3381, DOI 10.1021/jo982360z; Watanabe A, 2000, J AM CHEM SOC, V122, P5438, DOI 10.1021/ja9942080; Witting P, 1999, J CLIN INVEST, V104, P213, DOI 10.1172/JCI6391; Witting PK, 1996, J LIPID RES, V37, P853; YAMAMOTO K, 1987, CHEM LETT, P1149, DOI 10.1246/cl.1987.1149; YAMAMOTO K, 1988, BIOCHIM BIOPHYS ACTA, V958, P19, DOI 10.1016/0005-2760(88)90241-X; YOSHIDA Y, 1994, BBA-GEN SUBJECTS, V1200, P85, DOI 10.1016/0304-4165(94)90121-X	53	80	81	TAYLOR & FRANCIS INC	PHILADELPHIA	325 CHESTNUT ST, SUITE 800, PHILADELPHIA, PA 19106 USA	1521-6543			IUBMB LIFE	IUBMB Life	OCT-NOV	2000	50	4-5					323	329		10.1080/15216540051081119		7	Biochemistry & Molecular Biology; Cell Biology	Biochemistry & Molecular Biology; Cell Biology	420JQ	WOS:000168002200012		
J	Zhang, SL; Wang, RH; Oyanagi, Y; Li, W				Zhang, SL; Wang, RH; Oyanagi, Y; Li, W			A kind of bivariate cubic splines and related linear operators on type-1 triangulation	JAPAN JOURNAL OF INDUSTRIAL AND APPLIED MATHEMATICS			English	Article						B-spline; bivariate cubic spline; linear spline operator; error estimate		Let Delta (mn) be a grid partition of curves that divide a rectangular domain into a finite or countable number of cells in R-2, called type-1 triangulations. A kind of bivariate cubic splines is considered. A class of linear spline operators based on the bivariate cubic splines on the partition is given and shown to satisfy the identities about certain polynomials. In addition, these identities enable us to give error estimates for approximation from the entire space of the cubic spline function with the grid partition Delta (mn).	Univ Tokyo, Dept Appl Phys, Bunkyo Ku, Tokyo 1138565, Japan; Dalian Univ Technol, Inst Math Sci, Dalian 116024, Peoples R China; Univ Tokyo, Dept Informat Sci, Tokyo 1130033, Japan; Univ Tsukuba, Doctoral Program Engn, Tsukuba, Ibaraki 3058573, Japan	Zhang, SL (reprint author), Univ Tokyo, Dept Appl Phys, Bunkyo Ku, Tokyo 1138565, Japan.						CHUI CK, 1984, J APPR THEO APPL, V1, P11; CHUI CK, 1984, SCI SIN A-MATH P A T, V27, P1129; CHUI CK, 1983, CMS C P AM MATH SOC, V3, P51; CHUI CK, 1984, J MATH ANAL APPL, V101, P540, DOI 10.1016/0022-247X(84)90118-5; FREDRICKSON PO, 1971, 717 LAK U; WANG RH, 1985, J COMPUT APPL MATH, V12-3, P163, DOI 10.1016/0377-0427(85)90014-7; WANG RH, 1979, SCI SINICA MATH, V1, P215	7	0	0	KINOKUNIYA CO LTD	TOKYO	17-7 SHINJUKU 3-CHOME, SHINJUKU-KU, TOKYO, 163-8636, JAPAN	0916-7005			JPN J IND APPL MATH	Jpn. J. Ind. Appl. Math.	OCT	2000	17	3					391	402				12	Mathematics, Applied	Mathematics	372FV	WOS:000165224400005		
J	Funabiki, T				Funabiki, T			Professional roots and branches	JAPAN QUARTERLY			English	Article									Univ Tokyo, Tokyo, Japan	Funabiki, T (reprint author), Univ Tokyo, Tokyo, Japan.							0	0	0	ASAHI SHIMBUN PUB CO	CHUO-KU TOKYO	5-3-2 TSUKIJI, CHUO-KU TOKYO, 104-11, JAPAN	0021-4590			JPN QUART	Jpn. Q.	OCT-DEC	2000	47	4					67	72				6	Area Studies; Asian Studies	Area Studies; Asian Studies	366LH	WOS:000090006500009		
J	Yoshida, K				Yoshida, K			Importing diversity: Inside Japan's jet program	JAPAN QUARTERLY			English	Book Review									Univ Tokyo, Ctr Teaching Foreign Languages, Tokyo, Japan	Yoshida, K (reprint author), Univ Tokyo, Ctr Teaching Foreign Languages, Tokyo, Japan.						McConnell D, 2000, IMPORTING DIVERSITY	1	0	0	ASAHI SHIMBUN PUB CO	CHUO-KU TOKYO	5-3-2 TSUKIJI, CHUO-KU TOKYO, 104-11, JAPAN	0021-4590			JPN QUART	Jpn. Q.	OCT-DEC	2000	47	4					99	100				2	Area Studies; Asian Studies	Area Studies; Asian Studies	366LH	WOS:000090006500014		
J	Jarasiunas, K; Mizeikis, V; Iwamoto, S; Nishioka, M; Someya, T; Fukutani, K; Arakawa, Y; Shimura, T; Kuroda, K				Jarasiunas, K; Mizeikis, V; Iwamoto, S; Nishioka, M; Someya, T; Fukutani, K; Arakawa, Y; Shimura, T; Kuroda, K			Characterization of proton-irradiated InGaAs/GaAs multiple quantum well structures by nonresonant transient four-wave mixing technique	JAPANESE JOURNAL OF APPLIED PHYSICS PART 1-REGULAR PAPERS BRIEF COMMUNICATIONS & REVIEW PAPERS			English	Article						proton irradiation; radiation-induced defect; InGaAs/GaAs; MQW; carrier lifetime; carrier transport; transient four-wave mixing	SEMIINSULATING GAAS; ULTRAFAST CARRIER; IMPLANTED GAAS; DEEP LEVELS; SEMICONDUCTORS; SCATTERING; DYNAMICS; LIFETIME; LAYERS	Effects of proton irradiation and thermal annealing on free carrier lifetime and transport in a InGaAs/GaAs multiple quantum well (MQW) structure and its substrate have been studied by using the nonresonant transient four-wave mixing technique. Under the excitation of the surface region of the structure by 0.53 mum wavelength, we determined the carrier lifetime tau = 150-600 ps, bipolar diffusion coefficient D = 24-26 cm(2) s(-1), and mobility-lifetime product mu tau x (2-6) x 10(-7) cm(2) V(-1) in 3 MeV proton irradiated and annealed MQW samples. At excitation by 1.06 mum wavelength, we studied the full proton penetration range. including the substrate. We found an unexpected twofold increase in carrier bulk lifetime with increasing irradiation dose. Features of this effect at low photoexcitation and its absence at high photoexcitation are attributed to carrier separation by potential fluctuations in the vicinity of irradiation-created deep defects. These features indicate that proton-irradiated semi-insulating GaAs exhibits properties of mesoscopic pointlike defects, similar to those previously reported in nonstoichiometric crystals of GaAs. This result is important to understand the mechanism of carrier compensation in proton-irradiated semiconductors.	Vilnius State Univ, Inst Mat Sci & Appl Res, LT-2040 Vilnius, Lithuania; Univ Tokyo, Inst Ind Sci, Meguro Ku, Tokyo 1538505, Japan; Univ Tokyo, Adv Sci & Technol Res Ctr, Meguro Ku, Tokyo 1538904, Japan	Jarasiunas, K (reprint author), Vilnius State Univ, Inst Mat Sci & Appl Res, Sauletekio Al 9,Buil 3, LT-2040 Vilnius, Lithuania.						WARREN AC, 1990, APPL PHYS LETT, V57, P1331, DOI 10.1063/1.103474; HOFFMAN CA, 1978, APPL PHYS LETT, V33, P536, DOI 10.1063/1.90428; Othonos A, 1998, J APPL PHYS, V83, P1789, DOI 10.1063/1.367411; Nolte DD, 1999, J APPL PHYS, V85, P6259, DOI 10.1063/1.370284; STEEPLES K, 1980, APPL PHYS LETT, V36, P981, DOI 10.1063/1.91390; Dao LV, 1998, APPL PHYS LETT, V72, P2008, DOI 10.1063/1.121248; DELPON EL, 1998, P C LAS EL OPT 98 SA, P536; DEVEAUD B, 1993, NATO ADV SCI INST SE, V228, P119; DYMENT JC, 1973, J APPL PHYS, V44, P207, DOI 10.1063/1.1661863; Jarasiunas K, 1997, INST PHYS CONF SER, P1005; Kazukauskas V, 1996, J APPL PHYS, V80, P2269, DOI 10.1063/1.363055; LAMBSDORFF M, 1991, APPL PHYS LETT, V58, P1881, DOI 10.1063/1.105061; NIKI S, 1989, APPL PHYS LETT, V55, P1339, DOI 10.1063/1.101649; Nolte DD, 1997, APPL PHYS LETT, V70, P3401, DOI 10.1063/1.119184; Nolte DD, 1998, PHYS REV B, V58, P7994, DOI 10.1103/PhysRevB.58.7994; PETRAUSKAS M, 1992, SEMICOND SCI TECH, V7, P1355, DOI 10.1088/0268-1242/7/11/012; Sasaki T, 1998, J APPL PHYS, V83, P4069, DOI 10.1063/1.367226; SILBERBERG Y, 1985, APPL PHYS LETT, V46, P701, DOI 10.1063/1.95479; Tan HH, 1996, IEEE J SEL TOP QUANT, V2, P636; VAITKUS J, 1992, SEMICOND SCI TECH, V7, pA131, DOI 10.1088/0268-1242/7/1A/024; Walukiewicz W, 1996, APPL PHYS LETT, V69, P2569, DOI 10.1063/1.117702; WANG Q, 1992, J OPT SOC AM B, V9, P1626, DOI 10.1364/JOSAB.9.001626	22	6	6	JAPAN SOC APPLIED PHYSICS	TOKYO	KUDAN-KITA BUILDING 5TH FLOOR, 1-12-3 KUDAN-KITA, CHIYODA-KU, TOKYO, 102-0073, JAPAN	0021-4922			JPN J APPL PHYS 1	Jpn. J. Appl. Phys. Part 1 - Regul. Pap. Brief Commun. Rev. Pap.	OCT	2000	39	10					5781	5787		10.1143/JJAP.39.5781		7	Physics, Applied	Physics	368VW	WOS:000090139000013		
J	Tagami, K; Tsukada, M				Tagami, K; Tsukada, M			Simulated noncontact atomic force microscopy images of Si(001) surface with silicon tip	JAPANESE JOURNAL OF APPLIED PHYSICS PART 1-REGULAR PAPERS BRIEF COMMUNICATIONS & REVIEW PAPERS			English	Article						nc-AFM; simulated images; Si(001) surface; tight-binding	ULTRAHIGH-VACUUM NONCONTACT; SI(100) SURFACE; RESOLUTION; GAAS(110); CHARGE; DIMERS; AFM	We simulated the noncontact atomic force microscopy (nc-AFM) images of Si(001) surfaces using the Si tip based on the tight-binding model. We find that only up dimer atoms are observed slightly outside the dimer sites. This outward shift is explained based on two points. One point is that the dangling bonds on the up dimer atoms, which interact with the tip apex, are tilted outward. The other point is that the space between the adjacent dimer rows looks slightly bright on the c(4 x 2) phase since the tip located above the midpoint of the two dimer rows is subjected to attractive forces from the up dimer atoms on both sides.	Univ Tokyo, Grad Sch Sci, Dept Phys, Bunkyo Ku, Tokyo 1130033, Japan	Tagami, K (reprint author), Univ Tokyo, Grad Sch Sci, Dept Phys, Bunkyo Ku, 7-3-1 Hongo, Tokyo 1130033, Japan.	tagami@cms.phys.s.u-tokyo.ac.jp	Tsukada, Masaru/E-5182-2010				Elstner M, 1998, PHYS REV B, V58, P7260, DOI 10.1103/PhysRevB.58.7260; Perez R, 1998, PHYS REV B, V58, P10835, DOI 10.1103/PhysRevB.58.10835; Fukui K, 1997, PHYS REV LETT, V79, P4202, DOI 10.1103/PhysRevLett.79.4202; Giessibl F. J., 1995, SCIENCE, V267, P1451; Ke SH, 1999, PHYS REV B, V60, P11631, DOI 10.1103/PhysRevB.60.11631; Kitamura S, 1996, JPN J APPL PHYS 2, V35, pL668, DOI 10.1143/JJAP.35.L668; KITAMURA S, 1995, JPN J APPL PHYS 2, V34, pL145, DOI 10.1143/JJAP.34.L145; RAMSTAD A, 1995, PHYS REV B, V51, P14504, DOI 10.1103/PhysRevB.51.14504; Sasaki N, 2000, APPL SURF SCI, V157, P367, DOI 10.1016/S0169-4332(99)00552-8; Sasaki N, 1999, APPL SURF SCI, V140, P339, DOI 10.1016/S0169-4332(98)00551-0; Sasaki N, 2000, JPN J APPL PHYS 2, V39, pL174, DOI 10.1143/JJAP.39.L174; Shigekawa H, 1997, PHYS REV B, V55, P15448, DOI 10.1103/PhysRevB.55.15448; Sugawara Y, 1999, APPL SURF SCI, V140, P371, DOI 10.1016/S0169-4332(98)00557-1; TAGAMI K, UNPUB APPL SURF SCI; TAGAMI K, UNPUB J PHYS SOC JPN; Tobik J, 1999, PHYS REV B, V60, P11639, DOI 10.1103/PhysRevB.60.11639; Uchihashi T, 1999, APPL SURF SCI, V140, P304, DOI 10.1016/S0169-4332(98)00545-5; Yokoyama K, 2000, JPN J APPL PHYS 2, V39, pL113, DOI 10.1143/JJAP.39.L113; Yokoyama T, 2000, PHYS REV B, V61, pR5078, DOI 10.1103/PhysRevB.61.R5078	19	15	15	JAPAN SOC APPLIED PHYSICS	TOKYO	KUDAN-KITA BUILDING 5TH FLOOR, 1-12-3 KUDAN-KITA, CHIYODA-KU, TOKYO, 102-0073, JAPAN	0021-4922			JPN J APPL PHYS 1	Jpn. J. Appl. Phys. Part 1 - Regul. Pap. Brief Commun. Rev. Pap.	OCT	2000	39	10					6025	6028		10.1143/JJAP.39.6025		4	Physics, Applied	Physics	368VW	WOS:000090139000060		
J	Murakami, H; Morita, R; Watanabe, T; Asai, K; Honma, I; Zhou, HS; Yamashita, M; Ishigure, K; Shigekawa, H				Murakami, H; Morita, R; Watanabe, T; Asai, K; Honma, I; Zhou, HS; Yamashita, M; Ishigure, K; Shigekawa, H			Determination of third-order optical nonlinearity dispersion of 1-methyl-1 '-octadecyl-2,2 '-cyanine perchlorate Langmuir-Blodgett films using electroabsorption spectroscopy	JAPANESE JOURNAL OF APPLIED PHYSICS PART 1-REGULAR PAPERS SHORT NOTES & REVIEW PAPERS			English	Article						J-aggregate; Langmuir-Blodgett film; cyanine dye; electroabsorption spectroscopy; third-order optical nonlinearity	POLYMER-FILMS; COMPLEXES	The absorption and electroabsorption (EA) spectra of 1-methyl-1'-octadecyl-2,2'-cyanine perchlorate (S120) Langmuir-Blodgett films were measured. From these results, dispersion of the third-order nonlinear optical susceptibility chi ((3))(-omega; 0, 0, omega) in the range of 1.8 to 2.7 eV was determined. In addition, the linear-polarizability difference Delta alpha and the permanent dipole-moment difference Delta mu between excited and ground states were evaluated. Upon comparison with the results of measurement of the S120 monomer film, it was found that the third-order nonlinear optical susceptibility of the S120 LB film is strongly enhanced by a factor of 1000. It was concluded that this strong enhancement is attributed to the fact that S120 molecules with a short methyne chain that tightly binds two quinoline rings form a rigid J-aggregate with a one-dimensional structure that hardly twists, so as to yield a sharp absorption band with a large transition moment. Finally, we evaluated the average aggregation number of the S120 LB film to be 3-4.	Hokkaido Univ, Dept Appl Phys, Kita Ku, Sapporo, Hokkaido 0608628, Japan; Univ Tokyo, Dept Quantum Engn & Syst Sci, Bunkyo Ku, Tokyo 1130032, Japan; AIST, Electrotech Lab, Div Energy, Tsukuba, Ibaraki 3058568, Japan; Univ Tsukuba, Inst Appl Phys, Tsukuba, Ibaraki 3058573, Japan; CREST, Japan Sci & Technol Corp, JST, Yokohama, Kanagawa, Japan	Murakami, H (reprint author), Hokkaido Univ, Dept Appl Phys, Kita Ku, Kita-13,Nishi-8, Sapporo, Hokkaido 0608628, Japan.						REIMERS JR, 1991, J PHYS CHEM-US, V95, P9773, DOI 10.1021/j100177a032; Jelley EE, 1936, NATURE, V138, P1009, DOI 10.1038/1381009a0; OH DH, 1991, J AM CHEM SOC, V113, P6880, DOI 10.1021/ja00018a026; BOYD RW, 1992, NONLINEAR OPTICS, P101; DU WC, 1993, THIN SOLID FILMS, V232, P237, DOI 10.1016/0040-6090(93)90015-H; Jia WY, 1996, CHEM PHYS LETT, V255, P385, DOI 10.1016/0009-2614(96)00385-5; Liptay W., 1974, EXCITED STATES, V1, P129; Markov RV, 1998, P SOC PHOTO-OPT INS, V3347, P176, DOI 10.1117/12.301407; MISAWA K, 1994, CHEM PHYS LETT, V220, P251, DOI 10.1016/0009-2614(94)00180-4; Misawa K., 1995, Nonlinear Optics, Principles, Materials, Phenomena, and Devices, V14; Murakami H, 1999, JPN J APPL PHYS 1, V38, P4056, DOI 10.1143/JJAP.38.4056; Scheibe G., 1936, ANGEW CHEM, V49, P563; SHELKOVNIKOV VV, 1995, J MATER CHEM, V5, P1331, DOI 10.1039/jm9950501331; WADA T, 1994, MOL CRYST LIQ CRYS A, V247, P139, DOI 10.1080/10587259408039199	14	2	2	INST PURE APPLIED PHYSICS	MINATO-KU TOKYO	DAINI TOYOKAIJI BLDG, 4-24-8 SHINBASHI, MINATO-KU TOKYO, 105-004, JAPAN	0021-4922			JPN J APPL PHYS 1	Jpn. J. Appl. Phys. Part 1 - Regul. Pap. Short Notes Rev. Pap.	OCT	2000	39	10					5838	5841		10.1143/JJAP.39.5838		4	Physics, Applied	Physics	368VW	WOS:000090139000023		
J	Shinoura, N; Sakurai, S; Asai, A; Kirino, T; Hamada, H				Shinoura, N; Sakurai, S; Asai, A; Kirino, T; Hamada, H			Transduction of a fiber-mutant adenovirus for the HSVtk gene highly augments the cytopathic effect towards gliomas	JAPANESE JOURNAL OF CANCER RESEARCH			English	Article						apoptosis; HSVtk; fiber-mutant; adenovirus; glioma	THYMIDINE KINASE GENE; BRAIN-TUMORS; RECOMBINANT ADENOVIRUSES; MALIGNANT GLIOMA; FAS LIGAND; THERAPY; CELLS; GANCICLOVIR; EXPRESSION; APOPTOSIS	Suicide gene therapy utilizing the herpes simplex thymidine kinase (HSVtk)/ganciclovir (GCV) system has been performed to kill cancer cells. However, the low transduction efficiency of HSVtk gene into cancer cells critically limits its efficacy in cancer treatment in clinical situations. To improve delivery of the HSVtk gene into cancer cells, we transduced U-87MG and U-373MG glioma cells with adenovirus (Adv) vectors with a fiber mutant, F/K20, which has a stretch of 20 lysine residues added at the C-terminus of the fiber, for the HSVtk gene (Adv-TK-F/K20), and compared the cytopathic effect of AdV-TK-F/K20 with that of the Adv for HSVtk with wild-type fiber (Adv-TK), The cytopathic effect of AdV-TK-F/K20 in U-87MG and U-373MG cells was approximately 140 and 40 times, respectively, stronger than that of Adv-TK, At the same multiplicity of infection (MOI) in each cell line, Adv-TK-F/K20 induced a higher degree of apoptosis (U-87MG, 35%; U-373MG, 77%) than Adv-TK (U-87MG, 0.11%; U-373MG, 27%) in U-87MG (MOI 0.03) and U-373MG cells (MOI 0.1), Cleavage of poly(ADP-ribose)polymerase (PARP) was more marked in the cells that were infected with Adv-TK-F/K20 than in cells that were infected with Adv-TK, These results indicate that gene therapy utilizing Adv-TK-F/K20 may be a promising therapeutic modality for the treatment of gliomas.	Tokyo Metropolitan Komagome Hosp, Dept Neurosurg, Bunkyo Ku, Tokyo 1138677, Japan; Japanese Fdn Canc Res, Ctr Canc Chemotherapy, Dept Mol Biotherapy Res, Toshima Ku, Tokyo 1708455, Japan; Kyoritsu Coll Pharm, Dept Biochem, Minami Ku, Tokyo 1058512, Japan; Univ Tokyo, Dept Neurosurg, Bunkyo Ku, Tokyo 1138655, Japan; CREST, Kawaguchi 3320012, Japan; Sapporo Med Univ, Dept Mol Med, Chuo Ku, Sapporo, Hokkaido 0608556, Japan	Shinoura, N (reprint author), Tokyo Metropolitan Komagome Hosp, Dept Neurosurg, Bunkyo Ku, 3-18-22 Hon Komagome, Tokyo 1138677, Japan.						Yoshida Y, 1998, HUM GENE THER, V9, P2503, DOI 10.1089/hum.1998.9.17-2503; Parr MJ, 1997, NAT MED, V3, P1145, DOI 10.1038/nm1097-1145; CULVER KW, 1992, SCIENCE, V256, P1550, DOI 10.1126/science.1317968; Ram Z, 1997, NAT MED, V3, P1354, DOI 10.1038/nm1297-1354; FREEMAN SM, 1993, CANCER RES, V53, P5274; Beltinger C, 1999, P NATL ACAD SCI USA, V96, P8699, DOI 10.1073/pnas.96.15.8699; OLDFIELD EH, 1993, HUM GENE THER, V4, P39, DOI 10.1089/hum.1993.4.1-39; Craperi D, 1999, HUM GENE THER, V10, P679, DOI 10.1089/10430349950018751; Lanuti M, 1999, GENE THER, V6, P1600, DOI 10.1038/sj.gt.3300987; Miyake S, 1996, P NATL ACAD SCI USA, V93, P1320, DOI 10.1073/pnas.93.3.1320; Miyao Y, 1997, JPN J CANCER RES, V88, P678; MOSMANN T, 1983, J IMMUNOL METHODS, V65, P55, DOI 10.1016/0022-1759(83)90303-4; Shinoura N, 1999, CANCER RES, V59, P3411; Shinoura N, 1998, HUM GENE THER, V9, P1983, DOI 10.1089/hum.1998.9.14-1983; SHULER M, 1998, HUM GENE THER, V9, P2075; TRASK TW, 1998, P AM SOC GEN THER 1; Wei SJ, 1999, GENE THER, V6, P420, DOI 10.1038/sj.gt.3300817; Wildner O, 1999, GENE THER, V6, P57, DOI 10.1038/sj.gt.3300810; Yoshida Y, 1997, BIOCHEM BIOPH RES CO, V230, P426, DOI 10.1006/bbrc.1996.5975; Zuckerman JB, 1999, HUM GENE THER, V10, P2973, DOI 10.1089/10430349950016384	20	7	7	BUSINESS CENTER ACADEMIC SOCIETIES JAPAN	TOKYO	5-16-9 HONKOMAGOME, BUNKYO-KU, TOKYO, 113-8633, JAPAN	0910-5050			JPN J CANCER RES	Jpn. J. Cancer Res.	OCT	2000	91	10					1028	1034				7	Oncology	Oncology	367TN	WOS:000090077700012		
J	Shinoura, N; Yamamoto, N; Asai, A; Kirino, T; Hamada, H				Shinoura, N; Yamamoto, N; Asai, A; Kirino, T; Hamada, H			Adenovirus-mediated transfer of Fas ligand gene augments radiation-induced apoptosis in U-373MG glioma cells	JAPANESE JOURNAL OF CANCER RESEARCH			English	Article						apoptosis; radiation; Fas ligand; glioma; adenovirus	DAMAGE-INDUCED APOPTOSIS; WILD-TYPE P53; IN-VIVO; GAMMA-IRRADIATION; TUMOR-CELLS; ACTIVATION; EXPRESSION; PATHWAY; BRAIN; CD95	Most malignant astrocytomas (gliomas) express a high level of Fas, whereas the surrounding normal tissues such as neurons and astrocytes express a very low level of Fas, Thus, transduction of Fas ligand would selectively kill malignant astrocytoma cells. On the other hand, glioma cells harboring p53 mutation have been reported to be resistant to conventional therapies including radiation. To override the resistance mechanism of glioma cells with p53 mutation to radiation, we transduced U-373MG malignant astrocytoma (glioma) cells harboring mutant p53 with Fas ligand via an adenovirus (Adv) vector in combination with X-ray irradiation, and evaluated the degree of apoptosis, The degree of apoptosis in U-373MG cells infected with the Adv for Fas ligand (Adv-FL) and treated with irradiation (81%) was much higher than that in U-373MG cells infected with Adv-FL and not treated with irradiation (0.8%) or that in U-373MG cells infected with the control Adv for lacZ and treated with irradiation (5.0%), In U-373MG cells infected with Adv-FL, irradiation increased the expression of Fas ligand, Coincident with the increase in Fas ligand, there was a marked reduction in the caspase-3 level and a marked increase in the cleaved form of poly(ADP-ribose) polymerase (PARP), which are downstream components of Fas ligand-mediated apoptosis, This suggests that the enhanced activation of caspase-3 by the transduction of Fas ligand combined with irradiation, induced extensive apoptosis in U-373MG cells. In summary, transduction of Fas ligand may override the resistance mechanism to radiotherapy in glioma cells harboring p53 mutation.	Japanese Fdn Canc Res, Ctr Canc Chemotherapy, Dept Mol Biotherapy Res, Toshima Ku, Tokyo 1708455, Japan; Tokyo Metropolitan Komagome Hosp, Dept Neurosurg, Bunkyo Ku, Tokyo 1138677, Japan; Sapporo Med Univ, Dept Mol Med, Chuo Ku, Sapporo, Hokkaido 0608556, Japan; Univ Tokyo, Dept Neurosurg, Bunkyo Ku, Tokyo 1138655, Japan; CREST, Kawaguchi 3320012, Japan	Shinoura, N (reprint author), Japanese Fdn Canc Res, Ctr Canc Chemotherapy, Dept Mol Biotherapy Res, Toshima Ku, 1-37-1 Kami Ikebukuro, Tokyo 1708455, Japan.						Enari M, 1996, NATURE, V380, P723, DOI 10.1038/380723a0; Saas P, 1997, J CLIN INVEST, V99, P1173, DOI 10.1172/JCI119273; Shrieve DC, 1999, J NEUROSURG, V90, P72, DOI 10.3171/jns.1999.90.1.0072; Newton K, 2000, J EXP MED, V191, P195, DOI 10.1084/jem.191.1.195; CLARKE AR, 1993, NATURE, V362, P849, DOI 10.1038/362849a0; Yu YJ, 1998, CANCER RES, V58, P4277; Fulda S, 1998, CELL DEATH DIFFER, V5, P884, DOI 10.1038/sj.cdd.4400419; LOWE SW, 1993, NATURE, V362, P847, DOI 10.1038/362847a0; Gjerset RA, 1995, MOL CARCINOGEN, V14, P275, DOI 10.1002/mc.2940140408; Zhao QL, 1999, INT J RADIAT BIOL, V75, P493, DOI 10.1080/095530099140429; KANEGAE Y, 1995, NUCLEIC ACIDS RES, V23, P3816, DOI 10.1093/nar/23.19.3816; Abdulkarim B, 2000, INT J CANCER, V86, P229, DOI 10.1002/(SICI)1097-0215(20000415)86:2<229::AID-IJC12>3.0.CO;2-1; Hakem R, 1998, CELL, V94, P339, DOI 10.1016/S0092-8674(00)81477-4; Lee JU, 1999, EUR J CANCER, V35, P1374, DOI 10.1016/S0959-8049(99)00134-3; Boesen-de Cock JGR, 1999, J BIOL CHEM, V274, P14255, DOI 10.1074/jbc.274.20.14255; Datta R, 1997, J BIOL CHEM, V272, P1965; Dowling P, 1996, J EXP MED, V184, P1513, DOI 10.1084/jem.184.4.1513; Fuchs EJ, 1997, CANCER RES, V57, P2550; Gallardo D, 1996, CANCER RES, V56, P4891; Gratas C, 1997, BRAIN PATHOL, V7, P863, DOI 10.1111/j.1750-3639.1997.tb00889.x; HERR I, 1997, EMBO J, V16, P6209; Husain N, 1998, ACTA NEUROPATHOL, V95, P287; Kataoka T, 1998, J IMMUNOL, V161, P3936; Kitada S, 1996, ONCOGENE, V12, P187; Miyake S, 1996, P NATL ACAD SCI USA, V93, P1320, DOI 10.1073/pnas.93.3.1320; RensingEhl A, 1996, EUR J IMMUNOL, V26, P2271, DOI 10.1002/eji.1830260945; Sakakura C, 1996, INT J CANCER, V67, P101, DOI 10.1002/(SICI)1097-0215(19960703)67:1<101::AID-IJC17>3.0.CO;2-H; SARKARIA JN, 1995, INT J RADIAT ONCOL, V32, P931, DOI 10.1016/0360-3016(94)00621-Q; Shinoura N, 2000, CANCER GENE THER, V7, P224, DOI 10.1038/sj.cgt.7700110; Shinoura N, 1998, HUM GENE THER, V9, P1983, DOI 10.1089/hum.1998.9.14-1983; Shinoura N, 2000, CANCER GENE THER, V7, P739, DOI 10.1038/sj.cgt.7700158; TACHIBANA O, 1995, CANCER RES, V55, P5528; Tepper AD, 1999, J CLIN INVEST, V103, P971, DOI 10.1172/JCI5457; Villunger A, 1997, CANCER RES, V57, P3331; WELLER M, 1994, J CLIN INVEST, V94, P954, DOI 10.1172/JCI117462; Yoshida Y, 1997, BIOCHEM BIOPH RES CO, V230, P426, DOI 10.1006/bbrc.1996.5975; Yount GL, 1999, CANCER RES, V59, P1362	37	11	13	BUSINESS CENTER ACADEMIC SOCIETIES JAPAN	TOKYO	5-16-9 HONKOMAGOME, BUNKYO-KU, TOKYO, 113-8633, JAPAN	0910-5050			JPN J CANCER RES	Jpn. J. Cancer Res.	OCT	2000	91	10					1044	1050				7	Oncology	Oncology	367TN	WOS:000090077700014		
J	Ikeda, Y; Ueno, A; Naraba, H; Matsuki, N; Oh-ishi, S				Ikeda, Y; Ueno, A; Naraba, H; Matsuki, N; Oh-ishi, S			Intracellular Ca2+ increase in Neuro-2A cells and rat astrocytes following stimulation of bradykinin B-2 receptor	JAPANESE JOURNAL OF PHARMACOLOGY			English	Article						bradykinin; Neuro-2A; astrocyte; intracellular Ca2+; bradykinin B-2 receptor	KALLIKREIN-KININ SYSTEM; ACUTE-INFLAMMATION; DEFICIENT RATS; ACTIVATION; MECHANISMS; AGONIST; TISSUE; BRAIN; EDEMA	Murine neuroblastoma cell line Neuro-2A cells and rat brain astrocytes showed a dose-dependent increase in intracellular Ca2+ in response to bradykinin, when assessed by a single cell image analyzing system. The Ca2+ increase in Neuro-2A cells by bradykinin was also examined by a suspension fluorescent assay using fura-2 loading. The Ca2+ increase in both cases was suppressed by a bradykinin B-2 receptor antagonist, Hoe 140, but not by a B-1 receptor antagonist, des-Arg-Hoe 140, suggesting that the effect occurred via specific B-2 receptor activation. RT-PCR for bradykinin B-2 receptor mRNA showed that both Neuro-2A cells and the astrocytes expressed B-2 receptor mRNA. Binding of [H-3]bradykinin to Neuro-2A cells was assessed, and a specific binding constant of 0.75 nM was determined. Furthermore, the increase in [Ca2+](i) by bradykinin could be caused by a release of Ca2+ from storage sites in the endoplasmic reticulum, since thapsigargin and U-73122 attenuated the effect of bradykinin in Neuro-2A as well as in astrocytes. These results indicate that both astrocytes and neuroblastoma Neuro-2A cells stimulated by bradykinin could express a bradykinin B-2 receptor-mediated intracellular Ca2+ increase leading to signal transduction.	Kitasato Univ, Sch Pharmaceut Sci, Dept Pharmacol, Minato Ku, Tokyo 1088641, Japan; Univ Tokyo, Fac Pharmaceut Sci, Dept Pharmacol, Bunkyo Ku, Tokyo 1130033, Japan	Oh-ishi, S (reprint author), Kitasato Inst, Minato Ku, 5-9-1 Shirokane, Tokyo 1088642, Japan.		Ikeda-Matsuo, Yuri/G-7112-2012				Abe K, 1997, JPN J PHARMACOL, V75, P433, DOI 10.1254/jjp.75.433; STEPHENS GJ, 1993, GLIA, V9, P269, DOI 10.1002/glia.440090405; OHISHI S, 1987, AGENTS ACTIONS, V21, P384, DOI 10.1007/BF01966523; PROUD D, 1988, ANNU REV IMMUNOL, V6, P49; CHAKI S, 1993, MOL PHARMACOL, V43, P603; Colman RW, 1997, BLOOD, V90, P3819; Raidoo DM, 1998, PHARMACOL THERAPEUT, V79, P105, DOI 10.1016/S0163-7258(98)00011-4; KAMIYA T, 1993, STROKE, V24, P571; OHISHI S, 1986, AGENTS ACTIONS, V18, P450, DOI 10.1007/BF01965011; BROSSART P, 1995, CANCER RES, V55, P4065; Chen CC, 1997, J NEUROCHEM, V69, P1409; Chen CC, 1996, GLIA, V16, P210, DOI 10.1002/(SICI)1098-1136(199603)16:3<210::AID-GLIA3>3.0.CO;2-5; DAMAS J, 1992, BRAIN RES, V569, P63, DOI 10.1016/0006-8993(92)90369-K; Hembree TN, 1996, J CELL PHYSIOL, V169, P248; Ikeda Y, 1997, JPN J PHARMACOL, V74, P165, DOI 10.1254/jjp.74.165; KIZUKI K, 1994, BRAIN RES, V634, P305, DOI 10.1016/0006-8993(94)91934-8; MITSUI K, 1991, J NEUROCHEM, V57, P556, DOI 10.1111/j.1471-4159.1991.tb03786.x; Naraba H, 1998, FEBS LETT, V435, P96, DOI 10.1016/S0014-5793(98)01045-X; Ueno A, 1998, JPN J PHARMACOL, V78, P109, DOI 10.1254/jjp.78.109; WANG DZ, 1994, BBA-GENE STRUCT EXPR, V1219, P171, DOI 10.1016/0167-4781(94)90264-X	20	12	12	JAPANESE PHARMACOLOGICAL SOC	KYOTO	EDITORIAL OFF, KANTOHYA BLDG GOKOMACHI-EBISUGAWA NAKAGYO-KU, KYOTO, 604, JAPAN	0021-5198			JPN J PHARMACOL	Jpn. J. Pharmacol.	OCT	2000	84	2					140	145		10.1254/jjp.84.140		6	Pharmacology & Pharmacy	Pharmacology & Pharmacy	367NV	WOS:000090069100005		
J	Teramoto, S; Ishii, T; Matsuse, T; Fukuchi, Y				Teramoto, S; Ishii, T; Matsuse, T; Fukuchi, Y			Recombinant adeno-associated virus vectors efficiently transduce foreign gene into bovine aortic endothelial cells: Comparison with adenovirus vectors	JAPANESE JOURNAL OF PHARMACOLOGY			English	Article						endothelial cell; gene transfer; adeno-associated virus vector; adenovirus vector	AIRWAY EPITHELIAL-CELLS; NITRIC-OXIDE SYNTHASE; VASCULAR CELLS; EXPRESSION; APOPTOSIS; THERAPY; LUNG; INJECTION; DELIVERY	Because the features and kinetics of adeno-associated virus (AAV)-mediated gene transfer to endothelial cells (EC) are yet to be ultimately determined, we tested variables pertinent to the efficiency of AAV-mediated gene transfer to bovine aortic endothelial cells (BAEC). The variables with AAV vectors were compared with the better characterized adenovirus (Ad) vectors. There is a dose-response relationship between multiplicity of infection (moi) of AAV or Ad vectors and transduction efficiency in BAEC. The higher moi of AAV vectors achieved more than 80% of transduction efficiency in cultured BAEC. AAV and Ad vectors showed an incubation-time-dependent increase in transduction efficiency of LacZ gene to the BAEC up to 12 h of vector exposure. Although the similar kinetics of transduction efficiency of LacZ gene to BAEC was found in both vectors, the duration of gene expression was longer in AAV vector than that in Ad vectors in vitro. These results indicate that AAV-vector is efficient for gene transfer to EC, and higher moi of vectors or a longer period exposure of vectors to EC can facilitate efficient transduction of a foreign gene into cultured EC. For the duration of gene expression, the AAV vectors may be better than Ad vectors.	Int Univ Hlth & Welf, Med Res Ctr, San No Hosp, Dept Internal Med,Minato Ku, Tokyo 1070052, Japan; Tokyo Univ Hosp, Dept Geriatr Med, Tokyo 1138655, Japan; Yokohama City Univ, Med Ctr, Dept Pulm Med, Yokohama, Kanagawa 2320024, Japan; Juntendo Univ, Sch Med, Dept Resp Med, Tokyo 1138421, Japan	Teramoto, S (reprint author), Int Univ Hlth & Welf, Med Res Ctr, San No Hosp, Dept Internal Med,Minato Ku, 8-5-35 Akasaka, Tokyo 1070052, Japan.						Ferrari FK, 1996, J VIROL, V70, P3227; FLOTTE TR, 1995, GENE THER, V2, P357; SAMULSKI RJ, 1989, J VIROL, V63, P3822; RUSSELL DW, 1994, P NATL ACAD SCI USA, V91, P8915, DOI 10.1073/pnas.91.19.8915; Bereta J, 1995, FEBS LETT, V377, P21, DOI 10.1016/0014-5793(95)01301-6; Carter Barrie J., 1992, Current Opinion in Biotechnology, V3, P533, DOI 10.1016/0958-1669(92)90082-T; Channon KM, 1996, CARDIOVASC RES, V32, P962; Conrad CK, 1996, GENE THER, V3, P658; Crawford LE, 1996, J BIOL CHEM, V271, P26863; Ferrari FK, 1997, NAT MED, V3, P1295, DOI 10.1038/nm1197-1295; FLOTTE TR, 1993, P NATL ACAD SCI USA, V90, P10613, DOI 10.1073/pnas.90.22.10613; Gerszten RE, 1996, CIRC RES, V79, P1205; Gnatenko D, 1997, J INVEST MED, V45, P87; JONES LW, 1983, 18TH P INT C COSM RA, V5, P17; Lynch CM, 1997, CIRC RES, V80, P497; Maeda Y, 1997, CARDIOVASC RES, V35, P514, DOI 10.1016/S0008-6363(97)00163-6; Rolling F, 1997, GENE THER, V4, P757, DOI 10.1038/sj.gt.3300465; Svensson EC, 1999, CIRCULATION, V99, P201; Teramato S, 2000, LANCET, V355, P1911, DOI 10.1016/S0140-6736(05)73358-4; Teramoto S, 1998, J VIROL, V72, P8904; TERAMOTO S, 1998, AM J RESP CRIT CARE, V61, P891; Teramoto S, 1999, BRIT J ANAESTH, V83, P296; Teramoto S, 1999, THROMB RES, V93, P35, DOI 10.1016/S0049-3848(98)00150-9; Teramoto S, 1999, JPN J PHARMACOL, V81, P73, DOI 10.1254/jjp.81.73; TERAMOTO S, 1995, HUM GENE THER, V6, P1045, DOI 10.1089/hum.1995.6.8-1045; Teramoto S, 1999, EUR RESPIR J, V13, P1125, DOI 10.1034/j.1399-3003.1999.13e31.x; Teramoto S, 1997, LIFE SCI, V61, P891, DOI 10.1016/S0024-3205(97)00591-2; Tripathy SK, 1996, NAT MED, V2, P545, DOI 10.1038/nm0596-545; Turunen P, 1996, THROMB RES, V81, P635, DOI 10.1016/0049-3848(96)00039-4; Tzeng E, 1997, SURGERY, V122, P255, DOI 10.1016/S0039-6060(97)90016-7; Weigel G, 1997, THROMB RES, V87, P363, DOI 10.1016/S0049-3848(97)00140-0; YANG YP, 1994, P NATL ACAD SCI USA, V91, P4407, DOI 10.1073/pnas.91.10.4407; YHAHERTTUALA S, 2000, LANCET, V355, P213	33	5	6	JAPANESE PHARMACOLOGICAL SOC	KYOTO	EDITORIAL OFF, KANTOHYA BLDG GOKOMACHI-EBISUGAWA NAKAGYO-KU, KYOTO, 604, JAPAN	0021-5198			JPN J PHARMACOL	Jpn. J. Pharmacol.	OCT	2000	84	2					206	212		10.1254/jjp.84.206		7	Pharmacology & Pharmacy	Pharmacology & Pharmacy	367NV	WOS:000090069100013		
J	Komiyama, T; Kawai, T; Furubayashi, T				Komiyama, T; Kawai, T; Furubayashi, T			Muscular fatigue in the soleus and tibialis anterior during repetitive 1-min maximum voluntary contractions in human subjects	JAPANESE JOURNAL OF PHYSICAL FITNESS AND SPORTS MEDICINE			Japanese	Article						muscle fatigue; EMG analysis; muscle contraction; lower leg muscles	HUMAN MUSCLE FATIGUE; REFLEX INHIBITION; EXCITABILITY		Chiba Univ, Fac Educ, Dept Hlth & Sport Sci, Inage Ku, Chiba, Japan; MIZUNO Co, Lab Sport Sci, Suminoe Ku, Osaka, Japan; Univ Tokyo, Grad Sch Med, Dept Neurol, Div Neurosci,Bunnkyo Ku, Tokyo, Japan	Komiyama, T (reprint author), Chiba Univ, Fac Educ, Dept Hlth & Sport Sci, Inage Ku, 1-33 Yayoicho, Chiba, Japan.						ENOKA RM, 1992, J APPL PHYSIOL, V72, P1631; Gandevia SC, 1995, ADV EXP MED BIOL, V384, P281; Gandevia SC, 1996, J PHYSIOL-LONDON, V490, P529; MERLETTI R, 1990, J APPL PHYSIOL, V69, P1810; Taylor JL, 1996, J PHYSIOL-LONDON, V490, P519; Bigland-Ritchie B, 1981, Exerc Sport Sci Rev, V9, P75; BIGLANDRITCHIE B, 1995, NEURAL MUSCULAR MECH, P361; BONGIOVANNI LG, 1990, J PHYSIOL-LONDON, V423, P1; GARLAND SJ, 1990, J PHYSIOL-LONDON, V429, P17; KERNELL D, 1982, EXP BRAIN RES, V46, P197; KUKULKA CG, 1986, NEUROSCI LETT, V68, P327, DOI 10.1016/0304-3940(86)90511-2; MACEFIELD G, 1991, J PHYSIOL-LONDON, V440, P497; Marsden C. D., 1983, MOTOR CONTROL MECH H, P169; MCARDLE WD, 1994, ESSENTIALS EXERCISE, P370; VANDERVOORT AA, 1983, EXP NEUROL, V81, P141, DOI 10.1016/0014-4886(83)90163-2; WOODS JJ, 1987, J NEUROPHYSIOL, V58, P125	16	0	0	JAPANESE SOC PHYSICAL FITNESS SPORTS MEDICINE	TOKYO	C/O BUSINESS CENTER ACAD SOC JAPAN, 5-16-9 HONKOMAGOME, BUNKYO-KU, TOKYO, 113, JAPAN	0039-906X			JPN J PHYS FIT SPORT	Jpn. J. Phys. Fit. Sports Med.	OCT	2000	49	5					597	601				5	Physiology; Sport Sciences	Physiology; Sport Sciences	383KC	WOS:000165880800007		
J	Kim, YB; Ki, SW; Yoshida, M; Horinouchi, S				Kim, YB; Ki, SW; Yoshida, M; Horinouchi, S			Mechanism of cell cycle arrest caused by histone deacetylase inhibitors in human carcinoma cells	JOURNAL OF ANTIBIOTICS			English	Article							RETINOBLASTOMA PROTEIN; TRICHOSTATIN-A; GENE; EXPRESSION; BUTYRATE; PHOSPHORYLATION; TRANSCRIPTION; PROMOTER; POTENT; D1	Inhibitors of histone deacetylase (HDAC) block cell cycle progression at G1 in many cell types. We investigated the mechanism by which trichostatin A (TSA), a specific inhibitor of HDAC, induces G1 arrest in human cervix carcinoma HeLa cells. TSA treatment induced histone hyperacetylation followed by growth arrest in G1 as well as hypophosphorylation of pRb. The Cdk4 kinase activity was essentially unchanged during the TSA-induced G1 arrest. On the other hand, the arrest was accompanied by down-regulation of kinase activity of Cdk2, although the total protein levels of Cdk2 and its activator Cdc25A were unaffected. Upon TSA treatment, amounts of cyclin E and the CDK inhibitor p21(WAF1/Cip1) were markedly increased, while that of cyclin A was reduced. The induction of p21 and down-regulation of cyclin A correlated well with the decreased Cdk2 activity and cell cycle arrest. Furthermore, gel filtration chromatography showed the association of p21 with the cyclin E-Cdk2 complex, suggesting that the activation of Cdk2 by the enhanced expression of cyclin E is blocked by the increased p21. The elevated expression of p21 is also observed in cells treated with trapoxin and FR901228, structurally unrelated histone deacetylase inhibitors. A human colorectal carcinoma cell line lacking both alleles of the p21 gene (p21 -/-) was resistant to TSA several times more than the parental line (p21 +/+). These results suggest that the suppression of Cdk2 kinase activity due to p21 overexpression play a critical role in HDAC inhibitor-induced growth inhibition.	Japan Sci & Technol Corp, CREST Res Project, Yokohama, Kanagawa, Japan	Yoshida, M (reprint author), Univ Tokyo, Grad Sch Agr & Life Sci, Dept Biotechnol, Bunkyo Ku, Tokyo 1138657, Japan.		Yoshida, Minoru/C-8049-2014				WEINBERG RA, 1995, CELL, V81, P323, DOI 10.1016/0092-8674(95)90385-2; HOFFMANN I, 1994, EMBO J, V13, P4302; Sambucetti LC, 1999, J BIOL CHEM, V274, P34940, DOI 10.1074/jbc.274.49.34940; Archer SY, 1998, P NATL ACAD SCI USA, V95, P6791, DOI 10.1073/pnas.95.12.6791; Delavaine L, 1999, ONCOGENE, V18, P5381, DOI 10.1038/sj.onc.1202923; Kuo MH, 1998, BIOESSAYS, V20, P615, DOI 10.1002/(SICI)1521-1878(199808)20:8<615::AID-BIES4>3.0.CO;2-H; YOSHIDA M, 1990, J BIOL CHEM, V265, P17174; Lallemand F, 1996, BIOCHEM BIOPH RES CO, V229, P163, DOI 10.1006/bbrc.1996.1774; POON RYC, 1995, MOL BIOL CELL, V6, P1197; Nakajima H, 1998, EXP CELL RES, V241, P126, DOI 10.1006/excr.1998.4027; Ohtani K, 1995, P NATL ACAD SCI USA, V92, P12146, DOI 10.1073/pnas.92.26.12146; Kim YB, 1999, ONCOGENE, V18, P2461, DOI 10.1038/sj.onc.1202564; Saito A, 1999, P NATL ACAD SCI USA, V96, P4592, DOI 10.1073/pnas.96.8.4592; Vaziri C, 1998, CELL GROWTH DIFFER, V9, P465; Gabrielli BG, 1999, J BIOL CHEM, V274, P13961, DOI 10.1074/jbc.274.20.13961; SCHULZE A, 1995, P NATL ACAD SCI USA, V92, P11264, DOI 10.1073/pnas.92.24.11264; Brehm A, 1998, NATURE, V391, P597; GU Y, 1992, EMBO J, V11, P3995; HOSHIKAWA Y, 1994, EXP CELL RES, V214, P189, DOI 10.1006/excr.1994.1248; KIJIMA M, 1993, J BIOL CHEM, V268, P22429; LUKAS J, 1995, MOL CELL BIOL, V15, P2600; MAGNAGHI JL, 1998, NATURE, V391, P601; MOSMANN T, 1983, J IMMUNOL METHODS, V65, P2180; Stiegler P, 1998, CANCER RES, V58, P5049; TOMMASINO M, 1995, BIOESSAYS, V17, P509, DOI 10.1002/bies.950170607; YOSHIDA M, 1988, EXP CELL RES, V177, P122, DOI 10.1016/0014-4827(88)90030-4	26	75	83	JAPAN ANTIBIOT RES ASSN	TOKYO	2 20 8 KAMIOSAKI SHINAGAWA KU, TOKYO, 141, JAPAN	0021-8820			J ANTIBIOT	J. Antibiot.	OCT	2000	53	10					1191	1200				10	Biotechnology & Applied Microbiology; Immunology; Microbiology; Pharmacology & Pharmacy	Biotechnology & Applied Microbiology; Immunology; Microbiology; Pharmacology & Pharmacy	367XX	WOS:000090088200024		
J	Fujiwara, A; Ishii, K; Watanuki, T; Suematsu, H; Nakao, H; Ohwada, K; Fujii, Y; Murakami, Y; Mori, T; Kawada, H; Kikegawa, T; Shimomura, O; Matsubara, T; Hanabusa, H; Daicho, S; Kitamura, S; Katayama, C				Fujiwara, A; Ishii, K; Watanuki, T; Suematsu, H; Nakao, H; Ohwada, K; Fujii, Y; Murakami, Y; Mori, T; Kawada, H; Kikegawa, T; Shimomura, O; Matsubara, T; Hanabusa, H; Daicho, S; Kitamura, S; Katayama, C			Synchrotron radiation X-ray powder diffractometer with a cylindrical imaging plate	JOURNAL OF APPLIED CRYSTALLOGRAPHY			English	Article							LASER-STIMULATED LUMINESCENCE; PHASE-TRANSITION	A synchrotron radiation X-ray powder diffractometer for samples of very small amount has been developed to collect high-quality diffraction patterns under extreme conditions, i.e. at low temperature and/or high pressure. A new cylindrical imaging plate (CIP) is used as a detector, in addition to a conventional flat-type imaging plate (FIP). By using the CIP system, the diffraction data in a diffraction angle range -44 less than or equal to 2 theta less than or equal to 122 degrees are collected with a dynamic range of about 10(6). The alignment of the diffractometer, measurement and analysis are automatically operated by a workstation. A performance test shows that the CIP system has spatial resolution of about 0.07 degrees with a dynamic range of 10(6). The diffraction pattern of a standard sample of Si measured by the CIP system has high quality; the refinement of the structure reaches R-w = 3.68% even in the case of a small amount of sample (about 2 mu g) and a short exposure time (60 s). Examples of experiments at low temperatures under ambient and high pressures are also presented.	Univ Tokyo, Sch Sci, Dept Phys, Bunkyo Ku, Tokyo 1130033, Japan; Univ Tokyo, Inst Solid State Phys, Neutron Scattering Lab, Tokai, Ibaraki 3191106, Japan; High Energy Accelerator Res Org, Inst Mat Struct Sci, Photon Factory, Tsukuba, Ibaraki 3050801, Japan; Mac Sci Co Ltd, Kohoku Ku, Yokohama, Kanagawa 2220033, Japan	Fujiwara, A (reprint author), Univ Tokyo, Sch Sci, Dept Phys, Bunkyo Ku, 7-3-1 Hongo, Tokyo 1130033, Japan.		Fujiwara, Akihiko/F-3031-2015	Fujiwara, Akihiko/0000-0002-1319-388X			AMEMIYA Y, 1987, SCIENCE, V237, P164, DOI 10.1126/science.3496662; AMEMIYA Y, 1995, J SYNCHROTRON RADIAT, V2, P13, DOI 10.1107/S0909049594007405; MIYAHARA J, 1986, NUCL INSTRUM METH A, V246, P572, DOI 10.1016/0168-9002(86)90156-7; YOUNG RA, 1982, J APPL CRYSTALLOGR, V15, P430, DOI 10.1107/S002188988201231X; Ishii K, 1999, PHYS REV B, V59, P3956, DOI 10.1103/PhysRevB.59.3956; Izumi F, 1993, RIETVELD METHOD; Kim Y., 1994, Journal of the Ceramic Society of Japan, V102; Menoni C. S., 1984, High Temperatures - High Pressures, V16; Nakao H, 1998, J PHYS SOC JPN, V67, P4117, DOI 10.1143/JPSJ.67.4117; Ohwada K, 2000, J PHYS SOC JPN, V69, P639, DOI 10.1143/JPSJ.69.639; SHIMOMURA O, 1992, REV SCI INSTRUM, V63, P967, DOI 10.1063/1.1143793	11	42	43	MUNKSGAARD INT PUBL LTD	COPENHAGEN	35 NORRE SOGADE, PO BOX 2148, DK-1016 COPENHAGEN, DENMARK	0021-8898			J APPL CRYSTALLOGR	J. Appl. Crystallogr.	OCT 1	2000	33		5				1241	1245		10.1107/S0021889800009286		5	Chemistry, Multidisciplinary; Crystallography	Chemistry; Crystallography	357RX	WOS:000089515600007		
J	Matsukawa, R; Hotta, M; Masuda, Y; Chihara, M; Karube, I				Matsukawa, R; Hotta, M; Masuda, Y; Chihara, M; Karube, I			Antioxidants from carbon dioxide fixing Chlorella sorokiniana	JOURNAL OF APPLIED PHYCOLOGY			English	Article; Proceedings Paper	8th Tri Annual International Conference on Applied Algology (8th ICAA)	SEP 26-OCT 01, 1999	MONTECATINI TERME, ITALY	Addavita Ltd, Beckman Coulter SpA, Blackwell Sci Asia, Consorzio Turistico Montespertoli, Dainippon Ink & Chem Inc, Earthrise Farms, Exenia Grp Srl, Microalgae SpA, Micro Gaia Co, New Ambadi Estates Pvt Ltd, Nihon Chlorella Co Ltd, Nikken Sohonsha Co, Sanatur GmbH, Sogesca Srl, Tung Hai Chlorella Co, UNESCO Venice Off ROSTE		antioxidants; Chlorella sorokiniana; carotenoids; lutein; aqueous extracts	ESSENTIAL FATTY-ACIDS; DUNALIELLA-SALINA; BETA-CAROTENE; VITAMIN-C; STRAINS; STRESS; LIGHT; ENRICHMENT; LUTEIN; DAMAGE	Chlorella sorokiniana H-84, which has tolerance to high temperatures and high concentrations of CO2, has been isolated from a hot spring in Japan. Large-scale culturing of C. sorokiniana was carried out in air containing 10% CO2. Analysis of the biomass shows that protein, carbohydrate and lipids comprised 68.5, 11.9 and 10.0% of dry matter, respectively. The total carotenoids comprised 0.69% dry matter. The lutein and beta -carotene contents were 4300 and 600 mug g(-1) dry weight, respectively. The alpha -tocopherol content was 112 mug g(-1) dry weight. These carotenoids and alpha -tocopherol are known to possess radical scavenging activity. Two fractions with radical scavenging activity were isolated from the aqueous extract of C. sorokiniana H-84. The extract showed several single peaks by reversed phase HPLC analysis and two of them had molecular weights of 710 and 1286, respectively.	Res Inst Innovat Technol Earth, Tokyo, Japan; Univ Tokyo, Adv Sci & Technol Res Ctr, Tokyo 1538904, Japan; Sci Univ Tokyo, Fac Engn, Tokyo 162, Japan; Nat Hist Museum & Inst, Chiba, Japan	Matsukawa, R (reprint author), Res Inst Innovat Technol Earth, Tokyo, Japan.						Stahl W, 1998, FEBS LETT, V427, P305, DOI 10.1016/S0014-5793(98)00434-7; SIEFERMANNHARMS D, 1985, BIOCHIM BIOPHYS ACTA, V811, P325, DOI 10.1016/0304-4173(85)90006-0; Hamasaki K, 1998, NIPPON SUISAN GAKK, V64, P841; BLOIS MS, 1958, NATURE, V181, P1199, DOI 10.1038/1811199a0; SAKAI N, 1995, ENERG CONVERS MANAGE, V36, P693, DOI 10.1016/0196-8904(95)00100-R; BAR E, 1995, J PLANT PHYSIOL, V146, P527; Neidhardt J, 1998, PHOTOSYNTH RES, V56, P175, DOI 10.1023/A:1006024827225; *AOAC, 1995, OFF METH ASS OFF AN; Belkoura M, 1994, ANN LIMNOL-INT J LIM, V30, P3, DOI 10.1051/limn/1994004; COWAN AK, 1995, J PLANT PHYSIOL, V146, P554; Gapasin RSJ, 1998, AQUACULTURE, V162, P269, DOI 10.1016/S0044-8486(98)00205-1; KESSLER E, 1992, J PHYCOL, V28, P550, DOI 10.1111/j.0022-3646.1992.00550.x; Leach G, 1998, J SCI FOOD AGR, V76, P298, DOI 10.1002/(SICI)1097-0010(199802)76:2<298::AID-JSFA953>3.0.CO;2-0; LICHTENTHALER HK, 1987, METABOLISM STRUCTURE, P63; Mahasneh IA, 1997, CYTOBIOS, V90, P153; Martin KR, 1996, J NUTR, V126, P2098; MARUYAMA I, 1989, NIPPON SUISAN GAKK, V55, P1785; Matsukawa R, 1998, STUD SURF SCI CATAL, V114, P641; Schwartz JL, 1996, J NUTR, V126, pS1221; TOJO K, 1989, J SOC COSMET CHEM, V40, P119; Yoshimatsu T, 1997, HYDROBIOLOGIA, V358, P153, DOI 10.1023/A:1003161214088	21	14	18	KLUWER ACADEMIC PUBL	DORDRECHT	SPUIBOULEVARD 50, PO BOX 17, 3300 AA DORDRECHT, NETHERLANDS	0921-8971			J APPL PHYCOL	J. Appl. Phycol.	OCT	2000	12	3-5					263	267		10.1023/A:1008141414115		5	Biotechnology & Applied Microbiology; Marine & Freshwater Biology	Biotechnology & Applied Microbiology; Marine & Freshwater Biology	366CK	WOS:000089987100010		
J	Watanabe, K; Miura, N				Watanabe, K; Miura, N			Magneto-optical spectra of excitons and Landau subbands in strained CdTe epitaxial films under high magnetic fields	JOURNAL OF APPLIED PHYSICS			English	Article							HOT WALL EPITAXY; GAAS; SEMICONDUCTORS; PARAMETERS; LAYERS; BANDS; ZNTE	High quality CdTe thin epitaxial films were grown on (100)-GaAs substrates by hot wall epitaxy. Doublet structures consisting of a heavy hole exciton and a light hole exciton were observed in reflection and absorption spectra. This splitting is caused by biaxial thermal strain. Magnetoreflection and magnetoabsorption spectra were measured in magnetic fields up to 40 T. It was found from the diamagnetic shift of the excitons that the hole effective masses are drastically changed from unstrained crystals. Interband transitions between Landau subbands were clearly observed in the magnetoabsorption spectra at strong magnetic fields. (C) 2000 American Institute of Physics. [S0021-8979(00)01420-1].	Univ Yamanashi, Fac Engn, Yamanashi 4008511, Japan; Univ Tokyo, Inst Solid State Phys, Kashiwa, Chiba 2778581, Japan	Watanabe, K (reprint author), Univ Yamanashi, Fac Engn, Takeda 4-3-11, Yamanashi 4008511, Japan.						Aliev G. N., 1992, Soviet Physics - Solid State, V34; Pfeffer P, 1996, PHYS REV B, V53, P12813, DOI 10.1103/PhysRevB.53.12813; LAWAETZ P, 1971, PHYS REV B, V4, P3460, DOI 10.1103/PhysRevB.4.3460; TAGUCHI T, 1975, PHYS STATUS SOLIDI B, V68, P727, DOI 10.1002/pssb.2220680234; PIDGEON CR, 1966, PHYS REV, V146, P575, DOI 10.1103/PhysRev.146.575; SHAHZAD K, 1988, PHYS REV B, V38, P8309, DOI 10.1103/PhysRevB.38.8309; ENDERS P, 1995, PHYS REV B, V51, P16695, DOI 10.1103/PhysRevB.51.16695; CAMASSEL J, 1973, SOLID STATE COMMUN, V13, P63, DOI 10.1016/0038-1098(73)90068-9; HEISINGER P, 1975, PHYS STATUS SOLIDI B, V67, P641; ITOH T, 1992, J CRYST GROWTH, V117, P835, DOI 10.1016/0022-0248(92)90867-I; LEE JH, 1992, SOLID STATE COMMUN, V84, P901, DOI 10.1016/0038-1098(92)90455-I; LINK P, 1992, J APPL PHYS, V72, P3730, DOI 10.1063/1.352292; MAYER H, 1993, PHYS REV B, V47, P12929, DOI 10.1103/PhysRevB.47.12929; OLEGO DJ, 1987, APPL PHYS LETT, V51, P127, DOI 10.1063/1.98590; PERKOWIT.S, 1974, PHYS REV B, V9, P545, DOI 10.1103/PhysRevB.9.545; SCHLIERKAMP M, 1989, PHYS REV B, V40, P3077, DOI 10.1103/PhysRevB.40.3077; SEKI S, 1994, J APPL PHYS, V76, P3250, DOI 10.1063/1.357468; TAKEYAMA S, 1990, PHYS REV B, V41, P4513, DOI 10.1103/PhysRevB.41.4513; THOMAS DG, 1961, J APPL PHYS, V32, P2298, DOI 10.1063/1.1777063	19	4	4	AMER INST PHYSICS	MELVILLE	2 HUNTINGTON QUADRANGLE, STE 1NO1, MELVILLE, NY 11747-4501 USA	0021-8979			J APPL PHYS	J. Appl. Phys.	OCT 1	2000	88	7					4245	4249		10.1063/1.1290464		5	Physics, Applied	Physics	355DY	WOS:000089371600070		
J	Kouzaki, M; Shinohara, M; Fukunaga, T				Kouzaki, M; Shinohara, M; Fukunaga, T			Decrease in maximal voluntary contraction by tonic vibration applied to a single synergist muscle in humans	JOURNAL OF APPLIED PHYSIOLOGY			English	Article						tonic muscle vibration; synergistic muscles; maximal voluntary contraction; electromyogram	INHIBITION	The purpose of the study was to examine the effect of prolonged tonic vibration applied to a single synergist muscle on maximal voluntary contraction (MVC) and maximal rate of force development (dF/dt(max)). The knee extension MVC force and surface electromyogram (EMG) from the rectus femoris (RF), vastus lateralis (VL), and vastus medialis (VM) during MVC were recorded before and after vibration of RF muscle at 30 Hz for 30 min. MVC, dF/dt(max), and the integrated EMG (iEMG) of RF decreased significantly after prolonged tonic vibration in spite of no changes in iEMG of VL and VM. The present results indicate that MVC and dF/dt(max) may be influenced by the attenuated Ia afferent functions of a single synergist muscle.	Univ Tokyo, Lab Sports Sci, Dept Life Sci, Grad Sch Arts & Sci,Meguro Ku, Tokyo 1538902, Japan	Kouzaki, M (reprint author), Univ Tokyo, Lab Sports Sci, Dept Life Sci, Grad Sch Arts & Sci,Meguro Ku, 3-8-1 Komaba, Tokyo 1538902, Japan.		fukunaga, tetsuo/C-6635-2009; 	Shinohara, Minoru/0000-0002-9260-0366			ARMSTRONG RB, 1993, J APPL PHYSIOL, V74, P2990; BURKE D, 1976, J PHYSIOL-LONDON, V261, P695; HULTBORN H, 1987, J PHYSIOL-LONDON, V389, P757; Kossev A, 1999, MUSCLE NERVE, V22, P946, DOI 10.1002/(SICI)1097-4598(199907)22:7<946::AID-MUS22>3.0.CO;2-O; Avela J, 1999, J APPL PHYSIOL, V86, P1283; BONGIOVANNI LG, 1990, J PHYSIOL-LONDON, V423, P15; BONGIOVANNI LG, 1990, J PHYSIOL-LONDON, V423, P1; CURTIS DR, 1960, J PHYSIOL-LONDON, V150, P374; HAGBARTH KE, 1986, J PHYSIOL-LONDON, V380, P575; HAYWARD LF, 1986, EXP NEUROL, V94, P333, DOI 10.1016/0014-4886(86)90107-X	10	51	51	AMER PHYSIOLOGICAL SOC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	8750-7587			J APPL PHYSIOL	J. Appl. Physiol.	OCT	2000	89	4					1420	1424				5	Physiology; Sport Sciences	Physiology; Sport Sciences	362AE	WOS:000089755800022		
J	Matsumoto, A; Shikata, K; Takeuchi, F; Kojima, N; Mizuochi, T				Matsumoto, A; Shikata, K; Takeuchi, F; Kojima, N; Mizuochi, T			Autoantibody activity of IgG rheumatoid factor increases with decreasing levels of galactosylation and sialylation	JOURNAL OF BIOCHEMISTRY			English	Article						autoantibodies; glycosylation; IgG; rheumatoid arthritis; rheumatoid factor	IMMUNOGLOBULIN-G; OLIGOSACCHARIDE CHAINS; CARBOHYDRATE CHAINS; STRUCTURAL-CHANGES; SYNOVIAL-FLUID; ARTHRITIS; ANTIBODIES; MOIETY	The occurrence of N-linked oligosaccharides lacking galactose is significantly higher than normal in serum IgG of patients with rheumatoid arthritis (RA) in whom rheumatoid factor (RF), an autoantibody against autologous IgG, has been detected. In the present study, IgGs with and without RF activity (IgGRF and non-RF IgG, respectively) were prepared from sera of RA patients, and their oligosaccharide structures were characterized in order to investigate the relationship between RF activity and glycosylation, Three IgGRF fractions and a non-RF IgG fraction were obtained based on their ability to bind to an IgG-Sepharose column, The specific RF activity, as measured by immunoassays, was highest in the IgGRF fraction, which bound most avidly to the IgG-Sepharose, When the oligosaccharides were released by hydrazinolysis, and analyzed by MALDI-TOF mass spectrometry and HPLC, in combination with sequential exoglycosidase treatment, all the IgG samples were found to contain a series of biantennary complex-type oligosaccharides. The incidence of galactose-free oligosaccharides was significantly higher in both IgGRFs and non-RF IgG from RA patients compared with IgG from healthy individuals. In all IgGRFs, the levels of sialylation and galactosylation were lower than those in non-RF IgG; from RA patients; the sialylation of non-RF IgG was the same as that of IgG from healthy individuals, In addition, the decreases in galactosylation and sialylation of oligosaccharides in IgGRF correlated well with the increase in RF activity. These findings could contribute to our understanding of the mechanisms of IgG-IgG complex formation and the pathogenicity of these complexes in RA patients.	Tokai Univ, Dept Appl Biochem, Kanagawa 2591292, Japan; Univ Tokyo, Fac Med, Dept Internal Med, Bunkyo Ku, Tokyo 1138655, Japan	Mizuochi, T (reprint author), Tokai Univ, Dept Appl Biochem, Kanagawa 2591292, Japan.						PAREKH RB, 1985, NATURE, V316, P452, DOI 10.1038/316452a0; PAREKH RB, 1988, LANCET, V1, P966; MATSUI T, 1992, J BIOL CHEM, V267, P8723; Shikata K, 1998, GLYCOCONJUGATE J, V15, P683, DOI 10.1023/A:1006936431276; MIZUOCHI T, 1982, J IMMUNOL, V129, P2016; ZACK DJ, 1995, J IMMUNOL, V155, P5057; BEDWELL AE, 1987, ANN RHEUM DIS, V46, P55, DOI 10.1136/ard.46.1.55; BHOOLA KD, 1992, BRIT J RHEUMATOL, V31, P509; DULARAY B, 1990, CLIN EXP IMMUNOL, V79, P195; HEYMAN B, 1985, J IMMUNOL, V134, P4018; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Leader KA, 1996, BRIT J RHEUMATOL, V35, P335; Li Y.-T., 1972, METHOD ENZYMOL, V28, P702; Mizuochi T, 1993, Methods Mol Biol, V14, P55; MIZUOCHI T, 1987, ARCH BIOCHEM BIOPHYS, V257, P387, DOI 10.1016/0003-9861(87)90581-9; MIZUOCHI T, 1984, RYUMACHI, V24, P581; MIZUOCHI T, 1990, J IMMUNOL, V145, P1794; MIZUOCHI T, 1982, J BIOCHEM-TOKYO, V92, P283; Moriwaki T, 1997, GLYCOCONJUGATE J, V14, P225, DOI 10.1023/A:1018593805890; NOSE M, 1983, P NATL ACAD SCI-BIOL, V80, P6632, DOI 10.1073/pnas.80.21.6632; Roitt I M, 1988, Recenti Prog Med, V79, P314; RUDD PM, 1991, MOL IMMUNOL, V28, P1369, DOI 10.1016/0161-5890(91)90039-M; SALMON JA, 1983, ANN RHEUM DIS, V42, P36, DOI 10.1136/ard.42.1.36; Tang W, 1998, GLYCOCONJUGATE J, V15, P929, DOI 10.1023/A:1006971318736; VANZEBEN D, 1994, BRIT J RHEUMATOL, V33, P36; WINCHEST.RJ, 1969, ANN NY ACAD SCI, V168, P195, DOI 10.1111/j.1749-6632.1969.tb43108.x	26	48	48	JAPANESE BIOCHEMICAL SOC	TOKYO	ISHIKAWA BLDG-3F, 25-16 HONGO-5-CHOME, BUNKYO-KU, TOKYO, 113, JAPAN	0021-924X			J BIOCHEM-TOKYO	J. Biochem. (Tokyo)	OCT	2000	128	4					621	628				8	Biochemistry & Molecular Biology	Biochemistry & Molecular Biology	362TR	WOS:000089794800009		
J	Fukuda, M; Mikoshiba, K				Fukuda, M; Mikoshiba, K			Calcium-dependent and -independent hetero-oligomerization in the synaptotagmin family	JOURNAL OF BIOCHEMISTRY			English	Article						Ca2+ sensor; C2 domain; exocytosis; self-oligomerization; synaptotagmin	HIGH-POLYPHOSPHATE BINDING; SYNAPTIC-VESICLE; C2A DOMAIN; INOSITOL-1,3,4,5-TETRAKISPHOSPHATE BINDING; PHOSPHOLIPID-BINDING; ANTIBODY INJECTION; SYNAPSES; CELLS; IV; VI	Synaptotagmins constitute a family of membrane proteins that are characterized by one transmembrane region and two C2 domains. Recent genetic and biochemical studies have indicated that oligomerization of synaptotagmin (Syt) I is important for expression of function during exocytosis of synaptic vesicles. However, little is known about hetero-oligomerization in the synaptotagmin family. In this study, we showed that the synaptotagmin family is a type I membrane protein (N-lumen/C-cytoplasm) by introducing an artificial N-glycosylation site at the N-terminal domain, and systematically examined all the possible combinations of hetero-oligomerization among synaptotagmin family proteins (Syts I-XI), We classified the synaptotagmin family into four distinct groups based on differences in Ca2+-dependent and -independent oligomerization activity. Group A Syts (III, V,VI, and X) form strong homo- and hetero-oligomers by disulfide bonds at an N-terminal cysteine motif irrespective of the presence of Ca2+ [Fukuda, M., Kanno, E,, and Mikoshiba, K (1999) J. Biol. Chem. 274, 31421-31427], Group B Syts (I, II, VIII, and M) show moderate homo-oligomerization irrespective of the presence of Ca2+. Group C synaptotagmins are characterized by weak Ca2+-dependent (Syts M) or no homo-oligomerization activity (Syt IV). Syt VII (Group D) has unique Ca2+-dependent homooligomerization properties with EC,, values of about 150 mu M Ca2+ [Fukuda, M,, and Mikoshiba, K. (2000) J. Biol. Chem. 275, 28180-28185]. Syts IV,VIII, and XI did not show any apparent hetero-oligomerization activity, but some sets of synaptotagmin isoforms can hetero-oligomerize in a Ca2+-dependent and/or -independent manner. Our data suggest that Ca2+-dependent and -independent hetero-oligomerization of synaptotagmins may create a variety of Ca2+-sensors.	Inst Phys & Chem Res, Brain Sci Inst, Dev Neurobiol Lab, Wako, Saitama 3510198, Japan; Univ Tokyo, Inst Med Sci, Dept Mol Neurobiol, Minato Ku, Tokyo 1088639, Japan; Japan Sci & Technol Corp, ERATO, Calciosignal Net Project, Bunkyo Ku, Tokyo 1130021, Japan	Fukuda, M (reprint author), Inst Phys & Chem Res, Brain Sci Inst, Dev Neurobiol Lab, 2-1 Hirosawa, Wako, Saitama 3510198, Japan.		Fukuda, MItsunori/I-1511-2015				FUKUDA M, 1995, P NATL ACAD SCI USA, V92, P10708, DOI 10.1073/pnas.92.23.10708; Yang B, 1999, J BIOL CHEM, V274, P5649, DOI 10.1074/jbc.274.9.5649; Fasshauer D, 1999, J BIOL CHEM, V274, P15440, DOI 10.1074/jbc.274.22.15440; MIKOSHIBA K, 1995, P NATL ACAD SCI USA, V92, P10703, DOI 10.1073/pnas.92.23.10703; MATTHEW WD, 1981, J CELL BIOL, V91, P257, DOI 10.1083/jcb.91.1.257; Chapman ER, 1998, J BIOL CHEM, V273, P32966, DOI 10.1074/jbc.273.49.32966; Ibata K, 2000, J NEUROCHEM, V74, P518, DOI 10.1046/j.1471-4159.2000.740518.x; Sudhof TC, 1996, NEURON, V17, P379, DOI 10.1016/S0896-6273(00)80171-3; Schiavo G, 1998, BIOCHEM BIOPH RES CO, V248, P1, DOI 10.1006/bbrc.1998.8527; Martinez I, 2000, J CELL BIOL, V148, P1141, DOI 10.1083/jcb.148.6.1141; Lloyd TE, 2000, NEURON, V26, P45, DOI 10.1016/S0896-6273(00)81136-8; LI C, 1995, NATURE, V375, P594, DOI 10.1038/375594a0; Butz S, 1999, J BIOL CHEM, V274, P18290, DOI 10.1074/jbc.274.26.18290; Fukuda M, 1996, J BIOL CHEM, V271, P8430; Berton F, 1997, J NEUROSCI, V17, P1206; Berton F, 2000, EUR J NEUROSCI, V12, P1294, DOI 10.1046/j.1460-9568.2000.00013.x; Chapman ER, 1996, J BIOL CHEM, V271, P5844; Chapman ER, 1996, BIOCHEM BIOPH RES CO, V225, P326, DOI 10.1006/bbrc.1996.1174; Damer CK, 1996, J NEUROCHEM, V67, P1661; FUKUDA M, 1995, J BIOL CHEM, V270, P26523; Fukuda M, 1997, BIOCHEM J, V323, P421; Fukuda M, 1997, BIOESSAYS, V19, P593, DOI 10.1002/bies.950190710; Fukuda M, 2000, J BIOL CHEM, V275, P28180; Fukuda M, 2000, BIOCHEM BIOPH RES CO, V270, P528, DOI 10.1006/bbrc.2000.2434; Fukuda M, 1999, J BIOL CHEM, V274, P31421, DOI 10.1074/jbc.274.44.31421; FUKUDA M, 1994, J BIOL CHEM, V269, P29206; Fukuda M, 1999, J BIOL CHEM, V274, P31428, DOI 10.1074/jbc.274.44.31428; Ibata K, 1998, J BIOL CHEM, V273, P12267, DOI 10.1074/jbc.273.20.12267; Kida Y, 2000, J CELL BIOL, V150, P719, DOI 10.1083/jcb.150.4.719; Kraszewski K, 1996, J NEUROSCI, V16, P5905; KRAZEWSKI K, 1995, J NEUROSCI, V15, P4328; Lang JC, 1997, EMBO J, V16, P5837, DOI 10.1093/emboj/16.19.5837; Littleton JT, 1999, NATURE, V400, P757, DOI 10.1038/23462; LITTLETON JT, 1995, TRENDS NEUROSCI, V18, P177; MALGAROLI A, 1995, SCIENCE, V268, P1624, DOI 10.1126/science.7777862; Mehrotra B, 1997, J BIOL CHEM, V272, P4237; MIZUSHIMA S, 1990, NUCLEIC ACIDS RES, V18, P5332; Mochida S, 1997, NEUROSCIENCE, V77, P937; NIINOBE M, 1994, BIOCHEM BIOPH RES CO, V205, P1036, DOI 10.1006/bbrc.1994.2770; OharaImaizumi M, 1997, P NATL ACAD SCI USA, V94, P287, DOI 10.1073/pnas.94.1.287; Osborne SL, 1999, J BIOL CHEM, V274, P59, DOI 10.1074/jbc.274.1.59; PERIN MS, 1991, J BIOL CHEM, V266, P623; Sugita S, 1996, J BIOL CHEM, V271, P1262; Thomas DM, 1998, J NEUROSCI, V18, P3511; ULLRICH B, 1994, NEURON, V13, P1281, DOI 10.1016/0896-6273(94)90415-4; ULLRICH B, 1995, NEUROPHARMACOLOGY, V34, P1371, DOI 10.1016/0028-3908(95)00132-P; Veit M, 1996, FEBS LETT, V385, P119, DOI 10.1016/0014-5793(96)00362-6; vonPoser C, 1997, J BIOL CHEM, V272, P14314, DOI 10.1074/jbc.272.22.14314	48	31	32	JAPANESE BIOCHEMICAL SOC	TOKYO	ISHIKAWA BLDG-3F, 25-16 HONGO-5-CHOME, BUNKYO-KU, TOKYO, 113, JAPAN	0021-924X			J BIOCHEM-TOKYO	J. Biochem. (Tokyo)	OCT	2000	128	4					637	645				9	Biochemistry & Molecular Biology	Biochemistry & Molecular Biology	362TR	WOS:000089794800011		
J	Kawakami, Y; Lieber, RL				Kawakami, Y; Lieber, RL			Interaction between series compliance and sarcomere kinetics determines internal sarcomere shortening during fixed-end contraction	JOURNAL OF BIOMECHANICS			English	Article						frog; semitendinosus muscle; contractile and elastic components	ISOMETRIC CONTRACTIONS; GASTROCNEMIUS-MUSCLE; SKELETAL-MUSCLE; TENDON; FIBERS; LENGTH; CAT; STRAIN; MODEL; FORCE	The interaction between contractile force and in-series compliance was investigated for the intact skeletal muscle-tendon unit (MTU) of Rana pipiens semitendinosus muscles during fixed-end contraction. It was hypothesized that internal sarcomere shortening is a function of the length-force characteristics of contractile and series elastic components. The MTUs (n = 18) were dissected, and, while submerged in Ringer's solution, muscles were activated at nine muscle lengths(-2 to +6 mm relative to optimal length in 1 mm intervals), while measuring muscle force and sarcomere length (SL) by laser diffraction. The MTU was clamped either at the bone (n = 6), or at the proximal and distal ends of the aponeuroses (n = 6). Muscle fibers were also trimmed along with aponeuroses down to 5-20 fibers and identical measurements were performed (n = 6). The magnitude of shortening decreased as MTU length increased. The magnitude of shortening ranged from -0.08 to 0.3 mu m, and there was no significant difference between Delta SL as a function of clamp location. When aponeuroses were trimmed, sarcomere shortening was not observed at L-0 and longer. These results suggest that the aponeurosis is the major contributor to in-series compliance. Results also support our hypothesis but there also appear to be other factors affecting internal sarcomere shortening. The functional consequence of internal sarcomere shortening as a function of sarcomere length was to skew the muscle length-tension relationship to longer sarcomere lengths. (C) 2000 Elsevier Science Ltd. All rights reserved.	Univ Calif San Diego, Vet Affairs Med Ctr, Dept Orthopaed & Bioengn, San Diego, CA 92161 USA; Univ Tokyo, Dept Life Sci, Meguro Ku, Tokyo 1538902, Japan	Lieber, RL (reprint author), Univ Calif San Diego, Vet Affairs Med Ctr, Dept Orthopaed & Bioengn, San Diego, CA 92161 USA.	rlieber@ucsd.edu					LIEBER RL, 1991, AM J PHYSIOL, V261, pC86; Roberts TJ, 1997, SCIENCE, V275, P1113, DOI 10.1126/science.275.5303.1113; HIGUCHI H, 1995, BIOPHYS J, V69, P1000; LIEBER RL, 1984, BIOPHYS J, V45, P1007; GRIFFITHS RI, 1991, J PHYSIOL-LONDON, V436, P219; LIEBER RL, 1988, AM J PHYSIOL, V254, pC759; HERZOG W, 1992, J BIOMECH, V25, P945, DOI 10.1016/0021-9290(92)90235-S; PURSLOW PP, 1989, J BIOMECH, V22, P21, DOI 10.1016/0021-9290(89)90181-4; ETTEMA GJC, 1989, J BIOMECH, V22, P1209, DOI 10.1016/0021-9290(89)90223-6; GORDON AM, 1966, J PHYSIOL-LONDON, V184, P170; HILL AV, 1951, LANCET, V24, P947; Hoffer JA, 1989, PROG BRAIN RES, V80, P75; HUIJING PA, 1989, ACTA ANAT, V135, P46; LIEBER RL, 1992, J BIOMECH, V25, P421, DOI 10.1016/0021-9290(92)90261-X; LIEBER RL, 1989, P 12 INT C BIOM U CA; LIEBER RL, 1983, J GEN PHYSIOL, V82, P347, DOI 10.1085/jgp.82.3.347; LUTZ GJ, 1994, SCIENCE, V263, P370, DOI 10.1126/science.8278808; MAI MT, 1990, J BIOMECH, V23, P271, DOI 10.1016/0021-9290(90)90017-W; ROELEVELD K, 1993, J APPL PHYSIOL, V74, P1348; TRESTIK CL, 1993, J BIOMECH ENG-T ASME, V115, P225, DOI 10.1115/1.2895479; VANSOEST AJ, 1995, J BIOMECH, V28, P801, DOI 10.1016/0021-9290(94)00131-M; Zajac FE, 1989, CRC CRITICAL REV BIO, V17, P359	22	37	37	ELSEVIER SCI LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND	0021-9290	1873-2380		J BIOMECH	J. Biomech.	OCT	2000	33	10					1249	1255		10.1016/S0021-9290(00)00095-6		7	Biophysics; Engineering, Biomedical	Biophysics; Engineering	353ZE	WOS:000089304700009		
J	Nagano, A; Gerritsen, KGM; Fukashiro, S				Nagano, A; Gerritsen, KGM; Fukashiro, S			A sensitivity analysis of the calculation of mechanical output through inverse dynamics: a computer simulation study	JOURNAL OF BIOMECHANICS			English	Article						inverse dynamics; simulation; vertical jumping	KNEE-JOINT; SKIN MOVEMENT; ACCURACY	The purpose of this study was to systematically determine the effect of experimental errors on the work output calculated using two different methods of inverse dynamics during vertical jumping: (a) the conventional (rotational) method and (b) the translational method. A two-dimensional musculoskeletal model was used to generate precisely known kinematics. Next, the location of each joint center (JC) and the location of each segment's center of mass (CM) were manipulated by +/- 10% of segment length to simulate errors in the location of joint Centers (Delta JC) and errors in the location of segment's center of mass (Delta CM), respectively. Work output was subsequently calculated by applying the two methods of inverse dynamics to the manipulated kinematic data. The results showed that the translational method of inverse dynamics was less sensitive (up to 13% error in total work output) to Delta JC and ACM than the rotational method (up to 28% error in total work output). The rotational method of inverse dynamics was particularly sensitive to simulated errors in JC. (C) 2000 Elsevier Science Ltd. All rights reserved.	Arizona State Univ, Dept Exercise Sci & Phys Educ, Biomech Lab, Tempe, AZ 85287 USA; Univ Tokyo, Dept Life Sci Sport Sci, Meguro Ku, Tokyo 1538902, Japan	Nagano, A (reprint author), Arizona State Univ, Dept Exercise Sci & Phys Educ, Biomech Lab, POB 870404, Tempe, AZ 85287 USA.	akinori.nagano@asu.edu					ACKLAND TR, 1988, J BIOMECH, V21, P319, DOI 10.1016/0021-9290(88)90261-8; YAMAGUCHI GT, 1989, J BIOMECH, V22, P1, DOI 10.1016/0021-9290(89)90179-6; Challis JH, 1996, J SPORT SCI, V14, P219, DOI 10.1080/02640419608727706; Lucchetti L, 1998, J BIOMECH, V31, P977, DOI 10.1016/S0021-9290(98)00083-9; [Anonymous], 1955, 55159 WADC TR; RUGG SG, 1990, J BIOMECH, V23, P495, DOI 10.1016/0021-9290(90)90305-M; Reinschmidt C, 1997, J BIOMECH, V30, P729, DOI 10.1016/S0021-9290(97)00001-8; BELL AL, 1990, J BIOMECH, V23, P617, DOI 10.1016/0021-9290(90)90054-7; Bogert A, 1994, J BIOMECH, V27, P1477; BREMERMANN H, 1970, Mathematical Biosciences, V9, P1, DOI 10.1016/0025-5564(70)90087-8; Bresler B, 1950, T AM SOC MECH ENG, V72, P27; Chandler R.F., 1975, 74137 AMRL TR WRIGHT; Clauser C.E., 1969, 6970 AMRL TR WRIGHT; Gerritsen K G, 1998, Motor Control, V2, P206; HINRICHS RN, 1990, J BIOMECH, V23, P949, DOI 10.1016/0021-9290(90)90361-6; MUNGIOLE M, 1990, J BIOMECH, V23, P1039, DOI 10.1016/0021-9290(90)90319-X; Nagano A, 1998, J BIOMECH, V31, P951, DOI 10.1016/S0021-9290(98)00094-3; NEPTUNE RR, 1995, J BIOMECH, V28, P423, DOI 10.1016/0021-9290(94)00080-N	18	10	10	ELSEVIER SCI LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND	0021-9290			J BIOMECH	J. Biomech.	OCT	2000	33	10					1313	1318		10.1016/S0021-9290(00)00086-5		6	Biophysics; Engineering, Biomedical	Biophysics; Engineering	353ZE	WOS:000089304700017		
J	Sakai, T; Morita, S; Shinomiya, K; Watanabe, A; Nakabayashi, N; Ishihara, K				Sakai, T; Morita, S; Shinomiya, K; Watanabe, A; Nakabayashi, N; Ishihara, K			Prevention of fibrous layer formation between bone and adhesive bone cement: In vivo evaluation of bone impregnation with 4-META/MMA-TBB cement	JOURNAL OF BIOMEDICAL MATERIALS RESEARCH			English	Article						adhesive bone cement; 4-META; TEM; hybrid layer; impregnation		We have studied a new adhesive bone cement, that consists of 4-methacryloyloxyethyl trimellitate anhydride (4-META) and methylmethacrylate (MMA) as monomers, tri-n-butyl borane (TBB) as the initiator, and polymethylmethacrylate powder (4-META/MMA-TBB cement). This cement has shown remarkable adhesive properties to bone in vitro. In this study, we assessed the interface in viz,a periodically. The femora of rabbits were fenestrated and filled with either the 4-META/MMA-TBB cement or a conventional polymethylmethacrylate cement. The animals were killed after 1, 4, 12, and 24 weeks to analyze the interlace by optical microscopy and transmission electron microscopy. Optical microscopic examinations showed that the cured 4-META/MMA-TBB adhesive cement bonded to bone directly for 24 weeks, whereas a fibrous tissue layer was observed between the bone and cured conventional cement at 12 weeks after the operation. The transmission electron microscopy views of 4-META/MMA-TBB cement bonded to bone demonstrated a unique "hybridized bone" with the cement in the subsurface of the substrate in every case. The formation of the hybridized bone indicates the bonding mechanism of the adhesive cement to bone, which prevents the fibrosis intervention between bone and cement. These results suggest that the biomechanical and adhesive properties of 4-META/MMA-TBB cement make it a useful bone-bonding agent in orthopedic surgery. (C) 2000 John Wiley & Sons, Inc.	Tokyo Med & Dent Univ, Fac Med, Dept Orthoped Surg, Bunkyo Ku, Tokyo 1138549, Japan; Tokyo Med & Dent Univ, Inst Biomat & Bioengn, Chiyoda Ku, Tokyo 1010062, Japan; Univ Tokyo, Grad Sch Engn, Dept Mat Sci, Bunkyo Ku, Tokyo 1138656, Japan	Sakai, T (reprint author), Tokyo Med & Dent Univ, Fac Med, Dept Orthoped Surg, Bunkyo Ku, 1-5-45 Yushima, Tokyo 1138549, Japan.						NAKABAYASHI N, 1982, J BIOMED MATER RES, V16, P265, DOI 10.1002/jbm.820160307; SEDEL L, 1990, J BONE JOINT SURG BR, V72, P658; MARTI RK, 1990, J BONE JOINT SURG AM, V72A, P346; CHARNLEY J, 1960, J BONE JOINT SURG BR, V42, P28; AMSTUTZ HC, 1982, CLIN ORTHOP RELAT R, P21; CHARNLEY J, 1979, LONG TERM CLIN RESUL, P45; FREEMAN MAR, 1982, J BONE JOINT SURG BR, V64, P489; IIDA M, 1974, CLIN ORTHOP RELAT R, P279; ISHIHARA K, 1989, J BIOMED MATER RES, V23, P1475, DOI 10.1002/jbm.820231209; ISHIHARA K, 1992, J BIOMED MATER RES, V26, P937, DOI 10.1002/jbm.820260708; JONES LC, 1987, CLIN ORTHOP RELAT R, P192; KAVANAGH BF, 1985, J BONE JOINT SURG AM, V67A, P517; Morita S, 1997, J BIOMED MATER RES, V34, P171, DOI 10.1002/(SICI)1097-4636(199702)34:2<171::AID-JBM5>3.0.CO;2-N; Takeyama M, 1978, J JPN SOC DENT APPAR, V19, P179; WEBER BG, 1993, J JPN ORTHOP ASSOC, V67, P391	15	7	7	JOHN WILEY & SONS INC	NEW YORK	605 THIRD AVE, NEW YORK, NY 10158-0012 USA	0021-9304			J BIOMED MATER RES	J. Biomed. Mater. Res.	OCT	2000	52	1					24	29		10.1002/1097-4636(200010)52:1<24::AID-JBM4>3.0.CO;2-R		6	Engineering, Biomedical; Materials Science, Biomaterials	Engineering; Materials Science	337NV	WOS:000088369000004		
J	Sakai, T; Morita, S; Shinomiya, K; Watanabe, A; Nakabayashi, N; Ishihara, K				Sakai, T; Morita, S; Shinomiya, K; Watanabe, A; Nakabayashi, N; Ishihara, K			In vivo evaluation of the bond strength of adhesive 4-META/MMA/TBB bone cement under weight-bearing conditions	JOURNAL OF BIOMEDICAL MATERIALS RESEARCH			English	Article						bone cement; 4-META; bonding; mechanical test		In order to minimize the problems associated with implant fixation using acrylic bone cement, we studied a new adhesive bone cement that consists of 4-methacryloyloxyethyl trimellitate anhydryde (4-META) and methylmethacrylate (MMA) as monomers, tri-n-butylborane (TBB) as an initiator, and PMMA powder (4-META/MMA-TBB cement). It shows remarkable adhesive properties to metal and bone in vitro. The purpose of this study was to evaluate the strength of the bond of the cement to both metal and bone in vivo under weight-bearing conditions. Metal prostheses were implanted in the right femora of 12 rabbits using either adhesive 4-META/MMA-TBB cement or the conventional PMMA cement, as the control, for fixation. After 4 and 12 weeks, both femora were excised and the same operations were performed in the left femora in vitro. Eighteen femora were sectioned for the mechanical assessment of the bone-cement and cement-implant interfaces. 4-META/MMA-TBB cement had a significantly higher interfacial shear strength than the conventional PMMA cement: 201 N and 90 N, on average, for the implant-cement interface (p < 0.01); and 138 N and 89 N, on average, for the bone-cement interface (p < 0.01), at 12 weeks. The present results suggest the efficacy of 4-META/MMA-TBB cement in providing greater fixation of implants to bone and promise a firmer intramedullary fixation than the control conventional PMMA. cement. (C) 2000 John Wiley & Sons, Inc.	Tokyo Med & Dent Univ, Fac Med, Dept Orthoped Surg, Bunkyo Ku, Tokyo 1138549, Japan; Tokyo Med & Dent Univ, Inst Biomat & Bioengn, Tokyo, Japan; Univ Tokyo, Grad Sch Engn, Dept Mat Sci, Tokyo, Japan	Sakai, T (reprint author), Tokyo Med & Dent Univ, Fac Med, Dept Orthoped Surg, Bunkyo Ku, 1-5-45 Yushima, Tokyo 1138549, Japan.						NAKABAYASHI N, 1982, J BIOMED MATER RES, V16, P265, DOI 10.1002/jbm.820160307; JASTY M, 1991, J BONE JOINT SURG BR, V73, P551; MARTI RK, 1990, J BONE JOINT SURG AM, V72A, P346; CHARNLEY J, 1960, J BONE JOINT SURG BR, V42, P28; AMSTUTZ HC, 1982, CLIN ORTHOP RELAT R, P21; CHARNLEY J, 1979, LONG TERM CLIN RESUL, P45; FREEMAN MAR, 1982, J BONE JOINT SURG BR, V64, P489; HUISKES R, 1996, CLIN ORTHOP RELAT R, V329, P326; ISHIHARA K, 1989, J BIOMED MATER RES, V23, P1475, DOI 10.1002/jbm.820231209; ISHIHARA K, 1992, J BIOMED MATER RES, V26, P937, DOI 10.1002/jbm.820260708; JONES LC, 1987, CLIN ORTHOP RELAT R, P192; KAVANAGH BF, 1985, J BONE JOINT SURG AM, V67A, P517; Lee RR, 1997, J BIOMED MATER RES, V38, P11; Morita S, 1999, J BIOMED MATER RES, V48, P759, DOI 10.1002/(SICI)1097-4636(1999)48:5<759::AID-JBM24>3.0.CO;2-G; Morita S, 1998, BIOMATERIALS, V19, P1601, DOI 10.1016/S0142-9612(97)00120-8; Morita S, 1997, J BIOMED MATER RES, V34, P171, DOI 10.1002/(SICI)1097-4636(199702)34:2<171::AID-JBM5>3.0.CO;2-N; SAKAI T, 1998, BONE JT LIG, V11, P1135; Takeyama M, 1978, J JPN SOC DENT APPAR, V19, P179	18	10	11	JOHN WILEY & SONS INC	NEW YORK	605 THIRD AVE, NEW YORK, NY 10158-0012 USA	0021-9304			J BIOMED MATER RES	J. Biomed. Mater. Res.	OCT	2000	52	1					128	134		10.1002/1097-4636(200010)52:1<128::AID-JBM16>3.0.CO;2-L		7	Engineering, Biomedical; Materials Science, Biomaterials	Engineering; Materials Science	337NV	WOS:000088369000016		
J	Ito, Y; Kennan, RP; Watanabe, E; Koizumi, H				Ito, Y; Kennan, RP; Watanabe, E; Koizumi, H			Assessment of heating effects in skin during continuous wave near infrared spectroscopy	JOURNAL OF BIOMEDICAL OPTICS			English	Article						optical imaging; near-infrared spectroscopy; laser heating	CEREBRAL BLOOD; MEDIAN NERVE; LASER; IRRADIATION; OXYGENATION; CONDUCTION; TOPOGRAPHY; RADIATION; LIGHT; BRAIN	Near infrared spectroscopy is an increasingly important tool for the investigation of human brain function, however, to date there have been few systematic evaluations of accompanying thermal effects due to absorption. We have measured the spatial distribution of temperature changes during near infrared irradiation (789 nm) as a function of laser power, in both excised tissue (chicken meat and skin) and in the forearm of an awake human volunteer. Light was applied using a 1 mm optical fiber which is characteristic of the topographic system. The temperature of excised chicken tissue increased linearly with power level as 0.097 and 0.042 degreesC/mW at depths of 0 and 1 mm, respectively. Human forearm studies yielded temperature changes of 0.101, 0.038, and 0.030 degreesC/mW at depths of 0.5, 1.0, and 1.5 mm, respectively. Due to direct irradiation of the thermocouple all measurements represent the maximum temperature increase from the laser. In all cases the estimated heating effects from continuous wave optical topography systems were small and well below levels which would endanger tissue cells. The close similarity between ex vivo and in vivo measurements suggests negligible contributions from blood flow in the skin which was further supported by measurements during cuff ischemia. Heating effects decreased sharply with both depth and lateral position; thus, for optode spacings greater than a few millimeters, fibers can be treated independently. Finite element analysis confirms that the experimental results are consistent with a simple heat conduction model. (C) 2000 Society of Photo-Optical Instrumentation Engineers. [S1083-3668(00)00104-0].	Univ Tokyo, Grad Sch Arts & Sci, Meguro Ku, Tokyo, Japan; Hitachi Cent Res Lab, Kokubunji, Tokyo 8158601, Japan; Yale Univ, Sch Med, Dept Diagnost Radiol, New Haven, CT 06511 USA; Tokyo Metropolitan Police Hosp, Dept Neurosurg, Chiyoda Ku, Tokyo 1028161, Japan; Hitachi Adv Res Lab, Hatoyama, Saitama 3500395, Japan	Koizumi, H (reprint author), Univ Tokyo, Grad Sch Arts & Sci, Meguro Ku, Tokyo, Japan.						KATO T, 1993, J CEREBR BLOOD F MET, V13, P516; HOSHI Y, 1993, NEUROSCI LETT, V150, P5, DOI 10.1016/0304-3940(93)90094-2; CHANCE B, 1993, P NATL ACAD SCI USA, V90, P3770, DOI 10.1073/pnas.90.8.3770; COPE M, 1988, MED BIOL ENG COMPUT, V26, P289, DOI 10.1007/BF02447083; DEWEY WC, 1977, RADIOLOGY, V123, P463; Millikan GA, 1942, REV SCI INSTRUM, V13, P434, DOI 10.1063/1.1769941; Watanabe E, 1998, NEUROSCI LETT, V256, P49, DOI 10.1016/S0304-3940(98)00754-X; JOBSIS FF, 1977, SCIENCE, V198, P1264, DOI 10.1126/science.929199; VILLRINGER A, 1993, NEUROSCI LETT, V154, P101, DOI 10.1016/0304-3940(93)90181-J; BASFORD JR, 1990, LASER SURG MED, V10, P25; BASFORD JR, 1993, LASER SURG MED, V13, P597, DOI 10.1002/lsm.1900130602; BIRNGRUBER R, 1984, T OPHTHAL SOC UK, V103, P422; Danno K, 1996, PHOTODERMATOL PHOTO, V12, P233; DEWEY WC, 1977, P 2 INT S ESS GERM J; Dusinberre G. M., 1961, HEAT TRANSFER CALCUL; FINSEN N, 1899, BEDEUTUNG CHEM STRAH; GREATHOUSE DG, 1985, PHYS THER, V65, P1184; Hahn GM, 1982, HYPERTHERMIA CANC; Hebden JC, 1997, BRIT J RADIOL, V70, pS206; Hobbie R. K., 1997, INTERMEDIATE PHYSICS; HUTTMANN G, 1998, P OPT SOC AM TRENDS, P300; KERFKENS G, 1989, PHYS MED BIOL, V34, P599; Lewis T., 1927, BLOOD VESSELS HUMAN; LIDE DR, 1999, CRC HDB CHEM PHYSICS; LOWE AS, 1994, LASER SURG MED, V14, P40, DOI 10.1002/lsm.1900140111; Maki A, 1995, MED PHYS, V22, P1997, DOI 10.1118/1.597496; Maki Atsushi, 1996, Frontiers of Medical and Biological Engineering, V7, P285; Millikan GA, 1933, J PHYSIOL-LONDON, V79, P152; PINCUS GREGORY, 1931, JOUR EXP MED, V54, P323, DOI 10.1084/jem.54.3.323; SHERMAN JH, 1994, HUMAN PHYSL MECH BOD; Sliney D.H., 1980, SAFETY LASERS OTHER; Watanabe E, 1998, J EPILEPSY, V11, P335, DOI 10.1016/S0896-6974(98)00037-1; 1993, PHYS MED BIOL, V43, P2465	33	35	36	SPIE-INT SOCIETY OPTICAL ENGINEERING	BELLINGHAM	1000 20TH ST, PO BOX 10, BELLINGHAM, WA 98225 USA	1083-3668			J BIOMED OPT	J. Biomed. Opt.	OCT	2000	5	4					383	390		10.1117/1.1287730		8	Biochemical Research Methods; Optics; Radiology, Nuclear Medicine & Medical Imaging	Biochemistry & Molecular Biology; Optics; Radiology, Nuclear Medicine & Medical Imaging	365ZR	WOS:000089980800005		
J	Maeda, Y; Ikeda, U; Shimpo, M; Shibuya, M; Monahan, J; Urabe, M; Ozawa, K; Shimada, K				Maeda, Y; Ikeda, U; Shimpo, M; Shibuya, M; Monahan, J; Urabe, M; Ozawa, K; Shimada, K			Adeno-associated virus-mediated vascular endothelial growth factor gene transfer into cardiac myocytes	JOURNAL OF CARDIOVASCULAR PHARMACOLOGY			English	Article						gene transfer; cardiac myocyte; angiogenesis; endothelial cell	RECOMBINANT ADENOASSOCIATED VIRUS; IN-VIVO; MYOCARDIAL ANGIOGENESIS; NONDIVIDING CELLS; RAT CARDIOCYTES; TYROSINE KINASE; AAV VECTORS; PHASE-I; EXPRESSION; EFFICIENT	Vascular endothelial growth factor (VEGF) is an angiogenic growth factor that stimulates endothelial cell proliferation, increases endothelial permeability, and promotes collateral vessel formation. We transferred human VEGF gene into rat cardiac myocytes using adeno-associated virus (AAV) vectors and investigated whether VEGF secreted from the transduced cardiac myocytes promoted proliferation of endothelial cells. We produced VEGF-expressing AAV vectors (AAV-VEGF) by the adenovirus-free method. Immunoblotting revealed VEGF protein expression in AAV-VEGF-transduced rat cardiac myocytes. More than 60% of cardiac myocytes were stained positively on immunohistochemical staining using anti-VEGF antibody, Concentration of VEGF in the culture medium of AAV-VEGF-transduced myocytes was increased in a vector dose-dependent manner, and VEGF secretion from the transduced myocytes persisted for greater than or equal to 14 days. Thymidine incorporation into human vascular endothelial cells was significantly increased by incubation with the conditioned medium from AAV-VEGF-transduced myocytes. This increased thymidine uptake was significantly inhibited by anti-VEGF antibody. We demonstrated here that AAV-mediated VEGF gene transfer into cardiac myocytes induces the secretion of functional VEGF.	Jichi Med Sch, Ctr Mol Med, Dept Cardiol, Minamikawachi, Tochigi 3290498, Japan; Jichi Med Sch, Ctr Mol Med, Div Genet Therapeut, Minamikawachi, Tochigi 3290498, Japan; Univ Tokyo, Inst Med Sci, Dept Genet, Tokyo, Japan; Avigen Inc, Alameda, CA USA	Ikeda, U (reprint author), Jichi Med Sch, Ctr Mol Med, Dept Cardiol, Minamikawachi, Tochigi 3290498, Japan.						Fisher KJ, 1997, NAT MED, V3, P306, DOI 10.1038/nm0397-306; Matsushita T, 1998, GENE THER, V5, P938, DOI 10.1038/sj.gt.3300680; Asahara T, 1996, CIRCULATION, V94, P3291; Losordo DW, 1998, CIRCULATION, V98, P2800; Neufeld G, 1999, FASEB J, V13, P9; SCHULICK AH, 1995, CIRCULATION, V91, P2407; KAPLITT MG, 1994, NAT GENET, V8, P148, DOI 10.1038/ng1094-148; Schwarz ER, 2000, J AM COLL CARDIOL, V35, P1323, DOI 10.1016/S0735-1097(00)00522-2; Rosengart TK, 1999, CIRCULATION, V100, P468; Springer ML, 1998, MOL CELL, V2, P549, DOI 10.1016/S1097-2765(00)80154-9; SHIBUYA M, 1990, ONCOGENE, V5, P519; Tsurumi Y, 1996, CIRCULATION, V94, P3281; Kessler PD, 1996, P NATL ACAD SCI USA, V93, P14082, DOI 10.1073/pnas.93.24.14082; Dutheil N, 2000, P NATL ACAD SCI USA, V97, P4862, DOI 10.1073/pnas.080079397; Fan DS, 1998, NEUROSCI LETT, V248, P61, DOI 10.1016/S0304-3940(98)00313-9; Fan DS, 1998, HUM GENE THER, V9, P2527; FERRARA N, 1992, ENDOCR REV, V13, P18, DOI 10.1210/er.13.1.18; Flotte T, 1996, HUM GENE THER, V7, P1145, DOI 10.1089/hum.1996.7.9-1145; FLOTTE TR, 1994, AM J RESP CELL MOL, V11, P517; FLOTTE TR, 1993, P NATL ACAD SCI USA, V90, P10613, DOI 10.1073/pnas.90.22.10613; Funayama H, 1998, CARDIOVASC RES, V37, P216, DOI 10.1016/S0008-6363(97)00224-1; GUZMAN RJ, 1993, CIRC RES, V73, P1202; KAMITANI T, 1992, CIRC RES, V71, P1457; Lazarous DF, 1999, CARDIOVASC RES, V44, P294, DOI 10.1016/S0008-6363(99)00203-5; Lee LY, 2000, ANN THORAC SURG, V69, P14, DOI 10.1016/S0003-4975(99)01102-9; LEUNG DW, 1989, SCIENCE, V246, P1306, DOI 10.1126/science.2479986; Maeda Y, 1997, CARDIOVASC RES, V35, P514, DOI 10.1016/S0008-6363(97)00163-6; Maeda Y, 1998, J MOL CELL CARDIOL, V30, P1341, DOI 10.1006/jmcc.1998.0697; Magovern CJ, 1996, ANN THORAC SURG, V62, P425, DOI 10.1016/0003-4975(96)00268-8; MUHLHAUSER J, 1995, CIRC RES, V77, P1077; Mack CA, 1998, J THORAC CARDIOV SUR, V115, P168, DOI 10.1016/S0022-5223(98)70455-6; PODSAKOFF G, 1994, J VIROL, V68, P5656; Sawano A, 1996, CELL GROWTH DIFFER, V7, P213; Svensson EC, 1999, CIRCULATION, V99, P201; YAMAMOTO K, 1993, J CLIN INVEST, V92, P1889, DOI 10.1172/JCI116781	35	11	11	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	530 WALNUT ST, PHILADELPHIA, PA 19106-3621 USA	0160-2446			J CARDIOVASC PHARM	J. Cardiovasc. Pharmacol.	OCT	2000	36	4					438	443		10.1097/00005344-200010000-00004		6	Cardiac & Cardiovascular Systems; Pharmacology & Pharmacy	Cardiovascular System & Cardiology; Pharmacology & Pharmacy	357ZF	WOS:000089532200004		
J	Chen, H; Ikeda, U; Shimpo, M; Maeda, Y; Shibuya, T; Ozawa, K; Shimada, K				Chen, H; Ikeda, U; Shimpo, M; Maeda, Y; Shibuya, T; Ozawa, K; Shimada, K			Inhibition of vascular endothelial growth factor activity by transfection with the soluble FLT-1 gene	JOURNAL OF CARDIOVASCULAR PHARMACOLOGY			English	Article						angiogenesis; endothelial cell; gene transfer; soluble receptor	PERMEABILITY FACTOR; IN-VIVO; FACTOR RECEPTOR; FACTOR VEGF; FACTOR EXPRESSION; TUMOR-CELLS; ANGIOGENESIS; NEOVASCULARIZATION; SUPPRESSION; PHVEGF(165)	Vascular endothelial growth factor (VEGF)-induced angiogenesis is involved in the etiology of some cardiovascular diseases. The soluble form of VEGF receptor, FLT-1 (sFLT-1), is a potent antagonist of VEGF. Therefore, we investigated whether transfection with the sFLT-1 gene could inhibit VEGF-induced angiogenesis. Human embryonic kidney (HEK)-293 cells were transfected with plasmids containing VEGF and sFLT-1 (pCMV-VEGF and pCMV-sFLT-1) by the calcium-phosphate co-precipitation method. VEGF- and/or sFLT-1-transfected HEK-293 cells were incubated for 24 h, and then conditioned medium was collected. The effects of conditioned medium on angiogenesis were tested by incorporation of [H-3]thymidine into human umbilical vein endothelial cells (HUVECs). Expression of VEGF protein was determined by Western blotting. The conditioned medium From sFLT-1 gene-transfected HEK-293 cells significantly inhibited recombinant VEGF-induced increase in [H-3]thymidine incorporation by HUVECs. VEGF gene-transfected HEK-293 cells secreted VEGF protein into conditioned medium. This conditioned medium increased [H-3]thymidine incorporation by HUVECs, which was significantly inhibited by ce-transfection of sFLT-1 gene with VEGF gene. These observations suggested that sFLT-1 gene transfer could inhibit VEGF-induced DNA synthesis of vascular endothelial cells.	Jichi Med Sch, Dept Cardiol, Minamikawachi, Tochigi 3290498, Japan; Jichi Med Sch, Dept Hematol, Minamikawachi, Tochigi 3290498, Japan; Univ Tokyo, Inst Med Sci, Dept Genet, Tokyo, Japan	Ikeda, U (reprint author), Jichi Med Sch, Dept Cardiol, Minamikawachi, Tochigi 3290498, Japan.						KIESER A, 1994, ONCOGENE, V9, P963; Hojo Y, 2000, J AM COLL CARDIOL, V35, P968, DOI 10.1016/S0735-1097(99)00632-4; Soker S, 1998, CELL, V92, P735, DOI 10.1016/S0092-8674(00)81402-6; Losordo DW, 1998, CIRCULATION, V98, P2800; Chen YX, 1999, ARTERIOSCL THROM VAS, V19, P131; KECK PJ, 1989, SCIENCE, V246, P1309, DOI 10.1126/science.2479987; Kendall RL, 1996, BIOCHEM BIOPH RES CO, V226, P324, DOI 10.1006/bbrc.1996.1355; Neufeld G, 1999, FASEB J, V13, P9; Barleon B, 1997, CANCER RES, V57, P5421; Wang H, 1998, CIRC RES, V83, P832; Millauer B, 1996, CANCER RES, V56, P1615; Baumgartner I, 1998, CIRCULATION, V97, P1114; KENDALL RL, 1993, P NATL ACAD SCI USA, V90, P10705, DOI 10.1073/pnas.90.22.10705; BROCK TA, 1991, AM J PATHOL, V138, P213; AIELLO LP, 1995, P NATL ACAD SCI USA, V92, P10457, DOI 10.1073/pnas.92.23.10457; Goldman CK, 1998, P NATL ACAD SCI USA, V95, P8795, DOI 10.1073/pnas.95.15.8795; Ramakrishnan S, 1996, CANCER RES, V56, P1324; Lazarous DF, 1996, CIRCULATION, V94, P1074; Senger DR, 1997, P NATL ACAD SCI USA, V94, P13612, DOI 10.1073/pnas.94.25.13612; Clauss M, 1996, J BIOL CHEM, V271, P17629; BROOKS PC, 1994, SCIENCE, V264, P569, DOI 10.1126/science.7512751; Cunningham SA, 1997, BIOCHEM BIOPH RES CO, V231, P596, DOI 10.1006/bbrc.1997.6156; de Boer OJ, 1999, CARDIOVASC RES, V41, P443, DOI 10.1016/S0008-6363(98)00255-7; Hagedorn M, 2000, CRIT REV ONCOL HEMAT, V34, P89, DOI 10.1016/S1040-8428(00)00056-1; HARADA S, 1994, J CLIN INVEST, V93, P2490, DOI 10.1172/JCI117258; HU DE, 1995, BRIT J PHARMACOL, V114, P262; JELLINEK D, 1994, BIOCHEMISTRY-US, V33, P10450, DOI 10.1021/bi00200a028; LEUNG DW, 1989, SCIENCE, V246, P1306, DOI 10.1126/science.2479986; Maeda Y, 2000, J PHARMACOL EXP THER, V292, P387; Nguyen JT, 1998, CANCER RES, V58, P5673; PEPPER MS, 1991, BIOCHEM BIOPH RES CO, V181, P902, DOI 10.1016/0006-291X(91)91276-I; Roeckl W, 1998, EXP CELL RES, V241, P161, DOI 10.1006/excr.1998.4039; Ryan AM, 1999, TOXICOL PATHOL, V27, P78, DOI 10.1177/019262339902700115; SENGER DR, 1983, SCIENCE, V219, P983, DOI 10.1126/science.6823562; TAKAHASHI M, 1995, ARTERIOSCL THROM VAS, V15, P629; Yonemitsu Y, 1996, LAB INVEST, V75, P313	36	17	18	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	530 WALNUT ST, PHILADELPHIA, PA 19106-3621 USA	0160-2446			J CARDIOVASC PHARM	J. Cardiovasc. Pharmacol.	OCT	2000	36	4					498	502		10.1097/00005344-200010000-00013		5	Cardiac & Cardiovascular Systems; Pharmacology & Pharmacy	Cardiovascular System & Cardiology; Pharmacology & Pharmacy	357ZF	WOS:000089532200013		
J	Yuan, YZ; Liu, HC; Imoto, H; Shido, T; Iwasawa, Y				Yuan, YZ; Liu, HC; Imoto, H; Shido, T; Iwasawa, Y			Performance and characterization of a new crystalline SbRe2O6 catalyst for selective oxidation of methanol to methylal	JOURNAL OF CATALYSIS			English	Article						Sb-Re-O mixed oxide catalysts; SbRe2O6; selective catalytic oxidation of methanol; methylal synthesis; XRD; XPS; Raman; SEM; TPD; TPR	12-MOLYBDOPHOSPHORIC ACID CATALYSTS; OXIDE CATALYSTS; MOLYBDENUM TRIOXIDE; METAL-OXIDES; SILICA; FORMALDEHYDE; ADSORPTION; MECHANISMS; BEHAVIOR; FORMATE	Three well-defined compounds, SbRe2O6, Sb4Re2O13, and SbOReO4 . 2H(2)O, and several supported Re catalysts were employed as catalysts for the selective oxidation of methanol to methylal (3CH(3)OH + 1/2O(2) --> CH2(OCH3)(2) + 2H(2)O). High selectivity of 92.5% to methylal was obtained on the new crystalline catalyst SbRe2O6 at 573 K, while no methylal formation or negligible activity was observed with the other catalysts. No structural change in the bulk and surface of the SbRe2O6 catalyst occurred after the methanol oxidation below 600 K as characterized by XRD, Raman, XPS, and SEM. The reaction rate increased with increasing methanol partial pressure, while the selectivity to methylal was independent of methanol partial pressure as well as O-2 partial pressure (<10 mol%). There existed two types of active lattice oxygen species in TPD experiments on SbRe2O6, both being responsible for the methylal formation. The high performance of SbRe2O6 for the selective synthesis of methylal from methanol may be ascribed to the Re-oxide species stabilized by the specific connection with Sb oxides at the crystal surface. (C) 2000 Academic Press.	Univ Tokyo, Grad Sch Sci, Dept Chem, Bunkyo Ku, Tokyo 1130033, Japan	Iwasawa, Y (reprint author), Xiamen Univ, Dept Chem, State Key Lab Phys Chem Solid Surface, Xiamen 361005, Peoples R China.		Yuan, YZ/G-4649-2010				AI M, 1982, J CATAL, V77, P279, DOI 10.1016/0021-9517(82)90168-3; Albonetti S, 1996, CATAL REV, V38, P413, DOI 10.1080/01614949608006463; PECORARO TA, 1981, J CATAL, V67, P430, DOI 10.1016/0021-9517(81)90303-1; Busca G, 1996, CATAL TODAY, V27, P457, DOI 10.1016/0920-5861(95)00162-X; OTSUKA K, 1986, APPL CATAL, V26, P401, DOI 10.1016/S0166-9834(00)82568-3; SHPIRO ES, 1978, J CATAL, V55, P402, DOI 10.1016/0021-9517(78)90227-0; TATIBOUET JM, 1983, J CATAL, V82, P240, DOI 10.1016/0021-9517(83)90136-7; CHAUVIN C, 1990, J CATAL, V121, P56, DOI 10.1016/0021-9517(90)90216-7; KIM DS, 1993, J CATAL, V141, P419, DOI 10.1006/jcat.1993.1151; TATIBOUET JM, 1981, J CATAL, V72, P375, DOI 10.1016/0021-9517(81)90022-1; Arora N, 1996, J CATAL, V159, P1, DOI 10.1006/jcat.1996.0058; BERRY FJ, 1981, ADV CATAL, V30, P97, DOI 10.1016/S0360-0564(08)60326-0; BLOM RH, 1962, IND ENG CHEM, V54, P17; Busca G. A., 1987, J PHYS CHEM-US, V91, P5236; Butz A, 1998, J SOLID STATE CHEM, V138, P232, DOI 10.1006/jssc.1998.7806; Castillo R, 1997, APPL CATAL A-GEN, V153, pL1, DOI 10.1016/S0926-860X(96)00356-0; CHUNG JS, 1988, J CATAL, V114, P354; CIMINO A, 1980, Z ANORG ALLG CHEM, V460, P86, DOI 10.1002/zaac.19804600109; DAVENPOR.WH, 1968, IND ENG CHEM, V60, P10, DOI 10.1021/ie50707a004; FOURNIER M, 1994, J CHEM SOC CHEM COMM, P307, DOI 10.1039/c39940000307; Gaigneaux EM, 2000, TOP CATAL, V11, P185, DOI 10.1023/A:1027283427485; GENTI G, 1986, CATAL REV SCI ENG, V28, P165; GRASSELLI RK, 1972, J CATAL, V25, P272; HARRISON WTA, 1993, CHEM MATER, V5, P1631, DOI 10.1021/cm00035a008; Inoue T, 1997, J CATAL, V171, P457, DOI 10.1006/jcat.1997.1826; Inoue T, 1997, J CATAL, V171, P184, DOI 10.1006/jcat.1997.1795; Inoue T, 2000, APPL CATAL A-GEN, V191, P131, DOI 10.1016/S0926-860X(99)00314-2; Jehng JM, 1996, CATAL TODAY, V28, P335, DOI 10.1016/S0920-5861(96)00047-8; Liu HC, 2000, J PHYS CHEM B, V104, P2033, DOI 10.1021/jp993132r; LIU YC, 1985, J CATAL, V94, P108, DOI 10.1016/0021-9517(85)90086-7; Mol J. C., 1975, ADV CATAL, V24, P131, DOI 10.1016/S0360-0564(08)60481-2; MOULIJN JA, 1988, J MOL CATAL, V46, P1, DOI 10.1016/0304-5102(88)85080-6; NILSSON R, 1994, J CATAL, V148, P501, DOI 10.1006/jcat.1994.1236; OLSTHOORN AA, 1976, J CATAL, V44, P207, DOI 10.1016/0021-9517(76)90391-2; RocchiccioliDeltcheff C, 1996, J MOL CATAL A-CHEM, V114, P331, DOI 10.1016/S1381-1169(96)00336-6; Shannon IJ, 1998, J CHEM SOC FARADAY T, V94, P1495, DOI 10.1039/a800054i; SLEIGHT AW, 1975, INORG CHEM, V14, P597, DOI 10.1021/ic50145a032; SMITH ARR, 1979, J SOLID STATE CHEM, V30, P345; Tatibouet JM, 1997, APPL CATAL A-GEN, V148, P213, DOI 10.1016/S0926-860X(96)00236-0; TATIBOUET JM, 1980, B SOC CHIM FR, V9, P343; THOMAS R, 1982, J CATAL, V76, P241, DOI 10.1016/0021-9517(82)90255-X; Wang CB, 1999, LANGMUIR, V15, P1223, DOI 10.1021/la9807210; Watanabe H, 1998, J SOLID STATE CHEM, V138, P245, DOI 10.1006/jssc.1998.7776; Watanabe H, 1997, INORG CHEM, V36, P4610, DOI 10.1021/ic970395w; WINTER ERS, 1968, J CHEM SOC A, P2889, DOI 10.1039/j19680002889; YANG TJ, 1987, J CATAL, V103, P55, DOI 10.1016/0021-9517(87)90092-3; Yuan YZ, 2000, CHEM LETT, P674, DOI 10.1246/cl.2000.674	47	48	60	ACADEMIC PRESS INC	SAN DIEGO	525 B ST, STE 1900, SAN DIEGO, CA 92101-4495 USA	0021-9517			J CATAL	J. Catal.	OCT 1	2000	195	1					51	61		10.1006/jcat.2000.2990		11	Chemistry, Physical; Engineering, Chemical	Chemistry; Engineering	363KP	WOS:000089835100007		
J	Hayashi, K; Hayashi, H; Oshika, T; Hayashi, F				Hayashi, K; Hayashi, H; Oshika, T; Hayashi, F			Fourier analysis of irregular astigmatism after implantation of 3 types of intraocular lenses	JOURNAL OF CATARACT AND REFRACTIVE SURGERY			English	Article							INCISION CATARACT-SURGERY; SCLERAL TUNNEL INCISION; CORNEAL TOPOGRAPHY DATA; VIDEOKERATOGRAPHY DATA; SIZE	Purpose: To evaluate irregular astigmatism after silicone, acrylic, and poly(methyl methacrylate) (PMMA) intraocular lens (IOL) implantation using Fourier analysis of videokeratography data. Methods: Two hundred forty eyes having phacoemulsification and IOL implantation were randomly assigned to 1 of 3 groups: 3.5 mm incision and silicone IOL, 4.1 mm incision and acrylic IOL, or 6.5 mm incision and PMMA IOL. All eyes had videokeratographic examinations preoperatively and 2, 4, and 10 days and 1 and 3 months postoperatively. The dioptric data of the central cornea were decomposed into spherical equivalent, regular astigmatism, and irregular astigmatism (decentration and higher-order irregularity) components using Fourier analysis. Results: Regular astigmatism in the PMMA group was greater than in the silicone and acrylic groups. Decentration in all 3 groups increased significantly postoperatively but virtually returned to preoperative levels by 10 days. No significant difference was observed among the 3 groups. Higher-order irregularity significantly increased after surgery in all 3 groups. The higher-order irregularity in the PMMA group persisted for up to 1 month, while that in the silicone and acrylic groups returned to preoperative levels by 4 days, resulting in significant differences between these groups 10 days and 1 month after IOL implantation. Conclusion: Irregular astigmatism, both the decentration and higher-order irregularity components, increased significantly after 3 types of scleral tunnel incisions for silicone, acrylic, or PMMA IOL implantation but returned to preoperative levels soon after surgery except for the higher order irregularity after PMMA IOL implantation. J Cataract Refract Surg 2000; 26:1510-1516 (C) 2000 ASCRS and ESCRS.	Hayashi Eye Hosp, Hakata Ku, Fukuoka 812, Japan; Fukuoka Univ, Sch Med, Dept Ophthalmol, Fukuoka 81401, Japan; Univ Tokyo, Sch Med, Dept Ophthalmol, Tokyo 113, Japan	Hayashi, K (reprint author), Hayashi Eye Hosp, Hakata Ku, 4-7-13 Hakataekimae, Fukuoka 812, Japan.			HAYASHI, KEN/0000-0002-7297-1477			Tomidokoro A, 1999, CORNEA, V18, P412, DOI 10.1097/00003226-199907000-00004; Pfleger T, 1996, J CATARACT REFR SURG, V22, P72; HAYASHI K, 1995, OPHTHALMOLOGY, V102, P550; Keller PR, 1998, J CATARACT REFR SURG, V24, P1447; KOHNEN T, 1995, J CATARACT REFR SURG, V21, P417; Olson RJ, 1998, AM J OPHTHALMOL, V125, P612, DOI 10.1016/S0002-9394(98)00017-8; HJORTDAL JO, 1995, OPHTHAL PHYSL OPT, V15, P171, DOI 10.1016/0275-5408(95)90569-N; Olsen T, 1997, J CATARACT REFR SURG, V23, P337; AXT JC, 1993, J CATARACT REFR SURG, V19, P380; CRAVY TV, 1991, J CATARACT REFR SURG, V17, P415; ELMAGHRABY A, 1993, J CATARACT REFR SURG, V19, P494; Ernest P. H., 1990, SMALL INCISION CATAR, P103; ERNEST PH, 1992, SUTURELESS CATARACT, P51; MARTIN RG, 1993, J CATARACT REFR SURG, V19, P170; Olsen T, 1996, J CATARACT REFR SURG, V22, P318; Oshika T, 1998, INVEST OPHTH VIS SCI, V39, P705; RAASCH TW, 1995, OPTOMETRY VISION SCI, V72, P809, DOI 10.1097/00006324-199511000-00006; SHEPHERD JR, 1989, J CATARACT REFR SURG, V15, P85; STEINERT RF, 1991, OPHTHALMOLOGY, V98, P417; STEINERT RF, OPHTHALMOLOGY, V104, P1370; Tomidokoro A, 1998, CORNEA, V17, P517, DOI 10.1097/00003226-199809000-00009; WILSON SE, 1991, ARCH OPHTHALMOL-CHIC, V109, P349; Wirbelauer C, 1997, J CATARACT REFR SURG, V23, P365	23	14	15	AMER SOC CATARACT REFRACTIVE SURGERY	FAIRFAX	4000 LEGATO RD, SUITE 850, FAIRFAX, VA 22030 USA	0886-3350			J CATARACT REFR SURG	J. Cataract. Refract. Surg.	OCT	2000	26	10					1510	1516		10.1016/S0886-3350(00)00435-1		7	Ophthalmology; Surgery	Ophthalmology; Surgery	364VJ	WOS:000089913500021		
J	Behera, SK; Salvekar, PS; Yamagata, T				Behera, SK; Salvekar, PS; Yamagata, T			Simulation of interannual SST variability in the tropical Indian Ocean	JOURNAL OF CLIMATE			English	Article							INDONESIAN THROUGHFLOW; THERMODYNAMICS; DYNAMICS; PACIFIC; SEA	A 2.5-layer thermodynamic ocean model is used to investigate interannual variability in sea surface temperature (SST) of the tropical Indian Ocean. Simulated SST agrees well with the data. Model and observed SSTs exhibit large seasonal and interannual variability in the western and southeastern tropical Indian Ocean. Three processes, namely, latent heat flux, radiative Aux, and entrainment, play major roles in the evolution of model SST anomalies. Interannual heat flux is found to have greater influence on the SST anomalies in most parts of the model domain. On the other hand, influence of interannual wind is only pronounced near the coasts in the Arabian Sea during the Asian summer monsoon season and a region in the central part of the southern tropical Indian Ocean (STIO) during boreal winter Besides the El Nino-Southern Oscillation related basinwide warming, empirical orthogonal function analysis shows a dipole structure in both model and observed SST anomalies in the STIO. The eastern pole is anomalously cold with a peak occurring 4-8 months prior to the negative peak of the Southern Oscillation. A similar dipole structure in the latent heat flux anomalies explains the dipole in the SST anomalies.	Frontier Res Syst Global Change, IGCR, Minato Ku, Tokyo 1056791, Japan; Indian Inst Trop Meteorol, Pune, Maharashtra, India; Univ Tokyo, Grad Sch Sci, Dept Earth & Planetary Sci, Tokyo 113, Japan	Behera, SK (reprint author), Frontier Res Syst Global Change, IGCR, Minato Ku, Seavans N 7F,1-2-1 Shibaura, Tokyo 1056791, Japan.	skb@frontier.esto.or.jp	Yamagata, Toshio/A-1807-2009; Behera, Swadhin/B-7839-2009	Behera, Swadhin/0000-0001-8692-2388			Behera SK, 1999, GEOPHYS RES LETT, V26, P3001, DOI 10.1029/1999GL010434; Nicholls N, 1989, J CLIMATE, V2, P965, DOI 10.1175/1520-0442(1989)002<0965:SSTAAW>2.0.CO;2; Kalnay E, 1996, B AM METEOROL SOC, V77, P437, DOI 10.1175/1520-0477(1996)077<0437:TNYRP>2.0.CO;2; Murtugudde R, 1999, J CLIMATE, V12, P2300, DOI 10.1175/1520-0442(1999)012<2300:IVOTDA>2.0.CO;2; Saji NH, 1999, NATURE, V401, P360, DOI 10.1038/43855; Wallace JM, 1998, J GEOPHYS RES-OCEANS, V103, P14241, DOI 10.1029/97JC02905; MCCREARY JP, 1993, PROG OCEANOGR, V31, P181, DOI 10.1016/0079-6611(93)90002-U; REYNOLDS RW, 1994, J CLIMATE, V7, P929, DOI 10.1175/1520-0442(1994)007<0929:IGSSTA>2.0.CO;2; BEHERA SK, 1998, WOCE NEWS LETT, V33, P7; Godfrey JS, 1996, J GEOPHYS RES-OCEANS, V101, P12217, DOI 10.1029/95JC03860; HASTENRATH S, 1979, CLIMATE ATLAS INDIAN; HASTENRATH S, 1993, J GEOPHYS RES-OCEANS, V98, P6869, DOI 10.1029/92JC02956; KRAUS EB, 1967, TELLUS, V19, P98; LATIF M, 1998, 276 MAX PLANCK I MET; Meyers G, 1996, J GEOPHYS RES-OCEANS, V101, P12255, DOI 10.1029/95JC03729; Murtugudde R, 1998, J GEOPHYS RES-OCEANS, V103, P21425, DOI 10.1029/98JC02063; VENZKE S, 1997, 246 ENSO MAX PLANCK; Vinayachandran PN, 1998, J PHYS OCEANOGR, V28, P1946, DOI 10.1175/1520-0485(1998)028<1946:MROTSA>2.0.CO;2; Vinayachandran PN, 1999, GEOPHYS RES LETT, V26, P1613, DOI 10.1029/1999GL900179; Weller RA, 1998, DEEP-SEA RES PT II, V45, P1961, DOI 10.1016/S0967-0645(98)00060-5; Yamagata T, 1996, J GEOPHYS RES-OCEANS, V101, P12465, DOI 10.1029/95JC03623	21	64	71	AMER METEOROLOGICAL SOC	BOSTON	45 BEACON ST, BOSTON, MA 02108-3693 USA	0894-8755			J CLIMATE	J. Clim.	OCT 1	2000	13	19					3487	3499		10.1175/1520-0442(2000)013<3487:SOISVI>2.0.CO;2		13	Meteorology & Atmospheric Sciences	Meteorology & Atmospheric Sciences	367RJ	WOS:000090075000009		
J	Geng, QZ; Sumi, A; Numaguti, A				Geng, QZ; Sumi, A; Numaguti, A			Role of transients in the dynamics of east Asian summer seasonal mean circulation anomalies - A study of 1993 and 1994	JOURNAL OF CLIMATE			English	Article							EL-NINO; INTERANNUAL VARIABILITY; SNOW MASS; MONSOON; PATTERNS; PACIFIC; IMPACT; PROPAGATION; SYSTEMS; DROUGHT	By using the National Centers for Environmental prediction reanalysis data and a nonlinear barotropic model, the transient activities and the possible role of transient Vorticity fluxes in the maintenance of east Asian summer seasonal mean circulation anomalies associated with Japan's extremely cool and wet. summer of 1993 and hot and dry summer of 1994 are examined. Data analysis shows that the summertime atmospheric circulation and the transient activity anomalies exhibit nearly opposite patterns over east Asia during these two years. Vorticity budget calculations indicate that the anomalies of transient activities in these two years produced strong transient vorticity flux forcing anomalies that are comparable in magnitude to the divergent forcing anomalies over east Asia. The nonlinear barotropic model, when forced by the anomalous divergence and transient vorticity Aux forcing together, produces simulations that bear resemblance to the observed summertime seasonal mean circulation anomalies of 1993 and 1994. The response to the anomalous transient vorticity flux forcing is found to be similar in magnitude with the response to the anomalous divergence. The solution deteriorates if the transient vorticity flux forcing anomaly is not included. Both the vorticity budget analysis and model simulations in the present paper show that the transient vorticity flux forcing anomaly plays an important role in maintaining the observed circulation anomalies over east Asia during the 1993 and 1994 summers.	Univ Tokyo, Ctr Climate Syst Res, Tokyo, Japan	Geng, QZ (reprint author), Natl Res Inst Earth Sci & Disaster Prevent, Frontier Res Syst Global Change, 3-1 Tennodai, Tsukuba, Ibaraki 3050006, Japan.	geng@frontier.bosai.go.jp					Liu AZ, 1998, J ATMOS SCI, V55, P2810, DOI 10.1175/1520-0469(1998)055<2810:MOCADT>2.0.CO;2; WEBSTER PJ, 1992, Q J ROY METEOR SOC, V118, P877, DOI 10.1002/qj.49711850705; HOERLING MP, 1994, J CLIMATE, V7, P745, DOI 10.1175/1520-0442(1994)007<0745:OOETDE>2.0.CO;2; SARDESHMUKH PD, 1988, J ATMOS SCI, V45, P1228, DOI 10.1175/1520-0469(1988)045<1228:TGOGRF>2.0.CO;2; YASUNARI T, 1991, J METEOROL SOC JPN, V69, P473; BARNSTON AG, 1987, MON WEATHER REV, V115, P1083, DOI 10.1175/1520-0493(1987)115<1083:CSAPOL>2.0.CO;2; Zhang RH, 1996, J METEOROL SOC JPN, V74, P49; DUCHON CE, 1979, J APPL METEOROL, V18, P1016, DOI 10.1175/1520-0450(1979)018<1016:LFIOAT>2.0.CO;2; SIMMONS AJ, 1983, J ATMOS SCI, V40, P1363, DOI 10.1175/1520-0469(1983)040<1363:BWPAIA>2.0.CO;2; NITTA T, 1987, J METEOROL SOC JPN, V65, P373; Park CK, 1997, J CLIMATE, V10, P1056, DOI 10.1175/1520-0442(1997)010<1056:OTNOTE>2.0.CO;2; HELD IM, 1987, J ATMOS SCI, V44, P3576, DOI 10.1175/1520-0469(1987)044<3576:BMOTER>2.0.CO;2; GENG Q, 1997, CHIN J ATMOS SCI, V21, P81; GENG Q, 1997, ACTA METEOR SIN, V11, P1; Green J. S. A., 1977, Weather, V32; HOLTON JR, 1972, J ATMOS SCI, V29, P1124, DOI 10.1175/1520-0469(1972)029<1124:ADSOTV>2.0.CO;2; HOSKINS BJ, 1983, J ATMOS SCI, V40, P1595, DOI 10.1175/1520-0469(1983)040<1595:TSPAMF>2.0.CO;2; KANG IS, 1986, J ATMOS SCI, V43, P3045, DOI 10.1175/1520-0469(1986)043<3045:LANDMO>2.0.CO;2; KOK CJ, 1985, J ATMOS SCI, V42, P677, DOI 10.1175/1520-0469(1985)042<0677:PCOAIS>2.0.CO;2; MO KC, 1995, J ATMOS SCI, V52, P879, DOI 10.1175/1520-0469(1995)052<0879:PMOTSF>2.0.CO;2; Ose T, 1996, J METEOROL SOC JPN, V74, P845; PALMER TN, 1986, Q J ROY METEOR SOC, V112, P639, DOI 10.1002/qj.49711247305; Douville H, 1996, CLIM DYNAM, V12, P449, DOI 10.1007/BF02346818; SARDESHMUKH PD, 1984, MON WEA REV, V112, P2514; Shen XH, 1998, J METEOROL SOC JPN, V76, P217; Sheng J, 1998, J CLIMATE, V11, P523, DOI 10.1175/1520-0442(1998)011<0523:TROTDI>2.0.CO;2; TSUYUKI T, 1989, J METEOROL SOC JPN, V67, P231; Yang S, 1996, J CLIMATE, V9, P949, DOI 10.1175/1520-0442(1996)009<0949:PSAWTI>2.0.CO;2; YASUNARI T, 1997, METEOROLOGICAL RES N, V189; YEH TC, 1996, STUDY FEATURES CAUSE	30	7	7	AMER METEOROLOGICAL SOC	BOSTON	45 BEACON ST, BOSTON, MA 02108-3693 USA	0894-8755			J CLIMATE	J. Clim.	OCT 1	2000	13	19					3511	3531		10.1175/1520-0442(2000)013<3511:ROTITD>2.0.CO;2		21	Meteorology & Atmospheric Sciences	Meteorology & Atmospheric Sciences	367RJ	WOS:000090075000011		
J	Hayashi, T; Ueno, K; Saiki, K; Koma, A				Hayashi, T; Ueno, K; Saiki, K; Koma, A			Investigation of the growth mechanism of an InSe epitaxial layer on a MoS2 substrate	JOURNAL OF CRYSTAL GROWTH			English	Article						STM; layered material; InSe; MoS2; growth kinetics	ENERGY-ELECTRON-DIFFRACTION; MOLECULAR-BEAM EPITAXY; VANDERWAALS EPITAXY; SELECTIVE GROWTH; THIN-FILMS; HETEROSTRUCTURES; FABRICATION; MICROSCOPY; CRYSTALS; GASE	Sub-monolayer films of layered semiconductor InSe were grown on MoS2 substrates by molecular beam epitaxy, and the change in their growth features with Se/In flux ratio was investigated using scanning tunneling microscope in vacuum. It was found that InSe domains grown at 340 degrees C have a hexagonal shape when the Se/In ratio is about 17. Detailed images of the hexagonal InSe domains have revealed that adjacent sides of the hexagon have different structures; one is a straight edge and the other is a disordered edge. When the Se/In ratio was decreased, the disordered edges became predominant, the straight edges disappeared, and the InSe domain became triangular. On the contrary, when the Se/In ratio was increased, InSe domains became triangular ones consisting of only straight edges. The growth mechanism of InSe domains is discussed by considering the crystal structure of InSe and the reactivity of each side with incoming atoms. It is suggested that the balance of incorporation rate of In and Se atoms determines the structure of InSe domains. (C) 2000 Elsevier Science B.V. All rights reserved.	Univ Tokyo, Dept Chem, Bunkyo Ku, Tokyo 1130033, Japan; Univ Tokyo, Dept Complex Sci & Engn, Bunkyo Ku, Tokyo 1130033, Japan	Ueno, K (reprint author), Univ Tokyo, Dept Chem, Bunkyo Ku, 7-3-1 Hongo, Tokyo 1130033, Japan.		Saiki, Koichiro/E-4496-2011; Ueno, Keiji/B-2741-2012	Ueno, Keiji/0000-0002-5535-9382			Ueno K, 1999, JPN J APPL PHYS 1, V38, P511, DOI 10.1143/JJAP.38.511; KOMA A, 1985, J VAC SCI TECHNOL B, V3, P724, DOI 10.1116/1.583125; KOMA A, 1992, THIN SOLID FILMS, V216, P72, DOI 10.1016/0040-6090(92)90872-9; EMERY JY, 1992, J APPL PHYS, V71, P3256, DOI 10.1063/1.350972; GOUSKOV A, 1982, PROG CRYST GROWTH CH, V5, P323, DOI 10.1016/0146-3535(82)90004-1; SCHLAF R, 1995, J VAC SCI TECHNOL A, V13, P1761, DOI 10.1116/1.579766; FARGUES D, 1993, APPL SURF SCI, V65-6, P661, DOI 10.1016/0169-4332(93)90736-U; LANG O, 1995, J CRYST GROWTH, V146, P439, DOI 10.1016/0022-0248(94)00504-4; Liu W. K., 1999, THIN FILMS HETEROEPI; OHUCHI FS, 1991, J CRYST GROWTH, V111, P1033, DOI 10.1016/0022-0248(91)91127-V; Ueno K, 1997, APPL PHYS LETT, V70, P1104, DOI 10.1063/1.118498; UENO K, 1990, J VAC SCI TECHNOL A, V8, P68, DOI 10.1116/1.576983; Ueno K, 1998, APPL SURF SCI, V130, P670, DOI 10.1016/S0169-4332(98)00136-6; Ueno K, 1997, APPL SURF SCI, V113, P38, DOI 10.1016/S0169-4332(96)00837-9; Ye J, 1996, PHILOS MAG A, V73, P169; WILSON JA, 1969, ADV PHYS, V18, P193, DOI 10.1080/00018736900101307; Zhang Z., 1998, MORPHOLOGICAL ORG EP	17	11	11	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	0022-0248			J CRYST GROWTH	J. Cryst. Growth	OCT	2000	219	1-2					115	122		10.1016/S0022-0248(00)00627-8		8	Crystallography; Materials Science, Multidisciplinary; Physics, Applied	Crystallography; Materials Science; Physics	360PD	WOS:000089675700015		
J	Iwai, K				Iwai, K			A contribution to the evolutionary theory of innovation, imitation and growth	JOURNAL OF ECONOMIC BEHAVIOR & ORGANIZATION			English	Article; Proceedings Paper	ISER XI Workshop	1998	SIENA, ITALY			evolutionary economics; Schumpeter; disequilibrium; technological change; growth accounting		This paper develops mathematically tractable evolutionary models that can be used to analyze the development of industrial structure as a dynamic process moved by complex interactions among innovations, imitations and investments of satisficing, firms striving for survival and growth. It demonstrates that what the industry will approach in the long-run is not a neoclassical equilibrium of uniform technology but at best a statistical equilibrium of technological disequilibria which maintains a relative dispersion of efficiencies in a statistically balanced form. This paper also shows that these evolutionary models can simulate all the macroscopic characteristics of neoclassical growth models without assuming the full rationality of business behavior. (C) 2000 Elsevier Science B.V. All rights reserved.	Univ Tokyo, Fac Econ, Bunkyo Ku, Tokyo 1130033, Japan	Iwai, K (reprint author), Univ Tokyo, Fac Econ, Bunkyo Ku, Hongo 7-3-1, Tokyo 1130033, Japan.						AGHION P, 1997, ADV EC ECONOMETRICS, V2, pCH8; Aghion P., 1992, ECONOMETRICA, V60; Andersen E.S., 1994, EVOLUTIONARY EC POST; ARROW KJ, 1962, ROLE DIRECTION INVEN; BARRO R., 1999, EC GROWTH; COLEMAN J, 1957, SOCIOMETRY, V24; Cox D., 1965, THEORY STOCHASTIC PR; DOSSI G, 1988, TECHNICAL CHANGE EC; Feller W., 1966, INTRO PROBABILITY TH; FRANKE R, 1998, MARKET STRUCTURE AGG; GROSSMAN GM, 1993, INNOVATION GROWTH; IWAI K, 1999, AM J COMP LAW, V47; IWAI K, 1998, CIRJE DISCUSSION P F, V30; Iwai K., 1984, J EC BEHAV ORG, V5; Metcalfe J.S., 1991, EVOLUTIONARY THEORIE; Nelson R., 1982, EVOLUTIONARY THEORY; Romer P., 1990, J POLITICAL EC, P98; Sato K., 1975, PRODUCTION FUNCTIONS; SCHUMPETER J. A., 1950, CAPITALISM SOCIALISM; Schumpeter J. A., 1939, BUSINESS CYCLES; Schumpeter J.A., 1961, THEORY EC DEV; SEGERSTROM PS, 1991, J POLITICAL EC, V99; Simon H. A., 1957, MODELS MAN; Solow R.M, 1957, REV EC STAT, V39; WINTER SG, 1990, ORG EVOLUTION NEW DI	25	11	12	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	0167-2681			J ECON BEHAV ORGAN	J. Econ. Behav. Organ.	OCT	2000	43	2					167	198		10.1016/S0167-2681(00)00115-3		32	Economics	Business & Economics	355AV	WOS:000089364200002		
J	Kotani, A				Kotani, A			Theory of resonant X-ray emission spectra in strongly correlated electron systems	JOURNAL OF ELECTRON SPECTROSCOPY AND RELATED PHENOMENA			English	Article						resonant X-ray emission; rare earth compounds; transition metal compounds; multiplet effect; charge transfer effect; cluster size dependence	MAGNETIC CIRCULAR-DICHROISM; CORE-LEVEL SPECTROSCOPY; RARE-EARTH-OXIDES; CE COMPOUNDS; FLUORESCENCE SPECTROSCOPY; BAND-STRUCTURE; SCATTERING; ABSORPTION; LA2CUO4; PHOTOEMISSION	Theoretical calculations of resonant X-ray emission spectrum (RXES) in rare earth systems and transition metal compounds are presented and compared with recent experimental data. RXES is formulated as a coherent second-order optical process, in contrast to that X-ray absorption spectrum (XAS) and X-ray photoemission spectrum (XPS) are the first-order optical process, and is calculated with atomic model or impurity Anderson model. From the analysis of RXES we can obtain important information on electronic excitations in rare earth systems and transition metal compounds, such as the multiplet excitation, the charge transfer excitation and the crystal field level excitation. The cluster size dependence of XAS, XPS and RXES is also studied theoretically with a one-dimensional d-p model, which describes qualitatively the effect of translational symmetry for nominally d degrees (or f degrees) compounds such as TiO2 (CeO2). (C) 2000 Elsevier Science B.V. All rights reserved.	Univ Tokyo, Inst Solid State Phys, Minato Ku, Tokyo 1060032, Japan	Kotani, A (reprint author), Univ Tokyo, Inst Solid State Phys, Minato Ku, 7-22-1 Roppongi, Tokyo 1060032, Japan.						Agui A, 1997, PHYS REV B, V55, P2073, DOI 10.1103/PhysRevB.55.2073; KOTANI A, 1992, J ELECTRON SPECTROSC, V60, P257, DOI 10.1016/0368-2048(92)80024-3; Krisch MH, 1996, PHYS REV B, V54, P12673; CARLISLE JA, 1995, PHYS REV LETT, V74, P1234, DOI 10.1103/PhysRevLett.74.1234; Hill JP, 1998, PHYS REV LETT, V80, P4967, DOI 10.1103/PhysRevLett.80.4967; Pompa M, 1997, PHYS REV B, V56, P2267, DOI 10.1103/PhysRevB.56.2267; KOTANI A, 1988, ADV PHYS, V37, P37, DOI 10.1080/00018738800101359; WUILLOUD E, 1984, PHYS REV LETT, V53, P202, DOI 10.1103/PhysRevLett.53.202; RUBENSSON JE, 1990, PHYS REV LETT, V64, P1047, DOI 10.1103/PhysRevLett.64.1047; ZHANG FC, 1988, PHYS REV B, V37, P3759, DOI 10.1103/PhysRevB.37.3759; Taguchi M, 1997, J PHYS SOC JPN, V66, P247, DOI 10.1143/JPSJ.66.247; HAMALAINEN K, 1992, PHYS REV B, V46, P14274, DOI 10.1103/PhysRevB.46.14274; TANAKA S, 1994, J PHYS SOC JPN, V63, P2780, DOI 10.1143/JPSJ.63.2780; Shirley EL, 1998, PHYS REV LETT, V80, P794, DOI 10.1103/PhysRevLett.80.794; Butorin SM, 1996, PHYS REV LETT, V77, P574, DOI 10.1103/PhysRevLett.77.574; HAMALAINEN K, 1991, PHYS REV LETT, V67, P2850, DOI 10.1103/PhysRevLett.67.2850; Butorin SM, 1997, PHYS REV B, V55, P4242, DOI 10.1103/PhysRevB.55.4242; Nordgren EJ, 1996, J ELECTRON SPECTROSC, V78, P25, DOI 10.1016/S0368-2048(96)80020-X; Butorin SM, 1997, J PHYS-CONDENS MAT, V9, P8155, DOI 10.1088/0953-8984/9/38/019; deGroot FMF, 1997, PHYS REV B, V56, P7285, DOI 10.1103/PhysRevB.56.7285; Duda LC, 1998, J PHYS SOC JPN, V67, P416, DOI 10.1143/JPSJ.67.416; Gallet JJ, 1996, PHYS REV B, V54, P14238; Ide T, 1998, J PHYS SOC JPN, V67, P3621, DOI 10.1143/JPSJ.67.3621; JO T, 1986, J PHYS SOC JPN, V55, P2457, DOI 10.1143/JPSJ.55.2457; KANAMORI J, 1988, CORE LEVEL SPECTROSC; Kayanuma Y., 1988, Core-Level Spectroscopy in Condensed Systems. Proceedings of the Tenth Taniguchi International Symposium; KOTANI A, 1990, PROG THEOR PHYS SUPP, V101, P329, DOI 10.1143/PTPS.101.329; Kotani A, 1997, J PHYS IV, V7, P1, DOI 10.1051/jp4/1997002; Kotani A, 1996, J ELECTRON SPECTROSC, V78, P7, DOI 10.1016/S0368-2048(96)80017-X; Kramers HA, 1925, Z PHYS, V31, P681, DOI 10.1007/BF02980624; MA Y, 1992, PHYS REV LETT, V69, P2598, DOI 10.1103/PhysRevLett.69.2598; NAKANO T, 1987, J PHYS SOC JPN, V56, P2201, DOI 10.1143/JPSJ.56.2201; Nakazawa M, 1996, J PHYS SOC JPN, V65, P2303, DOI 10.1143/JPSJ.65.2303; Nakazawa M, 1998, J PHYS SOC JPN, V67, P323, DOI 10.1143/JPSJ.67.323; OKADA K, 1993, J ELECTRON SPECTROSC, V62, P131, DOI 10.1016/0368-2048(93)80010-J; TANAKA S, 1989, J PHYS SOC JPN, V58, P813, DOI 10.1143/JPSJ.58.813; TANAKA S, 1988, J PHYS-PARIS, V49, P735, DOI 10.1051/jphyscol:19888334; TANAKA S, 1990, J PHYS SOC JPN, V59, P1488, DOI 10.1143/JPSJ.59.1488; TANAKA S, 1993, J PHYS SOC JPN, V62, P464, DOI 10.1143/JPSJ.62.464; TANAKA S, 1989, J PHYS SOC JPN, V58, P1087, DOI 10.1143/JPSJ.58.1087; TANAKA S, 1991, J PHYS SOC JPN, V60, P3893, DOI 10.1143/JPSJ.60.3893; Tezuka Y, 1996, J PHYS SOC JPN, V65, P312, DOI 10.1143/JPSJ.65.312; VEENENDAAL MA, 1993, PHYS REV B, V47, P5307	43	15	15	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	0368-2048			J ELECTRON SPECTROSC	J. Electron Spectrosc. Relat. Phenom.	OCT	2000	110	1-3			SI		197	212		10.1016/S0368-2048(00)00165-1		16	Spectroscopy	Spectroscopy	362JH	WOS:000089774500013		
J	Imae, M; Inoue, Y; Fu, Z; Kato, H; Noguchi, T				Imae, M; Inoue, Y; Fu, Z; Kato, H; Noguchi, T			Gene expression of the three members of hepatocyte nuclear factor-3 is differentially regulated by nutritional and hormonal factors	JOURNAL OF ENDOCRINOLOGY			English	Article							TYROSINE AMINOTRANSFERASE GENE; BINDING PROTEIN-1 PROMOTER; TRANSCRIPTION FACTOR; GLUCOCORTICOID RESPONSE; GLUCOSE-HOMEOSTASIS; FAMILY; RAT; ELEMENT; MICE; HEAD	Hepatocyte nuclear factor-3 (HNF-3) belongs to a large family of forkhead transcription factors and is made up of three members (HNF-3 alpha, -3 beta and -3 gamma). It has been shown that HNF-3 regulates a number of metabolically important genes. However, the mechanisms underlying this regulation of HNF-3 activity by hormones and nutrition have not yet been well elucidated. In attempting to explore the regulation of gene expression of HNF-3 members by physiological status, we analyzed the effects of insulin. dexamethasone and protein malnutrition on the hepatic mRNA level of each member. Male Wistar rats were fed on a 12% casein diet, 12% gluten diet (deficient in lysine and threonine) or a protein-free diet for 1 week. The protein-free diet and gluten diet caused a 3.7-fold increase in HNF-3 gamma mRNA in the liver and did not affect the mRNA level of either HNF-3 alpha or HNF-3 beta. Daily administration of dexamethasone caused the mRNA levels of HNF-3 alpha and HNF-3 beta to increase (2.3- and 1.4-fold, respectively), but had no effect on the HNF-3 gamma mRNA level. In diabetic rats that had been injected with streptozotocin, an elevation of the hepatic mRNA levels of HNF-3 beta and HNF-3 gamma was observed (1.6-and 1.9-fold, respectively). Insulin replacement in the diabetic rats decreased both mRNA levels in a dose-dependent manner. HNF-3 alpha mRNA was not affected by insulin status. These results show that the genes of the three members of the HNF-3 family respond differently to hormonal and nutritional factors suggesting that the activities of HNF-3 members an regulated, at least in part, by the levels of their gene expression.	Univ Tokyo, Grad Sch Agr & Life Sci, Dept Appl Biol Chem, Bunkyo Ku, Tokyo 1138657, Japan	Noguchi, T (reprint author), Univ Tokyo, Grad Sch Agr & Life Sci, Dept Appl Biol Chem, Bunkyo Ku, Tokyo 1138657, Japan.		Fu, Zhengwei/G-3162-2011				Allander SV, 1997, ENDOCRINOLOGY, V138, P4291, DOI 10.1210/en.138.10.4291; GOSWAMI R, 1994, ENDOCRINOLOGY, V134, P736, DOI 10.1210/en.134.2.736; Wang JC, 1999, MOL ENDOCRINOL, V13, P604, DOI 10.1210/me.13.4.604; Nakae J, 1999, J BIOL CHEM, V274, P15982, DOI 10.1074/jbc.274.23.15982; QIAN XB, 1995, MOL CELL BIOL, V15, P1364; Takaishi H, 1999, P NATL ACAD SCI USA, V96, P11836, DOI 10.1073/pnas.96.21.11836; LAI E, 1991, GENE DEV, V5, P416, DOI 10.1101/gad.5.3.416; KATO H, 1994, MOL ENDOCRINOL, V8, P40, DOI 10.1210/me.8.1.40; CHOMCZYNSKI P, 1987, ANAL BIOCHEM, V162, P156, DOI 10.1006/abio.1987.9999; COSTANZA R., 1989, ECOL ECON, V1, P1, DOI DOI 10.1016/0921-8009(89)90014-1; Duncan DB, 1955, BIOMETRICS, V11, P42; GANSS R, 1994, MOL ENDOCRINOL, V8, P895, DOI 10.1210/me.8.7.895; Guo SD, 1999, J BIOL CHEM, V274, P17184, DOI 10.1074/jbc.274.24.17184; Kaestner KH, 1999, GENE DEV, V13, P495, DOI 10.1101/gad.13.4.495; Kaestner KH, 1998, MOL CELL BIOL, V18, P4245; KAESTNER KH, 1994, GENOMICS, V20, P377, DOI 10.1006/geno.1994.1191; Kato H, 1999, J PINEAL RES, V27, P24, DOI 10.1111/j.1600-079X.1999.tb00593.x; LAI E, 1990, GENE DEV, V4, P1427, DOI 10.1101/gad.4.8.1427; LAI E, 1993, P NATL ACAD SCI USA, V90, P10421, DOI 10.1073/pnas.90.22.10421; Lin BC, 1997, BIOCHEMISTRY-US, V36, P14096, DOI 10.1021/bi9703249; Marton A, 1996, MICROB DRUG RESIST, V2, P361, DOI 10.1089/mdr.1996.2.361; ROUX J, 1995, DNA CELL BIOL, V14, P385, DOI 10.1089/dna.1995.14.385; SAWAYA PL, 1994, J BIOL CHEM, V269, P22211; Shih DQ, 1999, P NATL ACAD SCI USA, V96, P10152, DOI 10.1073/pnas.96.18.10152; TAKAHASHI S, 1990, BRIT J NUTR, V63, P521, DOI 10.1079/BJN19900139; Takenaka A, 1996, J ENDOCRINOL, V150, P33, DOI 10.1677/joe.0.1500033	26	22	22	SOC ENDOCRINOLOGY	BRISTOL	17/18 THE COURTYARD, WOODLANDS, BRADLEY STOKE, BRISTOL BS32 4NQ, ENGLAND	0022-0795			J ENDOCRINOL	J. Endocrinol.	OCT	2000	167	1					R1	R5		10.1677/joe.0.167R001		5	Endocrinology & Metabolism	Endocrinology & Metabolism	406HR	WOS:000167209300021		
J	Toda, S; Kawahara, S; Kirino, Y				Toda, S; Kawahara, S; Kirino, Y			Image analysis of olfactory responses in the procerebrum of the terrestrial slug Limax marginatus	JOURNAL OF EXPERIMENTAL BIOLOGY			English	Article						slug; Limax marginatus; neural oscillation; olfaction; odour; optical recording; procerebrum	FICTIVE LOCOMOTION; MEMORY STATES; INTERNEURONS; NETWORK; MOLLUSK; BRAIN; OSCILLATIONS; MODULATION; WAVES; ODOR	Neural oscillations have been found to occur in the olfactory centers of some vertebrates and invertebrates, including the procerebrum of the terrestrial slug Limax marginatus. Using optical recording with the potential-sensitive dye di-4-ANEPPS, we analyzed the spatiotemporal pattern of procerebral neural activities in response to odorants applied to an in vitro brain-superior tentacle preparation, The odor of rat chow, on which the slugs were normally fed, increased the frequency of the oscillation. Garlic odor, which induced aversive behavior in the slug, caused a transient increase in oscillation frequency during stimulation, followed by a second increase in oscillation frequency when the stimulus was terminated. Wave propagation from the distal to the proximal region of the procerebrum was accelerated in parallel with modulation of the frequency. The cycle-by-cycle average of the optical signals showed that a large area of the cerebral ganglia, including the procerebrum, was depolarized during the initial increase in frequency. During the second increase, however, the net depolarization was most prominent in the terminal mass of the procerebrum, These results suggest that the level of depolarization generated by interactions among the neurites projecting to the terminal mass, such as the neurites of the nonbursting neurons, may control neural oscillations in the procerebrum.	Univ Tokyo, Sch Pharmaceut Sci, Lab Neurobiophys, Bunkyo Ku, Tokyo 1130033, Japan	Kawahara, S (reprint author), Univ Tokyo, Sch Pharmaceut Sci, Lab Neurobiophys, Bunkyo Ku, 7-3-1 Hongo, Tokyo 1130033, Japan.	kawahara@mol.f.u-tokyo.ac.jp					Kawahara S, 1997, J EXP BIOL, V200, P1851; GRILLNER S, 1995, TRENDS NEUROSCI, V18, P270, DOI 10.1016/0166-2236(95)93914-J; SCHAFFER P, 1994, PFLUG ARCH EUR J PHY, V426, P548, DOI 10.1007/BF00378533; FREEMAN WJ, 1978, ELECTROEN CLIN NEURO, V44, P586, DOI 10.1016/0013-4694(78)90126-8; Castelo-Branco M, 1998, J NEUROSCI, V18, P6395; LAURENT G, 1994, J NEUROSCI, V14, P2993; Watanabe S, 1998, J EXP BIOL, V201, P925; GELPERIN A, 1990, NATURE, V345, P437, DOI 10.1038/345437a0; CHASE R, 1989, J COMP NEUROL, V283, P143, DOI 10.1002/cne.902830112; Kimura T, 1998, LEARN MEMORY, V4, P365, DOI 10.1101/lm.4.5.365; Ritz R, 1997, CURR OPIN NEUROBIOL, V7, P536, DOI 10.1016/S0959-4388(97)80034-7; Brierley MJ, 1997, J NEUROPHYSIOL, V78, P3396; CHASE R, 1985, J NEUROSCI, V5, P2930; Degtyarenko MA, 1996, J NEUROPHYSIOL, V76, P2972; DELANEY KR, 1994, P NATL ACAD SCI USA, V91, P669, DOI 10.1073/pnas.91.2.669; Ermentrout B, 1998, J NEUROPHYSIOL, V79, P2677; Gelperin A, 1997, J NEUROSCI METH, V72, P97, DOI 10.1016/S0165-0270(96)02169-3; Gelperin A., 1985, P237; Gervais R, 1996, J NEUROPHYSIOL, V76, P1327; INOUE T, 1998, BIOIMAGES, V6, P59; Iwama A., 1997, Society for Neuroscience Abstracts, V23, P1342; KAWAHARA S, 1994, J COMP PHYSIOL A, V174, P111; Kimura T, 1998, LEARN MEMORY, V4, P376, DOI 10.1101/lm.4.5.376; Kimura T, 1998, LEARN MEMORY, V4, P389, DOI 10.1101/lm.4.5.389; KLEINFELD D, 1994, J NEUROPHYSIOL, V72, P1402; NICOLIS G, 1977, SELF ORGANIZATION NO; SAHLEY C, 1981, J COMP PHYSIOL, V144, P1; Sekiguchi T, 1997, LEARN MEMORY, V4, P356, DOI 10.1101/lm.4.4.356; Vinay L, 1996, J NEUROPHYSIOL, V76, P1224; YAMADA A, 1992, J NEUROSCI, V12, P729	30	7	7	COMPANY OF BIOLOGISTS LTD	CAMBRIDGE	BIDDER BUILDING CAMBRIDGE COMMERCIAL PARK COWLEY RD, CAMBRIDGE CB4 4DL, CAMBS, ENGLAND	0022-0949	1477-9145		J EXP BIOL	J. Exp. Biol.	OCT	2000	203	19					2895	2905				11	Biology	Life Sciences & Biomedicine - Other Topics	369PZ	WOS:000165077300002		
J	Ujiie, Y; Ujiie, H				Ujiie, Y; Ujiie, H			Distribution and oceanographic relationships of modern planktonic foraminifera in the Ryukyu Arc region, northwest Pacific Ocean	JOURNAL OF FORAMINIFERAL RESEARCH			English	Article							SEDIMENT TRAP; CHINA SEA; INDICATOR	Recent planktonic foraminifera were analyzed in 52 surface sediment samples collected from the Ryukyu Are region in the northwestern Pacific Ocean and adjacent East China Sea with the goals of establishing relationships between species distributions and oceanographic features with emphasis on the Kuroshio Current. Thirty-nine species of planktonic foraminifera were identified and grouped into 27 species and species groups based upon taxonomic and ecologic criteria. Calculation of a correlation matrix in the form of a similarity index allowed for a comparison of the relative abundances of the 27 species and species groups within and among all sample sites. Q-mode cluster analysis was subsequently applied using the UPGMA method, and five major site clusters A to E were distinguished. The geographic distribution of samples in site cluster A coincides well with the distribution of higher loading values of factor 2, identified by Q-mode factor analysis carried out using the same coefficient matrix. Similar associations were established for site cluster C-l with those of factor 1, and site clusters C-2, D and E with those of factor 3, These associations suggest that site cluster A reflects the main path of the Kuroshio Current, cluster C-l represents the open waters of the Pacific Ocean, and clusters C-2, D and E express susceptibility to carbonate dissolution at depths greater than 3000 m on the Ryukyu Trench slope. R-mode factor analysis using different loadings of factors 1 to 3 allows the 27 species and species groups to be classified into four groups A through D as follow: (1) Group A consists of taxa susceptible to carbonate dissolution such as the Globigerinoides ruber species group, G, sacculifer, etc. against group B which includes the Pulleniatina group, Neogloboquadrina dutertrei, Globorotalia tumida and G, menardii. Group B is dissolution resistant and also characterizes the Kuroshio Current. (2) Group C consists of Neogloboquadrina pachyderma (dextral), N, incompta and Turborotalia inflata, all indicative of "relatively cold" water. (3) Group D composed of Globigerina bulloides and Globigerinella calida suggests influence of coastal water invasion.	Univ Tokyo, Ocean Res Inst, Nakano Ku, Tokyo 1648639, Japan; Univ Ryukyus, Tokyo 1900015, Japan	Ujiie, Y (reprint author), Univ Tokyo, Ocean Res Inst, Nakano Ku, 1-15-1 Minamidai, Tokyo 1648639, Japan.						AHAGON N, 1993, MAR MICROPALEONTOL, V22, P255, DOI 10.1016/0377-8398(93)90047-2; Xu XD, 1999, MAR GEOL, V156, P285, DOI 10.1016/S0025-3227(98)00183-2; Li BH, 1997, MAR MICROPALEONTOL, V32, P59; UJIIE H, 1991, MAR MICROPALEONTOL, V18, P115, DOI 10.1016/0377-8398(91)90008-T; SAUTTER LR, 1991, J FORAMIN RES, V21, P347; BERGER WH, 1970, MAR GEOL, V8, P111, DOI 10.1016/0025-3227(70)90001-0; Ujiie H, 1999, MAR MICROPALEONTOL, V37, P23, DOI 10.1016/S0377-8398(99)00010-9; Be A.W.H., 1977, P1; BIOLZI M, 1991, MAR MICROPALEONTOL, V18, P129, DOI 10.1016/0377-8398(91)90009-U; BRADSHAW JOHN S., 1959, CONTR CUSHMAN FOUND FORAMINIFERAL RES, V10, P25; DAVIS J. C., 1973, STAT DATA ANAL GEOLO; Imbrie J, 1971, LATE CENOZOIC GLACIA, P71; KATOH O., 1996, J OCEANOGR, V52, P491, DOI 10.1007/BF02239051; Kawagata S, 1996, J FORAMIN RES, V26, P342; *KUR EXPL UT RES P, 1985, SUMM REP 1977 1982; MALMGREN B A, 1977, Journal of Foraminiferal Research, V7, P130; Nitani H, 1972, KUROSHIO ITS PHYS AS, P129; Oka E., 1998, J OCEANOGR, V54, P605, DOI DOI 10.1007/BF02823281; Ortiz JD, 1997, PALEOCEANOGRAPHY, V12, P175, DOI 10.1029/96PA02878; Park BK, 1998, J FORAMIN RES, V28, P321; Parket F. L., 1962, Micropaleontology, V8, P219, DOI 10.2307/1484745; Pflaumann U, 1999, MAR GEOL, V156, P41, DOI 10.1016/S0025-3227(98)00173-X; Srinivasan M.S., 1983, NEOGENE PLANKTONIC F; Takemoto Ayumi, 1997, Paleontological Research, V1, P291; THOMPSON PR, 1981, PALAEOGEOGR PALAEOCL, V35, P241, DOI 10.1016/0031-0182(81)90099-7; Ujiie H., 1963, Bulletin of the National Science Museum Tokyo, V6, P378; UJIIE H, 1992, 29 IGC FIELD TRIP GU, V5, P337; Ujiie H., 1962, Journal of the Geological Society of Japan, V68, P431; UJIIE H, 1969, Bulletin of the National Science Museum (Tokyo), V12, P735; UJIIE Y, 1999, 4 INT C AS MAR GEOL, P145; WANG P, 1987, ACTA OCEANOLOGICA SI, V6, P225; Wang P., 1985, P34; Watkins JM, 1998, MAR MICROPALEONTOL, V33, P157, DOI 10.1016/S0377-8398(97)00036-4	33	18	20	CUSHMAN FOUNDATION FORAMINIFERAL RES	CAMBRIDGE	MUSEUM COMPARATIVE ZOOLOGY, DEPT INVERTEBRATE PALEONTOLOGY 26 OXFORD ST, HARVARD UNIV, CAMBRIDGE, MA 02138 USA	0096-1191			J FORAMIN RES	J. Foraminifer. Res.	OCT	2000	30	4					336	360		10.2113/0300336		25	Paleontology	Paleontology	375EK	WOS:000165386400007		
J	Yamada, N; Tomita, G; Yamamoto, T; Kitazawa, Y				Yamada, N; Tomita, G; Yamamoto, T; Kitazawa, Y			Changes in the nerve fiber layer thickness following a reduction of intraocular pressure after trabeculectomy	JOURNAL OF GLAUCOMA			English	Article; Proceedings Paper	Annual Meeting of the Association-for-Research-in-Vision-and-Ophthalmology	MAY 09-14, 1999	FT LAUDERDALE, FLORIDA	Assoc Res Vis & Ophthalmol, Natl Hlth Public Serv Award, Childrens Hosp Res Fdn		glaucoma; intraocular pressure; nerve fiber layer; scanning laser polarimetry; trabeculectomy	SCANNING LASER POLARIMETRY; ADULT PATIENTS; OPEN-ANGLE; GLAUCOMA; REVERSAL; SENSITIVITY; TOPOGRAPHY	Purpose: To assess changes in the nerve fiber layer thickness after trabeculectomy using scanning laser polarimetry. Methods: The authors prospectively enrolled 46 eyes from 46 patients with primary open-angle glaucoma in whom intraocular pressure had been reduced by more than 30% after trabeculectomy without significant: ophthalmic complications and from whom good quality images were obtained by a scanning laser polarimetry preoperatively and at 3 to 6 months after trabeculectomy. In each enrolled eye, changes in the nerve fiber layer thickness after surgery in the defined ring (1.8 disc diameters) around the optic disc were calculated in 10 degrees intervals (36 sectors in total) and in the following 4 quadrants (the sum of 9 10 degrees sectors): superior, nasal, inferior, and temporal. Results: The mean intraocular pressure was 22.6 +/- 6.9 mm Hg preoperatively and 10.2 +/- 3.7 mm Hg postoperatively (P < 0.01). According to the analyses in every 10 degrees, the postoperative nerve fiber layer thickness was significantly greater than the preoperative nerve fiber layer thickness in the superotemporal region (10-50 degrees) and inferotemporal region (290-340 degrees) of the optic disc (P < 0.05). A stepwise multiple regression analysis showed that only the preoperative mean deviation in the Humphrey visual fields was a significant independent factor associated with changes in the nerve fiber layer thickness in the nasal and inferior quadrants. Conclusions: The thickness of the nerve fiber layer, as measured by scanning laser polarimetry, may increase after trabeculectomy, especially in the superotemporal and inferotemporal regions, and can be expected in cases in the early stage of glaucoma that have a better mean deviation.	Gifu Univ, Sch Med, Dept Ophthalmol, Gifu 5008705, Japan; Univ Tokyo, Dept Ophthalmol, Tokyo 113, Japan	Yamada, N (reprint author), Gifu Univ, Sch Med, Dept Ophthalmol, 40 Tsukasamachi, Gifu 5008705, Japan.						Lesk MR, 1999, OPHTHALMOLOGY, V106, P1013, DOI 10.1016/S0161-6420(99)00526-6; PEDERSON JE, 1982, ARCH OPHTHALMOL-CHIC, V100, P426; SOGANO S, 1993, OPHTHALMOLOGY, V100, P1253; Irak I, 1996, AM J OPHTHALMOL, V122, P690; WEINREB RN, 1995, AM J OPHTHALMOL, V119, P627; Topouzis F, 1999, OPHTHALMOLOGY, V106, P1147, DOI 10.1016/S0161-6420(99)90248-8; QUIGLEY HA, 1982, OPHTHALMOLOGY, V89, P219; Anton A, 1997, ARCH OPHTHALMOL-CHIC, V115, P331; TjonFoSang MJ, 1997, AM J OPHTHALMOL, V123, P62; Lee VWH, 1999, OPHTHALMOLOGY, V106, P1006, DOI 10.1016/S0161-6420(99)00524-2; Hollo G, 1997, BRIT J OPHTHALMOL, V81, P857, DOI 10.1136/bjo.81.10.857; WEINREB RN, 1995, AM J OPHTHALMOL, V120, P732; KATZ LJ, 1989, AM J OPHTHALMOL, V107, P485; Chi Q M, 1995, J Glaucoma, V4, P406; FUNK J, 1990, OPHTHALMIC SURG LAS, V21, P585; MATSUBARA K, 1990, Nippon Ganka Gakkai Zasshi, V94, P604; Park K H, 1997, Korean J Ophthalmol, V11, P1; Quigley II HA, 1985, SURV OPHTHALMOL, V30, P117, DOI 10.1016/0039-6257(85)90080-3; SHIN DH, 1989, ARCH OPHTHALMOL-CHIC, V107, P1599; SPAETH GL, 1979, DOC OPHTHALMOL P, V22, P11; Swindale NV, 1996, J GLAUCOMA, V5, P156; Yamada N, 1998, J GLAUCOMA, V7, P378	22	18	20	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	530 WALNUT ST, PHILADELPHIA, PA 19106-3621 USA	1057-0829			J GLAUCOMA	J. Glaucoma	OCT	2000	9	5					371	375				5	Ophthalmology	Ophthalmology	360NQ	WOS:000089674500005		
J	Hitomi, S; Kubota, M; Mori, N; Baba, S; Yano, H; Okuzumi, K; Kimura, S				Hitomi, S; Kubota, M; Mori, N; Baba, S; Yano, H; Okuzumi, K; Kimura, S			Control of a methicillin-resistant Staphylococcus aureus outbreak in a neonatal intensive care unit by unselective use of nasal mupirocin ointment	JOURNAL OF HOSPITAL INFECTION			English	Article						Staphylococcus aureus; methicillin resistance; mupirocin; intensive care units; neonatal	INTRANASAL MUPIROCIN; EPIDEMIOLOGY; MICROBIOLOGY; PREVENTION; INFECTIONS	In September 1996, an outbreak of methicillin-resistant Staphylococcus aureus (MRSA) colonization occurred in the neonatal intensive care unit (NICU) of our hospital. After failing to control the outbreak by conventional methods we implemented an intranasal blanket use programme of mupirocin ointment from the beginning of November 1997. In the programme, patients who had been carrying MRSA received intranasal administration of the ointment three times daily for the first three days and consecutively three times weekly, while newly admitted patients and those who had not been colonized were prophylactically medicated three times weekly. This blanket administration was executed for one month. Methicillin-resistant Staphylococcus aureus colonization became undetectable in all but one intubated inpatient who had already been colonized before the start of the programme, and no new acquisitions occurred until the middle of January 1998, seven weeks after the termination of the blanket use programme. The rate of colonized patients in the unit also decreased. During and after the programme, neither an increase in minimum inhibitory concentration for the antibiotic nor apparent adverse reactions in any of the treated patients were observed. We concluded that this procedure is an effective method of controlling an MRSA outbreak in an NICU when the outbreak cannot be managed with conventional measures. (C) 2000 The Hospital Infection Society.	Tokyo Univ Hosp, Dept Infect Control & Prevent, Bunkyo Ku, Tokyo 1138655, Japan; Tokyo Univ Hosp, Dept Paediat, Tokyo 1138655, Japan; Tokyo Univ Hosp, Dept Clin Lab, Tokyo 1138655, Japan	Hitomi, S (reprint author), Tokyo Univ Hosp, Dept Infect Control & Prevent, Bunkyo Ku, 7-3-1 Hongo, Tokyo 1138655, Japan.						ALLEN KD, 1994, J HOSP INFECT, V27, P29, DOI 10.1016/0195-6701(94)90065-5; Miller MA, 1996, INFECT CONT HOSP EP, V17, P811; MULLIGAN ME, 1993, AM J MED, V94, P313, DOI 10.1016/0002-9343(93)90063-U; DICE LR, 1945, ECOLOGY, V26, P297, DOI 10.2307/1932409; HADDAD Q, 1993, J HOSP INFECT, V23, P211, DOI 10.1016/0195-6701(93)90026-V; AYLIFFE GAJ, 1990, J HOSP INFECT, V16, P351; Bertino JS, 1997, AM J HEALTH-SYST PH, V54, P2185; BOYCE JM, 1992, INFECT CONT HOSP EP, V13, P725; BRADLEY SF, 1995, INFECT CONT HOSP EP, V16, P354; DAVIES EA, 1987, J HOSP INFECT, V10, P120, DOI 10.1016/0195-6701(87)90137-X; GILLESPIE WA, 1958, LANCET, V2, P1075; HUDSON IRB, 1994, J HOSP INFECT, V27, P81, DOI 10.1016/0195-6701(94)90001-9; JELLARD J, 1957, BRIT MED J, V1, P925; Kloos WE, 1995, STAPHYLOCOCCUS MICRO, P282; Mayall B, 1996, J HOSP INFECT, V32, P257, DOI 10.1016/S0195-6701(96)90036-5; MYLOTTE JM, 1996, INFECT CONTROL APPL, P1; SIMPSON IN, 1995, J CLIN MICROBIOL, V33, P2254; THOMPSON RL, 1982, ANN INTERN MED, V97, P309; WATKINSON M, 1992, J HOSP INFECT, V21, P131, DOI 10.1016/0195-6701(92)90032-H	19	42	42	W B SAUNDERS CO LTD	LONDON	24-28 OVAL RD, LONDON NW1 7DX, ENGLAND	0195-6701			J HOSP INFECT	J. Hosp. Infect.	OCT	2000	46	2					123	129		10.1053/jhin.2000.0786		7	Infectious Diseases	Infectious Diseases	367MG	WOS:000090065600007		
J	Andjelic, S; Hsia, C; Suzuki, H; Kadowaki, T; Koyasu, S; Liou, HC				Andjelic, S; Hsia, C; Suzuki, H; Kadowaki, T; Koyasu, S; Liou, HC			Phosphatidylinositol 3-kinase and NF-kappa B/Rel are at the divergence of CD40-mediated proliferation and survival pathways	JOURNAL OF IMMUNOLOGY			English	Article							ZINC-FINGER PROTEIN; HUMAN B-LYMPHOCYTES; PHOSPHOINOSITIDE 3-KINASE; SIGNAL-TRANSDUCTION; P85-ALPHA SUBUNIT; CELL-DEATH; BCL-X; APOPTOSIS; CD40; ACTIVATION	CD40 receptor ligation evokes several crucial outcomes for the fate of an activated B cell, including proliferation and survival. Although multiple signaling molecules in the CD40 pathways have been identified, their specific roles in regulating proliferation and maintaining cell viability are still obscure. In this report, we demonstrate that the activation of both phosphatidylinositol 3-kinase (PI-3K) and NF-kappa B/Rel transcription factors is crucial for CD40-mediated proliferation. Furthermore, our data indicate that PI-3K is indispensable for CD40-mediated NF-kappa B/Rel activation. This is achieved via activation of AKT and the degradation of I kappa B alpha. Furthermore, we show that PI-3K activity is necessary for the degradation of cyclin-dependent kinase inhibitor p27(kip). Therefore, both of these events comprise the mechanism by which PI-3K controls cell proliferation. In contrast to the absolute requirement of PI-3K and NF-kappa B/Rel for proliferation, these signaling molecules are only partially responsible for CD40-mediated survival, as blocking of PI-3K activity did not lead to apoptosis of anti-CD40-treated cells. However, the PI3K/NF-kappa B pathway is still required for CD40-induced Bcl-X gene expression. Taken together, our data indicate that multiple survival pathways are triggered via this receptor, whereas NF-kappa B/Rel and PI-3K are crucial for CD40-induced proliferation.	Univ Tokyo, Dept Internal Med, Grad Sch Med, Tokyo, Japan; Cornell Univ, Div Immunol, Dept Med, Weill Grad Sch Med Sci, New York, NY 10021 USA; Keio Univ, Sch Med, Dept Microbiol & Immunol, Tokyo, Japan	Andjelic, S (reprint author), Mojave Therapeut, 715 Old Saw Mill River Rd, Tarrytown, NY 10591 USA.		Suzuki, Harumi/L-1271-2013	Suzuki, Harumi/0000-0003-3616-9361			Andjelic S, 1998, EUR J IMMUNOL, V28, P570, DOI 10.1002/(SICI)1521-4141(199802)28:02<570::AID-IMMU570>3.0.CO;2-M; VLAHOS CJ, 1994, J BIOL CHEM, V269, P5241; Duckett CS, 1996, EMBO J, V15, P2685; Domin J, 1997, FEBS LETT, V410, P91, DOI 10.1016/S0014-5793(97)00617-0; Liou HC, 1999, INT IMMUNOL, V11, P361, DOI 10.1093/intimm/11.3.361; Tumang JR, 1998, EUR J IMMUNOL, V28, P4299, DOI 10.1002/(SICI)1521-4141(199812)28:12<4299::AID-IMMU4299>3.0.CO;2-Y; Tuscano JM, 1996, BLOOD, V88, P1359; Suzuki H, 1999, SCIENCE, V283, P390, DOI 10.1126/science.283.5400.390; LIOU HC, 1994, MOL CELL BIOL, V14, P5349; Fang W, 1997, AM J PHYSIOL-CELL PH, V272, pC950; Yeh WC, 1997, IMMUNITY, V7, P715, DOI 10.1016/S1074-7613(00)80391-X; SCHATTNER EJ, 1995, J EXP MED, V182, P1557, DOI 10.1084/jem.182.5.1557; Deveraux QL, 1997, NATURE, V388, P300; REN CL, 1994, J EXP MED, V179, P673, DOI 10.1084/jem.179.2.673; SHERR CJ, 1995, GENE DEV, V9, P1149, DOI 10.1101/gad.9.10.1149; GARRONE P, 1995, J EXP MED, V182, P1265, DOI 10.1084/jem.182.5.1265; Romashkova JA, 1999, NATURE, V401, P86; Fruman DA, 1999, SCIENCE, V283, P393, DOI 10.1126/science.283.5400.393; Kennedy SG, 1997, GENE DEV, V11, P701, DOI 10.1101/gad.11.6.701; Roy N, 1997, EMBO J, V16, P6914, DOI 10.1093/emboj/16.23.6914; Brennan P, 1997, IMMUNITY, V7, P679, DOI 10.1016/S1074-7613(00)80388-X; Lee SY, 1997, IMMUNITY, V7, P703, DOI 10.1016/S1074-7613(00)80390-8; Terauchi Y, 1999, NAT GENET, V21, P230; Maniatis T, 1997, SCIENCE, V278, P818, DOI 10.1126/science.278.5339.818; Ozes ON, 1999, NATURE, V401, P82; SARMA V, 1995, J BIOL CHEM, V270, P12343; BARRETT TB, 1991, J IMMUNOL, V146, P1722; NICOLETTI I, 1991, J IMMUNOL METHODS, V139, P271, DOI 10.1016/0022-1759(91)90198-O; Datta SR, 1997, CELL, V91, P231, DOI 10.1016/S0092-8674(00)80405-5; Kehry MR, 1996, J IMMUNOL, V156, P2345; Bossy-Wetzel E, 1999, MUTAT RES-DNA REPAIR, V434, P243, DOI 10.1016/S0921-8777(99)00032-4; Gold MR, 1999, J IMMUNOL, V163, P1894; KRIKOS A, 1992, J BIOL CHEM, V267, P17971; Liou HC, 1993, CURR OPIN CELL BIOL, V5, P477, DOI 10.1016/0955-0674(93)90014-H; Neumann M, 1996, J IMMUNOL, V157, P4862; WANG CY, 1998, SCIENCE, V281, P680; WANG ZH, 1995, J IMMUNOL, V155, P3722; WORM M, 1994, INT IMMUNOL, V6, P1883, DOI 10.1093/intimm/6.12.1883	38	64	64	AMER ASSOC IMMUNOLOGISTS	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0022-1767			J IMMUNOL	J. Immunol.	OCT 1	2000	165	7					3860	3867				8	Immunology	Immunology	357AZ	WOS:000089477500041		
J	Vestergaard, C; Bang, K; Gesser, B; Yoneyama, H; Matsushima, K; Larsen, CG				Vestergaard, C; Bang, K; Gesser, B; Yoneyama, H; Matsushima, K; Larsen, CG			A Th-2 chemokine, TARC, produced by keratinocytes may recruit CLA(+)CCR4(+) lymphocytes into lesional atopic dermatitis skin	JOURNAL OF INVESTIGATIVE DERMATOLOGY			English	Article						chemokine receptors; IFN gamma; immunohistochemistry; lymphocyte recirculation; TNF alpha	MEMORY T-CELLS; SELECTIVE HOMING RECEPTOR; CC-CHEMOKINE; BACTERIAL SUPERANTIGENS; ENDOTHELIAL-CELLS; GENE-EXPRESSION; TNF-ALPHA; IN-SITU; ANTIGEN; ADHESION	Atopic dermatitis is an inflammatory skin disease in which the inflammation is characterized by the influx of lymphocytes into the dermis. It is generally believed that atopic dermatitis is a Th-2-type disease, i.e., the T lymphocytes produce interleukin-1, interleukin-5, interleukin-10, and interleukin-13, although it has become evident in recent years that the cytokine profile in the skin changes during the course of the disease towards a Th-1-Th-2 mixed cytokine profile (interferon-gamma, tumor necrosis factor alpha, and interleukin-2). The lymphocytes that home into the skin express cutaneous lymphocyte-associated antigen, and it has recently been shown that most of the lymphocytes in this population express the chemokine receptor CCR4. CCR4 is the receptor for the CC chemokine TARC (thymus and activation regulated chemokine), and this chemokine is expressed predominantly by keratinocytes in the basal layer of the epidermis of lesional atopic dermatitis skin in mice. In humans, however, it was shown to be expressed in the endothelial cells of the dermis, We have examined the peripheral blood mononuclear cells of atopic dermatitis patients for the expression of cutaneous lymphocyte-associated antigen and CCR4 and compared them with peripheral blood mononuclear cells from normal controls. We found that the proportion of CLA(+)CCR4(+) lymphocytes is upregulated in atopic dermatitis patients. In addition we have examined skin biopsies of lesional and non-lesional skin from atopic dermatitis patients and found that the keratinocytes, but not the endothelial cells, produce TARC in the lesional but not in the nonlesional skin. To gain insight in the stimulatory mechanisms for TARC production in keratinocytes, as previously observed in mice, we cultured HaCaT cells and found that interferon-gamma and tumor necrosis factor alpha work synergistically to induce TARC production. These observations suggest that the induction of TARC production in keratinocytes plays an important role in the late phase skin invasion by CCR4(+)CLA(+) Th-2-type lymphocytes in atopic dermatitis.	Univ Aarhus, Marselisborg Hosp, Dept Dermatol, Res Lab B, DK-8000 Aarhus C, Denmark; Univ Tokyo, Dept Mol Prevent Med, Tokyo, Japan	Vestergaard, C (reprint author), Univ Aarhus, Marselisborg Hosp, Dept Dermatol, Res Lab B, PP Oerumsgade 11, DK-8000 Aarhus C, Denmark.						Akdis CA, 1999, J INVEST DERMATOL, V113, P628, DOI 10.1046/j.1523-1747.1999.00720.x; Liao F, 1999, J IMMUNOL, V162, P186; Thepen T, 1996, J ALLERGY CLIN IMMUN, V97, P828, DOI 10.1016/S0091-6749(96)80161-8; PICKER LJ, 1990, AM J PATHOL, V136, P1053; IMOKAWA G, 1991, J INVEST DERMATOL, V96, P523, DOI 10.1111/1523-1747.ep12470233; Vestergaard C, 1999, J CLIN INVEST, V104, P1097, DOI 10.1172/JCI7613; SPRINGER TA, 1994, CELL, V76, P301, DOI 10.1016/0092-8674(94)90337-9; Luster AD, 1998, NEW ENGL J MED, V338, P436; Middleton J, 1997, CELL, V91, P385, DOI 10.1016/S0092-8674(00)80422-5; D'Ambrosio D, 1998, J IMMUNOL, V161, P5111; GREWE M, 1994, LANCET, V343, P25, DOI 10.1016/S0140-6736(94)90879-6; Baggiolini M, 1998, NATURE, V392, P565, DOI 10.1038/33340; HAMID Q, 1994, J CLIN INVEST, V94, P870, DOI 10.1172/JCI117408; BABI LFS, 1995, J EXP MED, V181, P1935; Campbell JJ, 1999, NATURE, V400, P776, DOI 10.1038/23495; Ackermann L, 1998, ARCH DERMATOL RES, V290, P353, DOI 10.1007/s004030050317; Werfel T, 1996, J INVEST DERMATOL, V107, P871, DOI 10.1111/1523-1747.ep12331164; [Anonymous], 1980, ACTA DERM-VENEREOL S; BARKER JNWN, 1991, LANCET, V337, P211, DOI 10.1016/0140-6736(91)92168-2; TAYLOR RS, 1991, J IMMUNOL, V147, P3794; Deleuran M, 1996, J DERMATOL SCI, V13, P228, DOI 10.1016/S0923-1811(96)00539-7; Rollins BJ, 1997, BLOOD, V90, P909; KRAGBALLE K, 1985, BRIT J DERMATOL, V112, P263, DOI 10.1111/j.1365-2133.1985.tb04852.x; Grewe M, 1998, IMMUNOL TODAY, V19, P359, DOI 10.1016/S0167-5699(98)01285-7; Imai T, 1999, INT IMMUNOL, V11, P81, DOI 10.1093/intimm/11.1.81; BERG EL, 1991, J EXP MED, V174, P1461, DOI 10.1084/jem.174.6.1461; Imai T, 1997, J BIOL CHEM, V272, P15036, DOI 10.1074/jbc.272.23.15036; Rudikoff D, 1998, LANCET, V351, P1715, DOI 10.1016/S0140-6736(97)12082-7; BOS JD, 1986, J INVEST DERMATOL, V87, P358, DOI 10.1111/1523-1747.ep12524811; Sallusto F, 1998, J EXP MED, V187, P875, DOI 10.1084/jem.187.6.875; OHMEN JD, 1995, J IMMUNOL, V154, P1956; Bonecchi R, 1998, J EXP MED, V187, P129, DOI 10.1084/jem.187.1.129; Morales J, 1999, P NATL ACAD SCI USA, V96, P14470, DOI 10.1073/pnas.96.25.14470; Imai T, 1996, J BIOL CHEM, V271, P21514; Babi LFS, 1996, EUR J IMMUNOL, V26, P2056, DOI 10.1002/eji.1830260914; BOS JD, 1989, ARCH DERMATOL RES, V281, P24, DOI 10.1007/BF00424268; BOUKAMP P, 1994, KERATINOCYTE HDB, P485; COOPER KD, 1994, J INVEST DERMATOL, V102, P128, DOI 10.1111/1523-1747.ep12371746; de Vries IJM, 1998, J ALLERGY CLIN IMMUN, V102, P461, DOI 10.1016/S0091-6749(98)70136-8; HASHIMOTO S, 1999, IN PRESS BLOOD; Herz U, 1998, INT ARCH ALLERGY IMM, V115, P179, DOI 10.1159/000023899; LEUNG DYM, 1995, J EXP MED, V181, P747, DOI 10.1084/jem.181.2.747; PICKER LJ, 1992, ANNU REV IMMUNOL, V10, P561, DOI 10.1146/annurev.immunol.10.1.561; SOTER NA, 1989, ALLERGY, V44, P16, DOI 10.1111/j.1398-9995.1989.tb02449.x; ThestrupPedersen K, 1997, ACTA DERM-VENEREOL, V77, P20; UEHARA M, 1990, CLIN EXP DERMATOL, V15, P264, DOI 10.1111/j.1365-2230.1990.tb02086.x; Utgaard JO, 1998, J EXP MED, V188, P1751, DOI 10.1084/jem.188.9.1751; Wagers AJ, 1998, J EXP MED, V188, P2225, DOI 10.1084/jem.188.12.2225; Yoneyama H, 1998, J CLIN INVEST, V102, P1933, DOI 10.1172/JCI4619	49	204	210	BLACKWELL SCIENCE INC	MALDEN	350 MAIN ST, MALDEN, MA 02148 USA	0022-202X			J INVEST DERMATOL	J. Invest. Dermatol.	OCT	2000	115	4					640	646		10.1046/j.1523-1747.2000.00115.x		7	Dermatology	Dermatology	363CK	WOS:000089816700007		
J	Chun, KH; Imai, Y; Higashi, N; Irimura, T				Chun, KH; Imai, Y; Higashi, N; Irimura, T			Migration of dermal cells expressing a macrophage C-type lectin during the sensitization phase of delayed-type hypersensitivity	JOURNAL OF LEUKOCYTE BIOLOGY			English	Article						adjuvant; cell migration; cytokine	TUMOR-NECROSIS-FACTOR; CONTACT HYPERSENSITIVITY; DENDRITIC CELLS; LYMPH-NODES; LANGERHANS CELLS; IMMUNE-RESPONSE; SKIN; INDUCTION; SENSITIVITY; PROTEINS	Dermal cells expressing a macrophage C-type lectin (mMGL) were previously suggested to migrate to regional lymph nodes during the sensitization phase of delayed-type hypersensitivity (DTH). The migration seemed to be induced by the solvent used to dissolve the antigen, and the DTH response was significantly enhanced by the migration. In this study, immunohistochemical analysis of skin after epicutaneous application of one of such solvents, a mixture of acetone and dibutylphthalate (AD), revealed a transient decrease in the number of mMGL-positive cells in the dermis. A similar decrease in this cell population was also observed in an ex vivo assay with skin explants excised from AD-treated sites. Conditioned medium from organ culture of AD-treated skin induced a similar decrease of mMGL-positive cells in untreated dermis, indicating the involvement of soluble factors. mMGL-positive cells seemed to represent a unique subpopulation of F4/80-positive dermal cells.	Univ Tokyo, Lab Canc Biol & Mol Immunol, Grad Sch Pharmaceut Sci, Bunkyo Ku, Tokyo 1130033, Japan; Univ Shizuoka, Sch Pharmaceut Sci, Dept Microbiol, Shizuoka, Japan	Irimura, T (reprint author), Univ Tokyo, Lab Canc Biol & Mol Immunol, Grad Sch Pharmaceut Sci, Bunkyo Ku, 7-3-1 Hongo, Tokyo 1130033, Japan.		Imai, Yasuyuki/E-8701-2010				AIBA S, 1991, J IMMUNOL, V146, P2479; ENK AH, 1992, P NATL ACAD SCI USA, V89, P1398, DOI 10.1073/pnas.89.4.1398; Steinman RM, 1997, IMMUNOL REV, V156, P25, DOI 10.1111/j.1600-065X.1997.tb00956.x; Mizuochi S, 1997, GLYCOBIOLOGY, V7, P137, DOI 10.1093/glycob/7.1.137; Hart DNJ, 1997, BLOOD, V90, P3245; BARKER JNWN, 1991, LANCET, V337, P211, DOI 10.1016/0140-6736(91)92168-2; Inaba K, 1997, J EXP MED, V186, P665, DOI 10.1084/jem.186.5.665; Imai Y, 1995, IMMUNOLOGY, V86, P591; RHEINS LA, 1989, J INVEST DERMATOL, V93, P511, DOI 10.1111/1523-1747.ep12284064; Bacci S, 1997, EUR J IMMUNOL, V27, P442, DOI 10.1002/eji.1830270214; ROAKE JA, 1995, J EXP MED, V181, P2237, DOI 10.1084/jem.181.6.2237; Kuang YN, 1996, J BIOL CHEM, V271, P3975; ANSEL J, 1990, J INVEST DERMATOL, V94, pS101, DOI 10.1111/1523-1747.ep12876053; BOS JD, 1993, IMMUNOL TODAY, V14, P75, DOI 10.1016/0167-5699(93)90062-P; CUA DJ, 1995, EUR J IMMUNOL, V25, P2318, DOI 10.1002/eji.1830250830; Cumberbatch M, 1997, ARCH DERMATOL RES, V289, P277, DOI 10.1007/s004030050193; DOMOTO DT, 1980, J IMMUNOL, V125, P2161; ENK AH, 1993, J IMMUNOL, V150, P3698; ENK AH, 1995, J INVEST DERMATOL, V105, pS80, DOI 10.1111/1523-1747.ep12316112; Fields TA, 1997, BIOCHEM J, V321, P561; FURUE M, 1985, J INVEST DERMATOL, V85, P139, DOI 10.1111/1523-1747.ep12276557; GUTWALD J, 1991, J INVEST DERMATOL, V96, P695, DOI 10.1111/1523-1747.ep12470630; KIMURA T, 1995, J BIOL CHEM, V270, P16056; KRIPKE ML, 1990, J IMMUNOL, V145, P2833; Kupper T S, 1988, Adv Dermatol, V3, P293; KURIMOTO I, 1994, J IMMUNOL, V152, P3317; KURIMOTO I, 1995, IMMUNOLOGY, V85, P621; MICHAELSSON E, 1995, EUR J IMMUNOL, V25, P2234, DOI 10.1002/eji.1830250818; ODA S, 1988, J BIOCHEM-TOKYO, V104, P600; RAMBUKKANA A, 1992, SCAND J IMMUNOL, V36, P35, DOI 10.1111/j.1365-3083.1992.tb02938.x; Sato K, 1998, J IMMUNOL, V161, P6835; TAMMI R, 1987, INT J DERMATOL, V26, P150, DOI 10.1111/j.1365-4362.1987.tb00881.x; VANWILSEM EJG, 1994, J INVEST DERMATOL, V103, P217, DOI 10.1111/1523-1747.ep12393088	33	27	27	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0741-5400			J LEUKOCYTE BIOL	J. Leukoc. Biol.	OCT	2000	68	4					471	478				8	Cell Biology; Hematology; Immunology	Cell Biology; Hematology; Immunology	361MD	WOS:000089726100005		
J	Yamamoto, J; Adachi, Y; Onoue, Y; Adachi, YS; Okabe, Y; Itazawa, T; Toyoda, M; Seki, T; Morohashi, M; Matsushima, K; Miyawaki, T				Yamamoto, J; Adachi, Y; Onoue, Y; Adachi, YS; Okabe, Y; Itazawa, T; Toyoda, M; Seki, T; Morohashi, M; Matsushima, K; Miyawaki, T			Differential expression of the chemokine receptors by the Th1-and Th2-type effector populations within circulating CD4(+) T cells	JOURNAL OF LEUKOCYTE BIOLOGY			English	Article						CCR3; CCR4; CCR5; CXCR3; atopic dermatitis	TH1; LYMPHOCYTES; DISEASES; LIGANDS; SUBSETS; CCR8	The in vitro studies have proposed that human Th1 cells favor expression of CXCR3 or CCR5, whereas Th2 cells favor CCR3 and CCR4. In this study, the in vivo relevance of expression of these chemokine receptors on Th cells was investigated in patients with atopic dermatitis (AD) as the Th2-dominated disorder and nonatopic normal individuals. Flow-cytometric analysis using monoclonal antibodies against CXCR3, CCR5, CCR3, and CCR4 disclosed that a substantial proportion of memory (CD45RO(+)) CD4(+) T cells in the Mood of AD and normal patients expressed CXCR3, CCR5, or CCR4, but expression of CCR3 on these cells was negligible, Stimulation studies combined with intracellular cytokine staining revealed that the cells capable of producing Th2 cytokines, such as interleukin-4 (IL-4), IL-5, and IL-13, were restricted to the CCR4-expressing population within memory CD4(+) T cells. Concerning Th1 cytokine production, interferon-gamma (IFN-gamma)-producing cells resided exclusively in CXCR3-expressing memory CD4(+) T cells, although IFN-gamma production was found in both memory CD4(+) T cells with and without CCR5 expression. We observed that CCR4-expressing memory CD4(+) T cells in the blood were more increased in AD patients as compared with normal patients, whereas CXCR3-expressing memory CD4(+) T cells were present in a lower frequency in AD than seen in normal patients. These results suggest that CXCR3 and CCR4, but not CCR5 or CCR3, appear to serve as the useful markers for identification of circulating Th1 and Th2 effector populations.	Toyama Med & Pharmaceut Univ, Dept Pediat, Fac Med, Toyama 9300191, Japan; Toyama Med & Pharmaceut Univ, Dept Dermatol, Fac Med, Toyama 9300191, Japan; Univ Tokyo, Sch Med, Dept Mol Prevent Med, Tokyo 113, Japan	Adachi, Y (reprint author), Toyama Med & Pharmaceut Univ, Dept Pediat, Fac Med, 2630 Sugitani, Toyama 9300191, Japan.						Annunziato F, 1999, J LEUKOCYTE BIOL, V65, P691; Luster AD, 1998, NEW ENGL J MED, V338, P436; Rajka G, 1989, Acta Derm Venereol Suppl (Stockh), V144, P13; Bernardini G, 1998, EUR J IMMUNOL, V28, P582, DOI 10.1002/(SICI)1521-4141(199802)28:02<582::AID-IMMU582>3.0.CO;2-A; Sallusto F, 1998, IMMUNOL TODAY, V19, P568, DOI 10.1016/S0167-5699(98)01346-2; Mosmann TR, 1996, IMMUNOL TODAY, V17, P138, DOI 10.1016/0167-5699(96)80606-2; MIYAWAKI T, 1990, J EXP MED, V171, P1833, DOI 10.1084/jem.171.5.1833; Qin SX, 1998, J CLIN INVEST, V101, P746, DOI 10.1172/JCI1422; Sallusto F, 1997, SCIENCE, V277, P2005, DOI 10.1126/science.277.5334.2005; Campbell JJ, 1999, NATURE, V400, P776, DOI 10.1038/23495; Loetscher P, 1998, NATURE, V391, P344, DOI 10.1038/34814; Zingoni A, 1998, J IMMUNOL, V161, P547; Banchereau J, 1998, NATURE, V392, P245, DOI 10.1038/32588; Imai T, 1999, INT IMMUNOL, V11, P81, DOI 10.1093/intimm/11.1.81; Sallusto F, 1998, J EXP MED, V187, P875, DOI 10.1084/jem.187.6.875; Bonecchi R, 1998, J EXP MED, V187, P129, DOI 10.1084/jem.187.1.129; Holgate ST, 1999, NATURE, V402, pB2; Balashov KE, 1999, P NATL ACAD SCI USA, V96, P6873, DOI 10.1073/pnas.96.12.6873; KAGI MK, 1994, INT ARCH ALLERGY IMM, V103, P332; Kim CH, 1999, J LEUKOCYTE BIOL, V65, P6; Ochensberger B, 1999, EUR J IMMUNOL, V29, P11, DOI 10.1002/(SICI)1521-4141(199901)29:01<11::AID-IMMU11>3.0.CO;2-B; PICKER LJ, 1995, BLOOD, V86, P1408; Romagnani S, 1996, CLIN IMMUNOL IMMUNOP, V80, P225, DOI 10.1006/clin.1996.0118; Umetsu DT, 1997, J ALLERGY CLIN IMMUN, V100, P1	24	108	115	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0741-5400			J LEUKOCYTE BIOL	J. Leukoc. Biol.	OCT	2000	68	4					568	574				7	Cell Biology; Hematology; Immunology	Cell Biology; Hematology; Immunology	361MD	WOS:000089726100018		
J	Sugawara, Y; Shibata, N; Hara, S; Ikuhara, Y				Sugawara, Y; Shibata, N; Hara, S; Ikuhara, Y			Interface structure of face-centered-cubic-Ti thin film grown on 6H-SiC substrate	JOURNAL OF MATERIALS RESEARCH			English	Article							FCC TITANIUM; TERMINATION; MULTILAYERS; SURFACE	A titanium thin film was deposited on the flat (0001) face of a GH-SIC by electron beam evaporation at room temperature in a vacuum of 5.1 x 10(-8) Pa. The Ti film was epitaxially grown on the surface, and the interface between Ti and SiC was characterized by high-resolution electron microscopy. It was found that the structure of the deposited titanium is face-centered cubic (fcc), although bulk titanium metal usually has a hexagonal close-packed or body-centered cubic crystal structure. We believe that the unusual fee structure of Ti thin film is due to the high adhesion of the film to the substrate and the high degree of coherency between them. The orientation relationship of the fcc-Ti/6H-SiC interface was (111)(fcc-Ti)//(0001)(6H-SiC) and [(1) over bar 00](fcc-Ti)//[11 (2) over bar 0](6H-SiC). Preliminary calculations indicate that this orientation relationship maximizes the lattice coherency across the interface.	Japan Fine Ceram Ctr, Res & Dev Lab, Atsuta Ku, Nagoya, Aichi 4568587, Japan; Electrotech Lab, Div Sci Mat, Tsukuba, Ibaraki 3058568, Japan; Univ Tokyo, Inst Engn Res, Bunkyo Ku, Tokyo 1138656, Japan	Sugawara, Y (reprint author), Japan Fine Ceram Ctr, Res & Dev Lab, Atsuta Ku, 2-4-1 Mutsuno, Nagoya, Aichi 4568587, Japan.		Ikuhara, Yuichi/F-3066-2010; Ikuhara, Yuichi/N-1001-2015	Ikuhara, Yuichi/0000-0003-3886-005X			PORTER LM, 1995, J MATER RES, V10, P668, DOI 10.1557/JMR.1995.0668; Marcus PM, 1997, J PHYS-CONDENS MAT, V9, P6241, DOI 10.1088/0953-8984/9/29/009; SHECTMAN D, 1994, MATER LETT, V20, P329, DOI 10.1016/0167-577X(94)90039-6; HIGASHI GS, 1990, APPL PHYS LETT, V56, P656, DOI 10.1063/1.102728; Saleh AA, 1997, PHYS REV B, V56, P9841, DOI 10.1103/PhysRevB.56.9841; WATANABE S, 1991, JPN J APPL PHYS 1, V30, P3575, DOI 10.1143/JJAP.30.3575; CHEUNG NW, 1981, PHYS REV LETT, V46, P671, DOI 10.1103/PhysRevLett.46.671; FAN JF, 1988, JPN J APPL PHYS 2, V27, pL2125; Hara S, 1997, APPL SURF SCI, V117, P394, DOI 10.1016/S0169-4332(97)80113-4; HO PS, 1979, J VAC SCI TECHNOL, V16, P1120, DOI 10.1116/1.570171; Ikuhara Y, 1998, MICROSC RES TECHNIQ, V40, P206, DOI 10.1002/(SICI)1097-0029(19980201)40:3<206::AID-JEMT4>3.0.CO;2-S; Ikuhara Y, 1996, MATER SCI FORUM, V207-, P121; JOSELL D, 1995, MATER LETT, V22, P275, DOI 10.1016/0167-577X(94)00272-X; Monch W., 1995, SEMICONDUCTOR SURFAC; PIROUZ P, 1998, SOLID STATE PHENOM, V59, P51; Rhoderick E. H., 1988, METAL SEMICONDUCTOR; Ruhle M., 1990, METAL CERAMIC INTERF; SAVAGE DE, 1986, J VAC SCI TECHNOL B, V4, P943, DOI 10.1116/1.583496; Stemmer S, 1996, PHYS REV LETT, V77, P1797, DOI 10.1103/PhysRevLett.77.1797; SUGAWARA Y, UNPUB	20	18	18	MATERIALS RESEARCH SOCIETY	WARRENDALE	506 KEYSTONE DR, WARRENDALE, PA 15086 USA	0884-2914			J MATER RES	J. Mater. Res.	OCT	2000	15	10					2121	2124		10.1557/JMR.2000.0305		4	Materials Science, Multidisciplinary	Materials Science	360PM	WOS:000089676500012		
J	Nakagawa, S; Yoshikawa, H; Yasugi, T; Kimura, M; Kawana, K; Matsumoto, K; Yamada, M; Onda, T; Taketani, Y				Nakagawa, S; Yoshikawa, H; Yasugi, T; Kimura, M; Kawana, K; Matsumoto, K; Yamada, M; Onda, T; Taketani, Y			Ubiquitous presence of E6 and E7 transcripts in human papillomavirus - Positive cervical carcinomas regardless of its type	JOURNAL OF MEDICAL VIROLOGY			English	Article						HPV; RT-PCR; consensus primers; cervical neoplasia; E6/E7 transcripts	POLYMERASE CHAIN-REACTION; NUCLEOTIDE-SEQUENCE; MESSENGER-RNA; INTRAEPITHELIAL NEOPLASIA; PRECANCEROUS LESIONS; HUMAN KERATINOCYTES; GENE-PRODUCT; CANCER; PROTEIN; P53	The presence of human papillomavirus (HPV) DNA in almost all of the cervical carcinomas is one of the most compelling evidence for the viral carcinogenesis. HPVs are thought to induce cervical carcinoma most likely through the expression of E6 and E7 genes presumably by inactivating the tumor suppressor proteins, p53 and pRb, respectively. Thus far, the presence of HPV E6 and E7 transcripts have been identified only in cervical carcinoma-derived cell lines harboring type 16 or 18, and in a limited number of cervical neoplasia specimens positive for type 16, 18, 33 or 51. To see whether the expression of E6 and E7 genes is an essential finding in HPV-positive cervical carcinoma and cervical intraepithelial neoplasia (CIN), we constructed a reverse transcription-polymerase chain reaction (RT-PCR) assay using a pair of consensus primers in the E6 and E7 regions. Using the assay, E6 transcripts (full-length E6/E7 transcripts) and E7 transcripts (spliced E6/E7 transcripts, E6* mRNA) were identified in 97% (30/31) and 100% (all 31) of cervical carcinomas and in 100% (all 23) and 74% (17/23) of CINs, respectively. This assay also revealed unknown splice donor and acceptor sites of E6* mRNA of less frequent HPV types 31, 35, 52, 56, 58 and 59 based on sequence analyses of the PCR products. Thus, the present study demonstrates that E6 and E7 transcripts of HPV exist in virtually all HPV-positive cervical neoplasia specimens except for the absence of E7 transcripts in some of CINs. (C) 2000 Wiley-Liss, Inc.	Univ Tokyo, Fac Med, Dept Obstet & Gynecol, Bunkyo Ku, Tokyo 113, Japan	Nakagawa, S (reprint author), Univ Texas, Inst Mol & Cellular Biol, 2500 Speedway, Austin, TX 78712 USA.						Pim D, 1999, ONCOGENE, V18, P7403, DOI 10.1038/sj.onc.1203134; YOSHIKAWA H, 1991, JPN J CANCER RES, V82, P524; DYSON N, 1989, SCIENCE, V243, P934, DOI 10.1126/science.2537532; MUNGER K, 1992, CANCER SURV, V12, P197; NAKAGAWA S, 1995, VIROLOGY, V212, P535, DOI 10.1006/viro.1995.1511; SMOTKIN D, 1986, P NATL ACAD SCI USA, V83, P4680, DOI 10.1073/pnas.83.13.4680; BOSCH FX, 1995, J NATL CANCER I, V87, P796, DOI 10.1093/jnci/87.11.796; MUNGER K, 1989, EMBO J, V8, P4099; SHERMAN L, 1992, INT J CANCER, V50, P356, DOI 10.1002/ijc.2910500305; NEVINS JR, 1992, SCIENCE, V258, P424; HUIBREGTSE JM, 1991, EMBO J, V10, P4129; BARBOSA MS, 1988, VIROLOGY, V165, P134, DOI 10.1016/0042-6822(88)90666-6; COLE ST, 1986, J VIROL, V58, P991; CZEGLEDY J, 1994, INT J CANCER, V56, P182, DOI 10.1002/ijc.2910560206; CZEGLEDY J, 1995, INT J CANCER, V64, P211, DOI 10.1002/ijc.2910640312; FUJINAGA Y, 1991, J GEN VIROL, V72, P1039, DOI 10.1099/0022-1317-72-5-1039; GOLDSBOROUGH MD, 1989, VIROLOGY, V171, P306, DOI 10.1016/0042-6822(89)90545-X; HSU EM, 1993, INT J CANCER, V55, P397, DOI 10.1002/ijc.2910550311; LEHN H, 1985, P NATL ACAD SCI USA, V82, P5540, DOI 10.1073/pnas.82.16.5540; LUNGU O, 1991, J VIROL, V65, P4216; MUNGER K, 1989, J VIROL, V63, P4417; Nagano H, 1996, J Obstet Gynaecol Res, V22, P1; Nakagawa S, 1996, CANCER, V78, P1935, DOI 10.1002/(SICI)1097-0142(19961101)78:9<1935::AID-CNCR14>3.0.CO;2-Z; RHO J, 1994, VIROLOGY, V203, P158, DOI 10.1006/viro.1994.1467; SCHEFFNER M, 1990, CELL, V63, P1129, DOI 10.1016/0092-8674(90)90409-8; Selinka HC, 1998, LAB INVEST, V78, P9; SHIRASAWA H, 1988, J VIROL, V62, P1022; SMOTKIN D, 1989, J VIROL, V63, P1441; SNIJDERS PJF, 1992, J VIROL, V66, P3172; Sotlar K, 1998, GYNECOL ONCOL, V69, P114, DOI 10.1006/gyno.1998.4994; YOSHIKAWA H, 1990, INT J CANCER, V45, P990, DOI 10.1002/ijc.2910450537	31	39	40	WILEY-LISS	NEW YORK	DIV JOHN WILEY & SONS INC, 605 THIRD AVE, NEW YORK, NY 10158-0012 USA	0146-6615			J MED VIROL	J. Med. Virol.	OCT	2000	62	2					251	256		10.1002/1096-9071(200010)62:2<251::AID-JMV18>3.0.CO;2-V		6	Virology	Virology	350RL	WOS:000089114900018		
J	Kuriki, S; Takemura, A				Kuriki, S; Takemura, A			Shrinkage estimation towards a closed convex set with a smooth boundary	JOURNAL OF MULTIVARIATE ANALYSIS			English	Article						James-Stein estimator; second fundamental form; Weyl's tube formula; generalized curvature measure; cone of nonnegative definite matrices	MINIMAX ESTIMATORS; MULTIVARIATE	We give James-Stein type estimators of a multivariate normal mean vector by shrinkage towards a closed convex set K with a smooth or piecewise smooth boundary. The rate of shrinkage is determined by the curvature of the boundary of K at the projection point onto K. By considering a sequence of polytopes K-j converging to K, we show that a particular estimator we propose is the limit of a sequence of shrinkage estimators towards K-j given by M. E. Beck (1982). In fact our estimators reduce to the James-Stein estimator and to the Beck estimator when K is a point and a convex polyhedron, respectively. Therefore they can be considered as natural extensions of these estimators. Furthermore we apply the same method to the problem of improving the restricted mle by shrinkage towards the origin in the multivariate normal mean model where the mean vector is restricted to a closed convex cone with a smooth or piecewise smooth boundary. We demonstrate our estimators in two settings, one shrinking to a ball and the other shrinking to the cone of nonnegative definite matrices. (C) 2000 Academic Press.	Inst Stat Math, Minato Ku, Tokyo 106, Japan; Univ Tokyo, Tokyo, Japan	Kuriki, S (reprint author), Inst Stat Math, Minato Ku, Tokyo 106, Japan.						BARANCHI.AJ, 1970, ANN MATH STAT, V41, P642, DOI 10.1214/aoms/1177697104; Barlow R.E., 1972, STAT INFERENCE ORDER; Bergstrom H., 1982, WEAK CONVERGENCE MEA; BOCK ME, 1985, J MULTIVARIATE ANAL, V17, P127, DOI 10.1016/0047-259X(85)90075-2; BOCK ME, 1982, STAT DECISION THEORY, V1, P169; CHANG YT, 1981, KEIO SCI TECH REP, V34, P83; James W., 1961, 4TH P BERK S MATH ST, V1, P361; JUDGE GG, 1984, J ECONOMETRICS, V25, P165, DOI 10.1016/0304-4076(84)90044-7; Kubokawa T., 1998, APPL STAT SCI, VIII, P143; KUBOKAWA T, 1994, ANN STAT, V22, P290, DOI 10.1214/aos/1176325369; KURIKI S, 1993, ANN STAT, V21, P1379, DOI 10.1214/aos/1176349263; Kuriki S, 2000, ANN I STAT MATH, V52, P1, DOI 10.1023/A:1004191713375; NAIMAN DQ, 1990, ANN STAT, V18, P685, DOI 10.1214/aos/1176347621; Robert C. P., 1994, BAYESIAN CHOICE DECI; Robertson T., 1988, ORDER RESTRICTED STA; RUKHIN AL, 1995, INT STAT REV, V63, P95, DOI 10.2307/1403779; SCHNEIDER R, 1993, CONVEX BODIES BRUNNM; SENGUPTA D, 1991, SANKHYA SER A, V53, P389; SHAPIRO A, 1988, INT STAT REV, V56, P49, DOI 10.2307/1403361; SHEENA Y, 1995, J JAPAN STAT SOC, V25, P35; STEIN CM, 1981, ANN STAT, V9, P1135, DOI 10.1214/aos/1176345632; Takemura A, 1997, ANN STAT, V25, P2368; Webster R., 1994, CONVEXITY; Weyl H, 1939, AM J MATH, V61, P461, DOI 10.2307/2371513	24	9	9	ACADEMIC PRESS INC	SAN DIEGO	525 B ST, STE 1900, SAN DIEGO, CA 92101-4495 USA	0047-259X			J MULTIVARIATE ANAL	J. Multivar. Anal.	OCT	2000	75	1					79	111		10.1006/jmva.1999.1895		33	Statistics & Probability	Mathematics	367ZD	WOS:000090091900006		
J	Tsutsumi, K; Ueki, K; Morita, A; Kirino, T				Tsutsumi, K; Ueki, K; Morita, A; Kirino, T			Risk of rupture from incidental cerebral aneurysms	JOURNAL OF NEUROSURGERY			English	Article						cerebral aneurysm; subarachnoid hemorrhage	UNRUPTURED INTRACRANIAL ANEURYSMS; INTRA-CRANICAL ANEURYSMS; SACCULAR ANEURYSMS; NATURAL-HISTORY; CAROTID-ARTERY; MANAGEMENT; COMMUNITY	Object. Controversy still exists about the risk estimation for rupture of untreated saccular aneurysms presenting for causes other than subarachnoid hemorrhage (SAH). The object of this study was to address this issue. Methods. Between January 1976 and December 1997 in the Aizu Chuou Hospital, 62 patients underwent observation for more than 6 months for saccular, nonthrombotic, noncalcified unruptured aneurysms at locations not related to the cavernous sinus, which were detected in cerebral angiography studies performed for causes other than SAH. Clinical follow-up data in those 62 patients were reviewed to identify the risk of SAH. All patients were followed until July 1998, with the observation period ranging from 6 months to 17 years (mean 4.3 years). Seven patients (11.3%) developed SAH confirmed on computerized tomography (CT) scanning at a mean interval of 4.8 years, six of whom died and one of whom recovered with a major deficit. In addition, one patient died of the mass effect of the aneurysm, and another after sudden onset of headache and vomiting. The 5- and 10-year cumulative risks of CT-confirmed SAH calculated by the Kaplan-Meier method were 7.5% and 22.1%, respectively, for total cases, 33.5% and 55.9%, respectively, for large (> 10 mm) aneurysms, and 4.5% and 13.9%, respectively, for small (< 10 mm) aneurysms. Conclusions. Although based on a relatively small, single-institution series, our data indicated that the risk of rupture from incidental, intradural, saccular aneurysms was higher than previously reported, and may support preventive surgical treatment of incidental aneurysms, considering the fatality rate of SAH.	Aizu Chuo Hosp, Dept Neurosurg, Fukushima 965, Japan; Tokyo Univ Hosp, Dept Neurosurg, Tokyo 113, Japan	Tsutsumi, K (reprint author), Aizu Chuo Hosp, Dept Neurosurg, Tsuruga 1-1,Aizuwakamatsu, Fukushima 965, Japan.						WIRTH FP, 1983, NEUROSURGERY, V12, P507; JUVELA S, 1993, J NEUROSURG, V79, P174, DOI 10.3171/jns.1993.79.2.0174; HEISKANEN O, 1981, J NEUROSURG, V55, P524, DOI 10.3171/jns.1981.55.4.0524; WIEBERS DO, 1987, J NEUROSURG, V66, P23, DOI 10.3171/jns.1987.66.1.0023; KING JT, 1994, J NEUROSURG, V81, P837, DOI 10.3171/jns.1994.81.6.0837; Yasui N, 1997, NEUROSURGERY, V40, P1155, DOI 10.1097/00006123-199706000-00007; KUPERSMITH MJ, 1992, J NEUROSURG, V77, P690, DOI 10.3171/jns.1992.77.5.0690; WIEBERS DO, 1981, NEW ENGL J MED, V304, P696, DOI 10.1056/NEJM198103193041203; Iwamoto H, 1999, STROKE, V30, P1390; INAGAWA T, 1991, SURG NEUROL, V36, P99, DOI 10.1016/0090-3019(91)90225-X; SOLOMON RA, 1994, J NEUROSURG, V80, P440, DOI 10.3171/jns.1994.80.3.0440; ARTMANN H, 1984, SURG NEUROL, V21, P391, DOI 10.1016/0090-3019(84)90120-4; Ausman JI, 1999, SURG NEUROL, V51, P227; Berenstein A, 1999, NEW ENGL J MED, V340, P1439; CHANG HS, 1995, J NEUROSURG, V83, P413, DOI 10.3171/jns.1995.83.3.0413; Connolly ES, 1999, NEW ENGL J MED, V340, P1440; Wiebers D, 1998, NEW ENGL J MED, V339, P1725; KIYOHARA Y, 1989, STROKE, V20, P1150; LOCKSLEY HB, 1966, J NEUROSURG, V25, P321, DOI 10.3171/jns.1966.25.3.0321; Piepgras D G, 1989, Clin Neurosurg, V35, P511; Solomon RA, 1999, SURG NEUROL, V51, P361; Yoshimoto T, 1997, SURG NEUROL, V47, P522, DOI 10.1016/S0090-3019(96)00400-4	22	86	92	AMER ASSOC NEUROLOGICAL SURGEONS	CHARLOTTESVILLE	UNIV VIRGINIA, 1224 WEST MAIN ST, STE 450, CHARLOTTESVILLE, VA 22903 USA	0022-3085			J NEUROSURG	J. Neurosurg.	OCT	2000	93	4					550	553		10.3171/jns.2000.93.4.0550		4	Clinical Neurology; Surgery	Neurosciences & Neurology; Surgery	357BH	WOS:000089478300003		
J	Huang, J; Tsuchiya, B; Konashi, K; Yamawaki, M				Huang, J; Tsuchiya, B; Konashi, K; Yamawaki, M			Estimation of hydrogen redistribution in zirconium hydride under temperature gradient	JOURNAL OF NUCLEAR SCIENCE AND TECHNOLOGY			English	Article						hydrogen; zirconium hydrides; zirconium alloys; diffusion; kinetics; temperature gradients; radiation effects; temperature dependence		To evaluate irradiation behavior of delta -ZrHx+U fuel, thermal migration of hydrogen under temperature gradient has been estimated according to traditional diffusion theory. Hydrogen profiles at steady state and diffusion kinetics in single-phase delta -ZrHx have been calculated for a cylinder specimen. When a temperature gradient is imposed on the initial uniform ZrH1.6 hydride, considerable thermal migration from the higher temperature center region to the pellet surface can be expected. Larger temperature gradient and lower temperature will cause greater inclination of the hydrogen distribution. The hydrogen transportation process in single-phase delta -ZrHx as a function of time was simulated by a finite difference method. In the case of two-phase delta -ZrHx+45 wt%U, the uranium phase tends to slow down the thermal migration rate of hydrogen by about 50% compared with that in single phase delta -ZrHx though it may have little influence on the final hydrogen distribution in the delta -ZrHx matrix. For the cylinder specimen under the temperature conditions of interest, the steady state would be reached at an early stage of the typical irradiation cycle. Finally, the engineering impact due to the redistribution was discussed.	Tohoku Univ, Inst Mat Res, Oarai, Ibaraki 3111313, Japan; Univ Tokyo, Grad Sch Engn, Dept Quantum Engn & Syst Sci, Bunkyo Ku, Tokyo 1138656, Japan	Huang, J (reprint author), Tohoku Univ, Inst Mat Res, Narita Cho, Oarai, Ibaraki 3111313, Japan.		konashi, kenji/P-6215-2014				MAJER G, 1994, J PHYS-CONDENS MAT, V6, P2935, DOI 10.1088/0953-8984/6/15/015; DAVIES NF, 1970, AIAEC12963; GULBRANSEN EA, 1954, J ELECTROCHEM SOC, V101, P565; Kazarnikov VV, 1997, INT J HYDROGEN ENERG, V22, P169, DOI 10.1016/S0360-3199(96)00150-4; Mallett M.W., 1958, T ASM, V50, P981; Massalski T.B., 1990, BINARY ALLOY PHASE D, P2078; MERTEN U, 1963, J NUCL MATER, V10, P201, DOI 10.1016/0022-3115(63)90055-2; Olander D.R., 1976, TID26711P1; Paetz V., 1971, Z METALLKD, V62, P657; SIMNAD MT, 1981, NUCL ENG DES, V64, P403, DOI 10.1016/0029-5493(81)90135-7; SIMNAD MT, 1976, NUCL TECHNOL, V28, P31; SOMMER A, 1960, NAASR5066; SUGISAKI M, 1988, FUSION TECHNOL, V14, P723; WEST GB, 1986, GAA18641	14	12	12	ATOMIC ENERGY SOC JAPAN	TOKYO	1-1-13 SHIMBASHI MINATO-KU, TOKYO, 105, JAPAN	0022-3131			J NUCL SCI TECHNOL	J. Nucl. Sci. Technol.	OCT	2000	37	10					887	892				6	Nuclear Science & Technology	Nuclear Science & Technology	381KE	WOS:000165761300007		
J	Wada, Y; Watanabe, A; Tachibana, M; Uetake, N; Uchida, S; Ishigure, K				Wada, Y; Watanabe, A; Tachibana, M; Uetake, N; Uchida, S; Ishigure, K			Effects of hydrogen peroxide on intergranular stress corrosion cracking of stainless steel in nigh temperature water, (III) - Crack growth rates in corrosive environment determined by hydrogen peroxide	JOURNAL OF NUCLEAR SCIENCE AND TECHNOLOGY			English	Article						intergranular stress corrosion cracking; hydrogen water chemistry; hydrogen peroxide; crack growth rate; crack propagation; stainless steels; electrochemical corrosion potential; corrosion current	SYSTEMS	The stress corrosion cracking (SCC) of structural materials used in boiling water reactors has been studied at relatively low hydrogen peroxide (H2O2) concentrations, around 10 ppb, which was assumed to be representative of the corrosion environment formed in hydrogen water chemistry (HWC). The 1/4T compact tension specimen was used for measurement of crack growth rates (CGRs) of sensitized type 304 stainless steel in high temperature and high purity water. Crack length was monitored by a reversing direct current potential drop method. Since H2O2 is easily decomposed thermally, a polytetrafluoroethylene-lined autoclave was used to minimize its decomposition on the autoclave surface. The CGR in the H2O2 environment differed from that in the O-2 environment even though the electrochemical corrosion potential (ECP) for both conditions was the same. The data implied that the ECP could not be used as a common environmental deterministic parameter for SCC behavior at higher potentials for different oxidant conditions. The corrosion current density was found to play an important role as an environmental index for SCC, which was given as just the current density at the ECP at a specific oxidant concentration. The CGRs were found to be written as CGR = (3.8+/-0.6)x10(-3)i(cor)+(1.5+/-1.6)x10(-8)mm/s using the calculated corrosion current density i(cor) below 10(-4) A.cm(-2).	Hitachi Ltd, Power & Ind Syst R&D Lab, Hitachi, Ibaraki 3191221, Japan; Univ Tokyo, Grad Sch Engn, Dept Quantum Engn & Syst Sci, Bunkyo Ku, Tokyo 1130033, Japan	Wada, Y (reprint author), Hitachi Ltd, Power & Ind Syst R&D Lab, Omika Cho, Hitachi, Ibaraki 3191221, Japan.						ANDRESEN PL, 1988, MAT SCI ENG A-STRUCT, V103, P167, DOI 10.1016/0025-5416(88)90564-2; PARKINS RN, 1980, CORROS SCI, V20, P147, DOI 10.1016/0010-938X(80)90128-6; Kim YJ, 1999, CORROSION, V55, P81; ANZAI H, 1994, CORROS SCI, V36, P1201, DOI 10.1016/0010-938X(94)90144-9; HISHIDA M, 1985, CORROSION, V41, P570; HOLSER RA, 1990, CORROSION, V46, P764; HONDA T, 1988, BOSHOKU GIJUTSU, V37, P278; IBE E, 1985, NUCL SCI ENG, V89, P330; Kikuchi E, 1997, CORROSION, V53, P306; KIM YJ, 1996, P INT S ENV DEGR MAT, V2, P699; KIM YJ, 1998, P INT S ENV DEGR MAT, P641; KINO, ELECTROCHEMICAL OXYG, P92; MACDONALD DD, 1992, P 5 INT S ENV DEGR M, P935; Newman J. S., 1991, ELECTROCHEMICAL SYST; PARKER AF, 1979, J PEDIATR SURG, V14, P5; PRATER TA, 1981, P 2 INT C ENV DEGR E, P59; SAKAI M, 1992, P 12 INT CORR C CO B, V5, P4060; Uchida S, 1998, J NUCL SCI TECHNOL, V35, P301, DOI 10.3327/jnst.35.301; Uchida S, 2000, J NUCL SCI TECHNOL, V37, P257; WADA Y, UNPUB J NUCL SCI TEC; WADA Y, 1997, P PLANT AG LIF PRED, P749	21	22	22	ATOMIC ENERGY SOC JAPAN	TOKYO	1-1-13 SHIMBASHI MINATO-KU, TOKYO, 105, JAPAN	0022-3131			J NUCL SCI TECHNOL	J. Nucl. Sci. Technol.	OCT	2000	37	10					901	912				12	Nuclear Science & Technology	Nuclear Science & Technology	381KE	WOS:000165761300009		
J	Ernst, I; Fletcher, A; Hayward, C				Ernst, I; Fletcher, A; Hayward, C			Gyrodactylus anguillae (Monogenea : Gyrodactylidae) from anguillid eels (Anguilla australis and Anguilla reinhardtii) in Australia: A native or an exotic?	JOURNAL OF PARASITOLOGY			English	Article							FRESH-WATER EELS; PSEUDODACTYLOGYRUS-ANGUILLAE; EVOLUTION; COMMUNITIES	A species of Gyrodactylus collected from 2 species of anguillid eels (Anguilla australis Richardson, 1841 and Anguilla reinhardtii Steindachner, 1867) from Australia is identified as Gyrodactylus anguillae Ergens, 1960. The morphology of sclerites of G. anguillae specimens from Australia is in accordance with previous descriptions of specimens collected from A. anguilla (Linnaeus, 1758) from Europe and A. anguilla imported into Japan. Gyrodactylus anguillae was previously thought to be a parasite specific to A. anguilla, an eel that is native to freshwater catchments throughout Europe. Information on eel translocations and host and parasite biology is reviewed and it is hypothesized that G. anguillae is a naturally occurring parasite in Australia and not an introduction.	Univ Queensland, Dept Microbiol & Parasitol, Brisbane, Qld 4072, Australia; Rockhampton Mail Ctr, Queensland Dept Primary Ind, Rockhampton, Qld 4702, Australia; Univ Tokyo, Grad Sch Agr, Dept Aquat Biosci, Lab Fish Dis,Bunkyo Ku, Tokyo 1138657, Japan	Ernst, I (reprint author), Univ Queensland, Dept Microbiol & Parasitol, Brisbane, Qld 4072, Australia.						ALLEN GR, 1989, FRESWHATER FISHES AU; NIE P, 1991, J FISH BIOL, V39, P897, DOI 10.1111/j.1095-8649.1991.tb04419.x; MALMBERG G, 1970, ARK ZOOL, V23, P1; CONE DK, 1995, J FISH BIOL, V47, P177, DOI 10.1006/jfbi.1995.0124; Skorikova B, 1996, FOLIA PARASIT, V43, P155; MARCOGLIESE DJ, 1993, EVOLUTION, V47, P1632, DOI 10.2307/2410175; Aoyama J, 1997, NATURWISSENSCHAFTEN, V84, P17, DOI 10.1007/s001140050340; Crane J.S., 1980, Proceedings of the Annual Meeting of the World Mariculture Society, V11, P275; Ergens R., 1960, Ceskoslovenska Parasitologie, V7, P49; ERNST I, 1999, THESIS U QUEENSLAND; Kennedy CR, 1997, J HELMINTHOL, V71, P35; Kennedy CR, 1998, FOLIA PARASIT, V45, P77; KENNEDY CR, 1995, PARASITOLOGY, V111, P233; MCCOSKER JE, 1989, CALIF FISH GAME, V75, P4; OGAWA K, 1980, Fish Pathology, V15, P95; OGAWA K, 1986, FISH PATHOL, V21, P89; OGAWA K, 1978, B JPN SOC SCI FISH, V44, P613; Orecchia P., 1987, Parassitologia (Rome), V29, P37; ROFF JC, 1986, CAN J FISH AQUAT SCI, V43, P2044; Tsukamoto K, 1998, ENVIRON BIOL FISH, V52, P139, DOI 10.1023/A:1007427724175; Usui A., 1991, EEL CULTURE	21	8	8	AMER SOC PARASITOLOGISTS	LAWRENCE	810 EAST 10TH STREET, LAWRENCE, KS 66044 USA	0022-3395			J PARASITOL	J. Parasitol.	OCT	2000	86	5					1152	1156		10.1645/0022-3395(2000)086[1152:GAMGFA]2.0.CO;2		5	Parasitology	Parasitology	365NQ	WOS:000089957700048		
J	Kobayashi, Y; Miyaji, C; Watanabe, H; Umezu, H; Hasegawa, G; Abo, T; Arakawa, M; Kamata, N; Suzuki, H; Kodama, T; Naito, M				Kobayashi, Y; Miyaji, C; Watanabe, H; Umezu, H; Hasegawa, G; Abo, T; Arakawa, M; Kamata, N; Suzuki, H; Kodama, T; Naito, M			Role of macrophage scavenger receptor in endotoxin shock	JOURNAL OF PATHOLOGY			English	Article						scavenger receptor; knockout mice; endotoxin shock; Kupffer cells; cytokines; neutrophils	LOW-DENSITY-LIPOPROTEIN; INTERCELLULAR-ADHESION MOLECULE-1; KUPFFER CELLS; INFLAMMATORY PROTEIN-2; EXPRESSION CLONING; LIGAND-BINDING; LINEAGE CELLS; HOST-DEFENSE; SR-BI; LIPOPOLYSACCHARIDE	Lipopolysaccharide (LPS) is known to bind to several receptors on macrophages, including CD14 and macrophage scavenger receptor class A types I and II (MSR-A), and stimulates macrophages to release various inflammatory mediators. MSR-A recognizes a broad range of polyanionic ligands such as chemically modified lipoproteins, LPS of Gram-negative bacteria, and lipoteichoic acid of Gram-positive bacteria, suggesting a role in host defence, In this study, mice lacking MSR-A were used to elucidate the role of MSR-A in endotoxin shock. Peritoneal macrophages from MSR-A-deficient (MSR-A(-/-)) mice bound less remarkably to LPS than those from wild-type (MSR-A(+/+)) mice and the binding activity of MSR-A(+/+) macrophages to LPS was reduced by the addition of an anti-MSR-A antibody. Clearance of LPS in serum was retarded in MSR-A(-/-) mice after intraperitoneal administration of LPS, LPS-induced expression of cytokines in the liver was similar in MSR-A(+/+) and MSR-A(-/-) mice, but levels of interleukin (IL)-1 beta expression and serum IL-1 beta were lower in MSR-A(-/-) mice, Administration of large doses of LPS resulted in a higher mortality of MSR-A(+/+) mice and pretreatment with an IL-1 receptor antagonist reduced the mortality. Thus, MSR-A-mediated macrophage activation plays a negative role in protecting mice from endotoxin shock by enhancing IL-1 beta production by macrophages, Copyright (C) 2000 John Wiley & Sons, Ltd.	Niigata Univ, Sch Med, Dept Pathol 2, Niigata 9518510, Japan; Niigata Univ, Sch Med, Dept Med 2, Niigata 9518510, Japan; Niigata Univ, Sch Med, Dept Immunol, Niigata 9518510, Japan; Chugai Pharmaceut Co Ltd, Shizuoka 412, Japan; Univ Tokyo, Adv Sci & Technol Res Ctr, Dept Mol Biol & Med, Tokyo 1538904, Japan	Naito, M (reprint author), Niigata Univ, Sch Med, Dept Pathol 2, Asahimachi Dori 1, Niigata 9518510, Japan.						ELOMAA O, 1995, CELL, V80, P603, DOI 10.1016/0092-8674(95)90514-6; Bautista AP, 1997, HEPATOLOGY, V25, P335, DOI 10.1002/hep.510250214; MATSUMOTO A, 1990, P NATL ACAD SCI USA, V87, P9133, DOI 10.1073/pnas.87.23.9133; BOZIC CR, 1994, J BIOL CHEM, V269, P29355; RAMPRASAD MP, 1995, P NATL ACAD SCI USA, V92, P9580, DOI 10.1073/pnas.92.21.9580; Acton S, 1996, SCIENCE, V271, P518, DOI 10.1126/science.271.5248.518; RAETZ CRH, 1990, ANNU REV BIOCHEM, V59, P129, DOI 10.1146/annurev.biochem.59.1.129; ROHRER L, 1990, NATURE, V343, P570, DOI 10.1038/343570a0; Suzuki H, 1997, NATURE, V386, P292, DOI 10.1038/386292a0; Haziot A, 1996, IMMUNITY, V4, P407, DOI 10.1016/S1074-7613(00)80254-X; FERRERO E, 1993, P NATL ACAD SCI USA, V90, P2380, DOI 10.1073/pnas.90.6.2380; ACTON SL, 1994, J BIOL CHEM, V269, P21003; Sweet MJ, 1996, J LEUKOCYTE BIOL, V60, P8; Yamamoto T, 1996, AM J PATHOL, V149, P1271; Landschulz KT, 1996, J CLIN INVEST, V98, P984, DOI 10.1172/JCI118883; MATSUURA K, 1994, J EXP MED, V179, P1671, DOI 10.1084/jem.179.5.1671; KODAMA T, 1990, NATURE, V343, P531, DOI 10.1038/343531a0; WRIGHT SD, 1990, SCIENCE, V249, P1431, DOI 10.1126/science.1698311; PEARSON A, 1995, P NATL ACAD SCI USA, V92, P4056, DOI 10.1073/pnas.92.9.4056; HOLNESS CL, 1993, J BIOL CHEM, V268, P9661; FREEMAN M, 1990, P NATL ACAD SCI USA, V87, P8810, DOI 10.1073/pnas.87.22.8810; Ebe Y, 1999, PATHOL INT, V49, P519, DOI 10.1046/j.1440-1827.1999.00910.x; ASHKENAS J, 1993, J LIPID RES, V34, P983; DUNNE DW, 1994, P NATL ACAD SCI USA, V91, P1863, DOI 10.1073/pnas.91.5.1863; ENDEMANN G, 1993, J BIOL CHEM, V268, P11811; HAMPTON RY, 1991, NATURE, V352, P342, DOI 10.1038/352342a0; Haworth R, 1997, J EXP MED, V186, P1431, DOI 10.1084/jem.186.9.1431; HUGHES DA, 1995, EUR J IMMUNOL, V25, P466, DOI 10.1002/eji.1830250224; ISOBE Y, 1977, ACTA HISTOCHEM CYTOC, V10, P161; Ito S, 1999, ARCH HISTOL CYTOL, V62, P83, DOI 10.1679/aohc.62.83; Jaeschke H, 1996, SHOCK, V6, P351, DOI 10.1097/00024382-199611000-00009; MALONEY WC, 1960, J HISTOCHEM CYTOCHEM, V8, P200; Mato M, 1996, P NATL ACAD SCI USA, V93, P3269, DOI 10.1073/pnas.93.8.3269; NAITO M, 1991, AM J PATHOL, V139, P1411; Nogami S, 1998, AM J TROP MED HYG, V59, P843; SHIRATORI Y, 1993, HEPATOLOGY, V18, P1477, DOI 10.1016/0270-9139(93)90241-E; STANTON LW, 1992, J BIOL CHEM, V267, P22446; vanderLaan LJW, 1997, IMMUNOL LETT, V57, P203, DOI 10.1016/S0165-2478(97)00077-1; Wang JB, 1996, J LEUKOCYTE BIOL, V60, P372	39	48	49	JOHN WILEY & SONS LTD	W SUSSEX	BAFFINS LANE CHICHESTER, W SUSSEX PO19 1UD, ENGLAND	0022-3417			J PATHOL	J. Pathol.	OCT	2000	192	2					263	272				10	Oncology; Pathology	Oncology; Pathology	360ZA	WOS:000089696200018		
J	Nomura, K; Tokumistu, K; Hayakawa, T; Homonnay, Z				Nomura, K; Tokumistu, K; Hayakawa, T; Homonnay, Z			The influence of mechanical treatment on the absorption of CO2 by perovskite oxides	JOURNAL OF RADIOANALYTICAL AND NUCLEAR CHEMISTRY			English	Article; Proceedings Paper	International Conference on Mossbauer Spectroscopy of Sophisticated Oxides held at the Eotvos Workshops in Science 99	SEP 05-09, 1999	EOTVOS UNIV, BUDAPEST, HUNGARY		EOTVOS UNIV		MOSSBAUER	Perovskite oxides of composition (Sr1-xCax)(Fe0.5Co0.5)O3-delta were investigated for CO2 absorption properties and were proved to be useful as materials for CO2 absorption in the temperature range from 550 to 850 degreesC. The absorption rate of CO2 increased with Ca doping. The mechanical treatment of perovskite oxides for several minutes, especially for the oxides containing a small amount of Ca, was found to be effective for activating the oxides for CO2 absorption and for reducing the starting temperature of CO2 absorption by about 80 degreesC. However, it was not less effective to treat the oxides for a long time. The site distortion due to Sr and Ca ions at site A and the mixed valence states at site B were confirmed to be effective for CO2 absorption at high temperatures. During the absorption of CO2, a spinel compound was formed according to the following reaction: 2(Sr,Ca)(Fe,Co)O-2.5 + CO2 --> (Sr,Ca)CO3 + (Sr,Ca)(Fe,Co)(2)O-4.	Univ Tokyo, Grad Sch Engn, Bunkyo Ku, Tokyo 1138656, Japan; Tsukuba Res Ctr, Natl Inst Mat & Chem Res, Tsukuba, Ibaraki 305, Japan; Eotvos Lorand Univ, Dept Nucl Chem, H-1518 Budapest, Hungary	Nomura, K (reprint author), Univ Tokyo, Grad Sch Engn, Bunkyo Ku, Hongo 7-3-1, Tokyo 1138656, Japan.			Nomura, Kiyoshi/0000-0003-0625-1778			Nomura K, 1996, APPL CATAL A-GEN, V137, P25, DOI 10.1016/0926-860X(95)00317-7; GIBB TC, 1985, J CHEM SOC DALTON, P1455, DOI 10.1039/dt9850001455; JUHASZ G, UNPUB J SOLID STATE; MEADOWCR.DB, 1970, NATURE, V226, P847, DOI 10.1038/226847a0; Nomura K, 1998, HYPERFINE INTERACT, V112, P7, DOI 10.1023/A:1011003719888; Nomura K, 1997, CZECH J PHYS, V47, P517, DOI 10.1023/A:1021251221571; Nomura K, 1996, J RADIOAN NUCL CH AR, V202, P103, DOI 10.1007/BF02037942; NOMURA K, 1993, APPL CATAL A-GEN, V101, P63, DOI 10.1016/0926-860X(93)80138-G; TERAOKA Y, 1988, CHEM LETT, P503, DOI 10.1246/cl.1988.503	9	21	22	SPRINGER	DORDRECHT	VAN GODEWIJCKSTRAAT 30, 3311 GZ DORDRECHT, NETHERLANDS	0236-5731			J RADIOANAL NUCL CH	J. Radioanal. Nucl. Chem.	OCT	2000	246	1					69	77		10.1023/A:1006772812518		9	Chemistry, Analytical; Chemistry, Inorganic & Nuclear; Nuclear Science & Technology	Chemistry; Nuclear Science & Technology	366YV	WOS:000090034600012		
J	Kuno, A; Santos, RA; Matsuo, M; Takano, B				Kuno, A; Santos, RA; Matsuo, M; Takano, B			Characterization of natural chromite samples from ophiolite complexes in the Philippines by Fe-57 Mossbauer spectroscopy	JOURNAL OF RADIOANALYTICAL AND NUCLEAR CHEMISTRY			English	Article; Proceedings Paper	International Conference on Mossbauer Spectroscopy of Sophisticated Oxides held at the Eotvos Workkshops in Science 99	SEP 05-09, 1999	EOTVOS UNIV, BUDAPEST, HUNGARY		EOTVOS UNIV		MANTLE XENOLITHS; OXIDATION-STATE; SPINELS; SPECTRA	Mossbauer spectroscopy was applied to natural chromite samples from ophiolite complexes in the Philippines. Chemical and structural characterization of the chromite samples was also carried out using X-ray absorption fine structure (XAFS), X-ray diffraction (XRD) and X-ray fluorescence spectrometry (XRF). The Mossbauer spectra of the samples consisted of quadrupole doublets ascribable to Fe3+ in octahedral site, Fe3+ in tetrahedral site, and Fe2+ in tetrahedral site. The relative percentage of Fe3+ and Fe2+ ions suggested that these Philippine samples were formed under relatively high oxygen fugacity.	Univ Tokyo, Grad Sch Arts & Sci, Meguro Ku, Tokyo 1538902, Japan	Kuno, A (reprint author), Univ Tokyo, Grad Sch Arts & Sci, Meguro Ku, 3-8-1 Komaba, Tokyo 1538902, Japan.		Matsuo, M/A-2515-2013				OSBORNE MD, 1981, CONTRIB MINERAL PETR, V77, P251, DOI 10.1007/BF00373539; WOOD BJ, 1989, GEOCHIM COSMOCHIM AC, V53, P1277; HERZBERG CT, 1978, GEOCHIM COSMOCHIM AC, V42, P945, DOI 10.1016/0016-7037(78)90284-3; ARCULUS RJ, 1984, CONTRIB MINERAL PETR, V85, P85, DOI 10.1007/BF00380225; ROBBINS M, 1971, J PHYS CHEM SOLIDS, V32, P717, DOI 10.1016/S0022-3697(71)80412-2; Brandon AD, 1996, SCIENCE, V272, P861, DOI 10.1126/science.272.5263.861; ARCULUS RJ, 1981, GEOCHIM COSMOCHIM AC, V45, P899, DOI 10.1016/0016-7037(81)90118-6; BANCROFT GM, 1983, SOLID STATE COMMUN, V47, P623, DOI 10.1016/0038-1098(83)90764-0; BANCROFT GM, 1967, PHYS LETT A, VA 26, P17, DOI 10.1016/0375-9601(67)90534-8; CANIL D, 1990, CONTRIB MINERAL PETR, V104, P453, DOI 10.1007/BF01575622; CHEN YL, 1992, PHYS CHEM MINER, V19, P255; CHEN YL, 1992, HYPERFINE INTERACT, V70, P1029, DOI 10.1007/BF02397504; Das D, 1996, B MATER SCI, V19, P1095, DOI 10.1007/BF02744643; DYAR MD, 1989, AM MINERAL, V74, P969; FATSEAS GA, 1976, J PHYS, V37, P787, DOI 10.1051/jphyscol:19766166; Figueiras J, 1997, MINERAL MAG, V61, P627, DOI 10.1180/minmag.1997.061.408.02; Irvine T.N., 1965, CAN J EARTH SCI, V2, P648, DOI DOI 10.1139/E65-046; Kubo K., 1996, J GEOL SOC JPN, V102, P40; LODYA JA, 1994, HYPERFINE INTERACT, V93, P1789, DOI 10.1007/BF02072947; MCGUIRE AV, 1991, CONTRIB MINERAL PETR, V109, P252, DOI 10.1007/BF00306483; MITRA S, 1991, MINERAL MAG, V55, P535, DOI 10.1180/minmag.1991.055.381.06; NELL J, 1994, HYPERFINE INTERACT, V84, P427, DOI 10.1007/BF02060692; Nell J, 1998, HYPERFINE INTERACT, V111, P309, DOI 10.1023/A:1012686608151; NOMURA M, 1991, XRAY ABSORPTION FINE, P667; OSBORNE MD, 1984, J SOLID STATE CHEM, V53, P174, DOI 10.1016/0022-4596(84)90092-6; Rais A., 1997, MINERAL MAG, V61, P726, DOI 10.1180/minmag.1997.061.408.14; SANTOS RA, 1999, 9 ANN VM GOLDSCHM C; SUAREZ N, 1990, HYPERFINE INTERACT, V57, P2295, DOI 10.1007/BF02405803; Tominaga T., 1984, Nuclear Science Applications, Section B, V1	29	8	8	KLUWER ACADEMIC PUBL	DORDRECHT	SPUIBOULEVARD 50, PO BOX 17, 3300 AA DORDRECHT, NETHERLANDS	0236-5731			J RADIOANAL NUCL CH	J. Radioanal. Nucl. Chem.	OCT	2000	246	1					79	83		10.1023/A:1006724913427		5	Chemistry, Analytical; Chemistry, Inorganic & Nuclear; Nuclear Science & Technology	Chemistry; Nuclear Science & Technology	366YV	WOS:000090034600013		
J	Nakata, H; Fujihara, M; Suenaga, Y; Nagasawa, T; Fujii, T				Nakata, H; Fujihara, M; Suenaga, Y; Nagasawa, T; Fujii, T			Effect of wind blows on the transport and settlement of brown sole (Pleuronectes herzensteini) larvae in a shelf region of the Sea of Japan: numerical experiments with an Euler-Lagrangian model	JOURNAL OF SEA RESEARCH			English	Article; Proceedings Paper	4th International Symposium on Flatfish Ecology	OCT 18-23, 1999	ATLANTIC BEACH, NORTH CAROLINA	Netherlands Inst Sea Res, Marine Fisheries, N Carolina Div, N Carolina Sea Grant, N Carolina State Univ		egg and larval transport; Pleuronectes herzensteini; wind-induced drift; numerical simulation	NORTH-SEA; CLASS STRENGTH; INTERANNUAL VARIABILITY; PLATESSA L; FISH EGGS; ADVECTION	The transportation of eggs and larvae of brown sole in a shelf region of the Sea of Japan was explored using a 3D Euler-Lagrangian model, with special interest in the affect of wind blows on the larval retention. The general pattern of egg and larval transport from the spawning ground to the nursery was well reproduced under a constant westerly wind (4 m s(-1)), by assuming vertical movement of the eggs and larvae (upward in the earlier phase and downward in the later phase of the drift period). Using this model, the effect of westerly wind speed on egg and larval retention in the shelf was evaluated, and it was shown that when the wind speed exceeded a critical value (>5 m s(-1)), the retention rate could be rapidly reduced. An exploratory simulation of the effect of a one-day westerly blow with a speed of 15 m s(-1) on the retention further indicated that the westerly blow induced strong offshore drift of the shelf water at the subsurface, and that it could markedly reduce the retention rate in the earlier phase of the drift period when eggs stay in the lower layer, and in the final phase when larvae stay near the bottom before settlement. The numbers of juveniles which successfully settled on the nursery in the study area showed a significant negative correlation with the frequency of strong westerlies in April. This suggests that wind blows could seriously reduce the retention of the larvae just before settlement, providing field evidence to support the model results. Recent declines in the fishery catch can therefore be partly explained by recruitment failure due to the increase in the frequency of strong westerly blows. (C) 2000 Elsevier Science B.V. All rights reserved.	Univ Tokyo, Ocean Res Inst, Tokyo 164, Japan; Ehime Univ, Fac Agr, Matsuyama, Ehime 790, Japan; Kagawa Univ, Fac Engn, Miki, Kagawa, Japan; Japan Sea Natl Fisheries Res Inst, Niigata, Japan	Nakata, H (reprint author), Nagasaki Univ, Fac Fisheries, 1-14 Bunkyo Machi, Nagasaki 8528521, Japan.						CHECKLEY DM, 1988, NATURE, V335, P346, DOI 10.1038/335346a0; NELSON WR, 1977, FISH B-NOAA, V75, P23; Van der Veer HW, 1998, J SEA RES, V39, P29, DOI 10.1016/S1385-1101(97)00008-7; LOUGH RG, 1994, ICES MAR SC, V198, P356; RIJNSDORP AD, 1985, T AM FISH SOC, V114, P461, DOI 10.1577/1548-8659(1985)114<461:STTONS>2.0.CO;2; NORCROSS BL, 1984, T AM FISH SOC, V113, P153, DOI 10.1577/1548-8659(1984)113<153:OAETOF>2.0.CO;2; BARTSCH J, 1989, NATURE, V340, P632, DOI 10.1038/340632a0; PIHL L, 1990, HYDROBIOLOGIA, V195, P79, DOI 10.1007/BF00026815; van der Veer HW, 1999, MAR ECOL PROG SER, V184, P245, DOI 10.3354/meps184245; Nielsen E, 1998, J SEA RES, V39, P11, DOI 10.1016/S1385-1101(97)00014-2; VANDERVEER HW, 1986, MAR ECOL PROG SER, V29, P223, DOI 10.3354/meps029223; BAILEY KM, 1981, MAR ECOL PROG SER, V6, P1, DOI 10.3354/meps006001; BERGMAN MJN, 1989, P REUN CONS PERM INT, V191, P43; DEYOUNG B, 1994, ICES MAR SC, V198, P346; FUJIHARA M, 1998, FISH ENG, V35, P93; FUJIHARA M, 1997, FISHERIES ENG, V34, P147; Kasai A., 1992, Fisheries Oceanography, V1, P1, DOI 10.1111/j.1365-2419.1992.tb00020.x; MINAMI T, 1981, B JPN SOC SCI FISH, V47, P1411; NAKATA H, 1988, NIPPON SUISAN GAKK, V54, P1553; NAKATA H, 1988, NIPPON SUISAN GAKK, V54, P1545; NAKATA H, 2000, IN PRESS B TOHOKU NA, V62; Nakata H, 1996, SURVIVAL STRATEGIES IN EARLY LIFE STAGES OF MARINE RESOURCES, P227; Stabeno P. J., 1995, Canadian Special Publication of Fisheries and Aquatic Sciences, V121, P719; SUENAGA Y, 1996, FISHERIES ENG, V32, P219; Werner Francisco E., 1993, Fisheries Oceanography, V2, P43, DOI 10.1111/j.1365-2419.1993.tb00120.x; Werner FE, 1997, J SEA RES, V37, P195, DOI 10.1016/S1385-1101(97)00024-5; YANAGI T, 1980, J OCEANOGR SOC JPN, V36, P246, DOI 10.1007/BF02072125; YODER JA, 1983, ESTUAR COAST SHELF S, V17, P637, DOI 10.1016/0272-7714(83)90031-8	28	16	17	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	1385-1101			J SEA RES	J. Sea Res.	OCT	2000	44	1-2					91	100		10.1016/S1385-1101(00)00042-3		10	Marine & Freshwater Biology; Oceanography	Marine & Freshwater Biology; Oceanography	395TZ	WOS:000166598500009		
J	Nakayama, T; Shimizu, J; Kimura, K				Nakayama, T; Shimizu, J; Kimura, K			Thermoelectric properties of metal-doped beta-rhombohedral boron	JOURNAL OF SOLID STATE CHEMISTRY			English	Article; Proceedings Paper	13th International Symposium on Boron, Borides, and related Compounds (ISBB 99)	SEP 05-10, 1999	DINARD, FRANCE			beta-rhombohedral boron; metal doping; electrical conductivity; Seebeck coefficient; site occupancy; hopping conduction; power factor; figure-of-merit; covalent-metallic bonding conversion; electron-phonon interaction	ICOSAHEDRAL CLUSTERS	beta -Rhombohedral boron (beta -rh, boron) was doped with V, Cr, Fe, Co, or Zr to investigate the relationship between occupancies of the doping sites and thermoelectric properties. Doping with V or Cr, which preferentially occupy the A(1) sites, produces an increase in electrical conductivity and a negative Seebeck coefficient, while doping with Fe or Co, which occupy the A(1) and D sites equally, also increases the electrical conductivity though the Seebeck coefficient remains positive, Doping with Zr, which does not occupy the A(1) sites, slightly increases the electrical conductivity with a resultant larger Seebeck coefficient. Regarding Co- and Zr-doubly doped p-type beta -rh, boron, both properties are determined mainly by Co content. The observed temperature dependence of the electrical conductivity of metal-doped beta -boron clearly indicates variable range hopping conduction such that both properties increase with increasing temperature up to room temperature, in contrast to the behavior of ordinary metals and semiconductors. The power factors of Go-doped p-type beta -rh, boron and V- or Cr-doped n-type beta -rh, boron increased with increasing temperature, and doping with about 1 at.% metal atoms produced materials whose power factor at room temperature is three to four orders of magnitude larger than that of pure beta -rh. boron, Finally, 1 at.% Co doping decreased the thermal conductivity of beta -rh, boron from 16 to about 4-2 W/m.K, with the maximum ZT of p-type Co1.0B105 being subsequently estimated as 1.0 x 10(-6) at room temperature, (C) 2000 Academic Press.	Univ Tokyo, Dept Mat Sci, Bunkyo Ku, Tokyo 1138656, Japan; Univ Tokyo, Dept Adv Mat Sci, Bunkyo Ku, Tokyo 1138656, Japan	Nakayama, T (reprint author), Angstrom Technol Partnership, Joint Res Ctr Atom Technol, Tsukuba, Ibaraki, Japan.						Andersson S., 1970, J SOLID STATE CHEM, V2, P603, DOI 10.1016/0022-4596(70)90057-5; OVERHOF H, 1975, PHYS STATUS SOLIDI B, V67, P709, DOI 10.1002/pssb.2220670234; Terasaki I, 1997, PHYS REV B, V56, P12685; MATSUDA H, 1995, PHYS REV B, V52, P6102, DOI 10.1103/PhysRevB.52.6102; WOOD C, 1984, PHYS REV B, V29, P4582, DOI 10.1103/PhysRevB.29.4582; Fujimori M, 1999, PHYS REV LETT, V82, P4452, DOI 10.1103/PhysRevLett.82.4452; MOTT NF, 1969, PHILOS MAG, V19, P835, DOI 10.1080/14786436908216338; BRENIG W, 1973, Z PHYS, V258, P381, DOI 10.1007/BF01391502; CALLMER B, 1976, J SOLID STATE CHEM, V17, P165, DOI 10.1016/0022-4596(76)90217-6; CALLMER B, 1978, J SOLID STATE CHEM, V26, P275, DOI 10.1016/0022-4596(78)90162-7; DAROLLES JM, 1980, PHYS STATUS SOLIDI A, V58, pK71, DOI 10.1002/pssa.2210580158; EMIN D, 1969, ANN PHYS-NEW YORK, V53, P439, DOI 10.1016/0003-4916(69)90034-7; FRANZ R, 1991, AIP CONF PROC, V231, P29; FUJIMORI M, 1998, MATERIA JAPAN, V37, P606; Fujimori M, 1997, J SOLID STATE CHEM, V133, P310, DOI 10.1006/jssc.1997.7492; GAUBAUSKAS MF, 1986, J SOLID STATE CHEM, V63, P424; GEIST D, 1970, ACTA CRYSTALL B-STRU, VB 26, P1800, DOI 10.1107/S0567740870004910; GOLDSMID HJ, 1986, ELECT REFRIGERATION, P12; GOLIKOVA OA, 1974, PHYS STATUS SOLIDI A, V21, P405, DOI 10.1002/pssa.2210210202; Ioffe A. F., 1956, SEMICONDUCTOR THERMO; Izumi F, 1993, RIETVELD METHOD; KIMURA K, 1998, QUASICRYSTALS, P595; KOBAYASHI M, 1995, J ALLOY COMPD, V221, P120, DOI 10.1016/0925-8388(94)01438-8; Lundstrom T., 1985, AIP C P, V140, P19; MATSUDA H, 1997, HYOMEN KAGAKU, V18, P156; Matsuda H, 1996, J PHYS CHEM SOLIDS, V57, P1167, DOI 10.1016/0022-3697(95)00417-3; Nagai H, 1998, MATER T JIM, V39, P515; PISTOURLET B, 1967, P INT SOL EL C, P887; ROWE DM, 1983, MODERN THERMOELECTRI, P15; Slack G. A., 1987, P 9 INT S BOR BOR RE, P132; Terauchi M, 1997, J SOLID STATE CHEM, V133, P152, DOI 10.1006/jssc.1997.7335; TERKES PRH, 1985, AIP C P, V140, P346	32	34	34	ACADEMIC PRESS INC	SAN DIEGO	525 B ST, STE 1900, SAN DIEGO, CA 92101-4495 USA	0022-4596			J SOLID STATE CHEM	J. Solid State Chem.	OCT	2000	154	1					13	19		10.1006/jssc.2000.8804		7	Chemistry, Inorganic & Nuclear; Chemistry, Physical	Chemistry	371UM	WOS:000165197700005		
J	Takeda, M; Ichimura, M; Yamaguchi, H; Sakairi, Y; Kimura, K				Takeda, M; Ichimura, M; Yamaguchi, H; Sakairi, Y; Kimura, K			Preparation of boron-silicon thin film by pulsed laser deposition and its properties	JOURNAL OF SOLID STATE CHEMISTRY			English	Article; Proceedings Paper	13th International Symposium on Boron, Borides, and related Compounds (ISBB 99)	SEP 05-10, 1999	DINARD, FRANCE			pulsed laser deposition; amorphous film; band gap; electrical conductivity	BETA-RHOMBOHEDRAL BORON	Boron-silicon amorphous films were prepared by pulsed laser deposition technique, Band gap was estimated from the optical absorption spectrum for the films, and it increased with increasing silicon concentration. The values and concentration dependence of the band gap are nearly the same as those measured for amorphous B-Si prepared by electron beam evaporation. Electrical (dc) conductivity of the films was two or three orders of magnitude larger than that of amorphous boron, and its temperature dependence reveals variable-range-hopping-type behavior (Mott's low). Concentration dependence of the de conductivity is similar to that of metal-doped beta -rhombohedral boron, (C) 2000 Academic Press.	Nagaoka Univ Technol, Dept Mech Engn, Nagaoka, Niigata 9402188, Japan; Univ Tokyo, Dept Mat Sci, Tokyo 1138656, Japan	Takeda, M (reprint author), Nagaoka Univ Technol, Dept Mech Engn, Nagaoka, Niigata 9402188, Japan.						MIZUSHIMA I, 1993, APPL PHYS LETT, V63, P373, DOI 10.1063/1.110047; MATSUDA H, 1995, PHYS REV B, V52, P6102, DOI 10.1103/PhysRevB.52.6102; AUCIELLO O, 1994, HDB CRYSTAL GROWTH A, V3, pCH9; BEREZIN AA, 1974, J NON-CRYST SOLIDS, V16, P237, DOI 10.1016/0022-3093(74)90127-6; Chen LD, 1996, MATER T JIM, V37, P1182; FRANZ R, 1991, AIP CONF PROC, V231, P29; HORI A, 1994, J PHYS SOC JPN, V64, P3496; LUNDSTROM T, 1994, JJAP SERIES, V10, P1; Matsuda H, 1996, J PHYS CHEM SOLIDS, V57, P1167, DOI 10.1016/0022-3697(95)00417-3; Morosin B, 1986, AIP C P, V86, P70; Mott N.F., 1979, ELECT PROCESSES NONC; Takeda M, 1997, J SOLID STATE CHEM, V133, P201, DOI 10.1006/jssc.1997.7428; VLASSE M, 1986, J SOLID STATE CHEM, V63, P31, DOI 10.1016/0022-4596(86)90149-0; YAMAGUCHI H, 1999, T MAT RES SOC JPN, V24, P85	14	2	2	ACADEMIC PRESS INC	SAN DIEGO	525 B ST, STE 1900, SAN DIEGO, CA 92101-4495 USA	0022-4596			J SOLID STATE CHEM	J. Solid State Chem.	OCT	2000	154	1					141	144		10.1006/jssc.2000.8824		4	Chemistry, Inorganic & Nuclear; Chemistry, Physical	Chemistry	371UM	WOS:000165197700025		
J	Nogi, N; Noda, T; Tanaka, S				Nogi, N; Noda, T; Tanaka, S			Phonon properties of isotopically modified beta-rhombohedral boron	JOURNAL OF SOLID STATE CHEMISTRY			English	Article; Proceedings Paper	13th International Symposium on Boron, Borides, and related Compounds (ISBB 99)	SEP 05-10, 1999	DINARD, FRANCE					We examined optical phonon and thermal transport properties of beta -rhombohedral boron single crystals with different isotopic compositions (93.2% B-10 enriched, 99.0% B-11 enriched, and natural isotopic composition (19.8% B-10 + 80,2% B-11)), which were prepared by a floating zone method. The infrared-reflectance spectra of isotopically enriched B-10, B-11, and natural B-(beta -rhombohedral B) single crystals have been measured at room temperature. For the frequency of B-10, B-11, and natural B, both modes of IR-active A(2u) and E-u symmetry changed in frequency according to the inverse square root of mass number of B, The force constant was found to be slightly anisotropic for the intra-icosahedral vibrational modes between 650 and 1100 cm(-1). Also, the force constant for the A(2u) mode at about 1250 cm(-1) was comparable with the value based on the valence force model for boron carbide B13C2, indicating similar bond strength between pristine B and C-incorporated B, Thermal conductivity of the isotope-modified beta -rhombohedral boron crystals was examined by a steady heat flow method. Temperature range of the measurement was between 5 and 130 K, At 41 K, the thermal conductivity of B-10-enriched crystal was about 570 W/m(.)K, This is the largest value of beta -rhombohedral structure and 40% larger than that of natural beta -rhombohedral B crystal. The result of this thermal measurement indicated that the isotope enrichment made heat flow large because of decrease in the phonon scattering factor, (C) 2000 Academic Press.	Univ Tokyo, Dept Quantum Engn & Syst Sci, Bunkyo Ku, Tokyo 1138656, Japan; Natl Res Inst Met, Tsukuba, Ibaraki 3050047, Japan	Nogi, N (reprint author), Univ Tokyo, Dept Quantum Engn & Syst Sci, Bunkyo Ku, 7-3-1 Hongo, Tokyo 1138656, Japan.						GEBALLE TH, 1958, PHYS REV, V110, P773, DOI 10.1103/PhysRev.110.773; SLACK GA, 1971, PHYS REV B, V4, P1714, DOI 10.1103/PhysRevB.4.1714; CALLAWAY J, 1959, PHYS REV, V113, P1046, DOI 10.1103/PhysRev.113.1046; BINNENBRUCK H, 1979, Z NATURFORSCH A, V34, P787; BINNENBRUCK H, 1976, J LESS-COMMON MET, V47, P91, DOI 10.1016/0022-5088(76)90080-1; CALLMER B, 1977, ACTA CRYSTALLOGR B, V33, P1951, DOI 10.1107/S0567740877007389; FUCHS HD, 1992, PHYS REV B, V45, P4065, DOI 10.1103/PhysRevB.45.4065; HALLER EE, 1995, J APPL PHYS, V77, P2857, DOI 10.1063/1.358700; KLEMENS PG, 1955, P PHYS SOC LOND A, V68, P1113, DOI 10.1088/0370-1298/68/12/303; NOGI N, 1998, J SURF ANAL, V4, P280; SHIRAI K, 1997, J SOLID STATE CHEM, V113, P93; SHIRAI K, 1997, J SOLID STATE CHEM, V113, P217; WERHEIT H, 1991, 10 INT S BOR BOR REL	13	8	8	ACADEMIC PRESS INC	SAN DIEGO	525 B ST, STE 1900, SAN DIEGO, CA 92101-4495 USA	0022-4596			J SOLID STATE CHEM	J. Solid State Chem.	OCT	2000	154	1					296	300		10.1006/jssc.2000.8852		5	Chemistry, Inorganic & Nuclear; Chemistry, Physical	Chemistry	371UM	WOS:000165197700053		
J	Sakairi, Y; Takeda, M; Matsuda, H; Kimura, K; Edagawa, K				Sakairi, Y; Takeda, M; Matsuda, H; Kimura, K; Edagawa, K			Modulated photocurrent measurements on pure and V-doped beta-rhombohedral boron	JOURNAL OF SOLID STATE CHEMISTRY			English	Article; Proceedings Paper	13th International Symposium on Boron, Borides, and related Compounds (ISBB 99)	SEP 05-10, 1999	DINARD, FRANCE			modulated photocurrent; beta-rhombohedral boron; V-B alloys; metal-insulator transition; density of gap states	ICOSAHEDRAL CLUSTER SOLIDS; QUASI-CRYSTALS; RICH SOLIDS	The modulated photocurrent method has been applied to pure and vanadium (V)-doped beta -rhombohedral boron (beta -B) with the goal of investigating the difference in the distribution of electronic states in the band gap between them, Excitation light intensity dependence of the amplitude and phase shift of photocurrent shows that V-doped beta -B has a much larger trapping states density for photoexcited carriers than pure beta -B, With increasing temperature, the amplitude increases and decreases for pure and V-doped beta -B, respectively, indicating that the conduction mechanism for photoexcited carrier is completely different between the two samples. The unusual negative temperature dependence for V-doped beta -B is similar to that for Al-Pd-Re quasicrystal and the change of dependence from positive to negative is consistent with the approach to aluminum-based icosahedral quasicrystals in atomic structure and in transport properties by V-doping to beta -B, The modulated frequency dependence of the amplitude and phase shift cannot be explained by the usual photoconduction processes, which are indicating that the gap states distribution and photoconduction processes in these materials are complicated. (C) 2000 Academic Press.	Univ Tokyo, Inst Ind Sci, Tokyo 1538505, Japan; Univ Tokyo, Dept Mat Sci, Tokyo 1138656, Japan; Nagaoka Univ Technol, Dept Mech Engn, Nagaoka, Niigata 9402188, Japan; Univ Tokyo, Dept Adv Mat Sci, Tokyo 1130033, Japan	Sakairi, Y (reprint author), Univ Tokyo, Inst Ind Sci, 4-6-1 Komaba, Tokyo 1538505, Japan.						FRANZ R, 1989, EUROPHYS LETT, V9, P145, DOI 10.1209/0295-5075/9/2/009; Kimura K, 1997, J SOLID STATE CHEM, V133, P302, DOI 10.1006/jssc.1997.7491; Matsuda H, 1996, J PHYS CHEM SOLIDS, V57, P1167, DOI 10.1016/0022-3697(95)00417-3; OHEDA H, 1981, J APPL PHYS, V52, P1981; Sakairi Y, 1999, MATER RES SOC SYMP P, V553, P385; Sakairi Y, 1997, J SOLID STATE CHEM, V133, P195, DOI 10.1006/jssc.1997.7426; Takeda M, 1997, J SOLID STATE CHEM, V133, P224, DOI 10.1006/jssc.1997.7446; WERHEIT H, 1993, PHYS STATUS SOLIDI B, V176, P415, DOI 10.1002/pssb.2221760215; WERHEIT H, 1993, SOLID STATE COMMUN, V88, P421, DOI 10.1016/0038-1098(93)90605-M	9	2	2	ACADEMIC PRESS INC	SAN DIEGO	525 B ST, STE 1900, SAN DIEGO, CA 92101-4495 USA	0022-4596			J SOLID STATE CHEM	J. Solid State Chem.	OCT	2000	154	1					307	311		10.1006/jssc.2000.8854		5	Chemistry, Inorganic & Nuclear; Chemistry, Physical	Chemistry	371UM	WOS:000165197700055		
